PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bai, J; Yeh, SY; Qiu, XF; Hu, LY; Zeng, J; Cai, YK; Zuo, L; Li, GH; Yang, GS; Chang, C				Bai, Jian; Yeh, Shuyuan; Qiu, Xiaofu; Hu, Linyi; Zeng, Jun; Cai, Yangke; Zuo, Li; Li, Gonghui; Yang, Guosheng; Chang, Chawnshang			TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals	ONCOGENE			English	Article							PROSTATE-CANCER CELLS; ORPHAN RECEPTORS; GENE-EXPRESSION; VIMENTIN; INVASION; PROLIFERATION; TUMORIGENESIS; SUPERFAMILY; GROWTH; LUNG	While TR4 nuclear receptor plays key roles to promote prostate cancer progression, its roles to alter the progression of clear cell renal cell carcinoma (ccRCC), remains unclear. Here, we demonstrate that TR4 can promote the ccRCC cell vasculogenic mimicry (VM) formation and its associated metastasis via modulating the miR490-3p/vimentin (VIM) signals. Mechanism dissection revealed that TR4 might increase the oncogene VIM expression via decreasing the miR-490-3p expression through direct binding to the TR4-response-elements (TR4REs) on the promoter region of miR-490-3p, which might then directly target the 3' UTR of VIM-mRNA to increase its protein expression. Preclinical studies using the in vivo mouse model with xenografted RCC Caki-1 cells into the sub-renal capsule of nude mice also found that TR4 could promote the ccRCC VM and its associated metastasis via modulating the miR490-3p/VIM signals. Together, results from preclinical studies using multiple RCC cell lines and the in vivo mouse model all conclude that TR4 may play a key role to promote ccRCC VM formation and metastasis and targeting the newly identified TR4/miR-490-3p/VIM signals with small molecules may help us to develop a new therapeutic approach to better suppress the ccRCC metastasis.	[Bai, Jian; Qiu, Xiaofu; Zeng, Jun; Cai, Yangke; Zuo, Li; Yang, Guosheng] Guangdong Second Prov Gen Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Bai, Jian; Yeh, Shuyuan; Qiu, Xiaofu; Hu, Linyi; Li, Gonghui; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Bai, Jian; Yeh, Shuyuan; Qiu, Xiaofu; Hu, Linyi; Li, Gonghui; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Bai, Jian; Yeh, Shuyuan; Qiu, Xiaofu; Hu, Linyi; Li, Gonghui; Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA; [Zuo, Li] Nanjing Med Univ, Peoples Affiliated Hosp 2, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Chang, Chawnshang] China Med Univ & Hosp, Sex Hormone Res Ctr, Taichung 404, Taiwan	University of Rochester; University of Rochester; University of Rochester; Nanjing Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Yang, GS (corresponding author), Guangdong Second Prov Gen Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China.; Chang, C (corresponding author), Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.; Chang, C (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.; Chang, C (corresponding author), Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA.; Chang, C (corresponding author), China Med Univ & Hosp, Sex Hormone Res Ctr, Taichung 404, Taiwan.	2008yangguosheng@sina.com; chang@urmc.rochester.edu		Chang, Chawnshang/0000-0001-8510-3516	NIH [CA155477, CA156700]; George Whipple Professorship Endowment; Taiwan Department of Health Clinical Trial, Research Center of Excellence [DOH99-TD-B-111-004]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Whipple Professorship Endowment; Taiwan Department of Health Clinical Trial, Research Center of Excellence	This work was supported by NIH grants (CA155477 and CA156700), George Whipple Professorship Endowment and Taiwan Department of Health Clinical Trial, Research Center of Excellence (DOH99-TD-B-111-004 to China Medical University, Taichung, Taiwan). We thank Karen Wolf for help preparing the manuscript.	Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CHANG CS, 1994, P NATL ACAD SCI USA, V91, P6040, DOI 10.1073/pnas.91.13.6040; Chen K, 2016, BIOL CELL, V108, P41, DOI 10.1111/boc.201500033; Chen S, 2015, CANCER LETT, V362, P122, DOI 10.1016/j.canlet.2015.03.029; Chen XY, 2014, CLIN CANCER RES, V20, P2617, DOI 10.1158/1078-0432.CCR-13-3224; Chen YT, 2007, BRAIN RES, V1168, P72, DOI 10.1016/j.brainres.2007.06.069; Choi H, 2011, FEBS LETT, V585, P2763, DOI 10.1016/j.febslet.2011.08.002; Ciamporcero E, 2015, MOL CANCER THER, V14, P101, DOI 10.1158/1535-7163.MCT-14-0094; Collins LL, 2004, P NATL ACAD SCI USA, V101, P15058, DOI 10.1073/pnas.0405700101; Comperat E, 2012, Diagn Interv Imaging, V93, P221, DOI 10.1016/j.diii.2012.01.015; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Ding XF, 2015, INT J CANCER, V136, P955, DOI 10.1002/ijc.29049; Fuyuhiro Y, 2010, ANTICANCER RES, V30, P5239; Gilles C, 2003, CANCER RES, V63, P2658; Gu HH, 2014, BIOCHEM BIOPH RES CO, V444, P104, DOI 10.1016/j.bbrc.2014.01.020; HIROSE T, 1994, MOL ENDOCRINOL, V8, P1667, DOI 10.1210/me.8.12.1667; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lee YF, 2002, J STEROID BIOCHEM, V81, P291, DOI 10.1016/S0960-0760(02)00118-8; Li M, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-109; Lin SJ, 2014, CARCINOGENESIS, V35, P1399, DOI 10.1093/carcin/bgu052; Lin SJ, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-43; Liu QQ, 2016, J CELL MOL MED, V20, P1761, DOI 10.1111/jcmm.12851; Liu W, 2015, FEBS LETT, V589, P3148, DOI 10.1016/j.febslet.2015.08.034; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Mu XM, 2004, MOL CELL BIOL, V24, P5887, DOI 10.1128/MCB.24.13.5887-5899.2004; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Qiao LL, 2015, J CELL MOL MED, V19, P315, DOI 10.1111/jcmm.12496; Qiu XF, 2015, ONCOTARGET, V6, P15397, DOI 10.18632/oncotarget.3778; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Shen J, 2015, CANCER RES, V75, P754, DOI 10.1158/0008-5472.CAN-14-1301; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song QC, 2014, CANCER RES, V74, P3031, DOI 10.1158/0008-5472.CAN-13-2193; Stadler WM, 2005, CANCER-AM CANCER SOC, V104, P2323, DOI 10.1002/cncr.21453; Trog D, 2008, AMINO ACIDS, V34, P539, DOI 10.1007/s00726-007-0007-4; UPTON MP, 1986, AM J SURG PATHOL, V10, P560, DOI 10.1097/00000478-198608000-00006; Yamasaki T, 2013, J UROLOGY, V190, P1059, DOI 10.1016/j.juro.2013.02.089; Yang DR, 2013, J BIOL CHEM, V288, P16476, DOI 10.1074/jbc.M112.448142; Zhang LY, 2013, J BIOL CHEM, V288, P4035, DOI 10.1074/jbc.M112.410506; Zhao Y, 2008, CELL BIOCHEM FUNCT, V26, P571, DOI 10.1002/cbf.1478; Zhou L, 2016, J UROLOGY, V196, P335, DOI 10.1016/j.juro.2016.02.2971; Zhu J, 2015, MOL CANCER THER, V14, P1445, DOI 10.1158/1535-7163.MCT-14-0971; Zoni E, 2015, CANCER RES, V75, P2326, DOI 10.1158/0008-5472.CAN-14-2155	46	28	28	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 1	2018	37	44					5901	5912		10.1038/s41388-018-0269-1	http://dx.doi.org/10.1038/s41388-018-0269-1			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GY9EX	29973687				2022-12-26	WOS:000448943100007
J	Deng, SJ; Chen, HY; Ye, Z; Deng, SC; Zhu, S; Zeng, Z; He, C; Liu, ML; Huang, K; Zhong, JX; Xu, FY; Li, Q; Liu, Y; Wang, CY; Zhao, G				Deng, Shi-jiang; Chen, Heng-yu; Ye, Zeng; Deng, Shi-chang; Zhu, Shuai; Zeng, Zhu; He, Chi; Liu, Ming-liang; Huang, Kang; Zhong, Jian-xin; Xu, Feng-yu; Li, Qiang; Liu, Yang; Wang, Chun-you; Zhao, Gang			Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LONG NONCODING RNAS; CELLS; PROLIFERATION; HIF-1-ALPHA; INVASION; YB-1; CONTRIBUTES; EXPRESSION; MIGRATION	The contribution of long noncoding RNAs (lncRNAs) to pancreatic cancer progression and the regulatory mechanisms of their expression are attractive areas. In the present study, the overexpression of lncRNA-BX111887 (BX111) in pancreatic cancer tissues was detected by microarray and further validated in a cohort of pancreatic cancer tissues. We further demonstrated that knockdown or overexpression of BX111 dramatically repressed or enhanced proliferation and invasion of pancreatic cancer cells. Mechanically, BX111 activated transcription of ZEB1, a key regulator for epithelia-mesenchymal transition (EMT), via recruiting transcriptional factor Y-box protein (YB1) to its promoter region. Moreover, we revealed that BX111 transcription was induced by hypoxia-inducible factor (HIF-1 alpha) in response to hypoxia. In addition, BX111 contributed to the hypoxia- induced EMT of pancreatic cells by regulating expression of ZEB1 and its downstream proteins E-cadherin and MMP2. Coincidence with in vitro results, BX111 depletion effectively inhibited growth and metastasis of xenograft tumor in vivo. The clinical samples of pancreatic cancer further confirmed a positive association between BX111 and ZEB1. Moreover, high BX111 expression was correlated with late TNM stage, lymphatic invasion and distant metastasis, as well as short overall survival time in patients. Taken together, our findings implicate a hypoxia- induced lncRNA contributes to metastasis and progression of pancreatic cancer, and suggest BX111 might be applied as a potential biomarker and therapeutic target for pancreatic cancer.	[Deng, Shi-jiang; Chen, Heng-yu; Ye, Zeng; Deng, Shi-chang; Zhu, Shuai; Zeng, Zhu; He, Chi; Liu, Ming-liang; Huang, Kang; Zhong, Jian-xin; Xu, Feng-yu; Li, Qiang; Liu, Yang; Wang, Chun-you; Zhao, Gang] Huazhong Univ Sci & Technol, Union Hosp, Dept Pancreat Surg, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China	Huazhong University of Science & Technology	Zhao, G (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Pancreat Surg, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China.	gangzhao@hust.edu.cn	fuliyun_new, fuliyun_new/AAZ-4437-2020	Huang, Kang/0000-0003-1169-598X	National Science Foundation Committee (NSFC) of China [81372666, 81672406, 81502076]	National Science Foundation Committee (NSFC) of China(National Natural Science Foundation of China (NSFC))	This study was supported from the National Science Foundation Committee (NSFC) of China (Grant number: 81372666 and 81672406 to Gang Zhao; No. 81502076 to Shi-chang Deng)	Aghdassi A, 2012, GUT, V61, P439, DOI 10.1136/gutjnl-2011-300060; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Astanehe A, 2009, ONCOGENE, V28, P2406, DOI 10.1038/onc.2009.81; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cheng YT, 2015, ONCOTARGET, V6, P10840, DOI 10.18632/oncotarget.3450; Chou CC, 2015, ONCOTARGET, V6, P8271, DOI 10.18632/oncotarget.3186; Choudhry H, 2014, EMBO REP, V15, P70, DOI 10.1002/embr.201337642; Deng SC, 2015, ONCOTARGET, V6, P39661, DOI 10.18632/oncotarget.5350; Evdokimova V, 2006, CELL CYCLE, V5, P1143, DOI 10.4161/cc.5.11.2784; Evdokimova V, 2009, CELL CYCLE, V8, P2901, DOI 10.4161/cc.8.18.9537; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Gomez-Maldonado L, 2015, ONCOGENE, V34, P2609, DOI 10.1038/onc.2014.200; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Jooste V, 2016, INT J CANCER, V139, P1073, DOI 10.1002/ijc.30166; Kang SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112754; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Krebs AM, 2017, NAT CELL BIOL, V19, P518, DOI 10.1038/ncb3513; Krzywinski M, 2013, NAT METHODS, V10, P1139, DOI 10.1038/nmeth.2738; Lau E, 2014, NAT REV GENET, V15, DOI 10.1038/nrg3795; Lei JJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-66; Li L, 2016, MOL CANCER THER, V15, P2232, DOI 10.1158/1535-7163.MCT-16-0008; Li X, 2016, ONCOTARGET, V7, P6000, DOI 10.18632/oncotarget.6830; McCarty G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119837; Muers M, 2011, NAT REV GENET, V12, DOI 10.1038/nrg3088; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Salnikov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046391; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Sun YW, 2014, BRIT J CANCER, V111, P2131, DOI 10.1038/bjc.2014.520; Wang YF, 2014, NEOPLASIA, V16, P1094, DOI 10.1016/j.neo.2014.10.008; Xu XB, 2015, J BIOL CHEM, V290, P16653, DOI 10.1074/jbc.M115.636944; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhan HX, 2016, CANCER LETT, V374, P261, DOI 10.1016/j.canlet.2016.02.018; Zhang L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-108; Zhang WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116634; Zhou KR, 2017, NUCLEIC ACIDS RES, V45, pD43, DOI 10.1093/nar/gkw965; Zhu Y, 2016, J CELL MOL MED, V20, P688, DOI 10.1111/jcmm.12769	38	124	133	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 1	2018	37	44					5811	5828		10.1038/s41388-018-0382-1	http://dx.doi.org/10.1038/s41388-018-0382-1			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GY9EX	29970904				2022-12-26	WOS:000448943100001
J	Lee, JM; Han, HS; Jung, YS; Harris, RA; Koo, SH; Choi, HS				Lee, Ji-Min; Han, Hye-Sook; Jung, Yoon Seok; Harris, Robert A.; Koo, Seung-Hoi; Choi, Hueng-Sik			The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB COACTIVATOR CRTC2; HEPATIC GLUCONEOGENESIS; HETERODIMER PARTNER; KEY REGULATOR; TORC2; PGC-1; DISRUPTION; ZHANGFEI; REGION; LIVER	Under fasting conditions, activation of several hepatic genes sets the stage for gluconeogenesis in the liver. cAMP response element-binding protein (CREB), CREB-regulated transcription coactivator 2 (CRTC2), and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) are essential for this transcriptional induction of gluconeogenic genes. PGC-1insight that may help inform potential therapeutic approaches targeting PGC-l alpha-mediated regulation of hepatic glucose metabolism. induction is mediated by activation of a CREB/CRTC2 signaling complex, and recent findings have revealed that small heterodimer partner-interacting leucine zipper protein (SMILE), a member of the CREB/ATF family of basic region-leucine zipper (bZIP) transcription factors, is an insulin-inducible corepressor that decreases PGC-1 alpha expression and abrogates its stimulatory effect on hepatic gluconeogenesis. However, the molecular mechanism whereby SMILE suppresses PGC-1a expression is unknown. Here, we investigated SMII.E's effects on the CREB/CRTC2 signaling pathway and glucose metabolism. We found that SMILE significantly inhibits CREB/ CRTC2-induced PGC-1 alpha expression by interacting with and disrupting the CREB/CRTC2 complex. Consequently, SMILE decreased PGC-1 alpha-induced hepatic gluconeogenic gene expression. Furthermore, SMILE inhibited CREB/CRTC2-induced phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) gene expression by directly repressing the expression of these genes and by indirectly inhibiting the expression of PGC-1 alpha via CREB/CRTC2 repression. Indeed, enhanced gluconeogenesis and circulating blood glucose levels in mice injected with an adenovirus construct containing a constitutively active CRTC2 variant (CRTC2-S171A) were significantly reduced by WT SMILE, but not by leucine zipper-mutated SMILE. These results reveal that SMILE represses CREB/CRTC2-induced PGC-1 alpha expression, an insight that may help inform potential therapeutic approaches targeting PGC-1 alpha-mediated regulation of hepatic glucose metabolism.	[Lee, Ji-Min; Jung, Yoon Seok; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Sch Biol Sci & Technol, Gwangju 500757, South Korea; [Lee, Ji-Min; Jung, Yoon Seok; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Gwangju 500757, South Korea; [Han, Hye-Sook; Koo, Seung-Hoi] Korea Univ, Coll Life Sci & Biotechnol, Div Life Sci, 145 Anam Ro, Seoul 136713, South Korea; [Harris, Robert A.] Univ Kansas, Dept Biochem & Mol Biol, Med Ctr, Kansas City, KS 66160 USA	Chonnam National University; Chonnam National University; Korea University; University of Kansas; University of Kansas Medical Center	Choi, HS (corresponding author), Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Sch Biol Sci & Technol, Gwangju 500757, South Korea.; Choi, HS (corresponding author), Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Gwangju 500757, South Korea.; Koo, SH (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Div Life Sci, 145 Anam Ro, Seoul 136713, South Korea.	koohoi@korea.ac.kr; hsc@chonnam.ac.kr	Koo, Seung-Hoi/E-2763-2015	Koo, Seung-Hoi/0000-0001-8769-2879	National Research Foundation of Korea (NRF) by National Creative Research Initiatives [20110018305]; National Research Foundation of Korea [2015R1A2A1A01006687, 2017M3A9D5A01052447, 2015R1A5A1009024]; Korea University, Seoul, Korea	National Research Foundation of Korea (NRF) by National Creative Research Initiatives; National Research Foundation of Korea(National Research Foundation of Korea); Korea University, Seoul, Korea	This work was supported through the National Research Foundation of Korea (NRF) by National Creative Research Initiatives Grant 20110018305 (to H.-S.C) and National Research Foundation of Korea Grants 2015R1A2A1A01006687, 2017M3A9D5A01052447, and 2015R1A5A1009024 to (S.-H.K). The work was also supported by a grant from Korea University, Seoul, Korea (to S.-H.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhova O, 2005, J VIROL, V79, P14708, DOI 10.1128/JVI.79.23.14708-14718.2005; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; DWARKI VJ, 1990, EMBO J, V9, P225, DOI 10.1002/j.1460-2075.1990.tb08099.x; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lee JM, 2016, DIABETES, V65, P62, DOI 10.2337/db15-0249; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Lu R, 2000, NUCLEIC ACIDS RES, V28, P2446, DOI 10.1093/nar/28.12.2446; Misra J, 2011, J BIOL CHEM, V286, P41972, DOI 10.1074/jbc.M111.274514; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; QUINN PG, 1990, MOL CELL BIOL, V10, P3357, DOI 10.1128/MCB.10.7.3357; Saberi M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1137, DOI 10.1152/ajpendo.00158.2009; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wu XL, 1998, J BIOL CHEM, V273, P20820, DOI 10.1074/jbc.273.33.20820; WYNSHAWBORIS A, 1986, J BIOL CHEM, V261, P9714; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Xie YB, 2008, BIOCHEM J, V416, P463, DOI 10.1042/BJ20080782; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077256	24	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13125	13133		10.1074/jbc.RA118.002196	http://dx.doi.org/10.1074/jbc.RA118.002196			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29950523	hybrid, Green Published			2022-12-26	WOS:000442730200013
J	Farazuddin, M; Mishra, R; Jing, YX; Srivastava, V; Comstock, AT; Sajjan, US				Farazuddin, Mohammad; Mishra, Rahul; Jing, Yaxun; Srivastava, Vikram; Comstock, Adam T.; Sajjan, Umadevi S.			Quercetin prevents rhinovirus-induced progression of lung disease in mice with COPD phenotype	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY EPITHELIAL-CELLS; MACROPHAGE ELASTASE; EXACERBATIONS; INFECTION; REPLICATION; HYPERRESPONSIVENESS; INFLAMMATION; PROPIONATE; SALMETEROL	Acute exacerbations are the major cause of morbidity and mortality in patients with chronic obstructive pulmonary disease (COPD). Rhinovirus, which causes acute exacerbations may also accelerate progression of lung disease in these patients. Current therapies reduces the respiratory symptoms and does not treat the root cause of exacerbations effectively. We hypothesized that quercetin, a potent antioxidant and anti-inflammatory agent with antiviral properties may be useful in treating rhinovirus-induced changes in COPD. Mice with COPD phenotype maintained on control or quercetin diet and normal mice were infected with sham or rhinovirus, and after 14 days mice were examined for changes in lung mechanics and lung inflammation. Rhinovirus-infected normal mice showed no changes in lung mechanics or histology. In contrast, rhinovirus-infected mice with COPD phenotype showed reduction in elastic recoiling and increase in lung inflammation, goblet cell metaplasia, and airways cholinergic responsiveness compared to sham-infected mice. Interestingly, rhinovirus-infected mice with COPD phenotype also showed accumulation of neutrophils, CD11b(+)/CD11c(+ )macrophages and CD8(+) T cells in the lungs. Quercetin supplementation attenuated rhinovirus-induced all the pathologic changes in mice with COPD phenotype. Together these results indicate that quercetin effectively mitigates rhinovirus-induced progression of lung disease in a mouse model of COPD. Therefore, quercetin may be beneficial in the treatment of rhinovirus-associated exacerbations and preventing progression of lung disease in COPD.	[Farazuddin, Mohammad; Mishra, Rahul; Jing, Yaxun; Comstock, Adam T.; Sajjan, Umadevi S.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Srivastava, Vikram; Sajjan, Umadevi S.] Temple Univ, Dept Thorac Surg & Med, Philadelphia, PA 19122 USA; [Sajjan, Umadevi S.] Temple Univ, Dept Physiol, Philadelphia, PA 19122 USA; [Sajjan, Umadevi S.] Temple Univ, Lewis Katz Med Sch, Ctr Inflammat Translat & Clin Lung Res, Dept Physiol, Philadelphia, PA 19122 USA; [Sajjan, Umadevi S.] Temple Univ, Lewis Katz Med Sch, Ctr Inflammat Translat & Clin Lung Res, Dept Thorac Med & Surg, Philadelphia, PA 19122 USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sajjan, US (corresponding author), Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.; Sajjan, US (corresponding author), Temple Univ, Dept Thorac Surg & Med, Philadelphia, PA 19122 USA.; Sajjan, US (corresponding author), Temple Univ, Dept Physiol, Philadelphia, PA 19122 USA.; Sajjan, US (corresponding author), Temple Univ, Lewis Katz Med Sch, Ctr Inflammat Translat & Clin Lung Res, Dept Physiol, Philadelphia, PA 19122 USA.; Sajjan, US (corresponding author), Temple Univ, Lewis Katz Med Sch, Ctr Inflammat Translat & Clin Lung Res, Dept Thorac Med & Surg, Philadelphia, PA 19122 USA.	uma.sajjan@temple.edu	Farazuddin, Mohammad/AAI-2580-2021; dotson, eli/AAX-9949-2021; Srivastava, Vikram/AAA-6186-2019; Srivastava, Vikram/T-5213-2019	Srivastava, Vikram/0000-0003-1340-3725; Sajjan, Umadevi/0000-0003-4967-413X	NCCIH, NIH [AT7620, AT4793]; National Center for Comprehensive and Integrative Health of National Institutes of Health [AT7620, AT004793]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004793] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT007620] Funding Source: NIH RePORTER	NCCIH, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Comprehensive and Integrative Health of National Institutes of Health; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The funding for this study was provided by NCCIH, NIH, AT7620 and AT4793, both to US (https://nccih.nih.gov).; We thank Nathaniel Xander for technical assistance. This study was funded by National Center for Comprehensive and Integrative Health of National Institutes of Health, AT7620 and AT004793 to US.	Adeloye D, 2015, J GLOB HEALTH, V5, P186, DOI 10.7189/jogh.05.020415; Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1393; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Drummond MB, 2008, JAMA-J AM MED ASSOC, V300, P2407, DOI 10.1001/jama.2008.717; Footitt J, 2016, CHEST, V149, P62, DOI 10.1378/chest.14-2637; Ganesan S, 2016, J IMMUNOL, V197, P2409, DOI 10.4049/jimmunol.1502702; Ganesan S, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-11; Ganesan S, 2012, ANTIVIR RES, V94, P258, DOI 10.1016/j.antiviral.2012.03.005; Ganesan S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-131; Gansukh E, 2016, PHYTOMEDICINE, V23, P958, DOI 10.1016/j.phymed.2016.06.001; George SN, 2014, EUR RESP J; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hong JY, 2014, J ALLERGY CLIN IMMUN, V134, P429, DOI 10.1016/j.jaci.2014.04.020; Ishii T, 2014, EUR RESPIR J, V43, P82, DOI 10.1183/09031936.00174612; Kardos P, 2007, AM J RESP CRIT CARE, V175, P144, DOI 10.1164/rccm.200602-244OC; Kearley J, 2015, IMMUNITY, V42, P566, DOI 10.1016/j.immuni.2015.02.011; Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560; Kobori M, 2016, MOL NUTR FOOD RES, V60, P300, DOI 10.1002/mnfr.201500595; Koul PA, 2017, LUNG INDIA, V34, P29, DOI 10.4103/0970-2113.197099; Langsetmo L, 2008, AM J RESP CRIT CARE, V177, P396, DOI 10.1164/rccm.200708-1290OC; Laza-Stanca V, 2006, J VIROL, V80, P8248, DOI 10.1128/JVI.00162-06; Lerner CA, 2016, INT J BIOCHEM CELL B, V81, P294, DOI 10.1016/j.biocel.2016.07.026; Makwana R, 2012, BRIT J PHARMACOL, V165, P1978, DOI 10.1111/j.1476-5381.2011.01675.x; Mallia P, 2014, RESP MED, V108, P78, DOI 10.1016/j.rmed.2013.09.010; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Medoff BD, 2002, J IMMUNOL, V168, P5278, DOI 10.4049/jimmunol.168.10.5278; Molet S, 2005, INFLAMM RES, V54, P31, DOI 10.1007/s00011-004-1319-4; Newcomb DC, 2008, AM J RESP CRIT CARE, V177, P1111, DOI 10.1164/rccm.200708-1243OC; Sajjan U, 2001, INFECT IMMUN, V69, P5138, DOI 10.1128/IAI.69.8.5138-5150.2001; Sajjan U, 2009, AM J PHYSIOL-LUNG C, V297, pL931, DOI 10.1152/ajplung.00150.2009; Sajjan U, 2008, AM J RESP CRIT CARE, V178, P1271, DOI 10.1164/rccm.200801-136OC; Schneider D, 2010, AM J RESP CRIT CARE, V182, P332, DOI 10.1164/rccm.200911-1673OC; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Tabak C, 2001, AM J RESP CRIT CARE, V164, P61, DOI 10.1164/ajrccm.164.1.2010025; Tacon CE, 2010, AM J RESP CELL MOL, V43, P201, DOI 10.1165/rcmb.2009-0216OC; Wilkinson TMA, 2017, THORAX, V72, P919, DOI 10.1136/thoraxjnl-2016-209023	38	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199612	10.1371/journal.pone.0199612	http://dx.doi.org/10.1371/journal.pone.0199612			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975735	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500042
J	Boldrini, NAT; Volpini, LPB; de Freitas, LB; Musso, C; de Vargas, PRM; Spano, LC; Miranda, AE				Tosato Boldrini, Neide Aparecida; Bondi Volpini, Lays Paula; de Freitas, Luciana Bueno; Musso, Carlos; Merton de Vargas, Paulo Roberto; Spano, Liliana Cruz; Miranda, Angelica Espinosa			Anal HPV infection and correlates in HIV-infected patients attending a Sexually Transmitted Infection clinic in Brazil	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; INTRAEPITHELIAL NEOPLASIA; ANTIRETROVIRAL THERAPY; NATURAL-HISTORY; CERVICAL-CANCER; RISK-FACTORS; WOMEN; MEN; METAANALYSIS; PERSISTENCE	Objective To estimate the prevalence of anal HPV infection, genotype distribution, intraepithelial neoplasia (AIN) and correlates in a cohort of HIV-infected patients attending at Sexually Transmitted Infections (STI) clinic in Brazil. Study design A descriptive analysis was performed which includes, demographic, behavioral and clinical data. Anal specimens from HIV-positive men and women were collected during a regular visit and they were used for cytology and histopathology tests, as well as for HPV molecular identification. Results A total of 223 patients (143 females and 80 males) were enrolled in the study and, HPV was identified in 68.6% of the sample. The frequency of HR-HPV, HPV16/18 and multiple HPV infection were similar in both groups. The upstream regulatory region (URR) sequencing was carried out in 38 samples identified as HPV16-positive, and European variants were the most frequent (69.2%), followed by Africans (25.6%) and Asiatic-Americans (5.1%). Having more than 20 sexual partners was associated with multiple HPV infection (p = 0.000) while, anal sex and the first intercourse before 15 years of age was a risk factor for any HPV infection (p = 0.001). Being MSM (men who have sex with men) was a risk factor for any HPV and multiple infections (p = 0.002). The CD4 count >500 cells/mm(3) was a protective factor for the HPV16/18 (p = 0.048) and multiple infections (p = 0.023), and the undetectable viral load and HAART treatment were both protective for any HPV (p = 0.010), HR-HPV (p = 0.091) and multiple infections (p = 0.006). Abnormal anoscopy was found in 23.7% (53/223) of the total number of patients, and this was significantly associated with all types of investigated HPV infections (p<0.0001). Conclusions In this study, anal HPV infection was common among young HIV-positive men and women, particularly in MSM. Anal cancer screening in patients at risk, such as those who are HIV-positive, and mainly those with anal HPV infection and a history of STI, will increase the likelihood of detecting anal intraepithelial neoplasia.	[Tosato Boldrini, Neide Aparecida; Bondi Volpini, Lays Paula; de Freitas, Luciana Bueno; Spano, Liliana Cruz; Miranda, Angelica Espinosa] Univ Fed Espirito Santo, Postgrad Program Infect Dis, Vitoria, Brazil; [Tosato Boldrini, Neide Aparecida] Univ Fed Espirito Santo, Dept Gynecol & Obstet, Ctr Hlth Sci, Vitoria, Brazil; [Musso, Carlos; Merton de Vargas, Paulo Roberto] Univ Fed Espirito Santo, Dept Pathol, Ctr Hlth Sci, Vitoria, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo	Boldrini, NAT (corresponding author), Univ Fed Espirito Santo, Postgrad Program Infect Dis, Vitoria, Brazil.; Boldrini, NAT (corresponding author), Univ Fed Espirito Santo, Dept Gynecol & Obstet, Ctr Hlth Sci, Vitoria, Brazil.	neide.tosato@gmail.com	Miranda, Angelica/AAE-5571-2021	Miranda, Angelica/0000-0002-5556-8379; Tosato Boldrini, Neide Aparecida/0000-0003-1140-5057				Apgar BS, 2003, AM FAM PHYSICIAN, V68, P1992; Bernard HU, 1996, J INFECT DIS, V173, P516; Blas MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139524; Volpini LPB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176422; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Burd EM, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.DMIH2-0001-2015; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Chaturvedi AK, 2007, JNCI-J NATL CANCER I, V99, P1634, DOI 10.1093/jnci/djm201; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Colon-Lopez V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083209; Cubie HA, 2013, VIROLOGY, V445, P21, DOI 10.1016/j.virol.2013.06.007; D'Souza G, 2008, J GEN INTERN MED, V23, P1452, DOI 10.1007/s11606-008-0698-6; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Edgren G, 2007, LANCET ONCOL, V8, P311, DOI 10.1016/S1470-2045(07)70043-8; Estrade C, 2011, J CLIN MICROBIOL, V49, P3474, DOI 10.1128/JCM.05039-11; Freitas LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100746; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Goeieman BJ, 2017, JAIDS-J ACQ IMM DEF, V75, pE59, DOI 10.1097/QAI.0000000000001300; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hidalgo-Tenorio C, 2017, MEDICINE, V96, DOI [10.1097/md.0000000000008109, 10.1097/MD.0000000000008109]; Hillman RJ, 2016, J LOW GENIT TRACT DI, V20, P283, DOI 10.1097/LGT.0000000000000256; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; International Agency for Research on Cancer, 2012, IARC MON EV CARC RIS, V100E; Iribarren-Diaz M, 2017, REV ESP ENFERM DIG, V109, P242, DOI 10.17235/reed.2017.4274/2016; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Medical Advisory Secretariat, 2007, Ont Health Technol Assess Ser, V7, P1; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; Moscicki AB, 2015, J LOW GENIT TRACT DI, V19, DOI 10.1097/LGT.0000000000000117; Moscicki AB, 2014, CLIN INFECT DIS, V58, P804, DOI 10.1093/cid/cit947; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Nagata N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137434; Palefsky JM, 2001, J INFECT DIS, V183, P383, DOI 10.1086/318071; Palefsky JM, 2012, SEX TRANSM DIS, V39, P501, DOI 10.1097/OLQ.0b013e31825f7921; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Reusser NM, 2015, J CLIN MED, V4, P260, DOI 10.3390/jcm4020260; Roberts JR, 2017, WORLD J GASTRO ONCOL, V9, P50, DOI 10.4251/wjgo.v9.i2.50; Schiffman M, 2015, J CLIN MICROBIOL, V53, P52, DOI 10.1128/JCM.02116-14; Shvetsov YB, 2009, CLIN INFECT DIS, V48, P536, DOI 10.1086/596758; Stier EA, 2015, AM J OBSTET GYNECOL, V213, P278, DOI 10.1016/j.ajog.2015.03.034; Sudenga SL, 2017, J INFECTION, V75, P35, DOI 10.1016/j.jinf.2017.03.010; Taylor S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1633-9; Torres M, 2013, J CLIN MICROBIOL, V51, P3512, DOI 10.1128/JCM.01405-13; VANOORTMARSSEN GJ, 1995, INT J EPIDEMIOL, V24, P300; Xi LF, 1998, CANCER RES, V58, P3839; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; Yu JB, 2009, ONCOLOGY-NY, V23, P288	48	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199058	10.1371/journal.pone.0199058	http://dx.doi.org/10.1371/journal.pone.0199058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975716	Green Submitted, gold, Green Published			2022-12-26	WOS:000437424500020
J	Ahn, JG; Kim, DS; Kim, KH				Ahn, Jong Gyun; Kim, Dong Soo; Kim, Ki Hwan			Clinical characteristics and cytokine profiles of children with acute lower respiratory tract infections caused by human rhinovirus	PLOS ONE			English	Article							YOUNG-CHILDREN; MOLECULAR EPIDEMIOLOGY; VIRAL PATHOGENS; SEVERITY; LOAD; SYMPTOMS; DISEASE; ILLNESS; ASTHMA; HOSPITALIZATIONS	The clinical profile of human rhinovirus (HRV) with regard to lower respiratory infections remains unclear. We analyzed the clinical features and cytokine responses of HRV isolates in children with respiratory infections. Quantitative analysis and genotyping of the HRV-positive samples from 601 nasopharyngeal aspirates (NPAs) were performed using VP4/VP2 sequencing. To compare T-helper1 (Th1) type (IFN-gamma, TNF-alpha) and Th2 type (IL-4, IL-10) cytokine responses between HRV-A, B and C, the levels of the four cytokines were measured. The HRV-positive children had shorter fever duration (P = 0.018), and higher frequencies of chest retraction (P = 0.002) and wheezing (P = 0.022) than did the HRV-negative group. HRV-A was identified in 55 cases (58.5%), HRV-B in 8 (8.5%), and HRV-C in 31 (33.0%). There were no significant differences in the clinical data or NPA cytokines levels between patients with HRV-A and HRV-C infections. HRV is an important pathogen of the lower respiratory tract in young children. HRV-A and HRV-C are the dominant species that cause respiratory difficulty in young children.	[Ahn, Jong Gyun; Kim, Dong Soo; Kim, Ki Hwan] Yonsei Univ, Severance Childrens Hosp, Dept Pediat, Coll Med, Seoul, South Korea; [Ahn, Jong Gyun; Kim, Dong Soo] Yonsei Univ, Dept Med, Grad Sch, Seoul, South Korea; [Kim, Ki Hwan] Catholic Univ Korea, Incheon St Marys Hosp, Dept Pediat, Coll Med, Incheon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Catholic University of Korea	Kim, KH (corresponding author), Yonsei Univ, Severance Childrens Hosp, Dept Pediat, Coll Med, Seoul, South Korea.; Kim, KH (corresponding author), Catholic Univ Korea, Incheon St Marys Hosp, Dept Pediat, Coll Med, Incheon, South Korea.	khkim99@catholic.ac.kr		Ahn, Jong Gyun/0000-0001-5748-0015	Korea Centers for Disease Control and Prevention [2011E4700100]	Korea Centers for Disease Control and Prevention	This work was supported by the Korea Centers for Disease Control and Prevention [2011E4700100] to Dong Soo Kim.	Calvo C, 2010, PEDIATR INFECT DIS J, V29, P717, DOI 10.1097/INF.0b013e3181d7a708; Choi SH, 2015, J CLIN VIROL, V63, P70, DOI 10.1016/j.jcv.2014.12.016; Chun JK, 2009, EUR J CLIN MICROBIOL, V28, P841, DOI 10.1007/s10096-009-0701-0; Cox DW, 2013, AM J RESP CRIT CARE, V188, P1358, DOI 10.1164/rccm.201303-0498OC; Esposito S, 2014, EUR J CLIN MICROBIOL, V33, P41, DOI 10.1007/s10096-013-1926-5; Etemadi MR, 2013, J CLIN VIROL, V58, P671, DOI 10.1016/j.jcv.2013.05.017; Fry AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017780; Gern JE, 2002, PEDIAT ALLERG IMM-UK, V13, P386, DOI 10.1034/j.1399-3038.2002.01093.x; Gerna G, 2009, J MED VIROL, V81, P1498, DOI 10.1002/jmv.21548; Iwane MK, 2011, J INFECT DIS, V204, P1702, DOI 10.1093/infdis/jir634; Khetsuriani N, 2008, EMERG INFECT DIS, V14, P1793, DOI 10.3201/eid1411.080386; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Lau SKP, 2009, J INFECT DIS, V200, P1096, DOI 10.1086/605697; Lauinger IL, 2013, J CLIN VIROL, V58, P216, DOI 10.1016/j.jcv.2013.06.042; Hai LT, 2012, EMERG INFECT DIS, V18, P1886, DOI 10.3201/eid1811.120607; Lee WM, 2012, AM J RESP CRIT CARE, V186, P886, DOI 10.1164/rccm.201202-0330OC; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; Midulla F, 2012, EUR RESPIR J, V39, P396, DOI 10.1183/09031936.00188210; Miller EK, 2007, J INFECT DIS, V195, P773, DOI 10.1086/511821; Muller L, 2015, PEDIATR INFECT DIS J, V34, P907, DOI 10.1097/INF.0000000000000758; Onyango CO, 2012, J MED VIROL, V84, P823, DOI 10.1002/jmv.23251; Ozcan C, 2011, J ASTHMA, V48, P888, DOI 10.3109/02770903.2011.606579; Piotrowska Z, 2009, PEDIATR INFECT DIS J, V28, P25, DOI 10.1097/INF.0b013e3181861da0; Principi N, 2015, J CLIN VIROL, V66, P83, DOI 10.1016/j.jcv.2015.03.013; Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x; Takeyama A, 2012, J MED VIROL, V84, P1135, DOI 10.1002/jmv.23306; van Elden LJR, 2008, J CLIN VIROL, V41, P116, DOI 10.1016/j.jcv.2007.10.028; Xiang ZC, 2010, J CLIN VIROL, V49, P94, DOI 10.1016/j.jcv.2010.07.013; Zeng SZ, 2014, J MED VIROL, V86, P1983, DOI 10.1002/jmv.23861	31	7	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0198624	10.1371/journal.pone.0198624	http://dx.doi.org/10.1371/journal.pone.0198624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969445	Green Published, Green Submitted, gold			2022-12-26	WOS:000437246700003
J	Nguyen, UT; Lincoln, SA; Juarez, AGV; Schedler, M; Macalady, JL; Muller, R; Freeman, KH				Nguyen, Uyen T.; Lincoln, Sara A.; Juarez, Ana Gabriela Valladares; Schedler, Martina; Macalady, Jennifer L.; Mueller, Rudolf; Freeman, Katherine H.			The influence of pressure on crude oil biodegradation in shallow and deep Gulf of Mexico sediments	PLOS ONE			English	Article							AEROBIC BIODEGRADATION; MICROBIAL-DEGRADATION; SEA SEDIMENTS; HYDROCARBONS; BACTERIA; HOPANES; TEMPERATURE; PLUME	A significant portion of oil released during the Deepwater Horizon disaster reached the Gulf of Mexico (GOM) seafloor. Predicting the long-term fate of this oil is hindered by a lack of data about the combined influences of pressure, temperature, and sediment composition on microbial hydrocarbon remineralization in deep-sea sediments. To investigate crude oil biodegradation by native GOM microbial communities, we incubated core-top sediments from 13 GOM sites at water depths from 60-1500 m with crude oil under simulated aerobic seafloor conditions. Biodegradation occurred in all samples and followed a predictable compound class sequence dictated by molecular weight and structure. 45 to similar to 100% of total nalkane and 3 to 60% of total polycyclic aromatic hydrocarbons (PAH) were depleted. In reactors incubated at 4 degrees C and at pressures of 6-15 MPa, the depletion in total n-alkane was inversely correlated to pressure (R-2 similar to 0.85), equivalent to a 4% decrease in total n-alkane depletion for every 1 MPa increase. Our results indicated a modest inhibitory effect of pressure on biodegradation over our experimental range. However, the expansion of oil exploration to deeper waters (e.g., 5000 m) opens the risk of spills at conditions at which pressure might have a more pronounced effect	[Nguyen, Uyen T.; Lincoln, Sara A.; Macalady, Jennifer L.; Freeman, Katherine H.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Juarez, Ana Gabriela Valladares; Schedler, Martina; Mueller, Rudolf] Hamburg Univ Technol, Inst Tech Biocatalysis, Hamburg, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Hamburg University of Technology	Nguyen, UT (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	unguyen.psu.edu@gmail.com	Freeman, Katherine H/H-5140-2011; Macalady, Jennifer L./AAC-5154-2021	Freeman, Katherine H/0000-0002-3350-7671; Macalady, Jennifer L./0000-0001-5214-0601	Gulf of Mexico Research Institute	Gulf of Mexico Research Institute	This research was made possible by funds from the Gulf of Mexico Research Institute grant to the Center for Integrated Modeling and Analysis of Gulf Ecosystems (C-IMAGE) consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baelum J, 2012, ENVIRON MICROBIOL, V14, P2405, DOI 10.1111/j.1462-2920.2012.02780.x; Bagby SC, 2017, P NATL ACAD SCI USA, V114, pE9, DOI 10.1073/pnas.1610110114; Bao JP, 2009, SCI CHINA SER D, V52, P59, DOI 10.1007/s11430-009-5017-5; BAZYLINSKI DA, 1989, APPL ENVIRON MICROB, V55, P2832, DOI 10.1128/AEM.55.11.2832-2836.1989; Bost FD, 2001, ORG GEOCHEM, V32, P105, DOI 10.1016/S0146-6380(00)00147-9; Bragg J., 2007, ARCT MAR OILSP PROGR, P263; Butler E. L., BOOK ON SITE BIORECL, P515; Chanton J, 2015, ENVIRON SCI TECHNOL, V49, P847, DOI 10.1021/es5046524; Chen L., 2016, ENV EARTH SCI, V75; Cui ZS, 2008, ENVIRON MICROBIOL, V10, P2138, DOI 10.1111/j.1462-2920.2008.01637.x; Daly KL, 2016, ANTHROPOCENE, V13, P18, DOI 10.1016/j.ancene.2016.01.006; Del'Arco JP, 2001, ENVIRON POLLUT, V112, P515, DOI 10.1016/S0269-7491(00)00128-7; DSMZ GmbH, 2012, 141 METH MED; Frontera-Suau R, 2002, ENVIRON SCI TECHNOL, V36, P4585, DOI 10.1021/es025894X; Gibeaut J. C., 93038 EXX VALD TRUST; Grossi V, 2010, ENVIRON MICROBIOL, V12, P2020, DOI 10.1111/j.1462-2920.2010.02213.x; Hayes M. O., 1993, P INT OIL SPILL C FL, P373; Hazen TC, 2016, ENVIRON SCI TECHNOL, V50, P2121, DOI 10.1021/acs.est.5b03333; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; JANNASCH HW, 1982, APPL ENVIRON MICROB, V43, P1116, DOI 10.1128/AEM.43.5.1116-1124.1982; JANNASCH HW, 1977, APPL ENVIRON MICROB, V33, P642, DOI 10.1128/AEM.33.3.642-646.1977; LEAHY JG, 1990, MICROBIOL REV, V54, P305, DOI 10.1128/MMBR.54.3.305-315.1990; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; MOLDOWAN JM, 1995, GEOCHIM COSMOCHIM AC, V59, P1891, DOI 10.1016/0016-7037(95)00072-8; National Research Council (US) Committee on Oil in the Sea: Inputs Fates and Effects, 2003, OIL SEA; Orcutt BN, 2011, ISME J, V5, P692, DOI 10.1038/ismej.2010.157; Passow U, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035301; Peters K. E., 1993, BIOMARKER GUIDE INTE; Peters KE, 1996, ORG GEOCHEM, V24, P765, DOI 10.1016/S0146-6380(96)00086-1; Prince R. C., 2016, MARINE POLLUTION B; Prince R. C., ENV SCI TECHNOL; Redmond MC, 2012, P NATL ACAD SCI USA, V109, P20292, DOI 10.1073/pnas.1108756108; REQUEJO AG, 1989, NATURE, V342, P670, DOI 10.1038/342670a0; ROGOFF MH, 1959, J BACTERIOL, V77, P783, DOI 10.1128/JB.77.6.783-788.1959; Romero IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128371; ROWLAND SJ, 1986, ORG GEOCHEM, V9, P153, DOI 10.1016/0146-6380(86)90065-3; Schedler M, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0077-0; SCHWARZ JR, 1974, APPL MICROBIOL, V28, P982, DOI 10.1128/AEM.28.6.982-986.1974; SCHWARZ JR, 1975, CAN J MICROBIOL, V21, P682, DOI 10.1139/m75-098; Scoma A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01203; Seki H., 1969, INT REV GESAMTEN HYD, V54, P201; Short JW, 2007, ENVIRON SCI TECHNOL, V41, P1245, DOI 10.1021/es0620033; Smedile F., 2017, SPRINGER PROTOCOLS H, P33; Smith A, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003424; Stevens C. C, 2015, ENV ENG SCI, V32; Stout SA, 2016, MAR POLLUT BULL, V111, P365, DOI 10.1016/j.marpolbul.2016.07.036; Swannell RPJ, 1996, MICROBIOL REV, V60, P342, DOI 10.1128/MMBR.60.2.342-365.1996; Tapilatu Y, 2010, LETT APPL MICROBIOL, V50, P234, DOI 10.1111/j.1472-765X.2009.02766.x; Tkalich P, 2003, J HYDRAUL RES, V41, P115, DOI 10.1080/00221680309499955; Valentine DL, 2014, P NATL ACAD SCI USA, V111, P15906, DOI 10.1073/pnas.1414873111; Valladares Juarez A. G., 2015, ONLINE MONITORING CR, V8; Vila J, 2009, APPL ENVIRON MICROB, V75, P6232, DOI 10.1128/AEM.02726-08; Wang CY, 2014, ENVIRON SCI-PROC IMP, V16, P2408, DOI 10.1039/c4em00266k; Wang ZD, 1998, J CHROMATOGR A, V809, P89, DOI 10.1016/S0021-9673(98)00166-6; Wang ZD, 2003, MAR POLLUT BULL, V47, P423, DOI 10.1016/S0025-326X(03)00215-7; Watson JS, 2002, ORG GEOCHEM, V33, P1153, DOI 10.1016/S0146-6380(02)00086-4; Wenger LM, 2002, SPE RESERV EVAL ENG, V5, P375, DOI 10.2118/80168-PA; ZoBell C. E., 1968, B MISAKI MAR BIOL, V12, P77	59	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199784	10.1371/journal.pone.0199784	http://dx.doi.org/10.1371/journal.pone.0199784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969471	gold, Green Published, Green Submitted			2022-12-26	WOS:000437246700028
J	Ubillos, I; Aguilar, R; Sanz, H; Jimenez, A; Vidal, M; Valmaseda, A; Dong, Y; Gaur, D; Chitnis, CE; Dutta, S; Angov, E; Aponte, JJ; Campo, JJ; Valim, C; Harezlak, J; Dobano, C				Ubillos, Itziar; Aguilar, Ruth; Sanz, Hector; Jimenez, Alfons; Vidal, Marta; Valmaseda, Aida; Dong, Yan; Gaur, Deepak; Chitnis, Chetan E.; Dutta, Sheetij; Angov, Evelina; Aponte, John J.; Campo, Joseph J.; Valim, Clarissa; Harezlak, Jaroslaw; Dobano, Carlota			Analysis of factors affecting the variability of a quantitative suspension bead array assay measuring IgG to multiple Plasmodium antigens	PLOS ONE			English	Article							MALARIA VACCINE; ERYTHROCYTE INVASION; STATISTICAL-METHODS; CONTROLLED-TRIAL; PROTEIN; OPTIMIZATION; IMMUNOASSAYS; ANTIBODIES; DESIGN; INHIBITORS	Reducing variability of quantitative suspension array assays is key for multi-center and large sero-epidemiological studies. To maximize precision and robustness of an in-house IgG multiplex assay, we analyzed the effect of several conditions on variability to find the best combination. The following assay conditions were studied through a fractional factorial design: antigen-bead coupling (stock vs. several), sample predilution (stock vs. daily), temperature of incubation of sample with antigen-bead (22 degrees C vs. 37 degrees C), plate washing (manual vs. automatic) and operator expertise (expert vs. apprentice). IgG levels against seven P. falciparum antigens with heterogeneous immunogenicities were measured in test samples, in a positive control and in blanks. We assessed the variability and MFI quantification range associated to each combination of conditions, and their interactions, and evaluated the minimum number of samples and blank replicates to achieve good replicability. Results showed that antigen immunogenicity and sample seroreactivity defined the optimal dilution to assess the effect of assay conditions on variability. We found that a unique antigen-bead coupling, samples prediluted daily, incubation at 22 degrees C, and automatic washing, had lower variability. However, variability increased when performing several couplings and incubating at 22 degrees C vs. 37 degrees C. In addition, no effect of temperature was seen with a unique coupling. The expertise of the operator had no effect on assay variability but reduced the MFI quantification range. Finally, differences between sample replicates were minimal, and two blanks were sufficient to capture assay variability, as suggested by the constant Intraclass Correlation Coefficient of three and two blanks. To conclude, a single coupling was the variable that most consistently reduced assay variability, being clearly advisable. In addition, we suggest having more sample dilutions instead of replicates to increase the likelihood of sample MFIs falling in the linear part of the antigen-specific curve, thus increasing precision.	[Ubillos, Itziar; Aguilar, Ruth; Sanz, Hector; Jimenez, Alfons; Vidal, Marta; Valmaseda, Aida; Aponte, John J.; Campo, Joseph J.; Dobano, Carlota] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Catalonia, Spain; [Jimenez, Alfons] CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain; [Dong, Yan; Harezlak, Jaroslaw] RM Fairbanks Sch Publ Hlth, Dept Biostat, Indianapolis, IN USA; [Gaur, Deepak; Chitnis, Chetan E.] ICGEB, Malaria Grp, New Delhi, India; [Gaur, Deepak] Jawaharlal Nehru Univ, Sch Biotechnol, Lab Malaria & Vaccine Res, New Delhi, India; [Dutta, Sheetij; Angov, Evelina] WRAIR, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Valim, Clarissa] Michigan State Univ, Dept Osteopath Med Specialties, E Lansing, MI 48824 USA; [Valim, Clarissa] Harvard TH Chen Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Campo, Joseph J.] Antigen Discovery Inc, Irvine, CA USA	ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Jawaharlal Nehru University, New Delhi; Walter Reed Army Institute of Research (WRAIR); Michigan State University; Harvard University; Harvard T.H. Chan School of Public Health	Dobano, C (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Catalonia, Spain.	carlota.dobano@isglobal.org	Gaur, Deepak/AAF-4379-2019; Aguilar, Ruth/D-2147-2018; Costa, Marta Vidal/T-7772-2019; JIMENEZ, ALFONS/L-2106-2019; Dobaño, Carlota/N-4119-2014; Harezlak, Jaroslaw/P-8557-2014	Aguilar, Ruth/0000-0003-3277-3107; Costa, Marta Vidal/0000-0001-6891-7032; JIMENEZ, ALFONS/0000-0003-0301-3344; Dobaño, Carlota/0000-0002-6751-4060; Harezlak, Jaroslaw/0000-0002-3070-7686; Chitnis, Chetan/0000-0002-8773-9865	Instituto de Salud Carlos III [PI11/00423, PI14/01422]; National Institute of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID) [R01AI095789]; PATH Malaria Vaccine Initiative; Agency for Management of University and Research Grants [AGAUR 2014SGR991]; Antigen Discovery Inc.	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); National Institute of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PATH Malaria Vaccine Initiative; Agency for Management of University and Research Grants; Antigen Discovery Inc.	This work received support from the Instituto de Salud Carlos III, http://www.eng.isciii.es/ (PI11/00423, PI14/01422) (CD); National Institute of Health-National Institute of Allergy and Infectious Diseases, https://www.niaid.nih.gov/ (NIH-NIAID R01AI095789) (CD); PATH Malaria Vaccine Initiative, http://www.malariavaccine.org/ (CD); the Agency for Management of University and Research Grants, http://agaur.gencat.cat/en/lagaur/index.html (AGAUR 2014SGR991) (CD). ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya, http://cerca.cat/en/. JC receives support in the form of salary from Antigen Discovery Inc.; however, he was not affiliated with Antigen Discovery Inc. at the time of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Altekar M, 2007, CLIN LAB MED, V27, P139, DOI 10.1016/j.cll.2007.01.001; Andreasson U, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00179; Angov E, 2003, MOL BIOCHEM PARASIT, V128, P195, DOI 10.1016/S0166-6851(03)00077-X; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Baker HN, 2012, JOVE-J VIS EXP, DOI 10.3791/4084; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biancotto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076091; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Breen EJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26996; Bryan D, 2017, MALAR J ENGLAND, V16; Defawe OD, 2012, J IMMUNOL METHODS, V382, P117, DOI 10.1016/j.jim.2012.05.011; Doolan DL, 2011, INT J PARASITOL, V41, P3, DOI 10.1016/j.ijpara.2010.08.002; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Gottschalk PG, 2005, COMPUT METH PROG BIO, V80, P204, DOI 10.1016/j.cmpb.2005.08.003; Gottschalk PG, 2005, ANAL BIOCHEM, V343, P54, DOI 10.1016/j.ab.2005.04.035; GUERINMARCHAND C, 1987, NATURE, V329, P164, DOI 10.1038/329164a0; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Joelsson D, 2008, J IMMUNOL METHODS, V337, P35, DOI 10.1016/j.jim.2008.05.012; Kettman JR, 1998, CYTOMETRY, V33, P234, DOI 10.1002/(SICI)1097-0320(19981001)33:2<234::AID-CYTO19>3.3.CO;2-5; KHUSMITH S, 1991, SCIENCE, V252, P715, DOI 10.1126/science.1827210; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Lin A, 2015, METHODS MOL BIOL, V1318, P107, DOI 10.1007/978-1-4939-2742-5_11; Lucas JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182739; Fonseca AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181150; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073624; Montgomery D. C., 2005, DESIGN ANAL EXPT; Ord RL, 2015, HUM VACC IMMUNOTHER, V11, P1465, DOI 10.1080/21645515.2015.1026496; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Pulido-Olmo H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00853; Reddy KS, 2015, P NATL ACAD SCI USA, V112, P1179, DOI 10.1073/pnas.1415466112; Reddy KS, 2014, INFECT IMMUN, V82, P152, DOI 10.1128/IAI.00970-13; REIKEN SR, 1994, J IMMUNOL METHODS, V177, P199, DOI 10.1016/0022-1759(94)90157-0; ROBSON KJH, 1988, NATURE, V335, P79, DOI 10.1038/335079a0; Roman DL, 2009, J BIOMOL SCREEN, V14, P610, DOI 10.1177/1087057109336590; Rovira-Vallbona E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-181; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Ubillos I, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2365-7; Valekova Ivona, 2015, Methods Mol Biol, V1212, P39, DOI 10.1007/7651_2014_94; Vidal M, 2018, J IMMUNOL METHODS, V455, P41, DOI 10.1016/j.jim.2018.01.009; Wang Hao, 2018, Oncotarget, V9, P5600, DOI 10.18632/oncotarget.23789; Yasgar A, 2016, METHODS MOL BIOL, V1439, P77, DOI 10.1007/978-1-4939-3673-1_5; Yu ZTF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11339; ZHU JD, 1991, MOL BIOCHEM PARASIT, V48, P223, DOI 10.1016/0166-6851(91)90117-O	47	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199278	10.1371/journal.pone.0199278	http://dx.doi.org/10.1371/journal.pone.0199278			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966018	Green Published, gold, Green Submitted			2022-12-26	WOS:000437224100011
J	Wang, HL; Cheng, X; Ding, SW; Wang, DW; Chen, C; Xu, CL; Xie, H				Wang, Hong-Le; Cheng, Xi; Ding, Shan-Wen; Wang, Dong-Wei; Chen, Chun; Xu, Chun-Ling; Xie, Hui			Molecular identification and functional characterization of the cathepsin B gene (Ab-cb-1) in the plant parasitic nematode Aphelenchoides besseyi	PLOS ONE			English	Article							CYSTEINE PROTEASES; CAENORHABDITIS-ELEGANS; PLASMODIUM-FALCIPARUM; RADOPHOLUS-SIMILIS; PROTEINASES; EXPRESSION; CLONING; INHIBITION; STAGE	The rice white tip nematode, Aphelenchoides besseyi, is widely distributed in rice planting areas worldwide and causes serious economic losses. Cathepsin genes have been demonstrated to have importance in studying the reproduction, development, pathogenicity, and control methods of plant nematodes. In this paper, a novel cathepsin B gene, Ab-cb-1, was found and cloned. The Ab-cb-1 gene was 1347 bp in length and encodes 369 amino acids. The Ab-CB-1 protein contains characteristic occluding loops but no signal peptide. A homology analysis showed that Ab-CB-1 had the highest identity value (64%) to the known amino acid sequence of cathepsin B-like cysteine protease 6 from Toxocara canis. When Ab-cb-1 was expressed in a prokaryotic system, the protein massed approximately 45 kDa and could decompose carrot callus. Ab-cb-1 mRNA was localized in the nematode intestine. The relative expression level of Ab-cb-1 in the A. besseyi Ab-S24 population, which had high reproductivity, was approximately 6.9 times that in the Ab-N10 population, which had low reproductivity, and the difference was significant (p<0.05). The Ab-cb-1 expression level was highest in females; the expression levels in males, juveniles and eggs were 30%, 12.2% and 5% of that in females, respectively, and the differences were significant among all four stages (p<0.05). Nematodes of the Ab-S24 population were treated with Ab-cb-1 dsRNA for 12 h, 24 h, 36 h and 48 h, and their reproduction decreased with increasing time. These results demonstrated that Ab-CB-1 was a digestive enzyme with hydrolytic protease properties and that Ab-cb-1 played an important role in the reproduction of A. besseyi.	[Wang, Hong-Le; Cheng, Xi; Ding, Shan-Wen; Wang, Dong-Wei; Chen, Chun; Xu, Chun-Ling; Xie, Hui] South China Agr Univ, Lab Plant Nematol, Coll Agr, Guangzhou, Guangdong, Peoples R China; [Wang, Hong-Le; Cheng, Xi; Ding, Shan-Wen; Wang, Dong-Wei; Chen, Chun; Xu, Chun-Ling; Xie, Hui] South China Agr Univ, Coll Agr, Res Ctr Nematodes Plant Quarantine, Dept Plant Pathol,Guangdong Prov Key Lab Microbia, Guangzhou, Guangdong, Peoples R China; [Cheng, Xi] Fujian Agr & Forestry Univ, Coll Plant Protect, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Fujian, Peoples R China	South China Agricultural University; South China Agricultural University; Fujian Agriculture & Forestry University	Xie, H (corresponding author), South China Agr Univ, Lab Plant Nematol, Coll Agr, Guangzhou, Guangdong, Peoples R China.; Xie, H (corresponding author), South China Agr Univ, Coll Agr, Res Ctr Nematodes Plant Quarantine, Dept Plant Pathol,Guangdong Prov Key Lab Microbia, Guangzhou, Guangdong, Peoples R China.	xiehui@scau.edu.cn	Wang, Dongwei/M-7768-2017	Wang, Dongwei/0000-0001-5226-4241	National Natural Science Foundation of China [31371920, 31071665]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (No. 31371920 and 31071665 to H.X.).	BAILLY E, 1992, J PROTOZOOL, V39, P593, DOI 10.1111/j.1550-7408.1992.tb04856.x; Balboula AZ, 2010, MOL REPROD DEV, V77, P439, DOI 10.1002/mrd.21164; Bridge J., 1990, P69; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; CARMONA C, 1993, MOL BIOCHEM PARASIT, V62, P9, DOI 10.1016/0166-6851(93)90172-T; Cheng X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066011; Cheng XY, 2010, NEMATOLOGY, V12, P225, DOI 10.1163/138855409X12469541205044; COX GN, 1990, MOL BIOCHEM PARASIT, V41, P25, DOI 10.1016/0166-6851(90)90093-2; de Boer JM, 1998, J NEMATOL, V30, P309; DLUZEWSKI AR, 1986, EXP PARASITOL, V62, P416, DOI 10.1016/0014-4894(86)90050-0; Dutta TK, 2015, FRONTIERS MICROBIOLO, V260, P6; Elek Adnan Tu, 2009, RUSS J NEMATOL, V17, P135; Hashmi S, 2002, J BIOL CHEM, V277, P3477, DOI 10.1074/jbc.M106117200; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Koiwa H, 2000, FEBS LETT, V471, P67, DOI 10.1016/S0014-5793(00)01368-5; Li Y, 2015, INT J BIOL SCI, V11, P1073, DOI 10.7150/ijbs.12065; Lilley CJ, 1996, PARASITOLOGY, V113, P415, DOI 10.1017/S0031182000066555; Lilley CJ, 1997, MOL BIOCHEM PARASIT, V89, P195, DOI 10.1016/S0166-6851(97)00116-3; Lv CH, PLANT PROTECTION, V34, P17; Meemon K, 2004, MOL BIOCHEM PARASIT, V136, P1, DOI 10.1016/j.molbiopara.2004.02.010; Ni F, 2012, EXP PARASITOL, V131, P433, DOI 10.1016/j.exppara.2012.05.014; Nomura H, 2004, BIOMED RES-TOKYO, V25, P287, DOI 10.2220/biomedres.25.287; Pei YanYan, 2010, Journal of Northwest A & F University - Natural Science Edition, V38, P165; Qiu XW, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010125; Rao Y.S., 1985, AISWS Research Publication, P65; REISE RW, 1987, J NEMATOL, V19, P387; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Shingles J, 2007, EXP PARASITOL, V115, P114, DOI 10.1016/j.exppara.2006.07.008; Song G, 2010, BIOL REPROD, V82, P854, DOI 10.1095/biolreprod.109.080929; Thakur PK, 2014, INDIAN J EXP BIOL, V52, P223; Turk D, 1996, FEBS LETT, V384, P211, DOI 10.1016/0014-5793(96)00309-2; WANG F, 2014, PLOS ONE; Wang Gaofeng, 2011, Sheng Wu Gong Cheng Xue Bao, V27, P60; Wang K, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0107-5; Zhang C, 2012, EUR J PLANT PATHOL, V133, P899, DOI 10.1007/s10658-012-0015-4	37	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0199935	10.1371/journal.pone.0199935	http://dx.doi.org/10.1371/journal.pone.0199935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0PZ	29958285	gold, Green Submitted, Green Published			2022-12-26	WOS:000436793500023
J	AbdelKhalek, A; Abutaleb, NS; Mohammad, H; Seleem, MN				AbdelKhalek, Ahmed; Abutaleb, Nader S.; Mohammad, Haroon; Seleem, Mohamed N.			Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)	PLOS ONE			English	Article							INDUCED HEARING-LOSS; QUINUPRISTIN-DALFOPRISTIN; STAPHYLOCOCCAL INFECTIONS; CLOSTRIDIUM-DIFFICILE; COLONIZED PATIENTS; DOUBLE-BLIND; FAECIUM; MECHANISMS; MANAGEMENT; EMERGENCE	Enterococci represent one of the microbial world's most challenging enigmas. Colonization of the gastrointestinal tract (GIT) of high-risk/immunocompromised patients by enterococci exhibiting resistance to vancomycin (VRE) can lead to life-threating infections, including bloodstream infections and endocarditis. Decolonization of VRE from the GIT of high-risk patients represents an alternative method to suppress the risk of the infection. It could be considered as a preventative measure to protect against VRE infections in high-risk individuals. Though multiple agents (ramoplanin and bacitracin) have been evaluated clinically, no drugs are currently approved for use in VRE decolonization of the GIT. The present study evaluates ebselen, a clinical molecule, for use as a decolonizing agent against VRE. When evaluated against a broad array of enterococcal isolates in vitro, ebselen was found to be as potent as linezolid (minimum inhibitory concentration against 90% of clinical isolates tested was 2 mu g/ml). Though VRE has a remarkable ability to develop resistance to antibacterial agents, no resistance to ebselen emerged after a clinical isolate of vancomycin-resistant E. faecium was serially-passaged with ebselen for 14 days. Against VRE biofilm, a virulence factor that enables the bacteria to colonize the gut, ebselen demonstrated the ability to both inhibit biofilm formation and disrupt mature biofilm. Furthermore, in a murine VRE colonization reduction model, ebselen proved as effective as ramoplanin in reducing the bacterial shedding and burden of VRE present in the fecal content (by > 99.99%), cecum, and ileum of mice. Based on the promising results obtained, ebselen warrants further investigation as a novel decolonizing agent to quell VRE infection.	[AbdelKhalek, Ahmed; Abutaleb, Nader S.; Mohammad, Haroon; Seleem, Mohamed N.] Purdue Univ, Dept Comparat Pathobiol, Coll Vet Med, W Lafayette, IN 47907 USA; [Seleem, Mohamed N.] Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Seleem, MN (corresponding author), Purdue Univ, Dept Comparat Pathobiol, Coll Vet Med, W Lafayette, IN 47907 USA.; Seleem, MN (corresponding author), Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.	mseleem@purdue.edu	Seleem, Mohamed/H-2774-2018	Seleem, Mohamed/0000-0003-0939-0458; Abutaleb, Nader/0000-0003-1730-4150	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01A1130186]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI130186] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01A1130186 for MNS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo Higuita N I, 2014, ENTEROCOCCI FROM COM; [Anonymous], 2014, ENTEROCOCCI COMMENSA; Arias CA, 2010, CLIN MICROBIOL INFEC, V16, P555, DOI 10.1111/j.1469-0691.2010.03214.x; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Azad GK, 2014, MOL BIOL REP, V41, P4865, DOI 10.1007/s11033-014-3417-x; Bender KO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac9103; Bi R, 2017, J GLOB ANTIMICROB RE; Bonten MJM, 1998, ARCH INTERN MED, V158, P1127, DOI 10.1001/archinte.158.10.1127; Cetinkaya Y, 2000, CLIN MICROBIOL REV, V13, P686, DOI 10.1128/CMR.13.4.686-707.2000; Cheng VCC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-514; Chew P, 2010, DIABETES, V59, P3198, DOI 10.2337/db10-0195; CLSI CaLSI, 2012, M07A9 CLSI CALSI; Creti R, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-60; de Almeida LM, 2014, ANTIMICROB AGENTS CH, V58, P2993, DOI 10.1128/AAC.02399-14; Donabedian SM, 2006, J CLIN MICROBIOL, V44, P3361, DOI 10.1128/JCM.02412-05; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Fiedler S, 2016, J ANTIMICROB CHEMOTH, V71, P871, DOI 10.1093/jac/dkv420; Garcia LS, 2010, CLIN MICROBIOLOGY PR; Gustafsson TN, 2016, BBA-GEN SUBJECTS, V1860, P1265, DOI 10.1016/j.bbagen.2016.03.013; Herrero IA, 2002, NEW ENGL J MED, V346, P867, DOI 10.1056/NEJM200203143461121; Ho C, 2013, CADTH Technol Overv, V3, pe3202; Hollenbeck BL, 2012, VIRULENCE, V3, P421, DOI 10.4161/viru.21282; Kamboj M, 2011, INFECT CONT HOSP EP, V32, P391, DOI 10.1086/659152; Kauffman CA, 2003, J ANTIMICROB CHEMOTH, V51, P23, DOI 10.1093/jac/dkg273; Kil J, 2007, HEARING RES, V226, P44, DOI 10.1016/j.heares.2006.08.006; Kil J, 2017, LANCET, V390, P969, DOI 10.1016/S0140-6736(17)31791-9; Lebreton F., 2014, ENTEROCOCCI COMMENSA; Lynch E, 2009, DEV EBSELEN GLUTATHI; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; May HC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00336; Miller WR, 2014, EXPERT REV ANTI-INFE, V12, P1221, DOI 10.1586/14787210.2014.956092; Mohamed MF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07440-0; Mohamed MF, 2017, BBA-GEN SUBJECTS, V1861, P848, DOI 10.1016/j.bbagen.2017.01.029; Mohamed MF, 2014, ANTIMICROB AGENTS CH, V58, P4113, DOI 10.1128/AAC.02578-14; Mohammad H, 2018, INT J ANTIMICROB AGE; Mohammad H, 2017, J MED CHEM, V60, P2425, DOI 10.1021/acs.jmedchem.6b01780; Mohammad H, 2015, J ANTIBIOT, V68, P259, DOI 10.1038/ja.2014.142; Naaber P, 2004, ADV APPL MICROBIOL, V54, P231, DOI 10.1016/S0065-2164(04)54009-1; Ngo HX, 2016, BIOORGAN MED CHEM, V24, P6298, DOI 10.1016/j.bmc.2016.03.060; O'Driscoll T, 2015, INFECT DRUG RESIST, V8, P217, DOI 10.2147/IDR.S54125; Oh WS, 2005, ANTIMICROB AGENTS CH, V49, P5176, DOI 10.1128/AAC.49.12.5176-5178.2005; Organization WH, 2017, GLOB PRIOR LIST ANT; Poduval RD, 2000, AM J GASTROENTEROL, V95, P3513, DOI 10.1111/j.1572-0241.2000.03291.x; Rogers SA, 2010, ORG BIOMOL CHEM, V8, P3857, DOI 10.1039/c0ob00063a; Roghmann MC, 1997, CLIN INFECT DIS, V25, P1056, DOI 10.1086/516112; Singh N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2320; Stiefel U, 2004, ANTIMICROB AGENTS CH, V48, P2144, DOI 10.1128/AAC.48.6.2144-2148.2004; Stratton CW, 2003, EMERG INFECT DIS, V9, P10; Thangamani S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00750; Thangamani S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133877; Thangamani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11596; Thangamani S, 2015, CURR PHARM DESIGN, V21, P2089, DOI 10.2174/1381612821666150310104416; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12; Younis W, 2017, CURR PHARM DESIGN, V23, P2147, DOI 10.2174/1381612823666170209154745; Younis W, 2015, CURR PHARM DESIGN, V21, P4106, DOI 10.2174/1381612821666150506154434	56	31	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199710	10.1371/journal.pone.0199710	http://dx.doi.org/10.1371/journal.pone.0199710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953486	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400054
J	Fischer, JH; Debski, I; Miskelly, CM; Bost, CA; Fromant, A; Tennyson, AJD; Tessler, J; Cole, R; Hiscock, JH; Taylor, GA; Wittmer, HU				Fischer, Johannes H.; Debski, Igor; Miskelly, Colin M.; Bost, Charles A.; Fromant, Aymeric; Tennyson, Alan J. D.; Tessler, Jake; Cole, Rosalind; Hiscock, Johanna H.; Taylor, Graeme A.; Wittmer, Heiko U.			Analyses of phenotypic differentiations among South Georgian Diving Petrel (Pelecanoides georgicus) populations reveal an undescribed and highly endangered species from New Zealand	PLOS ONE			English	Article							BURROW-NESTING PETRELS; INTEGRATIVE TAXONOMY; BREEDING BIOLOGY; PROCELLARIIFORMES; ISLAND; ESTABLISHMENT; EXTINCTION; PTERODROMA; PACHYPTILA; MANAGEMENT	Unresolved taxonomy of threatened species is problematic for conservation as the field relies on species being distinct taxonomic units. Differences in breeding habitat and results from a preliminary molecular analysis indicated that the New Zealand population of the South Georgian Diving Petrel (Pelecanoides georgicus) was a distinct, yet undescribed, species. We measured 11 biometric characters and scored eight plumage characters in 143 live birds and 64 study skins originating from most populations of P. georgicus, to assess their taxonomic relationships. We analysed differences with principal component analyses (PCA), factorial ANOVAs, and Kruskal-Wallis rank sum tests. Results show that individuals from New Zealand differ significantly from P. georgicus from all other populations as following: 1) longer wings, 2) longer outer tail feathers, 3) deeper bills, 4) longer heads, 5) longer tarsi, 6) limited collar extent, 7) greater extent of contrasting scapulars, 8) larger contrasting markings on the secondaries, 9) paler ear coverts, 10) paler collars, and 11) paler flanks. Furthermore, we used a species delimitation test with quantitative phenotypic criteria; results reveal that the New Zealand population of P. georgicus indeed merits species status. We hereby name this new species Pelecanoides whenuahouensis sp. nov. Due to severe reductions in its range and the very low number of remaining birds (similar to 150 individuals limited to a single breeding colony on Codfish Island/ Whenua Hou) the species warrants listing as `Critically Endangered'. An abstract in the Maori language/Te Reo Maori can be found in S1 File.	[Fischer, Johannes H.; Tessler, Jake; Wittmer, Heiko U.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Debski, Igor; Taylor, Graeme A.] Dept Conservat, Aquat Unit, Wellington, New Zealand; [Miskelly, Colin M.; Tennyson, Alan J. D.] Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand; [Bost, Charles A.; Fromant, Aymeric] Univ Rochelle, CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Cole, Rosalind; Hiscock, Johanna H.] Murikihu Dist Off, Dept Conservat, Invercargill, New Zealand	Victoria University Wellington; Centre National de la Recherche Scientifique (CNRS)	Fischer, JH (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	johannesfischer@live.nl	Wittmer, Heiko U/D-4172-2015	Wittmer, Heiko U/0000-0002-8861-188X; Fischer, Johannes/0000-0003-3527-1671	National Geographic Society [WW-249C-17]; Ornithological Society of New Zealand; Coastal Restoration Trust of New Zealand; Centre for Biodiversity and Restoration Ecology; Australasian Seabird Group; French Polar Institute; Terres Australes et Antarctiques Francaises	National Geographic Society(National Geographic Society); Ornithological Society of New Zealand; Coastal Restoration Trust of New Zealand; Centre for Biodiversity and Restoration Ecology; Australasian Seabird Group; French Polar Institute; Terres Australes et Antarctiques Francaises	The New Zealand part of the fieldwork (JHF) was supported by the National Geographic Society (grant number WW-249C-17), the Ornithological Society of New Zealand (2015 Birds NZ Research Fund; https://www.osnz.org.nz/2015-BNZRF-Projects), the Coastal Restoration Trust of New Zealand (2016 Post Graduate Study Award; http://www.coastalrestorationtrust.org.nz/annual-awards/postgraduate-student-award/), the Centre for Biodiversity and Restoration Ecology (2015 CBRE Project Grant; https://www.victoria.ac.nz/sbs/research-centres-institutes/centre-biodiversity-restoration-ecology), the Australasian Seabird Group (2016 Student Grant; http://www.birdlife.org.au/locations/australasian-seabird-group/latest-news-asg), and a public crowdfunder (2016 Experiment Seabird Challenge; DOI: 10.18258/7331). The Kerguelen part of the field work (CAB) was supported by the French Polar Institute (Institut Paul-Emile Victor, Program 394 Oiseaux Plongeurs; http://www.institut-polaire.fr/ipev-en/support-for-science/supported-programs/) and the Terres Australes et Antarctiques Francaises. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrom P, 2016, AVIAN RES, V7, DOI [10.1186/s40657-015-0016-z, 10.1186/s40657-016-0037-2]; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; [Anonymous], 2018, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2018-2.RLTS.T2478A50349982.EN; Armstrong D. P., 2012, REINTRODUCTION BIOL; Bell BD, 1998, NEW ZEAL J ZOOL, V25, P139, DOI 10.1080/03014223.1998.9518144; BirdLife International, 2016, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-3.RLTS, DOI 10.2305/IUCN.UK.2016-3.RLTS]; Black A, 2005, ANTARCT SCI, V17, P67, DOI 10.1017/S0954102005002439; Bolton M, 2008, IBIS, V150, P717, DOI 10.1111/j.1474-919X.2008.00854.x; Bourne W. R. P., 1968, Bulletin of the British Ornithologists' Club, V88, P77; BRETAGNOLLE V, 1993, AM NAT, V142, P141, DOI 10.1086/285532; Brooke M, 2004, ALBATROSSES PETRELS; Brothers Nigel, 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P123; Brothers Nigel, 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P117; BROTHERS NP, 1984, AUST WILDLIFE RES, V11, P113; Burfield IJ, 2017, BIRD CONSERV INT, V27, P1, DOI 10.1017/S0959270917000065; Cole R., 2004, SUMMARY S GEORGIAN D; Collar NJ, 2014, FORKTAIL, P23; Collar NJ, 2016, PASSERINES, V2; Connolly F, 2017, IOC WORLD BIRD LIST, DOI [DOI 10.14344/IOC, 10.14344/IOC]; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; del Hoyo J, 2014, HBW BIRDLIFE INT ILL, V1; del Hoyo J, 2013, HDB BIRDS WORLD; Eaton JA, 2015, FORKTAIL, P107; Fischer, 2016, THESIS; Fischer JH, 2018, NOTORNIS, V65, P35; Fischer JH, 2018, BIRD CONSERV INT, V28, P216, DOI 10.1017/S0959270917000041; Fischer JH, 2017, NOTORNIS, V64, P48; Fischer JH, 2017, NOTORNIS, V64, P13; Garnett S. T., 2011, ACTION PLAN AUSTR BI; Gibson J. D., 1959, Emu, V59, P267; Gill B.J., 2010, CHECKLIST BIRDS NZ N, V4th edition; GMELIN JF, 1789, SYSTEMA NATURAE REGN; GRIFFITHS G C D, 1974, Acta Biotheoretica, V23, P85, DOI 10.1007/BF01556343; Gummer H, 2015, GLOB ECOL CONSERV, V3, P310, DOI 10.1016/j.gecco.2014.12.006; HARRIS M P, 1980, Ringing and Migration, V3, P60; HARRISON P., 1983, SEABIRDS IDENTIFICAT; Hay JM, 2010, CONSERV GENET, V11, P1063, DOI 10.1007/s10592-009-9952-7; Hirokoshi M, 2016, GGFORTIFY DATA VISUA; Holdaway RN, 2003, J ROY SOC NEW ZEAL, V33, P601, DOI 10.1080/03014223.2003.9517748; IMBER M J, 1980, Notornis, V27, P325; JONES E, 1980, Notornis, V27, P11; KINSKY FC, 1968, IBIS, V110, P100, DOI 10.1111/j.1474-919X.1968.tb07983.x; Lacepede BGE., 1799, TABLEAUX METHODIQUES; LESSON R. P, 1828, MANUEL OMITHOLOGIE D, P308; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; Mathews GM, 1912, BIRDS AUSTR, V3; Mathews GM, 1935, NOVIT ZOOL, V39, P252; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; Middleton A., 2007, 200 YEARS CODFISH IS; Miskelly CM, 2004, EMU, V104, P205, DOI 10.1071/MU03062; Miskelly CM, 2009, BIOL CONSERV, V142, P1965, DOI 10.1016/j.biocon.2009.03.027; Murphy RC, 1916, B AM MUS NAT HIST, V35, P65; Murphy RC, 1921, B AM MUS NAT HIST, V44, P495; Navarro J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12164; Onley D., 2007, ALBATROSSES PETRELS; OSBERT Salvin, 1896, CATALOGUE BIRDS COLL, V25; Palma Ricardo L., 2017, FAUNA OF NEW ZEALAND, P3, DOI 10.7931/J2/FNZ.76; Paterson AM, 2000, NEW ZEAL J ZOOL, V27, P415, DOI 10.1080/03014223.2000.9518250; PAYNE MR, 1979, NEW ZEAL J ZOOL, V6, P299, DOI 10.1080/03014223.1979.10428368; Penhallurick J, 2004, EMU, V104, P125, DOI 10.1071/MU01060; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2016, R A LANG ENV STAT CO; Rawlence NJ, 2016, ZOOL J LINN SOC-LOND, V177, P676, DOI 10.1111/zoj.12376; Rayner MJ, 2017, EMU, V117, P290, DOI 10.1080/01584197.2017.1303332; Rheindt FE, 2005, EMU, V105, P181, DOI 10.1071/MU04039; Robertson H.A., 2021, NZ THREAT CLASSIFICA; Sangster G, 2016, J AVIAN BIOL, V47, P159, DOI 10.1111/jav.00825; Sangster G, 2014, BIOL REV, V89, P199, DOI 10.1111/brv.12051; Sangster G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053712; Scofield P, 2013, BIRDS NZ PHOTOGRAPHI; SHIRIHAI H., 2008, COMPLETE GUIDE ANTAR, VSecond; Taylor G., 2002, S GEORGIAN DIVING PE; Taylor G. A., 2013, NZ BIRDS ONLINE; Taylor GA, 2000, ACTION PLAN SEABIRD; Tennyson AJD, 2017, J ORNITHOL, V158, P379, DOI 10.1007/s10336-016-1416-5; Tobias JA, 2010, IBIS, V152, P724, DOI 10.1111/j.1474-919X.2010.01051.x; Torchiano M, 2016, EFFSIZE EFFICIENT EF; Totterman SL, 2016, MAR ORNITHOL, V44, P11; Trainor S., 2009, S GEORGIAN DIVING PE; Trainor S., 2008, CODFISH ISLAND S GEO; van Balen S., 2011, BIRD CONSERV INT, V23, P91; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood JR, 2017, ZOOL J LINN SOC-LOND, V179, P201, DOI 10.1111/zoj.12432; Wood Jamie R., 2008, Notornis, V55, P46; Worthy T. H., 1998, Notornis, V45, P229	86	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0197766	10.1371/journal.pone.0197766	http://dx.doi.org/10.1371/journal.pone.0197766			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949581	Green Submitted, gold, Green Published			2022-12-26	WOS:000436549200009
J	Helle, C; Hillesund, ER; Overby, NC				Helle, Christine; Hillesund, Elisabet R.; Overby, Nina C.			Timing of complementary feeding and associations with maternal and infant characteristics: A Norwegian cross-sectional study	PLOS ONE			English	Article							BODY-MASS INDEX; MOTHERS NEGATIVE AFFECTIVITY; WEIGHT-GAIN; DIETARY PATTERNS; SOCIODEMOGRAPHIC FACTORS; ESPGHAN COMMITTEE; STATEWIDE SAMPLE; MENTAL-HEALTH; SOLID FOODS; CHILDREN	Norwegian Health authorities recommend solid food to be introduced between child age 4-6 months, depending on both the mother's and infant's needs. The aim of this paper is to describe timing of complementary feeding in a current sample of Norwegian mother/infant-dyads and explore potential associations between timing of introduction to solid foods and a wide range of maternal and infant characteristics known from previous literature to influence early feeding interactions. The paper is based on data from the Norwegian randomized controlled trial Early Food for Future Health. In 2016, a total of 715 mothers completed a web-based questionnaire at child age 5.5 months. We found that 5% of the infants were introduced to solid food before 4 months of age, while 14% were not introduced to solid food at 5.5 months of age. Introduction of solid food before 4 months of age was associated with the infant not being exclusive breastfed the first month, receiving only formula milk at 3 months, the mother being younger, not married/cohabitant, smoking, less educated and having more economic difficulties. Not being introduced to solid food at 5.5 months was associated with the infant being a girl, being exclusive breastfed the first month, receiving only breastmilk at 3 months, the mother being older, married and having 3 or more children. This study shows that there are still clear socioeconomic differences regarding timing of complementary feeding in Norway. Infants of younger, less educated and smoking mothers are at higher risk of not being fed in compliance with the official infant feeding recommendations. Our findings emphasize the importance of targeting socioeconomically disadvantaged mothers for support on healthy feeding practices focusing on the infant's needs to prevent early onset of social inequalities in health.	[Helle, Christine; Hillesund, Elisabet R.; Overby, Nina C.] Univ Agder, Dept Publ Hlth Sport & Nutr, Fac Hlth & Sport Sci, Kristiansand, Norway	University of Agder	Helle, C (corresponding author), Univ Agder, Dept Publ Hlth Sport & Nutr, Fac Hlth & Sport Sci, Kristiansand, Norway.	christine.helle@uia.no	Ãverby, Nina/ABB-5400-2021		University of Agder; Eckbo Foundation	University of Agder; Eckbo Foundation	This work was supported by The University of Agder (https://www.uia.no/en) and The Eckbo Foundation (https://www.eckbos-legat.no/). The study is financed by the University of Agder. The main study is an RCT, where we have developed, implemented and will evaluate the impact of an eHealth intervention on infant nutrition for parents. The Eckbo Foundation contributed financial resources to the development of this intervention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2012, NUTR METAB CARDIOVAS, V22, P765, DOI 10.1016/j.numecd.2012.03.011; Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; Agostoni C, 2009, J PEDIATR GASTR NUTR, V49, P112, DOI 10.1097/MPG.0b013e31819f1e05; Aronsson CA, 2015, MATERN CHILD NUTR, V11, P803, DOI 10.1111/mcn.12084; Baker JL, 2007, AM J CLIN NUTR, V86, P404, DOI 10.1093/ajcn/86.2.404; Barrera CM, 2018, J ACAD NUTR DIET, V118, P464, DOI 10.1016/j.jand.2017.10.020; BATES JE, 1979, CHILD DEV, V50, P794, DOI 10.1111/j.1467-8624.1979.tb02428.x; Bergmeier H, 2014, OBES REV, V15, P9, DOI 10.1111/obr.12066; Braid S, 2015, J PEDIATR GASTR NUTR, V60, P811, DOI 10.1097/MPG.0000000000000695; Brekke HK, 2005, BRIT J NUTR, V94, P377, DOI 10.1079/BJN20051499; Brown A, 2016, MATERN CHILD NUTR, V12, P500, DOI 10.1111/mcn.12166; Caroli M, 2012, NUTR METAB CARDIOVAS, V22, P813, DOI 10.1016/j.numecd.2012.07.007; Castro PD, 2015, PUBLIC HEALTH NUTR, V18, P292, DOI 10.1017/S1368980014000329; Clayton HB, 2013, PEDIATRICS, V131, pE1108, DOI 10.1542/peds.2012-2265; Cohen AK, 2013, AM J PUBLIC HEALTH, V103, P997, DOI 10.2105/AJPH.2012.300993; Costa T. H. M., 2010, J NUTR, V140, P2227, DOI DOI 10.3945/JN.110.123489; Dalgard OS, 2005, LEV 2006; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Doub AE, 2015, APPETITE, V92, P261, DOI 10.1016/j.appet.2015.05.028; Erkkola M, 2013, PUBLIC HEALTH NUTR, V16, P296, DOI 10.1017/S1368980012002595; Fink P, 2004, J PSYCHOSOM RES, V56, P371, DOI 10.1016/S0022-3999(03)00071-0; Gaffney KF, 2014, J PEDIATR HEALTH CAR, V28, P43, DOI 10.1016/j.pedhc.2012.10.005; Grote V, 2011, AM J CLIN NUTR, V94, p1785S, DOI 10.3945/ajcn.110.000810; Gudnadottir M, 2006, ACTA PAEDIATR, V95, P419, DOI 10.1080/0803520500434769; Hampson SE, 2010, INT J OBESITY, V34, P327, DOI 10.1038/ijo.2009.230; Harrison M, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12360; Haycraft E, 2013, J FAM PSYCHOL, V27, P159, DOI 10.1037/a0031110; Hayes MJ, 2011, INFANT CHILD DEV, V20, P495, DOI 10.1002/icd.720; Helle C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4731-8; Hodges EA, 2013, APPETITE, V65, P210, DOI 10.1016/j.appet.2013.02.010; Holseter C, 2015, TIDSSKR NORSKE LAEGE, V135, P433; Hurley KM, 2008, J NUTR, V138, P799, DOI 10.1093/jn/138.4.799; Hurley KM, 2015, MATERN CHILD NUTR, V11, P229, DOI 10.1111/mcn.12004; Klingberg S, 2017, PUBLIC HEALTH NUTR, V20, P1054, DOI [10.1017/S1368980016003104, 10.1017/s1368980016003104]; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Kristiansen AL, 2010, PUBLIC HEALTH NUTR, V13, P2087, DOI 10.1017/S1368980010002156; Kronborg H, 2015, SCAND J PUBLIC HEALT, V43, P138, DOI 10.1177/1403494814567171; Kronborg H, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-243; Kvalevaag AL, 2015, CHILD PSYCHIAT HUM D, V46, P874, DOI 10.1007/s10578-014-0527-6; Lande B, 2003, ACTA PAEDIATR, V92, P152, DOI 10.1111/j.1651-2227.2003.tb00519.x; McMeekin S, 2013, APPETITE, V60, P239, DOI 10.1016/j.appet.2012.10.005; McNally J, 2016, MATERN CHILD NUTR, V12, P205, DOI 10.1111/mcn.12230; Michael S, 2001, OPTIMAL DURATION EXC; Niegel S, 2007, J DEV BEHAV PEDIATR, V28, P462, DOI 10.1097/DBP.0b013e31811431e8; Nilsen RM, 2013, PAEDIATR PERINAT EP, V27, P553, DOI 10.1111/ppe.12077; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Norwegian Directorate of health, 2017, NORW DIET GUID INF N; Norwegian Directorate of Health hhnpa-o-s-k-l-u-, 2014, BREAST FEED INF NUTR; Norwegian Health Directorate, 2008, SPEDK 6 MONTHS NAT S; Norwegian Institute of Public Health, 2017, MED BIRTH REG; Norwegian Institute of Public Health, NORW MOTH CHILD COH; Norwegian Institute of Public Health, 2014, HLTH RISK US SNUS; Norwegian Institute of Public Health, SMOK US SNUS NORW; O'Donovan SM, 2015, PUBLIC HEALTH NUTR, V18, P2864, DOI 10.1017/S136898001500018X; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Patro-Golab B, 2016, OBES REV, V17, P1245, DOI 10.1111/obr.12476; Pearce J, 2013, INT J OBESITY, V37, P1295, DOI 10.1038/ijo.2013.99; Schrempft S, 2013, EUR J CLIN NUTR, V67, P652, DOI 10.1038/ejcn.2013.63; Scott JA, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-60; Smith HA, 2016, COCHRANE DB SYST REV, V8; Sun C, 2016, J PEDIATR-US, V179, P104, DOI 10.1016/j.jpeds.2016.08.064; Tambs K., 2014, Norsk Epidemiologi, V24, P195; Taveras EM, 2008, ARCH PEDIAT ADOL MED, V162, P305, DOI 10.1001/archpedi.162.4.305; University of Agder, 2016, EARL FOOD FUT HLTH; Vollrath ME, 2011, INT J PEDIATR OBES, V6, pE408, DOI 10.3109/17477166.2010.518240; Walsh A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2250-z; Weng SF, 2012, ARCH DIS CHILD, V97, P1019, DOI 10.1136/archdischild-2012-302263; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; Wijndaele K, 2009, J AM DIET ASSOC, V109, P2017, DOI 10.1016/j.jada.2009.09.003; Winkvist A, 2015, J NUTR, V145, P1263, DOI 10.3945/jn.114.202507; World Health Organisation, 2017, BMI CLASS; World Health Organization, 2018, CHILD GROWTH STAND; World Health Organozation, 2017, EXCL BREASTT; Ystrom E, 2008, J PEDIATR-US, V152, P68, DOI 10.1016/j.jpeds.2007.06.005; Ystrom E, 2012, MATERN CHILD NUTR, V8, P103, DOI 10.1111/j.1740-8709.2010.00257.x; Ystrom E, 2009, MATERN CHILD NUTR, V5, P234, DOI 10.1111/j.1740-8709.2008.00177.x; Zheng M, 2018, OBES REV, V19, P321, DOI 10.1111/obr.12632	77	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199455	10.1371/journal.pone.0199455	http://dx.doi.org/10.1371/journal.pone.0199455			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK9FZ	29949644	gold, Green Published, Green Submitted			2022-12-26	WOS:000436549200051
J	Mondesir, FL; Carson, AP; Durant, RW; Lewis, MW; Safford, MM; Levitan, EB				Mondesir, Favel L.; Carson, April P.; Durant, Raegan W.; Lewis, Marquita W.; Safford, Monika M.; Levitan, Emily B.			Association of functional and structural social support with medication adherence among individuals treated for coronary heart disease risk factors: Findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study	PLOS ONE			English	Article							DIABETES-MELLITUS; OLDER-ADULTS; SELF-CARE; OUTCOMES; NONADHERENCE; HYPERTENSION; METAANALYSIS; BLACK; DIRECTIONS; PREVALENCE	Background Functional social support has a stronger association with medical treatment adherence than structural social support in several populations and disease conditions. Using a contemporary U.S. population of adults treated with medications for coronary heart disease (CHD) risk factors, the association between social support and medication adherence was examined. Methods We included 17,113 black and white men and women with CHD or CHD risk factors aged >= 45 years recruited 2003-2007 from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Participants reported their perceived social support (structural social support: being partnered, number of close friends, number of close relatives, and number of other adults in household; functional social support: having a caregiver in case of sickness or disability; combination of structural and functional social support: number of close friends or relatives seen at least monthly). Medication adherence was assessed using a 4-item scale. Multi-variable adjusted Poisson regression models were used to calculate prevalence ratios (PR) for the association between social support and medication adherence. Results Prevalence of medication adherence was 68.9%. Participants who saw >10 close friends or relatives at least monthly had higher prevalence of medication adherence (PR = 1.06; 95% CI: 1.00, 1.11) than those who saw <= 3 per month. Having a caregiver in case of sickness or disability, being partnered, number of close friends, number of close relatives, and number of other adults in household were not associated with medication adherence after adjusting for covariates. Conclusions Seeing multiple friends and relatives was associated with better medication adherence among individuals with CHD risk factors. Increasing social support with combined structural and functional components may help support medication adherence.	[Mondesir, Favel L.; Carson, April P.; Levitan, Emily B.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Durant, Raegan W.] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL USA; [Lewis, Marquita W.] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA; [Safford, Monika M.] Weill Cornell Med, Dept Med, New York, NY USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Cornell University	Levitan, EB (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	elevitan@uab.edu		Levitan, Emily/0000-0002-5429-3852; Carson, April/0000-0002-7970-6756	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service [U01 NS041588]; National Institute of Neurological Disorders and Stroke or the National Institutes of Health. Representatives; American Heart Association Greater Southeast Affiliate Grant [16PRE29640015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080477] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Neurological Disorders and Stroke or the National Institutes of Health. Representatives; American Heart Association Greater Southeast Affiliate Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The REGARDS study is supported by a cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. Representatives of the funding agency have been involved in the review of the manuscript but not directly involved in the collection, management, analysis, or interpretation of the data. The authors thank the other investigators, the staff, and the participants of the REGARDS study for their valuable contributions. A full list of participating REGARDS investigators and institutions can be found at http://www.regardsstudy.org. This work was also supported by American Heart Association Greater Southeast Affiliate Grant 16PRE29640015 (MONDESIR); received by FLM. The authors are solely responsible for the design and conduct of this study, all study analyses, the drafting and editing of the manuscript, and its final contents. A.P.C. receives funding from Amgen for unrelated work, R.W.D receives funding from Amgen and Amarin for unrelated work, M.M.S receives funding from Amgen and diaDexus for unrelated work, E.B.L receives funding from Amgen for unrelated work and has consulted for Amgen and Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday L A, 1974, Health Serv Res, V9, P208; Albus C, 2010, ANN MED, V42, P487, DOI 10.3109/07853890.2010.515605; CHATTERS LM, 1985, J GERONTOL, V40, P605, DOI 10.1093/geronj/40.5.605; Cohen PN, 2002, SOCIOL PERSPECT, V45, P1, DOI 10.1525/sop.2002.45.1.1; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Edwards LV, 2006, QUAL HEALTH RES, V16, P679, DOI 10.1177/1049732305281597; Elliott WJ, 2000, POSTGRAD MED, V107, P29, DOI 10.3810/pgm.2000.03.940; Enzlin P, 2002, PATIENT EDUC COUNS, V48, P139, DOI 10.1016/S0738-3991(02)00009-5; Ford ME, 1998, J NATL MED ASSOC, V90, P361; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; Gerber BS, 2010, AM J GERIATR PHARMAC, V8, P136, DOI 10.1016/j.amjopharm.2010.03.002; Glasser SP, 2010, CLIN CARDIOL, V33, P280, DOI 10.1002/clc.20758; Gutierrez OM, 2013, JAMA-J AM MED ASSOC, V310, P706, DOI 10.1001/jama.2013.8777; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Irvin MR, 2012, J CLIN HYPERTENS, V14, P694, DOI 10.1111/j.1751-7176.2012.00690.x; Irvine J, 1999, PSYCHOSOM MED, V61, P566, DOI 10.1097/00006842-199907000-00023; Johnson VR, 2010, PATIENT EDUC COUNS, V79, P14, DOI 10.1016/j.pec.2009.07.002; KAPLAN RM, 1987, HEALTH PSYCHOL, V6, P387, DOI 10.1037/0278-6133.6.5.387; Kronish IM, 2013, PROG CARDIOVASC DIS, V55, P590, DOI 10.1016/j.pcad.2013.02.001; Larson SL, 2003, MED CARE, V41, P65, DOI 10.1097/01.MLR.0000076053.28108.F2; Magrin ME, 2015, ANN BEHAV MED, V49, P307, DOI 10.1007/s12160-014-9663-2; Marcum ZA, 2013, RES SOC ADMIN PHARM, V9, P817, DOI 10.1016/j.sapharm.2012.12.002; McDermott MM, 1997, ARCH INTERN MED, V157, P1921, DOI 10.1001/archinte.157.17.1921; Mondesir FL, 2016, J GERONTOL B-PSYCHOL, V71, P1081, DOI 10.1093/geronb/gbv061; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Naderi SH, 2012, AM J MED, V125, P882, DOI 10.1016/j.amjmed.2011.12.013; Ncama BP, 2008, INT J NURS STUD, V45, P1757, DOI 10.1016/j.ijnurstu.2008.06.006; Osborn CY, 2012, GEN HOSP PSYCHIAT, V34, P249, DOI 10.1016/j.genhosppsych.2012.01.015; Quality Metric, 2007, SF 12S EV SHORT HLTH; Rees CA, 2010, DIABETES EDUCATOR, V36, P435, DOI 10.1177/0145721710364419; Royston P, 2011, MULTIPLE IMPUTATION, V45, P20; Shenolikar RA, 2006, J NATL MED ASSOC, V98, P1071; Tang TS, 2008, DIABETES EDUCATOR, V34, P266, DOI 10.1177/0145721708315680; TAYLOR RJ, 1990, J MARRIAGE FAM, V52, P584, DOI 10.2307/352925; Trinacty CM, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-24; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; WILLIAMS HA, 1993, SOC SCI MED, V37, P1509, DOI 10.1016/0277-9536(93)90185-7; WILSON MN, 1990, J CLIN CHILD PSYCHOL, V19, P347, DOI 10.1207/s15374424jccp1904_6; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	42	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198578	10.1371/journal.pone.0198578	http://dx.doi.org/10.1371/journal.pone.0198578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK9FZ	29949589	Green Published, gold, Green Submitted			2022-12-26	WOS:000436549200017
J	Wommack, JC; Trzeciakowski, JP; Miranda, RC; Stowe, RP; Ruiz, RJ				Wommack, Joel C.; Trzeciakowski, Jerome P.; Miranda, Rajesh C.; Stowe, Raymond P.; Ruiz, R. Jeanne			Micro RNA clusters in maternal plasma are associated with preterm birth and infant outcomes	PLOS ONE			English	Article							PREGNANCY-ASSOCIATED MICRORNAS; IDENTIFICATION; CIRCULATION	The current study examined micro RNA (miRNAs) clusters from the maternal plasma to determine their association with preterm birth (PTB) and infant birth outcomes. A subsample of 42 participants who spontaneously delivered either preterm (<= 37 weeks) or term was selected from a parent sample of 515 pregnant Mexican American women. Plasma samples and prenatal data were collected at a single mid-gestation time point (22-24 weeks' gestation) and birth outcomes were obtained from medical records after delivery. Circulating miRNAs were analyzed by qPCR. When miRNAs were grouped according to chromosomal cluster rather than expression level, individual miRNAs correlated strongly with other individual miRNAs within their respective genomic locus. miRNAs from the c19mc cluster negatively correlated with c14mc miRNAs, and this relationship was more pronounced in PTB. Clusters c14mc was negatively associated with length of gestation; while the c19mc was positively associated with length of gestation and infant head circumference. Together, these findings suggest that groups of miRNAs from common chromosomal clusters, rather than individual miRNAs, operate as co-regulated groups of signaling molecules to coordinate length of gestation and infant outcomes. From this evidence, differences in cluster-wide expression of miRNAs are involved in spontaneous PTB.	[Wommack, Joel C.; Stowe, Raymond P.; Ruiz, R. Jeanne] Microgen Labs, La Marque, TX 77568 USA; [Trzeciakowski, Jerome P.; Miranda, Rajesh C.] Texas A&M Univ, Coll Med, Bryan, TX USA	Texas A&M University System; Texas A&M University College Station	Wommack, JC (corresponding author), Microgen Labs, La Marque, TX 77568 USA.	jwommack@microgenlabs.com		Miranda, Rajesh/0000-0002-8359-892X	NIH [R01NR0107891]; Microgen Labs LLC; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR007891] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microgen Labs LLC; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by an NIH grant (R01NR0107891) awarded to R.J. Ruiz. Microgen Labs LLC provided funding in the form of salaries for author [RS] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; [Anonymous], MIRNA TARG GEN PATHW; Ashton D, 2006, ETHNIC DIS, V16, P58; Balaraman S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165081; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Behrman RE, 2007, PRETERM BIRTH CAUSES; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205; Elovitz MA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.023; Gardiner E, 2012, MOL PSYCHIATR, V17, P827, DOI 10.1038/mp.2011.78; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Hromadnikova I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171756; Hromadnikova I, 2012, J MOL DIAGN, V14, P160, DOI 10.1016/j.jmoldx.2011.11.003; JENNRICH RI, 1970, J AM STAT ASSOC, V65, P904, DOI 10.2307/2284596; Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lin S, 2010, COMPUT BIOL CHEM, V34, P232, DOI 10.1016/j.compbiolchem.2010.08.001; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Morales-Prieto DM, 2014, PLACENTA, V35, pS39, DOI 10.1016/j.placenta.2013.11.017; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; Prieto DMM, 2011, J REPROD IMMUNOL, V88, P106, DOI 10.1016/j.jri.2011.01.004; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Ruiz RJ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0640-y; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Tsochandaridis M, 2015, BIOMED RES INT, V2015, P2949; Williams KC, 2012, P NATL ACAD SCI USA, V109, P7529, DOI 10.1073/pnas.1200650109; Yang SP, 2015, MOL MED REP, V12, P1145, DOI 10.3892/mmr.2015.3490; Zhu XM, 2009, AM J OBSTET GYNECOL, V661, pe1	30	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199029	10.1371/journal.pone.0199029	http://dx.doi.org/10.1371/journal.pone.0199029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949620	gold, Green Submitted, Green Published			2022-12-26	WOS:000436549200035
J	Wrenn, SM; Griswold, ED; Uhl, FE; Uriarte, JJ; Park, HE; Coffey, AL; Dearborn, JS; Ahlers, BA; Deng, B; Lam, YW; Huston, DR; Lee, PC; Wagner, DE; Weiss, DJ				Wrenn, Sean M.; Griswold, Ethan D.; Uhl, Franziska E.; Uriarte, Juan J.; Park, Heon E.; Coffey, Amy L.; Dearborn, Jacob S.; Ahlers, Bethany A.; Deng, Bin; Lam, Ying-Wai; Huston, Dryver R.; Lee, Patrick C.; Wagner, Darcy E.; Weiss, Daniel J.			Avian lungs: A novel scaffold for lung bioengineering	PLOS ONE			English	Article							EPITHELIAL-CELLS; COMPARATIVE DECELLULARIZATION; COMPARATIVE PHYSIOLOGY; EXCHANGE TISSUE; HIGH-THROUGHPUT; ACELLULAR HUMAN; PORCINE LUNGS; RECELLULARIZATION; EVOLUTION; MATRIX	Allogeneic lung transplant is limited both by the shortage of available donor lungs and by the lack of suitable long-term lung assist devices to bridge patients to lung transplantation. Avian lungs have different structure and mechanics resulting in more efficient gas exchange than mammalian lungs. Decellularized avian lungs, recellularized with human lung cells, could therefore provide a powerful novel gas exchange unit for potential use in pulmonary therapeutics. To initially assess this in both small and large avian lung models, chicken (Gallus gallus domesticus) and emu (Dromaius novaehollandiae) lungs were decellularized using modifications of a detergent-based protocol, previously utilized with mammalian lungs. Light and electron microscopy, vascular and airway resistance, quantitation and gel analyses of residual DNA, and immunohistochemical and mass spectrometric analyses of remaining extracellular matrix (ECM) proteins demonstrated maintenance of lung structure, minimal residual DNA, and retention of major ECM proteins in the decellularized scaffolds. Seeding with human bronchial epithelial cells, human pulmonary vascular endothelial cells, human mesenchymal stromal cells, and human lung fibroblasts demonstrated initial cell attachment on decellularized avian lungs and growth over a 7-day period. These initial studies demonstrate that decellularized avian lungs may be a feasible approach for generating functional lung tissue for clinical therapeutics.	[Wrenn, Sean M.] Univ Vermont, Dept Surg, Burlington, VT 05405 USA; [Wrenn, Sean M.; Griswold, Ethan D.; Uhl, Franziska E.; Uriarte, Juan J.; Park, Heon E.; Coffey, Amy L.; Dearborn, Jacob S.; Weiss, Daniel J.] Univ Vermont, Dept Med, Burlington, VT 05405 USA; [Griswold, Ethan D.] Rochester Inst Technol, Rochester, NY 14623 USA; [Park, Heon E.; Huston, Dryver R.; Lee, Patrick C.] Univ Vermont, Dept Mech Engn, Burlington, VT USA; [Ahlers, Bethany A.; Deng, Bin; Lam, Ying-Wai] Univ Vermont, Dept Biol, Burlington, VT USA; [Wagner, Darcy E.] Ludwig Maximilians Univ Munchen, Comprehens Pneumol Ctr, Munich, Germany; [Wagner, Darcy E.] Lund Univ, Lung Bioengn & Regenerat, Dept Expt Med Sci, Lund, Sweden	University of Vermont; University of Vermont; Rochester Institute of Technology; University of Vermont; University of Vermont; University of Munich; Lund University	Weiss, DJ (corresponding author), Univ Vermont, Dept Med, Burlington, VT 05405 USA.	daniel.weiss@uvm.edu	Wagner, Darcy E/R-4718-2017; Wrenn, Sean Marcus/GYU-6366-2022	Wagner, Darcy E/0000-0003-3794-1309; Griswold, Ethan/0000-0003-3699-2286; Wrenn, Sean/0000-0002-3579-845X; Uhl, Franziska Elisabeth/0000-0002-0641-4162; Lee, Patrick C./0000-0002-8341-6276	NIH/NHLBI [R21 EB024329]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB024329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH/NHLBI - R21 EB024329 (DJ Weiss). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram KM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-9; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Bonenfant NR, 2013, BIOMATERIALS, V34, P3231, DOI 10.1016/j.biomaterials.2013.01.031; Bonvillain RW, 2012, TISSUE ENG PT A, V18, P2437, DOI [10.1089/ten.tea.2011.0594, 10.1089/ten.TEA.2011.0594]; BRETZ WL, 1972, J EXP BIOL, V56, P57; Commins SP, 2009, J ALLERGY CLIN IMMUN, V123, P426, DOI 10.1016/j.jaci.2008.10.052; Contreras RG, 2002, PFLUG ARCH EUR J PHY, V444, P467, DOI 10.1007/s00424-002-0827-8; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Crotti S, 2013, CHEST, V144, P1018, DOI 10.1378/chest.12-1141; Daly AB, 2012, TISSUE ENG PT A, V18, P1, DOI [10.1089/ten.tea.2011.0301, 10.1089/ten.TEA.2011.0301]; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doufle G, 2016, CURR OPIN CRIT CARE, V22, P230, DOI 10.1097/MCC.0000000000000309; Farmer CG, 2015, PHYSIOLOGY, V30, P260, DOI 10.1152/physiol.00056.2014; Farmer CG, 2010, PHYSIOL BIOCHEM ZOOL, V83, P561, DOI 10.1086/605335; Farmer CG, 2015, ZOOLOGY, V118, P299, DOI 10.1016/j.zool.2015.06.001; Gilpin SE, 2014, J HEART LUNG TRANSPL, V33, P298, DOI 10.1016/j.healun.2013.10.030; Goodpaster T, 2008, J HISTOCHEM CYTOCHEM, V56, P347, DOI 10.1369/jhc.7A7287.2007; Han SW, 2006, ONCOGENE, V25, P4341, DOI 10.1038/sj.onc.1209460; Harvey EP, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004637; Kennedy JL, 2013, PEDIATRICS, V131, pE1545, DOI 10.1542/peds.2012-2585; King A. S., 1966, International Review of General and Experimental Zoology, V2, P171; Ko IK, 2015, BIOMATERIALS, V40, P72, DOI 10.1016/j.biomaterials.2014.11.027; Maina JN, 2000, ANAT REC, V261, P25; Maina JN, 2015, ANAT REC, V298, P1673, DOI 10.1002/ar.23162; Makanya AN, 2011, MICROSC RES TECHNIQ, V74, P159, DOI 10.1002/jemt.20887; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Nakamura Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09980-x; Nichols JE, 2013, TISSUE ENG PT A, V19, P2045, DOI [10.1089/ten.tea.2012.0250, 10.1089/ten.TEA.2012.0250]; Nichols JE, 2012, J CELL BIOCHEM, V113, P2185, DOI 10.1002/jcb.24112; Orlando G, 2013, ANN SURG, V258, P221, DOI 10.1097/SLA.0b013e31829c79cf; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Platz J, 2016, TISSUE ENG PART C-ME, V22, P725, DOI [10.1089/ten.TEC.2016.0109, 10.1089/ten.tec.2016.0109]; Ponganis PJ, 2015, J EXP BIOL, V218, P720, DOI 10.1242/jeb.113647; Price AP, 2015, TISSUE ENG PART C-ME, V21, P94, DOI [10.1089/ten.tec.2013.0756, 10.1089/ten.TEC.2013.0756]; Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]; Reed W, 2009, TRANSFUSION, V49, P786, DOI 10.1111/j.1537-2995.2008.02027.x; Ren X, 2015, NAT BIOTECHNOL, V33, P1097, DOI 10.1038/nbt.3354; Sokocevic D, 2013, BIOMATERIALS, V34, P3256, DOI 10.1016/j.biomaterials.2013.01.028; Squiers JJ, 2016, J THORAC CARDIOV SUR, V152, P20, DOI 10.1016/j.jtcvs.2016.02.067; Tacoma R, 2016, J PROTEOMICS, V130, P200, DOI 10.1016/j.jprot.2015.09.024; Valapour M, 2014, AM J TRANSPLANT, V14, P139, DOI 10.1111/ajt.12584; Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935; Wagner DE, 2014, CELL MOL BIOENG, V7, P184, DOI 10.1007/s12195-014-0323-1; Wagner DE, 2014, BIOMATERIALS, V35, P3281, DOI 10.1016/j.biomaterials.2013.12.103; Wagner DE, 2014, BIOMATERIALS, V35, P2664, DOI 10.1016/j.biomaterials.2013.11.078; Wagner DE, 2013, RESPIROLOGY, V18, P895, DOI 10.1111/resp.12102; Wallis JM, 2012, TISSUE ENG PART C-ME, V18, P420, DOI [10.1089/ten.tec.2011.0567, 10.1089/ten.TEC.2011.0567]; West JB, 2007, EUR RESPIR J, V29, P11, DOI 10.1183/09031936.00133306; West JB, 2011, COMPR PHYSIOL, V1, P1525, DOI 10.1002/cphy.c090001; West JB, 2009, AM J PHYSIOL-REG I, V297, pR1625, DOI 10.1152/ajpregu.00459.2009; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219; Zvarova B, 2016, TISSUE ENG PART C-ME, V22, P418, DOI [10.1089/ten.tec.2015.0439, 10.1089/ten.TEC.2015.0439]	52	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198956	10.1371/journal.pone.0198956	http://dx.doi.org/10.1371/journal.pone.0198956			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949597	Green Published, gold, Green Submitted			2022-12-26	WOS:000436549200032
J	Aki, T; Hashimoto, K; Ogasawara, M; Itoi, E				Aki, Takashi; Hashimoto, Ko; Ogasawara, Masanori; Itoi, Eiji			A whole-genome transcriptome analysis of articular chondrocytes in secondary osteoarthritis of the hip	PLOS ONE			English	Article							IGF-BINDING PROTEINS; GENE-EXPRESSION; ACETABULAR DYSPLASIA; EXTRACELLULAR-MATRIX; CPG SITES; IN-VITRO; CARTILAGE; MECHANISMS; BIOLOGY; JAPAN	Objective To date, exhaustive gene expression analyses of chondrocytes in hip osteoarthritis (OA) have yielded specific gene expression patterns. No study has reported on the exhaustive transcriptome of secondary hip OA based on acetabular dysplasia in a Japanese population, while previous reports have focused on primary or idiopathic hip OA in Caucasian populations. This study aims to search for specific gene expression patterns of secondary hip OA chondrocytes by transcriptome analysis. Design Human articular cartilage was obtained from femoral heads following hemiarthroplasty for femoral neck fracture (N = 8; non-OA) and total hip arthroplasty for secondary hip OA (N = 12). Total RNA was extracted from the articular cartilage and submitted for microarray analysis. The obtained data were used to perform gene expression analysis, GO enrichment analysis and pathway analysis and were compared with data from primary hip OA in Caucasian populations in the literature. Results We identified 888 upregulated (fold change: FC >= 2) and 732 downregulated (FC <= 0.5) genes in hip OA versus non-OA chondrocytes, respectively. Only 10% of upregulated genes were common between the secondary and primary OA. The newly found genes prominently overexpressed in the secondary hip OA chondrocytes were DPT, IGFBP7, and KLF2. Pathway analysis revealed extracellular matrix (ECM)-receptor interaction as an OArelated pathway, which was similar to previous reports in primary hip OA. Conclusions This is the first study to report the genome-wide transcriptome of secondary hip OA chondrocytes and demonstrates new potential OA-related genes. Gene expression patterns were different between secondary and primary hip OA, although the results of pathway and functional analysis were similar.	[Aki, Takashi; Hashimoto, Ko; Ogasawara, Masanori; Itoi, Eiji] Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Sendai, Miyagi, Japan	Tohoku University	Hashimoto, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Sendai, Miyagi, Japan.	khashimoto@med.tohoku.ac.jp		Hashimoto, Ko/0000-0002-9644-054X	HIROMI Medical Research Foundation; Takeda Science Foundation; JSPS KAKENHI [26870031, 16K10882]	HIROMI Medical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by HIROMI Medical Research Foundation, Takeda Science Foundation, and JSPS KAKENHI Grant Number 26870031 and 16K10882. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H; Akasaki Y, 2014, ARTHRITIS RHEUMATOL, V66, P3349, DOI 10.1002/art.38868; [Anonymous], 1971, J JPN ORTHOP ASSOC, V45, P826; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boon RA, 2010, BLOOD, V115, P2533, DOI 10.1182/blood-2009-06-228726; Cui S, 2015, ACTA HISTOCHEM, V117, P62, DOI 10.1016/j.acthis.2014.11.003; da Silva MA, 2009, J ORTHOP RES, V27, P593, DOI 10.1002/jor.20799; Eviatar T, 2003, ARTHRITIS RHEUM, V48, P410, DOI 10.1002/art.10761; Gehrsitz A, 2001, J ORTHOPAED RES, V19, P478, DOI 10.1016/S0736-0266(00)90028-7; Gelse K, 2012, OSTEOARTHR CARTILAGE, V20, P162, DOI 10.1016/j.joca.2011.12.004; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Hashimoto K, 2013, J BIOL CHEM, V288, P10061, DOI 10.1074/jbc.M112.421156; HOAGLUND FT, 1985, J BONE JOINT SURG AM, V67A, P1376, DOI 10.2106/00004623-198567090-00012; Hong S, 2009, FASEB J, V23, P3539, DOI 10.1096/fj.09-133215; Hunter DJ, 2014, NAT REV RHEUMATOL, V10, P437, DOI 10.1038/nrrheum.2014.44; Jingushi S, 2010, J ORTHOP SCI, V15, P626, DOI 10.1007/s00776-010-1507-8; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kou I, 2010, J BONE MINER METAB, V28, P395, DOI 10.1007/s00774-009-0145-8; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019; Morales TI, 2008, J ORTHOP RES, V26, P465, DOI 10.1002/jor.20549; NAKAMURA S, 1989, CLIN ORTHOP RELAT R, P190; Neogi T, 2013, RHEUM DIS CLIN N AM, V39, P1, DOI 10.1016/j.rdc.2012.10.004; Okamoto O, 2006, CONNECT TISSUE RES, V47, P177, DOI 10.1080/03008200600846564; Rahmati M, 2017, AGEING RES REV, V40, P20, DOI 10.1016/j.arr.2017.07.004; Rasheed Z, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3166; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Sekimoto T, 2017, BONE JOINT RES, V6, P439, DOI 10.1302/2046-3758.67.BJR-2016-0094.R1; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Snelling S, 2014, OSTEOARTHR CARTILAGE, V22, P334, DOI 10.1016/j.joca.2013.12.009; Spector T. D, 2004, OSTEOARTHR CARTILAGE, V12, pS39, DOI DOI 10.1016/J.J0CA.2003.09.005; Spector TD, 1996, BRIT MED J, V312, P940; Valdes AM, 2007, ARTHRITIS RHEUM-US, V56, P137, DOI 10.1002/art.22301; van Meurs JBJ, 2017, OSTEOARTHR CARTILAGE, V25, P181, DOI 10.1016/j.joca.2016.11.011; Wang DD, 2015, EUR REV MED PHARMACO, V19, P3367; Wang WY, 2016, GENE, V591, P43, DOI 10.1016/j.gene.2016.06.058; Xu Y, 2012, OSTEOARTHR CARTILAGE, V20, P1029, DOI 10.1016/j.joca.2012.05.006; Yoshimura N, 1998, BRIT J RHEUMATOL, V37, P1193; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Yuan YH, 2017, CELL PHYSIOL BIOCHEM, V42, P2159, DOI 10.1159/000479991; Zhang MC, 2016, INT J BIOCHEM CELL B, V72, P125, DOI 10.1016/j.biocel.2016.01.013; Zhang Q, 2015, OSTEOARTHR CARTILAGE, V23, P2259, DOI 10.1016/j.joca.2015.06.014	45	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199734	10.1371/journal.pone.0199734	http://dx.doi.org/10.1371/journal.pone.0199734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944724	Green Submitted, gold, Green Published			2022-12-26	WOS:000436377800057
J	Schneider, UV; Mikkelsen, ND; Scheutz, F; Friis-Moller, A; Lisby, G				Schneider, Uffe Vest; Mikkelsen, Nikolaj Dam; Scheutz, Flemming; Friis-Moller, Alice; Lisby, Gorm			Nonaplex PCR using Cliffhanger primers to identify diarrhoeagenic Escherichia coli from crude lysates of human faecal samples	PLOS ONE			English	Article							INFECTIOUS GASTROENTERITIS; ENTERIC PATHOGENS; AMPLIFICATION; MULTICENTER; DIAGNOSIS; DIARRHEA; CHILDREN; PANEL	Sensitive, probe-based detection of multiple DNA targets is limited by the competitive reannealing of the antiparallel duplex DNA helix with the complementary DNA strand. To address this, we developed Cliffhanger primers, which create single-stranded DNA overhangs on PCR amplicons while simultaneously increasing the multiplex PCR efficacy and allowing PCR amplification using crude lysates of human faecal samples. A multiplex PCR that targeted eight genes from diarrhoeagenic Escherichia coli plus an internal control was performed and compared to a routine method that consisted of culture followed by multiplex PCR with fragment length separation. A total of 2515 clinical faecal samples from patients with diarrhoea were tested using both methods, and there was a significant increase in clinical sensitivity and negative predictive value with the Cliffhanger method for seven out of eight genes. All Cliffhanger-only positive samples were confirmed by Sanger sequencing of the PCR amplicon. Notably, the Cliffhanger method reduced the total sample turn-around time in the laboratory from 20 hours to 6 hours. Hence, use of Cliffhanger primers increased assay robustness, decreased turn-around time and increased PCR efficacy. This increased the overall clinical sensitivity without the loss of specificity for a heavily multiplexed PCR assay.	[Schneider, Uffe Vest; Mikkelsen, Nikolaj Dam; Lisby, Gorm] Anapa Biotech AS, Horsholm, Denmark; [Schneider, Uffe Vest; Friis-Moller, Alice; Lisby, Gorm] Copenhagen Univ Hosp Hvidovre, Dept Clin Microbiol, Hvidovre, Denmark; [Schneider, Uffe Vest; Mikkelsen, Nikolaj Dam] Statens Serum Inst, Copenhagen, Denmark; [Scheutz, Flemming] Statens Serum Inst, Int Collaborating Ctr Reference & Res Escherichia, Dept Bacteria Parasites & Fungi, Copenhagen, Denmark	University of Copenhagen; Statens Serum Institut; Statens Serum Institut	Schneider, UV (corresponding author), Anapa Biotech AS, Horsholm, Denmark.; Schneider, UV (corresponding author), Copenhagen Univ Hosp Hvidovre, Dept Clin Microbiol, Hvidovre, Denmark.; Schneider, UV (corresponding author), Statens Serum Inst, Copenhagen, Denmark.	uffe.vest.schneider@regionh.dk	Schneider, Uffe Vest/GPT-3115-2022; Lisby, Gorm/GMX-0386-2022	Schneider, Uffe Vest/0000-0003-1372-7885; 	Anapa Biotech A/S	Anapa Biotech A/S	The use of TINA molecule-modified primers and Cliffhanger primers for commercial PCR assays is covered by patents WO 2009/112032 and WO 2011/137911 exclusively owned by Anapa Biotech A/S. Anapa Biotech A/S funded the study and the study was done in collaboration with the Department of Clinical Microbiology, Copenhagen University Hospital Hvidovre. Authors UVS, NDM and GL were employed by Anapa Biotech A/S during the course of the study. Anapa Biotech A/S provided support in the form of salaries for authors UVS, NDM and GL and did the study design, data collection and data analysis. Decision to publish and preparation of the manuscript was done by the Department of Clinical Microbiology, Copenhagen University Hospital Hvidovre.	Binnicker MJ, 2015, J CLIN MICROBIOL, V53, P3723, DOI 10.1128/JCM.02103-15; Boisen N, 2012, J INFECT DIS, V205, P431, DOI 10.1093/infdis/jir757; Bonkoungou IJO, 2012, CLIN MICROBIOL INFEC, V18, P901, DOI 10.1111/j.1469-0691.2011.03675.x; Brandal LT, 2007, J MICROBIOL METH, V68, P331, DOI 10.1016/j.mimet.2006.09.013; Buss SN, 2015, J CLIN MICROBIOL, V53, P915, DOI 10.1128/JCM.02674-14; Delannoy S, 2013, J CLIN MICROBIOL, V51, P3257, DOI 10.1128/JCM.01471-13; Goldfarb DM, 2014, J CLIN MICROBIOL, V52, P3922, DOI 10.1128/JCM.01894-14; Halligan E, 2014, CLIN MICROBIOL INFEC, V20, pO460, DOI 10.1111/1469-0691.12476; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Knudsen BE, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00095-16; Liu J, 2014, LANCET INFECT DIS, V14, P716, DOI 10.1016/S1473-3099(14)70808-4; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ngwa GA, 2013, J MICROBIOL METH, V92, P164, DOI 10.1016/j.mimet.2012.11.018; Perry MD, 2014, J MED MICROBIOL, V63, P1419, DOI 10.1099/jmm.0.074773-0; Persson S, 2007, CLIN MICROBIOL INFEC, V13, P516, DOI 10.1111/j.1469-0691.2007.01692.x; Schneider UV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020565; Schneider UV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038451; Wang M, 2008, J TRAVEL MED, V15, P110, DOI 10.1111/j.1708-8305.2008.00189.x; Wang WL, 2015, WORLD J GASTROENTERO, V21, P803, DOI 10.3748/wjg.v21.i3.803; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990	21	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199766	10.1371/journal.pone.0199766	http://dx.doi.org/10.1371/journal.pone.0199766			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944710	Green Submitted, Green Published, gold			2022-12-26	WOS:000436377800062
J	Wong, MK; Shawky, SA; Aryasomayajula, A; Green, MA; Ewart, T; Selvaganapathy, PR; Raha, S				Wong, Michael K.; Shawky, Sarah A.; Aryasomayajula, Aditya; Green, Madeline A.; Ewart, Tom; Selvaganapathy, P. Ravi; Raha, Sandeep			Extracellular matrix surface regulates self-assembly of three-dimensional placental trophoblast spheroids	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; CHORIOCARCINOMA CELLS; SYNCYTIAL FUSION; 1ST TRIMESTER; IN-VITRO; DIFFERENTIATION; INVASION; DISEASE; CYTOTROPHOBLASTS; EXPRESSION	The incorporation of the extracellular matrix (ECM) is essential for generating in vitro models that truly represent the microarchitecture found in human tissues. However, the cell-cell and cell-ECM interactions in vitro remains poorly understood in placental trophoblast biology. We investigated the effects of varying the surface properties (surface thickness and stiffness) of two ECMs, collagen I and Matrigel, on placental trophoblast cell morphology, viability, proliferation, and expression of markers involved in differentiation/syncytial fusion. Most notably, thicker Matrigel surfaces were found to induce the self-assembly of trophoblast cells into 3D spheroids that exhibited thickness-dependent changes in viability, proliferation, syncytial fusion, and gene expression profiles compared to two-dimensional cultures. Changes in F-actin organization, cell spread morphologies, and integrin and matrix metalloproteinase gene expression profiles, further reveal that the response to surface thickness may be mediated in part through cellular stiffness-sensing mechanisms. Our derivation of self-assembling trophoblast spheroid cultures through regulation of ECM surface alone contributes to a deeper understanding of cell-ECM interactions, and may be important for the advancement of in vitro platforms for research or diagnostics.	[Wong, Michael K.; Raha, Sandeep] McMaster Univ, Grad Program Med Sci, Hamilton, ON, Canada; [Wong, Michael K.; Shawky, Sarah A.; Green, Madeline A.; Raha, Sandeep] McMaster Med Ctr, Dept Pediat, Hamilton, ON, Canada; [Aryasomayajula, Aditya; Selvaganapathy, P. Ravi] McMaster Univ, Dept Mech Engn, Hamilton, ON, Canada; [Ewart, Tom] Evik Diagnost, Ottawa, ON, Canada	McMaster University; McMaster University; McMaster University	Raha, S (corresponding author), McMaster Univ, Grad Program Med Sci, Hamilton, ON, Canada.; Raha, S (corresponding author), McMaster Med Ctr, Dept Pediat, Hamilton, ON, Canada.	rahas@mcmaster.ca		Raha, Sandeep/0000-0001-7307-3292	NSERC; CRC; CIHR; NSERC-ENGAGE; Natural Science and Engineering Council of Canada [342032-2009]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); CIHR(Canadian Institutes of Health Research (CIHR)); NSERC-ENGAGE; Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Operational funds were awarded to PRS (fromNSERC-Discovery and CRC) and to SR (from CIHR and NSERC-ENGAGE). TE - is employed by a commercial entity, Evik Diagnostics. This organization had no influence on the experimental design, data analysis or the decision to publish. TE is not a shareholder, board member or financial director of Evik Diagnostics. In addition, Evik Diagnostics has not requested that any aspect of the research be withheld from publication or delayed for the purpose of securing intellectual property rights. Evik Diagnostics encouraged the free and full disclosure of this work. TE contributed his expertise in surface chemistry and 3D-cell cell culture along with development of the hCG ELISA to this project. Furthermore TE also facilitated the technical training of the research students MKW and MAG. Funding source:Natural Science and Engineering Council of Canada (http://www.nserc-crsnp.gc.ca/index_eng.asp) Grant No. 342032-2009. The funders outlined in the "Sources of Funding" had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. They only provided financial support in form of author's salaries (MKW, SAS, AA, MAG) and research materials. MKW received a Vanier studentship from NSERC.	Al-Nasiry S, 2006, HUM REPROD, V21, P193, DOI 10.1093/humrep/dei272; Bae YH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004838; Beck JN, 2013, BIOMATERIALS, V34, P9486, DOI 10.1016/j.biomaterials.2013.08.077; Benton G, 2014, ADV DRUG DELIVER REV, V79-80, P3, DOI 10.1016/j.addr.2014.06.005; Bischof P, 2000, HUM REPROD, V15, P51; Blundell C, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700786; Blundell C, 2016, LAB CHIP, V16, P3065, DOI 10.1039/c6lc00259e; Borges M, 2003, PLACENTA, V24, P959, DOI 10.1016/S0143-4004(03)00173-5; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Cole LA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-24; Corning, 2013, CORN MATR MATR FREQ; Denecke B, 2015, J TISSUE ENG REGEN M, V9, pE84, DOI 10.1002/term.1673; Dupressoir A, 2011, P NATL ACAD SCI USA, V108, pE1164, DOI 10.1073/pnas.1112304108; Ertl P., 2015, J CELL BIOL CELL MET, V2, P1, DOI [10.24966/CBCM-1943/100005, DOI 10.24966/CBCM-1943/100005]; Evans J, 2015, HUM REPROD, V30, P1029, DOI 10.1093/humrep/dev016; Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003; Gerbaud P, 2015, PLACENTA, V36, pS35, DOI 10.1016/j.placenta.2014.12.015; Gohner C, 2014, TOXICOL PATHOL, V42, P345, DOI 10.1177/0192623313482206; Handschuh K, 2007, PLACENTA, V28, P175, DOI 10.1016/j.placenta.2006.01.019; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; HOHN HP, 1992, DIFFERENTIATION, V51, P61, DOI 10.1111/j.1432-0436.1992.tb00681.x; Hohn HP, 1996, EUR J CELL BIOL, V69, P76; HOHN HP, 1994, EXP CELL RES, V215, P40, DOI 10.1006/excr.1994.1312; Huppertz B, 2014, PROG BIOPHYS MOL BIO, V114, P33, DOI 10.1016/j.pbiomolbio.2013.11.007; Huppertz B, 2011, ADV EXP MED BIOL, V713, P81, DOI 10.1007/978-94-007-0763-4_6; Huppertz B, 2011, CELL FUSIONS: REGULATION AND CONTROL, P203, DOI 10.1007/978-90-481-9772-9_9; Isaka K, 2003, PLACENTA, V24, P53, DOI 10.1053/plac.2002.0867; Ishikawa A, 2014, CYTOSKELETON, V71, P241, DOI 10.1002/cm.21165; Jose RR, 2016, ACS BIOMATER SCI ENG, V2, P1662, DOI 10.1021/acsbiomaterials.6b00088; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; KLIMAN HJ, 1990, P NATL ACAD SCI USA, V87, P3057, DOI 10.1073/pnas.87.8.3057; Kolahi KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041717; Korff T, 2004, EXP CELL RES, V297, P415, DOI 10.1016/j.yexcr.2004.03.043; Krtolica A, 2002, CYTOMETRY, V49, P73, DOI 10.1002/cyto.10149; Kuo CY, 2016, ACS BIOMATER SCI ENG, V2, P1817, DOI 10.1021/acsbiomaterials.6b00031; LaMarca HL, 2005, PLACENTA, V26, P709, DOI 10.1016/j.placenta.2004.11.003; Lee JS, 2016, J MATERN-FETAL NEO M, V29, P1046, DOI 10.3109/14767058.2015.1038518; Lei T, 2007, PLACENTA, V28, P14, DOI 10.1016/j.placenta.2006.01.020; Leong WS, 2010, BIOCHEM BIOPH RES CO, V401, P287, DOI 10.1016/j.bbrc.2010.09.052; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047; Mierke CT, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015003; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Mullen CA, 2015, BIOPHYS J, V108, P1604, DOI 10.1016/j.bpj.2015.02.022; Muoth C, 2016, NANOSCALE, V8, P17322, DOI 10.1039/c6nr06749b; Onogi A, 2011, PLACENTA, V32, P665, DOI 10.1016/j.placenta.2011.06.023; Orendi K, 2011, PLACENTA, V32, pS49, DOI 10.1016/j.placenta.2010.11.023; Orendi K, 2010, REPRODUCTION, V140, P759, DOI 10.1530/REP-10-0221; Quibel T, 2015, PRENATAL DIAG, V35, P1106, DOI 10.1002/pd.4654; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Robins JC, 2011, REPROD SCI, V18, P128, DOI 10.1177/1933719110381923; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Schweiger PJ, 2016, CURR OPIN CELL BIOL, V43, P22, DOI 10.1016/j.ceb.2016.07.003; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Snir A, 2013, THROMB RES, V132, P477, DOI 10.1016/j.thromres.2013.08.023; Tarrade A, 2001, LAB INVEST, V81, P1199, DOI 10.1038/labinvest.3780334; Tuuli MG, 2011, PLACENTA, V32, pS109, DOI 10.1016/j.placenta.2010.12.013; Zhou YX, 2016, STEM CELL REV REP, V12, P560, DOI 10.1007/s12015-016-9671-7	60	21	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199632	10.1371/journal.pone.0199632	http://dx.doi.org/10.1371/journal.pone.0199632			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940046	Green Published, Green Submitted, gold			2022-12-26	WOS:000436088700031
J	Kolbe, I; Carrasco-Benso, MP; Lopez-Minguez, J; Lujan, J; Scheer, FAJL; Oster, H; Garaulet, M				Kolbe, Isa; Paz Carrasco-Benso, Maria; Lopez-Minguez, Jesus; Lujan, Juan; Scheer, Frank A. J. L.; Oster, Henrik; Garaulet, Marta			Circadian period of luciferase expression shortens with age in human mature adipocytes from obese patients	FASEB JOURNAL			English	Article						peripheral clocks; adipose tissue; BMAL1 reporter; lenti virus; primary cells	CLOCK; RHYTHMS; SLEEP; PHASE	Daily rhythms in physiology and behavior change with age. An unresolved question is to what extent such age-related alterations in circadian organization are driven by the central clock in the suprachiasmatic nucleus (SCN), modifying timing signals to contributing peripheral tissue oscillators, and are mediated by underlying changes in the local cellular oscillators themselves. Using a bioluminescence reporter approach, we sought to determine whether circadian clock function in human adipocytes from subcutaneous (SAT) and visceral (VAT) adipose tissues changes with age. SAT and VAT biopsies were obtained from obese individuals during gastric bypass surgeries [n = 16; body mass index: 44.8 +/- 11.4 kg/m(2); age: 44 +/- 9 yr (range: 30-58)]. Cells were isolated and transduced with a lentiviral circadian reporter construct [brain and muscle aryl hydrocarbon receptor nuclear translocator-like:luciferase (BMAL:LUC)], and bioluminescence was recorded over a period of 3 d. Human BMAL1:LUC adipocytes displayed a robust luminescence rhythm with comparable within-individual periods in mature and preadipocytes (P > 0.05). With increasing age, the circadian period decreased in mature adipocytes (P = 0.005) ( = 4 min/yr; P < 0.05). Our ex vivo approach indicated that ageing changes the organization of endogenous circadian oscillators in human adipocytes, independent of SCN signaling.Kolbe, I., Carrasco-Benso, M. P., Lopez-Minguez, J., Lujan, J., Scheer, F. A. J. L., Oster, H., Garaulet, M. Circadian period of luciferase expression shortens with age in human mature adipocytes from obese patients.	[Kolbe, Isa; Oster, Henrik] Univ Lubeck, Inst Neurobiol, Lubeck, Germany; [Paz Carrasco-Benso, Maria; Lopez-Minguez, Jesus; Garaulet, Marta] Univ Murcia, Dept Physiol, Fac Biol, Murcia, Spain; [Paz Carrasco-Benso, Maria; Lopez-Minguez, Jesus; Garaulet, Marta] Biomed Res Inst Arrixaca, Murcia, Spain; [Lujan, Juan] Univ Hosp Virgen de la Arrixaca, Gen Surg Serv, Murcia, Spain; [Scheer, Frank A. J. L.] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Scheer, Frank A. J. L.] Harvard Med Sch, Div Sleep Med, Boston, MA USA	University of Lubeck; University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Oster, H (corresponding author), Univ Lubeck, Inst Neurobiol, Lubeck, Germany.; Garaulet, M (corresponding author), Univ Murcia, Virgen de la Arrixaca Univ Hosp, Campus Espinardo, Murcia, Spain.	henrik.oster@uni-luebeck.de; garaulet@um.es	Oster, Henrik/O-4426-2019; Scheer, Frank A.J.L./C-2795-2012; Oster, Henrik/D-2335-2013; Garaulet, Marta/K-6625-2014	Oster, Henrik/0000-0002-1414-7068; Scheer, Frank A.J.L./0000-0002-2014-7582; Oster, Henrik/0000-0002-1414-7068; Garaulet, Marta/0000-0002-4066-3509; Maria Paz, Carrasco-Benso/0000-0001-5611-4929; Lujan Mompean, Juan Antonio/0000-0003-4987-7578	Spanish Department of Investigation, Development, and Innovation [SAF2017-84135-R]; Spanish Federation of Rare Diseases (FEDER); U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK105072]; German Research Foundation [GRK-1957, SFB-134]; NIH NIDDK [R01 DK099512]; NIH National Heart, Lung and Blood Institute [R01 HL118601, R01 HL140574]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL140574, R01HL118601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105072, R01DK099512] Funding Source: NIH RePORTER	Spanish Department of Investigation, Development, and Innovation; Spanish Federation of Rare Diseases (FEDER); U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); German Research Foundation(German Research Foundation (DFG)); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work as supported in part by The Spanish Department of Investigation, Development, and Innovation (SAF2017-84135-R) including cofunding from the Spanish Federation of Rare Diseases (FEDER), and U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant R01DK105072 (to M.G.); German Research Foundation grants GRK-1957 and SFB-134 (to H.O.); and NIH NIDDK Grant R01 DK099512 and NIH National Heart, Lung and Blood Institute grants R01 HL118601 and R01 HL140574 (to F.A.J.L.S). H.O. is a Lichtenberg fellow of the Volkswagen Foundation. F.A.J.L.S. has received speaker fees from Bayer Healthcare (Montville, NJ, USA), Sentara Healthcare (Norfolk, VA, USA), Kellogg Company (Battle Creek, MI, USA), and Philips (Eindhoven, The Netherlands). The other authors declare no conflicts of interest.	Bailey SM, 2014, J ENDOCRINOL, V222, pR75, DOI 10.1530/JOE-14-0200; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Davis FC, 1998, AM J PHYSIOL-REG I, V275, pR960; Dijk DJ, 2000, CHRONOBIOL INT, V17, P285, DOI 10.1081/CBI-100101049; Duffy JF, 2002, NEUROSCI LETT, V318, P117, DOI 10.1016/S0304-3940(01)02427-2; Duffy JF, 1999, NEUROSCI LETT, V271, P77, DOI 10.1016/S0304-3940(99)00519-4; Froy O, 2018, ENDOCR REV, V39, P261, DOI 10.1210/er.2017-00193; Froy O, 2011, PHYSIOLOGY, V26, P225, DOI 10.1152/physiol.00012.2011; Abellan PG, 2011, NUTR HOSP, V26, P1394, DOI [10.3305/nh.2011.26.6.5305, 10.1590/S0212-16112011000600029]; Gomez-Abellan P, 2010, ENDOCRINOLOGY, V151, P115, DOI 10.1210/en.2009-0647; Gomez-Abellan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050435; Gomez-Santos C, 2009, OBESITY, V17, P1481, DOI 10.1038/oby.2009.164; Hamada T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11705; Hofman MA, 2006, AGEING RES REV, V5, P33, DOI 10.1016/j.arr.2005.07.001; Juda M, 2013, J BIOL RHYTHM, V28, P130, DOI 10.1177/0748730412475041; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Maronde E, 2003, CHRONOBIOL INT, V20, P671, DOI 10.1081/CBI-120022413; Moore SR, 2014, DIS MODEL MECH, V7, P1123, DOI 10.1242/dmm.014399; Pagani L, 2011, P NATL ACAD SCI USA, V108, P7218, DOI 10.1073/pnas.1008882108; PITTENDRIGH CS, 1974, SCIENCE, V186, P548, DOI 10.1126/science.186.4163.548; Pulimeno P, 2013, DIABETOLOGIA, V56, P497, DOI 10.1007/s00125-012-2779-7; Ramanathan C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004244; RENFREW JW, 1987, PHYSIOL BEHAV, V41, P627, DOI 10.1016/0031-9384(87)90321-0; ROSENBERG RS, 1991, AM J PHYSIOL, V261, pR491, DOI 10.1152/ajpregu.1991.261.2.R491; Schmidt Christina, 2012, Front Neurol, V3, P118, DOI 10.3389/fneur.2012.00118; Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957; Weinert D, 2001, CHRONOBIOL INT, V18, P921, DOI 10.1081/CBI-100107968; WITTING W, 1994, CHRONOBIOL INT, V11, P103, DOI 10.3109/07420529409055896; Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499; Yoshino J, 2013, DIABETES, V62, P2175, DOI 10.2337/db13-0457	31	5	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					175	180		10.1096/fj.201800441R	http://dx.doi.org/10.1096/fj.201800441R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29965796	Green Published			2022-12-26	WOS:000457401500014
J	Haglund, E; Nguyen, L; Schafer, NP; Lammert, H; Jennings, PA; Onuchic, JN				Haglund, Ellinor; Nguyen, Lannie; Schafer, Nicholas Peter; Lammert, Heiko; Jennings, Patricia Ann; Onuchic, Jose Nelson			Uncovering the molecular mechanisms behind disease-associated leptin variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; leptin; obesity; protein misfolding; protein structure; Bioinactive hormone; Congenital-leptin Deficiency; Pierced Lasso Topology	EARLY-ONSET OBESITY; MISSENSE MUTATION; PERIPHERAL ACTIONS; BINDING DOMAIN; GENE-MUTATIONS; DEFICIENCY; PROTEIN; PATHOPHYSIOLOGY; HYPOGONADISM; DYSFUNCTION	The pleiotropic hormone leptin has a pivotal role in regulating energy balance by inhibiting hunger and increasing energy expenditure. Homozygous mutations found in the leptin gene are associated with extreme obesity, marked hyperphagia, and impaired immune function. Although these mutations have been characterized in vivo, a detailed understanding of how they affect leptin structure and function remains elusive. In the current work, we used NMR, differential scanning calorimetry, molecular dynamics simulations, and bioinformatics calculations to characterize the effects of these mutations on leptin structure and function and binding to its cognate receptor. We found that mutations identified in patients with congenital leptin deficiency not only cause leptin misfolding or aggregation, but also cause changes in the dynamics of leptin residues on the receptor-binding interface. Therefore, we infer that mutation-induced leptin deficiency may arise from several distinct mechanisms including (i) blockade of leptin receptor interface II, (ii) decreased affinity in the second step of leptin's interaction with its receptor, (iii) leptin destabilization, and (iv) unsuccessful threading through the covalent loop, leading to leptin misfolding/aggregation. We propose that this expanded framework for understanding the mechanisms underlying leptin deficiency arising from genetic mutations may be useful in designing therapeutics for leptin-associated disorders.	[Haglund, Ellinor; Schafer, Nicholas Peter; Lammert, Heiko; Onuchic, Jose Nelson] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA; [Onuchic, Jose Nelson] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; [Onuchic, Jose Nelson] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Onuchic, Jose Nelson] Rice Univ, Dept Biosci, Houston, TX 77005 USA; [Nguyen, Lannie; Jennings, Patricia Ann] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	Rice University; Rice University; Rice University; Rice University; University of California System; University of California San Diego	Haglund, E; Onuchic, JN (corresponding author), Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA.; Onuchic, JN (corresponding author), Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA.; Onuchic, JN (corresponding author), Rice Univ, Dept Chem, Houston, TX 77005 USA.; Onuchic, JN (corresponding author), Rice Univ, Dept Biosci, Houston, TX 77005 USA.; Jennings, PA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ellinorh@rice.edu; pajennings@ucsd.edu; jonuchic@rice.edu		Schafer, Nicholas/0000-0001-9789-2516	Center for Theoretical Biological Physics; National Science Foundation (NSF) [PHY-1427654]; NSF [MCB-1241332, PHY-161407, CHE-1614101]; Welch Foundation [C-1792]; NIGMS, National Institutes of Health [R01 GM44557]; D. R. Bullard-Welch Chair at Rice University [C-0016]; Div Of Molecular and Cellular Bioscience [1241332] Funding Source: National Science Foundation	Center for Theoretical Biological Physics; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); NSF(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); D. R. Bullard-Welch Chair at Rice University; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Center for Theoretical Biological Physics, sponsored by National Science Foundation (NSF) Grant PHY-1427654, and NSF Grants MCB-1241332, PHY-161407, and CHE-1614101. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by Welch Foundation Grant C-1792.; Supported by NIGMS, National Institutes of Health, Grant R01 GM44557 and the D. R. Bullard-Welch Chair at Rice University, Grant C-0016.	Altawil AS, 2016, CLIN MED INSIGHTS-PE, V10, P115, DOI 10.4137/CMPed.S40432; Baratta Mario, 2002, Med Sci Monit, V8, pRA282; Baxter EL, 2013, P NATL ACAD SCI USA, V110, P948, DOI 10.1073/pnas.1208286110; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Blazer DG, 2006, GENES BEHAV SOCIAL E; Boute N, 2004, BIOCHIMIE, V86, P351, DOI 10.1016/j.biochi.2004.06.005; BRAY GA, 1979, PHYSIOL REV, V59, P719, DOI 10.1152/physrev.1979.59.3.719; Carpenter B, 2012, STRUCTURE, V20, P487, DOI 10.1016/j.str.2012.01.019; Chekhranova M K, 2008, Bioorg Khim, V34, P854; CONNOLLY ML, 1980, BIOPOLYMERS, V19, P1167, DOI 10.1002/bip.1980.360190606; Dabrowski-Tumanski P, 2016, NUCLEIC ACIDS RES, V44, pW383, DOI 10.1093/nar/gkw308; Dickie M. M., 1957, MOUSE NEWS LETT, V17, P52; Elias CF, 2013, CELL MOL LIFE SCI, V70, P841, DOI 10.1007/s00018-012-1095-1; Farooqi IS, 2014, J ENDOCRINOL, V223, pT63, DOI 10.1530/JOE-14-0480; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fatima W, 2011, INT J PEDIATR OBES, V6, P419, DOI 10.3109/17477166.2011.608431; Fietta P, 2005, Minerva Med, V96, P65; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fischer-Posovszky P, 2010, J CLIN ENDOCR METAB, V95, P2836, DOI 10.1210/jc.2009-2466; Fong TM, 1998, MOL PHARMACOL, V53, P234, DOI 10.1124/mol.53.2.234; Fruhbeck G, 2002, NUTR REV, V60, pS47, DOI 10.1301/002966402320634931; Fruhbeck G, 2001, P NUTR SOC, V60, P301, DOI 10.1079/PNS200196; Funcke Jan-Bernd, 2014, Mol Cell Pediatr, V1, P3, DOI 10.1186/s40348-014-0003-1; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Gibson WT, 2004, J CLIN ENDOCR METAB, V89, P4821, DOI 10.1210/jc.2004-0376; Gierut AM, 2017, BIOINFORMATICS, V33, P3819, DOI 10.1093/bioinformatics/btx493; Gong DW, 1996, J BIOL CHEM, V271, P3971; Haglund E, 2017, J PHYS CHEM B, V121, P706, DOI 10.1021/acs.jpcb.6b11506; Haglund E, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/35/354107; Haglund E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003613; Haglund E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045654; Hong CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015333; Iserentant H, 2005, J CELL SCI, V118, P2519, DOI 10.1242/jcs.02386; Khan S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-56; Kratzsch J, 2002, HORM RES, V57, P127, DOI 10.1159/000057963; LEIBEL RL, 1993, CRIT REV FOOD SCI, V33, P351, DOI 10.1080/10408399309527632; LEIBEL RL, 1990, WORLD REV NUTR DIET, V63, P90; Mancour LV, 2012, MOL CELL, V48, P655, DOI 10.1016/j.molcel.2012.09.003; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Mazen I, 2009, MOL GENET METAB, V97, P305, DOI 10.1016/j.ymgme.2009.04.002; Moharana K, 2014, STRUCTURE, V22, P866, DOI 10.1016/j.str.2014.04.012; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Moon BC, 1997, GENOMICS, V42, P152, DOI 10.1006/geno.1997.4701; Muoio DM, 2002, BEST PRACT RES CL EN, V16, P653, DOI 10.1053/beem.2002.0223; Murphy R., 2006, MISBEHAVING PROTEINS, P331; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Niemyska W, 2016, SCI REP-UK, V6, DOI 10.1038/srep36895; Niv-Spector L, 2010, MOL GENET METAB, V100, P193, DOI 10.1016/j.ymgme.2010.02.015; Noel JK, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004794; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; Peelman F, 2014, J ENDOCRINOL, V223, pT9, DOI 10.1530/JOE-14-0264; Pigeyre M, 2016, CLIN SCI, V130, P943, DOI 10.1042/CS20160136; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044; Saeed S, 2012, MOL GENET METAB, V106, P121, DOI 10.1016/j.ymgme.2012.03.001; Shabana, 2016, BIOL RES, V49, DOI [10.1186/S40659-016-0082-7, 10.1186/s40659-016-0082-7]; Sormanni P, 2015, J MOL BIOL, V427, P478, DOI 10.1016/j.jmb.2014.09.026; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Thakur S, 2014, CLIN GENET, V86, P391, DOI 10.1111/cge.12289; Verploegen SABW, 1997, FEBS LETT, V405, P237, DOI 10.1016/S0014-5793(97)00192-0; Wabitsch M, 2017, EUR J ENDOCRINOL, V176, P315, DOI 10.1530/EJE-16-0821; Wabitsch M, 2015, J CLIN ENDOCR METAB, V100, P3227, DOI 10.1210/jc.2015-2263; Wabitsch M, 2015, NEW ENGL J MED, V372, P48, DOI 10.1056/NEJMoa1406653; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Yang RH, 2007, CIRC RES, V101, P545, DOI 10.1161/CIRCRESAHA.107.156596; Zabeau L, 2004, MOL ENDOCRINOL, V18, P150, DOI 10.1210/me.2003-0078; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	70	5	5	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12919	12933		10.1074/jbc.RA118.003957	http://dx.doi.org/10.1074/jbc.RA118.003957			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29950524	hybrid, Green Published			2022-12-26	WOS:000442203500023
J	Silva-Aguiar, RP; Bezerra, NCF; Lucena, MC; Sirtoli, GM; Sudo, RT; Zapata-Sudo, G; Takiya, CM; Pinheiro, AAS; Dias, WB; Caruso-Neves, C				Silva-Aguiar, Rodrigo Pacheco; Bezerra, Nathalia C. F.; Lucena, Miguel C.; Sirtoli, Gabriela M.; Sudo, Roberto T.; Zapata-Sudo, Gisele; Takiya, Christina M.; Pinheiro, Ana Acacia S.; Dias, Wagner Barbosa; Caruso-Neves, Celso			O-GlcNAcylation reduces proximal tubule protein reabsorption and promotes proteinuria in spontaneously hypertensive rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAcylation; proteinuria; hypertension; kidney; endocytosis; O-linked N-acetylglucosamine (O-GlcNAc); megalin; SHR	N-ACETYLGLUCOSAMINE; RECEPTOR MEGALIN; GLCNAC; ALBUMINURIA; TRANSFERASE; FILTRATION; TRANSPORT; DISEASE; TARGET; STRESS	Hypertensive individuals are at greater risk for developing chronic kidney disease (CKD). Reducing proteinuria has been suggested as a possible therapeutic approach to treat CKD. However, the mechanisms underlying the development of proteinuria in hypertensive conditions are incompletely understood. Cardiac and vascular dysfunction is associated with changes in the O-GlcNAcylation pathway in hypertensive models. We hypothesized that O-GlcNAcylation is also involved in renal damage, especially development of proteinuria, associated with hypertension. Using the spontaneously hypertensive rat (SHR) model, we observed higher renal cortex O-GlcNAcylation, glutamine-fructose aminotransferase (GFAT), and O-GlcNAc transferase (OGT) protein expression, which positively correlated with proteinuria. Interestingly, this was observed in hypertensive, but not pre-hypertensive, rats. Pharmacological inhibition of GFAT decreased renal cortex O-GlcNAcylation, proteinuria, and albuminuria in SHR. Using a proximal tubule cell line, we observed that increased O-GlcNAcylation reduced megalin surface expression and albumin endocytosis in vitro, and the effects were correlated in vivo. Moreover, megalin is O-GlcNAcylated both in vitro and in vivo. In conclusion, our results demonstrate a new mechanism involved in hypertension-associated proteinuria.	[Silva-Aguiar, Rodrigo Pacheco; Bezerra, Nathalia C. F.; Lucena, Miguel C.; Sirtoli, Gabriela M.; Takiya, Christina M.; Pinheiro, Ana Acacia S.; Dias, Wagner Barbosa; Caruso-Neves, Celso] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil; [Sudo, Roberto T.; Zapata-Sudo, Gisele] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Desenvolvimento Farm, BR-21941902 Rio De Janeiro, Brazil; [Caruso-Neves, Celso] Inst Nacl Ciencia & Tecnol Med Regenerat INCT Reg, BR-21941902 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Caruso-Neves, C (corresponding author), Univ Fed Rio de Janeiro, CCS, Bloco C,Sala 34, BR-21941902 Rio De Janeiro, RJ, Brazil.	caruso@biof.ufrj.br	Caruso-Neves, Celso/C-4014-2013; Dias, Wagner/B-1401-2016; Zapata-Sudo, Gisele/AAG-8790-2020; Takiya, Christina/AAU-5959-2021; Silva-Aguiar, Rodrigo Pacheco/AAH-7924-2020	Caruso-Neves, Celso/0000-0002-2415-7753; Takiya, Christina/0000-0002-8019-628X; Silva-Aguiar, Rodrigo Pacheco/0000-0003-1975-8033; Pinheiro, Ana Acacia/0000-0002-3894-1645; Dias, Wagner/0000-0002-8378-8846	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grant [471771/2013-9]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants [E-26/201.197/2014, E-26/202.950/2016, APQ1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grant; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants	This work was supported by the following Brazilian funding agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grant 471771/2013-9 (to C. C. N.) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grants E-26/201.197/2014 and E-26/202.950/2016 (to C. C. N.) and APQ1 (to W. B. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Bakris GL, 2008, CLIN J AM SOC NEPHRO, V3, pS3, DOI 10.2215/CJN.03250807; Barnes JW, 2015, CIRCULATION, V131, P1260, DOI 10.1161/CIRCULATIONAHA.114.013878; Bay AEP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11550; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Carrero JJ, 2017, KIDNEY INT, V91, P244, DOI 10.1016/j.kint.2016.09.037; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Carson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099771; Christensen EI, 2012, PHYSIOLOGY, V27, P223, DOI 10.1152/physiol.00022.2012; D'Amico G, 2003, KIDNEY INT, V63, P809, DOI 10.1046/j.1523-1755.2003.00840.x; De S, 2014, MEMBRANES-BASEL, V4, P333, DOI 10.3390/membranes4030333; Degrell P, 2009, LIFE SCI, V84, P389, DOI 10.1016/j.lfs.2009.01.007; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Geng F, 2012, J CELL SCI, V125, P2615, DOI 10.1242/jcs.096735; Gianesello L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13789-z; Hilgers RHP, 2012, AM J PHYSIOL-HEART C, V303, pH513, DOI 10.1152/ajpheart.01175.2011; Hirano M, 2017, BBA-GEN SUBJECTS, V1861, P3106, DOI 10.1016/j.bbagen.2016.10.015; Hu JC, 2017, FREE RADICAL BIO MED, V103, P121, DOI 10.1016/j.freeradbiomed.2016.12.032; Koral K, 2014, AM J PHYSIOL-RENAL, V307, pF1380, DOI 10.1152/ajprenal.00454.2014; Landgraf SS, 2011, AM J PHYSIOL-RENAL, V300, pF499, DOI 10.1152/ajprenal.00384.2010; Lima VV, 2009, HYPERTENSION, V53, P166, DOI 10.1161/HYPERTENSIONAHA.108.116798; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; Martinez MR, 2017, BIOCHEM SOC T, V45, P237, DOI 10.1042/BST20160153; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mori KP, 2017, J AM SOC NEPHROL, V28, P278, DOI 10.1681/ASN.2015101168; Nagai M, 2003, MOL BIOL CELL, V14, P4984, DOI 10.1091/mbc.E03-06-0385; Oki T, 1999, GENOMICS, V57, P227, DOI 10.1006/geno.1999.5785; Ono S, 2017, NEPHROL DIAL TRANSPL, V32, P1477, DOI 10.1093/ndt/gfw463; Park MJ, 2014, J BIOL CHEM, V289, P13519, DOI 10.1074/jbc.M113.530139; Peruchetti DB, 2014, J BIOL CHEM, V289, P16790, DOI 10.1074/jbc.M114.549717; Queiroz-Madeira EP, 2010, BBA-BIOMEMBRANES, V1798, P360, DOI 10.1016/j.bbamem.2009.06.018; Ronco C, 2014, NEPHROL DIAL TRANSPL, V29, P958, DOI 10.1093/ndt/gft457; Russo LM, 2009, J AM SOC NEPHROL, V20, P489, DOI 10.1681/ASN.2008050503; Schiessl IM, 2016, J AM SOC NEPHROL, V27, P731, DOI 10.1681/ASN.2014111125; Sun J, 2017, KIDNEY INT REP, V2, P721, DOI 10.1016/j.ekir.2017.02.012; Theilig F, 2007, J AM SOC NEPHROL, V18, P1824, DOI 10.1681/ASN.2006111266; Udani S, 2011, NAT REV NEPHROL, V7, P11, DOI 10.1038/nrneph.2010.154; Vasconcelos-dos-Santos A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00138; Wang XY, 2009, CURR OPIN NEPHROL HY, V18, P412, DOI 10.1097/MNH.0b013e32832f5775; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yuseff MI, 2007, TRAFFIC, V8, P1215, DOI 10.1111/j.1600-0854.2007.00601.x; Zafir A, 2013, STEM CELLS, V31, P765, DOI 10.1002/stem.1325; Zeng QH, 2016, P NATL ACAD SCI USA, V113, P9333, DOI 10.1073/pnas.1606801113	48	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12749	12758		10.1074/jbc.RA118.001746	http://dx.doi.org/10.1074/jbc.RA118.001746			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29954945	Green Published, hybrid			2022-12-26	WOS:000442203500009
J	Akkari, N; Ganske, AS; Komericki, A; Metscher, B				Akkari, Nesrine; Ganske, Anne-Sarah; Komericki, Ana; Metscher, Brian			New avatars for Myriapods: Complete 3D morphology of type specimens transcends conventional species description (Myriapoda, Chilopoda)	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ANTENNAL SENSILLA	We present high-resolution X-ray microtomography (microCT) to enhance the standard morphological description of a recently described centipede, Eupolybothrus liburnicus Akkari, Komericki, Weigand, Edgecombe and Stoev, 2017. The 3D images of the holotype and paratype specimens are considered here as cybertypes for the species-a universal and virtual representation of the type material. This 'avatar' of the holotype is the first published male centipede cybertype. The microtomographic data of both types revealed further characters of systematic value and allowed us to hypothesise on the function of some of the male secondary structures and the mating behaviour of the species. Additionally, we compared part of the female reproductive system of E. liburnicus to species from the same genus, including E. cavernicoius Stoev & Komericki 2013, its closest congener. The highresolution 3D image data have been uploaded to an open repository (MorphoSource.org) to serve in any subsequent study on the species and genus, as we believe this would catalyse biosystematic research on this and other arthropod groups.	[Akkari, Nesrine; Ganske, Anne-Sarah] Nat Hist Museum Vienna, Zool Dept 3, Vienna, Austria; [Ganske, Anne-Sarah] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Komericki, Ana] Croatian Biospeleol Soc, Zagreb, Croatia; [Metscher, Brian] Univ Vienna, Dept Theoret Biol, Vienna, Austria	University of Vienna; University of Vienna	Akkari, N (corresponding author), Nat Hist Museum Vienna, Zool Dept 3, Vienna, Austria.	nesrine.akkari@nhm-wien.ac.at	Metscher, Brian/I-1238-2019; Akkari, Nesrine/X-5416-2019	Metscher, Brian/0000-0002-6514-4406; Akkari, Nesrine/0000-0001-5019-4833	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant as part of the BIG4 project: "Biosystematics, informatics and genomics of the big 4 insect groups: training tomorrow's researchers and entrepreneurs" [642241]	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant as part of the BIG4 project: "Biosystematics, informatics and genomics of the big 4 insect groups: training tomorrow's researchers and entrepreneurs"	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 642241 as part of the BIG4 project: "Biosystematics, informatics and genomics of the big 4 insect groups: training tomorrow's researchers and entrepreneurs."; We are most grateful to Alistair Robert Evans (Monash University), Gonzalo Giribet (Harvard University) and an anonymous reviewer for their useful comments on an earlier version of the manuscript. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 642241 as part of the BIG4 project: "Biosystematics, informatics and genomics of the big 4 insect groups: training tomorrow's researchers and entrepreneurs".	Akkari N, 2017, ZOOKEYS, P11, DOI [10.3897/zookeys.687.13884, 10.3897/zookeys.687.13844]; Akkari N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135243; Costello MJ, 2014, NEW PHYTOL, V202, P739, DOI 10.1111/nph.12689; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; EASON E H, 1970, Bulletin of the British Museum (Natural History) Zoology, V19, P289; EASON E H, 1973, Bulletin of the British Museum (Natural History) Zoology, V25, P39; Eberhard MJB, 2010, ARTHROPOD STRUCT DEV, V39, P230, DOI 10.1016/j.asd.2010.02.002; Ernst Alfred, 2009, Soil Organisms, V81, P399; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Friedrich F, 2014, ENTOMOL SCI, V17, P1, DOI 10.1111/ens.12053; Gignac PM, 2016, J ANAT, V228, P889, DOI 10.1111/joa.12449; Giribet G, 2015, ZOOL ANZ, V256, P96, DOI 10.1016/j.jcz.2015.01.003; KEIL T, 1976, ZOOMORPHOLOGIE, V84, P77, DOI 10.1007/BF02568558; Kenning M, 2017, PEERJ, V5, DOI 10.7717/peerj.4023; Klingel H, 1960, ZOOLOGISCHER ANZEI S, V23, P326; Lewis J. G. E., 1981, BIOL CENTIPEDES; Lui W, 2017, CRETACEOUS RES, V74, P100; Metscher Brian D, 2011, Cold Spring Harb Protoc, V2011, P1462, DOI 10.1101/pdb.prot067033; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Mora C, 2013, SCIENCE, V341, DOI 10.1126/science.1237254; Naumann Benjamin, 2017, Tropical Natural History, V17, P58; Pape T, 2016, NATURE, V537, P307, DOI 10.1038/537307b; PRUNESCO C., 1965, REV ROUMAINE BIOL SER ZOOL, V10, P11; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidbaur H, 2015, BRUKER MICROCT USER, V21, P1; Sombke A, 2015, J COMP NEUROL, V523, P1281, DOI 10.1002/cne.23741; Sombke A, 2011, J MORPHOL, V272, P1376, DOI 10.1002/jmor.10999; Stoev Pavel, 2013, Biodivers Data J, pe1013, DOI 10.3897/BDJ.1.e1013; Voigtlaender Karin, 2017, Tropical Natural History, V17, P63; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wanninger A, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00054; Wipfler B, 2016, CURR OPIN INSECT SCI, V18, P60, DOI 10.1016/j.cois.2016.09.004	32	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0200158	10.1371/journal.pone.0200158	http://dx.doi.org/10.1371/journal.pone.0200158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969504	Green Published, gold, Green Submitted			2022-12-26	WOS:000437246700049
J	Conti, S; Vexler, A; Edry-Botzer, L; Kalich-Philosoph, L; Corn, BW; Shtraus, N; Meir, Y; Hagoel, L; Shtabsky, A; Marmor, S; Earon, G; Lev-Ari, S				Conti, Sefora; Vexler, Akiva; Edry-Botzer, Liat; Kalich-Philosoph, Lital; Corn, Benjamin W.; Shtraus, Natan; Meir, Yaron; Hagoel, Lior; Shtabsky, Alexander; Marmor, Sylvia; Earon, Gideon; Lev-Ari, Shahar			Combined acetyl-11-keto-beta-boswellic acid and radiation treatment inhibited glioblastoma tumor cells	PLOS ONE			English	Article							NF-KAPPA-B; BOSWELLIC ACIDS; IONIZING-RADIATION; MALIGNANT GLIOMA; TOPOISOMERASE-I; APOPTOSIS; ACTIVATION; CANCER; BCL-2; PATHWAY	Glioblastoma multiforme (GBM) is the most common and most aggressive subtype of malignant gliomas. The current standard of care for newly diagnosed GBM patients involves maximal surgical debulking, followed by radiation therapy and temozolomide chemotherapy. Despite the advances in GBM therapy, its outcome remains poor with a median survival of less than two years. This poor outcome is partly due to the ability of GBM tumors to acquire adaptive resistance to therapy and in particular to radiation. One of the mechanisms contributing to GBM tumor progression and resistance is an aberrant activation of NF-kappa B, a family of inducible transcription factors that play a pivotal role in regulation of many immune, inflammatory and carcinogenic responses. Acetyl-11-keto-beta-boswellic acid (AKBA) is a pentacyclic terpenoid extracted from the gum Ayurvedic therapeutic plant Boswellia serrata. AKBA is anti-inflammatory agent that exhibits potent cytotoxic activities against various types of tumors including GBM. One of the mechanisms underlying AKBA anti-tumor activity is its ability to modulate the NF-kappa B signaling pathway. The present study investigated in vitro and in vivo the effect of combining AKBA with ionizing radiation in the treatment of GBM and assessed AKBA anti-tumor activity and radio-enhancing potential. The effect of AKBA and/ or radiation on the survival of cultured glioblastoma cancer cells was evaluated by XTT assay. The mode of interaction of treatments tested was calculated using CalcuSyn software. Inducing of apoptosis following AKBA treatment was evaluated using flow cytometry. The effect of combined treatment on the expression of PARP protein was analysed by Western blot assay. Ectopic (subcutaneous) GBM model in nude mice was used for the evaluation of the effect of combined treatment on tumor growth. Immunohistochemical analysis of formalin-fixed paraffin-embedded tumor sections was used to assess treatment-related changes in Ki-67, CD31, rho 53, Bcl-2 and NF-kappa B-inhibitor I kappa B-alpha. AKBA treatment was found to inhibit the survival of all four tested cell lines in a dose dependent manner. The combined treatment resulted in a more significant inhibitory effect compared to the effect of treatment with radiation alone. A synergistic effect was detected in some of the tested cell lines. Flow Yytometric analysis with Annexin V-FITC/PI double staining of AKBA treated cells indicated induction of apoptosis. AKBA apoptotic activity was also confirmed by PARP cleavage detected by Western blot analysis. The combined treatment suppressed tumor growth in vivo compared to no treatment and each treatment alone. Immunohistochemical analysis showed anti-angiogenic and anti-proliferative activity of AKBA in vivo. It also demonstrated a decrease in p53 nuclear staining and in Bcl-2 staining and an increase in I kappa B-alpha staining following AKBA treatment both alone and in combination with radiotherapy. In this study, we demonstrated that AKBA exerts potent anti-proliferative and apoptotic activity, and significantly inhibits both the survival of glioblastoma cells in vitro and the growth of tumors generated by these cells. Combination of AKBA with radiotherapy was found to inhibit factors which involved in cell death regulation, tumor progression and radioresistence, therefore it may serve as a novel approach for GBM patients.	[Conti, Sefora; Vexler, Akiva; Edry-Botzer, Liat; Kalich-Philosoph, Lital; Hagoel, Lior; Earon, Gideon; Lev-Ari, Shahar] Tel Aviv Univ, Tel Aviv Med Ctr, Inst Oncol, Lab Herbal Med & Canc Res,Fac Med, Tel Aviv, Israel; [Corn, Benjamin W.; Shtraus, Natan; Meir, Yaron] Tel Aviv Univ, Tel Aviv Med Ctr, Inst Radiotherapy, Fac Med, Tel Aviv, Israel; [Shtabsky, Alexander; Marmor, Sylvia] Tel Aviv Univ, Tel Aviv Med Ctr, Pathol Dept, Fac Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Lev-Ari, S (corresponding author), Tel Aviv Univ, Tel Aviv Med Ctr, Inst Oncol, Lab Herbal Med & Canc Res,Fac Med, Tel Aviv, Israel.	Shaharl@tlvmc.gov.il		lev-ari, shahar/0000-0003-0187-9427	Chaya and Kadish Shermeister Endowment	Chaya and Kadish Shermeister Endowment	The study was supported by the Chaya and Kadish Shermeister Endowment.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Ahmed KM, 2008, FREE RADICAL BIO MED, V44, P1, DOI 10.1016/j.freeradbiomed.2007.09.022; Almasan A, 1997, INT J RADIAT ONCOL, V39, P178, DOI 10.1016/S0360-3016(97)80645-1; Ammon H P, 1996, Eur J Med Res, V1, P369; Barani IJ, 2015, CANCER TREAT RES, V163, P49, DOI 10.1007/978-3-319-12048-5_4; BRACH MA, 1991, J CLIN INVEST, V88, P691, DOI 10.1172/JCI115354; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Chashoo G, 2011, CHEM-BIOL INTERACT, V189, P60, DOI 10.1016/j.cbi.2010.10.017; Chen G, 2010, ONCOL REP, V23, P997, DOI 10.3892/or_00000725; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Feldman JP, 2009, J APPL QUANT METHODS, V4, P455, DOI DOI 10.1111/J.2042-3306.2010.TB05629.X; Friedman A, 2008, NATURE, V455, P1061, DOI DOI 10.1038/NATURE07385; Glaser T, 1999, BRIT J CANCER, V80, P756, DOI 10.1038/sj.bjc.6690419; Gupta I, 1997, Eur J Med Res, V2, P37; Hoernlein RF, 1999, J PHARMACOL EXP THER, V288, P613; Jung M, 2001, SEMIN RADIAT ONCOL, V11, P346, DOI 10.1053/srao.2001.26034; Kruger P, 2008, DRUG METAB DISPOS, V36, P1135, DOI 10.1124/dmd.107.018424; Li M, 2007, P NATL ACAD SCI USA, V104, P18636, DOI 10.1073/pnas.0709307104; Liu JJ, 2002, CARCINOGENESIS, V23, P2087, DOI 10.1093/carcin/23.12.2087; Liu JJ, 2002, INT J MOL MED, V10, P501; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Magne N, 2006, CANCER LETT, V231, P158, DOI 10.1016/j.canlet.2005.01.022; Mealey J, 1978, EVALUATION BCNU RADI, V49, P333; Pang XF, 2009, CANCER RES, V69, P5893, DOI 10.1158/0008-5472.CAN-09-0755; Park B, 2011, INT J CANCER, V129, P23, DOI 10.1002/ijc.25966; Park YS, 2002, PLANTA MED, V68, P397, DOI 10.1055/s-2002-32090; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; PAULL KD, 1988, J HETEROCYCLIC CHEM, V25, P911, DOI 10.1002/jhet.5570250340; Puliyappadamba VT, 2014, MOL CELL ONCOL, V1, DOI 10.4161/23723548.2014.963478; Puliyappadamba VT, 2013, CELL REP, V4, P764, DOI 10.1016/j.celrep.2013.07.025; Royds JA, 2006, CELL DEATH DIFFER, V13, P1017, DOI 10.1038/sj.cdd.4401913; Suhail MM, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-129; Syrovets T, 2005, J BIOL CHEM, V280, P6170, DOI 10.1074/jbc.M409477200; Takada Y, 2015, ACETYL 11 KETO BETA; Toden S, 2015, CANCER PREV RES, V8, P431, DOI 10.1158/1940-6207.CAPR-14-0354; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; WELLER M, 1995, J CLIN INVEST, V95, P2633, DOI 10.1172/JCI117965; Winking M, 2000, J NEURO-ONCOL, V46, P97, DOI 10.1023/A:1006387010528; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Yamagishi JM N, 2009, INT J RADIAT BIOL, DOI [10.1080/095530097143374, DOI 10.1080/095530097143374]; Zhao WZ, 2003, CANCER DETECT PREV, V27, P67, DOI 10.1016/S0361-090X(02)00170-8	42	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0198627	10.1371/journal.pone.0198627	http://dx.doi.org/10.1371/journal.pone.0198627			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969452	Green Published, gold, Green Submitted			2022-12-26	WOS:000437246700004
J	Triantaphyllou, MV; Baumann, KH; Karatsolis, BT; Dimiza, MD; Psarra, S; Skampa, E; Patoucheas, P; Vollmar, NM; Koukousioura, O; Katsigera, A; Krasakopoulou, E; Nomikou, P				Triantaphyllou, Maria V.; Baumann, Karl-Heinz; Karatsolis, Boris-Theofanis; Dimiza, Margarita D.; Psarra, Stella; Skampa, Elisavet; Patoucheas, Pierros; Vollmar, Nele M.; Koukousioura, Olga; Katsigera, Anna; Krasakopoulou, Evangelia; Nomikou, Paraskevi			Coccolithophore community response along a natural CO2 gradient off Methana (SW Saronikos Gulf, Greece, NE Mediterranean)	PLOS ONE			English	Article							OCEAN ACIDIFICATION; LIFE-CYCLE; SEA; CARBON; CALCIFICATION; IMPACTS; FUTURE; CORAL; WATER; VARIABILITY	A natural pH gradient caused by marine CO2 seeps off the Methana peninsula (Saronikos Gulf, eastern Peloponnese peninsula) was used as a natural laboratory to assess potential effects of ocean acidification on coccolithophores. Coccolithophore communities were therefore investigated in plankton samples collected during September 2011, September 2016 and March 2017. The recorded cell concentrations were up to similar to 50 x10(3) cells/I, with a high Shannon index of up to 2.8, along a pH gradient from 7.61 to 8.18, with values being occasionally <7. Numerous holococcolithophore species represented 60-90% of the surface water assemblages in most samples during September samplings. Emiliania huxleyi was present only in low relative abundances in September samples, but it dominated in March assemblages. Neither malformed nor corroded coccolithophores were documented. Changes in the community structure can possibly be related to increased temperatures, while the overall trend associates low pH values with high cell densities. Our preliminary results indicate that in long-termed acidified, warm and stratified conditions, the study of the total coccolithophore assemblage may prove useful to recognize the intercommunity variability, which favors the increment of lightly calcified species such as holococcolithophores.	[Triantaphyllou, Maria V.; Karatsolis, Boris-Theofanis; Dimiza, Margarita D.; Skampa, Elisavet; Katsigera, Anna; Nomikou, Paraskevi] Univ Athens, Fac Geol & Geoenvironm Panepistimioupolis, Athens, Greece; [Baumann, Karl-Heinz; Vollmar, Nele M.] Univ Bremen, Geosci Dept, Bremen, Germany; [Psarra, Stella] Hellen Ctr Marine Res, Inst Oceanog, Attiki, Greece; [Patoucheas, Pierros; Koukousioura, Olga] Aristotle Univ Thessaloniki, Dept Geol, Thessaloniki, Greece; [Krasakopoulou, Evangelia] Univ Aegean, Dept Marine Sci, Lesvos, Greece	National & Kapodistrian University of Athens; University of Bremen; Hellenic Centre for Marine Research; Aristotle University of Thessaloniki; University of Aegean	Triantaphyllou, MV (corresponding author), Univ Athens, Fac Geol & Geoenvironm Panepistimioupolis, Athens, Greece.	mtriant@geol.uoa.gr	Dimiza, Margarita/A-6857-2015; Triantaphyllou, Maria/AAL-7877-2021	Dimiza, Margarita/0000-0002-9809-1902; Triantaphyllou, Maria/0000-0001-7508-7508; Krasakopoulou, Evangelia/0000-0002-1948-3482; Nomikou, Paraskevi/0000-0001-8842-9730; Vollmar, Nele Manon/0000-0003-4180-3443; Karatsolis, Boris- Theofanis/0000-0002-6248-2151; KOUKOUSIOURA, OLGA/0000-0001-8127-3331	IKYDA funding program of the DAAD [57260124]; NKUA/SARG [70/3/14850]	IKYDA funding program of the DAAD; NKUA/SARG	The work was partly funded by the IKYDA funding program of the DAAD (project 57260124 "AegeanCocco"). Publication fees were funded by the NKUA/SARG 70/3/14850 research project. The Municipality of Troizina-Methana supported our group with accommodation facilities. There was no additional external funding received for this study.	Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P1798, DOI 10.1111/j.1365-2486.2010.02364.x; Baggini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106520; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Beaufort L, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001493; Bethoux JP, 1999, PROG OCEANOGR, V44, P131, DOI 10.1016/S0079-6611(99)00023-3; Billard C., 1994, Systematics Association Special Volume Series, V51, P167; Boatta F, 2013, MAR POLLUT BULL, V73, P485, DOI 10.1016/j.marpolbul.2013.01.029; Bray L, 2014, MEDITERR MAR SCI, V15, P510, DOI 10.12681/mms.579; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Chevaldonne P, 2003, ECOL LETT, V6, P371, DOI 10.1046/j.1461-0248.2003.00439.x; Cros L, 2002, SCI MAR, V66, P5; Cros L, 2013, MAR ECOL PROG SER, V492, P57, DOI 10.3354/meps10473; Cros L, 2013, SCI MAR, V77, P63, DOI 10.3989/scimar.03727.27E; D'Amario B, 2017, J PLANKTON RES, V39, P781, DOI 10.1093/plankt/fbx044; Dando PR, 2000, PHYS CHEM EARTH PT B, V25, P1, DOI 10.1016/S1464-1909(99)00112-4; De Vargas C, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P271; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Dimiza MD, 2008, MICROPALEONTOLOGY, V54, P159; Dimiza MD, 2015, MICROPALEONTOLOGY, V61, P521; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2009, GEOPHYS MONOGR SER, V183, P175, DOI 10.1029/2005GM000337; Frada M, 2009, MAR MICROPALEONTOL, V71, P20, DOI 10.1016/j.marmicro.2009.01.001; Gambaiani DD, 2009, J MAR BIOL ASSOC UK, V89, P179, DOI 10.1017/S0025315408002476; Geisen M, 2002, EUR J PHYCOL, V37, P531, DOI 10.1017/S0967026202003852; Gibbs SJ, 2015, GEOLOGY, V44, DOI [10.1130/G37273, DOI 10.1130/G37273]; GOYET C, 1989, DEEP-SEA RES, V36, P1635, DOI 10.1016/0198-0149(89)90064-2; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Harper DAT, 2001, PALAEONTOL ELECTRON, V4; Harvey BP, 2013, ECOL EVOL, V3, P1016, DOI 10.1002/ece3.516; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; Houdan A., 2004, SYST BIODIVERS, V1, P453, DOI [10.1017/S1477200003001270, DOI 10.1017/S1477200003001270]; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Jackson EL, 2014, ICES J MAR SCI, V71, P2621, DOI 10.1093/icesjms/fsu099; Johnson VR, 2013, MAR BIOL, V160, P1813, DOI 10.1007/s00227-011-1840-2; Johnson VR, 2012, GLOBAL CHANGE BIOL, V18, P2792, DOI 10.1111/j.1365-2486.2012.02716.x; Jordan RW, 2000, MAR MICROPALEONTOL, V39, P113, DOI 10.1016/S0377-8398(00)00017-7; KLEIJNE A, 1991, MAR MICROPALEONTOL, V17, P1, DOI 10.1016/0377-8398(91)90023-Y; Kontoyiannis H, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC005026; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2013, NAT CLIM CHANGE, V3, P156, DOI [10.1038/NCLIMATE1680, 10.1038/nclimate1680]; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Le Quere C., 2009, GLOBAL CHANGE, V74, P28, DOI DOI 10.1073/PNAS.0702737104; Lee K, 2010, GEOCHIM COSMOCHIM AC, V74, P1801, DOI 10.1016/j.gca.2009.12.027; Lionello P, 2006, DEV EARTH ENV SCI, V4, P1, DOI 10.1016/s1571-9197(06)80003-0; Malinverno E, 2009, MAR MICROPALEONTOL, V71, P131, DOI 10.1016/j.marmicro.2009.02.002; Malinverno E, 2014, J MARINE SYST, V132, P13, DOI 10.1016/j.jmarsys.2013.12.009; Milazzo M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04189; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Noel MH, 2004, J PHYCOL, V40, P112, DOI 10.1046/j.1529-8817.2004.03053.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Papanikolaou ID, 2007, QUATERN INT, V171-72, P31, DOI 10.1016/j.quaint.2007.03.020; PARKE M, 1960, J MAR BIOL ASSOC UK, V39, P263, DOI 10.1017/S002531540001331X; Pavalakis P., 1989, BULL GEOL SOC GREECE, V3, P333; PEREZ FF, 1987, MAR CHEM, V21, P161, DOI 10.1016/0304-4203(87)90036-3; Pierrot DE., 2006, MS EXCEL PROGRAM DEV, DOI [10.3334/CDIAC/otg.CO2SYS_XLS_CDIAC105a, DOI 10.3334/CDIAC/OTG.CO2SYS_XLS_CDIAC105A]; Pinardi N, 2000, PALAEOGEOGR PALAEOCL, V158, P153, DOI 10.1016/S0031-0182(00)00048-1; Raven J., 2005, 1205 ROYAL SOC LOND; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rimmelin P, 2005, ANAL CHIM ACTA, V548, P174, DOI 10.1016/j.aca.2005.05.071; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rodolfo-Metalpa R, 2010, MAR ECOL-EVOL PERSP, V31, P447, DOI 10.1111/j.1439-0485.2009.00354.x; ROWSON JD, 1986, BRIT PHYCOL J, V21, P359, DOI 10.1080/00071618600650431; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SANDGREN CD, 1984, BRIT PHYCOL J, V19, P67, DOI 10.1080/00071618400650071; Schneider A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028842; Sinutok S, 2014, MAR BIOL, V161, P2143, DOI 10.1007/s00227-014-2494-7; Strickland J.D., 1972, J FISH RES BOARD CAN; Triantaphyllou M, 2010, GEOBIOS-LYON, V43, P99, DOI 10.1016/j.geobios.2009.09.002; Triantaphyllou MV, 2015, MICROPALEONTOLOGY, V61, P457; Triantaphyllou Maria V., 2002, Revue de Paleobiologie, V21, P353; Triantaphyllou MV, 2004, MICROPALEONTOLOGY, V50, P127, DOI 10.2113/50.Suppl_1.127; Triantaphyllou MV, 2003, J MICROPALAEONTOL, V22, P107, DOI 10.1144/jm.22.1.107; Tsakalakis I, 2014, 17 WORKSH INT ASS PH; Turley CM, 1999, PROG OCEANOGR, V44, P387, DOI 10.1016/S0079-6611(99)00033-6; Tyrrell T, 2008, J PLANKTON RES, V30, P141, DOI 10.1093/plankt/fbm105; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; Wall-Palmer D, 2013, QUATERNARY SCI REV, V81, P29, DOI 10.1016/j.quascirev.2013.09.019; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Young J.R., 2003, J NANNOPLANKTON RES, V1, P1; Young Jeremy R., 1994, P63; Ziveri P, 2000, PALAEOGEOGR PALAEOCL, V158, P175, DOI 10.1016/S0031-0182(00)00049-3; Ziveri P, 2014, BIOL BULL-US, V226, P282, DOI 10.1086/BBLv226n3p282; Ziveri Patrizia, 2008, CIESM Workshop Monographs, V36, P99	90	14	14	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0200012	10.1371/journal.pone.0200012	http://dx.doi.org/10.1371/journal.pone.0200012			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966023	Green Published, gold, Green Submitted			2022-12-26	WOS:000437224100038
J	Sarlls, JE; Lalonde, F; Rettmann, D; Shankaranarayanan, A; Roopchansingh, V; Talagala, SL				Sarlls, Joelle E.; Lalonde, Francois; Rettmann, Dan; Shankaranarayanan, Ajit; Roopchansingh, Vinai; Talagala, S. Lalith			Effectiveness of navigator-based prospective motion correction in MPRAGE data acquired at 3T	PLOS ONE			English	Article							IMAGE-BASED TRACKING; HEAD MOTION; MRI; BRAIN; SYSTEM; FMRI; PROMO	In MRI, subject motion results in image artifacts. High-resolution 3D scans, like MPRAGE, are particularly susceptible to motion because of long scan times and acquisition of data over multiple-shots. Such motion related artifacts have been shown to cause a bias in cortical measures extracted from segmentation of high-resolution MPRAGE images. Prospective motion correction (PMC) techniques have been developed to help mitigate artifacts due to subject motion. In this work, high-resolution MPRAGE images are acquired during intentional head motion to evaluate the effectiveness of navigator-based PMC techniques to improve both the accuracy and reproducibility of cortical morphometry measures obtained from image segmentation. The contribution of reacquiring segments of k-space affected by motion to the overall performance of PMC is assessed. Additionally, the effect of subject motion on subcortical structure volumes is investigated. In the presence of head motion, navigator-based PMC is shown to improve both the accuracy and reproducibility of cortical and subcortical measures. It is shown that reacquiring segments of k-space data that are corrupted by motion is an essential part of navigator-based PMC performance. Subcortical structure volumes are not affected by motion in the same way as cortical measures; there is not a consistent underestimation.	[Sarlls, Joelle E.; Talagala, S. Lalith] NINDS, NIH MRI Res Facil, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Lalonde, Francois; Roopchansingh, Vinai] NIMH, Funct MRI Facil, NIH, Bethesda, MD 20892 USA; [Rettmann, Dan] GE Healthcare, Rochester, MN USA; [Shankaranarayanan, Ajit] GE Healthcare, Menlo Pk, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); General Electric; General Electric	Sarlls, JE (corresponding author), NINDS, NIH MRI Res Facil, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	sarllsjo@mail.nih.gov		Sarlls, Joelle/0000-0002-4734-5351	National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institute of Mental Health at NIH	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Mental Health at NIH	JS, FL, VR, and LT are supported by the intramural research programs of the National Institute of Neurological Disorders and Stroke, and National Institute of Mental Health. DR and AS are employees of GE Healthcare. The funder provided support in the form of salaries for authors DR and AS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The intramural research programs of the National Institute of Neurological Disorders and Stroke, and the National Institute of Mental Health at NIH supported this research. D.R. and A.S. are employed by GE Healthcare Inc.	Banerjee S, 2013, MAGN RESON MED, V69, P421, DOI 10.1002/mrm.24269; Beatty P., 2007, P 15 ANN M ISMRM BER, P1749; Brown TT, 2010, NEUROIMAGE, V53, P139, DOI 10.1016/j.neuroimage.2010.06.017; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dold C, 2006, ACAD RADIOL, V13, P1093, DOI 10.1016/j.acra.2006.05.010; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Igata N, 2017, EUR RADIOL, V27, P3554, DOI 10.1007/s00330-016-4730-7; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Maclaren J, 2013, MAGN RESON MED, V69, P621, DOI 10.1002/mrm.24314; Qin L, 2009, MAGN RESON MED, V62, P924, DOI 10.1002/mrm.22076; Reuter M, 2015, NEUROIMAGE, V107, P107, DOI 10.1016/j.neuroimage.2014.12.006; Speck O, 2006, MAGN RESON MATER PHY, V19, P55, DOI 10.1007/s10334-006-0027-1; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Tisdall MD, 2016, NEUROIMAGE, V127, P11, DOI 10.1016/j.neuroimage.2015.11.054; van der Kouwe AJW, 2006, MAGN RESON MED, V56, P1019, DOI 10.1002/mrm.21038; Ward HA, 2000, MAGNET RESON MED, V43, P459, DOI 10.1002/(SICI)1522-2594(200003)43:3<459::AID-MRM19>3.0.CO;2-1; Watanabe K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38366; Welch EB, 2002, MAGN RESON MED, V47, P32, DOI 10.1002/mrm.10012; White N, 2010, MAGN RESON MED, V63, P91, DOI 10.1002/mrm.22176; Zaitsev M, 2006, NEUROIMAGE, V31, P1038, DOI 10.1016/j.neuroimage.2006.01.039	21	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199372	10.1371/journal.pone.0199372	http://dx.doi.org/10.1371/journal.pone.0199372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953459	Green Submitted, Green Published, gold			2022-12-26	WOS:000436645400027
J	Yan, P; Xu, L; He, NP				Yan, Pu; Xu, Li; He, Nianpeng			Variation in the calorific values of different plants organs in China	PLOS ONE			English	Article							BIOMASS; ROOT; ECOSYSTEMS; ALLOCATION; LEAF; TRAITS; FOREST; LEAVES	The calorific value (CAL, KJ g(-1)) of different plant organs are important plant traits. Variation in CAL among different plant organs reflects the energy utilization and distribution strategy of plant. Here, we explored how the CAL of different plant organs varies at the species and regional level in relation to vegetation type (3697 forests samples, 430 grasslands samples, and 146 deserts samples). The results showed that, in the forests and grasslands, CAL significantly differed among the different organs and functional types of plants. The CAL of different organs in forests was ordered as: leaf (19.71 +/- 1.82 KJ g(-1)) > branch (19.33 +/- 1.32 KJ g(-1)) > trunk (19.09 +/- 1.44 KJ g(-1)) > root (19.02 +/- 1.11 KJ g(-1)). For forests, the CAL of plant organs, except for the leaves of trees and shrubs, increased with increasing latitude (P < 0.01). In comparison, the CAL in the roots of shrubs and herbs decreased with increasing longitude (P < 0.01). Through delineating systematic references of CAL among different plant organs, our findings provide key parameters to improve estimates of biomass energy at regional and global scales.	[Yan, Pu; Xu, Li; He, Nianpeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Yan, Pu; He, Nianpeng] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, L (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	xuli@igsnrr.ac.cn		Yan, Pu/0000-0001-5614-9355	National Key R&D Project of China [2017YFA0604803]; Chinese Academy of Sciences Strategic Priority Research Program [XDA19020302]; National Natural Science Foundation of China [31770655, 41571130043]; program of Youth Innovation Research Team Project [LENOM2016Q0005]	National Key R&D Project of China; Chinese Academy of Sciences Strategic Priority Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program of Youth Innovation Research Team Project	The authors thank the National Key R&D Project of China (2017YFA0604803), the Chinese Academy of Sciences Strategic Priority Research Program (XDA19020302), the National Natural Science Foundation of China [31770655, 41571130043], and the program of Youth Innovation Research Team Project (LENOM2016Q0005) for providing funding.	ADAMANDIADOU S, 1978, FLORA, V167, P574; BLISS LC, 1962, ECOLOGY, V43, P753, DOI 10.2307/1933473; CASPERS N, 1977, OECOLOGIA, V26, P379, DOI 10.1007/BF00345536; Chinese Academy of Sciences Chinese Flora Editorial Board, 2013, CHIN FLOR; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Fu B., 2001, ACTA ECOL SIN, P1, DOI DOI 10.3321/j.issn:1000-0933.2001.01.001; [高凯 Gao Kai], 2012, [草业科学, Pratacultural Science], V29, P453; [高凯 Gao Kai], 2012, [生态学报, Acta Ecologica Sinica], V32, P588; GOLLEY FB, 1961, ECOLOGY, V42, P581, DOI 10.2307/1932247; [官丽莉 Guan Lili], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P452; Han WX, 2012, GLOBAL ECOL BIOGEOGR, V21, P376, DOI 10.1111/j.1466-8238.2011.00677.x; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Ji GL, 1985, PLATEAU METEOROLOGY, V4, P112; Ke ZL, 2008, SCI TECHNOLOGY ENG, V8, P5672; Li FL, 2015, ECOL EVOL, V5, P5344, DOI 10.1002/ece3.1794; Lin CC, 1999, ACTA ECOLOGICA SINIC, V19, P832; Lin Hua, 2007, Zhiwu Shengtai Xuebao, V31, P1103; Lin H, 2008, ECOL MODEL, V217, P132, DOI 10.1016/j.ecolmodel.2008.06.012; Liu GF, 2010, NEW PHYTOL, V188, P543, DOI 10.1111/j.1469-8137.2010.03388.x; Liu GW, 2018, NEW PHYTOL, V217, P784, DOI 10.1111/nph.14847; Long FL, 1934, PLANT PHYSIOL, V9, P323, DOI 10.1104/pp.9.2.323; Niklas KJ, 2002, AM NAT, V159, P482, DOI 10.1086/339459; Niu SL, 2018, FUNCT ECOL, V32, P4, DOI 10.1111/1365-2435.13023; Price CA, 2012, NEW PHYTOL, V193, P882, DOI 10.1111/j.1469-8137.2011.04022.x; Ren H, 1999, CHINESE J PLANT ECOL, V23, P53; Simpson AH, 2016, GLOBAL ECOL BIOGEOGR, V25, P964, DOI 10.1111/geb.12457; SINGH JS, 1973, OIKOS, V24, P186, DOI 10.2307/3543874; SINGH T, 1986, CAN J FOREST RES, V16, P1378, DOI 10.1139/x86-245; Song GY, 2016, FOREST RES, P133; Song GY, 2016, PLOS ONE, V6, P34290; Sun Y.M., 2006, RENEW ENERGY RESOUR, V02, P78, DOI DOI 10.3969/j.issn.1671-5292.2006.02.026; [田苗 Tian Miao], 2015, [生态学报, Acta Ecologica Sinica], V35, P7709; VOOKOVA B, 1985, EKOL CSFR, V4, P33; [王立海 WANG Li-Hai], 2009, [生态学报, Acta Ecologica Sinica], V29, P953; Wang Yang, 2017, Chinese Journal of Plant Ecology, V41, P209, DOI 10.17521/cjpe.2016.0043; [温军 Wen Jun], 2012, [草业科学, Pratacultural Science], V29, P1451; Yao FY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116391	37	10	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e099762	10.1371/journal.pone.0199762	http://dx.doi.org/10.1371/journal.pone.0199762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953550	gold, Green Published, Green Submitted			2022-12-26	WOS:000436645400062
J	Bertocchi, M; Pelizzone, I; Parmigiani, E; Ponzio, P; Macchi, E; Righi, F; Di Girolamo, N; Bigliardi, E; Denti, L; Bresciani, C; Di Ianni, F				Bertocchi, Mara; Pelizzone, Igor; Parmigiani, Enrico; Ponzio, Patrizia; Macchi, Elisabetta; Righi, Federico; Di Girolamo, Nicola; Bigliardi, Enrico; Denti, Laura; Bresciani, Carla; Di Ianni, Francesco			Monitoring the reproductive activity in captive bred female ball pythons (P. regius) by ultrasound evaluation and noninvasive analysis of faecal reproductive hormone (progesterone and 17 beta-estradiol) metabolites trends	PLOS ONE			English	Article							STEROID ANALYSIS; GLUCOCORTICOID METABOLITES; ADRENOCORTICAL FUNCTION; PLASMA PROGESTERONE; TESTOSTERONE CONCENTRATIONS; ULTRASONOGRAPHIC ANATOMY; PHYSIOLOGICAL VALIDATION; CORTISOL METABOLITES; GENDER DETERMINATION; TILIQUA-NIGROLUTEA	The royal python (Python regius) is commonly bred in captivity. To have a successful breeding season, accurate monitoring of the reproductive activity is necessary. The use of noninvasive monitoring methods in exotics is important in order to minimize stress. For this purpose ultrasound has been anecdotally used to monitor royal python reproductive activity. However, there is limited information regarding the reproductive cycle of this species. The aim of the present study is to monitor the female reproductive cycle of the royal python using ultrasonography and gonadal steroid metabolite measurements in the faeces. The reproductive activity of one hundred twenty-nine adult female P. regius was examined during two consecutive years. We performed brief scans on non-anaesthetized snakes using a portable ultrasound system and a 10-12 MHz linear array transducer (MyLab (TM) 30 Gold, Esaote). Ultrasound features, dimension and echogenicity of the reproductive structures were determined. During the second reproductive cycle, the hormonal profiles of 30 animals were also evaluated, with a monthly collection of faecal samples. These samples were classified according to reproductive stage, as identified by ultrasonographic examination, and the mean faecal progesterone and 17 beta-estradiol levels were calculated using the results from an enzyme-linked immunosorbent assay (ELISA). Progesterone levels increased during the reproductive cycle. Estradiol levels showed greater variability, although they appeared to increase before coupling when compared to the levels between coupling and egg laying. The present study suggests that it is possible to identify different phases in the female royal python reproductive cycle: anovulatory phase, transition, folliculogenesis and embryogenesis. Ultrasound is also useful for identifying follicular regression or slugs. Gonadal steroid metabolite measurements from the faeces could help integrate reproductive information. The use of ultrasonography in addition to the steroid metabolite measurement in the faeces gives an accurate picture of ovarian activity in captive adult female royal pythons.	[Bertocchi, Mara; Parmigiani, Enrico; Righi, Federico; Bigliardi, Enrico; Denti, Laura; Bresciani, Carla; Di Ianni, Francesco] Univ Parma, Dept Vet Sci, Via Taglio, Parma, Italy; [Pelizzone, Igor] Ambulatorio Vet Belvedere, Reggio Emilia, Italy; [Ponzio, Patrizia; Macchi, Elisabetta] Univ Torino, Dept Vet Sci, Via Leonardo da Vinci, Grugliasco, TO, Italy; [Di Girolamo, Nicola] Tai Wai Small Anim & Exot Hosp, Lap Wo Bldg, Sha Tin, Hong Kong, Peoples R China	University of Parma; University of Turin	Bigliardi, E (corresponding author), Univ Parma, Dept Vet Sci, Via Taglio, Parma, Italy.	enrico.bigliardi@gmail.com		Righi, Federico/0000-0001-9274-4143; Bertocchi, Mara/0000-0002-6695-9332; PONZIO, Patrizia/0000-0001-7724-7974				Alkindi AYA, 2006, TISSUE CELL, V38, P19, DOI 10.1016/j.tice.2005.10.001; Almeida-Santos SM, 2004, GEN COMP ENDOCR, V139, P143, DOI 10.1016/j.ygcen.2004.09.001; Amey AP, 2000, GEN COMP ENDOCR, V117, P335, DOI 10.1006/gcen.2000.7426; Asa CS, 1999, P AM ASS ZOO VET ANN, P95; Atkins N, 2002, J HERPETOL, V36, P106, DOI 10.2307/1565811; Aubret F, 2005, J HERPETOL, V39, P315, DOI 10.1670/111-02N; Banzato T, 2012, AM J VET RES, V73, P634, DOI 10.2460/ajvr.73.5.634; Berkeley EV, 1997, ZOO BIOL, V16, P121, DOI 10.1002/(SICI)1098-2361(1997)16:2<121::AID-ZOO3>3.0.CO;2-C; Bigliardi E, 2014, J VET SCI, V15, P267, DOI 10.4142/jvs.2014.15.2.267; Bigliardi E, 2011, VET RADIOL ULTRASOUN, V52, P107, DOI 10.1111/j.1740-8261.2010.01743.x; Bonnet X, 2001, GEN COMP ENDOCR, V121, P84, DOI 10.1006/gcen.2000.7574; Brasfield SM, 2008, ZOO BIOL, V27, P36, DOI 10.1002/zoo.20159; Brown JL, 1997, Z SAUGETIERKD, V62, P27; Casares M, 1997, J ZOO WILDLIFE MED, V28, P267; Casares VM., 1995, ZOOL GART, V65, P50; Chen TY, 2011, ZOO BIOL, V30, P689, DOI 10.1002/zoo.20376; COOPER TR, 1989, J ENDOCRINOL, V123, pR13, DOI 10.1677/joe.0.123R013; Custodia-Lora N, 2002, GEN COMP ENDOCR, V127, P1, DOI 10.1016/S0016-6480(02)00030-8; Dehnhard M, 2003, GEN COMP ENDOCR, V131, P345, DOI 10.1016/S0016-6480(03)00033-9; Dehnhard M, 2001, GEN COMP ENDOCR, V123, P111, DOI 10.1006/gcen.2001.7656; DeNardo DF, 2001, COPEIA, P1138; DEVOSJOLI P, 1995, BALL PYTHON MANUAL; Di Ianni F, 2015, VET RADIOL ULTRASOUN, V56, P40, DOI 10.1111/vru.12186; Di Ianni F, 2014, J EXOT PET MED, V23, P79, DOI 10.1053/j.jepm.2013.11.009; Dobeli M., 1992, P 1 INT S FAEC STER, P73; Edwards A, 2001, GEN COMP ENDOCR, V122, P260, DOI 10.1006/gcen.2001.7634; Enriquez KL, 2011, PHILIPP J VET MED, V48, P70; Ganesh C. B., 2007, Journal of Advanced Zoology, V28, P84; Ganswindt A, 2003, GEN COMP ENDOCR, V134, P156, DOI 10.1016/S0016-6480(03)00251-X; GAVAUD J, 1986, GEN COMP ENDOCR, V63, P11, DOI 10.1016/0016-6480(86)90176-0; Gnudi G, 2009, VET RADIOL ULTRASOUN, V50, P309, DOI 10.1111/j.1740-8261.2009.01540.x; Good T, 2003, PHYSIOL BEHAV, V80, P405, DOI 10.1016/j.physbeh.2003.09.006; Goymann W, 1999, GEN COMP ENDOCR, V114, P340, DOI 10.1006/gcen.1999.7268; Goymann W, 2005, ANN NY ACAD SCI, V1046, P35, DOI 10.1196/annals.1343.005; Graham L, 2001, ZOO BIOL, V20, P227, DOI 10.1002/zoo.1022; Graham LH, 1996, ZOO BIOL, V15, P71, DOI 10.1002/(SICI)1098-2361(1996)15:1<71::AID-ZOO7>3.0.CO;2-9; Graham SP, 2011, GEN COMP ENDOCR, V174, P348, DOI 10.1016/j.ygcen.2011.09.015; Groschl M, 2008, CLIN CHEM, V54, P1759, DOI 10.1373/clinchem.2008.108910; Hansen K, 2013, PHYSIOL BIOCHEM ZOOL, V86, P149, DOI 10.1086/668915; Hanzen C, 2000, VET J, V159, P161, DOI 10.1053/tvjl.1999.0398; Harper JM, 2000, PHYSIOL BIOCHEM ZOOL, V73, P12, DOI 10.1086/316721; Hayssen V, 2002, COMP BIOCHEM PHYS A, V132, P439, DOI 10.1016/S1095-6433(02)00086-7; Hernandez CE, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0061-3; Hernandez-Divers S, 2001, IN PRACTICE, V23, P370; Heulin B, 2008, AMPHIBIA-REPTILIA, V29, P135, DOI 10.1163/156853808783431479; HIGHFILL DR, 1975, GEN COMP ENDOCR, V27, P389, DOI 10.1016/0016-6480(75)90206-3; Hochleithner Claudia, 2004, Proceedings of the Annual Conference of the Association of Reptilian and Amphibian Veterinarians, V11, P41; Hofmeyr MD, 2004, J HERPETOL, V38, P172, DOI 10.1670/133-03A; Holmes KM, 2006, J HERPETOL, V40, P141, DOI 10.1670/235-04.1; Hunt KE, 2004, PHYSIOL BEHAV, V80, P595, DOI 10.1016/j.physbeh.2003.10.017; ISAZA R, 1993, VET RADIOL ULTRASOUN, V34, P445, DOI 10.1111/j.1740-8261.1993.tb02034.x; Jones SM, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 3: REPTILES, P89; Kawazu Isao, 2014, Current Herpetology, V33, P88, DOI 10.5358/hsj.33.88; Khan MZ, 2002, GEN COMP ENDOCR, V128, P57, DOI 10.1016/S0016-6480(02)00063-1; Kuchling G., 2015, International Zoo Yearbook, V49, P22, DOI 10.1111/izy.12081; Kummrow MS, 2011, ZOO BIOL, V30, P95, DOI 10.1002/zoo.20318; Lance VA, 2009, GEN COMP ENDOCR, V162, P251, DOI 10.1016/j.ygcen.2009.03.021; LASLEY BL, 1991, J ZOO WILDLIFE MED, V22, P23; Lind CM, 2010, GEN COMP ENDOCR, V166, P590, DOI 10.1016/j.ygcen.2010.01.026; Lovern MB, 2003, GEN COMP ENDOCR, V134, P109, DOI 10.1016/S0016-6480(03)00240-5; Lynch JW, 2003, GEN COMP ENDOCR, V132, P264, DOI 10.1016/S0016-6480(03)00093-5; Mader D. M., 2006, REPTILE MED SURG, P365; Manire CA, 2008, ZOO BIOL, V27, P213, DOI 10.1002/zoo.20171; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; MOORE MC, 1985, GEN COMP ENDOCR, V60, P144, DOI 10.1016/0016-6480(85)90308-9; Morrow CJ, 2002, GEN COMP ENDOCR, V126, P229, DOI 10.1006/gcen.2002.7797; NAULLEAU G, 1990, GEN COMP ENDOCR, V78, P433, DOI 10.1016/0016-6480(90)90032-H; Negrao JA, 2004, J DAIRY SCI, V87, P1713, DOI 10.3168/jds.S0022-0302(04)73324-X; Nielsen Emily L., 2016, Journal of Herpetological Medicine and Surgery, V26, P108, DOI 10.5818/1529-9651-26.3-4.108; Norris DO., 2007, VERTEBRATE ENDOCRINO, V4; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Pimm RH, 2015, ZOO BIOL, V34, P20, DOI 10.1002/zoo.21185; Prades R. B., 2013, Philippine Journal of Veterinary and Animal Sciences, V39, P115; PRYCE CR, 1993, J REPROD FERTIL, V99, P427; Radder RS, 2001, GEN COMP ENDOCR, V124, P285, DOI 10.1006/gcen.2001.7711; Redrobe S, 1997, PROCEEDINGS OF THE FOURTH ANNUAL CONFERENCE OF THE ASSOCIATION OF REPTILIAN AND AMPHIBIAN VETERINARIANS, P183; Rhen T, 2000, GEN COMP ENDOCR, V118, P322, DOI 10.1006/gcen.2000.7477; Rossi John, 2000, Journal of Herpetological Medicine and Surgery, V10, P24; Sacchi R, 2012, J ZOOL, V287, P301, DOI 10.1111/j.1469-7998.2012.00917.x; SAINSBURY AW, 1991, J ZOO WILDLIFE MED, V22, P421; Schatz S, 2001, VET RES COMMUN, V25, P271, DOI 10.1023/A:1010626608498; Schildger B.J., 1994, Seminars in Avian and Exotic Pet Medicine, V3, P147; Schilliger L.H., 2010, ULTRASOUND EXAMINATI; Schillinger L, 2006, J HERPETOL MED SURG, V16, P90; Schwarzenberger F, 2004, THERIOGENOLOGY, V62, P1677, DOI 10.1016/j.theriogenology.2004.03.007; Schwarzenberger F, 1996, ANIM REPROD SCI, V42, P515, DOI 10.1016/0378-4320(96)01561-8; Shine R, 2003, P ROY SOC B-BIOL SCI, V270, P995, DOI 10.1098/rspb.2002.2307; Sillman AJ, 1999, J EXP BIOL, V202, P1931; SILVERMAN S, 1993, VET CLIN N AM-SMALL, V23, P1287, DOI 10.1016/S0195-5616(93)50156-0; Snyder PS, 1999, VET RADIOL ULTRASOUN, V40, P66, DOI 10.1111/j.1740-8261.1999.tb01840.x; Stahl Scott J., 2002, Veterinary Clinics of North America Exotic Animal Practice, V5, P615, DOI 10.1016/S1094-9194(02)00017-8; Stahl SJ, 2001, SEMIN AVIAN EXOT PET, V10, P140, DOI 10.1053/saep.2001.24256; Stahlschmidt Z, 2011, BIOL J LINN SOC, V103, P772, DOI 10.1111/j.1095-8312.2011.01671.x; Stetter M., 2006, REPTILE MED SURG, P665; Sutherland C., 2009, BALL PYTHONS COMPLET; Sykes John M., 2010, Veterinary Clinics of North America Exotic Animal Practice, V13, P349, DOI 10.1016/j.cvex.2010.05.013; Taylor EN, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 3: REPTILES, P355; Taylor EN, 2005, COPEIA, P152, DOI 10.1643/CH-04-107R1; Taylor EN, 2004, GEN COMP ENDOCR, V136, P328, DOI 10.1016/j.ygcen.2004.01.008; Tempel DJ, 2004, CONSERV BIOL, V18, P538, DOI 10.1111/j.1523-1739.2004.00372.x; Terio KA, 2002, ZOO BIOL, V21, P215, DOI 10.1002/zoo.10036; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; Tumkiratiwong P, 2012, ZOOL STUD, V51, P692; Turner JW, 2003, GEN COMP ENDOCR, V133, P341, DOI 10.1016/S0016-6480(03)00196-5; Garcia-Valdez MV, 2016, HERPETOL CONSERV BIO, V11, P519; VINCENT IC, 1992, RES VET SCI, V53, P342, DOI 10.1016/0034-5288(92)90137-Q; Vitt L.J., 1992, P135; Volta A, 2014, REPROD DOMEST ANIM, V49, P202, DOI 10.1111/rda.12250; Walker SL, 2002, ZOO BIOL, V21, P321, DOI 10.1002/zoo.10052; WALLACE SS, 1992, AM J VET RES, V53, P209; Wasmeier GH, 2007, CORONARY ARTERY DIS, V18, P283, DOI 10.1097/MCA.0b013e3280d5a7e3; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Wilkinson Roger, 2004, P187, DOI 10.1002/9780470698877.ch8; Zug G.R., 2011, HERPETOLOGY INTRO BI	115	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199377	10.1371/journal.pone.0199377	http://dx.doi.org/10.1371/journal.pone.0199377			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949610	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200047
J	Wang, LJ; Lo, HF; Lin, CF; Ng, PS; Wu, YH; Lee, YS; Cheong, ML; Chen, HW				Wang, Liang-Jie; Lo, Hsiao-Fan; Lin, Cheng-Fu; Ng, Pui-Sze; Wu, Yi-Hung; Lee, Yun-Shien; Cheong, Mei-Leng; Chen, Hungwen			SFRP3 negatively regulates placental extravillous trophoblast cell migration mediated by the GCM1-WNT10B-FZD7 axis	FASEB JOURNAL			English	Article						trophoblast-decidual cell interaction; pregnancy; gene expression; cytoskeletal remodeling	CATENIN SIGNALING PATHWAY; PROTEIN; ACTIVATION; BMP2; WNT4; GCMA	Migration of placental extravillous trophoblast (EVT) cells into uterine decidua facilitates the establishment of blood circulation between mother and fetus and is modulated by EVT-decidual cell interaction. Poor or excessive EVT migration is associated with pregnancy complications such as preeclampsia or placenta accreta. Glial cells missing 1 (GCM1) transcription factor is essential for placental development, and decreased GCM1 activity is detected in preeclampsia. To study whether GCM1 regulates trophoblast cell migration, here we showed that GCM1 promotes BeWo and JAR trophoblast cell migration through a novel target gene, WNT10B. Moreover, WNT10B signaling stimulated cytoskeletal remodeling via Rac1 and frizzled 7 (FZD7) was identified as the cognate receptor for WNT10B to up-regulate cell migration. We further showed that secreted frizzled-related protein 3 (SFRP3) is expressed in uterine decidual cells by immunohistochemistry and that SFRP3 expression in telomerase-transformed human endometrial stromal cells (T-HESCs) is elevated under decidualization stimuli and further enhanced by bone morphogenetic protein 2 via SMAD1. SFRP3 blocked the interaction between FZD7 and WNT10B to decrease BeWo cell migration, which corroborated the elevated BeWo cell migration when cocultured with decidualized and SFRP3-knockdown T-HESC monolayer. Our results suggest that GCM1 up-regulates EVT cell migration through WNT10B and FZD7, which is negatively modulated by decidual SFRP3.Wang, L.-J., Lo, H.-F., Lin, C.-F., Ng, P.-S., Wu, Y.-H., Lee, Y.-S., Cheong, M.-L., Chen, H. SFRP3 negatively regulates placental extravillous trophoblast cell migration mediated by the GCM1-WNT10B-FZD7 axis.	[Wang, Liang-Jie; Lo, Hsiao-Fan; Ng, Pui-Sze; Wu, Yi-Hung; Chen, Hungwen] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lin, Cheng-Fu] Natl Taiwan Univ, Grad Inst Biochem Sci, Taipei, Taiwan; [Lee, Yun-Shien] Ming Chuan Univ, Dept Biotechnol, Taoyuan, Taiwan; [Cheong, Mei-Leng] Cathay Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Cheong, Mei-Leng] Taipei Med Univ, Sch Med, Dept Obstet & Gynecol, Coll Med, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Ming Chuan University; Cathay General Hospital; Taipei Medical University	Chen, HW (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	hwchen@gate.sinica.edu.tw	Chen, Hungwen/AAC-1394-2022		Ministry of Science and Technology [106-2311-B-001-013-MY3]; Academia Sinica	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by the Ministry of Science and Technology (Grant 106-2311-B-001-013-MY3) and Academia Sinica (to H.C.). The authors declare no conflicts of interest.	Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Aprelikova O, 2013, ONCOGENE, V32, P3246, DOI 10.1038/onc.2012.351; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Chang CW, 2011, MOL CELL BIOL, V31, P3820, DOI 10.1128/MCB.05582-11; Chang CW, 2005, MOL CELL BIOL, V25, P8401, DOI 10.1128/MCB.25.19.8401-8414.2005; Chang M, 2008, BIOL REPROD, V78, P841, DOI 10.1095/biolreprod.107.065599; Chen YY, 2014, J BIOL CHEM, V289, P22958, DOI 10.1074/jbc.M114.576744; Chiang MH, 2009, J BIOL CHEM, V284, P17411, DOI 10.1074/jbc.M109.016170; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li QX, 2013, ENDOCRINOLOGY, V154, P446, DOI 10.1210/en.2012-1585; Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915; Lin JZ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001669; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Matsuura K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1551; Nagano Makoto, 2012, Int J Cell Biol, V2012, P310616, DOI 10.1155/2012/310616; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pollheimer J, 2006, AM J PATHOL, V168, P1134, DOI 10.2353/ajpath.2006.050686; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Sonderegger S, 2010, ENDOCRINOLOGY, V151, P211, DOI 10.1210/en.2009-0557; Wang LJ, 2012, MOL CELL BIOL, V32, P3707, DOI 10.1128/MCB.00223-12; Wei SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028797; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200	32	4	4	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					314	326		10.1096/fj.201800124R	http://dx.doi.org/10.1096/fj.201800124R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29979633				2022-12-26	WOS:000457401500026
J	Lee, E; Collazo-Lorduy, A; Castillo-Martin, M; Gong, YX; Wang, L; Oh, WK; Galsky, MD; Cordon-Cardo, C; Zhu, J				Lee, Eunjee; Collazo-Lorduy, Ana; Castillo-Martin, Mireia; Gong, Yixuan; Wang, Li; Oh, William K.; Galsky, Matthew D.; Cordon-Cardo, Carlos; Zhu, Jun			Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR	ONCOGENE			English	Article							GENE-EXPRESSION SIGNATURE; ALKALOID EMETINE; DOWN-REGULATION; MICRORNA; CISPLATIN; TARGETS; CELLS	Bladder cancers can be categorized into subtypes according to gene expression patterns. P53-like muscle-invasive bladder cancers are generally resistant to cisplatin-based chemotherapy, but exhibit heterogeneous clinical outcomes with a prognosis intermediate to that of the luminal and basal subtypes. The optimal approach to p53-like tumors remains poorly defined and better means to risk-stratify such tumors and identification of novel therapeutic targets is urgently needed. MicroRNAs (miRNAs) play a key role in cancer, both in tumorigenesis and tumor progression. In the past few years, miRNA expression signatures have been reported as prognostic biomarkers in different tumor types including bladder cancer. However, miRNA's expression does not always correlate well with its activity. We previously developed ActMiR, a computational method for explicitly inferring miRNA activities. We applied ActMiR to The Cancer Genome Atlas (TCGA) bladder cancer data set and identified the activities of miR-106b-5p and miR-532-3p as potential prognostic markers of the p53-like subtype, and validated them in three independent bladder cancer data sets. Especially, higher miR-106b-5p activity was consistently associated with better survival in these data sets. Furthermore, we experimentally validated causal relationships between miR-106-5p and its predicted target genes in p53-like cell line HT1197. HT1197 cells treated with the miR-106b-5p-specific inhibitor were more invasive while cells treated with the miR-106b-5p-specific mimic were less invasive than corresponding controls. Altogether, our results suggest that miR-106b-5p activity can categorize p53-like bladder tumors into more and less-favorable prognostic groups, which provides critical information for personalizing treatment option for p53-like bladder cancers.	[Lee, Eunjee; Wang, Li; Zhu, Jun] Dept Genet & Genom Sci, New York, NY 10029 USA; [Lee, Eunjee; Wang, Li; Zhu, Jun] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Lee, Eunjee; Wang, Li; Zhu, Jun] Sema4, Stamford, CT 06902 USA; [Collazo-Lorduy, Ana; Castillo-Martin, Mireia; Cordon-Cardo, Carlos] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Castillo-Martin, Mireia] Champalimaud Ctr Unknown, Dept Pathol, Lisbon, Portugal; [Gong, Yixuan; Oh, William K.; Galsky, Matthew D.; Zhu, Jun] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Fundacao Champalimaud; Icahn School of Medicine at Mount Sinai	Zhu, J (corresponding author), Dept Genet & Genom Sci, New York, NY 10029 USA.; Zhu, J (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA.; Zhu, J (corresponding author), Sema4, Stamford, CT 06902 USA.; Zhu, J (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.	jun.zhu@mssm.edu	Oh, William/B-9163-2012	Oh, William/0000-0001-5113-8147; Zhu, Jun/0000-0003-0834-8178; Cordon-Cardo, Carlos/0000-0003-0858-5624	National Institutes of Health [R01-AG046170, U01-HG008451]; Spanish Society of Medical Oncology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG046170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Society of Medical Oncology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of Zhu laboratory for discussions. This work was partially supported by National Institutes of Health (grant numbers R01-AG046170, U01-HG008451); and the Spanish Society of Medical Oncology to ACL.	Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Aushev VN, 2018, CLIN CANCER RES, V24, P581, DOI 10.1158/1078-0432.CCR-17-0996; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ching CB, 2010, LAB INVEST, V90, P1406, DOI 10.1038/labinvest.2010.133; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Enokida H, 2016, INVESTIG CLIN UROL, V57, pS60, DOI 10.4111/icu.2016.57.S1.S60; Esposti DD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16226-3; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Foreman KE, 2014, J UROLOGY, V191, P502, DOI 10.1016/j.juro.2013.09.014; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guancial EA, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.04.014; Harrell F, 2013, NON TRADITIONAL REF, V3; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuzaka B, 2015, ARCH MED SCI, V11, P378, DOI 10.5114/aoms.2014.46796; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee E, 2016, BIOINFORMATICS, V32, P96, DOI 10.1093/bioinformatics/btv531; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; McConkey DJ, 2016, EUR UROL, V69, P855, DOI 10.1016/j.eururo.2015.08.034; Moller M, 2007, ONCOL REP, V18, P737; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Ochoa AE, 2016, ONCOTARGET, V7, P80164, DOI 10.18632/oncotarget.13284; Riester M, 2012, CLIN CANCER RES, V18, P1323, DOI 10.1158/1078-0432.CCR-11-2271; Robertson AG, 2017, CELL, V171, P540, DOI 10.1016/j.cell.2017.09.007; Seiler R, 2017, EUR UROL, V72, P142, DOI 10.1016/j.eururo.2017.03.021; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Q, 2015, INT J ONCOL, V46, P389, DOI 10.3892/ijo.2014.2703; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wu LJ, 2015, ONCOL LETT, V9, P213, DOI 10.3892/ol.2014.2706; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhao W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-419	41	17	17	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 1	2018	37	44					5858	5872		10.1038/s41388-018-0367-0	http://dx.doi.org/10.1038/s41388-018-0367-0			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GY9EX	29970902	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000448943100004
J	Brenke, JK; Popowicz, GM; Schorpp, K; Rothenaigner, I; Roesner, M; Meininger, I; Kalinski, C; Ringelstetter, L; R'kyek, O; Jurjens, G; Vincendeau, M; Plettenburg, O; Sattler, M; Krappmann, D; Hadian, K				Brenke, Jara K.; Popowicz, Grzegorz M.; Schorpp, Kenji; Rothenaigner, Ina; Roesner, Manfred; Meininger, Isabel; Kalinski, Cedric; Ringelstetter, Larissa; R'kyek, Omar; Juerjens, Gerrit; Vincendeau, Michelle; Plettenburg, Oliver; Sattler, Michael; Krappmann, Daniel; Hadian, Kamyar			Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; RHEUMATOID-ARTHRITIS; DRUG DISCOVERY; FREQUENT HITTERS; UBIQUITIN; ACTIVATION; MALT1; CELLS; IDENTIFICATION; OPPORTUNITIES	Constitutive NE-kappa B signaling represents a hallmark of chronic inflammation and autoimmune diseases. The E3 ligase TNF receptor-associated factor 6 (TRAF6) acts as a key regulator bridging innate immunity, pro-inflammatory cytokines, and antigen receptors to the canonical NF-kappa B pathway. Structural analysis and point mutations have unraveled the essential role of TRAF6 binding to the E2-conjugating enzyme ubiquitin-conjugating enzyme E2 N (Ubc13 or UBE2N) to generate Lys63-linked ubiquitin chains for inflammatory and immune signal propagation. Genetic mutations disrupting TRAF6-Ubc13 binding have been shown to reduce TRAF6 activity and, consequently, NE-kappa B activation. However, to date, no small-molecule modulator is available to inhibit the TRAF6-Ubc13 interaction and thereby counteract NF-kappa B signaling and associated diseases. Here, using a high-throughput small-molecule screening approach, we discovered an inhibitor of the TRAF6 -Ubc13 interaction that reduces TRAF6-Ubc13 activity both in vitro and in cells. We found that this compound, C25-140, impedes NF-kappa B activation in various immune and inflammatory signaling pathways also in primary human and murine cells. Importantly, C25-140 ameliorated inflammation and improved disease outcomes of autoimmune psoriasis and rheumatoid arthritis in preclinical in vivo mouse models. Hence, the first-in-class TRAF6-Ubc13 inhibitor C25-140 expands the toolbox for studying the impact of the ubiquitin system on immune signaling and underscores the importance of TRAF6 E3 ligase activity in psoriasis and rheumatoid arthritis. We propose that inhibition of TRAF6 activity by small molecules represents a promising novel strategy for targeting autoimmune and chronic inflammatory diseases.	[Brenke, Jara K.; Schorpp, Kenji; Rothenaigner, Ina; Ringelstetter, Larissa; Hadian, Kamyar] Helmholtz Zentrum Munchen, Assay Dev & Screening Platform, Inst Mol Toxicol & Pharmacol, D-85764 Neuherberg, Germany; [Popowicz, Grzegorz M.; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Struct Biol, D-85764 Neuherberg, Germany; [Meininger, Isabel; Vincendeau, Michelle; Krappmann, Daniel] Helmholtz Zentrum Munchen, Res Unit Cellular Signal Integrat, Inst Mol Toxicol & Pharmacol, D-85764 Neuherberg, Germany; [Kalinski, Cedric] Helmholtz Zentrum Munchen, Innovat Management, D-85764 Neuherberg, Germany; [R'kyek, Omar; Juerjens, Gerrit; Plettenburg, Oliver] Helmholtz Zentrum Munchen, Inst Med Chem, D-85764 Neuherberg, Germany; [Vincendeau, Michelle] Helmholtz Zentrum Munchen, Inst Virol, D-85764 Neuherberg, Germany; [Popowicz, Grzegorz M.; Sattler, Michael] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, D-85747 Garching, Germany; [Roesner, Manfred] Mroe Consulting, D-65817 Eppstein, Germany; [R'kyek, Omar; Juerjens, Gerrit; Plettenburg, Oliver] Leibnitz Univ Hannover, Inst Organ Chem, D-30167 Hannover, Germany; [Meininger, Isabel] AbbVie Deutschland GmbH, D-65189 Wiesbaden, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Leibniz University Hannover; AbbVie	Hadian, K (corresponding author), Helmholtz Zentrum Munchen GmbH, Inst Mol Toxicol & Pharmacol, Assay Dev & Screening Platform, D-85764 Neuherberg, Germany.	kamyar.hadian@helmholtz-muenchen.de	Hadian, Kamyar/B-6314-2013; Vincendeau, Michelle/AAD-4320-2022; Krappmann, Daniel/AAT-4354-2021; Sattler, Michael/A-2407-2012; Krappmann, Daniel/ABF-4038-2021; Plettenburg, Oliver/AAY-8083-2020	Hadian, Kamyar/0000-0001-8727-2575; Krappmann, Daniel/0000-0001-7640-3234; Sattler, Michael/0000-0002-1594-0527; Krappmann, Daniel/0000-0001-7640-3234; 	Life Science Foundation;  [SFB 1054]	Life Science Foundation; 	This work was supported by grants from the Life Science Foundation (to K. H.) and the SFB 1054 project A04 (to D. K.). A patent for the clinical use of C25-140 has been published by the European patent office.	Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Brenke JK, 2016, J BIOMOL SCREEN, V21, P596, DOI 10.1177/1087057116639992; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Choy EH, 2013, NAT REV RHEUMATOL, V9, P154, DOI 10.1038/nrrheum.2013.8; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; Gul S, 2014, EXPERT OPIN DRUG DIS, V9, P1393, DOI 10.1517/17460441.2014.954544; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Isaacs JD, 2015, NAT REV RHEUMATOL, V11, P627, DOI 10.1038/nrrheum.2015.138; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Kelly PN, 2015, J EXP MED, V212, P2189, DOI 10.1084/jem.20151074; Kliza K, 2017, NAT METHODS, V14, P504, DOI [10.1038/NMETH.4228, 10.1038/nmeth.4228]; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Landre V, 2014, ONCOTARGET, V5, P7988, DOI 10.18632/oncotarget.2431; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Meininger I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11292; Namjou B, 2012, ARTHRITIS RHEUM-US, V64, P1960, DOI 10.1002/art.34361; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Olson MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep14246; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pulvino M, 2012, BLOOD, V120, P1668, DOI 10.1182/blood-2012-02-406074; Schorpp K, 2016, J BIOMOL SCREEN, V21, P965, DOI 10.1177/1087057116641935; Schorpp K, 2014, J BIOMOL SCREEN, V19, P715, DOI 10.1177/1087057113516861; Scott DC, 2017, NAT CHEM BIOL, V13, P850, DOI 10.1038/nchembio.2386; Scott DE, 2016, NAT REV DRUG DISCOV, V15, P533, DOI 10.1038/nrd.2016.29; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sokka T, 2008, MOD RHEUMATOL, V18, P228, DOI 10.1007/s10165-008-0056-x; Strickson S, 2013, BIOCHEM J, V451, P427, DOI 10.1042/BJ20121651; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tanaka Y, 2013, MOD RHEUMATOL, V23, P415, DOI 10.1007/s10165-012-0799-2; Toubi E, 2004, AUTOIMMUNITY, V37, P183, DOI 10.1080/08916930410001704944; Vincendeau M, 2016, SCI REP-UK, V6, DOI 10.1038/srep18934; Visser K, 2009, ANN RHEUM DIS, V68, P1094, DOI 10.1136/ard.2008.092668; Walsh MC, 2015, IMMUNOL REV, V266, P72, DOI 10.1111/imr.12302; Wang HQ, 2015, MOL MED REP, V11, P2761, DOI 10.3892/mmr.2014.3104; Weber E, 2017, SLAS DISCOV, V22, P316, DOI 10.1177/1087057116681408; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wavers-de Boer K, 2012, ANN RHEUM DIS, V71, P1472, DOI 10.1136/annrheumdis-2011-200736; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zarzycka B, 2015, J CHEM INF MODEL, V55, P294, DOI 10.1021/ci500631e; Zhu LJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3866; Zotti T, 2012, J CELL PHYSIOL, V227, P1280, DOI 10.1002/jcp.24011	54	36	37	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13191	13203		10.1074/jbc.RA118.002649	http://dx.doi.org/10.1074/jbc.RA118.002649			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29950522	Green Published, hybrid			2022-12-26	WOS:000442730200018
J	Kefalas, G; Jouvet, N; Baldwin, C; Estall, JL; Larose, L				Kefalas, George; Jouvet, Nathalie; Baldwin, Cindy; Estall, Jennifer L.; Larose, Louise			Peptide-based sequestration of the adaptor protein Nck1 in pancreatic cells enhances insulin biogenesis and protects against diabetogenic stresses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); diabetes; adaptor protein; insulin synthesis; insulin secretion; lipotoxicity; cell therapy; adaptor protein Nck; cell-penetrating peptide; diabetes; PERK	ENDOPLASMIC-RETICULUM STRESS; GLUCOSE-HOMEOSTASIS; PERK EIF2AK3; BETA-CELLS; DEPENDENT ACTIVATION; SH2/SH3 ADAPTERS; KINASE PAK1; OBESE MICE; SURVIVAL; TRANSLATION	One feature of diabetes is the failure of pancreatic cells to produce insulin, but the molecular mechanisms leading to this failure remain unclear. Increasing evidence supports a role for protein kinase R-like endoplasmic reticulum kinase (PERK) in the development and function of healthy pancreatic cells. Previously, our group identified the adaptor protein Nck1 as a negative regulator of PERK. Indeed, we demonstrated that Nck1, by directly binding PERK autophosphorylated on Tyr(561), limits PERK activation and signaling. Accordingly, we found that stable depletion of Nck1 in cells promotes PERK activation and signaling, increases insulin biosynthesis, and improves cell viability in response to diabetes-related stresses. Herein, we explored the therapeutic potential of abrogating the interaction between Nck and PERK to improve -cell function and survival. To do so, we designed and used a peptide containing the minimal PERK sequence involved in binding Nck1 conjugated to the cell-permeable protein transduction domain from the HIV protein TAT. In the current study, we confirm that the synthetic TAT-Tyr(P)(561) phosphopeptide specifically binds the SH2 domain of Nck and prevents Nck interaction with PERK, thereby promoting basal PERK activation. Moreover, we report that treatment of cells with TAT-Tyr(P)(561) inhibits glucolipotoxicity-induced apoptosis, whereas it enhances insulin production and secretion. Taken together, our results support the potential of sequestering Nck using a synthetic peptide to enhance basal PERK activation and create more robust cells.	[Kefalas, George; Baldwin, Cindy; Larose, Louise] McGill Univ, Hlth Ctr, Res Inst, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada; [Kefalas, George; Estall, Jennifer L.; Larose, Louise] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H4A 3J1, Canada; [Jouvet, Nathalie; Baldwin, Cindy; Estall, Jennifer L.] Inst Rech Clin Montreal, 110 Ave Pins O, Montreal, PQ H2W 1R7, Canada	McGill University; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Larose, L (corresponding author), McGill Univ, Hlth Ctr, Res Inst, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.; Estall, JL (corresponding author), Inst Rech Clin Montreal, 110 Ave Pins O, Montreal, PQ H2W 1R7, Canada.	jennifer.estall@ircm.qc.ca; louise.larose@mcgill.ca		Estall, Jennifer/0000-0002-9838-1440	Canadian Institutes of Health Research Project [PJT-148771, PJT-374589]	Canadian Institutes of Health Research Project(Canadian Institutes of Health Research (CIHR))	This work is supported by Canadian Institutes of Health Research Project Grants PJT-148771 (to J. L. E.) and PJT-374589 (to L. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Borroto A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2140; Cardin E, 2007, FEBS J, V274, P5865, DOI 10.1111/j.1742-4658.2007.06110.x; Chan JY, 2013, DIABETES, V62, P1557, DOI 10.2337/db12-0701; Chen J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005648; Chen M, 1998, J BIOL CHEM, V273, P25171, DOI 10.1074/jbc.273.39.25171; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dusseault J, 2016, DIABETES, V65, P2652, DOI 10.2337/db15-1559; Feng DR, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-61; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Gandin V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11127; Gao Y, 2012, MOL CELL BIOL, V32, P5129, DOI 10.1128/MCB.01009-12; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Harding HP, 2012, J BIOL CHEM, V287, P44338, DOI 10.1074/jbc.M112.428987; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Julier C, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-29; Kebache S, 2004, J BIOL CHEM, V279, P9662, DOI 10.1074/jbc.M310535200; Kebache S, 2002, P NATL ACAD SCI USA, V99, P5406, DOI 10.1073/pnas.082483399; Labelle-Cote M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-443; Latreille M, 2006, J BIOL CHEM, V281, P26633, DOI 10.1074/jbc.M513556200; Latreille M, 2011, AM J PHYSIOL-ENDOC M, V300, pE423, DOI 10.1152/ajpendo.00088.2010; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; LI W, 1992, MOL CELL BIOL, V12, P5824, DOI 10.1128/MCB.12.12.5824; Lussier G, 1997, J BIOL CHEM, V272, P2688, DOI 10.1074/jbc.272.5.2688; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Masuda Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131012; Morris DC, 2017, MOL BIOL CELL, V28, P3500, DOI 10.1091/mbc.E17-02-0106; Mukherjee C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001933; Nguyen DT, 2004, MOL BIOL CELL, V15, P4248, DOI 10.1091/mbc.E03-11-0851; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Roy E, 2010, J IMMUNOL, V185, P7518, DOI 10.4049/jimmunol.1000008; Roy E, 2010, P NATL ACAD SCI USA, V107, P15529, DOI 10.1073/pnas.1009743107; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Wang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099684; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; Yagishita Y, 2014, DIABETES, V63, P605, DOI 10.2337/db13-0909; Yamani L, 2015, CELL SIGNAL, V27, P2555, DOI 10.1016/j.cellsig.2015.09.016; Yamani L, 2014, MOL BIOL CELL, V25, P702, DOI 10.1091/mbc.E13-09-0511; Yu QJ, 2015, P NATL ACAD SCI USA, V112, P15420, DOI 10.1073/pnas.1516362112; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	47	3	3	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12516	12524		10.1074/jbc.RA118.002728	http://dx.doi.org/10.1074/jbc.RA118.002728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29941454	Green Published, hybrid			2022-12-26	WOS:000441408500017
J	Deng, C; Sun, Y; Liu, H; Wang, W; Wang, JM; Zhang, FM				Deng, Chao; Sun, Yi; Liu, Hai; Wang, Wei; Wang, Jingmen; Zhang, Feimin			Selective adipogenic differentiation of human periodontal ligament stem cells stimulated with high doses of glucose	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OSTEOGENIC DIFFERENTIATION; SIGNALING PATHWAY; BONE; INFLAMMATION; MICROANGIOPATHIES; PROLIFERATION; ANGIOGENESIS; SCAFFOLD; OBESITY	Periodontal tissue damage, accompanied by the degradation and destruction of periodontal tissue collagen, is one of the most clinically common complications and difficulty self-repair in patients with diabetes. Human periodontal ligament stem cells (PDLSC) are the undifferentiated mesenchymal cells that persist in the periodontal ligament after development of periodontal tissue and the ability of PDLSC osteogenic differentiation is responsible for repairing periodontal tissue defects. However, the reasons of high glucose environment in diabetic patients inhibiting PDLSC to repair periodontal tissues are unclear. To address these issues, we propose exposing PDLSC to high-sugar mimics the diabetic environment and investigating the activity of osteogenic differentiation and adipogenic differentiation of PDLSC. At the cellular level, high glucose can promote the adipogenic differentiation and inhibit osteogenic differentiation to decrease the self-repair ability of PDLSC in periodontal tissues. Mechanistically at the molecular level, these effects are elicited via regulating the mRNA and protein expression of C/EBP beta, PPAR-gamma.	[Deng, Chao; Zhang, Feimin] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China; [Deng, Chao; Zhang, Feimin] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Prosthodont, Nanjing, Jiangsu, Peoples R China; [Deng, Chao; Sun, Yi; Liu, Hai; Wang, Wei; Wang, Jingmen] Wannan Med Coll, Sch Stomatol, Wuhu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Wannan Medical College	Zhang, FM (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China.; Zhang, FM (corresponding author), Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Prosthodont, Nanjing, Jiangsu, Peoples R China.	fmzhang@njmu.edu.cn			Universities Natural Science Foundation of Anhui Province [KJ2017A255]; Key research project fund of Wannan Medical College [WK2016Z03]; National Key Research and Development Plan [2016YFA0201704, 2017YFA0104301]	Universities Natural Science Foundation of Anhui Province; Key research project fund of Wannan Medical College; National Key Research and Development Plan	This work was supported by grants from the Universities Natural Science Foundation of Anhui Province (grant number KJ2017A255) (CD), Key research project fund of Wannan Medical College (grant numbers WK2016Z03) (CD), and National Key Research and Development Plan, 2016YFA0201704 and 2017YFA0104301, to FZ.	Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Cao XK, 2016, BIOMED PHARMACOTHER, V78, P156, DOI 10.1016/j.biopha.2016.01.007; Chen QX, 2017, CARBOHYD POLYM, V169, P255, DOI 10.1016/j.carbpol.2017.04.018; Chen Y, 2017, CELL BIOL INT, V41, P822, DOI 10.1002/cbin.10779; Chung SS, 2012, OBESITY, V20, P482, DOI 10.1038/oby.2011.212; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Duan PP, 2016, INT J BIOCHEM CELL B, V77, P23, DOI 10.1016/j.biocel.2016.05.015; Gagnon AM, 1998, OBES RES, V6, P157, DOI 10.1002/j.1550-8528.1998.tb00330.x; Hotamisligil GS, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.238; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Jia LW, 2008, BIOCHEM BIOPH RES CO, V368, P483, DOI 10.1016/j.bbrc.2008.01.097; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Li YM, 2007, BIOCHEM BIOPH RES CO, V363, P209, DOI 10.1016/j.bbrc.2007.08.161; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Liu OS, 2013, STEM CELLS, V31, P1371, DOI 10.1002/stem.1387; Mantovani A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185459; Mesia R, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000260; Mukai T, 2007, BIOCHEM BIOPH RES CO, V356, P1004, DOI 10.1016/j.bbrc.2007.03.099; Osawa H, 2007, BIOCHEM BIOPH RES CO, V355, P342, DOI 10.1016/j.bbrc.2007.01.144; Pal R, 2009, BLOOD, V114, P3890, DOI 10.1182/blood-2009-01-201111; Park IS, 2015, BIOCHEM BIOPH RES CO, V462, P171, DOI 10.1016/j.bbrc.2015.04.059; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shao D, 2018, MOL MED REP, V17, P1537, DOI 10.3892/mmr.2017.8094; Song DS, 2011, J PERIODONTAL RES, V46, P193, DOI 10.1111/j.1600-0765.2010.01328.x; Soskolne W A, 2001, Ann Periodontol, V6, P91, DOI 10.1902/annals.2001.6.1.91; Stellavato A, 2017, CELL PHYSIOL BIOCHEM, V44, P1078, DOI 10.1159/000485414; Suzuki M, 2000, J DIABETES COMPLICAT, V14, P40, DOI 10.1016/S1056-8727(00)00052-0; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tirino Virginia, 2012, Methods Mol Biol, V879, P443, DOI 10.1007/978-1-61779-815-3_26; Tominaga S, 2005, BIOCHEM BIOPH RES CO, V326, P499, DOI 10.1016/j.bbrc.2004.11.056; Turner PA, 2017, PROCESS BIOCHEM, V59, P312, DOI 10.1016/j.procbio.2017.02.003; Wang JC, 2013, EXCLI J, V12, P584; Wang P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169123; Wei K, 2017, BIOCHEM BIOPH RES CO, V489, P319, DOI 10.1016/j.bbrc.2017.05.130; Yang PH, 2016, BIOCHEM BIOPH RES CO, V472, P306, DOI 10.1016/j.bbrc.2016.02.117; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106	38	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199603	10.1371/journal.pone.0199603	http://dx.doi.org/10.1371/journal.pone.0199603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979705	Green Submitted, Green Published, gold			2022-12-26	WOS:000437809500021
J	Sengupta, S; Medendorp, WP; Praamstra, P; Selen, LPJ				Sengupta, Sonal; Medendorp, W. Pieter; Praamstra, Peter; Selen, Luc P. J.			Uncertainty modulated exploration in the trade-off between sensing and acting	PLOS ONE			English	Article							TIME; DELIBERATION; INFORMATION; PERCEPTION; ACCURACY; SPEED; HAND	Many sensorimotor activities have a time constraint for successful completion. In this case, any time devoted to sensory processing is at the expense of time available for motor execution. Earlier studies have explored how this competition between sensory processing and motor execution is resolved by using experimental designs that segregate the sensing and acting phase of the task. It was found that participants switch from the sensing to the acting stage such that the overall (sensorimotor) uncertainty in the outcome of the task is minimized. An unexplained observation in these studies is the substantial variability in switching times. We investigated the variability in switching time by correlating it with the underlying sensorimotor uncertainty. To this end, we used a modified version of the virtual ball catching paradigm proposed by Faisal & Wolpert (2009). Subjects were instructed to catch a ball, but as soon as they initiated their movement the ball disappeared. We extended the range of horizontal velocities and used two different start positions of the ball to quantify the dependence of sensory uncertainty on ball velocity. Velocity dependence of sensory uncertainty allowed us to manipulate sensory uncertainty and hence the sensorimotor uncertainty. We found that the variability in switching times is correlated with two factors. Firstly, variability in switching times is greater when variation in switching time has only minimal effects on sensorimotor uncertainty. Secondly, variability in switching times is greater when the sensorimotor uncertainty is larger. Our results suggest that the variability in switching time reflects an uncertainty-driven exploratory process.	[Sengupta, Sonal; Medendorp, W. Pieter; Praamstra, Peter; Selen, Luc P. J.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Sengupta, Sonal; Praamstra, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Selen, LPJ (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	l.selen@donders.ru.nl	Medendorp, W. Pieter/A-7369-2010; Selen, Luc/A-6066-2009	Medendorp, W. Pieter/0000-0001-9615-4220; Selen, Luc/0000-0001-5774-5415; Sengupta, Sonal/0000-0002-9920-2483	European Union Seventh Framework Programme (FP7) [604063]; European Research Council [EU-ERC-283567]; Netherlands Organization for Scientific Research [NWO-VICI 453-11-001, NWO-VENI 451-10-017]	European Union Seventh Framework Programme (FP7); European Research Council(European Research Council (ERC)European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The research leading to these results was funded by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 604063 (SS, WPM). The work has also been supported by the European Research Council, no. EU-ERC-283567 (WPM) and the Netherlands Organization for Scientific Research, no. NWO-VICI 453-11-001 (WPM) and no. NWO-VENI 451-10-017 (LPJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balota DA, 2011, CURR DIR PSYCHOL SCI, V20, P160, DOI 10.1177/0963721411408885; Battaglia PW, 2007, J NEUROSCI, V27, P6984, DOI 10.1523/JNEUROSCI.1309-07.2007; Beck JM, 2012, NEURON, V74, P30, DOI 10.1016/j.neuron.2012.03.016; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bestmann S, 2008, CURR BIOL, V18, P775, DOI 10.1016/j.cub.2008.04.051; Briere J, 2017, Q J EXP PSYCHOL, V70, P736, DOI 10.1080/17470218.2016.1156716; Brouwer AM, 2002, PERCEPT PSYCHOPHYS, V64, P1160, DOI 10.3758/BF03194764; Cashaback JGA, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005623; COLES MGH, 1985, J EXP PSYCHOL HUMAN, V11, P529, DOI 10.1037/0096-1523.11.5.529; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dessing JC, 2004, ECOL PSYCHOL, V16, P1, DOI 10.1207/s15326969eco1601_1; Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Hamrick J, 2011, P COGN SCI SOC, V33; HEATHCOTE A, 1991, PSYCHOL BULL, V109, P340, DOI 10.1037/0033-2909.109.2.340; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; Hudson TE, 2007, J NEUROPHYSIOL, V98, P3034, DOI 10.1152/jn.00858.2007; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lacquaniti F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/615854; Nagengast AJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000857; Pekny SE, 2015, J NEUROSCI, V35, P4015, DOI 10.1523/JNEUROSCI.3244-14.2015; Pessiglione M, 2005, J COGNITIVE NEUROSCI, V17, P1886, DOI 10.1162/089892905775008661; Praamstra P, 2014, EXP BRAIN RES, V232, P21, DOI 10.1007/s00221-013-3715-x; Rushton SK, 2009, VISION RES, V49, P1919, DOI 10.1016/j.visres.2008.12.012; Scheidt RA, 2000, J NEUROPHYSIOL, V84, P853, DOI 10.1152/jn.2000.84.2.853; Selen LPJ, 2012, J NEUROSCI, V32, P2276, DOI 10.1523/JNEUROSCI.5273-11.2012; Smith KA, 2013, COGSCI; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Tresilian JR, 2009, BRAIN RES, V1250, P202, DOI 10.1016/j.brainres.2008.11.001; VANDONKELAAR P, 1992, EXP BRAIN RES, V91, P151, DOI 10.1007/BF00230023; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; ZELAZNIK HN, 1988, J EXP PSYCHOL HUMAN, V14, P221, DOI 10.1037/0096-1523.14.2.221	36	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199544	10.1371/journal.pone.0199544	http://dx.doi.org/10.1371/journal.pone.0199544			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM1FJ	29979698	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500020
J	Kaur, G; Helmer, RA; Smith, LA; Martinez-Zaguilan, R; Dufour, JM; Chilton, BS				Kaur, Gurvinder; Helmer, Rebecca A.; Smith, Lisa A.; Martinez-Zaguilan, Raul; Dufour, Jannette M.; Chilton, Beverly S.			Alternative splicing of helicase-like transcription factor (Hltf): Intron retention-dependent activation of immune tolerance at the feto-maternal interface	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; FUNCTIONAL IMPACT; HIV-1 INFECTION; NK CELLS; CANCER; PROTEIN; IMPLANTATION; TRANSPORT; HYPOXIA; PATHWAY	Hltf is regulated by intron retention, and global Hltf-deletion causes perinatal lethality from hypoglycemia. In heart, full-length Hltf is a transcriptional regulator of Hif-1 alpha that controls transport systems. Thus, we tested the hypothesis that Hltf deletion from placenta caused or exacerbated neonatal hypoglycemia via Hif-1 alpha regulation of nutrient transporters. RNA-seq data analyses identified significant changes in transcript expression and alternative splicing (AS) in E18.5 placentome. iPathwayGuide was used for gene ontology (GO) analysis of biological processes, molecular functions and cellular components. Elim pruning algorithm identified hierarchical relationships. The methylome was interrogated by Methyl-MiniSeq Epiquest analysis. GO analysis identified gene enrichment within biological processes. Protein expression was visualized with immunohistochemistry. Although two Hltf mRNA isoforms are quantifiable in most murine tissues, only the truncated Hltf isoform is expressed in placenta. The responsible intron retention event occurs in the absence of DNA methylation. iPathwayGuide analysis identified 157 target genes of 11,538 total genes with measured expression. These were obtained using a threshold of 0.05 for statistical significance (p-value) and a long fold change of expression with absolute value of at least 0.6. Hltf deletion altered transcription of trophoblast lineage-specific genes, and increased transcription of the Cxcr7 (p = 0.004) gene whose protein product is a co-receptor for human and simian immunodeficiency viruses. Concomitant increased Cxcr7 protein was identified with immunolabeling. Hltf deletion had no effect on transcription or site-specific methylation patterns of Hif-1 alpha, the major glucose transporters, or System A amino acid transporters. There was no measureable evidence of uteroplacental dysfunction or fetal compromise. iPathGuide analysis revealed Hltf suppresses cytolysis (10/21 genes; p-value 1.900e-12; p-value correction: Elim pruning; GO:019835) including the perforin-granzyme pathway in uterine natural killer cells. Our findings 1) prove the truncated Hltf protein isoform is a transcription factor, 2) establish a functional link between AS of Hltf and immunosuppression at the feto-maternal interface, 3) correlate intron retention with the absence of DNA methylation, and 4) underscore the importance of differential splicing analysis to identify Hltf's functional diversity.	[Kaur, Gurvinder; Helmer, Rebecca A.; Dufour, Jannette M.; Chilton, Beverly S.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79409 USA; [Smith, Lisa A.] Texas Tech Univ, Hlth Sci Ctr, Dept Pathol, Lubbock, TX 79430 USA; [Martinez-Zaguilan, Raul] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Chilton, BS (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79409 USA.	Beverly.Chilton@ttuhsc.edu		Chilton, Beverly/0000-0002-8066-8697	South Plains Foundation; TTUHSC collaborative research grant from the School of Medicine; Laura W. Bush Institute for Women's Health research program from the University Medical Center	South Plains Foundation; TTUHSC collaborative research grant from the School of Medicine; Laura W. Bush Institute for Women's Health research program from the University Medical Center	Funding sources were all local or institutional and included the South Plains Foundation, TTUHSC collaborative research grant from the School of Medicine, and the Laura W. Bush Institute for Women's Health research program from the University Medical Center. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Baralle FE, 2017, NAT REV MOL CELL BIO, V18, P437, DOI 10.1038/nrm.2017.27; Baumann MU, 2007, AM J PHYSIOL-CELL PH, V293, pC477, DOI 10.1152/ajpcell.00075.2007; Brett KE, 2014, INT J MOL SCI, V15, P16153, DOI 10.3390/ijms150916153; Buchanan SM, 2010, P NATL ACAD SCI USA, V107, P17774, DOI 10.1073/pnas.1013105107; Burton GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0066; Capouillez A, 2009, HISTOPATHOLOGY, V55, P77, DOI 10.1111/j.1365-2559.2009.03330.x; Chen WV, 2013, DEVELOPMENT, V140, P3297, DOI 10.1242/dev.090621; Cho S, 2011, J CANCER RES CLIN, V137, P629, DOI 10.1007/s00432-010-0925-5; Climente-Gonzalez H, 2017, CELL REP, V20, P2215, DOI 10.1016/j.celrep.2017.08.012; Cross JC, 2016, CURR BIOL, V26, pR157; Croy BA, 2010, METHODS MOL BIOL, V612, P465, DOI 10.1007/978-1-60761-362-6_31; Deng YC, 2018, SEMIN CANCER BIOL, V50, P53, DOI 10.1016/j.semcancer.2018.01.005; Dhont L, 2016, CELL MOL LIFE SCI, V73, P129, DOI 10.1007/s00018-015-2060-6; Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531; Gaynor LM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00467; Greenwood JD, 2000, PLACENTA, V21, P693, DOI 10.1053/plac.2000.0556; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasegawa S, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00114; Hay William W Jr, 2006, Trans Am Clin Climatol Assoc, V117, P321; Hayward CE, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00028; HaywardLester A, 1996, MOL ENDOCRINOL, V10, P1335, DOI 10.1210/me.10.11.1335; Helmer RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080461; Helmer RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066799; Hewetson A, 2008, MOL ENDOCRINOL, V22, P813, DOI 10.1210/me.2007-0432; Holtan SG, 2009, MAYO CLIN PROC, V84, P985, DOI 10.1016/S0025-6196(11)60669-1; Hrecka K, 2016, P NATL ACAD SCI USA, V113, pE3921, DOI 10.1073/pnas.1605023113; Kile AC, 2015, MOL CELL, V58, P1090, DOI 10.1016/j.molcel.2015.05.013; KIM J, 2012, BMC GENOMICS, V13; Lahouassa H, 2016, P NATL ACAD SCI USA, V113, P5311, DOI 10.1073/pnas.1600485113; Leal FE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00315; MacKay C, 2009, BIOCHEM BIOPH RES CO, V390, P187, DOI 10.1016/j.bbrc.2009.08.151; Macklin PS, 2017, PLACENTA, V56, P8, DOI 10.1016/j.placenta.2017.03.010; Marquez Y, 2015, GENOME RES, V25, P995, DOI 10.1101/gr.186585.114; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; McClive PJ, 2001, MOL REPROD DEV, V60, P225, DOI 10.1002/mrd.1081; Miettinen TP, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700058; Mikulak J, 2017, AIDS, V31, P2317, DOI 10.1097/QAD.0000000000001645; Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107; Paffaro VA, 2003, PLACENTA, V24, P479, DOI 10.1053/plac.2002.0919; Pagliarini V, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/543067; Peng XX, 2007, J BIOL CHEM, V282, P381, DOI 10.1074/jbc.M606353200; Piechowski J, 2015, B CANCER, V102, P806, DOI 10.1016/j.bulcan.2015.06.003; Quillay H, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0271-z; Ross CA, 2015, NUTR CANCER, V67, P61, DOI 10.1080/01635581.2014.956257; Schoenfelder KP, 2015, J CELL BIOL, V209, P485, DOI 10.1083/jcb.201502016; Sharp AN, PREECLAMPSIA IS ASS; SHERIDAN PL, 1995, J BIOL CHEM, V270, P4575, DOI 10.1074/jbc.270.9.4575; Staiger D, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0704-3; Sun HY, 2013, CELL MOL IMMUNOL, V10, P202, DOI 10.1038/cmi.2013.9; Tadesse S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086791; Tripathi V, 2009, J CLIN IMMUNOL, V29, P379, DOI 10.1007/s10875-008-9258-4; Upadhyay S, JCB; Vanichkina DP, 2018, SEMIN CELL DEV BIOL, V75, P40, DOI 10.1016/j.semcdb.2017.07.030; Vaughan OR, 2017, PROG MOL BIOL TRANSL, V145, P217, DOI 10.1016/bs.pmbts.2016.12.008; Wojtuszkiewicz A, 2015, EXPERT OPIN DRUG MET, V11, P673, DOI 10.1517/17425255.2015.993316; Wolterink-Donselaar IG, 2009, LAB ANIMAL, V38, P35, DOI 10.1038/laban0109-35; Wong JJL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15134; Yap K, 2016, BIOCHEM SOC T, V44, P1079, DOI 10.1042/BST20160103; Zavan B, 2012, ANAT REC, V295, P1221, DOI 10.1002/ar.22498; Zhang JH, 2009, PLACENTA, V30, P968, DOI 10.1016/j.placenta.2009.08.011	60	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200211	10.1371/journal.pone.0200211	http://dx.doi.org/10.1371/journal.pone.0200211			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975766	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500077
J	Shin, HW; Lee, NS				Shin, Hye Woo; Lee, Nam Sook			Understanding plastome evolution in Hemiparasitic Santalales: Complete chloroplast genomes of three species, Dendrotrophe varians, Helixanthera parasitica, and Macrosolen cochinchinensis	PLOS ONE			English	Article							TRANSFER-RNA GENES; PHYLOGENETIC-RELATIONSHIPS; MITOCHONDRIAL GENOMES; PARASITIC PLANTS; INVERTED REPEAT; LIFE-STYLE; SEQUENCE; RECOMBINATION; DEGRADATION; ALIGNMENT	Santalales is a large order, with over 2200 species, most of which are root or aerial (stem) hemiparasites. In this study, we report the newly assembled chloroplast genome of Dendrotrophe varians (140,666 bp) in the family Amphorogynaceae and the cp genomes of Helixanthera parasitica (124,881 bp) and Macrosolen cochinchinensis (122,986 bp), both in the family Loranthaceae. We compared the cp genomes of 11 Santalales including eight currently available cp genomes. Santalales cp genomes are slightly or not reduced in size (119-147 kb), similar to other hemiparasitic species, when compared with typical angiosperm cp genomes (120-170 kb). In a phylogeny examining gene content, the NADH dehydrogenase gene group is the only one among eight functional gene groups that lost complete functionally in all examined Santalales. This supports the idea that the functional loss of ndh genes is the initial stage in the evolution of the plastome of parasitic plants, but the loss has occurred independently multiple times in angiosperms, while they are not found in some parasites. This suggests that the functional loss of ndh genes is not essential for the transition from autotroph to parasite. We additionally examined the correlation between gene content and type of parasitism (obligate/facultative and stem/root parasites) of all hemiparasitic species in which cp genomes have been reported to date. Correlation was not found in any types of parasitism.	[Shin, Hye Woo] Ewha Womans Univ, Grad Sch, Interdisciplinary Program EcoCreat, Seoul, South Korea; [Lee, Nam Sook] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Lee, NS (corresponding author), Ewha Womans Univ, Dept Life Sci, Seoul, South Korea.	namsook@ewha.ac.kr	Shin, Hye Woo/AAD-7844-2020		BK21 Plus Program (Creative Academy of Eco Science) - Ministry of Education [31Z20130012990]; National Research Foundation of Korea	BK21 Plus Program (Creative Academy of Eco Science) - Ministry of Education; National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by the BK21 Plus Program (Creative Academy of Eco Science, 31Z20130012990) funded by the Ministry of Education and National Research Foundation of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, PARASITIC PLANTS IBE; [Anonymous], 1969, BIOL PARASITIC FLOWE; Barrett CF, 2014, MOL BIOL EVOL, V31, P3095, DOI 10.1093/molbev/msu252; Barrett CF, 2012, AM J BOT, V99, P1513, DOI 10.3732/ajb.1200256; Bellot S, 2016, GENOME BIOL EVOL, V8, P2214, DOI 10.1093/gbe/evw147; Bellot S, 2016, GENOME BIOL EVOL, V8, P189, DOI 10.1093/gbe/evv251; Cusimano N, 2016, NEW PHYTOL, V210, P680, DOI 10.1111/nph.13784; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Day Anil, 2007, V19, P65, DOI 10.1007/4735_2007_0231; DEPAMPHILIS CW, 1990, NATURE, V348, P337, DOI 10.1038/348337a0; Der JP, 2008, SYST BOT, V33, P107, DOI 10.1600/036364408783887438; Doyle J. J., 1987, PHYTOCHEM B, P11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan WS, 2016, SCI REP-UK, V6, DOI 10.1038/srep36285; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Greiner S, 2008, NUCLEIC ACIDS RES, V36, P2366, DOI 10.1093/nar/gkn081; Guisinger MM, 2011, MOL BIOL EVOL, V28, P583, DOI 10.1093/molbev/msq229; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hilu KW, 2003, AM J BOT, V90, P1758, DOI 10.3732/ajb.90.12.1758; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irving LJ, 2009, ADV BOT RES, V50, P87, DOI 10.1016/S0065-2296(08)00803-3; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Krause K, 2008, CURR GENET, V54, P111, DOI 10.1007/s00294-008-0208-8; KUIJT J, 1968, BRITTONIA, V20, P136, DOI 10.2307/2805616; Kuijt J, 2014, FLOWERING PLANTS; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058747; Li Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13401-4; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Malecot V, 2002, HIST CLASSIFICATION, P6; Malecot V, 2008, SYST BOT, V33, P97, DOI 10.1600/036364408783887384; Martin M, 2010, PLANT PHYSIOL BIOCH, V48, P636, DOI 10.1016/j.plaphy.2010.04.009; McNeal JR, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-57; Molina J, 2014, MOL BIOL EVOL, V31, P793, DOI 10.1093/molbev/msu051; Naumann J, 2016, GENOME BIOL EVOL, V8, P345, DOI 10.1093/gbe/evv256; Nickrent DL, 2010, TAXON, V59, P538, DOI 10.1002/tax.592019; Nickrent DL, 1997, PARASITIC PLANT CONN; OGIHARA Y, 1988, P NATL ACAD SCI USA, V85, P8573, DOI 10.1073/pnas.85.22.8573; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; Peng Y, 2003, BOT B ACAD SINICA, P44; Petersen G, 2015, GENOME BIOL EVOL, V7, P2520, DOI 10.1093/gbe/evv165; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raubeson LA, 2005, CHLOROPLAST GENOMES, DOI [10.1079/9780851999043.0045, DOI 10.1079/9780851999043.0045]; Reed CF, 1955, MEM SOC BROT, V10, P29; Roquet C, 2016, ANN BOT-LONDON, V118, P885, DOI 10.1093/aob/mcw135; Ruhlman TA, 2014, METHODS MOL BIOL, V1132, P3, DOI 10.1007/978-1-62703-995-6_1; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Soltis DE, 2003, AM J BOT, V90, P461, DOI 10.3732/ajb.90.3.461; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Su HJ, 2016, MITOCHONDRIAL DNA B, V1, P767, DOI 10.1080/23802359.2016.1238753; Su HJ, 2015, TAXON, V64, P491; Sugiura M., 1992, CHLOROPLAST GENOME, P149; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Vidal-Russell R, 2008, AM J BOT, V95, P1015, DOI 10.3732/ajb.0800085; Vidal-Russell R, 2008, MOL PHYLOGENET EVOL, V47, P523, DOI 10.1016/j.ympev.2008.01.016; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Westwood JH, 2010, TRENDS PLANT SCI, V15, P227, DOI 10.1016/j.tplants.2010.01.004; Wicke S, 2016, P NATL ACAD SCI USA, V113, P9045, DOI 10.1073/pnas.1607576113; Wicke S, 2013, PLANT CELL, V25, P3711, DOI 10.1105/tpc.113.113373; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; WOLFE KH, 1992, J MOL EVOL, V35, P304, DOI 10.1007/BF00161168; Wu CS, 2017, GENOME BIOL EVOL, V9, P2604, DOI 10.1093/gbe/evx177; Wurdack KJ, 2009, AM J BOT, V96, P1551, DOI 10.3732/ajb.0800207; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xiang QY, 2002, MOL PHYLOGENET EVOL, V24, P35, DOI 10.1016/S1055-7903(02)00267-1; Yang GS, 2017, CONSERV GENET RESOUR, V9, P415, DOI 10.1007/s12686-017-0697-1; Zhu AD, 2016, NEW PHYTOL, V209, P1747, DOI 10.1111/nph.13743	73	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200293	10.1371/journal.pone.0200293	http://dx.doi.org/10.1371/journal.pone.0200293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975758	Green Submitted, gold, Green Published			2022-12-26	WOS:000437424500081
J	Cali, C; Wawrzyniak, M; Becker, C; Maco, B; Cantoni, M; Jorstad, A; Nigro, B; Grillo, F; De Paola, V; Fua, P; Knott, GW				Cali, Corrado; Wawrzyniak, Marta; Becker, Carlos; Maco, Bohumil; Cantoni, Marco; Jorstad, Anne; Nigro, Biagio; Grillo, Federico; De Paola, Vincenzo; Fua, Pascal; Knott, Graham William			The effects of aging on neuropil structure in mouse somatosensory cortex-A 3D electron microscopy analysis of layer 1	PLOS ONE			English	Article							AGE-RELATED-CHANGES; DENDRITIC SPINES; PREFRONTAL CORTEX; ULTRASTRUCTURAL ANALYSIS; SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; VISUAL-CORTEX; SYNAPSES; RECEPTOR; BRAIN	This study has used dense reconstructions from serial EM images to compare the neuropil ultrastructure and connectivity of aged and adult mice. The analysis used models of axons, dendrites, and their synaptic connections, reconstructed from volumes of neuropil imaged in layer 1 of the somatosensory cortex. This shows the changes to neuropil structure that accompany a general loss of synapses in a well-defined brain region. The loss of excitatory synapses was balanced by an increase in their size such that the total amount of synaptic surface, per unit length of axon, and per unit volume of neuropil, stayed the same. There was also a greater reduction of inhibitory synapses than excitatory, particularly those found on dendritic spines, resulting in an increase in the excitatory/inhibitory balance. The close correlations, that exist in young and adult neurons, between spine volume, bouton volume, synaptic size, and docked vesicle numbers are all preserved during aging. These comparisons display features that indicate a reduced plasticity of cortical circuits, with fewer, more transient, connections, but nevertheless an enhancement of the remaining connectivity that compensates for a generalized synapse loss.	[Cali, Corrado; Maco, Bohumil; Nigro, Biagio; Knott, Graham William] Ecole Polytech Fed Lausanne, Sch Life Sci, BioEM Facil, Lausanne, Switzerland; [Cali, Corrado] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Wawrzyniak, Marta] Univ Limoges, Fac Sci & Technol, BioEPIX, XLI M, Limoges, France; [Becker, Carlos; Jorstad, Anne; Fua, Pascal] Ecole Polytech Fed Lausanne, Comp Vis Lab, Lausanne, Switzerland; [Cantoni, Marco] Ecole Polytech Fed Lausanne, Ctr Electron Microscopy, Lausanne, Switzerland; [Grillo, Federico] Kings Coll London, MRC, Ctr Dev Neurobiol, New Hunts House,Guys Campus, London, England; [De Paola, Vincenzo] Imperial Coll London, Fac Med, MRC, Clin Sci Ctr, London, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; King Abdullah University of Science & Technology; Universite de Limoges; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of London; King's College London; Imperial College London	Knott, GW (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, BioEM Facil, Lausanne, Switzerland.	Graham.Knott@epfl.ch	Calì, Corrado/AAS-9183-2021; De Paola, Vincenzo/B-4900-2016	Calì, Corrado/0000-0003-4856-0835; De Paola, Vincenzo/0000-0001-9987-8291; Jorstad, Anne/0000-0002-6438-1979; Maco, Bohumil/0000-0001-8444-313X; Knott, Graham W/0000-0002-2956-9052	Novartis Biomedical Foundation grant; Swiss National Science Foundation grant; EPSRC [EP/J021199/1] Funding Source: UKRI; MRC [MC_U120088464] Funding Source: UKRI	Novartis Biomedical Foundation grant; Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by a Novartis Biomedical Foundation grant, and a Swiss National Science Foundation grant to Graham Knott. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Bai L, 2004, NEUROBIOL AGING, V25, P201, DOI 10.1016/S0197-4580(03)00091-5; Becker C, 2012, LECT NOTES COMPUT SC, V7510, P585, DOI 10.1007/978-3-642-33415-3_72; Bloss EB, 2011, J NEUROSCI, V31, P7831, DOI 10.1523/JNEUROSCI.0839-11.2011; Bopp R, 2017, J NEUROSCI, V37, P2435, DOI 10.1523/JNEUROSCI.2557-16.2017; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; Braitenberg V, 2013, SPRINGER SCI BUS MED; Burianova J, 2009, EXP GERONTOL, V44, P161, DOI 10.1016/j.exger.2008.09.012; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Cali C, 2016, J COMP NEUROL, V524, P23, DOI 10.1002/cne.23852; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Coleman P. D., 1986, STABILITY DENDRITES; COLEMAN PD, 1987, NEUROBIOL AGING, V8, P521, DOI 10.1016/0197-4580(87)90127-8; Dickstein DL, 2013, NEUROSCIENCE, V251, P21, DOI 10.1016/j.neuroscience.2012.09.077; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; FELDMAN ML, 1975, ANAT EMBRYOL, V148, P279, DOI 10.1007/BF00319848; FLOOD DG, 1993, NEUROBIOL AGING, V14, P575, DOI 10.1016/0197-4580(93)90042-A; Geinisman Y, 2000, CEREB CORTEX, V10, P952, DOI 10.1093/cercor/10.10.952; Grillo F. W., 2015, J CHEM NEUROANAT; Hara Y, 2014, P NATL ACAD SCI USA, V111, P486, DOI 10.1073/pnas.1311310110; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Higley MJ, 2014, NAT REV NEUROSCI, V15, P567, DOI 10.1038/nrn3803; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Hof PR, 2002, BRAIN RES, V928, P175, DOI 10.1016/S0006-8993(01)03345-5; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Jorstad A., 2014, NEUROINFORMATICS; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Knott G, 2011, JOVE-J VIS EXP, DOI 10.3791/2588; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Korogod N, 2015, ELIFE, V4, DOI 10.7554/eLife.05793; Kubota Y, 2007, J NEUROSCI, V27, P1139, DOI 10.1523/JNEUROSCI.3846-06.2007; LEUBA G, 1983, NEUROPATH APPL NEURO, V9, P467, DOI 10.1111/j.1365-2990.1983.tb00130.x; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Ling LL, 2005, NEUROSCIENCE, V132, P1103, DOI 10.1016/j.neuroscience.2004.12.043; Luebke JI, 2015, CEREB CORTEX, V25, P1454, DOI 10.1093/cercor/bht336; Maco B, 2014, METHOD CELL BIOL, V124, P339, DOI [10.1016/B978-0-12.801075-4.00016-1, 10.1016/B978-0-12-801075-4.00016-1]; Magnusson KR, 2012, FUTUR NEUROL, V7, P627, DOI 10.2217/FNL.12.54; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Mostany R, 2013, J NEUROSCI, V33, P4094, DOI 10.1523/JNEUROSCI.4825-12.2013; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nicholson DA, 2004, J NEUROSCI, V24, P7648, DOI 10.1523/JNEUROSCI.1725-04.2004; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Peters A, 2008, NEUROSCIENCE, V152, P970, DOI 10.1016/j.neuroscience.2007.07.014; Peters A, 2001, CEREB CORTEX, V11, P93, DOI 10.1093/cercor/11.2.93; Peters A, 1998, CEREB CORTEX, V8, P671, DOI 10.1093/cercor/8.8.671; Rodriguez-Moreno Javier, 2018, Cereb Cortex, V28, P3159, DOI 10.1093/cercor/bhx187; Schikorski T, 1997, J NEUROSCI, V17, P5858; Shimada A, 2006, NEUROPATH APPL NEURO, V32, P1, DOI 10.1111/j.1365-2990.2006.00632.x; Smith TD, 2000, J NEUROSCI, V20, P6587, DOI 10.1523/JNEUROSCI.20-17-06587.2000; Stebbings K. A., 2015, J PHYSL, P1; Straehle CN, 2011, LECT NOTES COMPUT SC, V6891, P653, DOI 10.1007/978-3-642-23623-5_82; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; UEMURA E, 1985, EXP NEUROL, V87, P403, DOI 10.1016/0014-4886(85)90171-2; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Young ME, 2014, NEUROSCIENCE, V274, P33, DOI 10.1016/j.neuroscience.2014.05.008	65	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0198131	10.1371/journal.pone.0198131	http://dx.doi.org/10.1371/journal.pone.0198131			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966021	gold, Green Published, Green Submitted			2022-12-26	WOS:000437224100006
J	Chaukulkar, S; Sulaeman, H; Zink, AG; Vredenburg, VT				Chaukulkar, Shruti; Sulaeman, Hasan; Zink, Andrew G.; Vredenburg, Vance T.			Pathogen invasion and non-epizootic dynamics in Pacific newts in California over the last century	PLOS ONE			English	Article							FUNGUS BATRACHOCHYTRIUM-DENDROBATIDIS; EMERGING INFECTIOUS-DISEASE; EPIDEMIC DISEASE; POPULATION DECLINES; AMPHIBIAN DECLINES; TARICHA RIVULARIS; CHYTRIDIOMYCOSIS; EXTINCTIONS; EMERGENCE; SPREAD	Emerging infectious disease is a growing threat to global biodiversity. The infectious disease chytridiomycosis, caused by the fungal pathogen Batrachochytrium dendrobatidis (Bd) has led to the decline and extinction of hundreds of amphibian species. Severe Bd-caused epizootics have been documented in North, Central and South America-with many of the research focused on anurans. California, where Bd-related epizootics and amphibian declines have been reported, has some of the highest diversity of salamanders. After more than a decade since the first known epizootic in California, little is known about Bd disease dynamics in salamanders. Pacific newts (Genus: Taricha) are ideal study species because of their abundance, wide geographic range, occurrence in both aquatic and terrestrial habitats, and how little is known about Bd infection dynamics for this group. We conducted a retrospective study to determine the relationship between Pacific newts and the fungal pathogen. We tested 1895 specimens collected between 1889-2009 and found no evidence of Bd-infected Pacific newts until the late 1940's. Although we estimate that Bd emerged in this genus and rapidly spread geographically throughout California, we did not find evidence for epizootic dynamics. Bd infection prevalence and intensity, two measures commonly used to estimate dynamics, remained consistently low over time; suggesting Pacific newts may not be highly susceptible. Also, we found the timing of first Bd emergence in Pacific newts predate Bd emergence in other California salamander species. In addition, we found several environmental and anthropogenic factors correlated with Bd prevalence which may help explain Bddisease dynamics in the genus Taricha. Pacific newts may be a reservoir species that signal pathogen invasion into California salamanders, though further studies are needed.	[Chaukulkar, Shruti; Sulaeman, Hasan; Zink, Andrew G.; Vredenburg, Vance T.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	California State University System; San Francisco State University	Vredenburg, VT (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	vancev@sfsu.edu		Vredenburg, Vance/0000-0002-9682-1190	NSF (IOS) [1258133]; NSF (ICER) [1633948]; SFSU IRA grant	NSF (IOS)(National Science Foundation (NSF)); NSF (ICER); SFSU IRA grant	Funding was provided by NSF (IOS #1258133) to VTV and AGZ, and NSF (ICER# 1633948), www.NSF.gov, and SFSU IRA grant awarded to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; BISHOP DW, 1947, J HERED, V38, P291; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; BRADFORD DF, 1991, J HERPETOL, V25, P174, DOI 10.2307/1564645; Brem FMR, 2008, DIS AQUAT ORGAN, V81, P189, DOI 10.3354/dao01960; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Daszak P, 2005, ECOLOGY, V86, P3232, DOI 10.1890/05-0598; De Leon ME, 2017, ECOHEALTH, V14, P155, DOI 10.1007/s10393-016-1201-1; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Gabor CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056054; Gordon K., 1939, AMPHIBIA REPTILIA OR; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jenkinson TS, 2016, MOL ECOL, V25, P2978, DOI 10.1111/mec.13599; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; LICHT P, 1967, ECOLOGY, V48, P598, DOI 10.2307/1936504; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Padgett-Flohr GE, 2009, DIS AQUAT ORGAN, V83, P1, DOI 10.3354/dao02003; Pauza MD, 2010, DIS AQUAT ORGAN, V92, P193, DOI 10.3354/dao02212; Phillips BL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1290; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Raffel TR, 2010, ECOHEALTH, V7, P526, DOI 10.1007/s10393-010-0358-2; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Richards-Hrdlicka KL, 2013, DIS AQUAT ORGAN, V102, P169, DOI 10.3354/dao02552; Roedder D, 2013, N W J ZOOLOGY, V9; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Schloegel LM, 2010, ANIM CONSERV, V13, P53, DOI 10.1111/j.1469-1795.2009.00307.x; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Sette CM, 2015, BIOL CONSERV, V192, P20, DOI 10.1016/j.biocon.2015.08.039; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stebbins R.C., 2012, FIELD GUIDE AMPHIBIA; STEBBINS RC, 1985, PETERSON FIELD GUIDE; Strauss A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076035; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sulaeman H., 2018, PATHOGEN INVASION NO; Talley BL, 2015, BIOL CONSERV, V182, P254, DOI 10.1016/j.biocon.2014.12.007; TWITTY V, 1964, P NATL ACAD SCI USA, V51, P51, DOI 10.1073/pnas.51.1.51; TWITTY VC, 1959, SCIENCE, V130, P1735, DOI 10.1126/science.130.3391.1735; Venter O, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.67; Voyles J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035374; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wardziak T, 2013, DIS AQUAT ORGAN, V104, P215, DOI 10.3354/dao02602; Weinstein SB, 2009, COPEIA, P653, DOI 10.1643/CH-08-180; Yap TA, 2015, SCIENCE, V349, P481, DOI 10.1126/science.aab1052	57	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0197710	10.1371/journal.pone.0197710	http://dx.doi.org/10.1371/journal.pone.0197710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965970	gold, Green Published, Green Submitted			2022-12-26	WOS:000437224100002
J	Gao, Y; de Wit, M; Struys, EA; van der Linde, HCZ; Salomons, GS; Lamfers, MLM; Willemsen, R; Smite, PAES; French, PJ				Gao, Ya; de Wit, Maurice; Struys, Eduard A.; van der Linde, Herma C. Z.; Salomons, Gajja S.; Lamfers, Martine L. M.; Willemsen, Rob; Smite, Peter A. E. Sillevis; French, Pim J.			IDH1-mutated transgenic zebrafish lines: An in-vivo model for drug screening and functional analysis	PLOS ONE			English	Article							MUTANT IDH1; ISOCITRATE DEHYDROGENASE; SUBVENTRICULAR ZONE; MAFFUCCI SYNDROME; OLLIER DISEASE; MUTATIONS; GLIOMAS; TUMORS; D-2-HYDROXYGLUTARATE; DIFFERENTIATION	Introduction The gene encoding isocitrate dehydrogenase 1 (IDH1) is frequently mutated in several tumor types including gliomas. The most prevalent mutation in gliomas is a missense mutation leading to a substitution of arginine with histidine at the residue 132 (R132H). Wild type IDH1 catalyzes oxidative decarboxylation of isocitrate to alpha-ketoglutarate (alpha-KG) whereas mutant IDH1 converts alpha-KG into D2-hydroxyglutarate (D2HG). Unfortunately, there are few in vivo model systems for IDH-mutated tumors to study the effects of IDH1 mutations in tumor development. We have therefore created transgenic zebrafish lines that express various IDH1 mutants. Materials and methods IDH1 mutations (IDH1(R132H), IDH1(R132C) and loss-of-function mutation IDH1(G70D)), IDH1(wildtype) or eGFP were cloned into constructs with several brain-specific promoters (Nestin, Gfap or Gata2). These constructs were injected into fertilized zebrafish eggs at the one-cell stage. Results In total more than ten transgenic zebrafish lines expressing various brain-specific IDH1 mutations were created. A significant increase in the level of D2HG was observed in all transgenic lines expressing IDH1(R132C) or IDH1(R132H), but not in any of the lines expressing IDH1(wildtype), IDH1(G70D) or eGFP. No differences in 5-hydroxymethyl cytosine and mature collagen IV levels were observed between wildtype and mutant IDH1 transgenic fish. To our surprise, we failed to identify any strong phenotype, despite increased levels of the oncome-tabolite D2HG. No tumors were observed, even when backcrossing with tp53-mutant fish which suggests that additional transforming events are required for tumor formation. Elevated D2HG levels could be lowered by treatment of the transgenic zebrafish with an inhibitor of mutant IDH1 activity. Conclusions We have generated a transgenic zebrafish model system for mutations in IDH1 that can be used for functional analysis and drug screening. Our model systems help understand the biology of IDH1 mutations and its role in tumor formation.	[Gao, Ya; de Wit, Maurice; Smite, Peter A. E. Sillevis; French, Pim J.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Struys, Eduard A.; Salomons, Gajja S.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Amsterdam, Netherlands; [van der Linde, Herma C. Z.; Willemsen, Rob] Erasmus MC, Dept Genet, Rotterdam, Netherlands; [Lamfers, Martine L. M.] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	French, PJ (corresponding author), Erasmus MC, Dept Neurol, Rotterdam, Netherlands.	p.french@erasmusmc.nl		Lamfers, Martine/0000-0001-7745-9029; Gao, Ya/0000-0001-8087-1364; French, Pim/0000-0002-0668-9529	Erasmus MC; Stichting Stophersentumoren.nl	Erasmus MC; Stichting Stophersentumoren.nl	This study was financially supported by the Erasmus MC (Erasmus MC Grants 2013) and Stichting Stophersentumoren.nl (2013).	About I, 2000, AM J PATHOL, V157, P287, DOI 10.1016/S0002-9440(10)64539-7; Amankulor NM, 2017, GENE DEV, V31, P774, DOI 10.1101/gad.294991.116; Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Balvers RK, 2013, NEURO-ONCOLOGY, V15, P1684, DOI 10.1093/neuonc/not116; Bardella C, 2016, CANCER CELL, V30, P578, DOI 10.1016/j.ccell.2016.08.017; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Bralten LBC, 2011, ANN NEUROL, V69, P455, DOI 10.1002/ana.22390; Brooks E, 2014, J BIOMOL SCREEN, V19, P1193, DOI 10.1177/1087057114541148; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Draaisma K, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0265-4; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; GABRIEL JL, 1986, METABOLISM, V35, P661, DOI 10.1016/0026-0495(86)90175-7; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hemerly JP, 2010, EUR J ENDOCRINOL, V163, P747, DOI 10.1530/EJE-10-0473; Hirata M, 2015, P NATL ACAD SCI USA, V112, P2829, DOI 10.1073/pnas.1424400112; Jung IH, 2013, NEURO-ONCOLOGY, V15, P290, DOI 10.1093/neuonc/nos387; Koh HJ, 2004, J BIOL CHEM, V279, P39968, DOI 10.1074/jbc.M402260200; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Mahler J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-89; Meyer SC, 2014, LANCET ONCOL, V15, pE382, DOI 10.1016/S1470-2045(14)70008-7; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pirozzi CJ, 2017, MOL CANCER RES, V15, P507, DOI 10.1158/1541-7786.MCR-16-0485; Prensner JR, 2011, NAT MED, V17, P291, DOI 10.1038/nm0311-291; Pusch S, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-19; Reitman ZJ, 2015, BLOOD, V125, P336, DOI 10.1182/blood-2014-05-577940; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Struys EA, 2004, CLIN CHEM, V50, P1391, DOI 10.1373/clinchem.2004.033399; Tefferi A, 2010, LEUKEMIA, V24, P1128, DOI 10.1038/leu.2010.69; Tomasiewicz HG, 2002, J NEUROSCI RES, V70, P734, DOI 10.1002/jnr.10451; Unruh D, 2016, ACTA NEUROPATHOL, V132, P917, DOI 10.1007/s00401-016-1620-7; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhu JA, 2011, MED HYPOTHESES, V76, P602, DOI 10.1016/j.mehy.2011.01.011	43	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199737	10.1371/journal.pone.0199737	http://dx.doi.org/10.1371/journal.pone.0199737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953513	gold, Green Published, Green Submitted			2022-12-26	WOS:000436645400056
J	Gholizadeh, A; Dehghani, H; Khodadadi, M; Gulick, PJ				Gholizadeh, Amir; Dehghani, Hamid; Khodadadi, Mostafa; Gulick, Patrick J.			Genetic combining ability of coriander genotypes for agronomic and phytochemical traits in response to contrasting irrigation regimes	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; SATIVUM L. FRUIT; ESSENTIAL OIL; WATER-DEFICIT; YIELD; QUALITY; STRESS; ACCESSIONS; HETEROSIS; VARIANCE	Knowledge of genetic combining ability and gene action would help breeders to choose suitable parents and devise an appropriate breeding strategy for coriander. In the present study, six diverse genotypes of coriander, their 15 F(1)s and 15 F(2)s were evaluated through randomized complete block design with three replications to study genetic combining ability for agronomic and phytochemical traits in coriander. Plants were subjected to well-watered (WW), mild water-deficit stress (MWDS) and severe water-deficit stress (SWDS) irrigation regimes. The results indicate that water-deficit stress decreased all of the measured traits in both the F-1 and F-2 generations. General combining ability and specific combining ability effects were highly significant for all of the traits in both the F-1 and F-2 generations. Additive gene action was predominant for phonology and fruit yield component traits in all irrigation regimes in both the F-1 and F-2 generations. For fatty acid content and total lipid yield, nonadditive gene action was predominant in the F-1 generation while additive gene action was predominant in the F-2 generation under MWDS and SWDS conditions. The P-4 parent had the highest general combining ability for fruit yield components in both the F-1 and F-2 generations. The P-6 parent had the highest general combining ability for phenological and phytochemical traits. The P-4 and P-6 parents are promising material to develop early flowering and early maturing genotypes coupled with high total lipids in advanced generations of segregation.	[Gholizadeh, Amir; Dehghani, Hamid; Khodadadi, Mostafa] Tarbiat Modares Univ, Dept Plant Genet & Breeding, Fac Agr, Tehran, Iran; [Gulick, Patrick J.] Concordia Univ, Dept Biol, Montreal, PQ, Canada	Tarbiat Modares University; Concordia University - Canada	Dehghani, H (corresponding author), Tarbiat Modares Univ, Dept Plant Genet & Breeding, Fac Agr, Tehran, Iran.	dehghanr@modares.ac.ir	Gulick, Patrick J./AAH-2879-2019; Dehghani, Hamid/A-8985-2015	Dehghani, Hamid/0000-0003-3267-5144; khodadadi, mostafa/0000-0003-4134-9316; Gholizadeh, Amir/0000-0002-5204-844X	Tarbiat Modares University	Tarbiat Modares University	This work was supported by Tarbiat Modares University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinian S, 2014, IND CROP PROD, V54, P167, DOI 10.1016/j.indcrop.2014.01.028; Amiri-Oghan H, 2009, INT J PLANT PROD, V3, P19; BAKER RJ, 1978, CROP SCI, V18, P533, DOI 10.2135/cropsci1978.0011183X001800040001x; Banerjee PP, 2009, EUPHYTICA, V168, P11, DOI 10.1007/s10681-008-9871-6; Bannayan M, 2008, IND CROP PROD, V27, P11, DOI 10.1016/j.indcrop.2007.05.002; Bettaieb I, 2009, SCI HORTIC-AMSTERDAM, V120, P271, DOI 10.1016/j.scienta.2008.10.016; Bettaieb I, 2011, J AGR FOOD CHEM, V59, P328, DOI 10.1021/jf1037618; Blum A, 2011, PLANT BREEDING FOR WATER-LIMITED ENVIRONMENTS, P11, DOI 10.1007/978-1-4419-7491-4_2; CHARLES DJ, 1990, PHYTOCHEMISTRY, V29, P2837, DOI 10.1016/0031-9422(90)87087-B; dos Santos EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160647; Ebrahimi SN, 2010, NAT PROD RES, V24, P1287, DOI 10.1080/14786410903132316; Ekren S, 2012, AGR WATER MANAGE, V109, P155, DOI 10.1016/j.agwat.2012.03.004; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; GALES K, 1981, ANN APPL BIOL, V99, P323, DOI 10.1111/j.1744-7348.1981.tb04802.x; Gao W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076826; GRIFFING BRUCE, 1956, HEREDITY, V10, P31, DOI 10.1038/hdy.1956.2; Hamrouni I, 2001, PHYTOCHEMISTRY, V58, P277, DOI 10.1016/S0031-9422(01)00210-2; Hirut B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181541; Holland JB, 2006, CROP SCI, V46, P642, DOI 10.2135/cropsci2005.0191; Jacotot, 1994, OLIVAE, V54, P40; KALB TJ, 1984, J AM SOC HORTIC SCI, V109, P416; Khodadadi M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00568; Khodadadi M, 2016, IND CROP PROD, V94, P72, DOI 10.1016/j.indcrop.2016.08.030; Khodadadi M, 2016, SCI HORTIC-AMSTERDAM, V200, P73, DOI 10.1016/j.scienta.2016.01.003; Laribi B, 2009, IND CROP PROD, V30, P372, DOI 10.1016/j.indcrop.2009.07.005; Leilah AA, 2005, J ARID ENVIRON, V61, P483, DOI 10.1016/j.jaridenv.2004.10.011; Lopez PA, 2008, GENET RESOUR CROP EV, V55, P247, DOI 10.1007/s10722-007-9232-7; Moser BR, 2010, BIOMASS BIOENERG, V34, P550, DOI 10.1016/j.biombioe.2009.12.022; Msaada K, 2009, IND CROP PROD, V29, P269, DOI 10.1016/j.indcrop.2008.05.011; Msaada K, 2009, SCI HORTIC-AMSTERDAM, V120, P525, DOI 10.1016/j.scienta.2008.11.033; Musembi KB, 2015, EUPHYTICA, V201, P423, DOI 10.1007/s10681-014-1230-1; Nadjafi F, 2009, J ESSENT OIL BEAR PL, V12, P300, DOI 10.1080/0972060X.2009.10643724; Neffati M, 2008, IND CROP PROD, V28, P137, DOI 10.1016/j.indcrop.2008.02.005; Pereira AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178790; Petropoulos SA, 2008, SCI HORTIC-AMSTERDAM, V115, P393, DOI 10.1016/j.scienta.2007.10.008; Ramadan MF, 2002, EUR FOOD RES TECHNOL, V215, P204, DOI 10.1007/s00217-002-0537-7; Rotundo JL, 2009, FIELD CROP RES, V110, P147, DOI 10.1016/j.fcr.2008.07.012; SAS, 2003, SAS 9 1 VERS SAS 9 1; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Singh Munnu, 2000, Journal of Medicinal and Aromatic Plant Sciences, V22, P659; Sriti J, 2009, J SCI FOOD AGR, V89, P1659, DOI 10.1002/jsfa.3637; Townsend T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061989; Turner N. C., 1979, Stress physiology in crop plants., P343; Zehtab-Salmasi Saeid, 2006, Turkish Journal of Agriculture and Forestry, V30, P281; Zhang XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126828; Zhang YD, 2005, AGRON J, V97, P1097, DOI 10.2134/agronj2004.0260	46	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199630	10.1371/journal.pone.0199630	http://dx.doi.org/10.1371/journal.pone.0199630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953470	gold, Green Submitted, Green Published			2022-12-26	WOS:000436645400046
J	Ley, C; Sundaram, V; Sanchez, MD; Desai, M; Parsonnet, J				Ley, Catherine; Sundaram, Vandana; Sanchez, Maria de la Luz; Desai, Manisha; Parsonnet, Julie			Triclosan and triclocarban exposure, infectious disease symptoms and antibiotic prescription in infants-A community-based randomized intervention	PLOS ONE			English	Article							URINARY CONCENTRATIONS; US POPULATION; HEALTH	Background Triclosan and triclocarban (TCs) are broad-spectrum antimicrobials that, until recently, were found in a wide variety of household and personal wash products. Popular with consumers, TCs have not been shown to protect against infectious diseases. Objectives To determine whether use of TC-containing wash products reduces incidence of infection in children less than one year of age. Methods Starting in 2011, we nested a randomized intervention of wash products with and without TCs within a multiethnic birth cohort. Maternal reports of infectious disease symptoms and antibiotic use were collected weekly by automated survey; household visits occurred every four months. Antibiotic prescriptions were identified by medical chart review. Urinary triclosan levels were measured in a participant subset. Differences by intervention group in reported infectious disease (primary outcome) and antibiotic use (secondary outcome) were assessed using mixed effects logistic regression and Fisher's Exact tests, respectively. Results Infectious illness occurred in 6% of weeks, with upper respiratory illness the predominant syndrome. Among 60 (45%) TC-exposed and 73 (55%) non-TC-exposed babies, infectious disease reports did not differ in frequency between groups (likelihood ratio test: p = 0.88). Medical visits with antibiotic prescriptions were less common in the TC group than in the non-TC group (7.8% vs. 16.6%, respectively; p = 0.02). Conclusions Although randomization to TC-containing wash products was not associated with decreased infectious disease reports by mothers, TCs were associated with decreased antibiotic prescriptions, suggesting a benefit against bacterial infection. The recent removal of TCs from consumer wash products makes further elucidation of benefits and risks impracticable.	[Ley, Catherine; Sanchez, Maria de la Luz; Parsonnet, Julie] Stanford Sch Med, Dept Med, Div Infect Dis, Stanford, CA 94305 USA; [Sundaram, Vandana; Desai, Manisha] Stanford Sch Med, Dept Med, Quantitat Sci Unit, Stanford, CA USA; [Parsonnet, Julie] Stanford Sch Med, Dept Hlth Res & Policy, Div Epidemiol, Stanford, CA USA	Stanford University; Stanford University; Stanford University	Ley, C (corresponding author), Stanford Sch Med, Dept Med, Div Infect Dis, Stanford, CA 94305 USA.	cley@stanford.edu		Parsonnet, Julie/0000-0001-7342-5366	National Institutes of Health [5R01HD063142, 5R21ES023371]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health [grants 5R01HD063142 and 5R21ES023371], to Julie Parsonnet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2007, CLIN INFECT DIS, V45, pS137, DOI 10.1086/519255; Anderson SE, 2016, J IMMUNOTOXICOL, V13, P165, DOI 10.3109/1547691X.2015.1029146; Bever CS, 2018, CHEMOSPHERE, V203, P467, DOI 10.1016/j.chemosphere.2018.03.186; Bondi CAM., 2007, AM J INFECT CONTROL, V35, pE34, DOI [10.1016/j.ajic.2007.04.027, DOI 10.1016/J.AJIC.2007.04.027]; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P303, DOI 10.1289/ehp.10768; Chalew TEA, 2009, J AM WATER RESOUR AS, V45, P4, DOI 10.1111/j.1752-1688.2008.00284.x; Clayton EMR, 2011, ENVIRON HEALTH PERSP, V119, P390, DOI 10.1289/ehp.1002883; Dellanno C, 2009, AM J INFECT CONTROL, V37, P649, DOI 10.1016/j.ajic.2009.03.012; Halden RU, 2014, ENVIRON SCI TECHNOL, V48, P3603, DOI 10.1021/es500495p; Halliday G, 2009, INT PSYCHOGERIATR, V21, P1041, DOI 10.1017/S1041610209990135; Han C, 2016, ENVIRON POLLUT, V208, P803, DOI 10.1016/j.envpol.2015.11.002; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hurd-Brown T, 2013, J APPL TOXICOL, V33, P495, DOI 10.1002/jat.2767; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Larson EL, 2004, ANN INTERN MED, V140, P321, DOI 10.7326/0003-4819-140-5-200403020-00007; Lassen TH, 2013, ENVIRON RES, V126, P164, DOI 10.1016/j.envres.2013.07.001; Ley C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010810; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Luby SP, 2004, JAMA-J AM MED ASSOC, V291, P2547, DOI 10.1001/jama.291.21.2547; McBain AJ, 2003, APPL ENVIRON MICROB, V69, P5433, DOI 10.1128/AEM.69.9.5433-5442.2003; Niederman Richard, 2005, Evid Based Dent, V6, P33, DOI 10.1038/sj.ebd.6400318; Palmer RK, 2012, TOXICOL APPL PHARM, V258, P99, DOI 10.1016/j.taap.2011.10.012; Park GW, 2010, J FOOD PROTECT, V73, P2232, DOI 10.4315/0362-028X-73.12.2232; Poole AC, 2016, MSPHERE, V1, P1; Sapkota A, 2007, ENVIRON RES, V103, P21, DOI 10.1016/j.envres.2006.03.006; Stam J, 2012, ACTA PAEDIATR, V101, P929, DOI 10.1111/j.1651-2227.2012.02728.x; Su Y.-S., 2016, DATA ANAL USING REGR; US Department of Housing and Urban Development, 2007, MEAS OV HOUS; Vissing NH, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-160; Weatherly LM, 2017, J TOXICOL ENV HEAL B, V20, P447, DOI 10.1080/10937404.2017.1399306; Ye XY, 2016, ENVIRON SCI TECHNOL, V50, P13548, DOI 10.1021/acs.est.6b04668; Zoorob R, 2012, AM FAM PHYSICIAN, V86, P817	32	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							PII e0199298	10.1371/journal.pone.0199298	http://dx.doi.org/10.1371/journal.pone.0199298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953463	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400022
J	Basova, L; Najera, JA; Bortell, N; Wang, D; Moya, R; Lindsey, A; Semenova, S; Ellis, RJ; Marcondes, MCG				Basova, Liana; Najera, Julia A.; Bortell, Nikki; Wang, Di; Moya, Rosita; Lindsey, Alexander; Semenova, Svetlana; Ellis, Ronald J.; Marcondes, Maria Cecilia Garibaldi			Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infection	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CEREBROSPINAL-FLUID; MACROPHAGES; INCREASES; EFAVIRENZ; PROMOTER; CNS; POLYMORPHISMS; CORECEPTOR; MICROGLIA	The Human Immunodeficiency Virus (HIV) infects cells in the Central Nervous System (CNS), where the access of antiretrovirals and antibodies that can kill the virus may be challenging. As a result of the early HIV entry in the brain, infected individuals develop inflammation and neurological deficits at various levels, which are aggravated by drugs of abuse. In the non-human primate model of HIV, we have previously shown that drugs of abuse such as Methamphetamine (Meth) increase brain viral load in correlation with a higher number of CCR5-expressing myeloid cells. CCR5 is a chemokine receptor that may be involved in increasing inflammation, but also, it is a co-receptor for viral entry into target cells. CCR5-expressing myeloid cells are the main targets of HIV in the CNS. Thus, the identification of factors and mechanisms that impact the expression of CCR5 in the brain is critical, as changes in CCR5 levels may affect the infection in the brain. Using a well-characterized in vitro system, with the THP1 human macrophage cell line, we have investigated the hypothesis that the expression of CCR5 is acutely affected by Meth, and examined pathways by which this effect could happen. We found that Meth plays a direct role by regulating the abundance and nuclear translocation of transcription factors with binding sites in the CCR5 promoter. However, we found that the main factor that modifies the CCR5 gene promoter at the epigenetic level towards transcription is Dopamine (DA), a neurotransmitter that is produced primarily in brain regions that are rich in dopaminergic neurons. In THP1 cells, the effect of DA on innate immune CCR5 transcription was mediated by DA receptors (DRDs), mainly DRD4. We also identified a role for DRD1 in suppressing CCR5 expression in this myeloid cell system, with potential implications for therapy. The effect of DA on innate immune CCR5 expression was also detectable on the cell surface during acute time-points, using low doses. In addition, HIV Tat acted by enhancing the surface expression of CCR5, in spite of its poor effect on transcription. Overall, our data suggests that the exposure of myeloid cells to Meth in the context of presence of HIV peptides such as Tat, may affect the number of HIV targets by modulating CCR5 expression, through a combination of DA-dependent and-independent mechanisms. Other drugs that increase DA may affect similar mechanisms. The implications of these epigenetic and translational mechanisms in enhancing HIV infection in the brain and elsewhere are demonstrated.	[Basova, Liana; Moya, Rosita; Lindsey, Alexander; Marcondes, Maria Cecilia Garibaldi] San Diego Biomed Res Inst, San Diego, CA 92121 USA; [Basova, Liana; Najera, Julia A.; Bortell, Nikki; Wang, Di; Marcondes, Maria Cecilia Garibaldi] Scripps Res Inst, Dept Neurosci, La Jolla, CA 92037 USA; [Wang, Di; Semenova, Svetlana; Ellis, Ronald J.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Bortell, Nikki] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO USA	Scripps Research Institute; University of California System; University of California San Diego; University of Colorado System; University of Colorado Anschutz Medical Campus	Marcondes, MCG (corresponding author), San Diego Biomed Res Inst, San Diego, CA 92121 USA.; Marcondes, MCG (corresponding author), Scripps Res Inst, Dept Neurosci, La Jolla, CA 92037 USA.	cmarcondes@SDBRI.ORG	Ellis, Ronald/K-3543-2015	Ellis, Ronald/0000-0003-4931-752X; Marcondes, Maria Cecilia/0000-0002-4705-372X	NIH NIDA [R01DA036164]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036164] Funding Source: NIH RePORTER	NIH NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was completely funded by the NIH NIDA R01DA036164 awarded to MCGM. The funder had no role in study design, data collection and analysis. decision to publish, or preparation of the manuscript.; The authors do not have any conflict of interests. We thank Dr. Bill Webb (TSRI, Scripps Center for Metabolomics and Mass Spectrometry, La Jolla, CA), for experimental assistance in catecholamine measurements, Dr. Emma Crook (SDBRI, San Diego Biomedical Research Institute, San Diego, CA) for her attempts to infect THP1 cells. Dr. Bruce Torbett for discussions during the conceptualization process, Dr. Howard Fox (University of Nebraska Medical Center, Omaha, NE), Dr. Marco Cosentino (University degli Studi dell'Insubria, Centro di Ricerche in 1,artnacologia Medica, Varese, Lombardia, Italy), and Dr. Peter Jesse Gaskill (Drexel University College of Medicine, Philadelphia, PA, USA) for the wonderful discussions and scientific input. We also thank Christine Auciello and Gary Podschun (SDBRI) for administrative assistance. This research was fully funded by NIH NIDA R01DA036164 to MCGM.	Apostolova N, 2015, J ANTIMICROB CHEMOTH, V70, P2693, DOI 10.1093/jac/dkv183; Apostolova N, 2011, HEPATOLOGY, V54, P1009, DOI 10.1002/hep.24459; Best BM, 2011, J ANTIMICROB CHEMOTH, V66, P354, DOI 10.1093/jac/dkq434; Bortell N, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0825-6; Bosshart H, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.53; Coley JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117450; Comi C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020242; Cosentino M, 2015, HUM IMMUNOL, V76, P747, DOI 10.1016/j.humimm.2015.09.032; Dahl V, 2014, AIDS, V28, P2251, DOI 10.1097/QAD.0000000000000400; Desplats P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102555; Ferrari M, 2016, EUR J CLIN PHARMACOL, V72, P1335, DOI 10.1007/s00228-016-2111-4; Fowler JS, 2007, J NUCL MED, V48, P1724, DOI 10.2967/jnumed.107.040279; Fowler JS, 2008, NEUROIMAGE, V43, P756, DOI 10.1016/j.neuroimage.2008.07.020; Gaskill PJ, 2008, J VIROL, V82, P1615, DOI 10.1128/JVI.01757-07; Gaskill PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108232; Gaskill PJ, 2013, J NEUROIMMUNE PHARM, V8, P621, DOI 10.1007/s11481-013-9443-y; Gaskill PJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-203; Gaskill PJ, 2009, AM J PATHOL, V175, P1148, DOI 10.2353/ajpath.2009.081067; Guignard F, 1998, J IMMUNOL, V160, P985; Harrington PR, 2009, AIDS, V23, P907, DOI 10.1097/QAD.0b013e3283299129; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Kesby JP, 2018, ADDICT BIOL, V23, P206, DOI 10.1111/adb.12502; Kesby JP, 2017, BRAIN BEHAV IMMUN, V65, P210, DOI 10.1016/j.bbi.2017.05.004; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Liang H, 2008, AM J PATHOL, V172, P1617, DOI 10.2353/ajpath.2008.070971; Marcondes FC, 2010, AM J PATHOLOGY; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; Marcondes MCG, 2003, AIDS, V17, P1605, DOI 10.1097/00002030-200307250-00004; Moriuchi H, 1997, J IMMUNOL, V159, P5441; Moriuchi M, 1999, BLOOD, V93, P1433, DOI 10.1182/blood.V93.4.1433.404a36c_1433_1435; Mummidi S, 1997, J BIOL CHEM, V272, P30662, DOI 10.1074/jbc.272.49.30662; Nair MPN, 2009, J NEUROIMMUNE PHARM, V4, P129, DOI 10.1007/s11481-008-9128-0; Najera JA, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0145-0; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Rippeth JD, 2004, J INT NEUROPSYCH SOC, V10, P1, DOI 10.1017/S1355617704101021; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; Schnell G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000395; Shah M, 2006, AIDS RES HUM RETROV, V22, P177, DOI 10.1089/aid.2006.22.177; Taylor SB, 2013, SUBST ABUSE REHABIL, V4, P29, DOI 10.2147/SAR.S39684; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208	41	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199861	10.1371/journal.pone.0199861	http://dx.doi.org/10.1371/journal.pone.0199861			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944719	Green Published, gold, Green Submitted			2022-12-26	WOS:000436377800066
J	Brunello, G; Brun, P; Gardin, C; Ferroni, L; Bressan, E; Meneghello, R; Zavan, B; Sivolella, S				Brunello, Giulia; Brun, Paola; Gardin, Chiara; Ferroni, Letizia; Bressan, Eriberto; Meneghello, Roberto; Zavan, Barbara; Sivolella, Stefano			Biocompatibility and antibacterial properties of zirconium nitride coating on titanium abutments: An in vitro study	PLOS ONE			English	Article							OF-THE-LITERATURE; SURFACE-ROUGHNESS; IMPLANT SURFACES; SOFT-TISSUES; PLAQUE; VIVO; ADHESION; COLONIZATION; RESTORATIONS; RELIABILITY	Improving soft tissue attachment and reducing bacterial colonization on titanium abutments are key factors for the long-term maintenance of healthy soft and hard peri-implant tissues. This in vitro study was conducted to compare the biocompatibility and antibacterial activity of four different surfaces: uncoated Ti6Al4V, anodized, and coated with titanium nitride or zirconium nitride. Surface topography was investigated with a high-resolution system for measuring surface finishes. Human gingival fibroblast (HGF) adhesion and proliferation were examined using MTT assay, Scanning Electron Microscopy (SEM) imaging, immunofluorescence analysis and real-time PCR for selected target genes. The hemolysis and AMES tests were performed to assess the chemical compounds' blood compatibility and mutagenic potential, respectively. Antibacterial activity was tested against five bacterial strains isolated from the oral cavity (Streptococcus salivarius, S. sanguinis, S. mutans, S. sobrinus, S. oralis), and the percentage of dead bacteria was calculated. Roughness measurements confirmed a substantial similarity between the surfaces and their compatibility with clinical applications. MTT assay, SEM analysis and immunofluorescence staining showed adhesion and proliferation of HGFs cultured on all the examined surfaces. PCR confirmed that HGFs produced extracellular matrix components efficiently on all the surfaces. No hemolytic activity was detected, and the AMES test confirmed the surfaces' clinical safety. For all tested bacterial strains, biofilms grown on the zirconium nitride surface showed a higher percentage of dead bacteria than on the other disks. The titanium nitride surface inactivated bacterial biofilms, too, but to a lesser extent.	[Brunello, Giulia; Meneghello, Roberto] Univ Padua, Dept Management & Engn, Vicenza, Italy; [Brunello, Giulia; Bressan, Eriberto; Sivolella, Stefano] Univ Padua, Dept Neurosci, Sect Dent, Padua, Italy; [Brun, Paola] Univ Padua, Dept Mol Med, Padua, Italy; [Gardin, Chiara; Ferroni, Letizia; Zavan, Barbara] Univ Padua, Dept Biomed Sci, Padua, Italy; [Gardin, Chiara; Ferroni, Letizia; Zavan, Barbara] ES Hlth Sci Fdn, GVM Care & Res, Maria Cecilia Hosp, Cotignola, Italy	University of Padua; University of Padua; University of Padua; University of Padua; Maria Cecilia Hospital	Brunello, G (corresponding author), Univ Padua, Dept Management & Engn, Vicenza, Italy.; Brunello, G (corresponding author), Univ Padua, Dept Neurosci, Sect Dent, Padua, Italy.	giulia-bru@libero.it	Brunello, Giulia/G-2241-2018; Meneghello, Roberto/O-4072-2019; Meneghello, Roberto/I-8759-2012; sivolella, stefano/GLT-2325-2022	Brunello, Giulia/0000-0003-1436-0085; Meneghello, Roberto/0000-0002-8099-9795; Meneghello, Roberto/0000-0002-8099-9795; sivolella, stefano/0000-0003-1916-1640; Ferroni, Letizia/0000-0002-5457-0338				Albrektsson T, 2004, INT J PROSTHODONT, V17, P536; Ata-Ali J, 2011, MED ORAL PATOL ORAL, V16, pC937, DOI 10.4317/medoral.17227; Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3; Bressan E, 2011, CLIN ORAL IMPLAN RES, V22, P631, DOI 10.1111/j.1600-0501.2010.02008.x; Bumgardner JD, 2011, INT J ORAL MAX IMPL, V26, P553; Chang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052419; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Frankova J, 2013, J BIOMED MATER RES A, V101, P2915, DOI 10.1002/jbm.a.34598; Furst MM, 2007, CLIN ORAL IMPLAN RES, V18, P501, DOI 10.1111/j.1600-0501.2007.01381.x; Groessner-Schreiber B, 2004, EUR J ORAL SCI, V112, P516, DOI 10.1111/j.1600-0722.2004.00171.x; Groessner-Schreiber B, 2003, J BIOMED MATER RES A, V64A, P591, DOI 10.1002/jbm.a.10417; Grossner-Schreiber B, 2006, CLIN ORAL IMPLAN RES, V17, P736, DOI 10.1111/j.1600-0501.2006.01277.x; Grossner-Schreiber B, 2001, CLIN ORAL IMPLAN RES, V12, P543, DOI 10.1034/j.1600-0501.2001.120601.x; Grossner-Schreiber B, 2009, CLIN ORAL IMPLAN RES, V20, P817, DOI 10.1111/j.1600-0501.2009.01729.x; Guilherme NM, 2016, J PROSTHET DENT, V116, P206, DOI 10.1016/j.prosdent.2015.12.015; Happe A, 2013, INT J PERIODONT REST, V33, pE1; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Ji MK, 2015, J ADV PROSTHODONT, V7, P166, DOI 10.4047/jap.2015.7.2.166; Kertzman Z, 2008, J BIOMED MATER RES A, V84A, P1061, DOI 10.1002/jbm.a.31533; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Leutert CR, 2012, INT J ORAL MAX IMPL, V27, P505; Lin NM, 2012, SURF COAT TECH, V209, P212, DOI 10.1016/j.surfcoat.2012.07.046; Linkevicius T, 2015, CLIN ORAL IMPLAN RES, V26, P139, DOI 10.1111/clr.12631; Meissen R, 2014, INT J PERIODONT REST, V34, P91, DOI 10.11607/prd.1504; NAKAZATO G, 1989, International Journal of Oral and Maxillofacial Implants, V4, P321; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Pier-Francesco A, 2006, CLIN ORAL IMPLAN RES, V17, P633, DOI 10.1111/j.1600-0501.2006.01274.x; Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X; Quirynen M, 1996, Int J Oral Maxillofac Implants, V11, P169; QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801; Rehman A, 2012, INT J ORAL MAX IMPL, V27, P811; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rimondini L, 1997, J PERIODONTOL, V68, P556, DOI 10.1902/jop.1997.68.6.556; Scarano Antonio, 2003, J Oral Implantol, V29, P80, DOI 10.1563/1548-1336(2003)029<0080:BAOTNA>2.3.CO;2; Sghaireen MG, 2015, CLIN IMPLANT DENT R, V17, P554, DOI 10.1111/cid.12160; Subramani K, 2009, INT J ORAL MAX IMPL, V24, P616; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Wang YL, 2016, CLIN IMPLANT DENT R, V18, P618, DOI 10.1111/cid.12343; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416	39	40	40	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199591	10.1371/journal.pone.0199591	http://dx.doi.org/10.1371/journal.pone.0199591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944716	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800043
J	Chew, FLM; Salowi, MA; Mustari, Z; Husni, MA; Hussein, E; Adnan, TH; Ngah, NF; Limburg, H; Goh, PP				Chew, Fiona L. M.; Salowi, Mohamad Aziz; Mustari, Zuraidah; Husni, Mohd Aziz; Hussein, Elias; Adnan, Tassha Hilda; Ngah, Nor Fariza; Limburg, Hans; Goh, Pik-Pin			Estimates of visual impairment and its causes from the National Eye Survey in Malaysia (NESII)	PLOS ONE			English	Article							AVOIDABLE BLINDNESS; RAPID ASSESSMENT; CATARACT-SURGERY; PREVALENCE; VISION	Background Population-based data on prevalence, causes of blindness and extent of ophthalmological coverage is required for efficient implementation and evaluation of ocular health programs. In view of the scarcity of prevalence data for visual impairment and blindness in Malaysia, this study aims to estimate the prevalence and causes of visual impairment (VI) in the elderly, using Rapid Assessment of Avoidable Blindness (RAAB) survey technique. Methods Malaysia was divided into six regions, with each region consisting of 50 clusters. Multistage cluster sampling method was used and each cluster contained 50 residents aged 50 years and above. Eligible subjects were interviewed and pertinent demographic details, barriers to cataract surgery, medical and ocular history was noted. Subjects had visual acuity assessment with tumbling 'E' Snellen optotypes and ocular examination with direct ophthalmoscope. The primary cause of VI was documented. Results were calculated for individual zones and weighted average was used to obtain overall prevalence for the country. Inter-regional and overall prevalence for blindness, severe VI and moderate VI were determined. Causes of VI, cataract surgical coverage and barriers to cataract surgery were assessed. Results A total of 15,000 subjects were examined with a response rate of 95.3%. The age and gender-adjusted prevalence of blindness, severe visual impairment and moderate visual impairment were 1.2% (95% Confidence Interval: 1.0-1.4%), 1.0% (95% CI: 0.8-1.2%) and 5.9% (5.3-6.5%) respectively. Untreated cataract (58.6%), diabetic retinopathy (10.4%) and glaucoma (6.6%) were the commonest causes of blindness. Overall, 86.3% of the causes of blindness were avoidable. Cataract surgical coverage (CSC) in persons for blindness, severe visual impairment and moderate visual impairment was 90%, 86% and 66% respectively. Conclusion Increased patient education and further expansion of ophthalmological services are required to reduce avoidable blindness even further in Malaysia.	[Chew, Fiona L. M.; Salowi, Mohamad Aziz; Husni, Mohd Aziz; Hussein, Elias] Hosp Selayang, Dept Ophthalmol, Batu Caves, Selangor, Malaysia; [Salowi, Mohamad Aziz] Univ Sultan Zainal Abidin, Fac Med, Kuala Terengganu, Terengganu, Malaysia; [Mustari, Zuraidah] Hosp Sultanah Nur Zahirah, Dept Ophthalmol, Kuala Terengganu, Terengganu, Malaysia; [Adnan, Tassha Hilda; Goh, Pik-Pin] Hosp Kuala Lumpur, Clin Res Ctr, Kuala Lumpur, Wilayah Perseku, Malaysia; [Ngah, Nor Fariza] Hosp Shah Alam, Dept Ophthalmol, Shah Alam, Selangor, Malaysia; [Limburg, Hans] Hlth Informat Serv, Grootebroek, Netherlands	Universiti Sultan Zainal Abidin; Kementerian Kesihatan Malaysia	Chew, FLM (corresponding author), Hosp Selayang, Dept Ophthalmol, Batu Caves, Selangor, Malaysia.	sabrefmin@gmail.com		Adnan, Tassha Hilda/0000-0002-4301-1346	Ministry of Health of Malaysia; World Health Organization(WHO)	Ministry of Health of Malaysia; World Health Organization(WHO)(World Health Organization)	The study was performed using facilities provided by the Ministry of Health of Malaysia. Hans Limburg MD PhD is a freelance consultant in Public Eye Health. He has been contracted and paid by the World Health Organization(WHO) to conduct a RAAB training for RAAB survey teams in Alor Star, Malaysia from 23-26 September 2014. Dr Limburg has not received any payment for his contribution to this manuscript. Dr. Limburg is also affiliated with Health Information Services and received funding in the form of salary. WHO provided support in the form of salary for Hans Limburg, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Ministry of Health provided support in the form of health equipment and facilities but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SIT AN VISION 2020 W; Danquah L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094140; Department of Statistics Malaysia, 2010, PREL COUNT REP; Dineen B, 2006, OPHTHAL EPIDEMIOL, V13, P31, DOI 10.1080/09286580500473787; Eusebio C, 2007, BRIT J OPHTHALMOL, V91, P1588, DOI 10.1136/bjo.2007.119123; Foo CY, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1011-0; Heemraz BS, 2016, CAN J OPHTHALMOL, V51, P282, DOI 10.1016/j.jcjo.2016.02.004; Javed U, 2015, EYE, V29, P921, DOI 10.1038/eye.2015.70; Kuper Hannah, 2006, Community Eye Health, V19, P68; Lee MY, 2014, ASIA-PAC J OPHTHALMO, V3, P343, DOI 10.1097/APO.0000000000000030; Li EY, 2013, OPHTHALMOLOGY, V120, P2176, DOI 10.1016/j.ophtha.2013.04.003; Limburg H, 1998, Community Eye Health, V11, P3; Liu YC, 2017, LANCET, V390, P600, DOI 10.1016/S0140-6736(17)30544-5; Lou LX, 2017, AM J OPHTHALMOL, V180, P91, DOI 10.1016/j.ajo.2017.04.008; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Neena J, 2008, PLOS ONE, V3, P1, DOI 10.1136/BJO.2007.119123; Prevention of Blindness and Deafness, 2003, WHOPBL0391; Ramke J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172342; United Nations Department of Economic and Social Affairs, POP DIV WORLD POP PR; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang XZ, 2014, OPHTHALMOLOGY, V121, P1837, DOI 10.1016/j.ophtha.2014.03.017; Wu M, 2008, OPHTHALMOLOGY, V115, P969, DOI 10.1016/j.ophtha.2007.08.002; Zainal M, 2002, BRIT J OPHTHALMOL, V86, P951, DOI 10.1136/bjo.86.9.951	23	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0198799	10.1371/journal.pone.0198799	http://dx.doi.org/10.1371/journal.pone.0198799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944677	Green Published, gold, Green Submitted			2022-12-26	WOS:000436377800014
J	Harp, CRP; Archambault, AS; Sim, J; Shlomchik, MJ; Russell, JH; Wu, GF				Harp, Chelsea R. Parker; Archambault, Angela S.; Sim, Julia; Shlomchik, Mark J.; Russell, John H.; Wu, Gregory F.			B cells are capable of independently eliciting rapid reactivation of encephalitogenic CD4 T cells in a murine model of multiple sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTATION; DENDRITIC CELLS; CUTTING EDGE; CEREBROSPINAL-FLUID; DEFICIENT MICE; PLASMA-CELLS; RESPONSES	Recent success with B cell depletion therapies has revitalized efforts to understand the pathogenic role of B cells in Multiple Sclerosis (MS). Using the adoptive transfer system of experimental autoimmune encephalomyelitis (EAE), a murine model of MS, we have previously shown that mice in which B cells are the only MHCII-expressing antigen presenting cell (APC) are susceptible to EAE. However, a reproducible delay in the day of onset of disease driven by exclusive B cell antigen presentation suggests that B cells require optimal conditions to function as APCs in EAE. In this study, we utilize an in vivo genetic system to conditionally and temporally regulate expression of MHCII to test the hypothesis that B cell APCs mediate attenuated and delayed neuroinflammatory T cell responses during EAE. Remarkably, induction of MHCII on B cells following the transfer of encephalitogenic CD4 T cells induced a rapid and robust form of EAE, while no change in the time to disease onset occurred for recipient mice in which MHCII is induced on a normal complement of APC subsets. Changes in CD4 T cell activation over time did not account for more rapid onset of EAE symptoms in this new B cell-mediated EAE model. Our system represents a novel model to study how the timing of pathogenic cognate interactions between lymphocytes facilitates the development of autoimmune attacks within the CNS.	[Harp, Chelsea R. Parker; Archambault, Angela S.; Wu, Gregory F.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Sim, Julia; Russell, John H.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Shlomchik, Mark J.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Wu, Gregory F.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Wu, GF (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.; Wu, GF (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	wug@neuro.wustl.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Parker Harp, Chelsea/0000-0002-4205-9647	National Institutes of Health [1R01NS083678, 1F31NS096824, R01-AI043603]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institutes of Health grants and 1R01NS083678 and 1F31NS096824 (NINDS) and R01-AI043603 (NIAID).	AlbouzAbo S, 1997, EUR J BIOCHEM, V246, P59, DOI 10.1111/j.1432-1033.1997.t01-2-00059.x; Archambault AS, 2013, J IMMUNOL, V191, P545, DOI 10.4049/jimmunol.1201598; Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Bar-Or A, 2010, ANN NEUROL, V67, P452, DOI 10.1002/ana.21939; Barnett LG, 2014, J IMMUNOL, V192, P3607, DOI 10.4049/jimmunol.1301284; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Brennan KM, 2011, J NEUROIMMUNOL, V238, P87, DOI 10.1016/j.jneuroim.2011.08.002; Bulloch K, 2008, J COMP NEUROL, V508, P687, DOI 10.1002/cne.21668; CASTEN LA, 1988, J IMMUNOL, V140, P404; Cepok S, 2005, BRAIN, V128, P1667, DOI 10.1093/brain/awh486; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; Glatigny S, 2016, J IMMUNOL, V196, P3542, DOI 10.4049/jimmunol.1502614; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Harp CRP, 2015, J IMMUNOL, V194, P5077, DOI 10.4049/jimmunol.1402236; Harp CT, 2008, CLIN IMMUNOL, V128, P382, DOI 10.1016/j.clim.2008.05.002; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Ilyas AA, 2003, J NEUROIMMUNOL, V139, P76, DOI 10.1016/S0165-5728(03)00131-0; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Krishnamoorthy G, 2006, J CLIN INVEST, V116, P2385, DOI 10.1172/JCI28330; Kuerten S, 2012, ACTA NEUROPATHOL, V124, P861, DOI 10.1007/s00401-012-1023-3; Lambracht-Washington D, 2007, J NEUROIMMUNOL, V186, P164, DOI 10.1016/j.jneuroim.2007.03.002; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Lehmann-Horn K, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000212; Lehmann-Horn K, 2015, ANN NEUROL, V77, P902, DOI 10.1002/ana.24387; Li R, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00626; Li R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab4176; Lisak RP, 2017, J NEUROIMMUNOL, V309, P88, DOI 10.1016/j.jneuroim.2017.05.004; Lyons JA, 1999, EUR J IMMUNOL, V29, P3432, DOI 10.1002/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2; Magliozzi R, 2004, J NEUROIMMUNOL, V148, P11, DOI 10.1016/j.jneuroim.2003.10.056; Matyszak MK, 1997, ADV EXP MED BIOL, V417, P295; Molnarfi N, 2013, J EXP MED, V210, P2921, DOI 10.1084/jem.20130699; Oliver AR, 2003, J IMMUNOL, V171, P462, DOI 10.4049/jimmunol.171.1.462; Palanichamy A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008930; Petereit HF, 2008, ACTA NEUROL SCAND, V117, P399, DOI 10.1111/j.1600-0404.2007.00958.x; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Pierson ER, 2014, J IMMUNOL, V192, P929, DOI 10.4049/jimmunol.1302171; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Rangachari M, 2013, J AUTOIMMUN, V45, P31, DOI 10.1016/j.jaut.2013.06.008; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Steinman L, 2003, J EXP MED, V197, P1065, DOI 10.1084/jem.20030320; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Stern JNH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008879; Tesfagiorgis Y, 2017, J IMMUNOL, V199, P449, DOI 10.4049/jimmunol.1602042; von Budingen HC, 2012, J CLIN INVEST, V122, P4533, DOI 10.1172/JCI63842; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Wu GF, 2011, J AUTOIMMUN, V36, P56, DOI 10.1016/j.jaut.2010.10.006; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501	52	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199694	10.1371/journal.pone.0199694	http://dx.doi.org/10.1371/journal.pone.0199694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944721	Green Published, gold, Green Submitted			2022-12-26	WOS:000436377800055
J	Rossitto, M; Marchive, C; Pruvost, A; Sellem, E; Ghettas, A; Badiou, S; Sutra, T; Poulat, F; Philibert, P; Boizet-Bonhoure, B				Rossitto, Moira; Marchive, Candice; Pruvost, Alain; Sellem, Eli; Ghettas, Aurelie; Badiou, Stephanie; Sutra, Thibault; Poulat, Francis; Philibert, Pascal; Boizet-Bonhoure, Brigitte			Intergenerational effects on mouse sperm quality after in utero exposure to acetaminophen and ibuprofen	FASEB JOURNAL			English	Article						NSAID; analgesic; germ cell; differentiation; sperm parameters	GERM-CELL DIFFERENTIATION; MALE REPRODUCTIVE DISORDERS; DNA METHYLATION; SERTOLI-CELLS; LEYDIG-CELL; ANDROGEN RECEPTOR; INTRAUTERINE EXPOSURE; ANOGENITAL DISTANCE; MILD ANALGESICS; READ ALIGNMENT	Nonsteroidal antiinflammatory drugs and analgesic drugs, such as N-acetyl-p-aminophenol (APAP; acetaminophen, paracetamol), are widely used by pregnant women. Accumulating evidence has indicated that these molecules can favor genital malformations in newborn boys and reproductive disorders in adults. However, the consequences on postnatal testis development and adult reproductive health after exposure during early embryogenesis are still unknown. Using the mouse model, we show that in utero exposure to therapeutic doses of the widely used APAP-ibuprofen combination during the sex determination period leads to early differentiation and decreased proliferation of male embryonic germ cells, and early 5-methylcytosine and extracellular matrix protein deposition in 13.5 d postcoitum exposed testes. Consequently, in postnatal testes, Sertoli-cell maturation is delayed, the Leydig-cell compartment is hyperplasic, and the spermatogonia A pool is decreased. This results in a reduced production of testosterone and in epididymal sperm parameter defects. We observed a reduced sperm count (19%) in utero-exposed (F0) adult males and also a reduced sperm motility (40%) in their offspring (F1) when both parents were exposed, which leads to subfertility among the 6 mo old F1 animals. Our study suggests that the use of these drugs during the critical period of sex determination affects the germ-line development and leads to adverse effects that could be passed to the offspring.Rossitto, M., Marchive, C., Pruvost, A., Sellem, E., Ghettas, A., Badiou, S., Sutra, T., Poulat, F., Philibert, P., Boizet-Bonhoure, B. Intergenerational effects on mouse sperm quality after in utero exposure to acetaminophen and ibuprofen.	[Rossitto, Moira; Marchive, Candice; Poulat, Francis; Philibert, Pascal; Boizet-Bonhoure, Brigitte] Univ Montpellier, CNRS, Inst Human Genet, Montpellier, France; [Pruvost, Alain; Ghettas, Aurelie] Univ Paris Saclay, INRA, CEA, Small Mol Anal Mass Spectrometry SMArt MS,SPI, Gif Sur Yvette, France; [Sellem, Eli] INRA Domaine Vilvert, Res & Dev Dept, Allice, Biol Reprod, Jouy En Josas, France; [Badiou, Stephanie; Sutra, Thibault; Philibert, Pascal] CHU Montpellier, Hop Lapeyronie, Dept Biochim & Hormonol, Montpellier, France; [Badiou, Stephanie; Sutra, Thibault; Philibert, Pascal] Univ Montpellier, CNRS, INSERM,Unite 1046, PhyMedExp,Unit Mixte Rech UMR 9214, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Boizet-Bonhoure, B (corresponding author), Univ Montpellier, CNRS, Inst Human Genet, UMR9002, 141 Rue Cardonille, F-34396 Montpellier 5, France.	brigitte.boizet@igh.cnrs.fr	POULAT, FRANCIS/AAV-2170-2020; Philibert, Pascal/C-6728-2008	POULAT, FRANCIS/0000-0003-2070-1296; Philibert, Pascal/0000-0001-6384-521X; Sellem, Eliaou/0000-0001-9251-9077; PRUVOST, ALAIN/0000-0002-7781-7735	Centre National de la Recherche Scientifique (CNRS), the University of Montpellier; National Agency for the Safety of Health Products (ANSM) [2013-041]	Centre National de la Recherche Scientifique (CNRS), the University of Montpellier; National Agency for the Safety of Health Products (ANSM)	The authors thank J. Cau, M.-P. Blanchard, and A. Sarrazin (Institute of Human Genetics Imaging Facility, MRI Montpellier, University of Montpellier) for their help in microscopy and FACS analysis, and N. Pirot and F. Bernex (Reseau d'Histologie de Montpellier, University of Montpellier) for advice on histology staining and analysis. The authors thank the staff of the Institute of Human Genetics Animal Care Facility. The authors also thank N. di Clemente (University of Paris Diderot) for providing antibody against Amh/Mis, and Veronique Vidal and Yannick Lopez (Helixio, groupe Hybrigenics, Saint-Beauzire, France) for providing RNA-seq data. The authors are grateful to D. Giorgi for critical reading of the report and P. Clair (qPCR platform, Biocampus Montpellier) for advice on statistical analysis. This study was supported by the Centre National de la Recherche Scientifique (CNRS), the University of Montpellier, and by National Agency for the Safety of Health Products (ANSM) Grant 2013-041. The authors declare no conflicts of interest.	Albert O, 2013, HUM REPROD, V28, P1890, DOI 10.1093/humrep/det112; Axelstad M, 2014, REPRODUCTION, V147, P489, DOI 10.1530/REP-13-0447; Barrios F, 2010, J CELL SCI, V123, P871, DOI 10.1242/jcs.057968; Ben Maamar M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44184; Bhagwat S, 2014, FERTIL STERIL, V101, P95, DOI 10.1016/j.fertnstert.2013.09.016; Boissonnas CC, 2013, FERTIL STERIL, V99, P624, DOI 10.1016/j.fertnstert.2013.01.124; Cejvanovic V, 2014, SCAND J RHEUMATOL, V43, P424, DOI 10.3109/03009742.2014.902099; Cha YI, 2006, DEV BIOL, V289, P263, DOI 10.1016/j.ydbio.2005.10.013; Chakraborty P, 2014, STEM CELLS, V32, P860, DOI 10.1002/stem.1584; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen SR, 2015, REPRODUCTION, V149, pR159, DOI 10.1530/REP-14-0481; CHIABRANDO C, 1992, BIOCHIM BIOPHYS ACTA, V1133, P247, DOI 10.1016/0167-4889(92)90044-C; Cui XR, 2016, EXP THER MED, V12, P1973, DOI 10.3892/etm.2016.3569; Dean A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19789; Dierkes G, 2014, INT J HYG ENVIR HEAL, V217, P592, DOI 10.1016/j.ijheh.2013.11.005; Fortier MA, 2008, J PHYSIOL PHARMACOL, V59, P65; Frungieri MB, 2015, REPRODUCTION, V149, pR169, DOI 10.1530/REP-14-0392; Gallavan RH, 1999, REPROD TOXICOL, V13, P383, DOI 10.1016/S0890-6238(99)00036-2; Georg I, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101907; Gromoll J, 1996, J CLIN ENDOCR METAB, V81, P1367, DOI 10.1210/jc.81.4.1367; GUPTA C, 1986, P NATL ACAD SCI USA, V83, P4346, DOI 10.1073/pnas.83.12.4346; Hammoud SS, 2014, CELL STEM CELL, V15, P239, DOI 10.1016/j.stem.2014.04.006; Hammoud SS, 2010, FERTIL STERIL, V94, P1728, DOI 10.1016/j.fertnstert.2009.09.010; Helliwell RJA, 2004, PROSTAG LEUKOTR ESS, V70, P101, DOI 10.1016/j.plefa.2003.04.002; Henckel A, 2012, EMBO J, V31, P606, DOI 10.1038/emboj.2011.425; Holm JB, 2016, TOXICOL SCI, V150, P178, DOI 10.1093/toxsci/kfv332; Holm JB, 2015, TOXICOL SCI, V148, P288, DOI 10.1093/toxsci/kfv179; Ikegami K, 2010, CELL STRUCT FUNCT, V35, P15, DOI 10.1247/csf.09027; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Jorgensen N, 2016, HUM REPROD, V31, P947, DOI 10.1093/humrep/dew021; Kelsey G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0336; Kilcoyne KR, 2014, P NATL ACAD SCI USA, V111, pE1924, DOI 10.1073/pnas.1320735111; Kristensen DM, 2012, INT J ANDROL, V35, P377, DOI 10.1111/j.1365-2605.2012.01282.x; Kristensen DM, 2016, NAT REV ENDOCRINOL, V12, P381, DOI 10.1038/nrendo.2016.55; Kristensen DM, 2018, P NATL ACAD SCI USA, V115, pE715, DOI 10.1073/pnas.1715035115; Kristensen DM, 2011, HUM REPROD, V26, P235, DOI 10.1093/humrep/deq323; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leverrier-Penna S., HUM REPROD; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lind DV, 2017, HUM REPROD, V32, P223, DOI 10.1093/humrep/dew285; Lindemann CB, 2016, CYTOSKELETON, V73, P652, DOI 10.1002/cm.21338; Main KM, 2010, BEST PRACT RES CL EN, V24, P279, DOI 10.1016/j.beem.2009.10.003; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Marques CJ, 2011, EPIGENETICS-US, V6, P1354, DOI 10.4161/epi.6.11.17993; Mazaud-Guittot S, 2013, J CLIN ENDOCR METAB, V98, pE1757, DOI 10.1210/jc.2013-2531; McGill MR, 2012, TOXICOL APPL PHARM, V264, P387, DOI 10.1016/j.taap.2012.08.015; McKenna L, 2006, J ADV NURS, V56, P636, DOI 10.1111/j.1365-2648.2006.04037.x; Moniot B, 2014, DEVELOPMENT, V141, P3561, DOI 10.1242/dev.103408; Moniot B, 2011, DEV DYNAM, V240, P2335, DOI 10.1002/dvdy.22726; Moniot B, 2009, DEVELOPMENT, V136, P1813, DOI 10.1242/dev.032631; Naga Rani M A, 1989, J Indian Med Assoc, V87, P182; Ng JH, 2013, DEV CELL, V24, P324, DOI 10.1016/j.devcel.2012.12.011; Notarnicola C, 2006, GENE EXPR PATTERNS, V6, P695, DOI 10.1016/j.modgep.2006.01.001; O'Donnell L., 2014, SPERMATOGENESIS, V4, pe979623, DOI [10.4161/21565562.2014.979623, DOI 10.4161/21565562.2014.979623]; O'Hara L, 2015, BEST PRACT RES CL EN, V29, P595, DOI 10.1016/j.beem.2015.04.006; Oakes CC, 2007, DEV BIOL, V307, P368, DOI 10.1016/j.ydbio.2007.05.002; Oduwole OO, 2018, J CLIN INVEST, V128, P1787, DOI 10.1172/JCI96794; Oh CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107577; Parab S, 2015, CELL TISSUE RES, V359, P665, DOI 10.1007/s00441-014-2039-x; Prescott LF, 2000, BRIT J CLIN PHARMACO, V49, P291, DOI 10.1046/j.1365-2125.2000.00167.x; Rahmoun M, 2017, NUCLEIC ACIDS RES, V45, P7191, DOI 10.1093/nar/gkx328; Rajender S, 2011, MUTAT RES-REV MUTAT, V727, P62, DOI 10.1016/j.mrrev.2011.04.002; Ratnasooriya WD, 2000, ASIAN J ANDROL, V2, P247; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rebourcet D, 2014, DEVELOPMENT, V141, P2139, DOI 10.1242/dev.107029; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Rossitto M, 2015, SEMIN CELL DEV BIOL, V45, P84, DOI 10.1016/j.semcdb.2015.09.014; Rossitto M, 2015, REPRODUCTION, V149, pR49, DOI 10.1530/REP-14-0381; Schmahl J, 2004, DEVELOPMENT, V131, P3627, DOI 10.1242/dev.01239; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Semet M, 2017, ANDROLOGY-US, V5, P640, DOI 10.1111/andr.12366; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Shirakata Y, 2014, J REPROD DEVELOP, V60, P383, DOI 10.1262/jrd.2014-018; Siu SSN, 2000, HUM REPROD, V15, P2423, DOI 10.1093/humrep/15.11.2423; Skakkebaek NE, 2016, PHYSIOL REV, V96, P55, DOI 10.1152/physrev.00017.2015; Smarr MM, 2017, ANDROLOGY-US, V5, P1082, DOI 10.1111/andr.12413; Spiller CM, 2012, DEVELOPMENT, V139, P4123, DOI 10.1242/dev.083006; Stutz G, 2000, ARCH ANDROLOGY, V44, P117; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; TRAN D, 1987, J HISTOCHEM CYTOCHEM, V35, P733, DOI 10.1177/35.7.3295030; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tseng YT, 2015, REPRODUCTION, V150, pR77, DOI 10.1530/REP-14-0679; van den Driesche S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4097; Wakui S, 2014, TOXICOL PATHOL, V42, P877, DOI 10.1177/0192623313502879; Wang RS, 2006, ENDOCRINOLOGY, V147, P5624, DOI 10.1210/en.2006-0138; Wei YC, 2015, HUM REPROD UPDATE, V21, P194, DOI 10.1093/humupd/dmu061; Werler MM, 2005, AM J OBSTET GYNECOL, V193, P771, DOI 10.1016/j.ajog.2005.02.100; Wermann H, 2010, J PATHOL, V221, P433, DOI 10.1002/path.2725; Western PS, 2010, FASEB J, V24, P3026, DOI 10.1096/fj.09-151555; Yano CL, 2002, CONTRACEPTION, V66, P463, DOI 10.1016/S0010-7824(02)00407-9	93	13	13	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					339	357		10.1096/fj.201800488RRR	http://dx.doi.org/10.1096/fj.201800488RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29979629	Green Submitted			2022-12-26	WOS:000457401500028
J	Ye, CJ; Yu, ZL; Xiong, YW; Wang, Y; Ruan, YN; Guo, YP; Chen, MM; Luan, SL; Zhang, EL; Liu, HB				Ye, Chengjin; Yu, Zhaoli; Xiong, Yiwei; Wang, Yu; Ruan, Yina; Guo, Yueping; Chen, Mianmian; Luan, Shilu; Zhang, Enli; Liu, Hebin			STAU1 binds to IBDV genomic double-stranded RNA and promotes viral replication via attenuation of MDA5-dependent interferon induction	FASEB JOURNAL			English	Article						RNA-binding protein; innate antiviral response; RIG-I-like receptors	BURSAL DISEASE VIRUS; PROTEIN-KINASE PKR; RIG-I; STRESS GRANULES; INNATE IMMUNITY; NUCLEOTIDE-SEQUENCE; ANTIVIRAL RESPONSE; SEGMENT-A; STAUFEN1; MDA5	Infectious bursal disease virus (IBDV) infection triggers the induction of type I IFN, which is mediated by melanoma differentiation-associated protein 5 recognition of the viral genomic double-stranded RNA (dsRNA). However, the mechanism of IBDV overcoming the type I IFN antiviral response remains poorly characterized. Here, we show that IBDV genomic dsRNA selectively binds to the host cellular RNA binding protein Staufen1 (STAU1) in vitro and in vivo. The viral dsRNA binding region was mapped to the N-terminal moiety of STAU1 (residues 1-468). Down-regulation of STAU1 impaired IBDV replication and enhanced IFN- transcription in response to IBDV infection, while having little effect on the viral attachment to the host cells and cellular entry. Conversely, overexpression of STAU1 but not the IBDV dsRNA-binding deficient STAU1 mutant (469-702) led to a suppression of IBDV dsRNA-induced IFN- promoter activity. Moreover, we found that the binding of STAU1 to IBDV dsRNA decreased the association of melanoma differentiation-associated protein 5 but not VP3 with the IBDV dsRNA in vitro. Finally, we showed that STAU1 and VP3 suppressed IFN- gene transcription in response to IBDV infection in an additive manner. Collectively, these findings provide a novel insight into the evasive strategies used by IBDV to escape the host IFN antiviral response.Ye, C., Yu, Z., Xiong, Y., Wang, Y., Ruan, Y., Guo, Y., Chen, M., Luan, S., Zhang, E., Liu, H. STAU1 binds to IBDV genomic double-stranded RNA and promotes viral replication via attenuation of MDA5-dependent interferon induction.	[Ye, Chengjin; Yu, Zhaoli; Wang, Yu; Ruan, Yina; Guo, Yueping; Chen, Mianmian; Luan, Shilu; Zhang, Enli; Liu, Hebin] Zhejiang A&F Univ, Dept Vet Med, Coll Anim Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Xiong, Yiwei; Liu, Hebin] Xian Jiaotong Liverpool Univ, Dept Biol Sci, Suzhou, Peoples R China	Zhejiang A&F University; Xi'an Jiaotong-Liverpool University	Liu, HB (corresponding author), Zhejiang A&F Univ, 666 Wusu St, Hangzhou 311300, Zhejiang, Peoples R China.	hb1liu@foxmail.com			Natural Scientific Foundation of Zhejiang Province [LY18C180002]; China Postdoctoral Science Foundation [2017M621977]; National Natural Science Foundation of China [31470840, 31502061]; Science and Technology Foundation of Jiangsu province [BK20131181]; ZAFU Research and Development Fund [2014FR019, 2015FR008]	Natural Scientific Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Jiangsu province; ZAFU Research and Development Fund	This work was supported by the Natural Scientific Foundation of Zhejiang Province (LY18C180002), the China Postdoctoral Science Foundation (2017M621977), the National Natural Science Foundation of China (31470840 and 31502061), the Science and Technology Foundation of Jiangsu province (BK20131181), and the ZAFU Research and Development Fund (2014FR019 and 2015FR008). The authors declare no conflicts of interest.	Abrahamyan LG, 2010, J CELL SCI, V123, P369, DOI 10.1242/jcs.055897; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Blackham SL, 2013, J GEN VIROL, V94, P2429, DOI 10.1099/vir.0.051383-0; Boot HJ, 2000, J VIROL METHODS, V84, P49, DOI 10.1016/S0166-0934(99)00132-9; Busnadiego I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046768; Chatel-Chaix L, 2004, MOL CELL BIOL, V24, P2637, DOI 10.1128/MCB.24.7.2637-2648.2004; Chatel-Chaix L, 2007, J VIROL, V81, P6216, DOI 10.1128/JVI.00284-07; Claudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80; Cubas-Gaona LL, 2018, J VIROL, V92, DOI [10.1128/JVI.00364-18, 10.1128/jvi.00364-18]; de Lucas S, 2010, J VIROL, V84, P7603, DOI 10.1128/JVI.00504-10; Dixit U, 2016, NUCLEIC ACIDS RES, V44, P5271, DOI 10.1093/nar/gkw312; Eldaghayes I, 2006, VIRAL IMMUNOL, V19, P83, DOI 10.1089/vim.2006.19.83; Ferrero D, 2015, J VIROL, V89, P11165, DOI 10.1128/JVI.00218-15; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Thomas MG, 2009, J CELL SCI, V122, P563, DOI 10.1242/jcs.038208; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Hayashi T, 2014, J INNATE IMMUN, V6, P58, DOI 10.1159/000351583; Karpala AJ, 2011, J IMMUNOL, V186, P5397, DOI 10.4049/jimmunol.1003712; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KIBENGE FSB, 1990, J GEN VIROL, V71, P569, DOI 10.1099/0022-1317-71-3-569; Kim MY, 2014, NUCLEIC ACIDS RES, V42, P6999, DOI 10.1093/nar/gku388; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Lee CC, 2006, J STRUCT BIOL, V155, P74, DOI 10.1016/j.jsb.2006.02.014; Lee CC, 2014, ARCH VIROL, V159, P1671, DOI 10.1007/s00705-014-1983-9; Lee JH, 2011, BIOCHEM BIOPH RES CO, V414, P153, DOI 10.1016/j.bbrc.2011.09.042; Li Y, 2012, P NATL ACAD SCI USA, V109, P11770, DOI 10.1073/pnas.1203405109; Li ZH, 2013, J VIROL, V87, P1221, DOI 10.1128/JVI.02421-12; Lombardo E, 1999, J VIROL, V73, P6973, DOI 10.1128/JVI.73.8.6973-6983.1999; Lombardo E, 2000, VIROLOGY, V277, P345, DOI 10.1006/viro.2000.0595; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; Mendez F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123470; Milev MP, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-41; Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000; Ona A, 2004, VIROLOGY, V322, P135, DOI 10.1016/j.virol.2004.01.025; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sharma JM, 2000, DEV COMP IMMUNOL, V24, P223, DOI 10.1016/S0145-305X(99)00074-9; Smith Geoffrey L., 1994, Trends in Microbiology, V2, P81, DOI 10.1016/0966-842X(94)90539-8; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; SPIES U, 1989, NUCLEIC ACIDS RES, V17, P7982, DOI 10.1093/nar/17.19.7982; Tacken MGJ, 2002, J VIROL, V76, P11301, DOI 10.1128/JVI.76.22.11301-11311.2002; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Vessey JP, 2008, P NATL ACAD SCI USA, V105, P16374, DOI 10.1073/pnas.0804583105; von Einem UI, 2004, J GEN VIROL, V85, P2221, DOI 10.1099/vir.0.19772-0; Ye C., 2017, J VIROL, V91; Ye CJ, 2018, J VIROL, V92, DOI 10.1128/JVI.01345-17; Ye CJ, 2014, J VIROL, V88, P11154, DOI 10.1128/JVI.01115-14; Yu L, 2001, AVIAN DIS, V45, P862, DOI 10.2307/1592866	58	16	17	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					286	300		10.1096/fj.201800062RR	http://dx.doi.org/10.1096/fj.201800062RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29979632				2022-12-26	WOS:000457401500024
J	Hodgkinson, K; Forrest, LA; Vuong, N; Garson, K; Djordjevic, B; Vanderhyden, BC				Hodgkinson, Kendra; Forrest, Laura A.; Nhung Vuong; Garson, Kenneth; Djordjevic, Bojana; Vanderhyden, Barbara C.			GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer	ONCOGENE			English	Article							MESENCHYMAL TRANSITION; PI3K/AKT PATHWAY; E-CADHERIN; GROWTH; ALPHA; 17-BETA-ESTRADIOL; INVASION; ACTIVATION; TARGETS; CELLS	Estrogenic hormone replacement therapy increases the risk of developing ovarian cancer, and estrogen promotes tumour initiation and growth in mouse models of this disease. GREB1 (Growth regulation by estrogen in breast cancer 1) is an ESR1 (estrogen receptor 1)-upregulated protein which may mediate estrogen action. GREB1 knockdown prevents hormone-driven proliferation of several breast and prostate cancer cell lines and prolongs survival of mice engrafted with ovarian cancer cells, but its mechanism of action remains unclear. In this study, we explored GREB1 function in ovarian cancer. GREB1 overexpression in ovarian cancer cell lines increased cell proliferation and migration and promoted a mesenchymal morphology associated with increased Col1a2, which encodes a collagen I subunit. GREB1 knockdown inhibited proliferation and promoted an epithelial morphology associated with decreased Col1a2. In human tissues, GREB1 was expressed in all ESR1-expressing tissues throughout the normal female reproductive tract, in addition to several tissues that did not show ESR1 expression. In a TMA of ovarian cancer cases, GREB1 was expressed in 75-85% of serous, endometrioid, mucinous, and clear cell carcinomas. Serous, endometrioid, and mucinous ovarian cancers were almost always positive for either ESR1 or GREB1, suggesting a possible reliance on signalling through ESR1 and/or GREB1. Targeting GREB1 may inhibit tumour-promoting pathways both downstream and independent of ESR1 and is therefore a possible treatment strategy worthy of further investigation.	[Hodgkinson, Kendra; Forrest, Laura A.; Nhung Vuong; Garson, Kenneth; Vanderhyden, Barbara C.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Hodgkinson, Kendra; Forrest, Laura A.; Nhung Vuong; Garson, Kenneth; Vanderhyden, Barbara C.] Ottawa Hosp, Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [Djordjevic, Bojana] Univ Ottawa, Ottawa Hosp, Dept Pathol & Lab Med, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Vanderhyden, BC (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.; Vanderhyden, BC (corresponding author), Ottawa Hosp, Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada.	bvanderhyden@ohri.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank Dr. Kenneth S. Korach for kindly providing us with his conditional ESR1-deletion mice (30). We also thank the tissue donors and their families, who made this research possible. This work was supported by a grant from the Canadian Institutes of Health Research (BCV), a donation from The Carol Annibale Ovarian Cancer Foundation, Ontario Graduate Scholarships (to K.H., N.V.), and a Queen Elizabeth II Graduate Scholarship in Science and Technology (to K.H.).	Allred DC, 2010, MODERN PATHOL, V23, pS52, DOI 10.1038/modpathol.2010.55; Armaiz-Pena GN, 2009, CLIN CANCER RES, V15, P2971, DOI 10.1158/1078-0432.CCR-08-2525; Brodeur AC, 2017, INT J NEPHROL RENOV, V10, P251, DOI 10.2147/IJNRD.S141393; Cardenas H, 2014, EPIGENETICS-US, V9, P1461, DOI 10.4161/15592294.2014.971608; Cheng JC, 2011, CANCER LETT, V304, P107, DOI 10.1016/j.canlet.2011.02.008; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; Ding JX, 2006, GYNECOL ONCOL, V103, P623, DOI 10.1016/j.ygyno.2006.04.023; Ebell MH, 2016, AM J PREV MED, V50, P384, DOI 10.1016/j.amepre.2015.09.023; Gamwell LF, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100347; Gapstur SM, 2015, LANCET, V385, P1835, DOI 10.1016/S0140-6736(14)61687-1; Gershenson DM, 2017, J CLIN ONCOL, V35, P1103, DOI 10.1200/JCO.2016.71.0632; Ghosh MG, 2000, CANCER RES, V60, P6367; Gupta PB, 2007, CANCER RES, V67, P2062, DOI 10.1158/0008-5472.CAN-06-3895; Haakensen VD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-332; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Hnatyszyn HJ, 2010, BREAST CANCER RES TR, V122, P371, DOI 10.1007/s10549-009-0584-x; Hua KQ, 2008, INT J ONCOL, V33, P959, DOI 10.3892/ijo_00000083; Laviolette LA, 2014, INT J CANCER, V135, P1072, DOI 10.1002/ijc.28741; Laviolette LA, 2010, ENDOCRINOLOGY, V151, P929, DOI 10.1210/en.2009-0602; Lee Kyu-Sup, 1992, Kurume Medical Journal, V39, P285; Lim D, 2013, PATHOLOGY, V45, P229, DOI 10.1097/PAT.0b013e32835f2264; Lippman Marc E, 2008, Trans Am Clin Climatol Assoc, V119, P77; Lu ZY, 2014, MOL MED REP, V10, P2433, DOI 10.3892/mmr.2014.2561; Mabuchi S, 2015, GYNECOL ONCOL, V137, P173, DOI 10.1016/j.ygyno.2015.02.003; McCloskey CW, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00053; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Mori Y, 2008, EXP CELL RES, V314, P1094, DOI 10.1016/j.yexcr.2007.12.010; Mullany LK, 2014, MOL ENDOCRINOL, V28, P127, DOI 10.1210/me.2013-1308; Okano K, 2012, MOL CELL BIOCHEM, V369, P247, DOI 10.1007/s11010-012-1388-6; Pellegrini C, 2012, FERTIL STERIL, V98, P1200, DOI 10.1016/j.fertnstert.2012.06.056; Rae JM, 2006, PROSTATE, V66, P886, DOI 10.1002/pros.20403; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Ribeiro JR, 2014, J STEROID BIOCHEM, V143, P160, DOI 10.1016/j.jsbmb.2014.02.010; SAWADA M, 1990, INT J CANCER, V45, P359, DOI 10.1002/ijc.2910450225; Shu DY, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20611; Spillman MA, 2010, CANCER RES, V70, P8927, DOI 10.1158/0008-5472.CAN-10-1238; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Sundar S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4443; Tan S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3644; Welboren WJ, 2009, ENDOCR-RELAT CANCER, V16, P1073, DOI 10.1677/ERC-09-0086; Yan Y, 2013, MOL CELL BIOCHEM, V378, P1, DOI 10.1007/s11010-013-1579-9	42	35	37	3	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 1	2018	37	44					5873	5886		10.1038/s41388-018-0377-y	http://dx.doi.org/10.1038/s41388-018-0377-y			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GY9EX	29973689	Green Published, hybrid			2022-12-26	WOS:000448943100005
J	Golfmann, K; Meder, L; Koker, M; Volz, C; Borchmann, S; Tharun, L; Dietlein, F; Malchers, F; Florin, A; Buttner, R; Rosen, N; Rodrik-Outmezguine, V; Hallek, M; Ullrich, RT				Golfmann, Kristina; Meder, Lydia; Koker, Mirjam; Volz, Caroline; Borchmann, Sven; Tharun, Lars; Dietlein, Felix; Malchers, Florian; Florin, Alexandra; Buettner, Reinhard; Rosen, Neal; Rodrik-Outmezguine, Vanessa; Hallek, Michael; Ullrich, Roland T.			Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer	ONCOGENE			English	Article							ACQUIRED-RESISTANCE; CARCINOMA-CELLS; GROWTH; RECEPTOR; ACTIVATION; SURVIVAL; BGJ398; TUMORS; AKT	FGFR1 amplification has been found in 15% of patients with breast cancer and has been postulated as a promising marker to predict response against FGFR inhibitors. However, early phase clinical trials of selective FGFR inhibitors demonstrated only limited efficacy in FGFR1-amplified breast cancer patients. We found that BGJ398, an FGFR inhibitor, effectively inhibited phosphorylation of FGFR1 and MEK/ERK signaling in FGFR1-amplified breast cancer without affecting tumor cell proliferation. However, FGFR1 knockout inhibited tumor angiogenesis in vivo. We unraveled that FGFR1 regulates the secretion of the proangiogenic vascular endothelial growth factor (VEGF) in a MAPK-dependent manner. We further found that FGF-FGFR1 signaling induces an autocrine activation of VEGF-VEGFR1 pathway that again amplifies VEGF secretion via VEGF-VEGFR1-AKT signaling. Targeting both VEGFR1 and FGFR1 resulted in synergistic anti-angiogenic treatment effects in vivo. We thus postulate synergistic treatment effects in FGFR1/VEGFR1-positive breast cancer patients by dual targeting of FGFR and VEGFR.	[Golfmann, Kristina; Meder, Lydia; Koker, Mirjam; Volz, Caroline; Borchmann, Sven; Hallek, Michael; Ullrich, Roland T.] Univ Hosp Cologne, Dept Internal Med 1, Kerpener Str 62, D-50937 Cologne, Germany; [Golfmann, Kristina; Meder, Lydia; Koker, Mirjam; Volz, Caroline; Borchmann, Sven; Buettner, Reinhard; Hallek, Michael; Ullrich, Roland T.] Univ Cologne, Ctr Mol Med Cologne, Robert Koch Str 21, D-50931 Cologne, Germany; [Borchmann, Sven] Univ Hosp Cologne, Dept Internal Med 1, German Hodgkin Study Grp, Kerpener Str 62, D-50937 Cologne, Germany; [Borchmann, Sven; Dietlein, Felix] Univ Hosp Cologne, Else Kroner Forsch Kolleg Clonal Evolut Canc, D-50931 Cologne, Germany; [Tharun, Lars; Florin, Alexandra; Buettner, Reinhard] Univ Hosp Cologne, Inst Pathol, Kerpener Str 62, D-50937 Cologne, Germany; [Dietlein, Felix] Dana Faber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Dietlein, Felix] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Malchers, Florian] Univ Hosp Cologne, Dept Translat Genom, Weyertal 115b, D-50931 Cologne, Germany; [Malchers, Florian; Hallek, Michael; Ullrich, Roland T.] Univ Hosp Cologne, Ctr Integrated Oncol Cologne Bonn, Kerpener Str 62, D-50937 Cologne, Germany; [Rosen, Neal; Rodrik-Outmezguine, Vanessa] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, 1275 York Ave, New York, NY 10021 USA	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Cologne; University of Cologne; Memorial Sloan Kettering Cancer Center	Ullrich, RT (corresponding author), Univ Hosp Cologne, Dept Internal Med 1, Kerpener Str 62, D-50937 Cologne, Germany.; Ullrich, RT (corresponding author), Univ Cologne, Ctr Mol Med Cologne, Robert Koch Str 21, D-50931 Cologne, Germany.; Ullrich, RT (corresponding author), Univ Hosp Cologne, Ctr Integrated Oncol Cologne Bonn, Kerpener Str 62, D-50937 Cologne, Germany.	roland.ullrich@uk-koeln.de	Hallek, Michael/Y-3191-2019; Borchmann, Sven/ABB-5244-2021; Rosen, Neal/ABF-2677-2020	Hallek, Michael/0000-0002-7425-4455; Borchmann, Sven/0000-0001-6662-6864; Malchers, Florian/0000-0002-3443-4419; Meder, Lydia/0000-0002-9547-5812	Thyssen Foundation [10.16.1.028MN]; Nachwuchsforschungsgruppen-NRW [1411ng005]; Deutsche Forschungsgemeinschaft (DFG) [UL379/1-1]; Deutsche Krebshilfe [70113009]	Thyssen Foundation; Nachwuchsforschungsgruppen-NRW; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Thyssen Foundation (Grant No.: 10.16.1.028MN to RTU), by the Nachwuchsforschungsgruppen-NRW (Grant No.: 1411ng005 to RTU), by the Deutsche Forschungsgemeinschaft (DFG) (Grant No.: UL379/1-1 to RTU) and by the Deutsche Krebshilfe (Grant No.: 70113009 to RTU).	Andre F, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.tps1134; Andre F, 2015, BREAST CANCER RES TR, V150, P1, DOI 10.1007/s10549-015-3301-y; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Dales JP, 2003, ANN PATHOL, V23, P297; Datta J, 2017, MOL CANCER THER, V16, P614, DOI 10.1158/1535-7163.MCT-15-1010; Goyal L, 2017, CANCER DISCOV, V7, P252, DOI 10.1158/2159-8290.CD-16-1000; Helsten T, 2016, CLIN CANCER RES, V22, P259, DOI 10.1158/1078-0432.CCR-14-3212; Herrera-Abreu MT, 2013, CANCER DISCOV, V3, P1058, DOI 10.1158/2159-8290.CD-12-0569; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kopetz S, 2010, J CLIN ONCOL, V28, P453, DOI 10.1200/JCO.2009.24.8252; Kut C, 2007, BRIT J CANCER, V97, P978, DOI 10.1038/sj.bjc.6603923; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Malchers F, 2017, CLIN CANCER RES, V23, P5527, DOI 10.1158/1078-0432.CCR-17-0478; Malchers F, 2014, CANCER DISCOV, V4, P246, DOI 10.1158/2159-8290.CD-13-0323; Musolino A, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0807-8; Mylona E, 2007, GYNECOL ONCOL, V104, P557, DOI 10.1016/j.ygyno.2006.09.031; Nogova L, 2017, J CLIN ONCOL, V35, P157, DOI 10.1200/JCO.2016.67.2048; Ocana A, 2017, ONCOTARGET, V8, P22218, DOI 10.18632/oncotarget.14731; Packer LM, 2017, MOL CANCER THER, V16, P637, DOI 10.1158/1535-7163.MCT-16-0415; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Terry S, 2015, ONCOTARGET, V6, P11994, DOI 10.18632/oncotarget.2740; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wu Y, 2006, INT J CANCER, V119, P1519, DOI 10.1002/ijc.21865	25	23	24	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 18	2018	37	42					5682	5693		10.1038/s41388-018-0380-3	http://dx.doi.org/10.1038/s41388-018-0380-3			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX3JJ	29970903				2022-12-26	WOS:000447619100007
J	Mary, C; Fouillen, A; Bessette, B; Nanci, A; Baron, C				Mary, Charline; Fouillen, Aurelien; Bessette, Benoit; Nanci, Antonio; Baron, Christian			Interaction via the N terminus of the type IV secretion system (T4SS) protein VirB6 with VirB10 is required for VirB2 and VirB5 incorporation into T-pili and for T4SS function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; protein secretion; virulence factor; bacterial pathogenesis; bacteria; Agrobacterium tumefaciens; protein-protein interaction; T-pilus; type IV secretion system; virulence	CORE COMPONENT VIRB8; INCN PLASMID PKM101; AGROBACTERIUM-TUMEFACIENS; DNA SUBSTRATE; PERIPLASMIC DOMAIN; MACHINERY; APPARATUS; MEMBRANES; PATHWAY; BIOLOGY	Many bacterial pathogens employ multicomponent protein complexes such as type IV secretion systems (T4SSs) to transfer virulence factors into host cells. Here we studied the interaction between two essential T4SS components: the very hydrophobic inner membrane protein VirB6, which may be a component of the translocation channel, and VirB10, which links the inner and outer bacterial membranes. To map the interaction site between these two T4SS components, we conducted alanine scanning and deleted six-amino acid stretches from the N-terminal periplasmic domain of VirB6 from Brucella suis. Using the bacterial two-hybrid system to analyze the effects of these alterations on the VirB6-VirB10 interaction, we identified the amino acid regions 16-21 and 28-33 and Leu-18 in VirB6 as being required for this interaction. SDS-PAGE coupled with Western blotting of cell lysates and native PAGE of detergent-extracted membrane proteins revealed that the corresponding VirB6 residues in Agrobacterium tumefaciens (Phe-20 and amino acids 18-23 and 30-35) modulate the stability of both VirB6 and VirB5. However, the results from immuno-EM and super-resolution microscopy suggested that these regions and residues are not required for membrane association or for polar localization of VirB6. The six-amino acid deletions in the N terminus of VirB6 abolished pilus formation and virulence of A. tumefaciens, and the corresponding deletions in the VirB6 homolog TraD from the plasmid pKM101-T4SS abrogated plasmid transfer. Our results indicate that specific residues of the VirB6 N-terminal domain are required for VirB6 stabilization, its interaction with VirB10, and the incorporation of VirB2 and VirB5 into T-pili.	[Mary, Charline; Fouillen, Aurelien; Bessette, Benoit; Nanci, Antonio; Baron, Christian] Univ Montreal, Fac Med, Dept Biochem & Mol Med, Pavillon Roger Gaudry,CP 6128,CP 6128, Montreal, PQ H3C 3J7, Canada; [Fouillen, Aurelien; Nanci, Antonio] Univ Montreal, Fac Dent Med, Dept Stomatol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Baron, C (corresponding author), Univ Montreal, Fac Med, Dept Biochem & Mol Med, Pavillon Roger Gaudry,CP 6128,CP 6128, Montreal, PQ H3C 3J7, Canada.	christian.baron@umontreal.ca	Fouillen, Aurelien/P-7002-2019	Fouillen, Aurelien/0000-0002-0326-9932; Mary, Charline/0000-0003-3056-8839; Nanci, Antonio/0000-0003-0616-843X; Baron, Christian/0000-0002-0132-2111	Canadian Institutes of Health Research [MOP-84239]; NSERC-CREATE program on the Cellular Dynamics of Macromolecular Complexes; Canada Foundation for Innovation; Fonds de recherche du Quebec-Sante; Canada Research Chair in Calcified Tissues, Biomaterials, and Structural Imaging	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NSERC-CREATE program on the Cellular Dynamics of Macromolecular Complexes; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Canada Research Chair in Calcified Tissues, Biomaterials, and Structural Imaging	This work was supported by grants from the Canadian Institutes of Health Research (MOP-84239 to C.B.), the NSERC-CREATE program on the Cellular Dynamics of Macromolecular Complexes (to C.B.), the Canada Foundation for Innovation, and the Fonds de recherche du Quebec-Sante (to C.B.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Canada Research Chair in Calcified Tissues, Biomaterials, and Structural Imaging.	Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Banta LM, 2011, J BACTERIOL, V193, P2566, DOI 10.1128/JB.00038-11; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Cascales E, 2013, J BACTERIOL, V195, P2691, DOI 10.1128/JB.00114-13; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Giraldo AMV, 2015, FEBS LETT, V589, P1883, DOI 10.1016/j.febslet.2015.05.051; Giraldo AMV, 2012, BIOCHEMISTRY-US, V51, P3881, DOI 10.1021/bi300298v; Gordon JE, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0010-2013; Hapfelmeier S, 2000, J BACTERIOL, V182, P4505, DOI 10.1128/JB.182.16.4505-4511.2000; Jakubowski SJ, 2009, MOL MICROBIOL, V71, P779, DOI 10.1111/j.1365-2958.2008.06565.x; Jakubowski SJ, 2004, J MOL BIOL, V341, P961, DOI 10.1016/j.jmb.2004.06.052; Jakubowski SJ, 2003, J BACTERIOL, V185, P2867, DOI 10.1128/JB.185.9.2867-2878.2003; Judd PK, 2005, P NATL ACAD SCI USA, V102, P11498, DOI 10.1073/pnas.0505290102; Judd PK, 2005, MOL MICROBIOL, V55, P115, DOI 10.1111/j.1365-2958.2004.04378.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; LANGER PJ, 1981, MOL GEN GENET, V182, P268, DOI 10.1007/BF00269669; Low HH, 2014, NATURE, V508, P550, DOI 10.1038/nature13081; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Paschos A, 2011, INFECT IMMUN, V79, P1033, DOI 10.1128/IAI.00993-10; Redzej A, 2017, EMBO J, V36, P3080, DOI 10.15252/embj.201796629; Sagulenko E, 2001, J BACTERIOL, V183, P5813, DOI 10.1128/JB.183.20.5813-5825.2001; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P5563, DOI 10.1128/JB.181.18.5563-5571.1999; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P7485, DOI 10.1128/JB.181.24.7485-7492.1999; Sharifahmadian M, 2017, FEBS LETT, V591, P2491, DOI 10.1002/1873-3468.12770; Sivanesan D, 2010, BIOCHEMISTRY-US, V49, P4483, DOI 10.1021/bi902201y; THORSTENSON YR, 1993, J BACTERIOL, V175, P5233, DOI 10.1128/JB.175.16.5233-5241.1993; Trokter M, 2014, CURR OPIN STRUC BIOL, V27, P16, DOI 10.1016/j.sbi.2014.02.006; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; VAN LAREBEKE N, 1974, NATURE, V252, P169, DOI 10.1038/252169a0; WINANS SC, 1985, J BACTERIOL, V161, P402, DOI 10.1128/JB.161.1.402-410.1985; Yuan Q, 2005, J BIOL CHEM, V280, P26349, DOI 10.1074/jbc.M502347200; ZINONI F, 1990, P NATL ACAD SCI USA, V87, P4660, DOI 10.1073/pnas.87.12.4660; Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x	38	6	8	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13415	13426		10.1074/jbc.RA118.002751	http://dx.doi.org/10.1074/jbc.RA118.002751			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29976757	Green Published, hybrid			2022-12-26	WOS:000443375500006
J	Jamsheer, KM; Shukla, BN; Jindal, S; Gopan, N; Mannully, CT; Laxmi, A				Jamsheer, Muhammed K.; Shukla, Brihaspati N.; Jindal, Sunita; Gopan, Nandu; Mannully, Chanchal Thomas; Laxmi, Ashverya			The FCS-like zinc finger scaffold of the kinase SnRK1 is formed by the coordinated actions of the FLZ domain and intrinsically disordered regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PHOSPHORYLATION; HUMAN INTERACTOME; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; BINDING REGIONS; LAND PLANTS; LIFE-SPAN; EVOLUTION; AMPK; SEQUENCE	The SNF1-related protein kinase 1 (SnRK1) is a heterotrimeric eukaryotic kinase that interacts with diverse proteins and regulates their activity in response to starvation and stress signals. Recently, the FCS-like zinc finger (FLZ) proteins were identified as a potential scaffold for SnRK1 in plants. However, the evolutionary and mechanistic aspect of this complex formation is currently unknown. Here, in silico analyses predicted that FLZ proteins possess conserved intrinsically disordered regions (IDRs) with a propensity for protein binding in the N and C termini across the plant lineage. We observed that the Arabidopsis FLZ proteins promiscuously interact with SnRK1 subunits, which formed different isoenzyme complexes. The FLZ domain was essential for mediating the interaction with SnRK1 alpha subunits, whereas the IDRs in the N termini facilitated interactions with the beta and beta gamma subunits of SnRK1. Furthermore, the IDRs in the N termini were important for mediating dimerization of different FLZ proteins. Of note, the interaction of FLZ with SnRK1 was confined to cytoplasmic foci, which colocalized with the endoplasmic reticulum. An evolutionary analysis revealed that in general, the IDR-rich regions are under more relaxed selection than the FLZ domain. In summary, the findings in our study reveal the structural details, origin, and evolution of a land plant-specific scaffold of SnRK1 formed by the coordinated actions of IDRs and structured regions in the FLZ, proteins. We propose that the FLZ, protein complex might be involved in providing flexibility, thus enhancing the binding repertoire of the SnRK1 hub in land plants.	[Jamsheer, Muhammed K.; Shukla, Brihaspati N.; Jindal, Sunita; Mannully, Chanchal Thomas; Laxmi, Ashverya] Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi 110067, India; [Gopan, Nandu] Jawaharial Nehru Ctr Adv Sci Res, Jakkur 560064, Bengaluru, India; [Mannully, Chanchal Thomas] Vellore Inst Technol, Vellore 632014, Tamil Nadu, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Vellore Institute of Technology	Laxmi, A (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi 110067, India.	ashverya_laxmi@nipgr.ac.in	Jindal, Sunita/AAO-5556-2020	Gopan, Nandu/0000-0002-7227-3441; Jindal, Sunita/0000-0002-0318-2204; Jamsheer K, Muhammed/0000-0002-2135-8760	Department of Biotechnology, Government of India [BT/PR8001/BRB/10/1211/2013, BT/PR12855/BPA/118/87/2015]; National Institute of Plant Genome Research; University Grants Commission, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Institute of Plant Genome Research; University Grants Commission, Government of India(University Grants Commission, India)	This work was supported in part by Project Grant BT/PR8001/BRB/10/1211/2013 from the Department of Biotechnology, Government of India, and a Core Grant from the National Institute of Plant Genome Research. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a research fellowship from the University Grants Commission, Government of India.; Recipients of research fellowships from the National Institute of Plant Genome Research.; Recipient of Research Fellowship BT/PR12855/BPA/118/87/2015 from the Project Grant from the Department of Biotechnology, Government of India.	Afek A, 2011, J MOL BIOL, V409, P439, DOI 10.1016/j.jmb.2011.03.056; Ahrens J, 2016, MOL BIOL EVOL, V33, P2248, DOI 10.1093/molbev/msw092; Ahrens JB, 2017, CELL MOL LIFE SCI, V74, P3163, DOI 10.1007/s00018-017-2559-0; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Bitrian M, 2011, PLANT J, V65, P829, DOI 10.1111/j.1365-313X.2010.04462.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bowman JL, 2017, CELL, V171, P287, DOI 10.1016/j.cell.2017.09.030; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Broeckx T, 2016, J EXP BOT, V67, P6215, DOI 10.1093/jxb/erw416; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Chen XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067120; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Cumberworth A, 2013, BIOCHEM J, V454, P361, DOI 10.1042/BJ20130545; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dobrenel T, 2016, ANNU REV PLANT BIOL, V67, P261, DOI 10.1146/annurev-arplant-043014-114648; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Emanuelle S, 2015, PLANT J, V82, P183, DOI 10.1111/tpj.12813; Erce MA, 2013, MOL CELL PROTEOMICS, V12, P3184, DOI 10.1074/mcp.M113.031500; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Gao JJ, 2012, BIOCOMPUT-PAC SYM, P94; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Glab N, 2017, PLANT J, V89, P1031, DOI 10.1111/tpj.13445; Goldstein RA, 2008, CURR OPIN STRUC BIOL, V18, P170, DOI 10.1016/j.sbi.2008.01.006; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harper TM, 2018, J BIOL CHEM, V293, P13778, DOI 10.1074/jbc.R117.794438; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; He YH, 2004, PLANT MOL BIOL, V54, P1, DOI 10.1023/B:PLAN.0000028730.10834.e3; Heilbronn LK, 2005, PLOS MED, V2, P721, DOI 10.1371/journal.pmed.0020231; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; Hou XN, 2013, PLANT MOL BIOL REP, V31, P791, DOI 10.1007/s11105-012-0549-9; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Hu JF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004508; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jamsheer KM, 2018, PLANT J, V94, P232, DOI 10.1111/tpj.13854; Jamsheer KM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00746; Jamsheer KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134328; Jamsheer KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099074; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Kato H, 2018, J EXP BOT, V69, P291, DOI 10.1093/jxb/erx267; Kramer EM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00869; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Li A, 2006, BIOCHEM BIOPH RES CO, V350, P818, DOI 10.1016/j.bbrc.2006.08.199; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malhis N, 2015, BIOINFORMATICS, V31, P1738, DOI 10.1093/bioinformatics/btv060; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Minina EA, 2013, AGING CELL, V12, P327, DOI 10.1111/acel.12048; Nagulapalli M, 2016, NUCLEIC ACIDS RES, V44, P1591, DOI 10.1093/nar/gkv1135; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nietzsche M, 2016, CURR PLANT BIOL, V5, P36, DOI 10.1016/j.cpb.2015.10.004; Nietzsche M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00054; Nukarinen E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31697; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Peng ZL, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv585; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Ramon M, 2013, PLANT J, V75, P11, DOI 10.1111/tpj.12192; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Roustan V, 2016, J EXP BOT, V67, P3897, DOI 10.1093/jxb/erw211; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schaefer C, 2010, BIOINFORMATICS, V26, P625, DOI 10.1093/bioinformatics/btq012; Schepetilnikov M, 2013, EMBO J, V32, P1087, DOI 10.1038/emboj.2013.61; Sharifpoor S, 2012, GENOME RES, V22, P791, DOI 10.1101/gr.129213.111; Shaw AJ, 2011, AM J BOT, V98, P352, DOI 10.3732/ajb.1000316; Shi SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038772; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Toth-Petroczy A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000243; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Winter DL, 2015, PROTEOMICS, V15, P2166, DOI 10.1002/pmic.201400521; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yan J, 2016, MOL BIOSYST, V12, P697, DOI 10.1039/c5mb00640f; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	88	20	37	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13134	13150		10.1074/jbc.RA118.002073	http://dx.doi.org/10.1074/jbc.RA118.002073			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29945970	Green Published, hybrid			2022-12-26	WOS:000442730200014
J	Santa, JD; Berdugo-Cely, J; Cely-Pardo, L; Soto-Suarez, M; Mosquera, T; Galeano, CH				David Santa, Juan; Berdugo-Cely, Jhon; Cely-Pardo, Liliana; Soto-Suarez, Mauricio; Mosquera, Teresa; Galeano M, Carlos H.			QTL analysis reveals quantitative resistant loci for Phytophthora infestans and Tecia solanivora in tetraploid potato (Solanum tuberosum L.)	PLOS ONE			English	Article							LATE BLIGHT RESISTANCE; LINKAGE ANALYSIS; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; THEORETICAL BASIS; ABC TRANSPORTERS; FIELD-RESISTANCE; TRAIT LOCI; AUXIN	Late blight and Guatemalan potato tuber moth caused by Phytophthora infestans and Tecia solanivora, respectively, are major phytosanitary problems on potato crops in Colombia and Ecuador. Hence, the development of resistant cultivars is an alternative for their control. However, breeding initiatives for durable resistance using molecular tools are limited due to the genome complexity and high heterozygosity in autotetraploid potatoes. To contribute to a better understanding of the genetic basis underlying the resistance to P. infestans and T. solanivora in potato, the aim of this study was to identify QTLs for resistance to P. infestans and T. solanivora using a F1 tetraploid potato segregant population for both traits. Ninetyfour individuals comprised this population. Parent genotypes and their progeny were genotyped using SOLCAP 12K potato array. Forty-five percent of the markers were polymorphic. A genetic linkage map was built with a length of 968.4 cM and 1,287 SNPs showing good distribution across the genome. Severity and incidence were evaluated in two crop cycles for two years. QTL analysis revealed six QTLs linked to P. infestans, four of these related to previous QTLs reported, and two novel QTLs (qrAUDPC-3 and qrAUDPC-8). Fifteen QTLs were linked to T. solanivora, being qIPC-6 and qOPA-6.1, and qIPC-10 and qIPC-10.1 stable in two different trials. This study is one of the first to identify QTLs for T. solanivora. As the population employed is a breeding population, results will contribute significantly to breeding programs to select resistant plant material, especially in countries where P. infestans and T. solanivora limit potato production.	[David Santa, Juan; Berdugo-Cely, Jhon; Cely-Pardo, Liliana; Soto-Suarez, Mauricio] Corp Colombiana Invest Agr AGROSAVIA, Ci Tibaitata, Cundinamarca, Colombia; [David Santa, Juan; Mosquera, Teresa] Univ Nacl Colombia, Fac Agr Sci, Bogota, Colombia; [Galeano M, Carlos H.] Corp Colombiana Invest Agr AGROSAVIA, Ci Palmira, Valle Del Cauca, Colombia	Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Universidad Nacional de Colombia; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA	Galeano, CH (corresponding author), Corp Colombiana Invest Agr AGROSAVIA, Ci Palmira, Valle Del Cauca, Colombia.	cgaleano@corpoica.org.co		Cely-Pardo, Nubia Liliana/0000-0001-9948-9798; Berdugo, Jhon/0000-0003-4124-9243; Soto-Suarez, Mauricio/0000-0002-2392-2839; Galeano Mendoza, Carlos Hernando/0000-0002-5801-2421; Berdugo-Cely, Jhon A./0000-0002-2675-0462	Corporacion Colombiana de Investigacion Agropecuaria (Corpoica); Colombian Ministry of Agriculture and Rural Development (MADR)	Corporacion Colombiana de Investigacion Agropecuaria (Corpoica); Colombian Ministry of Agriculture and Rural Development (MADR)	This study was financed by Corporacion Colombiana de Investigacion Agropecuaria (Corpoica), and the Colombian Ministry of Agriculture and Rural Development (MADR).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; [Anonymous], 2005, EPPO B, V35, P399; Arias R, 1997, SEM EXP AV MAN POL G; Arora R. K., 2014, Potato Journal, V41, P16; Ballvora A, 2002, PLANT J, V30, P361, DOI 10.1046/j.1365-313X.2001.01292.x; Benavides M, 2000, PAPAS COLOMBIANAS, V2, P62; Berdugo-Cely J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173039; Bienert MD, 2012, PLANT J, V72, P745, DOI 10.1111/j.1365-313X.2012.05108.x; Birhman RK, 1995, ANN APPL BIOL, V127, P353, DOI 10.1111/j.1744-7348.1995.tb06679.x; Bormann CA, 2004, MOL PLANT MICROBE IN, V17, P1126, DOI 10.1094/MPMI.2004.17.10.1126; Bosa CF, 2005, ENTOMOL EXP APPL, V114, P137, DOI 10.1111/j.1570-7458.2005.00252.x; Bourke PM, 2015, GENETICS, V115; Bradeen J, 2017, GENETICS GENOMICS BR; Brigneti G, 2004, PLANT J, V39, P264, DOI 10.1111/j.1365-313X.2004.02122.x; Broman KW, 2009, STAT BIOL HEALTH, P135, DOI 10.1007/978-0-387-92125-9_5; Brouwer DJ, 2004, GENOME, V47, P475, DOI 10.1139/G04-001; Bryan GJ, 2004, MOL BREEDING, V14, P105, DOI 10.1023/B:MOLB.0000037999.13581.9c; Butler NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144591; Cadena Marleny, 2005, Agron. colomb., V23, P112; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chen WX, 2016, J EXP BOT, V67, P4979, DOI 10.1093/jxb/erw263; Collins A, 1999, MOL BREEDING, V5, P387, DOI 10.1023/A:1009601427062; Costanzo S, 2004, PLANT BREEDING, V123, P377, DOI 10.1111/j.1439-0523.2004.00999.x; Cui FH, 2013, PLANT PHYSIOL, V162, P1018, DOI 10.1104/pp.113.219659; da Silva W, 2017, G3-GENES GENOM GENET, Vg3; Danan S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-16; DeYoung BJ, 2001, PLANT MOL BIOL, V46, P505, DOI 10.1023/A:1010672910703; Erb M, 2009, PLANT J, V59, P292, DOI 10.1111/j.1365-313X.2009.03868.x; Falconer D. S., 1996, Introduction to quantitative genetics.; Fedepapa, 1998, TECHNICAL REPORTS; Bosa CF, 2011, REV COLOMB ENTOMOL, V37, P1; Forbes G, 2014, MODULO; Fowden M, 1984, MEJORAMIENTO PLANTAS, DOI [10.1111/j.1365-313X.2009.03868.x, DOI 10.1111/J.1365-313X.2009.03868.X]; Fry WE, 2015, PHYTOPATHOLOGY, V105, P966, DOI 10.1094/PHYTO-01-15-0005-FI; Fry WE, 2016, ANNU REV PHYTOPATHOL, V54, P529, DOI 10.1146/annurev-phyto-080615-095951; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Gebhardt C, 2001, ANNU REV PHYTOPATHOL, V39, P79, DOI 10.1146/annurev.phyto.39.1.79; Gebhardt C, 2016, THEOR APPL GENET, V129, P2281, DOI 10.1007/s00122-016-2804-1; Goff KE, 2007, GENE REGUL SYST BIO, V1, P167; Gupta S, 2012, PLOS ONE, V7; Hackett CA, 1998, GENET RES, V71, P143, DOI 10.1017/S0016672398003188; Hackett CA, 2017, J HERED, V108, P438, DOI 10.1093/jhered/esx022; Hackett CA, 2014, THEOR APPL GENET, V127, P1885, DOI 10.1007/s00122-014-2347-2; Hackett CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063939; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Hwang JU, 2016, MOL PLANT, V9, P338, DOI 10.1016/j.molp.2016.02.003; Itkin M, 2013, SCIENCE, V341, P175, DOI 10.1126/science.1240230; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; Karlsson MF, 2017, CHEMOECOLOGY, V27, P187, DOI 10.1007/s00049-017-0244-2; Kloosterman B, 2013, NATURE, V495, P246, DOI 10.1038/nature11912; Kolliopoulou A, 2014, CURR OPIN INSECT SCI, V6, P28, DOI 10.1016/j.cois.2014.09.019; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kretzschmar T, 2011, ESSAYS BIOCHEM, V50, P145, DOI [10.1042/BSE0500145, 10.1042/bse0500145]; Kumar P, 2016, OECOLOGIA, V182, P177, DOI 10.1007/s00442-016-3633-2; La Camera S, 2011, PLANT J, V68, P507, DOI 10.1111/j.1365-313X.2011.04706.x; LEONARDSSCHIPPERS C, 1994, GENETICS, V137, P67; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Liu Z, 2015, PLANT PHYSIOL, V167, P1659, DOI 10.1104/pp.15.00053; Llorente F, 2008, MOL PLANT, V1, P496, DOI 10.1093/mp/ssn025; Luo ZW, 2000, THEOR APPL GENET, V100, P1067, DOI 10.1007/s001220051388; Luo ZW, 2004, P NATL ACAD SCI USA, V101, P7040, DOI 10.1073/pnas.0304482101; Manrique-Carpintero NC, 2014, THEOR APPL GENET, V127, P391, DOI 10.1007/s00122-013-2226-2; Massa AN, 2015, G3-GENES GENOM GENET, V5, P2357, DOI 10.1534/g3.115.019646; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Mosquera T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156254; Mullner D, 2013, J STAT SOFTW, V53, P1; Nustez C, VARIEDADES COLOMBIAN; Oberhagemann P, 1999, MOL BREEDING, V5, P399, DOI 10.1023/A:1009623212180; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; ORTIZ R, 1990, EUPHYTICA, V50, P119, DOI 10.1007/BF00023634; Pan SQ, 2000, PLANT CELL, V12, P125, DOI 10.1105/tpc.12.1.125; Piisila E M, 2015, BMC PLANT BIOL, V15, DOI [10.1186/s12870-014-0394-0, DOI 10.1186/S12870-014-0394-0]; PNRT INIAP, 1997, ANN REPORT; Poveda K, 2012, ENTOMOL EXP APPL, V143, P245, DOI 10.1111/j.1570-7458.2012.01256.x; Preedy KF, 2016, THEOR APPL GENET, V129, P2117, DOI 10.1007/s00122-016-2761-8; Quattrocchio F, 2006, PLANT CELL, V18, P1274, DOI 10.1105/tpc.105.034041; R Development Core Team R. R, 2011, R FDN STAT COMP, V1; Ramakrishnan AP, 2015, AM J POTATO RES, V92, P455, DOI 10.1007/s12230-015-9455-7; Richter R, 2013, P NATL ACAD SCI USA, V110, P13192, DOI 10.1073/pnas.1304250110; Rodríguez Luis Ernesto, 2010, Agron. colomb., V28, P9; Rodriguez T, 2016, BIOCH GENETICS MOL B; Schonhals EM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3979-9; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sharma SK, 2013, G3-GENES GENOM GENET, V3, P2031, DOI 10.1534/g3.113.007153; Simko I, 2002, AM J POTATO RES, V79, P125, DOI 10.1007/BF02881521; SINDEN SL, 1980, AM POTATO J, V57, P331, DOI 10.1007/BF02854028; Sliwka J, 2007, THEOR APPL GENET, V115, P101, DOI 10.1007/s00122-007-0546-9; Spooner DM, 2016, J SYST EVOL, V54, P191, DOI 10.1111/jse.12203; Strauss SY, 2003, ECOLOGY, V84, P2074, DOI 10.1890/02-0267; Sukhotu T, 2006, GENOME, V49, P636, DOI 10.1139/G06-014; Tan MYA, 2010, THEOR APPL GENET, V121, P117, DOI 10.1007/s00122-010-1295-8; Torres F, 1998, BIOL MANEJO INTEGRAD; Vales MI, 2005, THEOR APPL GENET, V111, P1260, DOI 10.1007/s00122-005-0043-y; Valkonen JPT, 1996, CRIT REV PLANT SCI, V15, P1, DOI 10.1080/713608127; Vert G, 2008, P NATL ACAD SCI USA, V105, P9829, DOI 10.1073/pnas.0803996105; Villanueva D, 2013, ING CIENC, V9; Visker MHPW, 2003, THEOR APPL GENET, V106, P317, DOI 10.1007/s00122-002-1021-2; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Voorrips RE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-172; Vos PG, 2015, THEOR APPL GENET, V128, P2387, DOI 10.1007/s00122-015-2593-y; Wang SL, 2015, PLANT CELL REP, V34, P1459, DOI 10.1007/s00299-015-1800-2; Xu F, 2014, BRIEF BIOINFORM, V15, P1044, DOI 10.1093/bib/bbt073; Xu SZ, 2003, GENETICS, V165, P2259; Xu YX, 2016, PLANT PHYSIOL BIOCH, V98, P46, DOI 10.1016/j.plaphy.2015.11.014; Yao CP, 2012, PLANT J, V71, P1015, DOI 10.1111/j.1365-313X.2012.05048.x; Yogendra KN, 2014, FUNCT INTEGR GENOMIC, V14, P285, DOI 10.1007/s10142-013-0358-8	106	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199716	10.1371/journal.pone.0199716	http://dx.doi.org/10.1371/journal.pone.0199716			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979690	Green Published, gold, Green Submitted			2022-12-26	WOS:000437809500029
J	Mejia, OAV; Antunes, MJ; Goncharov, M; Dallan, LRP; Veronese, E; Lapenna, GA; Lisboa, LAF; Dallan, LAO; Brandao, CMA; Zubelli, J; Tarasoutchi, F; Pomerantzeff, PMA; Jatene, FB				Mejia, Omar A. V.; Antunes, Manuel J.; Goncharov, Maxim; Dallan, Luis R. P.; Veronese, Elinthon; Lapenna, Gisele A.; Lisboa, Luiz A. F.; Dallan, Luis A. O.; Brandao, Carlos M. A.; Zubelli, Jorge; Tarasoutchi, Flavio; Pomerantzeff, Pablo M. A.; Jatene, Fabio B.			Predictive performance of six mortality risk scores and the development of a novel model in a prospective cohort of patients undergoing valve surgery secondary to rheumatic fever	PLOS ONE			English	Article							LEFT ATRIAL SIZE; OPERATIVE MORTALITY; HOSPITAL MORTALITY; CARDIAC-SURGERY; HEART-SURGERY; EUROSCORE; DISEASE; REPLACEMENT; CANDIDATE; OUTCOMES	Background Mortality prediction after cardiac procedures is an essential tool in clinical decision making. Although rheumatic cardiac disease remains a major cause of heart surgery in the world no previous study validated risk scores in a sample exclusively with this condition. Objectives Develop a novel predictive model focused on mortality prediction among patients undergoing cardiac surgery secondary to rheumatic valve conditions. Methods We conducted prospective consecutive all-comers patients with rheumatic heart disease (RHD) referred for surgical treatment of valve disease between May 2010 and July of 2015. Risk scores for hospital mortality were calculated using the 2000 Bernstein-Parsonnet, EuroSCORE II, InsCor, AmblerSCORE, GuaragnaSCORE, and the New York SCORE. In addition, we developed the rheumatic heart valve surgery score (RheSCORE). Results A total of 2,919 RHD patients underwent heart valve surgery. After evaluating 13 different models, the top performing areas under the curve were achieved using Random Forest (0.982) and Neural Network (0.952). Most influential predictors across all models included left atrium size, high creatinine values, a tricuspid procedure, reoperation and pulmonary hypertension. Areas under the curve for previously developed scores were all below the performance for the RheSCORE model: 2000 Bernstein-Parsonnet (0.876), EuroSCORE II (0.857), InsCor (0.835), Ambler (0.831), Guaragna (0.816) and the New York score (0.834). A web application is presented where researchers and providers can calculate predicted mortality based on the RheSCORE. Conclusions The RheSCORE model outperformed pre-existing scores in a sample of patients with rheumatic cardiac disease.	[Mejia, Omar A. V.; Goncharov, Maxim; Dallan, Luis R. P.; Veronese, Elinthon; Lapenna, Gisele A.; Lisboa, Luiz A. F.; Dallan, Luis A. O.; Brandao, Carlos M. A.; Pomerantzeff, Pablo M. A.; Jatene, Fabio B.] Univ Sao Paulo, Dept Thorac & Cardiovasc Surg, Inst Heart, Med Ctr, Sao Paulo, Brazil; [Antunes, Manuel J.] Univ Hosp, Ctr Cardiothorac Surg, Coimbra, Portugal; [Antunes, Manuel J.] Fac Med, Coimbra, Portugal; [Zubelli, Jorge] Natl Inst Pure & Appl Math, Rio De Janeiro, RJ, Brazil; [Tarasoutchi, Flavio] Univ Sao Paulo, Dept Clin Unit Heart Valve Dis, Inst Heart, Med Ctr, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Universidade de Sao Paulo	Mejia, OAV (corresponding author), Univ Sao Paulo, Dept Thorac & Cardiovasc Surg, Inst Heart, Med Ctr, Sao Paulo, Brazil.	omar.mejia@incor.usp.br	Zubelli, Jorge P/B-6166-2008; de Almeida Brandão, Carlos Manuel/H-5208-2013; LISBOA, LUIZ AUGUSTO F./E-1162-2012; Zubelli, Jorge/AAA-1468-2022; Zubelli, Jorge/GVU-6903-2022; Veronese, Elinthon T/AAR-9786-2020; Dallan, Luis A.O/I-2728-2013	Zubelli, Jorge P/0000-0003-1581-9505; LISBOA, LUIZ AUGUSTO F./0000-0002-2137-0604; Zubelli, Jorge/0000-0003-1581-9505; Veronese, Elinthon T/0000-0001-5468-053X; dallan, luis alberto/0000-0002-8655-8966				Ambler G, 2005, CIRCULATION, V112, P224, DOI 10.1161/CIRCULATIONAHA.104.515049; Sa MPBD, 2012, REV BRAS CIR CARDIOV, V27, P1, DOI 10.5935/1678-9741.20120003; Bernstein AD, 2000, ANN THORAC SURG, V69; Brandao CMD, 2002, EUR J CARDIO-THORAC, V22, P922; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; COHN LH, 1982, CIRCULATION, V66, P153; De Bacco G, 2008, REV BRAS CIR CARDIOV, V23, P336, DOI 10.1590/S0102-76382008000300009; Dillon J, 2015, J THORAC CARDIOV SUR, V149, P771, DOI 10.1016/j.jtcvs.2014.08.066; Finucane K, 2013, GLOB HEART, V8, P213, DOI 10.1016/j.gheart.2013.08.010; Guerino MT, 2011, VACCINE, V29, P8250, DOI 10.1016/j.vaccine.2011.08.113; Hannan EL, 2007, ANN THORAC SURG, V83, P921, DOI 10.1016/j.athoracsur.2006.09.051; Hickey GL, 2013, EUR J CARDIO-THORAC, V43, P1146, DOI 10.1093/ejcts/ezs584; Jones JM, 2001, J THORAC CARDIOV SUR, V122, P913, DOI 10.1067/mtc.2001.116470; McCarthy PM, 2004, J THORAC CARDIOV SUR, V127, P674, DOI 10.1016/j.jtcvs.2003.11.019; Meja OAV, 2013, ARQ BRAS CARDIOL, V100, P246, DOI 10.5935/abc.20130043; Nashef SA, 2012, EUR J CARDIO-THORAC; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; PARSONNET V, 1989, CIRCULATION, V79, P3; PIEHLER JM, 1995, J THORAC CARDIOV SUR, V109, P30, DOI 10.1016/S0022-5223(95)70418-3; Rankin JS, 2006, J THORAC CARDIOV SUR, V131, P547, DOI 10.1016/j.jtcvs.2005.10.041; REED D, 1991, CIRCULATION, V84, P23, DOI 10.1161/01.CIR.84.1.23; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Guaragna JCVD, 2010, ARQ BRAS CARDIOL, V94, P541, DOI 10.1590/S0066-782X2010005000026; Mejia OAV, 2011, REV BRAS CIR CARDIOV, V26, P1, DOI 10.1590/S0102-76382011000100004; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449	25	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199277	10.1371/journal.pone.0199277	http://dx.doi.org/10.1371/journal.pone.0199277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979692	Green Submitted, gold, Green Published			2022-12-26	WOS:000437809500011
J	Sierra-Arguello, YM; Furian, TQ; Perdoncini, G; Moraes, HLS; Salle, CTP; Rodrigues, LB; dos Santos, LR; Gomes, MJP; do Nascimento, VP				Sierra-Arguello, Yuli Melisa; Furian, Thales Quedi; Perdoncini, Gustavo; Moraes, Hamilton L. S.; Salle, Carlos T. P.; Rodrigues, Laura B.; dos Santos, Luciana Ruschel; Pereira Gomes, Marcos Jose; do Nascimento, Vladimir Pinheiro			Fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli from poultry and human samples assessed by PCR-restriction fragment length polymorphism assay	PLOS ONE			English	Article							MILLER-FISHER-SYNDROMES; GUILLAIN-BARRE; ANTIMICROBIAL RESISTANCE; ANIMALS; FOOD; SUSCEPTIBILITY; IDENTIFICATION; MUTATIONS; STRAINS; TRENDS	The objective of this study was to determine fluoroquinolone resistance in Campylobacter spp from poultry and human isolates. Forty-one Campylobacter jejuni isolates (30 of poultry origin and 11 of human origin) and 11 Campylobacter coli isolates (10 of human origin and 1 of poultry origin) were examined for ciprofloxacin, norfloxacin, and nalidixic acid resistance using the minimal inhibitory concentration (MIC) method. Thereafter, the isolates were analyzed by PCR-Restriction Fragment Length Polymorphism (RFLP) assay for detection of Thr-86 mutation. Finally, DNA sequencing was performed for confirmation of gyrA gene mutation. A complete correlation was observed between MICs, PCR-RFLP assay, and sequencing. The results revealed high quinolone resistance rates for C. jejuni (100%) and C. coli (100%) isolates obtained from poultry and moderate resistance for C. jejuni (9.1%) and C. coli (40%) samples of human origin. A mutation in codon 86 of the gyrA gene with a Thr-to-Ile substitution is reported to be the main cause of high resistance to quinolones. This mutation can be analyzed by PCR-RFLP assay, which has been proven to be a simple and fast method for the detection of fluoroquinolone resistance in Campylobacter spp.	[Sierra-Arguello, Yuli Melisa; Furian, Thales Quedi; Perdoncini, Gustavo; Moraes, Hamilton L. S.; Salle, Carlos T. P.; do Nascimento, Vladimir Pinheiro] Univ Fed Rio Grande do Sul, Fac Vet Med, Ctr Diag & Res Avian Pathol CDPA, Porto Alegre, RS, Brazil; [Pereira Gomes, Marcos Jose] Univ Fed Rio Grande do Sul, Fac Vet Med, Lab Vet Bacteriol, Porto Alegre, RS, Brazil; [Rodrigues, Laura B.; dos Santos, Luciana Ruschel] Univ Passo Fundo, Fac Vet Med, Passo Fundo, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade de Passo Fundo	Sierra-Arguello, YM (corresponding author), Univ Fed Rio Grande do Sul, Fac Vet Med, Ctr Diag & Res Avian Pathol CDPA, Porto Alegre, RS, Brazil.	yuli_melisasierra@yahoo.com	do Nascimento, Vladimir Pinheiro/G-5593-2012; Moraes, Hamilton L.S./B-5734-2014	do Nascimento, Vladimir Pinheiro/0000-0002-7720-3274; Sierra Arguello, Yuli Melisa/0000-0002-0439-0195	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [5772/109]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [578124/2008-4, 303086/2013-0, 476092/2013-2]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES): YMS - grant no. 5772/109 (http://www.capes.gov.br/) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq): VPN - grants no. 578124/2008-4, 303086/2013-0, and 476092/2013-2 (http://cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredson DA, 2007, FEMS MICROBIOL LETT, V277, P123, DOI 10.1111/j.1574-6968.2007.00935.x; Alonso R, 2004, ANTIMICROB AGENTS CH, V48, P4886, DOI 10.1128/AAC.48.12.4886-4888.2004; [Anonymous], 2006, 1027212006 ISO; [Anonymous], 2017, ANN REPORT; Bachoual R, 2001, MICROB DRUG RESIST, V7, P257, DOI 10.1089/10766290152652800; Borsoi A, 2009, POULTRY SCI, V88, P750, DOI 10.3382/ps.2008-00466; Bywater R, 2004, J ANTIMICROB CHEMOTH, V54, P744, DOI 10.1093/jac/dkh422; Clinical and Laboratory Standards Institute, 2010, M45A2 CLIN LAB STAT; Clinical and Laboratory Standards Institute, 2008, M31A3 CLIN LAB STAND; Crushell E, 2004, PEDIATR RES, V55, P3, DOI 10.1203/01.PDR.0000099794.06260.71; Denis M, 1999, LETT APPL MICROBIOL, V29, P406, DOI 10.1046/j.1472-765X.1999.00658.x; Doyle M., 2006, COMPR REV FOOD SCI F, V5, P71; El-Adawy H, 2012, AVIAN DIS, V56, P685, DOI 10.1637/10135-031912-Reg.1; Endtz HP, 2000, J CLIN MICROBIOL, V38, P2297; Ge BL, 2013, J MICROBIOL METH, V95, P57, DOI 10.1016/j.mimet.2013.06.021; Gibreel A, 1998, ANTIMICROB AGENTS CH, V42, P3276, DOI 10.1128/AAC.42.12.3276; Gilliss D, 2013, MMWR-MORBID MORTAL W, V62, P283; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Linton D, 1997, J CLIN MICROBIOL, V35, P2568, DOI 10.1128/JCM.35.10.2568-2572.1997; Luangtongkum T, 2012, ANTIMICROB AGENTS CH, V56, P1300, DOI 10.1128/AAC.05516-11; McDermott PF, 2002, J INFECT DIS, V185, P837, DOI 10.1086/339195; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; Moore JE, 2005, VET RES, V36, P351, DOI 10.1051/vetres:2005012; Piddock LJV, 2003, J ANTIMICROB CHEMOTH, V51, P19, DOI 10.1093/jac/dkg033; Pope JE, 2007, SEMIN ARTHRITIS RHEU, V37, P48, DOI 10.1016/j.semarthrit.2006.12.006; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121; Van Looveren M, 2001, J ANTIMICROB CHEMOTH, V48, P235, DOI 10.1093/jac/48.2.235; Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138; Wardak Sebastian, 2005, Medycyna Doswiadczalna i Mikrobiologia, V57, P295	30	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199974	10.1371/journal.pone.0199974	http://dx.doi.org/10.1371/journal.pone.0199974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979715	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500046
J	Souza-Shibatta, L; Tonini, JFR; Abrahao, VP; Jarduli, LR; Oliveira, C; Malabarba, LR; Sofia, SH; Shibatta, OA				Souza-Shibatta, Lenice; Tonini, Joao F. R.; Abrahao, Vitor P.; Jarduli, Lucas R.; Oliveira, Claudio; Malabarba, Luiz R.; Sofia, Silvia H.; Shibatta, Oscar A.			Reappraisal of the systematics of Microglanis cottoides (Siluriformes, Pseudopimelodidae), a catfish from southern Brazil	PLOS ONE			English	Article							FRESH-WATER FISHES; RIVER-BASIN; DNA BARCODE; GENUS; BIOGEOGRAPHY; TAXONOMY; PHYLOGEOGRAPHY; IDENTIFICATION; CHARACIFORMES; ICHTHYOFAUNA	The southern region of Brazil is characterized by high species diversity and endemism of freshwater fishes distributed across geographically isolated river basins. Microglanis cottoides has a widespread range across these river basins and occurs in sympatry with other endemic species of the genus (e.g. M. cibelae, M. eurystoma, and M. malabarbai). Herein we tested the monophyly of M. cottoides and presented for the first time information about the molecular phylogeny of species in the genus. The results suggest that M. cottoides currently forms a non-monophyletic group which includes populations endemic to the Uruguay River basin that are more closely related to M. malabarbai, and excludes M. cibelae, found to be nested within M. cottoides. Based on an integrative approach using morphological and molecular data, we propose M. cibelae as a junior synonym of M. cottoides, and the populations of the Uruguay River basin previously assigned to M. cottoides in fact belong to M. malabarbai. Our molecular phylogeny shows that M. cottoides is sister to M. parahybae, which is also a coastal species, and M. malabarbai is sister of M. garavelloi, both endemic to inland river basins. The time-calibrated phylogeny indicates that the separation between inland and the coastal clades occurred in the Tertiary period, and that the species within the coastal basins diverged in the Pliocene, which overlaps with the diversification times estimated for the two inland species as well. This pattern of diversification corroborates some previous studies with other fishes from the same region.	[Souza-Shibatta, Lenice; Sofia, Silvia H.] Univ Estadual Londrina, Dept Biol Geral, Lab Genet & Ecol Anim, Londrina, PR, Brazil; [Tonini, Joao F. R.] Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Abrahao, Vitor P.] Univ Sao Paulo, Museu Zool, Sao Paulo, SP, Brazil; [Jarduli, Lucas R.] Fac Integradas Ourinhos, Ourinhos, SP, Brazil; [Oliveira, Claudio] Univ Estadual Paulista UNESP, Inst Biociencias, Dept Morfol, Lab Biol & Genet Peixes, Botucatu, SP, Brazil; [Malabarba, Luiz R.] Univ Fed Rio Grande do Sul, Dept Zool, Porto Alegre, RS, Brazil; [Shibatta, Oscar A.] Univ Estadual Londrina, Dept Biol Anim & Vegetal, Londrina, PR, Brazil	Universidade Estadual de Londrina; Harvard University; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Federal do Rio Grande do Sul; Universidade Estadual de Londrina	Souza-Shibatta, L (corresponding author), Univ Estadual Londrina, Dept Biol Geral, Lab Genet & Ecol Anim, Londrina, PR, Brazil.	lenicesouza@hotmil.com	Malabarba, Luiz R/I-3225-2012; de Sá, Rafael/E-2924-2010; Sofia, Silvia/S-1925-2019; Sofia, Silvia H/C-9643-2013; Jarduli, Lucas Ribeiro/AAG-9834-2021; Shibatta, Oscar A/I-1392-2012; Oliveira, Claudio/D-7713-2012	Malabarba, Luiz R/0000-0002-9607-3735; de Sá, Rafael/0000-0002-4730-3805; Sofia, Silvia H/0000-0002-3443-0696; Jarduli, Lucas Ribeiro/0000-0002-5796-6434; Shibatta, Oscar A/0000-0003-2883-5934; Oliveira, Claudio/0000-0002-7010-8880; Abrahao, Vitor/0000-0002-6596-5079	Conselho Nacional Desenvovlvimento Cientifico Tecnologico (CNPq) [478336/2013-6]; Fundacao Araucaria [22633]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Harvard Open Access Equity Fund (HOPE)	Conselho Nacional Desenvovlvimento Cientifico Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Harvard Open Access Equity Fund (HOPE)	This study was funded by Conselho Nacional Desenvovlvimento Cientifico Tecnologico (CNPq, http://cnpq.br/ - proc.478336/2013-6), Fundacao Araucaria (http://www.fappr.pr.gov.br/,05/2011 Prot.: 22633), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and Harvard Open Access Equity Fund (HOPE, ttps://osc.hul.harvard.edu/programs/hope/) for the payment of publication fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; ABREU JGN, 2005, REV BRAS GEOFIS, V23, P123, DOI DOI 10.1590/S0102-261X2005000200002; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; [Anonymous], 2014, TRACER V1 6; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Ayala-Varela FP, 2014, AMPHIB REPTILE CONSE, V8; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bellafronte E, 2013, NEOTROP ICHTHYOL, V11, P497, DOI 10.1590/S1679-62252013000300003; Bertaco Vinicius A., 2005, Neotrop. ichthyol., V3, P61, DOI 10.1590/S1679-62252005000100002; Bizerril CRSF, 1994, ACTA BIOL LEOPOLDENS, V16, P51; Brigido MM, 1 INT C BIOINF COMP; Buckup PA, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P203; Camelier P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194247; Carvalho DC, 2011, MITOCHONDR DNA, V22, P97, DOI 10.3109/19401736.2011.588219; Ciccotto PJ, 2016, COPEIA, V104, P879, DOI 10.1643/CI-16-433; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Conti LA, 2009, BRAZ J OCEANOGR, V57, P113, DOI 10.1590/S1679-87592009000200004; Costa-Silva GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135075; Craw D, 2007, J GEOL SOC LONDON, V164, P785, DOI 10.1144/0016-76492006-064; Crawford AJ, 2013, MOL ECOL RESOUR, V13, P1005, DOI 10.1111/1755-0998.12054; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; dos Reis S.F., 1988, Revista Brasileira de Zoologia, V5, P571; Drummond A.J., 2015, BAYESIAN EVOLUTIONAR, DOI 10.1017/CBO9781139095112; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Eschmeyer W.N., 2017, SPECIES FISHES FAMIL; Frantine-Silva W, 2015, MOL ECOL RESOUR, V15, P1226, DOI 10.1111/1755-0998.12385; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gomes A. Lourenco, 1946, OCCAS PAPER MUS ZOOL UNIV MICHIGAN, V494, P1; Ruiz WBG, 2016, ICHTHYOL EXPLOR FRES, V27, P211; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hudson HD, 2010, PHYLOGENETIC NETWORK; Jarduli LR, 2013, NEOTROP ICHTHYOL, V11, P507, DOI 10.1590/S1679-62252013000300004; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kullander SO, 1983, REVISION S AM CICHIL; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Langeani F., 2007, BIOTA NEOTROP, V7, P1, DOI DOI 10.1590/S1676-06032007000300020; Li WLS, 2012, MOL BIOL EVOL, V29, P751, DOI 10.1093/molbev/msr232; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; LUCENA CAS, 1992, ICHTHYOL EXPLOR FRES, V3, P97; Lucinda Paulo H. F., 2005, Neotrop. ichthyol., V3, P259, DOI 10.1590/S1679-62252005000200003; Lundberg JG, 1997, VERTEBRATE PALEONTOL; Lundberg JG, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P281; Mabragana E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028655; Malabarba Luiz R., 1998, Ichthyological Exploration of Freshwaters, V9, P243; Malabarba MC, 1998, PHYLOGENY CLASSIFICA, P69; Marceniuk AP, 2011, BIOTA NEOTROP, V11, P217, DOI 10.1590/S1676-06032011000300020; Mees G.F., 1974, Zoologische Verh Leiden, VNo. 132, P1; Melo BF, 2016, ZOOL SCR, V45, P650, DOI 10.1111/zsc.12178; Menezes N.A., 1988, P295; MENEZES NA, 1990, P BIOL SOC WASH, V103, P380; Menezes NA, 2007, PEIXES AGUA DOCE MAT; Menezes Naercio A., 2008, Zootaxa, V1726, P33; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miquelarena AM, 2004, J APPL ICHTHYOL, V20, P234, DOI 10.1111/j.1439-0426.2004.00502.x; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Mori Horacio, 2006, Zootaxa, V1302, P31; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Moritz C, 1998, MOL ECOL, V7, P419, DOI 10.1046/j.1365-294x.1998.00317.x; Myers G. S., 1938, Smithsonian Report Washington, V1937, P339; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Oyakawa OT, 2006, PEIXES RIACHOS MATA; Oyakawa OT, 2011, CHECKLIST PEIXES AGU, V11, P19; Pante E, 2015, SYST BIOL, V64, P152, DOI 10.1093/sysbio/syu083; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Pereira LHG, 2011, MITOCHONDR DNA, V22, P71, DOI 10.3109/19401736.2010.532213; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Quevedo R, 2002, COPEIA, P402; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; REIS RE, 1990, REV SUISSE ZOOL, V97, P729, DOI 10.5962/bhl.part.79760; Ribeiro AC, 2013, NEOTROP ICHTHYOL, V11, P319, DOI 10.1590/S1679-62252013000200010; Ribeiro AC, 2006, NEOTROP ICHTHYOL, V4, P225, DOI 10.1590/S1679-62252006000200009; Ribeiro AC, 2015, ZOOTAXA, V3949, P41, DOI 10.11646/zootaxa.3949.1.2; Ribolli J, 2017, NEOTROP ICHTHYOL, V15, DOI 10.1590/1982-0224-20160147; Rosso JJ, 2012, MOL ECOL RESOUR, V12, P999, DOI 10.1111/1755-0998.12010; Sambrook J., 2001, MOL CLONING LAB MANU; Nguyen SN, 2014, ZOOTAXA, V3784, P48, DOI 10.11646/zootaxa.3784.1.2; Serra Jane Piton, 2007, Biota Neotrop., V7, P0, DOI 10.1590/S1676-06032007000100011; Shibatta OA., 2007, CATALOGO ESPECIES PE, P103; Shibatta OA, 2003, CHECK LIST FRESHWATE, P401; Shibatta Oscar Akio, 2005, Neotrop. ichthyol., V3, P579, DOI 10.1590/S1679-62252005000400015; Shimabukuro-Dias CK, 2017, MITOCHONDRIAL DNA A, V28, P588, DOI 10.3109/24701394.2016.1149826; SILVA JFP, 2004, NEOTROP ICHTHYOL, V2, P55; Suguio K., GEOLOGIA QUATERNARIO; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teran GE, 2016, ICHTHYOL EXPLOR FRES, V27, P193; Thomaz AT, 2015, J BIOGEOGR, V42, P2389, DOI 10.1111/jbi.12597; Vari R.P., 1988, P343; Vari R. P., 1992, SMITHSONIAN CONTRIBU, V529, P1, DOI DOI 10.5479/SI.00810282.529; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Weitzman S.H., 1982, P403; Weitzman S.H., 1988, P379; Weschenfelder J, 2008, REV BRAS GEOFIS, V26, P367, DOI DOI 10.1590/S0102-261X2008000300009; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878	100	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199963	10.1371/journal.pone.0199963	http://dx.doi.org/10.1371/journal.pone.0199963			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975765	Green Published, gold, Green Submitted			2022-12-26	WOS:000437424500056
J	Wallstrom, T; Bjorklund, J; Frykman, J; Jarnbert-Pettersson, H; Akerud, H; Darj, E; Gemzell-Danielsson, K; Wiberg-Itzel, E				Wallstrom, Tove; Bjorklund, Jenny; Frykman, Joanna; Jarnbert-Pettersson, Hans; Akerud, Helena; Darj, Elisabeth; Gemzell-Danielsson, Kristina; Wiberg-Itzel, Eva			Induction of labor after one previous Cesarean section in women with an unfavorable cervix: A retrospective cohort study	PLOS ONE			English	Article							ATTEMPTED VAGINAL BIRTH; UTERINE RUPTURE; RISK-FACTORS; MISOPROSTOL; DELIVERY; COMPLICATIONS; ROUTES; TRIAL	Objective Uterine rupture is a well-known but unusual complication in vaginal deliveries with a Cesarean section in the history. The risk of uterine rupture is at least two-fold when labor is induced. In Sweden, women are allowed to deliver vaginally after one previous Cesarean section, regardless if labor starts spontaneously or is induced. The aim of the study is to compare the proportion of uterine ruptures between the three methods (balloon catheter, Minprostin (R) and Cytotec (R)) for induction of labor in women with an unfavorable cervix and one previous Cesarean section. Material and methods Retrospective cohort study of all women with one previous Cesarean section and induction of labor with an unfavorable cervix at the four largest clinics in Stockholm during 20122015. Inclusion criteria: Women with a previous Cesarean section and induction of labor with a viable fetus, cephalic presentation, singleton, at >= 34 w, (n = 910). Results 3.0% (27/910) of the women with induction of labor had a uterine rupture, 91% of them had no previous vaginal delivery. The proportion of uterine ruptures was 2.0% (6/295) with orally administrated Cytotec (R), 2.1% (7/335) with balloon catheter and 5.0% (14/ 281) when Minprostin (R) was used. Conclusions No difference in the proportion of uterine ruptures was shown when orally administrated Cytotec (R) and balloon catheter were compared (p = 0.64). Orally administrated Cytotec (R) and balloon catheter give a high success rate of vaginal deliveries (almost 70%) despite an unfavorable cervix.	[Wallstrom, Tove; Bjorklund, Jenny; Frykman, Joanna; Jarnbert-Pettersson, Hans; Wiberg-Itzel, Eva] Karolinska Inst, Dept Clin Sci & Educ, Womens Clin, Sodersjukhuset, Sweden; [Akerud, Helena; Darj, Elisabeth] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Darj, Elisabeth] Norwegian Univ Sci & Technol, NTNU, Dept Publ Hlth & Nursing, Oslo, Norway; [Gemzell-Danielsson, Kristina] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Uppsala University; Norwegian University of Science & Technology (NTNU); Karolinska Institutet; Karolinska University Hospital	Wallstrom, T (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Womens Clin, Sodersjukhuset, Sweden.	tove.wallstrom@sll.se						American College of Obstetricians and Gynecologists, 2010, OBSTET GYNECOL, V116, P450, DOI DOI 10.1097/AOG.0B013E3181EEB251; Aronsson A, 2004, HUM REPROD, V19, P81, DOI 10.1093/humrep/deh005; Aslan H, 2004, EUR J OBSTET GYN R B, V113, P45, DOI 10.1016/S0301-2115(03)00363-4; Bulletins-Obstetrics ACoP ACOG Practice Bulletin, 2004, OBSTET GYNECOL, V104, P639, DOI DOI 10.1097/00006250-200409000-00052; Chauhan SP, 2003, AM J OBSTET GYNECOL, V189, P408, DOI 10.1067/S0002-9378(03)00675-6; Danielsson KG, 1999, OBSTET GYNECOL, V93, P275, DOI 10.1016/S0029-7844(98)00436-0; Dekker GA, 2010, BJOG-INT J OBSTET GY, V117, P1358, DOI 10.1111/j.1471-0528.2010.02688.x; Deutchman M, 2003, AM FAM PHYSICIAN, V67, P931; Dodd JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004906.pub3; Guise JM, 2004, BMJ-BRIT MED J, V19, P329, DOI DOI 10.1136/BMJ.329.7456.19; Harper LM, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.09.022; Hesselman S, 2015, BJOG-INT J OBSTET GY, V122, P1535, DOI 10.1111/1471-0528.13015; How HY, 2001, AM J OBSTET GYNECOL, V185, P911, DOI 10.1067/mob.2001.117358; Kaczmarczyk M, 2007, BJOG-INT J OBSTET GY, V114, P1208, DOI 10.1111/j.1471-0528.2007.01484.x; Krispin E, 2017, J MATERN-FETAL NEO M, P1, DOI [10.1080/147670582017.1306513, DOI 10.1080/147670582017.1306513]; Landon MB, 2004, NEW ENGL J MED, V351, P2581, DOI 10.1056/NEJMoa040405; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; Markou GA, 2017, EUR J OBSTET GYN R B, V217, P126, DOI 10.1016/j.ejogrb.2017.09.001; National Institutes of Health, 2010, Semin Perinatol, V34, P351, DOI 10.1053/j.semperi.2010.06.002; Plaut MM, 1999, AM J OBSTET GYNECOL, V180, P1535, DOI 10.1016/S0002-9378(99)70049-9; Sentilhes L, 2013, EUR J OBSTET GYN R B, V170, P25, DOI 10.1016/j.ejogrb.2013.05.015; Smith GCS, 2004, BRIT MED J, V329, P375, DOI 10.1136/bmj.38160.634352.55; Stock SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060404; Tang J, 2013, INT J GYNECOL OBSTET, V121, P186, DOI 10.1016/j.ijgo.2012.12.009; Weimar CHE, 2010, EUR J OBSTET GYN R B, V151, P41, DOI 10.1016/j.ejogrb.2010.03.023; West HM, 2017, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858CD009792.PUB3; Wing DA, 1998, OBSTET GYNECOL, V91, P828, DOI 10.1016/S0029-7844(97)00553-X; Zelop CM, 2000, AM J OBSTET GYNECOL, V183, P1184, DOI 10.1067/mob.2000.109048; 2005, INT J GYNECOL OBSTET, V89, P319	29	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0200024	10.1371/journal.pone.0200024	http://dx.doi.org/10.1371/journal.pone.0200024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965989	Green Submitted, Green Published, gold			2022-12-26	WOS:000437224100039
J	Lesicka, M; Jablonska, E; Wieczorek, E; Seroczynska, B; Siekierzycka, A; Skokowski, J; Kalinowski, L; Wasowicz, W; Reszka, E				Lesicka, Monika; Jablonska, Ewa; Wieczorek, Edyta; Seroczynska, Barbara; Siekierzycka, Anna; Skokowski, Jaroslaw; Kalinowski, Leszek; Wasowicz, Wojciech; Reszka, Edyta			Altered circadian genes expression in breast cancer tissue according to the clinical characteristics	PLOS ONE			English	Article							TUMOR PROGRESSION; CLOCK GENES; DISRUPTION; MELATONIN; PER1; ORGANIZATION; BIOLOGY; SYSTEM; PLAYS; WORLD	Breast cancer has a multifactorial etiology. One of the supposed and novel mechanisms is an alteration of circadian gene expression. Circadian genes play a crucial role in many physiological processes. These processes, such as genomic stability, DNA repair mechanism and apoptosis, are frequently disrupted in breast tumors. To assess the significance of circadian gene expression in breast cancer, we carried out an analysis of CLOCK, BMAL1, NPAS2, PER1, PER2, PER3 and CRY1, CRY2, TIMELESS, CSNK1E expression by the use of the quantitative Real-Time PCR technique in tumor tissue and non-tumor adjacent normal tissue sampled from 107 women with a newly diagnosed disease. The obtained data were compared to the clinical and histopathological features. PER1, PER2, PER3, CRY2 were found to be significantly down-expressed, while CLOCK, TIMELESS were over-expressed in the studied tumor samples compared to the non-tumor samples. Only gene expression of CRY1 was significantly down-regulated with progression according to the TNM classification. We found significantly decreased expression of CRY2, PER1, PER2 genes in the ER/PR negative breast tumors compared to the ER/PR positive tumors. Additionally, expression of CRY2, NPAS2 genes had a decreased level in the poorly differentiated tumors in comparison with the well and moderately differentiated ones. Our results indicate that circadian gene expression is altered in breast cancer tissue, which confirms previous observations from various animal and in vitro studies.	[Lesicka, Monika; Jablonska, Ewa; Wieczorek, Edyta; Reszka, Edyta] Nofer Inst Occupat Med, Dept Mol Genet & Epigenet, Lodz, Poland; [Seroczynska, Barbara; Siekierzycka, Anna; Skokowski, Jaroslaw; Kalinowski, Leszek] Med Univ Gdansk, Dept Med Lab Diagnost, Gdansk, Poland; [Seroczynska, Barbara; Siekierzycka, Anna; Skokowski, Jaroslaw; Kalinowski, Leszek] Med Univ Gdansk, Bank Frozen Tissues & Genet Specimens, Gdansk, Poland; [Skokowski, Jaroslaw] Med Univ Gdansk, Dept Surg Oncol, Gdansk, Poland; [Skokowski, Jaroslaw; Kalinowski, Leszek] Biobanking & Biomol Resources Res Infrastruct BBM, Gdansk, Poland; [Wasowicz, Wojciech] Nofer Inst Occupat Med, Dept Biol & Environm Monitoring, Lodz, Poland	Nofer Institute of Occupational Medicine; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Nofer Institute of Occupational Medicine	Lesicka, M (corresponding author), Nofer Inst Occupat Med, Dept Mol Genet & Epigenet, Lodz, Poland.	monika.lesicka@imp.lodz.pl	Reszka, Edyta/F-6008-2010; Wieczorek, Edyta/F-7057-2010; Kalinowski, Leszek/N-3076-2019; Jablonska, Ewa/F-6005-2010; Lesicka, Monika/G-7673-2015	Reszka, Edyta/0000-0003-2153-4864; Wieczorek, Edyta/0000-0002-4390-2042; Kalinowski, Leszek/0000-0001-7270-1592; Jablonska, Ewa/0000-0002-3946-3964; Lesicka, Monika/0000-0003-2095-8681; Wasowicz, Wojciech/0000-0002-2991-9040; Skokowski, Jaroslaw/0000-0002-3079-3502	National Science Center [2014/15/N/NZ5/01671]; Ministry of Science and Higher Education Poland [DIR/WK/2017/01]; Internal grant for statutory activity at Nofer Institute of Occupational Medicine [IMP 14.4/2018]	National Science Center(National Science Centre, Poland); Ministry of Science and Higher Education Poland(Ministry of Science and Higher Education, Poland); Internal grant for statutory activity at Nofer Institute of Occupational Medicine	This work was supported by the National Science Center (Grant No. 2014/15/N/NZ5/01671) (to ML), https://www.ncn.gov.pl/?language=en, and partially supported by Ministry of Science and Higher Education Poland DIR/WK/2017/01 (to LK), http://www.nauka.gov.pl.en/, and Internal grant for statutory activity at Nofer Institute of Occupational Medicine IMP 14.4/2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakeman V, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0743-z; Cadenas C, 2014, CELL CYCLE, V13, P3282, DOI 10.4161/15384101.2014.954454; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; Chi LM, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0838-1; Climent J, 2010, J CLIN ONCOL, V28, P3770, DOI 10.1200/JCO.2009.27.0215; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Evans JA, 2013, PROG MOL BIOL TRANSL, V119, P283, DOI 10.1016/B978-0-12-396971-2.00010-5; Filipski E, 2002, J NATL CANCER I, V94, P690; Fu A, 2012, MOL CARCINOGEN, V51, P923, DOI 10.1002/mc.20862; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2013, PROG MOL BIOL TRANSL, V119, P221, DOI 10.1016/B978-0-12-396971-2.00009-9; Gery S, 2007, ONCOGENE, V26, P7916, DOI 10.1038/sj.onc.1210585; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; HAMILTON T, 1969, BRIT J SURG, V56, P764, DOI 10.1002/bjs.1800561018; Hoffman AE, 2010, CANCER PREV RES, V3, P539, DOI 10.1158/1940-6207.CAPR-09-0127; Hoffman AE, 2010, CANCER RES, V70, P1459, DOI 10.1158/0008-5472.CAN-09-3798; Hua H, 2006, CANCER SCI, V97, P589, DOI 10.1111/j.1349-7006.2006.00225.x; Kelleher FC, 2014, CANCER LETT, V342, P9, DOI 10.1016/j.canlet.2013.09.040; Kettner NM, 2014, ANN MED, V46, P208, DOI 10.3109/07853890.2014.914808; Kuo SJ, 2009, VIRCHOWS ARCH, V454, P467, DOI 10.1007/s00428-009-0761-7; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Mao YY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-498; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reszka E, 2016, ADV CLIN CHEM, V75, P53, DOI 10.1016/bs.acc.2016.03.005; Stevens RG, 2006, CANCER CAUSE CONTROL, V17, P501, DOI 10.1007/s10552-005-9001-x; Stevens RG, 2005, EPIDEMIOLOGY, V16, P254, DOI 10.1097/01.ede.0000152525.21924.54; Stevens RG, 1996, ENVIRON HEALTH PERSP, V104, P135, DOI 10.2307/3432703; Stevens RG, 2014, CA-CANCER J CLIN, V64, P207, DOI 10.3322/caac.21218; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tarone RE, 2005, EPIDEMIOLOGY, V16, P710, DOI 10.1097/01.ede.0000172463.66664.70; Tarone RE, 2005, EPIDEMIOLOGY, V16, P1; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; Winter SL, 2007, NEOPLASIA, V9, P797, DOI 10.1593/neo.07595; Xiao LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095878; Yi C, 2009, BREAST CANC RES TREA, V120, P663	37	30	36	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0199622	10.1371/journal.pone.0199622	http://dx.doi.org/10.1371/journal.pone.0199622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0PZ	29958276	Green Submitted, gold, Green Published			2022-12-26	WOS:000436793500013
J	Kober, KI; Cano, A; Geraud, C; Sipila, K; Mobasseri, SA; Philippeos, C; Pisco, AO; Stannard, A; Martin, A; Salvador, F; Santos, V; Boutros, M; Rognoni, E; Watt, FM				Kober, Katharina Isabelle; Cano, Amparo; Geraud, Cyril; Sipilae, Kalle; Mobasseri, Seyedeh Atefeh; Philippeos, Christina; Pisco, Angela Oliveira; Stannard, Andrew; Martin, Alberto; Salvador, Fernando; Santos, Vanesa; Boutros, Michael; Rognoni, Emanuel; Watt, Fiona M.			Loxl2 is dispensable for dermal development, homeostasis and tumour stroma formation	PLOS ONE			English	Article							COLLAGEN HYBRIDIZING PEPTIDES; LYSYL OXIDASE; EXTRACELLULAR-MATRIX; PULMONARY-FIBROSIS; AMINE OXIDASE; BETA-CATENIN; CELL; SKIN; PROTEIN; FAMILY	Lysyl oxidase-like 2 (LOXL2) is a copper-dependent monoamine oxidase that contributes to the remodelling of the extracellular matrix (ECM) by cross linkage of collagen and elastin fibres and has emerged as a potential therapeutic target in cancer and fibrosis. In the skin, LOXL2 is essential for epidermal cell polarity and differentiation. However, its role in the dermis has not been evaluated. We found that Loxl2 is dispensable for mouse dermal development, maturation and homeostasis, yet affects dermal stiffness. Neither loss of Loxl2 nor increased Loxl2 expression affected dermal architecture following treatment with the phorbol ester TPA. Furthermore, Loxl2 expression did not alter the stroma of DMBA-TPA-induced tumours. We conclude that, although Loxl2 is expressed in both dermis and epidermis, its function appears largely confined to the epidermis.	[Kober, Katharina Isabelle; Boutros, Michael] German Canc Res Ctr, Div Signaling & Funct Genom, Heidelberg, Germany; [Kober, Katharina Isabelle; Boutros, Michael] Heidelberg Univ, Med Fac Mannheim, Dept Cell & Mol Biol, Heidelberg, Germany; [Cano, Amparo; Martin, Alberto; Salvador, Fernando; Santos, Vanesa] UAM, Inst Invest Biorned Alberto Sols, IdiPAZ, Dept Bioquim,CSIC, Madrid, Spain; [Cano, Amparo; Martin, Alberto; Salvador, Fernando; Santos, Vanesa] CIBERONC, Ctr Invest Biomed Red, Madrid, Spain; [Geraud, Cyril] Heidelberg Univ, Med Fac Mannheim, Dept Dermatol Venereol & Allergol, Sect Clin & Mol Dermatol, Mannheim, Germany; [Geraud, Cyril] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci, Mannheim, Germany; [Sipilae, Kalle; Mobasseri, Seyedeh Atefeh; Philippeos, Christina; Pisco, Angela Oliveira; Rognoni, Emanuel; Watt, Fiona M.] Guys Hosp, Kings Coll London, Ctr Stem Cells & Regenerat Med, London, England; [Stannard, Andrew] Kings Coll London, Dept Phys, London, England; [Pisco, Angela Oliveira] Chan Zuckerberg Biohub, San Francisco, CA USA; [Martin, Alberto] Inst Salud Carlos III, IIER, Madrid, Spain; [Salvador, Fernando] Inst Res Biomed IRB Barcelona, Oncol Program, Barcelona, Spain	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Instituto de Salud Carlos III; Instituto de Investigacion de Enfermedades Raras (IIER); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Rognoni, E; Watt, FM (corresponding author), Guys Hosp, Kings Coll London, Ctr Stem Cells & Regenerat Med, London, England.	emanuel.rognoni@kcl.ac.uk; fiona.watt@kcl.ac.uk	Watt, Fiona/AHB-0226-2022; Pisco, Angela Oliveira/K-4563-2012; Boutros, Michael/C-3566-2008; Philippeos, Christina/S-3780-2019; Rognoni, Emanuel/M-3024-2019	Watt, Fiona/0000-0001-9151-5154; Pisco, Angela Oliveira/0000-0003-0142-2355; Boutros, Michael/0000-0002-9458-817X; Philippeos, Christina/0000-0001-8654-0291; Rognoni, Emanuel/0000-0001-6050-2860; Martin, Alberto/0000-0003-3427-7684; Geraud, Cyrill/0000-0001-9432-6869; Kober, Katharina Isabelle/0000-0002-8076-3379; Stannard, Andrew/0000-0001-6283-667X	Medical Research Council [G1100073]; Cancer Research UK [C219/A23522]; Wellcome Trust [096540/Z/11/Z]; Spanish Ministry of Economy and Innovation [SAF2016-76504-R]; Institute de Salud Carlos III (RTICC) [RD12/0036/0007, CB16/12/00295]; Worldwide Cancer Research [12-1057]; EMBO long-term fellowship [aALTF594-2014]; EMBO Advanced Fellowship [aALTF 523-2017]; Finnish Cultural Foundation Fellowship; Research Training Group "Hallmarks of Skin Cancer" of the German Research Foundation (Deutsche Forschungsgemeinschaft/DFG) [RTG2099, GTK2099/RT2099, 3]; German Research Foundation (Deutsche Forschungsgemeinschaft/DFG) [GRK2099/RTG2099, 7]; Engineering and Physical Sciences Research Council [EP/K00641X/1, EP/M022536/1]; Nikon Imaging Centre at KCL and of the Light Microscopy Core Facility at DKFZ; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; King's College Hospital NHS Foundation Trust; EPSRC [EP/M022536/1, EP/K00641X/1, EP/M507222/1] Funding Source: UKRI; MRC [G1100073] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/M507222/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); Spanish Ministry of Economy and Innovation(Spanish Government); Institute de Salud Carlos III (RTICC); Worldwide Cancer Research; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); EMBO Advanced Fellowship; Finnish Cultural Foundation Fellowship(Finnish Cultural Foundation); Research Training Group "Hallmarks of Skin Cancer" of the German Research Foundation (Deutsche Forschungsgemeinschaft/DFG)(German Research Foundation (DFG)); German Research Foundation (Deutsche Forschungsgemeinschaft/DFG)(German Research Foundation (DFG)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Nikon Imaging Centre at KCL and of the Light Microscopy Core Facility at DKFZ; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award; King's College Hospital NHS Foundation Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	F.M.W. gratefully acknowledges financial support from the Medical Research Council (G1100073), Cancer Research UK (C219/A23522) and the Wellcome Trust (096540/Z/11/Z). Research in A.C.'s lab is supported by the Spanish Ministry of Economy and Innovation (SAF2016-76504-R), Institute de Salud Carlos III (RTICC: RD12/0036/0007 and CIBERONC: CB16/12/00295) and Worldwide Cancer Research (formerly AICR) (12-1057). E.R. is the recipient of an EMBO long-term fellowship (aALTF594-2014) and an EMBO Advanced Fellowship (aALTF 523-2017). K.S. is the recipient of a Finnish Cultural Foundation Fellowship. K.I.K. was supported by the Research Training Group RTG2099 "Hallmarks of Skin Cancer" of the German Research Foundation (Deutsche Forschungsgemeinschaft/DFG) GTK2099/RT2099, project 3 (M.B.). This work was supported in part by grants from the German Research Foundation (Deutsche Forschungsgemeinschaft/DFG) GRK2099/RTG2099, project 7 (C.G.). A.S. is supported by the Engineering and Physical Sciences Research Council (EP/K00641X/1 and EP/M022536/1). The authors would like to acknowledge the excellent support of the Nikon Imaging Centre at KCL and of the Light Microscopy Core Facility (Dr. F. Bestvater) at DKFZ. We also gratefully acknowledge the use of Core Facilities provided by the generous financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Aumiller V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00270-0; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bergmeier V, 2018, MATRIX BIOL, V65, P59, DOI 10.1016/j.matbio.2017.07.005; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Cano A, 2012, FUTURE ONCOL, V8, P1095, DOI [10.2217/FON.12.105, 10.2217/fon.12.105]; Collins CA, 2011, DEVELOPMENT, V138, P5189, DOI 10.1242/dev.064592; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Fitzgerald AMP, 1996, BURNS, V22, P200, DOI 10.1016/0305-4179(95)00119-0; FURSTENBERGER G, 1983, J INVEST DERMATOL, V81, pS157, DOI 10.1111/1523-1747.ep12540971; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hornstra IK, 2003, J BIOL CHEM, V278, P14387, DOI 10.1074/jbc.M210144200; Hwang J, 2017, ACS NANO, V11, P9825, DOI 10.1021/acsnano.7b03150; Iturbide A, 2015, FEBS J, V282, P1768, DOI 10.1111/febs.12961; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kim YM, 2011, MOL BIOL REP, V38, P145, DOI 10.1007/s11033-010-0088-0; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Maki JM, 2009, HISTOL HISTOPATHOL, V24, P651, DOI 10.14670/HH-24.651; Martin A, 2015, EMBO J, V34, P1090, DOI 10.15252/embj.201489975; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Philippeos C, 2018, J INVEST DERMATOL, V138, P811, DOI 10.1016/j.jid.2018.01.016; Pickup MW, 2013, CANCER RES, V73, P5336, DOI 10.1158/0008-5472.CAN-13-0012; Raghu G, 2017, LANCET RESP MED, V5, P22, DOI 10.1016/S2213-2600(16)30421-0; Rezza A, 2016, CELL REP, V14, P3001, DOI 10.1016/j.celrep.2016.02.078; Rognoni E, 2016, DEVELOPMENT, V143, P2522, DOI 10.1242/dev.131797; Salvador F, 2017, CANCER RES, V77, P5846, DOI 10.1158/0008-5472.CAN-16-3152; Sennett R, 2015, DEV CELL, V34, P577, DOI 10.1016/j.devcel.2015.06.023; Trackman PC, 2016, EXPERT OPIN THER TAR, V20, P935, DOI 10.1517/14728222.2016.1151003; Watt FM, 2014, SCIENCE, V346, P937, DOI 10.1126/science.1253734; Zhang J, 2015, HUM MOL GENET, V24, P6174, DOI 10.1093/hmg/ddv333; Zitnay JL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14913	39	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199679	10.1371/journal.pone.0199679	http://dx.doi.org/10.1371/journal.pone.0199679			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953488	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400051
J	Al-Shamsi, S; Regmi, D; Govender, RD				Al-Shamsi, S.; Regmi, D.; Govender, R. D.			Chronic kidney disease in patients at high risk of cardiovascular disease in the United Arab Emirates: A population-based study	PLOS ONE			English	Article							CKD-EPI EQUATION; SCREENING-PROGRAM; DIABETES-MELLITUS; RENAL-DISEASE; PREVALENCE; PROGRESSION; SMOKING; BURDEN; EPIDEMIOLOGY; PREVENTION	Chronic kidney disease has become an increasingly significant clinical and public health issue, accounting for 1.1 million deaths worldwide. Information on the epidemiology of chronic kidney disease and associated risk factors is limited in the United Arab Emirates. Therefore, this study aimed to evaluate the incidence and causes of chronic kidney disease stages 3-5 in adult United Arab Emirates nationals with or at high risk of cardiovascular disease. This retrospective study included 491 adults with or at high risk of cardiovascular disease (diabetes mellitus or associated clinical disease) who attended outpatient clinics at a tertiary care hospital in Al-Ain, United Arab Emirates. Estimated glomerular filtration rate was assessed every 3 months from baseline to June 30, 2017. Chronic kidney disease stages 3-5 were defined as an estimated glomerular filtration rate < 60 mUmin/1.73 m(2) for >= 3 months. Multivariable Cox's proportional hazards analysis was used to determine the independent risk factors associated with developing chronic kidney disease stages 3-5. The cumulative incidence of chronic kidney disease stages 3-5 over a 9-year period was 11.4% (95% confidence interval 8.6, 14.0). The incidence rate of these disease stages was 164.8 (95% confidence interval 121.6, 207.9) per 10,000 person-years. The independent risk factors for developing chronic kidney disease stages 3-5 were older age, history of coronary heart disease, history of diabetes mellitus, and history of smoking. These data may be useful to develop effective strategies to prevent chronic kidney disease development in high-risk United Arab Emirates nationals.	[Al-Shamsi, S.] United Arab Emirates Univ, Dept Internal Med, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [Regmi, D.; Govender, R. D.] United Arab Emirates Univ, Dept Family Med, Coll Med & Hlth Sci, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Al-Shamsi, S (corresponding author), United Arab Emirates Univ, Dept Internal Med, Coll Med & Hlth Sci, Al Ain, U Arab Emirates.	salshamsi@uaeu.ac.ae	Govender, Romona/AAR-9829-2020; Shamsi, Saif Al/AAR-3410-2020	Govender, Romona/0000-0003-3393-9594; Shamsi, Saif Al/0000-0001-9755-3493				Adamczak Marcin, 2002, Kidney Int Suppl, P62, DOI 10.1046/j.1523-1755.61.s80.28.x; Aden B, 2013, INT J PREVENTIVE MED, V4, P1290; Afkarian M, 2016, JAMA-J AM MED ASSOC, V316, P602, DOI 10.1001/jama.2016.10924; Al Shamsi S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010832; Alhyas Layla, 2011, JRSM Short Rep, V2, P55, DOI 10.1258/shorts.2011.011019; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Brancati FL, 1997, JAMA-J AM MED ASSOC, V278, P2069, DOI 10.1001/jama.278.23.2069; Brown Loretta Jackson, 2010, Nephrol Nurs J, V37, P133; Chico-Moraleja RM, 2015, PLOS ONE, V10, DOI DOI 10.1371/journal.pone.0122030; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Elihimas Júnior Ubiracé Fernando, 2014, Braz. J. Nephrol., V36, P519, DOI 10.5935/0101-2800.20140074; Farag YMK, 2012, NEPHRON CLIN PRACT, V121, pC120, DOI 10.1159/000345149; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Fraser SDS, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0189-z; Hajat C, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-18; Hajat C, 2012, AM J PUBLIC HEALTH, V102, P909, DOI 10.2105/AJPH.2011.300290; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hillege HL, 2003, EUR HEART J, V24, P412, DOI 10.1016/S0195-668X(02)00526-2; Hooi LS, 2013, KIDNEY INT, V84, P1034, DOI 10.1038/ki.2013.220; Jones-Burton C, 2007, AM J NEPHROL, V27, P342, DOI 10.1159/000103382; Kang YU, 2016, KOREAN J INTERN MED, V31, P920, DOI 10.3904/kjim.2014.243; Kazancioglu R, 2013, KIDNEY INT SUPPL, V3, P368, DOI 10.1038/kisup.2013.79; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2001, NEPHROL DIAL TRANSPL; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Michels WM, 2010, CLIN J AM SOC NEPHRO, V5, P1003, DOI 10.2215/CJN.06870909; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; National High Blood Pressure Education Program, 2004, 7 NAT HEART LUNG BLO; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Orth SR, 2008, CLIN J AM SOC NEPHRO, V3, P226, DOI 10.2215/CJN.03740907; Parving HH, 2001, KIDNEY INT, V60, P2041, DOI 10.1046/j.1523-1755.2001.00020.x; Remuzzi G, 2006, J AM SOC NEPHROL, V17, pS90, DOI 10.1681/ASN.2005121324; Richards N, 2015, SAUDI J KIDNEY DIS T, V26, P1028, DOI 10.4103/1319-2442.164600; Rodriguez-Poncelas A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-46; Ruggenenti P, 2001, LANCET, V357, P1601, DOI 10.1016/S0140-6736(00)04728-0; Saadi H, 2007, DIABETES RES CLIN PR, V78, P369, DOI 10.1016/j.diabres.2007.04.008; Sepanlou SG, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0176540, 10.1371/journal.pone.]; Shen YJ, 2017, ENDOCRINE, V55, P75, DOI 10.1007/s12020-016-1014-6; Staples A, 2010, CURR OPIN PEDIATR, V22, P161, DOI 10.1097/MOP.0b013e328336ebb0; Sudchada P, 2016, INT UROL NEPHROL, V48, P1511, DOI 10.1007/s11255-016-1357-1; Tohidi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045304; Tsai WC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003013; Vijayakumar P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171027; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017	46	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199920	10.1371/journal.pone.0199920	http://dx.doi.org/10.1371/journal.pone.0199920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949629	Green Submitted, Green Published, gold			2022-12-26	WOS:000436549200072
J	Muller, C; Elliott, J; Pugh, TAM; Ruane, AC; Ciais, P; Balkovic, J; Deryng, D; Folberth, C; Izaurralde, RC; Jones, CD; Khabarov, N; Lawrence, P; Liu, W; Reddy, AD; Schmid, E; Wang, XH				Mueller, Christoph; Elliott, Joshua; Pugh, Thomas A. M.; Ruane, Alex C.; Ciais, Philippe; Balkovic, Juraj; Deryng, Delphine; Folberth, Christian; Izaurralde, R. Cesar; Jones, Curtis D.; Khabarov, Nikolay; Lawrence, Peter; Liu, Wenfeng; Reddy, Ashwan D.; Schmid, Erwin; Wang, Xuhui			Global patterns of crop yield stability under additional nutrient and water inputs	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CLIMATE-CHANGE; MODEL; SCALE; IRRIGATION; SYSTEM; IMPACT; MAIZE; INTENSIFICATION; VARIABILITY	Agricultural production must increase to feed a growing and wealthier population, as well as to satisfy increasing demands for biomaterials and biomass-based energy. At the same time, deforestation and land-use change need to be minimized in order to preserve biodiversity and maintain carbon stores in vegetation and soils. Consequently, agricultural land use needs to be intensified in order to increase food production per unit area of land. Here we use simulations of AgMIP's Global Gridded Crop Model Intercomparison (GGCMI) phase 1 to assess implications of input-driven intensification (water, nutrients) on crop yield and yield stability, which is an important aspect in food security. We find region- and crop-specific responses for the simulated period 1980-2009 with broadly increasing yield variability under additional nitrogen inputs and stabilizing yields under additional water inputs (irrigation), reflecting current patterns of water and nutrient limitation. The different models of the GGCMI ensemble show similar response patterns, but model differences warrant further research on management assumptions, such as variety selection and soil management, and inputs as well as on model implementation of different soil and plant processes, such as on heat stress, and parameters. Higher variability in crop productivity under higher fertilizer input will require adequate buffer mechanisms in trade and distribution/storage networks to avoid food price volatility.	[Mueller, Christoph] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Elliott, Joshua] Univ Chicago, Chicago, IL 60637 USA; [Elliott, Joshua] ANL Computat Inst, Chicago, IL USA; [Elliott, Joshua; Ruane, Alex C.; Deryng, Delphine] Columbia Univ, Ctr Climate Syst Res, New York, NY USA; [Pugh, Thomas A. M.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Pugh, Thomas A. M.] Univ Birmingham, Birmingham Inst Forest Res, Birmingham, W Midlands, England; [Pugh, Thomas A. M.] Karlsruhe Inst Technol, IMK IFU, Garmisch Partenkirchen, Germany; [Ruane, Alex C.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Ciais, Philippe; Liu, Wenfeng; Wang, Xuhui] Lab Sci Climat & Environm, Gif Sur Yvette, France; [Balkovic, Juraj; Folberth, Christian; Khabarov, Nikolay] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, Laxenburg, Austria; [Balkovic, Juraj] Comenius Univ, Dept Soil Sci, Fac Nat Sci, Bratislava, Slovakia; [Deryng, Delphine] Climate Analyt, Berlin, Germany; [Izaurralde, R. Cesar; Jones, Curtis D.; Reddy, Ashwan D.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Izaurralde, R. Cesar] Texas A&M Univ, Texas AgriLife Res & Extens, Temple, TX USA; [Lawrence, Peter] Natl Ctr Atmospher Res, Earth Syst Lab, POB 3000, Boulder, CO 80307 USA; [Liu, Wenfeng] Swiss Fed Inst Aquat Sci & Technol, Eawag, Dubendorf, Switzerland; [Schmid, Erwin] Univ Nat Resources & Life Sci, Inst Sustainable Econ Dev, Vienna, Austria; [Wang, Xuhui] Peking Univ, Sino French Inst Earth Syst Sci, Beijing, Peoples R China	Potsdam Institut fur Klimafolgenforschung; University of Chicago; Columbia University; University of Birmingham; University of Birmingham; Helmholtz Association; Karlsruhe Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); International Institute for Applied Systems Analysis (IIASA); Comenius University Bratislava; University System of Maryland; University of Maryland College Park; Texas A&M University System; National Center Atmospheric Research (NCAR) - USA; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Natural Resources & Life Sciences, Vienna; Peking University	Muller, C (corresponding author), Potsdam Inst Climate Impact Res, Potsdam, Germany.	Christoph.Mueller@pik-potsdam.de	Ciais, Philippe/A-6840-2011; Liu, Wenfeng/D-3715-2017; Deryng, Delphine/AAN-6255-2020; Schmid, Erwin/Z-1946-2019; Izaurralde, Roberto César/E-5257-2019; Pugh, Thomas A M/A-3790-2010; Ruane, Alex/ABD-5612-2021; wang, xuhui/H-8605-2019; Müller, Christoph/E-4812-2016; Deryng, Delphine/AAN-8899-2021	Ciais, Philippe/0000-0001-8560-4943; Liu, Wenfeng/0000-0002-8699-3677; Deryng, Delphine/0000-0001-6214-7241; Schmid, Erwin/0000-0003-4783-9666; Pugh, Thomas A M/0000-0002-6242-7371; wang, xuhui/0000-0003-0818-9816; Müller, Christoph/0000-0002-9491-3550; Izaurralde, Roberto/0000-0002-8797-9500; Folberth, Christian/0000-0002-6738-5238; Balkovic, Juraj/0000-0003-2955-4931	MACMIT project through the German Federal Ministry of Education and Research (BMBF) [01LN1317A]; European Commission [603542]	MACMIT project through the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	CM acknowledges financial support from the MACMIT project (01LN1317A) funded through the German Federal Ministry of Education and Research (BMBF, www.bmbf.de). TAMP acknowledges funding from the European Commission's 7th Framework Programme, under Grant Agreement number 603542 (LUC4C, https://ec.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kaisi MM, 2013, J SOIL WATER CONSERV, V68, p19A, DOI 10.2489/jswc.68.1.19A; Bodin P, 2016, AGR SYST, V148, P159, DOI 10.1016/j.agsy.2016.07.012; Bodirsky BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139201; Bodirsky BL, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/111005; Bodirsky BL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4858; Deryng D, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2009GB003765; Deryng D, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034011; Drewniak B, 2013, GEOSCI MODEL DEV, V6, P495, DOI 10.5194/gmd-6-495-2013; Elliott J., 2015, GEOSCI MODEL DEV, V8, P261, DOI [10.5194/gmd-8-261-2015, DOI 10.5194/gmd-8-261-2015, DOI 10.5194/GMD-8-261-2015]; Elliott J, 2014, ENVIRON MODELL SOFTW, V62, P509, DOI 10.1016/j.envsoft.2014.04.008; Elliott J, 2014, P NATL ACAD SCI USA, V111, P3239, DOI 10.1073/pnas.1222474110; Falkenmark M, 2005, HYDROL EARTH SYST SC, V9, P15, DOI 10.5194/hess-9-15-2005; Fasahat P, 2015, BIOM BIOSTAT INT J, V2; Fereres E, 2007, J EXP BOT, V58, P147, DOI 10.1093/jxb/erl165; Folberth C., 2016, BIOGEOSCIENCES DISCU, P1, DOI [10.5194/bg-2016-527, DOI 10.5194/BG-2016-527]; Folberth C, 2012, AGR ECOSYST ENVIRON, V151, P21, DOI 10.1016/j.agee.2012.01.026; Frieler K, 2017, EARTHS FUTURE, V5, P605, DOI 10.1002/2016EF000525; Huang J, 2017, J CLEAN PROD, V159, P171, DOI 10.1016/j.jclepro.2017.05.008; Hutchings NJ, 2012, BIOGEOSCIENCES, V9, P4487, DOI 10.5194/bg-9-4487-2012; Irvine IC, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1857; Izaurralde RC, 2012, MANAGING AGRICULTURAL GREENHOUSE GASES: COORDINATED AGRICULTURAL RESEARCH THROUGH GRACENET TO ADDRESS OUR CHANGING CLIMATE, P293, DOI 10.1016/B978-0-12-386897-8.00017-6; Izaurralde RC, 2006, ECOL MODEL, V192, P362, DOI 10.1016/j.ecolmodel.2005.07.010; Jagermeyr J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/2/025002; Jagermeyr J, 2015, HYDROL EARTH SYST SC, V19, P3073, DOI 10.5194/hess-19-3073-2015; Jagermeyr J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15900; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Keating BA, 2003, EUR J AGRON, V18, P267, DOI 10.1016/S1161-0301(02)00108-9; Kihara J, 2016, AGR ECOSYST ENVIRON, V229, P1, DOI 10.1016/j.agee.2016.05.012; Lau WKM, 2012, J HYDROMETEOROL, V13, P392, DOI 10.1175/JHM-D-11-016.1; Liu JG, 2007, AGR SYST, V94, P478, DOI 10.1016/j.agsy.2006.11.019; Liu WF, 2016, SCI TOTAL ENVIRON, V572, P526, DOI 10.1016/j.scitotenv.2016.08.093; Liu WF, 2016, AGR FOREST METEOROL, V221, P164, DOI 10.1016/j.agrformet.2016.02.017; Muller C, 2017, GEOSCI MODEL DEV, V10, P1403, DOI 10.5194/gmd-10-1403-2017; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Njoroge S, 2017, FIELD CROP RES, V214, P321, DOI 10.1016/j.fcr.2017.09.026; Nziguheba G, 2009, PLANT SOIL, V314, P143, DOI 10.1007/s11104-008-9714-1; Phalan B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0285; Portmann FT, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003435; Porwollik V, 2017, EUR J AGRON, V88, P10, DOI 10.1016/j.eja.2016.08.006; Ray DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6989; Rosenzweig C, 2013, AGR FOREST METEOROL, V170, P166, DOI 10.1016/j.agrformet.2012.09.011; Rosenzweig C, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/12/1/010301; Schauberger B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13931; Schauberger B, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/12/123001; Schewe J, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa678e; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Van Asselen S, 2013, GLOBAL CHANGE BIOL, V19, P3648, DOI 10.1111/gcb.12331; Warszawski L, 2014, P NATL ACAD SCI USA, V111, P3228, DOI 10.1073/pnas.1312330110; Weedon GP, 2014, WATER RESOUR RES, V50, P7505, DOI 10.1002/2014WR015638; Williams J. R, 1995, EPIC MODEL COMPUTER, P909; Wu X, 2016, GEOSCI MODEL DEV DIS, V8, P4653, DOI DOI 10.5194/GMDD-8-4653-2015	53	33	33	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198748	10.1371/journal.pone.0198748	http://dx.doi.org/10.1371/journal.pone.0198748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949598	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000436549200023
J	Tajadura-Jimenez, A; Deroy, O; Marquardt, T; Bianchi-Berthouze, N; Asai, T; Kimura, T; Kitagawa, N				Tajadura-Jimenez, Ana; Deroy, Ophelia; Marquardt, Torsten; Bianchi-Berthouze, Nadia; Asai, Tomohisa; Kimura, Toshitaka; Kitagawa, Norimichi			Audio-tactile cues from an object's fall change estimates of one's body height	PLOS ONE			English	Article							VISUAL GRAVITATIONAL MOTION; PERIPERSONAL SPACE; INTERNAL-MODELS; HAND; RECALIBRATION; PERCEPTION; OWNERSHIP; REPRESENTATION; INTEGRATION; EMBODIMENT	When we drop an object from our hands, we use internal models of both our body height and object-motion to predict when it will hit the floor. What happens if the sensory feedback finally received from the impact conflicts with this prediction? The present study shows that such conflict results in changes in the internal estimates of our body height: When the object people dropped takes longer than expected to hit the floor, they report feeling taller and behave as if their legs were longer. This provides the first evidence of cross-modal recalibration of body-height representations as a function of changes in the distant environment. Crucially, the recalibration results from a mismatch between the predicted and actual outcome of an action, the ball's release and impact, which are causally-related but separated in space and time. These results suggest that implicit models of object-motion can interact with implicit and explicit models of one's body height.	[Tajadura-Jimenez, Ana; Bianchi-Berthouze, Nadia] UCL, UCLIC, London, England; [Tajadura-Jimenez, Ana] Univ Carlos III Madrid, Comp Sci Dept, DEI Interact Syst Grp, Leganes, Spain; [Tajadura-Jimenez, Ana; Asai, Tomohisa; Kimura, Toshitaka; Kitagawa, Norimichi] NTT Corp, Human & Informat Sci Lab, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan; [Deroy, Ophelia] Univ London, Sch Adv Study, Ctr Study Senses, London, England; [Deroy, Ophelia] Ludwig Maximilians Univ Munchen, Munich Ctr Neurosci, Munich, Germany; [Marquardt, Torsten] UCL, UCL Ear Inst, London, England; [Kitagawa, Norimichi] Ritsmeikan Univ, BKC Res Org Social Sci, Kusatsu, Shiga, Japan; [Kitagawa, Norimichi] Yoshika Inst Psychol, Yoshika, Shimane, Japan	University of London; University College London; Universidad Carlos III de Madrid; Nippon Telegraph & Telephone Corporation; University of London; University of London School of Advanced Study; University of Munich; University of London; University College London; Ritsumeikan University	Tajadura-Jimenez, A (corresponding author), UCL, UCLIC, London, England.; Tajadura-Jimenez, A (corresponding author), Univ Carlos III Madrid, Comp Sci Dept, DEI Interact Syst Grp, Leganes, Spain.; Tajadura-Jimenez, A; Kitagawa, N (corresponding author), NTT Corp, Human & Informat Sci Lab, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan.; Kitagawa, N (corresponding author), Ritsmeikan Univ, BKC Res Org Social Sci, Kusatsu, Shiga, Japan.; Kitagawa, N (corresponding author), Yoshika Inst Psychol, Yoshika, Shimane, Japan.	a.tajadura@ucl.ac.uk; kitagawa.norimichi@icloud.com	Tajadura-Jimenez, Ana/O-2906-2019; Tajadura-Jimenez, Ana/B-2355-2015	Tajadura-Jimenez, Ana/0000-0003-3166-3512; Tajadura-Jimenez, Ana/0000-0003-3166-3512; Deroy, Ophelia/0000-0001-9431-3136; Berthouze, Nadia/0000-0001-8921-0044	Economic and Social Research Council (ESRC, UK) [ES/K001477/1]; research project "DEEP BRAIN COMMUNICATION" - The Nippon Telegraph and Telephone Corporation of Japan; ("MAGIC SHOES: Changing sedentary lifestyles by altering mental body-representation using sensory feedback"; AEI/FEDER, UE), Ministerio de Economia, Industria y Competitividad of Spain [RYC-2014-15421, PSI2016-79004-R]; Arts and Humanities Research Council (AHRC, UK) [AH/L007053/1]; AHRC [AH/L007053/1] Funding Source: UKRI; ESRC [ES/K001477/1] Funding Source: UKRI	Economic and Social Research Council (ESRC, UK)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); research project "DEEP BRAIN COMMUNICATION" - The Nippon Telegraph and Telephone Corporation of Japan; ("MAGIC SHOES: Changing sedentary lifestyles by altering mental body-representation using sensory feedback"; AEI/FEDER, UE), Ministerio de Economia, Industria y Competitividad of Spain; Arts and Humanities Research Council (AHRC, UK)(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	ATJ was supported by the Economic and Social Research Council (ESRC, UK, http://esrc.ac.uk) grant ES/K001477/1 ("The hearing body"), by the research project "DEEP BRAIN COMMUNICATION" funded by The Nippon Telegraph and Telephone Corporation of Japan (http://www.ntt.co.jp/index_e.html), and by RYC-2014-15421 and PSI2016-79004-R ("MAGIC SHOES: Changing sedentary lifestyles by altering mental body-representation using sensory feedback"; AEI/FEDER, UE), Ministerio de Economia, Industria y Competitividad of Spain (http://www.mineco.gob.es). OD was supported by the Arts and Humanities Research Council (AHRC, UK, http://www.ahrc.ac.uk) RTS ("Rethinking the senses") grant AH/L007053/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; Banakou D, 2013, P NATL ACAD SCI USA, V110, P12846, DOI 10.1073/pnas.1306779110; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Gaveau J, 2016, ELIFE, V5, DOI 10.7554/eLife.16394; Haggard P, 2009, PERCEPTION, V38, P1796, DOI 10.1068/p6399; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Keizer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064602; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; LACQUANITI F, 1989, J NEUROSCI, V9, P149; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Linkenauger SA, 2009, PSYCHOL SCI, V20, P1373, DOI 10.1111/j.1467-9280.2009.02447.x; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2015, EUR PSYCHOL, V20, P6, DOI 10.1027/1016-9040/a000198; Longo MR, 2012, CURR DIR PSYCHOL SCI, V21, P140, DOI 10.1177/0963721411434982; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Marino BFM, 2010, EXP BRAIN RES, V202, P499, DOI 10.1007/s00221-009-2143-4; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Miller WL, 2008, J NEUROPHYSIOL, V99, P1969, DOI 10.1152/jn.00889.2007; Noel JP, 2016, NEUROPSYCHOLOGIA, V82, P84, DOI 10.1016/j.neuropsychologia.2016.01.005; Pozeg P, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01749; Pozeg P, 2017, NEUROLOGY, V89, P1894, DOI 10.1212/WNL.0000000000004585; Salomon R, 2017, COGNITION, V166, P174, DOI 10.1016/j.cognition.2017.05.028; Schicke T, 2006, P NATL ACAD SCI USA, V103, P11808, DOI 10.1073/pnas.0601486103; Schicke T, 2009, EXP BRAIN RES, V192, P703, DOI 10.1007/s00221-008-1587-2; Serino A, 2013, CONSCIOUS COGN, V22, P1239, DOI 10.1016/j.concog.2013.08.013; Serino A, 2010, NEUROSCI BIOBEHAV R, V34, P224, DOI 10.1016/j.neubiorev.2009.04.004; Simon DM, 2017, FRONT INTEGR NEUROSC, V11, DOI 10.3389/fnint.2017.00008; Stone KD, 2018, EXP BRAIN RES, V236, P161, DOI 10.1007/s00221-017-5115-0; Tajadura-Jimenez A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05870-4; Tajadura-Jimenez A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00689; Tajadura-Jimenez A, 2012, CURR BIOL, V22, pR516, DOI 10.1016/j.cub.2012.04.028; Tsakiris M, 2005, COGN NEUROPSYCHOL, V22, P387, DOI 10.1080/02643290442000158; Tsakiris M, 2011, P R SOC B, V278; Van der Burg E, 2013, J NEUROSCI, V33, P14633, DOI 10.1523/JNEUROSCI.1182-13.2013; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; van Elk M, 2013, CONSCIOUS COGN, V22, P545, DOI 10.1016/j.concog.2013.02.006; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Zago M, 2008, VISION RES, V48, P1532, DOI 10.1016/j.visres.2008.04.005	40	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199354	10.1371/journal.pone.0199354	http://dx.doi.org/10.1371/journal.pone.0199354			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK9FZ	29949607	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200044
J	Robert, A; Tian, PR; Adam, SA; Kittisopikul, M; Jaqaman, K; Goldman, RD; Gelfand, VI				Robert, Amelie; Tian, Peirun; Adam, Stephen A.; Kittisopikul, Mark; Jaqaman, Khuloud; Goldman, Robert D.; Gelfand, Vladimir I.			Kinesin-dependent transport of keratin filaments: a unified mechanism for intermediate filament transport	FASEB JOURNAL			English	Article						vimentin; KIF5B; photoconversion	HEAVY-CHAIN; TARGETED DISRUPTION; VIMENTIN; DYNAMICS; ACTIN; NEUROFILAMENTS; MOVEMENT; BINDING; TAIL; ORGANIZATION	Keratin intermediate filaments (IFs) are the major cytoskeletal component in epithelial cells. The dynamics of keratin IFs have been described to depend mostly on the actin cytoskeleton, but the rapid transport of fully polymerized keratin filaments has not been reported. In this work, we used a combination of photoconversion experiments and clustered regularly interspaced short palindromic repeats/clustered regularly interspaced short palindromic repeats-associated protein 9 genome editing to study the role of microtubules and microtubule motors in keratin filament transport. We found that long keratin filaments, like other types of IFs, are transported along microtubules by kinesin-1. Our data revealed that keratin and vimentin are nonconventional kinesin-1 cargoes because their transport did not require kinesin light chains, which are a typical adapter for kinesin-dependent cargo transport. Furthermore, we found that the same domain of the kinesin heavy chain tail is involved in keratin and vimentin IF transport, strongly suggesting that multiple types of IFs move along microtubules using an identical mechanism.Robert, A., Tian, P., Adam, S. A., Kittisopikul, M., Jaqaman, K., Goldman, R. D., Gelfand, V. I. Kinesin-dependent transport of keratin filaments: a unified mechanism for intermediate filament transport.	[Robert, Amelie; Tian, Peirun; Adam, Stephen A.; Kittisopikul, Mark; Goldman, Robert D.; Gelfand, Vladimir I.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave,Ward 11-100, Chicago, IL 60611 USA; [Kittisopikul, Mark; Jaqaman, Khuloud] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Jaqaman, Khuloud] Univ Texas Southwestern Med Ctr Dallas, Lyda Hill Dept Bioinformat, Dallas, TX 75390 USA	Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gelfand, VI (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave,Ward 11-100, Chicago, IL 60611 USA.	vgelfand@northwestern.edu	tian, peirun/GQZ-8607-2022; Kittisopikul, Mark/V-7680-2019; Gelfand, Vladimir/D-2545-2013	Kittisopikul, Mark/0000-0002-9558-6248; Adam, Stephen/0000-0003-3444-7655; Gelfand, Vladimir/0000-0002-6361-2798; Jaqaman, Khuloud/0000-0003-3471-1911	U.S. National Institutes of Health, National Institute of General Medical Science [P01GM09697, R01 GM52111]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM096971, R35GM119619, R01GM052111] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Fatima Gyoeva (Institute of Protein Research, Russian Academy of Sciences, Moscow, Russia) for the C terminus and head domain polyclonal antibodies against kinesin, and David Kirchenbuechler (Center for Advanced Microscopy/Nikon Imaging Center, Northwestern University, Chicago, IL, USA) for help with quantification of IF distribution. Research reported in this publication was supported by the of the U.S. National Institutes of Health, National Institute of General Medical Science (P01GM09697 and R01 GM52111). The authors declare no conflicts of interest.	Costigliola N, 2017, P NATL ACAD SCI USA, V114, P5195, DOI 10.1073/pnas.1614610114; Diefenbach RJ, 1998, BIOCHEMISTRY-US, V37, P16663, DOI 10.1021/bi981163r; Gan Z, 2016, CELL SYST, V3, P252, DOI 10.1016/j.cels.2016.08.007; Gyoeva FK, 2004, BIOCHEMISTRY-US, V43, P13525, DOI 10.1021/bi049288l; GYOEVA FK, 1991, NATURE, V353, P445, DOI 10.1038/353445a0; Hackney DD, 2009, BIOCHEMISTRY-US, V48, P3448, DOI 10.1021/bi8022575; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; HOLLENBECK PJ, 1989, J CELL SCI, V92, P621; Hookway C, 2015, MOL BIOL CELL, V26, P1675, DOI 10.1091/mbc.E14-09-1398; HUNT RC, 1990, J CELL PHYSIOL, V145, P187, DOI 10.1002/jcp.1041450202; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jolly AL, 2010, P NATL ACAD SCI USA, V107, P12151, DOI 10.1073/pnas.1004736107; Jones J.C.R., 2017, COLD SPRING HARB PER, V9; Kolsch A, 2010, J CELL SCI, V123, P2266, DOI 10.1242/jcs.068080; Kolsch A, 2009, CELL MOTIL CYTOSKEL, V66, P976, DOI 10.1002/cm.20395; Leduc C, 2017, J CELL BIOL, V216, P1689, DOI 10.1083/jcb.201607045; Leube Rudolf E, 2011, Bioarchitecture, V1, P39; Liovic M, 2003, J CELL SCI, V116, P1417, DOI 10.1242/jcs.00363; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Moch M, 2013, P NATL ACAD SCI USA, V110, P10664, DOI 10.1073/pnas.1306020110; Nieuwenhuizen RPJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131756; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Pu J, 2016, J CELL SCI, V129, P4329, DOI 10.1242/jcs.196287; Robert A, 2016, BIOESSAYS, V38, P232, DOI 10.1002/bies.201500142; Robert A, 2015, P NATL ACAD SCI USA, V112, pE3505, DOI 10.1073/pnas.1505303112; Robert A, 2014, FASEB J, V28, P2879, DOI 10.1096/fj.14-250019; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Sanghvi-Shah R, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00081; Schwarz N, 2015, SCI REP-UK, V5, DOI 10.1038/srep09007; Seeger MA, 2010, J BIOL CHEM, V285, P8155, DOI 10.1074/jbc.M109.068247; Seiler S, 2000, NAT CELL BIOL, V2, P333, DOI 10.1038/35014022; Shimi T, 2015, MOL BIOL CELL, V26, P4075, DOI 10.1091/mbc.E15-07-0461; SKOUFIAS DA, 1994, J BIOL CHEM, V269, P1477; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Theiss C, 2005, EUR J CELL BIOL, V84, P29, DOI 10.1016/j.ejcb.2004.09.001; Uchida A, 2013, P NATL ACAD SCI USA, V110, pE2696, DOI 10.1073/pnas.1221835110; Uchida A, 2009, MOL BIOL CELL, V20, P4997, DOI 10.1091/mbc.E09-04-0304; Van Ginkel M., 2002, IMAGE ANAL USING ORI; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008; Wang L, 2001, MOL BIOL CELL, V12, P3257, DOI 10.1091/mbc.12.10.3257; Wang Z, 2013, DEVELOPMENT, V140, P617, DOI 10.1242/dev.085969; Windoffer R, 2006, J CELL BIOL, V173, P341, DOI 10.1083/jcb.200511124; Windoffer R, 2004, MOL BIOL CELL, V15, P2436, DOI 10.1091/mbc.E03-09-0707; Windoffer R, 1999, J CELL SCI, V112, P4521; Woll S, 2005, EUR J CELL BIOL, V84, P311, DOI 10.1016/j.ejcb.2004.12.004; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147	51	11	11	2	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					388	399		10.1096/fj.201800604R	http://dx.doi.org/10.1096/fj.201800604R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29944446	Green Published			2022-12-26	WOS:000457401500031
J	Menade, M; Kozlov, G; Trempe, JF; Pande, H; Shenker, S; Wickremasinghe, S; Li, XL; Hojjat, H; Dicaire, MJ; Brais, B; McPherson, PS; Wong, MJH; Young, JC; Gehring, K				Menade, Marie; Kozlov, Guennadi; Trempe, Jean-Francois; Pande, Harshit; Shenker, Solomon; Wickremasinghe, Sihara; Li, Xinlu; Hojjat, Hamed; Dicaire, Marie-Josee; Brais, Bernard; McPherson, Peter S.; Wong, Michael J. H.; Young, Jason C.; Gehring, Kalle			Structures of ubiquitin-like (Ubl) and Hsp90-like domains of sacsin provide insight into pathological mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; structural biology; neurodegenerative disease; molecular chaperone; biophysics; ARSACS disease; sacsin protein; Hsp90; TRAP1; X-ray crystallography	RECESSIVE SPASTIC ATAXIA; X-RAY SOLUTION; MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; PROTEIN SACSIN; ARSACS; SYSTEM; REFINEMENT; CHAPERONE; DEFECTS	Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a neurodegenerative disease that is caused by mutations in the SACS gene. The product of this gene is a very large 520-kDa cytoplasmic protein, sacsin, with a ubiquitin-like (Ubl) domain at the N terminus followed by three large sacsin internal repeat (SIRPT) supradomains and C-terminal J and HEPN domains. The SIRPTs are predicted to contain Hsp90-like domains, suggesting a potential chaperone activity. In this work, we report the structures of the Hsp90-like Sr1 domain of SIRPT1 and the N-terminal Ubl domain determined at 1.55- and 2.1-angstrom resolutions, respectively. The Ubl domain crystallized as a swapped dimer that could be relevant in the context of full-length protein. The Sr1 domain displays the Bergerat protein fold with a characteristic nucleotide-binding pocket, although it binds nucleotides with very low affinity. The Sr1 structure reveals that ARSACS-causing missense mutations (R272H, R272C, and T201K) disrupt protein folding, most likely leading to sacsin degradation. This work lends structural support to the view of sacsin as a molecular chaperone and provides a framework for future studies of this protein.	[Menade, Marie; Kozlov, Guennadi; Trempe, Jean-Francois; Pande, Harshit; Shenker, Solomon; Wickremasinghe, Sihara; Li, Xinlu; Hojjat, Hamed; Wong, Michael J. H.; Young, Jason C.; Gehring, Kalle] McGill Univ, McGill Ctr Struct Biol, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Dicaire, Marie-Josee; Brais, Bernard; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Trempe, Jean-Francois] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler,Rm 473, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Brais, Bernard/Y-3910-2019; Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	National Science Foundation (NSF); NIGMS, National Institutes of Health (NIH) via NSF [DMR-0225180]; National Center for Research Resources (NCRR), NIH [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NIGMS, National Institutes of Health (NIH) via NSF; National Center for Research Resources (NCRR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Tin Pan for technical assistance. Data were acquired at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS). CHESS is supported by the National Science Foundation (NSF) and NIGMS, National Institutes of Health (NIH) via NSF Award DMR-0225180, and the MacCHESS resource is supported by National Center for Research Resources (NCRR), NIH Award RR-01646.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Anderrson JF, 2011, J MOL BIOL, V411, P870, DOI 10.1016/j.jmb.2011.06.016; Anderson JF, 2010, J MOL BIOL, V400, P665, DOI 10.1016/j.jmb.2010.05.023; Baets J, 2010, NEUROLOGY, V75, P1181, DOI 10.1212/WNL.0b013e3181f4d86c; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Blumkin L, 2015, EUR J PAEDIATR NEURO, V19, P472, DOI 10.1016/j.ejpn.2015.02.005; BOUCHARD JP, 1978, CAN J NEUROL SCI, V5, P61, DOI 10.1017/S0317167100024793; Bouchard JP, 1998, NEUROMUSCULAR DISORD, V8, P474, DOI 10.1016/S0960-8966(98)00055-8; Bradshaw TY, 2016, HUM MOL GENET, V25, P3232, DOI 10.1093/hmg/ddw173; Criscuolo C, 2015, J NEUROL, V262, P2755, DOI 10.1007/s00415-015-7911-4; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Girard M, 2012, P NATL ACAD SCI USA, V109, P1661, DOI 10.1073/pnas.1113166109; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Grynberg M, 2003, TRENDS BIOCHEM SCI, V28, P224, DOI 10.1016/S0968-0004(03)00060-4; Guernsey DL, 2010, J NEUROL SCI, V288, P79, DOI 10.1016/j.jns.2009.09.034; Kamionka M, 2004, PROTEIN SCI, V13, P2370, DOI 10.1110/ps.04824304; Kozlov G, 2011, J BIOL CHEM, V286, P20407, DOI 10.1074/jbc.M111.232884; Lariviere R, 2015, HUM MOL GENET, V24, P727, DOI 10.1093/hmg/ddu491; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Li XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137298; Liu L, 2016, J NEUROL SCI, V362, P111, DOI 10.1016/j.jns.2016.01.026; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; MATSUMURA M, 1984, J BACTERIOL, V160, P413, DOI 10.1128/JB.160.1.413-420.1984; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Richter AM, 2004, NEUROGENETICS, V5, P165, DOI 10.1007/s10048-004-0179-y; Romano A, 2013, HUM MUTAT, V34, P525, DOI 10.1002/humu.22269; Seo YH, 2015, ARCH PHARM RES, V38, P1582, DOI 10.1007/s12272-015-0636-1; Shrestha L, 2016, CELL CHEM BIOL, V23, P158, DOI 10.1016/j.chembiol.2015.12.006; Sung N, 2016, ACTA CRYSTALLOGR D, V72, P904, DOI 10.1107/S2059798316009906; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takado Y, 2007, MOVEMENT DISORD, V22, P748, DOI 10.1002/mds.21365; Thiffault I, 2013, CAN J NEUROL SCI, V40, P61, DOI 10.1017/S0317167100012968; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Vermeer S, 2008, NEUROGENETICS, V9, P207, DOI 10.1007/s10048-008-0131-7; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wriggers W, 2001, STRUCTURE, V9, P779, DOI 10.1016/S0969-2126(01)00648-7	49	6	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12832	12842		10.1074/jbc.RA118.003939	http://dx.doi.org/10.1074/jbc.RA118.003939			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29945973	Green Published, hybrid			2022-12-26	WOS:000442203500016
J	Wang, S; Ren, SW; Bai, RX; Xiao, PH; Zhou, Q; Zhou, Y; Zhou, ZG; Niu, YY; Ji, WZ; Chen, YC				Wang, Shuang; Ren, Shuaiwei; Bai, Raoxian; Xiao, Puhao; Zhou, Qin; Zhou, Yin; Zhou, Zhigang; Niu, Yuyu; Ji, Weizhi; Chen, Yongchang			No off-target mutations in functional genome regions of a CRISPR/Cas9-generated monkey model of muscular dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gel electrophoresis; gene knockout; gene mapping; gene therapy; gene silencing; gene transfer; genetic disease; CRISPR; Cas9; efficiency; nonhuman primate; off-target; safety	CYNOMOLGUS MONKEY; CRISPR-CAS9; GENERATION; CELLS; GENE	CRISPR/Cas9 is now widely used in biomedical research and has great potential for clinical applications. However, the safety and efficacy of this gene-editing technique are significant issues. Recent reports on mouse models and human cells have raised concerns that off-target mutations could hamper applying the CRISPR technology in patients. The high similarities of nonhuman primates to humans in genome content and organization, genetic diversity, physiology, and cognitive abilities have made these animals ideal experimental models for understanding human diseases and developing therapeutics. Off-target mutations of CRISPR/Cas9 have been analyzed in previous studies of nonhuman primates, but no report has investigated genome-wide off-target effects in living monkeys. Here, we used rhesus monkeys in which a genetic disorder mimicking Duchenne muscular dystrophy had previously been produced with CRISPR/Cas9. Using whole-genome sequencing to comprehensively assess on- and off-target mutations in these animals, we found that CRISPR/Cas9-based gene editing is active on the expected genomic sites without producing off-target modifications in other functional regions of the genome. These findings suggest that the CRISPR/Cas9 technique could be relatively safe and effective in modeling genetic disease in nonhuman primates and in future therapeutic research of human diseases.	[Wang, Shuang; Ren, Shuaiwei; Bai, Raoxian; Xiao, Puhao; Zhou, Qin; Zhou, Yin; Zhou, Zhigang; Niu, Yuyu; Ji, Weizhi; Chen, Yongchang] Kunming Univ Sci & Technol, Inst Primate Translat Med, Yunnan Key Lab Primate Biomed Res, Kunming 650500, Yunnan, Peoples R China; [Wang, Shuang; Ren, Shuaiwei; Bai, Raoxian; Xiao, Puhao; Zhou, Qin; Zhou, Yin; Zhou, Zhigang; Niu, Yuyu; Ji, Weizhi; Chen, Yongchang] Yunnan Prov Acad Sci & Technol, Kunming 650051, Yunnan, Peoples R China	Kunming University of Science & Technology	Ji, WZ; Chen, YC (corresponding author), Kunming Univ Sci & Technol, Inst Primate Translat Med, Kunming 650500, Yunnan, Peoples R China.	wji@lpbr.cn; chenyc@lpbr.cn			National Key Research and Development Program of China [2018YFA0107902, 2016YFA010401]; National Natural Science Foundation of China [U1602224]; Basic Research Project of Yunnan Province [2015FA037]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Project of Yunnan Province	This work was supported by National Key Research and Development Program of China Grants 2018YFA0107902 and 2016YFA010401, National Natural Science Foundation of China Grant U1602224, and Basic Research Project of Yunnan Province Grant 2015FA037. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson KR, 2018, NAT METHODS, V15, P512, DOI 10.1038/s41592-018-0011-5; Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120; Cui YQ, 2018, CELL RES, V28, P383, DOI 10.1038/cr.2018.10; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2014, J BIOL CHEM, V289, P4594, DOI 10.1074/jbc.R113.488247; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Zhao H, 2017, CELL RES, V27, P1293, DOI 10.1038/cr.2017.95	14	23	24	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11654	11658		10.1074/jbc.AC118.004404	http://dx.doi.org/10.1074/jbc.AC118.004404			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29941452	Green Published, hybrid			2022-12-26	WOS:000440134500001
J	George, G; Chetty, T; Strauss, M; Inoti, S; Kinyanjui, S; Mwai, E; Romo, ML; Oruko, F; Odhiambo, JO; Nyaga, E; Mantell, JE; Govender, K; Kelvin, EA				George, Gavin; Chetty, Taruna; Strauss, Michael; Inoti, Silas; Kinyanjui, Samuel; Mwai, Eva; Romo, Matthew L.; Oruko, Faith; Odhiambo, Jacob O.; Nyaga, Eston; Mantell, Joanne E.; Govender, Kaymarlin; Kelvin, Elizabeth A.			Costing analysis of an SMS-based intervention to promote HIV self-testing amongst truckers and sex workers in Kenya	PLOS ONE			English	Article							DRIVERS; PREVALENCE; RISK; SERVICES; AFRICA; WOMEN	Objective HIV testing rates in many sub-Saharan African countries have remained suboptimal, and there is an urgent need to explore strategic yet cost-effective approaches to increase the uptake of HIV testing, especially among high-risk populations. Methods A costing analysis was conducted for a randomized controlled trial (RCT) with male truckers and female sex workers (FSWs) registered in the electronic health record system (EHRS) of the North Star Alliance, which offers healthcare services at major transit hubs in Southern and East Africa. The RCT selected a sample of truckers and FSWs who were irregular HIV testers, according to the EHRS, and evaluated the effect of SMSs promoting the availability of HIV self-testing (HIVST) kits in Kenyan clinics (intervention program) versus a general SMS reminding clients to test for HIV (enhanced and standard program) on HIV testing rates. In this paper, we calculated costs from a provider perspective using a mixed-methods approach to identify, measure, and value the resources utilized within the intervention and standard programs. The results of the analysis reflect the cost per client tested. Results The cost of offering HIVST was calculated to be double that of routine facility-based testing (USD 10.13 versus USD 5.01 per client tested), primarily due to the high price of the self-test kit. In the two study arms that only offered provider-administered HIV testing in the clinic, only 1% of truckers and 6% of FSWs tested during the study period, while in the intervention arm, which also offered HST, approximately 4% of truckers and 11% of FSWs tested. These lower than expected outcomes resulted in relatively high cost per client estimates for all three study arms. Within the intervention arm, 65% of truckers and 72% of FSWs who tested chose the HIVST option. However, within the intervention arm, the cost per additional client tested was lower for FSWs than for truckers, at USD 0.15 per additional client tested versus USD 0.58 per additional client tested, driven primarily by the higher response rates. Conclusion Whilst the availability of HIVST increased HIV testing among both truckers and FSWs, the cost of providing HIVST is higher than that of a routine health facility-based test, driven primarily by the price of the HIV self-test kit. Future research needs to identify strategies which increase demand for HIVST, and determine whether these strategies and the subsequent increased demand for HIVST are cost-effective in relation to the conventional facility based testing currently available.	[George, Gavin; Chetty, Taruna; Strauss, Michael; Govender, Kaymarlin] Univ KwaZulu Natal, Hlth Econ & HIV & AIDS Res Div, Durban, South Africa; [Inoti, Silas; Kinyanjui, Samuel; Mwai, Eva; Oruko, Faith; Odhiambo, Jacob O.; Nyaga, Eston] North Star Alliance, Nairobi, Kenya; [Romo, Matthew L.; Kelvin, Elizabeth A.] CUNY, Dept Epidemiol & Biostat, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Romo, Matthew L.; Kelvin, Elizabeth A.] CUNY, Inst Implementat Sci Populat Hlth, New York, NY 10021 USA; [Mantell, Joanne E.] New York State Psychiat Inst & Hosp, HIV Ctr Clin & Behav Studies, Dept Psychiat, Div Gender Sexual & Hlth, New York, NY 10032 USA; [Mantell, Joanne E.] Columbia Univ, New York, NY USA	University of Kwazulu Natal; City University of New York (CUNY) System; City University of New York (CUNY) System; New York State Psychiatry Institute; Columbia University	George, G (corresponding author), Univ KwaZulu Natal, Hlth Econ & HIV & AIDS Res Div, Durban, South Africa.	georgeg@ukzn.ac.za	George, Gavin L/N-5756-2013; Govender, Kaymarlin/M-1660-2019	George, Gavin L/0000-0001-7258-8470; Romo, Matthew/0000-0002-3038-0644; govender, kaymarlin/0000-0002-9586-1510	International Initiative for Impact Evaluation [TW2.2.06]; instein-Rockefeller-CUNY Center for AIDS Research [P30-A1124414]; National Institutes of Health (NIH); NIAID; NCI; NICHD; NHBL; NIDA; NIMH; NIA; FIC; OAR; National Institute of Mental Health (NIMH); Columbia University [P30-MH43520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI124414] Funding Source: NIH RePORTER	International Initiative for Impact Evaluation; instein-Rockefeller-CUNY Center for AIDS Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHBL; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC; OAR; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Columbia University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a grant from the International Initiative for Impact Evaluation (31E # TW2.2.06 supplement, Kelvin Principal Investigator) (EK). Elizabeth Kelvin was also supported by the Einstein-Rockefeller-CUNY Center for AIDS Research [P30-A1124414] which is supported by the following National Institutes of Health (NIH) Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHBL, NIDA, NIMH, NIA, FIC and OAR. Support for Joanne Mantel also came from a center grant from the National Institute of Mental Health (NIMH) to the HIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University [P30-MH43520; Principal Investigator: Robert H. Remien, Ph.D.].	Azuonwu O, 2011, J COMMUN HEALTH, V36, P583, DOI 10.1007/s10900-010-9344-4; Botao C, 2016, AIDS BEHAV, V20, P811, DOI 10.1007/s10461-015-1194-8; BWAYO JJ, 1991, E AFR MED J, V68, P714; Cambiano V, 2015, J INFECT DIS, V212, P570, DOI 10.1093/infdis/jiv040; Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Conserve DF, 2017, J TELEMED TELECARE, V23, P347, DOI 10.1177/1357633X16639186; Creese A, 1994, COST ANAL PRIMARY HL; de Tolly K, 2012, TELEMED E-HEALTH, V18, P18, DOI 10.1089/tmj.2011.0058; Delany-Moretlwe S, 2014, INT J STD AIDS, V25, P428, DOI 10.1177/0956462413512803; Frye V, 2017, LANCET HIV, V4, pE232, DOI 10.1016/S2352-3018(17)30024-3; Grabbe KL, 2010, JAIDS-J ACQ IMM DEF, V54, P317, DOI 10.1097/QAI.0b013e3181ced126; Granich R, 2017, LANCET, V390, P341, DOI 10.1016/S0140-6736(17)31872-X; Heard AC, 2016, AIDS CARE, V28, P1528, DOI 10.1080/09540121.2016.1191602; Hendriks ME, 2014, STEP BY STEP GUIDELI, V2014, P7; International Labour Organisation, 2005, HIV AIDS TRANSP SECT; IRIN, 2013, TACKL HIV KEN TRANSP; Jamil MS, 2017, LANCET HIV, V4, pE241, DOI 10.1016/S2352-3018(17)30023-1; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2000, COST GUID HIV PREV S; KELVIN EA, 2017, AIDS CARE; Kelvin EA, 2018, AIDS BEHAV, V22, P580, DOI 10.1007/s10461-017-1783-9; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Maheswaran H, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0577-7; Mavedzenge SN, 2013, CLIN INFECT DIS, V57, P126, DOI 10.1093/cid/cit156; Njuguna N, 2016, SEX TRANSM DIS, V43, P353, DOI 10.1097/OLQ.0000000000000450; Ojo O, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005274.pub3; Patel AR, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006078; Progressio, 2013, HIV ZIMB TAL TRUCK D; Rakwar J, 1999, AIDS, V13, P607, DOI 10.1097/00002030-199904010-00010; Ramjee G, 2002, SEX TRANSM DIS, V29, P44, DOI 10.1097/00007435-200201000-00008; Regondi I, 2013, DEV SO AFR, V30, P616, DOI 10.1080/0376835X.2013.830239; Strauss M, 2018, AIDS CARE, V30, P72, DOI 10.1080/09540121.2017.1367086; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; The Campbell and Cochrane Economics Methods Group ( CCEMG) and the Evidence for Policy and Practice Information and Coordinating Centre ( EPPI- Centre), 2016, CCEMG EPPI CTR COST; Thirumurthy H, 2016, LANCET HIV, V3, pE266, DOI 10.1016/S2352-3018(16)00041-2; World Health Organization, 2017, MARK TECHN LANDSC 20	35	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0197305	10.1371/journal.pone.0197305	http://dx.doi.org/10.1371/journal.pone.0197305			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM1FJ	29979704	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500002
J	Himel, AR; Cabral, SA; Shaffery, JP; Grayson, BE				Himel, Alexandra R.; Cabral, Sharon A.; Shaffery, James P.; Grayson, Bernadette E.			Anxiety behavior and hypothalamic-pituitary-adrenal axis altered in a female rat model of vertical sleeve gastrectomy	PLOS ONE			English	Article							GASTRIC BYPASS-SURGERY; NATIONAL EPIDEMIOLOGIC SURVEY; BODY-MASS INDEX; QUALITY-OF-LIFE; BARIATRIC SURGERY; PSYCHIATRIC-DISORDERS; SELF-HARM; METABOLIC SYNDROME; MESSENGER-RNA; WEIGHT-LOSS	Surgical weight loss results in a host of metabolic changes that culminate in net positive health benefit to the patients. However, the psychological impact of these surgeries has not been fully studied. On one hand, surgical weight loss has been reported to improve standard quality of life and resolution of symptoms of depression. But on the other hand, reports of self-harm and increased ER visits for self-harm suggest other psychological difficulties. Inability to handle anxiety following surgical weight loss has alarming potential ramifications for these gastric surgery patients. In the present study, we used models of diet-induced obesity and vertical sleeve gastrectomy (VSG) to ask whether anxiety behavior and hypothalamic-pituitary-adrenal (HPA) axis gene changes were affected by surgical weight loss under two diet regimens: i.e. low-fat diet (LFD) and high-fat diet (HFD). We show reduced exploratory behavior in the open field test but increased time in the open arms of the elevated plus maze. Furthermore, we show increased plasma levels of corticosterone in female VSG recipients in the estrus phase and increased levels of hypothalamic arginine-vasopressin (avp), pro-opiomelanocortin (pomc), and tyrosine hydroxylase (th). We report reduced dopamine receptor D1 (drd1) gene in prefrontal cortex (PFC) in VSG animals in comparison to Sham. Further we report diet-driven changes in stress-relevant gene targets in the hypothalamus (oxt, pomc, crhr1) and adrenal (nr3c1, nr3c2, mc2r). Taken together, these data suggest a significant impact of both surgical weight loss and diet on the HPA axis and further impact on behavior. Additional assessment is necessary to determine whether molecular and hormonal changes of surgical weight loss are the source of these findings.	[Himel, Alexandra R.; Grayson, Bernadette E.] Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA; [Cabral, Sharon A.; Shaffery, James P.] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Grayson, BE (corresponding author), Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA.	bgrayson@umc.edu			Department of Defense [SC150016]; National Institute of General Medical Sciences [P20GM104357, P20GM121334]; National Institute of General Medical Sciences of the National Institutes of Health, Center for Psychiatric Neuroscience (CPN)-COBRE [P30GM103328]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357, P20GM121334] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences of the National Institutes of Health, Center for Psychiatric Neuroscience (CPN)-COBRE; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	BEG is supported by the Department of Defense Award Number SC150016 and partially by the National Institute of General Medical Sciences Award Number P20GM104357 and P20GM121334. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The work performed by SAC and JPS is through the Animal Behavior Core supported, in part, by funds from the National Institute of General Medical Sciences of the National Institutes of Health, Center for Psychiatric Neuroscience (CPN)-COBRE (P30GM103328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbatini F, 2010, SURG ENDOSC, V24, P1005, DOI 10.1007/s00464-009-0715-9; Aguera Z, 2015, EUR EAT DISORD REV, V23, P509, DOI 10.1002/erv.2404; Angrisani L, 2017, OBES SURG, V27, P2279, DOI 10.1007/s11695-017-2666-x; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Batsis JA, 2008, MAYO CLIN PROC, V83, P897, DOI 10.4065/83.8.897; Bhatti JA, 2016, JAMA SURG, V151, P226, DOI 10.1001/jamasurg.2015.3414; Buchwald H., 2004, JAMA (Journal of the American Medical Association), V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0; Burgmer R, 2014, OBES SURG, V24, P1670, DOI 10.1007/s11695-014-1226-x; Canetti L, 2016, EUR J CLIN NUTR, V70, P17, DOI 10.1038/ejcn.2015.112; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Coleman KJ, 2014, SURG OBES RELAT DIS, V10, P396, DOI 10.1016/j.soard.2014.02.044; Coluccia A, 2007, NEUROTOXICOL TERATOL, V29, P282, DOI 10.1016/j.ntt.2006.10.005; Cortese S, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0754-1; Cortese S, 2016, AM J PSYCHIAT, V173, P34, DOI 10.1176/appi.ajp.2015.15020266; Cortese S, 2013, BRIT J PSYCHIAT, V203, P24, DOI 10.1192/bjp.bp.112.123299; Deblon N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025565; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x; Dreber H, 2017, CLIN OBES, V7, P1, DOI 10.1111/cob.12170; Duncan PM, 2001, PHARMACOL BIOCHEM BE, V69, P291, DOI 10.1016/S0091-3057(01)00538-X; Figlewicz DP, 1998, BRAIN RES BULL, V46, P199, DOI 10.1016/S0361-9230(98)00009-4; Fisher D, 2017, OBESITY, V25, P850, DOI 10.1002/oby.21814; Fox CK, 2016, CLIN PEDIATR, V55, P1120, DOI 10.1177/0009922815615825; Goldstein RB, 2008, COMPR PSYCHIAT, V49, P225, DOI 10.1016/j.comppsych.2007.10.005; Grayson BE, 2014, INT J OBESITY, V38, P349, DOI 10.1038/ijo.2013.100; Grayson BE, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0126-x; Grayson BE, 2014, STRESS, V17, P484, DOI 10.3109/10253890.2014.967677; Grayson BE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006505; Hankir MK, 2017, CELL METAB, V25, P335, DOI 10.1016/j.cmet.2016.12.006; Herpertz S, 2015, SURG OBES RELAT DIS, V11, P1361, DOI 10.1016/j.soard.2015.04.008; Hoffman KL, 2016, 3 MODELING DISORDERS, P87; Hsu CY, 2010, J GASTROEN HEPATOL, V25, P1321, DOI 10.1111/j.1440-1746.2010.06235.x; Huang Hui-Chun, 2007, J Chin Med Assoc, V70, P16; Hussain T, 2017, J CLIN DIAGN RES, V11, pVC05, DOI 10.7860/JCDR/2017/25801.10011; Jarvholm K, 2012, OBESITY, V20, P318, DOI 10.1038/oby.2011.310; Kinley DJ, 2015, GEN HOSP PSYCHIAT, V37, P288, DOI 10.1016/j.genhosppsych.2015.03.022; Klonsky ED, 2003, AM J PSYCHIAT, V160, P1501, DOI 10.1176/appi.ajp.160.8.1501; Komada Munekazu, 2008, J Vis Exp, DOI 10.3791/1088; Kovacs Z, 2017, ACTA PSYCHIAT SCAND, V135, P149, DOI 10.1111/acps.12669; Lawson WJ, 2017, MENOPAUSE, V24, P426, DOI 10.1097/GME.0000000000000764; LEVIN BE, 1979, BRAIN RES, V171, P560, DOI 10.1016/0006-8993(79)91063-1; LEVIN BE, 1986, PHARMACOL BIOCHEM BE, V24, P299, DOI 10.1016/0091-3057(86)90354-0; MAKINO S, 1995, ENDOCRINOLOGY, V136, P3299, DOI 10.1210/en.136.8.3299; Malpass GE, 2010, BASIC CLIN PHARMACOL, V106, P435, DOI 10.1111/j.1742-7843.2010.00544.x; Mannan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157240; Matini Diana, 2014, Med J Islam Repub Iran, V28, P109; Moreira FP, 2017, J PSYCHIATR RES, V92, P119, DOI 10.1016/j.jpsychires.2017.03.025; Murphy R, 2018, OBES SURG, V28, P293, DOI 10.1007/s11695-017-2872-6; Neovius M, 2018, LANCET DIABETES ENDO, V6, P197, DOI 10.1016/S2213-8587(17)30437-0; Pedditizi E, 2016, AGE AGEING, V45, P14, DOI 10.1093/ageing/afv151; Petkova B, 1991, EFFECT AT 2 EXPLORAT; Petry NM, 2008, PSYCHOSOM MED, V70, P288, DOI 10.1097/PSY.0b013e3181651651; Rajan TM, 2017, J POSTGRAD MED, V63, P182, DOI 10.4103/jpgm.JPGM_712_16; Rosenberger PH, 2006, J CLIN PSYCHIAT, V67, P1080, DOI 10.4088/JCP.v67n0710; Rutledge T, 2012, OBES SURG, V22, P1734, DOI 10.1007/s11695-012-0722-0; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Sierzantowicz R, 2017, ADV CLIN EXP MED, V26, P491, DOI 10.17219/acem/62246; Spann RA, 2018, CLIN SCI, V132, P295, DOI 10.1042/CS20171416; Stefater MA, 2010, GASTROENTEROLOGY, V138, P2426, DOI 10.1053/j.gastro.2010.02.059; Strassnig M, 2017, BIPOLAR DISORD, V19, P336, DOI 10.1111/bdi.12505; Tindle HA, 2010, AM J MED, V123, P1036, DOI 10.1016/j.amjmed.2010.06.016; Vangoitsenhoven R, 2016, ACTA CLIN BELG, V71, P395, DOI 10.1080/17843286.2016.1174393; William J, 2017, MENOPAUSE; Willmer M, 2015, OBES SURG, V25, P319, DOI 10.1007/s11695-014-1398-4	64	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200026	10.1371/journal.pone.0200026	http://dx.doi.org/10.1371/journal.pone.0200026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM1FJ	29979735	Green Published, gold, Green Submitted			2022-12-26	WOS:000437809500054
J	Carron, M; Ieppariello, G; Martelli, G; Gabellini, G; Foletto, M; Perissinotto, E; Ori, C				Carron, Michele; Ieppariello, Giovanna; Martelli, Gabriele; Gabellini, Giulia; Foletto, Mirto; Perissinotto, Egle; Ori, Carlo			Dual effects of leptin in perioperative gas exchange of morbidly obese patients	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; BARIATRIC SURGERY; POSTOPERATIVE HYPOXEMIA; RESPIRATORY-FUNCTION; CIRCULATING LEPTIN; GENDER-DIFFERENCES; LUNG-VOLUMES; SERUM LEPTIN; BODY-MASS; ASTHMA	Leptin has shown positive effects on respiratory function in experimental settings. The role of leptin on perioperative respiratory function in morbidly obese patients has not been established. We performed a retrospective analysis of morbidly obese patients undergoing laparoscopic sleeve gastrectomy. Fasting serum leptin and interleukin (IL)-6 were measured preoperatively, and arterial blood gases were obtained pre- and postoperatively. Outcome variables were arterial partial pressure of oxygen (PaO2), arterial partial pressure of carbon dioxide (PaCO2), and differences in PaO2 and PaCO2 between pre- and postoperative values (Delta PaO2, Delta PaCO2; postoperative minus preoperative). Patients with lower (< 40 mu g/L) and higher (>= 40 mu g/L) leptin levels were compared. Bravais-Pearson's correlation, multiple linear regression, and logistic regression analysis were performed. A total of 112 morbidly obese patients were included. Serum leptin was significantly higher in females than in males (42.86 +/- 12.89 vs. 30.67 +/- 13.39 mu g/L, p<0.0001). Leptin was positively correlated with body mass index (r = 0.238; p = 0.011), IL-6 (r = 0.473; p<0.0001), and Delta PaO2 (r = 0.312; p = 0.0008). Leptin was negatively correlated with preoperative PaO2 (r= -0.199; p = 0.035). Preoperative PaO2 was lower, Delta PaCO2 was smaller, and Delta PaO2 was greater in the high leptin group than in the low leptin group. In multiple regression analysis, leptin was negatively associated with preoperative PaO2 (estimate coefficient = -0.147; p = 0.023). In logistic regression analysis, leptin was associated with improved Delta PaO2 (odds ratio [OR] = 1.104; p = 0.0138) and Delta PaCO2 (OR = 0.968; p = 0.0334). Leptin appears to have dual effects related to perioperative gas exchange in obese patients undergoing bariatric surgery. It is associated with worse preoperative oxygenation but improved respiratory function after surgery.	[Carron, Michele; Ieppariello, Giovanna; Martelli, Gabriele; Gabellini, Giulia; Ori, Carlo] Univ Padua, Sect Anesthesiol & Intens Care, Dept Med DIMED, Padua, Italy; [Foletto, Mirto] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Sect Surg, Padua, Italy; [Perissinotto, Egle] Univ Padua, Dept Cardiac Thorac & Vasc, Unit Biostat Epidemiol & Publ Hlth, Padua, Italy	University of Padua; University of Padua; University of Padua	Carron, M (corresponding author), Univ Padua, Sect Anesthesiol & Intens Care, Dept Med DIMED, Padua, Italy.	michele.carron@unipd.it	Foletto, Mirto/AAD-4525-2021; foletto, mirto/I-5182-2018	foletto, mirto/0000-0001-6594-4852; Martelli, Gabriele/0000-0001-6729-2982	Department of Medicine at the University of Padua	Department of Medicine at the University of Padua	The authors would like to acknowledge the support of the Department of Medicine at the University of Padua. The authors received no specific funding for this work.	Adams JP, 2000, BRIT J ANAESTH, V85, P91, DOI 10.1093/bja/85.1.91; Ahmad S, 2008, ANESTH ANALG, V107, P138, DOI 10.1213/ane.0b013e318174df8b; Bassi M, 2015, LIFE SCI, V125, P25, DOI 10.1016/j.lfs.2015.01.019; Boon M, 2016, BRIT J ANAESTH, V117, P410, DOI 10.1093/bja/aew246; Carron M, 2012, BRIT J ANAESTH, V109, P829, DOI 10.1093/bja/aes368; Carron M, 2013, OBES SURG, V23, P1558, DOI 10.1007/s11695-013-0926-y; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Fantuzzi G, 2013, CYTOKINE, V64, P1, DOI 10.1016/j.cyto.2013.06.317; Futier E, 2014, ANESTHESIOLOGY, V121, P400, DOI 10.1097/ALN.0000000000000335; Gruchala-Niedoszytko M, 2013, ADV MED SCI-POLAND, V58, P15, DOI 10.2478/v10039-012-0082-y; Guler N, 2004, J ALLERGY CLIN IMMUN, V114, P254, DOI 10.1016/j.jaci.2004.03.053; Hellstrom L, 2000, J INTERN MED, V247, P457, DOI 10.1046/j.1365-2796.2000.00678.x; Jenks MZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07473-5; Ji Q, 2008, CIRC J, V72, P1975, DOI 10.1253/circj.CJ-08-0369; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Keglowich L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089875; Littleton SW, 2012, RESPIROLOGY, V17, P43, DOI 10.1111/j.1440-1843.2011.02096.x; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; Malli F, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-152; McGlinch BP, 2006, MAYO CLIN PROC, V81, pS25; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; O'Donnell CP, 2000, RESP PHYSIOL, V119, P163, DOI 10.1016/S0034-5687(99)00111-5; Olfert IM, 2004, J PHYSIOL-LONDON, V557, P529, DOI 10.1113/jphysiol.2003.056887; Parameswaran Krishnan, 2006, Can Respir J, V13, P203; Pelosi P, 1996, CHEST, V109, P144, DOI 10.1378/chest.109.1.144; Pelosi P, 1998, ANESTH ANALG, V87, P654, DOI 10.1097/00000539-199809000-00031; Pelosi P, 2010, BEST PRACT RES-CLIN, V24, P211, DOI 10.1016/j.bpa.2010.02.001; Phipps PR, 2002, THORAX, V57, P75, DOI 10.1136/thorax.57.1.75; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Seyfart T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189042; Shapiro SD, 2014, J APPL PHYSIOL, V116, P1334, DOI 10.1152/japplphysiol.00958.2013; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Shore SA, 2010, J APPL PHYSIOL, V108, P735, DOI 10.1152/japplphysiol.00749.2009; Sideleva O, 2012, AM J RESP CRIT CARE, V186, P598, DOI 10.1164/rccm.201203-0573OC; Sood A, 2006, THORAX, V61, P300, DOI 10.1136/thx.2004.031468; Sood A, 2010, J APPL PHYSIOL, V108, P744, DOI 10.1152/japplphysiol.00838.2009; Steier J, 2014, THORAX, V69, P752, DOI 10.1136/thoraxjnl-2014-205148; Stelzer I, 2012, TRANSL RES, V159, P118, DOI 10.1016/j.trsl.2011.10.001; Tatsumi K, 2005, CHEST, V127, P716, DOI 10.1378/chest.127.3.716; Thomas PS, 2001, IMMUNOL CELL BIOL, V79, P132, DOI 10.1046/j.1440-1711.2001.00980.x; Tung A, 2010, BRIT J ANAESTH, V105, pI24, DOI 10.1093/bja/aeq293; VAUGHAN RW, 1975, ANN SURG, V182, P705, DOI 10.1097/00000658-197512000-00008; White DP, 2005, AM J RESP CRIT CARE, V172, P1363, DOI 10.1164/rccm.200412-1631SO; Yao QL, 2016, SLEEP, V39, P1097, DOI 10.5665/sleep.5762; Yee BJ, 2006, RESPIRATION, V73, P209, DOI 10.1159/000088358; Zavorsky GS, 2008, OBES REV, V9, P326, DOI 10.1111/j.1467-789X.2008.00471.x; Zavorsky GS, 2007, CHEST, V131, P362, DOI 10.1378/chest.06-1513; Zavorsky GS, 2008, OBES SURG, V18, P1587, DOI 10.1007/s11695-008-9527-6	48	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199610	10.1371/journal.pone.0199610	http://dx.doi.org/10.1371/journal.pone.0199610			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975721	Green Submitted, Green Published, gold			2022-12-26	WOS:000437424500041
J	Davidsen, J; Larsen, S; Coskun, M; Gogenur, I; Dahlgaard, K; Bennett, EP; Troelsen, JT				Davidsen, Johanne; Larsen, Sylvester; Coskun, Mehmet; Gogenur, Ismail; Dahlgaard, Katja; Bennett, Eric Paul; Troelsen, Jesper Thorvald			The VTI1A-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; COLORECTAL-CANCER; GENE-EXPRESSION; DOWN-REGULATION; CATENIN; PROLIFERATION; HOMEOSTASIS; ISOFORMS; BINDING; CACO-2	Sequencing of primary colorectal tumors has identified a gene fusion in approximately 3% of colorectal cancer patients of the VTI1A and TCF7L2 genes, encoding a VTI1A-TCF4 fusion protein containing a truncated TCF4. As dysregulation of the Wnt signaling pathway is associated with colorectal cancer development and progression, the functional properties and transcriptional regulation of the VTI1A-TCF4 fusion protein may also play a role in these processes. Functional characteristics of the VTI1A-TCF4 fusion protein in Wnt signaling were analyzed in NCI-H508 and LS174T colon cancer cell lines. The NCI-H508 cell line, containing the VTI1A-TCF7L2 fusion gene, showed no active Wnt signaling, and overexpression of the VTI1A-TCF4 fusion protein in LS174T cells along with a Wnt signaling luciferase reporter plasmid showed inhibition of activity. The transcriptional regulation of the VTI1A-TCF4 fusion gene was investigated in LS174T cells where the activity of the VTI1A promoter was compared to that of the TCF7L2 promoter, and the transcription factor CDX2 was analyzed for gene regulatory activity of the VTI1A promoter through luciferase reporter gene assay using colon cancer cell lines as a model. Transfection of LS174T cells showed that the VTI1A promoter is highly active compared to the TCF7L2 promoter, and that CDX2 activates transcription of VTI1A. These results suggest that the VTI1A-TCF4 fusion protein is a dominant negative regulator of the Wnt signaling pathway, and that transcription of VTI1A is activated by CDX2.	[Davidsen, Johanne; Larsen, Sylvester; Dahlgaard, Katja; Troelsen, Jesper Thorvald] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark; [Davidsen, Johanne; Gogenur, Ismail] Zealand Univ Hosp, Dept Surg, Roskilde, Denmark; [Larsen, Sylvester] Naestved Hosp, Dept Clin Immunol, Naestved, Denmark; [Coskun, Mehmet] Herlev Hosp, Dept Gastroenterol, Herlev, Denmark; [Bennett, Eric Paul] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Odontol, Copenhagen, Denmark	Roskilde University; Naestved Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Troelsen, JT (corresponding author), Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark.	troelsen@ruc.dk	Bennett, Eric/AAG-6120-2020; Davidsen, Johanne/O-8904-2016; Troelsen, Jesper Thorvald T/B-6264-2013	Bennett, Eric/0000-0002-4976-0647; Davidsen, Johanne/0000-0003-4655-1513; Troelsen, Jesper Thorvald T/0000-0002-4177-3267; Gogenur, Ismail/0000-0002-3753-268X; Dahlgaard, Katja/0000-0002-2822-4685; Larsen, Sylvester/0000-0002-5736-8055	Sundhed og Sygdom, Det Frie Forskningsrad [4004-00140B]; University of Copenhagen Excellence Programme for Interdiciplinary Research [CDO2016]; Danmarks Grundforskningsfond [DNRF107]	Sundhed og Sygdom, Det Frie Forskningsrad; University of Copenhagen Excellence Programme for Interdiciplinary Research; Danmarks Grundforskningsfond(Danmarks Grundforskningsfond)	This work was supported by Sundhed og Sygdom, Det Frie Forskningsrad (4004-00140B) (Dr Jesper Thorvald Troelsen); University of Copenhagen Excellence Programme for Interdiciplinary Research (CDO2016) (Dr Eric Paul Bennett); and Danmarks Grundforskningsfond (DNRF107) (Dr Eric Paul Bennett). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus-Hill ML, 2011, P NATL ACAD SCI USA, V108, P4914, DOI 10.1073/pnas.1102300108; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Boyd M, 2010, J BIOL CHEM, V285, P25115, DOI 10.1074/jbc.M109.089516; Coskun M, 2012, BBA-MOL BASIS DIS, V1822, P843, DOI 10.1016/j.bbadis.2012.01.012; Erdfelder F, 2010, HEMATOL REP, V2, P24, DOI 10.4081/hr.2010.e3; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Goncalves V, 2008, RNA, V14, P2538, DOI 10.1261/rna.1253408; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Hryniuk A, 2014, J BIOL CHEM, V289, P33343, DOI 10.1074/jbc.M114.583823; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kriegl L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-123; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Li YR, 2009, CANCER RES, V69, P3332, DOI 10.1158/0008-5472.CAN-08-3380; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariadason JM, 2001, CANCER RES, V61, P3465; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Natoli M, 2013, EUR J PHARM BIOPHARM, V85, P20, DOI 10.1016/j.ejpb.2013.03.018; Nome T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091264; Olsen AK, 2013, CARCINOGENESIS, V34, P1361, DOI 10.1093/carcin/bgt037; Olsen AK, 2012, AM J PHYSIOL-GASTR L, V302, pG277, DOI 10.1152/ajpgi.00362.2011; Olsen J, 2014, SURG ONCOL, V23, P167, DOI 10.1016/j.suronc.2014.07.003; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Pinto R, 2017, NUCLEIC ACIDS RES, V45, P1; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Salari K, 2012, P NATL ACAD SCI USA, V109, pE3196, DOI 10.1073/pnas.1206004109; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Verzi MP, 2010, P NATL ACAD SCI USA, V107, P15157, DOI 10.1073/pnas.1003822107	34	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200215	10.1371/journal.pone.0200215	http://dx.doi.org/10.1371/journal.pone.0200215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975781	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500078
J	Stuart-Fox, D; Newton, E; Mulder, RA; D'Alba, L; Shawkey, MD; Igic, B				Stuart-Fox, Devi; Newton, Elizabeth; Mulder, Raoul A.; D'Alba, Liliana; Shawkey, Matthew D.; Igic, Branislav			The microstructure of white feathers predicts their visible and near-infrared reflectance properties	PLOS ONE			English	Article							STRUCTURAL COLORS; REGRESSION; BIRDS	Research on the optical properties of animal integuments, including fur, feather, skin and cuticle, has focussed almost exclusively on animal-visible wavelengths within the narrow range of 300-700 nm. By contrast, the near-infrared (NIR) portion of direct sunlight, spanning 700-2600 nm, has been largely ignored despite its potentially important thermal consequences. We quantified variation in visible and NIR reflectance and transmission for white body contour feathers of 50 bird species, and examined how well they are predicted by feather macro- and micro-structural morphology. Both visible and NIR reflectance of the feathers varied substantially across species. Larger, thicker, and sparser feathers that are characteristic of larger species, and feathers with rounder barbs and more closely spaced barbules, had high average reflectance, particularly within avian-visible wavelengths (300700 nm). Feathers with rounder barbs and more closely situated barbules also had high average reflectance, particularly for NIR wavelengths. Barb roundness and barbule density were the only predictors of NIR reflectance after accounting for variation in visible reflectance and body size. Our results highlight the potential for adaptive variation in NIR reflectance mediated by feather structure, which may inform the design of functional materials to control light and heat.	[Stuart-Fox, Devi; Newton, Elizabeth; Mulder, Raoul A.] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia; [D'Alba, Liliana; Shawkey, Matthew D.] Univ Ghent, Evolut & Opt Nanostruct Grp, Dept Biol, Ghent, Belgium; [Igic, Branislav] Australian Natl Univ, Res Sch Biol, Div Ecol & Evolut, Canberra, ACT, Australia	University of Melbourne; Ghent University; Australian National University	Stuart-Fox, D (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.	d.stuart-fox@unimelb.edu.au	D'Alba, Liliana/AAC-4969-2022	D'Alba, Liliana/0000-0002-2478-3455; Stuart-Fox, Devi/0000-0003-3362-1412	Australian Research Council [DP120100105]; Air Force Office of Scientific Research [FA9550-16-1-0331]	Australian Research Council(Australian Research Council); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This study was supported by an Australian Research Council grant (DP120100105) to DSF and Air Force Office of Scientific Research grant FA9550-16-1-0331 to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERDAHL P, 1984, APPL OPTICS, V23, P370, DOI 10.1364/AO.23.000370; Berthier S, 2005, APPL PHYS A-MATER, V80, P1397, DOI 10.1007/s00339-004-3185-x; Caro T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0333; DYCK J, 1979, Dansk Ornitologisk Forenings Tidsskrift, V73, P41; Elliott A, 2017, HDB BIRDS WORLD ALIV; Enright JM, 2015, CURR BIOL, V25, P3048, DOI 10.1016/j.cub.2015.10.018; Erbil HY, 2003, SCIENCE, V299, P1377, DOI 10.1126/science.1078365; Fox J., 2010, TIME SERIES REGRESSI; FUGLE GN, 1984, ANIM BEHAV, V32, P86, DOI 10.1016/S0003-3472(84)80327-9; Galvan I, 2008, BEHAV ECOL SOCIOBIOL, V63, P303, DOI 10.1007/s00265-008-0662-9; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; Goris RC, 2011, J HERPETOL, V45, P2, DOI 10.1670/10-238.1; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; GRANQVIST CG, 1980, APPL PHYS LETT, V36, P139, DOI 10.1063/1.91406; Gueymard CA, 2001, SOL ENERGY, V71, P325, DOI 10.1016/S0038-092X(01)00054-8; Hanssen SA, 2006, ANIM BEHAV, V71, P337, DOI 10.1016/j.anbehav.2005.04.021; Herman A, P SPIE, VViii; Ho LST, 2014, SYST BIOL, V63, P397, DOI 10.1093/sysbio/syu005; Igic B, 2018, SCI NAT-HEIDELBERG, V105, DOI 10.1007/s00114-018-1543-3; Igic B, 2016, J EXP BIOL, V219, P1851, DOI 10.1242/jeb.137182; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kinoshita S., 2008, STRUCTURAL COLORS RE; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; Mennill DJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P350, DOI 10.1007/s00265-003-0581-8; NORRIS KENNETH STAFFORD, 1967, P162; Orme D, 2013, CAPER PACKAGE COMP A, V5; Pinheiro J, 2009, R PACKAGE VERSION, V3, P96; Rephaeli E, 2013, NANO LETT, V13, P1457, DOI 10.1021/nl4004283; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Schmitz H, 1997, NATURE, V386, P773, DOI 10.1038/386773a0; SCHOR R, 1961, BIOPHYS J, V1, P467, DOI 10.1016/S0006-3495(61)86903-8; Seago AE, 2009, J R SOC INTERFACE, V6, pS165, DOI 10.1098/rsif.2008.0354.focus; Shawkey MD, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1499-8; Shawkey MD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0536; Shawkey MD, 2009, J R SOC INTERFACE, V6, pS221, DOI 10.1098/rsif.2008.0459.focus; Shawkey MD, 2005, BIOL LETTERS, V1, P121, DOI 10.1098/rsbl.2004.0289; Shcherbakov D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064429; Shi NN, 2015, SCIENCE, V349, P298, DOI 10.1126/science.aab3564; Smith G, 2016, NANOPHOTONICS-BERLIN, V5, P55, DOI 10.1515/nanoph-2016-0014; Stuart-Fox D, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0345; Sun JY, 2013, RSC ADV, V3, P14862, DOI 10.1039/c3ra41096j; Vukusic P, 2007, SCIENCE, V315, P348, DOI 10.1126/science.1134666; Wiersma DS, 2013, NAT PHOTONICS, V7, P188, DOI [10.1038/NPHOTON.2013.29, 10.1038/nphoton.2013.29]; Wu LP, 2016, ADV OPT MATER, V4, P195, DOI 10.1002/adom.201500428; Xiao M, 2015, ACS NANO, V9, P5454, DOI 10.1021/acsnano.5b01298	47	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199129	10.1371/journal.pone.0199129	http://dx.doi.org/10.1371/journal.pone.0199129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975724	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500023
J	Sonnier, G; Bohlen, PJ; Swain, HM; Orzell, SL; Bridges, EL; Boughton, EH				Sonnier, Gregory; Bohlen, Patrick J.; Swain, Hilary M.; Orzell, Steve L.; Bridges, Edwin L.; Boughton, Elizabeth H.			Assessing the success of hydrological restoration in two conservation easements within Central Florida ranchland	PLOS ONE			English	Article							INTERMOUNTAIN DEPRESSIONAL WETLANDS; WOODY PLANT ENCROACHMENT; FLORISTIC QUALITY INDEX; ECOSYSTEM SERVICES; AGRICULTURAL LANDSCAPES; MANAGEMENT INTENSITY; EPHEMERAL WETLANDS; GRAZING IMPACTS; BETA DIVERSITY; CLIMATE-CHANGE	In the USA, the United States Department of Agriculture (USDA) Natural Resource Conservation Service (NRCS) has restored millions of acres of wetlands through its Wetland Reserve Easement (WRE) programs. However, few quantitative studies have explored whether WREs have enhanced wetland hydrology and wetland plant communities. Additionally, USDA Compatible Use Permits for cattle grazing and other management practices are sometimes issued for WREs, but little is known about potential benefits/detriments of such practice on the success of wetland restoration. In this study, we tested if hydrological restoration of previously drained species poor pastures increased water depth and hydroperiod. Restoration involved plugging key ditches, adding water control structures and a berm. We also tested if hydrological restoration increased plant diversity (alpha and beta), floristic quality (using coefficient of conservatism) and increased the cover of wetland species (using species wetland status). Finally, we tested if cattle grazing had an effect on the success of restoration by comparing grazed plots to fenced plots. We studied two conservation easements (a total of 748 acres) located on semi-native pastures in central Florida, USA. We monitored vegetation using permanent transects stratified by vegetation type before (2004-2005) and after (2012) the restoration (2008). We assessed wetland hydroperiod using groundwater wells set up in 2003 and located within and outside the boundaries of these two easements. We used linear mixed models and multivariate analyses to compare vegetation and hydroperiods pre- and post-restoration. Number of flooded days increased following restoration in one of the easements, but we did not detect significant changes in hydrology in the other easement. Floristic quality, beta diversity and cover of obligate wetland species increased in both conservation easements and in most vegetation types. These vegetation changes were likely due to restoration activities since annual rainfall was not significantly different pre- and post-restoration. Cattle grazing did not have a negative or positive effect on the success of restoration, nor did we detect any positive effect of grazing on the success of restoration. Overall, our study shows that hydrological restoration can enhance wetland hydroperiod, water depth and wetland vegetation, but more resources should be allocated to short- and long-term monitoring of the restoration success.	[Sonnier, Gregory; Swain, Hilary M.; Boughton, Elizabeth H.] Archbold Biol Stn, Venus, FL 33960 USA; [Bohlen, Patrick J.] Univ Cent Florida, Orlando, FL 32816 USA; [Orzell, Steve L.] Avon Pk Air Force Range, Avon Pk, FL USA; [Bridges, Edwin L.] Bot & Ecol Consultant, Bremerton, WA USA	State University System of Florida; University of Central Florida	Sonnier, G (corresponding author), Archbold Biol Stn, Venus, FL 33960 USA.	gre.sonnier@gmail.com	Sonnier, Grégory/AAM-2589-2020; Boughton, Elizabeth H/AAA-6439-2020	Sonnier, Grégory/0000-0002-0614-7033; Boughton, Elizabeth H/0000-0003-0932-280X; Bohlen, Patrick/0000-0002-3080-6297	Natural Resources Conservation Service (NRCS) [68-4209-16-500]; Mosaic Compagny	Natural Resources Conservation Service (NRCS); Mosaic Compagny	The authors (GS and EHB) received funding from the Natural Resources Conservation Service (NRCS, Agreement number 68-4209-16-500, www.nrcs.usda.gov/) and from The Mosaic Compagny (www.mosaicco.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Boughton EH, 2016, J APPL ECOL, V53, P159, DOI 10.1111/1365-2664.12536; Boughton EH, 2011, APPL VEG SCI, V14, P210, DOI 10.1111/j.1654-109X.2010.01116.x; Boughton EH, 2010, ECOGRAPHY, V33, P461, DOI 10.1111/j.1600-0587.2009.06010.x; Bourdaghs M, 2006, WETLANDS, V26, P718, DOI 10.1672/0277-5212(2006)26[718:PAPOTF]2.0.CO;2; Bridges EL, 2013, VEGETATION MONITORIN, P53; Brinson MM, 2002, ENVIRON CONSERV, V29, P115, DOI 10.1017/S0376892902000085; Casasus I, 2007, AGR ECOSYST ENVIRON, V121, P365, DOI 10.1016/j.agee.2006.11.012; Cohen MJ, 2016, P NATL ACAD SCI USA, V113, P1978, DOI 10.1073/pnas.1512650113; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Dahl TE, 2014, STATUS TRENDS PRAIRI, P67; de Groot R, 2012, ECOSYST SERV, V1, P50, DOI 10.1016/j.ecoser.2012.07.005; De Steven D, 2011, ECOL APPL, V21, pS3, DOI 10.1890/09-0231.1; Eckles SD, 2011, ECOL APPL, V21, pS1, DOI 10.1890/09-0506.1; FLEISCHNER TL, 1994, CONSERV BIOL, V8, P629, DOI 10.1046/j.1523-1739.1994.08030629.x; Grman E, 2014, J ECOL, V102, P1017, DOI 10.1111/1365-2745.12267; Guzha AC, 2012, J IRRIG DRAIN ENG, V138, P651, DOI 10.1061/(ASCE)IR.1943-4774.0000430; Hayes GF, 2003, CONSERV BIOL, V17, P1694, DOI 10.1111/j.1523-1739.2003.00281.x; Heisterkamp S., 2016, COMPUTER SOFTWARE, V3, P1, DOI DOI 10.1016/J.CR0PR0.2007.08.015; Hilderbrand RH, 2005, ECOL SOC, V10; Hobbs Richard J., 2004, P72; Jones WM, 2011, BIOL CONSERV, V144, P511, DOI 10.1016/j.biocon.2010.10.005; Junk WJ, 2013, AQUAT SCI, V75, P113, DOI 10.1007/s00027-012-0253-8; Li WH, 2017, J APPL ECOL, V54, P963, DOI 10.1111/1365-2664.12806; Maginel CJ, 2016, ECOL INDIC, V67, P58, DOI 10.1016/j.ecolind.2016.02.035; Marty JT, 2015, RESTOR ECOL, V23, P548, DOI 10.1111/rec.12226; Marty JT, 2005, CONSERV BIOL, V19, P1626, DOI 10.1111/j.1523-1739.2005.00198.x; Mausbach MJ, 2004, J SOIL WATER CONSERV, V59, p96A; McIndoe Janna M., 2008, Proceedings of the Indiana Academy of Science, V117, P16; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Miller EA, 1998, J VEG SCI, V9, P265, DOI 10.2307/3237126; Moges A, 2017, AQUAT BOT, V138, P9, DOI 10.1016/j.aquabot.2016.12.001; Mohandass D, 2016, APPL ECOL ENV RES, V14, P233, DOI 10.15666/aeer/1404_233268; Mortellaro S., 2012, SOUTHEAST NAT, V11, P1, DOI DOI 10.1656/058.011.M301; Myers RL, 1990, ECOSYSTEMS FLORIDA; Oksanen J., 2016, VEGAN COMMUNITY ECOL, P4, DOI DOI 10.4135/9781412971874.N145; Pyke CR, 2005, CONSERV BIOL, V19, P1619, DOI 10.1111/j.1523-1739.2005.00233.x; Reiner R, 2011, NAT AREA J, V31, P408, DOI 10.3375/043.031.0411; Riedel JL, 2013, RANGELAND ECOL MANAG, V66, P224, DOI 10.2111/REM-D-11-00196.1; Rundel PW, 2014, BIOL INVASIONS, V16, P663, DOI 10.1007/s10530-013-0614-9; Saintilan N, 2015, NEW PHYTOL, V205, P1062, DOI 10.1111/nph.13147; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schieltz JM, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/11/113003; Semlitsch RD, 1998, CONSERV BIOL, V12, P1129, DOI 10.1046/j.1523-1739.1998.98166.x; Su H, 2015, ECOL EVOL, V5, P2445, DOI 10.1002/ece3.1531; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Suir GM, 2017, TR1715 ERDCEL TR; Swain H.M., 2013, RANGELANDS, V35, P75, DOI DOI 10.2111/RANGELANDS-D-13-00053.1; Teuber LM, 2013, AGR ECOSYST ENVIRON, V175, P21, DOI 10.1016/j.agee.2013.04.017; Thiere G, 2009, BIOL CONSERV, V142, P964, DOI 10.1016/j.biocon.2009.01.006; Toth LA, 2017, RESTOR ECOL, V25, P342, DOI 10.1111/rec.12427; Wamsley TV, 2010, OCEAN ENG, V37, P59, DOI 10.1016/j.oceaneng.2009.07.018; WHYTE RJ, 1981, J RANGE MANAGE, V34, P64, DOI 10.2307/3898457; Zedler JB, 2003, FRONT ECOL ENVIRON, V1, P65, DOI 10.1890/1540-9295(2003)001[0065:WAYSRI]2.0.CO;2; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zedler JB, 2000, TRENDS ECOL EVOL, V15, P402, DOI 10.1016/S0169-5347(00)01959-5	59	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199333	10.1371/journal.pone.0199333	http://dx.doi.org/10.1371/journal.pone.0199333			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969464	Green Submitted, Green Published, gold			2022-12-26	WOS:000437246700015
J	Wada, H; Shimizu, A; Osada, T; Tanaka, Y; Fukaya, S; Sasaki, E				Wada, Hiroshi; Shimizu, Atsushi; Osada, Toshihiro; Tanaka, Yuki; Fukaya, Satoshi; Sasaki, Eiji			Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; TUMOR-SPECIFIC CTLS; CLEAVAGE MOTIFS; CANCER-PATIENTS; INTERFERON-GAMMA; ANTITUMOR CTL; PROTEASOME; IDENTIFICATION; ANTIGEN; PREDICTION	Recently, many autologous tumor antigens have been examined for their potential use in cancer immunotherapy. However, the success of cancer vaccines in clinical trials has been limited, partly because of the limitations of using single, short peptides in most attempts. With this in mind, we aimed to develop multivalent synthetic long peptide (SLP) vaccines containing multiple cytotoxic T-lymphocyte (CTL) epitopes. However, to confirm whether a multivalent vaccine can induce an individual epitope-specific CTL, the only viable screening strategies currently available are interferon-gamma (IFN-mu enzyme-linked immunospot (ELISPOT) assays using human peripheral blood mononuclear cells, or expensive human leukocyte antigen (HLA)-expressing mice. In this report, we evaluated the use of our developed murine-20S immunoproteasome (i20S) digestion assay, and found that it could predict the results of IFN-mu ELISPOT assays. Importantly, the murine-i20S digestion assay not only predicted CTL induction, but also antitumor activity in an HLA-expressing mouse model. We conclude that the murine-i20S digestion assay is an extremely useful tool for the development of "all functional" multivalent SLP vaccines.	[Wada, Hiroshi; Shimizu, Atsushi; Osada, Toshihiro; Tanaka, Yuki; Fukaya, Satoshi; Sasaki, Eiji] Taiho Pharmaceut Co Ltd, Discovery & Preclin Res Div, Tsukuba, Ibaraki, Japan	Taiho Pharmaceutical	Wada, H (corresponding author), Taiho Pharmaceut Co Ltd, Discovery & Preclin Res Div, Tsukuba, Ibaraki, Japan.	h-wada@taiho.co.jp		Osada, Toshihiro/0000-0001-8331-9655	Taiho Pharmaceutical Co. Ltd.	Taiho Pharmaceutical Co. Ltd.	All of the authors are salaried employee of the Taiho Pharmaceutical Co. Ltd. However, the funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; Bijker MS, 2008, EUR J IMMUNOL, V38, P1033, DOI 10.1002/eji.200737995; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Cormier JN, 1997, CANCER J, V3, P37; Diez-Rivero CM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-479; Ghaffari-Nazari H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142563; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; Groettrup M, 1996, EUR J IMMUNOL, V26, P863, DOI 10.1002/eji.1830260421; Harada N, 2017, J IMMUNOL, V198, P516, DOI 10.4049/jimmunol.1502367; Harashima N, 2001, EUR J IMMUNOL, V31, P323, DOI 10.1002/1521-4141(200102)31:2<323::AID-IMMU323>3.0.CO;2-0; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hisamatsu H, 1996, J EXP MED, V183, P1807, DOI 10.1084/jem.183.4.1807; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Holzhutter HG, 1999, J MOL BIOL, V286, P1251, DOI 10.1006/jmbi.1998.2530; Holzhutter HG, 2000, BIOPHYS J, V79, P1196, DOI 10.1016/S0006-3495(00)76374-0; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Imai N, 2001, INT J CANCER, V94, P237, DOI 10.1002/ijc.1461; Ito M, 2000, INT J CANCER, V88, P633, DOI 10.1002/1097-0215(20001115)88:4<633::AID-IJC18>3.3.CO;2-E; Ito M, 2001, CANCER RES, V61, P2038; Itoh K, 2006, CANCER SCI, V97, P970, DOI 10.1111/j.1349-7006.2006.00272.x; Joura EA, 2014, CANCER EPIDEM BIOMAR, V23, P1997, DOI 10.1158/1055-9965.EPI-14-0410; Kakimi K, 2011, INT J CANCER, V129, P2836, DOI 10.1002/ijc.25955; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Kuttler C, 2000, J MOL BIOL, V298, P417, DOI 10.1006/jmbi.2000.3683; Livingston BD, 2001, VACCINE, V19, P4652, DOI 10.1016/S0264-410X(01)00233-X; Lu J, 2004, J IMMUNOL, V172, P4575, DOI 10.4049/jimmunol.172.7.4575; MARTINEZ CK, 1991, NATURE, V353, P664, DOI 10.1038/353664a0; Naito M, 2007, BRIT J CANCER, V97, P1648, DOI 10.1038/sj.bjc.6604071; Nakao M, 2000, J IMMUNOL, V164, P2565, DOI 10.4049/jimmunol.164.5.2565; Nandi D, 1996, J IMMUNOL, V156, P2361; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Nussbaum AK, 2001, IMMUNOGENETICS, V53, P87, DOI 10.1007/s002510100300; Nussbaum AK, 1998, P NATL ACAD SCI USA, V95, P12504, DOI 10.1073/pnas.95.21.12504; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Rosalia RA, 2013, EUR J IMMUNOL, V43, P2554, DOI 10.1002/eji.201343324; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Salgaller ML, 1996, CANCER RES, V56, P4749; Saxova P, 2003, INT IMMUNOL, V15, P781, DOI 10.1093/intimm/dxg084; Serrano B, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-38; Speetjens FM, 2009, CLIN CANCER RES, V15, P1086, DOI 10.1158/1078-0432.CCR-08-2227; Toes REM, 1996, J IMMUNOL, V156, P3911; Toes REM, 1996, P NATL ACAD SCI USA, V93, P7855, DOI 10.1073/pnas.93.15.7855; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Valmori Danila, 2003, Cancer Immun, V3, P15; Wu DD, 2014, CANCER LETT, V351, P13, DOI 10.1016/j.canlet.2014.05.002; Zaks TZ, 1998, CANCER RES, V58, P4902; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zwaveling S, 2002, J IMMUNOL, V169, P350, DOI 10.4049/jimmunol.169.1.350	51	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199249	10.1371/journal.pone.0199249	http://dx.doi.org/10.1371/journal.pone.0199249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969453	gold, Green Submitted, Green Published			2022-12-26	WOS:000437246700012
J	Richmond, A; Liang, ZW; Mulaj, V; Ryckmans, J; Stijntjes, G				Richmond, Annalise; Liang, Zhiwu; Mulaj, Valmire; Ryckmans, Jan; Stijntjes, Gerard			The importance of an ecologically valid method in the evaluation of toddler interaction with coloured liquid laundry detergent capsules	PLOS ONE			English	Article							INFANTS	The colour and appearance of liquid laundry capsules have been implicated in the risk of attracting the attention of toddlers, and therefore contributing to poisoning incidents in the home by encouraging interaction. This research set out to explore if differences in colours and contrasting colour designs used in mono and multi-coloured capsules result in different levels of attractiveness. This was performed using two study settings: a laboratory setting (out of context), and by comparison, a more ecologically valid setting, mimicking the realworld. Capsule attractiveness to toddlers was measured by visual attention (measured through eye tracking) and grasping choice (measured as frequency of grasping in a behavioural task). Results from the research in the out of context setting showed statistically significant differences in visual attention and grasping choice between colours and contrasting designs. In the visual attention study a preference for multi-coloured capsules was shown. In the grasping choice study, in addition to multi-coloured, mono-coloured white or purple capsules were also preferred. In the more ecologically valid setting, there were no statistically significant differences in the visual attention or grasping choice between any of the capsules. These results were consistent with each other and in line with market data reflecting poisoning incident rates, which show no change with colour or contrasting colour design. We suggest that the results from out of context studies might not be a reliable indicator of real world behaviour. Given the importance of toddler home safety, using a methodology that is aligned with market numbers is crucial to develop countermeasures.	[Richmond, Annalise; Liang, Zhiwu; Stijntjes, Gerard] Procter & Gamble, Strombeek Bever, Belgium; [Mulaj, Valmire; Ryckmans, Jan] Haystack NV, Heverlee, Belgium	Procter & Gamble	Richmond, A (corresponding author), Procter & Gamble, Strombeek Bever, Belgium.	richmond.a@pg.com			Procter & Gamble Services Company	Procter & Gamble Services Company(Procter & Gamble)	This work was sponsored and undertaken by Procter & Gamble Services Company. The funder provided support in the form of salaries for authors AR, GS and ZL who are employees of Procter & Gamble Services Company. AR led the design and analysis of the study and translated the results to the key findings and conclusions. GS assisted in the discussion and design of the study and helped to translate the results to the key findings and conclusions. ZL led the statistical analysis of the study (named as coauthor). The funder also provided for the cost of materials/research facilities, recruitment costs, and also paid a one-off consultancy fee to haystack NV to consult in the design and lead the execution of the study and data collection. Haystack NV employees were VM who led the execution and data collection of the study and JR who assisted in the design of the study.	Brewer M. B., 2000, HDB RES METHODS SOCI, P3, DOI DOI 10.1017/CBO9780511996481.005; Celentano A, 2012, CLIN TOXICOL, V50, P353; Crozier W.R., 1999, PIGMENT RESIN TECHNO, V28, P6, DOI [10.1108/03699429910252315, DOI 10.1108/03699429910252315]; Franklin A, 2010, DEVELOPMENTAL SCI, V13, P346, DOI 10.1111/j.1467-7687.2009.00884.x; International Association for Soaps, 2015, DET MAINT PROD I S E; Jadva V, 2010, ARCH SEX BEHAV, V39, P1261, DOI 10.1007/s10508-010-9618-z; Johnson RM, 2000, UNDERSTANDING HB INT; Kekatos M., 2017, DAILY MAIL; Mohney Gillian, 2016, ABC NEWS; Oakes LM, 2010, INFANCY, V15, P1, DOI 10.1111/j.1532-7078.2010.00030.x; Sawtooth, 2008, MAX DIFF SYST TECHN; SCCS (Scientific Committee on Consumer Safety), 9 PLEN M SCI COMM CO; Settimi L, 2018, INJURY PREV, V24, P5, DOI 10.1136/injuryprev-2016-042263; Shonkwiler R., 2009, EXPLORATIONS MONTE C; Staples R, 1932, J EXP PSYCHOL, V15, P119, DOI 10.1037/h0071205; Taylor C, 2013, PSYCHON B REV, V20, P916, DOI 10.3758/s13423-013-0411-6; WHO, 2008, WORLD HLTH REPORT 20	17	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199976	10.1371/journal.pone.0199976	http://dx.doi.org/10.1371/journal.pone.0199976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL5QR	29966022	Green Published, Green Submitted, gold			2022-12-26	WOS:000437224100033
J	Deng, ZP; Cao, MY; Rai, L; Gao, W				Deng, Zhaopeng; Cao, Maoyong; Rai, Laxmisha; Gao, Wei			A two-stage classification method for borehole-wall images with support vector machine	PLOS ONE			English	Article							FEATURES	Analyzing geological drilling hole images acquired by Axial View Panoramic Borehole Televiewer (APBT) is a key step to explore the geological structure in a geological exploration. Conventionally, the borehole images are examined by technicians, which is inefficient and subjective. In this paper, three dominant types of borehole-wall images on coal-rock mass structure, namely, border images, fracture images and intact rock mass images are mainly studied. The traditional image classification methods based on unified feature extraction algorithm and single classifier is not effect for the borehole images. Therefore, this paper proposes a novel two-stage classification approach to improve the classification performance of borehole images. In the first-stage classification, the border images are identified from three kinds of images based on texture features and gray-scale histograms features. For the remaining two types of images, in the second-stage classification, Gabor filter is first applied to segment the region of interest (ROI) (such as microfracture, absciss layer and horizontal cracks, etc.) and the central interference region. Then, using the same feature vector after eliminating the central interference region, fracture images are separated from intact rock mass images. We test our two-stage classification system with real borehole images. The results of experimental show that the two-stage classification method can effectively classify three major borehole-wall images with the correction rate of 95.55% in the first stage and 95% in the second stage.	[Deng, Zhaopeng; Cao, Maoyong] Shandong Univ Sci & Technol, Dept Elect Engn & Automat, Qingdao, Shandong, Peoples R China; [Rai, Laxmisha; Gao, Wei] Shandong Univ Sci & Technol, Dept Elect Commun & Phys, Qingdao, Shandong, Peoples R China	Shandong University of Science & Technology; Shandong University of Science & Technology	Cao, MY (corresponding author), Shandong Univ Sci & Technol, Dept Elect Engn & Automat, Qingdao, Shandong, Peoples R China.	my-cao@263.net	Rai, Laxmisha/B-6552-2008	Rai, Laxmisha/0000-0003-1494-1138				Al-Samarraie H, 2017, INTERACT LEARN ENVIR, V25, P452, DOI 10.1080/10494820.2016.1138313; Ashraf AB, 2010, IEEE T PATTERN ANAL, V32, P1335, DOI 10.1109/TPAMI.2010.75; Bass C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183309; Bissi L, 2013, J VIS COMMUN IMAGE R, V24, P838, DOI 10.1016/j.jvcir.2013.05.011; Cao Z., 2017, PATTERN RECOGN, V21, P364, DOI [10.1016/j.patcog.2017.07.032, DOI 10.1016/J.PATCOG.2017.07.032]; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen CJ, 2015, SENSORS-BASEL, V15, P7807, DOI 10.3390/s150407807; Chen HM, 2016, ROCK MECH ROCK ENG, V49, P555, DOI 10.1007/s00603-015-0748-4; Cheng J, 2015, PLOS ONE, V10, P31; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; Dhara AK, 2016, J DIGIT IMAGING, V29, P466, DOI 10.1007/s10278-015-9857-6; Geng YS, 2016, IEEE T MOBILE COMPUT, V15, P656, DOI 10.1109/TMC.2015.2416186; Guo HS, 2015, PATTERN RECOGN, V48, P1577, DOI 10.1016/j.patcog.2014.12.009; He F., 2014, J ELECTRON IMAGING, V23, P572; Hu YF, 2016, IEEE T MED IMAGING, V35, P1522, DOI 10.1109/TMI.2016.2518958; Jungmann M, 2011, COMPUT GEOSCI-UK, V37, P541, DOI 10.1016/j.cageo.2010.08.008; KANAORI Y, 1983, ROCK MECH ROCK ENG, V16, P133, DOI 10.1007/BF01032795; Keskin F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052807; Khojasteh P, 2015, J PETROL SCI ENG, V125, P67, DOI 10.1016/j.petrol.2014.10.023; Krishnan KR, 2015, IET IMAGE PROCESS, V9, P261, DOI 10.1049/iet-ipr.2014.0202; Kuffer M, 2016, IEEE J-STARS, V9, P1830, DOI 10.1109/JSTARS.2016.2538563; Lahmiri S., 2011, 2011 IEEE 9th International New Circuits and Systems Conference (NEWCAS 2011), P53, DOI 10.1109/NEWCAS.2011.5981217; Lau J S O, 2011, CANADIAN GEOTECHNICA, V24, P499; Li SJ, 2013, ROCK MECH ROCK ENG, V46, P635, DOI 10.1007/s00603-012-0344-9; Lo HC, 2012, J ENVIRON ENG GEOPH, V17, P27, DOI 10.2113/JEEG17.1.27; Nissen S, 2003, IMPLEMENTATION FAST; Park S, 2011, IEEE T BIO-MED ENG, V58, P2885, DOI 10.1109/TBME.2011.2162330; Schepers R, 2001, INT J ROCK MECH MIN, V38, P867, DOI 10.1016/S1365-1609(01)00052-1; Shih CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067281; Shu L, 2017, COMPUT GEOSCI-UK, V106, P10, DOI 10.1016/j.cageo.2017.05.010; Skoczylas N, 2014, INT J ROCK MECH MIN, V72, P319, DOI 10.1016/j.ijrmms.2014.09.017; WANG Chuan-ying, 2001, CHINESE J ROCK MECH, V20, P1687; Wang H, 2017, PATTERN RECOGN, V61, P234, DOI 10.1016/j.patcog.2016.07.035; Wang MW, 2017, INFORM SCIENCES, V402, P50, DOI 10.1016/j.ins.2017.03.027; Williams JH, 2004, J APPL GEOPHYS, V55, P151, DOI 10.1016/j.jappgeo.2003.06.009; Xiao YX, 2016, ROCK MECH ROCK ENG, V49, P343, DOI 10.1007/s00603-015-0859-y; Yin XC, 2011, NEURAL COMPUT APPL, V20, P955, DOI 10.1007/s00521-010-0395-3; Zohreh M, 2016, ARAB J GEOSCI, V9, P1	38	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199749	10.1371/journal.pone.0199749	http://dx.doi.org/10.1371/journal.pone.0199749			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953481	Green Submitted, Green Published, gold			2022-12-26	WOS:000436645400059
J	Guo, CY; Qu, X; Rangaswamy, N; Leehy, B; Xiang, CX; Rice, D; Prasanna, G				Guo, Chenying; Qu, Xin; Rangaswamy, Nalini; Leehy, Barrett; Xiang, Chuanxi; Rice, Dennis; Prasanna, Ganesh			A murine glaucoma model induced by rapid in vivo photopolymerization of hyaluronic acid glycidyl methacrylate	PLOS ONE			English	Article							OPTIC-NERVE HEAD; ELEVATED INTRAOCULAR-PRESSURE; NORMAL-TENSION GLAUCOMA; RETINAL GANGLION-CELLS; OPEN-ANGLE GLAUCOMA; OCULAR HYPERTENSION; RAT MODEL; MOUSE MODEL; MICROGLIA; ASTROCYTES	Glaucoma is an optic neuropathy commonly associated with elevated intraocular pressure (10P) resulting in progressive loss of retinal ganglion cells (RGCs) and optic nerve degeneration, leading to blindness. New therapeutic approaches that better preserve the visual field by promoting survival and health of RGCs are highly needed since RGC death occurs despite good IOP control in glaucoma patients. We have developed a novel approach to reliably induce chronic IOP elevation in mouse using a photopolymerizable biomatrix, hyaluronic acid glycidyl methacrylate. This is achieved by rapid in vivo crosslinking of the biomatrix at the iridocorneal angle by a flash of ultraviolet A (UVA) light to impede the aqueous outflow pathway with a controllable manner. Sustained IOP elevation was induced after a single manipulation and was maintained at similar to 45% above baseline for >4 weeks. Significant thinning of the inner retina and similar to 35% reduction in RGCs and axons was noted within one month of 10P elevation. Optic nerve degeneration showed positive correlation with cumulative 10P elevation. Activation of astrocytes and microglia appeared to be an early event in response to IOP elevation preceding detectable RGC and axon loss. Attenuated glial reactivity was noted at later stage where significant RGC/axon loss had occurred suggesting astrocytes and microglia may play different roles over the course of glaucomatous degeneration. This novel murine glaucoma model is reproducible and displays cellular changes that recapitulate several pathophysiological features of glaucoma.	[Guo, Chenying; Qu, Xin; Rangaswamy, Nalini; Leehy, Barrett; Xiang, Chuanxi; Rice, Dennis; Prasanna, Ganesh] Novartis Inst BioMed Res, Dept Ophthalmol, Cambridge, MA 02139 USA	Novartis	Guo, CY; Prasanna, G (corresponding author), Novartis Inst BioMed Res, Dept Ophthalmol, Cambridge, MA 02139 USA.	chenying.guo@novartis.com; ganesh.prasanna@novartis.com			Novartis Institutes for Biomedical Research (NIBR)	Novartis Institutes for Biomedical Research (NIBR)	Novartis Institutes for Biomedical Research (NIBR) provided support in the form of salaries and research materials for authors CG, XQ, NR, BL, CX, DR, GP, and approved the submission and publication of the manuscript via the NIBR Open Access to Knowledge system. NIBR did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adachi K, 1998, GRAEF ARCH CLIN EXP, V236, P766, DOI 10.1007/s004170050156; Ahmed FAKM, 2001, BRAIN RES, V913, P133, DOI 10.1016/S0006-8993(01)02759-7; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Banati RB, 2003, BRIT MED BULL, V65, P121, DOI 10.1093/bmb/65.1.121; Bencherif SA, 2008, BIOMATERIALS, V29, P1739, DOI 10.1016/j.biomaterials.2007.11.047; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bolz S, 2008, GRAEF ARCH CLIN EXP, V246, P1249, DOI 10.1007/s00417-008-0872-x; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Bouhenni RA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/692609; Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963; Chen H, 2015, INVEST OPHTH VIS SCI, V56, P1971, DOI 10.1167/iovs.14-15691; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Chiu Kin, 2007, J Vis Exp, P549, DOI 10.3791/549; Cone FE, 2010, EXP EYE RES, V91, P415, DOI 10.1016/j.exer.2010.06.018; Cui Q, 2009, NEUROSCIENCE, V158, P1039, DOI 10.1016/j.neuroscience.2008.07.036; Fileta JB, 2008, J NEUROSCI METH, V170, P1, DOI 10.1016/j.jneumeth.2007.12.008; Flammer J, 2013, EUR HEART J, V34, P1270, DOI 10.1093/eurheartj/eht023; Formichella Cathryn R, 2014, J Clin Cell Immunol, V5; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Goldblum D, 2002, VISION RES, V42, P471, DOI 10.1016/S0042-6989(01)00194-8; Gross Ronald L, 2003, Trans Am Ophthalmol Soc, V101, P163; Gugleta K, 2013, J GLAUCOMA, V22, P501, DOI 10.1097/IJG.0b013e3182447d9b; Guo C, 2009, J COMP NEUROL, V512, P6, DOI 10.1002/cne.21846; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hanninen VA, 2002, CURR EYE RES, V25, P389; Hattenhauer MG, 1998, OPHTHALMOLOGY, V105, P2099, DOI 10.1016/S0161-6420(98)91133-2; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Ito YA, 2016, JOVE-J VIS EXP, DOI 10.3791/53731; Johnson EC, 2000, INVEST OPHTH VIS SCI, V41, P431; Johnson EC, 2009, J GLAUCOMA, V18, P341, DOI 10.1097/IJG.0b013e31818c6ef6; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P829; Land Walter G, 2015, Sultan Qaboos Univ Med J, V15, pe157; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Laquis S, 1998, BRAIN RES, V784, P100, DOI 10.1016/S0006-8993(97)01189-X; Lee BL, 1998, J GLAUCOMA, V7, P366; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Levkovitch-Verbin H, 2002, INVEST OPHTH VIS SCI, V43, P402; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Mac Nair CE, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0558-y; Matsumoto Y, 2014, JPN J OPHTHALMOL, V58, P290, DOI 10.1007/s10384-014-0311-y; McDowell CM, 2012, EXP EYE RES, V100, P65, DOI 10.1016/j.exer.2012.04.016; McGrady NR, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0346-3; Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451; Morgan JE, 2006, ADV EXP MED BIOL, V572, P397; MORRISON J, 1995, EXP EYE RES, V60, P127, DOI 10.1016/S0014-4835(95)80002-6; Morrison JC, 1997, EXP EYE RES, V64, P85, DOI 10.1006/exer.1996.0184; Mozaffarieh M, 2013, CURR OPIN PHARMACOL, V13, P43, DOI 10.1016/j.coph.2012.10.001; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Neufeld AH, 2003, NEUROSCIENTIST, V9, P485, DOI 10.1177/1073858403253460; Neufeld AH, 1999, ARCH OPHTHALMOL-CHIC, V117, P1050; Neufeld AH, 1999, P NATL ACAD SCI USA, V96, P9944, DOI 10.1073/pnas.96.17.9944; Nickells RW, 2007, CAN J OPHTHALMOL, V42, P278, DOI 10.3129/canjophthalmol.i07-036; Nissirios N, 2008, INVEST OPHTH VIS SCI, V49, P2478, DOI 10.1167/iovs.07-0965; Pang IH, 2007, J GLAUCOMA, V16, P483, DOI 10.1097/IJG.0b013e3181405d4f; Prasanna G, 2011, EXP EYE RES, V93, P170, DOI 10.1016/j.exer.2010.09.006; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Sappington RM, 2010, INVEST OPHTH VIS SCI, V51, P207, DOI 10.1167/iovs.09-3947; Schneider M, 2016, EXP EYE RES, V142, P49, DOI 10.1016/j.exer.2015.08.014; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; SHAREEF SR, 1995, EXP EYE RES, V61, P379, DOI 10.1016/S0014-4835(05)80131-9; Smedowski A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05910; Son JL, 2010, GLIA, V58, P780, DOI 10.1002/glia.20962; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Suh HS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-37; Sun D, 2013, GLIA, V61, P1218, DOI 10.1002/glia.22507; Sun D, 2009, J COMP NEUROL, V516, P1, DOI 10.1002/cne.22058; Tehrani S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167364; Tezel G, 2003, J GLAUCOMA, V12, P63, DOI 10.1097/00061198-200302000-00014; Urcola JH, 2006, EXP EYE RES, V83, P429, DOI 10.1016/j.exer.2006.01.025; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Wang JW, 2016, J GLAUCOMA, V25, P459, DOI 10.1097/IJG.0000000000000200; Wang L, 2002, INVEST OPHTH VIS SCI, V43, P1088; Wang X, 2000, EXP BRAIN RES, V132, P476, DOI 10.1007/s002210000360; Williams PA, 2017, EXP EYE RES, V157, P20, DOI 10.1016/j.exer.2017.02.014; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104; Zhao Da, 2017, Front Neurosci, V11, P41, DOI 10.3389/fnins.2017.00041; Zhi ZW, 2012, BIOMED OPT EXPRESS, V3, P2220, DOI 10.1364/BOE.3.002220	86	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0196529	10.1371/journal.pone.0196529	http://dx.doi.org/10.1371/journal.pone.0196529			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949582	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200005
J	Melati, BG; Leal, LC				Melati, Bruno Gabriel; Leal, Laura Carolina			Aggressive bodyguards are not always the best: Preferential interaction with more aggressive ant species reduces reproductive success of plant bearing extrafloral nectaries	PLOS ONE			English	Article							FUNCTIONAL-GROUPS; CLEANER FISH; COMMUNITIES; QUALITY; MUTUALISMS; DIVERSITY; ECOLOGY; PERSPECTIVES; POLLINATORS; COMPETITION	Variation in partner species and frequency of interaction between species pairs are potential drivers of the net outcome of generalized mutualisms. In ant-plant mutualisms, the quality of defence provided by ants is related to ant aggressiveness. Hence, we hypothesize that the performance of plants bearing extrafloral nectaries will be higher when they interact more frequently with more aggressive ant species. We estimated ant aggressiveness in the field by observing their behaviour towards soil baits. Afterwards, we observed the frequency with which individuals from these ant species visited plants through an entire reproductive cycle. We measured the production and persistence of plants reproductive structures through this period and the total seed production. Increasing in the interaction frequency with highly aggressive ants reduced the number of floral buds and seeds produced. Increased visitation frequency by less aggressive ants increased the number of floral buds and seeds per branch. The inverse relationship between ant aggressiveness and seed production may be influenced by the costs imposed by different mutualistic partners. Thus, frequent interaction with highly aggressive ants may lead to a higher accumulation of costs through time, resulting in a negative net outcome for the plants. Our results bring new evidence highlighting the importance to incorporate temporal aspects in the study of mutualistic interactions. We suggests that the quality of mutualistic partners must be understood as a function of its per-interaction benefit and their cumulative costs to their partner over time, what puts in check our current classification regarding partner quality in mutualistic systems.	[Melati, Bruno Gabriel; Leal, Laura Carolina] Univ Estadual Feira de Santana, Dept Ciencias Biol, Programa Posgrad Ecol & Evolucao, Novo Horizonte, BA, Brazil; [Leal, Laura Carolina] Univ Fed Sao Paulo, Dept Ecol & Biol Evolut, Sao Paulo, Brazil	Universidade Estadual de Feira de Santana; Universidade Federal de Sao Paulo (UNIFESP)	Leal, LC (corresponding author), Univ Estadual Feira de Santana, Dept Ciencias Biol, Programa Posgrad Ecol & Evolucao, Novo Horizonte, BA, Brazil.; Leal, LC (corresponding author), Univ Fed Sao Paulo, Dept Ecol & Biol Evolut, Sao Paulo, Brazil.	lacaleal@gmail.com	Leal, Laura Carolina/J-8497-2014	Leal, Laura Carolina/0000-0003-1570-8901	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We would like to thank Fabricio Baccaro, Paulo Enrique C. Peixoto and Danilo G. Muniz for their valuable suggestions in the earlier versions of this paper. We also thank P.E.C. Peixoto for all his contributions along the development of this study. L.C.L. and B.G.M. would like to thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the postdoc and master fellowship, respectively.	ANDERSEN AN, 1994, OECOLOGIA, V98, P15, DOI 10.1007/BF00326085; Andersen AN, 1997, J BIOGEOGR, V24, P433, DOI 10.1111/j.1365-2699.1997.00137.x; ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; ANDERSEN AN, 1992, AM NAT, V140, P401, DOI 10.1086/285419; Assuncao MA, 2014, FLORA, V209, P244, DOI 10.1016/j.flora.2014.03.003; Barbosa Danila de Araújo, 2007, Rev. bras. farmacogn., V17, P396, DOI 10.1590/S0102-695X2007000300016; Bartomeus I, 2016, FUNCT ECOL, V30, P1894, DOI 10.1111/1365-2435.12666; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Betts MG, 2015, P NATL ACAD SCI USA, V112, P3433, DOI 10.1073/pnas.1419522112; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Bronstein JL, 2015, MUTUALISM, P3; Bruna EM, 2014, ECOLOGY, V95, P3237, DOI 10.1890/14-0481.1; Bshary R, 2002, ANIM BEHAV, V63, P557, DOI 10.1006/anbe.2001.1923; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Cerda X, 2013, MYRMECOL NEWS, V18, P131; Chamberlain SA, 2008, ECOLOGY, V89, P1364, DOI 10.1890/07-1139.1; Del-Claro K, 2015, BIOTROPICA, V47, P459, DOI 10.1111/btp.12227; Dutton EM, 2016, AM NAT, V188, P38, DOI 10.1086/686766; Fiedler Konrad, 2001, Diversity and Distributions, V7, P45, DOI 10.1046/j.1472-4642.2001.00096.x; Heil M, 2015, ANNU REV ENTOMOL, V60, P213, DOI 10.1146/annurev-ento-010814-020753; Holldobler B., 1990, pi; Jones EI, 2015, ECOL LETT, V18, P1270, DOI 10.1111/ele.12507; Jones EI, 2012, ANN NY ACAD SCI, V1256, P66, DOI 10.1111/j.1749-6632.2012.06552.x; Leal LC, 2017, BIOL REV, V92, P1785, DOI 10.1111/brv.12307; Leal LC, 2014, OECOLOGIA, V174, P493, DOI 10.1007/s00442-013-2789-2; Leimar O, 1997, P ROY SOC B-BIOL SCI, V264, P1209, DOI 10.1098/rspb.1997.0167; Marazzi B, 2013, ANN BOT-LONDON, V111, P1243, DOI 10.1093/aob/mct109; Miller TEX, 2007, OIKOS, V116, P500, DOI 10.1111/j.2007.0030-1299.15317.x; Ness JH, 2006, ECOLOGY, V87, P912, DOI 10.1890/0012-9658(2006)87[912:IQAQOM]2.0.CO;2; Ness JH, 2006, OIKOS, V113, P506, DOI 10.1111/j.2006.0030-1299.14143.x; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; ODOWD DJ, 1979, OECOLOGIA, V43, P233, DOI 10.1007/BF00344773; Ohm JR, 2014, ECOLOGY, V95, P2924, DOI 10.1890/13-2309.1; Palmer TM, 2013, ECOLOGY, V94, P683, DOI 10.1890/12-1413.1; Parr CL, 2010, ANT ECOLOGY, P77; Prasad S, 2010, OIKOS, V119, P514, DOI 10.1111/j.1600-0706.2009.17971.x; Rudgers JA, 2003, OECOLOGIA, V135, P51, DOI 10.1007/s00442-002-1168-1; Shenoy M, 2010, BIOL J LINN SOC, V100, P538, DOI 10.1111/j.1095-8312.2010.01459.x; Silva J. M. C., 2017, CAATINGA LARGEST TRO, P3, DOI [10.1007/978-3-319-68339-3, DOI 10.1007/978-3-319-68339-3]; Simms EL, 2002, INTEGR COMP BIOL, V42, P369, DOI 10.1093/icb/42.2.369; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Flores-Flores RV, 2018, ACTA OECOL, V87, P13, DOI 10.1016/j.actao.2018.02.004; Vilela AA, 2018, J NAT HIST, V52, P415, DOI 10.1080/00222933.2018.1432774; Wackers FL, 2001, ANN BOT-LONDON, V87, P365, DOI 10.1006/anbo.2000.1342; Xu FF, 2010, INSECT SOC, V57, P343, DOI 10.1007/s00040-010-0089-y; Zuur Alain F., 2009, P1	47	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199764	10.1371/journal.pone.0199764	http://dx.doi.org/10.1371/journal.pone.0199764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949639	gold, Green Submitted, Green Published			2022-12-26	WOS:000436549200067
J	Wu, AG; Shah, AS; Haelle, TS; Lunos, SA; Pitt, MB				Wu, Andrew G.; Shah, Ashish S.; Haelle, Tara S.; Lunos, Scott A.; Pitt, Michael B.			Choosing the perfect shot - The loaded narrative of imagery in online news coverage of vaccines	PLOS ONE			English	Article							VACCINATION; HESITANCY; INFORMATION	Images in health communication have been shown to affect perspectives and attitudes towards health issues including vaccination. We seek to quantify the frequency of images used in online news coverage of vaccines that may convey varying sentiments about vaccination. To capture a breadth of vaccine-related news coverage, including international sources, we searched the following terms in Google News Archives: "autism and vaccine", "flu and vaccine", and "measles and Disneyland". We developed a coding tool that classified images as negative (eg, screaming child), positive (eg, happy child), neutral (eg, vaccine vial), or irrelevant (eg, picture of journalist). All images were coded independently by two researchers and discussed for consensus. We analyzed 734 images. Of the images which featured vaccines and/or a medical encounter (322), 28% had negative features and 30% had positive features. The remaining 137 images (43%) were neutral. There was no statistically significant difference between proportions of negative and positive imagery for each pair of search terms, which may be a reflection of random image selection. Ultimately, nearly one in eight images included in vaccine-related news coverage contains negative features which may be selected without careful consideration of the potential negative impact on public health initiatives regarding vaccination.	[Wu, Andrew G.; Shah, Ashish S.; Pitt, Michael B.] Univ Minnesota, Dept Pediat, Masonic Childrens Hosp, Minneapolis, MN 55455 USA; [Haelle, Tara S.] Covering Hlth, Med Studies, Columbia, MO USA; [Lunos, Scott A.] Univ Minnesota, Biostat Design & Anal Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Pitt, MB (corresponding author), Univ Minnesota, Dept Pediat, Masonic Childrens Hosp, Minneapolis, MN 55455 USA.	mbpitt@umn.edu		Pitt, Michael/0000-0002-7123-2613				[Anonymous], 2012, TARGET SURVEY SHOWS; [Anonymous], 2014, SPJ CODE ETHICS NASH; Betsch C, 2011, MED DECIS MAKING, V31, P742, DOI 10.1177/0272989X11400419; Betsch C, 2010, J HEALTH PSYCHOL, V15, P446, DOI 10.1177/1359105309353647; Cline RJW, 2001, HEALTH EDUC RES, V16, P671, DOI 10.1093/her/16.6.671; Deffenbaugh C., 2016, FOX6 NEWS       1025; Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657; Dugas AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056176; Flaherty DK, 2011, ANN PHARMACOTHER, V45, P1302, DOI 10.1345/aph.1Q318; Horne Z, 2015, P NATL ACAD SCI USA, V112, P10321, DOI 10.1073/pnas.1504019112; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Joffe H, 2008, DIOGENES, V55, P84, DOI 10.1177/0392192107087919; Joyner BL, 2009, PEDIATRICS, V124, pE416, DOI 10.1542/peds.2008-3735; Kantor J, 2016, JAMA DERMATOL, V152, P113, DOI 10.1001/jamadermatol.2015.3814; Kogut T, 2005, J BEHAV DECIS MAKING, V18, P157, DOI 10.1002/bdm.492; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Letchford A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149025; Lincoln YS., 2008, COLLECTING INTERPRET; McLean ACL, 2016, WORLD NEUROSURG, V90, P179, DOI 10.1016/j.wneu.2016.02.045; Nemeroff C., 2000, IMAGINING IMPOSSIBLE, P1; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Pitt MB, 2016, CHILDREN-BASEL, V3, DOI 10.3390/children3040023; Poland GA, 2011, NEW ENGL J MED, V364, P97, DOI 10.1056/NEJMp1010594; Salazar D., 2016, DRUG STORE NEWS; Siddiqui M, 2013, HUM VACC IMMUNOTHER, V9, P2643, DOI 10.4161/hv.27243; Taddio A, 2012, VACCINE, V30, P4807, DOI 10.1016/j.vaccine.2012.05.011; Willinger M, 2000, JAMA-J AM MED ASSOC, V283, P2135, DOI 10.1001/jama.283.16.2135; Windrem R, 2013, NBC NEWS; World Health Organization, 2015, VACC HES GROW CHALL	30	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199870	10.1371/journal.pone.0199870	http://dx.doi.org/10.1371/journal.pone.0199870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949630	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200071
J	Mbu, ET; Sauter, F; Zoufaly, A; Bronsvoort, BMD; Morgan, KL; Noeske, J; Abena, JLF; Sander, MS				Mbu, Eyongetah Tabenyang; Sauter, Florian; Zoufaly, Alexander; Bronsvoort, Barend M. de C.; Morgan, Kenton L.; Noeske, Jurgen; Abena, Jean-Louis Foe; Sander, Melissa S.			Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes	PLOS ONE			English	Article							NEGATIVE PULMONARY TUBERCULOSIS; HUMAN-IMMUNODEFICIENCY-VIRUS; RESOURCE-LIMITED SETTINGS; HIGH PREVALENCE; EPIDEMIOLOGY; INFECTION	Background Diagnosis of tuberculosis in people living with HIV is challenging due to non-specific clinical presentations and inadequately sensitive diagnostic tests. The WHO recommends screening using a clinical algorithm followed by rapid diagnosis using the Xpert MTB/RIF assay, and more information is needed to evaluate these recommendations in different settings. Methods From August 2012 to September 2013, consecutive adults newly diagnosed with HIV in Bamenda, Cameroon, were screened for TB regardless of symptoms by smear microscopy and culture; the Xpert MTB/RIF assay was performed retrospectively. Time to treatment and patient outcomes were obtained from routine registers. Results Among 1,149 people enrolled, 940 (82%) produced sputum for lab testing; of these, 68% were women, the median age was 35 years (IQR, 28-42 years), the median CD4 count was 291cells/mu L (IQR, 116-496 cells/mu L), and 86% had one or more of current cough, fever, night sweats, or weight loss. In total, 131 people (14%, 95% CI, 12-16%) had sputum culture-positive TB. The WHO symptom screening algorithm had a sensitivity of 92% (95% CI, 86-96%) and specificity of 15% (95% CI, 12-17%) in this population. Compared to TB culture, the sensitivity of direct smear microscopy was 25% (95% CI, 18-34%), and the sensitivity of Xpert was 68% (95% CI, 58-76); the sensitivity of both was higher for people reporting more symptoms. Only one of 69 people with smear-negative/culture-positive TB was started on TB treatment prior to culture positivity. Of 71 people with bacteriologically-confirmed TB and known outcome after 6 months, 13 (17%) had died, including 11 people with smear-negative TB and 6 people with both smear and Xpert-negative TB. Conclusions Use of the most sensitive rapid diagnostic test available is critical in people newly diagnosed with HIV in this setting to maximize the detection of bacteriologically-confirmed TB. However, this intervention is not sufficient alone and should be combined with more comprehensive clinical diagnosis of TB to improve outcomes.	[Mbu, Eyongetah Tabenyang; Sauter, Florian; Zoufaly, Alexander] Bamenda Reg Hosp, Approved Treatment Ctr HIV AIDS, Bamenda, Cameroon; [Bronsvoort, Barend M. de C.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Morgan, Kenton L.] Univ Liverpool, Inst Vet Sci, Leahurst, England; [Abena, Jean-Louis Foe] Natl TB Programme, Yaounde, Cameroon; [Sander, Melissa S.] TB Reference Lab Bamenda, Bamenda, Cameroon; [Sauter, Florian] Pediat Practice Ruth Katona, Freiburg, Germany; [Zoufaly, Alexander] Kaiser Franz Josef Hosp, Vienna, Austria	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Liverpool; Kaiser-Franz-Josef Hospital	Sander, MS (corresponding author), TB Reference Lab Bamenda, Bamenda, Cameroon.	melissa.sander@gmail.com	Noeske, Jűrgen/ABI-7430-2020		German International Cooperation (GIZ) in Cameroon; National TB Program of Cameroon	German International Cooperation (GIZ) in Cameroon; National TB Program of Cameroon	This study was supported by the German International Cooperation (GIZ) in Cameroon and the National TB Program of Cameroon. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman MW, 2015, INT J TUBERC LUNG D, V19, P1197, DOI 10.5588/ijtld.15.0230; Cattamanchi A, BMC INFECT DIS, V5, P1, DOI [10.1186/1471-2334-5-1, DOI 10.1186/1471-2334-5-1]; Corbett EL, 2013, INT J TUBERC LUNG D, V17, P1125, DOI 10.5588/ijtld.13.0117; Corbett EL, 2010, B WORLD HEALTH ORGAN, V88, P13, DOI 10.2471/BLT.08.055467; FIND, 2017, MULT NON INF DIAGN A; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Gupta RK, 2013, INT J TUBERC LUNG D, V17, P1014, DOI 10.5588/ijtld.13.0032; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Henostroza G, 2016, INT J TUBERC LUNG D, V20, P1033, DOI 10.5588/ijtld.15.0651; Kent PT, 1985, PUBLIC HLTH MYCOBACT; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2013, BMC MED BMC MED, V11, P1, DOI [10.1186/1741-7015-11-1, DOI 10.1186/1741-7015-11-1]; Lawn SD, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0822-8; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Oni T, 2011, THORAX, V66, P669, DOI 10.1136/thx.2011.160168; Saraceni V, 2015, J ACQ IMMUN DEF SYND, V67, P98, DOI [10.1097/QAI.0000000000000247.Prevalent, DOI 10.1097/QAI.0000000000000247.PREVALENT]; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; van't Hoog A, 2014, BMC INFECT DIS, V14, P1, DOI [10.1186/1471-2334-14-1, DOI 10.1186/1471-2334-14-1]; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; WHO, 2011, AUT REAL TIM NUCL AC; WHO, 2017, GLOB TUB REP 2017; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2011, GUID INT TUB CAS FIN, V1, P142	27	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199634	10.1371/journal.pone.0199634	http://dx.doi.org/10.1371/journal.pone.0199634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944701	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800048
J	Courtade, G; Forsberg, Z; Heggset, EB; Eijsink, VGH; Aachmann, FL				Courtade, Gaston; Forsberg, Zarah; Heggset, Ellinor B.; Eijsink, Vincent G. H.; Aachmann, Finn L.			The carbohydrate-binding module and linker of a modular lytic polysaccharide monooxygenase promote localized cellulose oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLOBIOSE DEHYDROGENASE; THERMOMONOSPORA-FUSCA; HYDROLYTIC EFFICIENCY; NMR-SPECTROSCOPY; PROTEIN DYNAMICS; CHEMICAL-SHIFT; ENZYMES; DOMAIN; DEGRADATION; SUBSTRATE	Lytic polysaccharide monooxygenases (LPMOs) are copper-dependent enzymes that catalyze the oxidative cleavage of polysaccharides such as cellulose and chitin, a feature that makes them key tools in industrial biomass conversion processes. The catalytic domains of a considerable fraction of LPMOs and other carbohydrate-active enzymes (CAZymes) are tethered to carbohydrate-binding modules (CBMs) by flexible linkers. These linkers preclude X-ray crystallographic studies, and the functional implications of these modular assemblies remain partly unknown. Here, we used NMR spectroscopy to characterize structural and dynamic features of full-length modular ScLPMO10C from Streptomyces coelicolor. We observed that the linker is disordered and extended, creating distance between the CBM and the catalytic domain and allowing these domains to move independently of each other. Functional studies with cellulose nanofibrils revealed that most of the substrate-binding affinity of full-length ScLPMO10C resides in the CBM. Comparison of the catalytic performance of full-length ScLPMO10C and its isolated catalytic domain revealed that the CBM is beneficial for LPMO activity at lower substrate concentrations and promotes localized and repeated oxidation of the substrate. 'taken together, these results provide a mechanistic basis for understanding the interplay between catalytic domains linked to CBMs in LPMOs and CAZymes in general.	[Courtade, Gaston; Aachmann, Finn L.] NTNU Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, NOBIPOL, Sem Saelands Vei 6-8, N-7491 Trondheim, Norway; [Forsberg, Zarah; Eijsink, Vincent G. H.] NMBU Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, N-1432 AS, Norway; [Heggset, Ellinor B.] RISE PFI AS, Hogskoleringen 6b, N-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Life Sciences	Aachmann, FL (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, NOBIPOL, Sem Saelands Vei 6-8, N-7491 Trondheim, Norway.	finn.l.aachmann@ntnu.no	Forsberg, Zarah/AAM-2395-2020; Heggset, Ellinor/J-4335-2016; Aachmann, Finn Lillelund/G-4136-2015	Heggset, Ellinor/0000-0001-8876-8898; Courtade, Gaston/0000-0002-1644-3223; Eijsink, Vincent/0000-0002-9220-8743; Aachmann, Finn Lillelund/0000-0003-1613-4663	NTNU Norwegian University of Science and Technology; OXYMOD project; Norwegian NMR Platform; FRIPRO project; Research Council of Norway [269408, 226244, 262853]	NTNU Norwegian University of Science and Technology; OXYMOD project; Norwegian NMR Platform; FRIPRO project; Research Council of Norway(Research Council of Norway)	This work was supported by SO funds from NTNU Norwegian University of Science and Technology and by the OXYMOD project, the Norwegian NMR Platform, and an FRIPRO project, all funded by Research Council of Norway Grants 269408, 226244, and 262853, respectively. The authors declare that they have no conflicts of interest with the contents of this article.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Amore A, 2017, P NATL ACAD SCI USA, V114, P13667, DOI 10.1073/pnas.1714249114; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brun E, 1997, BIOCHEMISTRY-US, V36, P16074, DOI 10.1021/bi9718494; CALZA RE, 1985, BIOCHEMISTRY-US, V24, P7797, DOI 10.1021/bi00347a044; Courtade G, 2017, BIOMOL NMR ASSIGN, V11, P257, DOI 10.1007/s12104-017-9759-2; Courtade G, 2017, CARBOHYD RES, V448, P212, DOI 10.1016/j.carres.2017.02.003; Courtade G, 2016, P NATL ACAD SCI USA, V113, P5922, DOI 10.1073/pnas.1602566113; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Czjzek M, 2017, METHODS MOL BIOL, V1588, P239, DOI 10.1007/978-1-4939-6899-2_19; Daragan VA, 1997, PROG NUCL MAG RES SP, V31, P63, DOI 10.1016/S0079-6565(97)00006-X; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Forsberg Z, 2018, J BIOL CHEM, V293, P1397, DOI 10.1074/jbc.M117.817130; Forsberg Z, 2016, J BIOL CHEM, V291, P7300, DOI 10.1074/jbc.M115.700161; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2014, BIOCHEMISTRY-US, V53, P1647, DOI 10.1021/bi5000433; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; FUSHMAN D, 1994, J BIOMOL NMR, V4, P61, DOI 10.1007/BF00178336; George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871; Gomes TCF, 2012, J COMPUT CHEM, V33, P1338, DOI 10.1002/jcc.22959; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harreither W, 2011, APPL ENVIRON MICROB, V77, P1804, DOI 10.1128/AEM.02052-10; Harris PV, 2014, CURR OPIN CHEM BIOL, V19, P162, DOI 10.1016/j.cbpa.2014.02.015; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Johansen KS, 2016, BIOCHEM SOC T, V44, P143, DOI 10.1042/BST20150204; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; MCGINNIS K, 1993, BIOCHEMISTRY-US, V32, P8157, DOI 10.1021/bi00083a015; ONG E, 1994, J BACTERIOL, V176, P999, DOI 10.1128/JB.176.4.999-1008.1994; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Poon DKY, 2007, J BIOL CHEM, V282, P2091, DOI 10.1074/jbc.M609670200; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Sammond DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048615; Sheldon RA, 2016, J MOL CATAL A-CHEM, V422, P3, DOI 10.1016/j.molcata.2016.01.013; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Takashima T, 2018, CARBOHYD RES, V458, P52, DOI 10.1016/j.carres.2018.02.004; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Varnai A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-30; Vermaas JV, 2015, J PHYS CHEM B, V119, P6129, DOI 10.1021/acs.jpcb.5b00778; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022	62	61	61	2	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13006	13015		10.1074/jbc.RA118.004269	http://dx.doi.org/10.1074/jbc.RA118.004269			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29967065	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000442730200003
J	Trumpp, NM; Kiefer, M				Trumpp, Natalie M.; Kiefer, Markus			Functional reorganization of the conceptual brain system after deafness in early childhood	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SIGN-LANGUAGE; CEREBRAL ORGANIZATION; REPRESENTATIONS; PLASTICITY; PICTURE; CORTEX; SOUND; MOTOR; ASSOCIATION	The neurodevelopmental consequences of deafness on the functional neuroarchitecture of the conceptual system have not been intensively investigated so far. Using functional magnetic resonance imaging (fMRI), we therefore identified brain areas involved in conceptual processing in deaf and hearing participants. Conceptual processing was probed by a pictorial animacy decision task. Furthermore, brain areas sensitive to observing verbal signs and to observing non-verbal visual hand actions were identified in deaf participants. In hearing participants, brain areas responsive to environmental sounds and the observation of visual hand actions were determined. We found a stronger recruitment of superior and middle temporal cortex in deaf compared to hearing participants during animacy decisions. This region, which forms auditory cortex in hearing people according to the sound listening task, was also activated in deaf participants, when they observed sign language, but not when they observed non-verbal hand actions. These results indicate that conceptual processing in deaf people more strongly depends on language representations compared to hearing people. Furthermore, additionally enhanced activation in visual and motor areas of deaf versus hearing participants during animacy decisions and a more frequent report of visual and motor features in the property listing task suggest that the loss of the auditory channel is partially compensated by an increased importance of visual and motor information for constituting object knowledge. Hence, our results indicate that conceptual processing in deaf compared to hearing people is more strongly based on the language system, complemented by an enhanced contribution of the visuo-motor system.	[Trumpp, Natalie M.; Kiefer, Markus] Ulm Univ, Dept Psychiat, Ulm, Germany	Ulm University	Trumpp, NM (corresponding author), Ulm Univ, Dept Psychiat, Ulm, Germany.	Natalie.Trumpp@uni-ulm.de		Trumpp, Natalie/0000-0001-9975-4870	German Research Foundation [DFG Ki 804/5-1]	German Research Foundation(German Research Foundation (DFG))	This research was supported by grants of the German Research Foundation to MK (DFG Ki 804/5-1), http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.R., 1983, ARCHITECTURE COGNITI; [Anonymous], 2008, SYMBOLS EMBODIMENT M; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bavelier D, 2001, J NEUROSCI, V21, P8931, DOI 10.1523/JNEUROSCI.21-22-08931.2001; Bavelier D, 2010, NAT NEUROSCI, V13, P1309, DOI 10.1038/nn1110-1309; Beilock SL, 2008, P NATL ACAD SCI USA, V105, P13269, DOI 10.1073/pnas.0803424105; Bellebaum C, 2013, CORTEX, V49, P1110, DOI 10.1016/j.cortex.2012.03.023; Bream PB, 1992, EINFUHRUNG GEBARDENS; Campbell R, 2008, J DEAF STUD DEAF EDU, V13, P3, DOI 10.1093/deafed/enm035; Caramazza A, 2003, TRENDS COGN SCI, V7, P354, DOI 10.1016/S1364-6613(03)00159-1; Cardin V, 2018, CEREB CORTEX, V28, P3540, DOI 10.1093/cercor/bhx222; Cardin V, 2016, J COGNITIVE NEUROSCI, V28, P20, DOI 10.1162/jocn_a_00872; Cardin V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2463; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Chauvey V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044020; de Zubicaray GI, 2001, HUM BRAIN MAPP, V14, P218, DOI 10.1002/hbm.1054; Emmorey K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00484; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Hayakawa S, 2018, COGNITION, V173, P8, DOI 10.1016/j.cognition.2017.12.010; Hoenig K, 2008, J COGNITIVE NEUROSCI, V20, P1799, DOI 10.1162/jocn.2008.20123; Hoenig K, 2011, NEUROIMAGE, V56, P1714, DOI 10.1016/j.neuroimage.2011.02.065; Hoffman P, 2012, APHASIOLOGY, V26, P1119, DOI 10.1080/02687038.2011.608838; Horn W., 1983, L P S LEISTUNGSPR FS, V2; Humphreys GW, 1999, PSYCHOL RES-PSYCH FO, V62, P118, DOI 10.1007/s004260050046; HUMPHREYS GW, 1988, COGNITIVE NEUROPSYCH, V5, P67, DOI 10.1080/02643298808252927; James TW, 2003, CURR BIOL, V13, P1792, DOI 10.1016/j.cub.2003.09.039; Kiefer M, 2001, MEM COGNITION, V29, P100, DOI 10.3758/BF03195745; Kiefer M, 2005, J COGNITIVE NEUROSCI, V17, P199, DOI 10.1162/0898929053124938; Kiefer M, 2007, J COGNITIVE NEUROSCI, V19, P525, DOI 10.1162/jocn.2007.19.3.525; Kiefer M, 2013, ACTION SCIENCE: FOUNDATIONS OF AN EMERGING DISCIPLINE, P381; Kiefer M, 2012, CORTEX, V48, P805, DOI 10.1016/j.cortex.2011.04.006; Kiefer M, 2008, J NEUROSCI, V28, P12224, DOI 10.1523/JNEUROSCI.3579-08.2008; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; MacSweeney M, 2002, BRAIN, V125, P1583, DOI 10.1093/brain/awf153; MacSweeney M, 2008, NEUROIMAGE, V40, P1369, DOI 10.1016/j.neuroimage.2007.12.047; MacSweeney M, 2015, BRAIN, V138, P2468, DOI 10.1093/brain/awv197; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; McClelland JL, 2003, NAT REV NEUROSCI, V4, P310, DOI 10.1038/nrn1076; McRae K, 1997, J EXP PSYCHOL GEN, V126, P99, DOI 10.1037/0096-3445.126.2.99; Meir I, 2017, COGNITION, V158, P189, DOI 10.1016/j.cognition.2016.10.011; NEVILLE HJ, 1990, ANN NY ACAD SCI, V608, P71, DOI 10.1111/j.1749-6632.1990.tb48892.x; Neville HJ, 1998, P NATL ACAD SCI USA, V95, P922, DOI 10.1073/pnas.95.3.922; Nieuwenhuys R., 2008, HUMAN CENTRAL NERVOU; Noppeney U, 2003, BRAIN, V126, P1620, DOI 10.1093/brain/awg152; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Pobric G, 2010, NEUROPSYCHOLOGIA, V48, P1336, DOI 10.1016/j.neuropsychologia.2009.12.036; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; RAUSCHECKER JP, 1993, J NEUROSCI, V13, P4538; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Rogers TT, 2004, PSYCHOL REV, V111, P205, DOI 10.1037/0033-295X.111.1.205; Rudner M, 2013, NEUROPSYCHOLOGIA, V51, P656, DOI 10.1016/j.neuropsychologia.2012.12.011; Sim EJ, 2015, CEREB CORTEX, V25, P2907, DOI 10.1093/cercor/bhu087; Simmons WK, 2008, J PHYSIOL-PARIS, V102, P106, DOI 10.1016/j.jphysparis.2008.03.014; Trumpp NM, 2013, CORTEX, V49, P474, DOI 10.1016/j.cortex.2012.02.002; Tyler LK, 2001, TRENDS COGN SCI, V5, P244, DOI 10.1016/S1364-6613(00)01651-X; Vachon P, 2013, NEUROSCIENCE, V245, P50, DOI 10.1016/j.neuroscience.2013.04.004; Vigliocco G, 2005, P ROY SOC B-BIOL SCI, V272, P1859, DOI 10.1098/rspb.2005.3169; Voss P, 2008, NEUROIMAGE, V40, P746, DOI 10.1016/j.neuroimage.2007.12.020; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176	65	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0198894	10.1371/journal.pone.0198894	http://dx.doi.org/10.1371/journal.pone.0198894			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL7YG	29975699	gold, Green Submitted, Green Published			2022-12-26	WOS:000437424500013
J	Subaiya, S; Tabu, C; N'ganga, J; Awes, AA; Sergon, K; Cosmas, L; Styczynski, A; Thuo, S; Lebo, E; Kaiser, R; Perry, R; Ademba, P; Kretsinger, K; Onuekwusi, I; Gary, H; Scobie, HM				Subaiya, Saleena; Tabu, Collins; N'ganga, James; Awes, Abdulkadir Amin; Sergon, Kibet; Cosmas, Leonard; Styczynski, Ashley; Thuo, Samson; Lebo, Emmaculate; Kaiser, Reinhard; Perry, Robert; Ademba, Peter; Kretsinger, Katrina; Onuekwusi, Iheoma; Gary, Howard; Scobie, Heather M.			Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016	PLOS ONE			English	Article							ELIMINATION; PROGRESS	Introduction To achieve measles elimination, two doses of measles-containing vaccine (MCV) are provided through routine immunization services or vaccination campaigns. In May 2016, Kenya conducted a measles-rubella (MR) vaccination campaign targeting 19 million children aged 9 months-14 years, with a goal of achieving >= 95% coverage. We conducted a post-campaign cluster survey to estimate national coverage and classify coverage in Kenya's 47 counties. Methods The stratified multi-stage cluster survey included data from 20,011 children in 8,253 households sampled using the recently revised World Health Organization coverage survey methodology (2015). Point estimates and 95% confidence intervals (95% CI) of national campaign coverage were calculated, accounting for study design. County vaccination coverage was classified as 'pass,' fail,' or 'intermediate,' using one-sided hypothesis tests against a 95% threshold. Results Estimated national MR campaign coverage was 95% (95% CI: 94%-96%). Coverage differed significantly (p < 0.05) by child's school attendance, mother's education, household wealth, and other factors. In classifying coverage, 20 counties passed (>= 95%), two failed (<95%), and 25 were intermediate (unable to classify either way). Reported campaign awareness among caretakers was 92%. After the 2016 MR campaign, an estimated 93% (95% CI: 92%-94%) of children aged 9 months to 14 years had received >= 2 MCV doses; 6% (95% CI: 6%-7%) had 1 MCV dose; and 0.7% (95% CI: 0.6%-0.9%) remained unvaccinated. Conclusions Kenya reached the MR campaign target of 95% vaccination coverage, representing a substantial achievement towards increasing population immunity. High campaign awareness reflected the comprehensive social mobilization strategy implemented in Kenya and supports the importance of including strong communications platforms in future vaccination campaigns. In counties with sub-optimal MR campaign coverage, further efforts are needed to increase MCV coverage to achieve the national goal of measles elimination by 2020.	[Subaiya, Saleena; Lebo, Emmaculate; Gary, Howard; Scobie, Heather M.] Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA 30333 USA; [Subaiya, Saleena; Styczynski, Ashley] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Tabu, Collins; Thuo, Samson; Ademba, Peter] Minist Hlth, Natl Vaccines & Immunizat Program, Nairobi, Kenya; [N'ganga, James; Awes, Abdulkadir Amin] Kenya Natl Bur Stat, Nairobi, Kenya; [Sergon, Kibet; Cosmas, Leonard; Onuekwusi, Iheoma] WHO, Country Off, Nairobi, Kenya; [Kaiser, Reinhard] WHO, Intercountry Support Team Eastern & Southern Afri, Harare, Zimbabwe; [Perry, Robert; Kretsinger, Katrina] WHO, Geneva, Switzerland; [Kaiser, Reinhard] Ctr Dis Control & Prevent, Div Global Hlth Protect, Freetown, Sierra Leone; [Perry, Robert] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Nairobi, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization; World Health Organization; World Health Organization	Scobie, HM (corresponding author), Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA 30333 USA.	vih8@cdc.gov		Styczynski, Ashley/0000-0002-4682-8087	World Health Organization (WHO); U.S. Centers for Disease Control and Prevention; Bill and Melinda Gates Foundation (BMGF) [OPP1084513]	World Health Organization (WHO)(World Health Organization); U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation)	The funding for this evaluation was provided by the World Health Organization (WHO) and U.S. Centers for Disease Control and Prevention. WHO funding was provided in part through a grant from the Bill and Melinda Gates Foundation (BMGF) (OPP1084513; Alya Dabbagh; www.gatesfoundation.org/). BMGF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, Wkly Epidemiol Rec, V89, P141; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P129; [Anonymous], 2017, WHO VACC PREV DIS MO; Centers for Disease Control and Prevention, 2007, MMWR-MORBID MORTAL W, V56, P969; Centers for Disease Control and Prevention, 2012, MMWR-MORBID MORTAL W, V61, P678; Cutts FT, 2016, VACCINE, V34, P4103, DOI 10.1016/j.vaccine.2016.06.053; Dabbagh A, 2017, MMWR-MORBID MORTAL W, V66, P1148, DOI 10.15585/mmwr.mm6642a6; Feldstein LR, 2017, MMWR-MORBID MORTAL W, V66, P1252, DOI 10.15585/mmwr.mm6645a3; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gavi the Vaccine Alliance, 2017, GUID POST CAMP SURV; Kaiser R, 2015, B WORLD HEALTH ORGAN, V93, P314, DOI 10.2471/BLT.14.146050; Kenya National Bureau of Statistics, 2018, POP HOUS CENS; Kenya National Bureau of Statistics, 2014, KEN DEM HLTH SURV; Lessler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067639; Manakongtreecheep Kasidet, 2017, Pan Afr Med J, V27, P15, DOI 10.11604/pamj.supp.2017.27.3.12118; Masresha BG, 2017, MMWR-MORBID MORTAL W, V66, P436, DOI 10.15585/mmwr.mm6617a2; Mbabazi WB, 2015, HEALTH POLICY PLANN, V30, P638, DOI 10.1093/heapol/czu042; Miles M, 2013, VACCINE, V31, P1560, DOI 10.1016/j.vaccine.2012.10.089; Ministry of Public Health and Sanitation, 2013, POST 2012 SIA MEAS C; Patel MK, 2016, MMWR-MORBID MORTAL W, V65, P1228, DOI 10.15585/mmwr.mm6544a6; Takahashi S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15585; Vijayaraghavan M, 2007, HEALTH POLICY, V83, P27, DOI 10.1016/j.healthpol.2006.11.008; Vynnycky E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149160; WHO, 2005, IMM COV CLUST SURV R; World Health Organization, 2016, PLANN IMPL HIGH QUAL; World Health Organization, 2015, VACC COV CLUST SURV; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P490; World Health Organization-Regional Office for Africa, 2008, 2 M AFR REG MEASL TE	29	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199786	10.1371/journal.pone.0199786	http://dx.doi.org/10.1371/journal.pone.0199786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965975	gold, Green Submitted, Green Published			2022-12-26	WOS:000437224100023
J	Wittkowski, KM; Dadurian, C; Seybold, MP; Kim, HS; Hoshino, A; Lyden, D				Wittkowski, Knut M.; Dadurian, Christina; Seybold, Martin P.; Kim, Han Sang; Hoshino, Ayuko; Lyden, David			Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; METHYL-BETA-CYCLODEXTRIN; LIPID RAFTS; ALPHA-V-BETA-3 INTEGRIN; CELLS; CHOLESTEROL; PROTEIN; METASTASIS; EXOSOMES; RISK	Most breast cancer deaths are caused by metastasis and treatment options beyond radiation and cytotoxic drugs, which have severe side effects, and hormonal treatments, which are or become ineffective for many patients, are urgently needed. This study reanalyzed existing data from three genome-wide association studies (GWAS) using a novel computational biostatistics approach (muGWAS), which had been validated in studies of 600-2000 subjects in epilepsy and autism. MuGWAS jointly analyzes several neighboring single nucleotide polymorphisms while incorporating knowledge about genetics of heritable diseases into the statistical method and about GWAS into the rules for determining adaptive genome-wide significance. Results from three independent GWAS of 1000-2000 subjects each, which were made available under the National Institute of Health's "Up For A Challenge" (U4C) project, not only confirmed cell-cycle control and receptor/AKT signaling, but, for the first time in breast cancer GWAS, also consistently identified many genes involved in endo-/exocytosis (EEC), most of which had already been observed in functional and expression studies of breast cancer. In particular, the findings include genes that translocate (ATP8A1, ATP8B1, ANO4, ABCA1) and metabolize (AGPAT3, AGPAT4, DGKQ, LPPR1) phospholipids entering the phosphatidylinositol cycle, which controls EEC. These novel findings suggest scavenging phospholipids as a novel intervention to control local spread of cancer, packaging of exosomes (which prepare distant microenvironment for organ-specific metastases), and endocytosis of beta 1 integrins (which are required for spread of metastatic phenotype and mesenchymal migration of tumor cells). Beta-cyclodextrins (beta CD) have already been shown to be effective in in vitro and animal studies of breast cancer, but exhibits cholesterol-related ototoxicity. The smaller alpha-cyclodextrins (alpha CD) also scavenges phospholipids, but cannot fit cholesterol. An in-vitro study presented here confirms hydroxypropyl (HP)-alpha CD to be twice as effective as HP beta CD against migration of human cells of both receptor negative and estrogen-receptor positive breast cancer. If the previous successful animal studies with beta CDs are replicated with the safer and more effective alpha CDs, clinical trials of adjuvant treatment with alpha CDs are warranted. Ultimately, all breast cancer are expected to benefit from treatment with HP alpha CD, but women with triple-negative breast cancer (TNBC) will benefit most, because they have fewer treatment options and their cancer advances more aggressively.	[Wittkowski, Knut M.; Dadurian, Christina] Rockefeller Univ, Ctr Clin & Translat Sci, 1230 York Ave, New York, NY 10021 USA; [Seybold, Martin P.] Univ Stuttgart, Inst Formale Methoden Informat, Stuttgart, Germany; [Kim, Han Sang; Hoshino, Ayuko; Lyden, David] Cornell Univ, Weill Med Coll, Dept Pediat & Cell & Dev Biol, New York, NY 10021 USA	Rockefeller University; University of Stuttgart; Cornell University	Wittkowski, KM (corresponding author), Rockefeller Univ, Ctr Clin & Translat Sci, 1230 York Ave, New York, NY 10021 USA.	kmw@rockefeller.edu	Kim, Han Sang/R-3768-2019	Kim, Han Sang/0000-0002-6504-9927; Wittkowski, Knut/0000-0002-9231-1986	National Center for Advancing Transla-tional Sciences (NCATS, National Institutes of Health [NIH]) Clinical Translational Sci-ence Award (CTSA) program [UL1 TR000043]; James Paduano Foundation; Nancy C. and Daniel P. Paduano Foundation; Children's Cancer and Blood Foundation; 5th District AHEPA Cancer Research Foundation; Susan G. Komen Postdoctoral Fellowship; Physician-Scientist Program from the Yonsei University College of Medicine; National Cancer Institute [U01-CA98233, U01-CA98710, U01-CA98216, U01-CA98758]; Intramural Research Program of the National Cancer Institute, Division of Cancer Epidemiology and Genetics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER	National Center for Advancing Transla-tional Sciences (NCATS, National Institutes of Health [NIH]) Clinical Translational Sci-ence Award (CTSA) program; James Paduano Foundation; Nancy C. and Daniel P. Paduano Foundation; Children's Cancer and Blood Foundation; 5th District AHEPA Cancer Research Foundation; Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); Physician-Scientist Program from the Yonsei University College of Medicine; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by grant # UL1 TR000043 from the National Center for Advancing Transla-tional Sciences (NCATS, National Institutes of Health [NIH], https://www.nih.gov/) Clinical Translational Sci-ence Award (CTSA) program (KMW). The authors gratefully acknowledge support from the following funding sources: The James Paduano Foundation, Nancy C. and Daniel P. Paduano Foundation, Children's Cancer and Blood Foundation, and 5th District AHEPA Cancer Research Foundation (https://5thdistrictahepa-crf.org/, all to DL), Susan G. Komen Postdoctoral Fellowship (http://www.komen.org/, AH), and Physician-Scientist Program from the Yonsei University College of Medicine (http://medicine.yonsei.ac.kr/en/, HSK). The Breast and Prostate Can-cer Cohort Consortium (BPC3) genome-wide association studies of advanced prostate cancer and estrogen-receptor negative breast cancer was supported by the National Cancer Institute (www.cancer.gov) under cooperative agreements U01-CA98233, U01-CA98710, U01-CA98216, and U01-CA98758 and the Intramural Research Program of the National Cancer Institute, Division of Cancer Epidemiology and Genetics. The fun-ders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056174; Antalis CJ, 2011, CLIN EXP METASTAS, V28, P733, DOI 10.1007/s10585-011-9405-9; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Aslibekyan S, 2013, CIRC-CARDIOVASC GENE, V6, P418, DOI [10.1161/circgenetics.113.000106, DOI 10.1161/CIRCGENETICS.113.000106]; Aslibekyan S, 2013, CIRC-CARDIOVASC GENE, V6, P409, DOI 10.1161/CIRCGENETICS.112.000010; Badana A, 2016, J BREAST CANCER, V19, P372, DOI 10.4048/jbc.2016.19.4.372; Bar-On P, 2006, J NEUROCHEM, V98, P1032, DOI 10.1111/j.1471-4159.2006.04017.x; Barsh GS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002812; Belguise K, 2012, ONCOGENE, V31, P4889, DOI 10.1038/onc.2011.659; Ben-Chetrit N, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005537; Benesch MGK, 2016, J BIOMED RES, V30, P272, DOI 10.7555/JBR.30.20150058; Bokel C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a017020; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Burdett T, 2016, NHGRI EBI CATALOG PU; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Chen MB, 2016, CANCER RES, V76, P2513, DOI 10.1158/0008-5472.CAN-15-1325; Chew CL, 2016, ONCOTARGET, V7, P5, DOI 10.18632/oncotarget.6663; Chistiakov DA, 2017, J MOL MED, V95, P1153, DOI 10.1007/s00109-017-1575-8; Chowdhury K, 2017, CANCER INVEST, V35, P403, DOI 10.1080/07357907.2017.1309548; Cicek MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038175; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Coisne C, 2016, MOLECULES, V21, DOI 10.3390/molecules21121748; Colacurcio DJ, 2016, AGEING RES REV, V32, P75, DOI 10.1016/j.arr.2016.05.004; Cosker KE, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020669; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Cronin S, 2015, JARO-J ASSOC RES OTO, V16, P599, DOI 10.1007/s10162-015-0528-6; Crumling MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053280; Cui F, 2016, BREAST CANCER RES TR, V155, P313, DOI 10.1007/s10549-015-3670-2; Czaplinska D, 2014, BBA-MOL CELL RES, V1843, P2461, DOI 10.1016/j.bbamcr.2014.06.022; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Davidson CD, 2016, ANN CLIN TRANSL NEUR, V3, P366, DOI 10.1002/acn3.306; De Franceschi N, 2015, J CELL SCI, V128, P839, DOI 10.1242/jcs.161653; Demircioglu F, 2016, CURR OPIN CELL BIOL, V42, P121, DOI 10.1016/j.ceb.2016.07.008; Donatello S, 2012, AM J PATHOL, V181, P2172, DOI 10.1016/j.ajpath.2012.08.025; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Emery G, 2006, CURR OPIN CELL BIOL, V18, P407, DOI 10.1016/j.ceb.2006.06.009; Fairus AKM, 2017, BIOCHIMIE, V135, P154, DOI 10.1016/j.biochi.2017.02.003; Farge E, 1999, AM J PHYSIOL-CELL PH, V276, pC725, DOI 10.1152/ajpcell.1999.276.3.C725; Fedele C, 2015, J BIOL CHEM, V290, P4545, DOI 10.1074/jbc.C114.617662; Fedida-Metula S, 2008, CARCINOGENESIS, V29, P1546, DOI 10.1093/carcin/bgn146; FRANK DW, 1976, AM J PATHOL, V83, P367; Frommlet F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148620; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Gotoh K, 2014, BIOCHEM BIOPH RES CO, V455, P285, DOI 10.1016/j.bbrc.2014.11.006; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; Grosse PY, 1998, BRIT J CANCER, V78, P1165, DOI 10.1038/bjc.1998.648; Guerra F., 2016, TRANSL MED COMMUN, V1, P3, DOI [10.1186/s41231-016-0002-4, DOI 10.1186/S41231-016-0002-4]; Guglielmi L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00034; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hall DP, 2014, CANCER CELL, V26, P738, DOI 10.1016/j.ccell.2014.09.015; Hanna S, 2014, INT J ONCOL, V44, P1499, DOI 10.3892/ijo.2014.2330; Harris DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117495; Hashimoto S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10656; Hastings C., 2009, COMPASSIONATE USE CL; Hayashi S, 2015, INT J CLIN ONCOL, V20, P262, DOI 10.1007/s10147-015-0788-5; Heusermann W, 2016, J CELL BIOL, V213, P173, DOI 10.1083/jcb.201506084; HOEFFDING W, 1948, ANN MATH STAT, V19, P293, DOI 10.1214/aoms/1177730196; Hoffman JD, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006690; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Huang Q, 2006, CANCER RES, V66, P5807, DOI 10.1158/0008-5472.CAN-06-0077; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ioannidis JPA, 2013, CIRC-CARDIOVASC GENE, V6, P413, DOI 10.1161/CIRCGENETICS.113.000106; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jaishy B, 2016, J LIPID RES, V57, P1619, DOI 10.1194/jlr.R067520; Kamar RI, 2012, BIOPHYS J, V103, P1627, DOI 10.1016/j.bpj.2012.07.052; Kawauchi T, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00394; Keerthikumar S, 2015, ONCOTARGET, V6, P15375, DOI 10.18632/oncotarget.3801; Kendellen MF, 2014, ONCOGENE, V33, P1297, DOI 10.1038/onc.2013.64; Kerr WG, 2011, ANN NY ACAD SCI, V1217, P1, DOI 10.1111/j.1749-6632.2010.05869.x; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Koumangoye RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024234; KRUSKAL WH, 1957, J AM STAT ASSOC, V52, P356, DOI 10.2307/2280906; Lagace Thomas A, 2015, Lipid Insights, V8, P65, DOI 10.4137/LPI.S31746; Leca J, 2016, J CLIN INVEST, V126, P4140, DOI 10.1172/JCI87734; LEROYLECHAT F, 1994, INT J PHARM, V101, P97, DOI 10.1016/0378-5173(94)90080-9; Li HZ, 2012, HUM GENET, V131, P1395, DOI 10.1007/s00439-012-1178-y; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lichtenhan JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175236; Liu WL, 2018, PROTEIN CELL, V9, P785, DOI 10.1007/s13238-017-0421-7; Liu Y, 2007, MOL MEMBR BIOL, V24, P91, DOI 10.1080/10929080600990500; Loftsson T, 2010, J PHARM PHARMACOL, V62, P1607, DOI 10.1111/j.2042-7158.2010.01030.x; Lowry MC, 2015, CLIN CHEM, V61, P1457, DOI 10.1373/clinchem.2015.240028; Maarup TJ, 2015, MOL GENET METAB, V116, P75, DOI 10.1016/j.ymgme.2015.07.001; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Maji S, 2017, MOL CANCER RES, V15, P93, DOI 10.1158/1541-7786.MCR-16-0163; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; McNamara CR, 2011, FUTURE MED CHEM, V3, P549, DOI [10.4155/fmc.11.12, 10.4155/FMC.11.12]; Mechanic LE, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006945; Menard JA, 2016, CANCER RES, V76, P4828, DOI 10.1158/0008-5472.CAN-15-2831; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mitra S, 2016, ONCOTARGET, V7, P40252, DOI 10.18632/oncotarget.9730; Montecucco F, 2015, VASC PHARMACOL, V72, P197, DOI 10.1016/j.vph.2015.04.008; Morgan MR, 2009, IUBMB LIFE, V61, P731, DOI 10.1002/iub.200; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Palaniyandi Kanagaraj, 2012, J Cancer Sci Ther, V4, P214; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Posor Y, 2015, BBA-MOL CELL BIOL L, V1851, P794, DOI 10.1016/j.bbalip.2014.09.014; Powis G, 1995, ACTA BIOCHIM POL, V42, P395; Raghu H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-647; Rajnavolgyi E, 2014, BEILSTEIN J ORG CHEM, V10, P3152, DOI 10.3762/bjoc.10.332; Ratajczak MZ, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0113-6; Resni N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137878; Ridgway ND, 1999, PROG LIPID RES, V38, P337, DOI 10.1016/S0163-7827(99)00007-7; Rios-Marco P, 2017, BBA-BIOMEMBRANES, V1859, P1657, DOI 10.1016/j.bbamem.2017.02.016; Rojas K, 2016, CLIN OBSTET GYNECOL, V59, P651, DOI 10.1097/GRF.0000000000000239; Roka E, 2015, MOLECULES, V20, P20269, DOI 10.3390/molecules201119694; Samie MA, 2014, J LIPID RES, V55, P995, DOI 10.1194/jlr.R046896; Schneider G, 2014, MOL CANCER RES, V12, P1560, DOI 10.1158/1541-7786.MCR-14-0188; SHIRATORI Y, 1994, J BIOL CHEM, V269, P11337; Shityakov S, 2016, J TOXICOL SCI, V41, P175, DOI 10.2131/jts.41.175; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh A, 2016, MOL CANCER RES, V14, P1136, DOI 10.1158/1541-7786.MCR-16-0058; Snowden SG, 2014, CIRC-CARDIOVASC GENE, V7, P955, DOI 10.1161/CIRCGENETICS.114.000606; Storch CH, 2007, J PHARMACOL EXP THER, V323, P257, DOI 10.1124/jpet.107.122994; Takahashi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21973; Tiribuzi R, 2011, J ALZHEIMERS DIS, V24, P785, DOI 10.3233/JAD-2011-100525; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; van Agthoven T, 2009, BRIT J CANCER, V101, P1824, DOI 10.1038/sj.bjc.6605423; Vance JE, 2014, J LIPID RES, V55, P1609, DOI 10.1194/jlr.R047837; VARTICOVSKI L, 1991, MOL CELL BIOL, V11, P1107, DOI 10.1128/MCB.11.2.1107; Viaud J, 2016, BIOCHIMIE, V125, P250, DOI 10.1016/j.biochi.2015.09.005; Vite CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010101; Wang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125766; Wang J, 2016, ACTA CHIR BELG, V116, P346, DOI 10.1080/00015458.2016.1181312; Wang SJ, 2015, ONCOTARGET, V6, P243, DOI 10.18632/oncotarget.2801; Ward S, 2010, PEDIATR RES, V68, P52, DOI [10.1203/PDR.0b013e3181df4623, 10.1203/00006450-201011001-00099]; Watson CA, 2013, ANTI-CANCER DRUG, V24, P704, DOI 10.1097/CAD.0b013e3283626fdd; Wen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153329; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Wittkowski KM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.124; Wittkowski KM, 2013, PHARMACOGENOMICS, V14, P391, DOI [10.2217/PGS.13.28, 10.2217/pgs.13.28]; Wittkowski KM, 2010, METHODS MOL BIOL, V620, P105, DOI 10.1007/978-1-60761-580-4_2; Woolley JF, 2015, TRENDS MOL MED, V21, P530, DOI 10.1016/j.molmed.2015.06.006; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; Yamaguchi R, 2015, FEBS LETT, V589, P4097, DOI 10.1016/j.febslet.2015.11.009; Yamashita T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005500; Yan HL, 2012, CELL SIGNAL, V24, P961, DOI 10.1016/j.cellsig.2011.12.019; Yao JQ, 2012, J EXP MED, V209, P2501, DOI 10.1084/jem.20121239; Yokoo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141946; Zafar A, 2014, MOL CELL BIOL, V34, P2961, DOI 10.1128/MCB.01693-13; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhang LD, 2013, CANCER RES, V73, P246, DOI 10.1158/0008-5472.CAN-12-2241; Zhang Q, 2006, J BIOL CHEM, V281, P18145, DOI 10.1074/jbc.M512566200; Zimmer S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6100	164	13	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199012	10.1371/journal.pone.0199012	http://dx.doi.org/10.1371/journal.pone.0199012			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965997	Green Submitted, Green Published, gold			2022-12-26	WOS:000437224100009
J	Zanocco, RP; Bresoli-Obach, R; Nonell, S; Lemp, E; Zanocco, AL				Zanocco, Renzo P.; Bresoli-Obach, Roger; Nonell, Santi; Lemp, Else; Zanocco, Antonio L.			Structure-activity study of furyl aryloxazole fluorescent probes for the detection of singlet oxygen	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; PHOTOSENSITIZED OXIDATION; MOLECULAR-OXYGEN; MAMMALIAN-CELLS; QUANTUM YIELDS; SENSOR GREEN; SYSTEMS; CHEMILUMINESCENCE; IDENTIFICATION; AROMATICITY	In this study, we report the synthesis and the photochemical behavior of a series of new "click-on" fluorescent probes designed to detect singlet oxygen. They include a highly fluorescent chemical structure, an aryloxazole ring, linked to a furan moiety operating as singlet oxygen trap. Their activity depends on both the structure of the aryloxazole fluorophore and the electron-donating and electron-accepting properties of the substituents attached to the C-5 of the furan ring. All probes are selectively oxidized by singlet oxygen to give a single fluorescent product in methanol and produce negligible amounts of singlet oxygen themselves by self-sensitization. The most promising dyad, (E)-2-(2-(5-methylfuran-2-yl)vinyl) naphtho[1,2-d]oxazole, FN-6, shows outstanding reactivity and sensitivity: it traps singlet oxygen with a rate constant (5,8 +/- 0.1) x 10(7) M-1 s(-1) and its fluorescence increases by a factor of 500 upon reaction. Analysis of the dyads reactivity in terms of linear free energy relationships using the modified Swain and Lupton parameter F and the Fukui condensed function for the electrophilic attack, suggests that cycloaddition of singlet oxygen to the furan ring is partially concerted and possibly involves an exciplex with a "more open" structure than could be expected for a concerted cycloaddition.	[Zanocco, Renzo P.; Lemp, Else; Zanocco, Antonio L.] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Quim Organ & Fisicoquim, Santiago, Chile; [Bresoli-Obach, Roger; Nonell, Santi] Univ Ramon Llull, Inst Quim Sarria, Barcelona, Spain	Universidad de Chile; Universitat Ramon Llull; Institut Quimic de Sarria	Zanocco, RP; Zanocco, AL (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Quim Organ & Fisicoquim, Santiago, Chile.	renzo.zanocco@ciq.uchile.cl; azanocco@ciq.uchile.cl	Obach, Roger Bresoli/ABG-5022-2020	ZANOCCO, ANTONIO/0000-0002-6521-5382; Bresoli-Obach, Roger/0000-0002-7819-7750	FONDECYT from the Chilean National Commission for Scientific and Technological Research (CONICYT) [1050210]; Spanish Ministerio de Economia y Competitividad [ELCTQ2013-48767-C3-1-R, CTQ2015-71896-REDT, CTQ2016-78454-C2-1-R]	FONDECYT from the Chilean National Commission for Scientific and Technological Research (CONICYT); Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by FONDECYT 1050210 from the Chilean National Commission for Scientific and Technological Research (CONICYT), www.fondecyt.cl, ALZ, ELCTQ2013-48767-C3-1-R, CTQ2015-71896-REDT and CTQ2016-78454-C2-1-R from the Spanish Ministerio de Economia y Competitividad, SN.	Abrahamse H, 2016, BIOCHEM J, V473, P347, DOI 10.1042/BJ20150942; Adam W, 2005, CHEM REV, V105, P3371, DOI 10.1021/cr0300035; Aleksandrov AA, 2011, RUSS J ORG CHEM+, V47, P710, DOI 10.1134/S1070428011050095; Babu PSS, 2017, SCI REP-UK, V7, DOI 10.1038/srep42126; Bauer G, 2016, ANTICANCER RES, V36, P5649, DOI 10.21873/anticanres.11148; Bresoli-Obach R, 2016, METHODS, V109, P64, DOI 10.1016/j.ymeth.2016.06.007; Cadet J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1219, DOI 10.1562/2006-06-09-IR-914; Cao YF, 2005, PHOTOCHEM PHOTOBIOL, V81, P1489, DOI 10.1562/2005-05-18-RA-532; Castaneda F, 2004, J PHOTOCH PHOTOBIO A, V168, P175, DOI 10.1016/j.jphotochem.2004.05.020; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Castro-Olivares R, 2009, J PHOTOCH PHOTOBIO A, V207, P160, DOI 10.1016/j.jphotochem.2009.05.012; Clennan EL, 2005, TETRAHEDRON, V61, P6665, DOI 10.1016/j.tet.2005.04.017; Contreras RR, 1999, CHEM PHYS LETT, V304, P405, DOI 10.1016/S0009-2614(99)00325-5; Curitol M, 2013, PHOTOCHEM PHOTOBIOL, V89, P1327, DOI 10.1111/php.12133; Cyranski M, TETRAHEDRON, V199, P13795; Dai ZC, 2013, J MATER CHEM B, V1, P924, DOI 10.1039/c2tb00350c; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991, DOI 10.1021/j100678a001; Di Mascio P, 1997, J PHOTOCH PHOTOBIO B, V38, P169, DOI 10.1016/S1011-1344(96)07444-1; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; EATON DF, 1988, PURE APPL CHEM, V60, P1107, DOI 10.1351/pac198860071107; Fayed TA, 2004, COLLOID SURFACE A, V236, P171, DOI 10.1016/j.colsurfa.2004.01.031; Flors C, 2006, J EXP BOT, V57, P1725, DOI 10.1093/jxb/erj181; FUKUI K, 1982, SCIENCE, V218, P747, DOI 10.1126/science.218.4574.747; Garcia-Diaz M, 2016, METHODS, V109, P158, DOI 10.1016/j.ymeth.2016.06.025; Girotti AW, 2001, J PHOTOCH PHOTOBIO B, V63, P103, DOI 10.1016/S1011-1344(01)00207-X; Gollmer A, 2011, PHOTOCHEM PHOTOBIOL, V87, P671, DOI 10.1111/j.1751-1097.2011.00900.x; Gunther G, 2000, BOL SOC CHIL QUIM, V45, P637; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Hideg E, 2011, BBA-BIOENERGETICS, V1807, P1658, DOI 10.1016/j.bbabio.2011.09.009; Kang P, 2002, J AM CHEM SOC, V124, P4865, DOI 10.1021/ja012038x; Kim S, 2014, J AM CHEM SOC, V136, P11707, DOI 10.1021/ja504279r; Kim S, 2013, J PHYS CHEM B, V117, P13985, DOI 10.1021/jp406638g; Krygowski TM, 1996, TETRAHEDRON, V52, P10255, DOI 10.1016/0040-4020(96)00560-1; Krygowski TM, 2001, CHEM REV, V101, P1385, DOI 10.1021/cr990326u; Lee JJ, 2013, CHEM COMMUN, V49, P3016, DOI 10.1039/c3cc40630j; Lee YEK, 2012, METHOD ENZYMOL, V504, P419, DOI 10.1016/B978-0-12-391857-4.00021-5; Lemp E, 2003, CURR ORG CHEM, V7, P799, DOI 10.2174/1385272033486657; Liu HW, 2016, CHEM COMMUN, V52, P12330, DOI 10.1039/c6cc05880a; Machado AEH, 2003, SPECTROCHIM ACTA A, V59, P345, DOI 10.1016/S1386-1425(02)00164-6; MacManus-Spencer LA, 2005, ANAL CHEM, V77, P1200, DOI 10.1021/ac048293s; Martinez GR, 2005, FREE RADICAL BIO MED, V38, P1491, DOI 10.1016/j.freeradbiomed.2005.02.008; Matheson IBC, 1970, CHEM PHYS LETT, V7, P475, DOI 10.1016/0009-2614(70)80341-4; MERKEL PB, 1971, CHEM PHYS LETT, V12, P120, DOI 10.1016/0009-2614(71)80630-9; Montalti M., 2006, HDB PHOTOCHEMISTRY; Nardi G, 2014, FREE RADICAL BIO MED, V77, P64, DOI 10.1016/j.freeradbiomed.2014.08.020; OKAMOTO M, 1990, J PHYS CHEM-US, V94, P669, DOI 10.1021/j100365a030; Pedersen SK, 2014, J ORG CHEM, V79, P3079, DOI 10.1021/jo500219y; Ragas X, 2011, CHEMPHYSCHEM, V12, P161, DOI 10.1002/cphc.201000919; Ragas X, 2009, CHEM COMMUN, P2920, DOI 10.1039/b822776d; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Ruiz-Gonzalez R, SINGLET OXYGEN APPL; Ruiz-Gonzalez R, 2013, PHOTOCHEM PHOTOBIOL, V89, P1427, DOI 10.1111/php.12106; Ruiz-Gonzalez R, 2013, J AM CHEM SOC, V135, P9564, DOI 10.1021/ja4020524; SCHMIDT R, 1994, J PHOTOCH PHOTOBIO A, V79, P11, DOI 10.1016/1010-6030(93)03746-4; Shen Y, 2010, P SOC PHOTO-OPT INS, V7845; Song D, 2013, ORG LETT, V15, P3582, DOI 10.1021/ol401421r; Sudhamani CN, 2017, MED CHEM RES, V26, P1160, DOI 10.1007/s00044-017-1831-z; SWAIN CG, 1968, J AM CHEM SOC, V90, P4328, DOI 10.1021/ja01018a024; Tiznado W, 2005, J PHYS CHEM A, V109, P3220, DOI 10.1021/jp0450787; WEISHAUPT KR, 1976, CANCER RES, V36, P2326; Westberg M, 2016, METHODS, V109, P81, DOI 10.1016/j.ymeth.2016.07.001; Westberg M, 2016, J PHOTOCH PHOTOBIO A, V321, P297, DOI 10.1016/j.jphotochem.2016.01.028; Wu HY, 2011, TRAC-TREND ANAL CHEM, V30, P133, DOI 10.1016/j.trac.2010.08.009; Xiao L, 2011, ACS NANO, V5, P3651, DOI 10.1021/nn1035262; Ye Y, 2003, J AM CHEM SOC, V125, P13926, DOI 10.1021/ja0378660; Zajac M, 2008, TETRAHEDRON, V64, P10605, DOI 10.1016/j.tet.2008.08.064; Zanocco AL, 1998, PHOTOCHEM PHOTOBIOL, V68, P487; Zanocco AL, 2007, PHOTOCHEM PHOTOBIOL, V83, P584, DOI 10.1562/2006-08-01-RA-991; Zhu DB, 2004, LUMINESCENCE, V19, P278, DOI 10.1002/bio.782	70	3	4	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0200006	10.1371/journal.pone.0200006	http://dx.doi.org/10.1371/journal.pone.0200006			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965981	Green Submitted, gold, Green Published			2022-12-26	WOS:000437224100037
J	de Laat, MA; Kheder, MH; Pollitt, CC; Sillence, MN				de Laat, Melody Anne; Kheder, Murad Hasan; Pollitt, Christopher Charles; Sillence, Martin Nicholas			Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation	PLOS ONE			English	Article							GYMNEMA-SYLVESTRE LEAVES; GLUCAGON-LIKE PEPTIDE-1; GLUCOSE-ABSORPTION; T1R FAMILY; HORSES; SECRETION; ACID; EXPRESSION; CELLS; RAT	Hyperinsulinemia is a major risk factor for equine laminitis, a debilitating and painful foot condition. Sweet taste receptor (T1R2/3) inhibitors have been used to reduce the insulin and glucose responses to oral carbohydrates in other species. However, their effect in horses has not been investigated. It would be useful to be able to attenuate the large postprandial insulin response that typically occurs when a carbohydrate-rich meal is fed to insulin-dysregulated horses. Here we have determined the efficacy of two T1R2/3 inhibitors, lactisole and Gymnema sylvestre, for reducing glucose uptake by the equine small intestine in vitro; and post-prandial insulin secretion in ponies in vivo, following a carbohydrate-based meal. We used gas chromatography-mass spectrometry to measure 2-deoxyglucose uptake by explants of small intestine, in the presence and absence of the T1R2/3 inhibitors. Lactisole and G sylvestre reduced 2-deoxyglucose uptake by the intestinal explants by 63% (P = 0.032) and 73% (P = 0.047), respectively, compared to control samples. The study in vivo investigated the effect of the inhibitors on the blood glucose and serum insulin responses to a meal containing D-glucose. Three doses of each inhibitor were tested using a Latin square design, and each dose was compared to a meal with no inhibitor added. Lactisole had no effect on glucose and insulin concentrations, whereas G sylvestre was partially effective at reducing post-prandial blood glucose (by -10%) and serum insulin concentrations (-25%) in seven ponies, with a most effective dose of 10 mg/kg bodyweight. These data provide preliminary support that T1R2/3 inhibitors may be a useful therapeutic strategy for the management of equine insulin dysregulation and the prevention of laminitis. However, further optimisation of the dose and delivery method for these compounds is required, as well as a direct investigation of their activity on the equine sweet taste receptor.	[de Laat, Melody Anne; Kheder, Murad Hasan; Sillence, Martin Nicholas] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld, Australia; [Pollitt, Christopher Charles] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia	Queensland University of Technology (QUT); University of Queensland	de Laat, MA (corresponding author), Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld, Australia.	melody.delaat@qut.edu.au	Pollitt, Christopher/L-3964-2019; de Laat, Melody A/F-2899-2015	de Laat, Melody A/0000-0001-7922-3642	Queensland University of Technology Bluebox; Australian Research Council [DE140100135]	Queensland University of Technology Bluebox; Australian Research Council(Australian Research Council)	Funded by Queensland University of Technology Bluebox: No role in the study. Australian Research Council; DE140100135, no role in the study.	Al-Romaiyan A, 2013, PHYTOTHER RES, V27, P1006, DOI 10.1002/ptr.4815; Bamford NJ, 2015, J ANIM SCI, V93, P3377, DOI 10.2527/jas.2014-8736; Bera R, 2016, PLANTA MED, V82, P544, DOI 10.1055/s-0042-101032; Carter RA, 2009, VET J, V179, P204, DOI 10.1016/j.tvjl.2008.02.029; Daly K, 2012, AM J PHYSIOL-REG I, V303, pR199, DOI 10.1152/ajpregu.00031.2012; de Laat MA, 2017, EQUINE VET J, V49, P238, DOI 10.1111/evj.12579; de Laat MA, 2016, AM J PHYSIOL-ENDOC M, V310, pE61, DOI 10.1152/ajpendo.00362.2015; de Laat MA, 2010, EQUINE VET J, V42, P129, DOI 10.2746/042516409X475779; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; Frank N, 2014, EQUINE VET J, V46, P103, DOI 10.1111/evj.12169; FUSHIKI T, 1992, J NUTR, V122, P2367, DOI 10.1093/jn/122.12.2367; Geor RJ, 2009, VET CLIN N AM-EQUINE, V25, P51, DOI 10.1016/j.cveq.2009.02.001; Gilor C, 2011, DOMEST ANIM ENDOCRIN, V40, P205, DOI 10.1016/j.domaniend.2011.01.002; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Hamano K, 2015, J ENDOCRINOL, V226, P57, DOI 10.1530/JOE-15-0102; Harada S, 2000, AM J PHYSIOL-REG I, V278, pR1513, DOI 10.1152/ajpregu.2000.278.6.R1513; HELLEKANT G, 1976, ACTA PHYSIOL SCAND, V98, P136, DOI 10.1111/j.1748-1716.1976.tb00233.x; Hellekant G, 1996, PHYSIOL BEHAV, V60, P469, DOI 10.1016/S0031-9384(96)80021-7; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Hustace JL, 2009, AM J VET RES, V70, P665, DOI 10.2460/ajvr.70.5.665; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Johnson P. J., 2004, Clinical Techniques in Equine Practice, V3, P45, DOI 10.1053/j.ctep.2004.07.004; Khan V, 2012, J PHARM BIOALLIED SC, V4, P27, DOI 10.4103/0975-7406.92727; Kheder MH, 2018, PEERJ, V6, DOI 10.7717/peerj.4316; Kumar V, 2013, Drug Res (Stuttg), V63, P625, DOI 10.1055/s-0033-1349852; Kyriazis GA, 2014, ENDOCRINOLOGY, V155, P2112, DOI 10.1210/en.2013-2015; Leach MJ, 2007, J ALTERN COMPLEM MED, V13, P977, DOI 10.1089/acm.2006.6387; Linardi RL, 2012, AM J VET RES, V73, P290, DOI 10.2460/ajvr.73.2.290; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Maillet EL, 2011, M S-MED SCI, V27, P177, DOI 10.1051/medsci/2011272177; Serrano-Rodriguez JM, 2017, RES VET SCI, V114, P117, DOI 10.1016/j.rvsc.2017.03.016; Merritt A M, 1999, Equine Vet J Suppl, P7; Nguyen CA, 2012, CURR MED CHEM, V19, P28; Nguyen NQ, 2015, J CLIN ENDOCR METAB, V100, P968, DOI 10.1210/jc.2014-3144; NINOMIYA Y, 1995, AM J PHYSIOL-REG I, V268, pR1019, DOI 10.1152/ajpregu.1995.268.4.R1019; Pollitt C. C., 2004, Clinical Techniques in Equine Practice, V3, P34, DOI 10.1053/j.ctep.2004.07.003; Sanematsu K, 2014, J BIOL CHEM, V289, P25711, DOI 10.1074/jbc.M114.560409; Schiffman SS, 1999, CHEM SENSES, V24, P439, DOI 10.1093/chemse/24.4.439; Shimizu K, 1997, J VET MED SCI, V59, P245, DOI 10.1292/jvms.59.245; Shirazi-Beechey SP, 2014, BRIT J NUTR, V111, pS8, DOI 10.1017/S0007114513002286; Sigoillot M, 2012, APPL MICROBIOL BIOT, V96, P619, DOI 10.1007/s00253-012-4387-3; Steinert RE, 2011, CLIN NUTR, V30, P524, DOI 10.1016/j.clnu.2011.01.007; Tinworth KD, 2011, DOMEST ANIM ENDOCRIN, V41, P81, DOI 10.1016/j.domaniend.2011.05.001; Uchida Y, 1997, CHEM SENSES, V22, P163, DOI 10.1093/chemse/22.2.163; Winnig M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-22; Young RL, 2009, GUT, V58, P337, DOI 10.1136/gut.2008.148932; Young RL, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00023	49	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0200070	10.1371/journal.pone.0200070	http://dx.doi.org/10.1371/journal.pone.0200070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0PZ	29958298	Green Published, gold, Green Submitted			2022-12-26	WOS:000436793500027
J	Davidson, KE; Byrne, BA; Pires, AFA; Magdesian, KG; Pereira, RV				Davidson, Kelly E.; Byrne, Barbara A.; Pires, Alda F. A.; Magdesian, K. Gary; Pereira, Richard V.			Antimicrobial resistance trends in fecal Salmonella isolates from northern California dairy cattle admitted to a veterinary teaching hospital, 2002-2016	PLOS ONE			English	Article							NORTHEASTERN UNITED-STATES; NONTYPHOIDAL SALMONELLA; QUINOLONE RESISTANCE; ESCHERICHIA-COLI; FOOD ANIMALS; NEW-YORK; MECHANISMS; PATHOGEN; CALVES; HERDS	Nontyphoidal Salmonella infections contribute to approximately 1.2 million annual illnesses in the United States. Historical and recent outbreaks have been associated with dairy products, ground beef, and direct contact with cattle. Salmonella antimicrobial resistance (AMR) is a serious concern that can reduce successful treatment of infections, increasing recovery time, medical costs, and mortality rates in humans and animals. This highlights the need to track AMR in Salmonella isolated from cattle to improve treatment plans, manage trends in AMR, and prevent future AMR development. A total of 242 Salmonella isolates were retrieved from 9,162 cattle fecal samples submitted to the University of California, Davis Veterinary Medical Teaching Hospital from 2002 to 2016. These isolates were tested for antimicrobial susceptibility using a standardized broth dilution panel. Multidrug resistance (MDR) to three or more classes of antimicrobials was observed in 50.8% of isolates, and the most common MDR pattern was amoxicillin-ampicillin-cefoxitin-ceftiofur-ceftriaxone-chloram-phenicol-streptomycin-tetracycline (23.2%). There were significantly greater odds for antimicrobial resistance to aminoglycosides (OR: 2.03, 95% CI: 1.1-3.7), penicillins (OR: 1.87, 95% CI: 1.007-3.5), and tetracyclines (OR: 1.87, 95% CI: 1.017-3.4) for the 2002-2009 period when compared to the 2010-2016 period. The most prevalent MDR serotypes were Newport (100% MDR, n = 52), Typhimurium (100%, n = 20), and Dublin (71% MDR, n = 46). Risk factors associated with higher odds for isolating MDR Salmonella included isolates from calves when compared to adult cattle (OR: 22.0; 95% C. I.: 3.9-125.7), and isolates obtained from cattle suspect of having salmonellosis versus from the infectious disease control surveillance program (OR: 13.7; 95% C. I.: 2.8-66.8). Despite a temporal trend for reduced AMR to most antimicrobial drug classes, a lack of this observed in the 2002-2009 period when compared to the 2010-2016 period for important drug classes such as cephalosporins (OR: 1.6, 95% CI: 0.87-3.1), and a trend for temporal increase in resistant to quinolones drugs (P value 0.004) highlight the relevance of AMR surveillance in cattle with Salmonella infections with the aim of targeting future prophylactic interventions.	[Davidson, Kelly E.; Pires, Alda F. A.; Pereira, Richard V.] Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA; [Byrne, Barbara A.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Magdesian, K. Gary] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Pereira, RV (corresponding author), Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA.	rvpereira@ucdavis.edu	Pereira, Richard/L-2684-2019	Pereira, Richard/0000-0003-2028-8761; Pires, Alda/0000-0001-9326-0298	U.S. Department of Agriculture [CA-V-PHR-4069-H]; Boehringer-Ingelheim Veterinary Scholars Program	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Boehringer-Ingelheim Veterinary Scholars Program	This study was supported by the U.S. Department of Agriculture Project number CA-V-PHR-4069-H (RVP), and by the Boehringer-Ingelheim Veterinary Scholars Program (KD), which provided financial support for a summer research experience for a veterinary student (students training in advanced research program). Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2009, JAVMA-J AM VET MED A, V235, P739, DOI 10.2460/javma.235.6.739; Angelo KM, 2016, J INFECT DIS, V214, P1565, DOI 10.1093/infdis/jiw415; [Anonymous], 2015, 2015 NARMS INTEGRATE; [Anonymous], 2014, HUM IS SURV REP; Berge ACB, 2005, PREV VET MED, V69, P25, DOI 10.1016/j.prevetmed.2005.01.013; Bosilevac JM, 2009, APPL ENVIRON MICROB, V75, P1892, DOI 10.1128/AEM.02530-08; Carroll LM, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00140-17, 10.1128/aem.00140-17]; Centers for Disease Control and Prevention (CDC), 2017, MULT OUTBR MULT RES; Centers for Disease Control and Prevention US Department of Health and Human Services, 2013, ANTIBIOTIC RESISTANC; Clinical and Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT DISK; Clinical & Laboratory Standards Institute (CLSI), 2017, PERFORMANCE STANDARD; Cloeckaert A, 2001, VET RES, V32, P291, DOI 10.1051/vetres:2001105; Cummings KJ, 2009, J DAIRY SCI, V92, P3766, DOI 10.3168/jds.2009-2093; Cummings KJ, 2013, FOODBORNE PATHOG DIS, V10, P353, DOI 10.1089/fpd.2012.1285; Cummings KJ, 2010, FOODBORNE PATHOG DIS, V7, P659, DOI 10.1089/fpd.2009.0462; Cummings KJ, 2009, JAVMA-J AM VET MED A, V234, P1578, DOI 10.2460/javma.234.12.1578; Divers TJ, 2008, REBHUNS DIS DAIRY CA, V2nd; FDA, 2017, EXTR US ANT 2017; FDA, 2017, NAT ANT RES MON SYST; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Hooper DC, 2015, ANN NY ACAD SCI, V1354, P12, DOI 10.1111/nyas.12830; Iwamoto M, 2017, FOODBORNE PATHOG DIS, V14, P74, DOI 10.1089/fpd.2016.2180; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Medalla F, 2017, EMERG INFECT DIS, V23, P29, DOI 10.3201/eid2301.160771; Nuccio SP, 2015, P NATL ACAD SCI USA, V112, P647, DOI 10.1073/pnas.1423499112; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Pereira RV, 2014, J DAIRY SCI, V97, P7633, DOI 10.3168/jds.2014-8588; Pereira RV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147525; Pusterla N, 2014, VET REC, V174, DOI 10.1136/vr.101975; Smith BP, 2004, JAVMA-J AM VET MED A, V225, P1186, DOI 10.2460/javma.2004.225.1186; TREK, SENS GRAM NEG NARMS; Turner AK, 2006, J ANTIMICROB CHEMOTH, V58, P733, DOI 10.1093/jac/dkl333; U.S. Food and Drug Administration, 2015, VET FEED DIR VFD FOO; USDA-NARMS, 2016, REP NARMS ON FARM SA; Valenzuela JR, 2017, J DAIRY SCI, V100, P1319, DOI 10.3168/jds.2016-11419; Warnick LD, 2003, PREV VET MED, V56, P285, DOI 10.1016/S0167-5877(02)00210-6	37	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199928	10.1371/journal.pone.0199928	http://dx.doi.org/10.1371/journal.pone.0199928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953552	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400096
J	Galdiero, MR; Varricchi, G; Loffredo, S; Bellevicine, C; Lansione, T; Ferrara, AL; Lannone, R; di Somma, S; Borriello, F; Clery, E; Triassi, M; Troncone, G; Marone, G				Galdiero, Maria Rosaria; Varricchi, Gilda; Loffredo, Stefania; Bellevicine, Claudio; Lansione, Tiziana; Ferrara, Anne Lise; Lannone, Raffaella; di Somma, Sarah; Borriello, Francesco; Clery, Eduardo; Triassi, Maria; Troncone, Giancarlo; Marone, Gianni			Potential involvement of neutrophils in human thyroid cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; TO-LYMPHOCYTE RATIO; INFLAMMATORY MICROENVIRONMENT; CELL RESPONSES; POOR-PROGNOSIS; MAST-CELLS; IN-VIVO; GM-CSF; ANGIOGENESIS; RECEPTOR	Background Neutrophil functions have long been regarded as limited to acute inflammation and the defense against microbes. The role(s) of neutrophils in cancer remain poorly understood. Neutrophils infiltrate tumors and are key effector cells in the orchestration of inflammatory responses. Thyroid cancer (TC) is the most recurrent endocrine malignant tumor and is responsible for 70% of deaths due to endocrine cancers. No studies are so far available on the role of neutrophils in TC. Objective Our purpose was to study the involvement of tumor-associated neutrophils in TC. Methods Highly purified human neutrophils (>99%) from healthy donors were stimulated in vitro with conditioned media derived from TC cell lines TPC1 and 8505c (TC-CMs). Neutrophil functions (e.g., chemotaxis, activation, plasticity, survival, gene expression, and protein release) were evaluated. Results TC-derived soluble factors promoted neutrophil chemotaxis and survival. Neutrophil chemotaxis toward a TC-CM was mediated, at least in part, by CXCL8/IL-8, and survival was mediated by granulocyte-macrophage colony-stimulating factor (GM-CSF). In addition, each TC-CM induced morphological changes and activation of neutrophils (e.g., CD11b and CD66b upregulation and CD62L shedding) and modified neutrophils' kinetic properties. Furthermore, each TC-CM induced production of reactive oxygen species, expression of proinflammatory and angiogenic mediators (CXCL8/IL 8, VEGF-A, and TNF-alpha), and a release of matrix metalloproteinase 9 (MMP-9). Moreover, in TC patients, tumor-associated neutrophils correlated with larger tumor size. Conclusions TC cell lines produce soluble factors able to "educate" neutrophils toward an activated functional state. These data will advance the understanding of the molecular and cellular mechanisms of innate immunity in TC.	[Galdiero, Maria Rosaria; Varricchi, Gilda; Loffredo, Stefania; Lansione, Tiziana; Ferrara, Anne Lise; Lannone, Raffaella; di Somma, Sarah; Borriello, Francesco; Marone, Gianni] Univ Naples Federico II, Dept Translat Med Sci DiSMeT, Naples, Italy; [Galdiero, Maria Rosaria; Varricchi, Gilda; Loffredo, Stefania; Lansione, Tiziana; Ferrara, Anne Lise; Lannone, Raffaella; di Somma, Sarah; Borriello, Francesco; Marone, Gianni] Univ Naples Federico II, Ctr Basic & Clin Immunol Res CISI, Naples, Italy; [Galdiero, Maria Rosaria; Varricchi, Gilda; Loffredo, Stefania; Lansione, Tiziana; Ferrara, Anne Lise; Lannone, Raffaella; di Somma, Sarah; Borriello, Francesco; Marone, Gianni] Univ Naples Federico II, WAO Ctr Excellence, Naples, Italy; [Bellevicine, Claudio; Clery, Eduardo; Triassi, Maria; Troncone, Giancarlo] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Borriello, Francesco] Boston Childrens Hosp, Div Infect Dis, Dept Med, Boston, MA USA; [Borriello, Francesco] Harvard Med Sch, Boston, MA USA; [Marone, Gianni] Natl Res Council CNR, Inst Expt Endocrinol & Oncol Gaetano Salvatore IE, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Galdiero, MR; Marone, G (corresponding author), Univ Naples Federico II, Dept Translat Med Sci DiSMeT, Naples, Italy.; Galdiero, MR; Marone, G (corresponding author), Univ Naples Federico II, Ctr Basic & Clin Immunol Res CISI, Naples, Italy.; Galdiero, MR; Marone, G (corresponding author), Univ Naples Federico II, WAO Ctr Excellence, Naples, Italy.; Marone, G (corresponding author), Natl Res Council CNR, Inst Expt Endocrinol & Oncol Gaetano Salvatore IE, Naples, Italy.	mariarosaria.galdiero@unina.it; marone@unina.it	Varricchi, Gilda/A-4620-2014; VARRICCHI, GILDA/AAB-9563-2022; Clery, Eduardo/L-7464-2019; GALDIERO, MARIA ROSARIA/J-6869-2018; Ferrara, Anne Lise/AGQ-4925-2022	VARRICCHI, GILDA/0000-0002-9285-4657; GALDIERO, MARIA ROSARIA/0000-0002-8086-9130; Bellevicine, Claudio/0000-0002-7479-6457; Ferrara, Anne Lise/0000-0003-1839-8873; Borriello, Francesco/0000-0001-9074-4828	Regione Campania CISI-Lab Project; CReME Project; TIMING Project	Regione Campania CISI-Lab Project; CReME Project; TIMING Project	This work was supported by grants from the Regione Campania CISI-Lab Project, CReME Project and TIMING Project (to G.M.).	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Antonelli A, 2009, ENDOCR-RELAT CANCER, V16, P1299, DOI 10.1677/ERC-08-0337; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barrera L, 2017, BRIT J CANCER, V117, P385, DOI 10.1038/bjc.2017.173; Bauerle KT, 2014, J CLIN ENDOCR METAB, V99, pE1436, DOI 10.1210/jc.2013-3636; Bhatti I, 2010, AM J SURG, V200, P197, DOI 10.1016/j.amjsurg.2009.08.041; Bleecker ER, 2016, LANCET, V388, P2115, DOI 10.1016/S0140-6736(16)31324-1; Bonavita E, 2015, ADV CANCER RES, V128, P141, DOI 10.1016/bs.acr.2015.04.013; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Borriello F, 2017, J IMMUNOL, V198, P3426, DOI 10.4049/jimmunol.1601497; Borriello F, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00680; Bouffi C, 2013, J IMMUNOL, V191, P4317, DOI 10.4049/jimmunol.1301465; Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567; Calzetti F, 2017, J ALLERGY CLIN IMMUN, V139, P352, DOI 10.1016/j.jaci.2016.06.025; Carling T, 2014, ANNU REV MED, V65, P125, DOI 10.1146/annurev-med-061512-105739; Condliffe AM, 1996, IMMUNOLOGY, V89, P105, DOI 10.1046/j.1365-2567.1996.d01-711.x; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Cunha LL, 2012, CLIN ENDOCRINOL, V77, P918, DOI 10.1111/j.1365-2265.2012.04482.x; Cunha LL, 2014, ENDOCR-RELAT CANCER, V21, pR85, DOI 10.1530/ERC-13-0431; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; de Oliveira S, 2016, NAT REV IMMUNOL, V16, P378, DOI 10.1038/nri.2016.49; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Donskov F, 2013, SEMIN CANC BIOL; Dumitru CA, 2012, J LEUKOCYTE BIOL, V91, P591, DOI 10.1189/jlb.0411193; Eruslanov EB, 2014, J CLIN INVEST, V124, P5466, DOI 10.1172/JCI77053; Fang WY, 2014, CARCINOGENESIS, V35, P1780, DOI 10.1093/carcin/bgu060; FitzGerald JM, 2016, LANCET, V388, P2128, DOI [10.1016/s0140-6736(16)31322-8, 10.1016/S0140-6736(16)31322-8]; Galdiero MR, 2018, J LEUKOCYTE BIOL, V103, P457, DOI 10.1002/JLB.3MR0717-292R; Galdiero MR, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00103; Galdiero MR, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1168556; Galdiero MR, 2016, INT J CANCER, V139, P446, DOI 10.1002/ijc.30076; Galdiero MR, 2013, IMMUNOBIOLOGY, V218, P1402, DOI 10.1016/j.imbio.2013.06.003; Galdiero MR, 2017, COLD SPRING HARB PER, DOI [https://doi.org/10.1016/S0140-6736(00)04046-0, DOI 10.1016/S0140-6736(00)04046-0]; Gong WJ, 2016, CLINICS, V71, P311, DOI 10.6061/clinics/2016(06)04; Granot Z, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/701067; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1420, DOI 10.1016/j.jaci.2011.01.054; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirt C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25990; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Jaillon S, 2013, SEMIN IMMUNOPATHOL, V35, P377, DOI 10.1007/s00281-013-0374-8; Jiang K, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005079; Jung KY, 2015, J PATHOL TRANSL MED, V49, P318, DOI 10.4132/jptm.2015.06.01; Kanda Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040867; Kim S, 2013, ENDOCRINOL METAB, V28, P192, DOI 10.3803/EnM.2013.28.3.192; Klion AD, 2003, BLOOD, V101, P4660, DOI 10.1182/blood-2003-01-0006; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Kutsuna H, 2004, AM J PHYSIOL-CELL PH, V286, pC55, DOI 10.1152/ajpcell.00131.2003; Lang BHH, 2014, WORLD J SURG, V38, P2605, DOI 10.1007/s00268-014-2630-z; Lee JJ, 2012, J ALLERGY CLIN IMMUN, V130, P572, DOI 10.1016/j.jaci.2012.07.025; Liu CL, 2013, J SURG ONCOL, V107, P493, DOI 10.1002/jso.23270; Mantovani A, 2011, EUR J IMMUNOL, V41, P2522, DOI 10.1002/eji.201141894; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Manukyan G, 2017, ONCOTARGET, V8, P84889, DOI 10.18632/oncotarget.20031; Marone G, 2016, EUR J PHARMACOL, V778, P146, DOI 10.1016/j.ejphar.2015.03.088; Melillo RM, 2010, ONCOGENE, V29, P6203, DOI 10.1038/onc.2010.348; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Mishalian I, 2017, IMMUNOBIOLOGY, V222, P82, DOI 10.1016/j.imbio.2016.02.001; Moloney JN, 2017, SEMIN CELL DEV BIOL; MUZIO M, 1994, BLOOD, V83, P1738, DOI 10.1182/blood.V83.7.1738.bloodjournal8371738; Nabhan F, 2017, ENDOCR-RELAT CANCER, V24, pR13, DOI 10.1530/ERC-16-0432; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Ohta A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00109; Passaro C, 2016, ONCOTARGET, V7, P1500, DOI 10.18632/oncotarget.6430; Peters SB, 1996, ENDOCR PATHOL, V7, P47, DOI 10.1007/BF02739914; Queen MM, 2005, CANCER RES, V65, P8896, DOI 10.1158/0008-5472.CAN-05-1734; Ribas A, 2016, J EXP MED, V213, P2835, DOI 10.1084/jem.20161462; Rotondi M, 2015, J CLIN ENDOCR METAB, V100, pE427, DOI 10.1210/jc.2014-3045; Rotondi M, 2013, CYTOKINE GROWTH F R, V24, P539, DOI 10.1016/j.cytogfr.2013.08.001; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Santoro M, 2015, NAT REV ENDOCRINOL, V11, P133, DOI 10.1038/nrendo.2014.209; Scapini P, 2004, J IMMUNOL, V172, P5034, DOI 10.4049/jimmunol.172.8.5034; Scapini P, 2014, BLOOD, V124, P710, DOI 10.1182/blood-2014-03-453217; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Stocks SC, 1996, EUR J IMMUNOL, V26, P2924, DOI 10.1002/eji.1830261218; Trellakis S, 2011, INT J CANCER, V129, P2183, DOI 10.1002/ijc.25892; Varricchi G, 2017, EXP DERMATOL, V26, P11, DOI 10.1111/exd.13107; Varricchi G, 2015, J AM ACAD DERMATOL, V73, P144, DOI 10.1016/j.jaad.2015.03.041; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Woytschak J, 2016, IMMUNITY, V45, P172, DOI 10.1016/j.immuni.2016.06.025; Zhou L, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1293211	84	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199740	10.1371/journal.pone.0199740	http://dx.doi.org/10.1371/journal.pone.0199740			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953504	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400058
J	Gargari, SA; Barzegar, A; Tarinejad, A				Gargari, Sahar Andarzi; Barzegar, Abolfazl; Tarinejad, Alireza			The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing beta-sheet conformation of monomeric A beta 17-42	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; LINEAR CONSTRAINT SOLVER; ALZHEIMERS-DISEASE; COGNITIVE DETERIORATION; IN-VITRO; PEPTIDE; PROTEIN; BINDING; NEURODEGENERATION; THERAPEUTICS	Alzheimer's disease (AD) is a kind of brain disease that arises due to the aggregation and fibrillation of amyloid beta-peptides (A beta). The peptide A beta 17-42 forms U-shape protofilaments of amyloid mature fibrils by cross-beta strands, detected in brain cells of individuals with AD. Targeting the structure of A beta 17-42 and destabilizing its beta-strands by natural compounds could be effective in the treatment of AD patients. Therefore, the interaction features of monomeric U-shape A beta 17-42 with natural flavonoids including myricetin, morin and flavone at different mole ratios were comprehensively studied to recognize the mechanism of A beta monomer instability using molecular dynamics (MD) simulations. We found that all flavonoids have tendency to interact and destabilize A beta-peptide structure with mole ratio-dependent effects. The interaction free energies of myricetin (with 6 OHs) and morin (with 5 OHs) were more negative compared to flavone, although the total binding energies of all flavonoids are favorable and negative. Myricetin, morin and flavone penetrated into the core of the A beta 17-42 and formed self-clusters of A beta 17-42-flavonoid complexes. Analysis of A beta 1742-flavonoids interactions identified that the hydrophobic interactions related to SASAdependent energy are weak in all complexes. However, the intermolecular H-bonds are a main binding factor for shifting U-shape rod-like state of A beta 17-42 to globular-like disordered state. Myricetin and morin polyphenols form H-bonds with both peptide's carbonyl and amine groups whereas flavone makes H-bonds only with amine substitution. As a result, polyphenols are more efficient in destabilizing beta-sheet structures of peptide. Accordingly, the natural polyphenolic flavonoids are useful in forming stable A beta 17-42-flavonoid clusters to inhibit A beta 17-42 aggregation and these compounds could be an effective candidate for therapeutically targeting U-shape protofilaments' monomer in amyloid mature fibrils.	[Gargari, Sahar Andarzi; Tarinejad, Alireza] Azarbaijan Shahid Madani Univ, Dept Biotechnol, Fac Agr, Tabriz, Iran; [Gargari, Sahar Andarzi] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran; [Gargari, Sahar Andarzi; Barzegar, Abolfazl] Univ Tabriz, RIFS, Dept Biophys, Tabriz, Iran; [Barzegar, Abolfazl] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Med Biotechnol, Tabriz, Iran	Azarbaijan Shahid Madani University; Tabriz University of Medical Science; University of Tabriz; Tabriz University of Medical Science	Tarinejad, A (corresponding author), Azarbaijan Shahid Madani Univ, Dept Biotechnol, Fac Agr, Tabriz, Iran.; Barzegar, A (corresponding author), Univ Tabriz, RIFS, Dept Biophys, Tabriz, Iran.; Barzegar, A (corresponding author), Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Med Biotechnol, Tabriz, Iran.	barzegar@tabrizu.ac.ir; tarinejad@aiaruniv.edu	Tarinejad, AliReza/AAB-8008-2022					Akaishi T, 2008, NEUROSCI LETT, V444, P280, DOI 10.1016/j.neulet.2008.08.052; BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; Barten DM, 2008, MOL NEUROBIOL, V37, P171, DOI 10.1007/s12035-008-8031-2; Beke T, 2006, J AM CHEM SOC, V128, P5158, DOI 10.1021/ja0585127; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Berhanu WM, 2015, J BIOMOL STRUCT DYN, V33, P1399, DOI 10.1080/07391102.2014.951689; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Cheon M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38196; Cheon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004258; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Denisov IG, 2009, PHARMACOL THERAPEUT, V124, P151, DOI 10.1016/j.pharmthera.2009.05.011; Dong MY, 2016, CHEMPHYSCHEM, V17, P2558, DOI 10.1002/cphc.201600256; Dumoulin M, 2007, PROTEIN MISFOLDING A, P285, DOI DOI 10.1007/978-0-387-36534-3_14; Fan HM, 2015, J PHYS CHEM B, V119, P11196, DOI 10.1021/acs.jpcb.5b03116; Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harrington CR, 2012, NEUROIMAG CLIN N AM, V22, P11, DOI 10.1016/j.nic.2011.11.003; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Ho L, 2009, J ALZHEIMERS DIS, V16, P59, DOI 10.3233/JAD-2009-0916; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaynes E.T., 2003, PROBABILITY THEORY L; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Khatua P, 2017, J CHEM INF MODEL, V57, P2378, DOI 10.1021/acs.jcim.7b00407; Kumar A, 2016, J BIOMOL STRUCT DYN, V34, P239, DOI 10.1080/07391102.2015.1022603; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Le Bourvellec C, 2012, CRIT REV FOOD SCI, V52, P213, DOI 10.1080/10408398.2010.499808; Lemkul JA, 2012, BIOCHEMISTRY-US, V51, P5990, DOI 10.1021/bi300113x; Lemkul JA, 2010, BIOCHEMISTRY-US, V49, P3935, DOI 10.1021/bi1000855; Liu FF, 2011, J PHYS CHEM B, V115, P11879, DOI 10.1021/jp202640b; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; MilnerWhite EJ, 1997, PROTEIN SCI, V6, P2477; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Ono K, 2006, BBA-MOL BASIS DIS, V1762, P575, DOI 10.1016/j.bbadis.2006.03.002; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porter CM, 2012, BIOORG CHEM, V43, P44, DOI 10.1016/j.bioorg.2011.11.001; Raman EP, 2009, BIOPHYS J, V97, P2070, DOI 10.1016/j.bpj.2009.07.032; Ross C.A., 2004, PROTEIN AGGREGATION; Salomon AR, 1996, BIOCHEMISTRY-US, V35, P13568, DOI 10.1021/bi9617264; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Southall NT, 2002, VIEW HYDROPHOBIC EFF; Szczepanik AM, 2001, J NEUROCHEM, V77, P304, DOI 10.1046/j.1471-4159.2001.t01-1-00240.x; Takeda T, 2010, PROTEINS, V78, P2849, DOI 10.1002/prot.22804; TERZI E, 1994, BIOCHEMISTRY-US, V33, P1345, DOI 10.1021/bi00172a009; Villmow M, 2016, BIOCHEM J, V473, P1355, DOI 10.1042/BCJ20160098; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700; Zhu JTT, 2007, J AGR FOOD CHEM, V55, P2438, DOI 10.1021/jf063299z	53	20	20	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199541	10.1371/journal.pone.0199541	http://dx.doi.org/10.1371/journal.pone.0199541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953467	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400041
J	Wang, ZL; Zhang, JH; Wu, FZ; Zhou, XG				Wang, Zhilin; Zhang, Jianhui; Wu, Fengzhi; Zhou, Xingang			Changes in rhizosphere microbial communities in potted cucumber seedlings treated with syringic acid	PLOS ONE			English	Article							SOIL PHENOLICS; FERULIC ACID; GROWTH; DIVERSITY; BIODIVERSITY; DEGRADATION; MECHANISMS; BACILLUS; SYSTEMS; FUNGAL	Phytotoxic effects of phenolic compounds have been extensively studied, but less attention has been given to the effects of these compounds on soil microbial communities, which are crucial to the productivity of agricultural systems. Responses of cucumber rhizosphere bacterial and fungal communities to syringic acid (SA), a phenolic compound with autotoxicity to cucumber, were analyzed by high-throughput sequencing of 16S rRNA gene and internal transcribed spacer amplicons. SA at the concentration of 0.1 mu mol g(-1) soil changed rhizosphere bacterial and fungal community compositions, decreased bacterial community diversity but increased fungal community richness and diversity (P<0.05). Moreover, SA increased the relative abundances of bacterial phylum Proteobacteria and fungal classes Leotiomycetes, Pezizomycetes, Tremellomycetes and Eurotiomycetes, but decreased the relative abundances of bacterial phylum Firmicutes and fungal class Sordariomycetes (P<0.05). At the genus level, SA decreased the relative abundances of microbial taxa with pathogen-antagonistic and/or plant growth promoting potentials, such as Pseudomonas spp. (P<0.05). Real-time PCR validated that SA decreased cucumber rhizosphere Pseudomonas spp. abundance (P<0.05). In vitro study showed that SA (0.01 to 10 mM) inhibited the growth of a strain of Pseudomonas spp. with pathogen-antagonistic activities to cucumber pathogen Fusarium oxysporum f.sp. cucumerinum Owen (P<0.05). Overall, SA changed cucumber rhizosphere bacterial and fungal community compositions, which may exert negative effects on cucumber seedling growth through inhibiting plant-beneficial microorganisms.	[Wang, Zhilin; Zhang, Jianhui; Wu, Fengzhi; Zhou, Xingang] Northeast Agr Univ, Dept Hort, Harbin, Heilongjiang, Peoples R China; [Wu, Fengzhi; Zhou, Xingang] Minist Agr, Key Lab Biol Genet Improvement Hort Crops Northea, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Ministry of Agriculture & Rural Affairs	Zhou, XG (corresponding author), Northeast Agr Univ, Dept Hort, Harbin, Heilongjiang, Peoples R China.; Zhou, XG (corresponding author), Minist Agr, Key Lab Biol Genet Improvement Hort Crops Northea, Harbin, Heilongjiang, Peoples R China.	xingangzhou@yahoo.com	Wu, Fengzhi/GLT-1760-2022		National Natural Science Foundation of China [31772361]; University Nursing Programme for Young Scholars with Creative Talents in Heilongjiang Province [UNPYSCT-2015002]; 'Academic Backbone' Project of Northeast Agricultural University [17XG05]; China Agricultural Research System [CARS-23-C-10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University Nursing Programme for Young Scholars with Creative Talents in Heilongjiang Province; 'Academic Backbone' Project of Northeast Agricultural University; China Agricultural Research System	This work was supported by the National Natural Science Foundation of China (31772361), University Nursing Programme for Young Scholars with Creative Talents in Heilongjiang Province (UNPYSCT-2015002), 'Academic Backbone' Project of Northeast Agricultural University (17XG05), and China Agricultural Research System (CARS-23-C-10).	Alabouvette C, 2009, NEW PHYTOL, V184, P529, DOI 10.1111/j.1469-8137.2009.03014.x; Antoun H, 1998, PLANT SOIL, V204, P57, DOI 10.1023/A:1004326910584; Badri DV, 2013, J BIOL CHEM, V288, P4502, DOI 10.1074/jbc.M112.433300; Bardgett RD, 2014, NATURE, V515, P505, DOI 10.1038/nature13855; Bender SF, 2016, TRENDS ECOL EVOL, V31, P440, DOI 10.1016/j.tree.2016.02.016; BLUM U, 1987, PLANT SOIL, V98, P111, DOI 10.1007/BF02381732; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casey JT, 2004, J MICROBIOL METH, V58, P327, DOI 10.1016/j.mimet.2004.04.017; Cook RJ, 2006, P NATL ACAD SCI USA, V103, P18389, DOI 10.1073/pnas.0605946103; Crowther TW, 2014, GLOBAL CHANGE BIOL, V20, P2983, DOI 10.1111/gcb.12565; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; de Werra P, 2011, APPL ENVIRON MICROB, V77, P2807, DOI 10.1128/AEM.01760-10; Derakhshani H, 2016, J BASIC MICROB, V56, P321, DOI 10.1002/jobm.201500420; DeRito CM, 2009, ISME J, V3, P477, DOI 10.1038/ismej.2008.122; Dietrich Diane, 2013, BMC Res Notes, V6, P219, DOI 10.1186/1756-0500-6-219; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Exposito RG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01243; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fudou R, 2001, J ANTIBIOT, V54, P149, DOI 10.7164/antibiotics.54.149; Garbeva P, 2004, FEMS MICROBIOL ECOL, V47, P51, DOI 10.1016/S0168-6496(03)00234-4; Ge T, 2017, BIOL FERT SOILS, V53, P37, DOI 10.1007/s00374-016-1155-z; HAIDER K, 1975, ARCH MICROBIOL, V105, P33, DOI 10.1007/BF00447109; Jia XL, 2017, ALLELOPATHY J, V41, P113, DOI 10.26651/2017-41-1-1088; Kaur H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004700; Khan AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158207; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lanoue A, 2010, NEW PHYTOL, V185, P577, DOI 10.1111/j.1469-8137.2009.03066.x; Lemos M, 2014, INT BIODETER BIODEGR, V86, P42, DOI 10.1016/j.ibiod.2013.06.011; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Liu JG, 2017, APPL SOIL ECOL, V110, P34, DOI 10.1016/j.apsoil.2016.11.001; Macia-Vicente JG, 2008, CAN J MICROBIOL, V54, P600, DOI [10.1139/W08-047, 10.1139/w08-047]; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mapperson RR, 2014, CURR MICROBIOL, V68, P30, DOI 10.1007/s00284-013-0415-5; Fernandez PM, 2017, EXTREMOPHILES, V21, P445, DOI 10.1007/s00792-017-0915-5; Medina A, 2011, SOIL BIOL BIOCHEM, V43, P1456, DOI 10.1016/j.soilbio.2011.03.016; Meidute S, 2008, SOIL BIOL BIOCHEM, V40, P2334, DOI 10.1016/j.soilbio.2008.05.011; Muscolo A, 2006, PLANT SOIL, V284, P305, DOI 10.1007/s11104-006-0040-1; Pierik R, 2013, FUNCT ECOL, V27, P841, DOI 10.1111/1365-2435.12010; Politycka B, 2017, ALLELOPATHY J, V41, P101, DOI 10.26651/2017-41-1-1087; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rahmoune B, 2017, J PLANT INTERACT, V12, P1, DOI 10.1080/17429145.2016.1269215; Rosenzweig N, 2012, PLANT DIS, V96, P718, DOI 10.1094/PDIS-07-11-0571; Sanchez-Maldonado AF, 2011, J APPL MICROBIOL, V111, P1176, DOI 10.1111/j.1365-2672.2011.05141.x; Sasse J, 2018, TRENDS PLANT SCI, V23, P25, DOI 10.1016/j.tplants.2017.09.003; Scavo A, 2018, SUSTAIN AGR REV, V28, P47, DOI 10.1007/978-3-319-90309-5_2; Scholer A, 2017, BIOL FERT SOILS, V53, P485, DOI 10.1007/s00374-017-1205-1; SHAFER SR, 1991, J CHEM ECOL, V17, P369, DOI 10.1007/BF00994339; Shang QH, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2051-2; Singh HP, 1999, CRIT REV PLANT SCI, V18, P757, DOI 10.1080/07352689991309478; Song Y, 2016, J AGR FOOD CHEM, V64, P5464, DOI 10.1021/acs.jafc.6b01035; Trezzi MM, 2016, J PLANT INTERACT, V11, P53, DOI 10.1080/17429145.2016.1159342; van der Putten WH, 2013, J ECOL, V101, P265, DOI 10.1111/1365-2745.12054; Vestergaard G, 2017, BIOL FERT SOILS, V53, P479, DOI 10.1007/s00374-017-1191-3; Weyens N, 2009, TRENDS BIOTECHNOL, V27, P591, DOI 10.1016/j.tibtech.2009.07.006; Wu HM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00659; Xue C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11124; Yadav AN, 2015, J BIOSCI BIOENG, V119, P683, DOI 10.1016/j.jbiosc.2014.11.006; YU JQ, 1994, J CHEM ECOL, V20, P21, DOI 10.1007/BF02065988; Yuan HZ, 2016, BIOL FERT SOILS, V52, P615, DOI 10.1007/s00374-016-1101-0; Zhou X, 2012, EUR J SOIL SCI, V63, P332, DOI 10.1111/j.1365-2389.2012.01442.x; Zhou XG, 2018, ALLELOPATHY J, V43, P255, DOI 10.26651/allelo.j./2018-43-2-1145; Zhou XG, 2014, PLANT SOIL ENVIRON, V60, P158, DOI 10.17221/924/2013-PSE; Zhou XG, 2018, BIOL FERT SOILS, V54, P363, DOI 10.1007/s00374-018-1265-x; Zhou XG, 2017, PLANT SOIL, V415, P507, DOI 10.1007/s11104-017-3181-5; Zhou XG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048288; Zhou XG, 2011, EUR J SOIL BIOL, V47, P279, DOI 10.1016/j.ejsobi.2011.07.001	66	26	26	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0200007	10.1371/journal.pone.0200007	http://dx.doi.org/10.1371/journal.pone.0200007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953531	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400109
J	Miller, JJ; Aoki, K; Mascari, CA; Beltrame, AK; Sokumbi, O; North, PE; Tiemeyer, M; Kriegel, AJ; Dahms, NM				Miller, James J.; Aoki, Kazuhiro; Mascari, Carly A.; Beltrame, Angela K.; Sokumbi, Olayemi; North, Paula E.; Tiemeyer, Michael; Kriegel, Alison J.; Dahms, Nancy M.			-Galactosidase A-deficient rats accumulate glycosphingolipids and develop cardiorenal phenotypes of Fabry disease	FASEB JOURNAL			English	Article						lysosomal storage disease; glycobiology; kidney; heart; animal model	ALPHA-GALACTOSIDASE; CLINICAL-MANIFESTATIONS; RENAL LESION; STORAGE; MODEL; SUBSTITUTION; HYPERTROPHY; OSTEOPENIA; PROTEIN; COHORT	Fabry disease is an X-linked lysosomal storage disease caused by -galactosidase A (-Gal A) deficiency. Kidney and heart failure are frequent complications in adulthood and greatly contribute to patient morbidity and mortality. Because -Gal A-deficient mouse models do not recapitulate cardiorenal findings observed in patients, a nonmouse model may be beneficial to our understanding of disease pathogenesis. In this study, we evaluated disease processes in a recently generated Fabry rat model. We found that male Fabry rats weighed significantly less than wild-type (WT) males, whereas female Fabry rats weighed significantly more than WT females. Whereas no difference in female survival was detected, we observed that male Fabry rats had a decreased lifespan. Skin histology revealed that inflammation and lipoatrophy may be chief disease mediators in patients. With respect to the kidney and heart, we found that both organs accumulate -Gal A substrates, including the established biomarkers, globotriaosylceramide and globotriaosylsphingosine. Longitudinal serum and urine chemistry panels demonstrated pronounced renal tubule dysfunction, which was confirmed histologically. Mitral valve thickening was observed in Fabry rats using echocardiography. We conclude that Fabry rats recapitulate important kidney and heart phenotypes experienced by patients and can be further used to study disease mechanisms and test therapies.Miller, J. J., Aoki, K., Mascari, C. A., Beltrame, A. K., Sokumbi, O., North, P. E., Tiemeyer, M., Kriegel, A. J., Dahms, N. M., -Galactosidase A-deficient rats accumulate glycosphingolipids and develop cardiorenal phenotypes of Fabry disease.	[Miller, James J.; Mascari, Carly A.; Beltrame, Angela K.; Dahms, Nancy M.] Med Coll Wisconsin, Dept Biochem, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA; [Sokumbi, Olayemi] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; [North, Paula E.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Kriegel, Alison J.] Med Coll Wisconsin, Dept Physiol, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA; [Aoki, Kazuhiro; Tiemeyer, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University System of Georgia; University of Georgia	Dahms, NM (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.; Kriegel, AJ (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.	akriegel@mcw.edu; ndahms@mcw.edu		Beltrame, Angela/0000-0003-0233-2618; Mascari, Carly/0000-0001-7594-9120; Aoki, Kazuhiro/0000-0003-0029-4291; Sokumbi, Olayemi/0000-0001-8060-4311	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01DK042667]; NIH National Institute of Neurological Disorders and Stroke [R21NS095627]; NIH National Institute of Allergy and Infectious Diseases [R21AI129873]; NIH National Institute of General Medical Sciences [P41GM103490]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [F30DK113641]; NIH National Heart, Lung, and Blood Institute [R24HL114474];  [T32GM080202]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL114474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI129873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042667, F30DK113641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490, T32GM080202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS095627] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. David Mattson for guidance, especially during the early stages of this project. The authors also thank Christine Duris, Stephanie Wirsbinski, Tatunya Bufford, and Qiuhui Yang of the Children's Hospital of Wisconsin Children's Research Institute Histology Core for histology and immunohistochemistry services. The electron microscopy services and interpretation by Clive Wells are greatly appreciated. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK042667 and NIH National Institute of Neurological Disorders and Stroke Grant R21NS095627 (to N.M.D.), NIH National Institute of Allergy and Infectious Diseases Grant R21AI129873 (to K.A.), NIH National Institute of General Medical Sciences Grant P41GM103490 (to M.T.), and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant F30DK113641 (to J.J.M.). J.J.M. is a trainee of the Medical College of Wisconsin Medical Scientist Training Program, which is partially supported by T32GM080202. The Fabry rat model was generated under R24HL114474, a resource grant from NIH National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; Ballabio A, 2016, EMBO MOL MED, V8, P73, DOI 10.15252/emmm.201505966; Barbey F, 2006, ARTERIOSCL THROM VAS, V26, P839, DOI 10.1161/01.ATV.0000209649.60409.38; BURKHOLDER PM, 1980, ARCH PATHOL LAB MED, V104, P17; Burton BK, 2017, J PEDIATR-US, V190, P130, DOI 10.1016/j.jpeds.2017.06.048; Cat AND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033743; COLLEY JR, 1958, BRIT MED J, V1, P1266, DOI 10.1136/bmj.1.5082.1266; Cox-Brinkman J, 2007, EUR J HUM GENET, V15, P535, DOI 10.1038/sj.ejhg.5201798; de Duve C, 2005, NAT CELL BIOL, V7, P847, DOI 10.1038/ncb0905-847; DEAN KJ, 1977, BIOCHEM BIOPH RES CO, V77, P1411, DOI 10.1016/S0006-291X(77)80136-8; ELLEDER M, 1990, VIRCHOWS ARCH A, V417, P449, DOI 10.1007/BF01606034; Elliott S, 2016, MOL GENET METAB, V118, P304, DOI 10.1016/j.ymgme.2016.05.015; Faggiano A, 2006, J CLIN ENDOCR METAB, V91, P4319, DOI 10.1210/jc.2006-0858; Fall B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168346; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Germain DP, 2005, CLIN GENET, V68, P93, DOI 10.1111/j.1399-0004.2005.00457.x; HENRY EW, 1963, CAN MED ASSOC J, V89, P206; Hopkin RJ, 2008, PEDIATR RES, V64, P550, DOI 10.1203/PDR.0b013e318183f132; Hopkins PV, 2015, J PEDIATR-US, V166, P172, DOI 10.1016/j.jpeds.2014.09.023; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; Kampmann C, 2008, ACTA PAEDIATR, V97, P463, DOI 10.1111/j.1651-2227.2008.00700.x; KRETCHMER N, 1974, KIDNEY INT, V5, P96, DOI 10.1038/ki.1974.13; Kriegel AJ, 2008, PHYSIOL GENOMICS, V36, P35, DOI 10.1152/physiolgenomics.00054.2008; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P819, DOI 10.1152/physiolgenomics.00175.2011; Labilloy A, 2014, MOL GENET METAB, V111, P184, DOI 10.1016/j.ymgme.2013.10.010; Lakoma J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108641; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; MAYES JS, 1981, CLIN CHIM ACTA, V112, P247, DOI 10.1016/0009-8981(81)90384-3; Mersebach H, 2007, GENET MED, V9, P812, DOI 10.1097/GIM.0b013e31815cb197; Miller JJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99171; Niemann M, 2011, ULTRASOUND MED BIOL, V37, P37, DOI 10.1016/j.ultrasmedbio.2010.10.017; Ohshima T, 1999, P NATL ACAD SCI USA, V96, P6423, DOI 10.1073/pnas.96.11.6423; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; PABICO RC, 1973, AM J MED, V55, P415, DOI 10.1016/0002-9343(73)90140-X; Platt FM, 2014, NATURE, V510, P68, DOI 10.1038/nature13476; Ries M, 2006, GENET MED, V8, P96, DOI 10.1097/01.gim.0000200950.25118.dd; Rodrigues LG, 2009, NEUROBIOL DIS, V33, P48, DOI 10.1016/j.nbd.2008.09.001; Rozenfeld P, 2017, MOL GENET METAB, V122, P19, DOI 10.1016/j.ymgme.2017.09.004; Sanchez-Nino MD, 2015, HUM MOL GENET, V24, P5720, DOI 10.1093/hmg/ddv291; Sanchez-Nino MD, 2011, NEPHROL DIAL TRANSPL, V26, P1797, DOI 10.1093/ndt/gfq306; Shin YJ, 2015, MOL MED REP, V12, P5049, DOI 10.3892/mmr.2015.4010; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Taguchi A, 2013, BIOCHEM J, V456, P373, DOI 10.1042/BJ20130825; UUMLCEYLER N, 2016, MOL PAIN, V12; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vedder AC, 2007, J INHERIT METAB DIS, V30, P68, DOI 10.1007/s10545-006-0484-8; VONSCHEIDT W, 1991, NEW ENGL J MED, V324, P395, DOI 10.1056/NEJM199102073240607; Wang RY, 2007, GENET MED, V9, P34, DOI 10.1097/GIM.0b013e31802d8321	48	14	14	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					418	429		10.1096/fj.201800771R	http://dx.doi.org/10.1096/fj.201800771R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29979634	Green Published			2022-12-26	WOS:000457401500033
J	St Amand, MM; Bond, MR; Riedy, J; Comly, M; Shiloach, J; Hanover, JA				St Amand, Melissa M.; Bond, Michelle R.; Riedy, Julia; Comly, Marcella; Shiloach, Joseph; Hanover, John A.			A genetic model to study O-GlcNAc cycling in immortalized mouse embryonic fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAcylation; O-GlcNAc transferase (OGT); (O-GlcNAc); fibroblast; glycogen synthase kinase 3 (GSK3); tauopathy; Tau protein (Tau); protein phosphorylation	RNA-POLYMERASE-II; N-ACETYLGLUCOSAMINE; INSULIN-RESISTANCE; X-CHROMOSOME; IN-VIVO; PHOSPHORYLATION; TRANSFERASE; TAU; GLYCOSYLATION; STRESS	O-GlcNAcylation is an abundant posttranslational protein modification in which the monosaccharide O-GlcNAc is added to Ser/Thr residues by O-GlcNAc transferase and removed by O-GlcNAcase. Analyses of O-GlcNAc-mediated signaling and metabolic phenomena are complicated by factors including unsatisfactory inhibitors and loss-of-function cell lines lacking identical genetic backgrounds. In this work, we generated immortalized WT, Oga knockout, and Ogt floxed allele (Ogt floxed) mouse embryonic fibroblast (MEF) cell lines with similar genetic backgrounds. These lines will facilitate experiments and serve as a platform to study O-GlcNAc cycling in mammals. As a test paradigm, we used the immortalized MEF lines to investigate how changes in O-GlcNAcylation affected pathological phosphorylation of the tau protein. The activity of glycogen synthase kinase 3 (GSK3), a kinase that phosphorylates tau, decreases when expressed in Oga knockout MEFs compared with WT cells. Phosphorylation at Thr(231) in recombinant, tauopathy-associated tau with a proline-to-leucine mutation at position 301 (P301L) was altered when expressed in MEFs with altered O-GlcNAc cycling. In aggregate, our data support that O-GlcNAc cycling indirectly affects tau phosphorylation at Thr(231), but tau phosphorylation was highly variable, even in genetically stable, immortalized MEF cells. The variable nature of tau phosphorylation observed here supports the need to use cells akin to those generated here with genetically defined lesions and similar backgrounds to study complex biological processes.	[St Amand, Melissa M.; Riedy, Julia; Shiloach, Joseph] NIDDK, Biotechnol Unit, NIH, Bethesda, MD 20892 USA; [St Amand, Melissa M.; Bond, Michelle R.; Comly, Marcella; Hanover, John A.] NIDDK, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hanover, JA (corresponding author), NIDDK, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA.	johnh@bdg8.niddk.nih.gov		Hanover, John/0000-0002-3154-9878	Intramural Research Program of the NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060102, ZIADK060103, ZIADK060101] Funding Source: NIH RePORTER	Intramural Research Program of the NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the NIDDK, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Chow CY, 2016, NAT REV GENET, V17, P63, DOI 10.1038/nrg.2015.9; Deng YQ, 2009, AM J PATHOL, V175, P2089, DOI 10.2353/ajpath.2009.090157; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Keembiyehetty C, 2015, J BIOL CHEM, V290, P7097, DOI 10.1074/jbc.M114.617779; Keembiyehetty CN, 2011, J CELL SCI, V124, P2851, DOI 10.1242/jcs.083287; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kim EJ, 2006, CARBOHYD RES, V341, P971, DOI 10.1016/j.carres.2006.03.004; Konrad RJ, 2002, BIOCHEM BIOPH RES CO, V293, P207, DOI 10.1016/S0006-291X(02)00200-0; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Lewis BA, 2014, J BIOL CHEM, V289, P34440, DOI 10.1074/jbc.R114.595439; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Macauley MS, 2010, BBA-GEN SUBJECTS, V1800, P107, DOI 10.1016/j.bbagen.2009.07.028; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Olivier-Van Stichelen S, 2017, J BIOL CHEM, V292, P6076, DOI 10.1074/jbc.M116.774042; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200	39	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13673	13681		10.1074/jbc.RA118.004059	http://dx.doi.org/10.1074/jbc.RA118.004059			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29954943	Green Published, hybrid			2022-12-26	WOS:000443375500026
J	Limi, S; Senecal, A; Coleman, R; Lopez-Jones, M; Guo, P; Polumbo, C; Singer, RH; Skoultchi, AI; Cvekl, A				Limi, Saima; Senecal, Adrien; Coleman, Robert; Lopez-Jones, Melissa; Guo, Peng; Polumbo, Christina; Singer, Robert H.; Skoultchi, Arthur, I; Cvekl, Ales			Transcriptional burst fraction and size dynamics during lens fiber cell differentiation and detailed insights into the denucleation process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING ENZYME; GENE-EXPRESSION REGULATION; MESSENGER-RNA SYNTHESIS; ALPHA-B-CRYSTALLIN; SINGLE-CELL; REGULATORY NETWORKS; MAMMALIAN-CELLS; POLYMERASE-II; A-CRYSTALLIN; EYE LENS	Genes are transcribed in irregular pulses of activity termed transcriptional bursts. Cellular differentiation requires coordinated gene expression; however, it is unknown whether the burst fraction (i.e. the number of active phases of transcription) or size/intensity (the number of RNA molecules produced within a burst) changes during cell differentiation. In the ocular lens, the positions of lens fiber cells correlate precisely with their differentiation status, and the most advanced cells degrade their nuclei. Here, we examined the transcriptional parameters of the beta-actin and lens differentiation-specific alpha-, beta-, and gamma-crystall in genes by RNA fluorescent in situ hybridization (FISH) in the lenses of embryonic day (E) E12.5, E14.5, and E16.5 mouse embryos and newborns. We found that cellular differentiation dramatically alters the burst fraction in synchronized waves across the lens fiber cell compartment with less dramatic changes in burst intensity. Surprisingly, we observed nascent transcription of multiple genes in nuclei just before nuclear destruction. Nuclear condensation was accompanied by transfer of nuclear proteins, including histone and nonhistone proteins, to the cytoplasm. Although lens-specific deletion of the chromatin remodeler SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (Smarca5/Snf2h) interfered with denucleation, persisting nuclei remained transcriptionally competent and exhibited changes in both burst intensity and fraction depending on the gene examined. Our results uncover the mechanisms of nascent transcriptional control during differentiation and chromatin remodeling, confirm the burst fraction as the major factor adjusting gene expression levels, and reveal transcriptional competence of fiber cell nuclei even as they approach disintegration.	[Limi, Saima; Cvekl, Ales] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Senecal, Adrien; Coleman, Robert; Lopez-Jones, Melissa; Guo, Peng; Polumbo, Christina; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Singer, Robert H.; Skoultchi, Arthur, I] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Singer, Robert H.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Cvekl, Ales] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cvekl, A (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ales.cvekl@einstein.yu.edu		Cvekl, Ales/0000-0002-3957-789X	National Institutes of Health from NCI [P30CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB021236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126045, T32GM007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA047729] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. Shalev Itzkovitz for the critical reading of the manuscript. We are grateful to Dr. Usha Andley for advice. We thank the Analytical Imaging core facility for their services. The imaging was conducted in the Analytical Imaging Facility, which is funded by National Institutes of Health Grant P30CA013330 from NCI.	Akinduro O, 2016, J INVEST DERMATOL, V136, P1460, DOI 10.1016/j.jid.2016.03.016; Alvarez-Saavedra M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5181; Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Bartman CR, 2016, MOL CELL, V62, P237, DOI 10.1016/j.molcel.2016.03.007; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Battich N, 2015, CELL, V163, P1596, DOI 10.1016/j.cell.2015.11.018; Brennan LA, 2018, EXP EYE RES, V174, P173, DOI 10.1016/j.exer.2018.06.003; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Caveney PM, 2017, ACS SYNTH BIOL, V6, P334, DOI 10.1021/acssynbio.6b00189; Chaffee BR, 2014, DEVELOPMENT, V141, P3388, DOI 10.1242/dev.106005; Chen WV, 2001, BBA-GENE STRUCT EXPR, V1519, P30, DOI 10.1016/S0167-4781(01)00201-9; Cho WK, 2016, ELIFE, V5, DOI 10.7554/eLife.13617; Corrigan AM, 2016, ELIFE, V5, DOI 10.7554/eLife.13051; Coulon A, 2013, NAT REV GENET, V14, P572, DOI 10.1038/nrg3484; Cvekl A, 2017, TRENDS GENET, V33, P677, DOI 10.1016/j.tig.2017.08.001; Cvekl A, 2014, DEVELOPMENT, V141, P4432, DOI 10.1242/dev.107953; Dahm R, 1998, EUR J CELL BIOL, V75, P237, DOI 10.1016/S0171-9335(98)80118-0; den Engelsman J, 2004, EUR J BIOCHEM, V271, P4195, DOI 10.1111/j.1432-1033.2004.04359.x; Dluhosova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087448; Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010; Eliscovich C, 2017, P NATL ACAD SCI USA, V114, pE1875, DOI 10.1073/pnas.1621440114; Erdel F, 2011, FEBS J, V278, P3608, DOI 10.1111/j.1742-4658.2011.08282.x; Fischer H, 2011, J INVEST DERMATOL, V131, P1208, DOI 10.1038/jid.2011.13; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; GORING DR, 1993, DEV DYNAM, V196, P143, DOI 10.1002/aja.1001960208; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Halpern KB, 2015, MOL CELL, V58, P147, DOI 10.1016/j.molcel.2015.01.027; He S, 2016, DEVELOPMENT, V143, P1937, DOI 10.1242/dev.135285; Hendy O, 2017, MOL BIOL CELL, V28, P3360, DOI 10.1091/mbc.E17-06-0408; Itzkovitz S, 2012, CELL, V148, P608, DOI 10.1016/j.cell.2011.12.025; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; KARASEK J, 1988, J INVEST DERMATOL, V91, P243, DOI 10.1111/1523-1747.ep12470372; Kiefer CM, 2011, BLOOD, V118, P6200, DOI 10.1182/blood-2011-06-363101; Levesque MJ, 2013, NAT METHODS, V10, P246, DOI [10.1038/NMETH.2372, 10.1038/nmeth.2372]; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Pietrowski D, 1997, BIOL CHEM, V378, P1183; PIETROWSKI D, 1994, GENE, V144, P171, DOI 10.1016/0378-1119(94)90375-1; Precht P, 2010, MOL IMMUNOL, V47, P2038, DOI 10.1016/j.molimm.2010.04.009; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rowan S, 2017, EXP EYE RES, V156, P72, DOI 10.1016/j.exer.2016.02.011; Sala A, 2011, EMBO J, V30, P1766, DOI 10.1038/emboj.2011.98; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Senecal A, 2014, CELL REP, V8, P75, DOI 10.1016/j.celrep.2014.05.053; Singh SK, 2016, GENE DEV, V30, P2527, DOI 10.1101/gad.285692.116; Sun J, 2015, MOL VIS, V21, P955; Sun J, 2015, NUCLEIC ACIDS RES, V43, P6827, DOI 10.1093/nar/gkv589; Tantale K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12248; van Bavel CC, 2009, MOL IMMUNOL, V47, P511, DOI 10.1016/j.molimm.2009.08.009; van den IJssel P, 2003, EXP CELL RES, V287, P249, DOI 10.1016/S0014-4827(03)00092-2; Vera M, 2016, ANNU REV GENET, V50, P267, DOI 10.1146/annurev-genet-120215-034854; VRENSEN GFJM, 1991, EXP EYE RES, V52, P647, DOI 10.1016/0014-4835(91)90017-9; Wolf L, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-88; Woo AJ, 2011, BLOOD, V118, P3684, DOI 10.1182/blood-2011-03-341446; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zenklusen D, 2010, METHOD ENZYMOL, V470, P641, DOI 10.1016/S0076-6879(10)70026-4; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhao BB, 2016, DEV CELL, V36, P498, DOI 10.1016/j.devcel.2016.02.001	70	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13176	13190		10.1074/jbc.RA118.001927	http://dx.doi.org/10.1074/jbc.RA118.001927			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29959226	hybrid, Green Published			2022-12-26	WOS:000442730200017
J	Napolitano, F; Serrapica, M; Braghieri, A; Claps, S; Serrapica, F; De Rosa, G				Napolitano, Fabio; Serrapica, Maria; Braghieri, Ada; Claps, Salvatore; Serrapica, Francesco; De Rosa, Giuseppe			Can we monitor adaptation of juvenile goats to a new social environment through continuous qualitative behaviour assessment?	PLOS ONE			English	Article							RESPONSES; HERD	We aimed to verify whether Continuous Qualitative Behaviour Assessment (10 observers used a list of six qualitative descriptors) paired with Temporal Dominant Behavioural Expression (the same observers were asked to select the dominant descriptor and to score its intensity level) was able to monitor fluctuations of animal behaviour expression over time. We applied these techniques to three groups of juvenile goats either weaned (group C), or un-weaned (groups WOM and WM). Each animal was separated from its group, moved to group C and tested for 30 min either while their mothers were at pasture, or while their mothers were in an adjacent pen (group WOM and WM, respectively). Animals from group C were separated from their group and immediately reintroduced to it. TDBE duration and score of each descriptor of behavioural expression were able to detect differences among groups but were unable to describe how the behaviour of the goats changed as the time progressed. TDBE curves described the evolution of each behavioural expression of each animal over time but were unable to detect differences among groups. The chi(2) test conducted on peaks of dominance, albeit displaying the variations of the behavioural expression over time and allowing the assessment of differences among groups, focussed on occurrences of higher agreement between observers while neglecting most of the information concerning the descriptors above the level of significance. Conversely, based on mixed analysis of variance with the fixed effects of group, test interval and group x test interval (animal nested into group and observer were considered to be random), most of the descriptors were able to discriminate the three experimental groups while preserving the information on the fluctuations of the behavioural expression of the animals during the test.	[Napolitano, Fabio; Serrapica, Maria; Braghieri, Ada; Serrapica, Francesco] Univ Basilicata, Scuola Sci Agr Forestali Alimentari & Ambientali, Potenza, Italy; [Claps, Salvatore] CREA Res Ctr Anim Prod & Acquaculture, Potenza, Italy; [De Rosa, Giuseppe] Univ Napoli Federico II, Dipartimento Agr, Naples, Italy	University of Basilicata; University of Naples Federico II	Napolitano, F (corresponding author), Univ Basilicata, Scuola Sci Agr Forestali Alimentari & Ambientali, Potenza, Italy.	fabio.napolitano@unibas.it	Serrapica, Francesco/AAW-5689-2020; Napolitano, Fabio/I-8739-2019; Braghieri, Ada/AAT-4877-2021; De Rosa, Giuseppe/AAL-4791-2020	Serrapica, Francesco/0000-0001-7838-2465; Napolitano, Fabio/0000-0002-7169-5300; Braghieri, Ada/0000-0001-9824-0579; De Rosa, Giuseppe/0000-0002-8528-051X; CLAPS, SALVATORE/0000-0003-2843-9544				ADDISON WE, 1982, APPL ANIM ETHOL, V8, P527, DOI 10.1016/0304-3762(82)90216-4; ALLEY JC, 1994, SMALL RUMINANT RES, V13, P103, DOI 10.1016/0921-4488(94)90038-8; Dinnella C, 2013, FOOD QUAL PREFER, V30, P33, DOI 10.1016/j.foodqual.2013.04.006; Dwyer C., 2009, The ethology of domestic animals: an introductory text, modular texts, P161, DOI 10.1079/9781845935368.0161; Fernandez MA, 2007, SMALL RUMINANT RES, V70, P228, DOI 10.1016/j.smallrumres.2006.03.008; HOGAN JA, 2005, BEHAV ANIMALS MECH F, P41; Labbe D, 2009, FOOD QUAL PREFER, V20, P216, DOI 10.1016/j.foodqual.2008.10.001; Muri K, 2013, ANIM WELFARE, V22, P385, DOI 10.7120/09627286.22.3.385; Napolitano F, 2008, APPL ANIM BEHAV SCI, V109, P342, DOI 10.1016/j.applanim.2007.03.009; Napolitano F, 2015, APPL ANIM BEHAV SCI, V166, P35, DOI 10.1016/j.applanim.2015.01.017; Napolitano F, 2012, APPL ANIM BEHAV SCI, V141, P91, DOI 10.1016/j.applanim.2012.08.002; Pineau N, 2009, FOOD QUAL PREFER, V20, P450, DOI 10.1016/j.foodqual.2009.04.005; Pineau N, 2012, FOOD QUAL PREFER, V26, P159, DOI 10.1016/j.foodqual.2012.04.004; Rousing T, 2006, APPL ANIM BEHAV SCI, V101, P40, DOI 10.1016/j.applanim.2005.12.009; Sant'Anna AC, 2013, LIVEST SCI, V157, P254, DOI 10.1016/j.livsci.2013.08.004; *SAS, 1990, SAS STAT US GUID VER; Sevi A, 2001, J ANIM SCI, V79, P1457; Stevenson-Hinde J., 1983, PRIMATE SOCIAL RELAT, P28; Stockman CA, 2011, ANIM PROD SCI, V51, P240, DOI 10.1071/AN10122; Stockman CA, 2012, APPL ANIM BEHAV SCI, V142, P125, DOI 10.1016/j.applanim.2012.10.016; Wemelsfelder F, 2001, ANIM BEHAV, V62, P209, DOI 10.1006/anbe.2001.1741	21	4	4	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200165	10.1371/journal.pone.0200165	http://dx.doi.org/10.1371/journal.pone.0200165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979730	gold, Green Published, Green Submitted			2022-12-26	WOS:000437809500070
J	Kittrell, H; Graber, W; Mariani, E; Czaja, K; Hajnal, A; Di Lorenzo, PM				Kittrell, Hannah; Graber, William; Mariani, Evelyn; Czaja, Krzysztof; Hajnal, Andras; Di Lorenzo, Patricia M.			Taste and odor preferences following Roux-en-Y surgery in humans	PLOS ONE			English	Article							GASTRIC BYPASS-SURGERY; BARIATRIC SURGERY; EATING BEHAVIOR; SWEET TASTE; WEIGHT-LOSS; OBESITY; MECHANISMS; DECREASES; APPETITE; DIETARY	It is well established that bariatric surgery, the most effective method to achieve long-term weight loss in obese subjects, reverses enhanced preference and intake of sweet/fatty foods. Although taste and odor preference changes following bariatric surgery have been previously described, their time course and relationship to weight loss remains an issue. The aim of this study was to determine the relationship between taste and odor preference changes and successful weight loss following bariatric surgery. A cross-sectional study was performed on 195 human subjects with body mass index (BMI) above 30 (at least class I obesity), who were scheduled to receive (n = 54) or had previously received (n = 141) Rouxen-Y gastric bypass (RYGB). A Self-Assessment Manikin test was used to measure each participant's affective reaction (ranging from pleasure to displeasure) to a variety of food-related and odor-related pictures. Results confirmed earlier reports about changes in sweet/fatty foods preference after surgery and revealed a shift in preference toward less caloriedense foods. Relatedly, endorsements of "favorite" foods were mostly sweet/fatty foods in subjects awaiting surgery but were shifted toward more healthy choices, particularly vegetables, in subjects post-RYGB surgery. However, food preference ratings trended toward presurgical levels as the time since surgery increased. Answers to open-ended questions about why their diet changed post-surgery revealed that changes in cravings, rather than changes in taste per se, were the major factor. Surprisingly, patients rating a coffee taste as more pleasing after surgery had a lower post-surgical BMI. No associations of odors with change in BMI were apparent. Results showed that following bariatric surgery taste preferences are significantly altered and that these changes correlate with lowered BMI. However, these changes fade as time since surgery lengthens. These results may suggest diagnostic criteria to identify people at risk for less than optimal changes in BMI following bariatric surgery.	[Kittrell, Hannah; Di Lorenzo, Patricia M.] SUNY Binghamton, Dept Psychol, Binghamton, NY 13902 USA; [Graber, William; Mariani, Evelyn] St Joseph Hosp, Hlth Ctr, Metab Surg, Syracuse, NY USA; [Czaja, Krzysztof] Univ Georgia, Vet Biosci & Diagnost Imaging, Athens, GA 30602 USA; [Hajnal, Andras] Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA USA; [Kittrell, Hannah] Columbia Univ, Teachers Coll, Dept Hlth & Behav Studies, New York, NY 10027 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University System of Georgia; University of Georgia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Columbia University; Columbia University Teachers College	Di Lorenzo, PM (corresponding author), SUNY Binghamton, Dept Psychol, Binghamton, NY 13902 USA.	diloren@binghamton.edu		Di Lorenzo, Patricia/0000-0003-3935-1089; Czaja, Krzysztof/0000-0002-7165-4218	National Institute on Deafness and Other Communicative Disorders [RO1 DC6013904]	National Institute on Deafness and Other Communicative Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by grant number RO1 DC6013904 from the National Institute on Deafness and Other Communicative Disorders (https://www.nidcd.nih.gov) to PMD, KC and AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthoud HR, 2012, PHYSIOL BEHAV, V107, P527, DOI 10.1016/j.physbeh.2012.04.004; Berthoud HR, 2011, PHYSIOL BEHAV, V105, P106, DOI 10.1016/j.physbeh.2011.01.023; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bueter M, 2011, PHYSIOL BEHAV, V104, P709, DOI 10.1016/j.physbeh.2011.07.025; BURGE JC, 1995, J AM DIET ASSOC, V95, P666, DOI 10.1016/S0002-8223(95)00182-4; Graham L, 2014, OBES SURG, V24, P1463, DOI 10.1007/s11695-014-1221-2; Hajnal A, 2010, AM J PHYSIOL-GASTR L, V299, pG967, DOI 10.1152/ajpgi.00070.2010; Hill AJ, 2007, P NUTR SOC, V66, P277, DOI 10.1017/S0029665107005502; Holinski F, 2015, OBES SURG, V25, P2314, DOI 10.1007/s11695-015-1683-x; Kruseman M, 2010, J AM DIET ASSOC, V110, P527, DOI 10.1016/j.jada.2009.12.028; le Roux CW, 2014, EXP PHYSIOL, V99, P1128, DOI 10.1113/expphysiol.2014.078378; Manning S, 2015, SURG ENDOSC, V29, P1484, DOI 10.1007/s00464-014-3829-7; Mathes CM, 2016, AM J PHYSIOL-REG I, V310, pR952, DOI 10.1152/ajpregu.00444.2015; Mathes CM, 2012, PHYSIOL BEHAV, V107, P476, DOI 10.1016/j.physbeh.2012.02.013; Miras AD, 2012, AM J CLIN NUTR, V96, P467, DOI 10.3945/ajcn.112.036921; Miras AD, 2010, CURR OPIN GASTROEN, V26, P140, DOI 10.1097/MOG.0b013e328333e94a; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; Palouzier-Paulignan B, 2012, CHEM SENSES, V37, P769, DOI 10.1093/chemse/bjs059; Pepino MY, 2014, OBESITY, V22, pE13, DOI 10.1002/oby.20649; Richardson BE, 2012, OBES SURG, V22, P283, DOI 10.1007/s11695-011-0487-x; Shin AC, 2011, INT J OBESITY, V35, P642, DOI 10.1038/ijo.2010.174; Thomas JR, 2010, J AM DIET ASSOC, V110, P608, DOI 10.1016/j.jada.2009.12.017; Tichansky David S, 2006, Surg Obes Relat Dis, V2, P440, DOI 10.1016/j.soard.2006.02.014; Tichansky DS, 2011, SURG ENDOSC, V25, P1176, DOI 10.1007/s00464-010-1335-0; Yeomans MR, 2006, PHYSIOL BEHAV, V89, P10, DOI [10.1016/j.physbeh.2006.04.010, 10.1016/j.physbeh.2006.01.029]	26	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199508	10.1371/journal.pone.0199508	http://dx.doi.org/10.1371/journal.pone.0199508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975712	gold, Green Published, Green Submitted			2022-12-26	WOS:000437424500035
J	Mantsios, A; Shembilu, C; Mbwambo, J; Likindikoki, S; Sherman, S; Kennedy, C; Kerrigan, D				Mantsios, Andrea; Shembilu, Catherine; Mbwambo, Jessie; Likindikoki, Samuel; Sherman, Susan; Kennedy, Caitlin; Kerrigan, Deanna			'That's how we help each other': Community savings groups, economic empowerment and HIV risk among female sex workers in Iringa, Tanzania	PLOS ONE			English	Article							QUALITATIVE RESEARCH; PREVENTION; INTERVENTION; INDIA; CHALLENGES; VULNERABILITIES; EXPERIENCES; INSECURITY; BANGALORE; SONAGACHI	Female sex workers (FSW) are a socially and economically marginalized population heavily affected by HIV. Community empowerment approaches focus on FSW taking collective action to address structural barriers to their health and have demonstrated effectiveness in reducing HIV risk. This study examines the potential for community savings groups (locally called michezo) among FSW in Iringa, Tanzania to reduce HIV risk and promote economic and community empowerment. We conducted 27 in-depth interviews (IDIs) with 15 FSW over time and 4 focus group discussions (FGDs) with 35 FSW participating in michezo, and 10 key informant interviews (KIIs) with group collectors. Content analysis was used to identify salient themes around participants' sex work and financial realities; the role of savings groups in their lives and work; and experiences with social cohesion associated with group participation. Michezo were described as providing a safety net for times of financial need, allowing FSW to create greater financial security for themselves and their families. Participation in the groups was also reported to facilitate both individual agency, resulting in members' ability to negotiate condom use and be selective about clients, and a sense of collective identity and solidarity. Participants described group challenges including high mobility and low income of FSW making it difficult for women to fulfill their financial obligations to the group. As a result, participants reported preferences for joining michezo whose members were perceived as more stable (e.g. older, married, from more established venues). Group collectors and members were eager to have michezo formally registered and become recognized by the broader community. Findings indicate that savings groups promote individual agency to reduce sexual risk behaviors and foster community empowerment among FSW. The groups hold potential as an empowerment strategy to enable sex workers to address structural sources of HIV vulnerability and help them achieve socioeconomic inclusion.	[Mantsios, Andrea; Sherman, Susan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA; [Shembilu, Catherine; Mbwambo, Jessie; Likindikoki, Samuel] Muhimbili Univ Hlth & Allied Sci, Dept Psychiat & Mental Hlth, Dar Es Salaam, Tanzania; [Kennedy, Caitlin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Kerrigan, Deanna] Amer Univ, Dept Sociol, Washington, DC 20016 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Muhimbili University of Health & Allied Sciences; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; American University	Mantsios, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA.	amantsios@jhu.edu			National Institute of Mental Health [R01MH104044]; National Institute of Allergy and Infectious Disease of the National Institutes of Health [T32AI050056]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI050056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104044] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Disease of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health through R01MH104044 (DK) and the National Institute of Allergy and Infectious Disease of the National Institutes of Health through T32AI050056 (AM). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha S, 2004, CULT HEALTH SEX, V6, P283, DOI 10.1080/13691050410001680474; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Beckham S, 2013, STRATEGIC ASSESSMENT; Bikaako-Kajura W., 2000, AIDS TRANSPORT EXPER; Blanchard JF, 2005, J INFECT DIS, V191, pS139, DOI 10.1086/425273; Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; Burt RS, 2005, BROKERAGE CLOSURE IN; Dertwinkel T, 2008, EC EXCLUSION ETHNIC, P19; Dworkin SL, 2009, AIDS BEHAV, V13, P462, DOI 10.1007/s10461-009-9532-3; Euser SM, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19279; Fehrenbacher AE, 2016, AIDS BEHAV, V20, P2332, DOI 10.1007/s10461-016-1412-z; Fitzgerald-Husek A, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-35; Ghose T, 2008, SOC SCI MED, V67, P311, DOI 10.1016/j.socscimed.2008.03.045; Giddens A., 1979, CENTRAL PROBLEMS SOC; Gurnani V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-755; Ivanoff Synneve Dahlin, 2006, Scand J Occup Ther, V13, P125, DOI 10.1080/11038120600691082; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9; Kerrigan D, 2015, LANCET; Kerrigan D, 2017, JAIDS-J ACQ IMM DEF, V74, pS60, DOI 10.1097/qai.0000000000001203; Kerrigan D, 2015, LANCET, V385, P172, DOI 10.1016/S0140-6736(14)60973-9; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mantsios A, 2018, AIDS BEHAV; Mathieson J, 2008, SOCIAL EXCLUSION MEA; Morgan D.L., 1997, QUALITATIVE RES METH, DOI [10.4135/9781412984287, DOI 10.4135/9781412984287]; Network of Sex Worker Projects (NSWP), 2015, EC EMP PROGR SEX WOR; Ngo AD, 2007, CULT HEALTH SEX, V9, P555, DOI 10.1080/13691050701380018; Onyeneho N G, 2009, Tanzan J Health Res, V11, P126; Oyefara J L, 2007, SAHARA J, V4, P626; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Phrasisombath K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1004; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Ranebennur V, 2014, HIV AIDS-RES PALLIAT, V6, P9, DOI 10.2147/HIV.S54062; Reed E, 2010, PUBLIC HEALTH REP, V125, P81, DOI 10.1177/00333549101250S412; Saggurti N, 2012, AIDS BEHAV, V16, P952, DOI 10.1007/s10461-011-9937-7; Scientific Software Development GmbH, 2013, ATLAS TI VERS 1 0 50; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Seidel G., 1982, SOC SCI MED, V1993, P36; Sen A., 2000, SOCIAL DEV PAPERS, V1; Souverein D, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.22943; Swendeman D, 2009, SOC SCI MED, V69, P1157, DOI 10.1016/j.socscimed.2009.07.035; Tanzania National AIDS Control Program PSI Tanzania., 2013, HIV BIOL BEH SURV TA; The Synergy Project & University of Washington Center for Health Education and Research, 2000, ROOM CHANGE PREVENTI; Tsai Laura Cordisco, 2013, Glob J Health Sci, V5, P41, DOI 10.5539/gjhs.v5n5p41; USAID Project Search, 2013, HIV FEM SEX WORK MEN; Whitney Moret ASPIRES FHI 360, 2014, EC STRENGTH FEM SEX	47	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199583	10.1371/journal.pone.0199583	http://dx.doi.org/10.1371/journal.pone.0199583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL7YG	29975737	Green Submitted, Green Published, gold			2022-12-26	WOS:000437424500039
J	Thakore, N; Norville, R; Franke, M; Calderon, R; Lecca, L; Villanueva, M; Murray, MB; Cooney, CG; Chandler, DP; Holmberg, RC				Thakore, Nitu; Norville, Ryan; Franke, Molly; Calderon, Roger; Lecca, Leonid; Villanueva, Michael; Murray, Megan B.; Cooney, Christopher G.; Chandler, Darrell P.; Holmberg, Rebecca C.			Automated TruTip nucleic acid extraction and purification from raw sputum	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS DNA; REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; INFLUENZA RNA EXTRACTION; SAMPLES; DIAGNOSIS; COMPLEX; SWABS	Automated nucleic acid extraction from primary (raw) sputum continues to be a significant technical challenge for molecular diagnostics. In this work, we developed a prototype open-architecture, automated nucleic acid workstation that includes a mechanical homogenization and lysis function integrated with heating and TruTip purification; optimized an extraction protocol for raw sputum; and evaluated system performance on primary clinical specimens. Eight samples could be processed within 70 min. The system efficiently homogenized primary sputa and doubled nucleic acid recovery relative to an automated protocol that did not incorporate sample homogenization. Nucleic acid recovery was at least five times higher from raw sputum as compared to that of matched sediments regardless of smear or culture grade, and the automated workstation reproducibly recovered PCR-detectable DNA to at least 80 CFU mL(-1) raw sputum. M. tuberculosis DNA was recovered and detected from 122/123 (99.2%) and 124/124 (100%) primary sputum and sediment extracts, respectively. There was no detectable cross-contamination across 53 automated system runs and amplification or fluorescent inhibitors (if present) were not detectable. The open fluidic architecture of the prototype automated workstation yields purified sputum DNA that can be used for any molecular diagnostic test. The ability to transfer TruTip protocols between personalized, on-demand pipetting tools and the fully automated workstation also affords public health agencies an opportunity to standardize sputum nucleic acid sample preparation procedures, reagents, and quality control across multiple levels of the health care system.	[Thakore, Nitu; Norville, Ryan; Cooney, Christopher G.; Chandler, Darrell P.; Holmberg, Rebecca C.] Akonni Biosyst Inc, Frederick, MD 21701 USA; [Franke, Molly; Lecca, Leonid; Murray, Megan B.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA; [Calderon, Roger; Lecca, Leonid] Socios Salud Sucursal Peru, Lima, Peru; [Villanueva, Michael] Lab Med Especialido, Juarez, Mexico	Harvard University; Harvard Medical School	Holmberg, RC (corresponding author), Akonni Biosyst Inc, Frederick, MD 21701 USA.	rholmberg@akonni.com	Franke, Molly/AAK-7559-2020	Franke, Molly/0000-0002-4890-5728; Calderon, Roger I./0000-0001-8932-0489; Lecca, Leonid/0000-0003-1363-3985	National Institutes of Health (NIH) under Center of Excellence in Translational Research (CETR) [U19 AI109755, R01AI111435, R44 EB011274, R44GM103053, HHSN272201600024C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109755, R01AI111435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R44EB011274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM103053] Funding Source: NIH RePORTER	National Institutes of Health (NIH) under Center of Excellence in Translational Research (CETR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) under the Center of Excellence in Translational Research (CETR) grant U19 AI109755, R01AI111435, and R44 EB011274, R44GM103053, and HHSN272201600024C. Authors Nitu Thakore, Ryan Norville, Christopher Cooney, Darrell Chandler, and Rebecca Holmberg are employed by Akonni Biosystems. This funding entity provided support in the form of salaries for the specified authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aldous WK, 2005, J CLIN MICROBIOL, V43, P2471, DOI 10.1128/JCM.43.5.2471-2473.2005; Amaro A, 2008, LETT APPL MICROBIOL, V47, P8, DOI 10.1111/j.1472-765X.2008.02372.x; Baxter CG, 2011, J MICROBIOL METH, V85, P75, DOI 10.1016/j.mimet.2011.01.024; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bouchara JP, 2009, J CLIN MICROBIOL, V47, P142, DOI 10.1128/JCM.01668-08; Chandler DP, 2012, J VIROL METHODS, V183, P8, DOI 10.1016/j.jviromet.2012.03.002; Chatterjee M, 2013, INDIAN J MED RES, V138, P541; Cui ZL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-276; de Boer R, 2010, J MICROBIOL METH, V80, P209, DOI 10.1016/j.mimet.2009.11.009; Denkinger CM, 2013, EXPERT REV MOL DIAGN, V13, P763, DOI 10.1586/14737159.2013.850034; Denkinger CM, 2015, J INFECT DIS S2, V211; FOLGUEIRA L, 1993, J CLIN MICROBIOL, V31, P1019, DOI 10.1128/JCM.31.4.1019-1021.1993; Fukasawa T, 2010, JPN J INFECT DIS, V63, P246; Gomez DI, 2011, TUBERCULOSIS, V91, pS43, DOI 10.1016/j.tube.2011.10.009; Griesemer SB, 2013, J CLIN VIROL, V58, P138, DOI 10.1016/j.jcv.2013.06.033; Holmberg R, 2013, JOVE-J VIS EXP, V76; Holmberg RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073068; Honore-Bouakline S, 2003, J CLIN MICROBIOL, V41, P2323, DOI 10.1128/JCM.41.6.2323-2329.2003; Hubers AJ, 2013, BRIT J CANCER, V109, P530, DOI 10.1038/bjc.2013.393; HURLEY SS, 1987, J CLIN MICROBIOL, V25, P2227, DOI 10.1128/JCM.25.11.2227-2229.1987; Javadi Alireza, 2014, Tanaffos, V13, P41; Jeong JH, 2014, J MED VIROL, V86, P2122, DOI 10.1002/jmv.23937; Kaser M, 2009, APPL ENVIRON MICROB, V75, P414, DOI 10.1128/AEM.01358-08; Kik SV, 2014, EUR RESPIR J, V44, P537, DOI 10.1183/09031936.00027714; KOCAGOZ T, 1993, J CLIN MICROBIOL, V31, P1435; Lee RS, 2017, J CLIN MICROBIOL, V55, P1249, DOI [10.1128/JCM.00358-17, 10.1128/jcm.00358-17]; Leung ETY, 2011, J CLIN MICROBIOL, V49, P2509, DOI 10.1128/JCM.00108-11; Linger Y, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01652-17, 10.1128/jcm.01652-17]; McNerney R, 2017, INT J INFECT DIS, V56, P130, DOI 10.1016/j.ijid.2016.11.422; Organization WH, 2016, GLOBAL TUBERCULOSIS; Perera Jennifer, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P693; Roychowdhury T, 2015, SCI REP-UK, V5, DOI 10.1038/srep12567; Savelkoul PHM, 2006, J MICROBIOL METH, V66, P177, DOI 10.1016/j.mimet.2005.12.003; Sebastian T, 2014, CLIN CHIM ACTA, V429, P198, DOI 10.1016/j.cca.2013.12.009; Stralin K, 2014, J CLIN MICROBIOL, V52, P83, DOI 10.1128/JCM.01742-13; Sung H, 2016, ANN LAB MED, V36, P457, DOI 10.3343/alm.2016.36.5.457; Thakore N, 2018, J MICROBIOL METHODS; Wolff BJ, 2017, J CLIN MICROBIOL, V55, P110, DOI 10.1128/JCM.01805-16; World Health Organization, 2008, WHOHTMTB2008392; World Health Organization, 2014, HIGH PRIOR TARG PROD	40	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199869	10.1371/journal.pone.0199869	http://dx.doi.org/10.1371/journal.pone.0199869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975759	gold, Green Published, Green Submitted			2022-12-26	WOS:000437424500052
J	Marete, A; Lund, MS; Boichard, D; Ramayo-Caldas, Y				Marete, Andrew; Lund, Mogens Sando; Boichard, Didier; Ramayo-Caldas, Yuliaxis			A system-based analysis of the genetic determinism of udder conformation and health phenotypes across three French dairy cattle breeds	PLOS ONE			English	Article							TRANSCRIPTION FACTOR CREB; GENOME-WIDE ASSOCIATION; MAMMARY-GLAND; SEQUENCE VARIANTS; PRODUCTION TRAITS; DENDRITIC CELLS; TRANSPORT; MILK; IMPUTATION; EXPRESSION	Using GWAS to identify candidate genes associated with cattle morphology traits at a functional level is challenging. The main difficulty of identifying candidate genes and gene interactions associated with such complex traits is the long-range linkage disequilibrium (LD) phenomenon reported widely in dairy cattle. Systems biology approaches, such as combining the Association Weight Matrix (AWM) with a Partial Correlation in an Information Theory (PCIT) algorithm, can assist in overcoming this LD. Used in a multi-breed and multi-phenotype context, the AWM-PCIT could aid in identifying udder traits candidate genes and gene networks with regulatory and functional significance. This study aims to use the AWM-PCIT algorithm as a post-GWAS analysis tool with the goal of identifying candidate genes underlying udder morphology. We used data from 78,440 dairy cows from three breeds and with own phenotypes for five udder morphology traits, five production traits, somatic cell score and clinical mastitis. Cows were genotyped with medium (50k) or low-density (7 to 10k) chips and imputed to 50k. We performed a within breed and trait GWAS. The GWAS showed 9,830 significant SNP across the genome (p < 0.05). Five thousand and ten SNP did not map a gene, and 4,820 SNP were within 10-kb of a gene. After accounting for 1SNP:1gene, 3,651 SNP were within 10-kb of a gene (sett ), and 2,673 significant SNP were further than 10-kb of a gene (set2). The two SNP sets formed 6,324 SNP matrix, which was fitted in an AWM-PCIT considering udder depth/ development as the key trait resulting in 1,013 genes associated with udder morphology, mastitis and production phenotypes. The AWM-PCIT detected ten potential candidate genes for udder related traits: ESR1, FGF2, FGFR2, GLI2, IQGAP3, PGR, PRLR, RREB1, BTRC, and TGFBR2.	[Marete, Andrew; Boichard, Didier; Ramayo-Caldas, Yuliaxis] Univ Paris Saclay, AgroParisTech, INRA, Genet Anim & Biol Integrat, Jouy En Josas, France; [Marete, Andrew; Lund, Mogens Sando] Aarhus Univ, Ctr Quantitat Genet & Genom, Tjele, Denmark	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Aarhus University	Marete, A (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, Genet Anim & Biol Integrat, Jouy En Josas, France.; Marete, A (corresponding author), Aarhus Univ, Ctr Quantitat Genet & Genom, Tjele, Denmark.	andrew.marete@mbg.au.dk	Lund, Mogens S/I-4321-2016; Boichard, Didier/AAD-8675-2020; Marete, Andrew Gitahi/P-5710-2019; Marete, Andrew G/U-3792-2017; Caldas, Yuliaxis Ramayo/B-6337-2014	Boichard, Didier/0000-0003-0361-2961; Marete, Andrew Gitahi/0000-0003-2301-4168; Marete, Andrew G/0000-0003-2301-4168; Caldas, Yuliaxis Ramayo/0000-0002-8142-0159	Erasmus Mundus Ph.D. grant; European Graduate School in Animal Breeding and Genetics (France); Viking Genetics (Denmark); Center for Genomic Selection in Animals and Plants (GenSAP) - Innovation Fund Denmark [0603-00519B]	Erasmus Mundus Ph.D. grant; European Graduate School in Animal Breeding and Genetics (France); Viking Genetics (Denmark); Center for Genomic Selection in Animals and Plants (GenSAP) - Innovation Fund Denmark	A. Marete is the recipient of an Erasmus Mundus Ph.D. grant. This work is funded by the European Graduate School in Animal Breeding and Genetics (France), Viking Genetics (Denmark) and the Center for Genomic Selection in Animals and Plants (GenSAP) funded by Innovation Fund Denmark (grant 0603-00519B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boichard D, 2012, ANIM PROD SCI, V52, P115, DOI 10.1071/AN11119; Bothwell M, 2014, Handb Exp Pharmacol, V220, P3, DOI 10.1007/978-3-642-45106-5_1; Bridges GA, 2012, ANIM REPROD SCI, V133, P16, DOI 10.1016/j.anireprosci.2012.06.013; COLEMANKRNACIK S, 1994, MOL ENDOCRINOL, V8, P218, DOI 10.1210/me.8.2.218; Druet T, 2010, J DAIRY SCI, V93, P5443, DOI 10.3168/jds.2010-3255; Elsik CG, 2016, NUCLEIC ACIDS RES, V44, pD834, DOI 10.1093/nar/gkv1077; Fontanesi L, 2014, ANIM GENET, V45, P576, DOI 10.1111/age.12164; Fortes MRS, 2011, J ANIM SCI, V89, P1669, DOI 10.2527/jas.2010-3681; Fortes MRS, 2010, P NATL ACAD SCI USA, V107, P13642, DOI 10.1073/pnas.1002044107; Garcia-Gamez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021158; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lee WJ, 2006, BBA-REV CANCER, V1765, P235, DOI 10.1016/j.bbcan.2005.12.001; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Madsen P, A USERS GUIDE TO DMU; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Maxymiv NG, 2012, COMP IMMUNOL MICROB, V35, P31, DOI 10.1016/j.cimid.2011.09.009; Parlato R, 2007, DEVELOPMENT, V134, P1663, DOI 10.1242/dev.02838; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Pausch H, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0190-4; Ramayo-Caldas Y, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0216-y; Ramayo-Caldas Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-232; Ramos RD, 2014, MOL REPROD DEV, V81, P584, DOI 10.1002/mrd.22323; Raven LA, 2016, MAMM GENOME, V27, P81, DOI 10.1007/s00335-015-9613-8; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Reverter Antonio, 2013, Methods Mol Biol, V1019, P437, DOI 10.1007/978-1-62703-447-0_20; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Rupp R, 1999, J DAIRY SCI, V82, P2198, DOI 10.3168/jds.S0022-0302(99)75465-2; SARGOLZAEI M, 2014, BMC GENOMICS, V15; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; TASKER JG, 1986, NEUROSCIENCE, V19, P495, DOI 10.1016/0306-4522(86)90276-9; Tiezzi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114919; van den Berg I, 2016, J DAIRY SCI, V99, P8932, DOI 10.3168/jds.2016-11073; VANRADEN PM, 1991, J DAIRY SCI, V74, P2737, DOI 10.3168/jds.S0022-0302(91)78453-1; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Wang X, 2008, J DAIRY SCI, V91, P2475, DOI 10.3168/jds.2007-0877; Watson-Haigh NS, 2010, BIOINFORMATICS, V26, P411, DOI 10.1093/bioinformatics/btp674; Widmann P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-798; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang SH, 2015, INT J MOL SCI, V16, P26530, DOI 10.3390/ijms161125976	43	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199931	10.1371/journal.pone.0199931	http://dx.doi.org/10.1371/journal.pone.0199931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965995	Green Published, Green Submitted, gold			2022-12-26	WOS:000437224100030
J	Amos-Kroohs, RM; Nelson, DW; Hacker, TA; Yen, CLE; Smith, SM				Amos-Kroohs, Robyn M.; Nelson, David W.; Hacker, Timothy A.; Yen, Chi-Liang Eric; Smith, Susan M.			Does prenatal alcohol exposure cause a metabolic syndrome? (Non-)evidence from a mouse model of fetal alcohol spectrum disorder	PLOS ONE			English	Article							ETHANOL EXPOSURE; DEVELOPMENTAL ORIGINS; GLUCOSE-INTOLERANCE; INSULIN-RESISTANCE; GROWTH RESTRICTION; BIRTH-WEIGHT; OBESITY; CHILDREN; AGE; EXPRESSION	Although prenatal alcohol exposure (PAE) reduces offspring growth, it may increase obesity risk at adolescence. Animal models of PAE display glucose intolerance and increased adiposity, suggesting that PAE causes metabolic reprogramming. We tested this hypothesis in a mouse model of binge PAE, wherein pregnant C57Bl/6J females received 3 g/kg alcohol (ETOH) daily from gestational day 12.5 to 17.5; maltodextrin (MD) and medium chain triglycerides (MCT) served as isocaloric nutritional controls, and sham (H2O) treatment controlled for gavage stress. Our comprehensive assessment quantified body composition, energy expenditure, glucose tolerance, and cardiovascular function in offspring at age 17 weeks. Although ETOH pups were initially lighter than all other groups, they did not have a unique obesogenic phenotype. Instead, a similar obesogenic phenotype emerged in all three caloric groups (MCT, MD, ETOH), such that caloric groups had greater post-weaning weight gain (both sexes), reduced gonadal fat weight (males), and reduced glucose clearance (males) compared against H2O offspring. PAE did not affect body composition, respiratory exchange ratio, metabolic adaption to high-fat or low-fat diet, eating behavior, and blood pressure, and ETOH values did not differ from those obtained from isocaloric controls. Exposure to a higher alcohol dose (4.5 g/kg) or a high-fat (60%) diet did not exacerbate differences in body composition or glucose tolerance. "PAE-specific" effects on postnatal growth, glucose tolerance, adiposity, or hypertension only emerged when PAE offspring were compared just against H2O controls, or against MD controls. We conclude that prior reports of obesity and glucose intolerance in adult PAE offspring reflect the contribution of added gestational calories, and not alcohol's pharmacologic action. Results suggest that the increased adiposity risk in FASD is not caused by metabolic reprogramming, and instead originates from behavioral, medication, and/or dietary practices. This study highlights the importance of appropriate dietary controls in nutritional studies of PAE.	[Amos-Kroohs, Robyn M.; Smith, Susan M.] Univ N Carolina, UNC Nutr Res Inst, Kannapolis, NC 28223 USA; [Amos-Kroohs, Robyn M.; Smith, Susan M.] Univ N Carolina, Dept Nutr, Kannapolis, NC 28223 USA; [Amos-Kroohs, Robyn M.; Nelson, David W.; Yen, Chi-Liang Eric; Smith, Susan M.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA; [Hacker, Timothy A.] Univ Wisconsin, Dept Med, Cardiovasc Res Ctr, Sch Med & Publ Hlth, Madison, WI USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Smith, SM (corresponding author), Univ N Carolina, UNC Nutr Res Inst, Kannapolis, NC 28223 USA.; Smith, SM (corresponding author), Univ N Carolina, Dept Nutr, Kannapolis, NC 28223 USA.; Smith, SM (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	Susan_Smith@unc.edu		Smith, Susan M/0000-0003-4782-6857	National Institute on Alcohol Abuse and Alcoholism [R01 AA22999, R37 AA11085, F32 AA0024364]; National Institute of Diabetes and Digestive and Kidney Disorders [T32 DK007665, R01 DK88210]; Vilas Associate Award from the University of Wisconsin-Madison; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA024364, R01AA011085, R01AA022999, R37AA011085] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Diabetes and Digestive and Kidney Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Vilas Associate Award from the University of Wisconsin-Madison; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by Awards R01 AA22999 (SMS), R37 AA11085 (SMS), and F32 AA0024364 (RMAK) from the National Institute on Alcohol Abuse and Alcoholism; T32 DK007665 (RMAK) and R01 DK88210 (CEY) from the National Institute of Diabetes and Digestive and Kidney Disorders; and a Vilas Associate Award from the University of Wisconsin-Madison (SMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos-Kroohs RM, 2016, J PEDIATR-US, V169, P194, DOI 10.1016/j.jpeds.2015.10.049; Amos-Kroohsa RM, 2015, TOXICOL REP, V2, P1046, DOI [10.1016/j.toxrep.2015.07.015, 10.1016/j.toxrep.2014.10.004]; [Anonymous], 1995, NUTR REQ LAB AN, V4th; Boehm SL, 1997, ALCOHOL, V14, P389, DOI 10.1016/S0741-8329(97)87950-5; Bouret S, 2015, PHYSIOL REV, V95, P47, DOI 10.1152/physrev.00007.2014; Brady ML, 2012, ALCOHOL CLIN EXP RES, V36, P457, DOI 10.1111/j.1530-0277.2011.01644.x; Carter RC, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0775; Carter RC, 2013, ALCOHOL CLIN EXP RES, V37, P452, DOI 10.1111/j.1530-0277.2012.01940.x; Carter RC, 2012, ALCOHOL CLIN EXP RES, V36, P1973, DOI 10.1111/j.1530-0277.2012.01810.x; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Chen L, 2004, AM J PHYSIOL-REG I, V286, pR554, DOI 10.1152/ajpregu.00076.2003; Chen L, 2004, J APPL PHYSIOL, V96, P167, DOI 10.1152/japplphysiol.00751.2003; Chen L, 2003, METABOLISM, V52, P454, DOI 10.1053/meta.2003.50073; Chen L, 2003, ENDOCRINOLOGY, V144, P500, DOI 10.1210/en.2002-220623; COLES CD, 1991, NEUROTOXICOL TERATOL, V13, P357, DOI 10.1016/0892-0362(91)90084-A; Day NL, 2002, ALCOHOL CLIN EXP RES, V26, P1584, DOI 10.1097/01.ALC.0000034036.75248.D9; Dobson CC, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.31; Dobson CC, 2014, ALCOHOL, V48, P687, DOI 10.1016/j.alcohol.2014.09.001; Fuglestad AJ, 2014, ALCOHOL CLIN EXP RES, V38, P2502, DOI 10.1111/acer.12516; Fuglestad AJ, 2013, NEUROTOXICOL TERATOL, V39, P128, DOI 10.1016/j.ntt.2013.06.005; Gao Y, 2013, J LIPID RES, V54, P1644, DOI 10.1194/jlr.M035493; Gardebjer EM, 2017, AM J PHYSIOL-ENDOC M, DOI [10.1152/ajpendo.00251.2017, DOI 10.1152/AJPENDO.00251.2017]; Gaskins RB, 2010, AM J PERINAT, V27, P721, DOI 10.1055/s-0030-1253555; Gray SP, 2008, AM J PHYSIOL-REG I, V295, pR568, DOI 10.1152/ajpregu.90316.2008; Gray SP, 2010, J AM SOC NEPHROL, V21, P1891, DOI 10.1681/ASN.2010040368; Kaminen-Ahola N, 2010, BIRTH DEFECTS RES A, V88, P818, DOI 10.1002/bdra.20729; Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811; Klug MG, 2003, NEUROTOXICOL TERATOL, V25, P689, DOI 10.1016/j.ntt.2003.07.017; Kodali VN, 2017, ALCOHOL CLIN EXP RES, V41, P334, DOI 10.1111/acer.13307; Long NM, 2010, J ANIM SCI, V88, P3546, DOI 10.2527/jas.2010-3083; Lorenz JN, 1997, AM J PHYSIOL-HEART C, V272, pH1137, DOI 10.1152/ajpheart.1997.272.3.H1137; Lunde ER, 2016, ALCOHOL CLIN EXP RES, V40, P1403, DOI 10.1111/acer.13114; Marquardt K, 2014, ALCOHOL CLIN EXP RES, V38, P2962, DOI 10.1111/acer.12577; Mattson SN, 2013, ALCOHOL CLIN EXP RES, V37, P517, DOI 10.1111/j.1530-0277.2012.01952.x; May PA, 2014, PEDIATRICS, V134, P855, DOI 10.1542/peds.2013-3319; Moore Eileen M, 2015, Curr Dev Disord Rep, V2, P219; Morris MJ, 2015, NEUROSCI BIOBEHAV R, V58, P36, DOI 10.1016/j.neubiorev.2014.12.002; Nelson DW, 2014, J BIOL CHEM, V289, P17338, DOI 10.1074/jbc.M114.555961; Nelson DW, 2011, J LIPID RES, V52, P1723, DOI 10.1194/jlr.M016840; Popova S, 2016, LANCET, V387, P978, DOI 10.1016/S0140-6736(15)01345-8; Probyn ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059718; Probyn ME, 2012, REPROD FERT DEVELOP, V24, P859, DOI 10.1071/RD11200; Raipuria M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120980; Rinaudo P, 2012, ANNU REV PHYSIOL, V74, P107, DOI 10.1146/annurev-physiol-020911-153245; SAMPSON PD, 1994, AM J PUBLIC HEALTH, V84, P1421, DOI 10.2105/AJPH.84.9.1421; Spohr HL, 2007, J PEDIATR-US, V150, P175, DOI 10.1016/j.jpeds.2006.11.044; Stojek MMK, 2017, CLIN PSYCHOL REV, V55, P1, DOI 10.1016/j.cpr.2017.04.007; STREISSGUTH AP, 1985, LANCET, V2, P85; STREISSGUTH AP, 1991, JAMA-J AM MED ASSOC, V265, P1961, DOI 10.1001/jama.265.15.1961; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Werts RL, 2014, ALCOHOL CLIN EXP RES, V38, P871, DOI 10.1111/acer.12284; Xia LP, 2014, TOXICOL LETT, V226, P98, DOI 10.1016/j.toxlet.2014.01.023; Yao XH, 2006, J APPL PHYSIOL, V100, P642, DOI 10.1152/japplphysiol.01115.2005; Yao XH, 2007, AM J PHYSIOL-REG I, V292, pR1926, DOI 10.1152/ajpregu.00822.2006; Yao XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059680; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211	57	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199213	10.1371/journal.pone.0199213	http://dx.doi.org/10.1371/journal.pone.0199213			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953483	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400018
J	Dalton, AS; Patterson, T; Roe, HM; Macomber, AL; Swindles, GT; Galloway, JM; Vermaire, JC; Crann, CA; Falck, H				Dalton, April S.; Patterson, Timothy; Roe, Helen M.; Macomber, Andrew L.; Swindles, Graeme T.; Galloway, Jennifer M.; Vermaire, Jesse C.; Crann, Carley A.; Falck, Hendrik			Late Holocene climatic variability in Subarctic Canada: Insights from a high-resolution lake record from the central Northwest Territories	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; DECADAL OSCILLATION; PACIFIC; SOLAR; DIATOMS; PERIODICITIES; SEDIMENTS; PATTERNS; SHIFTS; PRECIPITATION	We examined late Holocene (ca. 3300 yr BP to present-day) climate variability in the central Northwest Territories (Canadian Subarctic) using a diatom and sedimentological record from Danny's Lake (63.48 degrees N, 112.54 degrees W), located 40 km southwest of the modern-day tree-line. High-resolution sampling paired with a robust age model (25 radiocarbon dates) allowed for the examination of both lake hydroecological conditions (30-year intervals; diatoms) and sedimentological changes in the watershed (12-year intervals; grain size records) over the late Holocene. Time series analysis of key lake ecological indicators (diatom species Aulacoseira alpigena, Pseudostaurosira brevistriata and Achnanthidium minutissimum) and sedimentological parameters, reflective of catchment processes (coarse silt fraction), suggests significant intermittent variations in turbidity, pH and light penetration within the lake basin. In the diatom record, we observed discontinuous periodicities in the range of ca. 69, 88-100, 115-132, 141-188, 562, 750 and 900 years (>90% and >95% confidence intervals), whereas the coarse silt fraction was characterized by periodicities in the >901 and <61-year range (>95% confidence interval). Periodicities in the proxy data from the Danny's Lake sediment core align with changes in total solar irradiance over the past ca. 3300 yr BP and we hypothesize a link to the Suess Cycle, Gleissberg Cycle and Pacific Decadal Oscillation via occasional inland propagation of shifting air masses over the Pacific Ocean. This research represents an important baseline study of the underlying causes of climate variability in the Canadian Subarctic and provides details on the long-term climate variability that has persisted in this region through the past three thousand years.	[Dalton, April S.; Patterson, Timothy; Macomber, Andrew L.] Carleton Univ, Ottawa Carleton Geosci Ctr, Ottawa, ON, Canada; [Dalton, April S.; Patterson, Timothy; Macomber, Andrew L.] Carleton Univ, Dept Earth Sci, Ottawa, ON, Canada; [Dalton, April S.] Univ Toronto, Dept Earth Sci, Toronto, ON, Canada; [Roe, Helen M.; Macomber, Andrew L.] Queens Univ Belfast, Sch Nat & Built Environm, Belfast, Antrim, North Ireland; [Swindles, Graeme T.] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England; [Galloway, Jennifer M.] Commiss Geol Canada, Geol Survey Canada, Calgary, AB, Canada; [Galloway, Jennifer M.] Commiss Geol Canada, Geol Survey Canada, Nat Resources Canada, Ressources Nat Canada, Calgary, AB, Canada; [Vermaire, Jesse C.] Carleton Univ, Inst Environm Sci, Ottawa, ON, Canada; [Vermaire, Jesse C.] Carleton Univ, Dept Geog & Environm Studies, Ottawa, ON, Canada; [Crann, Carley A.] Univ Ottawa, AE Lalonde AMS Lab, Ottawa, ON, Canada; [Falck, Hendrik] Northwest Territories Geol Survey, Yellowknife, NT, Canada	Carleton University; University of Ottawa; Carleton University; University of Toronto; Queens University Belfast; University of Leeds; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; Carleton University; Carleton University; University of Ottawa	Dalton, AS (corresponding author), Carleton Univ, Ottawa Carleton Geosci Ctr, Ottawa, ON, Canada.; Dalton, AS (corresponding author), Carleton Univ, Dept Earth Sci, Ottawa, ON, Canada.; Dalton, AS (corresponding author), Univ Toronto, Dept Earth Sci, Toronto, ON, Canada.	aprils.dalton@mail.utoronto.ca	Swindles, Graeme/AAU-4321-2020	Swindles, Graeme/0000-0001-8039-1790; galloway, jennifer/0000-0002-4548-6396; Dalton, April Sue/0000-0002-0725-1385; Vermaire, Jesse/0000-0002-9921-6148	Natural Sciences and Engineering Research Council of Canada (NSERC) [STPGP 381471-09]; Geological Survey of Canada; Northwest Territories Geological Survey; North Slave Metis Alliance; Tibbitt to Contwoyto Winter Road Joint Venture; Polar Continental Shelf Program; Northern Scientific Training Program; Northwest Territories Cumulative Impact Monitoring Program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Geological Survey of Canada(Natural Resources Canada); Northwest Territories Geological Survey; North Slave Metis Alliance; Tibbitt to Contwoyto Winter Road Joint Venture; Polar Continental Shelf Program; Northern Scientific Training Program; Northwest Territories Cumulative Impact Monitoring Program	Financial and in-kind support for this research project was provided by a Natural Sciences and Engineering Research Council of Canada (NSERC) strategic project grant to RTP (#STPGP 381471-09), along with contributions and support from the Geological Survey of Canada, the Northwest Territories Geological Survey, the North Slave Metis Alliance, and the Tibbitt to Contwoyto Winter Road Joint Venture. We also acknowledge the support of the Polar Continental Shelf Program and Northern Scientific Training Program, as well as a grant provided by the Northwest Territories Cumulative Impact Monitoring Program to JMG and HF. http://www.nserc-crsng.gc.ca/index_eng.asp. http://www.nrcan.gc.ca/earth-sciences/science/geology/gsc/17100. http://www.nwtgeoscience.ca. http://www.nsma.net. http://www.jvtcwinterroad.ca/. http://www.nrcan.gc.ca/the-north/polar-continental-shelf-program/polar-shelf/10003. http://www.polarcom.gc.ca/eng/content/northern-scientific-training-program. http://www.enr.gov.nt.ca/en/services/cumulative-impact-monitoring-program-nwt-cimp.	Abbott MB, 1996, QUATERNARY RES, V45, P300, DOI 10.1006/qres.1996.0031; Academy of Natural Sciences and collaborators, 2011, ANSP NAWQA EPA 2011; Aitchison J, 1986, STAT ANAL COMPOSITIO; [Anonymous], BACILLARIOPHYCEAE SU; Babalola LO, 2013, J FORAMIN RES, V43, P127, DOI 10.2113/gsjfr.43.2.127; Bennett KD, 1996, NEW PHYTOL, V132, P155, DOI 10.1111/j.1469-8137.1996.tb04521.x; Berglund BE, 1986, HDB HOLOCENE PALEOEC, P527; Blaauw M., 2013, BACON MANUAL, V2; Blaauw M, 2011, BAYESIAN ANAL, V6, P457, DOI 10.1214/ba/1339616472; Crann CA, 2015, QUAT GEOCHRONOL, V27, P131, DOI 10.1016/j.quageo.2015.02.001; Dearing J., 1999, ENV MAGNETIC SUSCEPT; DeNicola DM, 2000, HYDROBIOLOGIA, V433, P111, DOI 10.1023/A:1004066620172; Deser C, 2010, ANNU REV MAR SCI, V2, P115, DOI 10.1146/annurev-marine-120408-151453; Douglas M. S. V., 2010, The diatoms: applications for the environmental and earth sciences, P249; Dyke AS, 2004, DEV QUA SCI, V2, P373, DOI 10.1016/S1571-0866(04)80209-4; ENGSTROM DR, 1987, CAN J FISH AQUAT SCI, V44, P1306, DOI 10.1139/f87-154; FEYNMAN J, 1984, J GEOPHYS RES-SPACE, V89, P3023, DOI 10.1029/JA089iA05p03023; Galloway JM, 2013, PALAEOGEOGR PALAEOCL, V386, P669, DOI 10.1016/j.palaeo.2013.06.031; Galloway JM, 2010, PALEOCLIMATOLOGICAL; Garcia A, 1998, SOL PHYS, V180, P495, DOI 10.1023/A:1005018712900; Gleissberg W., 1958, J BR ASTRON ASS, V68, P1148; Gleissberg W, 1939, OBS, V62, P158; Gouhier T., 2014, BIWAVELET CONDUCT UN; Gray LJ, 2010, REV GEOPHYS, V48, DOI 10.1029/2009RG000282; Griffith F., 2013, THESIS; GRIMM EC, 1987, COMPUT GEOSCI, V13, P13, DOI 10.1016/0098-3004(87)90022-7; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Huang CC, 2004, PALAEOGEOGR PALAEOCL, V205, P221, DOI 10.1016/j.palaeo.2003.12.009; Janelle DG, 1992, GEOGRAPHICAL SNAPSHO, P34; Jones VJ, 2004, J PALEOLIMNOL, V31, P445, DOI 10.1023/B:JOPL.0000022544.35526.11; Juggins S., 2015, RIOJA ANAL QUATERNAR; Juggins S., 2003, C2 SOFTWARE ECOLOGIC; Kaufman DS, 2004, QUATERNARY SCI REV, V23, P529, DOI 10.1016/j.quascirev.2003.09.007; Klein WH., 1949, MONTHLY WEATHER REV, V77, P99; Larsen JN, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1567; Lotter AF, 2000, AQUAT SCI, V62, P125, DOI 10.1007/s000270050002; Macumber AL, 2010, CLIMATOLOGICAL ASSES; Macumber AL, 2018, HOLOCENE, V28, P845, DOI 10.1177/0959683617752836; Macumber AL, 2011, J PALEOLIMNOL, V45, P307, DOI 10.1007/s10933-010-9487-4; McCabe GJ, 2004, P NATL ACAD SCI USA, V101, P4136, DOI 10.1073/pnas.0306738101; Miller GH, 2010, QUATERNARY SCI REV, V29, P1679, DOI 10.1016/j.quascirev.2010.03.001; Minobe S, 2000, PROG OCEANOGR, V47, P381, DOI 10.1016/S0079-6611(00)00042-2; Murray MR, 2002, J PALEOLIMNOL, V27, P173, DOI 10.1023/A:1014281412035; Natural Resources Canada, 2014, CLIM EST 1971 2000 3; Ogurtsov MG, 2002, SOL PHYS, V211, P371, DOI 10.1023/A:1022411209257; Parisien MA, 2003, CAN J FOREST RES, V33, P243, DOI [10.1139/x02-182, 10.1139/X02-182]; Patterson RT, 2007, MAR GEOL, V242, P123, DOI 10.1016/j.margeo.2007.04.003; Patterson RT, 2017, PALAEOGEOGR PALAEOCL, V477, P1, DOI 10.1016/j.palaeo.2017.03.031; Patterson RT, 2013, QUATERN INT, V310, P124, DOI 10.1016/j.quaint.2013.02.001; Patterson RT, 2011, QUATERN INT, V235, P13, DOI 10.1016/j.quaint.2010.06.016; PATTERSON RT, 1989, J PALEONTOL, V63, P245, DOI 10.1017/S0022336000019272; Patterson RT, 2004, SEDIMENT GEOL, V172, P67, DOI 10.1016/j.sedgeo.2004.07.007; Paul CA, 2010, PALAEOGEOGR PALAEOCL, V291, P205, DOI 10.1016/j.palaeo.2010.02.030; PETERSON CG, 1992, ECOLOGY, V73, P1445, DOI 10.2307/1940689; Pisaric MFJ, 2009, ARCT ANTARCT ALP RES, V41, P486, DOI 10.1657/1938-4246-41.4.486; Potapova M, 2007, J PHYCOL, V43, P561, DOI 10.1111/j.1529-8817.2007.00332.x; Prokoph A, 2004, ATMOS OCEAN, V42, P201, DOI 10.3137/ao.420304; R Core Team, 2021, R LANGUAGE ENV STAT; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Reyes AV, 2006, GEOLOGY, V34, P57, DOI 10.1130/G21902.1; Rodrigo-Gamiz M, 2014, QUATERNARY RES, V81, P78, DOI 10.1016/j.yqres.2013.10.009; Rosen P, 2000, J PALEOLIMNOL, V24, P109, DOI 10.1023/A:1008128014721; Ruhland K, 2003, ARCT ANTARCT ALP RES, V35, P110, DOI 10.1657/1523-0430(2003)035[0110:PEFDFR]2.0.CO;2; Ruhland K, 2005, PALAEOGEOGR PALAEOCL, V226, P1, DOI 10.1016/j.palaeo.2005.05.001; Ruhland K, 2008, GLOBAL CHANGE BIOL, V14, P2740, DOI 10.1111/j.1365-2486.2008.01670.x; RYDER JM, 1986, CAN J EARTH SCI, V23, P273, DOI 10.1139/e86-031; Saros JE, 2015, BIOL REV, V90, P522, DOI 10.1111/brv.12120; Schmidt Roland, 2004, Journal of Limnology, V63, P171; Schulz M, 2002, COMPUT GEOSCI-UK, V28, P421, DOI 10.1016/S0098-3004(01)00044-9; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shannon CE, 1948, BELL SYST TECH J, V27, P379; Shen CM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024804; Shinneman ALC, 2016, J PALEOLIMNOL, V56, P275, DOI 10.1007/s10933-016-9911-5; Smol J.P., 1988, VERH INT VEREIN LIMN, V23, P837, DOI [DOI 10.1080/03680770.1987.11899722, 10.1080/03680770.1987.11899722]; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; SMOL JP, 1985, HYDROBIOLOGIA, V123, P199, DOI 10.1007/BF00034378; Sorvari S, 1998, J PALEOLIMNOL, V20, P205, DOI 10.1023/A:1007953515620; Steinhilber F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040142; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Sulphur KC, 2016, GLOBAL PLANET CHANGE, V145, P42, DOI 10.1016/j.gloplacha.2016.08.003; Swindles GT, 2012, QUATERNARY SCI REV, V41, P94, DOI 10.1016/j.quascirev.2012.03.003; Thienpont JR, 2015, J BIOGEOGR, V42, P1553, DOI 10.1111/jbi.12519; Upiter LM, 2014, J PALEOLIMNOL, V52, P11, DOI 10.1007/s10933-014-9775-5; van Hengstum PJ, 2007, J PALEOLIMNOL, V37, P603, DOI 10.1007/s10933-006-9057-y; Viau AE, 2009, J CLIMATE, V22, P316, DOI 10.1175/2008JCLI2342.1; Wang Q, 2014, QUATERNARY SCI REV, V86, P1, DOI 10.1016/j.quascirev.2013.12.024; Wolf R., 1862, ASTRONOMISCHE MITTEI, V14, P1862; Wolfe AP, 2002, GEOLOGY, V30, P215, DOI 10.1130/0091-7613(2002)030<0215:CMTAOA>2.0.CO;2; Woo M, 2008, COLD REGION ATMOSPHE, V2, P497; Xu DK, 2014, SCI REP-UK, V4, DOI 10.1038/srep03611; Yu SY, 2007, RADIOCARBON, V49, P1241, DOI 10.1017/S0033822200043150	92	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199872	10.1371/journal.pone.0199872	http://dx.doi.org/10.1371/journal.pone.0199872			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953559	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000436645400084
J	Holland, J; Pan, QX; Grigoryan, G				Holland, Jack; Pan, Qinxin; Grigoryan, Gevorg			Contact prediction is hardest for the most informative contacts, but improves with the incorporation of contact potentials	PLOS ONE			English	Article							PROTEIN STRUCTURES; RESIDUE CONTACTS; SEQUENCE; COEVOLUTION; ACCURATE; MUTATIONS; ENERGIES	Co-evolution between pairs of residues in a multiple sequence alignment (MSA) of homologous proteins has long been proposed as an indicator of structural contacts. Recently, several methods, such as direct-coupling analysis (DCA) and MetaPSICOV, have been shown to achieve impressive rates of contact prediction by taking advantage of considerable sequence data. In this paper, we show that prediction success rates are highly sensitive to the structural definition of a contact, with more permissive definitions (i.e., those classifying more pairs as true contacts) naturally leading to higher positive predictive rates, but at the expense of the amount of structural information contributed by each contact. Thus, the remaining limitations of contact prediction algorithms are most noticeable in conjunction with geometrically restrictive contacts D precisely those that contribute more information in structure prediction. We suggest that to improve prediction rates for such "informative" contacts one could combine co-evolution scores with additional indicators of contact likelihood. Specifically, we find that when a pair of co-varying positions in an MSA is occupied by residue pairs with favorable statistical contact energies, that pair is more likely to represent a true contact. We show that combining a contact potential metric with DCA or MetaPSICOV performs considerably better than DCA or MetaPSICOV alone, respectively. This is true regardless of contact definition, but especially true for stricter and more informative contact definitions. In summary, this work outlines some remaining challenges to be addressed in contact prediction and proposes and validates a promising direction towards improvement.	[Holland, Jack; Pan, Qinxin; Grigoryan, Gevorg] Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA; [Grigoryan, Gevorg] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Grigoryan, G (corresponding author), Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA.; Grigoryan, G (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	gevorg.grigoryan@dartmouth.edu		Holland, Jack/0000-0001-6682-0659	National Institutes of Health [P20-GM113132]; National Science Foundation [DMR1534246]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health award P20-GM113132 and the National Science Foundation award DMR1534246 to GG.; This work was supported by the National Institutes of Health award P20-GM113132 (GG) and the National Science Foundation award DMR1534246 (GG).	Baker D., 2016, ROSETTA DECOY DATASE, DOI [10.5281/zenodo.48780, DOI 10.5281/ZENODO.48780]; Balakrishnan S, 2011, PROTEINS, V79, P1061, DOI 10.1002/prot.22934; Buchan DW, 2017, PROTEINS STRUCTURE F; dos Santos RN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13652; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Gao X, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-28; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; He BJ, 2017, BIOINFORMATICS, V33, P2296, DOI 10.1093/bioinformatics/btx164; Hoque MT, 2016, J COMPUT CHEM, V37, P1119, DOI 10.1002/jcc.24298; Jernigan RL, 1996, CURR OPIN STRUC BIOL, V6, P195, DOI 10.1016/S0959-440X(96)80075-3; Jones DT, 2015, BIOINFORMATICS, V31, P999, DOI 10.1093/bioinformatics/btu791; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kajan L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-85; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Kim DE, 2014, PROTEINS, V82, P208, DOI 10.1002/prot.24374; Lapedes A.S., 1999, LECT NOTES MONOGR SE, V33, P236, DOI [10.1214/lnms/1215455556, DOI 10.1214/LNMS/1215455556]; Liu Y, 2017, CELL SYSTEMS; Liu YF, 2012, BIOPHYS J, V103, P1950, DOI 10.1016/j.bpj.2012.09.023; Lu MY, 2008, J MOL BIOL, V376, P288, DOI 10.1016/j.jmb.2007.11.033; Mackenzie CO, 2016, P NATL ACAD SCI USA, V113, pE7438, DOI 10.1073/pnas.1607178113; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Mirzaie M, 2014, PROTEINS, V82, P415, DOI 10.1002/prot.24407; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Morcos F, 2014, P NATL ACAD SCI USA, V111, P12408, DOI 10.1073/pnas.1413575111; Morcos F, 2013, P NATL ACAD SCI USA, V110, P20533, DOI 10.1073/pnas.1315625110; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Olmea O, 1997, FOLD DES, V2, pS25, DOI 10.1016/S1359-0278(97)00060-6; Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208; Olson MA, 2013, PROTEINS, V81, P469, DOI 10.1002/prot.24204; Ovchinnikov S, 2016, PROTEINS, V84, P67, DOI 10.1002/prot.24974; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Pokarowski P, 2005, PROTEINS, V59, P49, DOI 10.1002/prot.20380; Pollock DD, 1997, PROTEIN ENG, V10, P647, DOI 10.1093/protein/10.6.647; Ruiz-Blanco YB, 2014, CHEM PHYS LETT, V610, P135, DOI 10.1016/j.cplett.2014.07.014; Seemayer S, 2014, BIOINFORMATICS, V30, P3128, DOI 10.1093/bioinformatics/btu500; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Simons KT, 1999, PROTEINS, V34, P82, DOI 10.1002/(SICI)1097-0134(19990101)34:1<82::AID-PROT7>3.0.CO;2-A; SIPPL MJ, 1995, CURR OPIN STRUC BIOL, V5, P229, DOI 10.1016/0959-440X(95)80081-6; Skolnick J, 2006, CURR OPIN STRUC BIOL, V16, P166, DOI 10.1016/j.sbi.2006.02.004; Stahl K, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1713-x; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P10340, DOI 10.1073/pnas.1207864109; TAYLOR WR, 1994, PROTEIN ENG, V7, P341, DOI 10.1093/protein/7.3.341; Vendruscolo M, 1998, J CHEM PHYS, V109, P11101, DOI 10.1063/1.477748; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang S, 2016, ACCURATE NOVO PREDIC; Zhang C, 2000, P NATL ACAD SCI USA, V97, P2550, DOI 10.1073/pnas.040573597; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015386; Zheng F, 2015, STRUCTURE, V23, P961, DOI 10.1016/j.str.2015.03.015; Zhou HY, 2011, BIOPHYS J, V101, P2043, DOI 10.1016/j.bpj.2011.09.012; Zhou JH, 2014, PROTEINS, V82, P556, DOI 10.1002/prot.24421	53	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199585	10.1371/journal.pone.0199585	http://dx.doi.org/10.1371/journal.pone.0199585			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953468	Green Submitted, Green Published, gold			2022-12-26	WOS:000436645400044
J	Kadariya, S; Aro, AR				Kadariya, Shanti; Aro, Arja R.			Barriers and facilitators to physical activity among urban residents with diabetes in Nepal	PLOS ONE			English	Article							SELF-MANAGEMENT; EXERCISE; ADULTS; PEOPLE; DIET; INDIVIDUALS; DIAGNOSIS; WOMEN; TIME; RISK	Introduction Physical activity is an important component of type 2 diabetes management. Physical activity level among general population in Nepal is reported to vary considerably. However, knowledge on physical activity in Nepali diabetics is very limited. Engagement in physical activity could be influenced by perception of barriers against adopting the behavior and benefits of adopting it. This study explores the prevalence of physical activity and factors that promote and hinder the behavior among urban residing diabetic patients from Nepal. Methods A descriptive cross-sectional design was adopted using a simple random sampling of type 2 diabetic patients from two diabetes clinics at Lalitpur and Kaski districts of Nepal. Two hundred and seventy participants were surveyed to obtain information on physical activity using Global Physical Activity Questionnaire. Metabolic equivalent values were calculated and categorized into high, moderate and low levels of physical activity. The information on perceived facilitators and barriers was collected by Exercise Barriers and Benefits Survey scale. Odds ratios and 95% confidence intervals of the measures were estimated using multinomial logistic regression. Results The study showed relatively high prevalence of physical activity among the urban Nepali diabetic patients; 52% were moderately active and 28% highly active. Travel and work-related activities were the major contributors. Male participants, educated and those living in extended families were more motivated for physical activity than their counterparts. Physical fitness, strength and flexibility, better sleep at night, social interaction and longevity, were identified as the major facilitators. Family responsibilities, busy schedule and family discouragement were identified as barriers against being physically active. Conclusion The diabetic patients were mostly moderately physically active. Future research could explore different context-specific ways of remaining physically active, apart from walking and doing household chores. More focus should also be placed on leisure time physical activity as it was found to be low. Interventions could be designed by promoting the facilitators and addressing the barriers of physical activity, which is likely to reduce the healthcare costs of management of diabetic complications.	[Kadariya, Shanti; Aro, Arja R.] Univ Southern Denmark, Unit Hlth Promot Res, Esbjerg, Denmark	University of Southern Denmark	Kadariya, S (corresponding author), Univ Southern Denmark, Unit Hlth Promot Res, Esbjerg, Denmark.	shantikadariya@gmail.com			PhD School at the University of Southern Denmark [15151]	PhD School at the University of Southern Denmark	This research was conducted as thesis project for the partial fulfilment of Master of Science in Public Health of SK. She was funded for this research through the undergraduate research fund (funding reference ID 15151) by the PhD School at the University of Southern Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kaabi Juma, 2009, Rev Diabet Stud, V6, P271, DOI 10.1900/RDS.2009.6.271; Allender S, 2006, HEALTH EDUC RES, V21, P826, DOI 10.1093/her/cyl063; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Aryal K, NONCOMMUNICABLE DIS; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Casey D, 2010, DIABETIC MED, V27, P79, DOI 10.1111/j.1464-5491.2009.02873.x; Chlebowy DO, 2010, DIABETES EDUCATOR, V36, P897, DOI 10.1177/0145721710385579; Creative Research Systems, 2016, SAMPL SIZ FORM 2016; Donahue Katrina E, 2006, Prev Chronic Dis, V3, pA119; Duclos Martine, 2011, Diabetes Care, V34, pe122, DOI 10.2337/dc11-0140; Fattahi A, 2014, IRANIAN J DIABETES O, V6; Ferrand C, 2008, HEALTH SOC CARE COMM, V16, P511, DOI 10.1111/j.1365-2524.2008.00773.x; Fritschi C, 2010, J PSYCHOSOM RES, V69, P33, DOI 10.1016/j.jpsychores.2010.01.021; Ghimire S., 2017, INT SCHOLARLY RES NO, V2017, P9, DOI 10.1155/2017/1273084; Halali F, 2016, HEALTH SOC CARE COMM, V24, pE92, DOI 10.1111/hsc.12263; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x; International Diabetes Federation (IDF), 2017, IDF DIABETES ATLAS; Jepson R., 2008, PHYS ACTIVITY BLACK; King KM, 2006, CAN J NURS RES, V38, P17; Kredlow MA, 2015, J BEHAV MED, V38, P427, DOI 10.1007/s10865-015-9617-6; Lawton J, 2006, HEALTH EDUC RES, V21, P43, DOI 10.1093/her/cyh042; Lidegaard LP, 2016, DIABETIC MED, V33, P1677, DOI 10.1111/dme.13167; Macniven R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-41; Mier Nelda, 2007, Prev Chronic Dis, V4, pA24; Nelson KM, 2002, DIABETES CARE, V25, P1722, DOI 10.2337/diacare.25.10.1722; Nepal Diabetes Association, 2016, PREV DIAB PEOPL 20 Y; Pai Lee-Wen, 2012, JBI Libr Syst Rev, V10, P1; PANTERBRICK C, 1993, HUM REPROD, V8, P684, DOI 10.1093/oxfordjournals.humrep.a138120; PANTERBRICK C, 1992, EUR J APPL PHYSIOL O, V64, P477, DOI 10.1007/BF00625071; Paparrigopoulos T, 2010, INT J CARDIOL, V143, P209, DOI 10.1016/j.ijcard.2008.11.178; Parajuli Janaki, 2014, BMC Res Notes, V7, P758, DOI 10.1186/1756-0500-7-758; Patel M, 2012, J HEALTH POPUL NUTR, V30, P447; Penn L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-235; Plotnikoff RC, 2007, DIABETES RES CLIN PR, V78, P115, DOI 10.1016/j.diabres.2007.02.016; Ranasinghe D Chathuranga, 2014, Int Arch Med, V7, P15, DOI 10.1186/1755-7682-7-15; Rhodes P, 2003, HEALTH SOC CARE COMM, V11, P45, DOI 10.1046/j.1365-2524.2003.00398.x; Schneider KL, 2014, MED SCI SPORT EXER, V46, P84, DOI 10.1249/MSS.0b013e3182a33010; SECHRIST KR, 1987, RES NURS HEALTH, V10, P357, DOI 10.1002/nur.4770100603; Sigal RJ, 2010, DIABETES CARE, V33, P147, DOI DOI 10.2337/DC10-9990; Sluik D, 2012, ARCH INTERN MED, V172, P1285, DOI 10.1001/archinternmed.2012.3130; Sohal T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136202; Song M, 2010, INT J OLDER PEOPLE N, V5, P211, DOI 10.1111/j.1748-3743.2009.00189.x; Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Vaidya A, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-39; WHO, 2014, NCD COUNTR PROF; World Health Organization, 2016, PHYS ACT FACTSH; World Health Organization, GLOB PHYS ACT QUEST; World Health Organization, 2016, DIAB FACTSH; WORLD HEALTH ORGANIZATION (WHO), GLOB STRAT DIET PHYS; Zoladz JA, 2010, J PHYSIOL PHARMACOL, V61, P533; Zuo H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-247	54	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199329	10.1371/journal.pone.0199329	http://dx.doi.org/10.1371/journal.pone.0199329			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL0GK	29953475	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400025
J	Liu, J; Gao, MX; Liu, JW; Guo, YX; Liu, D; Zhu, XY; Wu, DH				Liu, Jie; Gao, Meixiang; Liu, Jinwen; Guo, Yuxi; Liu, Dong; Zhu, Xinyu; Wu, Donghui			Spatial distribution patterns of soil mite communities and their relationships with edaphic factors in a 30-year tillage cornfield in northeast China	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; EARTHWORM COMMUNITY; BIOTIC INTERACTIONS; HETEROGENEITY; SCALE; FOREST; ECOLOGY; TRAITS	Spatial distribution is an important topic in community ecology and a key to understanding the structure and dynamics of populations and communities. However, the available information related to the spatial patterns of soil mite communities in long-term tillage agroecosystems remains insufficient. In this study, we examined the spatial patterns of soil mite communities to explain the spatial relationships between soil mite communities and soil parameters. Soil fauna were sampled three times (August, September and October 2015) at 121 locations arranged regularly within a 400 m x 400 m monitoring plot. Additionally, we estimated the physical and chemical parameters of the same sampling locations. The distribution patterns of the soil mite community and the edaphic parameters were analyzed using a range of geostatistical tools. Moran's I coefficient showed that, during each sampling period, the total abundance of the soil mite communities and the abundance of the dominant mite populations were spatially autocorrelated. The soil mite communities demonstrated clear patchy distribution patterns within the study plot. These patterns were sampling period-specific. Cross-semivariograms showed both negative and positive cross-correlations between soil mite communities and environmental factors. Mantel tests showed a significant and positive relationship between soil mite community and soil organic matter and soil pH only in August. This study demonstrated that in the cornfield, the soil mite distribution exhibited strong or moderate spatial dependence, and the mites formed patches with sizes less than one hundred meters. In addition, in this long-term tillage agroecosystem, soil factors had less influence on the observed pattern of soil mite communities. Further experiments that take into account human activity and spatial factors should be performed to study the factors that drive the spatial distribution of soil microarthropods.	[Liu, Jie; Liu, Jinwen; Guo, Yuxi; Wu, Donghui] Jilin Univ, Coll Earth Sci, Changchun, Jilin, Peoples R China; [Liu, Jie; Liu, Jinwen; Guo, Yuxi; Liu, Dong; Wu, Donghui] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Jilin, Peoples R China; [Gao, Meixiang] Harbin Normal Univ, Coll Geog Sci, Harbin, Heilongjiang, Peoples R China; [Liu, Jinwen] Jilin Acad Agr Sci, Changchun, Jilin, Peoples R China; [Zhu, Xinyu] Shangqiu Normal Univ, Coll Environm & Planning, Shangqiu, Peoples R China; [Wu, Donghui] Northeast Normal Univ, Sch Environm, Changchun, Jilin, Peoples R China; [Wu, Donghui] Northeast Normal Univ, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin, Peoples R China; [Wu, Donghui] Northeast Normal Univ, Jilin Prov Key Lab Anim Resource Conservat & Util, Changchun, Jilin, Peoples R China	Jilin University; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Harbin Normal University; Jilin Academy of Agricultural Sciences; Shangqiu Normal University; Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China	Wu, DH (corresponding author), Jilin Univ, Coll Earth Sci, Changchun, Jilin, Peoples R China.; Wu, DH (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Jilin, Peoples R China.; Gao, MX (corresponding author), Harbin Normal Univ, Coll Geog Sci, Harbin, Heilongjiang, Peoples R China.; Wu, DH (corresponding author), Northeast Normal Univ, Sch Environm, Changchun, Jilin, Peoples R China.; Wu, DH (corresponding author), Northeast Normal Univ, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin, Peoples R China.; Wu, DH (corresponding author), Northeast Normal Univ, Jilin Prov Key Lab Anim Resource Conservat & Util, Changchun, Jilin, Peoples R China.	gmx102@hotmail.com; wudonghui@iga.ac.cn		LIU, Jie/0000-0003-2137-1815	Key Program of National Natural Science of China [41430857]; National Natural Science Foundation of China [41501263]	Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Key Program of National Natural Science of China (41430857) to Donghui Wu and the National Natural Science Foundation of China (41501263) to Xinyu Zhu.	Astrom J, 2011, OECOLOGIA, V167, P747, DOI 10.1007/s00442-011-2024-y; Behan-Pelletier VM, 1999, AGR ECOSYST ENVIRON, V74, P411, DOI 10.1016/S0167-8809(99)00046-8; Benedito-Cecilio Evanilde, 2000, Acta Scientiarum, V22, P429; Birkhofer K, 2006, ECOGRAPHY, V29, P641, DOI 10.1111/j.0906-7590.2006.04661.x; Bonari G, 2016, ARTHROPOD-PLANT INTE, V11, P1; Boulangeat I, 2012, ECOL LETT, V15, P584, DOI 10.1111/j.1461-0248.2012.01772.x; Caruso T, 2012, J ANIM ECOL, V81, P214, DOI 10.1111/j.1365-2656.2011.01886.x; Condit R., 1998, TROPICAL FOREST CENS, P1; Crist TO, 1998, OECOLOGIA, V114, P410, DOI 10.1007/s004420050464; da Silva PM, 2012, LANDSCAPE ECOL, V27, P1337, DOI 10.1007/s10980-012-9788-2; Dallmeier F., 1992, LONG TERM MONITORING; Decaens T, 2001, ECOGRAPHY, V24, P671, DOI 10.1034/j.1600-0587.2001.240606.x; Dong CX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176828; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Gan H., 2013, ORIBATID MITE COMMUN; Gao M, 2016, ACTA ECOLOGICA SINIC, V36, P1; Gao MX, 2014, SOIL BIOL BIOCHEM, V79, P68, DOI 10.1016/j.soilbio.2014.09.003; Gist C, 1973, ECOLOGY, V54, P714; Gutierrez-Lopez M, 2010, PEDOBIOLOGIA, V53, P381, DOI 10.1016/j.pedobi.2010.07.003; Hasegawa M, 2001, EUR J SOIL BIOL, V37, P281, DOI 10.1016/S1164-5563(01)01099-8; Hassall M, 2002, EUR J SOIL BIOL, V38, P53, DOI 10.1016/S1164-5563(01)01124-4; Hernandez P, 2007, PEDOBIOLOGIA, V51, P13, DOI 10.1016/j.pedobi.2006.11.002; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; Hubert N, 2015, ECOL LETT, V18, P864, DOI 10.1111/ele.12458; Ingimarsdottir M, 2012, OECOLOGIA, V170, P745, DOI 10.1007/s00442-012-2334-8; Jimenez JJ, 2006, EUR J SOIL BIOL, V42, pS218, DOI 10.1016/j.ejsobi.2006.07.032; Jimenez JJ, 2012, OIKOS, V121, P915, DOI 10.1111/j.1600-0706.2012.20428.x; Jung WK, 2006, SOIL SCI SOC AM J, V70, P1387, DOI 10.2136/sssaj2005.0273; Kaneko N., 1995, Acta Zoologica Fennica, V196, P160; Krantz GW, 1978, MANUAL ACAROLOGY ORE; Kravchenko AN, 2003, SOIL SCI SOC AM J, V67, P1564, DOI 10.2136/sssaj2003.1564; Lavelle P, 2000, SOIL ECOLOGY, P1; Liang AZ, 2014, SCI WORLD J, DOI 10.1155/2014/514183; Lindo Z, 2008, ECOGRAPHY, V31, P53, DOI 10.1111/j.2007.0906-7590.05320.x; MANTEL N, 1967, CANCER RES, V27, P209; Margerie P, 2001, EUR J SOIL BIOL, V37, P291, DOI 10.1016/S1164-5563(01)01100-1; Moreira FMS, 2008, SOIL SCI SOC AM J, V76, P373; Mueller TG, 2004, SOIL SCI SOC AM J, V68, P2042, DOI 10.2136/sssaj2004.2042; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Noda T, 2004, POPUL ECOL, V46, P105, DOI 10.1007/s10144-004-0184-x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Pansu M., 2006, INT J CANCER, V115, P36; Proches S, 2010, ECOGRAPHY, V33, P128, DOI 10.1111/j.1600-0587.2009.06035.x; Rhodes EM, 2011, ENVIRON ENTOMOL, V40, P893, DOI 10.1603/EN10312; ROBERTSON GP, 1987, ECOLOGY, V68, P744, DOI 10.2307/1938482; ROBERTSON GP, 1995, ECOLOGY, V76, P1425, DOI 10.2307/1938145; Rossi JP, 1995, EUR J SOIL BIOL, V31, P173; Rossi JP, 2003, PEDOBIOLOGIA, V47, P497, DOI 10.1016/S0031-4056(04)70228-0; Rossi JP, 2003, PEDOBIOLOGIA, V47, P490, DOI 10.1078/0031-4056-00218; Rossi RE, 1992, ECOL MONOGR, V62, P217; Rteam R, 2014, COMPUTING, V14, P12; Silbernagel J., 2002, ECOLOGICAL INDICATOR, V2, P271; Staff S.S., 2010, KEYS SOIL TAXONOMY; Stoyan H, 2000, PLANT SOIL, V222, P203, DOI 10.1023/A:1004757405147; Thiele-Bruhn S, 2012, CURR OPIN ENV SUST, V4, P523, DOI 10.1016/j.cosust.2012.06.004; Wall DH, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P1; Walter DE, 2003, AUSTR ENTOMOLOGIST, V30, P179; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Widenfalk LA, 2016, SOIL BIOL BIOCHEM, V103, P52, DOI 10.1016/j.soilbio.2016.08.006; Widenfalk LA, 2015, OECOLOGIA, V179, P537, DOI 10.1007/s00442-015-3345-z	61	7	8	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199093	10.1371/journal.pone.0199093	http://dx.doi.org/10.1371/journal.pone.0199093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953452	Green Submitted, Green Published, gold			2022-12-26	WOS:000436645400014
J	Mortensen, JD; Vasavada, AN; Merryweather, AS				Mortensen, Jonathan D.; Vasavada, Anita N.; Merryweather, Andrew S.			The inclusion of hyoid muscles improve moment generating capacity and dynamic simulations in musculoskeletal models of the head and neck	PLOS ONE			English	Article							CERVICAL-SPINE; IN-VIVO; STRENGTH; MOVEMENTS; ROTATION; SEGMENTS; TENSION; FLEXION; ARMS; JAW	OpenSim musculoskeletal models of the head and neck can provide information about muscle activity and the response of the head and neck to a variety of situations. Previous models report weak flexion strength, which is partially due to lacking moment generating capacity in the upper cervical spine. Previous models have also lacked realistic hyoid muscles, which have the capability to improve flexion strength and control in the upper cervical spine. Suprahyoid and infrahyoid muscles were incorporated in an OpenSim musculoskeletal model of the head and neck. This model was based on previous OpenSim models, and now includes hyoid muscles and passive elements. The moment generating capacity of the model was tested by simulating physical experiments in the OpenSim environment. The flexor and extensor muscle strengths were scaled to match static experimental results. Models with and without hyoid muscles were used to simulate experimentally captured motions, and the need for reserve actuators was evaluated. The addition of hyoid muscles greatly increased flexion strength, and the model is the first of its kind to have realistic strength values in all directions. Less reserve actuator moment was required to simulate real motions with the addition of hyoid muscles. Several additional ways of improving flexion strength were investigated. Hyoid muscles add control and strength to OpenSim musculoskeletal models of the head and neck and improve simulations of head and neck movements.	[Mortensen, Jonathan D.; Merryweather, Andrew S.] Univ Utah, Dept Mech Engn, Salt Lake City, UT USA; [Vasavada, Anita N.] Washington State Univ, Gene & Linda Voiland Sch Chem & Bioengn, Pullman, WA 99164 USA; [Vasavada, Anita N.] Washington State Univ, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA; [Vasavada, Anita N.] Washington State Univ, Washington Ctr Muscle Biol, Pullman, WA 99164 USA	Utah System of Higher Education; University of Utah; Washington State University; Washington State University; Washington State University	Mortensen, JD (corresponding author), Univ Utah, Dept Mech Engn, Salt Lake City, UT USA.	Jon.Mortensen@utah.edu			National Science Foundation [1622741]; NIOSH (NIOSH Education and Research Center) [T42/CCT810426-10]	National Science Foundation(National Science Foundation (NSF)); NIOSH (NIOSH Education and Research Center)	This research was funded in part by grants from the National Science Foundation (#1622741) and NIOSH (NIOSH Education and Research Center training grant T42/CCT810426-10 to JDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEVO B, 1991, CLIN BIOMECH, V6, P111, DOI 10.1016/0268-0033(91)90008-E; Anderst W, 2013, SPINE, V38, pE594, DOI 10.1097/BRS.0b013e31828ca5c7; Borst J, 2011, CLIN BIOMECH, V26, P343, DOI 10.1016/j.clinbiomech.2010.11.019; Brolin K, 2008, INT J CRASHWORTHINES, V13, P487, DOI 10.1080/13588260802215510; Buchanan TS, 2004, J APPL BIOMECH, V20, P367, DOI 10.1123/jab.20.4.367; BUCHANAN TS, 1995, MED ENG PHYS, V17, P529, DOI 10.1016/1350-4533(95)00005-8; Cazzola D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169329; Chancey Valeta Carol, 2003, Stapp Car Crash J, V47, P135; de Bruijn E, 2016, MULTIBODY SYST DYN, V36, P339, DOI 10.1007/s11044-015-9461-z; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Dibb AT, 2013, TRAFFIC INJ PREV, V14, pS116, DOI 10.1080/15389588.2013.806795; Feller L., 2016, P IRCOBI C MAL SPAIN; Fernandez J, 2017, RAPID PREDICTION PER, P71; Fice JB, 2014, ANN BIOMED ENG, V42, P1846, DOI 10.1007/s10439-014-1046-0; Fice JB, 2012, J BIOMECH, V45, P1098, DOI 10.1016/j.jbiomech.2012.01.016; Hannam AG, 2008, J BIOMECH, V41, P1069, DOI 10.1016/j.jbiomech.2007.12.001; Hicks JL, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029304; Iida T, 2013, TOHOKU J EXP MED, V231, P223, DOI 10.1620/tjem.231.223; Jin X, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037399; Lee S- H, 2006, ACM T GRAPHICS TOG; Millard M, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023390; MORONEY SP, 1988, J ORTHOPAED RES, V6, P713, DOI 10.1002/jor.1100060514; Nightingale RW, 2007, J BIOMECH, V40, P535, DOI 10.1016/j.jbiomech.2006.02.015; OptiTrack, 2017, BIOMECH; Osth J, 2017, J BIOMECH, V51, P49, DOI 10.1016/j.jbiomech.2016.11.066; Pearson WG, 2011, DYSPHAGIA, V26, P345, DOI 10.1007/s00455-010-9315-z; Radu AI, 2017, IOP C SERIES MAT SCI; Siegmund GP, 2007, J BIOMECH ENG-T ASME, V129, P66, DOI 10.1115/1.2401185; Suderman BL, 2017, ANN BIOMED ENG, V45, P2009, DOI 10.1007/s10439-017-1830-8; Symeonidis I, 2010, 12 MED C MED BIOL EN; Thelen DG, 2003, J BIOMECH, V36, P321, DOI 10.1016/S0021-9290(02)00432-3; Van Ee CA, 2000, TENSILE PROPERTIES H; vanEijden TMGJ, 1997, ANAT REC, V248, P464; Vasavada AN, 2001, SPINE, V26, P1904, DOI 10.1097/00007632-200109010-00018; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Zheng LY, 2012, J BIOMECH, V45, P531, DOI 10.1016/j.jbiomech.2011.11.040	36	32	33	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199912	10.1371/journal.pone.0199912	http://dx.doi.org/10.1371/journal.pone.0199912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953539	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400093
J	Sharma, D; Coridon, H; Aubry, E; Houeijeh, A; Houfflin-Debarge, V; Besson, R; Deruelle, P; Storme, L				Sharma, Dyuti; Coridon, Helene; Aubry, Estelle; Houeijeh, Ali; Houfflin-Debarge, Veronique; Besson, Remi; Deruelle, Philippe; Storme, Laurent			Vasodilator effects of dehydroepiandrosterone (DHEA) on fetal pulmonary circulation: An experimental study in pregnant sheep	PLOS ONE			English	Article							PREPUBERTAL ANESTHETIZED PIGS; BLOOD-FLOW; VASCULAR-RESISTANCE; OVINE FETUS; HYPERTENSION; SULFATE; RATS; CHANNELS; INVOLVEMENT; PREVENTS	Persistent pulmonary hypertension (PPHN) remains a severe complication of the transition to extra-uterine life with significant morbidity and mortality in the newborns. Dehydroepiandrosterone (DHEA) represents a new pharmacological agent with vascular effects, including improvement of PPHN in several animal models. We hypothesized that DHEA could decrease pulmonary vascular resistance (PVR) in the pulmonary circulation of fetal sheep. We studied the effect of intravenous infusion of DHEA in fetal lambs using chronically instrumented sheep at 128 days of gestation. PVR was computed before and after intravenous infusion of increasing doses of DHEA. We assessed pre-treatment by L-nitroarginine, an inhibitor of NO production. Blood gases and doses of DHEA were measured in both sheep and fetus before/after DHEA infusion. Intravenous infusion of DHEA had a vasodilator effect with a significant decrease in PVR (respectively -11%, -14% and -36% after infusion of 6, 12 and 24 mg DHEA, p<0.01) without damaging effects on systemic circulation or on blood gases. The inhibitory effect of pre-treatment with L-nitroarginine resulted in a significant increase in PVR. We demonstrated a potent vasodilator effect of DHEA on fetal pulmonary circulation without deleterious effects. DHEA might represent a new treatment for PPHN.	[Sharma, Dyuti; Coridon, Helene; Aubry, Estelle; Houeijeh, Ali; Houfflin-Debarge, Veronique; Besson, Remi; Deruelle, Philippe; Storme, Laurent] Univ Lille, EA Perinatal Environm & Hlth 4489, Lille, France; [Sharma, Dyuti; Aubry, Estelle; Besson, Remi] CHU Lille, Hosp Jeanne de Flandre, Dept Pediat Surg, Lille, France; [Coridon, Helene] Hosp MFME, Dept Pediat Surg, Fort De France, Martinique, France; [Houeijeh, Ali; Storme, Laurent] CHRU Lille, CHU Lille, Hosp Jeanne de Flandre, Dept Neonatol, Lille, France; [Houfflin-Debarge, Veronique; Deruelle, Philippe] CHU Lille, Dept Obstet & Gynecol, Hosp Jeanne de Flandre, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Sharma, D (corresponding author), Univ Lille, EA Perinatal Environm & Hlth 4489, Lille, France.; Sharma, D (corresponding author), CHU Lille, Hosp Jeanne de Flandre, Dept Pediat Surg, Lille, France.	dyuti.sharma@chru-lille.fr	HOUEIJEH, ali/AAP-5295-2020					ASSALI NS, 1968, CIRC RES, V22, P573, DOI 10.1161/01.RES.22.5.573; Baulieu EE, 2000, P NATL ACAD SCI USA, V97, P4279, DOI 10.1073/pnas.97.8.4279; BAULIEU ETIENNE-EMILE, 1965, RECENT PROG HORMONE RES, V21, P411; Binello E, 2003, CURR OPIN PHARMACOL, V3, P635, DOI 10.1016/j.coph.2003.07.006; Bonnet S, 2003, P NATL ACAD SCI USA, V100, P9488, DOI 10.1073/pnas.1633724100; CASSIN S, 1964, J PHYSIOL-LONDON, V171, P80, DOI 10.1113/jphysiol.1964.sp007362; Chevalier M, 2012, BIOCHEM PHARMACOL, V83, P1530, DOI 10.1016/j.bcp.2012.02.025; Copeland JL, 2002, J GERONTOL A-BIOL, V57, pB158, DOI 10.1093/gerona/57.4.B158; Damasceno DC, 2013, REPROD SCI, V20, P730, DOI 10.1177/1933719112461186; de la Roque ED, 2013, PEDIATR RES, V74, P163, DOI 10.1038/pr.2013.73; de La Roque ED, 2012, ANN ENDOCRINOL-PARIS, V73, P20, DOI 10.1016/j.ando.2011.12.005; de la Roque ED, 2010, PHARMACOL THERAPEUT, V126, P186, DOI 10.1016/j.pharmthera.2010.02.003; Debonneuil EH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-144; Deruelle P, 2003, AM J OBSTET GYNECOL, V189, P208, DOI 10.1067/mob.2003.444; DONALDSON A, 1991, CLIN ENDOCRINOL, V35, P447, DOI 10.1111/j.1365-2265.1991.tb03564.x; Dubuis E, 2007, CARDIOVASC RES, V74, P337, DOI 10.1016/j.cardiores.2007.04.002; ENHORNIN.G, 1966, ACTA PAEDIATR SCAND, V55, P441, DOI 10.1111/j.1651-2227.1966.tb15234.x; Farrukh IS, 1998, AM J PHYSIOL-LUNG C, V274, pL186, DOI 10.1152/ajplung.1998.274.2.L186; Gupte SA, 2002, J PHARMACOL EXP THER, V301, P299, DOI 10.1124/jpet.301.1.299; Hampl V, 2003, EUR RESPIR J, V21, P862, DOI 10.1183/09031936.03.00084503; Homma N, 2008, AM J PHYSIOL-LUNG C, V295, pL71, DOI 10.1152/ajplung.90251.2008; Jaillard S, 2000, EUR J CARDIO-THORAC, V18, P328, DOI 10.1016/S1010-7940(00)00514-5; KINSELLA JP, 1995, J PEDIATR-US, V126, P853, DOI 10.1016/S0022-3476(95)70197-4; Lahm T, 2014, AM J PHYSIOL-LUNG C, V307, pL7, DOI 10.1152/ajplung.00337.2013; Liu DM, 2002, J BIOL CHEM, V277, P21379, DOI 10.1074/jbc.M200491200; Liu DM, 2004, STEROIDS, V69, P279, DOI 10.1016/j.steroids.2004.02.004; Mannic T, 2015, INT J ENDOCRINOL MET, V13, DOI 10.5812/ijem.24660; Martin R.J, 2020, FANAROFF MARTINS NEO, P1218; Molinari C, 2004, J PHYSIOL-LONDON, V557, P307, DOI 10.1113/jphysiol.2004.063354; Molinari C, 2003, J PHYSIOL-LONDON, V549, P937, DOI 10.1113/jphysiol.2003.040170; Oka M, 2007, CARDIOVASC RES, V74, P377, DOI 10.1016/j.cardiores.2007.01.021; Peng W, 1999, AM J RESP CELL MOL, V20, P737, DOI 10.1165/ajrcmb.20.4.3390; Savineau JP, 2013, BIOCHEM PHARMACOL, V85, P718, DOI 10.1016/j.bcp.2012.12.004; Sharma D, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070761; Simoncini T, 2003, ENDOCRINOLOGY, V144, P3449, DOI 10.1210/en.2003-0044; Tagashira H, 2011, MENOPAUSE, V18, P1317, DOI 10.1097/gme.0b013e31821f915b; Tuder RM, 2013, CLIN CHEST MED, V34, P639, DOI 10.1016/j.ccm.2013.08.009; Tummala S, 1999, CLIN BIOCHEM, V32, P355, DOI 10.1016/S0009-9120(99)00021-1; VELVIS H, 1991, PEDIATR RES, V30, P62, DOI 10.1203/00006450-199107000-00013; Vermeulen A, 1995, ANN NY ACAD SCI, V774, P121, DOI 10.1111/j.1749-6632.1995.tb17376.x; ZIEGLER JW, 1995, AM J PHYSIOL-HEART C, V269, pH473, DOI 10.1152/ajpheart.1995.269.2.H473	41	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198778	10.1371/journal.pone.0198778	http://dx.doi.org/10.1371/journal.pone.0198778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949623	Green Published, gold, Green Submitted			2022-12-26	WOS:000436549200026
J	Suratanee, A; Plaimas, K				Suratanee, Apichat; Plaimas, Kitiporn			Network-based association analysis to infer new disease-gene relationships using large- scale protein interactions	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EPIDERMOLYSIS-BULLOSA SIMPLEX; MOTTLED PIGMENTATION; HEPATOCELLULAR-CARCINOMA; MUSCULAR-DYSTROPHY; MUTATION; ANTIGEN; EXPRESSION; SITOSTEROLEMIA; DISORDERS	Protein-protein interactions integrated with disease-gene associations represent important information for revealing protein functions under disease conditions to improve the prevention, diagnosis, and treatment of complex diseases. Although several studies have attempted to identify disease-gene associations, the number of possible disease-gene associations is very small. High-throughput technologies have been established experimentally to identify the association between genes and diseases. However, these techniques are still quite expensive, time consuming, and even difficult to perform. Thus, based on currently available data and knowledge, computational methods have served as alternatives to provide more possible associations to increase our understanding of disease mechanisms. Here, a new network-based algorithm, namely, Disease-Gene Association (DGA), was developed to calculate the association score of a query gene to a new possible set of diseases. First, a large-scale protein interaction network was constructed, and the relationship between two interacting proteins was calculated with regard to the disease relationship. Novel plausible diseasegene pairs were identified and statistically scored by our algorithm using neighboring protein information. The results yielded high performance for disease-gene prediction, with an F-measure of 0.78 and an AUC of 0.86. To identify promising candidates of disease-gene associations, the association coverage of genes and diseases were calculated and used with the association score to perform gene and disease selection. Based on gene selection, we identified promising pairs that exhibited evidence related to several important diseases, e.g., inflammation, lipid metabolism, inborn errors, xanthomatosis, cerebellar ataxia, cognitive deterioration, malignant neoplasms of the skin and malignant tumors of the cervix. Focusing on disease selection, we identified target genes that were important to blistering skin diseases and muscular dystrophy. In summary, our developed algorithm is simple, efficiently identifies disease-gene associations in the protein-protein interaction network and provides additional knowledge regarding disease-gene associations. This method can be generalized to other association studies to further advance biomedical science.	[Suratanee, Apichat] King Mongkuts Univ Technol North Bangkok, Fac Appl Sci, Dept Math, Bangkok, Thailand; [Plaimas, Kitiporn] Chulalongkorn Univ, Fac Sci, Adv Virtual & Intelligent Comp AVIC Ctr, Dept Math & Comp Sci, Bangkok, Thailand	King Mongkuts University of Technology North Bangkok; Chulalongkorn University	Suratanee, A (corresponding author), King Mongkuts Univ Technol North Bangkok, Fac Appl Sci, Dept Math, Bangkok, Thailand.; Plaimas, K (corresponding author), Chulalongkorn Univ, Fac Sci, Adv Virtual & Intelligent Comp AVIC Ctr, Dept Math & Comp Sci, Bangkok, Thailand.	apichat.s@sci.kmutnb.ac.th; kitiporn.p@chula.ac.th	Suratanee, Apichat/ABG-1636-2021; Plaimas, Kitiporn/GLV-3478-2022	Suratanee, Apichat/0000-0002-3439-6619; Plaimas, Kitiporn/0000-0002-0416-8316	King Mongkut's University of Technology North Bangkok [KMUTNB-60-GOV-031]	King Mongkut's University of Technology North Bangkok	This research was funded by King Mongkut's University of Technology North Bangkok, contract no. KMUTNB-60-GOV-031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajagbe BO, 2015, J AOAC INT, V98, P716, DOI 10.5740/jaoacint.SGEAjagbe; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Carson MB, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S2-S9; Cheng W. F., 2003, Hong Kong Medical Journal, V9, P206; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; De Pita O, 1999, ACTA DERM-VENEREOL, V79, P132; Ebrahimi-Fakhari D, 2016, BRAIN, V139, P317, DOI 10.1093/brain/awv371; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Giannelli G, 2005, INT J CANCER, V116, P579, DOI 10.1002/ijc.20847; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Hammer MB, 2013, EUR J NEUROL, V20, P486, DOI 10.1111/j.1468-1331.2012.03883.x; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harel A, 2006, J INVEST DERMATOL, V126, P1654, DOI 10.1038/sj.jid.5700296; Horiguchi Y, 2005, J INVEST DERMATOL, V125, P83, DOI 10.1111/j.0022-202X.2005.23790.x; Irvine AD, 1997, J INVEST DERMATOL, V108, P809, DOI 10.1111/1523-1747.ep12292263; Janjic V, 2012, MOL BIOSYST, V8, P2614, DOI 10.1039/c2mb25230a; Karni S, 2009, J COMPUT BIOL, V16, P181, DOI 10.1089/cmb.2008.05TT; Kato H, 1996, ANTICANCER RES, V16, P2149; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; Kim J, 2017, SCI REP-UK, V7, DOI 10.1038/srep40154; Knox SS, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-11; Larsen ISB, 2017, J BIOL CHEM, V292, P11586, DOI 10.1074/jbc.M117.794487; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Li Ge, 2013, IUBMB Life, DOI [10.1002/iub.1165, 10.1002/iub.01165]; Li Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004346; Lim W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049869; Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011; Malik P, 2011, J LIPID RES, V52, P951, DOI 10.1194/jlr.M011122; Melenotte C, 2014, J CLIN LIPIDOL, V8, P451, DOI 10.1016/j.jacl.2014.06.003; Murakami T, 2006, ANN NEUROL, V60, P597, DOI 10.1002/ana.20973; Nagai H, 2016, BRIT J DERMATOL, V174, P633, DOI 10.1111/bjd.14083; Niu DM, 2010, J INHERIT METAB DIS, V33, P437, DOI 10.1007/s10545-010-9126-2; Ozgur A, 2008, BIOINFORMATICS, V24, pI277, DOI 10.1093/bioinformatics/btn182; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Ostergaard ST, 2018, J NEUROL NEUROSUR PS, V89, P506, DOI 10.1136/jnnp-2017-317018; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Pletscher-Frankild S, 2015, METHODS, V74, P83, DOI 10.1016/j.ymeth.2014.11.020; Pontisso P, 2004, BRIT J CANCER, V90, P833, DOI 10.1038/sj.bjc.6601543; Quarta S, 2010, J PATHOL, V221, P343, DOI 10.1002/path.2708; Radivojac P, 2008, PROTEINS, V72, P1030, DOI 10.1002/prot.21989; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Schule R, 2011, SEMIN NEUROL, V31, P484, DOI 10.1055/s-0031-1299787; Schumacher T, 2017, MOLECULES, V22, DOI 10.3390/molecules22040589; Signorino G, 2018, HUM MUTAT, V39, P266, DOI 10.1002/humu.23370; Sparks S. E., 1993, GENEREVIEWS R; SUMINAMI Y, 1991, BIOCHEM BIOPH RES CO, V181, P51, DOI 10.1016/S0006-291X(05)81380-4; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Takeda A, 2002, BIOL CHEM, V383, P1231, DOI 10.1515/BC.2002.136; Teare MD, 2005, LANCET, V366, P1036, DOI 10.1016/S0140-6736(05)67382-5; Wang DN, 2018, INT J NEUROSCI, V128, P199, DOI 10.1080/00207454.2017.1380640; Yamamoto T, 2016, J DERMATOL, V43, P1340, DOI 10.1111/1346-8138.13511; Yoshida A, 2000, J Atheroscler Thromb, V7, P33; Zhang ML, 2011, AM J HUM GENET, V88, P755, DOI 10.1016/j.ajhg.2011.05.006; Zivkovic SA, 2015, NEUROBIOLOGY OF BRAIN DISORDERS: BIOLOGICAL BASIS OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, P151, DOI 10.1016/B978-0-12-398270-4.00011-2	59	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199435	10.1371/journal.pone.0199435	http://dx.doi.org/10.1371/journal.pone.0199435			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949603	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200050
J	Song, K; Guo, Y; Wang, XL; Cai, H; Zheng, WC; Li, N; Song, XK; Ao, L; Guo, Z; Zhao, WY				Song, Kai; Guo, You; Wang, Xianlong; Cai, Hao; Zheng, Weicheng; Li, Na; Song, Xuekun; Ao, Lu; Guo, Zheng; Zhao, Wenyuan			Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit	FASEB JOURNAL			English	Article						CRC; relapse risk; relative expression orderings; fluorouracil	DIFFERENTIAL EXPRESSION ANALYSIS; PERSONALIZED APPROACH; BIOMARKER DISCOVERY; DRUG-SENSITIVITY; COLON; THERAPY; RISK; IDENTIFICATION; ADENOCARCINOMA; RECURRENCE	The current study suggests that the identification of predictive signatures of fluorouracil (5-FU) response for stage II and III colorectal cancer (CRC) could be confounded by chemotherapy-irrelevant low relapse risk. Using the samples of patients with stage II and III CRC who were treated with curative surgery only, we identified a signature with which to predict chemotherapy-irrelevant relapse risk for patients after curative surgery. By applying this signature to the samples of patients with stage II and III CRC who were treated with 5-FU-based adjuvant chemotherapy (ACT) after surgery, we predicted the relapse risk if treated with surgery only. From high-risk samples, we further identified another signature with which to predict therapeutic benefit from 5-FU-based ACT. On the basis of the relative expression orderings of gene pairs, a postsurgery relapse risk signature that consisted of 44 gene pairs was developed and verified in 3 independent data sets. A 5-FU therapeutic benefit signature that consisted of 4 gene pairs was then developed to predict the response of 5-FU-based ACT for those patients with high relapse risk after curative surgery. The signature was verified in 4 independent datasets. For patients with stage II and III CRC, the coupled signatures can first identify patients with high relapse risk after curative surgery, then predict therapeutic benefit from 5-FU-based ACT.Song, K., Guo, Y., Wang, X., Cai, H., Zheng, W., Li, N., Song, X., Ao, L., Guo, Z., Zhao, W. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.	[Song, Kai; Zheng, Weicheng; Song, Xuekun; Guo, Zheng; Zhao, Wenyuan] Harbin Med Univ, Dept Syst Biol, Coll Bioinformat Sci & Technol, Harbin 150081, Heilongjiang, Peoples R China; [Guo, You] Gannan Med Univ, Affiliated Hosp 1, Ganzhou, Jiangxi, Peoples R China; [Wang, Xianlong; Cai, Hao; Zheng, Weicheng; Li, Na; Ao, Lu; Guo, Zheng] Fujian Med Univ, Dept Bioinformat, Minist Educ Gastrointestinal Canc, Key Lab, Fuzhou, Fujian, Peoples R China; [Guo, Zheng] Fujian Med Univ, Fujian Key Lab Tumor Microbiol, Fuzhou, Fujian, Peoples R China	Harbin Medical University; Gannan Medical University; Fujian Medical University; Fujian Medical University	Guo, Z; Zhao, WY (corresponding author), Harbin Med Univ, Dept Syst Biol, Coll Bioinformat Sci & Technol, Harbin 150081, Heilongjiang, Peoples R China.	guoz@ems.hrbmu.edu.cn; zhaowenyuan@ems.hrbmu.edu.cn	Wang, Xianlong/AFU-4519-2022	Wang, Xianlong/0000-0001-8195-2027; , lu/0000-0001-7378-4967	National Natural Science Foundation of China [61601151, 81572935, 21534008]; Natural Science Foundation of Heilongjiang Province [C2016037]; Joint Scientific and Technology Innovation Fund of Fujian Province [2016Y9044]; Health and Family Planning Commission of Fujian Province [2017-ZQN-56]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Joint Scientific and Technology Innovation Fund of Fujian Province; Health and Family Planning Commission of Fujian Province	This work was supported by the National Natural Science Foundation of China (Grants 61601151, 81572935, and 21534008), the Natural Science Foundation of Heilongjiang Province (Grant C2016037), the Joint Scientific and Technology Innovation Fund of Fujian Province (Grant 2016Y9044), and the Health and Family Planning Commission of Fujian Province (Grant 2017-ZQN-56). The authors declare no conflicts of interest.	Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Cai H, 2015, ONCOTARGET, V6, P44593, DOI 10.18632/oncotarget.6260; Chen R, 2017, ONCOTARGET, V8, P6652, DOI 10.18632/oncotarget.14257; Cheng J, 2017, ONCOTARGET, V8, P30265, DOI 10.18632/oncotarget.15754; Crans GG, 2008, STAT MED, V27, P3598, DOI 10.1002/sim.3221; Dalerba P, 2016, NEW ENGL J MED, V374, P211, DOI 10.1056/NEJMoa1506597; Duffaud F, 2000, B CANCER, V87, P881, DOI 10.1093/jnci/92.3.205; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Figueredo A., 2008, COCHRANE DB SYST REV, V2008; Freidin MB, 2012, J MOL DIAGN, V14, P140, DOI 10.1016/j.jmoldx.2011.11.002; Gao SW, 2016, JAMA ONCOL, V2, P37, DOI 10.1001/jamaoncol.2015.3413; Geeleher P, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1050-9; Gelsomino G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-137; Gong X, 2011, MOL CANCER THER, V10, P752, DOI 10.1158/1535-7163.MCT-10-0837; Graham JS, 2012, EXPERT REV ANTICANC, V12, P99, DOI [10.1586/ERA.11.189, 10.1586/era.11.189]; Guan QZ, 2016, ONCOTARGET, V7, P68909, DOI 10.18632/oncotarget.11996; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Negrei C, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00172; Niedzwiecki D, 2011, J CLIN ONCOL, V29, P3146, DOI 10.1200/JCO.2010.32.5357; Qi LS, 2016, BRIT J CANCER, V115, P1513, DOI 10.1038/bjc.2016.370; Qi LS, 2016, BRIEF BIOINFORM, V17, P233, DOI 10.1093/bib/bbv064; Ragnhammar P, 2001, ACTA ONCOL, V40, P282, DOI 10.1080/02841860151116367; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Scholer LV, 2017, CLIN CANCER RES, V23, P5437, DOI 10.1158/1078-0432.CCR-17-0510; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sloothaak DAM, 2014, EJSO-EUR J SURG ONC, V40, P263, DOI 10.1016/j.ejso.2013.12.002; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Sveen A, 2012, CLIN CANCER RES, V18, P6001, DOI 10.1158/1078-0432.CCR-11-3302; Tong M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.51; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Tsuji S, 2012, BRIT J CANCER, V106, P126, DOI 10.1038/bjc.2011.505; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang HW, 2015, BIOINFORMATICS, V31, P62, DOI 10.1093/bioinformatics/btu522; Xu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15474; Yamaguchi K, 2013, ONCOL LETT, V6, P659, DOI 10.3892/ol.2013.1433; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2; Zhao WY, 2016, ONCOTARGET, V7, P19060, DOI 10.18632/oncotarget.7956; Zou M, 2015, METHODS, V83, P3, DOI 10.1016/j.ymeth.2015.05.011	49	11	11	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					151	162		10.1096/fj.201800222RRR	http://dx.doi.org/10.1096/fj.201800222RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29957060				2022-12-26	WOS:000457401500012
J	Wang, X; Jiang, L; Wallerman, O; Younis, S; Yu, Q; Klaesson, A; Tengholm, A; Welsh, N; Andersson, L				Wang, Xuan; Jiang, Lin; Wallerman, Ola; Younis, Shady; Yu, Qian; Klaesson, Axel; Tengholm, Anders; Welsh, Nils; Andersson, Leif			ZBED6 negatively regulates insulin production, neuronal differentiation, and cell aggregation in MIN6 cells	FASEB JOURNAL			English	Article						-cells; cell adhesion; transcriptome analysis; ChIP-seq	PANCREATIC BETA-CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; R-CADHERIN; GROWTH; IGF2; MUSCLE; BIRTH	Zinc finger BED domain containing protein 6 (Zbed6) has evolved from a domesticated DNA transposon and encodes a transcription factor unique to placental mammals. The aim of the present study was to investigate further the role of ZBED6 in insulin-producing cells, using mouse MIN6 cells, and to evaluate the effects of Zbed6 knockdown on basal -cell functions, such as morphology, transcriptional regulation, insulin content, and release. Zbed6-silenced cells and controls were characterized with a range of methods, including RNA sequencing, chromatin immunoprecipitation sequencing, insulin content and release, subplasma membrane Ca2+ measurements, cAMP determination, and morphologic studies. More than 700 genes showed differential expression in response to Zbed6 knockdown, which was paralleled by increased capacity to generate cAMP, as well as by augmented subplasmalemmal calcium concentration and insulin secretion in response to glucose stimulation. We identified >4000 putative ZBED6-binding sites in the MIN6 genome, with an enrichment of ZBED6 sites at upregulated genes, such as the -cell transcription factors v-maf musculoaponeurotic fibrosarcoma oncogene homolog A and Nk6 homeobox 1. We also observed altered morphology/growth patterns, as indicated by increased cell clustering, and in the appearance of axon-like Neurofilament, medium polypeptide and tubulin 3, class III-positive protrusions. We conclude that ZBED6 acts as a transcriptional regulator in MIN6 cells and that its activity suppresses insulin production, cell aggregation, and neuronal-like differentiation.Wang, X., Jiang, L., Wallerman, O., Younis, S., Yu, Q., Klaesson, A., Tengholm, A., Welsh, N., Andersson, L. ZBED6 negatively regulates insulin production, neuronal differentiation, and cell aggregation in MIN6 cells.	[Wang, Xuan; Yu, Qian; Tengholm, Anders; Welsh, Nils] Uppsala Univ, Sci Life Lab, Dept Med Cell Biol, Husargatan 3,Box 571, SE-75123 Uppsala, Sweden; [Jiang, Lin; Younis, Shady; Klaesson, Axel; Andersson, Leif] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden; [Jiang, Lin] Chinese Acad Agr Sci, Inst Anim Sci, Key Lab Farm Anim Genet Resources & Utilizat, Minist Agr China, Beijing, Peoples R China; [Wallerman, Ola; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Younis, Shady] Ain Shams Univ, Dept Anim Prod, Cairo, Egypt	Uppsala University; Uppsala University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs; Swedish University of Agricultural Sciences; Egyptian Knowledge Bank (EKB); Ain Shams University	Andersson, L (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.; Welsh, N (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Cell Biol, BMC, Husargatan 3,Box 571, SE-75123 Uppsala, Sweden.	nils.welsh@mcb.uu.se; leif.andersson@imbim.uu.se		Younis, Shady/0000-0002-4319-1738; YU, QIAN/0000-0003-4888-9446	Uppsala University and Hospital; SciLife Lab-Uppsala; Swedish Research Council [80576801, 70374401]; Swedish Research Council; Knut and Alice Wallenberg Foundation; Swedish Diabetes Association; Family Ernfors Fund; Barndiabetesfonden; EXODIAB; Novo-Nordisk Foundation; Beijing Natural Science Foundation [6164040]	Uppsala University and Hospital; SciLife Lab-Uppsala; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Diabetes Association; Family Ernfors Fund; Barndiabetesfonden; EXODIAB; Novo-Nordisk Foundation(Novo Nordisk Foundation); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	Sequencing was performed by the SNP&SEQ Technology Platform, supported by Uppsala University and Hospital, SciLife Lab-Uppsala, and the Swedish Research Council (80576801 and 70374401). Computer resources were supplied by UPPMAX. This work was supported by the Swedish Research Council, Knut and Alice Wallenberg Foundation, Swedish Diabetes Association, Family Ernfors Fund, Barndiabetesfonden, EXODIAB, and Novo-Nordisk Foundation. L.J. was supported by Beijing Natural Science Foundation (6164040). The authors declare no conflicts of interest.	Andersson L, 2010, TRANSCR-AUSTIN, V1, P144, DOI 10.4161/trns.1.3.13343; [Anonymous], [No title captured], DOI DOI 10.3760/CMA.J.ISSN.0578-1426.2016.06.006; Apostolopoulou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033289; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barbagallo D, 2014, MOL BIOL CELL, V25, P2333, DOI 10.1091/mbc.E14-02-0703; Belo J, 2013, STEM CELLS DEV, V22, P2935, DOI 10.1089/scd.2013.0106; Bernardo AS, 2008, MOL CELL ENDOCRINOL, V294, P1, DOI 10.1016/j.mce.2008.07.006; Bonacci TM, 2012, CELL SIGNAL, V24, P2102, DOI 10.1016/j.cellsig.2012.07.015; Calderari S, 2007, DIABETOLOGIA, V50, P1463, DOI 10.1007/s00125-007-0676-2; Casellas A, 2015, J BIOL CHEM, V290, P16772, DOI 10.1074/jbc.M115.642041; Devedjian JC, 2000, J CLIN INVEST, V105, P731, DOI 10.1172/JCI5656; Dioum EM, 2011, P NATL ACAD SCI USA, V108, P20713, DOI 10.1073/pnas.1118526109; Ebrahimie M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090885; Emond MR, 2011, J CELL BIOL, V195, P1115, DOI 10.1083/jcb.201108115; HALBAN PA, 1987, DIABETES, V36, P783, DOI 10.2337/diabetes.36.7.783; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; HUTTON JC, 1993, MOL ENDOCRINOL, V7, P1151, DOI 10.1210/me.7.9.1151; Idevall-Hagren O, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003932; Jiang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094187; Kragl M, 2010, ADV EXP MED BIOL, V654, P217, DOI 10.1007/978-90-481-3271-3_10; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Martens GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024134; McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628; Mercader JM, 2017, DIABETES, V66, P2903, DOI 10.2337/db17-0187; POLAK M, 1993, P NATL ACAD SCI USA, V90, P5781, DOI 10.1073/pnas.90.12.5781; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Szabat M, 2012, DIABETES, V61, P1365, DOI 10.2337/db11-1361; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Vidaltamayo R, 1996, ENDOCRINE, V4, P19, DOI 10.1007/BF02738870; Wang X, 2013, P NATL ACAD SCI USA, V110, P15997, DOI 10.1073/pnas.1303625110; Younis S, 2018, P NATL ACAD SCI USA, V115, pE2048, DOI 10.1073/pnas.1719278115; Zhang Y., 2008, GENOME BIOL, V9	37	10	10	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					88	100		10.1096/fj.201600835R	http://dx.doi.org/10.1096/fj.201600835R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29957057				2022-12-26	WOS:000457401500007
J	Du, WW; Yang, WN; Li, XM; Awan, FM; Yang, ZG; Fang, L; Lyu, JJ; Li, FY; Peng, C; Krylov, SN; Xie, YZ; Zhang, Y; He, CY; Wu, N; Zhang, C; Sdiri, M; Dong, J; Ma, J; Gao, CQ; Hibberd, S; Yang, BB				Du, William W.; Yang, Weining; Li, Xiangmin; Awan, Faryal Mehwish; Yang, Zhenguo; Fang, Ling; Lyu, Juanjuan; Li, Feiya; Peng, Chun; Krylov, Sergey N.; Xie, Yizhen; Zhang, Yaou; He, Chengyan; Wu, Nan; Zhang, Chao; Sdiri, Mouna; Dong, Jun; Ma, Jian; Gao, Chunqi; Hibberd, Steven; Yang, Burton B.			A circular RNA circ-DNMT1 enhances breast cancer progression by activating autophagy	ONCOGENE			English	Article							MATURE MIR-17-5P; SEQUENCING DATA; BINDING DOMAIN; NONCODING RNAS; FOXO3 ACTIVITY; GROWTH-FACTOR; TUMOR-GROWTH; HNRNP D0; P53; INHIBITION	Circular RNAs are a large group of noncoding RNAs that are widely expressed in mammalian cells. Genome-wide analyses have revealed abundant and evolutionarily conserved circular RNAs across species, which suggest specific physiological roles of these species. Using a microarray approach, we detected increased expression of a circular RNA circ-Dnmt1 in eight breast cancer cell lines and in patients with breast carcinoma. Silencing circ-Dnmt1 inhibited cell proliferation and survival. Ectopic circ-Dnmt1 increased the proliferative and survival capacities of breast cancer cells by stimulating cellular autophagy. We found that circ-Dnmt1-mediated autophagy was essential in inhibiting cellular senescence and increasing tumor xenograft growth. We further found that ectopically expressed circ-Dnmt1 could interact with both p53 and AUF1, promoting the nuclear translocation of both proteins. Nuclear translocation of p53 induced cellular autophagy while AUF1 nuclear translocation reduced Dnmt1 mRNA instability, resulting in increased Dnmt1 translation. From here, functional Dnmt1 could then translocate into the nucleus, inhibiting p53 transcription. Computational algorithms revealed that both p53 and AUF1 could bind to different regions of circ-Dnmt1 RNA. Our results showed that the highly expressed circular RNA circ-Dnmt1 could bind to and regulate oncogenic proteins in breast cancer cells. Thus circ-Dnmt1 appears to be an oncogenic circular RNA with potential for further preclinical research.	[Du, William W.; Yang, Weining; Li, Xiangmin; Awan, Faryal Mehwish; Yang, Zhenguo; Fang, Ling; Lyu, Juanjuan; Li, Feiya; Wu, Nan; Zhang, Chao; Sdiri, Mouna; Dong, Jun; Ma, Jian; Gao, Chunqi; Hibberd, Steven; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Li, Xiangmin; Xie, Yizhen] Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou 510070, Guangdong, Peoples R China; [Awan, Faryal Mehwish] NUST, ASAB, H-12, Islamabad, Pakistan; [Fang, Ling; He, Chengyan] Jilin Univ, China Japan Union Hosp, Jilin, Jilin, Peoples R China; [Peng, Chun] York Univ, Dept Biol, Toronto, ON, Canada; [Krylov, Sergey N.] York Univ, Dept Chem, 4700 Keele St, Toronto, ON M3J 1P3, Canada; [Krylov, Sergey N.] York Univ, Ctr Res Biomol Interact, 4700 Keele St, Toronto, ON M3J 1P3, Canada; [Xie, Yizhen] Yuewei Edible Fungi Technol Co Ltd, Guangzhou, Guangdong, Peoples R China; [Zhang, Yaou] Tsinghua Univ, Div Life Sci, Key Lab Hlth Sci & Technol, Grad Sch Shenzhen, Shenzhen 518055, Peoples R China; [Yang, Burton B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; National University of Sciences & Technology - Pakistan; Jilin University; York University - Canada; York University - Canada; York University - Canada; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; University of Toronto	Yang, BB (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada.; Yang, BB (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	byang@sri.utoronto.ca	Gao, Chun/AAP-2262-2020; ma, jian/AAV-9930-2021	Awan, Faryal Mehwish/0000-0002-8146-8929; Yang, Burton B/0000-0002-2892-7209	Canadian Institutes of Health Research [PJT-153105]; National Natural Science Foundation of Guangdong [2017A030310088]; Innovation and Entrepreneurship Leading Talent of Guangzhou Development Zone [2017-L181]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Innovation and Entrepreneurship Leading Talent of Guangzhou Development Zone	This work was supported by grants from Canadian Institutes of Health Research (PJT-153105), National Natural Science Foundation of Guangdong (2017A030310088), and Innovation and Entrepreneurship Leading Talent of Guangzhou Development Zone (2017-L181).	Bachmayr-Heyda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08057; Bai Y, 2018, J NEUROSCI, V38, P32, DOI 10.1523/JNEUROSCI.1348-17.2017; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230; Dempsey LA, 1998, GENOMICS, V49, P378, DOI 10.1006/geno.1998.5237; Du WW, 2017, EUR HEART J, V38, P1402, DOI 10.1093/eurheartj/ehw001; Du WW, 2017, CELL DEATH DIFFER, V24, P357, DOI 10.1038/cdd.2016.133; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; Du WW, 2015, MOL THER, V23, P1222, DOI 10.1038/mt.2015.64; Enuka Y, 2016, NUCLEIC ACIDS RES, V44, P1370, DOI 10.1093/nar/gkv1367; Georgia S, 2013, GENE DEV, V27, P372, DOI 10.1101/gad.207001.112; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hsiao KY, 2017, CANCER RES, V77, P2339, DOI 10.1158/0008-5472.CAN-16-1883; Huang RR, 2017, AUTOPHAGY, V13, P1722, DOI 10.1080/15548627.2017.1356975; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kastritis PL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0835; Katahira M, 2001, J MOL BIOL, V311, P973, DOI 10.1006/jmbi.2001.4862; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Liu YC, 2016, NUCLEIC ACIDS RES, V44, pD209, DOI 10.1093/nar/gkv940; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Miller SJ, 2000, MOL CELL BIOL, V20, P8420, DOI 10.1128/MCB.20.22.8420-8431.2000; Nagata T, 1999, J MOL BIOL, V287, P221, DOI 10.1006/jmbi.1999.2616; Panda AC, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx297; Pietal MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-333; Rutnam ZJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3914; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Shan SW, 2013, J CELL SCI, V126, P1517, DOI 10.1242/jcs.122895; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Tasdemir E, 2008, AUTOPHAGY, V4, P810, DOI 10.4161/auto.6486; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Torrisani J, 2007, MOL CELL BIOL, V27, P395, DOI 10.1128/MCB.01236-06; Tuszynska I, 2015, NUCLEIC ACIDS RES, V43, pW425, DOI 10.1093/nar/gkv493; Washietl S, 2012, WIRES RNA, V3, P759, DOI 10.1002/wrna.1134; Yang BL, 2000, J BIOL CHEM, V275, P21255, DOI 10.1074/jbc.M001443200; Yang Q, 2017, CELL DEATH DIFFER, V24, P1609, DOI 10.1038/cdd.2017.86; Yang W, 2016, ONCOGENE, V35, P3919, DOI 10.1038/onc.2015.460; Yang XL, 2013, NUCLEIC ACIDS RES, V41, P9688, DOI 10.1093/nar/gkt680; Yang YB, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx166; YEN RWC, 1992, NUCLEIC ACIDS RES, V20, P2287, DOI 10.1093/nar/20.9.2287; Yoshida Y, 2004, ONCOGENE, V23, P4371, DOI 10.1038/sj.onc.1207583; Zeng Y, 2017, THERANOSTICS, V7, P3842, DOI 10.7150/thno.19764; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zheng LL, 2016, NUCLEIC ACIDS RES, V44, pD196, DOI 10.1093/nar/gkv1273	48	163	171	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 1	2018	37	44					5829	5842		10.1038/s41388-018-0369-y	http://dx.doi.org/10.1038/s41388-018-0369-y			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GY9EX	29973691				2022-12-26	WOS:000448943100002
J	Nguyen-Tu, MS; Xavier, GD; Leclerc, I; Rutter, GA				Nguyen-Tu, Marie-Sophie; Xavier, Gabriela da Silva; Leclerc, Isabelle; Rutter, Guy A.			Transcription factor-7-like 2 (TCF7L2) gene acts downstream of the Lkb1/Stk11 kinase to control mTOR signaling, cell growth, and insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreatic islet; insulin secretion; cell growth; liver kinase B1 (LKB1); T-cell factor (TCF); pancreatic cell; TCF7L2	PEUTZ-JEGHERS-SYNDROME; BETA-CELLS; GLUCOSE-HOMEOSTASIS; LKB1; MASS; MICE; EXPRESSION; EXPANSION; IDENTITY; RISK	Variants in the transcription factor-7-like 2 (TCF7L2/TCF4) gene, involved in Wnt signaling, are associated with type 2 diabetes. Loss of Tcf7l2 selectively from the cell in mice has previously been shown to cause glucose intolerance and to lower cell mass. Deletion of the tumor suppressor liver kinase B1 (LKB1/STK11) leads to cell hyperplasia and enhanced glucose-stimulated insulin secretion, providing a convenient genetic model for increased cell growth and function. The aim of this study was to explore the possibility that Tcf7l2 may be required for the effects of Lkb1 deletion on insulin secretion in the mouse cell. Mice bearing floxed Lkb1 and/or Tcf7l2 alleles were bred with knockin mice bearing Cre recombinase inserted at the Ins1 locus (Ins1Cre), allowing highly cell-selective deletion of either or both genes. Oral glucose tolerance was unchanged by the further deletion of a single Tcf7l2 allele in these cells. By contrast, mice lacking both Tcf7l2 alleles on this background showed improved oral glucose tolerance and insulin secretion in vivo and in vitro compared with mice lacking a single Tcf7l2 allele. Biallelic Tcf7l2 deletion also enhanced cell proliferation, increased cell mass, and caused changes in polarity as revealed by the rosette-like arrangement of cells. Tcf7l2 deletion also increased signaling by mammalian target of rapamycin (mTOR), augmenting phospho-ribosomal S6 levels. We identified a novel signaling mechanism through which a modifier gene, Tcf7l2, lies on a pathway through which LKB1 acts in the cell to restrict insulin secretion.	Imperial Coll London, Imperial Ctr Translat & Expt Med, Dept Med, Sect Cell Biol & Funct Genom, London W12 0NN, England; Imperial Coll London, Imperial Ctr Translat & Expt Med, Div Diabet Endocrinol & Metab, Pancreat Islet & Diabet Consortium,Dept Med, London W12 0NN, England	Imperial College London; Imperial College London	Rutter, GA (corresponding author), Imperial Coll London, Hammersmith Hosp Campus, DuCane Rd, London W12 0NN, England.	g.rutter@imperial.ac.uk		Rutter, Guy/0000-0001-6360-0343; da Silva Xavier, Gabriela/0000-0002-0678-012X; Leclerc, Isabelle/0000-0003-0044-7921	Medical Research Council (MRC) Program [MR/J0003042/1, MR/N00275X/1, MR/L020149/1]; Wellcome Trust [WT098424AIA]; Royal Society Wolfson Research Merit Awards; Diabetes UK Project Grants [BDA11/0004210, BDA/15/0005275]; MRC [MR/L020149/1, MR/K001981/1, MR/N00275X/1] Funding Source: UKRI	Medical Research Council (MRC) Program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society Wolfson Research Merit Awards(Royal Society of London); Diabetes UK Project Grants; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council (MRC) Program Grants MR/J0003042/1, MR/N00275X/1, and MR/L020149/1 (DIVA); Wellcome Trust Senior Investigator Grant WT098424AIA; Royal Society Wolfson Research Merit Awards; and Diabetes UK Project Grants BDA11/0004210 and BDA/15/0005275 (to G. A. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Ahlqvist E, 2018, LANCET DIABETES ENDO, V6, P361, DOI 10.1016/S2213-8587(18)30051-2; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Boardman LA, 1998, ANN INTERN MED, V128, P896, DOI 10.7326/0003-4819-128-11-199806010-00004; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cruciani-Guglielmacci C, 2017, MOL METAB, V6, P340, DOI 10.1016/j.molmet.2017.01.009; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Fu A, 2015, DIABETOLOGIA, V58, P1513, DOI 10.1007/s00125-015-3579-7; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Habener J. F., 2014, ISLETS OF LANGERHANS, P391; Heni M, 2010, DIABETES, V59, P3247, DOI 10.2337/db10-0674; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kahn SE, 2009, DIABETOLOGIA, V52, P1003, DOI 10.1007/s00125-009-1321-z; Kone M, 2014, FASEB J, V28, P4972, DOI 10.1096/fj.14-257667; Liu K, 2014, TUMOR BIOL, V35, P995, DOI 10.1007/s13277-013-1133-0; Ma YM, 2010, ONCOL REP, V23, P1569, DOI 10.3892/or_00000797; Mehta ZB, 2016, AM J PHYSIOL-ENDOC M, V311, pE488, DOI 10.1152/ajpendo.00074.2016; Mezza T, 2014, DIABETES, V63, P994, DOI 10.2337/db13-1013; Mitchell RK, 2017, J BIOL CHEM, V292, P8892, DOI 10.1074/jbc.M117.784629; Mitchell RK, 2015, HUM MOL GENET, V24, P1390, DOI 10.1093/hmg/ddu553; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Muncan V, 2007, EMBO REP, V8, P966, DOI 10.1038/sj.embor.7401071; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Ossipova O, 2003, NAT CELL BIOL, V5, P889, DOI 10.1038/ncb1048; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Ravier MA, 2010, METHODS MOL BIOL, V633, P171, DOI 10.1007/978-1-59745-019-5_12; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Rutter GA, 2015, DIABETOLOGIA, V58, P31, DOI 10.1007/s00125-014-3405-7; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Sun G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1261, DOI 10.1152/ajpendo.00100.2010; Swisa A, 2015, J BIOL CHEM, V290, P20934, DOI 10.1074/jbc.M115.639237; Thorens B, 2015, DIABETOLOGIA, V58, P558, DOI 10.1007/s00125-014-3468-5; van de Bunt MV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005694; Xavier GD, 2012, DIABETOLOGIA, V55, P2667, DOI 10.1007/s00125-012-2600-7; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Zeggini E, 2007, DIABETOLOGIA, V50, P1, DOI 10.1007/s00125-006-0507-x; Zhou YD, 2014, HUM MOL GENET, V23, P6419, DOI 10.1093/hmg/ddu359	49	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14178	14189		10.1074/jbc.RA118.003613	http://dx.doi.org/10.1074/jbc.RA118.003613			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29967064	Green Published, hybrid			2022-12-26	WOS:000444070700038
J	Bortnov, V; Annis, DS; Fogerty, FJ; Barretto, KT; Turton, KB; Mosher, DF				Bortnov, Valeriu; Annis, Douglas S.; Fogerty, Frances J.; Barretto, Karina T.; Turton, Keren B.; Mosher, Deane F.			Myeloid-derived growth factor is a resident endoplasmic reticulum protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE-ISOMERASE; INTERACTION NETWORK; IDENTIFICATION; DRAFT; MAP	Human myeloid-derived growth factor (MYDGF, also known as C19orf10) is named based on its identification as a secreted monocyte/macrophage-derived mediator of cardiac repair following myocardial infarction in mice. Homologs of MYDGF, however, are present in organisms throughout and outside of the animal kingdom, some of which lack hematopoietic and circulatory systems. Moreover, the UPF0556 protein domain, which defines these homologs, lacks a known structure. As a result, the functions and properties of MYDGF are unclear. Our current work was initiated to test whether MYDGF is present in secretory vesicles of eosinophils, as it was recently reported to be abundant in these cells. However, we could not demonstrate secretion and unexpectedly discovered that MYDGF co-localizes with P4HB in the nuclear envelope, which comprises the bulk of endoplasmic reticulum (ER) in eosinophils, and with P4HB and RCAS1 in Golgi. We noted a ubiquitous C-terminal sequence BXEL (B, basic; X, variable residue; E, Glu; L, Leu) that has the potential to retain human MYDGF and its homologs in the ER. To test the functionality of this sequence, we expressed full-length human MYDGF or MYDGF lacking the C-terminal Glu-Leu residues in monolayers of human embryonic kidney 293 (HEK293) cells. Full-length MYDGF accumulated in cells whereas truncated MYDGF appeared in the medium. These observations reveal that MYDGF resides in the ER and the Golgi and provide a new framework for investigating and understanding this intriguing protein.	[Bortnov, Valeriu; Annis, Douglas S.; Fogerty, Frances J.; Barretto, Karina T.; Turton, Keren B.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, 420 Henry Mall, Madison, WI 53706 USA; [Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Biomol Chem, 420 Henry Mall, Madison, WI 53706 USA.	dfmosher@wisc.edu		Bortnov, Valeriu/0000-0002-1159-7338; Turton, Keren/0000-0001-9064-6523	University of Wisconsin-Madison Department of Biochemistry Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125390] Funding Source: NIH RePORTER	University of Wisconsin-Madison Department of Biochemistry Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Elle Grevstad for help in obtaining and processing microscopy data. Microscopy was performed at the University of Wisconsin- Madison Biochemistry Optical Core, which was established with support from the University of Wisconsin-Madison Department of Biochemistry Endowment.	ANDRES DA, 1991, J BIOL CHEM, V266, P14277; Bailey MJ, 2011, IMMUNOL CELL BIOL, V89, P283, DOI 10.1038/icb.2010.92; Bowley SR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14151; Cavalier-Smith T, 2015, MOL PHYLOGENET EVOL, V83, P293, DOI 10.1016/j.ympev.2014.08.011; Cavalier-Smith T, 2014, MOL PHYLOGENET EVOL, V81, P71, DOI 10.1016/j.ympev.2014.08.012; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Dias FF, 2014, J HISTOCHEM CYTOCHEM, V62, P450, DOI 10.1369/0022155414531437; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Han ST, 2014, AM J RESP CELL MOL, V50, P654, DOI 10.1165/rcmb.2013-0181OC; Higa A, 2014, MOL CELL BIOL, V34, P1839, DOI 10.1128/MCB.01484-13; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Korf-Klingebiel M, 2015, NAT MED, V21, P140, DOI 10.1038/nm.3778; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Maddison DR, 2007, ZOOTAXA, P19, DOI 10.11646/zootaxa.1668.1.4; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MAYENO AN, 1992, J LEUKOCYTE BIOL, V51, P172, DOI 10.1002/jlb.51.2.172; Mosher DF, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00159; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Owusu BY, 2018, J CELL COMMUN SIGNAL, V12, P289, DOI 10.1007/s12079-017-0426-2; Preston GM, 2017, BIOCHEM J, V474, P445, DOI 10.1042/BCJ20160582; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Riley BE, 2004, J BIOL CHEM, V279, P42290, DOI 10.1074/jbc.M406284200; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Shao SC, 2017, SCIENCE, V355, P298, DOI 10.1126/science.aah6130; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Straub C, 2009, PROTEOM CLIN APPL, V3, P1151, DOI 10.1002/prca.200900043; Sunagozaka H, 2011, INT J CANCER, V129, P1576, DOI 10.1002/ijc.25830; Tulin EE, 2003, J IMMUNOL, V170, P1593, DOI 10.4049/jimmunol.170.3.1593; Tulin EE, 2001, J IMMUNOL, V167, P6338, DOI 10.4049/jimmunol.167.11.6338; Wang P, 2004, CELL MOL LIFE SCI, V61, P2405, DOI 10.1007/s00018-004-4256-z; Weeraphan C, 2012, TALANTA, V99, P294, DOI 10.1016/j.talanta.2012.05.054; Weiler T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2145; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wilkerson EM, 2016, J PROTEOME RES, V15, P1524, DOI 10.1021/acs.jproteome.6b00006; Zhou JS, 2017, BLOOD, V130, P817, DOI 10.1182/blood-2016-12-755587	39	13	16	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13166	13175		10.1074/jbc.AC118.002052	http://dx.doi.org/10.1074/jbc.AC118.002052			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29954947	hybrid, Green Published			2022-12-26	WOS:000442730200016
J	Mehra, S; Ghoshn, D; Kumar, R; Mondal, M; Gadhe, LG; Das, S; Anoop, A; Jha, NN; Jacob, RS; Chatterjee, D; Ray, S; Singh, N; Kumar, A; Maji, SK				Mehra, Surabhi; Ghoshn, Dhiman; Kumar, Rakesh; Mondal, Mrityunjoy; Gadhe, Laxmikant G.; Das, Subhadeep; Anoop, Arunagiri; Jha, Narendra N.; Jacob, Reeba S.; Chatterjee, Debdeep; Ray, Soumik; Singh, Nitu; Kumar, Ashutosh; Maji, Samir K.			Glycosaminoglycans have variable effects on alpha-synuclein aggregation and differentially affect the activities of the resulting amyloid fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CIRCULAR-DICHROISM SPECTRA; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; IN-VITRO; ALZHEIMERS-DISEASE; PROTEIN; MUTATION; PEPTIDES; TOXICITY	Parkinson's disease is mainly a sporadic disorder in which both environmental and cellular factors play a major role in the initiation of this disease. Glycosaminoglycans (GAG) are integral components of the extracellular matrix and are known to influence amyloid aggregation of several proteins, including alpha-synuclein (alpha-Syn). However, the mechanism by which different GAGs and related biological polymers influence protein aggregation and the structure and intercellular spread of these aggregates remains elusive. In this study, we used three different GAGs and related charged polymers to establish their role in alpha-Syn aggregation and associated biological activities of these aggregates. Heparin, a representative GAG, affected alpha-Syn aggregation in a concentration-dependent manner, whereas biphasic alpha-Syn aggregation kinetics was observed in the presence of chondroitin sulfate B. Of note, as indicated by 2D NM R analysis, different GAGs uniquely modulated alpha-Syn aggregation because of the diversity of their interactions with soluble alpha-Syn. Moreover, subtle differences in the GAG backbone structure and charge density significantly altered the properties of the resulting amyloid fibrils. Each GAG/polymer facilitated the formation of morphologically and structurally distinct alpha-Syn amyloids, which not only displayed variable levels of cytotoxicity but also exhibited an altered ability to internalize into cells. Our study supports the role of GAGs as key modulators in alpha-Syn amyloid formation, and their distinct activities may regulate amyloidogenesis depending on the type of GAG being up- or down-regulated in vivo.	[Mehra, Surabhi; Ghoshn, Dhiman; Kumar, Rakesh; Mondal, Mrityunjoy; Gadhe, Laxmikant G.; Das, Subhadeep; Anoop, Arunagiri; Jha, Narendra N.; Jacob, Reeba S.; Chatterjee, Debdeep; Ray, Soumik; Singh, Nitu; Kumar, Ashutosh; Maji, Samir K.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Das, Subhadeep] Indian Inst Technol, IITB Monash Res Acad, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Maji, SK (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	samirmaji@iitb.ac.in	Arunagiri, Anoop/P-2528-2018; JHA, NARENDRA NATH/ABI-3727-2020; Maji, Samir K. K./B-9640-2019	Arunagiri, Anoop/0000-0001-9839-1860; JHA, NARENDRA NATH/0000-0002-1734-7663; Maji, Samir K. K./0000-0002-9110-1565; Chatterjee, Dr. Debdeep/0000-0001-8153-8651; Jacob, Reeba/0000-0002-0676-834X; Mondal, Mrityunjoy/0000-0003-2973-4633; Mehra, Surabhi/0000-0003-1777-673X; Das, Subhadeep/0000-0003-1870-8456	DBT-Neuroscience, Government of India [BT/PR14344Med/30/501/2010]; DBT-Basic Sciences [BT/PR13359/BRB/10/752/2009]; Council of Scientific and Industrial Research, India [37(1648)/15/EMRII]; University Grants Commission (Govt. of India)	DBT-Neuroscience, Government of India; DBT-Basic Sciences; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (Govt. of India)(University Grants Commission, India)	This work was supported by Grant BT/PR14344Med/30/501/2010 from DBT-Neuroscience, Government of India; Grant BT/PR13359/BRB/10/752/2009 from DBT-Basic Sciences; and Grant 37(1648)/15/EMRII from the Council of Scientific and Industrial Research, India. The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of a fellowship from the University Grants Commission (Govt. of India). Both authors contributed equally to this work.	Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Avila CL, 2014, J BIOL CHEM, V289, P13838, DOI 10.1074/jbc.M113.544288; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bourgault S, 2011, BIOCHEMISTRY-US, V50, P1001, DOI 10.1021/bi101822y; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DEWITT DA, 1994, BRAIN RES, V656, P205, DOI 10.1016/0006-8993(94)91386-2; Diaz-Nido J, 2002, PEPTIDES, V23, P1323, DOI 10.1016/S0196-9781(02)00068-2; El-Agnaf OMA, 2002, BIOCHEM SOC T, V30, P559; Ellett LJ, 2015, GLYCOBIOLOGY, V25, P745, DOI 10.1093/glycob/cwv014; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Fraser PE, 2001, J BIOL CHEM, V276, P6412, DOI 10.1074/jbc.M008128200; Gellermann GP, 2005, P NATL ACAD SCI USA, V102, P6297, DOI 10.1073/pnas.0407035102; Ghosh D, 2017, INT J BIOL MACROMOL, V100, P37, DOI 10.1016/j.ijbiomac.2016.10.021; Ghosh D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09228; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hegde ML, 2010, FRONT BIOSCI-LANDMRK, V15, P418, DOI 10.2741/3628; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Iannuzzi C, 2015, MOLECULES, V20, P2510, DOI 10.3390/molecules20022510; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jendresen CB, 2015, J BIOL CHEM, V290, P5053, DOI 10.1074/jbc.M114.600569; Jha NN, 2013, BIOCHEMISTRY-US, V52, P8800, DOI 10.1021/bi401398k; Valle-Delgado JJ, 2010, FASEB J, V24, P4250, DOI 10.1096/fj.09-153551; Karlsson M, 2001, Methods Mol Biol, V171, P159; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Levitan K, 2011, J MOL BIOL, V411, P329, DOI 10.1016/j.jmb.2011.05.046; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Madine J, 2013, BIOCHEMISTRY-US, V52, P8984, DOI 10.1021/bi401231u; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; MORITA H, 1995, CONTRIB NEPHROL, V112, P83; Morris AM, 2009, BIOPHYS CHEM, V140, P9, DOI 10.1016/j.bpc.2008.11.003; Motamedi-Shad N, 2009, J BIOCHEM, V146, P805, DOI 10.1093/jb/mvp128; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Novak U, 2000, J CLIN NEUROSCI, V7, P280, DOI 10.1054/jocn.1999.0212; PERRY G, 1992, BRAIN RES, V579, P350, DOI 10.1016/0006-8993(92)90074-J; Potter-Perigo S, 2003, ARCH BIOCHEM BIOPHYS, V413, P182, DOI 10.1016/S0003-9861(03)00116-4; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Ramachandran G, 2011, J BIOL CHEM, V286, P38948, DOI 10.1074/jbc.M111.271874; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Saric A, 2014, P NATL ACAD SCI USA, V111, P17869, DOI 10.1073/pnas.1410159111; Sidhu A, 2004, ANN NY ACAD SCI, V1035, P250, DOI 10.1196/annals.1332.016; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; SNOW AD, 1987, LAB INVEST, V56, P120; SNOW AD, 1990, LAB INVEST, V63, P601; Solomon JP, 2011, BIOCHEMISTRY-US, V50, P2486, DOI 10.1021/bi101905n; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Timmer NM, 2010, NEUROSCI RES, V66, P380, DOI 10.1016/j.neures.2009.12.012; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; VANGOOL D, 1993, DEMENTIA, V4, P308, DOI 10.1159/000107338; Vieira TCRG, 2014, FASEB J, V28, P2667, DOI 10.1096/fj.13-246777; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Wang PP, 2014, PROTEIN PEPTIDE LETT, V21, P1048, DOI 10.2174/0929866521666140626095145; Willander H, 2012, J BIOL CHEM, V287, P31608, DOI 10.1074/jbc.M112.393157; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wolf H, 2015, J VIROL, V89, P9853, DOI 10.1128/JVI.01276-15; Yoneda H, 2014, J RECEPT SIG TRANSD, V34, P21, DOI 10.3109/10799893.2013.845788; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang LJ, 2001, J BIOL CHEM, V276, P28806, DOI 10.1074/jbc.M100204200	74	30	30	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					12975	12991		10.1074/jbc.RA118.004267	http://dx.doi.org/10.1074/jbc.RA118.004267			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29959225	Green Published, hybrid			2022-12-26	WOS:000442730200001
J	Clark, WT; Yu, GK; Aoyagi-Scharber, M; LeBowitz, JH				Clark, Wyatt T.; Yu, G. Karen; Aoyagi-Scharber, Mika; LeBowitz, Jonathan H.			Utilizing ExAC to assess the hidden contribution of variants of unknown significance to Sanfilippo Type B incidence	PLOS ONE			English	Article							MUCOPOLYSACCHARIDOSIS TYPE IIIB; LYSOSOMAL STORAGE DISORDERS; PREVALENCE; DISEASE; PROTEIN; POPULATION; MUTATIONS	Given the large and expanding quantity of publicly available sequencing data, it should be possible to extract incidence information for monogenic diseases from allele frequencies, provided one knows which mutations are causal. We tested this idea on a rare, monogenic, lysosomal storage disorder, Sanfilippo Type B (Mucopolysaccharidosis type IIIB). Sanfilippo Type B is caused by mutations in the gene encoding alpha-N-acetylglucosaminidase (NAGLU). There were 189 NAGLU missense variants found in the ExAC dataset that comprises roughly 60,000 individual exomes. Only 24 of the 189 missense variants were known to be pathogenic; the remaining 165 variants were of unknown significance (VUS), and their potential contribution to disease is unknown. To address this problem, we measured enzymatic activities of 164 NAGLU missense VUS in the ExAC dataset and developed a statistical framework for estimating disease incidence with associated confidence intervals. We found that 25% of VUS decreased the activity of NAGLU to levels consistent with Sanfilippo Type B pathogenic alleles. We found that a substantial fraction of Sanfilippo Type B incidence (67%) could be accounted for by novel mutations not previously identified in patients, illustrating the utility of combining functional activity data for VUS with population-wide allele frequency data in estimating disease incidence.	[Clark, Wyatt T.; Yu, G. Karen; Aoyagi-Scharber, Mika; LeBowitz, Jonathan H.] BioMarin Pharmaceut, San Rafael, CA 94901 USA	BioMarin Pharmaceutical Inc.	LeBowitz, JH (corresponding author), BioMarin Pharmaceut, San Rafael, CA 94901 USA.	JLeBowitz@bmrn.com		lebowitz, jonathan/0000-0001-9323-2422	BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.	All authors are full time employees of BioMarin Pharmaceutical Inc. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Jasmi FA, 2013, JIMD REP, V10, P1, DOI 10.1007/8904_2012_182; [Anonymous], MOL OP ENV MOE; Baehner F, 2005, J INHERIT METAB DIS, V28, P1011, DOI 10.1007/s10545-005-0112-z; Ben Turkia Hadhami, 2009, Tunis Med, V87, P782; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dionisi-Vici C, 2002, J PEDIATR-US, V140, P321, DOI 10.1067/mpd.2002.122394; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller W., 1968, INTRO PROBABILITY TH, V1; Ficko-Blean E, 2008, P NATL ACAD SCI USA, V105, P6560, DOI 10.1073/pnas.0711491105; GOODMAN LA, 1962, J AM STAT ASSOC, V57, P54; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Heron B, 2011, AM J MED GENET A, V155A, P58, DOI 10.1002/ajmg.a.33779; Hopp K, 2015, J AM SOC NEPHROL; Hoskins RA, 2017, REPORTS CAGI CRITICA; Kan S, 2014, P NATL ACAD SCI USA, V111, P14870, DOI 10.1073/pnas.1416660111; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Leadley RM, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0173-x; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lin HY, 2009, AM J MED GENET A, V149A, P960, DOI 10.1002/ajmg.a.32781; Malm G, 2008, ACTA PAEDIATR, V97, P1577, DOI 10.1111/j.1651-2227.2008.00965.x; Matthijs G, 1998, AM J HUM GENET, V62, P542, DOI 10.1086/301763; Meijer OLM, 2016, J INHERIT METAB DIS, V39, P437, DOI 10.1007/s10545-016-9916-2; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Michelakakis H, 1994, GENETIC COUNSELING, V6, P43; Moyer VA, 2008, HASTINGS CENT REP, V38, P32, DOI 10.1353/hcr.0.0011; Musumeci O, 2015, NEUROMUSCULAR DISORD, V25, P719, DOI 10.1016/j.nmd.2015.07.002; Orsini JJ, 2016, GENET MED, V18, P239, DOI 10.1038/gim.2015.211; Pinto R, 2004, EUR J HUM GENET, V12, P87, DOI 10.1038/sj.ejhg.5201044; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Poupetova H, 2010, J INHERIT METAB DIS, V33, P387, DOI 10.1007/s10545-010-9093-7; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rivera-Colon Y, 2012, J MOL BIOL, V423, P736, DOI 10.1016/j.jmb.2012.08.020; Schrodi SJ, 2015, HUM GENET, V134, P659, DOI 10.1007/s00439-015-1551-8; Sleat DE, 2016, GENE, V593, P284, DOI 10.1016/j.gene.2016.08.031; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Valstar MJ, 2010, ANN NEUROL, V68, P876, DOI 10.1002/ana.22092; Valstar MJ, 2010, J INHERIT METAB DIS, V33, P759, DOI 10.1007/s10545-010-9199-y; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Weinberg W., 1908, JAHRESH VER VATERL N, V64, P369; Yin Y, 2017, HUMAN MUTATION; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200008	10.1371/journal.pone.0200008	http://dx.doi.org/10.1371/journal.pone.0200008			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979746	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500051
J	Pinto, MV; Poornima, HS; Rukmangada, MS; Triveni, R; Naik, VG				Pinto, Marian Vincent; Poornima, H. S.; Rukmangada, M. S.; Triveni, R.; Naik, V. Girish			Association mapping of quantitative resistance to charcoal root rot in mulberry germplasm	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; WRKY TRANSCRIPTION FACTORS; MULTILOCUS GENOTYPE DATA; FALSE DISCOVERY RATE; POPULATION-STRUCTURE; MACROPHOMINA-PHASEOLINA; BLIGHT RESISTANCE; LEAF RUST; L.; SOIL	Outbreaks of root rot disease in the productive South Indian sericulture belt have threatened the sustainability of the industry. Macrophomina phaseolina (Tassi) Goid. causing charcoal rot is the predominant pathogen to which all productive mulberry cultivars are susceptible. The present study was undertaken to identify molecular markers associated with charcoal rot resistance in mulberry. A mapping panel comprising 214 diverse entries from the Indian germplasm collection was assessed for charcoal rot resistance by artificial inoculation. Resistance to the pathogen was observed in 20 entries, and 51 were found to be moderately resistant. A total of 773 alleles generated across 105 SSR loci and 20,384 AFLP markers generated using 32 EcoRI-NN and MseI-CNN primer combinations were used in genetic analysis. The panel was weakly structured with two subpopulations. However, most entries were found to be admixtures. Survival of cuttings and number of roots per sapling were associated with root rot resistance. Association mapping was performed using different linear mixed models. Five AFLP markers explaining 9.6-12.7% of the total phenotypic variance were found to be significantly (p < 0.05) associated with root rot resistance. Significant associations were also detected in four AFLP markers for survival of cuttings, and these markers explained 10.7-14.2% of the total phenotypic variance. These markers should be validated using mapping populations derived from contrasting biparental combinations by linkage analysis for use in marker-assisted gene pyramiding for durable resistance. The resistant genotypes identified in this study will substantially contribute to genetic improvement of mulberry for charcoal rot resistance and can be integrated into conventional breeding programmes.	[Pinto, Marian Vincent; Poornima, H. S.; Rukmangada, M. S.; Triveni, R.; Naik, V. Girish] Cent Sericultural Res & Training Inst, Mol Biol Lab 1, Mysuru, Karnataka, India; [Naik, V. Girish] Reg Sericultural Res Stn, Chamarajanagar, Karnataka, India		Naik, VG (corresponding author), Cent Sericultural Res & Training Inst, Mol Biol Lab 1, Mysuru, Karnataka, India.; Naik, VG (corresponding author), Reg Sericultural Res Stn, Chamarajanagar, Karnataka, India.	vgirishnaik@gmail.com		Pinto, Marian Vincent/0000-0002-0503-9313; Naik, V Girish/0000-0002-5210-3154; M S, Rukmangada/0000-0002-4637-4396	Department of Biotechnology, Ministry of Science and Technology, Govt. of India, New Delhi [BT/PR5811/PDB/19/238/2012]; Council of Scientific and Industrial Research, New Delhi [09/1090(0001)/2013-EMR-I]	Department of Biotechnology, Ministry of Science and Technology, Govt. of India, New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This study was partially funded by the Department of Biotechnology, Ministry of Science and Technology, Govt. of India, New Delhi, with grant (No. BT/PR5811/PDB/19/238/2012) sanctioned to VGN. MVP was supported with fellowship [JRF/SRF-NET; Grant No. 09/1090(0001)/2013-EMR-I] awarded by the Council of Scientific and Industrial Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalendu T., 2009, Asian Journal of Agricultural Sciences, V1, P36; [Anonymous], [No title captured]; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Balakrishna R, 1989, GENETIC RESOURCES MU, P33; Baranwal VK, 2016, SCI REP-UK, V6, DOI 10.1038/srep30794; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borpuzari MM, 2013, CATALOGUE MULBERRY M, V5; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; BROWN AHD, 1989, USE PLANT GENETIC RE; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Central Sericultural Germplasm Resources Centre, 2017, ANN REP 2016 17; Central Sericultural Research and Training Institute, 2016, ANN REP 2015 16, P83; Central Sericultural Research and Training Institute, 2017, ANN REP 2016 17, P111; Central Silk Board, 2017, ANN REP 2016 17, P100; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; Chowdary N.B., 2006, THESIS; Clarke A., 2009, THESIS; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Colton LM, 2006, CROP SCI, V46, P589, DOI 10.2135/cropsci2005.0112; Dai F, 2015, CAN J FOREST RES, V46, P152; Das B.C., 1965, INDIAN J SERIC, V4, P1; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dodd JL, 1980, SORGHUM DIS WORLD RE, P300; Du W, 2016, PLANT MOL BIOL REP, V34, P365, DOI 10.1007/s11105-015-0927-1; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EDMUNDS LK, 1964, PHYTOPATHOLOGY, V54, P514; Edmunds LK, 1964, PLANT DIS REP, V48, P300; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FEDERER W. T., 1956, Hawaiian Planters' Record, V55, P191; GANGOPADHYAY S, 1979, PHYTOPATHOLOGY, V69, P1028; Gangwar S. K., 1991, Indian Phytopathology, V44, P545; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Haissig B. E., 1986, New root formation in plants and cuttings, P141; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HOGENBOOM NG, 1993, CURR PLANT SCI BIOT, V18, P5; Hongthongdaeng B, 1987, SERICOLOGIA, V27, P189; Huang N, 1997, THEOR APPL GENET, V95, P313, DOI 10.1007/s001220050565; Iqbal MJ, 2012, THEOR APPL GENET, V125, P517, DOI 10.1007/s00122-012-1850-6; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jordan WR, 1984, SORGHUM ROOT STALK R, P81; Koch R, 1891, P 10 INT MED C 1890, V1, P650; Komarek M, 2010, ENVIRON INT, V36, P138, DOI 10.1016/j.envint.2009.10.005; Krishnan R.R, 2014, THESIS; Krishnan RR, 2014, PLANT GENET RESOUR-C, V12, P129, DOI 10.1017/S1479262113000415; KULKARNI RN, 1982, PHYTOPATHOLOGY, V72, P1384, DOI 10.1094/Phyto-72-1384; Leroch M, 2011, J PHYTOPATHOL, V159, P63, DOI 10.1111/j.1439-0434.2010.01719.x; Liu CY, 2017, RUSS J PLANT PHYSL+, V64, P738, DOI 10.1134/S1021443717050053; Marasas CN, 2003, AGR ECON, V29, P253, DOI 10.1111/j.1574-0862.2003.tb00162.x; Mayek-Perez N, 2001, PHYSIOL MOL PLANT P, V59, P257, DOI 10.1006/pmpp.2001.0361; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; MEYER WA, 1973, PHYTOPATHOLOGY, V63, P613, DOI 10.1094/Phyto-63-613; MIDDLETON W, 1980, NEW PHYTOL, V84, P251, DOI 10.1111/j.1469-8137.1980.tb04425.x; MIHAIL JD, 1987, PHYTOPATHOLOGY, V77, P1126, DOI 10.1094/Phyto-77-1126; Mishra S, 2011, THESIS; Morkunas I, 2014, ACTA PHYSIOL PLANT, V36, P1607, DOI 10.1007/s11738-014-1559-z; Naik VN, 2010, P NE BORL COMM NAT C, P75; Naik VN, 2006, THESIS; Nalk V. Girish, 2006, Indian Journal of Genetics & Plant Breeding, V66, P287; Nelson CP, 2017, NAT GENET, V49, P1385, DOI 10.1038/ng.3913; Nelson E, 2004, ACTA HORTIC, P115, DOI 10.17660/ActaHortic.2004.635.15; Oraguzie N. C., 2007, Association mapping in plants, P1, DOI 10.1007/978-0-387-36011-9_1; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Perrier X., 2006, DARWIN SOFTWARE; Philip Tomy, 1995, Indian Journal of Sericulture, V34, P137; Philip Tomy, 2009, Indian Journal of Sericulture, V48, P1; Pinto MV, 2018, J GENET, V97, P31, DOI 10.1007/s12041-018-0900-5; Pollard KS, 2005, STAT BIOL HEALTH, P249; Prevost A, 1999, THEOR APPL GENET, V98, P107, DOI 10.1007/s001220051046; Pritchard JK, 2000, GENETICS, V155, P945; Radhakrishan N. V., 1995, Indian Phytopathology, V48, P492; Ramasamy RK, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-431; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; Sarkar A., 2003, ILLUSTRATED WORKING; Sarkar A, 2009, MULBERRY BREEDING; Sayre KD, 1998, CROP SCI, V38, P654, DOI 10.2135/cropsci1998.0011183X003800030006x; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Sharma DD, 2005, MULBERRY CROP PROTEC, P33; Sharma DD, 2005, MULBERRY CROP PROTEC, P195; SHORT GE, 1980, PHYTOPATHOLOGY, V70, P13, DOI 10.1094/Phyto-70-13; Sowmya P, 2018, THESIS; Sridar R, 2000, SERICOLOGIA, V40, P383; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Tabangin Meredith E, 2009, BMC Proc, V3 Suppl 7, pS41, DOI 10.1186/1753-6561-3-S7-S41; Tani N, 2005, MOL ECOL NOTES, V5, P398, DOI 10.1111/j.1471-8286.2005.00940.x; Tikader A, 2009, BUD GRAFTING A UNIQU; Tikader A, 2006, CATALOGUE MULBERRY M, V3; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang H, 2014, RUSS J BIOORG CHEM+, V40, P423, DOI 10.1134/S1068162014040037; Wang ML, 2011, THEOR APPL GENET, V123, P1307, DOI 10.1007/s00122-011-1668-7; Yadav BRD, 2011, ANN REP 2010 11, P19; Yanagawa H, 2003, FREQUENTLY ASKED QUE, P16; You MP, 2011, FUNCT PLANT BIOL, V38, P984, DOI 10.1071/FP11137; Young ND, 1999, MOL BREEDING, V5, P505; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	108	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200099	10.1371/journal.pone.0200099	http://dx.doi.org/10.1371/journal.pone.0200099			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979732	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500058
J	Rinaldi, S; Meloni, MA; Galleri, G; Maioli, M; Pigliaru, G; Cugia, G; Santaniello, S; Castagna, A; Fontani, V				Rinaldi, Salvatore; Meloni, Maria Antonia; Galleri, Grazia; Maioli, Margherita; Pigliaru, Gianfranco; Cugia, Giulia; Santaniello, Sara; Castagna, Alessandro; Fontani, Vania			Radio Electric Asymmetric Conveyer (REAC) technology to obviate loss of T cell responsiveness under simulated microgravity	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION; IMMUNE-SYSTEM; KAPPA-B; LYMPHOCYTES; SPACE; DIFFERENTIATION; ACTIVATION; EXPRESSION	Alterations of the gravitational environment are likely to modify cell behavior. Several studies have proven that T cells are sensitive to gravity alterations and that microgravity conditions may induce immunosuppression and weakened T cell immune response in humans during spaceflights. The aim of this work was to elucidate if a specific treatment of Radio Electric Asymmetric Conveyer (REAC) technology could restore, after mitogenic activation (Con A), a correct expression of cytokine IL2 gene and its receptor IL2R alpha, which are inhibited in T cells under microgravity conditions, as demonstrated in several studies. The results of this study, conducted in microgravity simulated with Random Positioning Machine (RPM), confirm the T cell activation recovery and offer the evidence that REAC technology could contribute to the understanding of T cell growth responsiveness in space, reducing the impact of weightlessness on the immune system experienced by humans in long duration space missions.	[Rinaldi, Salvatore; Meloni, Maria Antonia; Fontani, Vania] Rinaldi Fontani Fdn, Res Dept, Florence, Italy; [Rinaldi, Salvatore; Maioli, Margherita; Castagna, Alessandro; Fontani, Vania] Rinaldi Fontani Fdn, Dept Regenerat & Antiaging Med, Florence, Italy; [Rinaldi, Salvatore; Maioli, Margherita; Fontani, Vania] IRF Shanghai Med Sci, Shanghai, Peoples R China; [Galleri, Grazia] Univ Sassari, Dept Clin & Expt Med, Sassari, Italy; [Maioli, Margherita; Pigliaru, Gianfranco; Santaniello, Sara] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Maioli, Margherita; Pigliaru, Gianfranco; Santaniello, Sara] Natl Res Council CNR, Genet & Biomed Res Inst, Cagliari, Italy; [Cugia, Giulia] ViroStatic Srl, Alghero, Italy	University of Sassari; University of Sassari	Rinaldi, S (corresponding author), Rinaldi Fontani Fdn, Res Dept, Florence, Italy.; Rinaldi, S (corresponding author), Rinaldi Fontani Fdn, Dept Regenerat & Antiaging Med, Florence, Italy.; Rinaldi, S (corresponding author), IRF Shanghai Med Sci, Shanghai, Peoples R China.	srinaldi@irf.it	Galleri, Grazia/AAD-3278-2021	Galleri, Grazia/0000-0001-5379-9387; Fontani, Vania/0000-0003-0141-6270; Rinaldi, Salvatore/0000-0002-8961-6316	Virostatic s.r.l.	Virostatic s.r.l.	Virostatic s.r.l. provided support in the form of salaries for G.C., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; COGOLI A, 1993, J LEUKOCYTE BIOL, V54, P259, DOI 10.1002/jlb.54.3.259; COGOLI A, 1985, IMMUNOL TODAY, V6, P1, DOI 10.1016/0167-5699(85)90151-3; Cogoli-Greuter M, INFLUENCE MICROGRAVI; Cogoli-Greuter M, 1998, INFLUENCE MICROGRAVI, P27; COGOLIGREUTER M, 2004, J GRAVIT PHYSL, V11, P53; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Crucian B, 2015, NPJ MICROGRAVITY, V1, DOI 10.1038/npjmgrav.2015.13; DWYER JM, 1981, CLIN EXP IMMUNOL, V46, P237; Entschladen F, 1997, J IMMUNOL, V159, P3203; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Hammond TG, 1999, NAT MED, V5, P359, DOI 10.1038/7331; Hatton JP, 2002, J CELL BIOCHEM, V87, P39, DOI 10.1002/jcb.10273; Hauschild S, 2014, ACTA ASTRONAUT, V104, P365, DOI 10.1016/j.actaastro.2014.05.019; HOSON T, 1992, BOT MAG TOKYO, V105, P53, DOI 10.1007/BF02489403; Hughes-Fulford M, 2005, CELL SIGNAL, V17, P1111, DOI 10.1016/j.cellsig.2004.12.016; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Lang K, 2003, SCAND J IMMUNOL, V57, P350, DOI 10.1046/j.1365-3083.2003.01247.x; Luo HY, 2014, INT J MED SCI, V11, P87, DOI 10.7150/ijms.7651; Maioli M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28682; Maioli M, 2014, CELL TRANSPLANT, V23, P1489, DOI 10.3727/096368913X672037; Maioli M, 2014, AGE, V36, P9, DOI 10.1007/s11357-013-9537-8; Maioli M, 2012, CELL TRANSPLANT, V21, P1225, DOI 10.3727/096368911X600966; Maioli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015151; Meloni MA, 2006, PROTOPLASMA, V229, P243, DOI 10.1007/s00709-006-0210-2; Modiano JF, 1999, CELL IMMUNOL, V197, P19, DOI 10.1006/cimm.1999.1563; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Pietsch J, 2011, CURR MOL MED, V11, P350, DOI 10.2174/156652411795976600; Rinaldi S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06373; Rinaldi S, 2012, CLIN INTERV AGING, V7, P191, DOI 10.2147/CIA.S33312; Schwarzenberg M, 1999, ADV SPACE RES, V24, P793, DOI 10.1016/S0273-1177(99)00075-7; Shinde V, 2016, CELL PHYSIOL BIOCHEM, V38, P1483, DOI 10.1159/000443090; Tauber S, 2015, CELL PHYSIOL BIOCHEM, V35, P1034, DOI 10.1159/000373930; Ullrich Oliver, 2008, Cell Commun Signal, V6, P9, DOI 10.1186/1478-811X-6-9; Walther I, 1998, FEBS LETT, V436, P115, DOI 10.1016/S0014-5793(98)01107-7; Weil R, 2006, CELL DEATH DIFFER, V13, P826, DOI 10.1038/sj.cdd.4401856	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200128	10.1371/journal.pone.0200128	http://dx.doi.org/10.1371/journal.pone.0200128			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979723	gold, Green Submitted, Green Published			2022-12-26	WOS:000437809500062
J	Asim, KM; Idris, A; Lqbal, T; Martinez-Alvarez, F				Asim, Khawaja M.; Idris, Adnan; Lqbal, Talat; Martinez-Alvarez, Francisco			Earthquake prediction model using support vector regressor and hybrid neural networks	PLOS ONE			English	Article							SEISMICITY INDICATORS; MUTUAL INFORMATION; MAGNITUDE; QUIESCENCE	Earthquake prediction has been a challenging research area, where a future occurrence of the devastating catastrophe is predicted. In this work, sixty seismic features are computed through employing seismological concepts, such as Gutenberg-Richter law, seismic rate changes, foreshock frequency, seismic energy release, total recurrence time. Further, Maximum Relevance and Minimum Redundancy (mRMR) criteria is applied to extract the relevant features. A Support Vector Regressor (SVR) and Hybrid Neural Network (HNN) based classification system is built to obtain the earthquake predictions. HNN is a step wise combination of three different Neural Networks, supported by Enhanced Particle Swarm Optimization (EPSO), to offer weight optimization at each layer. The newly computed seismic features in combination with SVR-HNN prediction system is applied on Hindukush, Chile and Southern California regions. The obtained numerical results show improved prediction performance for all the considered regions, compared to previous prediction studies.	[Asim, Khawaja M.; Lqbal, Talat] Natl Ctr Phys, Ctr Earthquake Studies, Islamabad, Pakistan; [Idris, Adnan] Univ Poonch, Dept Comp Sci & IT, Rawalakot, Pakistan; [Martinez-Alvarez, Francisco] Pablo Olavide Univ, Dept Comp Sci, Seville, Spain	National Centre for Physics - Pakistan; Universidad Pablo de Olavide	Asim, KM (corresponding author), Natl Ctr Phys, Ctr Earthquake Studies, Islamabad, Pakistan.	asim.khawaja@ncp.edu.pk	Martínez-Álvarez, Francisco/L-5121-2014	Khawaja, Muhammad Asim/0000-0002-6196-4503; Martinez-Alvarez, Francisco/0000-0002-6309-1785	Spanish Ministry of Economy and Competitiveness [TIN2014-55894-C2-R]; Junta de Andalucia [P12-TIC-1728]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta de Andalucia(Junta de Andalucia)	This work was supported by the Spanish Ministry of Economy and Competitiveness, Junta de Andalucia under projects TIN2014-55894-C2-R and P12-TIC-1728, respectively.	Adeli H, 2009, NEURAL NETWORKS, V22, P1018, DOI 10.1016/j.neunet.2009.05.003; Alarifi Abdulrahman S. N., 2012, Journal of King Saud University Science, V24, P301, DOI 10.1016/j.jksus.2011.05.002; Alexandridis A, 2014, IEEE T GEOSCI REMOTE, V52, P5443, DOI 10.1109/TGRS.2013.2288979; Amjady N, 2011, IEEE T SUSTAIN ENERG, V2, P265, DOI 10.1109/TSTE.2011.2114680; Amjady N, 2009, IEEE T POWER SYST, V24, P306, DOI 10.1109/TPWRS.2008.2006997; [Anonymous], 2006, QUATERNARY FAULT FOL; Asencio-Cortes G, 2016, KNOWL-BASED SYST, V101, P15, DOI 10.1016/j.knosys.2016.02.014; Asencio-Cortes G, 2015, NEURAL COMPUT APPL, P1, DOI [10.1007/s00521-015-2121-7, DOI 10.1007/S00521-015-2121-7]; Asim KM, 2017, ACTA GEOPHYS, V65, P919, DOI 10.1007/s11600-017-0082-1; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheng R, 2017, COMPLEX INTELL SYST, V3, P67, DOI 10.1007/s40747-017-0039-7; Cheng R, 2016, IEEE T EVOLUT COMPUT, V20, P773, DOI 10.1109/TEVC.2016.2519378; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cosma G, 2017, EXPERT SYST APPL, V70, P1, DOI 10.1016/j.eswa.2016.11.006; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Grant RA, 2015, PHYS CHEM EARTH, V85-86, P69, DOI 10.1016/j.pce.2015.02.012; Gutierrez-Aviles D, 2015, EVOL BIOINFORM, V11, P121, DOI 10.4137/EBO.S25822; HABERMANN RE, 1988, PURE APPL GEOPHYS, V126, P279, DOI 10.1007/BF00879000; Idris A, 2012, COMPUT ELECTR ENG, V38, P1808, DOI 10.1016/j.compeleceng.2012.09.001; Jilani Z, 2017, J ENVIRON RADIOACTIV, V172, P43, DOI 10.1016/j.jenvrad.2017.03.010; KEILISBOROK VI, 1990, PHYS EARTH PLANET IN, V61, P73, DOI 10.1016/0031-9201(90)90096-G; Kossobokov V., 2002, J SEISMOLOGY EARTHQU, V4, P11; Kossobokov V, 1997, USER MANUAL M8 ALGOR, P6; Last M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146101; Li W, 2016, ADV SPACE RES, V57, P2141, DOI 10.1016/j.asr.2016.02.014; Martinez-Alvarez F, 2013, KNOWL-BASED SYST, V50, P198, DOI 10.1016/j.knosys.2013.06.011; MATTHEWS MV, 1988, PURE APPL GEOPHYS, V126, P357, DOI 10.1007/BF00879003; Morales-Esteban A, 2013, TECTONOPHYSICS, V593, P121, DOI 10.1016/j.tecto.2013.02.036; Morales-Esteban A, 2010, EXPERT SYST APPL, V37, P8333, DOI 10.1016/j.eswa.2010.05.050; Najeebullah, 2015, COMPUT ELECTR ENG, V45, P122, DOI 10.1016/j.compeleceng.2014.07.009; Nanjo KZ, 2006, TECTONOPHYSICS, V424, P351, DOI 10.1016/j.tecto.2006.03.043; Nayak D. R., 2013, INT J COMPUT APPL, V72, P32, DOI [10.5120/12580-9217, DOI 10.5120/12580-9217]; Panakkat A, 2007, INT J NEURAL SYST, V17, P13, DOI 10.1142/S0129065707000890; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pulinets S, 2011, J ASIAN EARTH SCI, V41, P371, DOI 10.1016/j.jseaes.2010.03.005; Reyes J, 2013, APPL SOFT COMPUT, V13, P1314, DOI 10.1016/j.asoc.2012.10.014; Romero-Zaliz RC, 2008, IEEE T EVOLUT COMPUT, V12, P679, DOI 10.1109/TEVC.2008.915995; Saba S, 2016, BAT ANN BASED EARTHQ, P1, DOI [10.1007/s00500-016-2158-2, DOI 10.1007/S00500-016-2158-2]; Tian Y, 2017, IEEE T EVOLUTIONARY; Tian Y, 2017, COMPLEX INTELL SYST, V3, P247, DOI 10.1007/s40747-017-0057-5; Toya Y, 2010, CONCURR COMP-PRACT E, V22, P1569, DOI 10.1002/cpe.1531; Wang Z, 2015, GEOSCIENCEWORLD; Wiemer S, 2000, B SEISMOL SOC AM, V90, P859, DOI 10.1785/0119990114; Zamani A, 2013, EARTH SCI INFORM, V6, P71, DOI 10.1007/s12145-013-0112-8; Zhang X, 2016, IEEE T EVOLUTIONARY	45	48	51	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199004	10.1371/journal.pone.0199004	http://dx.doi.org/10.1371/journal.pone.0199004			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975687	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500018
J	Jeong, DH; Kang, J; Jung, YJ; Yoo, B; Lee, CK; Kim, YG; Hong, S; Shim, TS; Jo, KW				Jeong, Dae Hyun; Kang, Jieun; Jung, Young Ju; Yoo, Bin; Lee, Chang-Keun; Kim, Yong-Gil; Hong, Seokchan; Shim, Tae Sun; Jo, Kyung-Wook			Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; GAMMA RELEASE ASSAYS; MODIFYING ANTIRHEUMATIC DRUGS; ANTI-TNF THERAPY; RHEUMATOID-ARTHRITIS; SKIN-TEST; RECOMMENDATIONS; METAANALYSIS; DIAGNOSIS; DISEASE	This study aims to compare the latent tuberculosis infection (LTBI) screening strategy of interferon-gamma release assay (IGRA)-alone and in combination with tuberculin skin tests (TSTs) before the initiation of tumor necrosis factor (TNF) inhibitor treatment in patients with inflammatory arthritis. Between January 2011 and June 2017, we enrolled 476 patients who were followed up for >= 1 year after the TNF inhibitor initiation in a tertiary referral center in South Korea. Inflammatory arthritis comprised rheumatoid arthritis in 266 (55.9%) and ankylosing spondylitis in 210 (44.1%) patients. The following strategies were used for LTBI screening during the study period: (i) from January 2011 to October 2014, the combination of TST and QuantiFERON-TB Gold In-Tube (QFT-GIT); (ii) between November 2014 and February 2015, QFT-GIT-alone and (iii) since March 2015, either the combination of TST and QFT-GIT or QFT-GIT-alone depending on the attending physician's choice. We compared the screening strategies of QFT-GIT alone and in combination with TST. Overall, 338 (71.0%) patients received LTBI screening tests using the combination of TST and QFT-GIT, and 138 (29.0%) received QFT-GIT-alone. In addition, the LTBI tests were positive in 159 (47.0%) of 338 patients using the combination tests, and 43.8% (148/338) required LTBI treatment. Meanwhile, the LTBI tests were positive in 32.6% (45/138) of QFT-GIT-alone patients, and 30.4% (42/138) required LTBI treatment. Among 338 patients who received combination tests, 2 patients developed active tuberculosis within 1 year after the TNF inhibitor initiation. Of patients who received QFT-GIT-alone, no patient developed tuberculosis. In conclusion, among patients who received QFT-GIT-alone, the number of patients who required LTBI treatment declined compared to the TST and QFT-GIT combination, and none developed active tuberculosis within 1 year, suggesting that QFT-GIT-alone could be a potential screening strategy for diagnosing LTBI in patients with inflammatory arthritis in South Korea.	[Jeong, Dae Hyun; Kang, Jieun; Jung, Young Ju; Shim, Tae Sun; Jo, Kyung-Wook] Univ Ulsan, Coll Med, Asan Med Ctr, Div Pulmonol & Crit Care Med, Seoul, South Korea; [Yoo, Bin; Lee, Chang-Keun; Kim, Yong-Gil; Hong, Seokchan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rheumatol, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Jo, KW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Pulmonol & Crit Care Med, Seoul, South Korea.	healthcliff6800@hanmail.net		KIM, YONG-GIL/0000-0002-8029-7355				Aaltonen KJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043508, 10.1371/journal.pone.0030275]; [Anonymous], 1996, MMWR Recomm Rep, V45, P1; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Bombardier C, 2012, J RHEUMATOL, V39, P1583, DOI 10.3899/jrheum.120165; Brode SK, 2014, INT J TUBERC LUNG D, V18, P1370, DOI 10.5588/ijtld.14.0120; Callhoff J, 2015, ANN RHEUM DIS, V74, P1241, DOI 10.1136/annrheumdis-2014-205322; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; de Leon DP, 2005, ANN RHEUM DIS, V64, P1360, DOI 10.1136/ard.2004.029041; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2009, Pneumologie, V63, P329, DOI 10.1055/s-0029-1214673; Dobler CC, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TNMI7-0026-2016; Dobler CC, 2015, INT J RHEUM DIS, V18, P264, DOI 10.1111/1756-185X.12672; European centre for disease prevention and control, US INT GAMM REL ASS; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242; Hewitt RJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1060; Hong YP, 1998, INT J TUBERC LUNG D, V2, P27; Hsia EC, 2013, ARTHRIT CARE RES, V65, P309, DOI 10.1002/acr.21788; Johnston JC, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TNMI7-0011-2016; Joos TJ, 2006, INT J TUBERC LUNG D, V10, P883; Kim JJ, 2014, KOREAN J RADIOL, V15, P651, DOI 10.3348/kjr.2014.15.5.651; Kim JH, 2015, EMERG INFECT DIS, V21, P1913, DOI 10.3201/eid2111.141894; Kim Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188076; Lee H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119260; Lee SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086419; Lee SH, 2015, TUBERC RESPIR DIS, V78, P56, DOI 10.4046/trd.2015.78.2.56; Lim CH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178035; Lim DH, 2017, KOREAN J INTERN MED, V32, P1090, DOI 10.3904/kjim.2015.357; Mancuso JD, 2017, CHEST, V152, P282, DOI 10.1016/j.chest.2017.01.001; Mariette X, 2003, Ann Rheum Dis, V62, P791, DOI 10.1136/ard.62.8.791; Mariette X, 2012, ANN RHEUM DIS, V71, P1783, DOI 10.1136/annrheumdis-2011-200408; Moon SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139621; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Munoz L, 2013, J INFECTION, V66, P381, DOI 10.1016/j.jinf.2012.12.005; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Park JS, 2011, TUBERC RESPIR DIS, V70, P143, DOI 10.4046/trd.2011.70.2.143; Park SJ, 2015, INT J TUBERC LUNG D, V19, P342, DOI 10.5588/ijtld.14.0554; Park YK, 2013, TUBERC RESPIR DIS, V74, P104, DOI 10.4046/trd.2013.74.3.104; Reid JK, 2007, CHEST, V131, P1806, DOI 10.1378/chest.06-1133; Richeldi L, 2009, CHEST, V136, P198, DOI 10.1378/chest.08-2575; Scrivo R, 2014, INT J RHEUM DIS, V17, P714, DOI 10.1111/1756-185X.12375; Shim TS, 2014, TUBERC RESPIR DIS, V76, P261, DOI 10.4046/trd.2014.76.6.261; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smith R, 2011, CURR OPIN RHEUMATOL, V23, P377, DOI 10.1097/BOR.0b013e3283474d62; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Sterne JAC, 1996, TUBERCLE LUNG DIS, V77, P117, DOI 10.1016/S0962-8479(96)90025-8; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; Winthrop KL, 2012, ANN RHEUM DIS, V71, P1757, DOI 10.1136/annrheumdis-2012-201979; Yoo JW, 2012, TUBERC RESPIR DIS, V72, P409, DOI 10.4046/trd.2012.72.5.409	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0198756	10.1371/journal.pone.0198756	http://dx.doi.org/10.1371/journal.pone.0198756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975703	Green Published, gold, Green Submitted			2022-12-26	WOS:000437424500010
J	Li, X; Ohgami, N; Yajima, I; Xu, HD; Iida, M; Oshino, R; Ninomiya, H; Shen, DD; Ahsan, N; Akhand, AA; Kato, M				Li, Xiang; Ohgami, Nobutaka; Yajima, Ichiro; Xu, Huadong; Iida, Machiko; Oshino, Reina; Ninomiya, Hiromasa; Shen, Dandan; Ahsan, Nazmul; Akhand, Anwarul Azim; Kato, Masashi			Arsenic level in toenails is associated with hearing loss in humans	PLOS ONE			English	Article							DRINKING-WATER; EXPOSURE; BLOOD; PREVALENCE; CHILDREN; ADULTS; ADJUSTMENT; MANGANESE; BARIUM; MODEL	Arsenic (As) pollution in drinking water is a worldwide health risk for humans. We previously showed hearing loss in young people who live in areas of As-polluted drinking water and in young mice orally treated with As. In this study, we epidemiologically examined associations between As levels in toenails and hearing in 145 Bangladeshi aged 12-55 years in 2014. Levels of As in toenails, but not those in urine, were shown to be significantly correlated with hearing loss at 4 kHz [odds ratio (OR) = 4.27; 95% confidence interval (CI): 1.51, 12.05], 8 kHz (OR = 3.91; 95% CI: 1.47, 10.38) and 12 kHz (OR = 4.15; 95% CI: 1.55, 11.09) by multivariate analysis with adjustments for age, sex, smoking and BMI. Our experimental study further showed a significant association between As levels in inner ears and nails (r = 0.8113, p = 0.0014) in mice orally exposed to As, suggesting that As level in nails is a suitable index to assess As level in inner ears. Taken together, the results of our study suggest that As level in nails could be a convenient and non-invasive biomarker for As-mediated hearing loss in humans.	[Li, Xiang; Ohgami, Nobutaka; Yajima, Ichiro; Xu, Huadong; Iida, Machiko; Oshino, Reina; Ninomiya, Hiromasa; Shen, Dandan; Kato, Masashi] Nagoya Univ, Dept Occupat & Environm Hlth, Grad Sch Med, Nagoya, Aichi, Japan; [Ohgami, Nobutaka; Yajima, Ichiro; Iida, Machiko; Oshino, Reina; Ninomiya, Hiromasa; Ahsan, Nazmul; Akhand, Anwarul Azim; Kato, Masashi] Voluntary Body Int Hlth Care Univ, Nagoya, Aichi, Japan; [Ahsan, Nazmul; Akhand, Anwarul Azim] Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka, Bangladesh	Nagoya University; University of Dhaka	Kato, M (corresponding author), Nagoya Univ, Dept Occupat & Environm Hlth, Grad Sch Med, Nagoya, Aichi, Japan.; Kato, M (corresponding author), Voluntary Body Int Hlth Care Univ, Nagoya, Aichi, Japan.	katomasa@med.nagoya-u.ac.jp	Ohgami, Nobutaka/I-4572-2014; Ahsan, Nazmul/AAE-6751-2020; KATO, Masashi/I-7250-2014	Ahsan, Nazmul/0000-0003-1311-1589; Xu, Huadong/0000-0003-2698-1807	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24108002, 16H01639, 18H04975, 15H01743, 15H02588, 16H02962, 17KT0033, 16K08343, 16K08440, 16K10152, 26670525]; Foundation from Center for Advanced Medical and Clinical Research Nagoya University Hospital; Aichi Health Promotion Foundation; Mitsubishi Foundation; AEON Environmental Foundation; Nagono Medical Foundation; Sumitomo Foundation [163119]; Salt Science Research Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation from Center for Advanced Medical and Clinical Research Nagoya University Hospital; Aichi Health Promotion Foundation; Mitsubishi Foundation; AEON Environmental Foundation; Nagono Medical Foundation; Sumitomo Foundation; Salt Science Research Foundation	This study was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas (24108002, 16H01639, 18H04975), Scientific Research (A) (15H01743 and 15H02588), (B) (16H02962, 17KT0033) and (C) (16K08343, 16K08440, 16K10152), Grant-in-Aid for Challenging Exploratory Research (26670525) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Foundation from Center for Advanced Medical and Clinical Research Nagoya University Hospital, Aichi Health Promotion Foundation, the Mitsubishi Foundation, AEON Environmental Foundation, Nagono Medical Foundation, Grant for Environmental Research Projects from the Sumitomo Foundation (163119) and The Salt Science Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly S, 1975, J Egypt Med Assoc, V58, P144; Anderson JE, 2014, WORLD J SURG, V38, P1954, DOI 10.1007/s00268-014-2490-6; BENCKO V, 1977, ENVIRON HEALTH PERSP, V19, P95, DOI 10.2307/3428457; CHEN CJ, 1992, BRIT J CANCER, V66, P888, DOI 10.1038/bjc.1992.380; Cherko M, 2016, MATURITAS, V88, P52, DOI 10.1016/j.maturitas.2016.03.008; Choi YH, 2012, ENVIRON HEALTH PERSP, V120, P1544, DOI 10.1289/ehp.1104863; CHOUCAIR AK, 1988, ANN NEUROL, V23, P628, DOI 10.1002/ana.410230621; Coronado-Gonzalez JA, 2007, ENVIRON RES, V104, P383, DOI 10.1016/j.envres.2007.03.004; Heine C, 2002, DISABIL REHABIL, V24, P763, DOI 10.1080/09638280210129162; Hoffman HJ, 2017, JAMA OTOLARYNGOL, V143, P274, DOI 10.1001/jamaoto.2016.3527; Kato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066681; Kim NH, 2013, AM J EPIDEMIOL, V177, P962, DOI 10.1093/aje/kws329; Krizman J, 2012, CLIN NEUROPHYSIOL, V123, P590, DOI 10.1016/j.clinph.2011.07.037; Kumasaka MY, 2013, ARCH TOXICOL, V87, P439, DOI 10.1007/s00204-012-0964-6; LAI MS, 1994, AM J EPIDEMIOL, V139, P484, DOI 10.1093/oxfordjournals.aje.a117031; Li X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06096-0; Liu JY, 2017, INT J HYG ENVIR HEAL, V220, P424, DOI 10.1016/j.ijheh.2016.12.004; Miller RC, 2004, CLIN CHEM, V50, P924, DOI 10.1373/clinchem.2004.032292; Mumford JL, 2007, ENVIRON HEALTH PERSP, V115, P690, DOI 10.1289/ehp.9686; Ohgami N, 2016, SCI REP-UK, V6, DOI 10.1038/srep36306; Ohgami N, 2016, J EXPO SCI ENV EPID, V26, P488, DOI 10.1038/jes.2015.62; Ohgami N, 2012, NEUROTOXICOLOGY, V33, P1276, DOI 10.1016/j.neuro.2012.07.008; Ohgami N, 2011, TOXICOL IND HEALTH, V27, P143, DOI 10.1177/0748233710382539; Paul S, 2015, ENVIRON INT, V81, P8, DOI 10.1016/j.envint.2015.04.002; Perry MR, 2013, P NATL ACAD SCI USA, V110, P19932, DOI 10.1073/pnas.1311535110; Rahman M, 1998, AM J EPIDEMIOL, V148, P198, DOI 10.1093/oxfordjournals.aje.a009624; Rodrigues EG, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0127-y; Sanchez-Soria P, 2012, TOXICOL PATHOL, V40, P504, DOI 10.1177/0192623311432297; Saunders JE, 2013, AUDIOL NEURO-OTOL, V18, P101, DOI 10.1159/000345470; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Shargorodsky J, 2011, ARCH OTOLARYNGOL, V137, P1177, DOI 10.1001/archoto.2011.202; Shiue I, 2015, ENVIRON SCI POLLUT R, V22, P20306, DOI 10.1007/s11356-015-5546-8; Shiue I, 2013, ENVIRON INT, V53, P41, DOI 10.1016/j.envint.2012.12.006; Su BM, 2017, JAMA OTOLARYNGOL, V143, P920, DOI 10.1001/jamaoto.2017.0953; Sumit AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118960; Szudek J, 2012, J OTOLARYNGOL-HEAD N, V41, pS78, DOI 10.2310/7070.2011.110089; Tsuji JS, 2015, TOXICOLOGY, V337, P91, DOI 10.1016/j.tox.2015.09.002; VALENTINE JL, 1979, ENVIRON RES, V20, P24, DOI 10.1016/0013-9351(79)90082-3; Van Tasell DJ, 2013, OTOL NEUROTOL, V34, P9, DOI 10.1097/MAO.0b013e318278c05d; Waalkes MP, 2007, TOXICOL APPL PHARM, V222, P271, DOI 10.1016/j.taap.2006.12.034; WHO, 1995, PHYS STAT UINT ANT; Yajima I, 2018, J EXPO SCI ENV EPID, V28, P64, DOI 10.1038/jes.2016.70; Yajima I, 2015, J INVEST DERMATOL, V135, P1147, DOI 10.1038/jid.2014.514	43	10	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0198743	10.1371/journal.pone.0198743	http://dx.doi.org/10.1371/journal.pone.0198743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975704	gold, Green Published, Green Submitted			2022-12-26	WOS:000437424500009
J	Salazar-Villanea, S; Butre, CI; Wierenga, PA; Bruininx, EMAM; Gruppen, H; Hendriks, WH; van der Poel, AFB				Salazar-Villanea, Sergio; Butre, Claire, I; Wierenga, Peter A.; Bruininx, Erik M. A. M.; Gruppen, Harry; Hendriks, Wouter H.; van der Poel, Antonius F. B.			Apparent ileal digestibility of Maillard reaction products in growing pigs	PLOS ONE			English	Article							N-EPSILON-CARBOXYMETHYLLYSINE; AMINO-ACID DIGESTIBILITY; METABOLIC TRANSIT; PROTEIN; LYSINE; MEAL; FOOD; ELIMINATION; EXTRUSION; RAPESEED	The absorption of Maillard reaction products (MRP) from dietary origin has been linked to the occurrence of chronic diseases. The aim of the present study was to determine the effects of toasting time of rapeseed meal (RSM) and the processing method of the diets (pelleting and extrusion) that included RSM on the apparent ileal digestibility (AID) of total lysine, fructosyl-lysine (FL), carboxymethyl-lysine (CML), carboxyethyl-lysine (CEL), lanthionine (LAN) and lysinoalanine (LAL) in growing pigs. The study consisted of a 2x3 factorial design with toasting time of RSM (60, 120 min) and diet processing method (mash, pelleted, extruded) as factors. Fifty growing pigs were individually fed one of the experimental diets for 4.5 consecutive days. Following euthanasia, samples of digesta were collected from the terminal 1.5 m of the small intestine. Increasing the toasting time of RSM increased the contents of FL, CML and CEL, whereas the additional effects of the diet processing methods were relatively small. Lysinoalanine and lanthionine were not detected in the diets; therefore, digestibility of these compounds could not be determined. The contents of FL, CML and CEL in the ileal chyme were positively correlated to their contents in the diets. The AID of the MRP from thermally-treated RSM were overall low and were not related to their contents in the diets. The AID of FL ranged between -8.5 and 19.1%, whilst AID of CML and CEL ranged from -0.2 to 18.3 and 3.6 to 30%, respectively. In conclusion, thermal treatments have clear effects on the contents of MRP in the diets. These compounds have relatively low digestibility in growing pigs.	[Salazar-Villanea, Sergio] Wageningen Livestock Res, Wageningen, Netherlands; [Salazar-Villanea, Sergio; Bruininx, Erik M. A. M.; Hendriks, Wouter H.; van der Poel, Antonius F. B.] Wageningen Univ & Res, Anim Nutr Grp, Wageningen, Netherlands; [Butre, Claire, I; Wierenga, Peter A.; Gruppen, Harry] Wageningen Univ & Res, Lab Food Chem, Wageningen, Netherlands; [Bruininx, Erik M. A. M.] Royal Dutch Agrifirm Grp, Agrifirm Innovat Ctr, Apeldoorn, Netherlands; [Salazar-Villanea, Sergio] Univ Costa Rica, Escuela Zootecnia, San Jose, Costa Rica	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Universidad Costa Rica	Salazar-Villanea, S (corresponding author), Wageningen Livestock Res, Wageningen, Netherlands.; Salazar-Villanea, S (corresponding author), Wageningen Univ & Res, Anim Nutr Grp, Wageningen, Netherlands.; Salazar-Villanea, S (corresponding author), Univ Costa Rica, Escuela Zootecnia, San Jose, Costa Rica.	sergio.salazarvillanea@ucr.ac.cr	Bruininx, Erik/J-1901-2019; Wierenga, Peter/AFS-7503-2022	Bruininx, Erik/0000-0003-0799-6528; Salazar Villanea, Sergio/0000-0002-0332-6263; Butre, Claire/0000-0001-5998-0603	Wageningen University & Research "IPOP Customized Nutrition" programme - Wageningen University Research; Dutch Ministry of Economic Affairs; WIAS; Agrifirm Innovation Center; ORFFA Additives BV; Ajinomoto Eurolysines.a.s; Stichting VICTAM BV; Universidad de Costa Rica	Wageningen University & Research "IPOP Customized Nutrition" programme - Wageningen University Research; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); WIAS; Agrifirm Innovation Center; ORFFA Additives BV; Ajinomoto Eurolysines.a.s; Stichting VICTAM BV; Universidad de Costa Rica	The authors gratefully acknowledge the financial support from the Wageningen University & Research "IPOP Customized Nutrition" programme financed by Wageningen University & Research, the Dutch Ministry of Economic Affairs, WIAS, Agrifirm Innovation Center, ORFFA Additives BV, Ajinomoto Eurolysines.a.s and Stichting VICTAM BV. SSV acknowledges the support of the Universidad de Costa Rica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Alamir I, 2013, AMINO ACIDS, V44, P1441, DOI 10.1007/s00726-012-1427-3; Almeida FN, 2014, ANIM FEED SCI TECH, V187, P44, DOI 10.1016/j.anifeedsci.2013.09.009; Bos C, 2007, J NUTR, V137, P594, DOI 10.1093/jn/137.3.594; Boutry C, 2008, P NUTR SOC, V67, pE201; Deglaire A, 2012, BR J NUTR S2, V108, P15; Deglaire A, 2009, BRIT J NUTR, V102, P1752, DOI 10.1017/S0007114509991267; Delgado-Andrade C, 2016, FOOD FUNCT, V7, P46, DOI [10.1039/c5fo00918a, 10.1039/C5FO00918A]; Delgado-Andrade C, 2012, AMINO ACIDS, V43, P595, DOI 10.1007/s00726-011-1107-8; Eklund M, 2015, J ANIM SCI, V93, P2813, DOI 10.2527/jas.2014-8210; Fang YQ, 2013, J FOOD ENG, V115, P220, DOI 10.1016/j.jfoodeng.2012.10.017; Friedman M, 1996, J AGR FOOD CHEM, V44, P631, DOI 10.1021/jf950394r; GERMOND JE, 1987, J TOXICOL ENV HEALTH, V22, P79, DOI 10.1080/15287398709531052; Gonzalez-Vega JC, 2011, J ANIM SCI, V89, P3617, DOI 10.2527/jas.2010-3465; Hellwig M, 2014, AMINO ACIDS, V46, P289, DOI 10.1007/s00726-013-1501-5; Hull GLJ, 2012, FOOD CHEM, V131, P170, DOI 10.1016/j.foodchem.2011.08.055; Krause R, 2003, EUR FOOD RES TECHNOL, V216, P277, DOI 10.1007/s00217-002-0649-0; Liang ZL, 2016, J SCI FOOD AGR, V96, P2555, DOI 10.1002/jsfa.7376; LIARDON R, 1987, J AGR FOOD CHEM, V35, P427, DOI 10.1021/jf00075a035; Morgan NK, 2014, ANIMAL, V8, P529, DOI 10.1017/S1751731114000068; Moughan PJ, 1996, J AGR FOOD CHEM, V44, P1520, DOI 10.1021/jf950428v; NIEDERWIESER A, 1975, PEDIATR RES, V9, P867, DOI 10.1203/00006450-197509110-00090; Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052; Rerat A, 2002, EUR J NUTR, V41, P1, DOI 10.1007/s003940200000; Rojas OJ, 2016, J ANIM SCI, V94, P1951, DOI 10.2527/jas.2015-0137; Roncero-Ramos I, 2013, FOOD FUNCT, V4, P1032, DOI 10.1039/c3fo30351a; Salazar-Villanea S, 2018, ANIMAL, V12, P950, DOI 10.1017/S1751731117002476; Somoza V, 2005, MOL NUTR FOOD RES, V49, P663, DOI 10.1002/mnfr.200500034; Somoza V, 2005, ANN NY ACAD SCI, V1043, P492, DOI 10.1196/annals.1333.056; Somoza V, 2006, MOL NUTR FOOD RES, V50, P833, DOI 10.1002/mnfr.200600021; van Boekel M, 2010, MOL NUTR FOOD RES, V54, P1215, DOI 10.1002/mnfr.200900608; van Rooijen C, 2016, J ANIM SCI, V94, P185, DOI 10.2527/jas.2015-9550	32	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199499	10.1371/journal.pone.0199499	http://dx.doi.org/10.1371/journal.pone.0199499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975743	Green Submitted, gold, Green Published			2022-12-26	WOS:000437424500034
J	Rocha-Ferreira, E; Vincent, A; Bright, S; Peebles, DM; Hristova, M				Rocha-Ferreira, Eridan; Vincent, Amy; Bright, Sarah; Peebles, Donald M.; Hristova, Mariya			The duration of hypothermia affects short-term neuroprotection in a mouse model of neonatal hypoxic ischaemic injury	PLOS ONE			English	Article							BRAIN-INJURY; MODERATE HYPOTHERMIA; CELL-DEATH; PHAGOCYTES; MICROGLIA; LIGHT; XENON; LONG	Neonatal hypoxic-ischaemic encephalopathy (HIE) is major cause of neonatal mortality and morbidity. Therapeutic hypothermia is standard clinical care for moderate hypoxic-ischaemic (HI) brain injury, however it reduces the risk of death and disability only by 11 % and 40% of the treated infants still develop disabilities. Thus it is necessary to develop supplementary therapies to complement therapeutic hypothermia in the treatment of neonatal HIE. The modified Rice-Vannucci model of HI in the neonatal mouse is well developed and widely applied with different periods of hypothermia used as neuroprotective strategy in combination with other agents. However, different studies use different periods, time of initiation and duration of hypothermia following HI, with subsequent varying degrees of neuroprotection. So far most rodent data is obtained using exposure to 5-6h of therapeutic hypothermia. Our aim was to compare the effect of exposure to three different short periods of hypothermia (1h, 1.5h and 2h) following HI insult in the postnatal day 7 C57/BI6 mouse, and to determine the shortest period providing neuroprotection. Our data suggests that 1h and 1.5h of hypothermia delayed by 20min following a 60min exposure to 8%O-2 do not prove neuroprotective. However, 2h of hypothermia significantly reduced tissue loss, TUNEL+ cell death and microglia and astroglia activation. We also observed improved functional outcome 7 days after HI. We suggest that the minimal period of cooling necessary to provide moderate short term neuroprotection and appropriate for the development and testing of combined treatment is 2h.	[Rocha-Ferreira, Eridan; Vincent, Amy; Bright, Sarah; Peebles, Donald M.; Hristova, Mariya] UCL Inst Womens Hlth Maternal & Fetal Med, Perinatal Brain Repair Grp, London, England	University of London; University College London	Hristova, M (corresponding author), UCL Inst Womens Hlth Maternal & Fetal Med, Perinatal Brain Repair Grp, London, England.	m.hristova@ucl.ac.uk		Hristova, Mariya/0000-0002-5017-5744	Wellcome Trust [WT088646MA, WT089624MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by research grants from Wellcome Trust (WT088646MA and WT089624MA).	Alonso-Alconada D, 2015, STROKE, V46, P275, DOI 10.1161/STROKEAHA.114.007330; Azzopardi D, 2016, LANCET NEUROL, V15, P145, DOI 10.1016/S1474-4422(15)00347-6; Bohatschek M, 2001, J NEUROSCI RES, V64, P508, DOI 10.1002/jnr.1103; Bona E, 1998, PEDIATR RES, V43, P738, DOI 10.1203/00006450-199806000-00005; Burnsed JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118889; Carlsson Y, 2012, PEDIATR RES, V71, P566, DOI 10.1038/pr.2012.15; Clarkson J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0115; Davidson JO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00198; Davidson JO, 2015, J CEREBR BLOOD F MET, V35, P751, DOI 10.1038/jcbfm.2014.259; Diaz J, 2017, DEV NEUROSCI-BASEL, V39, P257, DOI 10.1159/000454949; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Erkenstam NH, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00286; Fan XY, 2013, PEDIATR RES, V73, P18, DOI 10.1038/pr.2012.139; Faulkner S, 2011, ANN NEUROL, V70, P133, DOI 10.1002/ana.22387; Griesmaier E, 2014, BRAIN RES, V1556, P10, DOI 10.1016/j.brainres.2014.01.034; Hristova M, 2016, J NEUROCHEM, V136, P981, DOI 10.1111/jnc.13490; Hristova M, 2010, GLIA, V58, P11, DOI 10.1002/glia.20896; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Johnston MV, 2011, LANCET NEUROL, V10, P372, DOI 10.1016/S1474-4422(11)70016-3; Kattwinkel J, 2010, CIRCULATION, V122, pS909, DOI 10.1161/CIRCULATIONAHA.110.971119; Kendall GS, 2011, LAB INVEST, V91, P328, DOI 10.1038/labinvest.2010.192; Kendall GS, 2006, PEDIATR RES, V59, P227, DOI 10.1203/01.pdr.0000196805.68082.22; Kerenyi A, 2012, PEDIATR RES, V71, P573, DOI 10.1038/pr.2012.8; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kloss CUA, 1999, J COMP NEUROL, V411, P162, DOI 10.1002/(SICI)1096-9861(19990816)411:1<162::AID-CNE12>3.0.CO;2-W; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lange S, 2014, J NEUROCHEM, V130, P555, DOI 10.1111/jnc.12744; Lawn JE, 2005, NEONATAL SURVIVAL 1, P891; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Marion D, 2009, CURRENT AND FUTURE R; Moller JC, 1996, GLIA, V17, P121; Reinboth BS, 2016, EXP NEUROL, V283, P264, DOI 10.1016/j.expneurol.2016.06.024; Robertson NJ, 2013, BRAIN, V136, P90, DOI 10.1093/brain/aws285; Rocha-Ferreira E, 2015, NEUROSCIENCE, V311, P292, DOI 10.1016/j.neuroscience.2015.10.035; Rocha-Ferreira E, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4901014; Roedel A, 2006, LAB ANIM-UK, V40, P371, DOI 10.1258/002367706778476343; Roka A, 2010, EARLY HUM DEV, V86, P361, DOI 10.1016/j.earlhumdev.2010.05.013; Sabir H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156759; Sabir H, 2012, STROKE, V43, P3364, DOI 10.1161/STROKEAHA.112.674481; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Sheldon RA, 1998, BRAIN RES, V810, P114, DOI 10.1016/S0006-8993(98)00892-0; Smith Amanda L., 2015, NEURAL PLAST, P2349, DOI [10.16192/j.cnki.1003-2053.2015.02.013, DOI 10.16192/J.CNKI.1003-2053.2015.02.013]; Trescher WH, 1997, BRAIN DEV-JPN, V19, P326, DOI 10.1016/S0387-7604(97)00027-2; Vannucci RC, 1997, ANN NY ACAD SCI, V835, P234, DOI 10.1111/j.1749-6632.1997.tb48634.x; Wood T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23430; Wu YW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0191; Yang M, 2008, FRONT NEUROSCI-SWITZ, V2, P193, DOI 10.3389/neuro.01.029.2008	48	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199890	10.1371/journal.pone.0199890	http://dx.doi.org/10.1371/journal.pone.0199890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969470	Green Published, Green Submitted, gold			2022-12-26	WOS:000437246700034
J	Chen, ZJ; Ai, LB; Mboge, MY; Tu, CK; McKenna, R; Brown, KD; Heldermon, CD; Frost, SC				Chen, Zhijuan; Ai, Lingbao; Mboge, Mam Y.; Tu, Chingkuang; McKenna, Robert; Brown, Kevin D.; Heldermon, Coy D.; Frost, Susan C.			Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; TRANSPORT METABOLON; INTRACELLULAR PH; O-18 EXCHANGE; LACTIC-ACID; HUMAN GUT; MN/CA IX; IN-VIVO; HYPOXIA; CARCINOMA	Carbonic anhydrase IX (CAIX) and XII (CAXII) are transmembrane proteins that are associated with cancer progression. We have previously described the catalytic properties of CAIX in MDA-MB-231 breast cancer cells, a line of cells that were derived from a patient with triple negative breast cancer. We chose this line because CAIX expression in breast cancer is a marker of hypoxia and a prognosticator for reduced survival. However, CAXII expression is associated with better survival statistics than those patients with low CAXII expression. Yet CAIX and CAXII have similar catalytic activities. Here we compare the potential roles of CAIX and CAXII in the context of TNBC and estrogen receptor (ER)-positive breast cancer. In tumor graft models, we show that CAIX and CAXII exhibit distinct expression patterns and non-overlapping. We find the same pattern across a panel of TNBC and luminal breast cancer cell lines. This affords an opportunity to compare directly CAIX and CAXII function. Our data suggest that CAIX expression is associated with growth potentiation in the tumor graft model and in a TNBC line using knockdown strategies and blocking activity with an impermeant sulfonamide inhibitor, N-3500. CAXII was not associated with growth potentiation. The catalytic activities of both CAIX and CAXII were sensitive to inhibition by N-3500 and activated at low pH. However, pH titration of activity in membrane ghosts revealed significant differences in the catalytic efficiency and pKa values. These features provide evidence that CAIX is a more efficient enzyme than CAXII at low pH and that CAIX shifts the equilibrium between CO2 and bicarbonate in favor of CO2 production by consuming protons. This suggests that in the acidic microenvironment of tumors, CAIX plays a role in stabilizing pH at a value that favors cancer cell survival.	[Chen, Zhijuan; Mboge, Mam Y.; Tu, Chingkuang; McKenna, Robert; Brown, Kevin D.; Frost, Susan C.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Ai, Lingbao; Heldermon, Coy D.] Univ Florida, Dept Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Frost, SC (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	sfrost@ufl.edu		Frost, Susan/0000-0002-2020-097X; Heldermon, Coy/0000-0002-2148-2868	UF Health Cancer Center [CA 165284, CA 165284.03S1]; Gatorade Trust through Department of Medicine, University of Florida; UF Health Cancer Center; NATIONAL CANCER INSTITUTE [R01CA165284] Funding Source: NIH RePORTER	UF Health Cancer Center; Gatorade Trust through Department of Medicine, University of Florida; UF Health Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: CA 165284 nih.gov (SCF), CA 165284.03S1 nih.gov (MYM), UF Health Cancer Center cancer.ufl.edu (MYM). Author CDH's lab was supported by funds from Gatorade Trust through Department of Medicine, University of Florida, and by the UF Health Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LB, 2014, CANCER RES, V74, P4875, DOI 10.1158/0008-5472.CAN-13-3579; Barnett DH, 2008, CANCER RES, V68, P3505, DOI 10.1158/0008-5472.CAN-07-6151; Becker HM, 2007, J BIOL CHEM, V282, P13508, DOI 10.1074/jbc.M700066200; Chen ZJ, 2018, CANCER BIOL THER, V19, P598, DOI 10.1080/15384047.2018.1449612; Chia SK, 2001, J CLIN ONCOL, V19, P3660, DOI 10.1200/JCO.2001.19.16.3660; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Creighton CJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r28; Delacruz J, 2010, ANAL BIOCHEM, V403, P74, DOI 10.1016/j.ab.2010.04.019; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Ditte P, 2011, CANC RES; Fiaschi T, 2013, CELL CYCLE, V12, P1791, DOI 10.4161/cc.24902; Frost SC, 2014, SUBCELL BIOCHEM, V75, P9, DOI 10.1007/978-94-007-7359-2_2; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Generali D, 2006, ENDOCR-RELAT CANCER, V13, P921, DOI 10.1677/erc.1.01216; Helmlinger G, 2002, CLIN CANCER RES, V8, P1284; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; Hilvo M, 2009, J MED CHEM, V52, P646, DOI 10.1021/jm801267c; Hulikova A, 2009, FEBS LETT, V583, P3563, DOI 10.1016/j.febslet.2009.10.060; Ilie MI, 2011, INT J CANCER, V128, P1614, DOI 10.1002/ijc.25491; Jia ZJ, 2005, J BIOL CHEM, V280, P30564, DOI 10.1074/jbc.M501754200; Kivela A, 2000, AM J PATHOL, V156, P577, DOI 10.1016/S0002-9440(10)64762-1; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Li Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.188524; Li Y, 2011, BBA-MOL CELL RES, V1813, P159, DOI 10.1016/j.bbamcr.2010.09.018; Li Y, 2009, CANCER INVEST, V27, P613, DOI 10.1080/07357900802653464; Lou YM, 2011, CANCER RES, V71, P3364, DOI 10.1158/0008-5472.CAN-10-4261; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahon BP, 2016, BIOCHEMISTRY-US, V55, P4642, DOI 10.1021/acs.biochem.6b00243; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Morgan PE, 2007, AM J PHYSIOL-CELL PH, V293, pC738, DOI 10.1152/ajpcell.00157.2007; Nakagawa M, 2011, ANTICANCER RES, V31, P2389; NEWELL K, 1993, P NATL ACAD SCI USA, V90, P1127, DOI 10.1073/pnas.90.3.1127; Nguyen TN, 2000, EXP CELL RES, V258, P171, DOI 10.1006/excr.2000.4929; Nordfors K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-148; Opavsky R, 1996, GENOMICS, V33, P480, DOI 10.1006/geno.1996.0223; Pacchiano F, 2011, J MED CHEM, V54, P1896, DOI 10.1021/jm101541x; Parkkila S, 2001, P NATL ACAD SCI USA, V98, P1918, DOI 10.1073/pnas.98.4.1918; Pastorekova S, 1997, GASTROENTEROLOGY, V112, P398, DOI 10.1053/gast.1997.v112.pm9024293; Potter C, 2004, CELL CYCLE, V3, P164; Saarnio J, 1998, J HISTOCHEM CYTOCHEM, V46, P497, DOI 10.1177/002215549804600409; SCHWICKERT G, 1995, CANCER RES, V55, P4757; Shah GN, 2005, P NATL ACAD SCI USA, V102, P16771, DOI 10.1073/pnas.0508449102; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; SILVERMAN DN, 1981, RESP PHYSIOL, V44, P285, DOI 10.1016/0034-5687(81)90024-4; SILVERMAN DN, 1974, MOL PHARMACOL, V10, P820; Span PN, 2003, BRIT J CANCER, V89, P271, DOI 10.1038/sj.bjc.6601122; Sterling D, 2002, J BIOL CHEM, V277, P25239, DOI 10.1074/jbc.M202562200; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stillebroer AB, 2010, EUR UROL, V58, P75, DOI 10.1016/j.eururo.2010.03.015; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Svastova E, 2013, CELL ADHES MIGR, V7, P226, DOI 10.4161/cam.23257; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; TU C, 1978, J BIOL CHEM, V253, P8178; Watson PH, 2003, BRIT J CANCER, V88, P1065, DOI 10.1038/sj.bjc.6600796; Wykoff CC, 2001, AM J PATHOL, V158, P1011, DOI 10.1016/S0002-9440(10)64048-5; Wykoff CC, 2000, CANCER RES, V60, P7075; Yamagata M, 1998, BRIT J CANCER, V77, P1726, DOI 10.1038/bjc.1998.289; Zhang BY, 2013, BJU INT, V111, P1046, DOI 10.1111/bju.12075	60	34	34	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199476	10.1371/journal.pone.0199476	http://dx.doi.org/10.1371/journal.pone.0199476			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965974	Green Published, Green Submitted, gold			2022-12-26	WOS:000437224100012
J	Moriwaki, Y; Ohno, Y; Ishii, T; Takamura, Y; Kita, Y; Watabe, K; Sango, K; Tsuji, S; Misawa, H				Moriwaki, Yasuhiro; Ohno, Yuho; Ishii, Tomohiro; Takamura, Yuki; Kita, Yuko; Watabe, Kazuhiko; Sango, Kazunori; Tsuji, Shoutaro; Misawa, Hidemi			SIMPLE binds specifically to PI4P through SIMPLE-like domain and participates in protein trafficking in the trans-Golgi network and/or recycling endosomes	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; MEMBRANE-PROTEIN; ESCRT MACHINERY; DEGRADATION; RECEPTOR; LITAF; GENE; LIPOPOLYSACCHARIDE; MUTATIONS; INTERACTS	Small integral membrane protein of the lysosome/late endosome (SIMPLE) is a 161-amino acid cellular protein that contains a characteristic C-terminal domain known as the SIMPLE-like domain (SLD), which is well conserved among species. Several studies have demonstrated that SIMPLE localizes to the trans-Golgi network (TGN), early endosomes, lyso-somes, multivesicular bodies, aggresomes and the plasma membrane. However, the amino acid regions responsible for its subcellular localization have not yet been identified. The SLD resembles the FYVE domain, which binds phosphatidylinositol (3)-phosphate (PI3P) and determines the subcellular localization of FYVE domain-containing proteins. In the present study, we have found that SIMPLE binds specifically to PI4P through its SLD. SIMPLE co-localized with PI4P and Rab11, a marker for recycling endosomes (REs, organelles enriched in PI4P) in both the IMS32 mouse Schwann cell line and Hela cells. Sucrose density-gradient centrifugation revealed that SIMPLE co-fractionated with syntaxin-6 (a TGN marker) and Rab11. We have also found that SIMPLE knockdown impeded recycling of transferrin and of transferrin receptor. Our overall results indicate that SIMPLE may regulate protein trafficking physiologically by localizing to the TGN and/or REs by binding PI4P.	[Moriwaki, Yasuhiro; Ohno, Yuho; Ishii, Tomohiro; Takamura, Yuki; Kita, Yuko; Misawa, Hidemi] Keio Univ, Fac Pharm, Div Pharmacol, Minato Ku, Tokyo, Japan; [Ishii, Tomohiro; Watabe, Kazuhiko] Tokyo Metropolitan Inst Med Sci, Lab Neurodegenerat Pathol, Setagaya Ku, Tokyo, Japan; [Sango, Kazunori] Tokyo Metropolitan Inst Med Sci, Diabet Neuropathy Project, Setagaya Ku, Tokyo, Japan; [Tsuji, Shoutaro] Kanagawa Canc Ctr, Mol Diagnost Project, Res Inst, Yokohama, Kanagawa, Japan	Keio University; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Kanagawa Prefectural Cancer Center	Moriwaki, Y; Misawa, H (corresponding author), Keio Univ, Fac Pharm, Div Pharmacol, Minato Ku, Tokyo, Japan.	moriwaki-ys@pha.keio.ac.jp; misawa-hd@pha.keio.ac.jp		Moriwaki, Yasuhiro/0000-0001-9533-0421; Ishii, Tomohiro/0000-0003-3092-1401	JSPS KAKENHI Grant [15K21370, 16K15129]; MEXT KAKENHI Grant [25293020]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Smoking Research Foundation	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation	This work was supported in part by JSPS KAKENHI Grant Number 15K21370 (Y.M.) and 16K15129 (H.M.), MEXT KAKENHI Grant Number 25293020 (H.M.), MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2014-2016 (H.M.), Smoking Research Foundation (H.M.).	Bucci C, 2012, PROG NEUROBIOL, V99, P191, DOI 10.1016/j.pneurobio.2012.03.003; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Chies R, 2003, J CELL SCI, V116, P987, DOI 10.1242/jcs.00326; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Eaton HE, 2013, J VIROL, V87, P716, DOI 10.1128/JVI.01857-12; Eaton HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030003; Eaton HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016873; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hasdemir B, 2007, J BIOL CHEM, V282, P29646, DOI 10.1074/jbc.M702974200; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Ho AK, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0332-8; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jovic M, 2009, MOL BIOL CELL, V20, P2731, DOI 10.1091/mbc.E08-11-1102; Lacerda AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103454; Lee SM, 2012, J CELL BIOL, V199, P799, DOI 10.1083/jcb.201204137; Lee SM, 2011, J CELL SCI, V124, P3319, DOI 10.1242/jcs.087114; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Moriwaki Y, 2001, J BIOL CHEM, V276, P23065, DOI 10.1074/jbc.M011660200; Moriwaki Y, 2009, NEUROSCI RES, V64, P403, DOI 10.1016/j.neures.2009.04.014; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Neefjes J, 2014, TRENDS NEUROSCI, V37, P66, DOI 10.1016/j.tins.2013.11.006; Olkkonen VM, 2006, J CELL SCI, V119, P5031, DOI 10.1242/jcs.03303; Pietiainen V, 2013, J CELL SCI, V126, P3961, DOI 10.1242/jcs.128132; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Qin WX, 2016, BIOCHEM J, V473, P3965, DOI 10.1042/BCJ20160657; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Roberts RC, 2010, HUM MOL GENET, V19, P1009, DOI 10.1093/hmg/ddp565; Saifi GM, 2005, HUM MUTAT, V25, P372, DOI 10.1002/humu.20153; Schmidt O, 2012, CURR BIOL, V22, pR116, DOI 10.1016/j.cub.2012.01.028; Shirk AJ, 2005, J NEUROSCI RES, V82, P43, DOI 10.1002/jnr.20628; Stendel C, 2010, BRAIN, V133, P2462, DOI 10.1093/brain/awq168; Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Tsuji S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45768; WATABE K, 1995, J NEUROSCI RES, V41, P279, DOI 10.1002/jnr.490410215; Waugh MG, 2013, NAT PROTOC, V8, P2429, DOI 10.1038/nprot.2013.148; Zhu H, 2013, MOL BIOL CELL, V24, P1619, DOI 10.1091/mbc.E12-07-0544	40	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199829	10.1371/journal.pone.0199829	http://dx.doi.org/10.1371/journal.pone.0199829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953492	gold, Green Published, Green Submitted			2022-12-26	WOS:000436645400079
J	Oveges, N; Laszlo, I; Tanczos, K; Nemeth, M; Lebak, G; Tudor-Drobjewski, BA; Erces, D; Kaszaki, J; Rudas, L; Huber, W; Molnar, Z				Oveges, Nandor; Laszlo, Ildiko; Tanczos, Krisztian; Nemeth, Marton; Lebak, Gabor; Tudor-Drobjewski, Bianca-Andreea; Erces, Daniel; Kaszaki, Jozsef; Rudas, Laszlo; Huber, Wolfgang; Molnar, Zsolt			Mean arterial pressure targeted fluid resuscitation may lead to fluid overload: A bleeding-resuscitation animal experiment	PLOS ONE			English	Article							INTENSIVE-CARE; HEMORRHAGIC-SHOCK; BLOOD-PRESSURE; CARDIAC INDEX; ORGAN FAILURE; SEPTIC SHOCK; SEPSIS; SATURATION; TRAUMA; COHORT	Introduction Fluid resuscitation is the cornerstone of treatment in hemorrhagic shock. Despite increasing doubts, several guidelines recommend to maintain mean arterial pressure (MAP) > 65 mmHg as the most frequent indication of fluid therapy. Our aim was to investigate the effects of a MAP-guided management in a bleeding-resuscitation animal experiment. Materials and methods After anesthesia and instrumentation (t(bsl)) animals were bled till the initial stroke volume index dropped by 50% (t(0)). Fluid replacement was performed in 4 equivalent steps (t(1-4)) with balanced crystalloid solution to reach the baseline values of MAP. Invasive hemodynamic measurements and blood gas analyses were performed after each step. Results Mean arterial pressure dropped from t(bsl) to t(0) (114 +/- 11 vs 76.9 +/- 16.9 mmHg, p<0.001) and returned to baseline by t(4) (101.4 +/- 14.4 mmHg). From t(bsl)-t(0) stroke volume index (SVI), cardiac index (CI) decreased (SVI: 40 +/- 8.6 vs 19.3 +/- 3.6 ml/m(2), p<0.001; CI:3.4 +/- 0.3 vs 1.9 +/- 0.3 l/min/m(2), p<0.001), pulse pressure variation (PPV) increased (13.2 +/- 4.3 vs 22.1 +/- 4.3%, p<0.001). There was a decrease in oxygen delivery (464 +/- 45 vs 246 +/- 26.9 ml/min, p<0.001), central venous oxygen saturation (82.8 +/- 5.4 vs 53.6 +/- 12.1%, p<0.001) and increase in lactate levels (1.6 +/- 0.4 vs 3.5 +/- 1.6 mmol/l, p<0.005). SVI, CI and PPV returned to their initial values by t(2). To normalize MAP fluid therapy had to be continued till t(4), with the total infused volume of 4.5 +/- 0.8 I. Conclusion In the current experiment bleeding led to hemorrhagic shock, while MAP remained higher than 65 mmHg. Furthermore, MAP was unable to indicate the normalization of SVI, CI and PPV that resulted in unnecessary fluid administration. Our data give further evidence that MAP may be an inappropriate parameter to follow during fluid resuscitation.	[Oveges, Nandor; Laszlo, Ildiko; Tanczos, Krisztian; Nemeth, Marton; Lebak, Gabor; Rudas, Laszlo; Molnar, Zsolt] Univ Szeged, Dept Anesthesiol & Intens Therapy, Szeged, Hungary; [Tudor-Drobjewski, Bianca-Andreea] Med Univ Vienna, Dept Anesthesiol & Gen Intens Care Med, Vienna, Austria; [Erces, Daniel; Kaszaki, Jozsef] Univ Szeged, Inst Surg Res, Szeged, Hungary; [Huber, Wolfgang] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, Munich, Germany	Szeged University; Medical University of Vienna; Szeged University; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Oveges, N (corresponding author), Univ Szeged, Dept Anesthesiol & Intens Therapy, Szeged, Hungary.	nandor.oveges@gmail.com	Tudor-Drobjewski, Bianca-Andreea/GSD-2836-2022; Tánczos, Krisztián/GZM-5336-2022		National Research, Development and Innovation Office [NKFIH K116689]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	The study was supported by the National Research, Development and Innovation Office (NKFIH K116689) to Jozsef Kaszaki. (http://nkfih.gov.hu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels K, 2016, ANESTH ANALG, V122, P1866, DOI 10.1213/ANE.0000000000001340; BENJAMIN E, 1987, CRIT CARE MED, V15, P516, DOI 10.1097/00003246-198705000-00013; Bentzer P, 2016, JAMA-J AM MED ASSOC, V316, P1298, DOI 10.1001/jama.2016.12310; Bijker JB, 2007, ANESTHESIOLOGY, V107, P213, DOI 10.1097/01.anes.0000270724.40897.8e; BLAND RD, 1985, CRIT CARE MED, V13, P85, DOI 10.1097/00003246-198502000-00006; Cecconi M, 2015, INTENS CARE MED, V41, P1529, DOI 10.1007/s00134-015-3850-x; Cecconi M, 2014, INTENS CARE MED, V40, P1795, DOI 10.1007/s00134-014-3525-z; Choudhry MA, 2005, SHOCK, V24, P101, DOI 10.1097/01.shk.0000191341.31530.5e; Cuschieri J, 2005, INTENS CARE MED, V31, P818, DOI 10.1007/s00134-005-2602-8; Deitch EA, 2007, ANN SURG, V246, P447, DOI 10.1097/SLA.0b013e318148566; Dellinger RP, 2017, INTENS CARE MED, V43, P299, DOI 10.1007/s00134-017-4681-8; Howell MD, 2017, JAMA-J AM MED ASSOC, V317, P847, DOI 10.1001/jama.2017.0131; Jhanji S, 2010, CRIT CARE, V14, DOI 10.1186/cc9220; Linton RAF, 2002, J CARDIOTHOR VASC AN, V16, P4, DOI 10.1053/jcan.2002.29631; Magder SA, 2014, CRIT CARE MED, V42, P1241, DOI 10.1097/CCM.0000000000000324; Marik PE, 2013, CRIT CARE MED, V41, P1774, DOI 10.1097/CCM.0b013e31828a25fd; Martini WZ, 2013, J TRAUMA ACUTE CARE, V74, P732, DOI 10.1097/TA.0b013e31827f156d; Mees ST, 2008, SHOCK, V29, P670, DOI 10.1097/SHK.0b013e31815c3ea0; Molnar Z, 2017, CURR OPIN ANAESTHESI, P1; Monnet X, 2011, CRIT CARE MED, V39, P1394, DOI 10.1097/CCM.0b013e31820edcf0; MYTHEN MG, 1994, INTENS CARE MED, V20, P99, DOI 10.1007/BF01707662; Nemeth M, 2014, ACTA ANAESTH SCAND, V58, P611, DOI 10.1111/aas.12312; Pearse R, 2005, CRIT CARE, V9, pR694, DOI 10.1186/cc3888; Pierrakos C, 2012, INTENS CARE MED, V38, P422, DOI 10.1007/s00134-011-2457-0; Poeze M, 1999, CRIT CARE MED, V27, P1288, DOI 10.1097/00003246-199907000-00013; Polonen P, 1997, ACTA ANAESTH SCAND, P0, DOI [10.1007/s00134-005-2602-8, DOI 10.1007/S00134-005-2602-8]; Rivers EP, 2011, CHEST, V140; SHOEMAKER WC, 1988, CRIT CARE MED, V16, P1117, DOI 10.1097/00003246-198811000-00007; Sun YX, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1728-8; Tanczos K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/160979; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A	31	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0196188	10.1371/journal.pone.0196188	http://dx.doi.org/10.1371/journal.pone.0196188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953455	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000436645400002
J	Pinzari, M; Santonico, M; Pennazza, G; Martinelli, E; Capuano, R; Paolesse, R; Di Rao, M; D'Amico, A; Cesaroni, D; Sbordoni, V; Di Natale, C				Pinzari, Manuela; Santonico, Marco; Pennazza, Giorgio; Martinelli, Eugenio; Capuano, Rosamaria; Paolesse, Roberto; Di Rao, Massimo; D'Amico, Arnaldo; Cesaroni, Donatella; Sbordoni, Valerio; Di Natale, Corrado			Chemically mediated species recognition in two sympatric Grayling butterflies: Hipparchia fagi and Hipparchia hermione (Lepidoptera: Nymphalidae, Satyrinae)	PLOS ONE			English	Article							SEX; PHEROMONES; EVOLUTION; CHOICE; MOTHS	Pheromones are known to play an important role in butterfly courtship and may influence both individual reproductive success and reproductive isolation between species. Recent studies have focused on courtship in Hipparchia butterflies (Nymphalidae: Satyrinae) emphasizing morphological and behavioural traits, as well as genetic differences. Behavioural observations suggested a role for chemical cues in mate and species recognition, where the androconial scales on the forewings of these species may be involved in chemical communication between individuals. Cchemical-mediated signals have received relatively little attention in this genus. Here, we report the results of a three-year investigation of the volatile organic compounds (VOCs) released by Hipparchia fagi and H. hermione in order to identify differences in VOCs between these species where they live in syntopy. Our study was carried out using an array of cross-selective sensors known as an "Electronic Nose" (EN) that operates by converting chemical patterns into patterns of sensor signals. While the identity of volatile compounds remained unknown, sensor signals can be compared to identify similar or dissimilar chemical patterns. Based on the EN signals, our results showed that: 1) the two sexes have a similar VOCs pattern in H. fagi, while they significantly diverge in H. hermione; 2) VOCs patterns were different between females of the two species, while those of males were not.	[Pinzari, Manuela; Di Rao, Massimo; Cesaroni, Donatella; Sbordoni, Valerio] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Santonico, Marco; Pennazza, Giorgio] Univ Campus Biomed, CIR, Unit Elect Sensor Syst, Rome, Italy; [Martinelli, Eugenio; Capuano, Rosamaria; D'Amico, Arnaldo; Cesaroni, Donatella; Di Natale, Corrado] Univ Roma Tor Vergata, Dept Elect Engn, Rome, Italy; [Paolesse, Roberto] Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy	University of Rome Tor Vergata; University Campus Bio-Medico - Rome Italy; University of Rome Tor Vergata; University of Rome Tor Vergata	Pinzari, M (corresponding author), Univ Roma Tor Vergata, Dept Biol, Rome, Italy.	manuela.pinzari@uniroma2.it	Di Natale, Corrado/M-8701-2014; Paolesse, Roberto/AAI-3182-2020; Capuano, Rosamaria/U-6111-2019; Paolesse, Roberto/B-8966-2013; Martinelli, Eugenio/AAA-9105-2019	Di Natale, Corrado/0000-0002-0543-4348; Paolesse, Roberto/0000-0002-2380-1404; Martinelli, Eugenio/0000-0002-6673-2066; Sbordoni, Valerio/0000-0002-9510-1925; CESARONI, DONATELLA/0000-0001-9787-7148				Andersson J, P R SOC LOND B, V267, P1271; Andersson J, 2007, J EXP BIOL, V210, P964, DOI 10.1242/jeb.02726; [Anonymous], 2014, PHEROMONES ANIMAL BE; Ballantine D.S., 1997, ACOUSTIC WAVE SENSOR; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Boppre M., 1984, Symposia of the Royal Entomological Society of London, P259; Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; Catini A, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16101640; Costanzo K, 2007, P ROY SOC B-BIOL SCI, V274, P845, DOI 10.1098/rspb.2006.3729; Dapporto L, 2007, BIOL J LINN SOC, V91, P703, DOI 10.1111/j.1095-8312.2007.00833.x; Darragh K, 2017, PEERJ, V5, DOI 10.7717/peerj.3953; Di Natale C, 2000, SENSOR ACTUAT B-CHEM, V68, P319, DOI 10.1016/S0925-4005(00)00451-2; Dinca V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12395; Dion E, 2016, SCI REP-UK, V6, DOI 10.1038/srep39002; El-Sayed, 2017, PHEROBASE DATABASE P; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Faynel Christophe, 2012, P46; Garcia-Barros Enrique, 2000, Nota Lepidopterologica, V23, P119; Greenfield MD, 2002, SIGNALERS RECEIVERS; GRULA JW, 1980, J CHEM ECOL, V6, P241, DOI 10.1007/BF00987543; Heuskin S, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00037; Higgins LG, 1975, CLASSIFICATION EUROP; HORNER G, 1990, SENSOR ACTUAT B-CHEM, V2, P173, DOI 10.1016/0925-4005(90)85002-G; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; KUDRNA OA, 1977, REVISION GENUS HIPPA; Leonhardt SD, 2016, CELL, V164, P1277, DOI 10.1016/j.cell.2016.01.035; Li CZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04721-6; LINN CE, 1989, CHEM SENSES, V14, P421, DOI 10.1093/chemse/14.3.421; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Matthews RW, 2010, INSECT BEHAVIOR, SECOND EDITION, P217, DOI 10.1007/978-90-481-2389-6_6; Nieberding CM, 2012, ECOL LETT, V15, P415, DOI 10.1111/j.1461-0248.2012.01748.x; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; Omura H, 2005, APPL ENTOMOL ZOOL, V40, P421, DOI 10.1303/aez.2005.421; Omura H, 2015, ENTOMOL SCI, V18, P353, DOI 10.1111/ens.12126; Paolesse R, 2017, CHEM REV, V117, P2517, DOI 10.1021/acs.chemrev.6b00361; Pescador-Rubio A, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.5501; PHELAN PL, 1987, SCIENCE, V235, P205, DOI 10.1126/science.235.4785.205; Pinzari M, 2013, ETHOL ECOL EVOL, V25, P28, DOI 10.1080/03949370.2012.703244; Pinzari M, 2004, THESIS; Pinzari M, 2009, THESIS U ROME TOR VE; Pinzari M, 2009, J INSECT BEHAV, V22, P227, DOI 10.1007/s10905-008-9169-5; Ring T, 2009, ENCY INSECTS, P766; Ryan MF., 2002, INSECT CHEMORECEPTIO, P113, DOI DOI 10.1007/0-306-47581-2; Santonico M, 2012, SENSOR ACTUAT B-CHEM, V173, P555, DOI 10.1016/j.snb.2012.07.042; Sbordoni V, 2018, SATYRINAE 5; Sendoya SF, 2009, AM NAT, V174, P134, DOI 10.1086/599302; Smadja C, 2009, J RES LEPIDOPTERA, V102, P77; STAHLE L, 1990, CHEMOMETR INTELL LAB, V9, P127; Stitzel SE, 2011, ANNU REV BIOMED ENG, V13, P1, DOI [10.1146/annurev-bioeng-071910-124633, 10.1146/annurev-bioeng-071910-12463.3]; Symonds MRE, 2008, TRENDS ECOL EVOL, V23, P220, DOI 10.1016/j.tree.2007.11.009; Szymanska Ewa, 2012, Metabolomics, V8, P3; Tinbergen N, 1941, J ORNITHOL, V89, P132; Tinbergen N, 1932, ANIMAL ITS WORLD EXP, VI, P197; VANEWRIGHT RI, 1993, PHILOS T R SOC B, V340, P197, DOI 10.1098/rstb.1993.0058; Vanjari S, 2015, BIORCHIIVBETA, DOI 10.1101/033506.; Verity R, 1953, PAPILIONIDA, VV; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6	58	12	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199997	10.1371/journal.pone.0199997	http://dx.doi.org/10.1371/journal.pone.0199997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953554	gold, Green Published, Green Submitted			2022-12-26	WOS:000436645400108
J	Wu, LY; Ali, DC; Liu, P; Peng, C; Zhai, JX; Wang, Y; Ye, BP				Wu, Leyang; Ali, Daniel C.; Liu, Peng; Peng, Cheng; Zhai, Jingxin; Wang, Ying; Ye, Boping			Degradation of phenol via ortho-pathway by Kocuria sp. strain TIBETAN4 isolated from the soils around Qinghai Lake in China	PLOS ONE			English	Article							PSEUDOMONAS-PUTIDA; SALT-TOLERANT; SP-NOV; BIODEGRADATION; CLEAVAGE; WATER; IDENTIFICATION; INDUCTION; MEMBRANE	Based on the feature of high-altitude permafrost topography and the diverse microbial ecological communities of the Qinghai-Tibetan Plateau, soil samples from thirteen different collection points around Qinghai lake were collected to screen for extremophilic strains with the ability to degrade phenol, and one bacterial strain recorded as TIBETAN4 that showed effective biodegradation of phenol was isolated and identified. TIBETAN4 was closely related to Kocuria based on its observed morphological, molecular and biochemical characteristics. TIBETAN4 grew well in the LB medium at pH 7-9 and 0-4% NaCl showing alkalo-philicity and halophilism. The isolate could also tolerate up to 12.5 mM phenol and could degrade 5 mM phenol within 3 days. It maintained a high phenol degradation rate at pH 7-9 and 0-3% NaCl in MSM with 5 mM phenol added as the sole carbon source. Moreover, TIBETAN4 could maintain efficient phenol degradation activity in MSM supplemented with both phenol and glucose and complex water environments, including co-culture Penicillium strains or selection of non-sterilized natural lake water as a culture. It was found that TIBETAN4 showed enzymatic activity of phenol hydroxylase and catechol 1,2-dioxygenase after induction by phenol and the corresponding genes of the two enzymes were detected in the genome of the isolate, while catechol 2,3-dioxygenase or its gene was not, which means there could be a degradation pathway of phenol through the ortho-pathway. The Q-PCR results showed that the transcripts of both the phenol hydroxylase gene and catechol 1,2-dioxygenase gene were up-regulated under the stimulation of phenol, demonstrating again that the strain degraded phenol via ortho-degradation pathway.	[Wu, Leyang; Ali, Daniel C.; Liu, Peng; Peng, Cheng; Zhai, Jingxin; Wang, Ying; Ye, Boping] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Wang, Y; Ye, BP (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China.	waying@cpu.edu.cn; yebp@cpu.edu.cn						Adak A, 2006, COLLOID SURFACE A, V277, P63, DOI 10.1016/j.colsurfa.2005.11.012; Ali MI, 2017, INT J BIOL MACROMOLE; Arora PK, 2017, BIORESOURCE TECHNOLO; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao B, 2008, APPL MICROBIOL BIOT, V81, P99, DOI 10.1007/s00253-008-1728-3; Chen YX, 2003, BIOMED ENVIRON SCI, V16, P163; Cheng GD, 2005, J COLD REG ENG, V19, P19, DOI 10.1061/(ASCE)0887-381X(2005)19:1(19); Comte A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082397; Cui BL, 2015, SCI TOTAL ENVIRON, V527, P26, DOI 10.1016/j.scitotenv.2015.04.105; El-Naas MH, 2009, J HAZARD MATER, V164, P720, DOI 10.1016/j.jhazmat.2008.08.059; Fidalgo C, 2017, INT J SYST EVOL MICR, V67, P3057, DOI 10.1099/ijsem.0.002079; Fraraccio S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07760-1; GORCHEV HG, 1984, WHO CHRON, V38, P104; HAMZAH RY, 1994, APPL MICROBIOL BIOT, V41, P250, DOI 10.1007/BF00186968; Holt J. G., 1994, BERGEYS MANUAL DETER, P520; Ji YF, 2017, WATER RES, V123, P249, DOI 10.1016/j.watres.2017.06.081; Joesaar M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173180; Lopez-Munoz M, 2009, SEP PURIF TECHNOL, V66, P194, DOI 10.1016/j.seppur.2008.11.001; Kuiper I, 2004, MOL PLANT MICROBE IN, V17, P6, DOI 10.1094/MPMI.2004.17.1.6; Kurzbaum E, 2017, WATER RES, V121, P37, DOI 10.1016/j.watres.2017.04.079; Lapage PS, 1976, BIOCH TESTS IDENTIFI, V29, P958; Lee C, 2017, J ANTIBIOT, V70, P737, DOI 10.1038/ja.2017.39; Leitao AL, 2007, INT BIODETER BIODEGR, V59, P220, DOI 10.1016/j.ibiod.2006.09.009; Li J., 2015, PLOS ONE, V10; Li SJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06205; Liu YQ, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw033; Mahiudddin M., 2012, ISRN MICROBIOL, V2012, P1, DOI DOI 10.5402/2012/741820; Mirete S, 2016, CURR OPIN BIOTECH, V38, P143, DOI 10.1016/j.copbio.2016.01.017; NEUJAHR HY, 1980, BIOCHEMISTRY-US, V19, P4967, DOI 10.1021/bi00563a005; Page AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132062; Patel A, 2017, J HAZARD MATER, V340, P47, DOI 10.1016/j.jhazmat.2017.07.013; Reddy MS, 2005, ASIAN J ANIM VET ADV, V8, P841; Santos VL, 2004, PROCESS BIOCHEM, V39, P1001, DOI 10.1016/S0032-9592(03)00201-2; Sengupta S, 2000, APPL MICROBIOL BIOT, V53, P732, DOI 10.1007/s002530000327; Siciliano SD, 2001, APPL ENVIRON MICROB, V67, P2469, DOI 10.1128/AEM.67.6.2469-2475.2001; Silva CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061811; Silva JRO, 2017, CHEMOSPHERE, V185, P145, DOI 10.1016/j.chemosphere.2017.06.133; Singer AC, 2004, CURR OPIN MICROBIOL, V7, P239, DOI 10.1016/j.mib.2004.04.007; Sorokin DY, 2017, INT J SYST EVOL MICR, V67, P2604, DOI 10.1099/ijsem.0.001983; SPANNING A, 1990, J GEN MICROBIOL, V136, P1491, DOI 10.1099/00221287-136-8-1491; Tancsics A, 2012, ENVIRON SCI TECHNOL, V46, P232, DOI 10.1021/es201842h; Us Epa O Oiaa Tripd, 2009, TOX REL INV TRI PROG; Wang GZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19494; Wang YY, 2004, INT BIODETER BIODEGR, V53, P93, DOI 10.1016/j.ibiod.2003.10.005; Wei X, 2016, ENVIRON POLLUT, V210, P166, DOI 10.1016/j.envpol.2015.11.005; WOOLARD CR, 1995, WATER RES, V29, P1159, DOI 10.1016/0043-1354(94)00239-4; Xie ML, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00056	47	7	9	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199572	10.1371/journal.pone.0199572	http://dx.doi.org/10.1371/journal.pone.0199572			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949643	gold, Green Published, Green Submitted			2022-12-26	WOS:000436549200058
J	Delannay, C; Goindin, D; Kellaou, K; Ramdini, C; Gustave, J; Vega-Rua, A				Delannay, Christelle; Goindin, Daniella; Kellaou, Kevin; Ramdini, Cedric; Gustave, Joel; Vega-Rua, Anubis			Multiple insecticide resistance in Culex quinquefasciatus populations from Guadeloupe (French West Indies) and associated mechanisms	PLOS ONE			English	Article							MOSQUITO AEDES-AEGYPTI; NILE VIRUS; MALATHION RESISTANCE; CYTOCHROME-P450 GENES; DIPTERA-CULICIDAE; VECTOR COMPETENCE; DENGUE; CARBOXYLESTERASE; ORGANOPHOSPHATE; CARBAMATE	West Nile (WN) virus has been detected in Guadeloupe since 2002. Even if no WN human cases have been detected so far, mosquitoes from Culex genus especially Culex quinquefasciatus are recognized as potential WN vectors in Guadeloupe. To evaluate the impact of local vector control activities on this mosquito species we assessed the resistance levels of Cx. quinquefasciatus populations from three different sites from Guadeloupe (Abymes, Saint Franc E ois and Gourbeyre) to malathion, temephos and deltamethrin. In addition, the frequencies of the L1014F kdr and the G119S ace-1 mutations were established in Cx. quinquefasciatus populations, as well as the constitutive expressions of five cytochrome P450 genes. Mosquito populations tested displayed high resistance to deltamethrin, moderate resistance to malathion (Abymes, Gourbeyre) and low resistance to temephos (Abymes et Gourbeyre). Molecular analyses revealed high frequencies of both L1014F kdr and G119S ace-1 mutations in Cx. quinquefasciatus populations, as well as overexpression of cytochrome P450 genes CYP9J45, CYP9J40 and CYP6AA7. Finally, deltamethrin resistance and knock-down rates were strongly correlated with the frequency of the resistant kdr and ace-1 alleles, as well as with CYP9J40 overexpression. These results should be taken into account to refine the current vector control strategies to prevent the appearance of Cx. quinquefasciatus- borne diseases in Guadeloupe.	[Delannay, Christelle; Goindin, Daniella; Kellaou, Kevin; Vega-Rua, Anubis] Inst Pasteur Guadeloupe, Environm & Hlth Unit, Lab Med Entomol, Les Abymes, Guadeloupe, France; [Ramdini, Cedric; Gustave, Joel] Reg Hlth Agcy, Vector Control Serv Grande Terre, Airport Zone South Raizet, Les Abymes, Guadeloupe, France		Vega-Rua, A (corresponding author), Inst Pasteur Guadeloupe, Environm & Hlth Unit, Lab Med Entomol, Les Abymes, Guadeloupe, France.	avega@pasteur.fr			FEDER - European Union; Guadeloupe Region (Programme Operationnel FEDER-Guadeloupe-Conseil Regional) [2015-FED-192]; Health Regional Agency in Guadeloupe [42-2015]; FEDER; Regional Agency of Health in Guadeloupe	FEDER - European Union(European Commission); Guadeloupe Region (Programme Operationnel FEDER-Guadeloupe-Conseil Regional); Health Regional Agency in Guadeloupe; FEDER(European Commission); Regional Agency of Health in Guadeloupe	This work was supported by a FEDER grant, financed by the European Union and Guadeloupe Region (Programme Operationnel FEDER-Guadeloupe-Conseil Regional 2014-2020, grant number 2015-FED-192) and by the Health Regional Agency in Guadeloupe by the internal convention no. 42-2015; authors who have received the funding: AVR, CD, DG, KK. The funders (FEDER grant and Regional Agency of Health in Guadeloupe) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nevertheless, the authors CC and JG from the Regional Agency of Health in Guadeloupe have participated in the sampling campaigns in the field and have provided historical internal data about insecticide treatments.	Amorim LB, 2013, PEST MANAG SCI, V69, P1307, DOI 10.1002/ps.3502; Anses, 2011, RECH INS POT UT LUTT, P158; Asghar U., 2015, ADV ENTOMOLOGY, V3, P132, DOI DOI 10.4236/AE.2015.34016; Bhattacharya Sajal, 2016, Journal of Entomology and Zoology Studies, V4, P73; Bisset JA, 2011, MED VET ENTOMOL, V25, P233, DOI 10.1111/j.1365-2915.2011.00959.x; Bisset J, 2006, J MED ENTOMOL, V43, P1185, DOI 10.1603/0022-2585(2006)43[1185:SOIAAA]2.0.CO;2; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Ciota AT, 2013, VIRUSES-BASEL, V5, P3021, DOI 10.3390/v5123021; Coto MMR, 2000, J AM MOSQUITO CONTR, V16, P324; Cui F, 2007, FASEB J, V21, P3584, DOI 10.1096/fj.07-8237com; DDASS-Guadeloupe, 1998, RAPP ACT; Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115; GEORGHIOU GP, 1966, B WORLD HEALTH ORGAN, V35, P691; Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x; Gong YH, 2013, INT J BIOL SCI, V9, P863, DOI 10.7150/ijbs.6744; Gustave J, 1996, B SOC PATHOL EXOT, V89, P143; Gustave J, 2015, BILAN ACTIONS LUTTE; Hardstone MC, 2010, INSECT MOL BIOL, V19, P717, DOI 10.1111/j.1365-2583.2010.01030.x; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; HOLM S, 1979, SCAND J STAT, V6, P65; Institut National de Veille Sanitaire (INVS), 2016, POINT EP 24 NOV 41 2; Institut National de Veille Sanitaire (INVS), 2017, SURV VIR ZIK ANT GUY; Karunamoorthi K, 2013, HEALTH SCOPE, V2, DOI 10.17795/jhealthscope-9840; Karunaratne SHPP, 2001, B WORLD HEALTH ORGAN, V79, P1060; Kent RJ, 2010, PLOS NEGLECT TROP D, P4; Kleinschmidt-DeMasters BK, 2015, BRAIN PATHOL, V25, P625, DOI 10.1111/bpa.12280; KNUDSEN AB, 1983, MOSQ NEWS, V43, P269; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Koulnis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021192; Larrieu S, 2014, ACTA TROP, V131, P37, DOI 10.1016/j.actatropica.2013.11.023; Lefrancois T, 2005, EMERG INFECT DIS, V11, P1100, DOI 10.3201/eid1107.050105; Low V, 2013, PEST MANAG SCI, V69, P1362, DOI 10.1002/ps.3512; Mann BR, 2013, EMERG INFECT DIS, V19, P1418, DOI 10.3201/eid1909.130377; Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5; MAZZARRI MB, 1995, J AM MOSQUITO CONTR, V11, P315; Micieli MV, 2013, J MED ENTOMOL, V50, P853, DOI 10.1603/ME12226; Montagna CM, 2012, MEM I OSWALDO CRUZ, V107, P458, DOI 10.1590/S0074-02762012000400003; ORSTOM Guillet P., 1997, ORSTOM RAPPORT MISSI, V5, P1; PAHO/WHO, 2016, REG ZIK EP UPD AM, V2016; Pan American Health Organization (PAHO), 2015, NUMB REP CAS CHIK FE; Pocquet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077855; Ponce G, 2016, INSECT SCI, V23, P829, DOI 10.1111/1744-7917.12218; Pradel J, 2009, PREV VET MED, V92, P71, DOI 10.1016/j.prevetmed.2009.07.001; Quirin R, 2005, CAN FAM PHYSICIAN, V51, P1443; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richards SL, 2014, TROP MED INT HEALTH, V19, P610, DOI 10.1111/tmi.12277; Rosine J., RESISTANCE AEDES AEG; Settimi L, 2016, ENVIRON INT, V91, P332, DOI 10.1016/j.envint.2016.02.034; Vega-Rua A., 2015, PLOS NEGLECT TROP D, V9, P1; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; WHO, 2013, TEST PROC INS RES MA; World Health Organization, 2006, WHOCDSNTDWHOPESGCDPP, V2006; World Health Organization, 2005, GUIDELINES LAB FIELD; Xu Q, 2005, RESISTANCE MOSQUITO, V1102, P1096; ZIEGLER R, 1987, PESTIC BIOCHEM PHYS, V28, P279, DOI 10.1016/0048-3575(87)90026-5	55	19	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199615	10.1371/journal.pone.0199615	http://dx.doi.org/10.1371/journal.pone.0199615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944713	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800046
J	Rocha, JA; Rego, NCS; Carvalho, BTS; Silva, FI; Sousa, JA; Ramos, RM; Passos, ING; de Moraes, J; Leite, JRSA; Lima, FCA				Rocha, Jefferson A.; Rego, Nayra C. S.; Carvalho, Bruna T. S.; Silva, Francisco, I; Sousa, Jose A.; Ramos, Ricardo M.; Passos, Ionara N. G.; de Moraes, Josue; Leite, Jose R. S. A.; Lima, Francisco C. A.			Computational quantum chemistry, molecular docking, and ADMET predictions of imidazole alkaloids of Pilocarpus microphyllus with schistosomicidal properties	PLOS ONE			English	Article							DENSITY-FUNCTIONAL THEORY; POTENTIAL-DRUG TARGET; INTESTINAL-ABSORPTION; AUTOMATED DOCKING; CARBON NANOTUBES; EPIISOPILOTURINE; DISCOVERY; PERMEABILITY; ENERGY; ELECTRONEGATIVITY	Schistosomiasis affects million people and its control is widely dependent on a single drug, praziquantel. Computational chemistry has led to the development of new tools that predict molecular properties related to pharmacological potential. We conducted a theoretical study of the imizadole alkaloids of Pilocarpus microphyllus (Rutaceae) with schistosomicidal properties. The molecules of epiisopiloturine, epiisopilosine, isopilosine, pilosine, and macaubine were evaluated using theory models (B3lyp/SDD, B3lyp/6-31+ G(d, p), B3lyp/6-311++ G(d, p)). Absorption, distribution, metabolization, excretion, and toxicity (ADMET) predictions were used to determine the pharmacokinetic and pharmacodynamic properties of the alkaloids. After optimization, the molecules were submitted to molecular docking calculations with the purine nucleoside phosphorylase, thioredoxin glutathione reductase, methylthioadenosine phosphorylase, arginase, uridine phosphorylase, Cathepsin B1 and histone deacetylase 8 enzymes, which are possible targets of Schistosoma mansoni. The results showed that B3lyp/6-311++ G(d, p) was the optimal model to describe the properties studied. Thermodynamic analysis showed that epiisopiloturine and epiisopilosine were the most stable isomers; however, the epiisopilosine ligand achieved a superior interaction with the enzymes studied in the molecular docking experiments, which corroborated the results of previous experimental studies on schistosomiasis.	[Rocha, Jefferson A.; Rego, Nayra C. S.; Lima, Francisco C. A.] RENORBIO, Focal Point UFPI, Postgrad Program Northeast Network Biotechnol, Teresina, Piaui, Brazil; [Rocha, Jefferson A.; Passos, Ionara N. G.] Univ Fed Maranhao, CIENATEC UFMA, Res Grp Nat Sci & Biotechnol, Grajau, MA, Brazil; [Rocha, Jefferson A.; Rego, Nayra C. S.; Carvalho, Bruna T. S.; Silva, Francisco, I; Sousa, Jose A.; Lima, Francisco C. A.] Univ Estadual Piaui, Res Grp Computat Quantum Chem & Pharmaceut Planni, GPQQ&PF UESPI, Teresina, PI, Brazil; [Ramos, Ricardo M.] Fed Inst Piaui, Res Lab Informat Syst, Dept Informat Environm Hlth & Food Prod, LAPESI IFPI, Teresina, PI, Brazil; [de Moraes, Josue] Univ Guarulhos, NPDN UNG, Res Ctr Neglected Dis, Guarulhos, SP, Brazil; [Leite, Jose R. S. A.] Univ Brasilia, UnB, Area Morphol, Fac Med, Campus Darcy Ribeiro, Brasilia, DF, Brazil	Universidade Federal do Maranhao; Universidade Estadual do Piaui (UESPI); Instituto Federal do Piaui (IFPI); Universidade Guarulhos; Universidade de Brasilia	Rocha, JA (corresponding author), RENORBIO, Focal Point UFPI, Postgrad Program Northeast Network Biotechnol, Teresina, Piaui, Brazil.; Rocha, JA (corresponding author), Univ Fed Maranhao, CIENATEC UFMA, Res Grp Nat Sci & Biotechnol, Grajau, MA, Brazil.; Rocha, JA (corresponding author), Univ Estadual Piaui, Res Grp Computat Quantum Chem & Pharmaceut Planni, GPQQ&PF UESPI, Teresina, PI, Brazil.	jeffersonbiotec@gmail.com	Ramos, Ricardo M/Q-2133-2017; de Moraes, Josué/F-4762-2014; Sousa, Jose Antonio/AAP-9077-2020; Rocha, Jefferson/AAS-9043-2020; Passos, Ionara/AAS-2342-2020; Lima, Francisco das Chagas das Chagas Alves/D-8730-2017; Leite, Jose Roberto/H-9065-2013	Ramos, Ricardo M/0000-0003-2016-3344; de Moraes, Josué/0000-0003-1766-7031; Sousa, Jose Antonio/0000-0001-9457-2883; Rocha, Jefferson/0000-0001-6619-2293; Lima, Francisco das Chagas das Chagas Alves/0000-0002-0447-4911; Leite, Jose Roberto/0000-0002-1096-3236	Foundation for Scientific and Technological Research and Development of Maranhao FAPEMA; State Government of Maranhao and Secretary of State for Science, Technology and Innovation - SECTI [BD-02239/16]; FAPESP [2016/22488-3]	Foundation for Scientific and Technological Research and Development of Maranhao FAPEMA(Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA)); State Government of Maranhao and Secretary of State for Science, Technology and Innovation - SECTI; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Foundation for Scientific and Technological Research and Development of Maranhao FAPEMA, and the State Government of Maranhao and Secretary of State for Science, Technology and Innovation - SECTI provided support with a scholarship (BD-02239/16). The Federal University of Maranhao - UFMA provided the incentive. The FAPESP 2016/22488-3 also supported this work.	AMES BN, 1972, P NATL ACAD SCI USA, V69, P3128, DOI 10.1073/pnas.69.11.3128; Angelucci F, 2008, PROTEINS, V72, P936, DOI 10.1002/prot.21986; Atkins P., 2012, PRINCIPIOS QUIMICA Q, V5a; Azeredo FJ, 2009, REV BRAS FARM, V90, P321; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Casida M. E., 1995, RECENT ADV DENSITY F; Chen HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038261; Chen M, 2017, ENVIRON SCI-NANO, V4, P1954, DOI 10.1039/c7en00512a; Chen M, 2017, CHEMOSPHERE, V184, P127, DOI 10.1016/j.chemosphere.2017.05.162; Chen M, 2017, TRENDS BIOTECHNOL, V35, P836, DOI 10.1016/j.tibtech.2016.12.001; Chen M, 2017, ENVIRON SCI-NANO, V4, P720, DOI 10.1039/c7en00050b; Coleman RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075992; Neto AMD, 2016, BIOCHIMIE, V125, P12, DOI 10.1016/j.biochi.2016.02.007; da Silva RR, 2006, J PHYS CHEM A, V110, P1031, DOI 10.1021/jp054434y; de Lima LI, 2018, NANOMEDICINE-UK, V13, P689, DOI 10.2217/nnm-2017-0308; de Moraes J, 2015, FUTURE MED CHEM, V7, P801, DOI [10.4155/FMC.15.23, 10.4155/fmc.15.23]; Dennington R.D., 2008, GASSVIEW 5 5 0 8; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Frisch M.J., 2011, GAUSSIAN 09 VERSION, DOI 10.1021/ja5111392; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071; Goodsell D. S., 2005, PROTEIN PROTEIN INTE; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; GORELSKY S, 1999, SWIZARD; Guimaraes MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003656; Guimaraes MA, 2014, J NANOSCI NANOTECHNO, V14, P4519, DOI 10.1166/jnn.2014.8248; Hai Y, 2014, BIOCHEMISTRY-US, V53, P4671, DOI 10.1021/bi5004519; Horn M, 2011, ACS CHEM BIOL, V6, P609, DOI 10.1021/cb100411v; Kadam R. U., 2007, Indian Journal of Pharmaceutical Sciences, V69, P609; Kannan S, 2014, J CHEM INF MODEL, V54, P3005, DOI 10.1021/ci5004653; Kerns EH, 2008, DRUG-LIKE PROPERTIES: CONCEPTS, STRUCTURE DESIGN AND METHODS, P1; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kramer C, 2018, J MED CHEM, V61, P3277, DOI 10.1021/acs.jmedchem.7b00935; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; Lago EM, 2018, FUTURE MED CHEM, V10, P89, DOI 10.4155/fmc-2017-0112; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lu XQ, 2010, J PHYS CHEM A, V114, P1178, DOI 10.1021/jp909731t; Ma XL, 2005, ACTA PHARMACOL SIN, V26, P500, DOI 10.1111/j.1745-7254.2005.00068.x; Campelo YDM, 2017, BIOMED PHARMACOTHER, V88, P488, DOI 10.1016/j.biopha.2016.12.057; Mafud AC, 2018, TOXICOL IN VITRO, V50, P1, DOI 10.1016/j.tiv.2018.02.012; Mafud AC, 2016, TRENDS PARASITOL, V32, P874, DOI 10.1016/j.pt.2016.08.002; MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980; Melo CC, 2016, J CHEM INF MODEL, V56, P1357, DOI 10.1021/acs.jcim.6b00055; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Morris GM, 2008, CURR PROTOC BIOINFOR; Nicolau LAD, 2017, BIOMED PHARMACOTHER, V87, P188, DOI 10.1016/j.biopha.2016.12.101; Oprea TI, 2000, J COMPUT AID MOL DES, V14, P251, DOI 10.1023/A:1008130001697; Parr RG, 1999, J AM CHEM SOC, V121, P1922, DOI 10.1021/ja983494x; Pereira HD, 2005, J MOL BIOL, V353, P584, DOI 10.1016/j.jmb.2005.08.045; Postigo MP, 2010, J CHEM INF MODEL, V50, P1693, DOI 10.1021/ci100128k; Ramos RM, 2012, J MOL MODEL, V18, P4013, DOI 10.1007/s00894-012-1383-6; Rocha JA, 2017, PHYTOTHER RES, V31, P624, DOI 10.1002/ptr.5771; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Silva VG, 2013, J NAT PROD, V76, P1071, DOI 10.1021/np400099m; SINGH S, 1993, MED RES REV, V13, P569, DOI 10.1002/med.2610130504; SOLIS FJ, 1981, MATH OPER RES, V6, P19, DOI 10.1287/moor.6.1.19; Stolfa DA, 2014, J MOL BIOL, V426, P3442, DOI 10.1016/j.jmb.2014.03.007; Stratmann RE, 1998, J CHEM PHYS, V109, P8218, DOI 10.1063/1.477483; Teague SJ, 1999, ANGEW CHEM INT EDIT, V38, P3743, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U; Torini JR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005178; Veras LM, 2012, CURR MED CHEM, V19, P2051; Veras LMC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066702; VOIGTLANDER HW, 1978, ARCH PHARM, V311, P927, DOI 10.1002/ardp.19783111106; World Health Organization, SCHIST; Yamashita S, 2000, EUR J PHARM SCI, V10, P195, DOI 10.1016/S0928-0987(00)00076-2; Yee SY, 1997, PHARMACEUT RES, V14, P763, DOI 10.1023/A:1012102522787; Zhan CG, 2003, J PHYS CHEM A, V107, P4184, DOI 10.1021/jp0225774; Zhao YH, 2001, J PHARM SCI-US, V90, P749, DOI 10.1002/jps.1031	70	29	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0198476	10.1371/journal.pone.0198476	http://dx.doi.org/10.1371/journal.pone.0198476			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944674	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800009
J	Visscher, DR; Merrill, EH				Visscher, Darcy R.; Merrill, Evelyn H.			Functional connectivity in ruminants: A generalized state-dependent modelling approach	PLOS ONE			English	Article							KNOTS CALIDRIS-CANUTUS; CATCH-UP GROWTH; PREDATION RISK; SEXUAL SEGREGATION; TRADE-OFFS; HABITAT SELECTION; LANDSCAPE CONNECTIVITY; MOVEMENT DECISIONS; RED KNOTS; MATRIX HETEROGENEITY	Animal behaviour is increasingly seen as an important component in maintaining functional connectivity between patches in fragmented landscapes. However, models that explicitly incorporate behavioural trade-offs are rarely applied to landscape planning problems like connectivity. The aim of this study was to explore how state-dependent behaviour influenced functional connectivity between patches from a theoretical perspective. We investigated how inter-patch distances influenced functional connectivity using a dynamic state variable model framework. The decision making process of an individual ruminant facing fitness trade-offs in staying in its patch of origin or moving to another patch at various distances were explicitly modelled. We incorporated energetic costs and predation costs of feeding, ruminating, and resting while in the patch and for transit between patches based on inter-patch distance. Functional connectivity was maintained with isolated patches when they offered high intake and the inactivity of rumination associated with rapid gut fill resulted in reduced predation risk. Nevertheless, individuals in high energetic state often would forgo moving to another patch, whereas individuals in poor energetic states were forced to accept the cost of movement to best meet their requirements in the distant patch. The inclusion of state-dependent behavioural models provides important insights into functional connectivity in fragmented landscapes and helps integrate animal behaviour into landscape planning. We discuss the consequences of our findings for landscape planning to show how the approach provides a heuristic tool to assess alternative scenarios for restoring landscape functional connectivity.	[Visscher, Darcy R.] Kings Univ, Dept Biol, Edmonton, AB, Canada; [Merrill, Evelyn H.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Visscher, DR (corresponding author), Kings Univ, Dept Biol, Edmonton, AB, Canada.	darcy.visscher@kingsu.ca		Visscher, Darcy/0000-0002-4119-3991	Natural Sciences and Engineering Research Council of Canada; National Science Foundation [0078130]; Rocky Mountain Elk Foundation; Sunpine Forest Products Ltd.; Alberta Conservation Association	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation(National Science Foundation (NSF)); Rocky Mountain Elk Foundation; Sunpine Forest Products Ltd.; Alberta Conservation Association	This work was supported by Natural Sciences and Engineering Research Council of Canada Industrial Postgraduate grant Weyerhaeuser (DV, www.nserc-crsng.gc.ca/index_eng.asp); National Science Foundation grant (EM, No. 0078130, www.nsf.gov); Rocky Mountain Elk Foundation (EM); Sunpine Forest Products Ltd. (EM); and the Alberta Conservation Association (EM).	ABRAHAMS MV, 1989, ECOLOGY, V70, P999, DOI 10.2307/1941368; Anholt BR, 2000, ECOLOGY, V81, P3509, DOI 10.2307/177510; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Banks PB, 2000, P ROY SOC B-BIOL SCI, V267, P1621, DOI 10.1098/rspb.2000.1187; Barboza PS, 2000, J MAMMAL, V81, P473, DOI 10.1644/1545-1542(2000)081&lt;0473:SSIDDA&gt;2.0.CO;2; Bauer S, 2008, J ANIM ECOL, V77, P654, DOI 10.1111/j.1365-2656.2008.01381.x; Bauer S, 2013, J ANIM ECOL, V82, P498, DOI 10.1111/1365-2656.12054; Bauer S, 2010, ECOLOGY, V91, P1822, DOI 10.1890/09-1281.1; Belisle M, 2005, ECOLOGY, V86, P1988, DOI 10.1890/04-0923; Belisle M, 2001, ECOLOGY, V82, P1893, DOI 10.1890/0012-9658(2001)082[1893:IOFCOT]2.0.CO;2; Bender DJ, 2005, ECOLOGY, V86, P1023, DOI 10.1890/03-0769; Betts MG, 2015, LANDSCAPE ECOL, V30, P585, DOI 10.1007/s10980-015-0156-x; Bonenfant C, 2004, P ROY SOC B-BIOL SCI, V271, P883, DOI 10.1098/rspb.2003.2661; Bowman J, 2002, CAN J ZOOL, V80, P1556, DOI 10.1139/Z02-161; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Burrows MT, 2000, J ANIM ECOL, V69, P290, DOI 10.1046/j.1365-2656.2000.00391.x; Caro T, 2016, CURR OPIN BEHAV SCI, V12, P97, DOI 10.1016/j.cobeha.2016.09.008; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chetkiewicz CLB, 2006, ANNU REV ECOL EVOL S, V37, P317, DOI 10.1146/annurev.ecolsys.37.091305.110050; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; Clark CW, 2000, OX ECOL EV; Delibes M, 2001, ECOL LETT, V4, P401, DOI 10.1046/j.1461-0248.2001.00254.x; Dussault C, 2005, ECOGRAPHY, V28, P619, DOI 10.1111/j.2005.0906-7590.04263.x; Edwards SL, 2004, WILDLIFE SOC B, V32, P739, DOI 10.2193/0091-7648(2004)032[0739:WDFPIM]2.0.CO;2; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; FitzGibbon SI, 2007, LANDSCAPE ECOL, V22, P1513, DOI 10.1007/s10980-007-9139-x; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; Fortin D, 2004, ECOLOGY, V85, P2312, DOI 10.1890/03-0485; Fortin D, 2015, ANIM PROD SCI, V55, P376, DOI 10.1071/AN14428; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Found R, 2016, ANIM BEHAV, V115, P35, DOI 10.1016/j.anbehav.2016.02.007; Frair JL, 2008, J APPL ECOL, V45, P1504, DOI 10.1111/j.1365-2664.2008.01526.x; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Frank K, 1998, LANDSCAPE ECOL, V13, P363, DOI 10.1023/A:1008054906030; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Gardner RH, 2004, ECOL MODEL, V171, P339, DOI 10.1016/j.ecolmodel.2003.08.008; Genghini M, 2005, WILDLIFE BIOL, V11, P319, DOI 10.2981/0909-6396(2005)11[319:HIAEOB]2.0.CO;2; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Gravem SA, 2016, FUNCT ECOL, V30, P1574, DOI 10.1111/1365-2435.12628; Greggor AL, 2016, TRENDS ECOL EVOL, V31, P953, DOI 10.1016/j.tree.2016.09.001; Grignolio S, 2007, J MAMMAL, V88, P1488, DOI 10.1644/06-MAMM-A-351R.1; Gustafson EJ, 1996, ECOLOGY, V77, P94, DOI 10.2307/2265659; Gustine DD, 2006, J WILDLIFE MANAGE, V70, P1601, DOI 10.2193/0022-541X(2006)70[1601:IRSADS]2.0.CO;2; Hay CT, 2008, J ANIM ECOL, V77, P850, DOI 10.1111/j.1365-2656.2008.01409.x; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Holyoak M, 2000, AM NAT, V156, P378, DOI 10.1086/303395; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; Houston AI, 1999, MODELS ADAPTIVE BEHA; Johnson CJ, 2002, J ANIM ECOL, V71, P225, DOI 10.1046/j.1365-2656.2002.00595.x; Kindlmann P, 2008, LANDSCAPE ECOL, V23, P879, DOI 10.1007/s10980-008-9245-4; Kloppers EL, 2005, ECOL SOC, V10; Kotler BP, 1995, OIKOS, V74, P251, DOI 10.2307/3545654; Kramer DL, 2001, AM ZOOL, V41, P137, DOI 10.1668/0003-1569(2001)041[0137:TBEOIL]2.0.CO;2; Krishna YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151748; Kristan WB, 2003, OIKOS, V103, P457; Li CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080065; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Little AR, 2016, BASIC APPL ECOL, V17, P360, DOI 10.1016/j.baae.2015.12.003; Long RA, 2009, J MAMMAL, V90, P423, DOI 10.1644/08-MAMM-A-181.1; LUNDBERG P, 1993, OIKOS, V68, P224, DOI 10.2307/3544834; Luttbeg B, 2017, AM NAT, V189, P644, DOI 10.1086/691470; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Main MB, 2008, ECOLOGY, V89, P693, DOI 10.1890/07-0645.1; Marchand P, 2015, ANIM BEHAV, V102, P169, DOI 10.1016/j.anbehav.2015.01.011; Matter SF, 2009, OIKOS, V118, P1461, DOI 10.1111/j.1600-0706.2009.17438.x; McAdam AG, 1998, ANIM BEHAV, V55, P109, DOI 10.1006/anbe.1997.0592; McClure ML, 2016, LANDSCAPE ECOL, V31, P1419, DOI 10.1007/s10980-016-0347-0; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; MIQUELLE DG, 1990, BEHAV ECOL SOCIOBIOL, V27, P145, DOI 10.1007/BF00168458; Moen A.N., 1973, WILDLIFE ECOLOGY; Nassauer JI, 2004, LANDSCAPE ECOL, V19, P343, DOI 10.1023/B:LAND.0000030666.55372.ae; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; NEWMAN JA, 1995, FUNCT ECOL, V9, P255, DOI 10.2307/2390572; Nonacs P, 2001, BEHAV ECOL, V12, P71, DOI 10.1093/oxfordjournals.beheco.a000381; Noonburg EG, 2007, THEOR POPUL BIOL, V71, P182, DOI 10.1016/j.tpb.2006.09.004; Ovaskainen O, 2008, AM NAT, V171, P610, DOI 10.1086/587070; PARKER KL, 1984, J WILDLIFE MANAGE, V48, P474, DOI 10.2307/3801180; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Pinto N, 2009, LANDSCAPE ECOL, V24, P253, DOI 10.1007/s10980-008-9303-y; Radder RS, 2007, J EXP ZOOL PART A, V307A, P500, DOI 10.1002/jez.403; Revilla E, 2004, AM NAT, V164, pE130, DOI 10.1086/424767; Revilla E, 2008, P NATL ACAD SCI USA, V105, P19120, DOI 10.1073/pnas.0801725105; REYNOLDS HG, 1969, J FOREST, V67, P803; Richards SA, 2004, ISR J ZOOL, V50, P169; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rizkalla CE, 2007, BIOL CONSERV, V140, P339, DOI 10.1016/j.biocon.2007.08.019; Robinson BG, 2013, ANIM BEHAV, V85, P849, DOI 10.1016/j.anbehav.2013.02.004; Rogala JK, 2011, ECOL SOC, V16, DOI 10.5751/ES-04251-160316; Roitberg BD, 1997, OIKOS, V80, P234, DOI 10.2307/3546591; Rouquette JR, 2007, J APPL ECOL, V44, P692, DOI 10.1111/j.1365-2664.2007.01284.x; Ruckelshaus M, 1997, CONSERV BIOL, V11, P1298, DOI 10.1046/j.1523-1739.1997.96151.x; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Russell RE, 2003, OIKOS, V103, P142, DOI 10.1034/j.1600-0706.2003.12418.x; Russell RE, 2007, J MAMMAL, V88, P573, DOI 10.1644/06-MAMM-A-080R1.1; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Shannon G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094630; Sharpe PB, 1998, J MAMMAL, V79, P906, DOI 10.2307/1383098; Short JJ, 2003, J RANGE MANAGE, V56, P213, DOI 10.2307/4003809; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Stamps JA, 2006, ECOL LETT, V9, P1179, DOI 10.1111/j.1461-0248.2006.00972.x; Swihart RK, 2001, J THEOR BIOL, V210, P287, DOI 10.1006/jtbi.2001.2304; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Trussell GC, 2011, ECOLOGY, V92, P1799, DOI 10.1890/10-2222.1; Utz JL, 2016, WILDLIFE BIOL, V22, P167, DOI 10.2981/wlb.00121; van Beest FM, 2013, OECOLOGIA, V173, P409, DOI 10.1007/s00442-013-2647-2; Van Gils JA, 2005, J ANIM ECOL, V74, P120, DOI 10.1111/j.1365-2656.2004.00904.x; van Gils JA, 2006, ECOLOGY, V87, P1189, DOI 10.1890/0012-9658(2006)87[1189:FIATSE]2.0.CO;2; Van Soest P. J., 1984, NUTR ECOLOGY RUMINAN; Visscher DR, 2017, MAMMAL RES, V62, P129, DOI 10.1007/s13364-016-0290-0; Visscher DR, 2017, WILDLIFE SOC B, V41, P162, DOI 10.1002/wsb.741; Volk XK, 2018, LANDSCAPE ECOL, V33, P371, DOI 10.1007/s10980-018-0611-6; Volpe NL, 2014, ECOL APPL, V24, P2122, DOI 10.1890/13-2168.1; WAIRIMU S, 1992, CAN J ANIM SCI, V72, P619, DOI 10.4141/cjas92-074; Westphal MI, 2003, ECOL APPL, V13, P543, DOI 10.1890/1051-0761(2003)013[0543:TUOSDP]2.0.CO;2; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811; Yackulic CB, 2017, J ANIM ECOL, V86, P972, DOI 10.1111/1365-2656.12679; Yoder JM, 2004, BEHAV ECOL, V15, P469, DOI 10.1093/beheco/arh037; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0; Zollner PA, 2005, OIKOS, V108, P219, DOI 10.1111/j.0030-1299.2005.13711.x	126	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199671	10.1371/journal.pone.0199671	http://dx.doi.org/10.1371/journal.pone.0199671			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944693	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800052
J	Rahnamoun, H; Hong, J; Sun, ZX; Lee, J; Lu, HB; Lauberth, SM				Rahnamoun, Homa; Hong, Juyeong; Sun, Zhengxi; Lee, Jihoon; Lu, Hanbin; Lauberth, Shannon M.			Mutant p53 regulates enhancer-associated H3K4 monomethylation through interactions with the methyltransferase MLL4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ENHANCERS; CHROMATIN ORGANIZATION; TUMOR-SUPPRESSOR; GENE-EXPRESSION; CANCER; COMPLEX; METHYLATION; MLL3/MLL4; REVEALS; PROTEIN	Monomethylation of histone H3 lysine 4 (H3K4me1) is enriched at enhancers that are primed for activation and the levels of this histone mark are frequently altered in various human cancers. Yet, how alterations in H3K4m1 are established and the consequences of these epigenetic changes in tumorigenesis are not well understood. Using ChIP-Seq in human colon cancer cells, we demonstrate that mutant p53 depletion results in decreased H3K4me1 levels at active enhancers that reveal a striking colocalization of mutant p53 and the H3K4 monomethyltransferase MLL4 following chronic tumor necrosis factor alpha (TNF alpha) signaling. We further reveal that mutant p53 forms physiological associations and direct interactions with MLL4 and promotes the enhancer binding of MLL4, which is required for TNF alpha-inducible H3K4mel and histone H3 lysine 27 acetylation (H3K27ac) levels, enhancer-derived transcript (eRNA) synthesis, and mutant p53-dependent target gene activation. Complementary in vitro studies with recombinant chromatin and purified proteins demonstrate that binding of the MLL3/4 complex and H3K4me1 deposition is enhanced by mutant p53 and p300-mediated acetylation, which in turn reflects a MLL3/4-dependent enhancement of mutant p53 and p300-dependent transcriptional activation. Collectively, our findings establish a mechanism in which mutant p53 cooperates with MLL4 to regulate aberrant enhancer activity and tumor-promoting gene expression in response to chronic immune signaling.	[Rahnamoun, Homa; Hong, Juyeong; Sun, Zhengxi; Lee, Jihoon; Lu, Hanbin; Lauberth, Shannon M.] Univ Calif San Diego, Sect Mol Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Lauberth, SM (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	slauberth@ucsd.edu	Lee, Ji Hoon/AAV-5473-2021	Lee, Ji Hoon/0000-0002-7488-3999; Rahnamoun, Homa/0000-0002-0555-2328; Lauberth, Shannon/0000-0003-4131-8536; LEE, Ji-Hoon/0000-0002-4537-9638	Sidney Kimmel Foundation for Cancer Research [857A6A]; University of California Cancer Research Coordinating Committee [CRN-17-420616]; UCSD Cellular and Molecular Genetics Training Program through the National Institute of General Medical Sciences Institutional Grant [T32 GM007240]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	Sidney Kimmel Foundation for Cancer Research; University of California Cancer Research Coordinating Committee(University of California System); UCSD Cellular and Molecular Genetics Training Program through the National Institute of General Medical Sciences Institutional Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Sidney Kimmel Foundation for Cancer Research, Research Scholar Award 857A6A, and University of California Cancer Research Coordinating Committee Award CRN-17-420616 (to S. M. L.) and by the UCSD Cellular and Molecular Genetics Training Program through the National Institute of General Medical Sciences Institutional Grant T32 GM007240 (to H.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Aran D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r21; Aran D, 2013, CELL, V154, P11, DOI 10.1016/j.cell.2013.06.018; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bereczki O, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-57; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Cho YW, 2012, METHODS MOL BIOL, V809, P465, DOI 10.1007/978-1-61779-376-9_30; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dorighi KM, 2017, MOL CELL, V66, P568, DOI 10.1016/j.molcel.2017.04.018; Fontemaggi G, 2009, NAT STRUCT MOL BIOL, V16, P1086, DOI 10.1038/nsmb.1669; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Herz HM, 2014, MOL CELL, V53, P859, DOI 10.1016/j.molcel.2014.02.033; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kurdistani SK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-156; Laptenko O, 2016, TRENDS BIOCHEM SCI, V41, P1022, DOI 10.1016/j.tibs.2016.08.011; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Makova KD, 2015, NAT REV GENET, V16, P213, DOI 10.1038/nrg3890; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahnamoun H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01117-y; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Ryan RJH, 2015, CANCER DISCOV, V5, P1058, DOI 10.1158/2159-8290.CD-15-0370; Shinsky SA, 2015, J BIOL CHEM, V290, P25819, DOI 10.1074/jbc.M115.684142; Sigal A, 2000, CANCER RES, V60, P6788; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Wang CC, 2016, P NATL ACAD SCI USA, V113, P11871, DOI 10.1073/pnas.1606857113; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang SP, 2017, MOL CELL, V67, P308, DOI 10.1016/j.molcel.2017.06.028; Yan J, 2018, CELL RES, V28, P204, DOI 10.1038/cr.2018.1; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	51	16	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13234	13246		10.1074/jbc.RA118.003387	http://dx.doi.org/10.1074/jbc.RA118.003387			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29954944	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000442730200022
J	Nishigami, T; Tanaka, K; Mibu, A; Manfuku, M; Yono, S; Tanabe, A				Nishigami, Tomohiko; Tanaka, Katsuyoshi; Mibu, Akira; Manfuku, Masahiro; Yono, Satoko; Tanabe, Akihito			Development and psychometric properties of short form of central sensitization inventory in participants with musculoskeletal pain: A cross-sectional study	PLOS ONE			English	Article							QUALITY-OF-LIFE; CENTRAL SENSITIVITY SYNDROMES; SELF-EFFICACY QUESTIONNAIRE; GENERIC CORE SCALES; CATASTROPHIZING SCALE; DISABILITY QUESTIONNAIRE; CULTURAL ADAPTATION; KNEE OSTEOARTHRITIS; NEUROTROPHIC FACTOR; COPING STRATEGIES	Background The central sensitization inventory (CSI) comprises 25 items and is commonly used to measure somatic and emotional symptoms related to central sensitization symptoms. CSI was developed as an easy-to-administer screening instrument for patients at high risk of developing central sensitization in whom it was essential to quickly evaluate the condition. The purpose of the present study was to develop a short form of CSI and evaluate its psychometric properties using a contemporary approach called Rasch analysis. Methods A total of 505 patients with musculoskeletal disorders were recruited in this study. The CSI, pain intensity, pain interference, and the health-related quality of life (QOL) were evaluated for each participant. The original CSI items were consecutively analyzed using the Rasch model. Successive Rasch analyses were performed until a final set of items satisfied the model fit requirements. We also analyzed the psychometric properties of the original and short forms of CSI. Results Four consecutive Rasch analyses identified the removable items. Finally, the shortest questionnaire obtained that maintained the correct psychometric properties based on the Rasch model contained only 9 items (CSI-9). Rasch analysis showed that the CSI-9 had acceptable internal consistency, exhibited unidimensionality, had no notable differential item functioning, and was functional on the category rating scale. Conclusions The nine-item short form of CSI has acceptable psychometric properties and is suitable for use for patients with musculoskeletal pain. Thus, the CSI-9 can be used as a brief instrument to evaluate central sensitization.	[Nishigami, Tomohiko; Mibu, Akira] Konan Womans Univ, Dept Nursing & Phys Therapy, Kobe, Hyogo, Japan; [Tanaka, Katsuyoshi; Yono, Satoko; Tanabe, Akihito] Tanabe Orthopaed, Dept Rehabil, Osaka, Osaka, Japan; [Manfuku, Masahiro] Breast Care Sensyu Clin, Dept Rehabil, Kishiwada, Japan		Nishigami, T (corresponding author), Konan Womans Univ, Dept Nursing & Phys Therapy, Kobe, Hyogo, Japan.	t-nishi@konan-wu.ac.jp			Health Labour Sciences Research Grant [17948489]	Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Health Labour Sciences Research Grant Number 17948489, https://mhlw-grants.niph.go.jp, to TN. The funders had a role in the Publication Fees.	Alcala MJ, 2004, INFLAMM BOWEL DIS, V10, P383, DOI 10.1097/00054725-200407000-00009; Bennett EE, 2017, WORLD NEUROSURG, V104, P594, DOI 10.1016/j.wneu.2017.04.166; Bid Dibyendunarayan D., 2016, NATL J INTEGR RES ME, V7, P18; Bilbao A, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-75; Bot AGJ, 2014, J MUSCULOSKELET PAIN, V22, P145, DOI 10.3109/10582452.2014.883020; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Cagnie B, 2014, SEMIN ARTHRITIS RHEU, V44, P68, DOI 10.1016/j.semarthrit.2014.01.001; Caumo W, 2017, J PAIN RES, V10, P2109, DOI 10.2147/JPR.S131479; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cronbach LJ, 2004, EDUC PSYCHOL MEAS, V64, P391, DOI 10.1177/0013164404266386; Cuesta-Vargas AI, 2018, J PAIN, V19, P317, DOI 10.1016/j.jpain.2017.11.006; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hungi N, 2005, APPL RASCH MEASUREME; Cuesta-Vargas AI, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3515-4; Jafari P, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-27; Jensen MP, 2003, PAIN, V104, P453, DOI 10.1016/S0304-3959(03)00076-9; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Kim SH, 2015, PAIN PRACT, V15, pE46, DOI 10.1111/papr.12311; Knezevic A, 2018, PAIN PRACT, V18, P463, DOI 10.1111/papr.12618; Kook SH, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-41; Kregel J, 2016, CLIN J PAIN, V32, P624, DOI 10.1097/AJP.0000000000000306; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Linacre JM., 2012, USERS GUIDE WINSTEPS; Lluch E, 2014, EUR J PAIN, V18, P1367, DOI 10.1002/j.1532-2149.2014.499.x; Loeser JD, 2008, PAIN, V137, P473, DOI 10.1016/j.pain.2008.04.025; Marella M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-900; Mayer TG, 2012, PAIN PRACT, V12, P276, DOI 10.1111/j.1533-2500.2011.00493.x; McWilliams LA, 2015, EUR J PAIN, V19, P1342, DOI 10.1002/ejp.665; Mendoza TR, 2012, J PAIN, V13, P564, DOI 10.1016/j.jpain.2012.03.003; Moreton BJ, 2015, J REHABIL MED, V47, P655, DOI 10.2340/16501977-1977; Neblett R, 2017, SPINE J, V17, P1819, DOI 10.1016/j.spinee.2017.06.008; Neblett R, 2017, PAIN PRACT, V17, P166, DOI 10.1111/papr.12440; Neblett R, 2015, CLIN J PAIN, V31, P323, DOI 10.1097/AJP.0000000000000113; Neblett R, 2013, J PAIN, V14, P438, DOI 10.1016/j.jpain.2012.11.012; Nicholas MK, 2015, J PAIN, V16, P153, DOI 10.1016/j.jpain.2014.11.002; Nishigami T, 2017, J ORTHOP SCI, V22, P351, DOI 10.1016/j.jos.2016.11.015; Noten S, 2017, PAIN PRACT, V17, P267, DOI 10.1111/papr.12502; Pitance L., 2016, MAN THER, V25, P83, DOI [DOI 10.1016/J.MATH.2016.05.139, 10.1016/j.math.2016.05.139]; Plinsinga ML, 2015, J ORTHOP SPORT PHYS, V45, P864, DOI 10.2519/jospt.2015.5895; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Ramp M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-58; Rasch G., 1960, PROBABILISTIC MODELS; Riddle DL, 2013, PAIN MED, V14, P265, DOI 10.1111/pme.12007; Scerbo T, 2018, PAIN PRACT, V18, P544, DOI 10.1111/papr.12636; Tan G, 2006, J PAIN, V7, P252, DOI 10.1016/j.jpain.2005.11.007; Tanaka K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188719; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Trang T, 2011, NEURON GLIA BIOL, V7, P99, DOI 10.1017/S1740925X12000087; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Uki J, 1998, J PAIN SYMPTOM MANAG, V16, P364, DOI 10.1016/S0885-3924(98)00098-0; Van Oosterwijck J, 2013, EUR J PAIN, V17, P299, DOI 10.1002/j.1532-2149.2012.00193.x; Vergara M, 2016, INFLAMM BOWEL DIS, V22, P955, DOI 10.1097/MIB.0000000000000678; Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wright BD, 1982, RATING SCALE ANAL; Wright BD, 1979, BEST TEST DESIGN RAS; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004	61	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200152	10.1371/journal.pone.0200152	http://dx.doi.org/10.1371/journal.pone.0200152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL7YG	29975754	gold, Green Submitted, Green Published			2022-12-26	WOS:000437424500071
J	Chung, M; Borges, V; Gomes, JP; de Lencastre, H; Tomasz, A				Chung, Marilyn; Borges, Vitor; Gomes, Joao Paulo; de Lencastre, Herminia; Tomasz, Alexander			Phenotypic signatures and genetic determinants of oxacillin tolerance in a laboratory mutant of Staphylococcus aureus	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; AUTOLYSIN ATL; CELL-WALL; EXPRESSION; BACTERIA	Addition of beta-lactam antibiotics to growing cultures of bacteria inhibit synthesis of the bacterial cell wall peptidoglycan accompanied by killing (loss of viable titer) and lysis (physical disintegration) of the cells. However, it has also been well established that these antibiotics are not effective in killing non-growing or slow-growing bacteria and the mechanism of this "antibiotic tolerance" is not well understood. In this study, we report on the genetic basis and phenotypic properties of an antibiotic tolerant derivative of the methicillin susceptible S. aureus strain 27s. Cultures were exposed to "pulses" of high concentrations of oxacillin followed by outgrowth of the surviving bacteria. This procedure quickly selected for antibiotic tolerant mutants with an increased ability to survive antibiotic treatment without increase in the MIC value for the antibiotic. Such mutants also exhibited longer lag phase, decreased lysis, virtually no change in antibiotic susceptibilities, cross tolerance to D-cycloserine and vancomycin, and increase in biofilm formation in the presence of high concentrations of oxacillin. Whole genome sequencing showed that these altered properties were linked to mutations in the atl and gdpP genes.	[Chung, Marilyn; Tomasz, Alexander] Rockefeller Univ, Lab Microbiol & Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Borges, Vitor; Gomes, Joao Paulo] NIH, Dept Infect Dis, Bioinformat Unit, Lisbon, Portugal; [de Lencastre, Herminia] Univ Nova Lisboa, Lab Mol Genet, Inst Tecnol Quim & Biol Antonio Xavier ITQB, Oeiras, Portugal	Rockefeller University; Universidade Nova de Lisboa	Tomasz, A (corresponding author), Rockefeller Univ, Lab Microbiol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.	tomasz@rockefeller.edu		Gomes, Joao Paulo/0000-0002-2697-2399; Tomasz, Alexander/0000-0003-1520-1983; Borges, Vitor/0000-0003-3767-2209	US Public Health Service [2 R01 AI457838-15]; RB Roberts Bacterial Antibiotic Resistance Group (BARG); MOSTMICRO - FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI) [LISBOA-01-0145-FEDER-007660]; national funds through FCT - Fundacao para a Ciencia e a Tecnologia; project ONEIDA - FEEI - "Fundos Europeus Estruturais e de Investimento" from "Programa Operacional Regional Lisboa 2020" [LISBOA-01-0145-FEDER-016417]; national funds from FCT	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); RB Roberts Bacterial Antibiotic Resistance Group (BARG); MOSTMICRO - FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI); national funds through FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); project ONEIDA - FEEI - "Fundos Europeus Estruturais e de Investimento" from "Programa Operacional Regional Lisboa 2020"; national funds from FCT(Portuguese Foundation for Science and Technology)	This work was financially supported by a US Public Health Service Award 2 R01 AI457838-15 awarded to AT and by funds from the RB Roberts Bacterial Antibiotic Resistance Group (BARG) and by MOSTMICRO Project (LISBOA-01-0145-FEDER-007660) funded by FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI); and by national funds through FCT - Fundacao para a Ciencia e a Tecnologia and project ONEIDA (LISBOA-01-0145-FEDER-016417) co-funded by FEEI - "Fundos Europeus Estruturais e de Investimento" from "Programa Operacional Regional Lisboa 2020" and by national funds from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077122; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; CLSI, 2013, PERFORMANCE STANDARD; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Griffiths JM, 2012, ANTIMICROB AGENTS CH, V56, P579, DOI 10.1128/AAC.05148-11; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Kaplan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00198-12; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; O'Neill AJ, 2010, LETT APPL MICROBIOL, V51, P358, DOI 10.1111/j.1472-765X.2010.02885.x; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; OSHIDA T, 1992, J BACTERIOL, V174, P4952, DOI 10.1128/JB.174.15.4952-4959.1992; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000; Sieradzki K, 1997, J ANTIMICROB CHEMOTH, V39, P47, DOI 10.1093/jac/39.suppl_1.47; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Sugai M, 1997, J BACTERIOL, V179, P2958, DOI 10.1128/jb.179.9.2958-2962.1997; Szweda P, 2012, APPL MICROBIOL BIOT, V96, P1157, DOI 10.1007/s00253-012-4484-3; TOMASZ A, 1991, ANTIMICROB AGENTS CH, V35, P124, DOI 10.1128/AAC.35.1.124; Tram G., 2013, ADV MICROBIOL-NY, V3, P5, DOI [10.4236/aim.2013.32030, DOI 10.4236/AIM.2013.32030]; TUOMANEN E, 1986, ANTIMICROB AGENTS CH, V30, P521, DOI 10.1128/AAC.30.4.521; Zeden MS, 2018, J BIOL CHEM, V293, P3180, DOI 10.1074/jbc.M117.818716	26	7	7	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199707	10.1371/journal.pone.0199707	http://dx.doi.org/10.1371/journal.pone.0199707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969476	Green Submitted, Green Published, gold			2022-12-26	WOS:000437246700024
J	Zhu, R; Xu, DW; Yang, XQ; Zhang, JJ; Wang, SF; Shi, HY; Liu, XF				Zhu, Rui; Xu, Danwen; Yang, Xueqin; Zhang, Jianjun; Wang, Shifeng; Shi, Huoying; Liu, Xiufan			Genetic and biological characterization of H9N2 avian influenza viruses isolated in China from 2011 to 2014	PLOS ONE			English	Article							A VIRUS; PHYLOGENETIC ANALYSIS; CHICKENS; HEMAGGLUTININ; POULTRY; H7N9; REPLICATION; EVOLUTION; INFECTION; SUBTYPES	The genotypes of the H9N2 avian influenza viruses have changed since 2013 when almost all H9N2 viruses circulating in chickens in China were genotype 57 (G57) with the fittest lineage of each gene. To characterize the H9N2 variant viruses from 2011 to 2014, 28 H9N2 influenza viruses were isolated from live poultry markets in China from 2011-2014 and were analyzed by genetic and biological characterization. Our findings showed that 16 residues that changed antigenicity, two potential N-linked glycosylation sites, and one amino acid in the receptor binding site of the HA protein changed significantly from 2011-2014. Moreover, the HA and NA genes in the phylogenetic tree were mainly clustered into two independent branches, A and B, based on the year of isolation. H9N2 virus internal genes were related to those from the human-infected avian influenza viruses H5N1, H7N9, and H10N8. In particular, the NS gene in the phylogenetic tree revealed genetic divergence of the virus gene into three branches labeled A, B, and C, which were related to the H9N2, H10N8, and H7N9 viruses, respectively. Additionally, the isolates also showed varying levels of infection and airborne transmission. These results indicated that the H9N2 virus had undergone an adaptive evolution and variation from 2011-2014.	[Zhu, Rui; Xu, Danwen; Yang, Xueqin; Shi, Huoying; Liu, Xiufan] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China; [Zhu, Rui; Xu, Danwen; Yang, Xueqin; Shi, Huoying; Liu, Xiufan] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Zhang, Jianjun] Sinopharm Yangzhou VAC Biol Engn Co Ltd, Yangzhou, Jiangsu, Peoples R China; [Wang, Shifeng] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL USA	Yangzhou University; State University System of Florida; University of Florida	Shi, HY (corresponding author), Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China.; Shi, HY (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	hyshi@yzu.edu.cn		Zhu, Rui/0000-0002-8791-677X	National Natural Science Foundation of China [31672516, 31172300, 30670079]; Jiangsu province [BE2016343]; Jiangsu University and College Natural Science Foundation [12KJA230002]; Doctoral Program of Higher Education of China [20133250110002]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Sinopharm Yangzhou VAC Biological Engineering Co., Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu province; Jiangsu University and College Natural Science Foundation; Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Sinopharm Yangzhou VAC Biological Engineering Co., Ltd.	This work was supported by the National Natural Science Foundation of China (31672516, 31172300, and 30670079) to HS, Grant No. BE2016343 from Jiangsu province, the Jiangsu University and College Natural Science Foundation (12KJA230002), the Doctoral Program of Higher Education of China (20133250110002), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). Sinopharm Yangzhou VAC Biological Engineering Co., Ltd. provided financial support in the form of a salary for JZ. The specific role of this author is articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai ZP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000949; Chen F, 2012, VIRUS GENES, V45, P69, DOI 10.1007/s11262-012-0742-9; Chu J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14519-1; Cui LB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4142; Dong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017212; Edwards S, 2006, DEV BIOLOGICALS, V124, P159; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Horwood PF, 2018, EMERG INFECT DIS, V24, P352, DOI 10.3201/eid2402.171360; Jiang WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052671; Kaverin NV, 2004, J VIROL, V78, P240, DOI 10.1128/JVI.78.1.240-249.2004; Kishida N, 2004, ARCH VIROL, V149, P2095, DOI 10.1007/s00705-004-0372-1; Liu D, 2014, LANCET, V383, P869, DOI 10.1016/S0140-6736(14)60386-X; Liu HQ, 2003, AVIAN DIS, V47, P116, DOI 10.1637/0005-2086(2003)047[0116:PAOTHG]2.0.CO;2; Mok CKP, 2011, J VIROL, V85, P9641, DOI 10.1128/JVI.00702-11; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Okamatsu M, 2008, ARCH VIROL, V153, P2189, DOI 10.1007/s00705-008-0243-2; Pan Q, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-104; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Pu J, 2017, J VIROL, V91, DOI [10.1128/jvi.02055-16, 10.1128/JVI.02055-16]; Pu J, 2015, P NATL ACAD SCI USA, V112, P548, DOI 10.1073/pnas.1422456112; Reed LJ, 1938, AMJHYG, V27; Shanmuganatham KK, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.29; Shen HQ, 2015, J VET SCI, V16, P317, DOI 10.4142/jvs.2015.16.3.317; Shi HY, 2010, AVIAN DIS, V54, P22, DOI 10.1637/8937-052809-Reg.1; Shi WF, 2014, PROTEIN CELL, V5, P253, DOI 10.1007/s13238-014-0036-1; Sun XX, 2013, INFECT GENET EVOL, V20, P471, DOI 10.1016/j.meegid.2013.10.012; Sun YP, 2015, PROTEIN CELL, V6, P18, DOI 10.1007/s13238-014-0111-7; Sun YP, 2010, VET MICROBIOL, V146, P215, DOI 10.1016/j.vetmic.2010.05.010; Vandegrift KJ, 2010, ANN NY ACAD SCI, V1195, P113, DOI 10.1111/j.1749-6632.2010.05451.x; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wan ZM, 2014, J VIROL, V88, P3898, DOI 10.1128/JVI.03440-13; Wang J, 2018, BRIT POULTRY SCI, V59, P160, DOI 10.1080/00071668.2017.1406061; Wu AP, 2013, CELL HOST MICROBE, V14, P446, DOI 10.1016/j.chom.2013.09.001; Xia J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171564; Xiao CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19474; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Zhang PH, 2008, J GEN VIROL, V89, P3102, DOI 10.1099/vir.0.2008/005652-0; Zhong L, 2014, J VIROL, V88, P9568, DOI 10.1128/JVI.00943-14	39	20	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199260	10.1371/journal.pone.0199260	http://dx.doi.org/10.1371/journal.pone.0199260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969454	Green Published, gold, Green Submitted			2022-12-26	WOS:000437246700013
J	Dalvi, PS; Yang, S; Swain, N; Kim, J; Saha, S; Bourdon, C; Zhang, L; Chami, R; Bandsma, RHJ				Dalvi, Prasad S.; Yang, Steven; Swain, Nathan; Kim, Junsoo; Saha, Senjuti; Bourdon, Celine; Zhang, Ling; Chami, Rose; Bandsma, Robert H. J.			Long-term metabolic effects of malnutrition: Liver steatosis and insulin resistance following early-life protein restriction	PLOS ONE			English	Article							HIGH-FAT DIET; NONALCOHOLIC STEATOHEPATITIS; GLUCOSE-TOLERANCE; MALNOURISHED CHILDREN; HEPATIC STEATOSIS; CHRONIC DISEASE; HIGH-FRUCTOSE; ADULT HEALTH; MURINE MODEL; SAO-PAULO	Early postnatal-life malnutrition remains prevalent globally, and about 45% of all child deaths are linked to malnutrition. It is not clear whether survivors of childhood malnutrition suffer from long-term metabolic effects, especially when they are later in life exposed to a fat and carbohydrate rich obesogenic diet. The lack of knowledge around this dietary "double burden" warrants studies to understand the long-term consequences of children previously exposed to malnutrition. We hypothesized that an early-life nutritional insult of low protein consumption in mice would lead to long-term metabolic disturbances that would exacerbate the development of diet-induced insulin resistance and non-alcoholic fatty liver disease (NAFLD). We investigated the effects of feeding a low protein diet (4% wt/wt) immediately after weaning for four weeks and subsequent feeding of a high carbohydrate high fat feeding for 16 weeks on metabolic function and development of NAFLD. Mice exposed to early-life protein restriction demonstrated a transient glucose intolerance upon recovery by regular chow diet feeding. However, protein restriction after weaning in mice did not exacerbate an obesogenic diet-induced insulin resistance or progression to NAFLD. These data suggest that transient protein restriction in early-life does not exacerbate an obesogenic diet-induced NAFLD and insulin resistance.	[Dalvi, Prasad S.; Yang, Steven; Swain, Nathan; Kim, Junsoo; Saha, Senjuti; Bourdon, Celine; Zhang, Ling; Bandsma, Robert H. J.] Hosp Sick Children, Translat Med Res Program, Toronto, ON, Canada; [Dalvi, Prasad S.] Gannon Univ, Morosky Coll Hlth Profess & Sci, Erie, PA USA; [Chami, Rose] Univ Toronto, Fac Med, Dept Lab Med & Pathol, Toronto, ON, Canada; [Chami, Rose] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON, Canada; [Bandsma, Robert H. J.] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Bandsma, RHJ (corresponding author), Hosp Sick Children, Translat Med Res Program, Toronto, ON, Canada.; Bandsma, RHJ (corresponding author), Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada.	robert.bandsma@sickkids.ca		Saha, Senjuti/0000-0001-6087-6766; Chami, Rose/0000-0002-1242-9352	Hospital for Sick Children	Hospital for Sick Children(University of Toronto)	This work was supported through an internal grant from the Hospital for Sick Children.	Aguila M, 2003, LIVER INT, V23, P363, DOI 10.1034/j.1478-3231.2003.00858.x; ALLEYNE GAO, 1972, BRIT J NUTR, V27, P585, DOI 10.1079/BJN19720128; Bandsma RHJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE466, DOI 10.1152/ajpendo.00090.2015; Bandsma RHJ, 2010, PEDIATR RES, V68, P423, DOI 10.1203/PDR.0b013e3181f2b959; Barker DJP, 2012, PUBLIC HEALTH, V126, P185, DOI 10.1016/j.puhe.2011.11.014; BARKER DJP, 1986, LANCET, V1, P1077; Bartz S, 2014, J CLIN ENDOCR METAB, V99, P2128, DOI 10.1210/jc.2013-4018; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brown EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8806; Catta-Preta M, 2011, VIRCHOWS ARCH, V459, P477, DOI 10.1007/s00428-011-1147-1; De Bruyne RML, 2010, HEPATOL INT, V4, P375, DOI 10.1007/s12072-009-9160-z; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Di Giovanni V, 2016, J NUTR, V146, P2436, DOI 10.3945/jn.116.239145; Eriksson JG, 2002, DIABETOLOGIA, V45, P342, DOI 10.1007/s00125-001-0757-6; Franco VHM, 1999, J TROP PEDIATRICS, V45, P71, DOI 10.1093/tropej/45.2.71; Gonzalez-Barranco J, 2003, METABOLISM, V52, P1005, DOI 10.1016/S0026-0495(03)00151-3; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; Kawasaki T, 2009, J NUTR, V139, P2067, DOI 10.3945/jn.109.105858; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Kong LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109434; Kus V, 2008, AM J PHYSIOL-ENDOC M, V295, pE356, DOI 10.1152/ajpendo.90256.2008; Lelijveld N, 2016, LANCET GLOB HEALTH, V4, pE654, DOI 10.1016/S2214-109X(16)30133-4; Li ML, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/437107; Lieber CS, 2004, AM J CLIN NUTR, V79, P502; Liyanage Vichithra R B, 2014, Biology (Basel), V3, P670, DOI 10.3390/biology3040670; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Owczarzy R, 2008, NUCLEIC ACIDS RES, V36, pW163, DOI 10.1093/nar/gkn198; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Rising R, 2010, J NUTR METAB, V2010, DOI 10.1155/2010/171490; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004; Sargent G, 2016, J CELL BIOL, V214, P677, DOI 10.1083/jcb.201511034; Sawaya AL, 1998, J NUTR, V128, p415S, DOI 10.1093/jn/128.2.415S; Spoelstra MN, 2012, METABOLISM, V61, P1224, DOI 10.1016/j.metabol.2012.01.019; Tetri LH, 2008, AM J PHYSIOL-GASTR L, V295, pG987, DOI 10.1152/ajpgi.90272.2008; van Zutphen T, 2016, J HEPATOL, V65, P1198, DOI 10.1016/j.jhep.2016.05.046; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wang NJ, 2016, J CLIN ENDOCR METAB, V101, P2218, DOI 10.1210/jc.2016-1076; Wang YH, 2010, OBESITY, V18, P588, DOI 10.1038/oby.2009.296; YAJNIK CS, 1995, DIABETIC MED, V12, P330, DOI 10.1111/j.1464-5491.1995.tb00487.x; Zauner C, 2000, AM J CLIN NUTR, V71, P1511	50	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199916	10.1371/journal.pone.0199916	http://dx.doi.org/10.1371/journal.pone.0199916			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965973	Green Published, gold, Green Submitted			2022-12-26	WOS:000437224100028
J	Dumas, SN; Ntambi, JM				Dumas, Sabrina N.; Ntambi, James M.			Increased hydrophilic plasma bile acids are correlated with protection from adiposity in skin-specific stearoyl-CoA desaturase-1 deficient mice	PLOS ONE			English	Article							CHOLESTEROL; ATHEROSCLEROSIS; RECEPTOR; OBESITY; METABOLISM; MEMBRANE; DISEASE	Stearoyl-CoA desaturase 1 (SCD1) catalyzes the rate limiting step in monounsaturated fatty acid synthesis by inserting a double bond at the delta-9 position of long-chain fatty acids. SCD1 converts stearate (18:0) to oleate (18:1n9) and palmitate (16:0) to palmitoleate (16:1n7), respectively. Mice with global and skin-specific deletion (SKO) of SCD1 exhibit increased whole body energy expenditure and protection against diet-induced adiposity, hepatic steatosis, insulin sensitivity and glucose intolerance. The mechanisms that link cutaneous lipid homeostasis with whole body energy balance are presently unknown. In this study, we reveal that SKO mice demonstrate increased skin surface free cholesterol, decreased circulating total cholesterol and increased taurine-conjugated and hydrophilic bile acids. Tauro-8-muricholic acid, which is a marker of extrahepatic bile acid synthesis, is significantly elevated in SKO plasma. Bile acid signaling through the bile acid-specific receptor TGR5 is known to be protective against obesity and metabolic disease; a phenotype that is similar to SKO mice. We therefore examined TGR5 expression and its downstream mediator, DIO2, in various tissues and found that both TGR5 and DIO2 expression were significantly increased in brown adipose tissue. In sum, we suggest that skin-derived bile acids are involved in the lean and metabolically healthy phenotype of SKO mice.	[Dumas, Sabrina N.; Ntambi, James M.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA; [Ntambi, James M.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ntambi, JM (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.; Ntambi, JM (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	james.ntambi@wisc.edu			United States Department of Agriculture (USDA) Hatch W2005; University of Wisconsin-Madison's Science and Medicine Graduate Research Scholars (SciMed GRS)	United States Department of Agriculture (USDA) Hatch W2005; University of Wisconsin-Madison's Science and Medicine Graduate Research Scholars (SciMed GRS)	This work was supported by United States Department of Agriculture (USDA) Hatch W2005 (to J.M.N.) and University of Wisconsin-Madison's Science and Medicine Graduate Research Scholars (SciMed GRS) (to S.N.D).	Alrefai WA, 2007, PHARM RES-DORDR, V24, P1803, DOI 10.1007/s11095-007-9289-1; Attie AD, 2001, J LIPID RES, V42, P1717; Bray GA, 2016, LANCET, V387, P1947, DOI 10.1016/S0140-6736(16)00271-3; Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Centers for Disease Control and Prevention (CDC), OV OB; Duboc H, 2014, DIGEST LIVER DIS, V46, P302, DOI 10.1016/j.dld.2013.10.021; Fiorucci S, 2010, PROG LIPID RES, V49, P171, DOI 10.1016/j.plipres.2009.11.001; Flowers MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019734; Hebberd, 2006, BIOCH PHYSL MOL ASPE; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Ji CG, 2017, TRANSL RES, V182, P88, DOI 10.1016/j.trsl.2016.12.001; Kellner-Weibel G, 1999, ATHEROSCLEROSIS, V146, P309, DOI 10.1016/S0021-9150(99)00155-0; Kreznar JH, 2017, CELL REP, V18, P1739, DOI 10.1016/j.celrep.2017.01.062; MacDonald MLE, 2009, ARTERIOSCL THROM VAS, V29, P341, DOI 10.1161/ATVBAHA.108.181099; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Pappas A, 2009, DERM-ENDOCRINOL, V1, P72, DOI 10.4161/derm.1.2.7811; Pathak P, 2017, J BIOL CHEM, V292, P11055, DOI 10.1074/jbc.M117.784322; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Qi YP, 2015, BBA-MOL CELL BIOL L, V1851, P19, DOI 10.1016/j.bbalip.2014.04.008; Ross SE, 2016, J SPORT SCI, V34, P1148, DOI 10.1080/02640414.2015.1093650; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sampath H, 2009, J BIOL CHEM, V284, P19961, DOI 10.1074/jbc.M109.014225; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Smith LP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007333; Tabas I, 2002, J CLIN INVEST, V110, P583, DOI 10.1172/JCI200216381; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Zhao YDD, 2014, METABOLOMICS, V10, P1169, DOI 10.1007/s11306-014-0653-y	30	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199682	10.1371/journal.pone.0199682	http://dx.doi.org/10.1371/journal.pone.0199682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965978	gold, Green Submitted, Green Published			2022-12-26	WOS:000437224100018
J	Barlow, J; Solomon, TPJ; Affourtit, C				Barlow, Jonathan; Solomon, Thomas P. J.; Affourtit, Charles			Pro-inflammatory cytokines attenuate glucose-stimulated insulin secretion from INS-1E insulinoma cells by restricting mitochondrial pyruvate oxidation capacity - Novel mechanistic insight from real-time analysis of oxidative phosphorylation	PLOS ONE			English	Article							PANCREATIC BETA-CELL; MONOUNSATURATED FATTY-ACIDS; NITRIC-OXIDE PRODUCTION; FACTOR-KAPPA-B; UNCOUPLING PROTEIN-2; SKELETAL-MUSCLE; RAT ISLETS; DYSFUNCTION; APOPTOSIS; INHIBITION	Pro-inflammatory cytokines cause pancreatic beta cell failure during the development of type 2 diabetes. This beta cell failure associates with mitochondrial dysfunction, but the precise effects of cytokines on mitochondrial respiration remain unclear. To test the hypothesis that pro-inflammatory cytokines impair glucose-stimulated insulin secretion (GSIS) by inhibiting oxidative ATP synthesis, we probed insulin release and real-time mitochondrial respiration in rat INS-1E insulinoma cells that were exposed to a combination of 2 ng/mL interleukin-1-beta and 50 ng/mL interferon-gamma. We show that 24-h exposure to these cytokines dampens both glucose-and pyruvate-stimulated insulin secretion (P < 0.0001 and P < 0.05, respectively), but does not affect KCl-induced insulin release. Mirroring secretory defects, glucose-and pyruvate-stimulated mitochondrial respiration are lowered after cytokine exposure (P < 0.01). Further analysis confirms that cytokine-induced mitochondrial respiratory defects occur irrespective of whether fuel oxidation is coupled to, or uncoupled from, ATP synthesis. These observations demonstrate that pro-inflammatory cytokines attenuate GSIS by restricting mitochondrial pyruvate oxidation capacity. Interleukin-1-beta and interferon-gamma also increase mitochondrial superoxide levels (P < 0.05), which may reinforce the inhibition of pyruvate oxidation, and cause a modest (20%) but significant (P < 0.01) loss of INS-1E cells. Cytokine-induced INS-1E cell failure is insensitive to palmitoleate and linoleate, which is at odds with the cytoprotection offered by unsaturated fatty acids against harm caused by nutrient excess. Our data disclose a mitochondrial mechanism for cytokine-impaired GSIS in INS-1E cells, and suggest that inflammatory and nutrient-related beta cell failure emerge, at least partly, through distinct paths.	[Barlow, Jonathan; Affourtit, Charles] Univ Plymouth, Sch Biomed & Healthcare Sci, Plymouth, Devon, England; [Barlow, Jonathan; Solomon, Thomas P. J.] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Solomon, Thomas P. J.] Univ Birmingham, IMSR, Birmingham, W Midlands, England	University of Plymouth; University of Birmingham; University of Birmingham	Barlow, J (corresponding author), Univ Plymouth, Sch Biomed & Healthcare Sci, Plymouth, Devon, England.; Barlow, J (corresponding author), Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England.	j.p.barlow@bham.ac.uk	Affourtit, Charles/I-3958-2019; Solomon, Thomas PJ/I-4476-2019	Affourtit, Charles/0000-0003-1776-9943; Solomon, Thomas PJ/0000-0002-0579-284X; Barlow, Jonathan/0000-0002-9463-7234	Medical Research Council [G1100165]; European Commission (Marie Sklodowska-Curie Research Fellowship) [656775]; MRC [G1100165] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission (Marie Sklodowska-Curie Research Fellowship); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (New Investigator Research Grant G1100165 to CA), and the European Commission (Marie Sklodowska-Curie Research Fellowship 656775 to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affourtit C, 2018, BIOCHEM SOC T, V46, P555, DOI 10.1042/BST20170505; Affourtit C, 2011, FREE RADICAL BIO MED, V50, P609, DOI 10.1016/j.freeradbiomed.2010.12.020; Affourtit C, 2009, METHOD ENZYMOL, V457, P405, DOI 10.1016/S0076-6879(09)05023-X; Andersson AK, 2001, BIOCHEM BIOPH RES CO, V281, P396, DOI 10.1006/bbrc.2001.4361; Azevedo-Martins AK, 2003, DIABETES, V52, P93, DOI 10.2337/diabetes.52.1.93; Barg S, 2003, PHARMACOL TOXICOL, V92, P3, DOI 10.1034/j.1600-0773.2003.920102.x; Barlow J, 2016, BIOCHEM J, V473, P487, DOI 10.1042/BJ20151080; Barlow J, 2015, REDOX BIOL, V4, P14, DOI 10.1016/j.redox.2014.11.009; Barlow J, 2013, BIOCHEM J, V456, P417, DOI 10.1042/BJ20131002; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BEGGS M, 1990, FEBS LETT, V267, P217, DOI 10.1016/0014-5793(90)80928-C; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Brand MD, 2016, FREE RADICAL BIO MED, V100, P14, DOI 10.1016/j.freeradbiomed.2016.04.001; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Broniowska KA, 2015, J BIOL CHEM, V290, P7952, DOI 10.1074/jbc.M114.627869; Brown GC, 2007, FRONT BIOSCI; Burke SJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE715, DOI 10.1152/ajpendo.00153.2015; Cherry AD, 2015, ANTIOXID REDOX SIGN, V22, P965, DOI 10.1089/ars.2014.6200; Christensen CS, 2015, J CLIN ENDOCR METAB, V100, pE1289, DOI 10.1210/jc.2014-4506; Collier JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022485; Collier JJ, 2006, DIABETES, V55, P1398, DOI 10.2337/db05-1000; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Donath MY, 2013, DIABETES OBES METAB, V15, P193, DOI 10.1111/dom.12172; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Grant RW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00050; Hirschberg Jensen Verena, 2015, Biochem Biophys Rep, V1, P8; Hohmeier HE, 1998, J CLIN INVEST, V101, P1811, DOI 10.1172/JCI1489; Holohan C, 2008, J CELL MOL MED, V12, P591, DOI 10.1111/j.1582-4934.2007.00191.x; Hostens K, 1999, J CLIN INVEST, V104, P67, DOI 10.1172/JCI6438; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huber AH, 2006, BIOCHEMISTRY-US, V45, P14263, DOI 10.1021/bi060703e; Jaksch C, 2014, ENDOCRINE, V47, P117, DOI 10.1007/s12020-013-0133-6; Kabra UD, 2017, DIABETES, V66, P1247, DOI 10.2337/db16-1088; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kim HE, 2008, J ENDOCRINOL, V198, P549, DOI 10.1677/JOE-08-0131; Lin N, 2012, ENDOCRINE, V42, P107, DOI 10.1007/s12020-012-9633-z; Liu DB, 2000, DIABETES, V49, P1116, DOI 10.2337/diabetes.49.7.1116; Lortz S, 2013, DIABETOLOGIA, V56, P774, DOI 10.1007/s00125-012-2823-7; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Ma ZM, 1997, J BIOL CHEM, V272, P17827, DOI 10.1074/jbc.272.28.17827; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Meredith M, 1996, DIABETES, V45, P1783, DOI 10.2337/diabetes.45.12.1783; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Morgan D, 2007, DIABETOLOGIA, V50, P359, DOI 10.1007/s00125-006-0462-6; Morgan D, 2009, ENDOCRINOLOGY, V150, P2197, DOI 10.1210/en.2008-1149; Morgan NG, 2008, BIOCHEM SOC T, V36, P905, DOI 10.1042/BST0360905; Navarro G, 2016, CELL METAB, V23, P837, DOI 10.1016/j.cmet.2016.03.015; Newsholme P, 2009, DIABETOLOGIA, V52, P2489, DOI 10.1007/s00125-009-1536-z; Newsholme P, 2016, BIOCHEM J, V473, P4527, DOI 10.1042/BCJ20160503C; Nicholls DG, 2016, PHYSIOL REV, V96, P1385, DOI 10.1152/physrev.00009.2016; Nisr RB, 2016, BBA-BIOENERGETICS, V1857, P1403, DOI 10.1016/j.bbabio.2016.04.286; Pi J, 2010, DIABETES OBES METAB, V12, P141, DOI 10.1111/j.1463-1326.2010.01269.x; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Robson-Doucette CA, 2011, DIABETES, V60, P2710, DOI 10.2337/db11-0132; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Takeda T, 2001, BIOCHEM BIOPH RES CO, V284, P20, DOI 10.1006/bbrc.2001.4933; Vasu S, 2014, BBA-GEN SUBJECTS, V1840, P136, DOI 10.1016/j.bbagen.2013.08.022; WELSH N, 1992, BIOCHEM BIOPH RES CO, V182, P333, DOI 10.1016/S0006-291X(05)80149-4; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; Welters HJ, 2004, FEBS LETT, V560, P103, DOI 10.1016/S0014-5793(04)00079-1; Zhang SY, 1995, FEBS LETT, V377, P237, DOI 10.1016/0014-5793(95)01272-9	71	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199505	10.1371/journal.pone.0199505	http://dx.doi.org/10.1371/journal.pone.0199505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953508	gold, Green Published, Green Submitted			2022-12-26	WOS:000436645400035
J	Ilc, T; Arista, G; Tavares, R; Navrot, N; Duchene, E; Velt, A; Choulet, F; Paux, E; Fischer, M; Nelson, DR; Hugueney, P; Werck-Reichhart, D; Rustenholz, C				Ilc, Tina; Arista, Gautier; Tavares, Raquel; Navrot, Nicolas; Duchene, Eric; Velt, Amandine; Choulet, Frederic; Paux, Etienne; Fischer, Marc; Nelson, David R.; Hugueney, Philippe; Werck-Reichhart, Daniele; Rustenholz, Camille			Annotation, classification, genomic organization and expression of the Vitis vinifera CYPome	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; SEQUENCE ALIGNMENT; GENE; CYTOCHROME-P450; GRAPEVINE; METABOLISM; PROGRAM; VERSION; FAMILY; WINE	Cytochromes P450 are enzymes that participate in a wide range of functions in plants, from hormonal signaling and biosynthesis of structural polymers, to defense or communication with other organisms. They represent one of the largest gene/protein families in the plant kingdom. The manual annotation of cytochrome P450 genes in the genome of Vitis vinifera PN40024 revealed 579 P450 sequences, including 279 complete genes. Most of the P450 sequences in grapevine genome are organized in physical clusters, resulting from tandem or segmental duplications. Although most of these clusters are small (2 to 35, median = 3), some P450 families, such as CYP76 and CYP82, underwent multiple duplications and form large clusters of homologous sequences. Analysis of gene expression revealed highly specific expression patterns, which are often the same within the genes in large physical clusters. Some of these genes are induced upon biotic stress, which points to their role in plant defense, whereas others are specifically activated during grape berry ripening and might be responsible for the production of berry-specific metabolites, such as aroma compounds. Our work provides an exhaustive and robust annotation including clear identification, structural organization, evolutionary dynamics and expression patterns for the grapevine cytochrome P450 families, paving the way to efficient functional characterization of genes involved in grapevine defense pathways and aroma biosynthesis.	[Ilc, Tina; Navrot, Nicolas; Werck-Reichhart, Daniele] Univ Strasbourg, Inst Plant Mol Biol, Ctr Natl Rech Sci, Strasbourg, France; [Arista, Gautier; Duchene, Eric; Velt, Amandine; Fischer, Marc; Hugueney, Philippe; Rustenholz, Camille] Univ Strasbourg, INRA, SVQV, UMR A 1131, Colmar, France; [Tavares, Raquel] Univ Lyon 1, Lab Biometrie & Biol Evolut, Ctr Natl Rech Sci, Lyon, France; [Choulet, Frederic; Paux, Etienne] Univ Blaise Pascal, Lab Struct & Evolut Genome Ble, Inst Natl Rech Agronom, Clermont Ferrand, France; [Nelson, David R.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Clermont Auvergne (UCA); University of Tennessee System; University of Tennessee Health Science Center	Rustenholz, C (corresponding author), Univ Strasbourg, INRA, SVQV, UMR A 1131, Colmar, France.	camille.rustenholz@inra.fr	Hugueney, Philippe/AAU-5903-2020; WERCK-REICHHART, Danièle/U-3713-2019	Hugueney, Philippe/0000-0002-1641-9274; WERCK-REICHHART, Danièle/0000-0003-2869-4262; Choulet, Frederic/0000-0003-1788-7288; Paux, Etienne/0000-0002-3094-7129; Navrot, Nicolas/0000-0002-2141-1808; Velt, Amandine/0000-0003-2368-839X	French Agence Nationale de la Recherche to the InteGrape project [ANR-13-BSV6-0010]; European Union [289217]; INRA; Region Alsace	French Agence Nationale de la Recherche to the InteGrape project(French National Research Agency (ANR)); European Union(European Commission); INRA; Region Alsace(Region Grand-Est)	The authors acknowledge the support of the French Agence Nationale de la Recherche to the InteGrape project (ANR-13-BSV6-0010). The doctoral fellowship of Tina IIc was funded by the People Programme (Marie Curie Actions) of the European Union's 7th Framework Programme (FP7/2007-2013) under REA Grant Agreement 289217. The doctoral fellowship of Gautier Arista was funded by INRA and the Region Alsace. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anastasiou E, 2007, DEV CELL, V13, P843, DOI 10.1016/j.devcel.2007.10.001; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ayabe Shin-ichi, 2006, Phytochemistry Reviews, V5, P271, DOI 10.1007/s11101-006-9007-3; Bak Soren, 2011, Arabidopsis Book, V9, pe0144, DOI 10.1199/tab.0144; Bisson LF, 2002, NATURE, V418, P696, DOI 10.1038/nature01018; Boachon B, 2015, PLANT CELL, V27, P2972, DOI 10.1105/tpc.15.00399; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Borneman AR, 2013, TRENDS GENET, V29, P263, DOI 10.1016/j.tig.2012.10.014; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Canaguier A, 2017, GENOM DATA, V14, P56, DOI 10.1016/j.gdata.2017.09.002; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chakrabarti M, 2013, P NATL ACAD SCI USA, V110, P17125, DOI 10.1073/pnas.1307313110; Cheng DW, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-135; Costantini L, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00780; Da Silva C, 2013, GENOME, V1, P1, DOI [10.1105/tpc.113.118810, DOI 10.1105/TPC.113.118810]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duchene E, 2005, AGRON SUSTAIN DEV, V25, P93, DOI 10.1051/agro:2004057; Duchene E, 2010, CLIM RES, V41, P193, DOI 10.3354/cr00850; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehlting Jurgen, 2006, Phytochemistry Reviews, V5, P239, DOI 10.1007/s11101-006-9025-1; Falginella L, 2012, PLANTA, V236, P1037, DOI 10.1007/s00425-012-1658-2; Falginella L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-562; FAOSTAT, 2015, FOOD AGR COMM PROD C; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Ginglinger JF, 2013, PLANT CELL, V25, P4640, DOI 10.1105/tpc.113.117382; Gomez JF, 2015, J INTEGR PLANT BIOL, V57, P876, DOI 10.1111/jipb.12425; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gray DJ, 2014, PLANT SCI, V228, P3, DOI 10.1016/j.plantsci.2014.03.023; Grimplet Jerome, 2012, BMC Res Notes, V5, P213, DOI 10.1186/1756-0500-5-213; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamberger B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0426; Hansen CH, 2001, J BIOL CHEM, V276, P11078, DOI 10.1074/jbc.M010123200; Helliwell CA, 1998, P NATL ACAD SCI USA, V95, P9019, DOI 10.1073/pnas.95.15.9019; Hofer R, 2014, PLANT PHYSIOL, V166, P1149, DOI 10.1104/pp.114.244814; Ilc T, 2017, NEW PHYTOL, V213, P264, DOI 10.1111/nph.14139; Ito T, 2000, PLANT CELL, V12, P1541, DOI 10.1105/tpc.12.9.1541; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jones L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1081; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kolde R., 2015, PHEATMAP PRETTY HEAT, DOI DOI 10.1093/nar/gkv007; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langridge P, 2011, TRENDS BIOTECHNOL, V29, P33, DOI 10.1016/j.tibtech.2010.09.006; Lee S, 2010, P NATL ACAD SCI USA, V107, P21205, DOI 10.1073/pnas.1009975107; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu ZH, 2015, MOL PLANT, V8, P1751, DOI 10.1016/j.molp.2015.09.002; Liu ZX, 2016, 2016 17TH INTERNATIONAL CONFERENCE ON PARALLEL AND DISTRIBUTED COMPUTING, APPLICATIONS AND TECHNOLOGIES (PDCAT), P7, DOI [10.1109/PDCAT.2016.17, 10.1109/PDCAT.2016.018]; Lund ST, 2006, SCIENCE, V311, P804, DOI 10.1126/science.1118962; Martin DM, 2009, P NATL ACAD SCI USA, V106, P7245, DOI 10.1073/pnas.0901387106; MARTIN DM, 2010, BIOMED CENTRAL, V10, DOI DOI 10.1186/1471-2229-10-226; Miettinen K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4606; Miller M.A., 2010, P GAT COMP ENV WORKS; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Nelson D. R., 2008, Tropical Plant Biology, V1, P216, DOI 10.1007/s12042-008-9022-1; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Nelson David R., 2009, Human Genomics, V4, P59; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Nutzmann HW, 2014, CURR OPIN BIOTECH, V26, P91, DOI 10.1016/j.copbio.2013.10.009; Ramos MJN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1095; Palumbo MC, 2014, PLANT CELL, V26, P4617, DOI 10.1105/tpc.114.133710; Parage C, 2012, PLANT PHYSIOL, V160, P1407, DOI 10.1104/pp.112.202705; Perazzolli M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-660; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2021, R LANGUAGE ENV STAT; Richly E, 2002, MOL BIOL EVOL, V19, P76, DOI 10.1093/oxfordjournals.molbev.a003984; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Seo J, 2006, BIOINFORMATICS, V22, P808, DOI 10.1093/bioinformatics/btk052; SONNHAMMER ELL, 1995, GENE-COMBIS, V167, P1; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; Sweetman C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-691; Takos AM, 2012, TRENDS PLANT SCI, V17, P383, DOI 10.1016/j.tplants.2012.04.004; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vannozzi A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-130; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Venturini L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-41; Vitulo N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-99; Wang Q, 2012, J BIOL CHEM, V287, P6159, DOI 10.1074/jbc.M111.305599; Wellesen K, 2001, P NATL ACAD SCI USA, V98, P9694, DOI 10.1073/pnas.171285998; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Zohary D, 1972, SCIENCE, V187, P319	86	5	5	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199902	10.1371/journal.pone.0199902	http://dx.doi.org/10.1371/journal.pone.0199902			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953551	gold, Green Submitted, Green Published			2022-12-26	WOS:000436645400092
J	Lee, H; Kim, JE; Lee, S; Lee, CH				Lee, Hyojung; Kim, Jung Eun; Lee, Sunmi; Lee, Chang Hyeong			Potential effects of climate change on dengue transmission dynamics in Korea	PLOS ONE			English	Article							AEDES-ALBOPICTUS; TEMPERATURE; FEVER; POPULATION; OUTBREAK; TAIWAN; TOKYO; MODEL; RISK	Dengue fever is a major international public health concern, with more than 55% of the world population at risk of infection. Recent climate changes related to global warming have increased the potential risk of domestic outbreaks of dengue in Korea. In this study, we develop a two-strain dengue model associated with climate-dependent parameters based on Representative Concentration Pathway (RCP) scenarios provided by the Korea Meteorological Administration. We assess the potential risks of dengue outbreaks by means of the vector capacity and intensity under various RCP scenarios. A sensitivity analysis of the temperature-dependent parameters is performed to explore the effects of climate change on dengue transmission dynamics. Our results demonstrate that a higher temperature significantly enhances the potential threat of domestic dengue outbreaks in Korea. Furthermore, we investigate the effects of countermeasures on the cumulative incidence of humans and vectors. The current main control measures (comprising only travel restrictions) for infected humans in Korea are not as effective as combined control measures (travel restrictions and vector control), dramatically reducing the possibilities of dengue outbreaks.	[Lee, Hyojung] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Kim, Jung Eun; Lee, Chang Hyeong] Ulsan Natl Inst Sci & Technol, Dept Math Sci, Ulsan, South Korea; [Lee, Sunmi] Kyung Hee Univ, Dept Appl Math, Yongin, South Korea	Hokkaido University; Ulsan National Institute of Science & Technology (UNIST); Kyung Hee University	Lee, CH (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Math Sci, Ulsan, South Korea.	chlee@unist.ac.kr	Lee, Chang Hyeong/F-4142-2010	Lee, Chang Hyeong/0000-0003-3247-5791	Basic Science Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Education [2016R1D1A1B03934427]; National Research Foundation of Korea (NRF) grant - the Korean government (MSIP) [20161402]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Education; National Research Foundation of Korea (NRF) grant - the Korean government (MSIP)	Chang Hyeong Lee was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1B03934427). Sunmi Lee was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No.20161402).	Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001; Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421; ANDERSON R M, 1991; Andraud M, 2013, MATH BIOSCI, V244, P22, DOI 10.1016/j.mbs.2013.04.001; [Anonymous], 2017, JEJU TOURIST STAT; Badrinath S, 2010, INDIAN J MED MICROBI, V28, P271; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Berger S, 2015, INFECT DIS S KOREA; Chen SC, 2012, SCI TOTAL ENVIRON, V431, P385, DOI 10.1016/j.scitotenv.2012.05.012; Chen SC, 2010, SCI TOTAL ENVIRON, V408, P4069, DOI 10.1016/j.scitotenv.2010.05.021; Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616; Cho Hae-Wol, 2016, Osong Public Health Res Perspect, V7, P1, DOI 10.1016/j.phrp.2016.02.001; Choi Soo Han, 2010, Korean J Pediatr, V53, P701, DOI 10.3345/kjp.2010.53.6.701; Derouich M, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-4; Esteva L, 2003, J MATH BIOL, V46, P31, DOI 10.1007/s00285-002-0168-4; Ewing DA, 2016, J THEOR BIOL, V400, P65, DOI 10.1016/j.jtbi.2016.04.008; Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Graham RR, 1999, AM J TROP MED HYG, V61, P412, DOI 10.4269/ajtmh.1999.61.412; 김성화, 2015, [JOURNAL OF THE KOREAN HOUSING ASSOCIATION, 한국주거학회논문집], V26, P1, DOI 10.6107/JKHA.2015.26.1.001; Janreung S., 2014, INT J APPL PHYS MATH, V4, P55, DOI [10.7763/IJAPM.2014.V4.255, DOI 10.7763/IJAPM.2014.V4.255]; Jeong Young Eui, 2016, Osong Public Health Res Perspect, V7, P71, DOI 10.1016/j.phrp.2015.12.001; Kim JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173673; Korea Centers for Disease Control and Prevention(KCDC), 2017, INF DIS SURV YB 2016; Korean Statistical Information Service(KOSIS), 2017, POP PROJ SUMM IND PR; Kun Hu, 2013, Social Computing, Behavioral-Cultural Modeling and Prediction. 6th International Conference, SBP 2013. Proceedings, P486, DOI 10.1007/978-3-642-37210-0_53; Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103/141662, 10.3201/eid2103.141662]; Lee Jacob, 2014, [The Korean Journal of Medicine, 대한내과학회지], V86, P277, DOI 10.3904/kjm.2014.86.3.277; Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068512; Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046; Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783; Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568; Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105; Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; Park MS, 2013, P KOR WAT RES ASS C; Rodrigues H.S., 2013, C PAPERS SCI, V2013; Sharma N, 2013, TROP ANIM HEALTH PRO, V45, P1829, DOI 10.1007/s11250-013-0422-3; Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520; ten Bosch QA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004680; Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; Tsuda Y, 2016, JPN J INFECT DIS, V69, P1, DOI 10.7883/yoken.JJID.2014.576; Wang SF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.124; Wang SF, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.46; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103; Xu W, 2010, ARXIV10112009; Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040; Yang HM, 2011, BIOSYSTEMS, V103, P360, DOI 10.1016/j.biosystems.2010.11.002; Yang SC, 2018, PUBL HLTH WEEKL REP, V11, P463; Yeom JS, 2017, J KOREAN MED ASSOC, V60, P468, DOI 10.5124/jkma.2017.60.6.468; 신호성, 2011, [Health and Social Welfare Review, 보건사회연구], V31, P217	52	32	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199205	10.1371/journal.pone.0199205	http://dx.doi.org/10.1371/journal.pone.0199205			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953493	gold, Green Published			2022-12-26	WOS:000436645400017
J	Austad, K; Shah, P; Rohloff, P				Austad, Kirsten; Shah, Pooja; Rohloff, Peter			Correlates of long-acting reversible contraception uptake among rural women in Guatemala	PLOS ONE			English	Article								Objective In many low-resource settings around the world utilization of long-acting reversible contraception (LARC) is low, in part due to access barriers. We sought to explore LARC utilization patterns as well as factors associated with LARC initiation by women seeking contraception in rural Guatemala from a program working to reduce contraception access barriers. Study design We analyzed data from a program that provides family planning in six remote, primarily indigenous, villages in Guatemala with limited access to alternative health services. Methods are free and delivered directly within villages by culturally competent providers. We conducted a retrospective chart review of all 288 women who initiated a contraceptive method over a 16-month period and conducted a logistic regression to obtain adjusted odds ratios (OR) for predictors of LARC uptake. Results Overall 79.2% of women elected a LARC method. More than half of women (49.8%) switched to LARC from short-acting hormonal methods. In the univariate analysis prior use of short-acting method (p = 0.014), number of prior methods (p = 0.049), and current contraceptive use (p<0.01) were significantly associated with choosing a LARC. In the logistic regression model current use of contraception remained significant (OR 3.29, 95% CI 1.678.04). Report of abnormal bleeding or other side effects from prior short-acting method use did not predict LARC uptake (p = 0.82 and p = 0.079). Conclusions Most women in this marginalized population opted for a LARC method.	[Austad, Kirsten] Brigham & Womens Hosp, Dept Med, Div Womens Hlth, 75 Francis St, Boston, MA 02115 USA; [Austad, Kirsten; Shah, Pooja; Rohloff, Peter] Wuqu Kawoq Maya Hlth Alliance, Santiago Sacatepequez, Guatemala; [Shah, Pooja] UCSF Sch Med, San Francisco, CA USA; [Rohloff, Peter] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital	Rohloff, P (corresponding author), Wuqu Kawoq Maya Hlth Alliance, Santiago Sacatepequez, Guatemala.; Rohloff, P (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.	peter@wuqukawoq.org	Austad, Kirsten/ABC-7684-2021; Rohloff, Peter/P-8722-2017	Rohloff, Peter/0000-0001-7274-8315; Shah, Pooja/0000-0003-2183-9641; Austad, Kirsten/0000-0001-5237-2955	Brigham and Women's Hospital Global Women's Health Fellowship	Brigham and Women's Hospital Global Women's Health Fellowship	Dr. Kirsten Austad received funding from Brigham and Women's Hospital Global Women's Health Fellowship. The funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Adetunji J.A., 2011, ETUDE POPUL AFR, V25, P587, DOI DOI 10.11564/25-2-247; Alemayehu M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-6; Ali M, 2011, WORLD HLTH; Asnake Mengistu, 2013, Int J Gynaecol Obstet, V123 Suppl 1, pe29, DOI 10.1016/j.ijgo.2013.07.003; Belaid L, 2016, TROP MED INT HEALTH, V21, P1240, DOI 10.1111/tmi.12758; Bertrand JT, 2014, INT PERSPECT SEX R H, V40, P144, DOI 10.1363/4014414; Brown K, 2016, MATERN CHILD NUTR, V12, P262, DOI 10.1111/mcn.12141; Chary A, 2013, HUM ORGAN, V72, P87, DOI 10.17730/humo.72.2.f2014210742702r2; Curtis KM, 2017, NEW ENGL J MED, V376, P461, DOI 10.1056/NEJMcp1608736; Darroch JE, 2013, LANCET, V381, P1756, DOI 10.1016/S0140-6736(13)60597-8; Dassah ET, 2013, EUR J CONTRACEP REPR, V18, P293, DOI 10.3109/13625187.2013.790951; Dempsey AR, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.014; Farmer DB, 2015, GLOB HEALTH, V3, P242, DOI 10.9745/GHSP-D-14-00198; Goldstone P, 2014, MED J AUSTRALIA, V201, P412, DOI 10.5694/mja14.00011; Harper CC, 2015, LANCET, V386, P562, DOI 10.1016/S0140-6736(14)62460-0; Hosmer DW, 2013, WILEY SER PROBAB ST, P269; Hubacher D, 2011, CONTRACEPTION, V84, P413, DOI 10.1016/j.contraception.2011.02.007; Instituto Nacional de Estadistica (INE), 2012, CAR EST REP GUAT 201; Ministerio de Salud Publica y Asistencia Social (MSPAS), 2017, ENC NAC SAL MAT INF; Modesto W, 2014, HUM REPROD, V29, P1393, DOI 10.1093/humrep/deu089; O'Shea M, 2014, CONTRACEPTION, V90, P312, DOI 10.1016/j.contraception.2014.05.070; Powers BJ, 2015, WORLD HEAL ORG, V87, P276, DOI DOI 10.2165/00128413-200112870-00010; Prata N, 2009, PHILOS T R SOC B, V364, P3093, DOI 10.1098/rstb.2009.0172; Raine T, 2003, CONTRACEPTION, V68, P19, DOI 10.1016/S0010-7824(03)00107-0; Rees H, 2017, SAMJ S AFR MED J, V107, P939, DOI [10.7196/SAMJ.2017.v107i11.12903, 10.7196/samj.2017.v107i11.12903]; Reproductive Health Access Project, 2016, QUICK START ALG; Rios-Zertuche D, 2017, CONTRACEPTION, V95, P549, DOI 10.1016/j.contraception.2017.01.005; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Seiber EE, 2002, HEALTH POLICY PLANN, V17, P167, DOI 10.1093/heapol/17.2.167; Snow R, 1997, ACCEPTABILITY USERS; Speizer IS, 2009, REPROD HLTH, V6, P19, DOI [10.1186/1742-4755-6-19, DOI 10.1186/1742-4755-6-19]; Staveteig S, 2015, UPTAKE DISCONTINUATI, P1; Tibaijuka L, 2017, BMC WOMENS HEALTH, V17, P1, DOI [10.1186/s12905-016-0358-7, DOI 10.1186/S12905-016-0358-7]; Tilahun Y, 2017, GLOB HEALTH-SCI PRAC, V5, P592, DOI 10.9745/GHSP-D-17-00215; U.S. Agency for International Development (USAID, 2010, EXP CONTR CHOIC UND; [United Nation Department of Economic and Social Affairs PD], 2015, TRENDS CONTR US WORL, DOI [10.1016/j.contraception.2012.08.029, DOI 10.1016/J.CONTRACEPTION.2012.08.029]; USAID, 2015, TEST SERV DEL MOD OF; Whitaker AK, 2016, PATIENT EDUC COUNS, V99, P1663, DOI 10.1016/j.pec.2016.05.011; Whitaker AK, 2010, CONTRACEPTION, V81, P299, DOI 10.1016/j.contraception.2009.11.008	39	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199536	10.1371/journal.pone.0199536	http://dx.doi.org/10.1371/journal.pone.0199536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK9FZ	29949633	Green Submitted, Green Published, gold			2022-12-26	WOS:000436549200055
J	Tanney, JB; Renaud, JB; Miller, JD; McMullin, DR				Tanney, Joey B.; Renaud, Justin B.; Miller, J. David; McMullin, David R.			New 1,3-benzodioxin-4-ones from Synnemapestaloides ericacearum sp nov., a biosynthetic link to remarkable compounds within the Xylariales	PLOS ONE			English	Article							DIELS-ALDER REACTION; SECONDARY METABOLITES; FUNGAL ENDOPHYTES; PHYLOGENETIC ANALYSIS; SEIMATOSPORIUM; DIHYDROMALDOXIN; MALDOXONE; SEPTATE; DARK	Surveys of foliar endophytes from the Acadian forest region over the past three decades have identified numerous phylogenetically diverse fungi producing natural products toxic to forest pests and diseases. The life histories of some conifer endophytes can be restricted to plant foliage or may include saprotrophic phases on other plants tissues or even alternate hosts. Considering the potentially broad host preferences of conifer endophytes we explored fungi isolated from understory species and their metabolites as part of an ongoing investigation of fungal biodiversity from the Acadian forest. We report a hitherto unidentified Xylario-mycetidae species isolated from symptomatic Labrador tea (Rhododendron groenlandicum) leaves and mountain laurel (Kalmia latifolia) collected in coastal southern New Brunswick, Canada. Morphological and phylogenetic evidence demonstrated the unknown species was a novel Synnemapestaloides (Sporocadaceae) species, described here as Syn. ericacearum. A preliminary screening assay indicated that the culture filtrate extract of the new species was potently antifungal towards the biotrophic pathogen Microbotryum violaceum, warranting an investigation of its natural products. Two natural products possessing a rare 1,3-benzodioxin-4-one scaffold, synnemadoxins A-B (1-2), and their postulated precursor, synnemadiacid A (3), were characterized as new structures and assessed for antimicrobial activity. All isolated compounds elicited in vitro inhibitory antifungal activity towards M. violaceum at 2.3 mu g mL(-1) and moderate antibiotic activity. Further, the characterization of synnemadoxins A-B provided a perspective on the biosynthesis of some related 1,3-benzodioxin-4-ones produced by other fungi within the Xylariales.	[Tanney, Joey B.] Carleton Univ, Dept Biol, Ottawa, ON, Canada; [Renaud, Justin B.] Agr & Agri Food Canada, London Res & Dev Ctr, London, ON, Canada; [Miller, J. David; McMullin, David R.] Carleton Univ, Dept Chem, Ottawa, ON, Canada; [McMullin, David R.] Agr & Agri Food Canada, Charlottetown Res & Dev Ctr, Charlottetown, PE, Canada	Carleton University; Agriculture & Agri Food Canada; Carleton University; Agriculture & Agri Food Canada	McMullin, DR (corresponding author), Carleton Univ, Dept Chem, Ottawa, ON, Canada.; McMullin, DR (corresponding author), Agr & Agri Food Canada, Charlottetown Res & Dev Ctr, Charlottetown, PE, Canada.	david.mcmullin@carleton.ca		McMullin, David/0000-0001-9808-924X	Natural Science and Engineering Research Council (NSERC) of Canada; MITACS; JD Irving, Limited	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); MITACS; JD Irving, Limited	Funding was provided by the Natural Science and Engineering Research Council (NSERC) of Canada, MITACS, and JD Irving, Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeboya MO, 1996, J CHEM SOC PERK T 1, P1419, DOI 10.1039/p19960001419; Andrade R, 1996, CAN J CHEM, V74, P371, DOI 10.1139/v96-042; BECKE AD, 1992, J CHEM PHYS, V96, P2155, DOI 10.1063/1.462066; BONAR LEE, 1928, MYCOLOGIA [ NEW YORK], V20, P292; Case DA, 2012, AMBER 12; CLAYDON N, 1985, PHYTOCHEMISTRY, V24, P937, DOI 10.1016/S0031-9422(00)83157-X; de Hoog GS, 1998, MYCOSES, V41, P183, DOI 10.1111/j.1439-0507.1998.tb00321.x; Grunig CR, 2009, MYCOL RES, V113, P207, DOI 10.1016/j.mycres.2008.10.005; Handa Tomokazu, 2004, Mycoscience, V45, P137, DOI 10.1007/s10267-003-0163-7; Heinig U, 2013, FUNGAL DIVERS, V60, P161, DOI 10.1007/s13225-013-0228-7; Higginbotham S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084549; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hussain H, 2014, CHINESE CHEM LETT, V25, P1577, DOI 10.1016/j.cclet.2014.06.006; Hussain H, 2012, NAT PROD COMMUN, V7, P293; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Liu L, 2010, CHEM COMMUN, V46, P460, DOI 10.1039/b918330b; Liu L, 2013, J ORG CHEM, V78, P2992, DOI 10.1021/jo302804h; Liu L, 2011, CHEM-EUR J, V17, P2604, DOI 10.1002/chem.201003129; Liu L, 2009, ORG LETT, V11, P2836, DOI 10.1021/ol901039m; Maharachchikumbura SSN, 2014, STUD MYCOL, P121, DOI 10.1016/j.simyco.2014.09.005; Maharachchikumbura SSN, 2011, FUNGAL DIVERS, V50, P167, DOI 10.1007/s13225-011-0125-x; MASCLAUX F, 1995, J MED VET MYCOL, V33, P327; McMullin DR, 2017, CAN J MICROBIOL, V63, P621, DOI 10.1139/cjm-2017-0083; McMullin DR, 2017, J NAT PROD, V80, P1475, DOI 10.1021/acs.jnatprod.6b01157; Menkis A, 2004, MYCOL RES, V108, P965, DOI 10.1017/S0953756204000668; Nag Raj TR, 1993, COELOMYCETOUS ANAMOR; Hiep NT, 2012, J NAT PROD, V75, P784, DOI 10.1021/np200955z; Norphanphoun C, 2015, MYCOSPHERE, V6, P385, DOI 10.5943/mycosphere/6/3/12; Nylander JAA., 2004, MRMODELTEST 2 2; Okane I, 1996, CAN J BOT, V74, P1338, DOI 10.1139/b96-162; PIROZYNSKI KA, 1970, CAN J BOTANY, V48, P2199, DOI 10.1139/b70-318; Pitt J. I., 1979, The genus Penicillium and its teleomorphic states Eupenicillium and Talaromyces.; PURMALE L, 2012, ENVIRON EXP BIOL, V10, P1; Reddy CR, 2013, ORG BIOMOL CHEM, V11, P3355, DOI 10.1039/c3ob27518c; Richardson SN, 2014, FUNGAL ECOL, V11, P107, DOI 10.1016/j.funeco.2014.05.004; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Samson, 2009, FUNGAL BIODIVERSITY; SCHULZ B, 1995, MYCOL RES, V99, P1007, DOI 10.1016/S0953-7562(09)80766-1; SHOEMAKER R. A., 1964, CANADIAN JOUR BOT, V42, P403; SHOEMAKER R. A., 1964, CANADIAN JOUR BOT, V42, P411, DOI 10.1139/b64-041; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stierle AA, 2015, NAT PROD COMMUN, V10, P1671; Sumarah MW, 2008, J NAT PROD, V71, P1393, DOI 10.1021/np800192f; Sumarah MW, 2015, RECENT ADV PHYTOCHEM, V45, P195, DOI 10.1007/978-3-319-20397-3_8; Sumarah MW, 2009, NAT PROD COMMUN, V4, P1497; Sutton B. C., 1980, COELOMYCETES FUNGI I; Sutton BC, 1963, MYCOL PAP, V88, P1; Suzuki T, 2017, ORG LETT, V19, P922, DOI 10.1021/acs.orglett.7b00085; Suzuki T, 2013, ORG LETT, V15, P1748, DOI 10.1021/ol400549q; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tanney J.B., 2016, FUNGAL BIOL; Tanney JB, SPRINGER FORESTRY SE, VII; Tanney JB, 2016, MYCOLOGIA, V108, P255, DOI 10.3852/15-136; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang XN, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1190-9; Washida K, 2009, BIOSCI BIOTECH BIOCH, V73, P1355, DOI 10.1271/bbb.90015; Watanabe K, 2016, J FUNGI, V2, DOI 10.3390/jof2040028; Willoughby PH, 2014, NAT PROTOC, V9, P643, DOI 10.1038/nprot.2014.042; Wu GW, 2016, ORG LETT, V18, P1832, DOI 10.1021/acs.orglett.6b00562; Yu M, 2011, ORG LETT, V13, P4224, DOI 10.1021/ol201561w	62	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198321	10.1371/journal.pone.0198321	http://dx.doi.org/10.1371/journal.pone.0198321			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949590	Green Published, gold			2022-12-26	WOS:000436549200012
J	Xi, DP; He, HY; Yu, ZQ; Huang, QH; Hu, JF; Xu, YK; Shi, ZY; Qin, ZH; Wan, XQ				Xi, Dangpeng; He, Huaiyu; Yu, Zhiqiang; Huang, Qinghua; Hu, Jianfang; Xu, Yankang; Shi, Zhongye; Qin, Zuohuan; Wan, Xiaoqiao			New SIMS U-Pb age constraints on the largest lake transgression event in the Songliao Basin, NE China	PLOS ONE			English	Article							SEAWATER INCURSION EVENTS; NORTHEAST CHINA; CRETACEOUS CLIMATE; GREENHOUSE WORLD; EUSTASY; EVOLUTION; SYSTEM; RECORD	The largest lake transgression event (LTE) associated with lake anoxic events (LAE) and periodic seawater incursion events (SWIE) in the Songliao Basin, northeastern China, occurred during deposition of the Cretaceous Nenjiang Formation. The Yaojia-Nenjiang Formation boundary (YNB) marks the beginning of the LTE, as well as LAE and SWIE. However, there is an absence of direct radioisotopic dating, and therefore the age of the YNB, as well as the beginning of LTE, together with their relationship with other geological events, is strongly debated. Here we present a new SIMS U-Pb zircon age from the lowermost Nenjiang Formation. The bentonite bed located 9.88 m above the YNB of the X1-4 borehole was analyzed. Twenty-five analyses of 25 zircons were conducted, which produced a weighted mean age of 85.5 +/- 0.6 Ma (MSWD = 0.87). Based on the average sediment accumulation rate, the age of the YNB is suggested to be 85.7 Ma, indicating that the LTE began in the Early Santonian. The new ages provide a precise chronostratigraphic framework for climatic and geological events. Our new results imply that the beginning of the LTE, LAE and SWIE occurred almost simultaneously with short-term sea level rise, and probably had a close relationship with OAE3.	[Xi, Dangpeng; Yu, Zhiqiang; Xu, Yankang; Shi, Zhongye; Qin, Zuohuan; Wan, Xiaoqiao] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing, Peoples R China; [He, Huaiyu; Yu, Zhiqiang] Chinese Acad Sci, Inst Geol & Geophys, State Key Lab Lithospher Evolut, Beijing, Peoples R China; [He, Huaiyu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Huang, Qinghua] Daqing Oil Field Corp, Explorat & Dev Res Inst, Daqing, Heilongjiang, Peoples R China; [Hu, Jianfang] Chinese Acad Sci, Guangzhou Inst Geochem, Guangzhou, Guangdong, Peoples R China	China University of Geosciences; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sinopec; Chinese Academy of Sciences; Guangzhou Institute of Geochemistry, CAS	He, HY (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, State Key Lab Lithospher Evolut, Beijing, Peoples R China.; He, HY (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	huaiyuhe@mail.iggcas.ac.cn	He, Huaiyu/C-3414-2018	He, Huaiyu/0000-0002-4887-5274; Qin, Zuohuan/0000-0002-2103-4205	National Natural Science Foundation of China [41790452, 41302008, 41372110, 41425013, 41688103]; National Basic Research Program of China [2012CB822002]; State Key Laboratory of Biogeology and Environmental Geology [GBL21314]; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Biogeology and Environmental Geology; Chinese Academy of Sciences(Chinese Academy of Sciences)	D.X. acknowledges support from the National Natural Science Foundation of China (Grant Nos. 41790452 and 41302008; http://www.nsfc.gov.cn/publish/portal1/), the National Basic Research Program of China (Grant No. 2012CB822002; http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm), and State Key Laboratory of Biogeology and Environmental Geology (Grant No. GBL21314; http://en.cug.edu.cn/Key_Laboratories/Key_Laboratories_Research_Centers.htm). J.H. acknowledges support from the National Natural Science Foundation of China (Grant No. 41372110; http://www.nsfc.gov.cn/publish/portal1/). H.H. acknowledges support from the National Natural Science Foundation of China (Grant Nos. 41425013 and 41688103; http://www.nsfc.gov.cn/publish/portal1/), and the Strategic Priority Research Program of the Chinese Academy of Sciences (http://english.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechtel A, 2012, ORGANIC GEOCHEMISTRY, V31, P76; Cao HS, 2016, PALAEOGEOGR PALAEOCL, V451, P152, DOI 10.1016/j.palaeo.2016.02.041; Chamberlain CP, 2013, PALAEOGEOGR PALAEOCL, V385, P106, DOI 10.1016/j.palaeo.2012.03.020; Deng CL, 2013, PALAEOGEOGR PALAEOCL, V385, P44, DOI 10.1016/j.palaeo.2012.07.028; Feng ZQ, 2010, BASIN RES, V22, P79, DOI 10.1111/j.1365-2117.2009.00445.x; Feng ZH, 2011, SCI CHINA EARTH SCI, V54, P1304, DOI 10.1007/s11430-011-4268-0; Gao R.Q., 1992, ACTA PALAEONTOL SIN, V31, P19; GAO YF, 2008, DIZHI XUEBAO, V82, P669; Gao Y, 2015, GEOLOGY, V43, P287, DOI 10.1130/G36427.1; Gu Z. W., 1999, CRETACEOUS BIVALVES; Haq BU, 2014, GLOBAL PLANET CHANGE, V113, P44, DOI 10.1016/j.gloplacha.2013.12.007; Hay WW, 2012, EARTH-SCI REV, V115, P262, DOI 10.1016/j.earscirev.2012.09.008; He HY, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003901; Hou DJ, 2000, ORG GEOCHEM, V31, P763, DOI 10.1016/S0146-6380(00)00065-6; Hu JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09508; Hu XM, 2012, CRETACEOUS RES, V38, P1, DOI 10.1016/j.cretres.2012.04.012; Huang Qing-Hua, 1998, Acta Micropalaeontologica Sinica, V15, P417; Huang YJ, 2013, PALAEOGEOGR PALAEOCL, V385, P152, DOI 10.1016/j.palaeo.2013.03.017; Huber BT, 2002, GEOLOGY, V30, P123, DOI 10.1130/0091-7613(2002)030<0123:DSPROE>2.0.CO;2; Jenkyns HC, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002788; Jiro A S, 2008, CHEM GEOL, V249, P1; Li QL, 2010, J ANAL ATOM SPECTROM, V25, P1107, DOI 10.1039/b923444f; Li XH, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002400; Locklair R, 2011, SEDIMENT GEOL, V235, P38, DOI 10.1016/j.sedgeo.2010.06.026; Ludwig K., 2001, USERS MANUAL ISOPLOT, P56; Sageman BB, 2006, GEOLOGY, V34, P125, DOI 10.1130/G22074.1; Sames B, 2016, PALAEOGEOGR PALAEOCL, V441, P393, DOI 10.1016/j.palaeo.2015.10.045; SCHLANGER S O, 1976, Geologie en Mijnbouw, V55, P179; Skelton PW, 2003, CRETACEOUS WORLD; STACEY JS, 1975, EARTH PLANET SC LETT, V26, P207, DOI 10.1016/0012-821X(75)90088-6; Wagreich M, 2012, CLIM PAST, V8, P1447, DOI 10.5194/cp-8-1447-2012; Wagreich M, 2014, AUSTRIAN J EARTH SCI, V107, P115; [万晓樵 Wan Xiaoqiao], 2005, [地质学报, Acta Geologica Sinica], V79, P150; Wan XQ, 2013, PALAEOGEOGR PALAEOCL, V385, P31, DOI 10.1016/j.palaeo.2012.10.024; Wang CS, 2013, EARTH-SCI REV, V126, P275, DOI 10.1016/j.earscirev.2013.08.016; Wang CS, 2013, PALAEOGEOGR PALAEOCL, V385, P17, DOI 10.1016/j.palaeo.2012.01.030; Wang L, 2011, ORG GEOCHEM, V42, P1411, DOI 10.1016/j.orggeochem.2011.08.012; Wang P. J., 2001, DEPOSITIONAL EVENTS; Wang PJ, 2016, EARTH-SCI REV, V159, P82, DOI 10.1016/j.earscirev.2016.05.004; Wang PJ, 2015, AAPG BULL, V99, P499, DOI 10.1306/09041413095; Wang TT, 2016, EARTH PLANET SC LETT, V446, P37, DOI 10.1016/j.epsl.2016.04.007; Wendler JE, 2016, PALAEOGEOGR PALAEOCL, V441, P430, DOI 10.1016/j.palaeo.2015.08.014; WIEDENBECK M, 1995, GEOSTANDARD NEWSLETT, V19, P1, DOI 10.1111/j.1751-908X.1995.tb00147.x; Wu HC, 2013, PALAEOGEOGR PALAEOCL, V385, P55, DOI 10.1016/j.palaeo.2012.09.004; Xi DP, 2016, CRETACEOUS RES, V62, P172, DOI 10.1016/j.cretres.2015.10.025; Xi DP, 2011, ISL ARC, V20, P6, DOI 10.1111/j.1440-1738.2010.00753.x; Xi DP, 2011, CHINESE SCI BULL, V55, P3433, DOI DOI 10.1007/S11434-010-4269-Y; Yang W., 1985, PETROLEUM GEOLOGY SO; Zhang M.M., 1977, VERTEBRAT PALASIATIC, V15, P194	49	12	14	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199507	10.1371/journal.pone.0199507	http://dx.doi.org/10.1371/journal.pone.0199507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944691	Green Published, gold, Green Submitted			2022-12-26	WOS:000436377800038
J	Ince, LM; Zhang, ZG; Beesley, S; Vonslow, RM; Saer, B; Matthews, LC; Begley, N; Gibbs, JE; Ray, DW; Loudon, ASI				Ince, Louise M.; Zhang, Zhenguang; Beesley, Stephen; Vonslow, Ryan M.; Saer, Ben R.; Matthews, Laura C.; Begley, Nicola; Gibbs, Julie E.; Ray, David W.; Loudon, Andrew S. I.			Circadian variation in pulmonary inflammatory responses is independent of rhythmic glucocorticoid signaling in airway epithelial cells	FASEB JOURNAL			English	Article						circadian rhythms; inflammation; endocrinology; Ccsp-GR-; -S; LysM-GR-; -Y	INNATE IMMUNITY; GM-CSF; RECEPTOR; LUNG; LIPOPOLYSACCHARIDE; GRANULOCYTES; TRAFFICKING; MACROPHAGES; MIGRATION; CLOCKS	The circadian clock is a critical regulator of immune function. We recently highlighted a role for the circadian clock in a mouse model of pulmonary inflammation. The epithelial clock protein Bmal1 was required to regulate neutrophil recruitment in response to inflammatory challenge. Bmal1 regulated glucocorticoid receptor (GR) recruitment to the neutrophil chemokine, CXC chemokine ligand 5 (CXCL5), providing a candidate mechanism. We now show that clock control of pulmonary neutrophilia persists without rhythmic glucocorticoid availability. Epithelial GR-null mice had elevated expression of proinflammatory chemokines in the lung under homeostatic conditions. However, deletion of GR in the bronchial epithelium blocked rhythmic CXCL5 production, identifying GR as required to confer circadian control to CXCL5. Surprisingly, rhythmic pulmonary neutrophilia persisted, despite nonrhythmic CXCL5 responses, indicating additional circadian control mechanisms. Deletion of GR in myeloid cells alone did not prevent circadian variation in pulmonary neutrophilia and showed reduced neutrophilic inflammation in response to dexamethasone treatment. These new data show GR is required to confer circadian control to some inflammatory chemokines, but that this alone is insufficient to prevent circadian control of neutrophilic inflammation in response to inhaled LPS, with additional control mechanisms arising in the myeloid cell lineage.Ince, L. M., Zhang, Z., Beesley, S., Vonslow, R. M., Saer, B. R., Matthews, L. C., Begley, N., Gibbs, J. E., Ray, D. W., Loudon, A. S. I. Circadian variation in pulmonary inflammatory responses is independent of rhythmic glucocorticoid signaling in airway epithelial cells.	[Ince, Louise M.; Zhang, Zhenguang; Beesley, Stephen; Vonslow, Ryan M.; Saer, Ben R.; Matthews, Laura C.; Begley, Nicola; Gibbs, Julie E.; Ray, David W.; Loudon, Andrew S. I.] Univ Manchester, Sch Med Sci, Div Diabet Endocrinol & Gastroenterol, AV Hill Bldg,Oxford Rd, Manchester, Lancs, England; [Ince, Louise M.] Ludwig Maximilian Univ Munchen, Walter Brendel Ctr Expt Med, Munich, Germany; [Beesley, Stephen] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Matthews, Laura C.] Univ Leeds, Leeds Inst Canc & Pathol, Fac Med & Hlth, Leeds, W Yorkshire, England	University of Manchester; University of Munich; State University System of Florida; Florida State University; University of Leeds	Ray, DW; Loudon, ASI (corresponding author), Univ Manchester, Sch Med Sci, Div Diabet Endocrinol & Gastroenterol, AV Hill Bldg,Oxford Rd, Manchester, Lancs, England.	david.w.ray@manchester.ac.uk; andrew.loudon@manchester.ac.uk	beesley, stephen j/B-4841-2017; Ince, Louise/K-6149-2019	beesley, stephen j/0000-0001-6010-124X; Ince, Louise/0000-0002-2093-0876; Ray, David/0000-0002-4739-6773; Loudon, Andrew/0000-0003-3648-445X; Gibbs, Julie/0000-0002-4248-2947	Biotechnology and Biological Sciences Research Council (BBSRC; Swindon, United Kingdom); BBSRC [BB/K003097/1]; Wellcome Trust [107849/Z/15/Z]; MRC [MR/P023576/1, MR/K015885/1, MR/P011853/2, MR/M008908/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC; Swindon, United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Prof. Hugh Piggins, Dr. Alun Hughes, and Dr. David Spiller for their assistance with the bioluminescence recordings of lung sections; Dr. David Bechtold for assistance with surgical techniques; Louise Hunter for technical assistance during in vivo experiments; Peter Walker for training in histologic techniques and use of equipment; Dr. Gareth Howell for flow cytometry/fluorescence-activated cell sorting services; Stacey Holden, Michal Smiga, and Dr. Andy Hayes in the Genomic Core; Dr. Yasutaka Mizoro and Dr. Robert Maidstone for statistical input; the staff of the In Vivo Unit for their contribution to this paper (all from the University of Manchester); and Prof. Karen Chapman (University of Edinburgh, Edinburgh, United Kingdom) for the GR plasmid used for in situ hybridization. L.M.I. and S.B. were supported by postgraduate training studentships from the Biotechnology and Biological Sciences Research Council (BBSRC; Swindon, United Kingdom). A.S.I.L. acknowledges grant support from the BBSRC (Grant BB/K003097/1), and D.W.R. and A.S.I.L. are Wellcome Investigators, Wellcome Trust (107849/Z/15/Z). The authors declare no conflicts of interest.	Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Banuelos J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177884; Betsuyaku T, 2004, MICRON, V35, P229, DOI 10.1016/j.micron.2003.11.015; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Bozinovski S, 2002, J BIOL CHEM, V277, P42808, DOI 10.1074/jbc.M207840200; Caratti G, 2015, CLIN ENDOCRINOL, V83, P441, DOI 10.1111/cen.12728; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Charmandari E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025612; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; de Kloet ER, 2008, ENDOCRINOLOGY, V149, P3241, DOI 10.1210/en.2008-0471; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Gelati M, 2002, ARCH NEUROL-CHICAGO, V59, P774, DOI 10.1001/archneur.59.5.774; Gibbs JE, 2009, ENDOCRINOLOGY, V150, P268, DOI 10.1210/en.2008-0638; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kriebs A, 2017, P NATL ACAD SCI USA, V114, P8776, DOI 10.1073/pnas.1704955114; Laan M, 2003, EUR RESPIR J, V21, P387, DOI 10.1183/09031936.03.00303503; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Li SR, 2012, DEVELOPMENT, V139, P2500, DOI 10.1242/dev.079699; Lightman SL, 2008, EUR J PHARMACOL, V583, P255, DOI 10.1016/j.ejphar.2007.11.073; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manwani N, 2010, AM J RESP CELL MOL, V43, P599, DOI 10.1165/rcmb.2009-0263OC; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; Mitzner W, 2000, AM J PATHOL, V157, P93, DOI 10.1016/S0002-9440(10)64521-X; Mizgerd JP, 2002, SEMIN IMMUNOL, V14, P123, DOI 10.1006/smim.2001.0349; Mizobe K, 1997, J NEUROIMMUNOL, V73, P81, DOI 10.1016/S0165-5728(96)00169-5; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Okabe T, 2016, J CELL SCI, V129, P4143, DOI 10.1242/jcs.190959; Pariollaud M, 2018, J CLIN INVEST, V128, P2281, DOI 10.1172/JCI93910; Pezuk P, 2012, ENDOCRINOLOGY, V153, P4775, DOI 10.1210/en.2012-1486; Prodanovic D, 2018, FASEB J, V32, P1692, DOI 10.1096/fj.201700730R; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; Scheiermann C, 2018, NAT REV IMMUNOL, V18, P423, DOI 10.1038/s41577-018-0008-4; Sujino M, 2012, ENDOCRINOLOGY, V153, P2277, DOI 10.1210/en.2011-1794; Suzuki K, 2016, J EXP MED, V213, P2567, DOI 10.1084/jem.20160723; Trebble PJ, 2013, J CELL SCI, V126, P3159, DOI 10.1242/jcs.124784; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vettorazzi S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8796; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zen M, 2011, AUTOIMMUN REV, V10, P305, DOI 10.1016/j.autrev.2010.11.009	43	28	29	1	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					126	139		10.1096/fj.201800026RR	http://dx.doi.org/10.1096/fj.201800026RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29965797	Green Published, hybrid			2022-12-26	WOS:000457401500010
J	Tan, LX; Cho, KJ; Neupane, P; Capon, RJ; Hancock, JF				Tan, Lingxiao; Cho, Kwang-Jin; Neupane, Pratik; Capon, Robert J.; Hancock, John F.			An oxanthroquinone derivative that disrupts RAS plasma membrane localization inhibits cancer cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signaling; plasma membrane; Ras protein; GTPase Kras (KRAS); sphingolipid; cancer; endosome recycling; oxanthroquinone; sphingomyelin; trafficking	SMALL-MOLECULE INHIBITION; K-RAS; CAAX MOTIF; PROTEINS; TRAFFICKING; PALMITOYLATION; NANOCLUSTERS; ENDOSOMES; TARGETS	Oncogenic RAS proteins are commonly expressed in human cancer. To be functional, RAS proteins must undergo post-translational modification and localize to the plasma membrane (PM). Therefore, compounds that prevent RAS PM targeting have potential as putative RAS inhibitors. Here we examine the mechanism of action of oxanthroquinone G01 (G01), a recently described inhibitor of KRAS PM localization. We show that G01 mislocalizes HRAS and KRAS from the PM with similar potency and disrupts the spatial organization of RAS proteins remaining on the PM. G01 also inhibited recycling of epidermal growth factor receptor and transferrin receptor, but did not impair internalization of cholera toxin, indicating suppression of recycling endosome function. In searching for the mechanism of impaired endosomal recycling we observed that G01 also enhanced cellular sphingomyelin (SM) and ceramide levels and disrupted the localization of several lipid and cholesterol reporters, suggesting that the G01 molecular target may involve SM metabolism. Indeed, G01 exhibited potent synergy with other compounds that target SM metabolism in KRAS localization assays. Furthermore, G01 significantly abrogated RAS-RAF-MAPK signaling in Madin-Darby canine kidney (MDCK) cells expressing constitutively activated, oncogenic mutant RASG12V. G01 also inhibited the proliferation of RAS-less mouse embryo fibroblasts expressing oncogenic mutant KRASG12V or KRASG12D but not RAS-less mouse embryo fibroblasts expressing oncogenic mutant BRAFV600E. Consistent with these effects, G01 selectively inhibited the proliferation of KRAS-transformed pancreatic, colon, and endometrial cancer cells. Taken together, these results suggest that G01 should undergo further evaluation as a potential anti-RAS therapeutic.	[Tan, Lingxiao; Hancock, John F.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, McGovern Med Sch, Houston, TX 77030 USA; [Cho, Kwang-Jin] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Neupane, Pratik; Capon, Robert J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; Wright State University Dayton; University of Queensland	Hancock, JF (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, McGovern Med Sch, Houston, TX 77030 USA.	john.f.hancock@uth.tmc.edu	Capon, Robert/G-9238-2012; Cho, Kwang-jin/AAI-4923-2020	Capon, Robert/0000-0002-8341-7754; Hancock, John/0000-0003-0542-4710; Tan, Lingxiao/0000-0001-9758-891X	NATIONAL CANCER INSTITUTE [R00CA188593] Funding Source: NIH RePORTER; NCI NIH HHS [R00 CA188593] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ariotti N, 2014, J CELL BIOL, V204, P777, DOI 10.1083/jcb.201307055; Cho KJ, 2016, MOL CELL BIOL, V36, P363, DOI 10.1128/MCB.00719-15; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; GHOSH RN, 1995, J CELL BIOL, V128, P549, DOI 10.1083/jcb.128.4.549; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hancock JF, 2005, METHODS, V37, P165, DOI 10.1016/j.ymeth.2005.05.018; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Laude AJ, 2008, J CELL SCI, V121, P421, DOI 10.1242/jcs.020107; Maekawa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35762; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Papke B, 2017, SCIENCE, V355, P1158, DOI 10.1126/science.aam7622; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rodman JS, 2000, J CELL SCI, V113, P183; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Rowinsky EK, 2006, J CLIN ONCOL, V24, P2981, DOI 10.1200/JCO.2006.05.9808; Salim AA, 2014, ORG BIOMOL CHEM, V12, P4872, DOI 10.1039/c4ob00745j; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; van der Hoeven D, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00373-17; van der Hoeven D, 2013, MOL CELL BIOL, V33, P237, DOI 10.1128/MCB.00884-12; Zhou M, 2016, J CELL BIOL, V214, P445, DOI 10.1083/jcb.201604061; Zhou Y, 2017, CELL, V168, P239, DOI 10.1016/j.cell.2016.11.059; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	41	13	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13696	13706		10.1074/jbc.RA118.003907	http://dx.doi.org/10.1074/jbc.RA118.003907			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29970615	Green Published, hybrid			2022-12-26	WOS:000443375500028
J	Garcia-Martinez, A; Sottile, J; Fajardo, C; Riesgo, P; Camara, R; Simal, JA; Lamas, C; Sandoval, H; Aranda, I; Pico, A				Garcia-Martinez, Araceli; Sottile, Johana; Fajardo, Carmen; Riesgo, Pedro; Camara, Rosa; Simal, Juan Antonio; Lamas, Cristina; Sandoval, Hernan; Aranda, Ignacio; Pico, Antonio			Is it time to consider the expression of specific-pituitary hormone genes when typifying pituitary tumours?	PLOS ONE			English	Article							SILENT CORTICOTROPH ADENOMAS; HEALTH-ORGANIZATION CLASSIFICATION; SOMATOSTATIN-DOPAMINE MOLECULES; CENTRAL-NERVOUS-SYSTEM; GROWTH-HORMONE; MESSENGER-RNA; IN-VITRO; RECEPTOR; EPIDEMIOLOGY; SECRETION	The aim of the present study is to check whether we can replicate, in an independent series, previous results showing that the molecular study of pituitary-specific gene expression complements the inmunohistochemical identification of pituitary neuroendocrine tumours. We selected 112 patients (51 (46.4%) women; mean age 51.4 +/- 16 years; 102 macroadenomas (91.9%), 9 microadenomas (8.1%)) with complete clinical, radiological, immunohistochemical and molecular data from our data set of pituitary neuroendocrine tumours. Patients were different from those previously studied. We measured the expression of the pituitary-specific hormone genes and type 1 corticotrophin-releasing hormone and arginine vasopressin 1b receptors, by quantitative real-time polymerase chain reaction using TaqMan probes. Afterwards, we identified the different pituitary neuroendocrine tumour subtypes following the 2017 World Health Organization classification of pituitary tumours, calculating the concordance between their molecular and immuhistochemical identification. The concordance between molecular and immunohistochemical identification of functioning pituitary neuroendocrine tumours with the clinical diagnosis was globally similar to the previous series, where the SYBR Green technique was used instead of TaqMan probes. Our results also corroborated the poor correlation between molecular and immunohistochemical detection of the silent pituitary neuroendocrine tumour variants. This discrepancy was more remarkable in lactotroph, null-cell and plurihormonal pituitary neuroendocrine tumours. In conclusion, this study validates the results previously published by our group, highlighting a complementary role for the molecular study of the pituitary-specific hormone genes in the typification of pituitary neuroendocrine tumours subtypes.	[Garcia-Martinez, Araceli; Sottile, Johana] Hosp Gen Univ Alicante, Res Lab, Inst Hlth & Biomed Res ISABIAL, Alicante, Spain; [Fajardo, Carmen] Hosp La Ribera, Dept Endocrinol, Valencia, Spain; [Riesgo, Pedro] Hosp La Ribera, Neurosurg Dept, Valencia, Spain; [Camara, Rosa] Hosp Univ & Politecn La Fe, Dept Endocrinol, Valencia, Spain; [Simal, Juan Antonio] Hosp Univ & Politecn La Fe, Neurosurg Dept, Valencia, Spain; [Lamas, Cristina] Complejo Hosp Univ Albacete, Dept Endocrinol, Albacete, Spain; [Sandoval, Hernan] Complejo Hosp Univ Albacete, Neurosurg Dept, Albacete, Spain; [Aranda, Ignacio] Hosp Gen Univ Alicante, Dept Pathol, Alicante, Spain; [Pico, Antonio] Miguel Hernandez Univ, Dept Endocrinol, Hosp Gen Univ Alicante, Inst Hlth & Biomed Res ISABIAL,CIBERER, Alicante, Spain	General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; General University Hospital of Alicante; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL)	Pico, A (corresponding author), Miguel Hernandez Univ, Dept Endocrinol, Hosp Gen Univ Alicante, Inst Hlth & Biomed Res ISABIAL,CIBERER, Alicante, Spain.	antonio.pico@umh.es	pico, antonio/E-9061-2011; ARANDA, FRANCISCO I/L-5525-2015; Sandoval, Hernán/AAA-8463-2019; pico, antonio/B-6439-2018	pico, antonio/0000-0002-7549-7563; ARANDA, FRANCISCO I/0000-0003-2338-2286; pico, antonio/0000-0002-7549-7563; Garcia Martinez, Araceli/0000-0002-1052-1315; Sottile Barrios, Nancy Johana/0000-0002-5433-3201; Lamas Oliveira, Cristina/0000-0003-4622-9508; Fajardo-Montanana, Carmen/0000-0002-0784-0761	Novartis Oncology through the Spanish Society of Endocrinology and Nutrition (SEEN)	Novartis Oncology through the Spanish Society of Endocrinology and Nutrition (SEEN)	This work is funded by Novartis Oncology through the Spanish Society of Endocrinology and Nutrition (SEEN) to AP. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aflorei ED, 2014, J NEURO-ONCOL, V117, P379, DOI 10.1007/s11060-013-1354-5; Asa SL, 2017, ENDOCR-RELAT CANCER, V24, pC5, DOI 10.1530/ERC-17-0004; AUTELITANO DJ, 1989, MOL CELL ENDOCRINOL, V67, P101, DOI 10.1016/0303-7207(89)90235-9; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Ben-Shlomo A, 2018, PITUITARY, V21, P183, DOI 10.1007/s11102-018-0864-8; Casanueva FF, 2017, PITUITARY, V20, P489, DOI 10.1007/s11102-017-0838-2; Cooper O, 2015, PITUITARY, V18, P225, DOI 10.1007/s11102-014-0624-3; Cooper O, 2012, BEST PRACT RES CL EN, V26, P447, DOI 10.1016/j.beem.2012.01.002; Fougner SL, 2008, CLIN ENDOCRINOL, V68, P458, DOI 10.1111/j.1365-2265.2007.03065.x; Fusco A, 2008, EUR J ENDOCRINOL, V158, P595, DOI 10.1530/EJE-07-0806; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; Gruszka A, 2007, ENDOCRINOLOGY, V148, P6107, DOI 10.1210/en.2007-0378; Gruszka A, 2012, MOL CELL ENDOCRINOL, V362, P104, DOI 10.1016/j.mce.2012.05.020; HESHMATI HM, 1988, ACTA ENDOCRINOL-COP, V118, P533, DOI 10.1530/acta.0.1180533; Ibanez-Costa A, 2016, J ENDOCRINOL, V231, P135, DOI 10.1530/JOE-16-0332; Kleinschmidt-DeMasters BK, 2016, CURR OPIN ENDOCRINOL, V23, P476, DOI 10.1097/MED.0000000000000293; Lopes MBS, 2017, ACTA NEUROPATHOL, V134, P521, DOI 10.1007/s00401-017-1769-8; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Luque RM, 2013, J CLIN ENDOCR METAB, V98, P4160, DOI 10.1210/jc.2013-1992; Luque RM, 2016, ENDOCRINOL NUTR, V63, P274, DOI 10.1016/j.endonu.2016.03.001; MCCHESNEY R, 1991, MOL CELL ENDOCRINOL, V79, pR1, DOI 10.1016/0303-7207(91)90110-E; Mete O, 2016, MODERN PATHOL, V29, P131, DOI 10.1038/modpathol.2015.151; Miyai S, 2005, CELL TISSUE RES, V322, P269, DOI 10.1007/s00441-005-0033-z; Nishioka H, 2015, ENDOCR PATHOL, V26, P349, DOI 10.1007/s12022-015-9398-z; Ntali G, 2018, PITUITARY, V21, P111, DOI 10.1007/s11102-018-0869-3; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Raverot G, 2010, EUR J ENDOCRINOL, V163, P35, DOI 10.1530/EJE-10-0076; Richardson TE, 2015, J NEUROPATH EXP NEUR, V74, P1170, DOI [10.1097/NEN.0000000000000265, 10.1093/jnen/74.12.1170]; Sanchez-Tejada L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180039; Tani Y, 2011, ENDOCR J, V58, P297, DOI 10.1507/endocrj.K10E-389; Tateno T, 2007, EUR J ENDOCRINOL, V157, P717, DOI 10.1530/EJE-07-0428; Zhang W, 2010, HORM METAB RES, V42, P557, DOI 10.1055/s-0030-1252064	32	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0198877	10.1371/journal.pone.0198877	http://dx.doi.org/10.1371/journal.pone.0198877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979686	Green Submitted, Green Published, gold			2022-12-26	WOS:000437809500009
J	Hossain, MD; Aftab, A; Al Imam, MH; Mahmud, I; Chowdhury, IA; Kabir, RI; Sarker, M				Hossain, Mohammad Didar; Aftab, Afzal; Al Imam, Mahmudul Hassan; Mahmud, Ilias; Chowdhury, Imran Ahmed; Kabir, Razin Iqbal; Sarker, Malabika			Prevalence of work related musculoskeletal disorders (WMSDs) and ergonomic risk assessment among readymade garment workers of Bangladesh: A cross sectional study	PLOS ONE			English	Article							LOW-BACK-PAIN; GLOBAL BURDEN; UPPER-LIMB; NECK; QUESTIONNAIRE; WORKPLACE; EXPOSURE; DISEASE	Background Work related Musculoskeletal Disorders (WMSDs) are one of the most common occupational diseases which mainly affects the lower back, neck and upper and lower extremities. The aim of this study was to determine prevalence of WMSDs in nine body regions among Ready Made Garment (RMG) workers in Bangladesh and ergonomics assessment of their exposure to risk factors for the development of WMSDs. Methods This cross-sectional study was conducted among 232 RMG employees (male: 46; female: 186; age: > 18yrs) from nine RMG factories in Dhaka division during October 2015 to February 2016. Data were collected using a structured questionnaire consist of demographic questions, Nordic Musculoskeletal Questionnaire-Extended (NMQ-E) for WMSDs assessment in nine body regions and Quick Exposure Check (QEC) method for ergonomic assessment. Prevalence of WMSDs for each body region was determined. The association between WMSDs and ergonomic assessment of their exposure to risk factors were also analyzed. Results Respondents' mean age was 31.3 years (SD = 7). Their mean Body Mass Index (BMI) was 23.51 kg/m(2) (SD = 3.74). Among 186 female respondents, 46 reported lower back pain (24.7%) and 44 reported neck pain (23.7%). Among 46 male respondents, 10 reported neck pain (21.7%) while 6 reported knee pain (13%). Statistically significant relationship was found between twelve month WMSDs in anatomical region in elbows (p = 0.02), hips (p = 0.01), knees (p = 0.01) and ankle (p = 0.05) with age; upper back (p = 0.001), elbows (p = 0.001), wrists (p = 0.03), hips (p = 0.001) and ankles (p = 0.01) with job experience; hips with BMI (p = 0.03); elbows (p = 0.04) with daily working hour. QEC assessment showed that level of exposure to WMSDs risk was high among 80% of the study population (p< 0.003). Conclusion The study found that lower back and neck were the most affected areas among RMG workers. Moreover, QEC findings warned the level of exposure to WMSDs risks is high and ergonomics intervention along with investigation and change to decrease exposure level is essential. Addressing musculoskeletal risk factors through ergonomic interventions in terms of working space, workers sitting/standing posture, seat and hand position during work and work- rest cycle are encouraged in RMG sector and policy makers.	[Hossain, Mohammad Didar; Aftab, Afzal; Mahmud, Ilias; Chowdhury, Imran Ahmed; Kabir, Razin Iqbal; Sarker, Malabika] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Hossain, Mohammad Didar; Aftab, Afzal] Fdn Adv Innovat Technol & Hlth Faith, Dhaka, Bangladesh; [Al Imam, Mahmudul Hassan] CRP Chapain, Ctr Rehabil Paralysed CRP, Dhaka, Bangladesh; [Mahmud, Ilias] Qassim Univ, Coll Publ Hlth & Hlth Informat, Bukayriah, Qassim, Saudi Arabia; [Sarker, Malabika] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany	Bangladesh Rural Advancement Committee BRAC; BRAC University; Qassim University; Ruprecht Karls University Heidelberg	Hossain, MD (corresponding author), BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh.; Hossain, MD (corresponding author), Fdn Adv Innovat Technol & Hlth Faith, Dhaka, Bangladesh.	ddrhossain@yahoo.com	Al Imam, Mahmudul Hassan/AHE-3981-2022; Mahmud, Ilias/N-5085-2017; Al Imam, Mahmudul Hassan/AAN-6523-2020	Al Imam, Mahmudul Hassan/0000-0002-1670-9060; Mahmud, Ilias/0000-0003-1330-7813; Sarker, Malabika/0000-0001-7293-8805; Kabir, Razin Iqbal/0000-0003-3887-948X	International Labour Organization (ILO) country office for Bangladesh [5356658]	International Labour Organization (ILO) country office for Bangladesh	This study was funded by International Labour Organization (ILO) country office for Bangladesh, Grant number: 5356658, URL: http://www.ilo.org/dhaka/lang-en/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghili MM, 2012, INT J IND ERGONOM, V62, ps20; Ahmad SA, 2007, J PREV SOC MED, V26, P97; Ahmed F, 1997, EUR J CLIN NUTR, V51, P698, DOI 10.1038/sj.ejcn.1600469; Akhter S., 2010, J MECH ENG, V41, P65, DOI DOI 10.3329/JME.V41I1.5364; Arbuckle J.L., 2013, AMOS 22 COMPUTER SOF; Bandyopadhyay L, 2012, IOSR J DENT MED SCI, V2, P23, DOI [10.9790/0853-0262328, DOI 10.9790/0853-0262328]; Bangladesh Bureau of Statistics, STAT POCK BANGL 2013; Bangladesh Employer's Federation, 2006, HDB BANGL LAB ACT; Bao S, 2000, Int J Occup Saf Ergon, V6, P557; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bell JA, 2009, J OCCUP REHABIL, V19, P8, DOI 10.1007/s10926-009-9164-5; BERGQVIST U, 1995, ERGONOMICS, V38, P754, DOI 10.1080/00140139508925147; Burdorf A, 1997, SCAND J WORK ENV HEA, V23, P243, DOI 10.5271/sjweh.217; Choobineh A, 2007, J OCCUP HEALTH, V49, P418, DOI 10.1539/joh.49.418; Cook C, 2000, INT J IND ERGONOM, V26, P347, DOI 10.1016/S0169-8141(00)00010-X; David G, 2005, 211 U SURR HLTH SAF; David G, 2008, APPL ERGON, V39, P57, DOI 10.1016/j.apergo.2007.03.002; Dawson AP, 2010, INT J NURS STUD, V47, P604, DOI 10.1016/j.ijnurstu.2009.10.013; Dawson AP, 2009, J PAIN, V10, P517, DOI 10.1016/j.jpain.2008.11.008; DeSilva PV, 2013, GALLE MED J, V18, P1, DOI [10.4038/gmj.v18i1.5510., DOI 10.4038/GMJ.V18I1.5510]; Fatema K, 2014, J PUBLIC HEALTH AFR, V5, P104, DOI [10.4081/jphia.2014.373, 10.4081/jbhia.2014.373]; Gabbe BJ, 2003, BRIT J SPORT MED, V37, P545, DOI 10.1136/bjsm.37.6.545; Guo HR, 2004, J OCCUP HEALTH, V46, P26, DOI 10.1539/joh.46.26; Habib MM, 2015, WORK, V50, P357, DOI 10.3233/WOR-151991; Hagen KB, 1998, ERGONOMICS, V41, P1510, DOI 10.1080/001401398186243; Hasnain Golam, 2014, Electron Physician, V6, P801, DOI 10.14661/2014.801-807; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; ILO, 2016, IMPR WORK COND READ; ILO Regional Office for Asia and the Pacific, 2014, RES NOT REG EC SOC A; Islam LN, 2014, J ENV, V1, P21; Jahan N., 2015, SMU MED J, V2, P102; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Lemasters GK, 1998, OCCUP ENVIRON MED, V55, P421, DOI 10.1136/oem.55.6.421; Li GY, 1999, ERGONOMICS, V42, P674, DOI 10.1080/001401399185388; Luttmann A, 2003, PROTECTING WORKERS H, V5; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Macdonald F, 2006, OCCUP MED-OXFORD, V56, P232, DOI 10.1093/occmed/kql002; MacDonald LA, 2001, ERGONOMICS, V44, P696, DOI 10.1080/00140130110041121; Mehta R, 2012, J ERGONOMICS, V2, P102, DOI [10.4172/2165-7556.1000102, DOI 10.4172/2165-7556.1000102]; Moshiro C, 2005, INJURY PREV, V11, P48, DOI 10.1136/ip.2004.005645; National Institute for Occupational Safety and Health (NIOSH), 1997, DHHS NIOSH PUBLICATI, V97; Nelson NA, 2009, INT J IND ERGONOM, V39, P202, DOI 10.1016/j.ergon.2008.06.003; Nunes IL, 2009, WORK, V34, P133, DOI 10.3233/WOR-2009-0912; OHLSSON K, 1994, ERGONOMICS, V37, P891, DOI 10.1080/00140139408963698; Palmer K, 1999, OCCUP MED-OXFORD, V49, P171, DOI 10.1093/occmed/49.3.171; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Porter JM, 2002, OCCUP MED-OXFORD, V52, P4, DOI 10.1093/occmed/52.1.4; Punnett L, 2004, J ELECTROMYOGR KINES, V14, P13, DOI 10.1016/j.jelekin.2003.09.015; Rehman R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071891; Sarder B, 2006, J Hum Ergol (Tokyo), V35, P45; Siddiqi DM, 2009, FEMINIST REV, P154, DOI 10.1057/fr.2008.55; Sim J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-234; Smith DR, 2004, OCCUP MED-OXFORD, V54, P579, DOI 10.1093/occmed/kqh117; Thiehoff R, 2002, ORTHOPADE, V31, P949, DOI 10.1007/s00132-002-0350-9; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wahlstrom J, 2005, OCCUP MED-OXFORD, V55, P168, DOI 10.1093/occmed/kqi083; Zohir SC, 1996, GARMENT WORKERS BANG	57	34	36	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200122	10.1371/journal.pone.0200122	http://dx.doi.org/10.1371/journal.pone.0200122			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM1FJ	29979734	gold, Green Submitted, Green Published			2022-12-26	WOS:000437809500061
J	Chen, CK; Tsai, TH; Lin, YC; Lin, CC; Hsu, SC; Chung, CY; Pei, YC; Wong, AMK				Chen, Chih-Kuang; Tsai, Tsai-Hsuan; Lin, Yin-Chou; Lin, Chung-Chih; Hsu, Su-Chu; Chung, Chia-Ying; Pei, Yu-Cheng; Wong, Alice M. K.			Acceptance of different design exergames in elders	PLOS ONE			English	Article							USER ACCEPTANCE; OLDER-ADULTS; INFORMATION-TECHNOLOGY; MODEL; BALANCE; ONLINE; USABILITY; QUALITY; FITNESS	For promoting the successful aging of elderly residents of Chang Gung Silver Village in Taiwan, five interactive exergames were developed to promote the well-being of the elderly. The exergames included both physical games and cognitive games, and were implemented using various computer-based technologies in the Chang Gung Silver Village. The exergames were trialed by 39 elderly residents (15 male, 24 female; mean age 79.5 +/- 17.5 years) of Chang Gung Silver Village. Following the trials, the participants were requested to complete a Technology Acceptance Model 2 (TAM2) questionnaire. The results showed that the perceived playfulness and perceived usefulness of the exergames were significantly related to the users' usage behavior and intention to use for both the physical games and the cognitive games. However, a relationship between the output quality of the game and the usage behavior was apparent only in the case of the cognitive exergames. Finally, the impact of social influence on the intention to use and the usage behavior was more pronounced for the physical exergames. Overall, the results revealed that the acceptance of exergames by the elderly depends not so much on the awareness of fun in using the game, but the perceived usefulness of the related physical and cognitive abilities.	[Chen, Chih-Kuang; Lin, Yin-Chou; Chung, Chia-Ying; Pei, Yu-Cheng; Wong, Alice M. K.] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan, Taiwan; [Chen, Chih-Kuang; Lin, Yin-Chou; Lin, Chung-Chih; Chung, Chia-Ying; Pei, Yu-Cheng; Wong, Alice M. K.] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Tsai, Tsai-Hsuan] Chang Gung Univ, Dept Ind Design, Taoyuan, Taiwan; [Lin, Chung-Chih] Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan; [Hsu, Su-Chu] Taipei Natl Univ Arts, Dept New Media Art, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Wong, AMK (corresponding author), Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan, Taiwan.; Wong, AMK (corresponding author), Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan.	walice@cgmh.org.tw		Lin, Yin-Chou/0000-0002-1058-2329; Pei, Yu-Cheng/0000-0001-5986-0046	Chang Gung Medical Foundation [CMRPG5B0051-53, CMPRD3B0031-33, CMRPG5B0061-63]	Chang Gung Medical Foundation	This research was supported by the Chang Gung Medical Foundation, https://www.cgmh.org.tw/eng2002/center_main.htm, grants: CMRPG5B0051-53 (Alice M K Wong), CMPRD3B0031-33 (Chung-Chih Lin), and CMRPG5B0061-63 (Chia-Ying Chung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn T, 2007, INFORM MANAGE-AMSTER, V44, P263, DOI 10.1016/j.im.2006.12.008; Anderson-Hanley C, 2012, AM J PREV MED, V42, P109, DOI 10.1016/j.amepre.2011.10.016; [Anonymous], 2000, BOREDOM ANXIETY; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]; Ben-Sadoun G, 2016, J ALZHEIMERS DIS, V53, P1299, DOI 10.3233/JAD-160268; Bentler PM, 1980, SIGNIFICANCE TESTS G, P588; Bieryla KA, 2013, CLIN INTERV AGING, V8, P775, DOI 10.2147/CIA.S46164; Black J.T, 1992, MULTIVARIATE DATA AN; Carlson J, 2010, J SERV MARK, V24, P112, DOI 10.1108/08876041011031091; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Cook N, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5423; Crespo AH, 2008, INTERACT COMPUT, V20, P212, DOI 10.1016/j.intcom.2007.11.005; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; ENGEL GL, 1982, NEW ENGL J MED, V307, P760; Etnier JL, 2006, BRAIN RES REV, V52, P119, DOI 10.1016/j.brainresrev.2006.01.002; Fishbein M., 1975, BELIEF ATTITUDE INTE; Fox KR, 2007, OBES REV, V8, P115, DOI 10.1111/j.1467-789X.2007.00329.x; Fu AS, 2015, ARCH PHYS MED REHAB, V96, P2096, DOI 10.1016/j.apmr.2015.08.427; Gao Y, 2012, P SIGCHI C HUM FACT, P1863, DOI DOI 10.1145/2207676.2208323; Gerling KM, 2011, PROCEEDINGS OF THE 8TH INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTER ENTERTAINMENT TECHNOLOGY (ACE 2011); Harris Dale M, 2015, Front Aging Neurosci, V7, P167, DOI 10.3389/fnagi.2015.00167; Joseph F, 1986, MULTIVARIATE DATA AN; Kim HB, 2009, TOURISM MANAGE, V30, P266, DOI 10.1016/j.tourman.2008.07.001; Klompstra LV, 2014, EUR J CARDIOVASC NUR, V13, P388, DOI 10.1177/1474515113512203; Koufaris M, 2002, INFORM SYST RES, V13, P205, DOI 10.1287/isre.13.2.205.83; Lin HF, 2007, ELECTRON COMMER R A, V6, P433, DOI 10.1016/j.elerap.2007.02.002; Moon JW, 2001, INFORM MANAGE, V38, P217, DOI 10.1016/S0378-7206(00)00061-6; Moore GC, 1991, INFORM SYST RES, V2, P192, DOI 10.1287/isre.2.3.192; Myint Y.-L, 2009, P 3 INT CONV REH ENG, P1, DOI [https://doi.org/10.1145/1592700.1592712, DOI 10.1145/1592700.1592712]; O'Cass A., 2004, J PROD BRAND MANAG, V13, P257, DOI DOI 10.1108/10610420410546961; Ramon-Jeronimo MA, 2013, SOC SCI COMPUT REV, V31, P389, DOI 10.1177/0894439312473421; Schutzer KA, 2004, PREV MED, V39, P1056, DOI 10.1016/j.ypmed.2004.04.003; Scott J., 1995, ACM SIGNS DATABASE, V26, P43, DOI DOI 10.1145/206476.206484; Seyal A, 2002, DETERMINANTS ACAD US, P71; Triandis, 1971, ATTITUDE ATTITUDE CH; Tsai T-H, 2011, INT C UN ACC HUM COM; van Diest M, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-101; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Venkatesh V, 2008, DECISION SCI, V39, P273, DOI 10.1111/j.1540-5915.2008.00192.x; Whitlock L. A., 2011, P HUMAN FACTORS ERGO, V55, P187; Wong AMK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040591; Wuest S, 2014, GAMES HEALTH J, V3, P106, DOI 10.1089/g4h.2013.0093; Xue LS, 2012, INT J MED INFORM, V81, P637, DOI 10.1016/j.ijmedinf.2012.04.008	45	33	33	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200185	10.1371/journal.pone.0200185	http://dx.doi.org/10.1371/journal.pone.0200185			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL7YG	29975755	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500074
J	Kirshenbaum, M; Ben-David, A; Zilberberg, E; Elkan-Miller, T; Haas, J; Orvieto, R				Kirshenbaum, Michel; Ben-David, Alon; Zilberberg, Eran; Elkan-Miller, Tal; Haas, Jigal; Orvieto, Raoul			Influence of seasonal variation on in vitro fertilization success	PLOS ONE			English	Article							IMPLANTATION RATES; HUMAN-REPRODUCTION; IVF; PREGNANCY; MELATONIN; WOMEN	Objective To evaluate the influence of seasonal variation on in vitro fertilization (IVF) outcome in a large cohort population. Methods & materials A total of 5,765 IVF cycles conducted in Sheba medical center between 2013 and 2016 were retrospectively analyzed. The treatment cycles included 4214 ovarian stimulation and ovum pick up (OPU) cycles of which 3020 resulted in fresh embryo transfer and 1551 vitrified- warmed cycles of which1400 resulted in warmed embryo transfer. Cycles were assigned to seasons according to the date of OPU for fresh embryo transfer cycles or according to the date of embryo warming for vitrified warmed embryo transfer cycles. Results There were no statistically significant differences between the calendar months or seasons concerning the number of oocytes retrieved or fertilization rate in the fresh cycles. Throughout the 4 years of the study, the monthly clinical pregnancy rate fluctuated between 18.2% and 27.9% per fresh embryo transfer (mean 23.3%) and between 17.7% and 29.4% per vitrified warmed embryo transfer (mean 23%). These fluctuations did not follow any specific seasonal pattern. Conclusions Our study did not demonstrate any significant influence of the calendar months or seasons on the clinical pregnancy rates of fresh or vitrified warmed embryo transfers. It might be speculated that the complete pharmaceutical control of the ovarian and endometrial function, as well as the homogeneous treatments, procedures and laboratory equipment used during the study period have lowered the influence of seasonal effect on IVF treatment outcome.	[Kirshenbaum, Michel; Ben-David, Alon; Zilberberg, Eran; Elkan-Miller, Tal; Haas, Jigal; Orvieto, Raoul] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Ramat Gan, Israel; [Kirshenbaum, Michel; Ben-David, Alon; Zilberberg, Eran; Elkan-Miller, Tal; Haas, Jigal; Orvieto, Raoul] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Orvieto, Raoul] Tel Aviv Univ, Sackler Fac Med, Tarnesby Tarnowski Chair Family Planning & Fertil, Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Kirshenbaum, M (corresponding author), Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Ramat Gan, Israel.; Kirshenbaum, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	michal.siegel@gmail.com						FLEMING C, 1994, HUM REPROD, V9, P2164, DOI 10.1093/oxfordjournals.humrep.a138411; Gindes L, 2003, HUM REPROD, V18, P2485, DOI 10.1093/humrep/deg455; JAMES WH, 1990, J BIOSOC SCI, V22, P113, DOI 10.1017/S0021932000018423; LEVINE RJ, 1994, ANN NY ACAD SCI, V709, P29, DOI 10.1111/j.1749-6632.1994.tb30386.x; Levine RJ, 1999, SCAND J WORK ENV HEA, V25, P34; Maman E, 2012, REPROD BIOMED ONLINE, V25, P635, DOI 10.1016/j.rbmo.2012.09.003; ODEGARD O, 1977, BRIT J PSYCHIAT, V131, P339, DOI 10.1192/bjp.131.4.339; Orvieto R, 2016, J ASSIST REPROD GEN, V33, P611, DOI 10.1007/s10815-016-0685-5; REITER RJ, 1993, EXPERIENTIA, V49, P654, DOI 10.1007/BF01923947; Reiter RJ, 2014, FERTIL STERIL, V102, P321, DOI 10.1016/j.fertnstert.2014.06.014; Revelli A, 2005, GYNECOL ENDOCRINOL, V21, P12, DOI 10.1080/09513590500098307; ROJANSKY N, 1992, HUM REPROD, V7, P735, DOI 10.1093/oxfordjournals.humrep.a137729; Rojansky N, 2000, FERTIL STERIL, V74, P476, DOI 10.1016/S0015-0282(00)00669-5; STOLWIJK AM, 1994, HUM REPROD, V9, P2300, DOI 10.1093/oxfordjournals.humrep.a138441; Tamura H, 2009, FERTIL STERIL, V92, P328, DOI 10.1016/j.fertnstert.2008.05.016; Vandekerckhove F, 2016, FACTS VIEWS VIS OBGY, V8, P75; Wood Simon, 2006, Hum Fertil (Camb), V9, P223, DOI 10.1080/14647270600806557; Wunder DM, 2005, HUM REPROD, V20, P3122, DOI 10.1093/humrep/dei177; Ziebe S, 2007, HUM REPROD, V22, P2404, DOI 10.1093/humrep/dem221	19	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199210	10.1371/journal.pone.0199210	http://dx.doi.org/10.1371/journal.pone.0199210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975717	Green Submitted, Green Published, gold			2022-12-26	WOS:000437424500027
J	Li, CH; Roth, JD; Detwiler, JT				Li, Chen-Hua; Roth, James D.; Detwiler, Jillian T.			Isotopic turnover rates and diet-tissue discrimination depend on feeding habits of freshwater snails	PLOS ONE			English	Article							STABLE-ISOTOPES; CARBON ISOTOPES; LABORATORY EXPERIMENTS; MIXING MODELS; MOUSE-TISSUES; NITROGEN; FRACTIONATION; DELTA-C-13; ECOLOGY; DELTA-N-15	Estimates of animal diets and trophic structure using stable isotope analysis are strongly affected by diet-tissue discrimination and tissue turnover rates, yet these factors are often unknown for consumers because they must be measured using controlled-feeding studies. Furthermore, these parameters may be influenced by diet quality, growth, and other factors. We measured the effect of dietary protein content on diet-tissue discrimination and tissue turnover in three freshwater snail species. We fed lettuce to individually housed snails (n = 450 per species) for ten weeks, then half were switched to a high-protein diet. Isotopic values of muscle and gonad tissue were assessed at 48 and 80 days post-diet change. Snail discrimination factors varied by diet (low-protein > high-protein) and usually differed among species for both N and C, although species had similar carbon discrimination when fed the low-protein diet. Carbon turnover rates were similar among species for a given tissue type, but nitrogen turnover varied more among species. In addition, diet affected growth of species differently; some species grew larger on high-protein (H. trivolvis) while others grew larger on low-protein diet (Lymnaea spp.). These differences among species in growth influenced turnover rates, which were faster in the species with the highest growth rate following the diet switch from low to high-protein. Thus, growth is one of the main processes that affects tissue turnover, but growth and feeding preference did not affect diet-tissue discrimination, which was greater on low-protein than high-protein diets for all species regardless of growth performance. These results suggest that diet might influence two key parameters of stable isotope analysis differently.	[Li, Chen-Hua; Roth, James D.; Detwiler, Jillian T.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Li, Chen-Hua] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada	University of Manitoba; University of Calgary	Detwiler, JT (corresponding author), Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada.	Jillian.Detwiler@umanitoba.ca	Roth, James/N-4178-2016	Roth, James/0000-0002-0296-2786	Natural Sciences and Engineering Council (NSERC)	Natural Sciences and Engineering Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by a Natural Sciences and Engineering Council (NSERC) Discovery grant to J.T. Detwiler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation for the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Arneson LS, 2005, CAN J ZOOL, V83, P989, DOI 10.1139/Z05-083; Arneson LS, 2006, CAN J ZOOL, V84, P992, DOI 10.1139/Z06-081; Barquete V, 2013, J EXP MAR BIOL ECOL, V448, P121, DOI 10.1016/j.jembe.2013.06.021; Ben-David M, 2001, OECOLOGIA, V127, P180, DOI 10.1007/s004420000570; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Brown Kenneth M., 2001, P297; BROWN KM, 1982, ECOLOGY, V63, P412, DOI 10.2307/1938959; Burch J, 1982, EPA600382026; Caut S, 2010, J APPL ECOL, V47, P948, DOI 10.1111/j.1365-2664.2010.01832.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Elliott KH, 2017, METHODS MOL BIOL, V1609, P9, DOI 10.1007/978-1-4939-6996-8_2; Friesen OC, 2016, J ANIM ECOL, V85, P1265, DOI 10.1111/1365-2656.12544; FRY B, 1982, OECOLOGIA, V54, P200, DOI 10.1007/BF00378393; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Hersey KA, 2013, AM MIDL NAT, V170, P248, DOI 10.1674/0003-0031-170.2.248; Hobson KA, 1997, MAR MAMMAL SCI, V13, P359, DOI 10.1111/j.1748-7692.1997.tb00645.x; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hoffman JR, 2004, J SPORT SCI MED, V3, P118; Hopkins JB, 2016, METHODS ECOL EVOL, V7, P210, DOI 10.1111/2041-210X.12446; JANSE C, 1989, J GERONTOL, V44, pB148, DOI 10.1093/geronj/44.6.B148; Kurata K, 2001, MAR ECOL PROG SER, V223, P167, DOI 10.3354/meps223167; Kurle CM, 2014, ISOT ENVIRON HEALT S, V50, P307, DOI 10.1080/10256016.2014.908872; Kurle CM, 2009, FUNCT ECOL, V23, P733, DOI 10.1111/j.1365-2435.2009.01553.x; MacAvoy SE, 2005, CAN J ZOOL, V83, P631, DOI 10.1139/Z05-038; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Morishita F, 2010, CAN J ZOOL, V88, P825, DOI 10.1139/Z10-041; Norton CG, 2006, J MOLLUS STUD, V72, P143, DOI 10.1093/mollus/eyi057; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rau GH, 1992, MARINE ECOLOGY PROGR, P84; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Rybak AS, 2016, PHYCOL RES, V64, P207, DOI 10.1111/pre.12138; Sandland GJ, 2003, OECOLOGIA, V134, P479, DOI 10.1007/s00442-002-1127-x; Steinitz R, 2016, RAPID COMMUN MASS SP, V30, P9, DOI 10.1002/rcm.7410; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Vander Zanden MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116182; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Venables WN., 2002, MODERN APPL STAT S 4	50	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199713	10.1371/journal.pone.0199713	http://dx.doi.org/10.1371/journal.pone.0199713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975726	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500044
J	Triphan, SMF; Biederer, J; Burmester, K; Fellhauer, I; Vogelmeier, CF; Jorres, RA; Kauczor, HU; Heussel, CP; Wielputz, MO; Jobst, BJ				Triphan, Simon M. F.; Biederer, Juergen; Burmester, Kerstin; Fellhauer, Iven; Vogelmeier, Claus F.; Joerres, Rudolf A.; Kauczor, Hans-Ulrich; Heussel, Claus P.; Wielpuetz, Mark O.; Jobst, Bertram J.			Design and application of an MR reference phantom for multicentre lung imaging trials	PLOS ONE			English	Article							OBSTRUCTIVE-PULMONARY-DISEASE; QUALITY-ASSURANCE; COMPUTED-TOMOGRAPHY; SCANNER; T-1	Introduction As there is an increasing number of multicentre lung imaging studies with MRI in patients, dedicated reference phantoms are required to allow for the assessment and comparison of image quality in multi-vendor and multi-centre environments. However, appropriate phantoms for this purpose are so far not available commercially. It was therefore the purpose of this project to design and apply a cost-effective and simple to use reference phantom which addresses the specific requirements for imaging the lungs with MRI. Methods The phantom was designed to simulate 4 compartments (lung, blood, muscle and fat) which reflect the specific conditions in proton-MRI of the chest. Multiple phantom instances were produced and measured at 15 sites using a contemporary proton-MRI protocol designed for an in vivo COPD study at intervals over the course of the study. Measures of signal- and contrast-to-noise ratio, as well as structure and edge depiction were extracted from conventionally acquired images using software written for this purpose. Results For the signal to noise ratio, low intra-scanner variability was found with 4.5% in the lung compartment, 4.0% for blood, 3.3% for muscle and 3.7% for fat. The inter-scanner variability was substantially higher, with 41%, 32%, 27% and 32% for the same order of compartments. In addition, measures of structure and edge depiction were found to both vary significantly among several scanner types and among scanners of the same model which were equipped with different gradient systems. Conclusion The described reference phantom reproducibly quantified image quality aspects and detected substantial inter-scanner variability in a typical pulmonary multicentre proton MRI study, while variability was greater in lung tissue compared to other tissue types. Accordingly, appropriate reference phantoms can help to detect bias in multicentre in vivo study results and could also be used to harmonize equipment or data.	[Triphan, Simon M. F.; Biederer, Juergen; Burmester, Kerstin; Fellhauer, Iven; Kauczor, Hans-Ulrich; Heussel, Claus P.; Wielpuetz, Mark O.; Jobst, Bertram J.] Heidelberg Univ, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Triphan, Simon M. F.; Biederer, Juergen; Burmester, Kerstin; Fellhauer, Iven; Kauczor, Hans-Ulrich; Heussel, Claus P.; Wielpuetz, Mark O.; Jobst, Bertram J.] Translat Lung Res Ctr, Heidelberg, Germany; [Triphan, Simon M. F.; Biederer, Juergen; Burmester, Kerstin; Fellhauer, Iven; Vogelmeier, Claus F.; Joerres, Rudolf A.; Kauczor, Hans-Ulrich; Heussel, Claus P.; Wielpuetz, Mark O.; Jobst, Bertram J.] German Ctr Lung Res DZL, Giessen, Germany; [Biederer, Juergen] Cty Hosp Gross Gerau, Radiol Darmstadt, Gross Gerau, Germany; [Vogelmeier, Claus F.] Univ Med Ctr Giessen & Marburg, Dept Med Pulm & Crit Care Med, Marburg, Germany; [Joerres, Rudolf A.] Ludwig Maximilians Univ Munchen, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Joerres, Rudolf A.] CPC M, Munich, Germany; [Heussel, Claus P.; Wielpuetz, Mark O.; Jobst, Bertram J.] Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University Hospital of Giessen & Marburg; University of Munich; Ruprecht Karls University Heidelberg	Jobst, BJ (corresponding author), Heidelberg Univ, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.; Jobst, BJ (corresponding author), Translat Lung Res Ctr, Heidelberg, Germany.; Jobst, BJ (corresponding author), German Ctr Lung Res DZL, Giessen, Germany.; Jobst, BJ (corresponding author), Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Germany.	bertram.jobst@med.uni-heidelberg.de	Kauczor, Hans-Ulrich/AAU-5955-2021; Wielpütz, Mark Oliver/ADP-0499-2022; Wielpuetz, Mark/ABE-1790-2020; Kauczor, HU/AAX-6033-2021	Wielpütz, Mark Oliver/0000-0001-6962-037X; Wielpuetz, Mark/0000-0001-6962-037X; 	Competence Network on Asthma / COPD (ASCONET) through Federal Ministry of Education and Research Bundesministerium fur Bildung und Forschung, BMBF) of the federal government of Germany [01GI0884]	Competence Network on Asthma / COPD (ASCONET) through Federal Ministry of Education and Research Bundesministerium fur Bildung und Forschung, BMBF) of the federal government of Germany(Federal Ministry of Education & Research (BMBF))	This study is supported by the Competence Network on Asthma / COPD (ASCONET) through a grant from the Federal Ministry of Education and Research Bundesministerium fur Bildung und Forschung, BMBF) of the federal government of Germany (01GI0884, https://www.gesundheitsforschung-bmbf.de/de/krankheitsbezogenes-kompetenznetz-asthma-copd.php). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Bamba J, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20120445; Bamberg F, 2015, RADIOLOGY, V277, P206, DOI 10.1148/radiol.2015142272; Belli G, 2016, J MAGN RESON IMAGING, V43, P213, DOI 10.1002/jmri.24956; Biederer J, 2012, INSIGHTS IMAGING, V3, P355, DOI 10.1007/s13244-011-0146-8; Biederer J, 2014, SEMIN RESP CRIT CARE, V35, P74, DOI 10.1055/s-0033-1363453; Biederer J, 2012, INSIGHTS IMAGING, V3, P373, DOI 10.1007/s13244-011-0142-z; Chen Q, 1998, MAGN RESON MATER PHY, V7, P153; Chen-Mayer HH, 2017, MED PHYS, V44, P974, DOI 10.1002/mp.12087; Colombo P, 2004, MAGN RESON IMAGING, V22, P93, DOI 10.1016/j.mri.2003.04.001; Davids M, 2014, MAGN RESON IMAGING, V32, P771, DOI 10.1016/j.mri.2014.01.017; Flohr TG, 2005, MED PHYS, V32, P2536, DOI 10.1118/1.1949787; Fu L, 2006, AUTOMATED ANAL MULTI, P144; Gonzalez R. C., 2012, DIGITAL IMAGE PROCES; Gulliksrud K, 2014, PHYS MEDICA, V30, P521, DOI 10.1016/j.ejmp.2014.01.006; Hatabu H, 1999, EUR J RADIOL, V29, P245, DOI 10.1016/S0720-048X(98)00169-7; Hueper K, 2015, AM J RESP CRIT CARE, V192, P570, DOI 10.1164/rccm.201411-2120OC; Hueper K, 2013, INVEST RADIOL, V48, P223, DOI 10.1097/RLI.0b013e318281057d; Ihalainen TM, 2011, ACTA ONCOL, V50, P966, DOI 10.3109/0284186X.2011.582515; Jobst BJ., 2014, INSIGHTS IMAGING, V5, P340; Jobst BJ, 2015, INSIGHTS IMAGING, V6, P444; Kirby M, 2014, COPD-J COPD FDN, V1, P200, DOI 10.15326/jcopdf.1.2.2014.0136; KNIGHT JB, 1993, PHYS REV LETT, V70, P3728, DOI 10.1103/PhysRevLett.70.3728; Kuo W, 2016, EUROPEAN RESP J; Mulkern RV, 2008, ACAD RADIOL, V15, P1099, DOI 10.1016/j.acra.2008.04.004; Ohno Y, 2008, AM J RESP CRIT CARE, V177, P1095, DOI 10.1164/rccm.200709-1322OC; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Renvall V, 2009, MAGN RESON IMAGING, V27, P701, DOI 10.1016/j.mri.2008.11.007; ROSATO A, 1987, PHYS REV LETT, V58, P1038, DOI 10.1103/PhysRevLett.58.1038; Shu YH, 2014, J AM COLL RADIOL, V11, P94, DOI 10.1016/j.jacr.2013.09.024; Sieren JP, 2014, MED PHYS, V41, DOI 10.1118/1.4893498; Sieren JP, 2016, AM J RESP CRIT CARE, V194, P794, DOI 10.1164/rccm.201506-1208PP; Stahl M, 2017, AM J RESP CRIT CARE, V195, P349, DOI 10.1164/rccm.201604-0893OC; Torfeh T, 2015, MAGN RESON IMAGING, V33, P939, DOI 10.1016/j.mri.2015.04.003; Triphan SMF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172479; Triphan SMF, 2015, J MAGN RESON IMAGING, V42, P610, DOI 10.1002/jmri.24840; Triphan SMF, 2015, J MAGN RESON IMAGING, V41, P1708, DOI 10.1002/jmri.24692; Wielputz MO, 2016, ROFO-FORTSCHR RONTG, V188, P834, DOI 10.1055/s-0042-104936; Wielputz MO, 2015, CURR OPIN PULM MED, V21, P609, DOI 10.1097/MCP.0000000000000213; Wild JM, 2012, INSIGHTS IMAGING, V3, P345, DOI 10.1007/s13244-012-0176-x; Yu JS, 2011, MAGN RESON MED, V66, P248, DOI 10.1002/mrm.22829	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199148	10.1371/journal.pone.0199148	http://dx.doi.org/10.1371/journal.pone.0199148			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975714	gold, Green Published, Green Submitted			2022-12-26	WOS:000437424500025
J	Nakamura, R; Ishii, H; Endo, K; Hotta, A; Fujii, E; Miyazawa, K; Saitoh, M				Nakamura, Ryosuke; Ishii, Hiroki; Endo, Kaori; Hotta, Asami; Fujii, Eiji; Miyazawa, Keiji; Saitoh, Masao			Reciprocal expression of Slug and Snail in human oral cancer cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NEGATIVE FEEDBACK LOOP; TGF-BETA; PROMOTES METASTASIS; PANCREATIC-CANCER; EMT PROGRAMS; GROWTH; APOPTOSIS; DIFFERENTIATION; CHEMORESISTANCE	Snail, also called Snai1, is a key regulator of EMT. Snail plays crucial roles in cancer progression, including resistance to anti-tumor drugs and invasion by various cancer cells. Slug, also known as Snai2, is also involved in the aggravation of certain tumors. In this study, we examined the roles of Slug in human oral squamous cell carcinoma (OSCC) cells. Slug is highly expressed in these cells, and Slug siRNA effectively represses anti-tumor drug resistance and invasive properties. In addition, transforming growth factor (TGF)-beta upregulates the expression of Snail and Slug and promotes resistance to anti-tumor drugs in OSCC cells. Surprisingly, Slug siRNA appears to upregulate Snail expression considerably in OSCC cells. Snail siRNA also appears to upregulate Slug expression. Thus, either Slug or Snail siRNA alone partially mitigates malignant phenotypes in the presence of TGF-beta, whereas both Slug and Snail siRNAs together dramatically suppress them. Therefore, Slug and Snail in tandem, but not alone, are potential therapeutic targets for nucleic acid medicines to treat oral cancer.	[Nakamura, Ryosuke; Hotta, Asami; Saitoh, Masao] Univ Yamanashi, Ctr Med Educ & Sci, Interdisciplinary Grad Sch Med, Chuo Ku, Yamanashi, Japan; [Ishii, Hiroki; Endo, Kaori; Miyazawa, Keiji] Univ Yamanashi, Interdisciplinary Grad Sch Med, Dept Biochem, Chuo Ku, Yamanashi, Japan; [Nakamura, Ryosuke; Fujii, Eiji] Kofu Municipal Hosp, Dept Oral & Maxillofacial Surg, Kofu, Yamanashi, Japan; [Nakamura, Ryosuke] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial Surg, Tokyo, Japan	University of Yamanashi; University of Yamanashi; Tokyo Medical & Dental University (TMDU)	Saitoh, M (corresponding author), Univ Yamanashi, Ctr Med Educ & Sci, Interdisciplinary Grad Sch Med, Chuo Ku, Yamanashi, Japan.	msaitoh-ind@umin.ac.jp			Mitsubishi Foundation; JSPS KAKENHI [JP16K15786, JP15H05018]	Mitsubishi Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by The Mitsubishi Foundation and JSPS KAKENHI grant numbers JP16K15786 and JP15H05018.	Nieto MA, 2017, NAT CELL BIOL, V19, P416, DOI 10.1038/ncb3520; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Chen Y, 2013, J BONE MINER RES, V28, P1412, DOI 10.1002/jbmr.1871; David JM, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4030022; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Fernando RI, 2016, ONCOTARGET, V7, P42031, DOI 10.18632/oncotarget.9662; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Fukagawa A, 2015, CANCER MED-US, V4, P125, DOI 10.1002/cam4.347; Furuya S, 2017, FEBS OPEN BIO, V7, P1586, DOI 10.1002/2211-5463.12300; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Ishii H, 2014, J BIOL CHEM, V289, P27386, DOI 10.1074/jbc.M114.589432; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Krebs AM, 2017, NAT CELL BIOL, V19, P518, DOI 10.1038/ncb3513; Lee HH, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3668-8; Lee JH, 2017, NAT CELL BIOL, V19, P1260, DOI 10.1038/ncb3609; Moustakas A, 2016, J CLIN MED, V5, DOI 10.3390/jcm5070063; Nakamura R, 2015, BIOCHEM BIOPH RES CO, V458, P777, DOI 10.1016/j.bbrc.2015.02.013; Nawshad A, 2004, ARCH ORAL BIOL, V49, P675, DOI 10.1016/j.archoralbio.2004.05.007; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011; Palena C, 2012, FUTURE ONCOL, V8, P713, DOI [10.2217/FON.12.59, 10.2217/fon.12.59]; Saito D, 2013, J BIOCHEM, V153, P303, DOI 10.1093/jb/mvs144; Saitoh M, 2016, ONCOGENE, V35, P1049, DOI 10.1038/onc.2015.161; Saitoh M, 2015, CANCER SCI, V106, P481, DOI 10.1111/cas.12630; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Tang Y, 2016, NAT CELL BIOL, V18, P917, DOI 10.1038/ncb3394; Taya Y, 1999, DEVELOPMENT, V126, P3869; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yao C, 2016, STEM CELLS, V34, P820, DOI 10.1002/stem.2320; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Zarogoulidis Paul, 2013, Immunome Res, V9, P16535, DOI 10.1186/2090-5009-9-1; Zhang Zhiqian, 2011, Genes Cancer, V2, P782, DOI 10.1177/1947601911429743; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	42	32	32	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199442	10.1371/journal.pone.0199442	http://dx.doi.org/10.1371/journal.pone.0199442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969465	Green Published, gold			2022-12-26	WOS:000437246700016
J	Gonzalez, D; Ragusa, J; Angeletti, PC; Larsen, G				Gonzalez, Daniela; Ragusa, Jorge; Angeletti, Peter C.; Larsen, Gustavo			Preparation and characterization of functionalized heparin-loaded poly-epsilon- caprolactone fibrous mats to prevent infection with human papillomaviruses	PLOS ONE			English	Article							CONTROLLED-RELEASE; ELECTROSPUN NANOFIBERS; FIBER DIAMETER; DRUG-DELIVERY; SULFATE; SURFACE; MORPHOLOGY; PROTEIN; CHONDROCYTES; SCAFFOLDS	In this study, heparin-loaded poly-c-caprolactone (PCL) fibrous mats were prepared and characterized based on their physical, cytotoxic, thermal, and biological properties. The main objective of the work described here was to test the hypothesis that incorporation of heparin into a PCL carrier could serve as bio-compatible material capable of inhibiting Human Papillomavirus (HPV) infection. The idea of firmly anchoring heparin to capture soluble virus, vs. a slow heparin release to inhibit a virus in solution was tested. Thus, one material was produced via conventional heparin matrix encapsulation and electrohydrodynamic fiber processing in one step. A second type of material was obtained via heparin crosslinking. This was achieved by running a carbodiimide/N-hydroxysuccinimide (EDC/NHS) coupling reaction on preformed PCL fibers. In vitro HPV16 L1 protein binding capacity studies were performed. Infectivity assays were done using HPV16 pseudoviruses (PsVs) carrying a GFP plasmid to directly test the ability of the fibrous mats to prevent internalization of HPV PsVs. The crosslinked heparin material presented a dissociation constant (K-d) value comparable to those found in the literature for different heparin-protein L1 peptide interactions. Both materials significantly reduced internalization of HPV PsVs, with a reduction of 94% of PsVs internalization when matrix encapsulated heparin-loaded material was present. Differences in performance between the two proposed structures are discussed.	[Gonzalez, Daniela; Ragusa, Jorge; Larsen, Gustavo] Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA; [Angeletti, Peter C.] Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Larsen, G (corresponding author), Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA.; Angeletti, PC (corresponding author), Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE 68588 USA.	pangeletti2@unl.edu; glarsen1@unl.edu		Gonzalez, Daniela/0000-0002-8342-4639; Larsen, Gus (Gustavo)/0000-0003-0304-8336	Office of Research and Economic Development, Revision Awards Program, Category 1; Nebraska Tobacco Settlement Biomedical Research Development Fund	Office of Research and Economic Development, Revision Awards Program, Category 1; Nebraska Tobacco Settlement Biomedical Research Development Fund	This work was supported by the Office of Research and Economic Development, Revision Awards Program, Category 1. Funds for this award were provided by the Nebraska Tobacco Settlement Biomedical Research Development Fund (http://research.unl.edu/internal-funding-opportunities/) to GL and PA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abban CY, 2010, VIROLOGY, V403, P1, DOI 10.1016/j.virol.2010.04.007; American Cancer Society, 2017, CANC FACTS FIG 2017, DOI [10.1101/gad.1593107, DOI 10.1101/GAD.1593107]; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Chakraborty S, 2009, ADV DRUG DELIVER REV, V61, P1043, DOI 10.1016/j.addr.2009.07.013; Chan PKS, 2012, CRIT REV CL LAB SCI, V49, P117, DOI 10.3109/10408363.2012.707174; Christensen ND, 2001, ANTIMICROB AGENTS CH, V45, P3427, DOI 10.1128/AAC.45.12.3427-3432.2001; Cui WG, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014108; Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064; Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(01)00336-6; Donalisio M, 2010, ANTIMICROB AGENTS CH, V54, P4290, DOI 10.1128/AAC.00471-10; Duzyer S, 2011, J APPL POLYM SCI, V120, P759, DOI 10.1002/app.33092; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Gumusderelioglu M, 2011, CARBOHYD RES, V346, P606, DOI 10.1016/j.carres.2010.12.007; Gupta B, 2012, J APPL POLYM SCI, V123, P1944, DOI 10.1002/app.34728; Hinrichs WLJ, 1997, J CONTROL RELEASE, V45, P163, DOI 10.1016/S0168-3659(96)01571-4; Huang GP, 2015, J BIOMED MATER RES A, V103, P762, DOI 10.1002/jbm.a.35222; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Kahn JA, 2005, J ADOLESCENT HEALTH, V37, pS10, DOI 10.1016/j.jadohealth.2005.08.018; Kang IK, 1996, BIOMATERIALS, V17, P841, DOI 10.1016/0142-9612(96)81422-0; Kariyappa Rao, 2012, MAN MADE TEXT INDIA, P59; Lamour G, 2010, J CHEM EDUC, V87, P1403, DOI 10.1021/ed100468u; Larsen G, 2008, J NON-CRYST SOLIDS, V354, P5547, DOI 10.1016/j.jnoncrysol.2008.08.002; Lee J, 2012, ACTA BIOMATER, V8, P2549, DOI 10.1016/j.actbio.2012.03.030; Liao D, 2009, J CELL MOL MED, V13, P2736, DOI 10.1111/j.1582-4934.2008.00589.x; Liu XY, 2009, MATER LETT, V63, P263, DOI 10.1016/j.matlet.2008.10.006; Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028; MacIntosh FC, 1941, BIOCHEM J, V35, P776, DOI 10.1042/bj0350776; Markowitz LE, 2009, JNCI-J NATL CANCER I, V101, P439, DOI 10.1093/jnci/djp044; Murugesan S, 2008, CURR TOP MED CHEM, V8, P80; Noriega SE, 2012, CELLS TISSUES ORGANS, V195, P207, DOI 10.1159/000325144; Paneva D, 2008, EUR POLYM J, V44, P566, DOI 10.1016/j.eurpolymj.2008.01.010; RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; Schiller John T, 2010, Gynecol Oncol, V118, pS12, DOI 10.1016/j.ygyno.2010.04.004; Siepmann J, 2008, INT J PHARMACEUT, V364, P328, DOI 10.1016/j.ijpharm.2008.09.004; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; Singh S, 2011, BIOMATERIALS, V32, P2059, DOI 10.1016/j.biomaterials.2010.11.038; Skotak M, 2008, BIOMACROMOLECULES, V9, P1902, DOI 10.1021/bm800158c; Skotak M, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055012; Skotak M, 2010, J BIOMED MATER RES A, V95A, P828, DOI 10.1002/jbm.a.32850; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; Stanley MA, 2007, BIOCHEM SOC T, V35, P1456, DOI 10.1042/BST0351456; Sun J, 2012, J CHEM THERMODYN, V47, P130, DOI 10.1016/j.jct.2011.10.003; Sun JA, 2010, J PHYS CHEM B, V114, P9854, DOI 10.1021/jp1009719; Surviladze Z, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002519; VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang J, 2006, BIOCHEMISTRY-US, V45, P15740, DOI 10.1021/bi061346a; Wang ZX, 2013, J BIOACT COMPAT POL, V28, P154, DOI 10.1177/0883911512469707; Wei AF, 2010, J APPL POLYM SCI, V118, P346, DOI 10.1002/app.32363; Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002; Wu YQ, 2008, J BIOMAT SCI-POLYM E, V19, P573, DOI 10.1163/156856208784089616; Ye L, 2011, J BIOMAT SCI-POLYM E, V22, P389, DOI 10.1163/092050610X487710; Zhan J, 2012, J RES UPDATES POLYM, V1, P59, DOI DOI 10.6000/1929-5995.2012.01.02.1; Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6; Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6	61	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199925	10.1371/journal.pone.0199925	http://dx.doi.org/10.1371/journal.pone.0199925			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966006	Green Published, gold			2022-12-26	WOS:000437224100029
J	Mashaki, KM; Garg, V; Ghomi, AAN; Kudapa, H; Chitikineni, A; Nezhad, KZ; Yamchi, A; Soltanloo, H; Varshney, RK; Thudi, M				Mashaki, Keyvan Mandavi; Garg, Vanika; Ghomi, Ali Asghar Nasrollahnezhad; Kudapa, Himabindu; Chitikineni, Annapurna; Nezhad, Khalil Zaynali; Yamchi, Ahad; Soltanloo, Hasan; Varshney, Rajeev Kumar; Thudi, Mahendar			RNA-Seq analysis revealed genes associated with drought stress response in kabuli chickpea (Cicer arietinum L.)	PLOS ONE			English	Article							DRAFT GENOME SEQUENCE; TRANSCRIPTION FACTOR; SALT STRESS; EXPRESSION; TOLERANCE; PLANTS; CROP; ARABIDOPSIS; MECHANISMS; DISSECTION	Drought is the most important constraint that effects chickpea production globally. RNA-Seq has great potential to dissect the molecular mechanisms of tolerance to environmental stresses. Transcriptome profiles in roots and shoots of two contrasting Iranian kabuli chickpea genotypes (Bivanij and Hashem) were investigated under water-limited conditions at early flowering stage using RNA-Seq approach. A total of 4,572 differentially expressed genes (DEGs) were identified. Of these, 261 and 169 drought stress responsive genes were identified in the shoots and the roots, respectively, and 17 genes were common in the shoots and the roots. Gene Ontology (GO) analysis revealed several sub-categories related to the stress, including response to stress, defense response and response to stimulus in the tolerant genotype Bivanij as compared to the sensitive genotype Hashem under drought stress. In addition, several Transcription factors (TFs) were identified in major metabolic pathways such as, ABA, proline and flavonoid biosynthesis. Furthermore, a number of the DEGs were observed in "QTL-hotspot" regions which were reported earlier in chickpea. Drought tolerance dissection in the genotypes revealed that the genes and the pathways involved in shoots of Bivanij were the most important factor to make a difference between the genotypes for drought tolerance. The identified TFs in the experiment, particularly those which were up-regulated in shoots of Bivanij during drought stress, were potential candidates for enhancing tolerance to drought.	[Mashaki, Keyvan Mandavi; Ghomi, Ali Asghar Nasrollahnezhad; Nezhad, Khalil Zaynali; Yamchi, Ahad; Soltanloo, Hasan] Gorgan Univ Agr Sci & Nat Resources, Dept Plant Breeding & Biotechnol, Gorgan, Iran; [Mashaki, Keyvan Mandavi; Garg, Vanika; Kudapa, Himabindu; Chitikineni, Annapurna; Varshney, Rajeev Kumar; Thudi, Mahendar] Int Crops Res Inst Semi Arid Trop, Ctr Excellence Genom & Syst Biol, Hyderabad, Telangana, India	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Thudi, M (corresponding author), Int Crops Res Inst Semi Arid Trop, Ctr Excellence Genom & Syst Biol, Hyderabad, Telangana, India.	t.mahendar@cgiar.org	THUDI, MAHENDAR/GXA-1578-2022; Varshney, Rajeev K/C-5295-2014; Mashaki, Keyvan Mahdavi/AAF-2454-2020	THUDI, MAHENDAR/0000-0003-2851-6837; Varshney, Rajeev K/0000-0002-4562-9131; Mashaki, Keyvan Mahdavi/0000-0003-1131-8578; Garg, Vanika/0000-0001-6446-4603; Soltanloo, Hassan/0000-0003-2567-7686; Kudapa, Himabindu/0000-0003-0778-9959				Agarwal G, 2016, PLANT BIOTECHNOL J, V14, P1563, DOI 10.1111/pbi.12520; Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Bhardwaj AR, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0405-1; Bhargava S, 2013, PLANT BREEDING, V132, P21, DOI 10.1111/pbr.12004; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Din J, 2011, J ANIM PLANT SCI, V21, P78; Fracasso A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0800-x; Garg R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19228; Garg R, 2015, PLANT MOL BIOL REP, V33, P388, DOI 10.1007/s11105-014-0753-x; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Hsieh TH, 2010, PLANTA, V231, P1459, DOI 10.1007/s00425-010-1147-4; Hubner S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0528-z; Jaganathan D, 2015, MOL GENET GENOMICS, V290, P559, DOI 10.1007/s00438-014-0932-3; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Jaradat MR, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-192; Ju HW, 2013, PLANT SCI, V203, P1, DOI 10.1016/j.plantsci.2012.12.007; Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797; Kale SM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15296; Kashiwagi J, 2006, FIELD CROP RES, V95, P171, DOI 10.1016/j.fcr.2005.02.012; Katta MAVSK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139868; Nguyen KH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00449; Krishnamurthy L, 2013, FIELD CROP RES, V149, P354, DOI 10.1016/j.fcr.2013.05.022; Kudapa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086039; Lei YB, 2006, PHYSIOL PLANTARUM, V127, P182, DOI 10.1111/j.1399-3054.2006.00638.x; Liang XW, 2013, ANTIOXID REDOX SIGN, V19, P998, DOI 10.1089/ars.2012.5074; Liu LP, 2016, ENVIRON EXP BOT, V123, P50, DOI 10.1016/j.envexpbot.2015.10.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McAdam SAM, 2015, PLANT PHYSIOL, V167, P833, DOI 10.1104/pp.114.252940; Meena MK, 2015, FRONT PLANT SCI, V6, DOI [10.3339/fpls.2015.00683, 10.3389/fpls.2015.00683]; Michael TP, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0001in; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Ohashi H, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/104209; Patakas A, 2002, PLANT SCI, V163, P361, DOI 10.1016/S0168-9452(02)00140-1; Pourcel L, 2007, TRENDS PLANT SCI, V12, P29, DOI 10.1016/j.tplants.2006.11.006; Pradhan S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00698; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Sade N, 2012, PLANT SIGNAL BEHAV, V7, P767, DOI 10.4161/psb.20505; Sah SK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00571; Shao HB, 2008, INT J BIOL SCI, V4, P8; Su LT, 2014, GENE, V538, P46, DOI 10.1016/j.gene.2014.01.024; Takasaki H, 2015, PLANT J, V84, P1114, DOI 10.1111/tpj.13067; Thudi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38636; Thudi M, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-015-0690-3; Thudi M, 2014, FUNCT PLANT BIOL, V41, P1178, DOI 10.1071/FP13318; Thudi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096758; Thudi M, 2012, BRIEF FUNCT GENOMICS, V11, P3, DOI 10.1093/bfgp/elr045; Thudi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027275; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varshney RK, 2015, CRIT REV PLANT SCI, V34, P169, DOI 10.1080/07352689.2014.897909; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-523; WANG FS, 2017, MOL GENET GENOMICS, V76, P13087, DOI DOI 10.1007/S11042-016-3699-1; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu ZS, 2012, INT J MOL SCI, V13, P15706, DOI 10.3390/ijms131215706; Xu ZS, 2011, J INTEGR PLANT BIOL, V53, P570, DOI 10.1111/j.1744-7909.2011.01062.x; Xue GP, 2008, PLANT PHYSIOL, V146, P441, DOI 10.1104/pp.107.113076; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095, DOI 10.1093/oxfordjournals.pcp.a029093; Yoshida T, 2015, PLANT CELL ENVIRON, V38, P35, DOI 10.1111/pce.12351; Yu XW, 2016, PLANT CELL REP, V35, P613, DOI 10.1007/s00299-015-1907-5; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhou ZL, 2015, EVOL BIOINFORM, V11, P27, DOI 10.4137/EBO.S20620	69	40	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199774	10.1371/journal.pone.0199774	http://dx.doi.org/10.1371/journal.pone.0199774			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953498	Green Accepted, Green Published, gold			2022-12-26	WOS:000436645400063
J	Nyari, S; Khan, SA; Rawlinson, G; Waugh, CA; Potter, A; Gerdts, V; Timms, P				Nyari, Sharon; Khan, Shahneaz Ali; Rawlinson, Galit; Waugh, Courtney A.; Potter, Andrew; Gerdts, Volker; Timms, Peter			Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; INTRANASAL IMMUNIZATION; IMMUNE-RESPONSES; DENDRITIC CELLS; ADJUVANT; CHLORAMPHENICOL; COMBINATION; MUCOSAL; IGA; ENROFLOXACIN	Chlamydia pecorum is a mucosal infection, which causes debilitating disease of the urinary tract, reproductive tract and ocular sites of koalas (Phascolarctos cinereus). While antibiotics are available for treatment, they are detrimental to the koalas' gastrointestinal tract microflora leaving the implementation of a vaccine as an ideal option for the long-term management of koala populations. We have previously reported on the successes of an anti-chlamydial recombinant major outer membrane protein (rMOMP) vaccine however, recombinant protein based vaccines are not ideal candidates for scale up from the research level to small-medium production level for wider usage. Peptide based vaccines are a promising area for vaccine development, because peptides are stable, cost effective and easily produced. In this current study, we assessed, for the first time, the immune responses to a synthetic peptide based anti-chlamydial vaccine in koalas. Five healthy male koalas were vaccinated with two synthetic peptides derived from C. pecorum MOMP and another five healthy male koalas were vaccinated with full length recombinant C. pecorum MOMP (genotype G). Systemic (IgG) and mucosal (IgA) antibodies were quantified and pre-vaccination levels compared to post-vaccination levels (12 and 26 weeks). MOMP-peptide vaccinated koalas produced Chlamydia-specific IgG and IgA antibodies, which were able to recognise not only the genotype used in the vaccination, but also MOMPs from several other koala C. pecorum genotypes. In addition, IgA antibodies induced at the ocular site not only recognised recombinant MOMP protein but also, whole native chlamydial elementary bodies. Interestingly, some MOMP-peptide vaccinated koalas showed a stronger and more sustained vaccine-induced mucosal IgA antibody response than observed in MOMP-protein vaccinated koalas. These results demonstrate that a synthetic MOMP peptide based vaccine is capable of inducing a Chlamydia-specific antibody response in koalas and is a promising candidate for future vaccine development.	[Nyari, Sharon; Khan, Shahneaz Ali; Waugh, Courtney A.; Timms, Peter] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld, Australia; [Rawlinson, Galit] Lone Pine Koala Sanctuary, Fig Tree Pocket, Qld, Australia; [Potter, Andrew; Gerdts, Volker] Univ Saskatchewan, Vaccine & Infect Dis Org Int Vaccine Ctr VIDO Int, Saskatoon, SK, Canada	University of the Sunshine Coast; University of Saskatchewan	Timms, P (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld, Australia.	ptimms@usc.edu.au		Gerdts, Volker/0000-0001-8229-1611; Waugh, Courtney/0000-0001-5234-4137; Timms, Peter/0000-0002-1682-0025	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council Linkage program received by PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianov AK, 2005, BIOMACROMOLECULES, V6, P1375, DOI 10.1021/bm049329t; Armitage CW, 2014, IMMUNOLOGY, V143, P520, DOI 10.1111/imm.12317; Awate S, 2012, MOL IMMUNOL, V51, P292, DOI 10.1016/j.molimm.2012.03.026; Azmi F, 2014, HUM VACC IMMUNOTHER, V10, P778, DOI 10.4161/hv.27332; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Black LA, 2015, AUST VET J, V93, P420, DOI 10.1111/avj.12364; Black LA, 2013, J VET PHARMACOL THER, V36, P478, DOI 10.1111/jvp.12024; Bodley K., 2008, MED AUSTR MAMMALS; Bommana S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188370; Carey AJ, 2010, AM J REPROD IMMUNOL, V63, P161, DOI 10.1111/j.1600-0897.2009.00776.x; Cheng CM, 2011, VACCINE, V29, P6641, DOI 10.1016/j.vaccine.2011.06.105; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185; Desclozeaux M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178786; Elsawa Sherine F, 2004, Expert Rev Vaccines, V3, P563, DOI 10.1586/14760584.3.5.563; Garg R, 2014, J GEN VIROL, V95, P1043, DOI 10.1099/vir.0.062570-0; Garg R, 2014, J GEN VIROL, V95, P301, DOI 10.1099/vir.0.058461-0; Garg R, 2017, VACCINE, V35, P4486, DOI 10.1016/j.vaccine.2017.05.067; Garg R, 2016, VIROLOGY, V499, P288, DOI 10.1016/j.virol.2016.09.023; Gonzalez-Astudillo V, 2017, SCI REP-UK, V7, DOI 10.1038/srep42587; Govendir M, 2012, J VET PHARMACOL THER, V35, P147, DOI 10.1111/j.1365-2885.2011.01307.x; Griffith JE, 2010, J VET PHARMACOL THER, V33, P595, DOI 10.1111/j.1365-2885.2010.01169.x; Hancock REW, 2016, NAT REV IMMUNOL, V16, P321, DOI 10.1038/nri.2016.29; Harandi AM, 2009, EXPERT REV VACCINES, V8, P293, DOI 10.1586/14760584.8.3.293; Johnston SD, 2015, VET PATHOL, V52, P1254, DOI 10.1177/0300985815570069; Kametani Y, 2015, ANTIBODIES, V4, P225, DOI 10.3390/antib4030225; Khan SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156094; Khan SA, 2016, VACCINE, V34, P775, DOI 10.1016/j.vaccine.2015.12.050; Khan SA, 2014, VACCINE, V32, P5781, DOI 10.1016/j.vaccine.2014.08.037; Kollipara A, 2013, VET MICROBIOL, V167, P513, DOI 10.1016/j.vetmic.2013.08.009; Kollipara A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074808; Kollipara A, 2013, VACCINE, V31, P1217, DOI 10.1016/j.vaccine.2012.12.057; Kollipara A, 2012, VACCINE, V30, P1875, DOI 10.1016/j.vaccine.2011.12.125; Kovacs-Nolan J, 2009, VACCINE, V27, P2055, DOI 10.1016/j.vaccine.2009.01.118; Li WD, 2014, VACCINES-BASEL, V2, P515, DOI 10.3390/vaccines2030515; Liu TY, 2012, CURR TOP MED CHEM, V12, P1581, DOI 10.2174/156802612802652402; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; McColl K A, 1984, VET REC, V115, P25; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Menager J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089897; Nyari S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190114; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Rosalia RA, 2013, EUR J IMMUNOL, V43, P2554, DOI 10.1002/eji.201343324; Shizuo A, 2001, NAT IMMUNOL, V2, P675; Sioud M, 2009, SCAND J IMMUNOL, V70, P516, DOI 10.1111/j.1365-3083.2009.02326.x; Skwarczynski M, 2016, CHEM SCI, V7, P842, DOI 10.1039/c5sc03892h; Sultan H, 2017, ONCOTARGET, V8, P70317, DOI 10.18632/oncotarget.19688; Sun G, 2007, J BACTERIOL, V189, P6222, DOI 10.1128/JB.00552-07; Taha MA, 2011, WJV, V1, P138, DOI DOI 10.4236/WJV.2011.14014; Tan K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00783; Toes REM, 1996, J IMMUNOL, V156, P3911; Toes REM, 1996, P NATL ACAD SCI USA, V93, P7855, DOI 10.1073/pnas.93.15.7855; Trumpfheller C, 2012, J INTERN MED, V271, P183, DOI 10.1111/j.1365-2796.2011.02496.x; Tu JX, 2014, ACTA BIOCH BIOPH SIN, V46, P401, DOI 10.1093/abbs/gmu016; Wan C, 2011, AUST VET J, V89, P409, DOI 10.1111/j.1751-0813.2011.00827.x; Waugh C, 2016, BIOLOGICALS, V44, P588, DOI 10.1016/j.biologicals.2016.09.006; Waugh C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146934; Waugh CA, 2015, VACCINE, V33, P855, DOI 10.1016/j.vaccine.2014.12.052; Woof JM, 2004, IMMUNOLOGY, V113, P175, DOI 10.1111/j.1365-2567.2004.01958.x; Wuerth KC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187565; Zhang HW, 2009, J BIOL CHEM, V284, P9184, DOI 10.1074/jbc.M809456200	61	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0200112	10.1371/journal.pone.0200112	http://dx.doi.org/10.1371/journal.pone.0200112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953523	gold, Green Published, Green Submitted			2022-12-26	WOS:000436645400110
J	Song, MF; Guan, YH; Li, HT; Wei, SG; Zhang, LX; Zhang, ZL; Ma, XJ				Song, Mei-Fang; Guan, Yan-Hong; Li, Hai-Tao; Wei, Shu-Gen; Zhang, Li-Xia; Zhang, Zhong-Lian; Ma, Xiao-Jun			The effects of genetic variation and environmental factors on rhynchophylline and isorhynchophylline in Uncaria macrophylla Wall. from different populations in China	PLOS ONE			English	Article							MASS-SPECTROMETRY; ALKALOIDS; DISEASE	Uncaria macrophylla Wall. is an important Chinese medicinal herb. Rhynchophylline (RIN) and isorhynchophylline (IRN) are its major active compounds. We investigated the influence of genetic differentiation and environmental factors on the RIN and IRN to find the main influencing factors of their contents and lay the foundation for the following cultivation and breeding. We used inter-simple sequence repeat (ISSR) markers to investigate the genetic diversity, and high-performance liquid chromatography (HPLC) to measure the contents of RIN and IRN in 200 samples of U. macrophylla obtained from nine natural populations, and then to analyze the correlation between genetic differentiation, environmental factors of sampling sites and the contents of RIN and IRN. We found that High intra-population (80.05%) and low inter-population (19.95%) genetic diversity existed in the samples of U. macrophylla. To some extent, genetic differentiation and the contents of RIN and IRN had correlation in individual populations (such as JH, MH, XM, and ML). The RIN and IRN contents were significant negatively correlated with the precipitation in May (R-IRN = -0.771, p = 0.015) and June (R-RIN = -0.814, p = 0.008; R-IRN = -0.921, p = 0.000), indicating that precipitation was the main affecting factor of their contents. Interestingly, the analysis results showed that the RIN content had a significant positive correlation (r = 0.585, p = 0.000) with the IRN content (they are isomers); the proportion of RIN had a significant negative correlation with the sum of the two (r = -0.390, p<0.0001), while the proportion of IRN had a significant positive correlation (r = 0.390, p<0.0001). It meant that, with the total quantity of the two compounds increased, the proportion of RIN decreased and the proportion of IRN increased, illustrating that their conversion exist some regularity. Moreover, the content ratio of RIN and IRN was significant positively correlated with the January precipitation (r = 0.716, p = 0.030), implying that January may be the key period for the mutual transformation of RIN and IRN.	[Song, Mei-Fang; Guan, Yan-Hong; Li, Hai-Tao; Zhang, Li-Xia; Zhang, Zhong-Lian] Chinese Acad Med Sci, Peking Union Med Coll, Key Lab Dai & Southern Med Xishuangbanna Dai Auto, Yunnan Branch,Inst Med Plant Dev, Jinghong, Peoples R China; [Wei, Shu-Gen] Guangxi Bot Garden Med Plants, Nanning, Peoples R China; [Ma, Xiao-Jun] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Zhang, ZL (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Key Lab Dai & Southern Med Xishuangbanna Dai Auto, Yunnan Branch,Inst Med Plant Dev, Jinghong, Peoples R China.; Ma, XJ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing, Peoples R China.	zzl0605@163.com; mayixuan10@163.com		Wei, Shugen/0000-0003-3233-8017	Key Laboratory of Dai and Southern Medicine of Xishuangbanna Dai Autonomous Prefecture; special scientific research fund of public welfare profession of state administration of traditional chinese medicine [201507002]	Key Laboratory of Dai and Southern Medicine of Xishuangbanna Dai Autonomous Prefecture; special scientific research fund of public welfare profession of state administration of traditional chinese medicine	This research was supported by the Key Laboratory of Dai and Southern Medicine of Xishuangbanna Dai Autonomous Prefecture and supported by a grant (201507002, Quality guarantee system of Chinese herbal medicines) from the 2015 special scientific research fund of public welfare profession of state administration of traditional chinese medicine to XJM.	CHEN CX, 1992, ACTA PHARM SINIC, V13, P126; Chinese Pharmacopoeia Commission, 2015, PHARMACOPOEIA PEOPLE, P257; Hao Bo, 2014, Zhongguo Zhong Yao Za Zhi, V39, P4532; [黄瑞松 Huang Ruisong], 2012, [中草药, Chinese Traditional and Herbal Drugs], V43, P178; Lee CJ, 2014, BIOMED CHROMATOGR, V28, P901, DOI 10.1002/bmc.3206; Liu Lin, 2016, Yaoxue Xuebao, V51, P536, DOI 10.16438/j.0513-4870.2015-0997; Loh YC, 2017, J MED FOOD, V20, P895, DOI 10.1089/jmf.2016.3804; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Ng YP, 2015, NEUROCHEM INT, V89, P260, DOI 10.1016/j.neuint.2015.07.018; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Shi JS, 2003, ACTA PHARMACOL SIN, V24, P97; SHI JS, 1992, ACTA PHARM SINIC, V13, P35; Wu ZF, 2015, MOLECULES, V20, P14849, DOI 10.3390/molecules200814849; Xian YF, 2017, NEUROCHEM RES, V42, P678, DOI 10.1007/s11064-016-2124-5; Yeh FC, 2000, POPGENE 32 MICROSOFT; Yu Zaibai, 1999, Zhongguo Zhongyao Zazhi, V24, P198; Zhang Q, 2015, J ETHNOPHARMACOL, V173, P48, DOI 10.1016/j.jep.2015.06.011; 辛文波, 2009, [中草药, Chinese Traditional and Herbal Drugs], V40, P204	18	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199259	10.1371/journal.pone.0199259	http://dx.doi.org/10.1371/journal.pone.0199259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953548	Green Submitted, Green Published, gold			2022-12-26	WOS:000436645400020
J	Watanabe, K; Nozawa, S; Hsiang, T; Callan, B				Watanabe, Kyoko; Nozawa, Shunsuke; Hsiang, Tom; Callan, Brenda			The cup fungus Pestalopezia brunneopruinosa is Pestalotiopsis gibbosa and belongs to Sordariomycetes	PLOS ONE			English	Article							GENUS	Pestalopezia brunneopruinosa, the type species of Pestalopezia in Leotiomycetes, produces typical cup-shaped ascomata. Because its asexual morph has conidia comprised of five cells including apical and basal appendages and three pigmented median cells, it was first described as Pestalotia gibbosa, which belongs to Sordariomycetes. This contradiction has not been resolved due to the difficulty in isolating this fungus in culture. In this study, we isolated separate strains from the sexual morph and the asexual morph for molecular analysis. Phylogenetic trees of Sporocadaceae based on internal transcribed spacer, partial beta-tubul in, and partial translation elongation factor 1-alpha sequence datasets revealed that both strains fall into the same taxon, in a Glade in Pestalotiopsis sensu stricto alongside P. gaultheriae and P. spathulata. We provide the first evidence that fungi producing cupshaped ascomata in Pestalotiopsis belong to Sordariomycetes, and we have proposed the transfer of Pestalopezia brunneopruinosa to Pestalotiopsis gibbosa.	[Watanabe, Kyoko; Nozawa, Shunsuke] Tamagawa Univ, Grad Sch Agr, Machida, Tokyo, Japan; [Hsiang, Tom] Univ Guelph, Environm Sci, Guelph, ON, Canada; [Callan, Brenda] Nat Resources Canada, Pacific Forestry Ctr, Victoria, BC, Canada	University of Guelph; Natural Resources Canada	Watanabe, K (corresponding author), Tamagawa Univ, Grad Sch Agr, Machida, Tokyo, Japan.	wkyoko@agr.tamagawa.ac.jp			JSPS KAKENHI [25440218]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by JSPS KAKENHI Grant Number 25440218 https://www.jsps.go.jp/.	BARR ME, 1975, MYCOLOGIA, V67, P187, DOI 10.2307/3758246; Beimforde C, 2014, MOL PHYLOGENET EVOL, V78, P386, DOI 10.1016/j.ympev.2014.04.024; Bonar Lee, 1942, MYCOLOGIA, V34, P180, DOI 10.2307/3754810; De Notaris G, 1841, MEM REALE ACCAD SCI, V3, P80; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Jaklitsch WM, 2016, PERSOONIA, V37, P82, DOI 10.3767/003158516X690475; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirk PM, 2013, IMA FUNGUS, V4, P381, DOI 10.5598/imafungus.2013.04.02.17; Kirk PM., 2008, DICT FUNGI, V10th ed; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Maharachchikumbura SSN, 2014, STUD MYCOL, P121, DOI 10.1016/j.simyco.2014.09.005; Maharachchikumbura SSN, 2012, FUNGAL DIVERS, V56, P95, DOI 10.1007/s13225-012-0198-1; Nozawa S, 2017, MYCOSCIENCE, V58, P328, DOI 10.1016/j.myc.2017.02.008; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Reblova M, 2016, IMA FUNGUS, V7, P131, DOI 10.5598/imafungus.2016.07.01.08; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SEAVER F. J., 1942, Mycologia, V34, P298, DOI 10.2307/3754642; Silverio M. L., 2016, Agrotropica, V28, P151; STEYAERT R. L., 1949, BULL JARD BOT ETAT BRUXELLES, V19, P285, DOI 10.2307/3666710; Tamari Farshad, 2013, J Biomol Tech, V24, P113, DOI 10.7171/jbt.13-2403-001; Taylor JW, 2011, IMA FUNGUS, V2, P113, DOI 10.5598/imafungus.2011.02.02.01; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wingfield MJ, 2012, MOL PLANT PATHOL, V13, P604, DOI 10.1111/j.1364-3703.2011.00768.x; Zhang YM, 2013, SYDOWIA, V65, P113; Zhuang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047546	27	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0197025	10.1371/journal.pone.0197025	http://dx.doi.org/10.1371/journal.pone.0197025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949577	gold, Green Submitted, Green Published			2022-12-26	WOS:000436549200006
J	Deng, H; Hillpot, E; Yeboah, P; Mondal, S; Woodworth, CD				Deng, Han; Hillpot, Eric; Yeboah, Philomina; Mondal, Sumona; Woodworth, Craig D.			Susceptibility of epithelial cells cultured from different regions of human cervix to HPV16-induced immortalization	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; EPIDERMAL-GROWTH-FACTOR; TRANSFORMATION ZONE; HUMAN KERATINOCYTES; CANCER; EXPRESSION; INFECTION; INHIBITION; SUFFICIENT; ESTROGEN	Persistent infection with high-risk human papillomavirus (HPV) is a major risk factor for cervical cancer. Greater than 90% of these cancers originate in the cervical transformation zone (TZ), a narrow region of metaplastic squamous epithelium that develops at the squamocolumnar junction between the ectocervix and endocervix. It is unclear why the TZ has high susceptibility to malignant transformation and few studies have specifically examined cells from this region. We hypothesized that cells cultured from TZ are more susceptible to cellular immortalization, an alteration that contributes to malignant development. We cultured primary epithelial cells from each region of human cervix (ectocervix, endocervix and TZ) and measured susceptibility to immortalization after transfection with the complete HPV-16 genome or infection of HPV16 E6/E7 retroviruses. Cells cultured from each cervical region expressed keratin markers (keratin 14 and 18) that confirmed their region of origin. In contrast to our prediction, cells from TZ were equally susceptible to immortalization as cells from ectocervix or endocervix. Thus, increased susceptibility of the TZ to cervical carcinogenesis is not due to increased frequency of immortalization by HPV-16. We developed a series of HPV16-immortalized cell lines from ectocervix, endocervix and TZ that will enable comparisons of how these cells respond to factors that promote cervical carcinogenesis.	[Deng, Han; Hillpot, Eric; Yeboah, Philomina; Woodworth, Craig D.] Clarkson Univ, Dept Biol, Potsdam, NY 13699 USA; [Mondal, Sumona] Clarkson Univ, Dept Math, Potsdam, NY USA	Clarkson University; Clarkson University	Woodworth, CD (corresponding author), Clarkson Univ, Dept Biol, Potsdam, NY 13699 USA.	woodworth@clarkson.edu		Woodworth, Craig/0000-0003-0467-8460	National Cancer Institute [1R15CA173703-01]; US Biomax, Inc	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Biomax, Inc	This work was funded by an award from the National Cancer Institute 1R15CA173703-01 (CDW) and by an award from US Biomax, Inc (CDW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURGHARDT E, 1983, OBSTET GYNECOL, V62, P117; Castle PE, 2006, CANCER RES, V66, P1218, DOI 10.1158/0008-5472.CAN-05-3066; Castle PE, 2007, SEX TRANSM DIS, V34, P849, DOI 10.1097/OLQ.0b013e318064c8c5; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Cury PR, 2007, ARCH ORAL BIOL, V52, P585, DOI 10.1016/j.archoralbio.2006.11.006; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Elson DA, 2000, CANCER RES, V60, P1267; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Giannini SL, 2002, INT J CANCER, V97, P654, DOI 10.1002/ijc.10084; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herfs M, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040085; Herfs M, 2012, P NATL ACAD SCI USA, V109, P10516, DOI 10.1073/pnas.1202684109; Hwang LY, 2012, J INFECT DIS, V206, P504, DOI 10.1093/infdis/jis398; Koshiol JE, 2006, INT J CANCER, V119, P1623, DOI 10.1002/ijc.22015; Martens JE, 2004, ANTICANCER RES, V24, P771; Martens JE, 2009, INT J GYNECOL PATHOL, V28, P381, DOI 10.1097/PGP.0b013e31819932f8; Mcnairn AJ, 2011, EUR J DERMATOL, V21, P21, DOI 10.1684/ejd.2011.1267; MUNGER K, 1989, J VIROL, V63, P4417; Remoue F, 2003, AM J OBSTET GYNECOL, V189, P1660, DOI 10.1016/S0002-9378(03)00852-4; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Vandermark ER, 2012, VIROLOGY, V425, P53, DOI 10.1016/j.virol.2011.12.023; WOODWORTH C, 1986, CANCER RES, V46, P4018; WOODWORTH CD, 1992, ONCOGENE, V7, P619; Woodworth CD, 2005, MOL CANCER THER, V4, P650, DOI 10.1158/1535-7163.MCT-04-0238; WOODWORTH CD, 1988, CANCER RES, V48, P4620	27	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199761	10.1371/journal.pone.0199761	http://dx.doi.org/10.1371/journal.pone.0199761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944714	gold, Green Published, Green Submitted			2022-12-26	WOS:000436377800060
J	Ji, YY; Xu, HY; Zhang, Y; Liu, QL				Ji, Yuanyi; Xu, Huanyu; Zhang, Yu; Liu, Qiaolan			Heterogeneity of adolescent health risk behaviors in rural western China: A latent class analysis	PLOS ONE			English	Article							YOUNG ADULTHOOD; MULTIPLE; CHILDHOOD; MIXTURE; NUMBER; YOUTH	Background Adolescent health risk behaviors are a public health priority given their prevalence and their associations with chronic diseases and life quality in adulthood. This study examined the heterogeneity of adolescent health risk behaviors and the associations between demographic characteristics and subgroup membership in rural western China. Methods In fall 2015, 2805 students from rural middle schools in Sichuan Province were surveyed using the Health-Related Behavior Questionnaire for Adolescents. Latent class analysis (LCA) was used to identify subgroups of adolescents with distinct patterns of health risk behaviors. Differences in class membership related to selected demographic characteristics were examined using multinomial logistic regression analysis. Results A four-class model emerged: (1) high-risk group (n = 108, 4.0%), (2) high-physical-inactivity and suicide-risk group (n = 340, 12.1%), (3) moderate-risk group (n = 897, 32.0%), and (4) low-risk group (n = 1460, 52.1%). The multinomial logistic regression analysis revealed that boys and adolescents with poor parental relationships and high allowances (spending money) were significantly more likely to be in the high-risk group than the low-risk group. Conclusions Adolescents in rural western China are a heterogeneous population requiring different tailored and effective interventions.	[Ji, Yuanyi; Xu, Huanyu; Zhang, Yu; Liu, Qiaolan] Sichuan Univ, West China Sch Publ Hlth, Chengdu 0, Sichuan, Peoples R China	Sichuan University	Liu, QL (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu 0, Sichuan, Peoples R China.	liuqiaol@scu.edu.cn			National Natural Science Foundation of China [81472994, 30972546]; Fundamental Research Fund for Chinese Central Universities [skqy201212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Fund for Chinese Central Universities	This work was supported by the National Natural Science Foundation of China (NO:81472994 and 30972546) and the Fundamental Research Fund for Chinese Central Universities (NO:skqy201212) (QL).	Adamson G, 2007, PAIN, V129, P295, DOI 10.1016/j.pain.2006.10.015; Capron C, 2007, J ADOLESCENCE, V30, P175, DOI 10.1016/j.adolescence.2006.11.004; Centers for Disease Control and Prevention, 2016, YOUTH RISK BEHAV SUR; Cook EC, 2015, J ABNORM CHILD PSYCH, V43, P95, DOI 10.1007/s10802-014-9880-y; Corsi K. F., 2007, Journal of Child and Family Studies, V16, P808, DOI 10.1007/s10826-006-9127-9; Crofts N, 1996, ADDICTION, V91, P1187, DOI 10.1046/j.1360-0443.1996.918118710.x; DONOVAN JE, 1985, J CONSULT CLIN PSYCH, V53, P890, DOI 10.1037/0022-006X.53.6.890; Driskell MM, 2008, PREV MED, V46, P209, DOI 10.1016/j.ypmed.2007.07.028; Duan C., 2013, POPULATION J, V35, P37, DOI [10.3969/j.1004-129X.2013.03.004, DOI 10.3969/J.ISSN.1004-129X.2013.03.004]; Duan C. R, 2008, POPULATION RES, V32, P15, DOI [10.3969/j.issn.1000-6087.2008.03.002, DOI 10.3969/J.ISSN.1000-6087.2008.03.002]; DuRant RH, 1999, ARCH PEDIAT ADOL MED, V153, P286; Fine LJ, 2004, AM J PREV MED, V27, P18, DOI 10.1016/j.amepre.2004.04.017; Flisher AJ, 2006, SAMJ S AFR MED J, V96, P825; Gao Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-56; Garnett BR, 2015, J SCHOOL HEALTH, V85, P109, DOI 10.1111/josh.12225; Govender K, 2013, J SCHOOL HEALTH, V83, P614, DOI 10.1111/josh.12073; Guo Shuai-jun, 2013, Beijing Da Xue Xue Bao Yi Xue Ban, V45, P382; Hair EC, 2009, J ADOLESCENT HEALTH, V45, P253, DOI 10.1016/j.jadohealth.2009.02.009; JESSOR R, 1991, J ADOLESCENT HEALTH, V12, P597, DOI 10.1016/1054-139X(91)90007-K; Jessor R., 1991, ADOLESCENCE PROBLEM; Ji C. X., 2007, CHIN J SCH HLTH, V28, P289; Ji CY, 2007, COMPREHENSIVE REPORT, P322; Lanza ST, 2013, PREV SCI, V14, P157, DOI 10.1007/s11121-011-0201-1; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Miller AL, 2000, J CLIN PSYCHOL, V56, P1131, DOI 10.1002/1097-4679(200009)56:9<1131::AID-JCLP3>3.0.CO;2-8; Nakano T, 2013, J SCHOOL HEALTH, V83, P231, DOI 10.1111/josh.12021; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Piko BF, 2007, EUR J PUBLIC HEALTH, V17, P353, DOI 10.1093/eurpub/ckl257; Qiu HZ, 2008, LATENT CLASS MODELIN, P43; Riesch SK, 2006, J SPEC PEDIATR NURS, V11, P41, DOI 10.1111/j.1744-6155.2006.00042.x; Rosato NS, 2012, SOC WORK RES, V36, P61, DOI 10.1093/swr/svs006; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Spear HJ, 2001, PUBLIC HEALTH NURS, V18, P82, DOI 10.1046/j.1525-1446.2001.00082.x; Spring B, 2012, J PUBLIC HEALTH-UK, V34, pI3, DOI 10.1093/pubmed/fdr111; Wang M, 2013, THESIS NW A F U XIAN; [星一 Xing Yi], 2005, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V14, P740	36	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199286	10.1371/journal.pone.0199286	http://dx.doi.org/10.1371/journal.pone.0199286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK7JR	29944679	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800027
J	Wei, WJ; Zhang, S; Fleming, J; Chen, Y; Li, ZH; Fan, SH; Liu, Y; Wang, W; Wang, T; Liu, Y; Ren, BG; Wang, M; Jiao, JJ; Chen, YY; Zhou, Y; Zhou, YF; Gu, SJ; Zhang, XL; Wan, L; Chen, T; Zhou, L; Chen, Y; Zhang, XE; Li, CY; Zhang, HT; Bi, LJ				Wei, Wenjing; Zhang, Shuai; Fleming, Joy; Chen, Ying; Li, Zihui; Fan, Shanghua; Liu, Yi; Wang, Wei; Wang, Ting; Liu, Ying; Ren, Baiguang; Wang, Ming; Jiao, Jianjian; Chen, Yuanyuan; Zhou, Ying; Zhou, Yafeng; Gu, Shoujin; Zhang, Xiaoli; Wan, Li; Chen, Tao; Zhou, Lin; Chen, Yong; Zhang, Xian-En; Li, Chuanyou; Zhang, Hongtai; Bi, Lijun			Mycobacterium tuberculosis type III-A CRISPR/Cas system crRNA and its maturation have atypical features	FASEB JOURNAL			English	Article						Cas6; metal ion dependence; mature crRNA; hairpin	PROCESSES PRE-CRRNA; CRYSTAL-STRUCTURE; RNA RECOGNITION; CAS SYSTEMS; PROTEIN; EVOLUTION; COMPLEX; DNA; CLASSIFICATION; SEQUENCE	Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein (Cas) systems are prokaryotic adaptive immune systems against invading nucleic acids. CRISPR locus variability has been exploited in evolutionary and epidemiological studies of Mycobacterium tuberculosis, the causative agent of tuberculosis, for over 20 yr, yet the biological function of this type III-A system is largely unexplored. Here, using cell biology and biochemical, mutagenic, and RNA-seq approaches, we show it is active in invader defense and has features atypical of type III-A systems: mature CRISPR RNA (crRNA) in its crRNA-CRISPR/Cas protein complex are of uniform length (approximate to 71 nt) and appear not to be subject to 3-end processing after Cas6 cleavage of repeat RNA 8 nt from its 3 end. crRNAs generated resemble mature crRNA in type I systems, having both 5 (8 nt) and 3 (28 nt) repeat tags. Cas6 cleavage of repeat RNA is ion dependent, and accurate cleavage depends on the presence of a 3 hairpin in the repeat RNA and the sequence of its stem base nucleotides. This study unveils further diversity among CRISPR/Cas systems and provides insight into the crRNA recognition mechanism in M. tuberculosis, providing a foundation for investigating the potential of a type III-A-based genome editing system.Wei, W., Zhang, S., Fleming, J., Chen, Y., Li, Z., Fan, S., Liu, Y., Wang, W., Wang, T., Liu, Y., Ren, B., Wang, M., Jiao, J., Chen, Y., Zhou, Y., Zhou, Y., Gu, S., Zhang, X., Wan, L., Chen, T., Zhou, L., Chen, Y., Zhang, X.-E., Li, C., Zhang, H., Bi, L. Mycobacterium tuberculosis type III-A CRISPR/Cas system crRNA and its maturation have atypical features.	[Wei, Wenjing; Zhang, Shuai; Fleming, Joy; Chen, Ying; Fan, Shanghua; Wang, Ting; Liu, Ying; Ren, Baiguang; Wang, Ming; Jiao, Jianjian; Chen, Yuanyuan; Gu, Shoujin; Wan, Li; Zhang, Xian-En; Zhang, Hongtai; Bi, Lijun] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing 100101, Peoples R China; [Wei, Wenjing; Zhang, Shuai; Fleming, Joy; Chen, Ying; Fan, Shanghua; Wang, Ting; Liu, Ying; Ren, Baiguang; Wang, Ming; Jiao, Jianjian; Chen, Yuanyuan; Gu, Shoujin; Wan, Li; Zhang, Xian-En; Zhang, Hongtai; Bi, Lijun] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wei, Wenjing; Zhang, Shuai] Univ Chinese Acad Sci, Beijing, Peoples R China; [Fleming, Joy; Zhou, Ying; Zhou, Yafeng; Zhang, Xiaoli; Chen, Yong; Zhang, Xian-En; Bi, Lijun] Foshan Univ, Sch Stomatol & Med, Foshan, Peoples R China; [Li, Zihui; Liu, Yi; Wang, Wei; Li, Chuanyou] Capital Med Univ, Beijing Chest Hosp, Beijing 101149, Peoples R China; [Gu, Shoujin] Shanghai Univ Engn Sci, Sch Chem & Chem Engn, Shanghai, Peoples R China; [Chen, Tao; Zhou, Lin] Ctr TB Control Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Bi, Lijun] Guangdong Prov Key Lab TB Syst Biol & Translat Me, Foshan, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Foshan University; Capital Medical University; Shanghai University of Engineering Science	Zhang, HT (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing 100101, Peoples R China.; Zhang, HT (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Li, CY (corresponding author), Capital Med Univ, Beijing Chest Hosp, Beijing 101149, Peoples R China.; Bi, LJ (corresponding author), Chinese Acad Sci, Key Lab RNA Biol, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.; Bi, LJ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	lichuanyou6688@hotmail.com; hongtaizhang@aliyun.com; blj@ibp.ac.cn	ZHANG, Xian-En/AAJ-5579-2021; Chen, Yuanyuan/GXG-2130-2022	Fan, Shanghua/0000-0002-6596-8472	National Key Research and Development Program of China [2017YFD0500300]; National Natural Science Foundation of China [U1401224, 31400127, 31770148, 31770150]; CAS Science and Technology Service Network Program [KFZD-SW-207]; Strategic Priority Research Program of the CAS [XDA09030308, XDPB0302]; Special Fund for Public Welfare Research and Capacity Building in Guangdong Province [2014B030301002]; CAS Youth Innovation Promotion Association [2015072]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Science and Technology Service Network Program; Strategic Priority Research Program of the CAS; Special Fund for Public Welfare Research and Capacity Building in Guangdong Province; CAS Youth Innovation Promotion Association	The authors thank Prof. Yanli Wang, Prof. Tao Jiang, and Prof. Guofeng Zhu [all from the Institute of Biophysics (IBP), Chinese Academy of Sciences (CAS)] for constructive discussions on the manuscript; Zhenwei Yang of the Protein Science Core Facility at the Institute of Biophysics (CAS) for technical help with the isothermal calorimetry experiments; Dr. Hongjie Zhang (IBP Radioactive Isotope Laboratory for guidance in the safe handling of radiolabeled chemicals; and Lin Su, Tailin Liu, and Fansi Kong (Bionova Biotech Co. Ltd., Beijing, China) for help with RNA sequencing and analysis. This work was supported by National Key Research and Development Program of China Grant 2017YFD0500300; National Natural Science Foundation of China Grants U1401224, 31400127, 31770148, and 31770150; CAS Science and Technology Service Network Program Grant KFZD-SW-207; Strategic Priority Research Program of the CAS Grants XDA09030308 and XDPB0302; Special Fund for Public Welfare Research and Capacity Building in Guangdong Province Grant 2014B030301002; and CAS Youth Innovation Promotion Association Grant 2015072. The authors declare no conflicts of interest.	Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Barrangou R, 2015, CURR OPIN IMMUNOL, V32, P36, DOI 10.1016/j.coi.2014.12.008; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Garside EL, 2012, RNA, V18, P2020, DOI 10.1261/rna.033100.112; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Guan J, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00403-17; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; He LM, 2012, J CELL BIOCHEM, V113, P2464, DOI 10.1002/jcb.24121; Hinc K, 2006, ACTA BIOCHIM POL, V53, P497; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jesser R, 2019, RNA BIOL, V16, P481, DOI 10.1080/15476286.2018.1447742; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Killelea T, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160297; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lee MC, 2017, CRYSTALS, V7, DOI 10.3390/cryst7110344; [李勇鹏 Li Yongpeng], 2016, [东北林业大学学报, Journal of North-East Forestry University], V44, P34; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Makarova KS, 2017, CELL, V168, P946, DOI [10.1016/j.cell.2016.12.038, 10.1016/j.cell.2017.02.018]; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Nam KH, 2012, J BIOL CHEM, V287, P35943, DOI 10.1074/jbc.M112.382598; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Niewoehner O, 2014, NUCLEIC ACIDS RES, V42, P1341, DOI 10.1093/nar/gkt922; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Park HM, 2012, PROTEINS, V80, P1895, DOI 10.1002/prot.24061; PEREZSTABLE C, 1984, P NATL ACAD SCI-BIOL, V81, P5291, DOI 10.1073/pnas.81.17.5291; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Reeks J, 2013, BIOCHEM J, V452, P223, DOI 10.1042/BJ20130269; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; RIORDAN JF, 1977, ANN CLIN LAB SCI, V7, P119; Sefcikova J, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700019; Shao YM, 2016, STRUCTURE, V24, P547, DOI 10.1016/j.str.2016.02.009; Shao YM, 2013, STRUCTURE, V21, P385, DOI 10.1016/j.str.2013.01.010; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sokolowski RD, 2014, NUCLEIC ACIDS RES, V42, P6532, DOI 10.1093/nar/gku308; Tamulaitis G, 2017, TRENDS MICROBIOL, V25, P49, DOI 10.1016/j.tim.2016.09.012; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; van Duijn E, 2012, MOL CELL PROTEOMICS, V11, P1430, DOI 10.1074/mcp.M112.020263; Wakefield N, 2015, FEBS LETT, V589, P3197, DOI 10.1016/j.febslet.2015.09.005; Walker FC, 2017, NUCLEIC ACIDS RES, V45, P2112, DOI 10.1093/nar/gkw891; Wang RY, 2012, PROTEIN SCI, V21, P405, DOI 10.1002/pro.2028; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; WHO, 2017, WHO GLOB TUB REP 201; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735	63	16	20	2	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					1496	1509		10.1096/fj.201800557RR	http://dx.doi.org/10.1096/fj.201800557RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29979631				2022-12-26	WOS:000457401500117
J	Whitley, MJ; Arjunan, P; Nemeria, NS; Korotchkina, LG; Park, YH; Patel, MS; Jordan, F; Furey, W				Whitley, Matthew J.; Arjunan, Palaniappa; Nemeria, Natalia S.; Korotchkina, Lioubov G.; Park, Yun-Hee; Patel, Mulchand S.; Jordan, Frank; Furey, William			Pyruvate dehydrogenase complex deficiency is linked to regulatory loop disorder in the alpha V138M variant of human pyruvate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIAMIN DIPHOSPHATE; E1 SUBUNIT; DEPENDENT ENZYMES; STRUCTURAL BASIS; PHOSPHORYLATION; CATALYSIS; FEATURES; INTERMEDIATE; INACTIVATION; IONIZATION	The pyruvate dehydrogenase multienzyme complex (PDHc) connects glycolysis to the tricarboxylic acid cycle by producing acetyl-CoA via the decarboxylation of pyruvate. Because of its pivotal role in glucose metabolism, this complex is closely regulated in mammals by reversible phosphorylation, the modulation of which is of interest in treating cancer, diabetes, and obesity. Mutations such as that leading to the alpha V138M variant in pyruvate dehydrogenase, the pyruvate-decarboxylating PDHc E1 component, can result in PDHc deficiency, an inborn error of metabolism that results in an array of symptoms such as lactic acidosis, progressive cognitive and neuromuscular deficits, and even death in infancy or childhood. Here we present an analysis of two X-ray crystal structures at 2.7-angstrom resolution, the first of the disease-associated human alpha V138M E1 variant and the second of human wildtype (WT) E1 with a bound adduct of its coenzyme thiamin diphosphate and the substrate analogue acetylphosphinate. The structures provide support for the role of regulatory loop disorder in E1 inactivation, and the alpha V138M variant structure also reveals that altered coenzyme binding can result in such disorder even in the absence of phosphorylation. Specifically, both E1 phosphorylation at alpha Ser-264 and the alpha V138M substitution result in disordered loops that are not optimally oriented or available to efficiently bind the lipoyl domain of PDHc E2. Combined with an analysis of alpha V138M activity, these results underscore the general connection between regulatory loop disorder and loss of E1 catalytic efficiency.	[Whitley, Matthew J.; Arjunan, Palaniappa; Furey, William] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15261 USA; [Nemeria, Natalia S.; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Korotchkina, Lioubov G.; Park, Yun-Hee; Patel, Mulchand S.] Univ Buffalo State Univ New York, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14203 USA; [Furey, William] Vet Affairs Med Ctr, Biocrystallog Lab, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rutgers State University Newark; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Furey, W (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15261 USA.	fureyw@pitt.edu	Whitley, Matthew/I-9531-2019	Whitley, Matthew/0000-0001-8830-7514; Furey, William/0000-0002-7788-0689	DOE Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK080748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM116077, R01GM121469, R01GM061791, R01GM050380] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; Baykal AT, 2006, BIOCHEMISTRY-US, V45, P7522, DOI 10.1021/bi060395k; BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875; Byron O, 2017, SUBCELL BIOCHEM, V83, P523, DOI 10.1007/978-3-319-46503-6_19; CHUN K, 1993, HUM MOL GENET, V2, P449, DOI 10.1093/hmg/2.4.449; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferriero R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004986; Jordan F, 2003, NAT PROD REP, V20, P184, DOI 10.1039/b111348h; Jordan F, 2002, BIOORG CHEM, V30, P188, DOI 10.1006/bioo.2002.1249; Jordan F, 2014, BIOORG CHEM, V57, P251, DOI 10.1016/j.bioorg.2014.08.002; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato M, 2008, STRUCTURE, V16, P1849, DOI 10.1016/j.str.2008.10.010; Kerr D. S., 1996, ALPHA KETO ACID DEHY, P249; KOROTCHKINA LG, 1995, PROTEIN EXPRES PURIF, V6, P79, DOI 10.1006/prep.1995.1011; Korotchkina LG, 2001, J BIOL CHEM, V276, P5731, DOI 10.1074/jbc.M007558200; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; LIU TC, 1995, J BIOL CHEM, V270, P15545, DOI 10.1074/jbc.270.26.15545; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nemeria N, 2001, J BIOL CHEM, V276, P45969, DOI 10.1074/jbc.M104116200; Nemeria N, 2007, BIOCHEMISTRY-US, V46, P10739, DOI 10.1021/bi700838q; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Nemeria NS, 2006, BIOORG CHEM, V34, P362, DOI 10.1016/j.bioorg.2006.09.001; Nemeria NS, 2016, BIOCHEMISTRY-US, V55, P1135, DOI 10.1021/acs.biochem.5b01300; Nemeria NS, 2009, FEBS J, V276, P2432, DOI 10.1111/j.1742-4658.2009.06964.x; Patel KP, 2012, MOL GENET METAB, V105, P34, DOI 10.1016/j.ymgme.2011.09.032; Paulikat M, 2017, BIOCHEMISTRY-US, V56, P1854, DOI 10.1021/acs.biochem.6b00984; Pei XY, 2008, STRUCTURE, V16, P1860, DOI 10.1016/j.str.2008.10.009; Pletcher J., 1982, THIAMIN 20 YEARS PRO, P454; Seifert F, 2007, BIOCHEMISTRY-US, V46, P6277, DOI 10.1021/bi700083z; Seyda A, 2000, BIOCHEM BIOPH RES CO, V270, P1068, DOI 10.1006/bbrc.2000.2551	32	8	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13204	13213		10.1074/jbc.RA118.003996	http://dx.doi.org/10.1074/jbc.RA118.003996			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29970614	Green Published, hybrid			2022-12-26	WOS:000442730200019
J	Marbaix, S; Peetermans, WE; Verhaegen, J; Annemans, L; Sato, R; Mignon, A; Atwood, M; Weycker, D				Marbaix, Sophie; Peetermans, Willy E.; Verhaegen, Jan; Annemans, Lieven; Sato, Reiko; Mignon, Annick; Atwood, Mark; Weycker, Derek			Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection	PLOS ONE			English	Article							CONJUGATE VACCINE; POLYSACCHARIDE VACCINE; UNITED-STATES; OLDER-ADULTS; US ADULTS; DISEASE; IMMUNOGENICITY; PNEUMONIA; CHILDREN; EFFICACY	Background The Belgian Superior Health Council (SHC) recently added a 13-valent pneumococcal conjugate vaccine (PCV13) to its recommendations for adult pneumococcal vaccination. This study addresses the policy question regarding whether a single dose of PCV13 should be reimbursed among Belgian adults aged 65-84 years with chronic comorbidities ("moderate-risk" ) or immunosuppression ("high-risk"). Methods A cohort model was developed to project lifetime risks, consequences, and costs of invasive pneumococcal disease (IPD) and pneumococcal community-acquired pneumonia (CAP). Parameter values were estimated using published literature and available databases, and were reviewed by Belgian experts. PCV13 effectiveness was assumed to be durable during the first 5 years following receipt, and to progressively decline thereafter with 15 years protection. The Belgian National Health Insurance perspective was employed. Results Use of PCV13 (vs. no vaccine) in moderate/high-risk persons aged 65-84 years (n = 861,467; 58% vaccination coverage) would be expected to prevent 527 cases of IPD, 1,744 cases of pneumococcal CAP and 176 pneumococcal-related deaths, and reduce medical care costs by (sic)20.1 million. Vaccination costs, however, would increase by (sic)36.9 million and thus total overall costs would increase by (sic)16.8 million. Cost per QALY gained was (sic)17,126. In probabilistic sensitivity analyses, use of PCV13 was cost-effective in 97% of 1,000 simulations. Conclusions Reimbursement of PCV13 in moderate/high-risk Belgian adults aged 65-84 years would be cost-effective from the Belgian healthcare perspective.	[Marbaix, Sophie; Mignon, Annick] Pfizer NV SA, Brussels, Belgium; [Peetermans, Willy E.] Univ Hosp Leuven, Dept Internal Med, Leuven, Belgium; [Verhaegen, Jan] Univ Hosp Leuven, Dept Microbiol, Leuven, Belgium; [Annemans, Lieven] Univ Ghent, Ghent, Belgium; [Sato, Reiko] Pfizer Inc, Collegeville, PA USA; [Atwood, Mark; Weycker, Derek] PAI, Brookline, MA 02445 USA	Pfizer; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Ghent University; Pfizer; Policy Analysis Inc	Weycker, D (corresponding author), PAI, Brookline, MA 02445 USA.	dweycker@pai2.com			Pfizer Inc.; Pfizer	Pfizer Inc.(Pfizer); Pfizer(Pfizer)	Funding for this research was provided by Pfizer Inc. to Policy Analysis Inc. (PAI). Mark Atwood and Derek Weycker are employed by PAI; Sophie Marbaix and Annick Mignon are employed by Pfizer NV/SA, and Reiko Sato is employed by Pfizer Inc. PAI (DW, MA) and Pfizer (SM, AM, RS) provided support in the form of salaries for some authors, but did not have any additional role in model development, model estimation, analyses, the decision to publish, or the preparation of the manuscript.	Beutels P, 2006, KCE REPORTS; Beutels P, 2011, 155CD20111027321 KCE; Bhorat AE, 2015, AIDS, V29, P1345, DOI 10.1097/QAD.0000000000000689; Blommaert A., 2016, 274CS HTA KCE; Blommaert A, 2016, VACCINE, V34, P2106, DOI 10.1016/j.vaccine.2016.03.003; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; CBIP BCFI 2015, 2015, REP COMM MED; Chen JL, 2014, ADV THER, V31, P392, DOI 10.1007/s12325-014-0115-y; Cho BH, 2013, VACCINE, V31, P6011, DOI 10.1016/j.vaccine.2013.10.024; Conseil Superieur de le Sante, 2014, CSS9210; Cordonnier C, 2015, CLIN INFECT DIS, V61, P313, DOI 10.1093/cid/civ287; De Montalembert M, 2015, PEDIATR BLOOD CANCER, V62, P1427, DOI 10.1002/pbc.25502; Hak E, 2008, NETH J MED, V66, P378; Hoshi SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139140; Huang SS, 2011, VACCINE, V29, P3398, DOI 10.1016/j.vaccine.2011.02.088; Hung TY, 2017, CANCER-AM CANCER SOC, V123, P4215, DOI 10.1002/cncr.30764; Institut National d'assurance Maladie-Invalidite A, SOINS SANT PRIX HON; Institute of Public Health WIV-ISP, 2013, HLTH INT SURV; Jallow S, 2017, VACCINE, V35, P4321, DOI 10.1016/j.vaccine.2017.06.081; Jiang Y, 2014, EXPERT REV PHARM OUT, V14, P913, DOI 10.1586/14737167.2014.950232; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lombardi F, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0156523eCollection2016, DOI 10.1371/JOURNAL.PONE.0156523ECOLLECTION2016.]; Mangen MJJ, 2015, EUR RESPIR J, V46, P1407, DOI 10.1183/13993003.00325-2015; Gonzalez-Moro JMR, 2016, CLIN DRUG INVEST, V36, P41, DOI 10.1007/s40261-015-0345-z; Scientific Institute of Public Health, 2013, HISIA BELG HLTH INT; Smith KJ, 2008, VACCINE, V26, P1420, DOI 10.1016/j.vaccine.2008.01.007; Smith KJ, 2013, VACCINE, V31, P3950, DOI 10.1016/j.vaccine.2013.06.037; Stoecker C, 2016, J GEN INTERN MED, V31, P901, DOI 10.1007/s11606-016-3651-0; Suaya J A, PLOSONE UNPUB; Suaya JA, 2018, VACCINE, V36, P1477, DOI 10.1016/j.vaccine.2018.01.049; Truyers C, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-48; van Hoek AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149540; van Hoek AJ, 2012, J INFECTION, V65, P17, DOI 10.1016/j.jinf.2012.02.017; van Werkhoven CH, 2015, 25 EUR C CLIN MICR I; van Werkhoven CH, 2015, CLIN INFECT DIS, V61, P1835, DOI 10.1093/cid/civ686; Verhaegen J, 2014, EUROSURVEILLANCE, V19, P14, DOI 10.2807/1560-7917.ES2014.19.31.20869; Weycker D, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1432-4; Weycker D, 2012, VACCINE, V30, P5437, DOI 10.1016/j.vaccine.2012.05.076; Weycker D, 2010, VACCINE, V28, P4955, DOI 10.1016/j.vaccine.2010.05.030; Wroe PC, 2012, J INFECT DIS, V205, P1589, DOI 10.1093/infdis/jis240; Zimmerman RK, 2010, VACCINE, V28, P6470, DOI 10.1016/j.vaccine.2010.07.037	41	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199427	10.1371/journal.pone.0199427	http://dx.doi.org/10.1371/journal.pone.0199427			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979689	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500017
J	Rossetti, RAM; Lorenzi, NPC; Yokochi, K; Rosa, MBSD; Benevides, L; Margarido, PFR; Baracat, EC; Carvalho, JP; Villa, LL; Lepique, AP				Marques Rossetti, Renata Ariza; Cristina Lorenzi, Noely Paula; Yokochi, Kaori; Sartor de Faria Rosa, Maria Beatriz; Benevides, Luciana; Ramos Margarido, Paulo Francisco; Baracat, Edmund Chada; Carvalho, Jesus Paula; Villa, Luisa Lina; Lepique, Ana Paula			B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses	PLOS ONE			English	Article							T-CELLS; REGULATORY T; CANCER; INFLAMMATION; TUMORS; CARCINOGENESIS; IMMUNOTHERAPY; LEUKOCYTOSIS; VACCINATION; MELANOMA	Immune evasion by tumors includes several different mechanisms, including the inefficiency of antigen presenting cells (APCs) to trigger anti-tumor T cell responses. B lymphocytes may display a pro-tumoral role but can also be modulated to function as antigen presenting cells to T lymphocytes, capable of triggering anti-cancer immune responses. While dendritic cells, DCs, are the best APC population to activate naive T cells, DCs or their precursors, monocytes, are frequently modulated by tumors, displaying a tolerogenic phenotype in cancer patients. In patients with cervical cancer, we observed that monocyte derived DCs are tolerogenic, inhibiting allogeneic T cell activation compared to the same population obtained from patients with precursor lesions or cervicitis. In this work, we show that B lymphocytes from cervical cancer patients respond to treatment with sCD40L and IL-4 by increasing the CD80(+)CD86(+) population, therefore potentially increasing their ability to activate T cells. To test if B lymphocytes could actually trigger anti-tumor T cell responses, we designed an experimental model where we harvested T and B lymphocytes, or dendritic cells, from tumor bearing donors, and after APC stimulation, transplanted them, together with T cells into RAG1(-/-) recipients, previously injected with tumor cells. We were able to show that anti-CD40 activated B lymphocytes could trigger secondary T cell responses, dependent on MHC-II expression. Moreover, we showed that dendritic cells were resistant to the anti-CD40 treatment and unable to stimulate anti-tumor responses. In summary, our results suggest that B lymphocytes may be used as a tool for immunotherapy against cancer.	[Marques Rossetti, Renata Ariza; Lepique, Ana Paula] Univ Sao Paulo, Inst Ciencias Biomed, Dept Immunol, Sao Paulo, Brazil; [Cristina Lorenzi, Noely Paula; Yokochi, Kaori; Ramos Margarido, Paulo Francisco; Baracat, Edmund Chada] Univ Sao Paulo, Hosp Univ, Sao Paulo, Brazil; [Sartor de Faria Rosa, Maria Beatriz; Baracat, Edmund Chada; Carvalho, Jesus Paula; Villa, Luisa Lina] Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil; [Benevides, Luciana] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Immunol & Biochem, Ribeirao Preto, Brazil; [Villa, Luisa Lina] Univ Sao Paulo, Fac Med, Inst Radiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Lepique, AP (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Immunol, Sao Paulo, Brazil.	alepique@icb.usp.br	CARVALHO, JESUS PAULA/G-8387-2018; VILLA, LUISA/AAH-4761-2019; Baracat, Edmund C/H-3800-2012; Lepique, Ana Paula/T-2427-2019; Carvalho, Jesus Paula/O-7464-2019; Lepique, Ana Paula/D-5878-2013	CARVALHO, JESUS PAULA/0000-0003-4495-057X; VILLA, LUISA/0000-0003-4074-2335; Baracat, Edmund C/0000-0003-0111-9030; Lorenzi, Noely Paula/0000-0001-8144-1745; Lepique, Ana Paula/0000-0002-4707-2912	Sao Paulo Research Foundation [11/11121-8, 04/00749-2, 10/20010-2, 14/19326-6]; Universidade de Sao Paulo through the NUSCEP; Brazilian National Counsel of Technological and Scientific Development though INCT-HPV [573799/2008-3]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Universidade de Sao Paulo through the NUSCEP; Brazilian National Counsel of Technological and Scientific Development though INCT-HPV	RAMR had a PhD fellowship from the Sao Paulo Research Foundation (process 11/11121-8). This project was funded by the Sao Paulo Research Foundation (processes 04/00749-2, 10/20010-2, 14/19326-6) to APL. We also had a grant from the Universidade de Sao Paulo, through the NUSCEP to APL, and from the Brazilian National Counsel of Technological and Scientific Development, though INCT-HPV, grant 573799/2008-3 to LLV.	Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; [Anonymous], 2007, IARC MON HUM PAP, V90; Bethune MT, 2017, CURR OPIN BIOTECH, V48, P142, DOI 10.1016/j.copbio.2017.03.024; Bishop G. A, 2013, CYT GROWTH FACTOR RE, V14, P297; Boccardo E, 2010, CARCINOGENESIS, V31, P1905, DOI 10.1093/carcin/bgq176; Bolpetti A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-27; Cenni B, 2012, INT REV IMMUNOL, V31, P166, DOI 10.3109/08830185.2012.663838; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Doan T, 2000, CANCER RES, V60, P2810; Alvarez KLF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09079-3; Filley AC, 2017, J NEURO-ONCOL, V133, P223, DOI 10.1007/s11060-017-2446-4; FUCHS EJ, 1992, SCIENCE, V258, P1156, DOI 10.1126/science.1439825; Gunderson AJ, 2013, EXP CELL RES, V319, P1644, DOI 10.1016/j.yexcr.2013.03.005; Hodson DJ, 2009, ADV EXP MED BIOL, V633, P43, DOI 10.1007/978-0-387-79311-5_5; Horn T, 2016, WORLD J UROL, V34, P181, DOI 10.1007/s00345-015-1615-3; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kim S, 2008, J IMMUNOTHER, V31, P446, DOI 10.1097/CJI.0b013e31816d1d6a; Lepique AP, 2009, CLIN CANCER RES, V15, P4391, DOI 10.1158/1078-0432.CCR-09-0489; Lin KY, 1996, CANCER RES, V56, P21; Mabuchi S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju147; Mabuchi S, 2011, GYNECOL ONCOL, V122, P25, DOI 10.1016/j.ygyno.2011.03.037; Molina-Cerrillo J, 2017, CANCER TREAT REV, V58, P41, DOI 10.1016/j.ctrv.2017.06.001; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Montag DT, 2006, CLIN IMMUNOL, V121, P215, DOI 10.1016/j.clim.2006.06.013; MORRIS SC, 1994, J IMMUNOL, V152, P3777; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Nishijima TF, 2015, CANCER TREAT REV, V41, P971, DOI 10.1016/j.ctrv.2015.10.003; Ostrand-Rosenberg S, 2018, J IMMUNOL, V200, P422, DOI 10.4049/jimmunol.1701019; Piersma SJ, 2007, CANCER RES, V67, P354, DOI 10.1158/0008-5472.CAN-06-3388; Preston CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080063; Ramos RN, 2012, J LEUKOCYTE BIOL, V92, P673, DOI 10.1189/jlb.0112048; Ren HY, 2014, J IMMUNOTHER, V37, P383, DOI 10.1097/CJI.0000000000000051; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Rosenberg SA, 2004, P NATL ACAD SCI USA, V101, P14639, DOI 10.1073/pnas.0405730101; Schiffman M, 2013, CANCER EPIDEM BIOMAR, V22, P553, DOI 10.1158/1055-9965.EPI-12-1406; Shen M, 2016, ONCOTARGET, V7, P55828, DOI 10.18632/oncotarget.10094; Sicard A, 2016, NANO LETT, V16, P297, DOI 10.1021/acs.nanolett.5b03801; Sigfrid L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181156; Soong RS, 2014, CLIN CANCER RES, V20, P5456, DOI 10.1158/1078-0432.CCR-14-0344; Stone SC, 2014, IMMUN INFLAMM DIS, V2, P63, DOI 10.1002/iid3.21; Stone SC, 2014, J LEUKOCYTE BIOL, V96, P619, DOI 10.1189/jlb.3A0513-282R; Tadmor T, 2011, CANCER IMMUNOL IMMUN, V60, P609, DOI 10.1007/s00262-011-0972-z; Thaunat O, 2010, BLOOD, V116, P515, DOI 10.1182/blood-2010-01-266668; UCKER DS, 1992, J IMMUNOL, V149, P1583; van der Burg SH, 2007, P NATL ACAD SCI USA, V104, P12087, DOI 10.1073/pnas.0704672104; van Steenwijk PJD, 2010, CANCER RES, V70, P2707, DOI 10.1158/0008-5472.CAN-09-4299; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	49	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199034	10.1371/journal.pone.0199034	http://dx.doi.org/10.1371/journal.pone.0199034			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975708	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500019
J	Sahin, A; Sanchez, C; Bullain, S; Waterman, P; Weissleder, R; Carter, BS				Sahin, Ayguen; Sanchez, Carlos; Bullain, Szofia; Waterman, Peter; Weissleder, Ralph; Carter, Bob S.			Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-\-expressing artificial antigen presenting cells for adoptive cell therapy for glioma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HEMATOLOGIC MALIGNANCIES; GLIOBLASTOMA-MULTIFORME; CD28 COSTIMULATION; SUICIDE-GENE; STEM-CELLS; IMMUNOTHERAPY; CANCER; INTERLEUKIN-2; EXPANSION	Glioblastoma multiforme (GBM) is the most aggressive and deadly form of adult brain cancer. Despite of many attempts to identify potential therapies for this disease, including promising cancer immunotherapy approaches, it remains incurable. To address the need of improved persistence, expansion, and optimal antitumor activity of T-cells in the glioma milieu, we have developed an EGFRvIII-specific third generation (G3-EGFRvIII) chimeric antigen receptor (CAR) that expresses both co-stimulatory factors CD28 and OX40 (MR1-CD8TM-CD28-OX40-CD3 zeta). To enhance ex vivo target specific activation and optimize T-cell culturing conditions, we generated artificial antigen presenting cell lines (aAPC) expressing the extracellular and transmembrane domain of EGFRvIII (EGFRVIII Delta 654) with costimulatory molecules including CD32, CD80 and 4-1BBL (EGFRVIII Delta 654 aAPC and CD32-80-137L-EGFRVIII Delta 654 aAPC). We demonstrate that the highest cell growth was achieved when G3-EGFRvIII CAR T-cells were cocultured with both co-stimulatory aAPCs and with exposure to EGFRvIII (CD32-80-137L-EGFRVIII Delta 654 aAPCs) in culturing periods of three to six weeks. G3-EGFRvIII CAR T-cells showed an increased level of IFN-gamma when cocultured with CD32-80-137L-EGFRVIII Delta 654 aAPCs. Evaluation of G3-EGFRvIII CAR T-cells in an orthotropic human glioma xenograft model demonstrated a prolonged survival of G3-EGFRvIII CAR treated mice compared to control mice. Importantly, we observed survival of G3-EGFRvIII CAR T-cells within the tumor as long as 90 days after implantation in low-dose and single administration, accompanied by a marked tumor stroma demolition. These findings suggest that G3-EGFRvIII CAR cocultured with CD32-80-137L-EGFRVIII Delta 654 aAPCs warrants itself as a potential anti-tumor therapy strategy for glioblastoma.	[Sahin, Ayguen; Sanchez, Carlos; Bullain, Szofia; Carter, Bob S.] Massachusetts Gen Hosp, Dept Neurosurg, HMS MGH Ctr Nervous Syst Repair, Boston, MA 02114 USA; [Waterman, Peter; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Sahin, Ayguen] Canc Educ & Res Inst, Cambridge, MA 02140 USA; [Sanchez, Carlos] Univ New Mexico, Albuquerque, NM 87131 USA; [Bullain, Szofia] Univ Calif Irvine, Irvine, CA USA; [Waterman, Peter] DNANexus, Mountain View, CA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of New Mexico; University of California System; University of California Irvine	Sahin, A (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, HMS MGH Ctr Nervous Syst Repair, Boston, MA 02114 USA.; Sahin, A (corresponding author), Canc Educ & Res Inst, Cambridge, MA 02140 USA.	ayguensahin@gmail.com	Carter, Bob/AAB-4868-2021	Carter, Bob/0000-0002-3586-1324	Andrew Schabow American Brain Tumor Association Fellowship; National Institute of Health (NIH) T32 [5T32 CA071345-12]; DNANexus; NATIONAL CANCER INSTITUTE [P01CA069246, T32CA071345] Funding Source: NIH RePORTER	Andrew Schabow American Brain Tumor Association Fellowship; National Institute of Health (NIH) T32; DNANexus; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	BSC was supported by National Institute of Health (NIH)/National Cancer Institute (NCI) CA 69246 P01 grant "Gene Therapy for Brain Tumors" (https.//grants.nih.govig rants/funding/ac search results.litm?text_curr=p01); Goldhirsh Foundation in memory of Bernie Goldhirsh (http.//www.goldhirshtoundation.org); and The Brain Tumor Society (http://braintumor.org). AS was supported by Andrew Schabow American Brain Tumor Association Fellowship (http://www.abta.org). CS was supported by National Institute of Health (NIH) T32 training grant, 5T32 CA071345-12 (https://grants.nih.gov/grants/funding/ac_search_results.htm?textcurr432). Author Peter Waterman currently receives salary from DNANexus, a genome informatics and data management platform, and owns stocks in PerkinElmer, a multinational corporation focused in the business areas of human and environmental health. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2010, CLIN CANCER RES, V16, P474, DOI 10.1158/1078-0432.CCR-09-1322; Akiba H, 1999, J IMMUNOL, V162, P7058; Bachmann MF, 2007, EMBO REP, V8, P1142, DOI 10.1038/sj.embor.7401099; Brown CE, 2005, J IMMUNOL METHODS, V297, P39, DOI 10.1016/j.jim.2004.11.021; Brown CE, 2015, CLIN CANCER RES, V21, P4062, DOI 10.1158/1078-0432.CCR-15-0428; Bullain SS, 2009, J NEURO-ONCOL, V94, P373, DOI 10.1007/s11060-009-9889-1; Chen AI, 1999, IMMUNITY, V11, P689, DOI 10.1016/S1074-7613(00)80143-0; Davila ML, 2014, INT J HEMATOL, V99, P361, DOI 10.1007/s12185-013-1479-5; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; EKSTRAND AJ, 1994, ONCOGENE, V9, P2313; Griffioen M, 2009, HAEMATOL-HEMATOL J, V94, P1316, DOI 10.3324/haematol.2008.001677; Heimberger AB, 2003, CLIN CANCER RES, V9, P4247; Hombach A, 2001, CANCER RES, V61, P1976; Hombach AA, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19855; Hombach AA, 2011, INT J CANCER, V129, P2935, DOI 10.1002/ijc.25960; Jensen MC, 2000, MOL THER, V1, P49, DOI 10.1006/mthe.1999.0012; Jensen MC, 2010, BIOL BLOOD MARROW TR, V16, P1245, DOI 10.1016/j.bbmt.2010.03.014; Kahlon KS, 2004, CANCER RES, V64, P9160, DOI 10.1158/0008-5472.CAN-04-0454; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Lal A, 2002, CANCER RES, V62, P3335; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Lammering G, 2004, CLIN CANCER RES, V10, P6732, DOI 10.1158/1078-0432.CCR-04-0393; Lotze MT, 2012, AUTOPHAGY, V8, P1264, DOI 10.4161/auto.20752; Maher J., 2012, ISRN ONCOL, V2012, P1; Marin V, 2012, HUM GENE THER METHOD, V23, P376, DOI 10.1089/hgtb.2012.050; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Moeller M, 2007, CANCER RES, V67, P11428, DOI 10.1158/0008-5472.CAN-07-1141; Morgan RA, 2012, HUM GENE THER, V23, P1043, DOI 10.1089/hum.2012.041; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Murphy GJ, 2006, NAT MED, V12, P1093, DOI 10.1038/nm1376; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Ohno M, 2010, CANCER SCI, V101, P2518, DOI 10.1111/j.1349-7006.2010.01734.x; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Priceman SJ, 2015, CURR OPIN ONCOL, V27, P466, DOI 10.1097/CCO.0000000000000232; Pule MA, 2005, MOL THER, V12, P933, DOI 10.1016/j.ymthe.2005.04.016; Ramos CA, 2011, EXPERT OPIN BIOL TH, V11, P855, DOI 10.1517/14712598.2011.573476; Sampson JH, 2014, CLIN CANCER RES, V20, P972, DOI 10.1158/1078-0432.CCR-13-0709; Sampson JH, 2009, MOL CANCER THER, V8, P2773, DOI 10.1158/1535-7163.MCT-09-0124; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Song DG, 2011, CANCER RES, V71, P4617, DOI 10.1158/0008-5472.CAN-11-0422; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Szentirmai O, 2006, NEUROSURGERY, V58, P365, DOI 10.1227/01.NEU.0000195114.24819.4F; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; Wilkie S, 2012, J CLIN IMMUNOL, V32, P1059, DOI 10.1007/s10875-012-9689-9; Yvon E, 2009, CLIN CANCER RES, V15, P5852, DOI 10.1158/1078-0432.CCR-08-3163	48	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199414	10.1371/journal.pone.0199414	http://dx.doi.org/10.1371/journal.pone.0199414			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975720	Green Submitted, gold, Green Published			2022-12-26	WOS:000437424500031
J	Abe, K; Takahashi, A; Fujita, M; Imaizumi, H; Hayashi, M; Okai, K; Ohira, H				Abe, Kazumichi; Takahashi, Atsushi; Fujita, Masashi; Imaizumi, Hiromichi; Hayashi, Manabu; Okai, Ken; Ohira, Hiromasa			Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease	PLOS ONE			English	Article							REGULATORY T-CELLS; GUT MICROBIOTA; MEDICAL PROGRESS; MOUSE MODEL; INDUCTION; HEPATITIS; BACTERIA; HEALTH; METABOLISM; PROFILES	The gut microbiota has recently been recognized to play a role in the pathogenesis of autoimmune liver disease (AILD), mainly primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH). This study aimed to analyze and compare the composition of the oral microbiota of 56 patients with AILD and 15 healthy controls (HCs) and to evaluate its association with salivary immunological biomarkers and gut microbiota. The subjects included 39 patients with PBC and 17 patients with AIH diagnosed at our hospital. The control population comprised 15 matched HCs. Salivary and fecal samples were collected for analysis of the microbiome by terminal restriction fragment length polymorphism of 16S rDNA. Correlations between immunological biomarkers measured by Bio-Plex assay (Bio-Rad) and the oral microbiomes of patients with PBC and AIH were assessed. Patients with AIH showed a significant increase in Veillonella with a concurrent decrease in Streptococcus in the oral microbiota compared with the HCs. Patients with PBC showed significant increases in Eubacterium and Veillonella and a significant decrease in Fusobacterium in the oral microbiota compared with the HCs. Immunological biomarker analysis showed elevated levels of inflammatory cytokines (IL-1 beta, IFN-gamma, TNF-alpha, IL-8) and immunoglobulin A in the saliva of patients with AILD. The relative abundance of Veillonella was positively correlated with the levels of IL-1 beta, IL-8 and immunoglobulin A in saliva and the relative abundance of Lactobacillales in feces. Dysbiosis of the oral microbiota is associated with inflammatory responses and reflects changes in the gut microbiota of patients with AILD. Dysbiosis may play an important role in the pathogenesis of AILD.	[Abe, Kazumichi; Takahashi, Atsushi; Fujita, Masashi; Imaizumi, Hiromichi; Hayashi, Manabu; Okai, Ken; Ohira, Hiromasa] Fukushima Med Univ, Dept Gastroenterol, Sch Med, Fukushima, Japan; [Abe, Kazumichi] Hanawa Kosei Hosp, Dept Internal Med, Higashishirakawa, Japan	Fukushima Medical University	Abe, K (corresponding author), Fukushima Med Univ, Dept Gastroenterol, Sch Med, Fukushima, Japan.; Abe, K (corresponding author), Hanawa Kosei Hosp, Dept Internal Med, Higashishirakawa, Japan.	k-abe@fmu.ac.jp		Abe, Kazumichi/0000-0001-5359-9465				Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Atarashi K, 2017, SCIENCE, V358, P359, DOI 10.1126/science.aan4526; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Bajaj JS, 2015, HEPATOLOGY, V62, P1260, DOI 10.1002/hep.27819; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Berer K, 2017, P NATL ACAD SCI USA, V114, P10719, DOI 10.1073/pnas.1711233114; Cekanaviciute E, 2017, P NATL ACAD SCI USA, V114, P10713, DOI 10.1073/pnas.1711235114; Curtis MA, 2011, CELL HOST MICROBE, V10, P302, DOI 10.1016/j.chom.2011.09.008; Czaja AJ, 2016, WORLD J GASTROENTERO, V22, P9257, DOI 10.3748/wjg.v22.i42.9257; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Farnaud SJC, 2010, THESCIENTIFICWORLDJO, V10, P434, DOI 10.1100/tsw.2010.38; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Heller D, 2012, ARCH ORAL BIOL, V57, P973, DOI 10.1016/j.archoralbio.2012.02.003; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Hosomi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04511-0; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; JOHNSON PJ, 1993, HEPATOLOGY, V18, P998, DOI 10.1002/hep.1840180435; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Krawitt EL, 1996, NEW ENGL J MED, V334, P897, DOI 10.1056/NEJM199604043341406; Kummen M, 2017, GUT, V66, P611, DOI 10.1136/gutjnl-2015-310500; Li Y, 2017, AUTOIMMUN REV, V16, P885, DOI 10.1016/j.autrev.2017.07.002; Lin R, 2015, INT J CLIN EXP PATHO, V8, P5153; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Longhi MS, 2006, J IMMUNOL, V176, P4484, DOI 10.4049/jimmunol.176.7.4484; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Lu C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00906-1; Lv LX, 2016, ENVIRON MICROBIOL, V18, P2272, DOI 10.1111/1462-2920.13401; Matera G, 2009, CLIN VACCINE IMMUNOL, V16, P1804, DOI 10.1128/CVI.00310-09; MAYS TD, 1982, ANTIMICROB AGENTS CH, V21, P110, DOI 10.1128/AAC.21.1.110; Mishiro T, 2017, J GASTROEN HEPATOL, V4, DOI [10.1111/jgh.14040, DOI 10.1111/JGH.14040]; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Nagashima K., 2006, Bioscience and Microflora, V25, P99; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Phillips Robert, 2015, Nat Rev Rheumatol, V11, P502, DOI 10.1038/nrrheum.2015.109; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Said HS, 2014, DNA RES, V21, P15, DOI 10.1093/dnares/dst037; Sakamoto M, 2004, J MED MICROBIOL, V53, P563, DOI 10.1099/jmm.0.45576-0; SCHEUER PJ, 1967, P ROY SOC MED, V60, P1257, DOI 10.1177/003591576706001205; Selmi C, 2011, LANCET, V377, P1600, DOI 10.1016/S0140-6736(10)61965-4; Shimizu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153746; Siddiqui H, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.31119; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Tang RQ, 2018, GUT, V67, P534, DOI 10.1136/gutjnl-2016-313332; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yuksel M, 2015, HEPATOLOGY, V62, P1536, DOI 10.1002/hep.27998; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914	52	41	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0198757	10.1371/journal.pone.0198757	http://dx.doi.org/10.1371/journal.pone.0198757			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969462	Green Submitted, Green Published, gold			2022-12-26	WOS:000437246700006
J	Fan, L; Lukin, B; Zhao, JZ; Sun, JD; Dingle, K; Purtill, R; Tapp, S; Hou, XY				Fan, Lijun; Lukin, Bill; Zhao, Jingzhou; Sun, Jiandong; Dingle, Kaeleen; Purtill, Rhonda; Tapp, Sam; Hou, Xiang-Yu			Cost analysis of improving emergency care for aged care residents under a Hospital in the Nursing Home program in Australia	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MINIMIZATION ANALYSIS; PATIENT TRANSFER; OUTCOMES; APPROPRIATENESS; FACILITIES; TRANSFERS; DECISION; SERVICES	Background This study aims to examine the costs associated with a Hospital in the Nursing Home (HiNH) program in Queensland Australia directed at patients from residential aged care facilities (RACFs) with emergency care needs. Methods A cost analysis was undertaken comparing the costs under the HiNH program and the current practice, in parallel with a pre-post controlled study design. The study was conducted in two Queensland public hospitals: the Royal Brisbane and Women's Hospital (intervention hospital) and the Logan Hospital (control hospital). Main outcome measures were the associated incremental costs or savings concerning the HiNH program provision and the acute hospital care utilisation over one year after intervention. Results The initial deterministic analysis calculated the total induced mean costs associated with providing the HiNH program over one year as AU$488,116, and the total induced savings relating to acute hospital care service utilisation of AU$8,659,788. The total net costs to the health service providers were thus calculated at -AU$8,171,671 per annum. Results from the probabilistic sensitivity analysis (based on 10,000 simulations) showed the mean and median annual net costs associated with the HiNH program implementation were -AU $8,444,512 and-AU$8,202,676, and a standard deviation of 2,955,346. There was 95% certainty that the values of net costs would fall within the range from -AU$15,018,055 to -AU $3,358,820. Conclusions The costs relating to implementing the HiNH program appear to be much less than the savings in terms of associated decreases in acute hospital service utilisation. The HiNH service model is likely to have the cost-saving potential while improving the emergency care provision for RACF residents.	[Fan, Lijun] Sun Yat Sen Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Guangzhou, Guangdong, Peoples R China; [Fan, Lijun; Dingle, Kaeleen; Hou, Xiang-Yu] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia; [Lukin, Bill; Purtill, Rhonda; Tapp, Sam] Royal Brisbane & Womens Hosp, Dept Emergency Med, Brisbane, Qld, Australia; [Zhao, Jingzhou] Bur Investment Promot, Wuwei City, Gansu, Peoples R China; [Sun, Jiandong] Queensland Hlth, Brisbane, Qld, Australia	Sun Yat Sen University; Queensland University of Technology (QUT); Royal Brisbane & Women's Hospital; Queensland Health	Fan, L (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Guangzhou, Guangdong, Peoples R China.; Fan, L (corresponding author), Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia.	keirafanlj@163.com	Dingle, Kaeleen/G-4885-2010; Hou, Xiang-Yu Xiang-Yu/ACA-6525-2022	Dingle, Kaeleen/0000-0001-8210-8194; Lukin, William/0000-0001-8531-2529; Hou, Xiang-Yu/0000-0002-2015-3579; Fan, Lijun/0000-0001-5863-0169	Queensland Emergency Medicine Research Foundation (QEMRF) [QEMRF-PORJ-2009-014]; Natural Science Foundation of China [NSFC 71704192]	Queensland Emergency Medicine Research Foundation (QEMRF); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Queensland Emergency Medicine Research Foundation (QEMRF) (Project ID: QEMRF-PORJ-2009-014, Title: A Comprehensive Evaluation of a Hospital in Nursing Home Program in Three Queensland Hospitals, URL: http://emergencyfoundation.org.au/) to BL and the Natural Science Foundation of China (Grant No.: NSFC 71704192) to LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2014, AUSTR HLTH 2014; Arendts G, 2013, GERIATR GERONTOL INT, V13, P825, DOI 10.1111/ggi.12053; Arendts G, 2010, AUSTRALAS J AGEING, V29, P61, DOI 10.1111/j.1741-6612.2009.00415.x; Australian Institute of Health and Welfare (AIHW), 2012, AUSTR HOSP STAT 2011; BECK-FRIIS B, 1991, Scandinavian Journal of Primary Health Care, V9, P259, DOI 10.3109/02813439109018529; BERGMAN H, 1991, J AM GERIATR SOC, V39, P1164, DOI 10.1111/j.1532-5415.1991.tb03568.x; Board N, 2000, AUST NZ J PUBL HEAL, V24, P305, DOI 10.1111/j.1467-842X.2000.tb01573.x; Coast J, 1998, BRIT MED J, V316, P1802, DOI 10.1136/bmj.316.7147.1802; Codde J, 2010, AUSTRALAS J AGEING, V29, P150, DOI 10.1111/j.1741-6612.2010.00418.x; Crilly J, 2011, J CLIN NURS, V20, P1178, DOI 10.1111/j.1365-2702.2010.03371.x; DRANOVE D, 1985, INQUIRY-J HEALTH CAR, V22, P59; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Faddy M, 2009, VALUE HEALTH, V12, P309, DOI 10.1111/j.1524-4733.2008.00421.x; Fan LJ, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1275-z; Fan LJ, 2015, EMERG MED J, V32, P738, DOI 10.1136/emermed-2014-203770; Grabowski DC, 2007, HEALTH AFFAIR, V26, P1753, DOI 10.1377/hlthaff.26.6.1753; Gray LC, 2009, MED J AUSTRALIA, V191, P605, DOI 10.5694/j.1326-5377.2009.tb03345.x; Hensher M, 1996, J ROY SOC MED, V89, P548, DOI 10.1177/014107689608901003; HUGHES SL, 1992, HEALTH SERV RES, V26, P801; IHPA, 2012, NAT HOSP COST DAT CO; Inglada V, 2007, CONTRIB ECON, P1, DOI 10.1007/978-3-7908-1765-2; Jones J, 1999, BMJ-BRIT MED J, V319, P1547, DOI 10.1136/bmj.319.7224.1547; Jones JS, 1997, ACAD EMERG MED, V4, P908, DOI 10.1111/j.1553-2712.1997.tb03818.x; MacIntyre CR, 2002, INT J QUAL HEALTH C, V14, P285, DOI 10.1093/intqhc/14.4.285; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Queensland Government, 2012, DEP COMM SAF ANN REP; Rajacich D L, 1995, J Gerontol Nurs, V21, P36; Robinson JC, 2008, HEALTH AFFAIR, V27, P1353, DOI 10.1377/hlthaff.27.5.1353; Saliba D, 2000, J AM GERIATR SOC, V48, P154, DOI 10.1111/j.1532-5415.2000.tb03906.x; Shepperd S, 1998, BRIT MED J, V316, P1791, DOI 10.1136/bmj.316.7147.1791	30	1	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199879	10.1371/journal.pone.0199879	http://dx.doi.org/10.1371/journal.pone.0199879			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL5XD	29969468	gold, Green Published, Green Accepted			2022-12-26	WOS:000437246700033
J	Stander, BA; van Vollenstee, FA; Kallmeyer, K; Potgieter, M; Joubert, A; Swanepoel, A; Kotze, L; Moolman, S; Pepper, MS				Stander, Barend Andre; van Vollenstee, Fiona A.; Kallmeyer, Karlien; Potgieter, Marnie; Joubert, Annie; Swanepoel, Andri; Kotze, Lara; Moolman, Sean; Pepper, Michael S.			An in vitro and in vivo study on the properties of hollow polycaprolactone cell-delivery particles	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SOFT-TISSUE FILLERS; DERMAL FILLERS; BIODEGRADABLE POLYMERS; HYALURONIC-ACID; QUANTIFICATION; MICROPARTICLES; SAFETY	The field of dermal fillers is evolving rapidly and numerous products are currently on the market. Biodegradable polymers such as polycaprolactone (PCL) have been found to be compatible with several body tissues, and this makes them an ideal material for dermal filling purposes. Hollow PCL spheres were developed by the Council for Scientific and Industrial Research (CSIR) to serve both as an anchor point and a "tissue harbour" for cells. Particles were tested for cytotoxicity and cell adherence using mouse embryo fibroblasts (MEF). MEFs adhered to the particles and no significant toxic effects were observed based on morphology, cell growth, cell viability and cell cycle analysis, suggesting that the particles are suitable candidates for cell delivery systems in an in vivo setting. The objective of providing a "tissue harbour" was however not realized, as cells did not preferentially migrate into the ported particles. In vivo studies were conducted in BALB/c mice into whom particles were introduced at the level of the hypodermis. Mice injected with PCL particles (ported and non-ported; with or without MEFs) showed evidence of local inflammation and increased adipogenesis at the site of injection, as well as a systemic inflammatory response. These effects were also observed in mice that received apparently inert (polystyrene) particles. Ported PCL particles can therefore act as a cell delivery system and through their ability to induce adipogenesis, may also serve as a dermal bulking agent.	[Stander, Barend Andre; Joubert, Annie] Univ Pretoria, Fac Med, Dept Physiol, Pretoria, South Africa; [van Vollenstee, Fiona A.; Kallmeyer, Karlien; Potgieter, Marnie; Pepper, Michael S.] Univ Pretoria, Fac Med, Inst Cellular & Mol Med, Dept Immunol, Pretoria, South Africa; [van Vollenstee, Fiona A.; Kallmeyer, Karlien; Potgieter, Marnie; Pepper, Michael S.] Univ Pretoria, Fac Med, SAMRC Extramural Unit Stem Cell Res & Therapy, Pretoria, South Africa; [Swanepoel, Andri; Kotze, Lara; Moolman, Sean] CSIR, Mat Sci & Mfg, Polymers & Composites Competency Area, Pretoria, South Africa	University of Pretoria; University of Pretoria; University of Pretoria; Council for Scientific & Industrial Research (CSIR) - South Africa	Pepper, MS (corresponding author), Univ Pretoria, Fac Med, Inst Cellular & Mol Med, Dept Immunol, Pretoria, South Africa.; Pepper, MS (corresponding author), Univ Pretoria, Fac Med, SAMRC Extramural Unit Stem Cell Res & Therapy, Pretoria, South Africa.	michael.pepper@up.ac.za	Pepper, Michael S./M-6143-2014	Pepper, Michael S./0000-0001-6406-2380; Swanepoel, Andri/0000-0002-2253-5466; Moolman, Sean/0000-0002-3788-8221	Council for Scientific and Industrial Research, South Africa; Institute for Cellular and Molecular Medicine of the University of Pretoria; Medical Research Council of South Africa [SAMRC-RFA-UFSP-01-2013/STEM CELLS]; Medical Research Council of South Africa (SAMRC Extramural Unit for Stem Cell Research and Therapy); South African Medical Research Council [SAMRC-RFA-UFSP-01-2013/STEM CELLS]; South African Medical Research Council (SAMRC Extramural Unit for Stem Cell Research and Therapy)	Council for Scientific and Industrial Research, South Africa(Council of Scientific & Industrial Research (CSIR) - India); Institute for Cellular and Molecular Medicine of the University of Pretoria; Medical Research Council of South Africa(South African Medical Research Council); Medical Research Council of South Africa (SAMRC Extramural Unit for Stem Cell Research and Therapy); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African Medical Research Council (SAMRC Extramural Unit for Stem Cell Research and Therapy)	This work was funded by the Council for Scientific and Industrial Research, South Africa, by the Institute for Cellular and Molecular Medicine of the University of Pretoria and by the Medical Research Council of South Africa (Flagship Award SAMRC-RFA-UFSP-01-2013/STEM CELLS and the SAMRC Extramural Unit for Stem Cell Research and Therapy).r This work was funded by the Council for Scientific and Industrial Research, South Africa, by the Institute for Cellular and Molecular Medicine of the University of Pretoria and by the South African Medical Research Council (Flagship Award SAMRC-RFA-UFSP-01-2013/STEM CELLS and the SAMRC Extramural Unit for Stem Cell Research and Therapy). We would like to thank Professor Resia Pretorius from the Department of Physiological Sciences at the University of Stellenbosch for her assistance and guidance associated with the in vitro and in vivo morphology studies.	Alijotas-Reig J, 2013, SEMIN ARTHRITIS RHEU, V43, P241, DOI 10.1016/j.semarthrit.2013.02.001; Allen Matthew, 1994, Clinical Materials, V16, P189; Ammala A, 2013, INT J COSMETIC SCI, V35, P113, DOI 10.1111/ics.12017; [Anonymous], 2013, CLIN COSMET INVESTIG, DOI DOI 10.2147/CCID.S35251; ASPS, 2012 PLAST SURG PROC; Bacakova L, 2004, PHYSIOL RES, V53, pS35; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chen DR, 2000, POLYM DEGRAD STABIL, V67, P455, DOI 10.1016/S0141-3910(99)00145-7; Danz R, 2004, PLASDIC A USEFUL MOD; Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064; De Boulle Koenraad, 2004, J Cosmet Dermatol, V3, P2, DOI 10.1111/j.1473-2130.2004.00058.x; De Boulle K, 2013, DERMATOL SURG, V39, P1758, DOI 10.1111/dsu.12301; Doppalapudi S, 2014, POLYM ADVAN TECHNOL, V25, P427, DOI 10.1002/pat.3305; Figueiredo VM, 2013, J COSMET DERMATOL-US, V12, P73, DOI 10.1111/jocd.12020; Freshney R., 1995, ANIMAL CELL CULTURES; Funt D, 2013, CLIN COSMET INVESTI, V6, P295, DOI 10.2147/CCID.S50546; Gilbert E, 2014, J DRUGS DERMATOL, V13, P67; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Hayes T L, 1968, Adv Biol Med Phys, V12, P85; Huang S, 2012, J DERMATOL SCI, V66, P29, DOI 10.1016/j.jdermsci.2012.02.002; Huang XL, 2013, EUR J DERMATOL, V23, P592, DOI 10.1684/ejd.2013.2151; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Kruglikov IL, 2015, EXP DERMATOL, V24, P912, DOI 10.1111/exd.12852; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Kulichova D, 2014, EXPERT OPIN DRUG SAF, V13, P1215, DOI 10.1517/14740338.2014.939168; Laeschke K, 2004, SEMIN CUTAN MED SURG, V23, P214, DOI 10.1016/j.sder.2004.09.005; Naidoo K, 2008, MATER LETT, V62, P252, DOI 10.1016/j.matlet.2007.05.012; Pretorius E, 2007, EXP TOXICOL PATHOL, V59, P105, DOI 10.1016/j.etp.2007.02.011; Steynberg T., 2010, COMP IN VITRO EFFECT; Steynberg T, 2012, BIOMEDICAL RES, V23; Strober W, 2001, CURR PROTOC IMMUNO B, V3, p3B; Tran C, 2014, DERMATOLOGY, V228, P47, DOI 10.1159/000354384; Vine AK, 2009, RETINA-J RET VIT DIS, V29, P1, DOI 10.1097/IAE.0b013e31819091dc; Wollina U, 2013, CLIN DERMATOL, V31, P731, DOI [10.1016/j.clindermato1.2013.05.010, 10.1016/j.clindermatol.2013.05.010]	34	6	6	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0198248	10.1371/journal.pone.0198248	http://dx.doi.org/10.1371/journal.pone.0198248			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969443	Green Published, Green Submitted, gold			2022-12-26	WOS:000437246700002
J	Chen, YY; Fang, WH; Wang, CC; Kao, TW; Chang, YW; Yang, HF; Wu, CJ; Sun, YS; Chen, WL				Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Yang, Hui-Fang; Wu, Chen-Jung; Sun, Yu-Shan; Chen, Wei-Liang			Increased body fat percentage in patients with hepatitis B and C virus infection	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; LIVER FIBROSIS PROGRESSION; DIABETES-MELLITUS; NONALCOHOLIC STEATOHEPATITIS; NATURAL-HISTORY; RISK-FACTORS; RESISTANCE; DISEASE; PREVALENCE; MECHANISMS	Accumulated evidence has suggested associations between glucose abnormalities and insulin resistance with hepatitis C virus (HCV) and hepatitis B virus (HBV) infections. However, few studies have reported the effect of hepatitis virus infections on body composition. Our aim was to explore the association of hepatitis virus infections with percent body fat (PBF) in a cross-sectional analysis. A total of 69226 subjects obtained from the health examinations at Tri-Service General Hospital (TSGH) from 2010 to 2016 were enrolled in the study. Participants were divided into subgroups based on the presence of hepatitis B surface antigen (HBsAg) and anti-HCV. PBF was measured by bioelectrical impedance analysis (BIA). A multivariable linear regression model was applied to test the association of hepatitis virus infections with PBF and glycemic status. In male participants, hepatitis virus infections were closely associated with increased PBF, especially in those subjects with HCV/HBV coinfection. HCV/HBV coinfection was positively correlated with fasting plasma glucose and postprandial glucose while HCV and HBV mono-infection were not. The impact of hepatitis virus infection on increased PBF was observed in general population with gender difference. A further study on the treatment of hepatitis virus infection might help prevent the development of obesity-related diseases.	[Chen, Yuan-Yuei] Tri Serv Gen Hosp, Dept Internal Med, Songshan Branch, Taipei, Taiwan; [Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Yang, Hui-Fang; Wu, Chen-Jung; Sun, Yu-Shan; Chen, Wei-Liang] Tri Serv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Yang, Hui-Fang; Wu, Chen-Jung; Sun, Yu-Shan; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Kao, Tung-Wei; Chang, Yaw-Wen; Yang, Hui-Fang; Wu, Chen-Jung; Sun, Yu-Shan; Chen, Wei-Liang] Tri Serv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Kao, Tung-Wei] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Wu, Chen-Jung] Taoyuan Armed Forces Gen Hosp, Dept Community Med, Div Family Med, Taoyuan, Taiwan	Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Taiwan University	Chen, WL (corresponding author), Tri Serv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Tri Serv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan.	weiliang0508@gmail.com	Chang, Yaw-Wen/AAF-2630-2020	Chang, Yaw-Wen/0000-0002-8436-0518; Yang, Hui-Fang/0000-0001-6400-0462				Adinolfi LE, 2005, ALIMENT PHARM THER, V22, P52, DOI 10.1111/j.1365-2036.2005.02597.x; Akuta N, 2017, HEPATOL COMMUN, V1, P46, DOI 10.1002/hep4.1019; ALLISON MED, 1994, J HEPATOL, V21, P1135, DOI 10.1016/S0168-8278(05)80631-2; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bose SK, 2014, WORLD J DIABETES, V5, P52, DOI 10.4239/wjd.v5.i1.52; Bose SK, 2012, J VIROL, V86, P6315, DOI 10.1128/JVI.00050-12; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Dale A, 2016, LANCET, V387, P2378, DOI 10.1016/S0140-6736(16)30733-4; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Eguchi Y, 2009, LIVER INT, V29, P213, DOI 10.1111/j.1478-3231.2008.01853.x; FATTOVICH G, 1991, GUT, V32, P294, DOI 10.1136/gut.32.3.294; Grimbert S, 1996, GASTROEN CLIN BIOL, V20, P544; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Huang JF, 2013, KAOHSIUNG J MED SCI, V29, P61, DOI 10.1016/j.kjms.2012.11.001; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kawaguchi T, 2010, WORLD J GASTROENTERO, V16, P1943, DOI 10.3748/wjg.v16.i16.1943; Lebovitz HE, 2005, DIABETES CARE, V28, P2322, DOI 10.2337/diacare.28.9.2322; Lecube A, 2006, EPIDEMIOLOGY PATHOGE, V29, P1140, DOI [10.2337/dc05-1995, DOI 10.2337/DC05-1995]; Lefrere JJ, 1997, J INFECT DIS, V175, P316, DOI 10.1093/infdis/175.2.316; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; MCMAHON BJ, 1990, ARCH INTERN MED, V150, P1051, DOI 10.1001/archinte.150.5.1051; Papatheodoridis GV, 2006, J VIRAL HEPATITIS, V13, P303, DOI 10.1111/j.1365-2893.2005.00677.x; Patel P, 2013, NUTRIENTS, V5, P2019, DOI 10.3390/nu5062019; Pazienza V, 2007, HEPATOLOGY, V45, P1164, DOI 10.1002/hep.21634; PETRIDES AS, 1994, HEPATOLOGY, V19, P616, DOI 10.1002/hep.1840190312; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sergi G, 2017, AGING CLIN EXP RES, V29, P591, DOI 10.1007/s40520-016-0622-6; Shimizu I, 2003, LIVER INT, V23, P63, DOI 10.1034/j.1600-0676.2003.00811.x; Shimizu I, 2007, WORLD J GASTROENTERO, V13, P4295, DOI 10.3748/wjg.v13.i32.4295; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; Singh N, 2017, J MED SOC, V31, P19, DOI [10.4103/0972-4958.198431, DOI 10.4103/0972-4958.198431]; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; White DL, 2008, J HEPATOL, V49, P831, DOI 10.1016/j.jhep.2008.08.006; Yoneda M, 2007, J VIRAL HEPATITIS, V14, P600, DOI 10.1111/j.1365-2893.2006.00836.x; Zein CO, 2005, AM J GASTROENTEROL, V100, P48, DOI 10.1111/j.1572-0241.2005.40429.x	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0200164	10.1371/journal.pone.0200164	http://dx.doi.org/10.1371/journal.pone.0200164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965999	Green Published, Green Submitted, gold			2022-12-26	WOS:000437224100051
J	Gotz, A; Scharnagl, C				Goetz, Alexander; Scharnagl, Christina			Dissecting conformational changes in APP's transmembrane domain linked to epsilon-efficiency in familial Alzheimer's disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; MOLECULAR-DYNAMICS SIMULATIONS; CARBOXYL-TERMINAL FRAGMENT; GAMMA-SECRETASE; INTRAMEMBRANE PROTEOLYSIS; BACKBONE DYNAMICS; A-BETA; PRESENILIN MUTATIONS; MEMBRANE-PROTEINS; ENZYME CATALYSIS	The mechanism by which familial Alzheimer's disease (FAD) mutations within the transmembrane domain (TMD) of the Amyloid Precursor Protein (APP) affect epsilon-endoproteolysis is only poorly understood. Thereby, mutations in the cleavage domain reduce epsilon-efficiency of y-secretase cleavage and some even shift entry into production lines. Since cleavage occurs within the TMD, a relationship between processing and TMD structure and dynamics seems obvious. Using molecular dynamic simulations, we dissect the dynamic features of wild-type and seven FAD-mutants into local and global components. Mutations consistently enhance hydrogen-bond fluctuations upstream of the epsilon-cleavage sites but maintain strong helicity there. Dynamic perturbation-response scanning reveals that FAD-mutants target backbone motions utilized in the bound state. Those motions, obscured by large-scale motions in the pre-bound state, provide (i) a dynamic mechanism underlying the proposed coupling between binding and c-cleavage, (ii) key sites consistent with experimentally determined docking sites, and (iii) the distinction between mutants and wild-type.	[Goetz, Alexander; Scharnagl, Christina] Tech Univ Munich, Chair Phys Synthet Biol Syst, Freising Weihenstephan, Germany	Technical University of Munich	Scharnagl, C (corresponding author), Tech Univ Munich, Chair Phys Synthet Biol Syst, Freising Weihenstephan, Germany.	christina.scharnagl@tum.de	Gotz, Alexander/J-4336-2015	Gotz, Alexander/0000-0003-1434-611X	Deutsche Forschungsgemeinschaft (DFG) of the DFG research unit [FOR2290, SCHA630/4-1]; Leibniz Supercomputing Centre (LRZ) [ta511, pr92so]; Gauss Centre for Supercomputing (GCS) [pr48ko]	Deutsche Forschungsgemeinschaft (DFG) of the DFG research unit; Leibniz Supercomputing Centre (LRZ); Gauss Centre for Supercomputing (GCS)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de) within the framework of the DFG research unit FOR2290 (Grant SCHA630/4-1) to CS. Computing resources were provided by the Leibniz Supercomputing Centre (LRZ) through grants ta511 (Linux Cluster) and pr92so (SuperMUC) as well as by the Gauss Centre for Supercomputing (GCS) through grant pr48ko. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dieter Langosch for stimulating discussions and Norman Blumel for assistance with simulation setup and production runs. This work was supported by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de) within the framework of the DFG research unit FOR2290 (Grant SCHA630/4-1) to CS. Computing resources were provided by the Leibniz Supercomputing Centre (LRZ) through grants ta511 (Linux Cluster) and pr92so (SuperMUC) as well as by the Gauss Centre for Supercomputing (GCS) through grant pr48ko. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Ortiz R, 2017, CHEM SCI, V8, P5576, DOI 10.1039/c7sc00980a; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Atilgan AR, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3651807; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bolduc DM, 2016, ELIFE, V5, DOI 10.7554/eLife.17578; Bouguet-Bonnet S, 2008, J MOL BIOL, V377, P1474, DOI 10.1016/j.jmb.2008.01.081; Brown MC, 2018, BIOPHYS J, V114, P1579, DOI 10.1016/j.bpj.2018.01.043; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Cao Z, 2012, P NATL ACAD SCI USA, V109, P8121, DOI 10.1073/pnas.1201298109; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Chen WL, 2014, ACS SYM SER, V1174, P5; Clarkson MW, 2006, BIOCHEMISTRY-US, V45, P7693, DOI 10.1021/bi060652l; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Deatherage CL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602794; Deupi X, 2010, J STRUCT BIOL, V169, P116, DOI 10.1016/j.jsb.2009.09.009; Dimitrov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3246; Dominguez L, 2016, P NATL ACAD SCI USA, V113, pE5281, DOI 10.1073/pnas.1606482113; Dominguez L, 2014, J AM CHEM SOC, V136, P854, DOI 10.1021/ja410958j; Echave J, 2010, PROTEINS, V78, P173, DOI 10.1002/prot.22553; Elad N, 2015, J CELL SCI, V128, P589, DOI 10.1242/jcs.164384; Emberly EG, 2003, J MOL BIOL, V327, P229, DOI 10.1016/S0022-2836(03)00097-4; Erman B, 2006, BIOPHYS J, V91, P3589, DOI 10.1529/biophysj.106.090803; Fernandez MA, 2016, BIOCHEMISTRY-US, V55, P5675, DOI 10.1021/acs.biochem.6b00718; Freire E, 1999, P NATL ACAD SCI USA, V96, P10118, DOI 10.1073/pnas.96.18.10118; Fuchigami S, 2011, ADV CHEM PHYS, V145, P35; Fukumori A, 2016, EMBO J, V35, P1628, DOI 10.15252/embj.201694151; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Grossfield A, 2006, P NATL ACAD SCI USA, V103, P4888, DOI 10.1073/pnas.0508352103; Grossfield A, 2007, PROTEINS, V67, P31, DOI 10.1002/prot.21308; Gu J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-45; Guarnera E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004678; Guo ZY, 2013, J MOL MODEL, V19, P2901, DOI 10.1007/s00894-013-1819-7; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Haliloglu T, 2015, CURR OPIN STRUC BIOL, V35, P17, DOI 10.1016/j.sbi.2015.07.007; Hayward S, 1999, PROTEINS, V36, P425, DOI 10.1002/(SICI)1097-0134(19990901)36:4<425::AID-PROT6>3.3.CO;2-J; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Higashide H, 2017, J NEUROCHEM, V140, P955, DOI 10.1111/jnc.13942; Hogel P, 2018, BIOCHEMISTRY-US, V57, P1326, DOI 10.1021/acs.biochem.7b01197; Holmes O, 2012, BIOCHEMISTRY-US, V51, P3565, DOI 10.1021/bi300303g; Hub JS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000480; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikeguchi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.078102; Itkin A, 2017, ACS OMEGA, V2, P6525, DOI 10.1021/acsomega.7b00619; Kaether C, 2006, NEURODEGENER DIS, V3, P275, DOI 10.1159/000095267; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kim S, 2002, BIOPHYS J, V83, P2084, DOI 10.1016/S0006-3495(02)73969-6; Kleiweg, 2014, UT PERF CLUST VECT D; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Krivobokova T, 2012, BIOPHYS J, V103, P786, DOI 10.1016/j.bpj.2012.07.022; Kucukkal TG, 2015, CURR OPIN STRUC BIOL, V32, P18, DOI 10.1016/j.sbi.2015.01.003; Langosch D, 2015, TRENDS BIOCHEM SCI, V40, P318, DOI 10.1016/j.tibs.2015.04.001; Langosch D, 2017, BIOL CHEM, V398, P441, DOI 10.1515/hsz-2016-0269; Lemmin T, 2014, J BIOL CHEM, V289, P6763, DOI 10.1074/jbc.M113.470781; Lezon TR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000816; Li S, 2017, ACS CHEM NEUROSCI, V8, P1279, DOI 10.1021/acschemneuro.6b00425; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Linser R, 2015, P NATL ACAD SCI USA, V112, P12390, DOI 10.1073/pnas.1513782112; Liu T, 2006, PROTEINS, V62, P728, DOI 10.1002/prot.20749; Lu JX, 2011, BIOPHYS J, V100, P711, DOI 10.1016/j.bpj.2010.12.3696; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marcos E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002201; Matsumura N, 2014, J BIOL CHEM, V289, P5109, DOI 10.1074/jbc.M113.510131; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Ming D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.198103; Ming DM, 2006, J MOL BIOL, V358, P213, DOI 10.1016/j.jmb.2006.01.097; Ming DM, 2005, PROTEINS, V59, P697, DOI 10.1002/prot.20440; Moritsugu K, 2007, BIOPHYS J, V93, P3460, DOI 10.1529/biophysj.107.111898; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Nadezhdin KD, 2011, ACTA NATURAE, V3, P69, DOI 10.32607/20758251-2011-3-1-69-76; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Oestereich F, 2015, BIOCHEMISTRY-US, V54, P2777, DOI 10.1021/acs.biochem.5b00217; Olsson F, 2014, J BIOL CHEM, V289, P1540, DOI 10.1074/jbc.M113.498246; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Page RC, 2008, STRUCTURE, V16, P787, DOI 10.1016/j.str.2008.02.018; Page RM, 2010, J BIOL CHEM, V285, P17798, DOI 10.1074/jbc.M110.103283; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Pantelopulos GA, 2018, BBA-BIOMEMBRANES, V1860, P1698, DOI 10.1016/j.bbamem.2018.04.002; Pester O, 2013, CHEMBIOCHEM, V14, P1943, DOI 10.1002/cbic.201300322; Pester O, 2013, J AM CHEM SOC, V135, P1317, DOI 10.1021/ja3112093; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pisliakov AV, 2009, P NATL ACAD SCI USA, V106, P17359, DOI 10.1073/pnas.0909150106; PLEISS J, 1991, BIOPHYS J, V59, P795, DOI 10.1016/S0006-3495(91)82292-5; Poschner BC, 2009, J MOL BIOL, V386, P733, DOI 10.1016/j.jmb.2008.12.077; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Quint S, 2010, BIOPHYS J, V99, P2541, DOI 10.1016/j.bpj.2010.08.031; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; Ramaprasad ASE, 2017, J AM CHEM SOC, V139, P17508, DOI 10.1021/jacs.7b09268; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Roccatano D, 2002, P NATL ACAD SCI USA, V99, P12179, DOI 10.1073/pnas.182199699; Romo TD, 2014, J COMPUT CHEM, V35, P2305, DOI 10.1002/jcc.23753; Romo TD, 2011, J CHEM THEORY COMPUT, V7, P2464, DOI 10.1021/ct2002754; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sandebring A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055847; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato K, 2003, P NATL ACAD SCI USA, V100, P14086, DOI 10.1073/pnas.2334996100; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Scharnagl C, 2014, BIOPHYS J, V106, P1318, DOI 10.1016/j.bpj.2014.02.013; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Somavarapu AK, 2017, ACS CHEM NEUROSCI, V8, P2424, DOI 10.1021/acschemneuro.7b00208; Somavarapu AK, 2016, NEUROBIOL DIS, V89, P147, DOI 10.1016/j.nbd.2016.02.008; Stelzer W, 2016, CHEMISTRYSELECT, V1, P4408, DOI 10.1002/slct.201601090; Szaruga M, 2017, CELL, V170, P443, DOI 10.1016/j.cell.2017.07.004; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Taylor D, 2014, BIOINFORMATICS, V30, P3189, DOI 10.1093/bioinformatics/btu506; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Wang H, 2011, J MOL BIOL, V408, P879, DOI 10.1016/j.jmb.2011.03.028; Warshel A, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4947037; Weggen S, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt107; Wei GH, 2016, CHEM REV, V116, P6516, DOI 10.1021/acs.chemrev.5b00562; Winkler E, 2015, BIOCHEMISTRY-US, V54, P6149, DOI 10.1021/acs.biochem.5b00986; Winkler E, 2012, J BIOL CHEM, V287, P21326, DOI 10.1074/jbc.M112.356659; Woodcock HL, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3013558; Xu T-H, 2016, NATURE PUBLISHING GR, V2, P16026, DOI [10.1038/celldisc.2016.26, DOI 10.1038/CELLDISC.2016.26]; Yan Y, 2017, ACTA PHARMACOL SIN, V38, P1412, DOI 10.1038/aps.2017.35; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200; Zen A, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-26; Zheng WJ, 2007, PROTEINS, V67, P886, DOI 10.1002/prot.21326; Zheng WJ, 2005, BIOPHYS J, V89, P167, DOI 10.1529/biophysj.105.063305	128	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0200077	10.1371/journal.pone.0200077	http://dx.doi.org/10.1371/journal.pone.0200077			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966005	gold, Green Published			2022-12-26	WOS:000437224100045
J	Yilmaz, B; Spalinger, MR; Biedermann, L; Franc, Y; Fournier, N; Rossel, JB; Juillerat, P; Rogler, G; Macpherson, AJ; Scharl, M				Yilmaz, Bahtiyar; Spalinger, Marianne R.; Biedermann, Luc; Franc, Yannick; Fournier, Nicolas; Rossel, Jean-Benoit; Juillerat, Pascal; Rogler, Gerhard; Macpherson, Andrew J.; Scharl, Michael			The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PHOSPHATASE NONRECEPTOR TYPE-2; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; ULCERATIVE-COLITIS; GUT MICROBIOTA; IMMUNE-SYSTEM; BACTERIA; PATHOGENESIS; CELLS	Background Genetic risk factors, intestinal microbiota and a dysregulated immune system contribute to the pathogenesis of inflammatory bowel disease (IBD). We have previously demonstrated that dysfunction of protein tyrosine phosphatase non-receptor type 2 (PTPN2) and PTPN22 contributes to alterations of intestinal microbiota and the onset of chronic intestinal inflammation in vivo. Here, we investigated the influence of PTPN2 and PTPN22 gene variants on intestinal microbiota composition in IBD patients. Methods Bacterial DNA from mucosa-associated samples of 75 CD and 57 UC patients were sequenced using 16S rRNA sequencing approach. Microbial analysis, including alpha diversity, beta diversity and taxonomical analysis by comparing to PTPN2 (rs1893217) and PTPN22 (rs2476601) genotypes was performed in QIIME, the phyloseq R package and MaAsLin pipeline. Results In PTPN2 variant UC patients, we detected an increase in relative abundance of unassigned genera from Clostridiales and Lachnospiraceae families and reduction of Roseburia when compared to PTPN2 wild-type (WT) patients. Ruminoccocus was increased in PTPN22 variant UC patients. In CD patients with severe disease course, Faecalibacterium, Bilophila, Coprococcus, unclassified Erysipelotrichaeceae, unassigned genera from Clostridiales and Ruminococcaceae families were reduced and Bacteroides were increased in PTPN2 WT carriers, while Faecalibacterium, Bilophila, Coprococcus, and Erysipelotrichaeceae were reduced in PTPN22 WT patients when compared to patients with mild disease. In UC patients with severe disease, relative abundance of Lachnobacterium was reduced in PTPN2 and PTPN22 WT patients, Dorea was increased in samples from PTPN22 WT carriers and an unassigned genus from Ruminococcaceae gen. was increased in patients with PTPN2 variant genotype. Conclusions We identified that IBD-associated genetic risk variants, disease severity and the interaction of these factors are related to significant alterations in intestinal microbiota composition of IBD patients.	[Yilmaz, Bahtiyar; Juillerat, Pascal; Macpherson, Andrew J.] Univ Bern, Dept Biomed Res, Maurice Muller Labs, Bern, Switzerland; [Yilmaz, Bahtiyar; Juillerat, Pascal; Macpherson, Andrew J.] Univ Bern, Bern Univ Hosp, Dept Visceral Surg & Med, Bern, Switzerland; [Spalinger, Marianne R.; Biedermann, Luc; Rogler, Gerhard; Scharl, Michael] Univ Zurich, Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Franc, Yannick; Fournier, Nicolas; Rossel, Jean-Benoit] Lausanne Univ Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland	University of Bern; University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Scharl, M (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland.	michael.scharl@usz.ch	Yilmaz, Bahtiyar/U-6646-2019	Juillerat, Pascal/0000-0002-0947-5235; Scharl, Michael/0000-0002-6729-1469; Rossel, Jean-Benoit/0000-0001-5803-3233; Yilmaz, Bahtiyar/0000-0003-1888-9226	Swiss National Science Foundation [314730-146204, 314730_166381, CRSII3_154488/1]; Swiss IBD Cohort [3347CO-108792]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss IBD Cohort	This work was supported by research grants from the Swiss National Science Foundation to MS (Grant No. 314730-146204, Grant No. 314730_166381 and Grant No. CRSII3_154488/1) and the Swiss IBD Cohort (Grant No. 3347CO-108792) to GR. The funding institutions had no role in study design and data interpretation.	Alhagamhmad MH, 2016, J MED MICROBIOL, V65, P1049, DOI 10.1099/jmm.0.000331; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chu HT, 2016, SCIENCE, V352, P1116, DOI 10.1126/science.aad9948; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Diaz-Gallo LM, 2011, INFLAMM BOWEL DIS, V17, P2287, DOI 10.1002/ibd.21630; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Hadley Wickham, 2016, GGPLOT2 ELEGANT GRAP; Hai L, 2015, NATURE COMMUNICATION; Hart ML, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00792; Hedin CR, 2014, GUT, V63, P1578, DOI 10.1136/gutjnl-2013-306226; Hedjoudje A, 2017, ANN GASTROENTEROL, V30, P197, DOI 10.20524/aog.2017.0121; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Imhann F, 2018, GUT, V67, P108, DOI 10.1136/gutjnl-2016-312135; Irwin J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174954; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kasper SH, 2016, DIGESTION, V93, P249, DOI 10.1159/000445289; Kaur N, 2011, GUT MICROBES, V2, P211, DOI 10.4161/gmic.2.4.17863; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Macpherson AJ, 2017, NAT REV IMMUNOL, V17, P508, DOI 10.1038/nri.2017.58; Martinez C, 2008, AM J GASTROENTEROL, V103, P643, DOI 10.1111/j.1572-0241.2007.01592.x; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Momozawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016952; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Oksanen J., 2015, MULTIVARIATE ANAL EC; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Peyrin-Biroulet L, 2016, CLIN GASTROENTEROL H, V14, P348, DOI 10.1016/j.cgh.2015.06.001; Pittet V, 2009, INT J EPIDEMIOL, V38, P922, DOI 10.1093/ije/dyn180; Pollard K. S., 2005, BIOINFORMATICS COMPU, DOI DOI 10.1007/0-387-29362-0_23; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Sartor RB, 2017, GASTROENTEROLOGY, V152, P327, DOI 10.1053/j.gastro.2016.10.012; Scharl M, 2012, INFLAMM BOWEL DIS, V18, P1287, DOI 10.1002/ibd.21891; Scharl M, 2012, INFLAMM BOWEL DIS, V18, P900, DOI 10.1002/ibd.21913; Scharl M, 2011, GUT, V60, P189, DOI 10.1136/gut.2010.216606; Scharl M, 2010, INFLAMM BOWEL DIS, V16, P2055, DOI 10.1002/ibd.21325; Scharl M, 2009, GASTROENTEROLOGY, V137, P2030, DOI 10.1053/j.gastro.2009.07.078; Selber-Hnatiw S, 2017, FRONT MICROBIOL, V8, DOI [10.3389/fmicb.2017.017E5, 10.3389/fmicb.2017.01265]; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Spalinger MR, 2015, MUCOSAL IMMUNOL, V8, P918, DOI 10.1038/mi.2014.122; Spalinger MR, 2018, CELL REP, V22, P1835, DOI 10.1016/j.celrep.2018.01.052; Spalinger MR, 2017, AUTOPHAGY, V13, P1590, DOI 10.1080/15548627.2017.1341453; Spalinger MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160215; Spalinger MR, 2016, DIGESTION, V93, P182, DOI 10.1159/000444479; Spalinger MR, 2016, J CLIN INVEST, V126, P1783, DOI 10.1172/JCI83669; Spalinger MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072384; Spalinger MR, 2013, GASTROENTEROLOGY, V144, P978, DOI 10.1053/j.gastro.2013.01.048; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Swidsinski A, 2008, INFLAMM BOWEL DIS, V14, P147, DOI 10.1002/ibd.20330; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Whiteley AS, 2012, J MICROBIOL METH, V91, P80, DOI 10.1016/j.mimet.2012.07.008; Wright EK, 2015, INFLAMM BOWEL DIS, V21, P1219, DOI 10.1097/MIB.0000000000000382; Yilmaz B, 2014, CELL, V159, P1277, DOI 10.1016/j.cell.2014.10.053; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	63	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199664	10.1371/journal.pone.0199664	http://dx.doi.org/10.1371/journal.pone.0199664			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965986	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000437224100017
J	Gould, CF; Chillrud, SN; Phillips, D; Perzanowski, MS; Hernandez, D				Gould, Carlos F.; Chillrud, Steven N.; Phillips, Douglas; Perzanowski, Matthew S.; Hernandez, Diana			Soot and the city: Evaluating the impacts of Clean Heat policies on indoor/outdoor air quality in New York City apartments	PLOS ONE			English	Article							FINE PARTICULATE MATTER; UNITED-STATES; PM2.5 CONCENTRATIONS; RESIDENTIAL INDOOR; PERSONAL EXPOSURES; BLACK CARBON; POLLUTION; MORTALITY; POLLUTANTS; TOXICS	New York City has had a long history of implementing local policies to reduce air pollution. Enacted as a part of PIaNYC, the Clean Heat policies aim to lower wintertime ambient air pollution by phasing out dirty No. 6 heating fuel oil and transitioning to comparatively cleaner No. 4, No. 2, or natural gas. This study evaluates the impacts of policies on ambient air pollution and, given that people spend the majority of their time inside, importantly, indoor air pollution. Using a natural experiment, we evaluate the effects of the policies by measuring average two-week levels of indoor and outdoor black carbon (BC) and fine particulate matter (PM2.5) in 48 upper Manhattan apartments in successive winter heating seasons before and after mandated fuel transition. We failed to observe systematic improvements in indoor BC and PM2.5 concentrations in follow-up. However, outdoor levels of PM2.5 did improve, with statistical differences observed among buildings converting to the cleanest fuels. Non-statistical improvements were observed for outdoor BC. However, when accounting for meteorological differences, apartment characteristics, and behavioral patterns that may have influenced air pollution measurements, these differences were not significant. The study results have important policy and equity implications considering the differential improvements in air quality by conversion to No. 4 oil as compared to the cleaner No. 2 oil and natural gas.	[Gould, Carlos F.; Perzanowski, Matthew S.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Chillrud, Steven N.] Columbia Univ, Lamont Doherty Columbia Earth Observ, Palisades, NY USA; [Phillips, Douglas; Hernandez, Diana] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Hernandez, D (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10027 USA.	dh2494@cumc.columbia.edu		Gould, Carlos/0000-0002-7736-3905	National Institute of Environmental Health Sciences [R21 ES02410801, P30ES009089]; National Institute of General Medical Sciences [R25GM62454]; JPB Environmental Health Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES023770, P30ES009089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062454] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); JPB Environmental Health Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge support from the National Institute of Environmental Health Sciences under grant numbers R21 ES02410801 and P30ES009089 and the National Institute of General Medical Sciences R25GM62454 to CFG. This work was also sponsored by a JPB Environmental Health Fellowship granted to the author (DH) and managed by the Harvard T.H. Chan School of Public Health Grant.	Adamkiewicz G, 2011, AM J PUBLIC HEALTH, V101, pS238, DOI 10.2105/AJPH.2011.300119; American Lung Association, STAT AIR 2016; Avery CL, 2010, EPIDEMIOLOGY, V21, P215, DOI 10.1097/EDE.0b013e3181cb41f7; Bloomberg Michael R., 2007, PLANYC GREENER GREAT; Buttner Mark P., 2002, Aerobiologia, V18, P1, DOI 10.1023/A:1014977900352; Carrion D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010117; Cohen AJ, 2017, LANCET, V389, P1907, DOI [10.1016/s0140-6736(17)30505-6, 10.1016/S0140-6736(17)30505-6]; Cornell AG, 2012, J EXPO SCI ENV EPID, V22, P258, DOI 10.1038/jes.2012.3; Correia AW, 2013, EPIDEMIOLOGY, V24, P23, DOI 10.1097/EDE.0b013e3182770237; Dai LZ, 2014, ENVIRON HEALTH PERSP, V122, P837, DOI 10.1289/ehp.1307568; David Seamonds, 2016, BOTTOM BARREL HOW DI; Dominici F, 2007, AM J EPIDEMIOL, V166, P880, DOI 10.1093/aje/kwm222; Elminir HK, 2005, SCI TOTAL ENVIRON, V350, P225, DOI 10.1016/j.scitotenv.2005.01.043; Environmental Protection Agency, 2015, AIQ AUAL NAT SUMM; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Hernandez D, 2016, CITYSCAPE, V18, P277; Holliday KM, 2014, EPIDEMIOLOGY, V25, P35, DOI 10.1097/EDE.0000000000000006; Jung KH, 2010, ATMOS ENVIRON, V44, P4545, DOI 10.1016/j.atmosenv.2010.08.024; Kheirbek I, 2014, ENVIRON SCI TECHNOL, V48, P13573, DOI 10.1021/es503587p; Kinney PL, 2002, ENVIRON HEALTH PERSP, V110, P539, DOI 10.1289/ehp.02110s4539; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Lachenmyer C, 2000, AEROSOL SCI TECH, V32, P34, DOI 10.1080/027868200303911; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; Lioy PJ, 2010, ENVIRON HEALTH PERSP, V118, P1081, DOI 10.1289/ehp.0901634; Mayor's Office of Long-Term Planning and Sustainability, 2014, OIO BOIL D DET FUEL; Meng QY, 2005, J EXPO ANAL ENV EPID, V15, P17, DOI 10.1038/sj.jea.7500378; Morello-Frosch R, 2006, ENVIRON HEALTH PERSP, V114, P386, DOI 10.1289/ehp.8500; New York City Clean Heat, 2016, SPOT THE SOOT; New York State, 2015, PM2 MON; Parrish DD, 2011, ATMOS ENVIRON, V45, P7015, DOI 10.1016/j.atmosenv.2011.09.039; Pearce JL, 2011, ATMOS ENVIRON, V45, P1328, DOI 10.1016/j.atmosenv.2010.11.051; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Qian J, 2014, ATMOS ENVIRON, V89, P464, DOI 10.1016/j.atmosenv.2014.02.035; Schwartz J, 2000, AM J EPIDEMIOL, V151, P440, DOI 10.1093/oxfordjournals.aje.a010228; Schweizer C, 2007, J EXPO SCI ENV EPID, V17, P170, DOI 10.1038/sj.jes.7500490; Sheffield PE, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0010-2; The City of New York, 2016, 5 YEAR TRENDS BACK C; The City of New York, 2011, RUL GOV EM US 4 6 FU; The City of New York, 2011, PROM AM TITL 15 RUL; The City of New York, 2017, NEIGHBORHOOD AIR QUA; The City of New York, 2016, 5 YEAR TRENDS PM2 5; The City of New York, 2016, 5 YEAR TRENDS IN SO2; Thurston GD, 2016, ENVIRON HEALTH PERSP, V124, P785, DOI 10.1289/ehp.1509777; Yan BZ, 2011, ATMOS ENVIRON, V45, P7478, DOI 10.1016/j.atmosenv.2011.01.044	44	2	2	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199783	10.1371/journal.pone.0199783	http://dx.doi.org/10.1371/journal.pone.0199783			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953529	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400067
J	Santi, D; Locaso, M; Granata, AR; Trenti, T; Roli, L; Pacchioni, C; Rochira, V; Carani, C; Simoni, M				Santi, Daniele; Locaso, Michela; Granata, Antonio R.; Trenti, Tommaso; Roli, Laura; Pacchioni, Chiara; Rochira, Vincenzo; Carani, Cesare; Simoni, Manuela			Could chronic Vardenafil administration influence the cardiovascular risk in men with type 2 diabetes mellitus?	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ERECTILE DYSFUNCTION; PHOSPHODIESTERASE INHIBITORS; MYOCARDIAL-INFARCTION; CLINICAL-PRACTICE; SILDENAFIL; PREDICTION; GUIDELINES; FRAMINGHAM; COHORT	Introduction Appropriate algorithms for the prediction of cardiovascular risk are strongly suggested in clinical practice, although still controversial. In type 2 diabetes mellitus (T2DM), the beneficial effect of phosphodiesterase (PDE)-5 inhibitors is demonstrated on endothelial function but not on the estimation of cardiovascular risk. Aim To study whether the chronic Vardenafil administration to men with T2DM influences variables correlated with the predicted long-term cardiovascular risk calculated by different validated algorithms. Methods Per-protocol analysis of a longitudinal, prospective, randomized, placebo-controlled, double-blind, investigator-started, clinical trial. 54 male patients affected by T2DM were assigned to study (26patients) and control-group (28patients), respectively. The study included a treatment phase (24weeks) (Vardenafil/placebo 10mg twice-daily) and a follow-up phase (24weeks). Three time points were considered: baseline(V0), end of treatment (V1) and end of the study(V2). Parameters evaluated: endothelial health-related parameters and cardiovascular risk, assessed by calculating the Framingham (coronary hart disease [CHD], myocardial infarction [MI], stroke and cardiovascular disease [CVD]), ASSIGN and CUORE equations. Results Predicted cardiovascular risk at ten years resulted different using the three algorithms chosen, without differences between study and control groups and among visits. IL-6 was directly related to CHD, CVD and CUORE scores at V1 and with MI and STROKE at V2. Similarly, hs-CRP was directly related to CHD, MI, STROKE and CUORE only at V1 in the study group. Testosterone serum levels were inversely related to CHD and MI at V1 in study group. Discussion The predicted cardiovascular risk is different depending on the algorithm chosen. Despite no predictive risk reduction after six months of treatment, a possible effect of Vardenafil could be hypothesized through its action on inflammation markers reduction and through restoration of normal testosterone levels.	[Santi, Daniele; Locaso, Michela; Rochira, Vincenzo; Carani, Cesare; Simoni, Manuela] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Unit Endocrinol, Modena, Italy; [Santi, Daniele; Locaso, Michela; Granata, Antonio R.; Pacchioni, Chiara; Rochira, Vincenzo; Simoni, Manuela] Azienda Osped Univ Modena, Dept Med Specialties, Unit Endocrinol, Modena, Italy; [Trenti, Tommaso; Roli, Laura] Azienda USL Modena, Dept Lab Med & Pathol Anat, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital	Santi, D (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Unit Endocrinol, Modena, Italy.; Santi, D (corresponding author), Azienda Osped Univ Modena, Dept Med Specialties, Unit Endocrinol, Modena, Italy.	daniele.santi@unimore.it	Rochira, Vincenzo/F-4225-2015; Rochira, Vincenzo/S-7340-2019; Simoni, Manuela/A-9600-2013; Santi, Daniele/J-7005-2018; Trenti, Tommaso/K-8457-2016	Rochira, Vincenzo/0000-0001-8169-0696; Rochira, Vincenzo/0000-0001-8169-0696; Simoni, Manuela/0000-0002-2133-4304; Santi, Daniele/0000-0001-6607-7105; Trenti, Tommaso/0000-0001-8093-4011	"Progetti di Rilevante Interesse Nazionale" (PRIN)	"Progetti di Rilevante Interesse Nazionale" (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This study was not directly funded, but authors received a grant from "Progetti di Rilevante Interesse Nazionale" (PRIN).	Andersen MJ, 2013, CIRCULATION, V127, P1200, DOI 10.1161/CIRCULATIONAHA.112.000056; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Corbin JD, 2004, INT J IMPOT RES, V16, pS4, DOI 10.1038/sj.ijir.3901205; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Donfrancesco C, 2010, G ITAL CARDIOL, V11, p20S, DOI 10.1714/576.6810; Dunkem TR, 2005, CELL SIGNAL, V17, P331, DOI 10.1016/j.cellsig.2004.07.007; Ferrario M, 2005, INT J EPIDEMIOL, V34, P413, DOI 10.1093/ije/dyh405; Feuerborn R, 2017, ATHEROSCLEROSIS, V257, P29, DOI 10.1016/j.atherosclerosis.2016.12.009; Fox KM, 2003, EUR HEART J, V24, P2206, DOI 10.1016/j.ehj.2003.09.021; Giampaoli Simona, 2004, Ital Heart J Suppl, V5, P177; Giannetta E, 2012, CIRCULATION, V125, P2323, DOI 10.1161/CIRCULATIONAHA.111.063412; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Heiss C, 2006, J AM COLL CARDIOL, V47, P573, DOI 10.1016/j.jacc.2005.06.089; Hense HW, 2003, EUR HEART J, V24, P937, DOI 10.1016/S0195-668X(03)00081-2; Jackson R, 2000, BMJ-BRIT MED J, V320, P659, DOI 10.1136/bmj.320.7236.659; Kapur V, 2008, REV CARDIOVASC MED, V9, P187; Liao YL, 1999, AM HEART J, V137, P837, DOI 10.1016/S0002-8703(99)70407-2; McKenney JM, 2003, PHARMACOTHERAPY, V23, p26S, DOI 10.1592/phco.23.11.26S.32710; Menotti A, 1996, J Cardiovasc Risk, V3, P69, DOI 10.1097/00043798-199602000-00010; Menotti A, 1994, J Cardiovasc Risk, V1, P263; Menotti A, 2000, HEART, V84, P238, DOI 10.1136/heart.84.3.238; Milani E, 2005, COMP BIOCHEM PHYS C, V140, P251, DOI 10.1016/j.cca.2005.02.010; Naito R, 2017, INT HEART J, V58, P475, DOI 10.1536/ihj.17-191; Palmieri Luigi, 2004, Ann Ist Super Sanita, V40, P393; Pofi R, 2016, J ENDOCRINOL INVEST, V39, P131, DOI 10.1007/s40618-015-0339-y; Ronda N, 2013, VASC PHARMACOL, V58, P39, DOI 10.1016/j.vph.2012.08.005; Rosen RC, 2003, AM J CARDIOL, V92, p9M, DOI 10.1016/S0002-9149(03)00824-5; Santi D, 2016, EUR J ENDOCRINOL, V174, P513, DOI 10.1530/EJE-15-1100; Santi D, 2015, EUR J ENDOCRINOL, V172, pR103, DOI 10.1530/EJE-14-0700; Santilli F, 2015, THROMB HAEMOSTASIS, V114, P876, DOI 10.1160/TH15-03-0202; Tunstall-Pedoe H, 2006, HEART, V92, P307, DOI 10.1136/hrt.2005.077289; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wood D, 1998, EUR HEART J, V19, P1434; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	39	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199299	10.1371/journal.pone.0199299	http://dx.doi.org/10.1371/journal.pone.0199299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953477	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400023
J	Walsh, P; Rothenberg, SJ; Bang, H				Walsh, Paul; Rothenberg, Stephen J.; Bang, Heejung			Safety of ibuprofen in infants younger than six months: A retrospective cohort study	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ACUTE-RENAL-FAILURE; PUBLIC-HEALTH-SERVICE; REYES-SYNDROME; PRESCRIPTION DRUG; DOSE IBUPROFEN; KIDNEY INJURY; CHILDREN; ACETAMINOPHEN; INDOMETHACIN	Objective We hypothesized (1) that gastrointestinal (GI) and renal adverse events (AE) would occur more often in infants first prescribed ibuprofen before rather than after six months of age and (2) that ibuprofen would be associated with more adverse effects than acetaminophen in infants younger than six months. Methods We created two partly overlapping retrospective cohorts of infants aged less than six months when California Medicaid first paid for ibuprofen or acetaminophen between 2004 and 2010. In the first cohort we compared the incidence rate ratio (RR) of GI and renal AE between those infants first prescribed ibuprofen before six months of age with those first prescribed ibuprofen after six months of age. In the second cohort we compared the RR of GI and renal AE between infants younger than six months prescribed ibuprofen (+/-acetaminophen) with those prescribed only acetaminophen. Results We identified 41,669 prescriptions for ibuprofen and 176,991 prescriptions for acetaminophen in 180,333 eligible infants (median age 2.1 months). We did not observe higher RR of any AE in infants first prescribed ibuprofen before rather than after six months of age. Most infants prescribed ibuprofen were also prescribed acetaminophen. Any GI (adjusted (a) RR 1.25, 95% CI 1.13-1.38) and moderate or severe GI AE (aRR 1.24, 95% CI 1.09-1.40) were more common in infants younger than six months who were prescribed ibuprofen versus acetaminophen alone. Severe GI (aRR 0.63, 95% CI 0.27-1.45) and renal AE (aRR 1.84 95% CI 0.66-5.19) were not different between the ibuprofen (+/-acetaminophen) and acetaminophen-only groups. Conclusions GI and renal AEs were not higher in infants younger than six months who were prescribed ibuprofen compared with those aged six to 12 months. AEs were increased in infants younger than six months who were prescribed ibuprofen compared with infants who were prescribed acetaminophen alone.	[Walsh, Paul] Sutter Med Ctr Sacramento, Pediat Emergency Med, Sacramento, CA 95816 USA; [Rothenberg, Stephen J.] Ctr Invest Salud Poblac, Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Bang, Heejung] Univ Calif Davis, Dept Publ Hlth Sci, Div Biostat, Davis, CA 95616 USA	Instituto Nacional de Salud Publica; University of California System; University of California Davis	Walsh, P (corresponding author), Sutter Med Ctr Sacramento, Pediat Emergency Med, Sacramento, CA 95816 USA.	yousentwhohome@gmail.com	Rothenberg, Stephen J/A-1313-2008		Pediatric Emergency Medicine Research Foundation; National Heart, Lung, and Blood Institute [5K12HL108964]; National Institutes for Health [UL TR001860]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001860] Funding Source: NIH RePORTER	Pediatric Emergency Medicine Research Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Pediatric Emergency Medicine Research Foundation to Dr. Paul Walsh; National Heart, Lung, and Blood Institute grant number 5K12HL108964 to Dr. Paul Walsh; National Institutes for Health grant number UL TR001860 to Dr. Heejung Bang.	Ashraf E., 1999, Inflammopharmacology, V7, P219, DOI 10.1007/s10787-999-0005-0; Balestracci A, 2015, PEDIATR NEPHROL, V30, P1873, DOI 10.1007/s00467-015-3105-7; Belay ED, 1999, NEW ENGL J MED, V340, P1377, DOI 10.1056/NEJM199905063401801; Berezin SH, 2007, J PEDIATR GASTR NUTR, V44, P506, DOI 10.1097/MPG.0b013e31802d4add; Chen CY, 2016, PHARMACOEPIDEM DR S, V25, P678, DOI 10.1002/pds.3894; Choo PW, 1997, ANN EPIDEMIOL, V7, P440, DOI 10.1016/S1047-2797(97)00040-9; Clayton D, 1997, STATA TECHNICAL B RE, V7, P253; Clayton D, 1995, STATA TECHNICAL B, V5, P219; Crystal S, 2007, MED CARE, V45, pS58, DOI 10.1097/MLR.0b013e31805371bf; Davies NM, 1998, CLIN PHARMACOKINET, V34, P101, DOI 10.2165/00003088-199834020-00002; FLOWER RJ, 1972, NATURE, V240, P410, DOI 10.1038/240410a0; Gokmen T, 2011, J PEDIATR-US, V158, P549, DOI 10.1016/j.jpeds.2010.10.008; Hartung DM, 2008, MED CARE, V46, P565, DOI 10.1097/MLR.0b013e3181734a77; Henrich WL, 1996, AM J KIDNEY DIS, V27, P162, DOI 10.1016/S0272-6386(96)90046-3; Holder EP, 1997, DRUG SAFETY, V17, P369, DOI 10.2165/00002018-199717060-00003; HURWITZ ES, 1985, NEW ENGL J MED, V313, P849, DOI 10.1056/NEJM198510033131403; HURWITZ ES, 1987, JAMA-J AM MED ASSOC, V257, P1905, DOI 10.1001/jama.257.14.1905; Joint Formulary Committee, 2012, BRIT NAT FORM CHILDR, P503; Katz L., 1999, COMMUNICATION; Lahiri T, 2014, PEDIATR PULM, V49, P148, DOI 10.1002/ppul.22795; Leonard CE, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2247-7; Lesko SM, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.4.e39; Lesko SM, 1997, PEDIATRICS, V100, P954, DOI 10.1542/peds.100.6.954; Misurac JM, 2013, J PEDIATR-US, V162, P1153, DOI 10.1016/j.jpeds.2012.11.069; Moghal NE, 2004, ARCH DIS CHILD, V89, P276, DOI 10.1136/adc.2002.024141; Pierce CA, 2010, ANN PHARMACOTHER, V44, P489, DOI 10.1345/aph.1M332; Ruud LE, 2013, NEUROPHARMACOLOGY, V71, P124, DOI 10.1016/j.neuropharm.2013.03.012; Sauer B, 2008, 6 AG HEALTHC RES QUA; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Skuladottir HM, 2010, CLIN KIDNEY J, V3, P510, DOI 10.1093/ndtplus/sfq117; SOLOMON L, 1966, BMJ-BRIT MED J, V1, P961, DOI 10.1136/bmj.1.5493.961; Statacorp LLC, 1985, STAT LONG DAT PAN DA, P563; Sullivan JE, 2011, PEDIATRICS, V127, P580, DOI 10.1542/peds.2010-3852; Ulinski T, 2004, EUR J PEDIATR, V163, P148, DOI 10.1007/s00431-003-1392-7; Van Overmeire B, 2000, NEW ENGL J MED, V343, P674, DOI 10.1056/NEJM200009073431001; WATTAD A, 1994, PEDIATRICS, V93, P693; Winterstein AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4627; Ziesenitz V, 2017, PEDIATR DRUGS, V19, P277, DOI 10.1007/s40272-017-0235-3	38	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199493	10.1371/journal.pone.0199493	http://dx.doi.org/10.1371/journal.pone.0199493			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953460	Green Submitted, gold, Green Published			2022-12-26	WOS:000436645400032
J	Chen, FW; Lu, SF; Ding, X; He, XP				Chen, Fangwen; Lu, Shuangfang; Ding, Xue; He, Xipeng			Shale gas reservoir characterization: A typical case in the Southeast Chongqing of Sichuan Basin, China	PLOS ONE			English	Article							NORTHEASTERN BRITISH-COLUMBIA; PORE TYPES; METHANE; COAL; ADSORPTION; POROSITY; BARNETT; OIL	The Lower Silurian Longmaxi Shale in Southeast Chongqing of Sichuan Basin in China is considered to be a potential shale gas reservoir by many scholars in recent years. The special shale gas well, namely, Pengye-1 well, was selected as a case study to evaluate the characteristics of the shale gas reservoir. A series of experiments were performed to analyze the geochemical, mineralogical, and petrophysical features and gas content using samples of the Longmaxi Shale from Pengye-1 well. The results show that the organic and inorganic porosities of these samples are range of 0.08-2.73% and 0.06-2.65%, with the average of 1.10% and 1.76%, respectively. The inorganic pores primarily contribute to the porosity until the TOC content is more than 3%. Organic matter plays an important role in adsorbed gas content. The adsorbed gas is dominant in the Longmaxi Shale of Pengye-1 well, which ranges from 0.46 to 2.24 cm(3)/g, with an average of 1.38 cm(3)/g. The free gas content ranges from 0.45 to 0.84 cm(3)/g with an average of 0.68 cm(3)/g, and is 24.4-49.7 percent of total gas with an average of 37.5%. The bottom part of the Longmaxi Shale is the most favorable for shale gas exploring, which is higher of brittleness mineral content, porosity and gas content. Compare with the other five shales in America, the Lower Silurian Longmaxi Shale is derived from older sedimentary periods with significantly higher thermal maturity and has experienced several periods of intense tectonic, which are unfavorable for the shale gas enrichment.	[Chen, Fangwen; Lu, Shuangfang; Ding, Xue] China Univ Petr East China, Res Inst Unconvent Oil & Gas & New Energy, Qingdao, Shandong, Peoples R China; [Chen, Fangwen] Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Sichuan, Peoples R China; [He, Xipeng] SINOPEC, Res Inst Petr Explorat & Dev, East China Branch, Nanjing, Jiangsu, Peoples R China	China University of Petroleum; Chengdu University of Technology; Sinopec	Lu, SF (corresponding author), China Univ Petr East China, Res Inst Unconvent Oil & Gas & New Energy, Qingdao, Shandong, Peoples R China.	lusfupc@163.com		Chen, Fangwen/0000-0002-6200-1506	Open Fund of State Key Laboratory of Oil and Gas Reservoir Geology and Exploitation (Chengdu University of Technology) [PLC20180202]; National Science Foundation of China [41530315, 41302101, 41330313]; Key State Science and Technology Project [2016ZX05061]; Natural Science Foundation of Shandong Province [ZR2016DL07]; Fundamental Research Funds for the Central Universities [18CX02071A]	Open Fund of State Key Laboratory of Oil and Gas Reservoir Geology and Exploitation (Chengdu University of Technology); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key State Science and Technology Project; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Open Fund of State Key Laboratory of Oil and Gas Reservoir Geology and Exploitation (Chengdu University of Technology) (Grant No. PLC20180202), the National Science Foundation of China (Grant No. 41530315, 41302101, 41330313), the Key State Science and Technology Project (Grant No. 2016ZX05061), the Natural Science Foundation of Shandong Province (Grant No. ZR2016DL07), and the Fundamental Research Funds for the Central Universities (Grant No. 18CX02071A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Open Fund of State Key Laboratory of Oil and Gas Reservoir Geology and Exploitation (Chengdu University of Technology) (Grant No. PLC20180202), the National Science Foundation of China (Grant No. 41530315, 41302101, 41330313), the Key State Science and Technology Project (Grant No. 2016ZX05061), the Natural Science Foundation of Shandong Province (Grant No. ZR2016DL07), and the Fundamental Research Funds for the Central Universities (Grant No. 18CX02071A) for financially supporting this project.	Baskin DK, 1997, AAPG BULL, V81, P1437; BERTARD C, 1970, INT J ROCK MECH MIN, V7, P43, DOI 10.1016/0148-9062(70)90027-6; [毕赫 Bi He], 2014, [天然气地球科学, Natural Gas Geoscience], V25, P302; Chalmers GRL, 2008, B CAN PETROL GEOL, V56, P1, DOI 10.2113/gscpgbull.56.1.1; Chelini V., 2010, J LIMNOLOGY, DOI [10.2118/134292-MS, DOI 10.2118/134292-MS, 10.2118/ 134292-MS]; Chen Bo, 2009, CHINA PETROLEUM EXPL, V3, P15; Chen FW, 2018, ACTA GEOL SIN-ENGL, V92, P342, DOI 10.1111/1755-6724.13509; Chen FW, 2017, ENERG FUEL, V31, P11523, DOI 10.1021/acs.energyfuels.7b01088; Chen FW, 2018, J PETROL SCI ENG, V160, P207, DOI 10.1016/j.petrol.2017.10.063; Chen FW, 2014, SCI WORLD J, DOI 10.1155/2014/893520; Chen SB, 2011, ENERGY, V36, P6609, DOI 10.1016/j.energy.2011.09.001; [陈元壮 CHEN Yuanzhuang], 2007, [天然气工业, Natural Gas Industry], V27, P20; Curtis JB, 2002, AAPG BULL, V86, P1921, DOI 10.1306/61eeddbe-173e-11d7-8645000102c1865d; [戴鸿鸣 DAI Hongming], 2008, [天然气地球科学, Natural Gas Geoscience], V19, P503; Diamond WP, 1998, INT J COAL GEOL, V35, P311, DOI 10.1016/S0166-5162(97)00040-2; [董大忠 Dong Dazhong], 2011, [地质通报, Geological Bulletin of China], V30, P324; Fitzgerald JE, 2005, FUEL, V84, P2351, DOI 10.1016/j.fuel.2005.05.002; [付宜兴 FU Yixing], 2007, [大地构造与成矿学, Geotectonica et Metallogenia], V31, P308; Hartwig A., 2009, GEOPHYS RES ABSTRACT, V11, P2009; Hill D.G., 2000, GAS TIPS, V6, P4, DOI DOI 10.1016/J.FUEL.2005.05.002; Huang D.F., 1984, ACTA SEDIMENTOL SIN, V3, P18; Hunt J.M., 1996, PETROLEUM GEOLOGY GE; JACOB H, 1989, INT J COAL GEOL, V11, P65, DOI 10.1016/0166-5162(89)90113-4; Jia CZ, 2012, PETROL EXPLOR DEV+, V39, P139, DOI 10.1016/S1876-3804(12)60026-3; Jin Chong, 2012, Journal of Zhejiang University. Engineering Science, V46, P1910, DOI 10.3785/j.issn.1008-973X.2012.10.026; Katz B.J., 1983, ORG GEOCHEM, V4, P195, DOI [10.1016/0146-6380(83)90041-4, DOI 10.1016/0146-6380(83)90041-4]; Kissell F.N., 1973, 7767 US BUR MIN; Kuila U, 2014, FUEL, V117, P1115, DOI 10.1016/j.fuel.2013.09.073; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Li Jian-zhong, 2009, Natural Gas Industry, V29, P11, DOI 10.3787/j.issn.1000-0976.2009.05.003; [李一凡 Li Yifan], 2012, [天然气地球科学, Natural Gas Geoscience], V23, P299; LUFFEL DL, 1992, J PETROL TECHNOL, V44, P1184, DOI 10.2118/20571-PA; Montgomery SL, 2005, AAPG BULL, V89, P155, DOI 10.1306/09170404042; O'Brien NR, 1972, CANADIAN GEOTECHNICA, V9, P120, DOI DOI 10.1139/T72-011; OBRIEN NR, 1971, CLAY CLAY MINER, V19, P353, DOI 10.1346/CCMN.1971.0190603; [蒲泊伶 Pu Boling], 2010, [石油学报, Acta Petrolei Sinica], V31, P225; [邱楠生 Qiu Nansheng], 2005, [地学前缘, Earth science frontiers], V12, P561; Ross DJK, 2007, B CAN PETROL GEOL, V55, P51, DOI 10.2113/gscpgbull.55.1.51; Slatt RM, 2011, AAPG BULL, V95, P2017, DOI 10.1306/03301110145; [谭淋耘 Tan Linyun], 2015, [地质学报, Acta Geologica Sinica], V89, P1308; [唐颖 Tang Ying], 2011, [天然气工业, Natural Gas Industry], V31, P108; Tenger Gao C.L., 2006, PET GEOL EXP, V28, P359; Tian H, 2009, CHINESE SCI BULL, V54, P1217, DOI 10.1007/s11434-008-0590-0; Wang FY, 2013, PETROL EXPLOR DEV+, V40, P819, DOI 10.1016/S1876-3804(13)60111-1; Wang GC, 2017, J NAT GAS SCI ENG, V47, P59, DOI 10.1016/j.jngse.2017.10.003; [王艿川 Wang Naichuan], 2015, [天然气地球科学, Natural Gas Geoscience], V26, P760; Wang Y., 2000, NAT GAS GEOSCI, V11, P4; Zhang Jin-chuan, 2008, Natural Gas Industry, V28, P136; [张士万 Zhang Shiwan], 2007, [石油实验地质, Petroleum Geology & Experiment], V29, P361	49	10	10	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199283	10.1371/journal.pone.0199283	http://dx.doi.org/10.1371/journal.pone.0199283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949599	Green Submitted, gold, Green Published			2022-12-26	WOS:000436549200041
J	Qaseem, MF; Qureshi, R; Muqaddasi, QH; Shaheen, H; Kousar, R; Roder, MS				Qaseem, Mirza Faisal; Qureshi, Rahmatullah; Muqaddasi, Quddoos H.; Shaheen, Humaira; Kousar, Rehana; Roeder, Marion S.			Genome-wide association mapping in bread wheat subjected to independent and combined high temperature and drought stress	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; SPRING WHEAT; PHYSIOLOGICAL TRAITS; POPULATION-STRUCTURE; YIELD COMPONENTS; HEAT-STRESS; MOLECULAR CHARACTERIZATION; PLANT HEIGHT; WINTER-WHEAT; GRAIN-YIELD	Most investigations to date aiming to identify the genetic basis of the stress response of wheat (Triticum aestivum L.) have focused on the response to single stress agents such as high temperature or drought, even though in the natural situation, these stresses tend often to occur together. Here, a panel of 108 spring type bread wheat cultivars was phenotyped for 15 yield and yield related traits for two years (2014/15 and 2015/16) under non-stressed conditions, under high temperature stress, under drought and under a combined high temperature and drought regime. The mean loss in grain yield caused by all stress regimes was 51.33%. Analysis of variance (ANOVA) of yield trait showed significant differences among genotypes environments and their interactions (GxE). All the studied traits had higher heritability values which ranged from 0.35-0.94 under [C], 0.58-0.95 under [D], 0.62-0.93 under [H] and 0.60-0.95 under [HD]. GWAS was performed by using 9,646 informative SNP markers and based on these polymorphic SNPs population structure analysis divided whole germplasm into five major sub-populations. Mixed model association analysis detected 503 marker-trait associations (MTAs) at P <= 0.001 while 329 MTAs crossed FDR <= 0.05 for all traits with phenotypic variances (R-2) ranged from 24.83% to 12.51%. Seven new pleiotropic SNPs on chromosome 7D and IAAV8258 (86.91cM) and wsnp_Ex_c7168_12311649 (57.93cM) on chromosome 5A were most stable association in present study. Furthermore, candidate genes Psy and Sr25 (TG0040) were also significant in present study, these genes were previously mapped on 7A and 7D. The region on 7D was assiociated with 7DL.7Ag translocation from Lophopyrum carring rust resistance Yr16 and many other genes. Similarly region on chromosome 7A which was associated with Psy gene was linked with grain yellow pigment content QTLs. Favourable alleles controlling grain yield were of vital importance and incorporation of these alleles after validation through marker assisted selection and fine mapping could be helpful in wheat yield improvement stress and non-stress conditions.	[Qaseem, Mirza Faisal; Qureshi, Rahmatullah; Kousar, Rehana] PMAS Arid Agr Univ, Dept Bot, Rawalpindi, Pakistan; [Qaseem, Mirza Faisal; Muqaddasi, Quddoos H.; Roeder, Marion S.] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Breeding Res, Stadt Seeland Ot Gatersl, Germany; [Shaheen, Humaira] COMSATS Inst Informat Technol, Biosci Dept, Islamabad, Pakistan	Arid Agriculture University; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; COMSATS University Islamabad (CUI)	Qaseem, MF (corresponding author), PMAS Arid Agr Univ, Dept Bot, Rawalpindi, Pakistan.; Qaseem, MF (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Breeding Res, Stadt Seeland Ot Gatersl, Germany.	faisal.ali522@gmail.com	Qaseem, Mirza Faisal/AAB-5797-2021; Qureshi, Rahmatullah/F-1441-2018	Qureshi, Rahmatullah/0000-0001-9184-1216; Roder, Marion/0000-0002-9313-0650; Qaseem, Mirza Faisal/0000-0001-7973-408X				Ain QU, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.7015.00743, 10.3389/fpls.2015.00743]; Aoun M, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.01.0008; Aprile A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-821; Awasthi R, 2014, FUNCT PLANT BIOL, V41, P1148, DOI 10.1071/FP13340; Balla K, 2011, CZECH J FOOD SCI, V29, P117, DOI 10.17221/227/2010-CJFS; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett D, 2012, THEOR APPL GENET, V125, P255, DOI 10.1007/s00122-012-1831-9; Bilal M, 2015, COMPREHENSIVE REV EF; Bordes J, 2014, MOL BREEDING, V33, P755, DOI 10.1007/s11032-013-0004-0; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edae EA, 2014, THEOR APPL GENET, V127, P791, DOI 10.1007/s00122-013-2257-8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Gao FM, 2016, EUPHYTICA, V209, P789, DOI 10.1007/s10681-016-1682-6; Gao FM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01099; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hamidou F, 2013, J AGRON CROP SCI, V199, P1, DOI 10.1111/j.1439-037X.2012.00518.x; Havaux M, 1999, AUST J PLANT PHYSIOL, V26, P569, DOI 10.1071/PP99046; Jabeen M., 2017, QUANTIFICATION CLIMA, P387; Jedmowski C, 2015, J BOT, V2015; Jighly A, 2015, THEOR APPL GENET, V128, P1277, DOI 10.1007/s00122-015-2504-2; Johnson EB, 2008, EUPHYTICA, V163, P193, DOI 10.1007/s10681-007-9628-7; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kato K, 1999, THEOR APPL GENET, V98, P472, DOI 10.1007/s001220051094; Kilic H, 2010, NOT BOT HORTI AGROBO, V38, P164; KNOTT DR, 1968, CAN J GENET CYTOL, V10, P695, DOI 10.1139/g68-087; Kollers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057500; Kyparissis A, 1995, J EXP BOT, V46, P1825, DOI 10.1093/jxb/46.12.1825; LI CL, 2015, EUPHYTICA, V206, P89, DOI DOI 10.1007/s10681-015-1475-3; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lobell DB, 2012, NAT CLIM CHANGE, V2, P186, DOI [10.1038/nclimate1356, 10.1038/NCLIMATE1356]; Lopes MS, 2015, THEOR APPL GENET, V128, P453, DOI 10.1007/s00122-014-2444-2; Maccaferri M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-873; Mahrookashani A, 2017, J AGRON CROP SCI, V203, P453, DOI 10.1111/jac.12218; Mamta Gupta, 2015, Journal of Applied and Natural Science, V7, P739; Massman J, 2011, MOL BREEDING, V27, P439, DOI 10.1007/s11032-010-9442-0; Monneveux P, 2003, PLANT BREEDING, V122, P379, DOI 10.1046/j.1439-0523.2003.00856.x; Muqaddasi QH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00754; Pozniak CJ, 2007, THEOR APPL GENET, V114, P525, DOI 10.1007/s00122-006-0453-5; Pradhan GP, 2012, FUNCT PLANT BIOL, V39, P190, DOI 10.1071/FP11245; Prasad PVV, 2011, J AGRON CROP SCI, V197, P430, DOI 10.1111/j.1439-037X.2011.00477.x; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Reynolds M, 2008, CURR OPIN PLANT BIOL, V11, P171, DOI 10.1016/j.pbi.2008.02.005; REYNOLDS MP, 1994, AUST J PLANT PHYSIOL, V21, P717, DOI 10.1071/PP9940717; Sayre KD, 1997, CROP SCI, V37, P36, DOI 10.2135/cropsci1997.0011183X003700010006x; Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4; Sears ER, 1977, ANAL WHEA AGROPYRON; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Shindo C, 2003, HEREDITY, V90, P56, DOI 10.1038/sj.hdy.6800178; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Singh RP, 1998, CROP SCI, V38, P27, DOI 10.2135/cropsci1998.0011183X003800010005x; Sorrells ME, 2009, PLANT GENET GENOMICS, V7, P655, DOI 10.1007/978-0-387-77489-3_22; Sukumaran S, 2016, CROP SCI, V56, P2962, DOI 10.2135/cropsci2016.01.0066; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Tadesse W, 2014, CROP SCI, V54, P607, DOI 10.2135/cropsci2013.05.0289; Tahmasebi S, 2017, GENOME, V60, P26, DOI 10.1139/gen-2016-0017; Team C.W., 2014, IPCC 2014 CLIMATE CH, V151; Wang S-X, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0188662, DOI 10.1371/journal.pone.0172498]; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zanke CD, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00644; Zanke CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113287; Zhang LY, 2010, J INTEGR PLANT BIOL, V52, P996, DOI 10.1111/j.1744-7909.2010.00967.x; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264; Zhang N, 2017, THEOR APPL GENET, P1; Zhang W, 2008, THEOR APPL GENET, V116, P635, DOI 10.1007/s00122-007-0697-8	72	43	44	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199121	10.1371/journal.pone.0199121	http://dx.doi.org/10.1371/journal.pone.0199121			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949622	Green Submitted, Green Published, gold			2022-12-26	WOS:000436549200038
J	Dintrans, PV				Dintrans, Pablo Villalobos			Do long-term care services match population needs? A spatial analysis of nursing homes in Chile	PLOS ONE			English	Article							HEALTH; ASSOCIATION; SEGREGATION; COMPETITION; REGRESSION; OWNERSHIP; STABILITY; QUALITY	Chile is experiencing a period of rapid aging, which increases the need of long-term care services in the country. Nursing homes have been the traditional alternative to deal with the increase of elderly population in the country, with services supplied by a mix of for-profit and nonprofit providers. Additionally, population exhibits a high degree of geographical concentration. The study aims to identify the determinants of the geographical location of nursing homes in Chile at municipality level. The analysis takes into account the different location criteria for different types of nursing homes as well as potential spatial effects. The paper uses spatial analysis tools to identify clusters of nursing homes and population characteristics and to estimate the determinants of nursing homes availability and coverage in the country. The analysis-based on spatial global and local tests, and spatial autoregressive models-show the existence of clusters of nursing homes as well as clusters of municipalities according to elderly population, income, poverty, population density, and public health insurance coverage. Residuals from ordinary least squares regressions were spatially autocorrelated, showing the need of using spatial models. Estimations show that availability and coverage of nursing homes are positively related with municipality income, and that for-profit and nonprofit facilities respond differently to different factors. A negative coefficient was found for poverty in nonprofit nursing homes, raising doubts about the effectiveness of giving public subsidies to incentive the installation of facilities in areas with high needs and low income.	[Dintrans, Pablo Villalobos] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Dintrans, PV (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	pav783@mail.harvard.edu	Dintrans, Pablo Villalobos/AAM-6248-2020	Dintrans, Pablo Villalobos/0000-0002-2236-6447	PLOS	PLOS	Pablo Villalobos Dintrans received PLOS publication fee assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON WE, 1994, GERONTOLOGIST, V34, P775, DOI 10.1093/geront/34.6.775; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Amirkhanyan AA, 2008, J POLICY ANAL MANAG, V27, P326, DOI 10.1002/pam.20327; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., 2001, COMPANION TOTHEORETI; Anselin L, 2005, EXPLORING SPATIAL DA; Arbia G., 2014, PRIMER SPATIAL ECONO, DOI DOI 10.1057/9781137317940; Auchincloss AH, 2012, ANNU REV PUBL HEALTH, V33, P107, DOI 10.1146/annurev-publhealth-031811-124655; Bayer P., 2004, EQUILIBRIUM MODEL SO; Chacon S., 2015, TRIMEST ECON, V82, P351, DOI DOI 10.20430/ete.v82i326.168; Chairney S, 2013, GIS CRIME MAPPING; Chaix B, 2005, J EPIDEMIOL COMMUN H, V59, P517, DOI 10.1136/jech.2004.025478; Chou SY, 2002, J HEALTH ECON, V21, P293, DOI 10.1016/S0167-6296(01)00123-0; Comber AJ, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-44; Comondore VR, BMJ, V339; CORDEN A, 1992, T I BRIT GEOGR, V17, P80, DOI 10.2307/622638; DASPREMONT C, 1983, ECON LETT, V11, P19, DOI 10.1016/0165-1765(83)90156-8; DASPREMONT C, 1979, ECONOMETRICA, V47, P1145, DOI 10.2307/1911955; de Castro MC, 2007, HEALTH PLACE, V13, P368, DOI 10.1016/j.healthplace.2006.03.006; de Castro MC, 2006, GEOGR ANAL, V38, P180; Dijkstra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072730; Durlauf S.N., 1996, J ECON GROWTH, V1, P75, DOI 10.1007/BF00163343; Elacqua G, 2012, INT J EDUC DEV, V32, P444, DOI 10.1016/j.ijedudev.2011.08.003; Fisher T., 2017, IOP C SERIES MAT SCI, V245; Freedman VA, 2008, HLTH OLDER AGES CAUS; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Getis A., 2010, HDB APPL SPATIAL ANA; Gibson D, 2000, 5 AUSTR I HLTH WELF; HAMNETT C, 1992, AREA, V24, P130; Harrington C, 1988, Health Care Financ Rev, V9, P81; Harrington C, 2001, AM J PUBLIC HEALTH, V91, P1452, DOI 10.2105/AJPH.91.9.1452; Hotelling H, 1929, ECON J, V39, P41, DOI 10.2307/2224214; Manton KG, 1994, DEMOGRAPHY AGING; Bascunan MM, 2016, GEOSPATIAL HEALTH, V11, P263, DOI 10.4081/gh.2016.451; Mobley Lee R, 2006, Int J Health Geogr, V5, P19, DOI 10.1186/1476-072X-5-19; Monsalves, 2013, REV CHIL SALUD PUBLI, V17, P22, DOI [10.5354/0719-5281.2013.26633, DOI 10.5354/0717-3652.2013.26633]; Musa GJ, 2013, HEALTH SERV INSIGHTS, V6, P111, DOI 10.4137/HSI.S10471; OECD, 2013, GOOD LIFE OLD AGE MO; Oficina Nacional de Estadisticas (ONE), 2015, EST PROYECC NAC POBL, V1; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Organization WH, 2015, SUMM WORLD REP AG HL; Ramos I, 2016, GEOSPATIAL HEALTH, V11, P349, DOI 10.4081/gh.2016.452; Richardson DB, 2013, SCIENCE, V339, P1390, DOI 10.1126/science.1232257; Rivera-Hernandez M, 2014, J GERONTOL B-PSYCHOL, V70, P619; Sabatini F, 2001, EURE, V27, P21; Sabatini F, 2010, TENDENCIAS SEGREGACI; SALOP SC, 1979, BELL J ECON, V10, P141, DOI 10.2307/3003323; SENAMA, 2010, EST NAC DEP AD MAYOR; SENAMA, 2017, GUIA PROGR BEN SOC S; SHAKED A, 1982, REV ECON STUD, V49, P3, DOI 10.2307/2297136; Snow J., 1949, CHALLENGE EPIDEMIOLO; Tirole, 1990, THEORY IND ORG; Villalobos P., 2018, THESIS; Voss PR, 2006, POPUL RES POLICY REV, V25, P369, DOI 10.1007/s11113-006-9007-4; You NL, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101102; Zainol R, 2014, J MALAYSIAN I PLANNE, VV, P49	56	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199522	10.1371/journal.pone.0199522	http://dx.doi.org/10.1371/journal.pone.0199522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK7JR	29944690	Green Published, gold			2022-12-26	WOS:000436377800039
J	Ghosal, KJ; Patel, K; Singh, BR; Hale, ML				Ghosal, Koyel J.; Patel, Kruti; Singh, Bal Ram; Hale, Martha L.			Role of critical elements in botulinum neurotoxin complex in toxin routing across intestinal and bronchial barriers	PLOS ONE			English	Article							C PROGENITOR TOXIN; EPITHELIAL-CELLS; ENDOPEPTIDASE ACTIVITY; HA PROTEINS; TRANSCYTOSIS; BINDING; RECEPTOR; HEMAGGLUTININ; TRANSPORT; IDENTIFICATION	The highly potent botulinum neurotoxin serotype A (BoNT/A) inhibits neurotransmitter release at neuromuscular junctions resulting in flaccid muscle paralysis, respiratory arrest and death. In order to reach their neuronal cell targets, BoNT/A must cross epithelial cell barriers lining the intestines and airways. The toxin is produced as a large protein complex comprised of the neurotoxin and non-toxic neurotoxin-associated proteins (NAPs). Although NAPs are known to protect the toxin from harsh environments, their role in the movement of BoNT/A across epithelial barriers has not been fully characterized. In the current study, movement of the toxin across epithelial cells was examined macroscopically using a sensitive near infrared fluorescence transcytosis assay and microscopically using fluorescently labeled toxin and confocal microscopy. The studies show that the BoNT/A complex internalizes more rapidly than the pure toxin. The studies also show that one NAP protein, hemaglutinin 33 (Hn33), enhanced both the binding and movement of a deactivated recombinant botulinum neurotoxin A (DrBoNT) across epithelial cell monolayers and that the toxin associates with Hn33 on the cell surface. Collectively, the data demonstrate that, in addition to their protective role, NAPs and Hn33 play an important role in BoNT/A intoxication.	[Ghosal, Koyel J.; Patel, Kruti; Singh, Bal Ram] Univ Massachusetts Dartmouth, Dept Chem & Biochem, N Dartmouth, MA USA; [Hale, Martha L.] US Army, Med Res Inst Infect Dis, Mol & Translat Sci Div, Ft Detrick, MD 21702 USA; [Ghosal, Koyel J.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Patel, Kruti; Singh, Bal Ram] Inst Adv Sci, Botulinum Res Ctr, Dartmouth, MA USA	University of Massachusetts System; University Massachusetts Dartmouth; University System of Maryland; University of Maryland Baltimore	Hale, ML (corresponding author), US Army, Med Res Inst Infect Dis, Mol & Translat Sci Div, Ft Detrick, MD 21702 USA.	martha.l.hale6.civ@mail.mil		Hale, Martha/0000-0002-1108-9202	DTRA Research Plan [133249]; NIH [RO3AI103868]; DoD/Army [W81XWH-08-P-0705]; DARPA [W911NF-07-1-0623]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI103868] Funding Source: NIH RePORTER	DTRA Research Plan(United States Department of DefenseDefense Threat Reduction Agency); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD/Army(United States Department of Defense); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by DTRA Research Plan #133249 (MLH), NIH grant RO3AI103868 (BRS), DoD/Army Contract W81XWH-08-P-0705 & DARPA Grant W911NF-07-1-0623 (BRS).	Ahsan CR, 2005, J PHARMACOL EXP THER, V315, P1028, DOI 10.1124/jpet.105.092213; Ahsan SF, 2000, OTOLARYNG HEAD NECK, V122, P691, DOI 10.1016/S0194-5998(00)70198-7; Amieva MVR, 2004, LI COR BIOSCIENCES; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baskaran P, 2013, TOXICON, V72, P71, DOI 10.1016/j.toxicon.2013.06.014; Benefield DA, 2013, P NATL ACAD SCI USA, V110, P5630, DOI [10.1073/pnas.1222139110, 10.1073/pnas.12222139110]; Cai SO, 1999, BIOCHEMISTRY-US, V38, P6903, DOI 10.1021/bi990086c; Couesnon A, 2008, CELL MICROBIOL, V10, P375, DOI 10.1111/j.1462-5822.2007.01051.x; DASGUPTA BR, 1984, TOXICON, V22, P415, DOI 10.1016/0041-0101(84)90085-0; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Ellinger I, 1999, EUR J IMMUNOL, V29, P733, DOI 10.1002/(SICI)1521-4141(199903)29:03<733::AID-IMMU733>3.0.CO;2-C; Fujinaga Y, 1997, MICROBIOL-UK, V143, P3841, DOI 10.1099/00221287-143-12-3841; Fujinaga Y, 2000, FEBS LETT, V467, P179, DOI 10.1016/S0014-5793(00)01147-9; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; Gu SY, 2013, CURR TOP MICROBIOL, V364, P21, DOI 10.1007/978-3-642-33570-9_2; Gu SY, 2012, SCIENCE, V335, P977, DOI 10.1126/science.1214270; Hale M, 2012, BOTULINUM J, V2, P168, DOI 10.1504/TBJ.2012.050201; Hines HB, 2005, APPL ENVIRON MICROB, V71, P4478, DOI 10.1128/AEM.71.8.4478-4486.2005; Horowitz BZ, 2005, CRIT CARE CLIN, V21, P825, DOI 10.1016/j.ccc.2005.06.008; Jin YJ, 2009, MICROBIOL-SGM, V155, P35, DOI 10.1099/mic.0.021246-0; Johannessen LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056671; Kukreja RV, 2007, BIOCHEMISTRY-US, V46, P14316, DOI 10.1021/bi701564f; Lam TI, 2015, CELL MICROBIOL, V17, P1133, DOI 10.1111/cmi.12424; Lee K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003690; LEHR CM, 1993, PHARMACEUT RES, V10, P1796, DOI 10.1023/A:1018994703011; Maksymowych AB, 1998, J BIOL CHEM, V273, P21950, DOI 10.1074/jbc.273.34.21950; Maksymowych AB, 2004, J PHARMACOL EXP THER, V310, P633, DOI 10.1124/jpet.104.066845; Maksymowych AB, 1999, INFECT IMMUN, V67, P4708, DOI 10.1128/IAI.67.9.4708-4712.1999; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; Nishikawa A, 2004, BIOCHEM BIOPH RES CO, V319, P327, DOI 10.1016/j.bbrc.2004.04.183; Nuss JE, 2010, J BIOMOL SCREEN, V15, P42, DOI 10.1177/1087057109354779; Oguma K, 1999, J TOXICOL-TOXIN REV, V18, P17, DOI 10.3109/15569549909036015; OHISHI I, 1977, INFECT IMMUN, V16, P107, DOI 10.1128/IAI.16.1.107-109.1977; Osterman HL, NEAR INFRARED FLUORE; Park JB, 2003, INFECT IMMUN, V71, P1147, DOI 10.1128/IAI.71.3.1147-1154.2003; Peck MW, 2017, TOXINS, V9, DOI 10.3390/toxins9010038; Pike JA, 2017, METHODS, V115, P42, DOI 10.1016/j.ymeth.2017.01.005; Ravichandran E, 2006, J PHARMACOL EXP THER, V318, P1343, DOI 10.1124/jpet.106.104661; Ravichandran E, 2016, PHARM RES-DORDR, V33, P639, DOI 10.1007/s11095-015-1816-x; Rushing SR, 2009, TOXICON, V54, P184, DOI 10.1016/j.toxicon.2009.04.003; Sharma SK, 1998, J NAT TOXINS, V7, P239; Sharma SK, 2004, BIOCHEMISTRY-US, V43, P4791, DOI 10.1021/bi0355544; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Sockolosky JT, 2012, P NATL ACAD SCI USA, V109, P16095, DOI 10.1073/pnas.1208857109; Song QX, 2012, BIOMATERIALS, V33, P6769, DOI 10.1016/j.biomaterials.2012.05.066; SUGII S, 1977, INFECT IMMUN, V16, P910, DOI 10.1128/IAI.16.3.910-914.1977; Takahashi K, 1996, PHARMACOLOGY, V53, P37, DOI 10.1159/000139413; Verderio C, 2006, EMBO REP, V7, P995, DOI 10.1038/sj.embor.7400796; VILLEGAS JC, 1993, J NEUROCYTOL, V22, P67, DOI 10.1007/BF01181571; VONBONSDORFF CH, 1985, EMBO J, V4, P2781, DOI 10.1002/j.1460-2075.1985.tb04004.x; YANG W, 2008, BOTULINUM J, V1, P219, DOI DOI 10.1504/TBJ.2008.026477; Zhou Y, 2005, FEBS J, V272, P2717, DOI 10.1111/j.1742-4658.2005.04688.x; Zhou Y, 2007, PROTEIN J, V26, P29, DOI 10.1007/s10930-006-9041-4	53	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199524	10.1371/journal.pone.0199524	http://dx.doi.org/10.1371/journal.pone.0199524			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975725	Green Published, gold, Green Submitted			2022-12-26	WOS:000437424500037
J	Hu, YT; Liang, YP; Zhang, M; Tan, FQ; Zhong, SF; Li, X; Gong, GS; Chang, XL; Shang, J; Tang, SW; Li, T; Luo, PG				Hu, Yuting; Liang, Yinping; Zhang, Min; Tan, Feiquan; Zhong, Shengfu; Li, Xin; Gong, Guoshu; Chang, Xiaoli; Shang, Jing; Tang, Shengwen; Li, Tao; Luo, Peigao			Comparative transcriptome profiling of Blumeria graminis f. sp tritici during compatible and incompatible interactions with sister wheat lines carrying and lacking Pm40	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; GOLOVINOMYCES-ORONTII HAUSTORIA; POWDERY MILDEW FUNGI; SP HORDEI; ESTABLISHING COMPATIBILITY; MOLECULAR CHARACTERIZATION; EFFECTOR CANDIDATES; PRIMARY METABOLISM; PLANT-RESISTANCE; BARLEY LEAVES	Blumeria graminis f. sp. tritici (Bgt) is an obligate biotrophic fungus that causes wheat powdery mildew, which is a devastating disease in wheat. However, little is known about the pathogenesis of this fungus, and differences in the pathogenesis of the same pathogen at various resistance levels in hosts have not been determined. In the present study, leaf tissues of both Pm40-expressing hexaploid wheat line L658 and its Pm40-deficient sister line L958 were harvested at 0 (without inoculation), 6, 12, 24, 48 and 72 hours post-inoculation (hpi) with Bgt race 15 and then subjected to RNA sequencing (RNA-seq). In addition, we also observed changes in fungal growth morphology at the aforementioned time points. There was a high correlation between percentage of reads mapped to the Bgt reference genome and biomass of the fungus within the leaf tissue during the growth process. The percentage of mapped reads of Bgt in compatible interactions was significantly higher (at the p<0.05 level) than that of reads in incompatible interactions from 24 to 72 hpi. Further functional annotations indicated that expression levels of genes encoding H+-transporting ATPase, putative secreted effector proteins (PSEPs) and heat shock proteins (HSPs) were significantly up-regulated in compatible interactions compared with these levels in incompatible interactions, particularly at 72 hpi. Moreover, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis suggested that genes involved in the endocytosis pathway were also enriched in compatible interactions. Overall, genes encoding H+-transporting ATPase, PSEPs and HSPs possibly played crucial roles in successfully establishing the pathogenesis of compatible interactions during late stages of inoculation. The study results also indicated that endocytosis is likely to play a potential role in Bgt in establishing compatible interactions.	[Hu, Yuting; Liang, Yinping; Zhang, Min; Tan, Feiquan; Zhong, Shengfu; Li, Xin; Gong, Guoshu; Chang, Xiaoli; Shang, Jing; Tang, Shengwen; Li, Tao; Luo, Peigao] Sichuan Agr Univ, Coll Agron, Prov Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Zhang, M; Luo, PG (corresponding author), Sichuan Agr Univ, Coll Agron, Prov Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China.	yalanmin@126.com; lpglab@sicau.edu.cn			Science and Technology Planning Project of Sichuan Province of China [2016NYZ0053-4]; National Natural Science Foundation of China [31571661]; Science and Technology Department of Sichuan Province of China [2017JY0012]; Specific Foundation of Agronomy [nyhyzx3-15]	Science and Technology Planning Project of Sichuan Province of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Sichuan Province of China; Specific Foundation of Agronomy(Ministry of Science and Technology, China)	The financial support of the Science and Technology Planning Project of Sichuan Province of China (2016NYZ0053-4) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The responsible person of the Science and Technology Planning Project of Sichuan Province of China 2016NYZ0053-4; National Natural Science Foundation of China 31571661; Science and Technology Department of Sichuan Province of China 2017JY0012; Specific Foundation of Agronomy nyhyzx3-15 is Min Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar GB, 2016, PLANT PATHOL, V65, P953, DOI 10.1111/ppa.12476; Ahmed AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157586; Amselem J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2185-x; An QL, 2006, CELL MICROBIOL, V8, P1009, DOI 10.1111/j.1462-5822.2006.00683.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Belanger RR, 2003, PHYTOPATHOLOGY, V93, P402, DOI 10.1094/PHYTO.2003.93.4.402; Bindschedler LV, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00123; Bindschedler LV, 2011, METHODS, V54, P432, DOI 10.1016/j.ymeth.2011.03.006; Bindschedler LV, 2009, MOL CELL PROTEOMICS, V8, P2368, DOI 10.1074/mcp.M900188-MCP200; Both M, 2005, PLANT CELL, V17, P2107, DOI 10.1105/tpc.105.032631; Both M, 2005, MOL PLANT MICROBE IN, V18, P125, DOI 10.1094/MPMI-18-0125; Bourras S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00241; Bourras S, 2015, PLANT CELL, V27, P2991, DOI 10.1105/tpc.15.00171; Bruinsma J, 2009, P FAO EXP M FEED WOR, DOI [10.1016/j.ecolecon.2009.11.001, DOI 10.1016/J.ECOLECON.2009.11.001]; BUSHNELL WR, 1972, ANNU REV PHYTOPATHOL, V10, P151, DOI 10.1146/annurev.py.10.090172.001055; Conner RL, 2003, CAN J PLANT SCI, V83, P725, DOI 10.4141/P03-043; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Duplessis S, 2005, NEW PHYTOL, V165, P599, DOI 10.1111/j.1469-8137.2004.01248.x; Duplessis S, 2011, MOL PLANT MICROBE IN, V24, P808, DOI 10.1094/MPMI-01-11-0006; Franck WL, 2013, MOL CELL PROTEOMICS, V12, P2249, DOI 10.1074/mcp.M112.025874; Ghosh A, 2014, FEMS MICROBIOL LETT, V361, P17, DOI 10.1111/1574-6968.12605; GIL F, 1977, PHYSIOL PLANT PATHOL, V10, P1, DOI 10.1016/0048-4059(77)90002-9; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; Godfrey D, 2009, PROTEOMICS, V9, P3222, DOI 10.1002/pmic.200800645; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; GRIFFEY CA, 1993, PLANT DIS, V77, P618, DOI 10.1094/PD-77-0618; Hacquard S, 2013, P NATL ACAD SCI USA, V110, pE2219, DOI 10.1073/pnas.1306807110; Hahn M, 1997, MOL PLANT MICROBE IN, V10, P427, DOI 10.1094/MPMI.1997.10.4.427; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim JH, 2009, CURR GENET, V55, P593, DOI 10.1007/s00294-009-0272-8; Korn M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125960; Lamoth F, 2014, CURR FUNGAL INFECT R, V8, P296, DOI 10.1007/s12281-014-0195-9; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LEATH S, 1989, PHYTOPATHOLOGY, V79, P152, DOI 10.1094/Phyto-79-152; Liu WX, 2017, THEOR APPL GENET, V130, P841, DOI 10.1007/s00122-017-2855-y; Liu ZH, 2015, J PLANT REGIST, V9, P121, DOI 10.3198/jpr2014.01.0003crg; Manning VA, 2005, PLANT CELL, V17, P3203, DOI 10.1105/tpc.105.035063; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Micali CO, 2011, CELL MICROBIOL, V13, P210, DOI 10.1111/j.1462-5822.2010.01530.x; Noir S, 2009, MOL PLANT PATHOL, V10, P223, DOI 10.1111/j.1364-3703.2008.00524.x; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; Panstruga R, 2003, CURR OPIN PLANT BIOL, V6, P320, DOI 10.1016/S1369-5266(03)00043-8; Parlange F, 2015, FUNGAL GENET BIOL, V82, P181, DOI 10.1016/j.fgb.2015.06.009; Parlange F, 2011, FUNCT INTEGR GENOMIC, V11, P671, DOI 10.1007/s10142-011-0240-5; Pedersen C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-694; Pennington HG, 2016, J PROTEOME RES, V15, P826, DOI 10.1021/acs.jproteome.5b00732; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pliego C, 2013, MOL PLANT MICROBE IN, V26, P633, DOI 10.1094/MPMI-01-13-0005-R; Rajaraman J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01836; Requena N, 2003, PLANT PHYSIOL, V132, P1540, DOI 10.1104/pp.102.019042; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Schmidt SM, 2014, MOL PLANT PATHOL, V15, P535, DOI 10.1111/mpp.12110; Schulze-Lefert P, 2003, ANNU REV PHYTOPATHOL, V41, P641, DOI 10.1146/annurev.phyto.41.061002.083300; Spanu P D, 2014, GENOMICS PLANT ASS F, P161, DOI [10.1007/978-3-662-44053-7_7, DOI 10.1007/978-3-662-44053-7_7]; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Struck C, 1996, FUNGAL GENET BIOL, V20, P30, DOI 10.1006/fgbi.1996.0006; Struck C, 1998, MOL PLANT MICROBE IN, V11, P458, DOI 10.1094/MPMI.1998.11.6.458; Takamatsu Susumu, 2004, Mycoscience, V45, P147, DOI 10.1007/s10267-003-0159-3; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thomas SW, 2002, MOL PLANT MICROBE IN, V15, P847, DOI 10.1094/MPMI.2002.15.8.847; Thomas SW, 2001, FUNGAL GENET BIOL, V33, P195, DOI 10.1006/fgbi.2001.1281; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Voegele RT, 2003, NEW PHYTOL, V159, P93, DOI 10.1046/j.1469-8137.2003.00761.x; Wessling R, 2012, FUNGAL GENET BIOL, V49, P470, DOI 10.1016/j.fgb.2012.04.001; Whigham E, 2015, MOL PLANT MICROBE IN, V28, P968, DOI 10.1094/MPMI-02-15-0027-FI; Wicker T, 2013, NAT GENET, V45, P1092, DOI 10.1038/ng.2704; Wiersma AT, 2017, THEOR APPL GENET, V130, P1123, DOI 10.1007/s00122-017-2874-8; WOLF G, 1981, PHYTOPATHOLOGY, V71, P596, DOI 10.1094/Phyto-71-596; Zeng FS, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01146; Zhang WJ, 2012, MOL PLANT PATHOL, V13, P1110, DOI 10.1111/j.1364-3703.2012.00820.x	71	9	9	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0198891	10.1371/journal.pone.0198891	http://dx.doi.org/10.1371/journal.pone.0198891			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975700	gold, Green Published, Green Submitted			2022-12-26	WOS:000437424500012
J	Huang, B; Zhang, Q; Yuan, Y; Xin, N; He, K; Huang, Y; Tang, H; Gong, P				Huang, Bo; Zhang, Qin; Yuan, Ying; Xin, Na; He, Kun; Huang, Yan; Tang, Hua; Gong, Ping			Sema3a inhibits the differentiation of Raw264.7 cells to osteoclasts under 2Gy radiation by reducing inflammation	PLOS ONE			English	Article							SEMAPHORIN 3A; BONE LOSS; OSTEOPOROSIS; IRRADIATION; EXPRESSION; RECEPTORS; MICE	Astronauts and cancer patients receive different types of radiation, and radiation decreases bone strength and leads to radiation-induced osteoporosis. This effect is attributed to the activation of osteoclasts. Our aim was to study the effect of Sema3a on the differentiation of the murine macrophage cell line Raw264.7 into osteoclasts upon irradiation. Raw264.7 cells were divided into four groups: A, receiving no radiation; B, receiving no radiation + 50ngng/ml Sema3a; C, receiving 2Gy radiation; and D, receiving 2Gy radiation +50ngng/ml Sema3a. After treatment, cells were subjected to a proliferation assay, migration assay, live and apoptosis assay, and an ROS assay, along with analyses of bone resorption activity, TRAP staining and RT-PCR to assess the effect of Sema3a on Raw264.7 cells under 2Gy radiation. Sema3a inhibited the proliferation of Raw264.7 cells and showed statistical significance at a concentration of 100ngng/ml (P<0.05). Under 2Gy radiation, cell migration was reduced (P<0.05). In addition, 2Gy radiation resulted in more apoptotic cells, a higher level of ROS, larger bone resorption lacunae and more Trap-positive cells (p<0.05), and radiation increased CSTK, NFAT, TRAP-5b, Rankl/OPG, IL-1, IL-6, TNFa and P53 gene expression (P<0.05). Sema3a had an inhibitory effect on the differentiation of Raw264.7 cells and the migration and activity of osteoclasts upon irradiation but did not affect ROS. Sema3a also decreased the expression of CSTK, NFAT, TRAP-5b, Rankl/OPG, IL-1, IL-6 and TNFa on the 3rd and 7th days after irradiation (p<0.05), whereas P53 expression was increased (P<0.05). Sema3a reduced the inflammation induced by radiation and negatively regulated osteoclast differentiation. Sema3a promoted Raw264.7 cell apoptosis after irradiation, indicating that Sema3a could be a potential therapeutic target for radiation-induced osteoporosis.	[Huang, Bo; Zhang, Qin; Yuan, Ying; Xin, Na; Huang, Yan] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; [Huang, Bo; Zhang, Qin; Yuan, Ying; Xin, Na; He, Kun; Tang, Hua; Gong, Ping] Sichuan Univ, West China Hosp Stomatol, Dent Implant Ctr, Chengdu, Sichuan, Peoples R China; [Huang, Yan] Univ Leuven, Oral Imaging Ctr, Dept Imaging & Pathol, OMFS IMPATH Res Grp,Biomed Sci Grp, Leuven, Belgium	Sichuan University; Sichuan University; KU Leuven	Tang, H; Gong, P (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dent Implant Ctr, Chengdu, Sichuan, Peoples R China.	tanghua@126.com; dentistgong@hotmail.com	Huang, Bo/AAF-8433-2019	Gong, Ping/0000-0002-4782-1741	National Natural Science Foundation of China [813009061, 81571008]; ITI research Grant [973_2014]; Research Foundation Flanders; Research Foundation Flanders (FWO)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ITI research Grant; Research Foundation Flanders(FWO); Research Foundation Flanders (FWO)(FWO)	This work was supported by National Natural Science Foundation of China. NO.813009061(HT) and NO.81571008()PG, and ITI research Grant NO. 973_2014(HT). Y.H. gratefully acknowledges financial support from the Research Foundation Flanders (YH). The wedsite of the fundings are https://isisn.nsfc.gov.cn/egrantweb/ and https://www.iti.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (NO. 813009061 and NO. 81571008) and ITI research Grant NO. 973_2014. Y.H. gratefully acknowledges financial support from the Research Foundation Flanders (FWO).	Akmansu M, 2005, CYTOKINE, V31, P41, DOI 10.1016/j.cyto.2005.02.009; Alwood JS, 2015, J INTERF CYTOK RES, V35, P480, DOI 10.1089/jir.2014.0152; Bai Miaomiao, 2015, CURRENT PROTEIN PEPT, V16; Carlos RJ, 2013, ARTERIOSCLER THROMB, V33, P1881, DOI [10.1161/ATVBAHA.113.301331, DOI 10.1161/ATVBAHA.113.301331]; Catalano A, 2010, J IMMUNOL, V185, P6373, DOI 10.4049/jimmunol.0903527; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Green DE, 2012, J BONE MINER RES, V27, P749, DOI 10.1002/jbmr.1505; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Hong M, 2011, REND FIS ACC LINC S1, V25, pS65; Horton JA, 2013, STEM CELLS, V31, P2231, DOI 10.1002/stem.1483; Ji JD, 2009, HUM IMMUNOL, V70, P211, DOI 10.1016/j.humimm.2009.01.026; Kondo H, 2009, RADIAT RES, V171, P283, DOI 10.1667/RR1463.1; Kozuka T., 1992, EUR RADIOL, V2, P322, DOI [10.1007/bf00175435, DOI 10.1007/BF00175435]; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Li YF, 2015, J ORTHOP SCI, V20, P1114, DOI 10.1007/s00776-015-0771-z; Li ZX, 2017, FRONT CELL NEUROSCI, V11, DOI [10.3389/fncel.2017.00040, 10.3389/fncel.2017.00042]; Lin ZW, 2012, ADV SPACE RES, V49, P797, DOI 10.1016/j.asr.2011.11.025; Liu TT, 2014, REND LINCEI-SCI FIS, V25, pS17, DOI 10.1007/s12210-013-0277-6; Mukherjee D, 2014, J PATHOL, V232, P289, DOI 10.1002/path.4299; REN X, 2014, CELL ADHES MIGR, V8, P5; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; Sawajiri M, 2003, RADIAT ENVIRON BIOPH, V42, P219, DOI 10.1007/s00411-003-0204-9; Sibonga JD, 2013, CURR OSTEOPOROS REP, V11, P92, DOI 10.1007/s11914-013-0136-5; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Sujin Kanga, 2014, SEMINARS CELL DEV BI, V24, P163; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Takashi Sakai, 2014, J DERMATOLOGICAL SCI, P7667; Tamagnone L, 2004, EMBO REP, V5, P356, DOI 10.1038/sj.embor.7400114; Tanaka J, 2015, INT J OPHTHALMOL-CHI, V8, P1, DOI 10.3980/j.issn.2222-3959.2015.01.01; Verlinden L, 2013, BONE, V55, P465, DOI 10.1016/j.bone.2013.03.023; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; Willey JS, 2011, CLIN REV BONE MINER, V9, P54, DOI 10.1007/s12018-011-9092-8; Willey JS, 2010, BONE, V46, P101, DOI 10.1016/j.bone.2009.09.002; Willey Jeffrey S, 2013, CANC BONE, V19, P728; Willey JS, 2009, RADIAT RES, V170, P388; Yang B, 2012, MOL MED REP, V5, P955, DOI 10.3892/mmr.2012.765; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Yer KC, 2014, CLIN ORAL IMPLAN RES, V17, P337	40	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200000	10.1371/journal.pone.0200000	http://dx.doi.org/10.1371/journal.pone.0200000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975739	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500058
J	Lin, WJ; Huang, W; Ning, SJ; Wang, XH; Ye, Q; Wei, D				Lin, Wenjin; Huang, Wei; Ning, Shuju; Wang, Xiaohua; Ye, Qi; Wei, Daozhi			De novo characterization of the Baphicacanthus cusia(Nees) Bremek transcriptome and analysis of candidate genes involved in indican biosynthesis and metabolism	PLOS ONE			English	Article							ISATIS-INDIGOTICA FORT; RNA-SEQ; ULCERATIVE-COLITIS; POLYGONUM-TINCTORIUM; STROBILANTHES-CUSIA; OIL LINDIOIL; QING-DAI; EFFICACY; LEAVES; LEAF	Baphicacanthus cusia (Nees) Bremek is an herb widely used for the clinical treatment of colds, fever, and influenza in Traditional Chinese Medicine. The roots, stems and leaves can be used as natural medicine, in which indigo and indirubin are two main active ingredients. In this study, quantification of indigo, indirubin, indican and adenosine among various tissues of B. cusia was conducted using HPLC-DAD. Leaves have significantly higher contents than stems and roots (380.66, 315.15, 20,978.26, 4323.15 mu g/g in leaves, 306.36, 71.71, 3,056.78, 139.45 mu g/g in stems, and 9.31, 7.82, 170.45, 197.48 mu g/g in roots, respectively). De novo transcriptome sequencing of B. cusia was performed for the first time. The sequencing yielded 137,216,248, 122,837,394 and 140,240,688 clean reads from leaves, stems and roots respectively, which were assembled into 51,381 unique sequences. A total of 33,317 unigenes could be annotated using the databases of Nr, Swiss-Prot, KEGG and KOG. These analyses provided a detailed view of the enzymes involved in indican backbone biosynthesis, such as cytochrome P450, UDP-glycosyltransferase, glucosidase and tryptophan synthase. Analysis results showed that tryptophan synthase was the candidate gene involved in the tissue-specific biosynthesis of indican. We also detected sixteen types of simple sequence repeats in RNA-Seq data for use in future molecular mark assisted breeding studies. The results will be helpful in further analysis of B. cusia functional genomics, especially in increasing biosynthesis of indican through biotechnological approaches and metabolic regulation.	[Lin, Wenjin; Huang, Wei; Wang, Xiaohua; Ye, Qi; Wei, Daozhi] Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou, Fujian, Peoples R China; [Lin, Wenjin] Fujian Acad Med Sci, Fujian Key Lab Med Measurement, Fuzhou, Fujian, Peoples R China; [Ning, Shuju] Fujian Agr & Forestry Univ, Sch Crop Sci, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Wei, D (corresponding author), Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou, Fujian, Peoples R China.	Weidz888@sohu.com		Lin, Wenjin/0000-0002-4568-486X; Wei, Daozhi/0000-0002-3776-3023	National Natural Science Foundation of China [81573517]; Fujian Provincial Hospital, Fujian province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Provincial Hospital, Fujian province, China	This work was funded by 81573517, National Natural Science Foundation of China, https://isisn.nsfc.gov.cn; and 2017, high-level hospital grants from Fujian Provincial Hospital, Fujian province, China, http://www.fjsl.com.cn/.	[Anonymous], 2015, PHARMACOPOEIA PEOPLE; Betts NS, 2017, PLANT J, V91, P754, DOI 10.1111/tpj.13600; Braynen J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00768; Chen JF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-857; Committee E, 2002, FLORA REIPUBLICAE PO; Feng YZ, 2016, J AGR FOOD CHEM, V64, P3712, DOI 10.1021/acs.jafc.5b05918; Gilbert KG, 2004, BIOTECHNOL PROGR, V20, P1289, DOI 10.1021/bp0300624; Gu W, 2014, J NAT PROD, V77, P2590, DOI 10.1021/np5003274; Ho YL, 2003, AM J CHINESE MED, V31, P61, DOI 10.1142/S0192415X03000783; Hou Hui-chan, 2006, Zhong Yao Cai, V29, P681; Hu ZG, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/484670; Hua WP, 2014, MOL BIOL REP, V41, P4817, DOI 10.1007/s11033-014-3352-x; Hua YJ, 2016, GENE, V588, P7, DOI 10.1016/j.gene.2016.04.043; Li Jian-hong, 2014, Zhongguo Zhong Yao Za Zhi, V39, P3442; Li YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125722; Liau BC, 2007, J PHARMACEUT BIOMED, V43, P346, DOI 10.1016/j.jpba.2006.06.029; Lin YK, 2015, JAMA DERMATOL, V151, P672, DOI 10.1001/jamadermatol.2014.5460; Lin YK, 2014, PHYTOMEDICINE, V21, P1015, DOI 10.1016/j.phymed.2014.02.013; Mak NK, 2004, BIOCHEM PHARMACOL, V67, P167, DOI 10.1016/j.bcp.2003.08.020; Marcinek H, 2000, PHYTOCHEMISTRY, V53, P201, DOI 10.1016/S0031-9422(99)00430-6; Minami Y, 1997, PLANT CELL PHYSIOL, V38, P1069, DOI 10.1093/oxfordjournals.pcp.a029273; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NP C, 2015, PHARMACOPOEIA PEOPLE, P199; Rai A, 2017, J NAT MED-TOKYO, V71, P1, DOI 10.1007/s11418-016-1041-x; Sarangi BK, 2015, GENOM DATA, V6, P212, DOI 10.1016/j.gdata.2015.09.021; Scully ED, 2018, NEW PHYTOL, V217, P82, DOI 10.1111/nph.14815; Senthil K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1214-0; Song ZQ, 2017, INT J GENOMICS, V2017, DOI 10.1155/2017/9364594; Sugimoto S, 2016, J GASTROENTEROL, V51, P853, DOI 10.1007/s00535-016-1220-2; Sugimoto S, 2016, DIGESTION, V93, P193, DOI 10.1159/000444217; Suzuki H, 2013, WORLD J GASTROENTERO, V19, P2718, DOI 10.3748/wjg.v19.i17.2718; Tang XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102963; Tozzi S, 2005, PHOTOCHEM PHOTOBIOL, V81, P914, DOI 10.1562/2004-08-03-RA-258R1.1; Wang G, 2015, GENE, V555, P458, DOI 10.1016/j.gene.2014.10.058; Warzecha H, 2007, PLANT BIOTECHNOL J, V5, P185, DOI 10.1111/j.1467-7652.2006.00231.x; Wei SG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169177; Xiang Xiao-liang, 2010, Yingyong Shengtai Xuebao, V21, P689; Zhang L, 2016, PLANT BIOTECHNOL J, V14, P2217, DOI 10.1111/pbi.12576; Zhang L, 2016, GENE, V576, P150, DOI 10.1016/j.gene.2015.09.083; Zhang X, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/6735209; Zhang XR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147849; Zhao XH, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1475-4; Zhou BX, 2017, J ETHNOPHARMACOL, V199, P60, DOI 10.1016/j.jep.2017.01.038; Zhou J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00121; Zhou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116392; Zhu YY, 2015, GENE, V555, P362, DOI 10.1016/j.gene.2014.11.032	46	14	18	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199788	10.1371/journal.pone.0199788	http://dx.doi.org/10.1371/journal.pone.0199788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975733	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500047
J	Shibasaki, K; Asahi, T; Mizobuchi, K; Akishita, M; Ogawa, S				Shibasaki, Koji; Asahi, Toshiomi; Mizobuchi, Keiko; Akishita, Masahiro; Ogawa, Sumito			Rehabilitation strategy for hip fracture, focused on behavioral psychological symptoms of dementia for older people with cognitive impairment: A nationwide Japan rehabilitation database	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; FUNCTIONAL RECOVERY; ALZHEIMERS-DISEASE; ELDERLY-PATIENTS; GERIATRIC REHABILITATION; DEPRESSIVE SYMPTOMS; EXERCISE PROGRAM; ASSOCIATION; AGITATION; OUTCOMES	The aim is to investigate the relationship between a positive outcome on rehabilitation after hip fracture and behavioral psychological symptoms of dementia (BPSD) transition during rehabilitation. This study is a retrospective cohort study based on the Japan Rehabilitation Database. We recruited 756 subjects 65 years of age or older from 31 hospitals in the database. All subjects were in the hospital as patients undergoing rehabilitation for hip fracture. Functional independence measure (FIM), walking ability, Mini-Mental State Examination (MMSE), and BPSD were measured both at the beginning and at the end of rehabilitation. MMSE for 23 or under was defined as the cognitive-impaired group. MMSE for 24 or over was used as the cognitively intact group. Cognitive impaired participants were divided into four groups: participants presented no BPSD both at the beginning of rehabilitation and at the end of rehabilitation (Group (-/-)), participants presented BPSD at the beginning of rehabilitation but resolved at the end of rehabilitation (Group (+/-)), participants had no BPSD at the beginning of rehabilitation but appeared at the end of rehabilitation (Group (-/+)) and participants had sign of BPSD both at the beginning of rehabilitation and at the end of rehabilitation (Group (+/+)). The endpoints were waking ability, FIM gain. As results, one hundred thirty-seven cognitive-impaired older people patients out of 471 (29.1%) suffered from BPSD at the beginning of rehabilitation. FIM gains in cognitively intact group, Group (-/-), Group (+/-), Group (-/+) and Group (+/+) were 24.8 +/- 18.7, 17.5 +/- 16.9, 27.3 +/- 19.7, 17.8 +/- 12.2 and 12.2 +/- 17.2, respectively. The Group (+/-) was significantly connected to a positive outcome for rehabilitation. The present study suggested that the management of BPSD can lead to better functional recovery during rehabilitation.	[Shibasaki, Koji; Akishita, Masahiro; Ogawa, Sumito] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan; [Asahi, Toshiomi; Mizobuchi, Keiko] Asahi Neurol & Rehabil Hosp, Matsudo, Chiba, Japan	University of Tokyo	Ogawa, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan.	suogawa-tky@umin.ac.jp			Japan Hip Joint Foundation	Japan Hip Joint Foundation	This work was supported by the Japan Hip Joint Foundation.	Antonsdottir IM, 2015, EXPERT OPIN PHARMACO, V16, P1649, DOI 10.1517/14656566.2015.1059422; Barton C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-015-0618-1; Bostrom G, 2016, INT J GERIATR PSYCH, V31, P868, DOI 10.1002/gps.4401; Brodaty H, 2012, AM J GERIAT PSYCHIAT, V20, P549, DOI 10.1097/JGP.0b013e31822be242; Bruggemann L, 2007, J BEHAV MED, V30, P97, DOI 10.1007/s10865-006-9088-x; BUCHNER DM, 1987, JAMA-J AM MED ASSOC, V257, P1492, DOI 10.1001/jama.257.11.1492; Craig Jacqueline, 2014, Nurs Times, V110, P12; Crocco Elizabeth A, 2005, Curr Psychiatry Rep, V7, P32, DOI 10.1007/s11920-005-0021-8; Daniels Alan H, 2014, Am J Orthop (Belle Mead NJ), V43, pE146; de Oliveira AM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/218980; Ferrero-Arias J, 2011, ALZ DIS ASSOC DIS, V25, P213, DOI 10.1097/WAD.0b013e3182087dbc; Friedman SM, 2010, GERIATR ORTHOP SURG, V1, P52, DOI 10.1177/2151458510389463; Givens JL, 2008, J AM GERIATR SOC, V56, P1075, DOI 10.1111/j.1532-5415.2008.01711.x; Hebert-Davies J, 2012, INJURY, V43, P1978, DOI 10.1016/j.injury.2012.08.061; Hedman AMR, 2008, INT J OLDER PEOPLE N, V3, P178, DOI 10.1111/j.1748-3743.2008.00131.x; Jalbert JJ, 2010, J AM MED DIR ASSOC, V11, P120, DOI 10.1016/j.jamda.2009.10.001; Johansson C, 1996, AGING CLIN EXP RES, V8, P189, DOI 10.1007/BF03339676; Tarazona-Santabalbina FJ, 2015, GERIATR GERONTOL INT, V15, P289, DOI 10.1111/ggi.12271; Koenig AM, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-015-0640-7; Lee HB, 2011, J AM GERIATR SOC, V59, P2306, DOI 10.1111/j.1532-5415.2011.03725.x; Livingston G, 2014, BRIT J PSYCHIAT, V205, P436, DOI 10.1192/bjp.bp.113.141119; Lopez MG, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0135-8; Mitchell R, 2016, DISABIL REHABIL, V38, P2286, DOI 10.3109/09638288.2015.1123306; Momosaki R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122688; Morghen S, 2011, J AM GERIATR SOC, V59, P1497, DOI 10.1111/j.1532-5415.2011.03496.x; Mundi S, 2014, CAN J SURG, V57, pE141, DOI 10.1503/cjs.023413; O'Neil M. E., 2011, VA EVIDENCE BASED SY; Panza F, 2015, EXPERT OPIN PHARMACO, V16, P2581, DOI 10.1517/14656566.2015.1092520; Piscitelli P, 2012, CLIN CASES MINER BON, V9, P40; Poynter L, 2013, INT J CLIN PRACT, V67, P811, DOI 10.1111/ijcp.12161; Poynter L, 2011, J AM GERIATR SOC, V59, P2108, DOI 10.1111/j.1532-5415.2011.03658.x; Resnick B, 2016, J AM MED DIR ASSOC, V17, P200, DOI 10.1016/j.jamda.2015.10.004; Rosler A, 2009, ARCH GERONTOL GERIAT, V49, pE36, DOI 10.1016/j.archger.2008.08.003; Schaller F, 2012, BONE, V51, P347, DOI 10.1016/j.bone.2012.06.004; Schiffczyk C, 2013, DEMENT GERIATR COGN, V35, P300, DOI 10.1159/000348357; Schwenk M, 2014, J ALZHEIMERS DIS, V39, P487, DOI 10.3233/JAD-130470; Seematter-Bagnoud L, 2013, ARCH PHYS MED REHAB, V94, P2373, DOI 10.1016/j.apmr.2013.06.024; Seematter-Bagnoud L, 2012, J AM MED DIR ASSOC, V13, P692, DOI 10.1016/j.jamda.2012.05.006; Seitz DP, 2016, J AM GERIATR SOC, V64, P47, DOI 10.1111/jgs.13881; Seitz DP, 2014, J AM MED DIR ASSOC, V15, P334, DOI 10.1016/j.jamda.2013.12.011; Seitz DP, 2011, J AM MED DIR ASSOC, V12, P556, DOI 10.1016/j.jamda.2010.12.001; Shiri-Sharvit O, 2005, ARCH PHYS MED REHAB, V86, P1389, DOI 10.1016/j.apmr.2004.12.034; Stenvall M, 2012, ARCH GERONTOL GERIAT, V54, pE284, DOI 10.1016/j.archger.2011.08.013; Stromberg L, 1997, SCAND J CARING SCI, V11, P167, DOI 10.1111/j.1471-6712.1997.tb00450.x; Toba K, 2014, GERIATR GERONTOL INT, V14, P206, DOI 10.1111/ggi.12080; Tsuda Y, 2015, ARCH ORTHOP TRAUM SU, V135, P1511, DOI 10.1007/s00402-015-2321-8; Uriz-Otano F, 2015, J AM MED DIR ASSOC, V16, P215, DOI 10.1016/j.jamda.2014.09.009; Wang F, 2016, CURR NEUROPHARMACOL, V14, P307, DOI 10.2174/1570159X14666151208114232; Weller I, 2004, ANN EPIDEMIOL, V14, P319, DOI 10.1016/j.annepidem.2003.08.005; who, DEMENTIA; Yoshii I, 2016, J ORTHOP SCI, V21, P481, DOI 10.1016/j.jos.2016.03.005; Zerah L, 2017, J ALZHEIMERS DIS, V56, P145, DOI 10.3233/JAD-160655	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200143	10.1371/journal.pone.0200143	http://dx.doi.org/10.1371/journal.pone.0200143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL7YG	29975757	gold, Green Submitted, Green Published			2022-12-26	WOS:000437424500070
J	Chotipanich, J; Abu Bakar, SH; Arponwichanop, A; Yonezawa, T; Kheawhom, S				Chotipanich, Jutamart; Abu Bakar, Suraya Hanim; Arponwichanop, Amornchai; Yonezawa, Tetsu; Kheawhom, Soorathep			Copper conductive patterns through spray-pyrolysis of copper-diethanolamine complex solution	PLOS ONE			English	Article							LOW-TEMPERATURE; THERMAL-DECOMPOSITION; INK; FILM; PARTICLES; MORPHOLOGY; MECHANISM; SUBSTRATE; GRAPHENE; GROWTH	A simple and low-cost method to fabricate copper conductive patterns at low temperature is critical for printed electronics. Low-temperature spray-pyrolysis of copper-alkanolamine complex solution shows high potential for this application. However, the produced copper patterns exhibit a granular structure consisting of connected fine copper particles. In this work, low-temperature spray-pyrolysis of copper formate-diethanolamine complex solution under N-2 flow at a temperature of 200 degrees C was investigated. The effects of spraying conditions on microstructure and electrical properties of the patterns were examined. Our results revealed that the spraying rate is a critical parameter determining the degree of sintering and electrical resistivity of the patterns. A low spraying rate facilitates sintering, and hence well-sintered copper patterns with the lowest resistivity of 6.12 mu Omega.cm (3.6 times of bulk copper) on a polyimide substrate could be fabricated.	[Chotipanich, Jutamart; Abu Bakar, Suraya Hanim; Arponwichanop, Amornchai; Kheawhom, Soorathep] Chulalongkorn Univ, Fac Engn, Dept Chem Engn, Bangkok, Thailand; [Arponwichanop, Amornchai; Kheawhom, Soorathep] Chulalongkorn Univ, Computat Proc Engn Res Unit, Bangkok, Thailand; [Yonezawa, Tetsu] Hokkaido Univ, Fac Engn, Div Mat Sci & Engn, Sapporo, Hokkaido, Japan	Chulalongkorn University; Chulalongkorn University; Hokkaido University	Kheawhom, S (corresponding author), Chulalongkorn Univ, Fac Engn, Dept Chem Engn, Bangkok, Thailand.; Kheawhom, S (corresponding author), Chulalongkorn Univ, Computat Proc Engn Res Unit, Bangkok, Thailand.	soorathep.k@chula.ac.th	Kheawhom, Soorathep/L-2683-2018; Yonezawa, Tetsu/E-5514-2012; Hanim, Suraya/AAG-8001-2020	Kheawhom, Soorathep/0000-0002-3129-2750; Arpornwichanop, Amornchai/0000-0001-9259-5010	Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission [NRU-59-051-EN]; Rachadapisek Sompote Fund, Chulalongkorn University; Hokkaido University; Canon Foundation	Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission; Rachadapisek Sompote Fund, Chulalongkorn University; Hokkaido University; Canon Foundation(Canon Foundation)	The Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission (NRU-59-051-EN) is acknowledged. S.H. thanks the support from Rachadapisek Sompote Fund for postdoctoral Fellowship, Chulalongkorn University. T.Y. thanks the partial support from Hokkaido University and Canon Foundation. S.K. thanks Hokkaido University for the financial support for his stay in Sapporo.	Aiyer HN, 1999, J PHYS D APPL PHYS, V32, P1, DOI 10.1088/0022-3727/32/1/002; Amalina MN, 2013, PROCEDIA ENGINEER, V56, P731, DOI 10.1016/j.proeng.2013.03.186; Bedia A, 2015, ENRGY PROCED, V74, P529, DOI 10.1016/j.egypro.2015.07.740; Bromberg V, 2013, J MATER CHEM C, V1, P6842, DOI 10.1039/c3tc31361a; BYERLEY JJ, 1969, CAN J CHEMISTRY, V47, P3355, DOI 10.1139/v69-556; Cho S, 2016, J MATER CHEM C, V4, P10740, DOI 10.1039/c6tc04145k; Donthu SK, 2003, J ELECTRON MATER, V32, P531, DOI 10.1007/s11664-003-0138-7; Farraj Y, 2015, CHEM COMMUN, V51, P1587, DOI 10.1039/c4cc08749f; Gao YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045485; Greer JR, 2007, ACTA MATER, V55, P6345, DOI 10.1016/j.actamat.2007.07.040; Hallam T, 2015, PHYS STATUS SOLIDI B, V252, P2429, DOI 10.1002/pssb.201552269; Hwang J, 2014, B KOREAN CHEM SOC, V35, P147, DOI 10.5012/bkcs.2014.35.1.147; Jeong S, 2013, J MATER CHEM C, V1, P2704, DOI 10.1039/c3tc00904a; Kang HS, 2003, MATER LETT, V57, P1288, DOI 10.1016/S0167-577X(02)00973-4; Kheawhom S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.05DB14; Kim SJ, 2012, THIN SOLID FILMS, V520, P2731, DOI 10.1016/j.tsf.2011.11.056; Lee B, 2012, MET MATER INT, V18, P493, DOI 10.1007/s12540-012-3017-z; Lee J, 2014, APPL SURF SCI, V307, P42, DOI 10.1016/j.apsusc.2014.03.127; Leigh SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049365; Li WL, 2016, J MATER CHEM C, V4, P8802, DOI 10.1039/c6tc02914k; Mayanna SM, 1999, INDIAN J CHEM A, V38, P547; Ostfeld AE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15959; Panuthai N, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05HA11; Patil PS, 1999, MATER CHEM PHYS, V59, P185, DOI 10.1016/S0254-0584(99)00049-8; Perednis D, 2005, J ELECTROCERAM, V14, P103, DOI 10.1007/s10832-005-0870-x; Polino G, 2016, ORG ELECTRON, V34, P130, DOI 10.1016/j.orgel.2016.04.021; Raut NC, 2018, J MATER CHEM C, V6, P1618, DOI 10.1039/c7tc04804a; Saravanan V, 2015, J ANAL APPL PYROL, V111, P272, DOI 10.1016/j.jaap.2014.08.008; Shih SJ, 2014, POWDER TECHNOL, V264, P291, DOI 10.1016/j.powtec.2014.05.056; Shin DH, 2014, ACS APPL MATER INTER, V6, P3312, DOI 10.1021/am4036306; Song XY, 2006, J AM CERAM SOC, V89, P494, DOI 10.1111/j.1551-2916.2005.00777.x; Suren S, 2016, THIN SOLID FILMS, V607, P36, DOI 10.1016/j.tsf.2016.03.040; Wang BY, 2013, ACS APPL MATER INTER, V5, P4113, DOI 10.1021/am303268k; Wu XZ, 2017, NANOTECHNOLOGY, V28, DOI 10.1088/1361-6528/28/3/035203; Xu W, 2017, LANGMUIR, V33, P82, DOI 10.1021/acs.langmuir.6b03668; Yabuki A, 2014, MATER CHEM PHYS, V148, P299, DOI 10.1016/j.matchemphys.2014.07.047; Yabuki A, 2012, MATER RES BULL, V47, P4107, DOI 10.1016/j.materresbull.2012.08.052; YEO J, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0042315; Yonezawa T, 2016, RSC ADV, V6, P12048, DOI 10.1039/c5ra25058g; Yong YQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45150	40	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0200084	10.1371/journal.pone.0200084	http://dx.doi.org/10.1371/journal.pone.0200084			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969478	gold, Green Submitted, Green Published			2022-12-26	WOS:000437246700041
J	Luintel, H; Bluffstone, RA; Scheller, RM				Luintel, Harisharan; Bluffstone, Randall A.; Scheller, Robert M.			The effects of the Nepal community forestry program on biodiversity conservation and carbon storage	PLOS ONE			English	Article							FUELWOOD CHARACTERISTICS; PROPENSITY SCORE; TRADE-OFFS; TREE; BALANCE; WOOD; SEQUESTRATION; MULTIVARIATE; DYNAMICS; RESOURCE	Approximately 15.5% of global forest is controlled by similar to 1 billion local people and the area under community control is increasing. However, there is limited empirical evidence as to whether community control is effective in providing critical global ecosystem services, such as biodiversity conservation and carbon storage. We assess the effectiveness of one example of community-controlled forest, Nepal's Community Forestry Program (CFP), at providing biodiversity conservation and carbon storage. Using data from 620 randomly selected CFP and non-CFP forest plots, we apply a robust matching method based on covariates to estimate whether CFPs are associated with greater biodiversity conservation or carbon storage. Our results reveal a significant positive effect of CFP on biodiversity, which is robust against the influence of unobserved covariates. Our results also suggest a significant negative effect of the CFP on aboveground tree and sapling carbon (AGC) at the national scale (-15.11 Mg C ha(-1)). However, the CFP has a mixed effect on carbon across geographic and topographic regions and in forests with different canopy covers. Though there were no significant effects of the CFP on AGC at lower altitudes, in the Terai or hill regions, and under closed canopies, there were positive effects in open canopies (25.84 Mg C ha(-1)) at lower slopes (25.51 Mg C ha(-1)) and negative effects at higher altitudes (-22.81 Mg C ha(-1)) and higher slopes (-17.72 Mg C ha(-1)). Our sensitivity analysis revealed that the positive effects are robust to unobserved covariates, which is not true for the negative results. In aggregate, our results demonstrate that CFP can be an effective forest management strategy to contribute to global ecosystem services such as biodiversity, and to a lesser extent carbon.	[Luintel, Harisharan] SmartStart Res & Evaluat, Irvine, CA 92604 USA; [Luintel, Harisharan] ForestAct Nepal, Kathmandu, Nepal; [Bluffstone, Randall A.] Portland State Univ, Dept Econ, Portland, OR 97207 USA; [Scheller, Robert M.] North Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC USA	Portland State University; University of North Carolina; North Carolina State University	Luintel, H (corresponding author), SmartStart Res & Evaluat, Irvine, CA 92604 USA.; Luintel, H (corresponding author), ForestAct Nepal, Kathmandu, Nepal.	hluintel@gmail.com	Scheller, Robert M/B-3135-2009	Scheller, Robert M/0000-0002-7507-4499	World Bank Group [7161880, 7176679]	World Bank Group	This study was supported by the World Bank Group (grant # 7161880 and 7176679).	Acharya K. P., 2004, Journal of Forest and Livelihood, V4, P44; Agrawal A., 2008, DECENTRALIZATION FOR, P44; [Anonymous], 2015, STAT NEP FOR; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Beck T, 2001, WORLD DEV, V29, P119, DOI 10.1016/S0305-750X(00)00089-9; Beyene A. D., 2013, ENVIRON DEV ECON, P1; Bhatt BP, 2002, BIOMASS BIOENERG, V23, P257, DOI 10.1016/S0961-9534(02)00057-0; Bhattarai B., 2006, HANGING BALANCE EQUI, P143; Bluffstone RA, 2018, WORLD DEV, V101, P133, DOI 10.1016/j.worlddev.2017.07.030; Bottazzi P, 2014, DEV CHANGE, V45, P105, DOI 10.1111/dech.12076; Bowler DE, 2012, FRONT ECOL ENVIRON, V10, P29, DOI 10.1890/110040; Central Bureau of Statistics Nepal, 2011, NEP LIV STAND SURV 2; Charnley S, 2007, ANNU REV ANTHROPOL, V36, P301, DOI 10.1146/annurev.anthro.35.081705.123143; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Dehejia RH, 1999, J AM STAT ASSOC, V94, P1053, DOI 10.2307/2669919; Department of Forest, 2015, COMM FOR DAT; Diamond A, 2013, REV ECON STAT, V95, P932, DOI 10.1162/REST_a_00318; ECKHOLM EP, 1975, SCIENCE, V189, P764, DOI 10.1126/science.189.4205.764; Flint E. P, 1994, EFFECTS LAND USE CHA, P201; Gautam AP, 2002, MT RES DEV, V22, P63, DOI 10.1659/0276-4741(2002)022[0063:GAOLUL]2.0.CO;2; Gilmour D.A., 1991, VILLAGERS FORESTS FO; GILMOUR DA, 1990, FOREST ECOL MANAG, V32, P173, DOI 10.1016/0378-1127(90)90169-C; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Hansen BB, 2004, J AM STAT ASSOC, V99, P609, DOI 10.1198/016214504000000647; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Heinrich C., 2010, IDBTN161; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Imai K, 2008, J R STAT SOC A STAT, V171, P481, DOI 10.1111/j.1467-985X.2007.00527.x; Jackson J. K, 1994, MANUAL AFFORESTATION; Jain RK, 1999, BIORESOURCE TECHNOL, V68, P305, DOI 10.1016/S0960-8524(98)00173-4; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kandel P, 2016, SMALL-SCALE FOR, V15, P481, DOI 10.1007/s11842-016-9335-0; Kanel K. R., 2001, Journal of Tropical Forest Science, V13, P691; Kanel K.R., 2004, BANKO JANAKARI, V14, P19; Kataki R, 2002, BIOMASS BIOENERG, V22, P433, DOI 10.1016/S0961-9534(02)00026-0; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; Lamlom SH, 2003, BIOMASS BIOENERG, V25, P381, DOI 10.1016/S0961-9534(03)00033-3; Larson AM, 2008, ANNU REV ENV RESOUR, V33, P213, DOI 10.1146/annurev.environ.33.020607.095522; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; MacDicken K., 1997, GUIDE MONITORING CAR; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Ministry of Forest and Soil Conservation, 2000, FOR POL NEP 2000; Ministry of Forest and Soil Conservation, 2010, CARB MEAS GUID; Ministry of Forest and Soil Conservation, 1988, MAST PLAN FOR SECT; Ministry of Forests and Soil Conservation, 2013, PERS CHANG REV 30 YE; Ministry of Forests and Soil Conservation (MoFSC), 2014, NEP NAT BIOD STRAT A; Ministry of Law and Justice, 1993, FOR ACT OF NEP; Ministry of Law and Justice, 1995, FOR REG NEP; Mittermeier Russell A., 2004, P1; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; Ngugi MR, 2011, ECOL MODEL, V222, P785, DOI 10.1016/j.ecolmodel.2010.09.022; Niraula RR, 2013, J ENVIRON MANAGE, V126, P20, DOI 10.1016/j.jenvman.2013.04.006; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pandey SS, 2014, ENVIRON SCI POLICY, V38, P272, DOI 10.1016/j.envsci.2014.01.005; Pattanayak S.K., 2009, ROUGH GUIDE IMPACT E; Pokharel B, 2007, J COMMUNITY LIVELIHO, V6, P8; Rights and Resources Initiative, 2014, WHAT FUT REF PROGR S; Robinson EJZ, 2012, ENVIRON DEV ECON, V17, P1, DOI 10.1017/S1355770X11000209; Rosenbaum P. R., 2002, OBSERVATIONAL STUDIE; Rosenbaum PR, 2007, BIOMETRICS, V63, P456, DOI 10.1111/j.1541-0420.2006.00717.x; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; RUBIN DB, 1980, BIOMETRICS, V36, P293, DOI 10.2307/2529981; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Rubin DB, 2001, HLTH SERV OUTCOME RE, V2, P169, DOI 10.1023/A:1020363010465; Saxena A. K., 1987, VEGETATION, V50, P3, DOI DOI 10.1007/BF00120674; Sekhon JS, 2011, J STAT SOFTW, V42, P1; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; Shrestha Bharat Babu, 2006, Tropical Ecology, V47, P201; Shrestha U. B., 2010, International Journal of Biodiversity and Conservation, V2, P98; Tamrakar P.R., 2000, BIOMASS VOLUME TABLE; Thapa-Magar KB, 2015, J SUSTAIN FOREST, V34, P483, DOI 10.1080/10549811.2015.1031251; Wihersaari M, 2005, BIOMASS BIOENERG, V28, P435, DOI 10.1016/j.biombioe.2004.11.007; World Bank, 2001, COMM FOR NEP PREC, V217, P1; Yadav N. P., 2003, Journal of Forest and Livelihood, V3, P37	78	25	27	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199526	10.1371/journal.pone.0199526	http://dx.doi.org/10.1371/journal.pone.0199526			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK7JR	29944704	Green Published, gold			2022-12-26	WOS:000436377800040
J	Na, R; Bi, TY; Tjan, BS; Liu, ZL; Fang, F				Na, Ren; Bi, Taiyong; Tjan, Bosco S.; Liu, Zili; Fang, Fang			Effect of task difficulty on blood-oxygen-level-dependent signal: A functional magnetic resonance imaging study in a motion discrimination task	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; PERCEPTUAL DECISION; RESPONSE FUNCTIONS; COGNITIVE DEMANDS; PREFRONTAL CORTEX; WORKING-MEMORY; BASAL GANGLIA; FMRI; ATTENTION; BRAIN	There is much evidence that neural activity in the human brain is modulated by task difficulty, particularly in visual, frontal, and parietal cortices. However, some basic psychophysical tasks in visual perception do not give rise to this expected effect, at least not in the visual cortex. In the current study, we used functional magnetic resonance imaging (fMRI) to record brain activity while systematically manipulating task difficulty in a motion discrimination task, by varying the angular difference between the motion direction of random dots and a reference direction. We used both a blocked and an event-related design, and presented stimuli in both central and peripheral vision. The behavioral psychometric function, across angular differences of 3 degrees, 9 degrees, 15 degrees, or 80 degrees, spanned the full response range, as expected. The mean blood oxygen level dependent (BOLD) signals were also correlated within-participants between the blocked and event-related designs, across all brain areas tested. Within the visual cortex, the voxel response patterns correlated more within-conditions (e.g., 3 degrees and 3 degrees) than between-conditions (e.g., 3 degrees and 9 degrees), in both designs, further attesting to the reasonable quality of the BOLD data. Nevertheless, the BOLD-o-metric functions (i.e., BOLD activity as a function of task difficulty) were flat in the whole-brain and region-of-interest (ROI) analyses, including in the visual cortex, the parietal cortex, in both designs, and in foveal and peripheral visual fields alike. Indeed, there was little difference between BOLD activity during the 3 degrees and 80 degrees conditions. Some suggestive evidence of difficulty modulation was revealed only in the superior and inferior frontal gyri for the blocked design. We conclude that, in motion discrimination, there is no systematic BOLD modulation that accompanies the standard psychometric function across different hierarchies of cortical areas, except for the frontal lobe of the brain.	[Na, Ren; Fang, Fang] Sch Psychol & Cognit Sci, Beijing, Peoples R China; [Na, Ren; Fang, Fang] Beijing Key Lab Behav & Mental Hlth, Beijing, Peoples R China; [Na, Ren; Fang, Fang] Minist Educ, Key Lab Machine Percept, Beijing, Peoples R China; [Na, Ren; Fang, Fang] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Bi, Taiyong] Zunyi Med Univ, Sch Management, Zunyi, Guizhou, Peoples R China; [Tjan, Bosco S.] Univ Southern Calif, Dept Psychol, Los Angeles, CA USA; [Liu, Zili] UCLA, Dept Psychol, Los Angeles, CA 90095 USA; [Fang, Fang] Peking Univ, PKU DG McGovern Inst Brain Res, Beijing, Peoples R China	Zunyi Medical University; University of Southern California; University of California System; University of California Los Angeles; Peking University	Fang, F (corresponding author), Sch Psychol & Cognit Sci, Beijing, Peoples R China.; Fang, F (corresponding author), Beijing Key Lab Behav & Mental Hlth, Beijing, Peoples R China.; Fang, F (corresponding author), Minist Educ, Key Lab Machine Percept, Beijing, Peoples R China.; Fang, F (corresponding author), Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.; Liu, ZL (corresponding author), UCLA, Dept Psychol, Los Angeles, CA 90095 USA.; Fang, F (corresponding author), Peking Univ, PKU DG McGovern Inst Brain Res, Beijing, Peoples R China.	zili@psych.ucla.edu; ffang@pku.edu.cn			MOST (Ministry of Science and Technology) [2015CB351800]; NSFC (National Natural Science Foundation of China) [31421003, NSFC 61621136008, NSFC 61527804, NSFC 31671168]	MOST (Ministry of Science and Technology); NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC))	This work is supported by MOST (Ministry of Science and Technology) 2015CB351800, NSFC (National Natural Science Foundation of China) 31421003, NSFC 61621136008, NSFC 61527804, and NSFC 31671168.	Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Boudreau CE, 2006, J NEUROPHYSIOL, V96, P2377, DOI 10.1152/jn.01072.2005; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; DEMB JB, 1995, J NEUROSCI, V15, P5870; Desai R, 2006, J COGNITIVE NEUROSCI, V18, P278, DOI 10.1162/089892906775783633; Drager B, 2004, NEUROIMAGE, V23, P1152, DOI 10.1016/S1053-8119(04)00370-2; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gould RL, 2003, NEUROIMAGE, V20, P1006, DOI 10.1016/S1053-8119(03)00365-3; Hagen GF, 2006, INT J PSYCHOPHYSIOL, V59, P8, DOI 10.1016/j.ijpsycho.2005.08.003; Haxby JV, 2012, NEUROIMAGE, V62, P852, DOI 10.1016/j.neuroimage.2012.03.016; Herath P, 2001, CEREB CORTEX, V11, P796, DOI 10.1093/cercor/11.9.796; Jeter PE, 2009, J VISION, V9, DOI 10.1167/9.3.1; Kay KN, 2017, ELIFE, V6, DOI 10.7554/eLife.22341; Kay KN, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00247; Kayser AS, 2010, J NEUROSCI, V30, P15778, DOI 10.1523/JNEUROSCI.3163-10.2010; Kayser AS, 2010, J NEUROPHYSIOL, V103, P1179, DOI 10.1152/jn.00364.2009; Li X, 2008, P NATL ACAD SCI USA, V105, P6202, DOI 10.1073/pnas.0801390105; Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815; Liu ZL, 1999, P NATL ACAD SCI USA, V96, P14085, DOI 10.1073/pnas.96.24.14085; Livesey AC, 2007, NEUROPSYCHOLOGIA, V45, P321, DOI 10.1016/j.neuropsychologia.2006.06.033; Lu HJ, 2004, VISION RES, V44, P1817, DOI 10.1016/j.visres.2004.03.002; Lu ZL, 2011, J COGNITIVE NEUROSCI, V23, P1148, DOI 10.1162/jocn.2010.21511; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; Philiastides MG, 2006, J NEUROSCI, V26, P8965, DOI 10.1523/JNEUROSCI.1655-06.2006; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Sunaert S, 2000, NEUROIMAGE, V11, P612, DOI 10.1006/nimg.2000.0587; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Tregellas JR, 2006, NEUROIMAGE, V32, P307, DOI 10.1016/j.neuroimage.2006.02.036	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199440	10.1371/journal.pone.0199440	http://dx.doi.org/10.1371/journal.pone.0199440			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940043	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700018
J	Dall, E; Hollerweger, JC; Dahms, SO; Cui, H; Haussermann, K; Brandstetter, H				Dall, Elfriede; Hollerweger, Julia C.; Dahms, Sven O.; Cui, Haissi; Haeussermann, Katharina; Brandstetter, Hans			Structural and functional analysis of cystatin E reveals enzymologically relevant dimer and amyloid fibril states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEINASE-INHIBITOR; HUMAN STEFIN-B; CELL-PROLIFERATION; IN-VITRO; LEGUMAIN; ACTIVATION; PH; IDENTIFICATION; LOCALIZATION; DISTINCT	Protein activity is often regulated by altering the oligomerization state. One mechanism of multimerization involves domain swapping, wherein proteins exchange parts of their structures and thereby form long-lived dimers or multimers. Domain swapping has been specifically observed in amyloidogenic proteins, for example the cystatin superfamily of cysteine protease inhibitors. Cystatins are twin-headed inhibitors, simultaneously targeting the lysosomal cathepsins and legumain, with important roles in cancer progression and Alzheimer's disease. Although cystatin E is the most potent legumain inhibitor identified so far, nothing is known about its propensity to oligomerize. In this study, we show that conformational destabilization of cystatin E leads to the formation of a domain-swapped dimer with increased conformational stability. This dimer was active as a legumain inhibitor by forming a trimeric complex. By contrast, the binding sites toward papain-like proteases were buried within the cystatin E dimer. We also showed that the dimers could further convert to amyloid fibrils. Unexpectedly, cystatin E amyloid fibrils contained functional protein, which inhibited both legumain and papain-like enzymes. Fibril formation was further regulated by glycosylation. We speculate that cystatin amyloid fibrils might serve as a binding platform to stabilize the pH-sensitive legumain and cathepsins in the extracellular environment, contributing to their physiological and pathological functions.	[Dall, Elfriede; Hollerweger, Julia C.; Dahms, Sven O.; Brandstetter, Hans] Univ Salzburg, Dept Biosci, A-5020 Salzburg, Austria; [Cui, Haissi; Haeussermann, Katharina] Tech Univ Munich, Ctr Integrated Prot Sci Munich, D-85748 Munich, Germany	Salzburg University; Technical University of Munich; University of Munich	Brandstetter, H (corresponding author), Univ Salzburg, Dept Biosci, A-5020 Salzburg, Austria.	hans.brandstetter@sbg.ac.at	Brandstetter, Hans/E-6754-2011; Dall, Elfriede/F-1711-2017	Brandstetter, Hans/0000-0002-6089-3045; Dall, Elfriede/0000-0002-0823-8983; Dahms, Sven/0000-0002-0915-7579; Cui, Haissi/0000-0003-3358-8958	Austrian Science Fund (FWF) [W_01213]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF project W_01213). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHAMSON M, 1994, P NATL ACAD SCI USA, V91, P1416, DOI 10.1073/pnas.91.4.1416; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Briggs JJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-17; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; Cheng T, 2009, J INVEST DERMATOL, V129, P1232, DOI 10.1038/jid.2008.353; Dall E, 2015, ANGEW CHEM INT EDIT, V54, P2917, DOI 10.1002/anie.201409135; Dall E, 2013, P NATL ACAD SCI USA, V110, P10940, DOI 10.1073/pnas.1300686110; Dall E, 2012, ACTA CRYSTALLOGR F, V68, P24, DOI 10.1107/S1744309111048020; DeLano W.L., 2002, PYMOL MOL GRAPH SYST; Ekiel I, 1996, J BIOL CHEM, V271, P1314, DOI 10.1074/jbc.271.3.1314; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; GHISO J, 1986, P NATL ACAD SCI USA, V83, P2974, DOI 10.1073/pnas.83.9.2974; Grubb AO, 2001, ADV CLIN CHEM, V35, P63, DOI 10.1016/S0065-2423(01)35015-1; Hamilton G, 2008, EMBO J, V27, P499, DOI 10.1038/sj.emboj.7601979; Hasanbasic Samra, 2016, Mater Sociomed, V28, P235, DOI 10.5455/msm.2016.28.235-238; Haugen MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052980; Hedrich J, 2010, BIOCHEMISTRY-US, V49, P8599, DOI 10.1021/bi1004238; Janowski R, 2004, J MOL BIOL, V341, P151, DOI 10.1016/j.jmb.2004.06.013; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kokalj SJ, 2007, J MOL BIOL, V366, P1569, DOI 10.1016/j.jmb.2006.12.025; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Liu C, 2003, CANCER RES, V63, P2957; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Lunde NN, 2017, BIOCHIMIE, V139, P27, DOI 10.1016/j.biochi.2017.05.009; Nguyen A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147684; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Ni J, 1997, J BIOL CHEM, V272, P10853; Niesen F., 2010, EXCEL SCRIPT ANAL PR; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Orlikowska M, 2011, J STRUCT BIOL, V173, P406, DOI 10.1016/j.jsb.2010.11.009; Pirchl M, 2009, NEUROPSYCHIATRIE, V23, P187; Pulukuri SM, 2009, ONCOGENE, V28, P2829, DOI 10.1038/onc.2009.134; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rodziewicz-Motowidlo S, 2009, BIOPOLYMERS, V91, P373, DOI 10.1002/bip.21140; Schuttelkopf AW, 2006, J BIOL CHEM, V281, P16570, DOI 10.1074/jbc.M601033200; Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040; Skerget K, 2010, J BIOL CHEM, V285, P3201, DOI 10.1074/jbc.M109.024620; Smith R, 2012, BIOCHIMIE, V94, P2590, DOI 10.1016/j.biochi.2012.07.026; Sotiropoulou G, 1997, J BIOL CHEM, V272, P903, DOI 10.1074/jbc.272.2.903; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Turk V., BIOCH BIOPHYS ACTA, V1824, P68; Vidmar R, 2017, EMBO J, V36, P2455, DOI 10.15252/embj.201796750; Vigneswaran N, 2006, LIFE SCI, V78, P898, DOI 10.1016/j.lfs.2005.05.096; Wallin H, 2017, J BIOL CHEM, V292, P14413, DOI 10.1074/jbc.M117.776138; Williams J W, 1979, Methods Enzymol, V63, P437; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada M, 2000, NEUROPATHOLOGY, V20, P8, DOI 10.1046/j.1440-1789.2000.00268.x; Yamane T, 2002, BBA-PROTEIN STRUCT M, V1596, P108, DOI 10.1016/S0167-4838(02)00209-1; YATES CM, 1990, J NEUROCHEM, V55, P1624, DOI 10.1111/j.1471-4159.1990.tb04948.x; Zerovnik E, 2002, BIOCHEM SOC T, V30, P543; Zerovnik E, 2002, BBA-PROTEIN STRUCT M, V1594, P1, DOI 10.1016/S0167-4838(01)00295-3; Zhang ZT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14740	64	13	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13151	13165		10.1074/jbc.RA118.002154	http://dx.doi.org/10.1074/jbc.RA118.002154			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29967063	Green Published, hybrid			2022-12-26	WOS:000442730200015
J	Cai, XY; Nwokonko, RM; Loktionova, NA; Abdulqadir, R; Baraniak, JH; Wang, YJ; Trebak, M; Zhou, YD; Gill, DL				Cai, Xiangyu; Nwokonko, Robert M.; Loktionova, Natalia A.; Abdulqadir, Raz; Baraniak, James H.; Wang, Youjun; Trebak, Mohamed; Zhou, Yandong; Gill, Donald L.			Pore properties of Orai1 calcium channel dimers and their activation by the STIM1 ER calcium sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; calcium channel; ion channel; cell signaling; Orai1; STIM1; channel gating; selectivity filter; store-operated channel	OPERATED CA2+ CHANNELS; COILED-COIL DOMAIN; CRAC CHANNEL; ION SELECTIVITY; SUBUNIT STOICHIOMETRY; PLASMA-MEMBRANE; COMMUNICATION; MECHANISMS; PROTEINS; MUTATION	Store-operated Ca2+ entry signals are mediated by plasma membrane Orai channels activated through intermembrane coupling with Ca2+-sensing STIM proteins in the endoplasmic reticulum (ER). The nature of this elaborate Orai-gating mechanism has remained enigmatic. Based on the Drosophila Orai structure, mammalian Orai1 channels are hexamers comprising three dimeric subunit pairs. We utilized concatenated Orai1 dimers to probe the function of key domains within the channel pore and gating regions. The Orai1-E106Q selectivity-filter mutant, widely considered a dominant pore blocker, was surprisingly nondominant within concatenated heterodimers with Orai1-WT. The Orai1-E106Q/WT heterodimer formed STIM1-activated nonselective cation channels with significantly enlarged apparent pore diameter. Other Glu-106 substitutions entirely blocked the function of heterodimers with Orai1-WT. The hydrophobic pore-lining mutation V102C, which constitutively opens channels, was suppressed by Orai1-WT in the heterodimer. In contrast, the naturally occurring R91W pore-lining mutation associated with human immunodeficiency was completely dominant-negative over Orai-WT in heterodimers. Heterodimers containing the inhibitory K85E mutation extending outward from the pore helix gave an interesting partial effect on both channel activation and STIM1 binding, indicating an important allosteric link between the cytosolic Orai1 domains. The Orai1 C-terminal STIM1-binding domain mutation L273D powerfully blocked STIM1-induced channel activation. The Orai1-L273D/WT heterodimer had drastically impaired STIM1-induced channel gating but, unexpectedly, retained full STIM1 binding. This reveals the critical role of Leu-273 in transducing the STIM1-binding signal into the allosteric conformational change that initiates channel gating. Overall, our results provide important new insights into the role of key functional domains that mediate STIM1-induced gating of the Orai1 channel.	[Cai, Xiangyu; Nwokonko, Robert M.; Loktionova, Natalia A.; Abdulqadir, Raz; Baraniak, James H.; Trebak, Mohamed; Zhou, Yandong; Gill, Donald L.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA; [Wang, Youjun] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resources & Mol Dev, Beijing 100875, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Beijing Normal University	Zhou, YD; Gill, DL (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	zhouyd@psu.edu; dongill@psu.edu	zhou, Yandong/AAN-3947-2021; Nwokonko, Robert/ABH-3833-2020; Wang, Youjun/H-4016-2013	zhou, Yandong/0000-0003-3503-0296; Nwokonko, Robert/0000-0002-0793-7379; Wang, Youjun/0000-0003-0961-1716; Abdulqadir, Raz/0000-0003-4014-8213	National Institutes of Health [R01 GM120783, R01 GM109279, GM125376]; Penn State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111, R01HL123364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM125376, R01GM120783, R01GM109279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG050072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in whole or part by National Institutes of Health Grants R01 GM120783 and R01 GM109279 (to D. L. G.), National Institutes of Health Predoctoral Fellowship GM125376 (to R. M. N.), and a Penn State University Junior Faculty Development Program grant (to Y. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amcheslavsky A, 2015, BIOPHYS J, V108, P237, DOI 10.1016/j.bpj.2014.11.3473; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; Cai XY, 2016, J BIOL CHEM, V291, P25764, DOI 10.1074/jbc.M116.758813; Demuro A, 2011, P NATL ACAD SCI USA, V108, P17832, DOI 10.1073/pnas.1114814108; Derler I, 2016, AM J PHYSIOL-CELL PH, V310, pC643, DOI 10.1152/ajpcell.00007.2016; DWYER TM, 1980, J GEN PHYSIOL, V75, P469, DOI 10.1085/jgp.75.5.469; Fahrner M, 2018, J BIOL CHEM, V293, P1271, DOI 10.1074/jbc.M117.812693; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Gudlur A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6164; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hogan PG, 2015, CELL CALCIUM, V58, P357, DOI 10.1016/j.ceca.2015.07.001; Hou X., 2018, BIORXIV PREPRINT, DOI [10.1101/284034, DOI 10.1101/284034]; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Kar P, 2013, CHANNELS, V7, P374, DOI 10.4161/chan.25298; Li ZZ, 2011, CELL RES, V21, P305, DOI 10.1038/cr.2010.131; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Madl J, 2010, J BIOL CHEM, V285, P41135, DOI 10.1074/jbc.M110.177881; Mancarella S, 2011, J BIOL CHEM, V286, P44788, DOI 10.1074/jbc.M111.303081; Mancarella S, 2011, NAT CHEM BIOL, V7, P344, DOI 10.1038/nchembio.587; Maruyama Y, 2009, J BIOL CHEM, V284, P13676, DOI 10.1074/jbc.M900812200; Maus M, 2015, P NATL ACAD SCI USA, V112, P6206, DOI 10.1073/pnas.1418852112; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Palty R, 2017, CELL REP, V19, P1929, DOI 10.1016/j.celrep.2017.05.025; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Rothberg BS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003971; Shim AHR, 2015, J MOL BIOL, V427, P77, DOI 10.1016/j.jmb.2014.09.021; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Thompson JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01961; Thompson JL, 2009, J BIOL CHEM, V284, P6620, DOI 10.1074/jbc.M808346200; Tirado-Lee L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128622; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wang XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4183; Wei-LaPierre L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3805; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yen M, 2016, BIOPHYS J, V111, P1897, DOI 10.1016/j.bpj.2016.09.020; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhou Y, 2016, APIDOLOGIE, V1, P1, DOI DOI 10.1038/ncomms13725; Zhou YD, 2018, P NATL ACAD SCI USA, V115, pE3398, DOI 10.1073/pnas.1720810115; Zhou YD, 2017, CELL CALCIUM, V63, P8, DOI 10.1016/j.ceca.2017.01.001; Zhou YD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9395; Zhou YD, 2015, MOL CELL, V58, P197, DOI 10.1016/j.molcel.2015.04.003	56	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12962	12974		10.1074/jbc.RA118.003424	http://dx.doi.org/10.1074/jbc.RA118.003424			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29954946	Green Published, hybrid			2022-12-26	WOS:000442203500031
J	Chu, DC; Yen, YF; Hu, HY; Lai, YJ; Sun, WJ; Ko, MC; Huang, LY; Chen, CC; Curtis, JR; Lee, YL; Huang, SJ				Chu, Dachen; Yen, Yung-Feng; Hu, Hsiao-Yun; Lai, Yun-Ju; Sun, Wen-Jung; Ko, Ming-Chung; Huang, Li-Ying; Chen, Chu-Chieh; Curtis, J. Randall; Lee, Ya-Ling; Huang, Sheng-Jean			Factors associated with advance directives completion among patients with advance care planning communication in Taipei, Taiwan	PLOS ONE			English	Article							HEALTH-CARE; PREFERENCES; DISPARITY	Background Although advance directives (AD) have been implemented for years in western countries, the concept of AD is not promoted extensively in eastern countries. In this study we evaluate a program to systematically conduct advance care planning (ACP) communication for hospitalized patients in Taiwan and identify the factors associated with AD completion. Methods In this retrospective evaluation of a clinical ACP program, we identified adult patients with chronic life-limiting illness admitted to Taipei City Hospital between April 2015 and January 2016. Trained healthcare providers held an ACP meeting to discuss patients' preference regarding end-of-life care and AD completion. A multiple logistic regression was performed to determine the factors associated with the AD completion. Results A total of 2878 patients were determined to be eligible for ACP during the study, among which 1798 (62.5%) completed ACP and data was available for 1411 patients (49.1%). Of the 1411 patients who received ACP communication with complete data, the rate of AD completion was 82.6%. The overall mean (SD) age was 78.2 (14.4) years. Adjusting for other variables, AD completion was associated with patients aged >= 85 years [adjusted odds ratio (AOR) = 1.80, 95% CI 1.21-2.67], critical illness (AOR = 1.17, 95% CI 1.06-1.30), and social workers participating in ACP meetings (AOR = 1.74, 95% CI 1.24-2.45). Conclusion The majority of inpatients with chronic life-limiting illness had ACP communication as part of this ACP program and over 80% completed an AD. Our study demonstrates the feasibility of implementing ACP discussion in East Asia and suggests that social workers may be an important component of ACP communication with patients.	[Chu, Dachen; Huang, Sheng-Jean] Taipei City Hosp, Dept Neurosurg, Taipei, Taiwan; [Chu, Dachen; Yen, Yung-Feng; Hu, Hsiao-Yun] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chu, Dachen; Yen, Yung-Feng; Hu, Hsiao-Yun] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan; [Chu, Dachen; Yen, Yung-Feng; Lai, Yun-Ju] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chu, Dachen; Yen, Yung-Feng; Ko, Ming-Chung; Chen, Chu-Chieh] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan; [Yen, Yung-Feng] Taipei City Hosp, Infect Dis Sect, Taipei, Taiwan; [Hu, Hsiao-Yun] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Lai, Yun-Ju] Taichung Vet Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Puli Branch, Nantou, Taiwan; [Lai, Yun-Ju] Natl Taiwan Univ Sport, Dept Exercise Hlth Sci, Taichung, Taiwan; [Sun, Wen-Jung] Taipei City Hosp, Dept Community Med, Zhongxing Branch, Taipei, Taiwan; [Sun, Wen-Jung] Taipei City Hosp, Family Med Div, Zhongxing Branch, Taipei, Taiwan; [Ko, Ming-Chung] Taipei City Hosp, Dept Urol, Taipei, Taiwan; [Huang, Li-Ying] Fu Jen Catholic Univ, Sch Med, Coll Med, New Taipei, Taiwan; [Huang, Li-Ying] Fu Jen Catholic Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, New Taipei, Taiwan; [Curtis, J. Randall] Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, 325 9th Ave, Seattle, WA 98104 USA; [Lee, Ya-Ling] Taipei City Hosp, Dept Dent, Taipei, Taiwan; [Lee, Ya-Ling] Natl Yang Ming Univ, Sch Dent, Dept Dent, Taipei, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Surg, Coll Med, Taipei, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS); Taipei City Hospital; Taipei City Hospital; Taichung Veterans General Hospital; National Taiwan University of Sport; Taipei City Hospital; Taipei City Hospital; Taipei City Hospital; Fu Jen Catholic University; Fu Jen Catholic University; Fu Jen Catholic University Hospital; Harborview Medical Center; University of Washington; University of Washington Seattle; Taipei City Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital	Chu, DC (corresponding author), Taipei City Hosp, Dept Neurosurg, Taipei, Taiwan.; Chu, DC (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Chu, DC (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan.; Chu, DC (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chu, DC (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan.	DAD57@tpech.gov.tw	Lai, Yun-Ju/AAX-4990-2020	Curtis, J. Randall/0000-0001-9529-845X				Bays AM, 2014, J PALLIAT MED, V17, P159, DOI 10.1089/jpm.2013.0318; Bradley EH, 1998, ARCH FAM MED, V7, P417, DOI 10.1001/archfami.7.5.417; Braun KL, 2001, J AM GERIATR SOC, V49, P1708, DOI 10.1046/j.1532-5415.2001.49284.x; Bravo G, 2003, ALZ DIS ASSOC DIS, V17, P215, DOI 10.1097/00002093-200310000-00004; Brown Barbara A, 2003, J Gerontol Nurs, V29, P4; Chu LW, 2011, J AM MED DIR ASSOC, V12, P143, DOI 10.1016/j.jamda.2010.08.015; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Francoeur RB, 2016, SOC WORK PUBLIC HLTH, P1; Lin WY, 2014, SUPPORT CARE CANCER, V22, P1907, DOI 10.1007/s00520-014-2168-5; Lynn J, 2003, LIVING WELL END LIFE; Modrykamien Ariel M, 2015, Proc (Bayl Univ Med Cent), V28, P163; National Association of Social Workers, 1996, COD ETH NAT ASS SOC; Nicholas LH, 2011, JAMA-J AM MED ASSOC, V306, P1447, DOI 10.1001/jama.2011.1410; Rich SE, 2009, J AM GERIATR SOC, V57, P146, DOI 10.1111/j.1532-5415.2008.02090.x; Rosnick CB, 2003, J AGING HEALTH, V15, P409, DOI 10.1177/0898264303015002005; Rurup ML, 2006, SOC SCI MED, V62, P1552, DOI 10.1016/j.socscimed.2005.08.010; Seymour Jane, 2010, BMC Palliat Care, V9, P4, DOI 10.1186/1472-684X-9-4; Sharma RK, 2014, J GEN INTERN MED, V29, P750, DOI 10.1007/s11606-014-2791-3; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Ting Fion H., 2011, Hong Kong Medical Journal, V17, P105; Trarieux-Signol S, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-57; Vaughn G, 2000, J AM GERIATR SOC, V48, P554, DOI 10.1111/j.1532-5415.2000.tb05003.x; WENGER NS, 1995, ARCH INTERN MED, V155, P2056, DOI 10.1001/archinte.155.19.2056; Wong SY, 2012, HONG KONG MED J, V18, P178	25	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0197552	10.1371/journal.pone.0197552	http://dx.doi.org/10.1371/journal.pone.0197552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM1FJ	29979678	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500004
J	Khan, QA; Pediaditakis, P; Malakhau, Y; Esmaeilniakooshkghazi, A; Ashkavand, Z; Sereda, V; Krupenko, NI; Krupenko, SA				Khan, Qasim A.; Pediaditakis, Peter; Malakhau, Yuryi; Esmaeilniakooshkghazi, Amin; Ashkavand, Zahra; Sereda, Valentin; Krupenko, Natalia I.; Krupenko, Sergey A.			CHIP E3 ligase mediates proteasomal degradation of the proliferation regulatory protein ALDH1L1 during the transition of NIH3T3 fibroblasts from G(0)/G(1) to S-phase	PLOS ONE			English	Article							ONE-CARBON METABOLISM; CELL-CYCLE CONTROL; RAT 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE; CANCER-CELLS; TRANSCRIPTIONAL REGULATION; THYMIDYLATE SYNTHASE; UBIQUITIN LIGASES; NOTI-MICROARRAYS; EXPRESSION; HSP90	ALDH1L1 is a folate-metabolizing enzyme abundant in liver and several other tissues. In human cancers and cell lines derived from malignant tumors, the ALDH1L1 gene is commonly silenced through the promoter methylation. It was suggested that ALDH1L1 limits proliferation capacity of the cell and thus functions as putative tumor suppressor. In contrast to cancer cells, mouse cell lines NIH3T3 and AML12 do express the ALDH1L1 protein. In the present study, we show that the levels of ALDH1L1 in these cell lines fluctuate throughout the cell cycle. During S-phase, ALDH1L1 is markedly down regulated at the protein level. As the cell cultures become confluent and cells experience increased contact inhibition, ALDH1L1 accumulates in the cells. In agreement with this finding, NIH3T3 cells arrested in G1/S-phase by a thymidine block completely lose the ALDH1L1 protein. Treatment with the proteasome inhibitor MG-132 prevents such loss in proliferating NIH3T3 cells, suggesting the proteasomal degradation of the ALDH1L1 protein. The co-localization of ALDH1L1 with proteasomes, demonstrated by confocal microscopy, supports this mechanism. We further show that ALDH1L1 interacts with the chaperone-dependent E3 ligase CHIP, which plays a key role in the ALDH1L1 ubiquitination and degradation. In NIH3T3 cells, silencing of CHIP by siRNA halts, while transient expression of CHIP promotes, the ALDH1L1 loss. The downregulation of ALDH1L1 is associated with the accumulation of the ALDH1L1 substrate 10-formyltetrahydrofolate, which is required for de novo purine biosynthesis, a key pathway activated in S-phase. Overall, our data indicate that CHIP-mediated proteasomal degradation of ALDH1L1 facilitates cellular proliferation.	[Khan, Qasim A.; Pediaditakis, Peter; Malakhau, Yuryi; Esmaeilniakooshkghazi, Amin; Ashkavand, Zahra; Sereda, Valentin; Krupenko, Natalia I.; Krupenko, Sergey A.] Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA; [Krupenko, Natalia I.; Krupenko, Sergey A.] Univ North Carolina Chapel Hill, Dept Nutr, Chapel Hill, NC 27514 USA; [Khan, Qasim A.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Esmaeilniakooshkghazi, Amin] Univ Houston, Dept Biol & Biochem, Houston, TX USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Roswell Park Cancer Institute; University of Houston System; University of Houston	Krupenko, SA (corresponding author), Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA.; Krupenko, SA (corresponding author), Univ North Carolina Chapel Hill, Dept Nutr, Chapel Hill, NC 27514 USA.	sergey_krupenko@unc.edu	Ashkavand, Zahra/AAC-3685-2022		NIH (National Institute of Diabetes and Digestive and Kidney Diseases) [DK054388]	NIH (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH (National Institute of Diabetes and Digestive and Kidney Diseases) R01 grant DK054388 to SAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici M, 2004, ARCH BIOCHEM BIOPHYS, V422, P168, DOI 10.1016/j.abb.2003.12.014; Anderson DD, 2012, J BIOL CHEM, V287, P4790, DOI 10.1074/jbc.M111.302174; Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; Anthony TE, 2007, J COMP NEUROL, V500, P368, DOI 10.1002/cne.21179; Barbour KW, 2013, BIOSCIENCE REP, V33, P165, DOI 10.1042/BSR20120112; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cao Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116934; Chen XQ, 2012, MED ONCOL, V29, P1843, DOI 10.1007/s12032-011-0075-x; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Cong X, 2014, HUM PATHOL, V45, P1370, DOI 10.1016/j.humpath.2013.11.021; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; COOK RJ, 1982, BIOCHEMISTRY-US, V21, P4427, DOI 10.1021/bi00261a036; CORTNER J, 1991, CELL GROWTH DIFFER, V2, P465; DebRoy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070062; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dmitriev AA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/735292; Dmitriev AA, 2012, EPIGENETICS-US, V7, P502, DOI 10.4161/epi.19801; Dynlacht BD, 1997, NATURE, V389, P149, DOI 10.1038/38225; Edkins Adrienne L, 2015, Subcell Biochem, V78, P219, DOI 10.1007/978-3-319-11731-7_11; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Hoeferlin L Alexis, 2011, Genes Cancer, V2, P889, DOI 10.1177/1947601911432495; Iconomou M, 2016, BIOCHEM J, V473, P4083, DOI 10.1042/BCJ20160719; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Joshi V, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00093; Kampinga HH, 2003, MOL CELL BIOL, V23, P4948, DOI 10.1128/MCB.23.14.4948-4958.2003; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Krupenko NI, 2010, J BIOL CHEM, V285, P23054, DOI 10.1074/jbc.M110.128843; Krupenko SA, 2002, CELL GROWTH DIFFER, V13, P227; KRUPENKO SA, 1995, J BIOL CHEM, V270, P519, DOI 10.1074/jbc.270.2.519; KRUPENKO SA, 1995, BIOCHEM J, V306, P651, DOI 10.1042/bj3060651; KRUPENKO SA, 1995, PROTEIN EXPRES PURIF, V6, P457, DOI 10.1006/prep.1995.1061; Krupenko SA, 2009, CHEM-BIOL INTERACT, V178, P84, DOI 10.1016/j.cbi.2008.09.007; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Ma HT, 2011, METHODS MOL BIOL, V761, P151, DOI 10.1007/978-1-61779-182-6_10; Magro PG, 2004, CANCER RES, V64, P4338, DOI 10.1158/0008-5472.CAN-03-1045; Mocciaro A, 2012, J CELL SCI, V125, P255, DOI 10.1242/jcs.091199; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; MULLER R, 1995, TRENDS GENET, V11, P173, DOI 10.1016/S0168-9525(00)89039-3; Nakamura M, 2015, BIOCHEM BIOPH RES CO, V464, P1096, DOI 10.1016/j.bbrc.2015.07.083; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Oleinik NV, 2006, BIOCHEM PHARMACOL, V72, P256, DOI 10.1016/j.bcp.2006.04.005; Oleinik Natalia V, 2011, Genes Cancer, V2, P130, DOI 10.1177/1947601911405841; Oleinik NV, 2005, BIOCHEM J, V391, P503, DOI 10.1042/BJ20050533; Oleinik NV, 2003, MOL CANCER RES, V1, P577; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Paul I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/918183; PESTALOZZI BC, 1995, BRIT J CANCER, V71, P1151, DOI 10.1038/bjc.1995.225; Prakasam A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.316; Rizzardi Lindsay F, 2012, Genes Cancer, V3, P634, DOI 10.1177/1947601912473307; Rodriguez FJ, 2008, J NEUROPATH EXP NEUR, V67, P1194, DOI 10.1097/NEN.0b013e31818fbe1e; Senchenko VN, 2013, EPIGENETICS-US, V8, P409, DOI 10.4161/epi.24233; Slansky JE, 1996, BIOESSAYS, V18, P55, DOI 10.1002/bies.950180111; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tyers M, 2004, CURR OPIN CELL BIOL, V16, P602, DOI 10.1016/j.ceb.2004.09.013; Wang W, 2009, J BIOL CHEM, V284, P3521, DOI 10.1074/jbc.M806707200	64	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199699	10.1371/journal.pone.0199699	http://dx.doi.org/10.1371/journal.pone.0199699			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979702	Green Submitted, gold, Green Published			2022-12-26	WOS:000437809500028
J	Surma, S; Pitcher, TJ; Kumar, R; Varkey, D; Pakhomov, EA; Lam, ME				Surma, Szymon; Pitcher, Tony J.; Kumar, Rajeev; Varkey, Divya; Pakhomov, Evgeny A.; Lam, Mimi E.			Herring supports Northeast Pacific predators and fisheries: Insights from ecosystem modelling and management strategy evaluation	PLOS ONE			English	Article							FORAGE FISH; BRITISH-COLUMBIA; IMPACTS; ABUNDANCE; RECOVERY; PREY; HYPOTHESES; DYNAMICS; SERVICES; JUVENILE	This paper analyzes the trophic role of Pacific herring, the potential consequences of its depletion, and the impacts of alternative herring fishing strategies on a Northeast Pacific food web in relation to precautionary, ecosystem-based management. We used an Ecopath with Ecosim ecosystem model parameterized for northern British Columbia (Canada), employing Ecosim to simulate ecosystem effects of herring stock collapse. The ecological impacts of various herring fishing strategies were investigated with a Management Strategy Evaluation algorithm within Ecosim, accounting for variability in climatic drivers and stock assessment errors. Ecosim results suggest that herring stock collapse would have cascading impacts on much of the pelagic food web. Management Strategy Evaluation results indicate that herring and their predators suffer moderate impacts from the existing British Columbia harvest control rule, although more precautionary management strategies could substantially reduce these impacts. The non-capture spawn-on-kelp fishery, traditionally practiced by many British Columbia and Alaska indigenous peoples, apparently has extremely limited ecological impacts. Our simulations also suggest that adopting a maximum sustainable yield management strategy in Northeast Pacific herring fisheries could generate strong, cascading food web effects. Furthermore, climate shifts, especially when combined with herring stock assessment errors, could strongly reduce the biomasses and resilience of herring and its predators. By clarifying the trophic role of Pacific herring, this study aims to facilitate precautionary fisheries management via evaluation of alternative fishing strategies, and thereby to inform policy tradeoffs among multiple ecological and socioeconomic factors.	[Surma, Szymon; Pitcher, Tony J.; Varkey, Divya; Pakhomov, Evgeny A.; Lam, Mimi E.] Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada; [Kumar, Rajeev] Mem Univ Newfoundland, Ctr Fisheries Ecosyst Res, Fisheries & Marine Inst, St John, NF, Canada; [Pakhomov, Evgeny A.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC, Canada; [Pakhomov, Evgeny A.] Hakai Inst, Heriot Bay, BC, Canada; [Lam, Mimi E.] Univ Bergen, Ctr Study Sci & Humanities, Bergen, Norway	University of British Columbia; Memorial University Newfoundland; University of British Columbia; Hakai Institute; University of Bergen	Surma, S (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada.	s.surma@oceans.ubc.ca	Surma, Szymon/GOG-9811-2022	Surma, Szymon/0000-0002-0236-6757	Natural Science and Engineering Research Council of Canada [6564, 447247]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	SS received a doctoral scholarship (PGS-D) partially supporting this work from the Natural Science and Engineering Research Council of Canada (grant number 6564). TJP received a Strategic Grant partially supporting this work from the Natural Science and Engineering Research Council of Canada (grant number 447247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth CH, 2008, ECOL MODEL, V216, P354, DOI 10.1016/j.ecolmodel.2008.05.005; Anthony JA, 2000, J EXP MAR BIOL ECOL, V248, P53, DOI 10.1016/S0022-0981(00)00159-3; Benson AJ, 2002, FISH FISH, V3, P95, DOI 10.1046/j.1467-2979.2002.00078.x; Bertrand S, 2012, J APPL ECOL, V49, P1168, DOI 10.1111/j.1365-2664.2012.02190.x; Bishop MA, 2015, FISH OCEANOGR, V24, P1, DOI 10.1111/fog.12073; Brodeur RD, 2014, CAL COOP OCEAN FISH, V55, P96; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Cleary JS, 2010, ICES J MAR SCI, V67, P2005, DOI 10.1093/icesjms/fsq129; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Dahlheim ME, 2009, J BIOGEOGR, V36, P410, DOI 10.1111/j.1365-2699.2008.02007.x; DFO, 2015, 038 DFO, P038; Engelhard GH, 2014, ICES J MAR SCI, V71, P90, DOI 10.1093/icesjms/fst087; Essington TE, 2015, ICES J MAR SCI, V72, P1349, DOI 10.1093/icesjms/fsu242; Essington TE, 2015, P NATL ACAD SCI USA, V112, P6648, DOI 10.1073/pnas.1422020112; Essington TE, 2014, ECOL APPL, V24, P1543, DOI 10.1890/13-1403.1; Frid A, 2008, OIKOS, V117, P191, DOI 10.1111/j.2007.0030-1299.16134.x; Fulton EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084242; Gauvreau AM, 2017, ECOL SOC, V22, DOI 10.5751/ES-09201-220210; Gregr EJ, 2004, CAN TECH REP FISH AQ, P2503; Gruss A, 2016, ECOL MODEL, V340, P86, DOI 10.1016/j.ecolmodel.2016.09.011; HALL DL, 1988, CAN J FISH AQUAT SCI, V45, P888, DOI 10.1139/f88-107; Haltuch MA, 2009, FISH RES, V100, P42, DOI 10.1016/j.fishres.2009.03.001; Hannesson R, 2013, MAR POLICY, V38, P109, DOI 10.1016/j.marpol.2012.05.026; Hay DE, 2008, PROG OCEANOGR, V77, P233, DOI 10.1016/j.pocean.2008.03.015; Hilborn R, 2002, B MAR SCI, V70, P403; Hilborn R, 2017, FISH RES, V191, P211, DOI 10.1016/j.fishres.2017.01.008; Houle JE, 2013, J FISH BIOL, V83, P890, DOI 10.1111/jfb.12163; Hourston AS, 1978, 784 DEP FISH ENV; ICES, 2017, 2017ACOM23 ICES CM; Incardona JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep13499; Jones R, 2017, MAR POLICY, V80, P154, DOI 10.1016/j.marpol.2016.09.031; Kearney KA, 2013, MAR ECOL PROG SER, V491, P1, DOI 10.3354/meps10484; Keeling B, 2017, AQUAT CONSERV, V27, P814, DOI 10.1002/aqc.2757; Koehn LE, 2016, ECOL MODEL, V335, P87, DOI 10.1016/j.ecolmodel.2016.05.010; Kumar R., 2016, University of British Columbia Fisheries Centre Research Reports, V24, P1; Lam ME, 2017, SPF 2017 INT S DRIV, P139; Link JS, 2002, FISHERIES, V27, P18; Mackinson S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190015; Marasco RJ, 2007, CAN J FISH AQUAT SCI, V64, P928, DOI 10.1139/F07-062; Marty GD, 2003, CAN J FISH AQUAT SCI, V60, P1258, DOI [10.1139/f03-109, 10.1139/F03-109]; McClatchie S, 2017, GEOPHYS RES LETT, V44, P1877, DOI 10.1002/2016GL071751; McKechnie I, 2014, P NATL ACAD SCI USA, V111, pE807, DOI 10.1073/pnas.1316072111; Moran JR, 2018, DEEP-SEA RES PT II, V147, P187, DOI 10.1016/j.dsr2.2017.07.010; NMFS (National Marine Fisheries Service), 2014, THREATS EV EXT RISK; Osgood GJ, 2016, MAR COAST FISH, V8, P580, DOI 10.1080/19425120.2016.1223231; Pearson WH, 2012, REV FISH BIOL FISHER, V22, P95, DOI 10.1007/s11160-011-9225-7; Perry RI, 2008, PROG OCEANOGR, V77, P241, DOI 10.1016/j.pocean.2008.03.005; Pikitch E, 2012, LITTLE FISH BIG IMPA; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004; Pinsky ML, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1053; Pitcher TJ, 2017, REFLECTIONS CANADA I, P112; Plaganyi EE., 2007, FAO FISHERIES TECHNI; Plaganyi EE, 2014, FISH RES, V159, P68, DOI 10.1016/j.fishres.2014.05.011; Platts M., 2017, ROUTINE EVALUATING P; Punt AE, 2016, ECOL MODEL, V337, P79, DOI 10.1016/j.ecolmodel.2016.06.004; Punt AE, 2016, FISH FISH, V17, P303, DOI 10.1111/faf.12104; Sainsbury KJ, 2000, ICES J MAR SCI, V57, P731, DOI 10.1006/jmsc.2000.0737; Schweigert J, 1996, P INT S MAN STRAT EX, P167; Schweigert JF, 2010, ICES J MAR SCI, V67, P1903, DOI 10.1093/icesjms/fsq134; Scott J, 2017, SPF 2017 INT S DRIV, P139; Shelton AO, 2014, SCI REP-UK, V4, DOI 10.1038/srep07110; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Surma S., 2017, ICES PICES INT S DRI, P127; Surma S, 2018, MAR ECOL PROG SER, V588, P147, DOI 10.3354/meps12430; Surma S, 2015, FISH OCEANOGR, V24, P291, DOI 10.1111/fog.12109; Sydeman WJ, 2017, FISH RES, V194, P209, DOI 10.1016/j.fishres.2017.05.018; Sydeman WJ, 2017, FISH OCEANOGR, V26, P379, DOI 10.1111/fog.12204; Thornton T. F., 2010, J ECOLOGICAL ANTHR, V14, P81, DOI DOI 10.5038/2162-4593.14.1.7; Thynes T., 2016, 1J1602 AL DEP FISH G; Vollenweider JJ, 2011, MAR BIOL, V158, P413, DOI 10.1007/s00227-010-1569-3; Walters C, 1999, ECOSYSTEMS, V2, P539, DOI 10.1007/s100219900101; Walters C, 2016, ECOL MODEL, V337, P272, DOI 10.1016/j.ecolmodel.2016.07.014; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Ward EJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172898; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Weatherdon LV, 2016, PLOS ONE, V11, DOI DOI 10.1371/journal.pone.0145285; Williams Rob, 2007, Journal of Cetacean Research and Management, V9, P15; Willson MF, 2006, REV FISH BIOL FISHER, V16, P183, DOI 10.1007/s11160-006-9009-7; Womble JN, 2006, MAR ECOL PROG SER, V325, P281, DOI 10.3354/meps325281; Zheng J., 1993, P INT S MAN STRAT EX, P141	81	24	24	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0196307	10.1371/journal.pone.0196307	http://dx.doi.org/10.1371/journal.pone.0196307			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979718	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500001
J	Tyuryumina, EY; Neznanov, AA				Tyuryumina, Ella Ya; Neznanov, Alexey A.			Consolidated mathematical growth model of the primary tumor and secondary distant metastases of breast cancer (CoMPaS)	PLOS ONE			English	Article							NATURAL-HISTORY; LYMPH-NODES; PROGRESSION; DYNAMICS; RATES; CELL; SURVIVAL; KINETICS; SIZE	The goal of this research is to improve the accuracy of predicting the breast cancer (BC) process using the original mathematical model referred to as CoMPaS. The CoMPaS is the original mathematical model and the corresponding software built by modelling the natural history of the primary tumor (PT) and secondary distant metastases (MTS), it reflects the relations between the PT and MTS. The CoMPaS is based on an exponential growth model and consists of a system of determinate nonlinear and linear equations and corresponds to the TNM classification. It allows us to calculate the different growth periods of PT and MTS: 1) a non-visible period for PT, 2) a non-visible period for MTS, and 3) a visible period for MTS. The CoMPaS has been validated using 10-year and 15-year survival clinical data considering tumor stage and PT diameter. The following are calculated by CoMPaS: 1) the number of doublings for the non-visible and visible growth periods of MTS and 2) the tumor volume doubling time (days) for the non-visible and visible growth periods of MTS. The diameters of the PT and secondary distant MTS increased simultaneously. In other words, the non-visible growth period of the secondary distant MTS shrinks, leading to a decrease of the survival of patients with breast cancer. The CoMPaS correctly describes the growth of the PT for patients at the T1aN0M0, T1bN0M0, T1cN0M0, T2N0M0 and T3N0M0 stages, who does not have MTS in the lymph nodes (N0). Additionally, the CoMPaS helps to consider the appearance and evolution period of secondary distant MTS (M1). The CoMPaS correctly describes the growth period of PT corresponding to BC classification (parameter T), the growth period of secondary distant MTS and the 10-15-year survival of BC patients considering the BC stage (parameter M).	[Tyuryumina, Ella Ya; Neznanov, Alexey A.] Natl Res Univ Higher Sch Econ, Int Lab Intelligent Syst & Struct Anal, Fac Comp Sci, Moscow, Russia	HSE University (National Research University Higher School of Economics)	Tyuryumina, EY (corresponding author), Natl Res Univ Higher Sch Econ, Int Lab Intelligent Syst & Struct Anal, Fac Comp Sci, Moscow, Russia.	eyatyuryumina@gmail.com	Tyuryumina, Ella Y./AAI-1438-2019; Neznanov, Alexey/D-9584-2014	Tyuryumina, Ella Y./0000-0003-3034-8342; Neznanov, Alexey/0000-0001-9106-2298	Basic Research Program at the National Research University Higher School of Economics (HSE); Russian Academic Excellence Project "5-100"	Basic Research Program at the National Research University Higher School of Economics (HSE); Russian Academic Excellence Project "5-100"(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation)	This work was supported by the framework of the Basic Research Program at the National Research University Higher School of Economics (HSE) and supported within the framework of a subsidy of the Russian Academic Excellence Project "5-100". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, PRACT ONCOL; Benzekry S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003800; Bloom HJ, 1962, BMJ-BRIT MED J, V2, P213; Clare SE, 2000, BREAST CANCER RES, V2, P430, DOI 10.1186/bcr90; COLLINS VP, 1956, AMER J ROENTGENOL RA, V76, P988; Coumans FAW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-283; Engel J, 2003, INT J RADIAT ONCOL, V55, P1186, DOI 10.1016/S0360-3016(02)04476-0; Engel J, 2003, EUR J CANCER, V39, P1794, DOI 10.1016/S0959-8049(03)00422-2; Engel J, 2012, CANCER METAST REV, V31, P235, DOI 10.1007/s10555-011-9343-7; Friberg S, 1997, J SURG ONCOL, V65, P284, DOI 10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2; GULLINO PM, 1977, CANCER-AM CANCER SOC, V39, P2697, DOI 10.1002/1097-0142(197706)39:6<2697::AID-CNCR2820390656>3.0.CO;2-4; Holzel D, 2010, CANCER METAST REV, V29, P737, DOI 10.1007/s10555-010-9260-1; Klein CA, 2006, CELL CYCLE, V5, P1788, DOI 10.4161/cc.5.16.3097; KOSCIELNY S, 1985, BRIT J CANCER, V52, P515, DOI 10.1038/bjc.1985.222; KOSCIELNY S, 1989, BRIT J CANCER, V59, P775, DOI 10.1038/bjc.1989.162; LAIRD AK, 1965, BRIT J CANCER, V19, P278, DOI 10.1038/bjc.1965.32; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; LEE YTN, 1972, CANCER, V29, P344, DOI 10.1002/1097-0142(197202)29:2<344::AID-CNCR2820290213>3.0.CO;2-1; Lin RS, 2012, CANCER CAUSE CONTROL, V23, P175, DOI 10.1007/s10552-011-9866-9; Michaelson JS, 2009, CANCER, V115, P5084, DOI 10.1002/cncr.24542; Michaelson JS, 2003, CANCER, V98, P2133, DOI 10.1002/cncr.11765; Michaelson JS, 2002, CANCER, V95, P713, DOI 10.1002/cncr.10742; Molina-Pena R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026233; NORTON L, 1988, CANCER RES, V48, P7067; PEARLMAN AW, 1976, CANCER, V38, P1826, DOI 10.1002/1097-0142(197610)38:4<1826::AID-CNCR2820380460>3.0.CO;2-L; Rodriguez-Brenes IA, 2013, TRENDS ECOL EVOL, V28, P597, DOI 10.1016/j.tree.2013.05.020; SCHWARTZ M, 1961, CANCER, V14, P1272, DOI 10.1002/1097-0142(196111/12)14:6<1272::AID-CNCR2820140618>3.0.CO;2-H; Shah R, 2014, WORLD J CLIN ONCOL, V5, P283, DOI 10.5306/wjco.v5.i3.283; SPRATT JA, 1993, CANCER-AM CANCER SOC, V71, P2013, DOI 10.1002/1097-0142(19930315)71:6<2013::AID-CNCR2820710615>3.0.CO;2-V; SPRATT JA, 1993, CANCER-AM CANCER SOC, V71, P2020, DOI 10.1002/1097-0142(19930315)71:6<2020::AID-CNCR2820710616>3.0.CO;2-#; TUBIANA M, 1989, RADIOTHER ONCOL, V15, P1, DOI 10.1016/0167-8140(89)90113-8; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; VONFOURNIER D, 1980, CANCER-AM CANCER SOC, V45, P2198; Weedon-Fekjaer H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2092; Withers HR, 2006, SEMIN RADIAT ONCOL, V16, P111, DOI 10.1016/j.semradonc.2005.12.006	35	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200148	10.1371/journal.pone.0200148	http://dx.doi.org/10.1371/journal.pone.0200148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979733	gold, Green Submitted, Green Published			2022-12-26	WOS:000437809500065
J	Rohrlich, C; Merle, I; Hassani, IM; Verger, M; Zuin, M; Besse, S; Robene, I; Nibouche, S; Costet, L				Rohrlich, Clara; Merle, Isabelle; Hassani, Issa Mze; Verger, Manon; Zuin, Michel; Besse, Samantha; Robene, Isabelle; Nibouche, Samuel; Costet, Laurent			Variation in physiological host range in three strains of two species of the entomopathogenic fungus Beauveria	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; METARHIZIUM-ANISOPLIAE; BASSIANA STRAINS; PATHOGENIC FUNGI; VIRULENCE; DIPTERA; SPECIFICITY; BRONGNIARTII; RELATEDNESS; TEPHRITIDAE	Knowledge of the host range of a biocontrol agent (BCA) is fundamental. Host range determines the BCA's economic potential, as well as the possible risk for non-target organisms. Entomopathogenic fungal strains belonging to the genus Beauveria are widely used as BCA, but our knowledge of their physiological host range is only partial. The aim of this study was to improve our understanding of the physiological host range of three Beauveria strains belonging to two species, B. hoplocheli and B. bassiana. We performed laboratory mortality bioassays to assess their pathogenicity and virulence against nine insect pests, belonging to three orders: Lepidoptera, Coleoptera and Diptera. Mortality rate, mean survival time and mycosis rate were used to estimate virulence. Pathogenicity was assessed as the capacity to cause a disease and induce mortality. Virulence was assessed as the severity of the disease based on mortality rate, mean survival time and mycosis rate. The results of this study revealed significant differences in the physiological host range of the three Beauveria strains tested. The three strains were pathogenic to all Diptera and Lepidoptera species tested. In the case of the Coleoptera, only the B. hoplocheli strain was pathogenic to the white grub Hoplochelus marginalis and only the B. bassiana strains were pathogenic to Alphitobius diaperinus. The B. hoplocheli strain was less virulent on Lepidoptera and Diptera than the two B. bassiana strains. The latter both exhibited very similar virulence patterns. The fact that B. hoplocheli and B. bassiana strains have different host ranges means that they can be used as BCA to target different pests. Impacts on non-target insects across multiple orders cannot be ruled out in the absence of ecological host range studies.	[Rohrlich, Clara; Merle, Isabelle; Verger, Manon; Robene, Isabelle; Nibouche, Samuel; Costet, Laurent] UMR PVBMT, CIRAD, St Pierre, La Reunion, France; [Rohrlich, Clara; Zuin, Michel] BETEL Reunion, Arysta LifeSci Grp, St Pierre, La Reunion, France; [Rohrlich, Clara] Univ Reunion, UMR PVBMT, St Pierre, La Reunion, France; [Hassani, Issa Mze] INRAPE, Moroni, Comoros; [Besse, Samantha] NPP, Arysta LifeSci Grp, Pau, France	CIRAD; University of La Reunion	Costet, L (corresponding author), UMR PVBMT, CIRAD, St Pierre, La Reunion, France.	laurent.costet@cirad.fr	Costet, Laurent/AAQ-1579-2020; Nibouche, Samuel/C-1964-2008	Costet, Laurent/0000-0003-3199-2885; Nibouche, Samuel/0000-0003-2675-1382; Isabelle, Merle/0000-0003-3402-2892	European Agricultural Fund for Rural Development; Conseil Departemental de La Reunion; Conseil Regional de La Reunion; Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement; French Ministere de ('Agriculture et de l'Alimentation); French Ministere de la Transition Ecologique et Solidaire; Office National de l'Eau et des Milieux Aquatiques; ANRT (Association Nationale de la Recherche et de la Technologie) through the CIFRE [N 2014/1446]; Arysta LifeScience Group	European Agricultural Fund for Rural Development; Conseil Departemental de La Reunion; Conseil Regional de La Reunion; Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement; French Ministere de ('Agriculture et de l'Alimentation); French Ministere de la Transition Ecologique et Solidaire; Office National de l'Eau et des Milieux Aquatiques; ANRT (Association Nationale de la Recherche et de la Technologie) through the CIFRE(French National Research Agency (ANR)); Arysta LifeScience Group	This work was co-funded by 1) the European Agricultural Fund for Rural Development (htfps.//ec.europa.eu/agriculture/rural-development-2014-2020 en), by the Conseil Departemental de La Reunion (http:/www.cirad.fr/), by the Conseil Regional de La Reunion (https.//ww.regionreunon.com) and by the Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (https.//www.crad.fr/); 2) the French Ministere de ('Agriculture et de l'Alimentation (http://agriculture gouv.fr/), the French Ministere de la Transition Ecologique et Solidaire (https://www.ecologigue-solidaire.gouv.fr/) and received financial support from the Office National de l'Eau et des Milieux Aquatiques (http://www.onema.fr/) as part of the "Pour et Sur le Plan Ecophyto 2" AttractMyFly project; 3) the ANRT (Association Nationale de la Recherche et de la Technologie) through the CIFRE Ph.D grant N 2014/1446 of RC; 4) the Arysta LifeScience Group. The role of the Arysta LifeScience Group was limited. to the choice of the Beauveria strains studied and to providing support in the form of salaries for authors CR, SB and MZ; it did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was carried out on the Plant Protection Platform which is co-financed by the Groupe d'Interet Scientifique "Infrastructures en Biologie, Sante et Agronomie" (http://www.ibisa.net).	Besse S, 2008, 3 ANN BIOC IND M OCT; Bidochka MJ, 2002, ARCH MICROBIOL, V178, P531, DOI 10.1007/s00203-002-0490-7; Bonnet C., 2013, 3e Conference sur l'entretien des Zones Non Agricoles, Toulouse, France, 15-17 octobre 2013, P209; Bricca ES, 2014, FRUITS, V69, P189, DOI 10.1051/fruits/2014008; Brodeur J, 2012, EVOL APPL, V5, P470, DOI 10.1111/j.1752-4571.2012.00273.x; Carneiro AA, 2008, PESQUI AGROPECU BRAS, V43, P99, DOI [10.1016/j.jip.2010.01.001, DOI 10.1016/J.JIP.2010.01.001]; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; De La Rosa W, 2002, J ECON ENTOMOL, V95, P36, DOI 10.1603/0022-0493-95.1.36; Driesche R. van, 2016, CAB Reviews, V11, P1, DOI 10.1079/PAVSNNR201611044; Duyck PF, 2002, B ENTOMOL RES, V92, P461, DOI 10.1079/BER2002188; Ekesi S, 2002, BIOCONTROL SCI TECHN, V12, P7, DOI 10.1080/09583150120093077; European Food Safety Authority, 2015, EFSA Journal, V13, P4264; European Food Safety Authority, 2015, EFSA Journal, V13, P4261; FARGUES J, 1977, MYCOPATHOLOGIA, V62, P31, DOI 10.1007/BF00491993; Fargues J, 1998, BIOCONTROL SCI TECHN, V8, P323, DOI 10.1080/09583159830135; FENG MG, 1994, BIOCONTROL SCI TECHN, V4, P3, DOI 10.1080/09583159409355309; Glare T, 2012, TRENDS BIOTECHNOL, V30, P250, DOI 10.1016/j.tibtech.2012.01.003; Goble TA, 2014, BIOL CONTROL, V72, P91, DOI 10.1016/j.biocontrol.2014.02.006; Goettel M, 1990, SAFETY MICROBIAL INS, P209; Gryganskyi AP, 2013, PERSOONIA, V30, P94, DOI 10.3767/003158513X666330; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; Hajek AE, 2016, CLASSICAL BIOL CONTR; Hajek AE, 2007, FIELD MANUAL TECHNIQ, P816, DOI DOI 10.1007/978-1-4020-5933-9_40; Hassani IM, 2016, B ENTOMOL RES, V106, P749, DOI 10.1017/S0007485316000456; Hu X, 2014, P NATL ACAD SCI USA, V111, P16796, DOI 10.1073/pnas.1412662111; Imoulan A, 2017, J ASIA-PAC ENTOMOL, V20, P1204, DOI 10.1016/j.aspen.2017.08.015; Inglis GD, 2012, MANUAL TECHNIQUES IN, P189, DOI DOI 10.1016/B978-0-12-386899-2.00007-5; Jensen AB, 2006, MYCOL RES, V110, P941, DOI 10.1016/j.mycres.2006.06.003; Keller S, 1999, BIOCONTROL SCI TECHN, V9, P441, DOI 10.1080/09583159929703; LEATHERDALE D, 1970, Entomophaga, V15, P419, DOI 10.1007/BF02370311; Lu HL, 2016, ADV GENET, V94, P251, DOI 10.1016/bs.adgen.2015.11.002; Maurer P, 1997, MYCOL RES, V101, P159, DOI 10.1017/S0953756296002213; Meyling NV, 2009, MOL ECOL, V18, P1282, DOI 10.1111/j.1365-294X.2009.04095.x; Meyling NV, 2007, METHODS ISOLATION EN; Moonjely S, 2016, ADV GENET, V94, P107, DOI 10.1016/bs.adgen.2015.12.004; Neuveglise C, 1997, MOL ECOL, V6, P373, DOI 10.1046/j.1365-294X.1997.00202.x; NEUVEGLISE C, 1994, MYCOL RES, V98, P322, DOI 10.1016/S0953-7562(09)80460-7; Onstad D, 2006, ABRIDGED GLOSSARY TE; Ortiz-Urquiza A, 2010, J INVERTEBR PATHOL, V105, P270, DOI 10.1016/j.jip.2010.07.003; Pell J. K., 2001, Fungi as biocontrol agents: progress, problems and potential, P71, DOI 10.1079/9780851993560.0071; Quesada-Moraga E, 2006, J ECON ENTOMOL, V99, P1955, DOI 10.1603/0022-0493-99.6.1955; Quesada-Moraga E, 2006, MYCOPATHOLOGIA, V161, P323, DOI 10.1007/s11046-006-0014-0; Quesada-Moraga E, 2003, BIOCONTROL SCI TECHN, V13, P323, DOI 10.1080/0958315031000110346; Quesada-Moraga E, 2007, MYCOL RES, V111, P947, DOI 10.1016/j.mycres.2007.06.006; Rehner SA, 2011, MYCOLOGIA, V103, P1055, DOI 10.3852/10-302; Robene-Soustrade I, 2015, MYCOLOGIA, V107, P1221, DOI 10.3852/14-344; SAS Institute, 2010, SAS STAT 9 3; Shah PA, 2003, APPL MICROBIOL BIOT, V61, P413, DOI 10.1007/s00253-003-1240-8; Shapiro-Ilan DI, 2005, J INVERTEBR PATHOL, V88, P1, DOI 10.1016/j.jip.2004.10.003; Talaei-Hassanloui R, 2006, BIOCONTROL SCI TECHN, V16, P525, DOI 10.1080/09583150500532758; Tefera T, 2003, J INVERTEBR PATHOL, V84, P90, DOI 10.1016/j.jip.2003.08.001; TODOROVA SI, 1994, ENTOMOPHAGA, V39, P159, DOI 10.1007/BF02372354; UMADEVI K, 2008, BIOCONTROL SCI TECHN, V18, P975; Valero-Jimenez CA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-479; van Lenteren JC, 2006, ANNU REV ENTOMOL, V51, P609, DOI 10.1146/annurev.ento.51.110104.151129; Vercambre B, 1994, 6 INT C INV PATH MIC, P283; Vestergaard S, 2003, PROG BIOL CONTROL, V1, P35; Wraight SP, 2010, J INVERTEBR PATHOL, V103, P186, DOI 10.1016/j.jip.2010.01.001; Zare M., 2014, J CROP PROT, V3, P425	59	18	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199199	10.1371/journal.pone.0199199	http://dx.doi.org/10.1371/journal.pone.0199199			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975710	Green Submitted, Green Published, gold			2022-12-26	WOS:000437424500026
J	Chai, SJ; Shi, JN; Huang, T; Guo, YL; Wei, J; Guo, MC; Li, LY; Dou, SJ; Liu, LJ; Liu, GZ				Chai, Shuaijie; Shi, Jianan; Huang, Teng; Guo, Yalu; Wei, Jian; Guo, Meicen; Li, Liyun; Dou, Shijuan; Liu, Lijuan; Liu, Guozhen			Characterization of Chlorella sorokiniana growth properties in monosaccharide-supplemented batch culture	PLOS ONE			English	Article							FATTY-ACIDS; CHLAMYDOMONAS-REINHARDTII; LIPID-ACCUMULATION; SEED OIL; MICROALGAE; BIODIESEL; CULTIVATION; PROTEIN; METABOLISM; STARVATION	To reveal growth properties of Chlorella sorokiniana UTEX 1230, four monosaccharides (glucose, fructose, galactose and xylose) were individually supplemented into medium as carbon sources for the cultivation of C. sorokiniana UTEX 1230. Supplementation with glucose increased OD750, biomass and lipid yield but decreased protein abundance per unit dry weight of biomass under all concentrations examined, the maximum OD750, biomass and lipid yield increased 2.04, 6.78 and 12.43 times, respectively, compared with autotrophic controls. A low concentration of glucose (< 4 g/L) simultaneously promoted the biosynthesis of chlorophylls and protein abundance per unit culture volume, but decreased the lipid content per unit dry weight of biomass and all supplemented glucose can be exhausted within 7 days. Higher glucose concentrations (> 4 g/L) decreased the biosynthesis of chlorophylls and protein abundance per unit culture volume, but increased the lipid content per unit dry weight of biomass. In glucose supplemented scenario, C. sorokiniana UTEX 1230 growth was light-independent. Supplementation with fructose promoted C. sorokiniana UTEX 1230 growth to a much lesser extent compared with glucose, whereas supplementation with galactose had no effect and supplementation with xylose even inhibited growth. Our findings represent basic experimental data on the effect of monosaccharides and can serve as the basis for a robust cultivation system to increase biomass and lipid yield.	[Chai, Shuaijie; Shi, Jianan; Huang, Teng; Guo, Yalu; Wei, Jian; Guo, Meicen; Li, Liyun; Dou, Shijuan; Liu, Lijuan; Liu, Guozhen] Hebei Agr Univ, Inst Bioenergy, Baoding, Hebei, Peoples R China	Hebei Agricultural University	Liu, GZ (corresponding author), Hebei Agr Univ, Inst Bioenergy, Baoding, Hebei, Peoples R China.	gzhliu@hebau.edu.cn		Liu, Guozhen/0000-0001-8511-7846	Key Discipline of Botany in Hebei Province; Key Laboratory of Hebei Province for Molecular Plant-Microbe Interaction	Key Discipline of Botany in Hebei Province; Key Laboratory of Hebei Province for Molecular Plant-Microbe Interaction	Funding provided by Key Discipline of Botany in Hebei Province and Key Laboratory of Hebei Province for Molecular Plant-Microbe Interaction to Dr. Guozhen Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara C, 2015, APPL MICROBIOL BIOT, V99, P2393, DOI 10.1007/s00253-014-6125-5; Bhatnagar A, 2011, APPL ENERG, V88, P3425, DOI 10.1016/j.apenergy.2010.12.064; BISMUT H, 1993, EUR J BIOCHEM, V213, P721, DOI 10.1111/j.1432-1033.1993.tb17812.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chioccioli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097269; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Goold HD, 2016, PLANT PHYSIOL, V171, P2406, DOI 10.1104/pp.16.00718; Hawkins RL, 1999, CURR MICROBIOL, V38, P360, DOI 10.1007/PL00006817; Kim BH, 2016, BIOMASS BIOENERG, V85, P300, DOI 10.1016/j.biombioe.2015.12.026; KNIGHT JA, 1972, CLIN CHEM, V18, P199; Kobayashi N, 2013, BIORESOURCE TECHNOL, V150, P377, DOI 10.1016/j.biortech.2013.10.032; KOHN BD, 1963, J BIOL CHEM, V238, P1193; Lee YK, 1996, J APPL PHYCOL, V8, P163, DOI 10.1007/BF02186320; Li TT, 2014, BIOMASS BIOENERG, V66, P204, DOI 10.1016/j.biombioe.2014.04.010; Li YQ, 2015, BIORESOURCE TECHNOL, V192, P781, DOI 10.1016/j.biortech.2014.07.028; Li YQ, 2014, BIORESOURCE TECHNOL, V174, P24, DOI 10.1016/j.biortech.2014.09.142; Lovato L, 2014, BIOMASS BIOENERG, V60, P247, DOI 10.1016/j.biombioe.2013.11.016; Martinez G, 2014, BIOMASS BIOENERG, V63, P22, DOI 10.1016/j.biombioe.2014.01.034; MATA TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI DOI 10.1016/J.RSER.2009.07.020; Metting FB, 1996, J IND MICROBIOL BIOT, V17, P477, DOI 10.1007/BF01574779; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mishra SK, 2014, BIORESOURCE TECHNOL, V155, P330, DOI 10.1016/j.biortech.2013.12.077; Pohndorf RS, 2016, BIOMASS BIOENERG, V93, P25, DOI 10.1016/j.biombioe.2016.06.020; Rawat I, 2013, APPL ENERG, V103, P444, DOI 10.1016/j.apenergy.2012.10.004; Rong RJ, 2016, J INTEGR AGR, V15, P726, DOI 10.1016/S2095-3119(15)61053-X; Rosenberg JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092460; Santos-Sanchez NF, 2016, APPL MICROBIOL BIOT, V100, P8667, DOI 10.1007/s00253-016-7818-8; Shah M, 2014, BIOMASS BIOENERG, V70, P225, DOI 10.1016/j.biombioe.2014.08.029; Shen XF, 2015, WATER RES, V81, P294, DOI 10.1016/j.watres.2015.06.003; SOROKIN C, 1953, SCIENCE, V117, P330, DOI 10.1126/science.117.3039.330; Spolaore P, 2006, J CHEM TECHNOL BIOT, V81, P1049, DOI 10.1002/jctb.1529; Wan MX, 2011, APPL MICROBIOL BIOT, V91, P835, DOI 10.1007/s00253-011-3399-8; Wang JH, 2017, APPL MICROBIOL BIOT, V101, P2659, DOI 10.1007/s00253-017-8184-x; Wase N, 2015, ALGAL RES, V11, P74, DOI 10.1016/j.algal.2015.06.002; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Woodworth BD, 2015, BIORESOURCE TECHNOL, V179, P159, DOI 10.1016/j.biortech.2014.11.098; Yurina NP, 2001, PLANT PHYSIOL BIOCH, V39, P807, DOI 10.1016/S0981-9428(01)01293-1; Zheng YB, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0125-7	39	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199873	10.1371/journal.pone.0199873	http://dx.doi.org/10.1371/journal.pone.0199873			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969497	Green Published, gold, Green Submitted			2022-12-26	WOS:000437246700032
J	Shen, L; Assanangkornchai, S; Liu, W; Cai, L; Li, F; Tang, SY; Shen, JC; McNeil, EB; Chongsuvivatwong, V				Shen, Ling; Assanangkornchai, Sawitri; Liu, Wei; Cai, Le; Li, Fei; Tang, Songyuan; Shen, Jiucheng; McNeil, Edward B.; Chongsuvivatwong, Virasakdi			Influence of social network on drug use among clients of methadone maintenance treatment centers in Kunming, China	PLOS ONE			English	Article							HIV RISK BEHAVIOR; SUBSTANCE USE; SUPPORT; YUNNAN; NORMS; METHAMPHETAMINE; ASSOCIATION; PREDICTORS; RETENTION; BALTIMORE	Aims To examine drug use behavior of clients attending Methadone Maintenance Treatment (MMT) programs and its relationship with the clients' social network characteristics. Design Cross-sectional study. Setting Four MMT clinics in Kunming, Yunnan province, China. Participants 324 consecutive MMT clients. Measurements A structured, self-completed questionnaire on background characteristics and existing social network. Current drug use was assessed by urine test for opiate metabolites. Analysis The association between client's social network characteristics and their own current drug use behavior is analysed using multiple logistic regression adjusting forsocio-demographic characteristics. Adjusted odds ratios (AOR) with 95% confidence intervals (CI) are obtained to give the strength of the associations. Findings MMT clients were more likely to concurrently use heroin while attending MMT if their social network had any of the following characteristics: more than half of the members were older than them (AOR = 1.03, 95% CI = 1.00,1.06), any member had a high level of influence on them (AOR = 6.47, 95% CI = 2.86,14.65) and any member joined them in using drugs (AOR = 1.94, 95% CI = 1.04,3.63). Having a social network member who could provide emotional support (AOR = 0.11, 95% CI = 0.03,0.35), having a spouse and/or child in their social network (AOR = 0.44, 95% CI = 0.24,0.81) and having a social network member with a high level of closeness (AOR = 0.28, 95% CI = 0.09,0.90) were associated with a decreased odds of heroin use. Conclusion Social networks who could provide MMT clients with emotional support and a close relationship were significant factors for reducing the risk of concurrent drug use among clients attending MMT clinics in Kunming, China. Behavioral interventions should address the role of family and social network members in providing support to these clients.	[Shen, Ling; Assanangkornchai, Sawitri; McNeil, Edward B.; Chongsuvivatwong, Virasakdi] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Thailand; [Shen, Ling; Liu, Wei; Cai, Le; Tang, Songyuan] Kunming Med Univ, Sch Publ Hlth, Kunming, Yunnan, Peoples R China; [Li, Fei] Kunming Med Univ, Sch Basic Med Sci, Kunming, Yunnan, Peoples R China; [Shen, Jiucheng] Yunnan Inst Drug Abuse, Kunming, Yunnan, Peoples R China	Prince of Songkla University; Kunming Medical University; Kunming Medical University	Assanangkornchai, S (corresponding author), Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Thailand.	savitree.a@psu.ac.th		McNeil, Edward Braddon/0000-0002-9492-1040; Assanangkornchai, Sawitri/0000-0003-2174-3287				Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051569; Barati M, 2014, J RES HEALTH SCI, V14, P221; Cao Xiao-bin, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P269; Chang YP, 2014, PUBLIC HEALTH ACTION, V4, P28, DOI 10.5588/pha.13.0101; Chen W, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-23; Cheng Xiao-Qing, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P792; *CHIN NHAFPCOTPSRO, 2015, 2015 CHIN AIDS RESP; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; De P, 2007, ADDICTION, V102, P1730, DOI 10.1111/j.1360-0443.2007.01936.x; El-Bassel N, 1998, AIDS CARE, V10, P735, DOI 10.1080/09540129848352; El-Bassel N, 2006, J URBAN HEALTH, V83, P602, DOI 10.1007/s11524-006-9075-0; Friedman SR, 2007, AIDS BEHAV, V11, P641, DOI 10.1007/s10461-006-9166-7; Friedman SR, 2001, J URBAN HEALTH, V78, P411, DOI 10.1093/jurban/78.3.411; GOEHL L, 1993, AM J DRUG ALCOHOL AB, V19, P251, DOI 10.3109/00952999309001617; Gyarmathy V Anna, 2006, Connect (Tor), V27, P25; Hall A, 1985, SOCIAL NETWORKS SOCI; Havens JR, 2009, J SUBST ABUSE TREAT, V36, P306, DOI 10.1016/j.jsat.2008.07.002; HOUSE JS, 1988, ANNU REV SOCIOL, V14, P293, DOI 10.1146/annurev.so.14.080188.001453; HURD GS, 1981, INT J FAM THER, V3, P246, DOI 10.1007/BF00924352; Janulis P, 2016, INT J DRUG POLICY, V27, P56, DOI 10.1016/j.drugpo.2015.09.006; Kamal F, 2007, Ir Med J, V100, P393; Knowlton AR, 2005, AIDS CARE, V17, P479, DOI 10.1080/0954012051233131314349; Koram N, 2011, AIDS BEHAV, V15, P1579, DOI 10.1007/s10461-011-9930-1; Latkin C, 1996, J ACQ IMMUN DEF SYND, V13, P273, DOI 10.1097/00042560-199611010-00010; LATKIN C, 1994, SEX TRANSM DIS, V21, P161, DOI 10.1097/00007435-199405000-00006; Latkin CA, 2010, AIDS BEHAV, V14, P1159, DOI 10.1007/s10461-009-9576-4; Latkin CA, 2005, AIDS CARE, V17, pS102, DOI 10.1080/09540120500121185; Latkin CA, 2003, SOC SCI MED, V56, P465, DOI 10.1016/S0277-9536(02)00047-3; Latkin C, 2009, HEALTH PSYCHOL, V28, P323, DOI 10.1037/a0014707; Latkin Carl M a W, 1995, DRUG ALCOHOL DEPEN; Li J, 2015, PUBLIC HEALTH, V129, P1237, DOI 10.1016/j.puhe.2015.07.020; Li L, 2011, DRUG ALCOHOL DEPEN, V116, P246, DOI 10.1016/j.drugalcdep.2010.12.007; Li L, 2012, ADDICT BEHAV, V37, P264, DOI 10.1016/j.addbeh.2011.11.004; Liao MZ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-172; Lin C, 2011, PUBLIC HEALTH, V125, P269, DOI 10.1016/j.puhe.2011.01.009; Lin CQ, 2011, SUBST USE MISUSE, V46, P1190, DOI 10.3109/10826084.2011.561905; Lin CQ, 2010, J SUBST ABUSE TREAT, V38, P119, DOI 10.1016/j.jsat.2009.09.002; Liu HJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-563; Luo XF, 2016, INT J ENV RES PUB HE, V13; MATTICK RP, 2003, COCHRANE DATABASE SY, V2; NEAIGUS A, 1994, SOC SCI MED, V38, P67, DOI 10.1016/0277-9536(94)90301-8; Neaigus A, 1995, NIDA Res Monogr, V151, P20; Shariatirad S, 2013, INT J DRUG POLICY, V24, P636, DOI [10.1016/j.drugpo.2013.04.003, 10.1016/j.drugpo.2013.05.003]; Strain EC, 1999, JAMA-J AM MED ASSOC, V281, P1000, DOI 10.1001/jama.281.11.1000; Suh Tongwoo M W, 1997, DRUG ALCOHOL DEPEN; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Sullivan SG, 2014, J SUBST ABUSE TREAT, V47, P86, DOI 10.1016/j.jsat.2013.12.004; Sun HM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005997; Trujillo KA, 2011, PHARMACOL BIOCHEM BE, V99, P451, DOI 10.1016/j.pbb.2011.04.014; Valente T., 2003, CONNECTIONS CONNECT, V25, P11; Valente TW, 2001, AM J PUBLIC HEALTH, V91, P406, DOI 10.2105/AJPH.91.3.406; VLAHOV D, 1990, AM J EPIDEMIOL, V132, P847, DOI 10.1093/oxfordjournals.aje.a115727; Wang L, 2015, ADDICTION, V110, P20, DOI 10.1111/add.12779; Wang M, 2017, J SUBST ABUSE TREAT, V77, P89, DOI 10.1016/j.jsat.2017.03.004; Wang RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133431; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zapka JG, 1993, AIDS ED PREVENTION	57	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0200105	10.1371/journal.pone.0200105	http://dx.doi.org/10.1371/journal.pone.0200105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL5XD	29969481	Green Published, gold, Green Submitted			2022-12-26	WOS:000437246700045
J	Shrestha, RB; Dunbar, MW; French, BW; Gassmann, AJ				Shrestha, Ram B.; Dunbar, Mike W.; French, Bryan W.; Gassmann, Aaron J.			Effects of field history on resistance to Bt maize by western corn rootworm, Diabrotica virgifera virgifera LeConte (Coleoptera: Chrysomelidae)	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS TOXINS; INSECT RESISTANCE; FITNESS COSTS; EVOLVED RESISTANCE; TRANSGENIC CORN; HOST-RANGE; CROPS; INJURY; EVOLUTION; POPULATIONS	Western corn rootworm, Diabrotica virgifera virgifera LeConte, has evolved resistance to transgenic maize, Zea maize L., that produces the insecticidai protein Cry3Bb1, which is derived from the bacterium Bacillus thuringiensis. We hypothesized that the level of Cry3Bb1 resistance in populations of western corn rootworm could be influenced by farming practices. To test this hypothesis, we evaluated the effect of field history on resistance to Cry3Bb1 maize by western corn rootworm. In 2013 and 2014, rootworm adults were collected from the four types of maize fields: 1) current problem fields, 2) past problem fields, 3) rotated maize fields, and 4) continuous maize fields. Those field populations along with seven Bt-susceptible control populations were tested for Cry3Bb1 resistance with both plant-based and diet-based bioassays. All field populations were resistant to Cry3Bb1 regardless of field history, however, some variation in the degree of resistance was found. For all categories of field populations, larval survivorship on Cry3Bb1 maize was significantly higher than control populations, and did not differ from survival on non-Bt maize. Evidence of resistance to Cry3Bb1 maize in plant-based bioassays was further supported by dietbased bioassays and we found a positive relationship between LC50 values from diet-based bioassays and the larval survivorship in plant-based bioassays. This study provides evidence of Cry3Bb1 resistance throughout the agricultural landscape studied, irrespective of the field history, and highlights the need for improved resistance management approaches, such as better use of integrated pest management to better delay pest resistance.	[Shrestha, Ram B.; Dunbar, Mike W.; Gassmann, Aaron J.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA; [French, Bryan W.] USDA ARS, North Cent Agr Res Lab, Brookings, SD USA; [Dunbar, Mike W.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA	Iowa State University; United States Department of Agriculture (USDA); Emory University	Shrestha, RB (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.	shrestrb@iastate.edu		Shrestha, Ram/0000-0001-5542-6269	Monsanto Corn Rootworm Knowledge Grant	Monsanto Corn Rootworm Knowledge Grant	This work was supported by a Monsanto Corn Rootworm Knowledge Grant (https://monsanto.com/products/product-stewardship/corn-rootworm-management/corn-rootworm-knowledge-research-program/) to AJG. Monsanto provided advice on conducting diet-based bioassays, provided laboratory materials for conducting diet-based bioassays, and a research scientist at Monsanto, Graham Head, provided comments on a completed draft of the manuscript. Aside from these interactions, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abendroth L., 2011, CORN GROWTH DEV; BRANSON TF, 1970, J ECON ENTOMOL, V63, P800, DOI 10.1093/jee/63.3.800; BRANSON TF, 1967, J ECON ENTOMOL, V60, P201, DOI 10.1093/jee/60.1.201; Clark TL, 2004, ENVIRON ENTOMOL, V33, P681, DOI 10.1603/0046-225X-33.3.681; Cullen EM, 2013, J INTEGR PEST MANAG, V4, pD1, DOI 10.1603/IPM13012; Deitloff J, 2016, PEST MANAG SCI, V72, P190, DOI 10.1002/ps.3988; Dun Z, 2010, J APPL ENTOMOL, V134, P409, DOI 10.1111/j.1439-0418.2009.01487.x; Dunbar MW, 2016, J ECON ENTOMOL, V109, P2096, DOI 10.1093/jee/tow163; Dunbar MW, 2013, J ECON ENTOMOL, V106, P168, DOI 10.1603/EC11291; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Fernandez-Cornejo J, 2014, GENETICALLY ENG CROP, P1; Gassmann AJ, 2016, J ECON ENTOMOL, V109, P1872, DOI 10.1093/jee/tow110; Gassmann AJ, 2016, CURR OPIN INSECT SCI, V15, P111, DOI 10.1016/j.cois.2016.04.001; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Gassmann AJ, 2012, J INVERTEBR PATHOL, V110, P287, DOI 10.1016/j.jip.2012.04.006; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Hammack L, 2003, J ECON ENTOMOL, V96, P1153, DOI 10.1603/0022-0493-96.4.1153; Hoffmann AM, 2015, J APPL ENTOMOL, V139, P403, DOI 10.1111/jen.12209; Hoffmann AM, 2014, J ECON ENTOMOL, V107, P352, DOI 10.1603/EC13247; Ingber DA, 2015, J ECON ENTOMOL, V108, P2421, DOI 10.1093/jee/tov199; Ives AR, 2002, ECOL LETT, V5, P792, DOI 10.1046/j.1461-0248.2002.00392.x; Jakka SRK, 2016, SCI REP-UK, V6, DOI 10.1038/srep27860; LEVINE E, 1991, ANNU REV ENTOMOL, V36, P229, DOI 10.1146/annurev.en.36.010191.001305; Levine Eli, 2002, American Entomologist, V48, P94; Ludwick DC, 2017, J APPL ENTOMOL, V141, P28, DOI 10.1111/jen.12377; Meihls LN, 2008, P NATL ACAD SCI USA, V105, P19177, DOI 10.1073/pnas.0805565105; Naranjo S. E., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1, DOI 10.1079/PAVSNNR20094011; Oleson JD, 2005, J ECON ENTOMOL, V98, P1, DOI 10.1603/0022-0493-98.1.1; Onstad DW, 2010, J ECON ENTOMOL, V103, P849, DOI 10.1603/EC09199; Onstad DW, 2008, INSECT RESISTANCE MA, P185; Oswald KJ, 2012, J APPL ENTOMOL, V136, P730, DOI 10.1111/j.1439-0418.2012.01704.x; Paolino AR, 2017, TOXINS, V9, DOI 10.3390/toxins9050159; Park Y, 2009, APPL ENVIRON MICROB, V75, P3086, DOI 10.1128/AEM.00268-09; Petzold-Maxwell JL, 2013, J ECON ENTOMOL, V106, P1941, DOI 10.1603/EC13216; Petzold-Maxwell JL, 2012, J ECON ENTOMOL, V105, P1407, DOI 10.1603/EC11425; Phipps RH, 2002, J ANIM FEED SCI, V11, P1; SAS Institute, 2015, SAS SOFTW V9 4 M3 20; Schrader PM, 2017, J APPL ENTOMOL, V141, P41, DOI 10.1111/jen.12329; Shaw J.T., 1976, Biological Notes Ill Nat Hist Surv, VNo. 96, pUnpaginated; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Shrestha Ram B., 2016, Journal of Economic Entomology, V109, P1399, DOI 10.1093/jee/tow087; Siegfried BD, 2005, J ECON ENTOMOL, V98, P1320, DOI 10.1603/0022-0493-98.4.1320; Sokal R.R., 2012, BIOMETRY; Spencer JL, 2003, J ECON ENTOMOL, V96, P1738, DOI 10.1603/0022-0493-96.6.1738; Tabashnik BE, 2004, J EVOLUTION BIOL, V17, P904, DOI 10.1111/j.1420-9101.2004.00695.x; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2017, NAT BIOTECHNOL, V35, P926, DOI 10.1038/nbt.3974; Tabashnik BE, 2014, J ECON ENTOMOL, V107, P496, DOI 10.1603/EC13458; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Thompson JN, 1997, ECOLOGY, V78, P1619; Tinsley NA, 2013, J APPL ENTOMOL, V137, P161, DOI 10.1111/j.1439-0418.2012.01736.x; US EPA Environmental Protection Agency, 2007, BIOP REG ACT DOC EV; Vaughn T, 2005, CROP SCI, V45, P931, DOI 10.2135/cropsci2004.0304; Wangila DS, 2015, J ECON ENTOMOL, V108, P742, DOI 10.1093/jee/tou063; Zukoff SN, 2016, J ECON ENTOMOL, V109, P1387, DOI 10.1093/jee/tow073	59	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0200156	10.1371/journal.pone.0200156	http://dx.doi.org/10.1371/journal.pone.0200156			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969492	Green Published, Green Submitted, gold			2022-12-26	WOS:000437246700048
J	De Rauw, K; Jacobs, S; Pierard, D				De Rauw, Klara; Jacobs, Steve; Pierard, Denis			Twenty-seven years of screening for Shiga toxin-producing Escherichia coli in a university hospital. Brussels, Belgium, 1987-2014	PLOS ONE			English	Article							PCR ASSAYS; O157; INFECTIONS; ALBERTII; MICROBIOLOGY; PROTOCOL; STRAINS; ENGLAND	Objective Since 1987 all fecal samples referred to the clinical microbiology laboratory of the UZ Brussel were screened for the presence of Shiga toxin-producing E. coli (STEC). In this study all STEC strains isolated over a period of 27 years (1987-2014) were reexamined to achieve deeper insight in the STEC infections in our patient population. Methods A total of 606 STEC strains from 604 patients were subjected to molecular methods for shiga toxin (stx) subtyping, detection of additional virulence genes, typing of the O-serogroups, and phylogenetic relatedness assessment of STEC O157:H7/H-. Results Since the introduction of PCR in 1991 the annual positivity rates varied between 1.1% and 2.7%. The isolation rate of STEC O157:H7/H- remained stable over the years while the isolation rate of non-O157 serotypes increased, mainly since 2011. The majority of the patients were children. Uncomplicated- and bloody diarrhea were the most prevalent gastrointestinal manifestations (respectively 51.9% and 13.6%), 4.3% of the strains were related to the hemolytic uremic syndrome (HUS), and 30.2% of the patients showed none of these symptoms. The strains were very diverse; they belonged to 72 different O-serovars and all stx subtypes except stx1d and stx2g were identified. Out of the 23 stx2f-positives one was associated with HUS and one belonged to the E. albertii species. As seen in other studies, the frequency of strains of the O157:H7/H- serotype and strains carrying stx2a, eaeA and ehxA was higher in patients with HUS. Conclusions The characteristics and trends of STEC infection seen in our patient population are similar to those noted in other countries. STEC infections in our hospital are mainly sporadic, and a substantial portion of the patients were asymptomatic carriers. Human STEC Stx2f infection was less rare than previously assumed and we report the first Belgian STEC stx2f HUS case and stx2f positive E. albertii infection.	[De Rauw, Klara; Jacobs, Steve; Pierard, Denis] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Belgian Natl Reference Ctr STEC VTEC, Dept Microbiol & Infect Control, Brussels, Belgium	University Hospital Brussels; Vrije Universiteit Brussel	De Rauw, K (corresponding author), Vrije Univ Brussel, Univ Ziekenhuis Brussel, Belgian Natl Reference Ctr STEC VTEC, Dept Microbiol & Infect Control, Brussels, Belgium.	klara.derauw@uzbrussel.be		Pierard, DEnis/0000-0002-7756-3691	Belgian Ministry of Social Affairs through a fund within the Health Insurance System	Belgian Ministry of Social Affairs through a fund within the Health Insurance System	Most of this work was performed on basis of own financing. Since October 2010, part of this work was performed in the frame of the Belgian National Reference Centre for STEC supported by the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NL, 2016, EMERG INFECT DIS, V22, P590, DOI 10.3201/eid2204.151485; Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3138; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Boisen N, 2012, J INFECT DIS, V205, P431, DOI 10.1093/infdis/jir757; Brandal LT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1017-6; Buvens G, 2012, J CLIN MICROBIOL, V50, P1336, DOI 10.1128/JCM.05317-11; Byrne L, 2014, J MED MICROBIOL, V63, P1181, DOI 10.1099/jmm.0.075895-0; De Rauw K, 2016, EUR J CLIN MICROBIOL, V35, P1479, DOI 10.1007/s10096-016-2688-7; De Rauw K, 2014, New Microbes New Infect, V2, P138, DOI 10.1002/nmi2.58; De Rauw K, 2016, DIAGN MICR INFEC DIS, V86, P35, DOI 10.1016/j.diagmicrobio.2016.05.016; Ethelberg S, 2004, EMERG INFECT DIS, V10, P842, DOI 10.3201/eid1005.030576; European Centre for Disease Prevention and Control, 2015, EUEEA20102012; Feng PCH, 2011, APPL ENVIRON MICROB, V77, P6699, DOI 10.1128/AEM.00370-11; Ferdous M, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.03.028; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Franz E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120353; Friesema I, 2014, EUROSURVEILLANCE, V19, P26, DOI 10.2807/1560-7917.ES2014.19.17.20787; Fruth A, 2015, INT J MED MICROBIOL, V305, P697, DOI 10.1016/j.ijmm.2015.08.020; Gaetan M, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-16; Gilmour MW, 2007, J MED MICROBIOL, V56, P620, DOI 10.1099/jmm.0.47053-0; Gould L. Hannah, 2009, Morbidity and Mortality Weekly Report, V58, P1; Haugum K, 2014, J CLIN MICROBIOL, V52, P3156, DOI 10.1128/JCM.00453-14; Haugum K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111788; Hyma KE, 2005, J BACTERIOL, V187, P619, DOI 10.1128/JB.187.2.619-628.2005; Kam KM, 2008, J CLIN MICROBIOL, V46, P2766, DOI 10.1128/JCM.00424-08; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; KARCH H, 1989, J CLIN MICROBIOL, V27, P2751, DOI 10.1128/JCM.27.12.2751-2757.1989; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; Kuehne A, 2016, EPIDEMIOL INFECT, V144, P3305, DOI 10.1017/S0950268816001436; Margot H, 2013, J FOOD PROTECT, V76, P871, DOI 10.4315/0362-028X.JFP-12-365; Newell DG, 2018, TRANSBOUND EMERG DIS; Nimri LF, 2013, DIAGN MICR INFEC DIS, V77, P91, DOI 10.1016/j.diagmicrobio.2013.06.028; OBRIEN AD, 1983, LANCET, V2, P573; Ooka T, 2013, EMERG INFECT DIS, V19, P144, DOI 10.3201/eid1901.120646; Ooka T, 2012, EMERG INFECT DIS, V18, P488, DOI 10.3201/eid1803.111401; Ooka T, 2009, J CLIN MICROBIOL, V47, P2888, DOI 10.1128/JCM.00792-09; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; PIERARD D, 1992, ACTA CLIN BELG, V47, P387, DOI 10.1080/17843286.1992.11718260; PIERARD D, 1990, EUR J CLIN MICROBIOL, V9, P198; Pierard Denis, 1997, Clin Microbiol Infect, V3, P531, DOI 10.1111/j.1469-0691.1997.tb00303.x; Scheutz F, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0019-2013; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Schmidt H, 2000, APPL ENVIRON MICROB, V66, P1205, DOI 10.1128/AEM.66.3.1205-1208.2000; Toth I, 2003, J CLIN MICROBIOL, V41, P4285, DOI 10.1128/JCM.41.9.4285-4291.2003; Tozzoli R, 2014, PATHOGENIC ESCHERICH, DOI [10.3201/eid2204.151485, DOI 10.3201/EID2204.151485]; U. S. Department of Health and Human Services CAG, 2014, FOODB DIS ACT SURV N; World Health Organization [WHO], 2015, ESTIMATES GLOBAL BUR	48	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199968	10.1371/journal.pone.0199968	http://dx.doi.org/10.1371/journal.pone.0199968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965972	Green Published, gold, Green Submitted			2022-12-26	WOS:000437224100031
J	Wilenius, J; Lehtinen, H; Paetau, R; Salmelin, R; Kirveskari, E				Wilenius, Juha; Lehtinen, Henri; Paetau, Ritva; Salmelin, Riitta; Kirveskari, Erika			A simple magnetoencephalographic auditory paradigm may aid in confirming left-hemispheric language dominance in epilepsy patients	PLOS ONE			English	Article							WADA TEST; LATERALIZATION; SPEECH; MEG; ORGANIZATION; VALIDATION; VOWELS; TONES	Objective The intracarotid amobarbital procedure (IAP) is the current "gold standard" in the preoperative assessment of language lateralization in epilepsy surgery candidates. It is, however, invasive and has several limitations. Here we tested a simple noninvasive language lateralization test performed with magnetoencephalography (MEG). Methods We recorded auditory MEG responses to pairs of vowels and pure tones in 16 epilepsy surgery candidates who had undergone IAP. For each individual, we selected the pair of planar gradiometer sensors with the strongest N100m response to vowels in each hemisphere and -from the vector sum of signals of this gradiometer pair-calculated the vowel/tone amplitude ratio in the left (L) and right (R) hemisphere and, subsequently, the laterality index: LI = (L-R)/(L+R). In addition to the analysis using a single sensor pair, an alternative analysis was performed using averaged responses over 18 temporal sensor pairs in both hemispheres. Results The laterality index did not correlate significantly with the lateralization data obtained from the IAP. However, an MEG pattern of stronger responses to vowels than tones in the left hemisphere and stronger responses to tones than vowels in the right hemisphere was associated with left-hemispheric language dominance in the IAP in all the six patients who showed this pattern. This results in a specificity of 100% and a sensitivity of 67% of this MEG pattern in predicting left-hemispheric language dominance (p = 0.01, Fisher's exact test). In the analysis using averaged responses over temporal channels, one additional patient who was left-dominant in IAP showed this particular MEG pattern, increasing the sensitivity to 78% (p = 0.003). Significance This simple MEG paradigm shows promise in feasibly and noninvasively confirming left-hemispheric language dominance in epilepsy surgery candidates. It may aid in reducing the need for the IAP, if the results are confirmed in larger patient samples.	[Wilenius, Juha; Paetau, Ritva; Kirveskari, Erika] Univ Helsinki, Clin Neurosci, Dept Clin Neurophysiol, HUS Med Imaging Ctr, Helsinki, Finland; [Wilenius, Juha; Lehtinen, Henri; Paetau, Ritva; Kirveskari, Erika] Helsinki Univ Hosp, Helsinki, Finland; [Lehtinen, Henri; Paetau, Ritva] Univ Helsinki, Epilepsy Unit, Dept Pediat Neurol, Helsinki, Finland; [Salmelin, Riitta] Aalto Univ, Dept Neurosci & Biomed Engn, Espoo, Finland	Hyvinkaan Sairaala; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Aalto University	Wilenius, J (corresponding author), Univ Helsinki, Clin Neurosci, Dept Clin Neurophysiol, HUS Med Imaging Ctr, Helsinki, Finland.; Wilenius, J (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	juha.wilenius@hus.fi	Salmelin, Riitta H/I-7044-2012	Salmelin, Riitta H/0000-0003-2499-193X; Wilenius, Juha/0000-0001-9712-1594	Helsinki University Hospital Research Fund; Finnish Epilepsy Research Foundation; University of Helsinki; Academy of Finland [255349, 256459, 283071]; Sigrid JuseAlius Foundation	Helsinki University Hospital Research Fund; Finnish Epilepsy Research Foundation; University of Helsinki; Academy of Finland(Academy of Finland); Sigrid JuseAlius Foundation	This work was supported by the Helsinki University Hospital Research Fund (URL: http://www.hus.fi/Sivut/default.aspx, No grant number available, author J.W.); the Finnish Epilepsy Research Foundation (URL: https://www.epilepsia.fi/fi/web/epilepsiatutkimussaatio/etusivu, No grant number available, author J.W.); University of Helsinki (URL: https://www.helsinki.fi/fi, Funded doctoral candidate position, No grant number available, author J.W.); Academy of Finland (URL: http://www.aka.fi/, Grant numbers #255349, #256459 and #283071, author R.S.); and the Sigrid JuseAlius Foundation (URL: http://sigridjuselius.fi/fi/etusivu/, No grant number available, author R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagic A, 2016, CLIN NEUROPHYSIOL, V127, P60, DOI 10.1016/j.clinph.2015.05.009; Bauer PR, 2014, J NEUROL NEUROSUR PS, V85, P581, DOI 10.1136/jnnp-2013-305659; BRADSHAW AR, 2017, PEERJ, V5, DOI DOI 10.7717/PEERJ.3557; Doss RC, 2009, EPILEPSIA, V50, P2242, DOI 10.1111/j.1528-1167.2009.02242.x; Eliashiv DS, 2014, J CLIN NEUROPHYSIOL, V31, P208, DOI 10.1097/WNP.0000000000000058; Findlay AM, 2012, ANN NEUROL, V71, P668, DOI 10.1002/ana.23530; Gootjes L, 1999, NEUROREPORT, V10, P2987, DOI 10.1097/00001756-199909290-00021; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hamberger MJ, 2007, NEUROPSYCHOL REV, V17, P477, DOI 10.1007/s11065-007-9046-6; Hamberger MJ, 2011, NEUROPSYCHOL REV, V21, P240, DOI 10.1007/s11065-011-9180-z; Hari R., 1990, ADV AUDIOL, V6, P222; Hirata M, 2010, J NEUROSURG, V112, P528, DOI 10.3171/2009.7.JNS09239; Kamada K, 2007, NEUROSURGERY, V60, P296, DOI 10.1227/01.NEU.0000249262.03451.0E; Kharkar S, 2015, EPILEPSY BEHAV, V46, P19, DOI 10.1016/j.yebeh.2014.11.029; Kilbride RD, 2013, J CLIN NEUROPHYSIOL, V30, P591, DOI 10.1097/01.wnp.0000436900.48243.9f; Kirveskari E, 2006, CLIN NEUROPHYSIOL, V117, P643, DOI 10.1016/j.clinph.2005.11.001; Krieg SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075403; KURTHEN M, 1992, BRAIN LANG, V43, P694, DOI 10.1016/0093-934X(92)90091-R; Loddenkemper T, 2008, EPILEPSY BEHAV, V13, P551, DOI 10.1016/j.yebeh.2008.05.014; Massot-Tarrus A, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0763-9; PAETAU R, 1995, J CLIN NEUROPHYSIOL, V12, P177, DOI 10.1097/00004691-199503000-00008; Papanicolaou AC, 2004, J NEUROSURG, V100, P867, DOI 10.3171/jns.2004.100.5.0867; Parviainen T, 2005, CEREB CORTEX, V15, P1054, DOI 10.1093/cercor/bhh206; Picht T, 2013, NEUROSURGERY, V72, P808, DOI 10.1227/NEU.0b013e3182889e01; Salmelin R, 2007, CLIN NEUROPHYSIOL, V118, P237, DOI 10.1016/j.clinph.2006.07.316; Tanaka N, 2013, AM J NEURORADIOL, V34, P558, DOI 10.3174/ajnr.A3233; Tarapore PE, 2013, NEUROIMAGE, V82, P260, DOI 10.1016/j.neuroimage.2013.05.018; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Vartiainen J, 2009, J NEUROSCI, V29, P9271, DOI 10.1523/JNEUROSCI.5860-08.2009; WADA J, 1960, J NEUROSURG, V17, P266, DOI 10.3171/jns.1960.17.2.0266; West S, 2015, COCHRANE DB SYST REV, V7	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0200073	10.1371/journal.pone.0200073	http://dx.doi.org/10.1371/journal.pone.0200073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966017	Green Published, Green Submitted, gold			2022-12-26	WOS:000437224100042
J	Reece, JS; Watson, A; Dalyander, PS; Edwards, CK; Geselbracht, L; LaPeyre, MK; Tirpak, BE; Tirpak, JM; Woodrey, M				Reece, Joshua Steven; Watson, Amanda; Dalyander, Patricia Soupy; Edwards, Cynthia Kallio; Geselbracht, Laura; LaPeyre, Megan K.; Tirpak, Blair E.; Tirpak, John M.; Woodrey, Mark			A multiscale natural community and species-level vulnerability assessment of the Gulf Coast, USA	PLOS ONE			English	Article							CLIMATE-CHANGE; EXTINCTION RISK; SEA-LEVEL; ADAPTIVE CAPACITY; OF-MEXICO; PRIORITIZATION; PERSPECTIVES; VARIABILITY; PROJECT; FLORIDA	Vulnerability assessments combine quantitative and qualitative evaluations of the exposure, sensitivity, and adaptive capacity of species or natural communities to current and future threats. When combined with the economic, ecological or evolutionary value of the species, vulnerability assessments quantify the relative risk to regional species and natural communities and can enable informed prioritization of conservation efforts. Vulnerability assessments are common practice in conservation biology, including the potential impacts of future climate scenarios. However, geographic variation in scenarios and vulnerabilities is rarely quantified. This gap is particularly limiting for informing ecosystem management given that conservation practices typically vary by sociopolitical boundaries rather than by ecological boundaries. To support prioritization of conservation actions across a range of spatial scales, we conducted the Gulf Coast Vulnerability Assessment (GCVA) for four natural communities and eleven focal species around the Gulf of Mexico based on current and future threats from climate change and land-use practices out to 2060. We used the Standardized Index of Vulnerability and Value (SIVVA) tool to assess both natural community and species vulnerabilities. We observed greater variation across ecologically delineated subregions within the Gulf Coast of the U.S. than across climate scenarios. This novel finding suggests that future vulnerability assessments incorporate regional variation and that conservation prioritization may vary across ecological subregions. Across subregions and climate scenarios the most prominent threats were legacy effects, primarily from habitat loss and degradation, that compromised the adaptive capacity of species and natural communities. The second most important threats were future threats from sea-level rise. Our results suggest that the substantial threats species and natural communities face from climate change and sea-level rise would be within their adaptive capacity were it not for historic habitat loss, fragmentation, and degradation.	[Reece, Joshua Steven] Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA; [Watson, Amanda] Mississippi State Univ, Starkville, MS USA; [Dalyander, Patricia Soupy] US Geol Survey, St Petersburg Coastal & Marine Sci Ctr, St Petersburg, FL USA; [Edwards, Cynthia Kallio] Wetland & Aquat Res Ctr, Gulf Coast Prairie Landscape Conservat Cooperat, Lafayette, LA USA; [Geselbracht, Laura] Nat Conservancy Florida, Maitland, FL USA; [LaPeyre, Megan K.] Louisiana State Univ, Agr Ctr, Louisiana Cooperat Fish & Wildlife Res Unit, US Geol Survey,Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA; [Tirpak, Blair E.] US Geol Survey, Wetland & Aquat Res Ctr, Lafayette, LA USA; [Tirpak, John M.] US Fish & Wildlife Serv, Gulf Restorat, Dept Interior, Lafayette, LA USA; [Woodrey, Mark] Mississippi State Univ, Coastal Res & Extens Ctr, Grand Bay Natl Estuarine Res Reserve, Moss Point, MS USA	California State University System; California State University Fresno; Mississippi State University; United States Department of the Interior; United States Geological Survey; Nature Conservancy; Louisiana State University System; Louisiana State University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; Mississippi State University	Reece, JS (corresponding author), Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA.	joreece@csufreson.edu		Tirpak, Blair/0000-0002-2679-8378; Tirpak, John/0000-0003-1937-9754	United States Geological Survey; United States Fish and Wildlife Service; Sam D. Hamilton Award for Transformational Conservation Science	United States Geological Survey(United States Geological Survey); United States Fish and Wildlife Service(US Fish & Wildlife Service); Sam D. Hamilton Award for Transformational Conservation Science	We acknowledge the generous support of the United States Geological Survey and the United States Fish and Wildlife Service and the funding that came with the 2015 Sam D. Hamilton Award for Transformational Conservation Science for the execution of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Anderson JB, 2014, MAR GEOL, V352, P348, DOI 10.1016/j.margeo.2013.12.008; [Anonymous], 2011, E OYSTER GULF MEXICO; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Bassler C, 2010, ECOL INDIC, V10, P341, DOI 10.1016/j.ecolind.2009.06.014; Balsillie J. H., 2004, HIGH RESOLUTION SEA; Bland LM, 2015, GUID APPL IUCN RED L; Brooks N, 2005, GLOBAL ENVIRON CHANG, V15, P151, DOI 10.1016/j.gloenvcha.2004.12.006; Caro T. M, 2010, CONSERVATION PROXY I; Clark JA, 2002, CONSERV BIOL, V16, P1510, DOI 10.1046/j.1523-1739.2002.01376.x; Clarke KC, 1998, INT J GEOGR INF SCI, V12, P699, DOI 10.1080/136588198241617; Dalton MS, 2010, 20101213 US GEOL SUR; De Lange HJ, 2010, SCI TOTAL ENVIRON, V408, P3871, DOI 10.1016/j.scitotenv.2009.11.009; Donoghue JF, 2011, CLIMATIC CHANGE, V107, P17, DOI 10.1007/s10584-011-0077-x; Field D.W., 1995, 123 NOAA NMFS; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Geselbracht LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132079; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; IPCC, 2014, CLIM CHANG SYNTH REP; IPCC, 2000, INTERGOVERNMENTAL PA; Jantz CA, 2010, COMPUT ENVIRON URBAN, V34, P1, DOI 10.1016/j.compenvurbsys.2009.08.003; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Karstensen KA, 2009, LAND COVER CHANGE LO, P12; Keith DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062111; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Loehle C, 2012, DIVERS DISTRIB, V18, P84, DOI 10.1111/j.1472-4642.2011.00856.x; Lowery MB, 2016, CLIMATE CHANGE SEA L; Madden CJ, 2006, COASTAL MARINE SYSTE; Maxwell S, 2016, NATURE, V536, P143, DOI 10.1038/536143a; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; Miller RM, 2006, SCIENCE, V313, P441, DOI 10.1126/science.313.5786.441a; NMFS (National Marine Fisheries Service) U. S. Fish and Wildlife Service and SEMARNAT, 2011, BIN REC PLAN KEMPS R; Noss R.F., 1995, ENDANGERED ECOSYSTEM; Noss R. F., 1992, CONSERVATION BIOL TH, P239; Noss RF, 2015, DIVERS DISTRIB, V21, P236, DOI 10.1111/ddi.12278; Noss RF, 2011, CLIMATIC CHANGE, V107, P1, DOI 10.1007/s10584-011-0109-6; Noss RF, 2014, 244146 U CENTR FLOR; OMERNIK J. M., 1995, G WRIGHT FORUM, V12, P35; Omernik James M., 2000, Transactions of the Wisconsin Academy of Sciences Arts and Letters, V88, P77; Omernik JM, 2004, ENVIRON MANAGE, V34, pS27, DOI 10.1007/s00267-003-5197-2; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Park R.A., 1989, EFFECTS SEA LEVEL RI; Park S. D. E., 2001, MSTOOLS MICROSATELLI; Parris A., 2012, GLOBAL SEA LEVEL RIS; PIMM SL, 1995, P NATL ACAD SCI USA, V92, P9343, DOI 10.1073/pnas.92.20.9343; Pliscoff P, 2014, ECOL MODEL, V288, P166, DOI 10.1016/j.ecolmodel.2014.06.003; Reece JS, 2014, NAT AREA J, V34, P31, DOI 10.3375/043.034.0105; Reece JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080658; Regan HM, 2008, DIVERS DISTRIB, V14, P462, DOI 10.1111/j.1472-4642.2007.00447.x; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Soule ME, 2005, BIOSCIENCE, V55, P168, DOI 10.1641/0006-3568(2005)055[0168:SISCPM]2.0.CO;2; Southeast Conservation Adaptation Strategy (SECAS), 2014, SE CONS AD STRAT SUM; Stoner AMK, 2013, INT J CLIMATOL, V33, P2473, DOI 10.1002/joc.3603; Strauss BH, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014033; Strauss SY, 2004, ANNU REV ECOL EVOL S, V35, P435, DOI 10.1146/annurev.ecolsys.35.112202.130215; Sullivan C, 2005, WATER SCI TECHNOL, V51, P69, DOI 10.2166/wst.2005.0111; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Vargas J, 2014, LANDSCAPE CONSERVATI; Vincent K, 2007, GLOBAL ENVIRON CHANG, V17, P12, DOI 10.1016/j.gloenvcha.2006.11.009; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Watson A., 2015, GULF COAST VULNERABI; Wilkinson TAC, 2009, MARINE ECOREGIONS N; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325	65	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0199844	10.1371/journal.pone.0199844	http://dx.doi.org/10.1371/journal.pone.0199844			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL0PZ	29958277	Green Published, gold, Green Submitted			2022-12-26	WOS:000436793500021
J	Stefanski, HE; Xing, Y; Taylor, PA; Maio, S; Henao-Meija, J; Williams, A; Flavell, RA; Hollander, GA; Blazar, BR				Stefanski, Heather E.; Xing, Yan; Taylor, Patricia A.; Maio, Stefano; Henao-Meija, Jorge; Williams, Adam; Flavell, Richard A.; Hollander, Georg A.; Blazar, Bruce R.			Despite high levels of expression in thymic epithelial cells, miR-181a1 and miR-181b1 are not required for thymic development	PLOS ONE			English	Article							T-LINEAGE COMMITMENT; GENE-EXPRESSION; MICRORNAS; DIFFERENTIATION; AIRE; INTERDEPENDENCE; SELECTION; TURNOVER	MicroRNAs (miRNAs) have been shown to be key modulators of post-transcriptional gene silencing in many cellular processes. In previous studies designed to understand the role of miRNAs in thymic development, we globally deleted miRNA exclusively in thymic epithelial cells (TECs), which are critical in thymic selection. This resulted in the loss of stromal cells that instruct T cell lineage commitment and affect thymocyte positive selection, required for mature T cell development. Since murine miR-181 is expressed in the thymus and miR-181 deficiency disrupts thymocyte development, we first quantified and thereby demonstrated that miR181a1 and miR181b1 are expressed in purified TECs. By generating mice with TEC targeted loss of miR-181a1 and miR-181b1 expression, we observed that neither TEC cellularity nor thymocyte number nor differentiation was adversely affected. Thus, disrupted thymopoiesis in miR-181 deficient mice was not due to miR-181 loss of expression in TECs. Importantly, in mice with restricted TEC deficiency of miR-181a1 and miR-181b1 , there were similar numbers of mature T cells in the periphery in regards to frequencies, differentiation, and function as compared to controls. Moreover miR-181a1 and miR-181b1 were not required for maintenance of thymus integrity over time, as thymic involution was not accelerated in gene-targeted mice. Taken together our data indicate that miR-181a1 and miR181b1 are dispensable for TEC differentiation, their control of thymocyte development and mature T cell export to and homeostasis within the periphery.	[Stefanski, Heather E.; Xing, Yan; Taylor, Patricia A.; Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Maio, Stefano; Hollander, Georg A.] Univ Oxford, Dept Paediat, Oxford, England; [Henao-Meija, Jorge] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Williams, Adam] JAX Genom Med, Jackson Lab, Farmington, CT USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Hollander, Georg A.] Univ Basel, Dept Biomed, Basel, Switzerland; [Hollander, Georg A.] Basel Univ, Childrens Hosp, Basel, Switzerland	University of Minnesota System; University of Minnesota Twin Cities; University of Oxford; University of Pennsylvania; Pennsylvania Medicine; Jackson Laboratory; Yale University; University of Basel	Stefanski, HE (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	stef0030@umn.edu		Hollander, Georg/0000-0002-8790-0874; Maio, Stefano/0000-0001-9518-6466; Stefanski, Heather/0000-0001-7527-9315	National Institutes of Health [R01 A1081918]; NATIONAL CANCER INSTITUTE [P01CA065493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019018] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by Foundation for the National Institutes of Health R01 A1081918 to BRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Coder B, 2015, ONCOTARGET, V6, P21777, DOI 10.18632/oncotarget.4970; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Guo DG, 2016, ACTA BIOCH BIOPH SIN, V48, P840, DOI 10.1093/abbs/gmw068; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Hollander G, 2006, IMMUNOL REV, V209, P28, DOI 10.1111/j.0105-2896.2006.00357.x; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lkhagvasuren E, 2013, J IMMUNOL, V190, P5110, DOI 10.4049/jimmunol.1203203; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Macedo C, 2015, IMMUNOBIOLOGY, V220, P93, DOI 10.1016/j.imbio.2014.08.015; Macedo C, 2013, IMMUNOBIOLOGY, V218, P554, DOI 10.1016/j.imbio.2012.06.013; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Passos GA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00352; Su DM, 2003, NAT IMMUNOL, V4, P1128, DOI 10.1038/ni983; Sun XH, 2014, TRENDS CARDIOVAS MED, V24, P105, DOI 10.1016/j.tcm.2013.09.002; Takahama Y, 2017, NAT REV IMMUNOL, V17, P295, DOI 10.1038/nri.2017.12; Ucar O, 2013, EUR J IMMUNOL, V43, P1769, DOI 10.1002/eji.201343343; van Ewijk W, 1999, SEMIN IMMUNOL, V11, P57, DOI 10.1006/smim.1998.0158; White AJ, 2010, J IMMUNOL, V185, P4769, DOI 10.4049/jimmunol.1002151; Wojciechowska A, 2017, ADV CLIN EXP MED, V26, P865, DOI 10.17219/acem/62915; Xing Y, 2014, JOVE-J VIS EXP, DOI 10.3791/51780; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Zuklys S, 2012, J IMMUNOL, V189, P3894, DOI 10.4049/jimmunol.1200783; Zuklys S, 2009, J IMMUNOL, V182, P2997, DOI 10.4049/jimmunol.0713723	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198871	10.1371/journal.pone.0198871	http://dx.doi.org/10.1371/journal.pone.0198871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949604	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200028
J	Takeuchi, N; Sugiyama, S; Inui, K; Kanemoto, K; Nishihara, M				Takeuchi, Nobuyuki; Sugiyama, Shunsuke; Inui, Koji; Kanemoto, Kousuke; Nishihara, Makoto			Long-latency suppression of auditory and somatosensory change-related cortical responses	PLOS ONE			English	Article							DENSE INHIBITORY CONNECTIVITY; DISYNAPTIC INHIBITION; MARTINOTTI CELLS; P50 SUPPRESSION; SENSORY MEMORY; CORTEX; SCHIZOPHRENIA; NEOCORTEX; TACTILE; SERIAL	Sensory suppression is a mechanism that attenuates selective information. As for long-latency suppression in auditory and somatosensory systems, paired-pulse suppression, observed as 2 identical stimuli spaced by approximately 500 ms, is widely known, though its mechanism remains to be elucidated. In the present study, we investigated the relationship between auditory and somatosensory long-latency suppression of change-related cortical responses using magnetoencephalography. Somatosensory change-related responses were evoked by an abrupt increase in stimulus strength in a train of current-constant square wave pulses at 100 Hz to the left median nerve at the wrist. Furthermore, auditory change-related responses were elicited by an increase in sound pressure by 15 dB in a continuous sound composed of a train of 25-ms pure tones. Binaural stimulation was used in Experiment 1, while monaural stimulation was used in Experiment 2. For both somatosensory and auditory stimuli, the conditioning and test stimuli were identical, and inserted at 2400 and 3000 ms, respectively. The results showed clear suppression of the test response in the bilateral parisylvian region, but not in the postcentral gyrus of the contralateral hemisphere in the somatosensory system. Similarly, the test response in the bilateral supratemporal plane (N100m) was suppressed in the auditory system. Furthermore, there was a significant correlation between suppression of right N100m and right parisylvian activity, suggesting that similar mechanisms are involved in both. Finally, a high test-retest reliability for suppression was seen with both modalities. Suppression revealed in the present study is considered to reflect sensory inhibition ability in individual subjects.	[Takeuchi, Nobuyuki; Kanemoto, Kousuke; Nishihara, Makoto] Aichi Med Univ, Neuropsychiat Dept, Nagakute, Aichi, Japan; [Sugiyama, Shunsuke] Gifu Univ, Dept Psychiat & Psychotherapy, Gifu, Japan; [Inui, Koji] Aichi Human Serv Ctr, Inst Human Dev Res, Kasugai, Aichi, Japan; [Inui, Koji] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi, Japan; [Nishihara, Makoto] Aichi Med Univ, Multidisciplinary Pain Ctr, Nagakute, Aichi, Japan	Aichi Medical University; Gifu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Aichi Medical University	Takeuchi, N (corresponding author), Aichi Med Univ, Neuropsychiat Dept, Nagakute, Aichi, Japan.	jamjam053@yahoo.co.jp		Takeuchi, Nobuyuki/0000-0001-8252-3662	JSPS KAKENHI [JP25351001, JP18K15498]; ImPACT Program of the Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan) [2015-PM11-23-01]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ImPACT Program of the Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan)	This work was supported by JSPS KAKENHI [grant number JP25351001 and JP18K15498] and the ImPACT Program of the Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan) [grant number 2015-PM11-23-01].	Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Arnfred SM, 2001, PSYCHIAT RES, V101, P221, DOI 10.1016/S0165-1781(01)00226-8; Bartlett EL, 2005, J NEUROPHYSIOL, V94, P83, DOI 10.1152/jn.01124.2004; Becker J, 2011, ARQ NEURO-PSIQUIAT, V69, P460, DOI 10.1590/S0004-282X2011000400010; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Bramon E, 2004, SCHIZOPHR RES, V70, P315, DOI 10.1016/j.schres.2004.01.004; BURTON H, 1995, J COMP NEUROL, V355, P539, DOI 10.1002/cne.903550405; Cadenhead KS, 2005, BIOL PSYCHIAT, V57, P1504, DOI 10.1016/j.biopsych.2005.03.003; Cheng CH, 2016, J AFFECT DISORDERS, V203, P199, DOI 10.1016/j.jad.2016.06.010; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Erwin RJ, 1998, SCHIZOPHR RES, V33, P157, DOI 10.1016/S0920-9964(98)00075-9; Eto K, 2012, J NEUROSCI, V32, P16552, DOI 10.1523/JNEUROSCI.2104-12.2012; Fino E, 2013, NEUROSCIENTIST, V19, P228, DOI 10.1177/1073858412456743; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Fuerst DR, 2007, PSYCHOPHYSIOLOGY, V44, P620, DOI 10.1111/j.1469-8986.2007.00524.x; Ganesan S, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3359/fnhum.2016.00433; Ghisolfi ES, 2006, J PSYCHIATR RES, V40, P535, DOI 10.1016/j.jpsychires.2006.02.006; Hamada Y, 2002, CLIN NEUROPHYSIOL, V113, P1787, DOI 10.1016/S1388-2457(02)00258-4; Holstein DH, 2013, PSYCHIAT RES, V205, P117, DOI 10.1016/j.psychres.2012.08.013; Inui K, 2004, CEREB CORTEX, V14, P851, DOI 10.1093/cercor/bhh043; Inui K, 2006, CEREB CORTEX, V16, P18, DOI 10.1093/cercor/bhi080; Inui K, 2003, NEUROSCIENCE, V120, P235, DOI 10.1016/S0306-4522(03)00261-6; Inui K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190481; Inui K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155972; Inui K, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-588; Inui K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-135; Inui K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-135; Jaaskelainen IP, 2011, BRAIN RES, V1422, P66, DOI 10.1016/j.brainres.2011.09.031; Jaaskelainen IP, 2004, NEUROREPORT, V15, P2741; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Javitt DC, 2015, AM J PSYCHIAT, V172, P17, DOI 10.1176/appi.ajp.2014.13121691; Karhu J, 1999, J NEUROPHYSIOL, V81, P2017, DOI 10.1152/jn.1999.81.5.2017; Karnani MM, 2014, CURR OPIN NEUROBIOL, V26, P96, DOI 10.1016/j.conb.2013.12.015; Kodaira M, 2013, BEHAV BRAIN RES, V256, P27, DOI 10.1016/j.bbr.2013.07.045; Lofberg O, 2013, NEUROSCIENCE, V243, P40, DOI 10.1016/j.neuroscience.2013.03.060; LU ZL, 1992, SCIENCE, V258, P1668, DOI 10.1126/science.1455246; Maruoka H, 2017, SCIENCE, V358, P610, DOI 10.1126/science.aam6125; Montoya P, 2006, ARTHRITIS RHEUM-US, V54, P1995, DOI 10.1002/art.21910; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Nakagawa K, 2014, NEUROIMAGE, V101, P416, DOI 10.1016/j.neuroimage.2014.07.035; Nishihara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106553; Nishihara M, 2011, NEUROSCI RES, V71, P145, DOI 10.1016/j.neures.2011.07.004; Olausson H, 2001, BRAIN, V124, P916, DOI 10.1093/brain/124.5.916; Otsuru N, 2011, NEUROSCIENCE, V182, P115, DOI 10.1016/j.neuroscience.2011.03.019; Otsuru N, 2012, PSYCHOPHARMACOLOGY, V224, P327, DOI 10.1007/s00213-012-2757-2; Patterson JV, 2008, PSYCHIAT RES, V158, P226, DOI 10.1016/j.psychres.2007.02.009; PONS TP, 1987, SCIENCE, V237, P417, DOI 10.1126/science.3603028; PONS TP, 1992, J NEUROPHYSIOL, V68, P518, DOI 10.1152/jn.1992.68.2.518; Potter D, 2006, SCHIZOPHRENIA BULL, V32, P692, DOI 10.1093/schbul/sbj050; Roux L, 2015, NEUROPHARMACOLOGY, V88, P10, DOI 10.1016/j.neuropharm.2014.09.011; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Takeuchi N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177747; Tame L, 2015, HUM BRAIN MAPP, V36, P1506, DOI 10.1002/hbm.22719; Tanaka E, 2009, NEUROIMAGE, V48, P464, DOI 10.1016/j.neuroimage.2009.06.037; Tanaka E, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-38; Thoma RJ, 2007, PSYCHIAT RES, V151, P189, DOI 10.1016/j.psychres.2006.10.011; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Urakawa T, 2010, PSYCHOPHYSIOLOGY, V47, P905, DOI 10.1111/j.1469-8986.2010.00987.x; Urakawa T, 2010, NEUROIMAGE, V52, P302, DOI 10.1016/j.neuroimage.2010.03.071; VOGT BA, 1978, J COMP NEUROL, V177, P179, DOI 10.1002/cne.901770202; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Wuhle A, 2010, PSYCHOPHYSIOLOGY, V47, P523, DOI 10.1111/j.1469-8986.2010.00964.x; Yamashiro K, 2011, PSYCHOPHYSIOLOGY, V48, P23, DOI 10.1111/j.1469-8986.2010.01038.x; Zhu J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001032	64	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199614	10.1371/journal.pone.0199614	http://dx.doi.org/10.1371/journal.pone.0199614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK7JR	29944700	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800045
J	Wan, JP; Yu, HHM; Chiang, ER; Wan, JY; Chou, PH; Hung, SC				Wan, Jung-Pan; Yu, Hsiang-Hsuan Michael; Chiang, En-Rung; Wan, Jir-You; Chou, Po-Hsin; Hung, Shih-Chieh			Corticosteroid inhibits differentiation of palmar fibromatosis-derived stem cells (FSCs) through downregulation of transforming growth factor-beta 1 (TGF-beta 1)	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; DUPUYTRENS-DISEASE; TRIAMCINOLONE ACETONIDE; RNA INTERFERENCE; IN-VITRO; EXPRESSION; DEXAMETHASONE; FIBROBLASTS; CONTRACTURE; INJECTION	Treatment for musculoskeletal fibromatosis remains challenging. Surgical excision for fibromatosis is the standard therapy but recurrence remains high. Corticosteroids, an antifibrogenic compound, have been used to treat early stage palmar fibromatosis, but the mechanism is unknown. We investigated the inhibitory mechanism effect of corticosteroids in the murine model of fibromatosis nodule as well as in cultured FSCs. Quantitative reverse transcription/polymerase chain reaction (PCR) analysis and immunofluorescence (IF) staining for markers of myofibroblasts (alpha-smooth muscle actin and type III collagen) were used to examine the effect of dexamethasone on myofibroblasic differentiation of FSCs both in vitro and in vivo. Transforming growth factor-beta 1 (TGF-beta 1) signaling and its downstream targets were examined using western blot analysis. TGF-beta 1 expression in FSCs before and after dexamethasone treatment was compared. In addition, inhibition of TGF-beta 1 expression was examined using RNA interference (RNAi) on FSCs, both in vitro and in vivo. Treating FSCs with dexamethasone inhibited FSCs' myofibroblastic differentiation in vitro. Treating FSCs with dexamethasone before or after implantation further inhibited formation of fibromatosis nodules. Dexamethasone suppressed expression of TGF-beta 1 and pSmad2/3 by FSCs in vitro. TGF-beta 1 knockdown FSCs showed reducing myofibroblastic differentiation both in vitro and in vivo. Finally, addition of TGF-beta 1 abolished dexamethasone-mediated inhibition of myofibroblastic differentiation. Dexamethasone inhibits the myofibroblastic differentiated potential of FSCs both in vitro and in vivo through inhibition of TGF-beta 1 expression in FSCs. TGF-beta 1 plays a key role in myofibroblastic differentiation.	[Wan, Jung-Pan; Chiang, En-Rung; Wan, Jir-You; Chou, Po-Hsin; Hung, Shih-Chieh] Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei, Taiwan; [Wan, Jung-Pan; Chiang, En-Rung; Wan, Jir-You; Chou, Po-Hsin; Hung, Shih-Chieh] Taipei Vet Gen Hosp, Dept Orthoped & Traumatol, Taipei, Taiwan; [Yu, Hsiang-Hsuan Michael] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA; [Hung, Shih-Chieh] China Med Univ Hosp, Integrat Stem Cell Ctr, Taichung, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; H Lee Moffitt Cancer Center & Research Institute; China Medical University Taiwan; China Medical University Hospital - Taiwan	Wan, JP (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei, Taiwan.; Wan, JP (corresponding author), Taipei Vet Gen Hosp, Dept Orthoped & Traumatol, Taipei, Taiwan.	jpwang801@gmail.com		Yu, Hsiang-Hsuan/0000-0002-0621-9519	Taipei Veterans General Hospital [V101131-001]; National Science Council [NSC 101-2314-B-075-070-MY2]; National Yang-Ming University, Ministry of Education	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); National Yang-Ming University, Ministry of Education	This study was supported in part by grants from Taipei Veterans General Hospital (V101131-001) to Jung-Pan Wang, National Science Council (NSC 101-2314-B-075-070-MY2) to Jung-Pan Wang, and National Yang-Ming University, Ministry of Education. This work was assisted in part by the Division of Experimental Surgery of the Department of Surgery, Taipei Veterans General Hospital.	BAIRD KS, 1993, J CLIN PATHOL, V46, P425, DOI 10.1136/jcp.46.5.425; Bayat A, 2007, BRIT J HOSP MED, V68, P604, DOI 10.12968/hmed.2007.68.11.27683; Bolkenius U, 2004, BIOCHEM BIOPH RES CO, V325, P1264, DOI 10.1016/j.bbrc.2004.10.164; Cheng K, 2009, MOL PHARMACEUT, V6, P772, DOI 10.1021/mp9000469; Connelly TJ, 1999, J AM ACAD DERMATOL, V41, P106, DOI 10.1016/S0190-9622(99)70415-9; Conroy H, 2012, CANCER IMMUNOL IMMUN, V61, P425, DOI 10.1007/s00262-011-1188-y; Dias JJ, 2006, J HAND SURG-BRIT EUR, V31B, P514, DOI 10.1016/j.jhsb.2006.05.005; ElSakka AI, 1997, J UROLOGY, V158, P1391, DOI 10.1016/S0022-5347(01)64223-X; Fan DL, 2012, INT J DERMATOL, V51, P463, DOI 10.1111/j.1365-4632.2011.05234.x; Gu L, 2004, ACTA PHARMACOL SIN, V25, P1479; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Ketchum LD, 2000, J HAND SURG-AM, V25A, P1157; Le Poole IC, 1999, BRIT J DERMATOL, V140, P409; Mauviel A, 2005, METH MOLEC MED, V117, P69; Meisler N, 1997, J INVEST DERMATOL, V108, P285, DOI 10.1111/1523-1747.ep12286461; Moore LD, 2008, CLIN CANCER RES, V14, P4961, DOI 10.1158/1078-0432.CCR-07-4604; PITTET B, 1994, PLAST RECONSTR SURG, V93, P1224, DOI 10.1097/00006534-199405000-00018; Rayan GM, 1996, J HAND SURG-AM, V21A, P1065, DOI 10.1016/S0363-5023(96)80317-0; Robbin MR, 2001, RADIOGRAPHICS, V21, P585, DOI 10.1148/radiographics.21.3.g01ma21585; Takabatake Y, 2005, GENE THER, V12, P965, DOI 10.1038/sj.gt.3302480; Tsai WC, 2003, J ORTHOPAED RES, V21, P265, DOI 10.1016/S0736-0266(02)00151-1; Wang JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024050; Wang JP, 2011, BIOCHEM BIOPH RES CO, V408, P269, DOI 10.1016/j.bbrc.2011.04.011; Wang JP, 2011, DIFFERENTIATION, V81, P119, DOI 10.1016/j.diff.2010.10.003; Yin CY, 2017, J HAND SURG-EUR VOL, V42, P678, DOI 10.1177/1753193417690961; Yu ZL, 2006, BIOCHEM BIOPH RES CO, V340, P929, DOI 10.1016/j.bbrc.2005.12.100	26	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0198326	10.1371/journal.pone.0198326	http://dx.doi.org/10.1371/journal.pone.0198326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944666	Green Published, gold, Green Submitted			2022-12-26	WOS:000436377800007
J	He, D; Zhang, JH; Wu, WW; Yi, N; He, W; Lu, P; Li, B; Yang, N; Wang, D; Xue, ZG; Zhang, P; Fan, GP; Zhu, XM				He, Di; Zhang, Junhui; Wu, Wanwan; Yi, Ning; He, Wen; Lu, Ping; Li, Bin; Yang, Nan; Wang, Di; Xue, Zhigang; Zhang, Peng; Fan, Guoping; Zhu, Xianmin			A novel immunodeficient rat model supports human lung cancer xenografts	FASEB JOURNAL			English	Article						CRISPR; Cas9; patient-derived xenograft; lung SCC	TUMOR XENOGRAFTS; LYMPHOID DEVELOPMENT; CELL-DEVELOPMENT; IMMUNE-SYSTEM; GAMMA-CHAIN; MOUSE MODEL; MICE; EXPRESSION; GENE; ENGRAFTMENT	Patient-derived xenograft (PDX) animal models allow the exogenous growth of human tumors, offering an irreplaceable preclinical tool for oncology research. Mice are the most commonly used host for human PDX models, however their small body size limits the xenograft growth, sample collection, and drug evaluation. Therefore, we sought to develop a novel rat model that could overcome many of these limitations. We knocked out Rag1, Rag2, and Il2rg in Sprague Dawley (SD) rats by clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 technology. The development of lymphoid organs is significantly impaired in Rag1(-/-)Rag2(-/-)Il2rg(-/Y) (designated as SD-RG) rats. Consequently, SD-RG rats are severely immunodeficient with an absence of mature T, B, and NK cells in the immune system. After subcutaneous injection of tumor cell lines of different origin, such as NCI-H460, U-87MG, and MDA-MB-231, the tumors grow significantly faster and larger in SD-RG rats than in nonobese diabetic-Cg-Prkdc(scid) Il2rg(tm1Wjl)/SzJ mice. Most important of all, we successfully established a PDX model of lung squamous cell carcinoma in which the grafts recapitulate the histopathologic features of the primary tumor for several passages. In conclusion, the severely immunodeficient SD-RG rats support fast growth of PDX compared with mice, thus holding great potential to serve as a new model for oncology research.He, D., Zhang, J., Wu, W., Yi, N., He, W., Lu, P., Li, B., Yang, N., Wang, D., Xue, Z., Zhang, P., Fan, G., Zhu, X. A novel immunodeficient rat model supports human lung cancer xenografts.	[He, Di; Wu, Wanwan; Wang, Di; Zhang, Peng; Fan, Guoping; Zhu, Xianmin] Tongji Univ, Shanghai Pulm Hosp, Sch Life Sci & Technol, Dept Thorac Surg, 1239 Siping Rd, Shanghai 200433, Peoples R China; [Zhang, Junhui; Yi, Ning; He, Wen; Lu, Ping; Xue, Zhigang] Tongji Univ, Dept Regenerat Med, Translat Ctr Stem Cell Res, Tongji Hosp,Suzhou Inst,Sch Med, Shanghai, Peoples R China; [Li, Bin] Alphacait AL Biotech Co, Hangzhou, Zhejiang, Peoples R China; [Yang, Nan] PharmaLegacy Labs Co, Shanghai, Peoples R China; [Fan, Guoping; Zhu, Xianmin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	Tongji University; Tongji University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhu, XM (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Sch Life Sci & Technol, Dept Thorac Surg, 1239 Siping Rd, Shanghai 200433, Peoples R China.; Fan, GP; Zhu, XM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	gfan@mednet.ucla.edu; xianminzhu@hotmail.com	Zhu, Xianmin/M-6437-2017	Zhu, Xianmin/0000-0003-1405-9700; Lu, Ping/0000-0002-0127-3911	National Program on the Key Basic Research Project (973 Program) [2015CB964702, 2015CB964601]; National Natural Science Foundation of China [81570521, 81470244, 81622001, 81430026, 91642108]; Experimental Animal Research Fund, Science and Technology Commission of Shanghai Municipality [18140903900, 15140903900]; Fundamental Research Funds for the Central Universities; Jiangsu Science and Technology Planning Project [BM2014052]; Guangxi Science and Technology Planning Project [14251001]; EyeCure Therapeutics (Jiangsu, China)	National Program on the Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Experimental Animal Research Fund, Science and Technology Commission of Shanghai Municipality; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Jiangsu Science and Technology Planning Project; Guangxi Science and Technology Planning Project; EyeCure Therapeutics (Jiangsu, China)	The authors thank P.Z. for his equal contribution to leading the project with G.F. and X.Z. The authors also thank Jiayu Chen, Xiaochen Kou, Yanhong Zhao, and Wenqiang Liu in Shaorong Gao's group at Tongji University for their kind help in zygote microinjection and transfer. This work was supported by the National Program on the Key Basic Research Project (973 Program 2015CB964702 and 2015CB964601); the National Natural Science Foundation of China (Grants 81570521, 81470244, 81622001, 81430026, and 91642108); the Experimental Animal Research Fund, Science and Technology Commission of Shanghai Municipality (Grants 18140903900 and 15140903900); the Fundamental Research Funds for the Central Universities (to X.Z.); the Jiangsu Science and Technology Planning Project (Grant BM2014052); and the Guangxi Science and Technology Planning Project (Grant 14251001), with additional funding from EyeCure Therapeutics (Jiangsu, China). The authors declare no conflicts of interest.	Aparicio S, 2015, NAT REV CANCER, V15, P311, DOI 10.1038/nrc3944; BANKSSCHLEGEL SP, 1985, CANCER RES, V45, P1187; Belinsky SA, 2015, ANNU REV PHYSIOL, V77, P453, DOI 10.1146/annurev-physiol-021014-072018; Belinsky SA, 2011, CANCER RES, V71, P454, DOI 10.1158/0008-5472.CAN-10-3184; Bertotti A, 2015, NATURE, V526, P263, DOI 10.1038/nature14969; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Byrne AT, 2017, NAT REV CANCER, V17, P254, DOI 10.1038/nrc.2016.140; CANCER G, 2012, NATURE, V491, P288, DOI DOI 10.1038/NATURE11404; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Day CP, 2015, CELL, V163, P39, DOI 10.1016/j.cell.2015.08.068; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Elmore SA, 2012, TOXICOL PATHOL, V40, P148, DOI 10.1177/0192623311427571; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hosur V, 2017, J CELL BIOCHEM, V118, P3043, DOI 10.1002/jcb.26002; HOWARD RB, 1991, CANCER RES, V51, P3274; Ilie M, 2015, CANCER MED-US, V4, P201, DOI 10.1002/cam4.357; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; John T, 2011, CLIN CANCER RES, V17, P134, DOI 10.1158/1078-0432.CCR-10-2224; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Jung CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31455; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; Kim HR, 2017, ANN ONCOL, V28, P1250, DOI 10.1093/annonc/mdx098; Lavender KJ, 2013, BLOOD, V122, P4013, DOI 10.1182/blood-2013-06-506949; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Liu Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep11397; Loukopoulos P, 2004, PANCREAS, V29, P193, DOI 10.1097/00006676-200410000-00004; March TH, 2001, VET PATHOL, V38, P483, DOI 10.1354/vp.38-5-483; Mashimo T, 2012, CELL REP, V2, P685, DOI 10.1016/j.celrep.2012.08.009; Mazurier F, 1999, J INTERF CYTOK RES, V19, P533, DOI 10.1089/107999099313983; Menoret S., 2018, TRANSPLANTATION; Menoret S, 2013, FASEB J, V27, P703, DOI 10.1096/fj.12-219907; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; ROLINK A, 1991, CELL, V66, P1081, DOI 10.1016/0092-8674(91)90032-T; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Strowig T, 2011, P NATL ACAD SCI USA, V108, P13218, DOI 10.1073/pnas.1109769108; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Taira T, 2012, LUNG CANCER, V76, P423, DOI 10.1016/j.lungcan.2011.11.010; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Travis WD, 2013, J CLIN ONCOL, V31, P992, DOI 10.1200/JCO.2012.46.9270; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang YY, 2017, MOL THER-NUCL ACIDS, V6, P269, DOI 10.1016/j.omtn.2017.01.003; Weeden CE, 2017, MOL CANCER THER, V16, P1610, DOI 10.1158/1535-7163.MCT-17-0174; Xu SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28508; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Zhao XM, 2012, NEURO-ONCOLOGY, V14, P574, DOI 10.1093/neuonc/nos061; Zschemisch NH, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-60	60	16	16	1	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					140	150		10.1096/fj.201800102RR	http://dx.doi.org/10.1096/fj.201800102RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29944447				2022-12-26	WOS:000457401500011
J	Hamidi, T; Singh, AK; Veland, N; Vemulapalli, V; Chen, JJ; Hardikar, S; Bao, JQ; Fry, CJ; Yang, V; Lee, KA; Guo, A; Arrowsmith, CH; Bedford, MT; Chen, TP				Hamidi, Tewfik; Singh, Anup Kumar; Veland, Nicolas; Vemulapalli, Vidyasiri; Chen, Jianji; Hardikar, Swanand; Bao, Jianqiang; Fry, Christopher J.; Yang, Vicky; Lee, Kimberly A.; Guo, Ailan; Arrowsmith, Cheryl H.; Bedford, Mark T.; Chen, Taiping			Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomarker; post-translational modification (PTM); epigenetics; histone methylation; ribosome function; Lsd1; Rpl29; Set7/9	EMBRYONIC STEM-CELLS; DNA METHYLATION; HISTONE DEMETHYLATION; NONHISTONE PROTEINS; MASS-SPECTROMETRY; IN-VIVO; INHIBITORS; TRANSCRIPTION; LSD1; MAINTENANCE	Set7/9 (also known as Set7, Set9, Setd7, and Kmt7) is a lysine methyltransferase that catalyzes the methylation of multiple substrates, including histone H3 and non-histone proteins. Although not essential for normal development and physiology, Set7/9-mediated methylation events play important roles in regulating cellular pathways involved in various human diseases, making Set7/9 a promising therapeutic target. Multiple Set7/9 inhibitors have been developed, which exhibit varying degrees of potency and selectivity in vitro. However, validation of these compounds in vivo has been hampered by the lack of a reliable cellular biomarker for Set7/9 activity. Here, we report the identification of Rpl29, a ribosomal protein abundantly expressed in all cell types, as a major substrate of Set7/9. We show that Rpl29 lysine 5 (Rpl29K5) is methylated exclusively by Set7/9 and can be demethylated by Lsd1 (also known as Kdm1a). Rpl29 is not a core component of the ribosome translational machinery and plays a regulatory role in translation efficiency. Our results indicate that Rpl29 methylation has no effect on global protein synthesis but affects Rpl29 subcellular localization. Using an Rpl29 methylation-specific antibody, we demonstrate that Rpl29K5 methylation is present ubiquitously and validate that (R)-PFI-2, a Set7/9 inhibitor, efficiently reduces Rpl29K5 methylation in cell lines. Thus, Rpl29 methylation can serve as a specific cellular biomarker for measuring Set7/9 activity.	[Hamidi, Tewfik; Singh, Anup Kumar; Veland, Nicolas; Vemulapalli, Vidyasiri; Chen, Jianji; Hardikar, Swanand; Bao, Jianqiang; Bedford, Mark T.; Chen, Taiping] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA; [Hamidi, Tewfik; Singh, Anup Kumar; Veland, Nicolas; Vemulapalli, Vidyasiri; Chen, Jianji; Hardikar, Swanand; Bao, Jianqiang; Bedford, Mark T.; Chen, Taiping] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Smithville, TX 78957 USA; [Veland, Nicolas; Vemulapalli, Vidyasiri; Chen, Jianji; Bedford, Mark T.; Chen, Taiping] Univ Texas MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Program Genet & Epigenet, Houston, TX 77030 USA; [Fry, Christopher J.; Yang, Vicky; Lee, Kimberly A.; Guo, Ailan] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Guo, Ailan] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Chen, TP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA.; Chen, TP (corresponding author), Bluefin Biomed Inc, 33 Tozer Rd, Beverly, MA 01915 USA.	tchen2@mdanderson.org	Chen, Jianji/GPX-4751-2022; Bao, Jianqiang/T-7299-2019	Chen, Jianji/0000-0003-4098-1811; Veland, Nicolas/0000-0002-3096-7867	National Institutes of Health NIDDK [1R01DK106418-01]; Center for Cancer Epigenetics (CCE) at MDACC; Cancer Prevention and Research Institute of Texas (CPRIT) [RP140106]; Cure on the Colorado fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106418] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Cancer Epigenetics (CCE) at MDACC; Cancer Prevention and Research Institute of Texas (CPRIT); Cure on the Colorado fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health NIDDK Grant 1R01DK106418-01 (to T. C.). C. J. F., V. Y., and K. A. L. are employees of Cell Signaling Technology Inc. (CST). A. G. was a former employee of CST and is a current employee of Bluefin Biomedicine, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipients of scholarships from the Center for Cancer Epigenetics (CCE) at MDACC.; Supported by a Research Training Award RP140106 from the Cancer Prevention and Research Institute of Texas (CPRIT).; Supported by the Cure on the Colorado fellowship.	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Barsyte-Lovejoy D, 2014, P NATL ACAD SCI USA, V111, P12853, DOI 10.1073/pnas.1407358111; Campaner S, 2011, MOL CELL, V43, P681, DOI 10.1016/j.molcel.2011.08.007; Carlson SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026435; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Dan JM, 2017, CELL REP, V20, P1936, DOI 10.1016/j.celrep.2017.07.070; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Elkouris M, 2016, CELL REP, V15, P2733, DOI 10.1016/j.celrep.2016.05.051; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Francis NJ, 2012, J BIOMOL SCREEN, V17, P1102, DOI 10.1177/1087057112452137; Fujiwara T, 2016, BIOORGAN MED CHEM, V24, P4318, DOI 10.1016/j.bmc.2016.07.024; Gandin V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11127; Gandin V, 2014, JOVE-J VIS EXP, DOI 10.3791/51455; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Kim SJ, 2013, BLOOD, V122, P4086, DOI 10.1182/blood-2013-02-483487; Kirn-Safran CB, 2007, DEV DYNAM, V236, P447, DOI 10.1002/dvdy.21046; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Lehnertz B, 2011, MOL CELL, V43, P673, DOI 10.1016/j.molcel.2011.08.006; Maganti AV, 2015, J BIOL CHEM, V290, P9812, DOI 10.1074/jbc.M114.616219; Meng FW, 2015, J MED CHEM, V58, P8166, DOI 10.1021/acs.jmedchem.5b01154; Mori S, 2010, BIOORGAN MED CHEM, V18, P8158, DOI 10.1016/j.bmc.2010.10.022; Munro S, 2010, ONCOGENE, V29, P2357, DOI 10.1038/onc.2009.511; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nicholson TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060913; Nicholson TB, 2009, EPIGENETICS-US, V4, P129, DOI 10.4161/epi.4.3.8443; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Niwa H, 2013, ACTA CRYSTALLOGR D, V69, P595, DOI 10.1107/S0907444912052092; Odintsova TI, 2003, J PROTEIN CHEM, V22, P249, DOI 10.1023/A:1025068419698; Oudhoff MJ, 2016, DEV CELL, V37, P47, DOI 10.1016/j.devcel.2016.03.002; Oudhoff MJ, 2013, DEV CELL, V26, P188, DOI 10.1016/j.devcel.2013.05.025; Rohde LH, 1996, J BIOL CHEM, V271, P11824, DOI 10.1074/jbc.271.20.11824; Sasaki K, 2016, J AM SOC NEPHROL, V27, P203, DOI 10.1681/ASN.2014090850; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Takemoto Y, 2016, J MED CHEM, V59, P3650, DOI 10.1021/acs.jmedchem.5b01732; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Veland N, 2017, CELL REP, V21, P3390, DOI 10.1016/j.celrep.2017.11.082; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Williamson NA, 1997, EUR J BIOCHEM, V246, P786, DOI 10.1111/j.1432-1033.1997.00786.x; Wozniak GG, 2014, BBA-GENE REGUL MECH, V1839, P1353, DOI 10.1016/j.bbagrm.2014.03.002; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Zhang X, 2015, CELL MOL LIFE SCI, V72, P4257, DOI 10.1007/s00018-015-2001-4; Zheng YC, 2015, MED RES REV, V35, P1032, DOI 10.1002/med.21350	55	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12770	12780		10.1074/jbc.RA118.002890	http://dx.doi.org/10.1074/jbc.RA118.002890			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29959229	Green Published, hybrid			2022-12-26	WOS:000442203500011
J	Jermakowicz, WJ; Cajigas, I; Dan, L; Guerra, S; Sur, S; D'Haese, PF; Kanner, AM; Jagid, JR				Jermakowicz, Walter J.; Cajigas, Iahn; Dan, Lia; Guerra, Santiago; Sur, Samir; D'Haese, Pierre-Francois; Kanner, Andres M.; Jagid, Jonathan R.			Ablation dynamics during laser interstitial thermal therapy for mesiotemporal epilepsy	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; ADNI HARMONIZED PROTOCOL; MAGNETIC-RESONANCE; HIPPOCAMPAL SEGMENTATION; IN-VIVO; VALIDATION; BRAIN; LITT; AMYGDALOHIPPOCAMPOTOMY; THERMOTHERAPY	Introduction The recent emergence of laser interstitial thermal therapy (LITT) as a frontline surgical tool in the management of brain tumors and epilepsy is a result of advances in MRI thermal imaging. A limitation to further improving LITT is the diversity of brain tissue thermoablative properties, which hinders our ability to predict LITT treatment-related effects. Utilizing the mesiotemporal lobe as a consistent anatomic model system, the goal of this study was to use intraoperative thermal damage estimate (TDE) maps to study short-and long-term effects of LITT and to identify preoperative variables that could be helpful in predicting tissue responses to thermal energy. Methods For 30 patients with mesiotemporal epilepsy treated with LITT at a single institution, intraoperative TDE maps and pre-, intra-and post-operative MRIs were co-registered in a common reference space using a deformable atlas. The spatial overlap of TDE maps with manually-traced immediate (post-ablation) and delayed (6-month) ablation zones was measured using the dice similarity coefficient (DSC). Then, motivated by simple heat-transfer models, ablation dynamics were quantified at amygdala and hippocampal head from TDE pixel time series fit by first order linear dynamics, permitting analysis of the thermal time constant (tau). The relationships of these measures to 16 independent variables derived from patient demographics, mesiotemporal anatomy, preoperative imaging characteristics and the surgical procedure were examined. Results TDE maps closely overlapped immediate ablation borders but were significantly larger than the ablation cavities seen on delayed imaging, particularly at the amygdala and hippocampal head. The TDEs more accurately predicted delayed LITT effects in patients with smaller perihippocampal CSF spaces. Analyses of ablation dynamics from intraoperative TDE videos showed variable patterns of lesion progression after laser activation. Ablations tended to be slower for targets with increased preoperative T2 MRI signal and in close proximity to large, surrounding CSF spaces. In addition, greater laser energy was required to ablate mesial versus lateral mesiotemporal structures, an effect associated with laser trajectory and target contrast-enhanced T1 MRI signal. Conclusions Patient-specific variations in mesiotemporal anatomy and pathology may influence the thermal coagulation of these tissues. We speculate that by incorporating demographic and imaging data into predictive models we may eventually enhance the accuracy and precision with which LITT is delivered, improving outcomes and accelerating adoption of this novel tool.	[Jermakowicz, Walter J.; Cajigas, Iahn; Dan, Lia; Guerra, Santiago; Sur, Samir; Jagid, Jonathan R.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [D'Haese, Pierre-Francois] Vanderbilt Univ, Dept Elect Engn & Comp Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Kanner, Andres M.] Univ Miami, Miller Sch Med, Dept Neurol, Epilepsy Div, Miami, FL 33136 USA	University of Miami; Vanderbilt University; University of Miami	Jagid, JR (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.	jjagid@med.miami.edu	Cajigas, Iahn/O-9260-2018; Jermakowicz, Walter/AAC-5467-2019	Cajigas, Iahn/0000-0002-5808-453X; Jermakowicz, Walter/0000-0001-6517-208X	National Institutes of Health (NIH) [R01-EB006136, R01-NS095291]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS095291] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the National Institutes of Health (NIH) for their support of Neurotargetting LLC and their CranialSuite clinical software (R01-EB006136 and R01-NS095291 to Dr. Pierre-Francois D'Haese). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsina KB, 2017, AM J ROENTGENOL, V208, P48, DOI 10.2214/AJR.16.16144; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P126, DOI 10.1016/j.jalz.2014.02.009; Breen MS, 2007, ANN BIOMED ENG, V35, P1391, DOI 10.1007/s10439-007-9300-3; Drane DL, 2015, EPILEPSIA, V56, P101, DOI 10.1111/epi.12860; Frisoni GB, 2015, ALZHEIMERS DEMENT, V11, P111, DOI 10.1016/j.jalz.2014.05.1756; Jermakowicz WJ, 2017, EPILEPSIA, V58, P801, DOI 10.1111/epi.13715; Jermakowicz WJ, 2016, WORLD NEUROSURG, V94, P418, DOI 10.1016/j.wneu.2016.06.126; Jermakowicz WJ IM, 2017, OPERATIVE NEUROSURGE; Kamath AA, 2017, STEREOT FUNCT NEUROS, V95, P417, DOI 10.1159/000485387; Kang JY, 2016, EPILEPSIA, V57, P325, DOI 10.1111/epi.13284; Lehmann KS, 2011, INT J COLORECTAL DIS, V26, P799, DOI 10.1007/s00384-011-1175-y; McDannold N, 2005, INT J HYPERTHER, V21, P533, DOI 10.1080/02656730500096073; McNichols RJ, 2004, LASER SURG MED, V34, P48, DOI 10.1002/lsm.10243; Patel NV, 2015, J NEUROSURG-PEDIATR, V15, P363, DOI 10.3171/2014.10.PEDS13698; Patel NV, 2013, LASER SURG MED, V45, P362, DOI 10.1002/lsm.22151; Patel NV, 2017, OPER NEUROSURG HAGER; Pearce JA, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031851; Rohde GK, 2003, IEEE T MED IMAGING, V22, P1470, DOI 10.1109/TMI.2003.819299; Saccomancli P, 2012, IEEE ENG MED BIO, P5687, DOI 10.1109/EMBC.2012.6347286; Saccomandi P, 2012, IEEE T BIO-MED ENG, V59, P2958, DOI 10.1109/TBME.2012.2210895; Sharma M, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.7.FOCUS16216; Sun XNR, 2015, NEUROSURGERY, V77, P51, DOI 10.1227/NEU.0000000000000732; Tiwari P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114293; Tiwari P, 2013, PROC SPIE, V8671, DOI 10.1117/12.2008157; Waseem H, 2015, EPILEPSY BEHAV, V51, P152, DOI 10.1016/j.yebeh.2015.07.022; Whelan WM, 1999, LASER SURG MED, V24, P202, DOI 10.1002/(SICI)1096-9101(1999)24:3<202::AID-LSM5>3.0.CO;2-8; Willie JT, 2014, NEUROSURGERY, V74, P569, DOI 10.1227/NEU.0000000000000343; Wong T, 2017, WORLD NEUROSURG, V104, P192, DOI 10.1016/j.wneu.2017.04.167; Yeniaras E, 2014, INT J COMPUT ASS RAD, V9, P659, DOI 10.1007/s11548-013-0948-x; Yung JP, 2010, MED PHYS, V37, P5313, DOI 10.1118/1.3490085; Zachenhofer I, 2011, ACTA NEUROCHIR, V153, P239, DOI 10.1007/s00701-010-0802-7; Zhu D, 2002, LASER SURG MED, V31, P313, DOI 10.1002/lsm.10108; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096	33	14	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199190	10.1371/journal.pone.0199190	http://dx.doi.org/10.1371/journal.pone.0199190			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979717	gold, Green Submitted, Green Published			2022-12-26	WOS:000437809500010
J	Mzobe, P; Berggren, M; Pilesjo, P; Lundin, E; Olefeldt, D; Roulet, NT; Persson, A				Mzobe, Pearl; Berggren, Martin; Pilesjo, Petter; Lundin, Erik; Olefeldt, David; Roulet, Nigel T.; Persson, Andreas			Dissolved organic carbon in streams within a subarctic catchment analysed using a GIS/remote sensing approach	PLOS ONE			English	Article							PERMAFROST THAW; NORTHERN SWEDEN; SURFACE WATERS; CLIMATE; VEGETATION; LAKE; BROWNIFICATION; PRECIPITATION; ECOSYSTEMS; CHEMISTRY	Climate change projections show that temperature and precipitation increases can alter the exchange of greenhouse gases between the atmosphere and high latitude landscapes, including their freshwaters. Dissolved organic carbon (DOC) plays an important role in greenhouse gas emissions, but the impact of catchment productivity on DOC release to subarctic waters remains poorly known, especially at regional scales. We test the hypothesis that increased terrestrial productivity, as indicated by the normalized difference vegetation index (NDVI), generates higher stream DOC concentrations in the Stordalen catchment in subarctic Sweden. Furthermore, we aimed to determine the degree to which other generic catchment properties (elevation, slope) explain DOC concentration, and whether or not land cover variables representing the local vegetation type (e.g., mire, forest) need to be included to obtain adequate predictive models for DOC delivered into rivers. We show that the land cover type, especially the proportion of mire, played a dominant role in the catchment's release of DOC, while NDVI, slope, and elevation were supporting predictor variables. The NDVI as a single predictor showed weak and inconsistent relationships to DOC concentrations in recipient waters, yet NDVI was a significant positive regulator of DOC in multiple regression models that included land cover variables. Our study illustrates that vegetation type exerts primary control in DOC regulation in Stordalen, while productivity (NDVI) is of secondary importance. Thus, predictive multiple linear regression models for DOC can be utilized combining these different types of explanatory variables.	[Mzobe, Pearl; Berggren, Martin; Pilesjo, Petter; Persson, Andreas] Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Skane, Sweden; [Pilesjo, Petter] Lund Univ, GIS Ctr, Lund, Skane, Sweden; [Lundin, Erik] Umea Univ, Dept Ecol & Environm Sci, Climate Impacts Res Ctr, Umea, Sweden; [Olefeldt, David] Univ Alberta, Agr Life & Environm Sci Renewable Resources, Edmonton, AB, Canada; [Roulet, Nigel T.] McGill Univ, Dept Geog, Montreal, PQ, Canada	Lund University; Lund University; Umea University; University of Alberta; McGill University	Mzobe, P (corresponding author), Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Skane, Sweden.	pearl.mzobe@nateko.lu.se	Roulet, Nigel/W-3402-2019; Berggren, Martin/G-1401-2012	Roulet, Nigel/0000-0001-9571-1929; Berggren, Martin/0000-0003-0657-0971; Lundin, Erik/0000-0002-3785-8305; Mzobe, Pearl/0000-0001-8554-9585	EUROSA Project (Erasmus Mundus Action 2 Partnerships scholarship programme)	EUROSA Project (Erasmus Mundus Action 2 Partnerships scholarship programme)	The EUROSA Project (Erasmus Mundus Action 2 Partnerships scholarship programme) provided PM with an exchange scholarship at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren A, 2008, FRESHWATER BIOL, V53, P964, DOI 10.1111/j.1365-2427.2008.01955.x; Agren A, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000381; Agren AM, 2014, BIOGEOSCIENCES, V11, P1199, DOI 10.5194/bg-11-1199-2014; Andersson A, 2015, AMBIO, V44, pS345, DOI 10.1007/s13280-015-0654-8; Aufdenkampe AK, 2011, FRONT ECOL ENVIRON, V9, P53, DOI 10.1890/100014; Backstrand K, 2010, BIOGEOSCIENCES, V7, P95; Borge AF, 2017, CRYOSPHERE, V11, P1, DOI 10.5194/tc-11-1-2017; Brothers S, 2014, LIMNOL OCEANOGR, V59, P1388, DOI 10.4319/lo.2014.59.4.1388; Camino-Serrano M, 2014, GLOBAL BIOGEOCHEM CY, V28, P497, DOI 10.1002/2013GB004726; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; de Wit HA, 2016, ENVIRON SCI TECH LET, V3, P430, DOI 10.1021/acs.estlett.6b00396; de Wit HA, 2016, BIOGEOCHEMISTRY, V127, P305, DOI 10.1007/s10533-016-0182-z; Deng J, 2014, BIOGEOSCIENCES, V11, P4753, DOI 10.5194/bg-11-4753-2014; Finstad AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep31944; Giesler R, 2014, BIOGEOSCIENCES, V11, P525, DOI 10.5194/bg-11-525-2014; Graneli W, 2012, ENCY LAKERESERVOIR, DOI DOI 10.1007/978-1-4020-4410-6_256; Hallinger M, 2010, NEW PHYTOL, V186, P890, DOI 10.1111/j.1469-8137.2010.03223.x; Hedenas H, 2011, AMBIO, V40, P672, DOI 10.1007/s13280-011-0173-1; Hirsch RM, 2010, J AM WATER RESOUR AS, V46, P857, DOI 10.1111/j.1752-1688.2010.00482.x; Hodgkins SB, 2014, P NATL ACAD SCI USA, V111, P5819, DOI 10.1073/pnas.1314641111; Hugelius G, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001606; Jennings E, 2010, AQUAT ECOL SER, V4, P199, DOI 10.1007/978-90-481-2945-4_12; Jin HX, 2014, REMOTE SENS ENVIRON, V152, P512, DOI 10.1016/j.rse.2014.07.010; Johansson M, 2006, AMBIO, V35, P190, DOI 10.1579/0044-7447(2006)35[190:WDTCPO]2.0.CO;2; Johansson T, 2006, GLOBAL CHANGE BIOL, V12, P2352, DOI 10.1111/j.1365-2486.2006.01267.x; Jonsson M, 2015, FRESHWATER BIOL, V60, P78, DOI 10.1111/fwb.12468; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Kicklighter DW, 2013, ECOL APPL, V23, P1817, DOI 10.1890/11-1050.1; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; Kokfelt U, 2009, GLOBAL CHANGE BIOL, V15, P1652, DOI 10.1111/j.1365-2486.2009.01880.x; Kokfelt U, 2010, J PALEOLIMNOL, V44, P327, DOI 10.1007/s10933-010-9406-8; Kothawala DN, 2014, GLOBAL CHANGE BIOL, V20, P1101, DOI 10.1111/gcb.12488; Koven CD, 2011, P NATL ACAD SCI USA, V108, P14769, DOI 10.1073/pnas.1103910108; Kritzberg ES, 2012, BIOGEOSCIENCES, V9, P1465, DOI 10.5194/bg-9-1465-2012; Kritzberg ES, 2014, FRESHWATER BIOL, V59, P325, DOI 10.1111/fwb.12267; Lal R, 2010, ADV SOIL SCI-SER, P1; Lantmateriet, 2016, GSD HOJDD GRID 2; Lapierre JF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3972; Larsen S, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003908; Larsen S, 2011, GLOBAL CHANGE BIOL, V17, P1186, DOI 10.1111/j.1365-2486.2010.02257.x; Lauerwald R, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001820; Lennon JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075771; Lundin EJ, 2013, J GEOPHYS RES-BIOGEO, V118, P1200, DOI 10.1002/jgrg.20092; Maybeck M., 2009, BIOGEOCHEMISTRY INLA, P118; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Mormul RP, 2012, BIOL INVASIONS, V14, P2091, DOI 10.1007/s10530-012-0216-y; Olefeldt D, 2013, GLOBAL CHANGE BIOL, V19, P589, DOI 10.1111/gcb.12071; Olefeldt D, 2013, HYDROL PROCESS, V27, P2280, DOI 10.1002/hyp.9358; Olefeldt D, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001819; ORNL DAAC, 2008, MODIS COLL 6 LAND PR, DOI [10.3334/ORNLDAAC/124111, DOI 10.3334/ORNLDAAC/124111]; Petrescu AMR, 2008, BIOGEOSCIENCES, V5, P111, DOI 10.5194/bg-5-111-2008; Rafique R, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8030177; Ravindranath N.H., 2007, CARBON INVENTORY MET; Raymond PA, 2016, ECOLOGY, V97, P5, DOI 10.1890/14-1684.1; Roulet N, 2006, NATURE, V444, P283, DOI 10.1038/444283a; Schubert P, 2010, REMOTE SENS ENVIRON, V114, P1178, DOI 10.1016/j.rse.2010.01.005; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Selvam BP, 2017, SCI REP-UK, V7, DOI 10.1038/srep45811; Smith Benjamin, 2008, P221, DOI 10.1007/978-3-540-72786-6_4; Swindles GT, 2015, SCI REP-UK, V5, DOI 10.1038/srep17951; Tang J, 2015, BIOGEOSCIENCES, V12, P2791, DOI 10.5194/bg-12-2791-2015; Tuvendal M, 2011, ECOL SOC, V16, DOI 10.5751/ES-04456-160421; Vonk JE, 2015, BIOGEOSCIENCES, V12, P7129, DOI 10.5194/bg-12-7129-2015; Walvoord MA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030216; Wang Q, 2005, GLOBAL ECOL BIOGEOGR, V14, P379, DOI 10.1111/j.1466-822x.2005.00153.x; Wessels KJ, 2008, J ARID ENVIRON, V72, P1940, DOI 10.1016/j.jaridenv.2008.05.011; Yengoh GT, 2015, USE NORMALIZED DIFFE, P31, DOI [10.1007/978-3-319-24112-8_5, DOI 10.1007/978-3-319-24112-8_5]; Zhang T, 2003, PERMAFROST, VOLS 1 AND 2, P1289; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025	69	4	4	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199608	10.1371/journal.pone.0199608	http://dx.doi.org/10.1371/journal.pone.0199608			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979688	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500022
J	Tanaka, Y; Kanazawa, M; Kano, M; Tashiro, M; Fukudo, S				Tanaka, Yukari; Kanazawa, Motoyori; Kano, Michiko; Tashiro, Manabu; Fukudo, Shin			Relationship between sympathoadrenal and pituitary-adrenal response during colorectal distention in the presence of corticotropin-releasing hormone in patients with irritable bowel syndrome and healthy controls	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; LOCUS-COERULEUS; HPA AXIS; STRESS; BRAIN; ACTIVATION; DYSREGULATION; ANTAGONIST; SEX; MODULATION	Corticotropin-releasing hormone (CRH) mediates stress responses in the brain-gut axis. Administration of CRH modulates brain activation, for example by controlling the autonomic nervous system in response to colorectal distention. Here, we investigated the relationship between sympathoadrenal and hypothalamic-pituitary-adrenal (HPA) responses to colorectal distention in patients with irritable bowel syndrome (IBS). We enrolled 32 patients with IBS (16 women and 16 men) and 32 healthy subjects (16 women and 16 men), and randomly divided them between CRH and saline injection groups. The patients randomly underwent no (0 mmHg), mild (20 mmHg), or strong (40 mmHg) colorectal distension. CRH (2 mu g/kg) or saline was then administered via injection, and the distention protocol was repeated. The heart rate (HR) and HR variability (HRV; calculated as the low [LF] to high frequency [HF] peak ratio, LF/HF) were analyzed using electrocardiography. Plasma noradrenaline, adrenaline, adrenocorticotropic hormone (ACTH), and cortisol levels were measured at the time of each distention. Plasma adrenaline levels were shown to be associated with plasma ACTH levels in HCs injected with CRH during distention using structural equation modeling analysis. Patients with IBS injected with placebo during distention displayed a closer association between these two parameters than those injected with CRH. Generalized estimating equation analysis revealed a significant distention x group x drug interaction for HF power. Moreover, there was a strong correlation between adrenaline and HRV upon CRH injection in controls, but not patients with IBS. The relationship between HPA-sympathoadrenal responses and CRH levels during colorectal distention differs between patients with IBS and controls. Modulation of adrenal gland activity in response to ACTH stimulation may contribute to the brain-gut pathophysiology characteristic of IBS.	[Tanaka, Yukari; Kanazawa, Motoyori; Kano, Michiko; Fukudo, Shin] Tohoku Univ, Dept Behav Med, Grad Sch Med, Sendai, Miyagi, Japan; [Kano, Michiko] Tohoku Univ, Dept Frontier Res Inst Interdisciplinary Sci, Grad Sch Med, Sendai, Miyagi, Japan; [Tashiro, Manabu] Tohoku Univ, Cyclotron RI Ctr, Grad Sch Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Fukudo, S (corresponding author), Tohoku Univ, Dept Behav Med, Grad Sch Med, Sendai, Miyagi, Japan.	sfukudo@med.tohoku.ac.jp	Tashiro, Manabu/T-2859-2019; Fukudo, Shin/J-4813-2014		Ministry of Education, Science, and Culture of Japan; Japan Society for the Promotion of Science [15H04799]; Ministry of Health, Welfare, and Labor of Japan [29-2]	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Welfare, and Labor of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan, Japan Society for the Promotion of Science (15H04799 to SF), and Grant-in-Aid for Scientific Research from the Ministry of Health, Welfare, and Labor of Japan (29-2 to SF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Arlt J, 2003, NEUROPEPTIDES, V37, P362, DOI 10.1016/j.npep.2003.09.006; Barbara G, 2004, GASTROENTEROLOGY, V126, P693, DOI 10.1053/j.gastro.2003.11.055; Buchman Timothy G, 2002, Curr Opin Crit Care, V8, P311, DOI 10.1097/00075198-200208000-00007; Chang L, 2009, NEUROGASTROENT MOTIL, V21, P149, DOI 10.1111/j.1365-2982.2008.01171.x; Chang L, 2012, AM J GASTROENTEROL, V107, P262, DOI 10.1038/ajg.2011.423; DEMEERSMAN RE, 1993, AM HEART J, V125, P726, DOI 10.1016/0002-8703(93)90164-5; Dinan TG, 2006, GASTROENTEROLOGY, V130, P304, DOI 10.1053/j.gastro.2005.11.033; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Elenkov IJ, 2008, J IMMUNOL, V181, P1737, DOI 10.4049/jimmunol.181.3.1737; Fukudo S, 2006, GUT, V55, P146, DOI 10.1136/gut.2005.070888; Fukudo S, 1998, GUT, V42, P845, DOI 10.1136/gut.42.6.845; Fukudo S., 2012, PHYSL GASTROINTESTIN, V1, P791; Fukudo S, 2013, NAT REV GASTRO HEPAT, V10, P569, DOI 10.1038/nrgastro.2013.166; Fukudo S, 2011, J GASTROEN HEPATOL, V26, P110, DOI 10.1111/j.1440-1746.2011.06631.x; GOLDSMITH RL, 1992, J AM COLL CARDIOL, V20, P552, DOI 10.1016/0735-1097(92)90007-A; Goldstein David S, 2008, Endocr Regul, V42, P111; Hamaguchi T, 2004, NEUROGASTROENT MOTIL, V16, P299, DOI 10.1111/j.1365-2982.2004.00498.x; Hubbard CS, 2011, J NEUROSCI, V31, P12491, DOI 10.1523/JNEUROSCI.1860-11.2011; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Mazurak N, 2012, NEUROGASTROENT MOTIL, V24, P206, DOI 10.1111/j.1365-2982.2011.01866.x; McCall JG, 2015, NEURON, V87, P605, DOI 10.1016/j.neuron.2015.07.002; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; McEwen BS, 2002, NEUROBIOL AGING, V23, P921, DOI 10.1016/S0197-4580(02)00027-1; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Poehlman ET, 1997, EUR J CLIN INVEST, V27, P23, DOI 10.1046/j.1365-2362.1996.640620.x; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Sagami Y, 2004, GUT, V53, P958, DOI 10.1136/gut.2003.018911; Saito K, 2005, GASTROENTEROLOGY, V129, P1533, DOI 10.1053/j.gastro.2005.07.053; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; SATO N, 1995, PSYCHOSOM MED, V57, P331, DOI 10.1097/00006842-199507000-00004; Spielberger CD, 1970, STAI MANUAL STATETRA; Suzuki H, 2009, PSYCHOSOM MED, V71, P619, DOI 10.1097/PSY.0b013e31819b69ca; Tache Y, 2007, J CLIN INVEST, V117, P33, DOI 10.1172/JCI30085; Tanaka Y, 2018, J NEUROGASTROENTEROL, V24, P87, DOI 10.5056/jnm16216; Tanaka Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157347; Tanaka Y, 2011, J NEUROGASTROENTEROL, V17, P131, DOI 10.5056/jnm.2011.17.2.131; Tillisch K, 2005, GUT, V54, P1396, DOI 10.1136/gut.2004.058685; Van Bockstaele EJ, 1998, J NEUROENDOCRINOL, V10, P743, DOI 10.1046/j.1365-2826.1998.00254.x; van Stegeren AH, 2005, NEUROIMAGE, V24, P898, DOI 10.1016/j.neuroimage.2004.09.011; Videlock EJ, 2016, PSYCHONEUROENDOCRINO, V69, P67, DOI 10.1016/j.psyneuen.2016.03.016; Videlock EJ, 2009, GASTROENTEROLOGY, V137, P1954, DOI 10.1053/j.gastro.2009.08.058; Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392; Winston JH, 2010, GASTROENTEROLOGY, V138, P294, DOI 10.1053/j.gastro.2009.09.054; Wurtman RJ, 2002, METABOLISM, V51, P11, DOI 10.1053/meta.2002.33185; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zuckerman-Levin N, 2001, J CLIN ENDOCR METAB, V86, P5920, DOI 10.1210/jc.86.12.5920; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	50	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199698	10.1371/journal.pone.0199698	http://dx.doi.org/10.1371/journal.pone.0199698			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979696	Green Submitted, Green Published, gold			2022-12-26	WOS:000437809500027
J	Lee, YJ; Han, E; Wilberg, MJ; Lee, WC; Choi, KS; Kang, CK				Lee, Young-Jae; Han, Eunah; Wilberg, Michael J.; Lee, Won Chan; Choi, Kwang-Sik; Kang, Chang-Keun			Physiological processes and gross energy budget of the submerged longline-cultured Pacific oyster Crassostrea gigas in a temperate bay of Korea	PLOS ONE			English	Article							SUSPENSION-FEEDING BIVALVES; OXYGEN-CONSUMPTION RATES; SYSTEM-SCALE REMOVAL; BIOCHEMICAL-COMPOSITION; CERASTODERMA-EDULE; JAPANESE OYSTER; BIODEPOSITION; MOLLUSKS; AQUACULTURE; ENERGETICS	Physiological processes and gross energy budget of the longline-cultured Pacific oyster Crassostrea gigas were investigated in Geoje-Hansan Bay, Korea during two entire culturing periods. Based on physiological measurements of food consumption, feces production, ammonium excretion, and respiration from July 2008 to February 2009 and from July 2013 to February 2014, scope for growth appeared to be positive during most of the culturing period, except for one period with extremely high temperatures (up to 25 degrees C). Estimates of physiological energy production matched well with tissue energy increment measured by gross biochemical composition during the culturing period, suggesting that the oysters might adjust their physiological performance to relatively low concentrations of suspended particulate matter in the bay to optimize energy acquisition. Such an adaptive adjustment includes an increased absorption of energy and a reduced loss of metabolic and excretory energy, resulting in positive production under high culturing density. Using physiological measurements, we further assessed the feedback effects of the longline aquaculture of oysters on the bay system. Ecological efficiency, estimated by a series of energetic efficiencies at the whole bay level, was low compared with Lindeman's law of trophic efficiency. Biodeposition and ammonia excretion rates in this study were relatively low compared with other intertidal plastic bag cultures. These results indicate that the cultured oysters might have only minor effects on benthic and pelagic environments of the bay. Overall, our results suggest that the adaptive physiological performance of oysters and consequently weak feed-back effects on ambient habitats should facilitate sustainable longline aquaculture in the bay for a prolonged period without severe habitat deterioration.	[Lee, Young-Jae; Han, Eunah; Kang, Chang-Keun] Gwangju Inst Sci & Technol, Sch Earth Sci & Environm Engn, Gwangju, South Korea; [Han, Eunah; Wilberg, Michael J.] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [Lee, Won Chan] Natl Inst Fisheries Sci, Marine Environm Res Div, Busan, South Korea; [Choi, Kwang-Sik] Jeju Natl Univ, Fac Marine Biomed Sci, Jeju, South Korea	Gwangju Institute of Science & Technology (GIST); University System of Maryland; University of Maryland Center for Environmental Science; National Institute of Fisheries Science; Jeju National University	Kang, CK (corresponding author), Gwangju Inst Sci & Technol, Sch Earth Sci & Environm Engn, Gwangju, South Korea.	ckkang@gist.ac.kr	Kang, Chang-Keun/GLR-8512-2022; Choi, Kwang-Sik Albert/B-5367-2011; Wilberg, Michael/D-6289-2013	Wilberg, Michael/0000-0001-8982-5946; Chang-Keun, Kang/0000-0002-9734-9043	National Institute of Fisheries Science [R2017032]; "Long-term change of structure and function in marine ecosystems of Korea" - Ministry of Oceans and Fisheries, Korea	National Institute of Fisheries Science; "Long-term change of structure and function in marine ecosystems of Korea" - Ministry of Oceans and Fisheries, Korea	This research was financed by National Institute of Fisheries Science [grant no. R2017032] (www.nifs.go.kr). This research was also partially supported by "Long-term change of structure and function in marine ecosystems of Korea" funded by the Ministry of Oceans and Fisheries, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacher C., 1987, MODELISATION CROISSA; Barille L, 1997, J EXP MAR BIOL ECOL, V212, P149, DOI 10.1016/S0022-0981(96)02756-6; BAYNE BL, 1977, J MAR BIOL ASSOC UK, V57, P355, DOI 10.1017/S0025315400021809; Bayne BL, 1998, J EXP MAR BIOL ECOL, V219, P1, DOI 10.1016/S0022-0981(97)00172-X; Bayne BL., 1976, ESTUARINE PROCESSES, V1, P432, DOI DOI 10.1016/B978-0-12-751801-5.50043-5; BAYNE BL, 1983, MOLLUSCA 1, V4, P407; Bayne B, 2017, DEV AQUAC FISH SCI, V41, P703, DOI 10.1016/B978-0-12-803472-9.00010-8; BERNARD FR, 1974, J FISH RES BOARD CAN, V31, P185, DOI 10.1139/f74-030; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOUGRIER S, 1995, AQUACULTURE, V134, P143, DOI 10.1016/0044-8486(95)00036-2; Bougrier S, 1998, J EXP MAR BIOL ECOL, V219, P205, DOI 10.1016/S0022-0981(97)00181-0; Byron C, 2011, MAR POLICY, V35, P363, DOI 10.1016/j.marpol.2010.10.016; CAREFOOT TH, 1967, J MAR BIOL ASSOC UK, V47, P565, DOI 10.1017/S0025315400035190; Crisp D., 1975, PRODUCTIVITY WORLD E, P71; Dame R.F., 1997, AQUAT ECOL, V31, P409, DOI [10.1023/A:1009997011583, DOI 10.1023/A:1009997011583]; DAME RF, 1976, ESTUAR COAST MAR SCI, V4, P243, DOI 10.1016/0302-3524(76)90058-X; Dame Richard F., 1993, NATO ASI Series Series G Ecological Sciences, V33, P245; Deslous-Paoli J.-M., 1984, Haliotis, V14, P79; Deslous-Paoli J.-M., 1987, Haliotis, V16, P233; DESLOUSPAOLI JM, 1992, HYDROBIOLOGIA, V231, P85, DOI 10.1007/BF00006500; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dumbauld BR, 2009, AQUACULTURE, V290, P196, DOI 10.1016/j.aquaculture.2009.02.033; ELLIOTT JM, 1975, OECOLOGIA, V19, P195, DOI 10.1007/BF00345305; Farias A, 2003, J EXP MAR BIOL ECOL, V289, P263, DOI 10.1016/S0022-0981(03)00049-2; Filgueira R, 2006, LIMNOL OCEANOGR-METH, V4, P284, DOI 10.4319/lom.2006.4.284; Gabbott P.A., 1983, P165; GERDES D, 1983, AQUACULTURE, V31, P221, DOI 10.1016/0044-8486(83)90314-9; GERDES D, 1983, AQUACULTURE, V31, P195, DOI 10.1016/0044-8486(83)90313-7; Gnaiger E., 1983, CALCULATION ENERGETI, P337, DOI [10.1007/978-3-642-81863-9_30, DOI 10.1007/978-3-642-81863-9_30]; Gosling E., 2015, MARINE BIVALVE MOLLU, V2nd; Griffiths C.L., 1987, P1; Hargrave BT, 2008, MAR ECOL PROG SER, V365, P137, DOI 10.3354/meps07636; Haure J, 1998, AQUACULTURE, V169, P211, DOI 10.1016/S0044-8486(98)00383-4; HAVEN DS, 1966, LIMNOL OCEANOGR, V11, P487, DOI 10.4319/lo.1966.11.4.0487; Hayakawa Y, 2001, ICES J MAR SCI, V58, P435, DOI 10.1006/jmsc.2000.1036; Heral M., 1990, P342; Heral M, 1993, BIVALVE FILTER FEEDE, P455; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; 김진호, 2016, [Journal of the Korean Society of Marine Environment & Safety, 해양환경안전학회지], V22, P20, DOI 10.7837/kosomes.2016.22.1.020; Huang CH, 2008, MAR ECOL PROG SER, V358, P1, DOI 10.3354/meps07465; Iglesias JIP, 1998, J EXP MAR BIOL ECOL, V219, P71, DOI 10.1016/S0022-0981(97)00175-5; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kang C.-K., 1999, J KOREAN SOC OCEANOG, V34, P86; Kang CK, 2011, AQUACULTURE, V319, P168, DOI 10.1016/j.aquaculture.2011.06.016; Kang CK, 2009, AQUAT BIOL, V6, P289, DOI 10.3354/ab00126; Kang CK, 2000, J SHELLFISH RES, V19, P771; Kang CK., 1993, B KOREAN FISH SOC, V26, P557; Kang HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152427; Kobayashi M, 1997, AQUACULTURE, V149, P285, DOI 10.1016/S0044-8486(96)01456-1; Kooijman S.A.L.M, 1986, SPRINGER LECT NOTES, V68, P266; Kooijman SALM, 2000, DYNAMIC ENERGY BUDGE; Lee BD, 1991, B KOREAN FISH SOC, V24, P39, DOI DOI 10.1007/BF02697696; Lee YJ, 2017, ESTUAR COAST, V40, P1551, DOI 10.1007/s12237-017-0252-z; Lin HJ, 2009, ICES J MAR SCI, V66, P797, DOI 10.1093/icesjms/fsp078; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacDonald B., 2006, SCALLOPS BIOL ECOLOG, P417, DOI DOI 10.1016/S0167-9309(06)80034-7; MANN R, 1991, Journal of Shellfish Research, V10, P379; MARSH JB, 1966, J LIPID RES, V7, P574; McKindsey CW, 2006, AQUACULTURE, V261, P451, DOI 10.1016/j.aquaculture.2006.06.044; Miossec L., 2009, ICES, V299, P1; Mitchell IM, 2006, AQUACULTURE, V257, P194, DOI 10.1016/j.aquaculture.2005.02.061; Mondol MR, 2016, AQUACULTURE, V463, P224, DOI 10.1016/j.aquaculture.2016.05.047; Navarro Enrique, 1993, NATO ASI Series Series G Ecological Sciences, V33, P25; Navarro JM, 1997, MAR ECOL PROG SER, V152, P175, DOI 10.3354/meps152175; NEWELL RIE, 1980, MAR BIOL, V56, P11, DOI 10.1007/BF00390589; Newell RIE, 2004, J SHELLFISH RES, V23, P51; NFRDI (National Fisheries Research and Development Institute), 2009, ANN REP ENV RES AQ F; NFRDI (National Fisheries Research and Development Institute), 2007, ANN MON REP MAR ENV; NFRDI (National Fisheries Research and Development Institute), 2013, ANN MON REP MAR ENV; NFRDI (National Fisheries Research and Development Institute), 2014, ANN MON REP MAR ENV; Nizzoli D, 2006, MAR ECOL PROG SER, V315, P151, DOI 10.3354/meps315151; Orensanz Jose Maria (Lobo), 2002, Biological Invasions, V4, P115; Osborne P. L., 2000, TROPICAL ECOSYSTEMS; Ostroumov S, 2005, NATO SCI S SS IV EAR, V47, P147; Packard G.C., 1987, P216; PARK YG, 2016, FISHERIES AQUATIC SC, V19, P110; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Peterson BJ, 1999, J EXP MAR BIOL ECOL, V240, P37, DOI 10.1016/S0022-0981(99)00040-4; Pomeroy L.R., 1979, Marine Science (Plenum), V10, P163; Porter ET, 2009, ENCLOSED EXPT ECOSYS, P190; Prins T.C., 1998, AQUAT ECOL, V31, P349, DOI DOI 10.1023/A:1009924624259; PRINS TC, 1994, HYDROBIOLOGIA, V283, P413, DOI 10.1007/BF00024645; RODHOUSE PG, 1987, MAR ECOL PROG SER, V36, P225, DOI 10.3354/meps036225; Smaal A.C., 1993, NATO ASI Series Series G Ecological Sciences, V33, P271; Smaal AC, 1997, AQUAT LIVING RESOUR, V10, P23, DOI 10.1051/alr:1997003; Sokal RR, 1994, BIOMETRY PRINCIPLES, V3rd; Sornin J.-M., 1983, J MOLLUSC STUD A S, V12A, P185; Souchu P, 2001, MAR ECOL PROG SER, V218, P141, DOI 10.3354/meps218141; STUART V, 1984, MAR ECOL PROG SER, V16, P27, DOI 10.3354/meps016027; WINTER JE, 1978, AQUACULTURE, V13, P1, DOI 10.1016/0044-8486(78)90124-2	90	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199752	10.1371/journal.pone.0199752	http://dx.doi.org/10.1371/journal.pone.0199752			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975779	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500046
J	Farcas, AD; Mot, AC; Zagrean-Tuza, C; Toma, V; Cimpoiu, C; Hosu, A; Parvu, M; Roman, I; Silaghi-Dumitrescu, R				Farcas, Anca D.; Mot, Augustin C.; Zagrean-Tuza, Cezara; Toma, Vlad; Cimpoiu, Claudia; Hosu, Anamaria; Parvu, Marcel; Roman, Ioana; Silaghi-Dumitrescu, Radu			Chemo-mapping and biochemical-modulatory and antioxidant/prooxidant effect of Galium verum extract during acute restraint and dark stress in female rats	PLOS ONE			English	Article							OXIDATIVE STRESS; BEHAVIORAL ALTERATIONS; CHLOROGENIC ACID; FREE-RADICALS; IN-VITRO; ANTIOXIDANTS; QUERCETIN; CORTICOSTERONE; EXPRESSION; MECHANISMS	Galium verum is a well-known medicinal plant which is used in various pathologies. G. verum extracts are characterized here using chromatography, where among the rich pool of phenolic acids of flavonoids two known anti-stress modulators, chlorogenic acid and rutin are identified in high quantities. Additionally, the extracts are characterized using a series of in vitro assays (EPR, DPPH, TPC and TEAC). Considering the chemical findings, the potential beneficial effects of the G. verum extract are explored here in a living organism exposed to stress induced oxidative damages. Thus, the biochemical-modulatory and antioxidant roles of two doses of G. verum extract are examined in animals exposed to acute restraint and dark stress (S). The animals were divided in groups [control, S, SG1 (exposed to 25 mg G. verum extract), SG2 (50 mg extract)]. Increased levels of lipid peroxidation (TBARS from 4.43 to 8.06 nmol/mL), corticosterone from 0.43 to 1.96 mu g/dL and epinephrine from 44.43 to 126.7 mu g/mL, as well as decreased antioxidant enzymes activities (SOD/ CAT) were observed in the S group. The G. verum extract afforded a near-normal equilibrium within the biochemical parameters of animals exposed to RS, by reducing oxidative damage (TBARS at a 3.73 nmol/mL; CS at 0.90 mu g/dL; EP at 63.72 mu g/mL) and by restoring the antioxidant balance.	[Farcas, Anca D.; Toma, Vlad; Parvu, Marcel] Babes Bolyai Univ, Fac Biol & Geol, Cluj Napoca, Romania; [Farcas, Anca D.; Toma, Vlad; Roman, Ioana] Inst Biol Res, Cluj Napoca, Romania; [Farcas, Anca D.; Toma, Vlad; Roman, Ioana] Branch NIRDSB, Bucharest, Romania; [Farcas, Anca D.; Toma, Vlad] Natl Inst Res & Dev Isotop & Mol Technol, Cluj Napoca, Romania; [Mot, Augustin C.; Zagrean-Tuza, Cezara; Cimpoiu, Claudia; Hosu, Anamaria; Silaghi-Dumitrescu, Radu] Babes Bolyai Univ, Fac Chem & Chem Engn, Cluj Napoca, Romania	Babes Bolyai University from Cluj; National Research Institute for Biological Sciences; National Institute for Research & Development of Isotopic & Molecular Technologies Cluj-Napoca; Babes Bolyai University from Cluj	Roman, I (corresponding author), Inst Biol Res, Cluj Napoca, Romania.; Roman, I (corresponding author), Branch NIRDSB, Bucharest, Romania.; Mot, AC (corresponding author), Babes Bolyai Univ, Fac Chem & Chem Engn, Cluj Napoca, Romania.	augustinmot@chem.ubbciuj.ro; ioana.roman@icbcluj.ro	Pârvu, Marcel/AAH-9752-2020; Zagrean-Tuza, Cezara/AAY-1822-2021; Mot, Augustin C./D-3017-2011; Ioana, Roman/AAX-9721-2021; Mot, Augustin/AAP-4356-2021; Stoica, Anca-Daniela/Y-6506-2018; Silaghi-Dumitrescu, Radu/A-2883-2008; Cimpoiu, Claudia/AAM-3356-2020; Hosu, Anamaria/J-8561-2012; Toma, Vlad-Alexandru/S-1514-2019; Claudia, Cimpoiu/AAU-5767-2021	Pârvu, Marcel/0000-0002-5892-9280; Mot, Augustin C./0000-0002-1679-0487; Mot, Augustin/0000-0002-1679-0487; Stoica, Anca-Daniela/0000-0002-7510-5793; Silaghi-Dumitrescu, Radu/0000-0003-3038-7747; Cimpoiu, Claudia/0000-0001-5960-9118; Toma, Vlad-Alexandru/0000-0002-1141-2559; Hosu, Anamaria/0000-0001-6596-2428; ROMAN, IOANA/0000-0001-8002-8035	Institute of Biological Research Cluj-Napoca branch of National Institute of Research and Development for Biological Sciences Bucuresti, Romania (RNASRI) [PN 16 19/22.02.2016 - BIODIVERS]; CNCS - UEFISCDI [PN-II-RU-TE-2014-4-2555]	Institute of Biological Research Cluj-Napoca branch of National Institute of Research and Development for Biological Sciences Bucuresti, Romania (RNASRI); CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was supported in part by the Institute of Biological Research Cluj-Napoca, branch of National Institute of Research and Development for Biological Sciences Bucuresti, Romania (RNASRI grant number PN 16 19/22.02.2016 - BIODIVERS). ADF and ACM acknowledge the CNCS - UEFISCDI, project number PN-II-RU-TE-2014-4-2555 for financial support.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Bao Li, 2008, Zhongguo Zhong Yao Za Zhi, V33, P664; Beara IN, 2012, LWT-FOOD SCI TECHNOL, V47, P64, DOI 10.1016/j.lwt.2012.01.001; Benedec D, 2014, J FOOD QUALITY, V37, P259, DOI 10.1111/jfq.12090; Carrasco GA, 2003, EUR J PHARMACOL, V463, P235, DOI 10.1016/S0014-2999(03)01285-8; Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003; Demirezer LO, 2006, TURK J CHEM, V30, P525; Domitrovic R, 2014, TOXICOLOGY, V324, P98, DOI 10.1016/j.tox.2014.07.004; Embuscado ME, 2015, J FUNCT FOODS, V18, P811, DOI 10.1016/j.jff.2015.03.005; Feliu-Hemmelmann K, 2013, INT J CLIN EXP MED, V6, P444; Feng Y, 2016, CHLOROGENIC ACID PRO, DOI [10.3109/13880209.2015.1093510, DOI 10.3109/13880209.2015.1093510]; Fu Y, 2012, J ETHNOPHARMACOL, V139, P26, DOI 10.1016/j.jep.2011.08.077; Gallego-Villar L, 2014, BIOCHEM BIOPH RES CO, V452, P457, DOI 10.1016/j.bbrc.2014.08.091; Ganesan B, 2011, CELL STRESS CHAPERON, V16, P641, DOI 10.1007/s12192-011-0276-4; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; Grundmann O, 2010, NEUROPHARMACOLOGY, V58, P767, DOI 10.1016/j.neuropharm.2009.12.014; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; Itagaki S, 2009, FOOD CHEM, V114, P466, DOI 10.1016/j.foodchem.2008.09.073; Jentzsch AM, 1996, FREE RADICAL BIO MED, V20, P251, DOI 10.1016/0891-5849(95)02043-8; Ji LL, 1997, AGE, V20, P91, DOI 10.1007/s11357-997-0009-x; Kabbaj M, 2000, J NEUROSCI, V20, P6983, DOI 10.1523/JNEUROSCI.20-18-06983.2000; Kimura Y, 2004, J ETHNOPHARMACOL, V95, P447, DOI 10.1016/j.jep.2004.08.027; Kitamura Y, 2005, TOXICOL PATHOL, V33, P584, DOI 10.1080/01926230500246675; Koriem KMM, 2014, CHLOROGENIC CAFTARIC, V2014, DOI [10.1155/2014/583494, DOI 10.1155/2014/583494]; Lakic NS, 2010, CENT EUR J BIOL, V5, P331, DOI 10.2478/s11535-010-0022-4; Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016; Liu DX, 2014, BEHAV BRAIN RES, V264, P9, DOI 10.1016/j.bbr.2014.01.039; LUM G, 1995, LAB MED, V26, P273, DOI 10.1093/labmed/26.4.273; Manach C, 1997, FEBS LETT, V409, P12, DOI 10.1016/S0014-5793(97)00467-5; Mot AC, 2015, METHODS MOL BIOL, V1208, P247, DOI 10.1007/978-1-4939-1441-8_18; Mot AC, 2014, FOOD CHEM, V143, P214, DOI 10.1016/j.foodchem.2013.07.128; Mot AC, 2009, REDOX REP, V14, P267, DOI 10.1179/135100009X12525712409814; Muqbil I, 2006, CANCER LETT, V240, P213, DOI 10.1016/j.canlet.2005.09.008; Ochi M, 2008, LIFE SCI, V82, P862, DOI 10.1016/j.lfs.2008.01.020; Ohta Y, 2009, J CLIN BIOCHEM NUTR, V45, P347, DOI 10.3164/jcbn.09-59; Olteanu Z, 2013, ROM AGRIC RES, V30, P163; Parashar A, 2017, NEUROSCI LETT, V656, P65, DOI 10.1016/j.neulet.2017.04.058; Park JS, 2006, J AGR FOOD CHEM, V54, P2951, DOI 10.1021/jf052900a; Pergolizzi B, 2017, MOL CELL BIOCHEM, V434, P51, DOI 10.1007/s11010-017-3036-7; Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; Rajendran P, 2014, CLIN CHIM ACTA, V436, P332, DOI 10.1016/j.cca.2014.06.004; Rangan GK, 2002, NEPHRON, V90, P313, DOI 10.1159/000049067; Sahin E, 2007, CLIN EXP PHARMACOL P, V34, P425, DOI 10.1111/j.1440-1681.2007.04584.x; Samhan-Arias AK, 2004, FREE RADICAL BIO MED, V37, P48, DOI 10.1016/j.freeradbiomed.2004.04.002; Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035; Selman C, 2000, FREE RADICAL BIO MED, V28, P1279, DOI 10.1016/S0891-5849(00)00263-X; Sheikh N, 2007, J ETHNOPHARMACOL, V111, P671, DOI 10.1016/j.jep.2007.01.025; Toumi ML, 2016, J BIOSCIENCES, V41, P237, DOI 10.1007/s12038-016-9613-1; Ugochukwu NH, 2003, J BIOSCIENCES, V28, P1, DOI 10.1007/BF02970124	50	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0200022	10.1371/journal.pone.0200022	http://dx.doi.org/10.1371/journal.pone.0200022			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969484	Green Published, gold, Green Submitted			2022-12-26	WOS:000437246700037
J	Nijboer, TCW; Winters, C; Kollen, BJ; Kwakkel, G				Nijboer, Tanja C. W.; Winters, Caroline; Kollen, Boudewijn J.; Kwakkel, Gert			Impact of clinical severity of stroke on the severity and recovery of visuospatial neglect	PLOS ONE			English	Article							RIGHT-HEMISPHERE; RANDOMIZED-TRIAL; NATURAL-HISTORY; SPATIAL NEGLECT; VISUAL NEGLECT; UPPER-LIMB; REHABILITATION; DIASCHISIS; GENERALIZABILITY; IMPROVEMENT	Background and purpose There is growing evidence that visuospatial neglect (VSN) is associated with lower functional performance in other modalities and is not restricted to the lesioned hemisphere alone, and may also affect the non-lesioned hemisphere in severe first-ever strokes. We aimed to investigate the longitudinal association between the severity of VSN, as reflected by the extent of ipsilesional and contralesional spatial attention deficit, and clinical severity of stroke. Methods This is a secondary data analysis with merged data from two prospective cohort studies. Resulting in 90 patients and 8 longitudinal measurements at 1, 2, 3, 4, 5, 8, 12, and 26 weeks post-stroke onset. A letter cancellation test (LCT) was used as the primary outcome measure to demonstrate presence and severity of VSN. The clinical severity of stroke was classified using the Bamford Classification. Results No significant association between clinical severity and the number of ipsilesional, as well as contralesional, omissions on the LCT was observed. Recovery of VSN at the contralesional hemiplegic, as well as ipsilesional non-hemiplegic side, was only dependent on 'time' as a reflection of spontaneous neurobiological recovery post-stroke. The recovery of the ipsilesional extension of VSN was significantly slower for the total anterior circulation infarct (TACI) group compared to the non-TACI group. Conclusions Larger strokes have a significant negative impact on recovery of visual attention at the non-hemiplegic side. No clinical determinants that regulate spontaneous time-dependent recovery of VSN were found. While early 'stroke severity' has been regarded as a strong predictor of functional outcome at a group level, other prognostic factors (demographic, stroke related) need to be determined.	[Nijboer, Tanja C. W.] Univ Utrecht, Expt Psychol, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Hoogstr Rehabil Ctr, Utrecht, Netherlands; [Winters, Caroline; Kwakkel, Gert] Vrije Univ Amsterdam, Med Ctr, Dept Rehabil Med, Amsterdam Movement Sci, Amsterdam, Netherlands; [Winters, Caroline; Kwakkel, Gert] Vrije Univ Amsterdam, Amsterdam Neurosci Campus, Amsterdam, Netherlands; [Winters, Caroline] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Kwakkel, Gert] Ctr Rehabil & Rheumatol READE, Dept Neurorehabil, Amsterdam, Netherlands; [Kwakkel, Gert] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; Northwestern University	Nijboer, TCW (corresponding author), Univ Utrecht, Expt Psychol, Utrecht, Netherlands.; Nijboer, TCW (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.; Nijboer, TCW (corresponding author), Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands.; Nijboer, TCW (corresponding author), Hoogstr Rehabil Ctr, Utrecht, Netherlands.	t.c.w.nijboer@uu.nl		Nijboer, Tanja/0000-0001-6683-0267; Kwakkel, Gert/0000-0002-4041-4043	NWO (Netherlands Organization for Scientific Research) [451-10-013]; EXPLICIT-stroke grant of ZonMw [89000001]; 4D-EEG (ERC) [291339-4D-EEG]	NWO (Netherlands Organization for Scientific Research)(Netherlands Organization for Scientific Research (NWO)); EXPLICIT-stroke grant of ZonMw; 4D-EEG (ERC)	Supported by a grant from NWO (Netherlands Organization for Scientific Research; grant 451-10-013 to TCWN, and by the EXPLICIT-stroke grant of ZonMw (grant 89000001) and 4D-EEG (ERC advanced grant 291339-4D-EEG) to GK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; BAMFORD J, 1987, STROKE, V18, P545, DOI 10.1161/01.STR.18.3.545; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Bernhardt J, 2017, NEUROREHAB NEURAL RE, V31, P793, DOI 10.1177/1545968317732668; Boyd LA, 2017, INT J STROKE, V12, P480, DOI 10.1177/1747493017714176; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Collin C, 1988, Int Disabil Stud, V10, P61; COLLIN C, 1990, J NEUROL NEUROSUR PS, V53, P576, DOI 10.1136/jnnp.53.7.576; Corbett D, 2017, INT J STROKE, V12, P462, DOI 10.1177/1747493017711814; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Halligan P.W., 1993, UNILATERAL NEGLECT C; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Kalra L, 1997, STROKE, V28, P1386, DOI 10.1161/01.STR.28.7.1386; Katz N, 1999, ARCH PHYS MED REHAB, V80, P379, DOI 10.1016/S0003-9993(99)90273-3; Kinsbourne M., 1987, NEUROPHYSIOLOGICAL N, P69, DOI DOI 10.1016/S0166-4115(08)61709-4; Kinsbourne M., 1993, UNILATERAL NEGLECT C, P63, DOI 10.4324/9780203765258; Koch G, 2008, BRAIN, V131, P3147, DOI 10.1093/brain/awn273; Kwakkel G, 2002, J NEUROL NEUROSUR PS, V72, P473; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Kwakkel G, 2017, INT J STROKE, V12, P451, DOI 10.1177/1747493017711813; Kwakkel G, 2016, NEUROREHAB NEURAL RE, V30, P804, DOI 10.1177/1545968315624784; Kwakkel G, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-49; Lazar RM, 2010, STROKE, V41, P1485, DOI 10.1161/STROKEAHA.109.577338; Lunven M, 2015, BRAIN, V138, P746, DOI 10.1093/brain/awu389; Nijboer TCW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100584; Nijboer TCW, 2013, CORTEX, V49, P2021, DOI 10.1016/j.cortex.2012.11.006; Rasquin S, 2009, TIJDSCHRIFT NEUROPSY, V3, P44; Smith C J, 2001, J Stroke Cerebrovasc Dis, V10, P205, DOI 10.1053/jscd.2001.29825; Ten Brink AF, 2016, BEHAV BRAIN RES, V304, P71, DOI 10.1016/j.bbr.2016.02.004; Veerbeek JM, 2017, NEUROREHAB NEURAL RE, V31, P107, DOI 10.1177/1545968316666957; Von Monakow C., 1969, DIASCHISIS; Ward NS, 2017, NAT REV NEUROL, V13, P244, DOI 10.1038/nrneurol.2017.34; Winters C, 2017, NEUROREHAB NEURAL RE, V31, P334, DOI 10.1177/1545968316680492; Winters C, 2015, NEUROREHAB NEURAL RE, V29, P614, DOI 10.1177/1545968314562115	40	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0198755	10.1371/journal.pone.0198755	http://dx.doi.org/10.1371/journal.pone.0198755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966012	Green Published, gold			2022-12-26	WOS:000437224100008
J	Vroegindewey, MM; Schuurman, AS; Oemrawsingh, RM; van Geuns, RJ; Kardys, I; Ligthart, J; Daemen, J; Boersma, E; Serruys, PW; Akkerhuis, KM				Vroegindewey, Maxime M.; Schuurman, Anne-Sophie; Oemrawsingh, Rohit M.; van Geuns, Robert-Jan; Kardys, Isabella; Ligthart, Jurgen; Daemen, Joost; Boersma, Eric; Serruys, Patrick W.; Akkerhuis, K. Martijn			SYNTAX score II predicts long-term mortality in patients with one- or two-vessel disease	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; SIROLIMUS-ELUTING STENT; CLINICAL-OUTCOMES; LEFT MAIN; BYPASS-SURGERY; VESSEL DISEASE; REVASCULARIZATION; POPULATION; VALIDATION; PRECOMBAT	Objective SYNTAX score II (SSII) is a long-term mortality prediction model to guide the decision making of the heart-team between coronary artery bypass grafting or percutaneous coronary intervention (PCI) in patients with left main or three-vessel coronary artery disease. This study aims to investigate the long-term predictive value of SSII for all-cause mortality in patients with one- or two-vessel disease undergoing PCI. Methods A total of 628 patients (76% men, mean age: 61 +/- 10 years) undergoing PCI due to stable angina pectoris (43%) or acute coronary syndrome (57%), included between January 2008 and June 2013, were eligible for the current study. SSII was calculated using the original SYNTAX score website (www.syntaxscore.com). Cox regression analysis was used to assess the association between continuous SSII and long-term all-cause mortality. The area under the receiver-operating characteristic curve was used to assess the performance of SSII. Results SSII ranged from 6.6 to 58.2 (median: 20.4, interquartile range: 16.1-26.8). In multivariable analysis, SSII proved to be an independent significant predictor for 4.5-year mortality (hazard ratio per point increase: 1.10; 95% confidence interval: 1.07-1.13; p<0.001). In terms of discrimination, SSII had a concordance index of 0.77. Conclusion In addition to its established value in patients with left main and three-vessel disease, SSII may also predict long-term mortality in PCI-treated patients with one- or two-vessel disease.	[Vroegindewey, Maxime M.; Schuurman, Anne-Sophie; Oemrawsingh, Rohit M.; van Geuns, Robert-Jan; Kardys, Isabella; Ligthart, Jurgen; Daemen, Joost; Boersma, Eric; Serruys, Patrick W.; Akkerhuis, K. Martijn] Erasmus MC, Dept Cardiol, Thoraxctr, Rotterdam, Netherlands; [Oemrawsingh, Rohit M.] Amphia Ziekenhuis, Dept Cardiol, Breda, Netherlands; [Serruys, Patrick W.] Imperial Coll London, Dept Cardiol, London, England	Erasmus University Rotterdam; Erasmus MC; Amphia Hospital; Imperial College London	Akkerhuis, KM (corresponding author), Erasmus MC, Dept Cardiol, Thoraxctr, Rotterdam, Netherlands.	k.m.akkerhuis@erasmusmc.nl	van Geuns, Robert-Jan M/N-7976-2017; van Geuns, Robert/AAR-6386-2021	van Geuns, Robert-Jan M/0000-0003-2943-5932; Oemrawsingh, Rohit M./0000-0002-3617-3929; Vroegindewey, Maxime/0000-0003-1607-5616	Seventh Framework Programme (FP7) [FP7-HEALTH-2007-2.4.2-1]; Astra Zeneca; InfraredX; Volcano Corporation; Abbott Vascular; Boston Scientific; Abbott Laboratories; AstraZeneca; Biotrinik; Cardialysis; GLG Research; Medtronic; Sino Medical Sciences Technology; Societe Europa Digital Publishing; Stentys France; Svelte Medical Systems Philips/Volcano; St. Jude Medical; Qualimed; Xeltis	Seventh Framework Programme (FP7)(European Commission); Astra Zeneca(AstraZeneca); InfraredX; Volcano Corporation; Abbott Vascular(Abbott Laboratories); Boston Scientific(Boston Scientific); Abbott Laboratories(Abbott Laboratories); AstraZeneca(AstraZeneca); Biotrinik; Cardialysis; GLG Research; Medtronic(Medtronic); Sino Medical Sciences Technology; Societe Europa Digital Publishing; Stentys France; Svelte Medical Systems Philips/Volcano; St. Jude Medical(St. Jude Medical); Qualimed; Xeltis	ATHEROREMO-IVUS was funded by the Seventh Framework Programme (FP7), theme FP7-HEALTH-2007-2.4.2-1. IBIS-3 was supported by Astra Zeneca, InfraredX and Volcano Corporation. The study was initiated by the investigators, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. van Geuns received grants from Abbott Vascular and Boston Scientific. Dr. Serruys received personal fees from Abbott Laboratories, AstraZeneca, Biotrinik, Cardialysis, GLG Research, Medtronic, Sino Medical Sciences Technology, Societe Europa Digital Publishing, Stentys France, Svelte Medical Systems Philips/Volcano, St. Jude Medical, Qualimed, Xeltis. The specific roles of these authors are articulated in the 'author contributions' section.	Campos CM, 2014, CIRC J, V78, P1942, DOI 10.1253/circj.CJ-14-0204; Cavalcante R, 2017, EUR HEART J, V38, P1969, DOI 10.1093/eurheartj/ehx138; de Boer SPM, 2014, EUROINTERVENTION, V10, P953, DOI 10.4244/EIJY13M08_01; Escaned J, 2017, EUR HEART J, V38, P3124, DOI 10.1093/eurheartj/ehx512; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Farooq V, 2013, LANCET, V381, P639, DOI 10.1016/S0140-6736(13)60108-7; Garg S, 2011, JACC-CARDIOVASC INTE, V4, P432, DOI 10.1016/j.jcin.2011.01.008; Garg S, 2011, JACC-CARDIOVASC INTE, V4, P66, DOI 10.1016/j.jcin.2010.09.017; Garg S, 2010, CATHETER CARDIO INTE, V75, P946, DOI 10.1002/ccd.22372; Girasis C, 2011, EUR HEART J, V32, P3115, DOI 10.1093/eurheartj/ehr369; Haiek C, 2017, CATHETER CARDIO INTE, V89, P37, DOI 10.1002/ccd.26468; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rodriguez AE, 2015, CARDIOVASC REVASCULA, V16, P418, DOI 10.1016/j.carrev.2015.07.001; Sianos Georgios, 2005, EuroIntervention, V1, P219; Simsek C, 2012, EUROINTERVENTION, V8, P235, DOI 10.4244/EIJV8I2A37; Sotomi Y, 2016, JACC-CARDIOVASC INTE, V9, P1564, DOI 10.1016/j.jcin.2016.04.023; Tonelli M, 2012, LANCET, V380, P807, DOI 10.1016/S0140-6736(12)60572-8; Wykrzykowska JJ, 2010, J AM COLL CARDIOL, V56, P272, DOI 10.1016/j.jacc.2010.03.044	18	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0200076	10.1371/journal.pone.0200076	http://dx.doi.org/10.1371/journal.pone.0200076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965993	Green Published, gold			2022-12-26	WOS:000437224100044
J	Lopez-Gonzalez, N; Andres-Sanchez, S; Rojas-Andres, BM; Martinez-Ortega, MM				Lopez-Gonzalez, Noemi; Andres-Sanchez, Santiago; Rojas-Andres, Blanca M.; Montserrat Martinez-Ortega, M.			Divide and conquer! Data-mining tools and sequential multivariate analysis to search for diagnostic morphological characters within a plant polyploid complex (Veronica subsect. Pentasepalae, Plantaginaceae)	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; CLASSIFICATION TREES; LOGISTIC-REGRESSION; SPECIES BOUNDARIES; DECISION TREE; ECOLOGICAL DIFFERENTIATION; TRADITIONAL MORPHOMETRICS; DISCRIMINANT FUNCTION; RETICULATE EVOLUTION; GENETIC DIVERSITY	This study exhaustively explores leaf features seeking diagnostic characters to aid the classification (assigning cases to groups, i.e. populations to taxa) in a polyploid plant-species complex. A challenging case study was selected: Veronica subsection Pentasepalae, a taxonomically intricate group. The "divide and conquer" approach was implemented-that is, a difficult primary dataset was split into more manageable subsets. Three techniques were explored: two data-mining tools (artificial neural networks and decision trees) and one unsupervised discriminant analysis. However, only the decision trees and discriminant analysis were finally used to select diagnostic traits. A previously established classification hypothesis based on other data sources was used as a starting point. A guided discriminant analysis (i.e. involving manual character selection) was used to produce a grouping scheme fitting this hypothesis so that it could be taken as a reference. Sequential unsupervised multivariate analysis enabled the recognition of all species and infraspecific taxa; however, a suboptimal classification rate was achieved. Decision trees resulted in better classification rates than unsupervised multivariate analysis, but three complete taxa were misidentified (not present in terminal nodes). The variable selection led to a different grouping scheme in the case of decision trees. The resulting groups displayed low misclassification rates when analyzed using artificial neural networks. The decision trees as well as the discriminant analysis are recommended in the search of diagnostic characters. Due to the high sensitivity that artificial neural networks have to the combination of input/output layers, they are proposed as evaluation tools for morphometric studies. The "divide and conquer" principle is a promising strategy, providing success in the present case study.	[Lopez-Gonzalez, Noemi; Andres-Sanchez, Santiago; Rojas-Andres, Blanca M.; Montserrat Martinez-Ortega, M.] Univ Salamanca, Dept Botan & Biobanco ADN Vegetal, Salamanca, Spain; [Andres-Sanchez, Santiago] Univ Salamanca, Dept Didact Matemat & Didact Ciencias Expt, Salamanca, Spain; [Rojas-Andres, Blanca M.] Univ Leipzig, Inst Biol, Dept Mol Evolut & Plant Systemat & Herbarium LZ, Leipzig, Germany	University of Salamanca; University of Salamanca; Leipzig University	Lopez-Gonzalez, N (corresponding author), Univ Salamanca, Dept Botan & Biobanco ADN Vegetal, Salamanca, Spain.	noe_lg@usal.es	Rojas-Andrés, Blanca/B-3290-2017; López-González, Noemí/P-3136-2019; Martinez-Ortega, M. Montserrat/L-5607-2015; Andres-Sanchez, Santiago/A-1893-2016	Rojas-Andrés, Blanca/0000-0001-7164-1313; López-González, Noemí/0000-0001-6961-4658; Martinez-Ortega, M. Montserrat/0000-0002-3887-2416; Andres-Sanchez, Santiago/0000-0002-8088-1607	Spanish Ministry of Research, Development and Innovation [CGL2012-32574, CGL2009-07555, CGL2014-52787-C3-2-P, AP2010-2968, AP2008-03434]	Spanish Ministry of Research, Development and Innovation	This research was financially supported by the Spanish Ministry of Research, Development and Innovation through the projects [CGL2012-32574], [CGL2009-07555] and [CGL2014-52787-C3-2-P], http://www.idi.mineco.gob.es/portal/site/MICINN/?lang_choosen=en; Spanish Ministry of Research, Development and Innovation through PhD scholarships to NLG [AP2010-2968] and BMRA [AP2008-03434]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2004, BIOL J LINN SOC, V82, P467, DOI 10.1111/j.1095-8312.2004.00333.x; Ackerfield Jennifer, 2002, Adansonia (Paris), V24, P197; Aitkenhead MJ, 2008, EXPERT SYST APPL, V34, P18, DOI 10.1016/j.eswa.2006.08.008; Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x; Andrade I. M., 2008, Kew Bulletin, V63, P193, DOI 10.1007/s12225-008-9032-z; Andres-Sanchez S, 2009, BOT J LINN SOC, V159, P68, DOI 10.1111/j.1095-8339.2008.00917.x; Bai Y, 2011, J COMPUT GRAPH STAT, V20, P63, DOI 10.1198/jcgs.2010.09035; Baker MA, 2000, SYST BOT, V25, P577, DOI 10.2307/2666722; Baker R., 2010, INT ENCY ED, V7, P112, DOI [DOI 10.1016/B978-0-08-044894-7.01318-X, 10.4018/978-1-59140-557-3.ch075]; Balao F, 2011, NEW PHYTOL, V192, P256, DOI 10.1111/j.1469-8137.2011.03787.x; Barciova L, 2009, ACTA ZOOL ACAD SCI H, V55, P31; Bardy KE, 2011, TAXON, V60, P108, DOI 10.1002/tax.601010; Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3; Beck MW, 2013, VISUALIZING NEURAL N; Beentje H., 2010, KEW PLANT GLOSSARY I; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Breiman L, 1996, ANN STAT, V24, P2350; Breiman L., 2017, CLASSIFICATION REGRE; Brinkmann G, 1997, MATH PROGRAM, V79, P71, DOI 10.1007/BF02614312; Brown ML, 2003, IND MANAGE DATA SYST, V103, P611, DOI 10.1108/02635570310497657; Chakaravarthy VT, 2007, P 26 ACM SIGMOD SIGA, P53; Chen X, 2011, WIRES DATA MIN KNOWL, V1, P55, DOI 10.1002/widm.14; Clark J. Y., 2012, 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), P343, DOI 10.1109/CIBCB.2012.6217250; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Delen D, 2005, ARTIF INTELL MED, V34, P113, DOI 10.1016/j.artmed.2004.07.002; Depypere L, 2009, BELG J BOT, V142, P163; Dobigny G, 2002, BIOL J LINN SOC, V77, P319, DOI 10.1046/j.1095-8312.2002.00074.x; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Dubey BP, 2006, BIOSYST ENG, V95, P61, DOI 10.1016/j.biosystemseng.2006.06.001; Fawcett JA., 2013, PHYS STRUCTURE BEHAV, P277, DOI DOI 10.1007/978-3-7091-1160-4_17; Feldesman MR, 2002, AM J PHYS ANTHROPOL, V119, P257, DOI 10.1002/ajpa.10102; Fischer CC, 2006, NAT MATER, V5, P641, DOI 10.1038/nmat1691; Goloboff P, 2008, CLADISTICS, V24, P91; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hall M. A., 2000, P 17 INT C MACH LEAR; Hassoun MH., 1995, FUNDAMENTALS ARTIFIC, DOI 10.1109/JPROC.1996.503146; Henderson A, 2006, BOT J LINN SOC, V151, P103, DOI 10.1111/j.1095-8339.2006.00526.x; Horandl E, 2009, TAXON, V58, P1194, DOI 10.1002/tax.584012; Hu W, 2008, DATA KNOWL ENG, V67, P140, DOI 10.1016/j.datak.2008.06.003; Huang ML, 2012, J BIOMED SCI ENG, V5, P525; Jensen RJ, 2002, TAXON, V51, P475, DOI 10.2307/1554860; Jiao Y, 2002, NATURE, V473, P97; Joly S, 2007, SYST BOT, V32, P819, DOI 10.1600/036364407783390863; Kafkas S, 2001, THEOR APPL GENET, V102, P908, DOI 10.1007/s001220000526; Karels TJ, 2004, OIKOS, V105, P575, DOI 10.1111/j.0030-1299.2004.12732.x; Klecka W. R., 1980, DISCRIMINANT ANAL; Koutecky P, 2007, FOLIA GEOBOT, V42, P77, DOI 10.1007/BF02835103; Kurt I, 2008, EXPERT SYST APPL, V34, P366, DOI 10.1016/j.eswa.2006.09.004; Lambert SM, 2006, PLANT SPEC BIOL, V21, P93, DOI 10.1111/j.1442-1984.2006.00155.x; Lavergne S, 2010, ANN BOT-LONDON, V105, P109, DOI 10.1093/aob/mcp271; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Li XD, 2012, PLANTA, V236, P579, DOI 10.1007/s00425-012-1629-7; Lindbladh MS, 2002, AM J BOT, V89, P1459, DOI 10.3732/ajb.89.9.1459; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Lorenz C, 2015, ACTA TROP, V152, P165, DOI 10.1016/j.actatropica.2015.09.011; Lorenz C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0581-8; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Maier HR, 2000, ENVIRON MODELL SOFTW, V15, P101, DOI 10.1016/S1364-8152(99)00007-9; Maimon O, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P1, DOI 10.1007/978-0-387-09823-4; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mandakova T, 2008, PLANT SYST EVOL, V274, P155, DOI 10.1007/s00606-008-0040-0; Manel S, 1999, ECOL MODEL, V120, P337, DOI 10.1016/S0304-3800(99)00113-1; Marhold K, 2011, REGNUM VEG, V153, P73; Martinez-Ortega MM, 2004, SYST BOT, V29, P965, DOI 10.1600/0363644042451071; Martonez Ortega MM, 2009, FLORA IBERICA, P360; May L, 2012, REV PALAEOBOT PALYNO, V180, P15, DOI 10.1016/j.revpalbo.2012.04.007; Mendoza M, 2007, SYST ASSOC SPEC VOL, V74, P261; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Muir G, 2000, NATURE, V405, P1016, DOI 10.1038/35016640; Olden JD, 2004, ECOL MODEL, V178, P389, DOI 10.1016/j.ecolmodel.2004.03.013; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padilla-Garcia N, 2018, MOL PHYLOGENET EVOL, V119, P196, DOI 10.1016/j.ympev.2017.11.007; Paliwal M, 2009, EXPERT SYST APPL, V36, P2, DOI 10.1016/j.eswa.2007.10.005; Pandolfi C, 2009, EUPHYTICA, V166, P411, DOI 10.1007/s10681-008-9828-9; Parsons S, 2000, J EXP BIOL, V203, P2641; Pearson DL, 2011, BIOSCIENCE, V61, P58, DOI 10.1525/bio.2011.61.1.11; Pedersen HAE, 2016, ANN BOT-LONDON, V118, P125, DOI 10.1093/aob/mcw071; PEEV D, 1995, FLORA REIPUBLICAE BU, P142; PENAS DE GILES J., 2004, ATLAS LIBRO ROJO FLO, P564; Petrova Ana, 2009, Phytologia Balcanica, V15, P63; Pillon Y, 2007, CONSERV GENET, V8, P177, DOI 10.1007/s10592-006-9160-7; Plotze RD, 2005, CAN J BOT, V83, P287, DOI [10.1139/b05-002, 10.1139/B05-002]; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsey J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0352; Raudnitschka D, 2007, SYST BIODIVERS, V5, P333, DOI 10.1017/S1477200007002435; Razi MA, 2005, EXPERT SYST APPL, V29, P65, DOI 10.1016/j.eswa.2005.01.006; Reichenbacher B, 2009, ENVIRON BIOL FISH, V86, P507, DOI 10.1007/s10641-009-9549-5; Riedmiller M., 1994, RPROP DESCRIPTION IM; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Galdon BR, 2010, J AGR FOOD CHEM, V58, P11435, DOI 10.1021/jf102014j; Rohlf FJ, 2006, NTSYS PC NUMERAL TAX; ROJAS M, 1992, CONSERV BIOL, V6, P170, DOI 10.1046/j.1523-1739.1992.620170.x; Rojas-Andres BM, 2016, PHYTOTAXA, V285, P1, DOI 10.11646/phytotaxa.285.1.1; Rojas-Andres BM, 2015, BOT J LINN SOC, V179, P670, DOI 10.1111/boj.12345; Samper C, 2004, PHILOS T R SOC B, V359, P721, DOI 10.1098/rstb.2004.1476; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Schander C, 2005, MAR BIOL RES, V1, P79, DOI 10.1080/17451000510018962; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Soltis DE, 2016, AM J BOT, V103, P1146, DOI 10.3732/ajb.1500501; Soltis PS, 2015, CURR OPIN GENET DEV, V35, P119, DOI 10.1016/j.gde.2015.11.003; Stace CA, 2000, TAXON, V49, P451, DOI 10.2307/1224344; Steinberg D., 1995, CART TREE STRUCTURED; Strelcov E, 2014, ACS NANO, V8, P6449, DOI 10.1021/nn502029b; Suehs CM, 2004, HEREDITY, V92, P31, DOI 10.1038/sj.hdy.6800374; Sugumaran V, 2007, MECH SYST SIGNAL PR, V21, P930, DOI 10.1016/j.ymssp.2006.05.004; Sutton CD, 2005, HANDB STAT, V24, P303, DOI 10.1016/S0169-7161(04)24011-1; Taylor HR, 2017, GLOB ECOL CONSERV, V10, P231, DOI 10.1016/j.gecco.2017.04.001; Thiers B., INDEX HERBARIORUM GL; Tison JM, FLORA GALLICA FLORE; Tovar-Sanchez E, 2004, AM J BOT, V91, P1352, DOI 10.3732/ajb.91.9.1352; Tso GKF, 2007, ENERGY, V32, P1761, DOI 10.1016/j.energy.2006.11.010; Turgeon J, 2003, CONSERV GENET, V4, P67, DOI 10.1023/A:1021860910719; Viscosi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025630; Walters SM, 1972, FLORA EUROPAEA, P242; Watzl B., 1910, ABHANDLUNGEN KAISERL, V5, P1; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Zozomova-Lihova J, 2015, AM J BOT, V102, P1380, DOI 10.3732/ajb.1500052	121	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0199818	10.1371/journal.pone.0199818	http://dx.doi.org/10.1371/journal.pone.0199818			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0PZ	29958275	Green Published, Green Submitted, gold			2022-12-26	WOS:000436793500018
J	Deckers, T; Lambrechts, T; Viazzi, S; Hall, GN; Papantoniou, I; Bloemen, V; Aerts, JM				Deckers, Thomas; Lambrechts, Toon; Viazzi, Stefano; Hall, Gabriella Nilsson; Papantoniou, Ioannis; Bloemen, Veerle; Aerts, Jean-Marie			High-throughput image-based monitoring of cell aggregation and microspheroid formation	PLOS ONE			English	Article							DIFFERENTIAL ADHESION HYPOTHESIS; EMBRYOID BODY FORMATION; STEM-CELL; SPHEROID CULTURE; IN-VITRO; 3D; CANCER; SIZE; MODELS; TISSUE	Studies on monolayer cultures and whole-animal models for the prediction of the response of native human tissue are associated with limitations. Therefore, more and more laboratories are tending towards multicellular spheroids grown in vitro as a model of native tissues. In addition, they are increasingly used in a wide range of biofabrication methodologies. These 3D microspheroids are generated through a self-assembly process that is still poorly characterised, called cellular aggregation. Here, a system is proposed for the automated, non-invasive and high throughput monitoring of the morphological changes during cell aggregation. Microwell patterned inserts were used for spheroid formation while an automated microscope with 4x bright-field objective captured the morphological changes during this process. Subsequently, the acquired time-lapse images were automatically segmented and several morphological features such as minor axis length, major axis length, roundness, area, perimeter and circularity were extracted for each spheroid. The method was quantitatively validated with respect to manual segmentation on four sets of +/- 60 spheroids. The average sensitivities and precisions of the proposed segmentation method ranged from 96.67-97.84% and 96.77-97.73%, respectively. In addition, the different morphological features were validated, obtaining average relative errors between 0.78-4.50%. On average, a spheroid was processed 73 times faster than a human operator. As opposed to existing algorithms, our methodology was not only able to automatically monitor compact spheroids but also the aggregation process of individual spheroids, and this in an accurate and high-throughput manner. In total, the aggregation behaviour of more than 700 individual spheroids was monitored over a duration of 16 hours with a time interval of 5 minutes, and this could be increased up to 48,000 for the described culture format. In conclusion, the proposed system has the potential to be used for unravelling the mechanisms involved in spheroid formation and monitoring their formation during large-scale manufacturing protocols.	[Deckers, Thomas; Lambrechts, Toon; Viazzi, Stefano; Aerts, Jean-Marie] Katholieke Univ Leuven, M3 BIORES, Leuven, Belgium; [Deckers, Thomas; Bloemen, Veerle] Katholieke Univ Leuven, Biomed Hlth Engn, Campus Grp T, Leuven, Belgium; [Deckers, Thomas; Lambrechts, Toon; Viazzi, Stefano; Hall, Gabriella Nilsson; Papantoniou, Ioannis; Bloemen, Veerle; Aerts, Jean-Marie] Katholieke Univ Leuven, Div Skeletal Tissue Engn Leuven, Prometheus, Leuven, Belgium; [Hall, Gabriella Nilsson; Papantoniou, Ioannis] Katholieke Univ Leuven, Skeletal Biol & Engn Res Ctr, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven	Aerts, JM (corresponding author), Katholieke Univ Leuven, M3 BIORES, Leuven, Belgium.; Aerts, JM (corresponding author), Katholieke Univ Leuven, Div Skeletal Tissue Engn Leuven, Prometheus, Leuven, Belgium.	jean-marie.aerts@kuleuven.be	Bloemen, Veerle/B-2971-2019; Papantoniou, Ioannis/ABF-1528-2021	Bloemen, Veerle/0000-0003-0332-2833; Papantoniou, Ioannis/0000-0002-4754-5492; Aerts, Jean-Marie/0000-0001-5548-9163; Nilsson Hall, Gabriella/0000-0001-7803-652X; Lambrechts, Toon/0000-0002-1021-6011	KU Leuven [IMP/016/028, GOA/13/016]; Research Foundation of Flanders fellowship (FWO) [1S05116N, 1207916N]; Flemish Institute for Technological Research (IWT project) [120154]	KU Leuven(KU Leuven); Research Foundation of Flanders fellowship (FWO)(FWO); Flemish Institute for Technological Research (IWT project)	This work is part of Prometheus, the KU Leuven R&D division for skeletal tissue engineering (https://www.kuleuven.be/prornetheus). T.D. has received funding from KU Leuven (IMP/016/028, https://www.kuleuven.be/kuleuven/). T.L. was funded by KU Leuven concerted research actions (GOA/13/016, https://www.kuleuven.be/kuleuven/). G.N.H. was funded by Research Foundation of Flanders fellowship (FWO project number: 1S05116N, www.fwo.be). I.P. was funded by a Research Foundation of Flanders fellowship (FWO project number: 1207916N, www.fwo.be). S.V. was funded by the Flemish Institute for Technological Research (IWT project number 120154, https://www.vlaio.be/nl/anderedoelgroepen/tetra-technologie-transfer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli T, 2015, EXPERT OPIN BIOL TH, V12, P1347, DOI [10.1517/14712598.2012.707181, DOI 10.1517/14712598.2012.707181.ADVANCES]; Amack JD, 2012, SCIENCE, V338, P212, DOI 10.1126/science.1223953; Babur BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058865; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Celli JP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03751; Choi YY, 2010, BIOMATERIALS, V31, P4296, DOI 10.1016/j.biomaterials.2010.01.115; Dahlmann J, 2013, BIOMATERIALS, V34, P2463, DOI 10.1016/j.biomaterials.2012.12.024; Davies E., 2005, MACHINE VISION THEOR, V3rd; Fang Li C., 2006, CELL TISSUE RES, V324, P411; Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003; Foty RA, 1996, DEVELOPMENT, V122, P1611; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI 10.1089/ten.TEC.2009.0432; Gevaert E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105171; Glicklis R, 2004, BIOTECHNOL BIOENG, V86, P672, DOI 10.1002/bit.20086; Gong X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130348; Han Y, 2006, J BIOSCI BIOENG, V102, P430, DOI 10.1263/jbb.102.430; Harma V, 2012, ONCOGENE, V31, P2075, DOI 10.1038/onc.2011.396; Harma V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096426; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hong SH, 2010, STEM CELL RES, V5, P120, DOI 10.1016/j.scr.2010.04.007; Kim JM, 2011, STEM CELLS DEV, V20, P1925, DOI 10.1089/scd.2010.0476; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Lee J, 2009, SMALL, V5, P1213, DOI 10.1002/smll.200801788; Leijten J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36011; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Manning ML, 2010, P NATL ACAD SCI USA, V107, P12517, DOI 10.1073/pnas.1003743107; Mehesz AN, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/025002; Messana JM, 2008, J TISSUE ENG REGEN M, V2, P499, DOI 10.1002/term.125; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Mohr JC, 2010, BIOMATERIALS, V31, P1885, DOI 10.1016/j.biomaterials.2009.11.033; Naber HPH, 2011, JOVE-J VIS EXP, P1, DOI [DOI 10.3791/3337, 10.3791/3337]; Nath S, 2016, PHARMACOL THERAPEUT, V163, P94, DOI 10.1016/j.pharmthera.2016.03.013; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Patra B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21061; Perche F, 2012, CANCER BIOL THER, V13, P1205, DOI 10.4161/cbt.21353; Pettinato G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100742; Piccinini F, 2015, COMPUT METH PROG BIO, V119, P43, DOI 10.1016/j.cmpb.2015.02.006; Roberts Lawrence Gilman, 1963, MACHINE PERCEPTION 3; Roberts SJ, 2015, BONE, V70, P10, DOI 10.1016/j.bone.2014.08.007; Rodday B, 2011, J BIOMOL SCREEN, V16, P1119, DOI 10.1177/1087057111419501; Roeder AHK, 2012, DEVELOPMENT, V139, P3071, DOI 10.1242/dev.076414; Roth A, 2014, ADV DRUG DELIVER REV, V69, P179, DOI 10.1016/j.addr.2013.12.005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Smeets B, 2016, P NATL ACAD SCI USA, V113, P14621, DOI 10.1073/pnas.1521151113; Song W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16884; Teixeira LSM, 2012, EUR CELLS MATER, V23, P387, DOI 10.22203/eCM.v023a30; Tesei A, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-257; Tsai AC, 2015, TISSUE ENG PT A, V21, P1705, DOI [10.1089/ten.tea.2014.0314, 10.1089/ten.TEA.2014.0314]; Valamehr B, 2008, P NATL ACAD SCI USA, V105, P14459, DOI 10.1073/pnas.0807235105; Viazzi S, 2015, BIOSYST ENG, V138, P104, DOI 10.1016/j.biosystemseng.2015.06.006; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wong C, 2012, JOVE-J VIS EXP, DOI 10.3791/4218; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; YUEN HK, 1990, IMAGE VISION COMPUT, V8, P71, DOI 10.1016/0262-8856(90)90059-E	59	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199092	10.1371/journal.pone.0199092	http://dx.doi.org/10.1371/journal.pone.0199092			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953450	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400013
J	Horehledova, B; Mihl, C; Schwemmer, C; Hendriks, BMF; Eijsvoogel, NG; Kietselaer, BLJH; Wildberger, JE; Das, M				Horehledova, Barbora; Mihl, Casper; Schwemmer, Chris; Hendriks, Babs M. F.; Eijsvoogel, Nienke G.; Kietselaer, Bastiaan L. J. H.; Wildberger, Joachim E.; Das, Marco			Aortic root evaluation prior to transcatheter aortic valve implantation-Correlation of manual and semi-automatic measurements	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; HIGH-RISK PATIENTS; ANNULAR ASSESSMENT; REPLACEMENT TAVR; PROSTHESIS; STENOSIS; REGURGITATION; DISEASE; MDCT	Background Pre-procedural TAVI planning requires highly sophisticated and time-consuming manual measurements performed by experienced readers. Semi-automatic software may assist with partial automation of assessment of multiple parameters. The aim of this study was to evaluate differences between manual and semi-automatic measurements in terms of agreement and time. Methods One hundred and twenty TAVI candidates referred for the retrospectively ECG-gated CTA (2nd and 3rd generation dual source CT) were evaluated. Fully manual and semi-automatic measurements of fourteen aortic root parameters were assessed in the 20% phase of the R-R interval. Reading time was compared using paired samples t-test. Inter-software agreement was calculated using the Intraclass correlation coefficient (ICC) in a 2-way mixed effects model. Differences between manual and semi-automatic measurements were evaluated using Bland-Altman analysis. Results The time needed for evaluation using semi-automatic assessment (3 min 24 s +/- 1 min 7 s) was significantly lower (p<0.001) compared to a fully manual approach (6 min 31 sec +/- 1 min 1 sec). Excellent inter-software agreement was found (ICC = 0.93 +/- 0.0; range: 0.90-0.95). The same prosthesis size from manual and semi-automatic measurements was selected in 92% of cases, when sizing was based on annular area. Prosthesis sizing based on annular short diameter and perimeter agreed in 99% and 96% cases, respectively. Conclusion Use of semi-automatic software in pre-TAVI evaluation results in comparable results in respect of measurements and selected valve prosthesis size, while necessary reading time is significantly lower.	[Horehledova, Barbora; Mihl, Casper; Hendriks, Babs M. F.; Eijsvoogel, Nienke G.; Kietselaer, Bastiaan L. J. H.; Wildberger, Joachim E.; Das, Marco] Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, Maastricht, Netherlands; [Horehledova, Barbora; Mihl, Casper; Hendriks, Babs M. F.; Eijsvoogel, Nienke G.; Kietselaer, Bastiaan L. J. H.; Wildberger, Joachim E.; Das, Marco] Maastricht Univ, Med Ctr, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Schwemmer, Chris] Siemens Healthcare GmbH, Computed Tomog Res & Dev, Forchheim, Germany; [Kietselaer, Bastiaan L. J. H.] Maastricht Univ, Med Ctr, Dept Cardiol, Maastricht, Netherlands; [Kietselaer, Bastiaan L. J. H.] Stichting Zuyderland Med Ctr, Dept Cardiol, Heerlen, Netherlands; [Das, Marco] Helios Kliniken Duisburg GmbH, Dept Diagnost & Intervent Radiol, Duisburg, Germany	Maastricht University; Maastricht University; Siemens AG; Maastricht University	Horehledova, B (corresponding author), Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, Maastricht, Netherlands.; Horehledova, B (corresponding author), Maastricht Univ, Med Ctr, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands.	barbora.horehledova@mumc.nl	Hendriks, Babs/AAF-8699-2020	Hendriks, Babs/0000-0001-9163-337X; Mihl, Casper/0000-0003-1348-6970; Wildberger, Joachim/0000-0002-4810-6854				Achenbach S, 2012, J CARDIOVASC COMPUT, V6, P366, DOI 10.1016/j.jcct.2012.11.002; Bae KT, 2010, RADIOL CLIN N AM, V48, P9, DOI 10.1016/j.rcl.2009.08.012; Buzzatti N, 2013, EUR J CARDIO-THORAC, V43, P43, DOI 10.1093/ejcts/ezs155; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cribier A, 2004, J AM COLL CARDIOL, V43, P698, DOI 10.1016/j.jacc.2003.11.026; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; de Heer LM, 2011, INT J CARDIOVAS IMAG, V27, P1195, DOI 10.1007/s10554-011-9838-x; Grube E, 2007, J AM COLL CARDIOL, V50, P69, DOI 10.1016/j.jacc.2007.04.047; Grube E, 2006, CIRCULATION, V114, P1616, DOI 10.1161/CIRCULATIONAHA.106.639450; Hausleiter J, 2010, JACC-CARDIOVASC IMAG, V3, P1113, DOI 10.1016/j.jcmg.2010.08.016; Imai K, 2010, PHYS MEDICA, V26, P157, DOI 10.1016/j.ejmp.2009.11.003; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Jilaihawi H, 2012, J AM COLL CARDIOL, V59, P1275, DOI 10.1016/j.jacc.2011.11.045; Jurencak T, 2015, EUR RADIOL, V25, P1975, DOI 10.1007/s00330-015-3607-5; Kalisz K, 2016, RADIOGRAPHICS, V36, P2064, DOI 10.1148/rg.2016160079; Kempfert J, 2012, EUR J CARDIO-THORAC, V42, P627, DOI 10.1093/ejcts/ezs064; Kok M, 2016, EUR RADIOL, V26, P2426, DOI 10.1007/s00330-015-4080-x; Leber AW, 2003, HEART, V89, P633, DOI 10.1136/heart.89.6.633; Lehmkuhl L, 2013, INT J CARDIOVAS IMAG, V29, P693, DOI 10.1007/s10554-012-0123-4; Lou J, 2015, J CARDIOVASC COMPUT, V9, P42, DOI 10.1016/j.jcct.2014.11.003; Murphy DT, 2016, J CARDIOVASC COMPUT, V10, P37, DOI 10.1016/j.jcct.2015.07.008; Rivard AL, 2009, J HEART VALVE DIS, V18, P662; Smid M, 2010, EUR J RADIOL, V74, P152, DOI 10.1016/j.ejrad.2009.01.028; Svensson LG, 2008, J CARDIOVASC SURG, V49, P297; Van Linden A, 2014, EUR J CARDIO-THORAC, V46, P207, DOI 10.1093/ejcts/ezt600; Watanabe Y, 2013, JACC-CARDIOVASC INTE, V6, P955, DOI 10.1016/j.jcin.2013.05.008; Webb JG, 2006, CIRCULATION, V113, P842, DOI 10.1161/CIRCULATIONAHA.105.582882; Webb JG, 2007, CIRCULATION, V116, P755, DOI 10.1161/CIRCULATIONAHA.107.698258; Weininger M, 2011, AM J ROENTGENOL, V196, pW260, DOI 10.2214/AJR.10.5814; Willson AB, 2012, J AM COLL CARDIOL, V59, P1287, DOI 10.1016/j.jacc.2011.12.015	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199732	10.1371/journal.pone.0199732	http://dx.doi.org/10.1371/journal.pone.0199732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953507	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400055
J	Beacham, TD; Araujo, HA; Tucker, S; Trudel, M				Beacham, Terry D.; Araujo, H. Andres; Tucker, Strahan; Trudel, Marc			Validity of inferring size-selective mortality and a critical size limit in Pacific salmon from scale circulus spacing	PLOS ONE			English	Article							JUVENILE SOCKEYE-SALMON; STEELHEAD ONCORHYNCHUS-MYKISS; EARLY MARINE GROWTH; STOCK-SPECIFIC SIZE; COHO SALMON; BRITISH-COLUMBIA; CHINOOK SALMON; PINK SALMON; PERIOD HYPOTHESIS; ATLANTIC SALMON	Size-selective mortality owing to lack of energy reserves during the first marine winter has been suggested to be a result of juvenile salmon failing to reach a critical size or condition by the end of their first marine summer and not surviving the following winter due to this presumed energy deficit. This hypothesis implies strong size dependency of mortality, and is subject to empirical data support for acceptance. Scale circulus spacing has been interpreted as an index for body size, and we reviewed the effect of size-selective mortality with a knife-edge mortality function on descriptive statistics for a scale circulus spacing index (SCSI). In order to invoke size selection as an important driver of mortality during the first year of ocean rearing, it is necessary to demonstrate not only that size-selective mortality is directed towards the smaller members of the population, but that the selective nature of the mortality can account for a substantial portion of the observed mortality. If the assumption is made that a random sample of a single juvenile population has been obtained, then studies that employ a SCSI to infer size-selective mortality coupled with a critical size limit must demonstrate a shift toward larger values of the SCSI, but also a concomitant reduction in the variance and range of the SCSI and an increase in the skewness and kurtosis of the SCSI values. Through simulation we found that the percentage of adults that displayed a SCSI value greater than the maximum observed in the juvenile sample was highly dependent on the initial juvenile sample size and size-selective mortality rate. Geographical distributions of juvenile Pacific salmon can be stratified by size, with larger individuals migrating earlier from local ocean entry locations than smaller individuals, and thus differential timing migration of juveniles based upon body size prior to the collection of the marine juvenile sample may be a more plausible explanation of published trends in the SCSI, rather than invoking substantial size-selective mortality and a critical size limit.	[Beacham, Terry D.; Araujo, H. Andres; Tucker, Strahan; Trudel, Marc] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada; [Trudel, Marc] Fisheries & Oceans Canada, St Andrews Biol Stn, St Andrews, NB, Canada	Fisheries & Oceans Canada; Fisheries & Oceans Canada	Beacham, TD (corresponding author), Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada.	Terry.Beacham@dfo-mpo.gc.ca	Trudel, Marc/H-1955-2012	Trudel, Marc/0000-0002-3397-1642	Fisheries and Oceans Canada	Fisheries and Oceans Canada	This work was supported by the Fisheries and Oceans Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barr DR, 1999, AM STAT, V53, P357, DOI 10.2307/2686057; Beacham TD, 2017, T AM FISH SOC, V146, P395, DOI 10.1080/00028487.2017.1285349; Beacham TD, 2016, MAR COAST FISH, V8, P292, DOI 10.1080/19425120.2016.1161683; Beacham TD, 2014, T AM FISH SOC, V143, P876, DOI 10.1080/00028487.2014.889751; Beakes MP, 2014, J FISH BIOL, V84, P58, DOI 10.1111/jfb.12254; Beamish Richard J., 2016, North Pacific Anadromous Fish Commission Bulletin, P455, DOI 10.23849/npafcb6/455.468.; Beamish RJ, 2004, T AM FISH SOC, V133, P26, DOI 10.1577/T03-028; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Bond MH, 2008, CAN J FISH AQUAT SCI, V65, P2242, DOI 10.1139/F08-131; Claiborne AM, 2011, T AM FISH SOC, V140, P1135, DOI 10.1080/00028487.2011.607050; Cowan JH, 2000, REV FISH BIOL FISHER, V10, P61, DOI 10.1023/A:1008932401381; Farley EV, 2011, ICES J MAR SCI, V68, P1138, DOI 10.1093/icesjms/fsr021; Farley EV, 2007, FISH B-NOAA, V105, P121; Farley Edward V. Jr, 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P311; FISHER JP, 1990, FISH B-NOAA, V88, P637; Freshwater C, 2017, MAR ECOL PROG SER, V579, P97, DOI 10.3354/meps12279; Freshwater C, 2016, CAN J FISH AQUAT SCI, V73, P1723, DOI 10.1139/cjfas-2015-0425; Friedland KD, 2000, CAN J FISH AQUAT SCI, V57, P1181, DOI 10.1139/cjfas-57-6-1181; Friedland KD, 1996, J FISH BIOL, V48, P1, DOI 10.1111/j.1095-8649.1996.tb01414.x; Fukuwaka MA, 1997, CAN J FISH AQUAT SCI, V54, P631, DOI 10.1139/cjfas-54-3-631; Fukuwaka MA, 2008, ICES J MAR SCI, V65, P930, DOI 10.1093/icesjms/fsn076; HARTT AC, 1980, SALMONID ECOSYSTEMS, P00025; Howard Kathrine G., 2016, North Pacific Anadromous Fish Commission Bulletin, P1, DOI 10.23849/npafcb6/1.11; Ishida Y, 2002, PROG OCEANOGR, V55, P223, DOI 10.1016/S0079-6611(02)00080-0; Marco-Rius F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061744; Meyer D., 2017, E1071 MISC FUNCTIONS; Moss JH, 2005, T AM FISH SOC, V134, P1313, DOI 10.1577/T05-054.1; Murphy JM, 2017, DEEP-SEA RES PT II, V135, P156, DOI 10.1016/j.dsr2.2016.06.002; PARKER RR, 1968, J FISH RES BOARD CAN, V25, P757, DOI 10.1139/f68-068; SUGIURA N, 1985, BIOMETRIKA, V72, P219, DOI 10.1093/biomet/72.1.219; Thompson JN, 2014, T AM FISH SOC, V143, P910, DOI 10.1080/00028487.2014.901253; Trudel M., 2013, DEPTH DISTRIBUTION 1; Tucker S, 2011, T AM FISH SOC, V140, P1101, DOI 10.1080/00028487.2011.607035; Tucker S, 2009, T AM FISH SOC, V138, P1458, DOI 10.1577/T08-211.1; Tucker S, 2016, ECOLOGY, V97, P461, DOI 10.1890/15-0564.1; Yasumiishi EM, 2016, MAR COAST FISH, V8, P315, DOI 10.1080/19425120.2016.1167793; Zavolokin AV, 2013, RUSS J MAR BIOL+, V39, P501, DOI 10.1134/S1063074013070067	38	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199418	10.1371/journal.pone.0199418	http://dx.doi.org/10.1371/journal.pone.0199418			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944683	Green Published, gold, Green Submitted			2022-12-26	WOS:000436377800033
J	Pohlmann, D; Schlickeiser, S; Metzner, S; Lenglinger, M; Winterhalter, S; Pleyer, U				Pohlmann, Dominika; Schlickeiser, Stephan; Metzner, Sylvia; Lenglinger, Matthias; Winterhalter, Sibylle; Pleyer, Uwe			Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs' Uveitis	PLOS ONE			English	Article							IDIOPATHIC ANTERIOR UVEITIS; AQUEOUS-HUMOR; RUBELLA-VIRUS; HETEROCHROMIC IRIDOCYCLITIS; EXPRESSION PROFILE; ANTIBODY-SYNTHESIS; CYTOKINE PROFILES; CYCLITIS; CHEMOKINES; GLAUCOMA	Posner-Schlossman-Syndrome (PSS) is clinically characterized by acute, recurrent, mild, unilateral uveitis anterior accompanied by elevated intraocular pressure (IOP). Fuchs' Uveitis (FU) is a chronic, low-grade-inflammatory disorder, involving anterior uvea and vitreous. The clinical findings show remarkable similarities as well as differences. In our study, we determine the composition of immune mediators in aqueous humor of patients with PSS and FU and evaluate if immune mediators play a crucial role in specific viral intraocular inflammation and IOP rises. Aqueous humor samples from 81 uveitis patients (=eyes) presenting with either PSS or FU were collected at one time point. Local intraocular antibody synthesis to rubella virus was confirmed in 65 patients, whereas 16 were tested positively for human cytomegalovirus. Thirteen patients with PSS and 10 patients with FU were treated with glaucoma medications. Additionally, 11 cataract patients acted as control group. Immune mediator concentrations were measured by Bio-Plex Pro assay. We observed in both PSS (IFN-gamma: 174.9 pg/mL; TNF-alpha: 25.1 pg/mL) and FU (IFN-gamma: 25.4 pg/mL; TNF-alpha: 27.2 pg/mL) groups a significantly increased level of T-helper 1 immune mediators compared to controls (IFN-gamma, TNF-alpha: 0 pg/mL) [median]. Notably, PSS patients (IL-1RA: 73.4 pg/mL; IL-8: 199.4 pg/mL; IL-10: 33.4 pg/mL; IP-10: 126350 pg/mL) showed a stronger and more active ocular inflammatory response, than FU patients (IL-1RA: 4.3 pg/mL; IL-8: 72.4 pg/mL; IL-10: 1.6 pg/mL; IP-10: 57400 pg/mL). Furthermore, a negative correlation between mediators and IOP was seen in the PSS group, potentially caused by acetazolamide- treatment. Our findings show that immune mediators play a crucial role in specific viral intraocular inflammation and influence IOP levels. Remarkable similarities but also significant differences of immune mediator concentrations are apparent in PSS compared to FU. High concentrations of IL-1RA, IL-8, IL-10, and IP-10 correlate with active inflammation in PSS, while FU may trigger chronic inflammation. Our data also substantiated a very similar composition of cytokines in those patients from the PSS group suffering from ocular hypertension and thus offers a potential explanation model for a negative correlation between mediators and IOP.	[Pohlmann, Dominika; Metzner, Sylvia; Lenglinger, Matthias; Winterhalter, Sibylle; Pleyer, Uwe] Charite Univ Med Berlin, Dept Ophthalmol, Berlin, Germany; [Pohlmann, Dominika; Metzner, Sylvia; Lenglinger, Matthias; Winterhalter, Sibylle; Pleyer, Uwe] Free Univ Berlin, Berlin, Germany; [Pohlmann, Dominika; Metzner, Sylvia; Lenglinger, Matthias; Winterhalter, Sibylle; Pleyer, Uwe] Humboldt Univ, Berlin, Germany; [Pohlmann, Dominika; Metzner, Sylvia; Lenglinger, Matthias; Winterhalter, Sibylle; Pleyer, Uwe] Berlin Inst Hlth, Berlin, Germany; [Schlickeiser, Stephan] Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Pohlmann, D (corresponding author), Charite Univ Med Berlin, Dept Ophthalmol, Berlin, Germany.; Pohlmann, D (corresponding author), Free Univ Berlin, Berlin, Germany.; Pohlmann, D (corresponding author), Humboldt Univ, Berlin, Germany.; Pohlmann, D (corresponding author), Berlin Inst Hlth, Berlin, Germany.	dominika.pohlmann@charite.de		Schlickeiser, Stephan/0000-0003-3142-2890; Pohlmann, Dominika/0000-0002-9866-0431	German Research Foundation (DFG); Charite - Universitatsmedizin Berlin	German Research Foundation (DFG)(German Research Foundation (DFG)); Charite - Universitatsmedizin Berlin	We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charite - Universitatsmedizin Berlin.	Carlyn CJ, 2015, DIAGN MICR INFEC DIS, V83, P312, DOI 10.1016/j.diagmicrobio.2015.07.003; Chee SP, 2008, AM J OPHTHALMOL, V146, P883, DOI 10.1016/j.ajo.2008.09.001; Curnow SJ, 2005, INVEST OPHTH VIS SCI, V46, P4251, DOI 10.1167/iovs.05-0444; de Groot-Mijnes JDF, 2010, AM J OPHTHALMOL, V150, P628, DOI 10.1016/j.ajo.2010.05.015; De-La-Torre A, 2014, CYTOKINE, V68, P23, DOI 10.1016/j.cyto.2014.03.005; Fuchs E., 1906, Z AUGENHEILKD, V15, P191; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Koizumi N, 2015, BRIT J OPHTHALMOL, V99, P54, DOI 10.1136/bjophthalmol-2013-304625; Lacomba MS, 2000, ARCH OPHTHALMOL-CHIC, V118, P768, DOI 10.1001/archopht.118.6.768; Lahmar I, 2009, J INFECT DIS, V199, P1239, DOI 10.1086/597478; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044453; Liekfeld A, 2000, GRAEF ARCH CLIN EXP, V238, P222, DOI 10.1007/s004170050347; Muhaya M, 1998, CLIN EXP IMMUNOL, V111, P123; MURRAY PI, 1990, INVEST OPHTH VIS SCI, V31, P917; POSNER A, 1948, ARCH OPHTHALMOL-CHIC, V39, P517; Quentin CD, 2004, AM J OPHTHALMOL, V138, P46, DOI 10.1016/j.ajo.2004.02.055; RICHARDSON TM, 1977, ARCH OPHTHALMOL-CHIC, V95, P1015, DOI 10.1001/archopht.1977.04450060101010; ROTH M, 1979, OPHTHALMOLOGY, V86, P1613; Ruokonen PC, 2010, GRAEF ARCH CLIN EXP, V248, P565, DOI 10.1007/s00417-009-1239-7; Schwaighofer H, 1997, TRANSPLANTATION, V63, P52, DOI 10.1097/00007890-199701150-00010; Sijssens KM, 2007, EXP EYE RES, V85, P443, DOI 10.1016/j.exer.2007.06.011; Stunf S, 2012, MOL VIS, V18, P2909; Suzuki J, 2010, GRAEF ARCH CLIN EXP, V248, P1487, DOI 10.1007/s00417-010-1434-6; Suzuki K, 2010, CASE REP OPHTHALM, V1, P5, DOI 10.1159/000313842; Takase H, 2006, INVEST OPHTH VIS SCI, V47, P1557, DOI 10.1167/iovs.05-0836; Wang CQ, 2016, HLTH EC REV, V04, P3; Zhang Y, 1999, INFECT IMMUN, V67, P4383, DOI 10.1128/IAI.67.9.4383-4392.1999; Zhao BB, 2015, EXP EYE RES, V138, P80, DOI 10.1016/j.exer.2015.06.018	28	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199301	10.1371/journal.pone.0199301	http://dx.doi.org/10.1371/journal.pone.0199301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944680	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800029
J	Pujades-Rodriguez, M; Assi, V; Gonzalez-Izquierdo, A; Wilkinson, T; Schnier, C; Sudlow, C; Hemingway, H; Whiteley, WN				Pujades-Rodriguez, Mar; Assi, Valentina; Gonzalez-Izquierdo, Arturo; Wilkinson, Tim; Schnier, Christian; Sudlow, Cathie; Hemingway, Harry; Whiteley, William N.			The diagnosis, burden and prognosis of dementia: A record-linkage cohort study in England	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; ATTRITION	Objectives Electronic health records (EHR) might be a useful resource to study the risk factors and clinical care of people with dementia. We sought to determine the diagnostic validity of dementia captured in linked EHR. Methods and findings A cohort of adults in linked primary care, hospital, disease registry and mortality records in England, [CALIBER (CArdiovascular disease research using LInked Bespoke studies and Electronic health Records)]. The proportion of individuals with dementia, Alzheimer's disease, vascular and rare dementia in each data source was determined. A comparison was made of symptoms and care between people with dementia and age-, sex-and general practice-matched controls, using conditional logistic regression. The lifetime risk and prevalence of dementia and mortality rates in people with and without dementia were estimated with random-effects Poisson models. There were 47,386 people with dementia: 12,633 with Alzheimer's disease, 9540 with vascular and 1539 with rare dementia. Seventy-four percent of cases had corroborating evidence of dementia. People with dementia were more likely to live in a deprived area (conditional OR 1.26; 95% CI: 1.20-1.31 most vs least deprived), have documented memory impairment (cOR = 11.97; 95% CI: 11.24-1 2.75), falls (cOR = 2.36; 95% CI: 2.31-2.41), depression (cOR = 2.03; 95% CI: 1.98-2.09) or anxiety (cOR = 1.27; 95% CI: 1.23-1.32). The lifetime risk of dementia at age 65 was 9.2% (95% CI: 9.0%-9.4%), in men and 14.9% (95% CI: 14.7%-15.1%) in women. The population prevalence of recorded dementia increased from 0.3% in 2000 to 0.7% in 2010. A higher mortality rate was observed in people with than without dementia (IRR = 1.56; 95% CI: 1.54-1.58). Conclusions Most people with a record of dementia in linked UK EHR had some corroborating evidence for diagnosis. The estimated 10-year risk of dementia was higher than published population-based estimations. EHR are therefore a promising source of data for dementia research.	[Pujades-Rodriguez, Mar] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Assi, Valentina; Wilkinson, Tim; Schnier, Christian; Sudlow, Cathie] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Gonzalez-Izquierdo, Arturo; Hemingway, Harry] UCL, Inst Hlth Informat, London, England; [Gonzalez-Izquierdo, Arturo; Hemingway, Harry] Hlth Data Res UK London, London, England; [Wilkinson, Tim; Sudlow, Cathie] Hlth Data Res UK Scotland, Edinburgh, Midlothian, Scotland; [Wilkinson, Tim; Schnier, Christian; Sudlow, Cathie; Whiteley, William N.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland	University of Leeds; University of Edinburgh; University of London; University College London; University of Edinburgh	Whiteley, WN (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.	william.whiteley@ed.ac.uk	Schnier, Christian/AAV-7458-2021; Pujades-Rodriguez, Mar/T-1129-2018; Wilkinson, Tim/L-5184-2019; Hemingway, Harry/C-1219-2009	Schnier, Christian/0000-0001-7238-7871; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Wilkinson, Tim/0000-0001-8952-0982; Sudlow, Cathie/0000-0002-7725-7520; Whiteley, William/0000-0002-4816-8991; Hemingway, Harry/0000-0003-2279-0624; Gonzalez-Izquierdo, Arturo/0000-0002-0984-5830	Wellcome Trust; National Institute for Health Research (NIHR) Programme Grants for Applied Research programme [RP-PG-0407-10314]; MRC Clinician Scientist Fellowship [G0902303]; CSO Scottish Senior Fellowship Award [SCAF/17/01]; MRC [MR/P001823/1, G0902303] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) Programme Grants for Applied Research programme(National Institute for Health Research (NIHR)); MRC Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CSO Scottish Senior Fellowship Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CALIBER was funded by the Wellcome Trust and The National Institute for Health Research (NIHR) Programme Grants for Applied Research programme (grant RP-PG-0407-10314) to HH. WNW was funded for part of this study by an MRC Clinician Scientist Fellowship (grant G0902303) and by a CSO Scottish Senior Fellowship Award (SCAF/17/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Eefsting JA, 1996, PSYCHOL MED, V26, P1223, DOI 10.1017/S0033291700035947; Francesconi P, 2007, AGING CLIN EXP RES, V19, P390; Gallagher AM, 2011, PHARMACOEPIDEM DR S, V20, pS230; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Mathur R, 2014, J PUBLIC HEALTH-UK, V36, P684, DOI 10.1093/pubmed/fdt116; Matthews FE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11398; Matthews FE, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-12; Noble M, 2007, INDICES DEPRIVATION; Romero JP, 2014, J ALZHEIMERS DIS, V39, P741, DOI 10.3233/JAD-131622; Perera G, 2018, ALZHEIMERS DEMENT, V14, P130, DOI 10.1016/j.jalz.2017.06.2270; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Seshadri S, 2006, STROKE, P37; van de Vorst IE, 2015, NETH J MED, V73, P69	16	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199026	10.1371/journal.pone.0199026	http://dx.doi.org/10.1371/journal.pone.0199026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944675	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800018
J	Theodore, FL; Moreno-Saracho, JE; Bonvecchio, A; Morales-Ruan, MD; Tolentino-Mayo, L; Lopez-Olmedo, N; Shamah-Levy, T; Rivera, JA				Theodore, Florence L.; Moreno-Saracho, Jessica E.; Bonvecchio, Anabelle; del Carmen Morales-Ruan, Maria; Tolentino-Mayo, Lizbeth; Lopez-Olmedo, Nancy; Shamah-Levy, Teresa; Rivera, Juan A.			Lessons learned and insights from the implementation of a food and physical activity policy to prevent obesity in Mexican schools: An analysis of nationally representative survey results	PLOS ONE			English	Article							HEALTH-PROMOTION PROGRAM; CHILDREN; NUTRITION	Obesity is a serious problem among children in Mexico. In 2010, the government implemented a national food and physical activity policy in elementary schools, to prevent obesity. The goal of this study is to assess the implementation of this policy, using the logic model from a descriptive survey with national representativeness at the elementary school level and based on a stratified cluster design. We used a systematic random sampling of schools (n = 122), stratified into public and private. We administered questionnaires to 116 principals, 165 members of the Food and Physical Activity Committees, 132 food school food vendors, 119 teachers, 348 parents. This study evidences a significant deviation in implementation from what had been planned. Our lessons learned are the importance to: base the design/implementation of the policy on a theoretical framework, make programs appealing to stakeholders, select concrete and measurable objective or goals, and support stakeholders during the implementation process.	[Theodore, Florence L.; Moreno-Saracho, Jessica E.; Bonvecchio, Anabelle; Tolentino-Mayo, Lizbeth; Lopez-Olmedo, Nancy; Rivera, Juan A.] Ctr Invest Nutr & Salud, Inst Nacl Salud Publ, Ciudad De Mexico, Mexico; [del Carmen Morales-Ruan, Maria; Shamah-Levy, Teresa] Ctr Invest Evaluac & Encuestas, Inst Nacl Salud Publ, Ciudad De Mexico, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Bonvecchio, A (corresponding author), Ctr Invest Nutr & Salud, Inst Nacl Salud Publ, Ciudad De Mexico, Mexico.	bonvecchio@insp.mx	Morales-Ruán, Carmen/AEA-4558-2022	Morales Ruan, Carmen/0000-0002-6754-4630; Theodore, Florence L./0000-0002-8111-0871; Bonvecchio, Anabelle/0000-0002-2765-0818	Ministry of Education of Mexico; Bloomberg Philanthropies	Ministry of Education of Mexico; Bloomberg Philanthropies	The Ministry of Education of Mexico funded this study and Bloomberg Philanthropies funded the publication of this article.	Avula R, 2013, J NUTR; Blaine R, 2017, USING SCH STAFF MEMB, V14, DOI [10.5888/pcd14.160381, DOI 10.5888/PCD14.160381]; Bonvecchio A, 2014, SALUD PUBLICA MEXICO, V56, pS139; Charvel S, 2015, J PUBLIC HEALTH POL, V36, P426, DOI 10.1057/jphp.2015.28; Consejo Nacional de Evaluacion, EV POL SOC CONS NAC; Cotton K., 1989, SCH IMPROVEMENT RES, V6; Epstein J, 1982, ELEMENTARY SCH J, V83; Flynn MAT, 2006, OBES REV, V7, P7, DOI 10.1111/j.1467-789X.2006.00242.x; Garrett JL, 2008, J NUTR, V138, P646, DOI 10.1093/jn/138.3.646; Habicht JP, 2014, ADV NUTR, V5, P27, DOI 10.3945/an.113.004689; Harachi TW, 1999, AM J COMMUN PSYCHOL, V27, P711; Harnack L, 2000, J AM DIET ASSOC, V100, P701, DOI 10.1016/S0002-8223(00)00204-2; Horodyska K, BMC PUBLIC HLTH; Jennings-Aburto N, 2009, SALUD PUBLICA MEXICO, V51, P141, DOI 10.1590/S0036-36342009000200010; Jimenez-Aguilar A, 2017, J PUBLIC HEALTH POL, V38, P407, DOI 10.1057/s41271-017-0090-z; Menon P, 2014, ANN NY ACAD SCI, V1332, P39, DOI 10.1111/nyas.12447; Morales F., 1998, PARTICIPACIO PADRES; Murayama Rend?n C, 2012, OBESIDAD MEXICO RECO, P79; Osganian SK, 2003, HEALTH EDUC BEHAV, V30, P410, DOI 10.1177/1090198103252766; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Safdie M, 2013, SALUD PUBLICA MEXICO, V55, pS357; Saunders RP, 2005, HEALTH PROMOT PRACT, V6, P134, DOI 10.1177/1524839904273387; SEP SSA, 2010, ACT PROGR SCH CONT P; Singh AS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-304; Olivares CS, 2009, ARCH LATINOAM NUTR, V59, P166; Van Lippevelde W, 2012, INT J PUBLIC HEALTH, V57, P673, DOI 10.1007/s00038-012-0335-3; van Nassau F, 2016, HEALTH EDUC RES, V31, P220, DOI 10.1093/her/cyw007; van Nassau F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1201; Waters E, 2011, 12 COCHR COLL; World Health Organization, 2008, SCH POL FRAM IMPL WH	30	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0198585	10.1371/journal.pone.0198585	http://dx.doi.org/10.1371/journal.pone.0198585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK7JR	29944659	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800011
J	Wang, LW; Wagner, LE; Alzayady, KJ; Yule, DI				Wang, Liwei; Wagner, Larry E., II; Alzayady, Kamil J.; Yule, David, I			Region-specific proteolysis differentially modulates type 2 and type 3 inositol 1,4,5-trisphosphate receptor activity in models of acute pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CERULEIN-INDUCED PANCREATITIS; CA2+ RELEASE; TRISPHOSPHATE RECEPTOR; ZYMOGEN ACTIVATION; ENZYME ACTIVATION; VACUOLE FORMATION; DOWN-REGULATION; PROTEIN-KINASE; ACINAR-CELLS; INJURY	Fine-tuning of the activity of inositol 1,4,5-trisphosphate receptors (IP3R) by a diverse array of regulatory inputs results in intracellular Ca2+ signals with distinct characteristics. These events allow the activation of specific downstream effectors. We reported previously that region-specific proteolysis represents a novel regulatory event for type 1 IP3R (R1). Specifically, caspase-fragmented R1 display a marked increase in single-channel open probability. More importantly, the distinct characteristics of the Ca2+ signals elicited via fragmented R1 can activate alternate downstream effectors. In this report, we expand these studies to investigate whether all IP3R subtypes are regulated by proteolysis. We now show that type 2 and type 3 IP3R (R2 and R3, respectively) are proteolytically cleaved in rodent models of acute pancreatitis. Surprisingly, fragmented IP3R retained tetrameric architecture, remained embedded in endoplasmic reticulum membranes and were not functionally disabled. Proteolysis was associated with a marked attenuation of the frequency of Ca2+ signals in pancreatic lobules. Consistent with these data, expression of DNAs encoding complementary R2 and R3 peptides mimicking fragmented receptors at particular sites, resulted in a significant decrease in the frequency of agonist-stimulated oscillations. Further, proteolysis of R2 resulted in a marked decrease in single-channel open probability. Taken together, proteolytic fragmentation modulates R2 and R3 activity in a region-specific manner, and this event may contribute to the altered Ca2+ signals in pancreatic acinar cells during acute pancreatitis.	[Wang, Liwei; Wagner, Larry E., II; Alzayady, Kamil J.; Yule, David, I] Univ Rochester, Dept Pharmacol & Physiol, Rochester, NY 14642 USA	University of Rochester	Yule, DI (corresponding author), Univ Rochester, Dept Pharmacol & Physiol, Med Ctr, Rm 4-5320, Rochester, NY 14642 USA.	david_yule@urmc.rochester.edu			NIDCR, National Institutes of Health [R01DE014756, R01DE019245]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019245, R01DE014756] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIDCR, National Institutes of Health Grants R01DE014756 and R01DE019245. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADLER G, 1982, DIGEST DIS SCI, V27, P993, DOI 10.1007/BF01391745; Alzayady KJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad6281; Alzayady KJ, 2015, MOL BIOL EVOL, V32, P2236, DOI 10.1093/molbev/msv098; Alzayady KJ, 2013, J BIOL CHEM, V288, P29772, DOI 10.1074/jbc.M113.502203; Alzayady KJ, 2013, J BIOL CHEM, V288, P11122, DOI 10.1074/jbc.M113.453241; [Anonymous], PANCREAPEDIA EXOCRIN; BALLDIN G, 1979, SURGERY, V85, P451; Berridge MJ, 2016, PHYSIOL REV, V96, P1261, DOI 10.1152/physrev.00006.2016; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Chandrasekhar R, 2016, J BIOL CHEM, V291, P4846, DOI 10.1074/jbc.M115.705301; Chaudhuri A, 2005, AM J PHYSIOL-GASTR L, V288, pG235, DOI 10.1152/ajpgi.00334.2004; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; DeSmedt H, 1997, BIOCHEM J, V322, P575; Diaz F, 2000, CELL CALCIUM, V27, P315, DOI 10.1054/ceca.2000.0126; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; FUJINO I, 1995, CELL TISSUE RES, V280, P201, DOI 10.1007/s004410050345; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P974, DOI 10.1053/gast.2002.32409; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; Huang W, 2017, GUT, V66, P301, DOI 10.1136/gutjnl-2015-309363; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; KAISER AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1295, DOI 10.1152/ajpcell.1995.269.5.C1295; Kopil CM, 2011, J BIOL CHEM, V286, P35998, DOI 10.1074/jbc.M111.254177; Kruger B, 2000, AM J PATHOL, V157, P43, DOI 10.1016/S0002-9440(10)64515-4; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; Luyten T, 2017, BBA-MOL CELL RES, V1864, P947, DOI 10.1016/j.bbamcr.2017.02.013; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Mooren FC, 2003, J BIOL CHEM, V278, P9361, DOI 10.1074/jbc.M207454200; Muili KA, 2013, J BIOL CHEM, V288, P21065, DOI 10.1074/jbc.M113.471425; Muili KA, 2013, J BIOL CHEM, V288, P570, DOI 10.1074/jbc.M112.428896; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Sah RP, 2012, CURR OPIN GASTROEN, V28, P507, DOI 10.1097/MOG.0b013e3283567f52; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Sneyd J, 2017, P NATL ACAD SCI USA, V114, P1456, DOI 10.1073/pnas.1614613114; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Teos LY, 2015, SCI REP-UK, V5, DOI 10.1038/srep13953; Voronina S, 2002, J PHYSIOL-LONDON, V540, P49, DOI 10.1113/jphysiol.2002.017525; Voronina S, 2015, BIOCHEM J, V465, P405, DOI 10.1042/BJ20140398; Wagner LE, 2012, J PHYSIOL-LONDON, V590, P3245, DOI 10.1113/jphysiol.2012.228320; Wang LW, 2017, J BIOL CHEM, V292, P11714, DOI 10.1074/jbc.M117.789917; Wang LW, 2016, J PHYSIOL-LONDON, V594, P2867, DOI 10.1113/JP271140; Ward JB, 1996, GASTROENTEROLOGY, V111, P481, DOI 10.1053/gast.1996.v111.pm8690215; Wen L, 2015, GASTROENTEROLOGY, V149, P481, DOI 10.1053/j.gastro.2015.04.015; WILLIAMS JA, 1978, AM J PHYSIOL, V235, pE517, DOI 10.1152/ajpendo.1978.235.5.E517; Wojcikiewicz RJH, 1999, GASTROENTEROLOGY, V116, P1194, DOI 10.1016/S0016-5085(99)70023-5; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wright FA, 2016, PROG MOL BIOL TRANSL, V141, P141, DOI 10.1016/bs.pmbts.2016.02.004; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Yule DI, 2010, CELL CALCIUM, V47, P469, DOI 10.1016/j.ceca.2010.04.005	63	6	6	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13112	13124		10.1074/jbc.RA118.003421	http://dx.doi.org/10.1074/jbc.RA118.003421			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29970616	Green Published, hybrid			2022-12-26	WOS:000442730200012
J	Alonso, MBD; Hernandez, IL; de la Fuente, MA; Garcia-Sancho, J; Giraldez, F; Schimmang, T				Duran Alonso, Maria Beatriz; Lopez Hernandez, Iris; Angel de la Fuente, Miguel; Garcia-Sancho, Javier; Giraldez, Fernando; Schimmang, Thomas			Transcription factor induced conversion of human fibroblasts towards the hair cell lineage	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; IN-VITRO; TRANSIENT EXPRESSION; GENETIC CORRECTION; MAMMALIAN COCHLEA; MOUSE FIBROBLASTS; RETINOIC ACID; HEARING-LOSS; GENERATION; DIFFERENTIATION	Hearing loss is the most common sensorineural disorder, affecting over 5% of the population worldwide. Its most frequent cause is the loss of hair cells (HCs), the mechanosensory receptors of the cochlea. HCs transduce incoming sounds into electrical signals that activate auditory neurons, which in turn send this information to the brain. Although some spontaneous HC regeneration has been observed in neonatal mammals, the very small pool of putative progenitor cells that have been identified in the adult mammalian cochlea is not able to replace the damaged HCs, making any hearing impairment permanent. To date, guided differentiation of human cells to HC-like cells has only been achieved using either embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs). However, use of such cell types suffers from a number of important disadvantages, such as the risk of tumourigenicity if transplanted into the host's tissue. We have obtained cells expressing hair cell markers from cultures of human fibroblasts by overexpression of GFI1, Pou4f3 and ATOH1 (GPA), three genes that are known to play a critical role in the development of HCs. Immunocyto-chemical, qPCR and RNAseq analyses demonstrate the expression of genes typically expressed by HCs in the transdifferentiated cells. Our protocol represents a much faster approach than the methods applied to ESCs and iPSCs and validates the combination of GPA as a set of genes whose activation leads to the direct conversion of human somatic cells towards the hair cell lineage. Our observations are expected to contribute to the development of future therapies aimed at the regeneration of the auditory organ and the restoration of hearing.	[Duran Alonso, Maria Beatriz; Lopez Hernandez, Iris; Angel de la Fuente, Miguel; Garcia-Sancho, Javier; Schimmang, Thomas] Univ Valladolid, Inst Biol & Genet Mol, C Sanz & Fores 3, Valladolid, Spain; [Duran Alonso, Maria Beatriz; Lopez Hernandez, Iris; Angel de la Fuente, Miguel; Garcia-Sancho, Javier; Schimmang, Thomas] CSIC, C Sanz & Fores 3, Valladolid, Spain; [Giraldez, Fernando] Univ Pompeu Fabra, CEXS, Parc Recerca Biomed Barcelona, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University	Alonso, MBD; Schimmang, T (corresponding author), Univ Valladolid, Inst Biol & Genet Mol, C Sanz & Fores 3, Valladolid, Spain.; Alonso, MBD; Schimmang, T (corresponding author), CSIC, C Sanz & Fores 3, Valladolid, Spain.	mbduran@ibgm.uva.es; schimman@ibgm.uva.es	Alonso, M. Beatriz Durán/L-5858-2017; de la Fuente, Miguel A/C-7478-2013; Schimmang, Thomas/Z-2834-2019	Alonso, M. Beatriz Durán/0000-0001-7784-0591; de la Fuente, Miguel A/0000-0003-4619-8756; Schimmang, Thomas/0000-0002-3801-1640	Junta de Castilla y Leon [VA024U16]; Fundacion La Marato [201227-3031]; Red de Terapia Celular; Red de medicina regenerativa y terapia celular de Castilla y Leon	Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion La Marato; Red de Terapia Celular; Red de medicina regenerativa y terapia celular de Castilla y Leon	The project was funded by Junta de Castilla y Leon (Project VA024U16, Feder 2014-2020), Fundacion La Marato (Project 201227-3031), Red de Terapia Celular and Red de medicina regenerativa y terapia celular de Castilla y Leon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud N, 2017, J TISSUE ENG REGEN M, V11, P2629, DOI 10.1002/term.2163; Banasik MB, 2010, GENE THER, V17, P150, DOI 10.1038/gt.2009.135; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Cai TT, 2015, J NEUROSCI, V35, P5870, DOI 10.1523/JNEUROSCI.5083-14.2015; Chai RJ, 2011, JARO-J ASSOC RES OTO, V12, P455, DOI 10.1007/s10162-011-0267-2; Chang JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18324-8; Chen JR, 2016, CELL DEATH DIFFER, V23, P1347, DOI 10.1038/cdd.2016.16; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Chen Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02996; Chonko KT, 2013, DEV BIOL, V381, P401, DOI 10.1016/j.ydbio.2013.06.022; de Felipe MMC, 2011, HISTOL HISTOPATHOL, V26, P923, DOI 10.14670/HH-26.923; Costa A, 2015, DEVELOPMENT, V142, P1948, DOI 10.1242/dev.119149; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DeJonge RE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162508; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doetzlhofer A, 2004, DEV BIOL, V272, P432, DOI 10.1016/j.ydbio.2004.05.013; Alonso MBD, 2012, REGEN MED, V7, P769, DOI [10.2217/rme.12.65, 10.2217/RME.12.65]; Eguizabal C, 2013, SEMIN REPROD MED, V31, P82, DOI 10.1055/s-0032-1331802; Fu YB, 2015, CELL RES, V25, P1013, DOI 10.1038/cr.2015.99; Gao X, 2018, NATURE, V553, P217, DOI 10.1038/nature25164; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Helyer R, 2007, EUR J NEUROSCI, V25, P957, DOI 10.1111/j.1460-9568.2007.05338.x; Hertzano R, 2004, HUM MOL GENET, V13, P2143, DOI 10.1093/hmg/ddh218; Horio Fukuko, 2017, eNeurologicalSci, V6, P9, DOI 10.1016/j.ensci.2016.11.002; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Izumikawa M, 2008, HEARING RES, V240, P52, DOI 10.1016/j.heares.2008.02.007; Kelaini S, 2014, STEM CELLS CLONING, V7, P19, DOI 10.2147/SCCAA.S38006; KELLEY MW, 1993, DEVELOPMENT, V119, P1041; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Koehler KR, 2017, NAT BIOTECHNOL, V35, P583, DOI 10.1038/nbt.3840; Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298; Kuo BR, 2015, J NEUROSCI, V35, P10786, DOI 10.1523/JNEUROSCI.0967-15.2015; Ladewig J, 2013, NAT REV MOL CELL BIO, V14, P225, DOI 10.1038/nrm3543; Liu XP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11508; Liu Z, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-550; Liu ZY, 2012, J NEUROSCI, V32, P6600, DOI 10.1523/JNEUROSCI.0818-12.2012; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; McLean WJ, 2017, CELL REP, V18, P1917, DOI 10.1016/j.celrep.2017.01.066; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mitchell RR, 2014, STEM CELLS DEV, V23, P1937, DOI 10.1089/scd.2014.0023; Nishimura K, 2012, CELL TRANSPLANT, V21, P763, DOI 10.3727/096368911X623907; Ohnishi H, 2015, NEUROSCI LETT, V599, P49, DOI 10.1016/j.neulet.2015.05.032; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Ouji Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.230; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pay SL, 2018, HUM GENE THER METHOD, V29, P44, DOI 10.1089/hgtb.2017.082; Perny M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00409; Pluta K, 2009, ACTA BIOCHIM POL, V56, P531; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronaghi M, 2014, STEM CELLS DEV, V23, P1275, DOI 10.1089/scd.2014.0033; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Serrano F, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0349-5; Shearer RF, 2015, GENES CELLS, V20, P1, DOI 10.1111/gtc.12183; Shi FX, 2012, J NEUROSCI, V32, P9639, DOI 10.1523/JNEUROSCI.1064-12.2012; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Tang ZH, 2016, STEM CELL TRANSL MED, V5, P561, DOI 10.5966/sctm.2015-0252; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Vangipuram M, 2013, JOVE-J VIS EXP, DOI 10.3791/3779; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Walters BJ, 2017, CELL REP, V19, P307, DOI 10.1016/j.celrep.2017.03.044; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yang SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029652, 10.1371/journal.pone.0035836]; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	74	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200210	10.1371/journal.pone.0200210	http://dx.doi.org/10.1371/journal.pone.0200210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979748	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500078
J	da Silva, H; Nucci, MP; Mamani, JB; Mendez-Otero, R; Nucci, LP; Tannus, A; Gamarra, LF				da Silva, Helio; Nucci, Mariana P.; Mamani, Javier B.; Mendez-Otero, Rosalie; Nucci, Leopoldo P.; Tannus, Alberto; Gamarra, Lionel F.			Evaluation of temperature induction in focal ischemic thermocoagulation model	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; ANIMAL-MODELS; ENERGY-METABOLISM; CORTICAL ISCHEMIA; BRAIN; STROKE; CELLS; BLOOD; RECOVERY; STIMULATION	The thermocoagulation model, which consists of focal cerebral ischemia with craniectomy, is helpful in studying permanent ischemic brain lesions and has good reproducibility and low mortality. This study analyzed the best conditions for inducing a focal ischemic lesion by thermocoagulation. We investigated parameters such as temperature and thermal dissipation in the brain tissue during induction and analyzed real-time blood perfusion, histological changes, magnetic resonance imaging (MRI), and motor behavior in a permanent ischemic stroke model. We used three-month-old male Wistar rats, weighing 300-350 g. In the first experiment, the animals were divided into four groups (n = 5 each): one sham surgery group and three ischemic lesion groups having thermocoagulation induction (TCI) temperatures of 200 degrees C, 300 degrees C, and 400 degrees C, respectively, with blood perfusion (basal and 30 min after TCI) and 2,3,5-Triphenyl-tetrazolium chloride (TTC) evaluation at 2 h after TCI. In the second experiment, five groups (n = 5 each) were analyzed by MRI (basal and 24 h after TCI) and behavioral tests (basal and seven days after TCI) with the control group added for the surgical effects. The MRI and TTC analyses revealed that ischemic brain lesions expressively evolved, especially at TCI temperatures of 300 degrees C and 400 degrees C, and significant motor deficits were observed as the animals showed a decrease frequency of movement and an asymmetric pattern. We conclude that a TCI temperature of 400 degrees C causes permanent ischemic stroke and motor deficit.	[da Silva, Helio; Mamani, Javier B.; Nucci, Leopoldo P.; Gamarra, Lionel F.] Hosp Israelite Albert Einstein, Sao Paulo, Brazil; [da Silva, Helio; Gamarra, Lionel F.] Santa Casa Misericordia Sao Paulo, Sao Paulo, Brazil; [Nucci, Mariana P.] Univ Sao Paulo, Hosp Clin HCFMUSP, Sao Paulo, SP, Brazil; [Mendez-Otero, Rosalie] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Nucci, Leopoldo P.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Tannus, Alberto] Univ Sao Paulo, CIERMag Inst Fis Sao Carlos, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Gamarra, LF (corresponding author), Hosp Israelite Albert Einstein, Sao Paulo, Brazil.; Gamarra, LF (corresponding author), Santa Casa Misericordia Sao Paulo, Sao Paulo, Brazil.	lgamarra@einstein.br	Mamani, Javier B/D-3924-2013; GAMARRA, LIONEL/AAF-7201-2020; Nucci, Mariana/AAC-4990-2020; Nucci, Mariana/AAM-6841-2021; Gamarra, Lionel fernel/AAA-9638-2020; Mendez-Otero, Rosalia/AAL-7551-2020; Tannus, Alberto/B-9821-2012	Nucci, Mariana/0000-0002-1502-9215; Gamarra, Lionel fernel/0000-0002-3910-0047; Mendez-Otero, Rosalia/0000-0002-1798-9930; BUSTAMANTE MAMANI, JAVIER/0000-0001-5038-0070; Tannus, Alberto/0000-0002-1675-1971	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq-465259/2014-6, CNPq-400856/2016-6]; Sao Paulo State Research Support Foundation [FAPESP: 2014/50983-3, FAPESP:2016/21470-3]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Support Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR), CNPq-465259/2014-6, and CNPq-400856/2016-6 to LFG; Sao Paulo State Research Support Foundation, FAPESP: 2014/50983-3, and FAPESP:2016/21470-3 to LFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaut J, 2007, METAB BRAIN DIS, V22, P251, DOI 10.1007/s11011-007-9057-2; Baumler W, 2007, LASER SURG MED, V39, P132, DOI 10.1002/lsm.20408; Black JF, 2004, PHOTOCHEM PHOTOBIOL, V80, P89, DOI 10.1562/2004-03-05-RA-102.1; Bock NA, 2006, J NEUROSCI, V26, P4455, DOI 10.1523/JNEUROSCI.5438-05.2006; Chen LK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32291; Chen R, 2015, SCIENCE, V347, P1477, DOI 10.1126/science.1261821; Choi DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005482; Coelho BP, 2014, NEUROSCI RES, V88, P67, DOI 10.1016/j.neures.2014.08.007; DAVIS M, 1995, STROKE, V26, P1072, DOI 10.1161/01.STR.26.6.1072; Desland FA, 2014, J CENT NERV SYST DIS, V6, P7, DOI [10.4137/JCNSD.S13194, 10.4137/JCNSNSD.S13194]; dos Santos AD, 2010, BRAIN RES, V1306, P149, DOI 10.1016/j.brainres.2009.09.094; Sampaio MDD, 2013, BRAIN RES, V1492, P130, DOI 10.1016/j.brainres.2012.11.026; Elwassif MM, 2006, J NEURAL ENG, V3, P306, DOI 10.1088/1741-2560/3/4/008; Fluri F, 2015, DRUG DES DEV THER, V9, P3445, DOI 10.2147/DDDT.S56071; Garbuzova-Davis S, 2017, STEM CELLS, V35, P1246, DOI 10.1002/stem.2578; Giraidi-Guimaraes A, 2009, BRAIN RES, V1266, P108, DOI 10.1016/j.brainres.2009.01.062; Glat MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148170; Rodrigues AMG, 2013, BRAIN RES, V1503, P53, DOI 10.1016/j.brainres.2013.01.039; Gotts JE, 2005, J COMP NEUROL, V488, P201, DOI 10.1002/cne.20609; Hansel G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090693; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; IBM Corp, 2015, REL 2015 IBM SPSS ST; KATSURA K, 1994, BIOCHEM SOC T, V22, P991, DOI 10.1042/bst0220991; Keangin P, 2011, INT COMMUN HEAT MASS, V38, P757, DOI 10.1016/j.icheatmasstransfer.2011.03.027; Kim S, 2007, IEEE T NEUR SYS REH, V15, P493, DOI 10.1109/TNSRE.2007.908429; Kumar A, 2016, BRAIN RES BULL, V122, P35, DOI 10.1016/j.brainresbull.2016.02.016; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Li WL, 2008, DEV NEUROBIOL, V68, P1474, DOI 10.1002/dneu.20674; Lodygensky GA, 2008, INT J DEV NEUROSCI, V26, P13, DOI 10.1016/j.ijdevneu.2007.08.018; Lopez-Valdes HE, 2014, STROKE, V45, P2093, DOI 10.1161/STROKEAHA.113.004476; MARTIN RL, 1994, TRENDS NEUROSCI, V17, P251, DOI 10.1016/0166-2236(94)90008-6; Meng SZ, 2005, EXP BRAIN RES, V166, P56, DOI 10.1007/s00221-005-2340-8; Mutoh T, 2018, CLIN EXP PHARMACOL P, V45, P344, DOI 10.1111/1440-1681.12874; Nonose Y, 2018, MOL NEUROBIOL, V55, P2025, DOI 10.1007/s12035-017-0458-x; Nucci LP, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0015-3; Figueredo YN, 2016, J PHARM PHARMACOGN R, V4, P153; Pan QW, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0243-1; Papoti D, 2010, CONCEPT MAGN RESON B, V37B, P193, DOI 10.1002/cmr.b.20168; Patkar S, 2012, STEM CELL RES, V8, P14, DOI 10.1016/j.scr.2011.07.001; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Phillis JW, 1996, J NEUROCHEM, V67, P1525; Rasband WS, 2012, ASCL; Samson AL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16171; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Shigematsu K, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0297-1; Small DL, 2000, BRIT MED BULL, V56, P307, DOI 10.1258/0007142001903238; Stowe AM, 2008, J CEREBR BLOOD F MET, V28, P612, DOI 10.1038/sj.jcbfm.9600560; SZELE FG, 1995, J NEUROSCI, V15, P4429; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wise SP, 1986, SENSORY MOTOR AREAS, V5, P243; Wolf Patrick D., 2008, P63; Wu CF, 2015, EXP THER MED, V10, P159, DOI 10.3892/etm.2015.2450; Yang YY, 2017, J NEUROSCI, V37, P4692, DOI 10.1523/JNEUROSCI.3233-16.2017; Zille M, 2012, J CEREBR BLOOD F MET, V32, P213, DOI 10.1038/jcbfm.2011.150; Zuo W, 2016, BRIT J PHARMACOL, V173, P1665, DOI 10.1111/bph.13468	56	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200135	10.1371/journal.pone.0200135	http://dx.doi.org/10.1371/journal.pone.0200135			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975761	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500069
J	Leblois, J; Massart, S; Soyeurt, H; Grelet, C; Dehareng, F; Schroyen, M; Li, B; Wavreille, J; Bindelle, J; Everaert, N				Leblois, Julie; Massart, Sebastien; Soyeurt, Helene; Grelet, Clement; Dehareng, Frederic; Schroyen, Martine; Li, Bing; Wavreille, Jose; Bindelle, Jerome; Everaert, Nadia			Feeding sows resistant starch during gestation and lactation impacts their faecal microbiota and milk composition but shows limited effects on their progeny	PLOS ONE			English	Article							DIETARY FIBER; GENE-EXPRESSION; GUT MICROBIOME; HOST RESPONSE; PIGS; PIGLETS; PERFORMANCE; NUTRITION; CYTOKINE; IMMUNITY	Background Establishment of a beneficial microbiota profile for piglets as early in life as possible is important as it will impact their future health. In the current study, we hypothesized that resistant starch (RS) provided in the maternal diet during gestation and lactation will be fermented in their hindgut, which would favourably modify their milk and/or gut microbiota composition and that it would in turn affect piglets' microbiota profile and their absorptive and immune abilities. Methods In this experiment, 33% of pea starch was used in the diet of gestating and lactating sows and compared to control sows. Their faecal microbiota and milk composition were determined and the colonic microbiota, short-chain fatty acids (SCFA) production and gut health related parameters of the piglets were measured two days before weaning. In addition, their overall performances and post-weaning faecal score were also assessed. Results The RS diet modulated the faecal microbiota of the sows during gestation, increasing the Firmicutes: Bacteroidetes ratio and the relative abundance of beneficial genera like Bifidobacterium but these differences disappeared during lactation and maternal diets did not impact the colonic microbiota of their progeny. Milk protein concentration decreased with RS diet and lactose concentration increased within the first weeks of lactation while decreased the week before weaning with the RS diet. No effect of the dietary treatment, on piglets' bodyweight or diarrhoea frequency post-weaning was observed. Moreover, the intestinal morphology measured as villus height and crypt depths, and the inflammatory cytokines in the intestine of the piglets were not differentially expressed between maternal treatments. Only zonula occludens 1 (ZO-1) was more expressed in the ileum of piglets born from RS sows, suggesting a better closure of the mucosa tight junctions. Conclusion Changes in the microbiota transferred from mother to piglets due to the inclusion of RS in the maternal diet are rather limited even though milk composition was affected.	[Leblois, Julie; Schroyen, Martine; Li, Bing; Bindelle, Jerome; Everaert, Nadia] Univ Liege, Teaching & Res Ctr, Gembloux Agrobio Tech, Precis Livestock & Nutr Unit,TERRA, Gembloux, Belgium; [Leblois, Julie] Natl Sci Res Fdn, FRIA FNRS, Res Fdn Ind & Agr, Brussels, Belgium; [Massart, Sebastien] Univ Liege, Teaching & Res Ctr, Gembloux Agrobio Tech, Lab Urban & Integrated PhytoPathol,TERRA, Gembloux, Belgium; [Soyeurt, Helene] Univ Liege, Lab Stat Informat & Modelling Appl Bioengn, AGROBIOCHEM Dept, Teaching & Res Ctr TERRA,Gembloux Agrobio Tech, Gembloux, Belgium; [Grelet, Clement; Dehareng, Frederic] Walloon Agr Res Ctr, Valorisat Agr Prod Dept, Gembloux, Belgium; [Wavreille, Jose] Walloon Agr Res Ctr, Prod & Sect Dept, Gembloux, Belgium	University of Liege; University of Liege; University of Liege	Leblois, J; Everaert, N (corresponding author), Univ Liege, Teaching & Res Ctr, Gembloux Agrobio Tech, Precis Livestock & Nutr Unit,TERRA, Gembloux, Belgium.; Leblois, J (corresponding author), Natl Sci Res Fdn, FRIA FNRS, Res Fdn Ind & Agr, Brussels, Belgium.	j.leblois@live.be; nadia.everaert@ulg.ac.be	Everaert, Nadia/AAJ-7714-2021; Dehareng, Frederic/P-4956-2017; Soyeurt, Hélène/AAQ-3778-2020	Dehareng, Frederic/0000-0002-6733-4334; Soyeurt, Hélène/0000-0001-9883-9047; Grelet, Clement/0000-0003-3313-485X; Bindelle, Jerome/0000-0001-6974-4313; Schroyen, Martine/0000-0003-3855-8141; Leblois, Julie/0000-0001-5112-0262; Everaert, Nadia/0000-0001-9282-6288	Research Foundation for Industry and Agriculture, National Scientific Research Foundation (FRIA-FNRS) [FC05289]; University of Liege; COST action PiGutNet [FA1401]	Research Foundation for Industry and Agriculture, National Scientific Research Foundation (FRIA-FNRS)(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege); COST action PiGutNet(European Cooperation in Science and Technology (COST))	The Research Foundation for Industry and Agriculture, National Scientific Research Foundation (FRIA-FNRS http://www.fnrs.be/index. php) funded this research as a grant attributed to Julie Leblois, consisting in PhD financing (ref FC05289). The University of Liege (https://www.uliege.be) granted Nadia Everaert with a welcome grant for her to begin her own research in this laboratory.; We are thankful to the feed company Dumoulin for the help in feed formulation and to the Walloon Agricultural Research Centre for providing the animals, equipment and practical assistance. The COST action PiGutNet (FA1401) is acknowledged for their support.	Alassane-Kpembi I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07155-2; Allen JM, 2015, J APPL PHYSIOL, V118, P1059, DOI 10.1152/japplphysiol.01077.2014; [Anonymous], 2013, IN VITRO PRODUCTION; [Anonymous], 2016, EFFECT DIVERGENCE FE; [Anonymous], 2012, NUTR PHYSL PIGS EMPH; Bian GR, 2016, ENVIRON MICROBIOL, V18, P1566, DOI 10.1111/1462-2920.13272; Bindelle J, 2008, BIOTECHNOL AGRON SOC, V12, P69; Bird AR, 2007, BRIT J NUTR, V97, P134, DOI 10.1017/S0007114507250433; Chatelais L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019594; Chen H, 2013, BRIT J NUTR, V110, P1837, DOI 10.1017/S0007114513001293; Dozois CM, 1997, VET IMMUNOL IMMUNOP, V58, P287, DOI 10.1016/S0165-2427(97)00039-1; Everaert N, 2017, ANIM FEED SCI TECH, V233, P89, DOI 10.1016/j.anifeedsci.2017.06.011; Farmer C, 2004, CAN J ANIM SCI, V84, P581, DOI 10.4141/A03-125; Feng ZM, 2015, APPL PHYSIOL NUTR ME, V40, DOI 10.1139/apnm-2014-0434; Gerrits WJJ, 2012, J NUTR, V142, P238, DOI 10.3945/jn.111.147496; Giuberti G, 2015, ANIM FEED SCI TECH, V201, P1, DOI 10.1016/j.anifeedsci.2015.01.004; Gourbeyre P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12225; Gresse R, 2017, TRENDS MICROBIOL, V25, P851, DOI 10.1016/j.tim.2017.05.004; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hu CH, 2013, J ANIM SCI, V91, P1094, DOI 10.2527/jas.2012-5796; Hurley WL, 2015, GESTATING AND LACTATING SOW, P193, DOI 10.3920/978-90-8686-803-2_9; Krogh U, 2017, ANIMAL, V11, P975, DOI [10.1017/S1751731116002585, 10.1017/s1751731116002585]; Lalles JP, 2009, ANIMAL, V3, P1625, DOI 10.1017/S175173110900398X; Lalles JP, 2004, ANIM RES, V53, P301, DOI 10.1051/animres:2004018; Le Bourgot C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107508; Le Huerou-Luron I., 2003, BIOL INTESTINE GROWI, P491; Leblois J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07228-2; Leonard SG, 2012, J ANIM SCI, V90, P505, DOI 10.2527/jas.2010-3243; Loisel F, 2013, J ANIM SCI, V91, P5269, DOI 10.2527/jas.2013-6526; Maga EA, 2012, APPL ENVIRON MICROB, V78, P6153, DOI 10.1128/AEM.00956-12; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Meissonnier GM, 2008, TOXICOL APPL PHARM, V231, P142, DOI 10.1016/j.taap.2008.04.004; Meurens F, 2009, VET RES, V40, DOI 10.1051/vetres:2008043; Montagne L, 2007, BRIT J NUTR, V97, P45, DOI 10.1017/S000711450720580X; O'Doherty JV, 2017, ANIM PROD SCI, V57, P2376, DOI 10.1071/AN17272; Passlack N, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0351-7; Pieper R, 2015, ANIM PROD SCI, V55, P1367, DOI 10.1071/AN15278; Royaee AR, 2004, VET IMMUNOL IMMUNOP, V102, P199, DOI 10.1016/j.vetimm.2004.09.018; Salmon H, 2009, DEV COMP IMMUNOL, V33, P384, DOI 10.1016/j.dci.2008.07.007; Sassone-Corsi M, 2015, J IMMUNOL, V194, P4081, DOI 10.4049/jimmunol.1403169; Schokker D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100040; Starke IC, 2013, BENEF MICROBES, V4, P345, DOI 10.3920/BM2013.0021; Sun Y, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00741; Tao N, 2010, J AGR FOOD CHEM, V58, P4653, DOI 10.1021/jf100398u; Themeier H, 2005, CARBOHYD POLYM, V61, P72, DOI 10.1016/j.carbpol.2005.02.017; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Yan H, 2017, J ANIM PHYSIOL AN N, V101, P190, DOI 10.1111/jpn.12440	49	18	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199568	10.1371/journal.pone.0199568	http://dx.doi.org/10.1371/journal.pone.0199568			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969488	Green Submitted, Green Published, gold			2022-12-26	WOS:000437246700018
J	Huang, HY; Luo, XY; Cheng, X; Shi, B; Li, JT				Huang, Hanyao; Luo, Xiangyou; Cheng, Xu; Shi, Bing; Li, Jingtao			Biomechanical simulation of correcting primary unilateral cleft lip nasal deformity	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; CEPHALIC TRIM; TIP SUPPORT; RHINOPLASTY; STABILITY; SEPTUM; REPAIR; MODEL; NOSE	For better outcomes of the primary correction of cleft lip nasal deformity, it is important to clarify the specific morphological and biomechanical consequences of major surgical maneuvers during cleft lip nose correction. In this study, a finite element model was established basing on the micro-MRI imaging of an infant specimen with unilateral complete cleft lip deformity. Alar base adduction was simulated as a medially-directed force on the lateral crus (F1); columella straightening was simulated as a laterally-directed force on the medial crus (F2); and nasal tip enhancement was simulated as an anteriorly-directed force on the intermediate crus (F3). The deformation and stress distribution consequent to each force vector or different force combinations were analyzed in details. Our biomechnical analyses suggested that W\when loaded alone, the three forces generated disparate morphological changes. The combination of different force loadings generated obviously different outcomes. F3 generated the most intensive stress when compared to F1 and F2. When F2 was loaded on top of F1-F3 combination, it further relieved nasal deviation without incurring significant increase in stress. Our simulation suggested that alar base adduction, columella straightening, and nasal tip elevation should all be included in a competent cleft lip nose correction.	[Huang, Hanyao; Luo, Xiangyou; Cheng, Xu; Shi, Bing; Li, Jingtao] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; [Huang, Hanyao; Luo, Xiangyou; Cheng, Xu; Shi, Bing; Li, Jingtao] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, Chengdu, Sichuan, Peoples R China; [Huang, Hanyao; Luo, Xiangyou; Cheng, Xu; Shi, Bing; Li, Jingtao] Sichuan Univ, West China Hosp Stomatol, Dept Oral Maxillofacial Surg, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, JT (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.; Li, JT (corresponding author), Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, Chengdu, Sichuan, Peoples R China.; Li, JT (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Oral Maxillofacial Surg, Chengdu, Sichuan, Peoples R China.	lijingtao86@163.com	Huang, Hanyao/AAX-9478-2020	Huang, Hanyao/0000-0002-6805-0157; Li, Jingtao/0000-0002-0774-194X	National Natural Science Foundation of China [81500829]; Sichuan University [2017SCU04A22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan University(Sichuan University)	This work was supported by the National Natural Science Foundation of China, (grant No. 81500829) and Sichuan University Outstanding Junior Researcher Funding (grant No. 2017SCU04A22) granted to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fisher DM, 1998, PLAST RECONSTR SURG, V101, P1448, DOI 10.1097/00006534-199805000-00003; Gudis DA, 2014, CURR OPIN OTOLARYNGO, V22, P260, DOI 10.1097/MOO.0000000000000066; Huang HY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195583; HUFFMAN WC, 1949, PLAST RECONSTR SURG, V4, P225, DOI 10.1097/00006534-194905000-00001; Jung JW, 2014, INT J PRECIS ENG MAN, V15, P2611, DOI 10.1007/s12541-014-0634-0; Leary RP, 2015, JAMA FACIAL PLAST SU, V17, P413, DOI 10.1001/jamafacial.2015.0941; Lee JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153056; Lee JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119996; Lee SJ, 2010, LARYNGOSCOPE, V120, P1931, DOI 10.1002/lary.21072; Lee SJ, 2010, LARYNGOSCOPE, V120, P1508, DOI 10.1002/lary.20976; Liong Kyrin, 2013, J Med Eng, V2013, P250274, DOI 10.1155/2013/250274; Luo XY, 2015, BIOMATERIALS, V57, P59, DOI 10.1016/j.biomaterials.2015.03.062; Manuel CT, 2017, ANN BIOMED ENG, V45, P829, DOI 10.1007/s10439-016-1729-9; Manuel CT, 2014, LARYNGOSCOPE, V124, P649, DOI 10.1002/lary.24321; Mau T, 2007, LARYNGOSCOPE, V117, P1902, DOI 10.1097/MLG.0b013e3181255ec4; MCCOMB H, 1985, PLAST RECONSTR SURG, V75, P791, DOI 10.1097/00006534-198506000-00003; McComb HK, 1996, CLEFT PALATE-CRAN J, V33, P23, DOI 10.1597/1545-1569(1996)033<0023:PROTUC>2.3.CO;2; Nolst Trenite GJ, 1993, RHINOPLASTY PRACTICA; Oliaei S, 2012, ARCH FACIAL PLAST S, V14, P27, DOI 10.1001/archfacial.2011.1354; Shamouelian D, 2015, LARYNGOSCOPE, V125, P326, DOI 10.1002/lary.24845; Singh GD, 2005, CLEFT PALATE-CRAN J, V42, P403, DOI 10.1597/04-063.1; Tjoa T, 2016, JAMA FACIAL PLAST SU, V18, P136, DOI 10.1001/jamafacial.2015.1954; Vyas RM, 2014, CLIN PLAST SURG, V41, P165, DOI 10.1016/j.cps.2013.12.009; Wolfe SA, 2004, PLAST RECONSTR SURG, V114, P1, DOI 10.1097/01.PRS.0000130416.86351.24; Wu JJ, 2016, ANN PLAS SURG, V76, P111, DOI 10.1097/SAP.0000000000000219	25	7	8	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199964	10.1371/journal.pone.0199964	http://dx.doi.org/10.1371/journal.pone.0199964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953512	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400104
J	Ji, TY; Corbalan-Garcia, S; Hubbard, SR				Ji, Tianyang; Corbalan-Garcia, Senena; Hubbard, Stevan R.			Crystal structure of the C-terminal four-helix bundle of the potassium channel KCa3.1	PLOS ONE			English	Article							DIPHOSPHATE KINASE-B; K+ CHANNEL; HISTIDINE PHOSPHORYLATION; DOMAIN; ACTIVATION; COMPLEX; MECHANISM; REVEALS	KCa3.1 (also known as SK4 or IK1) is a mammalian intermediate-conductance potassium channel that plays a critical role in the activation of T cells, B cells, and mast cells, effluxing potassium ions to maintain a negative membrane potential for influxing calcium ions. KCa3.1 shares primary sequence similarity with three other (low-conductance) potassium channels: KCa2.1, KCa2.2, and KCa2.3 (also known as SK1-3). These four homotetrameric channels bind calmodulin (CaM) in the cytoplasmic region, and calcium binding to CaM triggers channel activation. Unique to KCa3.1, activation also requires phosphorylation of a single histidine residue, His358, in the cytoplasmic region, which relieves copper-mediated inhibition of the channel. Near the cytoplasmic C-terminus of KCa3.1 (and KCa2.1-2.3), secondary-structure analysis predicts the presence of a coiled-coil/heptad repeat. Here, we report the crystal structure of the C-terminal coiled-coil region of KCa3.1, which forms a parallel four-helix bundle, consistent with the tetrameric nature of the channel. Interestingly, the four copies of a histidine residue, His389, in an 'a' position within the heptad repeat, are observed to bind a copper ion along the four-fold axis of the bundle. These results suggest that His358, the inhibitory histidine in KCa3.1, might coordinate a copper ion through a similar binding mode.	[Ji, Tianyang; Hubbard, Stevan R.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst,Dept Biochem & Mol Pharmacol, New York, NY 10003 USA; [Corbalan-Garcia, Senena] Univ Murcia, Dept Biochem & Mol Biol A, Sch Vet, Biomed Res Inst Murcia IMIBArrixaca, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain	New York University; University of Murcia	Hubbard, SR (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst,Dept Biochem & Mol Pharmacol, New York, NY 10003 USA.	stevan.hubbard@med.nyu.edu	Corbalan-Garcia, Senena/C-6477-2009	Corbalan-Garcia, Senena/0000-0003-1840-5578; Hubbard, Stevan/0000-0002-2707-9383	NIAID [R21AI107443]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107443] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIAID, Grant# R21AI107443. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Arrigoni C, 2016, CELL, V164, P922, DOI 10.1016/j.cell.2016.02.001; Chang A, 2018, NEURON, V97, P836, DOI 10.1016/j.neuron.2018.01.035; Di L, 2010, J BIOL CHEM, V285, P38765, DOI 10.1074/jbc.M110.168070; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; HESS JF, 1988, NATURE, V336, P139, DOI 10.1038/336139a0; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; Kim JY, 2008, PROTEINS, V70, P568, DOI 10.1002/prot.21634; Klumpp S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.261pe13; Lee CH, 2018, SCIENCE, V360, P508, DOI 10.1126/science.aas9466; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024; Sachyani D, 2014, STRUCTURE, V22, P1582, DOI 10.1016/j.str.2014.07.016; Schumacher MA, 2004, STRUCTURE, V12, P849, DOI 10.1016/S0969-2126(04)00112-1; Srivastava S, 2008, P NATL ACAD SCI USA, V105, P14442, DOI 10.1073/pnas.0803678105; Srivastava S, 2016, ELIFE, V5, DOI 10.7554/eLife.16093; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun J, 2017, CELL, V169, P1042, DOI 10.1016/j.cell.2017.05.019; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199942	10.1371/journal.pone.0199942	http://dx.doi.org/10.1371/journal.pone.0199942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953543	Green Submitted, gold, Green Published			2022-12-26	WOS:000436645400099
J	Silakit, R; Kitirat, Y; Thongchot, S; Loilome, W; Techasen, A; Ungarreevittaya, P; Khuntikeo, N; Yongvanit, P; Yang, JH; Kim, NH; Yook, JI; Namwat, N				Silakit, Runglawan; Kitirat, Yingpinyapat; Thongchot, Suyanee; Loilome, Watcharin; Techasen, Anchalee; Ungarreevittaya, Piti; Khuntikeo, Narong; Yongvanit, Puangrat; Yang, Ji Hye; Kim, Nam Hee; Yook, Jong In; Namwat, Nisana			Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; EPITHELIAL OVARIAN-CANCER; MIR-210 LINKS HYPOXIA; HEPATOCELLULAR-CARCINOMA; INHIBITS PROLIFERATION; PANCREATIC-CANCER; PROGNOSTIC-FACTOR; MIMICKING AGENT; COBALT CHLORIDE; HIGH EXPRESSION	MicroRNA-210 (miR-210) is a robust target for hypoxia-inducible factor, and its overexpression has been detected in a variety of solid tumors. However, the role of miR-210 in the development, progression and response to therapy in cholangiocarcinoma (CCA) remains undefined. We report here that high miR-210 expression was significantly correlated with the shorter survival of CCA patients. Overexpression of miR-210 inhibited CCA cell proliferation at the G2/M phase and reduced the gemcitabine sensitivity in CCA cells under CoCl2-induced pseudohypoxia. Concomitantly, inhibition of endogenous miR-210 activity using miRNA sponges increased cell proliferation under CoCl2-induced pseudohypoxia, resulting in an increase in gemcitabine sensitivity in CCA cells. We showed that HIF-3 alpha, a negative controller of HIF-1 alpha, was a target of miR-210 constituting a feed-forward hypoxic regulatory loop. Our data suggest an important role of miR-210 in sustaining HIF-1 alpha activity via the suppression of HIF-3 alpha, regulating cell growth and chemotherapeutic drug resistance in CCA.	[Silakit, Runglawan; Kitirat, Yingpinyapat; Thongchot, Suyanee; Loilome, Watcharin; Namwat, Nisana] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand; [Silakit, Runglawan; Kitirat, Yingpinyapat; Thongchot, Suyanee; Loilome, Watcharin; Techasen, Anchalee; Ungarreevittaya, Piti; Khuntikeo, Narong; Yongvanit, Puangrat; Namwat, Nisana] Khon Kaen Univ, Cholangiocarcinoma Res Inst, Khon Kaen, Thailand; [Techasen, Anchalee] Khon Kaen Univ, Fac Associated Med Sci, Khon Kaen, Thailand; [Ungarreevittaya, Piti] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen, Thailand; [Khuntikeo, Narong] Khon Kaen Univ, Fac Med, Dept Surg, Khon Kaen, Thailand; [Yang, Ji Hye; Kim, Nam Hee; Yook, Jong In] Yonsei Univ, Coll Dent, Oral Canc Res Inst, Dept Oral Pathol, Seoul, South Korea	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Yonsei University; Yonsei University Health System	Namwat, N (corresponding author), Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand.; Namwat, N (corresponding author), Khon Kaen Univ, Cholangiocarcinoma Res Inst, Khon Kaen, Thailand.; Yook, JI (corresponding author), Yonsei Univ, Coll Dent, Oral Canc Res Inst, Dept Oral Pathol, Seoul, South Korea.	JIYOOK@yuhs.ac; nisana@kku.ac.th	Loilome, Watcharin/AAW-6203-2021	Yook, Jong In/0000-0002-7318-6112; Kim, Nam Hee/0000-0002-3087-5276	Thailand Research Fund through Khon Kaen University; Royal Golden Jubilee Ph.D. Program [PHD/0185/2552]; Cholangiocarcinoma Screening and Care Program, Khon Kaen University Thailand [CASCAP07]; National Research Foundation of Korea - Korea government (MSIP) [NRF-2014R1A2A1A05004670]; National Research Foundation of Korea by Korea government (MOE) [NRF-2014R1A6A3A04055110]	Thailand Research Fund through Khon Kaen University; Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Cholangiocarcinoma Screening and Care Program, Khon Kaen University Thailand; National Research Foundation of Korea - Korea government (MSIP); National Research Foundation of Korea by Korea government (MOE)	This study was supported by the Thailand Research Fund through Khon Kaen University and the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0185/2552) to RS and NN and a grant from Cholangiocarcinoma Screening and Care Program (CASCAP07), Khon Kaen University Thailand to NN. This work was also supported by grants from the National Research Foundation of Korea (NRF-2014R1A2A1A05004670) funded by the Korea government (MSIP) to JIY, a grant from the National Research Foundation of Korea (NRF-2014R1A6A3A04055110) funded by the Korea government (MOE) to JIY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal M, 2003, CURR CANCER DRUG TAR, V3, P193, DOI 10.2174/1568009033481967; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chang W, 2013, J VET SCI, V14, P69, DOI 10.4142/jvs.2013.14.1.69; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Gee HE, 2010, CANCER-AM CANCER SOC, V116, P2148, DOI 10.1002/cncr.25009; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Gores GJ, 2003, HEPATOLOGY, V37, P961, DOI 10.1053/jhep.2003.50200; Grasselli F, 2005, REPROD FERT DEVELOP, V17, P715, DOI 10.1071/RD05059; Greither T, 2012, INT J CANCER, V130, P1230, DOI 10.1002/ijc.26109; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ho VT, 1996, BIOCHEM BIOPH RES CO, V223, P175, DOI 10.1006/bbrc.1996.0865; Hong L, 2012, GENE, V507, P135, DOI 10.1016/j.gene.2012.07.025; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Ivan M, 2014, ADV EXP MED BIOL, V772, P205, DOI 10.1007/978-1-4614-5915-6_10; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kai AKL, 2016, HEPATOLOGY, V64, P473, DOI 10.1002/hep.28577; Kasuya K, 2011, ONCOL REP, V26, P1399, DOI 10.3892/or.2011.1457; Kiga K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5497; Kim NH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001744; Kobayashi S, 2015, GENES CELLS, V20, P224, DOI 10.1111/gtc.12215; Lazaridis KN, 2005, GASTROENTEROLOGY, V128, P1655, DOI 10.1053/j.gastro.2005.03.040; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Li L, 2014, INT J ONCOL, V44, P2111, DOI 10.3892/ijo.2014.2368; Li ZF, 2016, MOL MED REP, V13, P2769, DOI 10.3892/mmr.2016.4878; Lopez-Sanchez LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099143; Maynard MA, 2007, CELL CYCLE, V6, P2810, DOI 10.4161/cc.6.22.4947; Miwa S, 2015, CELL CYCLE, V14, P621, DOI 10.4161/15384101.2014.991604; Qiu SW, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-10; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rocha S, 2007, TRENDS BIOCHEM SCI, V32, P389, DOI 10.1016/j.tibs.2007.06.005; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Semenza GL, 2002, INTERNAL MED, V41, P79, DOI 10.2169/internalmedicine.41.79; Seubwai W, 2012, ASIAN PAC J CANCER P, V13, P53, DOI 10.7314/APJCP.2012.13.KKSuppl.53; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Shukla SK, 2017, CANCER CELL, V32, P71, DOI 10.1016/j.ccell.2017.06.004; Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3; Tan WQ, 2015, WORLD J GASTROENTERO, V21, P13030, DOI 10.3748/wjg.v21.i46.13030; Tanaka T, 2009, BIOCHEM J, V424, P143, DOI 10.1042/BJ20090120; Thongchot S, 2014, ASIAN PAC J CANCER P, V15, P5873, DOI 10.7314/APJCP.2014.15.14.5873; Thongprasert S, 2005, ANN ONCOL, V16, P93, DOI 10.1093/annonc/mdi712; Valle JW, 2009, BRIT J CANCER, V101, P621, DOI 10.1038/sj.bjc.6605211; Vanichapol T, 2015, MOL MED REP, V12, P3265, DOI 10.3892/mmr.2015.3865; Wang ZG, 2017, ONCOL REP, V37, P3010, DOI 10.3892/or.2017.5511; Wang ZG, 2013, ONCOL RES, V21, P145, DOI 10.3727/096504013X13841340689573; Wattanawongdon W, 2015, INT J ONCOL, V47, P398, DOI 10.3892/ijo.2015.3019; Wotschofsky Z, 2013, CLIN CHIM ACTA, V416, P5, DOI 10.1016/j.cca.2012.11.010; Yang W, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-102; Yang W, 2012, EXP CELL RES, V318, P944, DOI 10.1016/j.yexcr.2012.02.010; Zhang L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-108; Zuo JH, 2015, J CELL BIOCHEM, V116, P1039, DOI 10.1002/jcb.25059	51	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199827	10.1371/journal.pone.0199827	http://dx.doi.org/10.1371/journal.pone.0199827			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953500	gold, Green Published, Green Submitted			2022-12-26	WOS:000436645400078
J	Wang, XL; Qin, RR; Sun, RH; Hou, XG; Qi, L; Shi, J				Wang, Xiao-Ling; Qin, Rong-Rong; Sun, Run-Hong; Hou, Xiao-Gai; Qi, Lin; Shi, Jiang			Effects of plant population density and root-induced cytokinin on the corn compensatory growth during post-drought rewatering	PLOS ONE			English	Article							REGULATED DEFICIT IRRIGATION; SIZE VARIABILITY; USE EFFICIENCY; SPRING WHEAT; WATER-STRESS; GRAIN-YIELD; LANE LATE; NITROGEN; PHOTOSYNTHESIS; BIOSYNTHESIS	The effect of plant population density (PPD) and root-induced leaf cytokinin on the compensatory growth of potted corn seedlings during post-drought rewatering was investigated. The study design comprised four treatments: (1) wetness with low PPD, (2) wetness with high PPD, (3) rewatering with low PPD, and (4) rewatering with high PPD. Results showed that drought stress restrained the growth of corns. By contrast, rewatering enhanced the net photosynthetic rate and growth of corns. During the 8 days of rewatering, compensatory growth during post-drought rewatering occurred in corns with high PPD; however, such compensatory growth did not occur in corns with low PPD. Zeatin riboside concentrations in leaves and xylem saps were significantly higher under rewatering treatment than those under wet treatment. High leaf cytokinin concentration accelerated corn growth. The coefficients of variation and Gini-coefficient of wet treatment were significantly higher than those of rewatering treatment under high PPD, demonstrating that intense intraspecific competition occurred in the wet treatment. Extreme intraspecific competition negatively affected net photosynthetic rate. In brief, the interactions between root-induced leaf cytokinin and weak intraspecific competition promoted the compensatory growth under high PPD.	[Wang, Xiao-Ling; Qin, Rong-Rong; Hou, Xiao-Gai; Qi, Lin] Henan Univ Sci & Technol, Dept Biol Sci, Coll Agron, Luoyang, Henan, Peoples R China; [Sun, Run-Hong] Henan Acad Agr Sci, Inst Plant Protect Res, Henan Key Lab Control Crop Dis & Insect Pests, IPM Key Lab Southern Part North China,Minist Agr, Zhengzhou, Henan, Peoples R China; [Shi, Jiang] Henan Univ Sci & Technol, Dept Biotechnol, Coll Agron, Luoyang, Henan, Peoples R China	Henan University of Science & Technology; Henan Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Henan University of Science & Technology	Hou, XG (corresponding author), Henan Univ Sci & Technol, Dept Biol Sci, Coll Agron, Luoyang, Henan, Peoples R China.	hkdhxg@126.com		Hou, Xiao-Gai/0000-0003-3633-1285	National Natural Science Foundation of China [U1304326, 31370697]; Excellent Youth Foundation of He'nan Scientific Committee [174100510004]; Revival Plan A of Subject Advance Program of Henan University of Science and Technology [13660001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of He'nan Scientific Committee; Revival Plan A of Subject Advance Program of Henan University of Science and Technology	This work was supported by the National Natural Science Foundation of China program grants U1304326 to XLW and 31370697 (http://www.nsfc.gov.cn), the Excellent Youth Foundation of He'nan Scientific Committee grant 174100510004 to XLW (http://www.hnkjt.gov.cn/2016/06/21/1466473164491.html), and the Revival Plan A of Subject Advance Program of Henan University of Science and Technology (13660001) to XGH. The funders had no role in data collection.	Ballester C, 2013, IRRIGATION SCI, V31, P333, DOI 10.1007/s00271-011-0311-3; Cornet D, 2014, EUR J AGRON, V55, P100, DOI 10.1016/j.eja.2014.02.002; Cui NB, 2009, AGR WATER MANAGE, V96, P1237, DOI 10.1016/j.agwat.2009.03.015; Dodd IC, 2005, PLANT SOIL, V274, P251, DOI 10.1007/s11104-004-0966-0; Du YJ, 2006, AGR WATER MANAGE, V79, P265, DOI 10.1016/j.agwat.2005.02.018; Gao ZJ, 2017, J INTEGR AGR, V16, P1227, DOI [10.1016/S2095-3119(16)61397-7, 10.1016/s2095-3119(16)61397-7]; Ghahfarokhi MG, 2015, ARCH AGRON SOIL SCI, V61, P493, DOI 10.1080/03650340.2014.943198; He Z, GUIDANCE EXPT CHEM C; Intrigliolo DS, 2013, IRRIGATION SCI, V31, P959, DOI 10.1007/s00271-012-0372-y; Khan A, 2017, FIELD CROP RES, V209, P129, DOI 10.1016/j.fcr.2017.04.019; Kobayashi H, 2012, PHOTOSYNTHETICA, V50, P317, DOI 10.1007/s11099-012-0030-x; Kobayashi H, 2010, PHOTOSYNTHETICA, V48, P249, DOI 10.1007/s11099-010-0031-6; Laureysens I, 2005, FOREST ECOL MANAG, V218, P115, DOI 10.1016/j.foreco.2005.06.016; Lu YL, 2009, PLANT SOIL, V315, P67, DOI 10.1007/s11104-008-9733-y; Luo HH, 2016, PHOTOSYNTHETICA, V54, P65, DOI 10.1007/s11099-015-0165-7; Pan XY, 2003, FIELD CROP RES, V80, P195, DOI 10.1016/S0378-4290(02)00175-2; Peake AS, 2013, FIELD CROP RES, V146, P31, DOI 10.1016/j.fcr.2013.02.012; Perez-Perez JG, 2008, IRRIGATION SCI, V26, P519, DOI 10.1007/s00271-008-0113-4; Ren BZ, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1445-9; Rossini MA, 2016, FIELD CROP RES, V198, P280, DOI 10.1016/j.fcr.2016.07.004; Sakakibara H, 2006, TRENDS PLANT SCI, V11, P440, DOI 10.1016/j.tplants.2006.07.004; Shao GC, 2010, SCI HORTIC-AMSTERDAM, V126, P172, DOI 10.1016/j.scienta.2010.07.003; Tamaki V, 2007, J PLANT PHYSIOL, V164, P1543, DOI 10.1016/j.jplph.2007.01.010; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Velicka R, 2007, RUSS J PLANT PHYSL+, V54, P545, DOI 10.1134/S1021443707040176; Wang XL, 2016, AGR WATER MANAGE, V166, P77, DOI 10.1016/j.agwat.2015.12.007; WEINER J, 1986, OIKOS, V47, P211, DOI 10.2307/3566048; Xiong YC, 2007, ENVIRON EXP BOT, V59, P193, DOI 10.1016/j.envexpbot.2005.12.003; Xu LX, 2011, J AM SOC HORTIC SCI, V136, P247, DOI 10.21273/JASHS.136.4.247; Yao HS, 2015, FIELD CROP RES, V184, P39, DOI 10.1016/j.fcr.2015.09.005; Yao X, 2012, RUSS J PLANT PHYSL+, V59, P701, DOI 10.1134/S1021443712060192; Zaicovski CB, 2008, POSTHARVEST BIOL TEC, V49, P436, DOI 10.1016/j.postharvbio.2008.02.001; Zhang DM, 2016, FIELD CROP RES, V197, P1, DOI 10.1016/j.fcr.2016.06.003; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhu SF, 2005, PLANT PHYSIOL, V139, P1935, DOI 10.1104/pp.105.072306; Zou Q., 1995, GUIDE PHYSL BIOCH EX	36	5	5	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0198878	10.1371/journal.pone.0198878	http://dx.doi.org/10.1371/journal.pone.0198878			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953445	Green Submitted, Green Published, gold			2022-12-26	WOS:000436645400009
J	Richters, A; Nieuwboer, MS; Rikkert, MGMO; Melis, RJF; Perry, M; van der Marck, MA				Richters, Anke; Nieuwboer, Minke S.; Rikkert, Marcel G. M. Olde; Melis, Rene J. F.; Perry, Marieke; van der Marck, Marjolein A.			Longitudinal multiple case study on effectiveness of network-based dementia care towards more integration, quality of care, and collaboration in primary care	PLOS ONE			English	Article							MANAGEMENT	Introduction This study aimed to provide insight into the merits of DementiaNet, a network-based primary care innovation for community-dwelling dementia patients. Methods Longitudinal mixed methods multiple case study including 13 networks of primary care professionals as cases. Data collection comprised continuously-kept logs; yearly network maturity score (range 0-24), yearly quality of care assessment (quality indicators, 0-100), and indepth interviews. Results Networks consisted of median nine professionals (range 5-22) covering medical, care and welfare disciplines. Their follow-up was 1-2 years. Average yearly increase was 2.03 (95%CI:1.20-2.96) on network maturity and 8.45 (95%-CI:2.80-14.69) on quality indicator score. High primary care practice involvement and strong leadership proved essential in the transition towards more mature networks with better quality of care. Discussion Progress towards more mature networks favored quality of care improvements. DementiaNet appeared to be effective to realize transition towards network-based care, enhance multidisciplinary collaboration, and improve quality of dementia care.	[Richters, Anke; Rikkert, Marcel G. M. Olde; Perry, Marieke] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Geriatr Med, Nijmegen, Netherlands; [Richters, Anke; Nieuwboer, Minke S.; Rikkert, Marcel G. M. Olde; Melis, Rene J. F.; Perry, Marieke; van der Marck, Marjolein A.] Radboud Univ Nijmegen, Med Ctr, Radboudumc Alzheimer Ctr, Nijmegen, Netherlands; [Richters, Anke; Nieuwboer, Minke S.; Rikkert, Marcel G. M. Olde; Melis, Rene J. F.; Perry, Marieke; van der Marck, Marjolein A.] Radboud Univ Nijmegen, Med Ctr, Dept Geriatr Med, Nijmegen, Netherlands; [Melis, Rene J. F.; van der Marck, Marjolein A.] Radboud Univ Nijmegen, Med Ctr, Dept Geriatr Med, Radboud Inst Hlth Sci, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van der Marck, MA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboudumc Alzheimer Ctr, Nijmegen, Netherlands.; van der Marck, MA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Geriatr Med, Nijmegen, Netherlands.; van der Marck, MA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Geriatr Med, Radboud Inst Hlth Sci, Nijmegen, Netherlands.	Marjolein.vanderMarck@radboudumc.nl	van der Marck, Marjolein A./A-9722-2013; Melis, René/J-5943-2012; Perry, Marieke/A-3115-2016; Nieuwboer, Minke S/P-8344-2015; Rikkert, M.G.M. Olde/H-8078-2014; Richters, Anke/AAJ-7631-2021	van der Marck, Marjolein A./0000-0002-5540-7479; Melis, René/0000-0002-7863-4738; Perry, Marieke/0000-0003-0675-9678; Rikkert, M.G.M. Olde/0000-0003-1397-1677; Richters, Anke/0000-0002-1580-1543	Alzheimer Nederland [WE.09-2013-04]	Alzheimer Nederland	This study was funded by Alzheimer Nederland (project number WE.09-2013-04 to MOR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskerville NB, 2012, ANN FAM MED, V10, P63, DOI 10.1370/afm.1312; Bloem BR, 2014, LANCET NEUROL, V13, P649, DOI 10.1016/S1474-4422(14)70118-8; Bohmer RMJ, 2016, NEW ENGL J MED, V375, P709, DOI 10.1056/NEJMp1606458; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; Boustani MA, 2010, CLIN INTERV AGING, V5, P141; Callahan CM, 2011, AGING MENT HEALTH, V15, P5, DOI 10.1080/13607861003801052; Craig P, 2013, INT J NURS STUD, V50, P585, DOI 10.1016/j.ijnurstu.2012.09.009; D'Amour D, 2008, BMC HEALTH SERV RES, V8, DOI [10.1186/1472-6963-8-40, 10.1186/1472-6963-8-188]; Dreier-Wolfgramm A, 2017, Z GERONTOL GERIATR, V50, pS68, DOI 10.1007/s00391-017-1220-8; Fetters MD, 2013, HEALTH SERV RES, V48, P2134, DOI 10.1111/1475-6773.12117; Guetterman TC, 2015, ANN FAM MED, V13, P554, DOI 10.1370/afm.1865; Iliffe S, 2017, Z GERONTOL GERIATR, V50, pS63, DOI 10.1007/s00391-016-1175-1; Iliffe S, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18490; Iliffe SWJ., 2015, CHANGING PRACTICE DE; Nieuwboer MS, 2017, Z GERONTOL GERIATR, V50, pS78, DOI 10.1007/s00391-017-1196-4; Parchman ML, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-93; Reeves S, 2018, J INTERPROF CARE, V32, P1, DOI 10.1080/13561820.2017.1400150; Richters A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016433; Rutter H, 2018, CLIN CHEM, V64, P44, DOI 10.1373/clinchem.2017.272831; Rutter H, 2017, LANCET, V390, P2602, DOI 10.1016/S0140-6736(17)31267-9; Shaw EK, 2013, ANN FAM MED, V11, P220, DOI 10.1370/afm.1505; Somme D, 2012, ALZHEIMERS DEMENT, V8, P426, DOI 10.1016/j.jalz.2011.06.004; Thyrian JR, 2017, JAMA PSYCHIAT, V74, P996, DOI 10.1001/jamapsychiatry.2017.2124; Valentijn PP, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0278-x; van der Marck Marjolein A, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS167, DOI 10.1016/S1353-8020(13)70040-3; Wilcock J, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-397; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Wubbeler M, 2017, HEALTH SOC CARE COMM, V25, P285, DOI 10.1111/hsc.12315	28	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198811	10.1371/journal.pone.0198811	http://dx.doi.org/10.1371/journal.pone.0198811			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949608	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200027
J	Cavalcante, DDB; Brizon, VSC; Probst, LF; Meneghim, MD; Pereira, AC; Ambrosano, GMB				Barros Cavalcante, Denise De Fatima; Candido Brizon, Valeria Silva; Probst, Livia Fernandes; Meneghim, Marcelo de Castro; Pereira, Antonio Carlos; Bovi Ambrosano, Glaucia Maria			Did the Family Health Strategy have an impact on indicators of hospitalizations for stroke and heart failure? Longitudinal study in Brazil: 1998-2013	PLOS ONE			English	Article							CARE-SENSITIVE HOSPITALIZATIONS; AVOIDABLE HOSPITALIZATION; CARDIOVASCULAR-DISEASE; MORTALITY; INEQUALITIES; BURDEN; TRENDS; RATES	Introduction The objective was to analyze whether socioeconomic factors related to the context and those related to the model of care - specifically the coverage of primary care by the Family Health Strategy (ESF) - had an impact on hospitalizations due to heart failure (HF) and stroke, in the State of Sao Paulo/Brazil between 1998 and 2013. Methods A longitudinal ecological study involving 645 municipalities was conducted in the state of Sao Paulo/Brazil from 1998 to 2013, using the Hospital Information System (SIH - DataSUS database). The hospitalizations for primary care sensitive conditions: Stroke and heart failure (HF) that correspond to the International Classification of Diseases (ICD 10): I50, I63 to I67; I69, G45 to G46 were analyzed longitudinally during the period indicated regarding the percentage of people covered by the Family Health Program (PSF) adjusted for confounders (population size, gross domestic product -GDP and human development index-HDI). Results There was a significant decrease in the number of hospitalizations for heart failure and stroke per 10000 (inhabitants) in the period (p < 0.0001), with a significant relationship with increased proportion of ESF (p < 0.0001), and this remained significant even when possible confounders (population size, GDP and HDI) were included in the model (p < 0.0001). Conclusions GDP per capita was close to or higher than that if many European countries, which shows the relevance of the study. The health care model based on the Family Health Strategy positively impacted hospitalization indicators for heart failure and stroke, indicating that this model is effective in the prevention of primary care sensitive conditions.	[Barros Cavalcante, Denise De Fatima; Candido Brizon, Valeria Silva; Probst, Livia Fernandes; Meneghim, Marcelo de Castro; Pereira, Antonio Carlos; Bovi Ambrosano, Glaucia Maria] Univ Estadual Campinas, UNICAMP, Piracicaba Dent Sch, Dept Community Dent, Piracicaba, SP, Brazil	Universidade Estadual de Campinas	Brizon, VSC (corresponding author), Univ Estadual Campinas, UNICAMP, Piracicaba Dent Sch, Dept Community Dent, Piracicaba, SP, Brazil.	dradenisecavalcante@gmail.com	Probst, Livia Fernandes/B-3475-2016	Probst, Livia Fernandes/0000-0002-4696-0862; Ambrosano, Glaucia Maria Bovi/0000-0001-5950-6370; Barros Cavalcante, Denise de Fatima/0000-0002-9166-0367; Pereira, Antonio Carlos/0000-0003-1703-8171				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Alfradique ME, 2009, CAD SAUDE PUBLICA, V25, P1337, DOI 10.1590/S0102-311X2009000600016; Asaria P, 2012, INT J EPIDEMIOL, V41, P1737, DOI 10.1093/ije/dys151; Batista SRR, REV SAUDE PUBLICA, V46, P34; Boing AF, 2012, REV SAUDE PUBL, V46, P359, DOI 10.1590/S0034-89102012005000011; Bonita R., 2006, BASIC EPIDEMIOLOGY, V2nd ed.; BRASIL. Ministerio da SaUde, 2011, PLAN AC ESTR ENTR DO; Cabral Norberto L, 2012, Am J Public Health, V102, pe90, DOI 10.2105/AJPH.2012.301024; Caminal J, 2004, EUROPEAN J PUBLIC HL, V14; Chaix B, 2012, INT J EPIDEMIOL, V41, P1283, DOI 10.1093/ije/dyr107; Galil AGD, 2016, INT J CARDIOL, V221, P1004, DOI 10.1016/j.ijcard.2016.07.041; Freund T, 2014, Z EVIDENZ FORTBILD Q, V108, P251, DOI 10.1016/j.zefq.2014.05.001; Gaziano TA, 2007, HEALTH AFFAIR, V26, P13, DOI 10.1377/hlthaff.26.1.13; Gibson OR, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-336; Hogerzeil H, 2011, WORLD MED SITUATION, V3; Hone T, 2017, HEALTH AFFAIR, V36, P149, DOI 10.1377/hlthaff.2016.0966; Lentsck Maicon Henrique, 2015, Rev. bras. epidemiol., V18, P372, DOI 10.1590/1980-5497201500020007; Macinko J, 2006, J EPIDEMIOL COMMUN H, V60, P13, DOI 10.1136/jech.2005.038323; Macinko J, 2011, AM J PUBLIC HEALTH, V101, P1963, DOI 10.2105/AJPH.2010.198887; Malta DC, 2014, EPIDEMIOL SERV SAUDE, V23, P599, DOI [10.5123/S1679-49742014000400002, 10.5123/S1679-49742014000400017, 10.5123/S1679-49742014000300002]; Malta DC, 2013, EPIDEMIOL SERV SAUDE, V22, P151, DOI 10.5123/S1679-49742013000100016; Ministe A rio da SauAde, 1998, PORT GM 3 916 30 OUT; Ministe A rio da SauAde, DAD COB PROGR SAUD F; Ministerio da Saude, 2014, POL NAC CONTR TAB RE; Niti M, 2003, J EPIDEMIOL COMMUN H, V57, P17, DOI 10.1136/jech.57.1.17; Organizacai Mundial de Saude, CALSS EST INT DOENC; Pappas G, 1997, AM J PUBLIC HEALTH, V87, P811, DOI 10.2105/AJPH.87.5.811; Portes LH, 2015, REV PANAM SALUD PUBL, V38, P370; Purdy S, 2009, PUBLIC HEALTH, V123, P169, DOI 10.1016/j.puhe.2008.11.001; Rasella D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4014; Rosano A, 2013, EUR J PUBLIC HEALTH, V23, P356, DOI 10.1093/eurpub/cks053; SAS, 1999, SAS SOFTW VERS 9 1; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Schmittdiel JA, 2006, ANN FAMILY MED, V4; Schramm Joyce Mendes de Andrade, 2004, Ciênc. saúde coletiva, V9, P897, DOI 10.1590/S1413-81232004000400011; Paniz VMV, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00009915; WHO, 2008, PREV CHRON DIS VIT I	37	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0198428	10.1371/journal.pone.0198428	http://dx.doi.org/10.1371/journal.pone.0198428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK7JR	29944665	Green Submitted, gold, Green Published			2022-12-26	WOS:000436377800008
J	Imai, N; Ferguson, NM				Imai, Natsuko; Ferguson, Neil M.			Targeting vaccinations for the licensed dengue vaccine: Considerations for serosurvey design	PLOS ONE			English	Article							INAPPROPRIATE SUBGROUP ANALYSES; IMMUNOLOGICAL BEHAVIOR; VIRUS-INFECTION; CAUSE HARM; CHILDREN; RATES; CONTROVERSY; HALSTEAD; EFFICACY; DISEASE	Background The CYD-TDV vaccine was unusual in that the recommended target population for vaccination was originally defined not only by age, but also by transmission setting as defined by seroprevalence. WHO originally recommended countries consider vaccination against dengue with CYD-TDV vaccine in geographic settings only where prior infection with any dengue serotype, as measured by seroprevalence, was >170% in the target age group. Vaccine was not recommended in settings where seroprevalence was <50%. Test- and-vaccinate strategies suggested following new analysis by Sanofi will still require age-stratified seroprevalence surveys to optimise age-group targeting. Here we address considerations for serosurvey design in the context of vaccination program planning. Methods To explore how the design of seroprevalence surveys affects estimates of transmission intensity, 100 age-specific seroprevalence surveys were simulated using a beta-binomial distribution and a simple catalytic model for different combinations of age-range, survey size, transmission setting, and test sensitivity/specificity. We then used a Metropolis-Hastings Markov Chain Monte-Carlo algorithm to estimate the force of infection from each simulated dataset. Results Sampling from a wide age-range led to more accurate estimates than merely increasing sample size in a narrow age-range. This finding was consistent across all transmission settings. The optimum test sensitivity and specificity given an imperfect test differed by setting with high sensitivity being important in high transmission settings and high specificity important in low transmission settings. Conclusions When assessing vaccination suitability by seroprevalence surveys, countries should ensure an appropriate age-range is sampled, considering epidemiological evidence about the local burden of disease.	[Imai, Natsuko; Ferguson, Neil M.] Imperial Coll London, MRC Ctr Global Infect Dis Anal, Dept Infect Dis Epidemiol, London, England	Imperial College London	Imai, N (corresponding author), Imperial Coll London, MRC Ctr Global Infect Dis Anal, Dept Infect Dis Epidemiol, London, England.	n.imai@imperial.ac.uk	Ferguson, Neil/B-8578-2008; Imai, Natsuko/J-5817-2017	Ferguson, Neil/0000-0002-1154-8093; Imai, Natsuko/0000-0002-4218-9716	UK Medical Research Council [MR/R015600/1]; MRC [MR/R015600/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the UK Medical Research Council (www.mrc.ac.uk) for Centre funding (MR/R015600/1) (NMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alere.com, 2016, PANB DENG IGG IND EL; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11; Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Chakravarti A, 2000, DIAGN MICR INFEC DIS, V36, P273, DOI 10.1016/S0732-8893(99)00150-9; Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269; Dans AL, 2018, J CLIN EPIDEMIOL, V95, P142, DOI 10.1016/j.jclinepi.2017.12.025; Dans AL, 2018, J CLIN EPIDEMIOL, V95, P137, DOI 10.1016/j.jclinepi.2017.11.019; FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811; Focusdx.com, 2016, DENG VIR SER TEST; Gailhardou S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004821; GOH KT, 1987, T ROY SOC TROP MED H, V81, P687, DOI 10.1016/0035-9203(87)90456-1; GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859; GRIFFITHS D. A., 1974, Applied Statistics, V23, P330, DOI 10.2307/2347126; Hadinegoro RS, 2016, VACCINE, V34, P4273, DOI 10.1016/j.vaccine.2016.06.015; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; Hadinegoro SRS, 2018, J CLIN EPIDEMIOL, V95, P140, DOI 10.1016/j.jclinepi.2017.12.024; Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089; Halstead SB, 2016, VACCINE, V34, P4275, DOI 10.1016/j.vaccine.2016.06.013; Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004; Health Sciences Authority Singapore, 2016, HSA APPR DENGV VAC; Hens N, 2010, EPIDEMIOL INFECT, V138, P802, DOI 10.1017/S0950268809990781; Houghton-Triviño Natalia, 2008, Rev. salud pública, V10, P299; Imai N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004833; Imai N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003719; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Maxim LD, 2014, INHAL TOXICOL, V26, P811, DOI 10.3109/08958378.2014.955932; Muench H, 1934, J AM STAT ASSOC, V29, P25, DOI 10.2307/2278457; Pasteur Sanofi, SAN UPD INF DENG VAC; Pasteur Sanofi, 2016, SAN PAST DENG VACC A; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; R Core Team, 2016, R FDN STAT COMP; Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111; Rodriguez-Barraquer I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003906; Rodriguez-Barraquer I, 2014, AM J EPIDEMIOL, V179, P353, DOI 10.1093/aje/kwt256; Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935; Saez-Llorens X, 2017, LANCET INFECT DIS, V17, P615, DOI 10.1016/S1473-3099(17)30166-4; Sang CT, 1998, CLIN DIAGN LAB IMMUN, V5, P7, DOI 10.1128/CDLI.5.1.7-10.1998; Shepard DS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003306; Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Standardia.com, 2016, SD DENG IGG CAPT ELI; Thai KTD, 2010, EPIDEMIOL INFECT, V138, P585, DOI 10.1017/S095026880999046X; The Strategic Advisory Group of Experts (SAGE), 2016, SUMM APR 2016 M STRA, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; World Health Organization, 2016, DENG VACC WHO POS PA, DOI [10.1371/jour, DOI 10.1371/JOUR]; World Health Organization, 2017, INF VACC PROGR GUID; Yap G, 2013, AM J TROP MED HYG, V88, P1065, DOI 10.4269/ajtmh.12-0150; Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667	51	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199450	10.1371/journal.pone.0199450	http://dx.doi.org/10.1371/journal.pone.0199450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944696	Green Submitted, gold, Green Published			2022-12-26	WOS:000436377800035
J	Tarry-Adkins, JL; Aiken, CE; Ashmore, TJ; Fernandez-Twinn, DS; Chen, JH; Ozanne, SE				Tarry-Adkins, Jane L.; Aiken, Catherine E.; Ashmore, Thomas J.; Fernandez-Twinn, Denise S.; Chen, Jian-Hua; Ozanne, Susan E.			A suboptimal maternal diet combined with accelerated postnatal growth results in an altered aging profile in the thymus of male rats	FASEB JOURNAL			English	Article						developmental programming; involution; immunosenescence	MITOCHONDRIAL UNCOUPLING PROTEIN-1; TELOMERE LENGTH; PRENATAL UNDERNUTRITION; OXIDATIVE STRESS; AGE; EXPRESSION; SIZE; SENESCENCE.; VACCINATION; INVOLUTION	Reduced fetal nutrition and rapid postnatal growth accelerates the aging phenotype in many organ systems; however, effects on the immune system are unclear. We addressed this by studying the thymus from a rat model of developmental programming. The recuperated group was generated by in utero protein restriction, followed by cross-fostering to control-fed mothers, and were then compared with controls. Fat infiltration and adipocyte size increased with age (P < 0.001) and in recuperated thymi (P < 0.05). Cortex/medulla ratio decreased with age (P < 0.001) and decreased (P < 0.05) in 12-mo recuperated thymi. Age-associated decreases in thymic-epithelial cell (P < 0.01) and thymocyte markers (P < 0.01) were observed in both groups and was decreased (P < 0.05) in recuperated thymi. These data demonstrate effects of developmental programming upon thymic involution. The recuperated group had longer thymic telomeres than controls (P < 0.001) at 22 d and at 3 mo, which was associated with increased expression of telomere-length maintenance molecules [telomerase RNA component (Terc; P < 0.01), P23 (P = 0.02), and Ku70 and Ku80 (P < 0.01)]. By 12 mo, recuperated offspring had shorter thymic telomeres than controls had (P < 0.001) and reduced DNA damage-response markers [(DNA-PKcs, Mre11 (P < 0.01), Xrcc4 (P = 0.02), and -H2ax (P < 0.001], suggesting failure of earlier compensatory responses. Our results suggest that low birth weight with rapid postnatal growth results in premature thymic maturation, resulting in accelerated thymic aging. This could lead to increased age-associated vulnerability to infection.Tarry-Adkins, J. L., Aiken, C. E., Ashmore, T. J., Fernandez-Twinn, D. S., Chen, J.-H., Ozanne, S. E. A suboptimal maternal diet combined with accelerated postnatal growth results in an altered aging profile in the thymus of male rats.	[Tarry-Adkins, Jane L.; Aiken, Catherine E.; Ashmore, Thomas J.; Fernandez-Twinn, Denise S.; Chen, Jian-Hua; Ozanne, Susan E.] Univ Cambridge, Metab Res Labs, Level 4,Box 289,Hills Rd, Cambridge CB2 0QQ, England; [Tarry-Adkins, Jane L.; Aiken, Catherine E.; Ashmore, Thomas J.; Fernandez-Twinn, Denise S.; Chen, Jian-Hua; Ozanne, Susan E.] Addenbrookes Hosp, Addenbrookes Treatment Ctr, Metab Dis Unit, MRC,Wellcome Trust,Inst Metab Sci, Level 4,Box 289,Hills Rd, Cambridge CB2 0QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute	Tarry-Adkins, JL (corresponding author), Univ Cambridge, Metab Res Labs, Level 4,Box 289,Hills Rd, Cambridge CB2 0QQ, England.; Tarry-Adkins, JL (corresponding author), Addenbrookes Hosp, Addenbrookes Treatment Ctr, Metab Dis Unit, MRC,Wellcome Trust,Inst Metab Sci, Level 4,Box 289,Hills Rd, Cambridge CB2 0QQ, England.	janeadkins@googlemail.com	Fernandez-Twinn, Denise/B-3881-2011	Fernandez-Twinn, Denise/0000-0003-2610-277X; Ozanne, Susan/0000-0001-8753-5144	British Heart Foundation [PG/09/037/27387, FS/09/029/27902]; Medical Research Council (MRC) [MC_UU_12012/4]; Isaac Newton Trust/Wellcome Institutional Strategic Support Fund (ISSF)/University of Cambridge Joint Research Grant; MRC [MC_UU_12012/4, MC_UU_00014/4] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Isaac Newton Trust/Wellcome Institutional Strategic Support Fund (ISSF)/University of Cambridge Joint Research Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank James Warner, Gregory Strachan, and M. S. Martin-Gronert (University of Cambridge Metaboloc Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science) for technical assistance. This work was supported by The British Heart Foundation (Grants PG/09/037/27387 and FS/09/029/27902), the Medical Research Council (MRC; Grant MC_UU_12012/4), and by an Isaac Newton Trust/Wellcome Institutional Strategic Support Fund (ISSF)/University of Cambridge Joint Research Grant. S.E.O. is a member of the MRC Metabolic Diseases Unit. The authors declare no conflicts of interest.	Adams AE, 2008, BBA-BIOENERGETICS, V1777, P772, DOI 10.1016/j.bbabio.2008.04.020; Adams AE, 2010, BBA-BIOENERGETICS, V1797, P807, DOI 10.1016/j.bbabio.2010.04.016; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Aspinall R, 2000, J CLIN IMMUNOL, V20, P250, DOI 10.1023/A:1006611518223; Aspinall R, 1997, J IMMUNOL, V158, P3037; Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x; Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871; Carroll AM, 2005, J BIOL CHEM, V280, P15534, DOI 10.1074/jbc.M413315200; Chen JH, 2010, CLIN SCI, V118, P429, DOI 10.1042/CS20090429; Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; Diala I, 2013, EMBO REP, V14, P356, DOI 10.1038/embor.2013.16; Dixit VD, 2010, CURR OPIN IMMUNOL, V22, P521, DOI 10.1016/j.coi.2010.06.010; Georgakopoulou EA, 2013, AGING-US, V5, P37; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Gui JG, 2012, AGING DIS, V3, P280; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Kirwan M, 2009, BRIT J HAEMATOL, V144, P771, DOI 10.1111/j.1365-2141.2008.07516.x; Li Z, 2016, CELL DEATH DIFFER, V23, P1765, DOI 10.1038/cdd.2016.65; McDade TW, 2001, J NUTR, V131, P1225, DOI 10.1093/jn/131.4.1225; McDade TW, 2001, AM J CLIN NUTR, V74, P543; MILLER JF, 1961, LANCET, V2, P748; Moore SE, 2009, ACTA PAEDIATR, V98, P1168, DOI 10.1111/j.1651-2227.2009.01292.x; Moore SE, 2004, AM J CLIN NUTR, V80, P453, DOI 10.1093/ajcn/80.2.453; Olearo E, 2012, PRENATAL DIAG, V32, P662, DOI 10.1002/pd.3883; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; Palmer DB, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00316; Pearse G, 2006, TOXICOL PATHOL, V34, P504, DOI 10.1080/01926230600865549; Rezzani R, 2014, AGE, V36, P313, DOI 10.1007/s11357-013-9564-5; Sasaki T, 2010, GERIATR GERONTOL INT, V10, pS10, DOI 10.1111/j.1447-0594.2010.00601.x; Sfeir A, 2012, J CELL SCI, V125, P4173, DOI 10.1242/jcs.106831; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523; Tarry-Adkins Jane L, 2017, Ageing Res Rev, V39, P96, DOI 10.1016/j.arr.2016.08.003; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Weng NP, 1998, IMMUNITY, V9, P151, DOI 10.1016/S1074-7613(00)80597-X; Zlamy M, 2009, REJUV RES, V12, P249, DOI 10.1089/rej.2009.0864	42	9	9	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					239	253		10.1096/fj.201701350RR	http://dx.doi.org/10.1096/fj.201701350RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29975569	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-26	WOS:000457401500020
J	Dobkowska-Chudon, W; Wrobel, M; Karlowicz, P; Dabrowski, A; Krupienicz, A; Targowski, T; Nowicki, A; Olszewski, R				Dobkowska-Chudon, Wioletta; Wrobel, Miroslaw; Karlowicz, Pawel; Dabrowski, Andrzej; Krupienicz, Andrzej; Targowski, Tomasz; Nowicki, Andrzej; Olszewski, Robert			Detecting cerebrovascular changes in the brain caused by hypertension in atrial fibrillation group using acoustocerebrography	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; HEALTH-CARE PROFESSIONALS; RISK-FACTORS; INTRACEREBRAL HEMORRHAGE; CEREBRAL MICROBLEEDS; SCIENTIFIC STATEMENT; BLOOD-PRESSURE; STROKE; PREVENTION; DISEASE	Acoustocerebrography is a novel, non-invasive, transcranial ultrasonic diagnostic method based on the transmission of multispectral ultrasound signals propagating through the brain tissue. Dedicated signal processing enables the estimation of absorption coefficient, frequency- dependent attenuation, speed of sound and tissue elasticity. Hypertension and atrial fibrillation are well known factors correlated with white matter lesions, intracerebral hemorrhage and cryptogenic stroke numbers. The aim of this study was to compare the acousto-cerebrography signal in the brains of asymptomatic atrial fibrillation patients with and without hypertension. The study included 97 asymptomatic patients (40 female and 57 male, age 66.26 +/- 6.54 years) who were clinically monitored for atrial fibrillation. The patients were divided into two groups: group I (patients with hypertension) n = 75, and group II (patients without hypertension) n = 22. Phase and amplitude of all spectral components for the received signals from the brain path were extracted and compared to the phase and amplitude of the transmitted pulse. Next, the time of flight and the attenuation of each frequency component were calculated. Additionally, a fast Fourier transformation was performed and its features were extracted. After introducing a machine learning technique, the ROC plot of differentiations between group I and group II with an AUC of 0.958 (sensitivity 0.99 and specificity 0.968) was obtained. It can be assumed that the significant difference in the acoustocerebrography signals in patients with hypertension is due to changes in the brain tissue, and it allows for the differentiating of high-risk patients with asymptomatic atrial fibrillation and hypertension.	[Dobkowska-Chudon, Wioletta] Dist Hosp, Cardiol, Radom, Poland; [Wrobel, Miroslaw] Sonovum AG, Leipzig, Germany; [Karlowicz, Pawel] Sonomed Sp Zoo, Warsaw, Poland; [Dabrowski, Andrzej] MTZ Clin Res, Warsaw, Poland; [Krupienicz, Andrzej] Med Univ Warsaw, Warsaw, Poland; [Targowski, Tomasz; Olszewski, Robert] Natl Inst Geriatr Rheumatol & Rehabil, Dept Geriatr, Warsaw, Poland; [Nowicki, Andrzej; Olszewski, Robert] Polish Acad Sci, IPPT, Dept Ultrasound, Warsaw, Poland	Medical University of Warsaw; National Institute of Geriatrics, Rheumatology & Rehabilitation; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences	Olszewski, R (corresponding author), Natl Inst Geriatr Rheumatol & Rehabil, Dept Geriatr, Warsaw, Poland.; Olszewski, R (corresponding author), Polish Acad Sci, IPPT, Dept Ultrasound, Warsaw, Poland.	robert.olszewski@me.com	Olszewski, Robert/GSI-6473-2022; Targowski, Tomasz/ABB-4143-2020; Nowicki, Andrzej/S-9411-2017	Targowski, Tomasz/0000-0002-0008-1256; Nowicki, Andrzej/0000-0002-9260-8237	Development Bank of Saxony (EFRE) [100109012/990.301573]; Sonovum AG; SonoMED; EFRE [100109012/990.30157]	Development Bank of Saxony (EFRE); Sonovum AG; SonoMED; EFRE	This work was supported by the Development Bank of Saxony (EFRE Grant No.100109012/990.301573 to MW, PK, and AD), Sonovum AG, and SonoMED. This support was used for covering part of the construction of the scanning device and conducting the process of data acquisition. PK serves as a CEO to SonoMED. MW serves as a CTO to Sonovum AG and holds potential financial interest through patented technology. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in the conduct of the studies and analysis of the data but Sonovum AG and SonoMED contributed to the preparation of the manuscript.; MW, AD, PK are supported in their fundamental research on ACG by an EFRE Grant No. 100109012/990.30157.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Anselmino M, 2014, HEART RHYTHM, V11, P2, DOI 10.1016/j.hrthm.2013.10.020; Badheka AO, 2014, AM J CARDIOL, V114, P727, DOI 10.1016/j.amjcard.2014.06.002; Basile AM, 2006, CEREBROVASC DIS, V21, P315, DOI 10.1159/000091536; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; De Cocker LJ, 2016, NEUROIMAGE, P30661; Delgado P, 2014, HYPERTENSION, V64, P658, DOI 10.1161/HYPERTENSIONAHA.114.03563; Dobkowska-Chudon W, 2016, HYDROACOUSTIC, V19, P83; Fanning JP, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0119-0; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Franklin SS, 1997, CIRCULATION, V96, P308; Gbadebo TD, 2011, AM HEART J, V162, P31, DOI 10.1016/j.ahj.2011.03.030; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Go Orson, 2009, Curr Cardiol Rep, V11, P430; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hahne K, 2016, VASC HEALTH RISK MAN, V12, P65, DOI 10.2147/VHRM.S81807; Hasim S, 2015, ARXIV150706947V1CSCL; Heiss WD, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0725-0; Hui DS, 2015, AM HEART J, V169, P448, DOI 10.1016/j.ahj.2014.12.015; Iadecola C, 2016, HYPERTENSION, V68, pE67, DOI 10.1161/HYP.0000000000000053; Jaakkola J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168010; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Kohara K, 1999, AM J CARDIOL, V83, P367, DOI 10.1016/S0002-9149(98)00870-4; Kwon HM, 2007, J NEUROL SCI, V252, P159, DOI 10.1016/j.jns.2006.11.003; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Psaty BM, 1997, CIRCULATION, V96, P2455; Raman Mekala R, 2016, Alzheimers Dement (Amst), V5, P5, DOI 10.1016/j.dadm.2016.12.006; Richoz B, 1997, Rev Med Suisse Romande, V117, P931; Selvetella G, 2003, STROKE, V34, P1766, DOI 10.1161/01.STR.0000078310.98444.1D; Smith EE, 2017, STROKE, V48, pE44, DOI 10.1161/STR.0000000000000116; Stehling C, 2008, ACAD RADIOL, V15, P895, DOI 10.1016/j.acra.2008.01.013; Vemulapalli S, 2016, AM HEART J, V178, P74, DOI 10.1016/j.ahj.2016.05.001; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Wrobel M, 2015, BIOCYBERN BIOMED ENG, V36, P18, DOI DOI 10.1016/J.BBE.2015.10.004; Yamada S, 2012, EUR J NEUROL, V19, P98, DOI 10.1111/j.1468-1331.2011.03451.x	36	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199999	10.1371/journal.pone.0199999	http://dx.doi.org/10.1371/journal.pone.0199999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979716	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500050
J	Besser, REJ; Ludvigsson, J; Hindmarsh, PC; Cole, TJ				Besser, Rachel E. J.; Ludvigsson, Johnny; Hindmarsh, Peter C.; Cole, Tim J.			Exploring C-peptide loss in type 1 diabetes using growth curve analysis	PLOS ONE			English	Article							BETA-CELL FUNCTION; DIAGNOSIS; CHILDREN; AGE; KETOACIDOSIS; ADOLESCENTS; FALL; ASSOCIATION; EXCRETION; DURATION	Objectives C-peptide (CP) loss in type 1 diabetes (T1D) is highly variable, and factors influencing it are poorly understood. We modelled CP values in T1D patients from diagnosis for up to 6 years, treating the serial data as growth curves plotted against time since diagnosis. The aims were to summarise the pattern of CP loss (i.e. growth curve shape) in individual patients in simple terms, and to identify baseline characteristics that predict this pattern in individuals. Materials and methods Between 1976 and 2011, 442 T1D patients initially aged < 18y underwent 120-minute mixed meal tolerance tests (MMTT) to calculate area under the curve (AUC) CP, at 3, 9,18, 30, 48 and 72 months after diagnosis (n = 1537). The data were analysed using the novel SITAR mixed effects growth curve model (Superlmposition by Translation And Rotation). It fits a mean AUC growth curve, but also allows the curve's mean level and rate of fall to vary between individuals so as to best fit the individual patient curves. These curve adjustments define individual curve shape. Results The square root (root) AUC scale provided the best fit. The mean levels and rates of fall for individuals were normally distributed and uncorrelated with each other. Age at diagnosis and root AUC at 3 months strongly predicted the patient-specific mean levels, while younger age at diagnosis (p < 0.0001) and the 120-minute CP value of the 3-month MMTT (p = 0.002) predicted the patient-specific rates of fall. Conclusions SITAR growth curve analysis is a useful tool to assess CP loss in type 1 diabetes, explaining patient differences in terms of their mean level and rate of fall. A definition of rapid CP loss could be based on a quantile of the rate of fall distribution, allowing better understanding of factors determining CP loss and stratification of patients into targeted therapies.	[Besser, Rachel E. J.] UCL, Great Ormond St Inst Child Hlth, Genet & Epigenet Hlth & Dis, London, England; [Ludvigsson, Johnny] Linkoping Univ, Med Fac, Dept Clin & Expt Med, Div Pediat, Linkoping, Sweden; [Hindmarsh, Peter C.] UCL, Dev Endocrinol Res Grp, Great Ormond St Inst Child Hlth, London, England; [Cole, Tim J.] UCL, Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London, England; [Besser, Rachel E. J.] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Dept Pediat Diabet & Endocrinol, Oxford, England; [Besser, Rachel E. J.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford, England	University of London; University College London; Linkoping University; University of London; University College London; University of London; University College London; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford	Besser, REJ (corresponding author), UCL, Great Ormond St Inst Child Hlth, Genet & Epigenet Hlth & Dis, London, England.; Besser, REJ (corresponding author), Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Dept Pediat Diabet & Endocrinol, Oxford, England.; Besser, REJ (corresponding author), Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford, England.	rachel.basser@ouh.nhs.uk	Cole, Tim J/B-7883-2008; Ludvigsson, Johnny/AAI-2051-2020	Cole, Tim J/0000-0001-5711-8200; Ludvigsson, Johnny/0000-0003-1695-5234; Besser, Rachel/0000-0002-4645-6324	National Institute of Health Research (NIHR) from Academic Clinical Lectureship award; Barndiabetesfonden (The Swedish Child Diabetes Foundation); Swedish Research Council; UK Medical Research Council [MR/M012069/1]; MRC [MR/M012069/1, MR/R010692/1] Funding Source: UKRI	National Institute of Health Research (NIHR) from Academic Clinical Lectureship award; Barndiabetesfonden (The Swedish Child Diabetes Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	REJB was funded from the National Institute of Health Research (NIHR) from an Academic Clinical Lectureship award. Further financial support for this study was from the Barndiabetesfonden (The Swedish Child Diabetes Foundation) and the Swedish Research Council. TJC was funded by UK Medical Research Council grant MR/M012069/1. REJB researched the data and wrote the manuscript. JL and PCH contributed to discussion and reviewed/edited the manuscript. TJC analysed the data, contributed to discussion and reviewed/edited the manuscript. REJB and JL had full access to the data and take responsibility for the integrity of the data and the accuracy of the data analysis.	Barker A, 2014, DIABETES OBES METAB, V16, P262, DOI 10.1111/dom.12216; Besser REJ, 2013, PEDIATR ENDOCR REV P, V10, P494; Besser REJ, 2013, DIABETES CARE, V36, P195, DOI 10.2337/dc12-0836; Bowden SA, 2008, PEDIATR DIABETES, V9, P197, DOI 10.1111/j.1399-5448.2008.00376.x; Cole TJ, 2014, ANN HUM BIOL, V41, P76, DOI 10.3109/03014460.2013.856472; Cole TJ, 2015, ARCH DIS CHILD, V100, P138, DOI 10.1136/archdischild-2014-306399; Cole TJ, 2014, ARCH DIS CHILD-FETAL, V99, pF34, DOI 10.1136/archdischild-2012-303536; Cole TJ, 2010, INT J EPIDEMIOL, V39, P1558, DOI 10.1093/ije/dyq115; Dabelea D, 2012, DIABETOLOGIA, V55, P3359, DOI 10.1007/s00125-012-2719-6; Davis AK, 2015, DIABETES CARE, V38, P476, DOI 10.2337/dc14-1952; Desai M, 2007, DIABETOLOGIA, V50, P68, DOI 10.1007/s00125-006-0513-z; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Effects of age duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group, 1987, J CLIN ENDOCR METAB, V65, P30, DOI [10.1210/jcem-65-1-30, DOI 10.1210/JCEM-65-1-30]; GACS G, 1985, EUR J PEDIATR, V143, P183, DOI 10.1007/BF00442133; Greenbaum CJ, 2012, DIABETES, V61, P2066, DOI 10.2337/db11-1538; Greenbaum CJ, 2009, DIABETES CARE, V32, P1839, DOI 10.2337/dc08-2326; Hao W, 2016, DIABETES CARE, V39, P1664, DOI 10.2337/dc16-0360; HEDING LG, 1975, DIABETOLOGIA, V11, P541, DOI 10.1007/BF01222104; KNIP M, 1986, DIABETOLOGIA, V29, P347, DOI 10.1007/BF00903342; Komulainen J, 1996, ARCH DIS CHILD, V75, P410, DOI 10.1136/adc.75.5.410; Lachin JM, 2014, DIABETES, V63, P739, DOI 10.2337/db13-0881; Lachin JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026471; Lauria A, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0522; LUDVIGSSON J, 1976, DIABETOLOGIA, V12, P627, DOI 10.1007/BF01220642; Ludvigsson J, 2013, DIABETES RES CLIN PR, V100, P203, DOI 10.1016/j.diabres.2013.03.003; Mortensen HB, 2010, PEDIATR DIABETES, V11, P218, DOI 10.1111/j.1399-5448.2009.00566.x; Nordwall M, 2008, DIABETES-METAB RES, V24, P472, DOI 10.1002/dmrr.871; SCHIFFRIN A, 1992, DIABETES CARE, V15, P997, DOI 10.2337/diacare.15.8.997; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Steele C, 2004, DIABETES, V53, P426, DOI 10.2337/diabetes.53.2.426; WALLENSTEEN M, 1987, ACTA PAEDIATR SCAND, V76, P82, DOI 10.1111/j.1651-2227.1987.tb10419.x; WALLENSTEEN M, 1988, DIABETOLOGIA, V31, P664, DOI 10.1007/BF00278749; Wang LM, 2012, DIABETES CARE, V35, P465, DOI 10.2337/dc11-1236	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199635	10.1371/journal.pone.0199635	http://dx.doi.org/10.1371/journal.pone.0199635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969494	Green Published, gold, Green Submitted			2022-12-26	WOS:000437246700020
J	Harding, KL; Aguayo, VM; Webb, P				Harding, Kassandra L.; Aguayo, Victor M.; Webb, Patrick			Factors associated with wasting among children under five years old in South Asia: Implications for action	PLOS ONE			English	Article							NUTRITIONAL-STATUS; HEALTH SURVEYS; LOW-INCOME; UNDERNUTRITION; METAANALYSIS; PREVALENCE; MORTALITY; PATTERNS; GROWTH; BIRTH	South Asia continues to carry the greatest share and number of wasted children worldwide. Understanding the determinants of wasting is important as policymakers renew efforts to tackle this persistent public health and development problem. Using data from national surveys in Bangladesh, India, the Maldives, Nepal, Pakistan and Afghanistan, this analysis explores factors associated with wasting among children aged 0 to 59 months (n = 252,797). We conducted multivariate mixed logistic regression and backwards stepwise methods to identify parsimonious models for each country separately (all p values < 0.05). Younger children (0 to 5 months), and those whose mothers had a low body mass index (< 18.5 kg/m(2)) had greater odds of being wasted in all countries. Later birth order, being male, maternal illiteracy, short maternal stature, lack of improved water source, and household poverty were also associated with wasting in various countries, but not systematically in all. Seasonality was also not consistently associated with wasting in the final models. These findings suggest that pre-conception (adolescence), pregnancy and early postpartum, represent windows of opportunity for tackling child wasting, not only stunting. Our analysis suggests that the underlying determinants of wasting and stunting in South Asia are similar, but not universal across geographies. Cost-effective interventions to prevent both stunting and wasting, and to treat severe wasting, need to be scaled up urgently. Separating these two manifestations of child undernutrition in conceptual and programmatic terms may unnecessarily impair progress to reach the Sustainable Development Goals targets aimed at addressing both child stunting and wasting.	[Harding, Kassandra L.; Webb, Patrick] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Harding, Kassandra L.] Yale Univ, Yale Sch Publ Hlth, New Haven, CT USA; [Aguayo, Victor M.] United Nat Childrens Fund UNICEF Programme Div, New York, NY USA	Tufts University; Yale University	Harding, KL (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.; Harding, KL (corresponding author), Yale Univ, Yale Sch Publ Hlth, New Haven, CT USA.	Kassandra.harding@yale.edu	Webb, Patrick/P-3420-2017	Webb, Patrick/0000-0002-9857-3354	Regional Office for South Asia of the United Nations Children's Fund (UNICEF) [43169667]; UNICEF ROSA	Regional Office for South Asia of the United Nations Children's Fund (UNICEF); UNICEF ROSA	This work was supported by the Regional Office for South Asia of the United Nations Children's Fund (UNICEF) (contract number 43169667 to PW) and Victor Aguayo, Associate Director, Chief Nutrition in the Programme Division of UNICEF was a key collaborator in the design and content of this study.; The Authors acknowledge UNICEF ROSA for funding this work and thank the DHS for access to the data used in this analysis, Grace Namirembe and Lichen Liang at Tufts University for their input on analytic methods, and Nina Badgaiyan, a consultant to UNICEF ROSA, for her support in navigating the Afghanistan National Nutrition Survey data.	Achadi E, 2016, GLOBAL NUTR REPORT 2; Balarajan YS, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002233; Bhutta ZA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.67; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Fernandez ID, 2002, B WORLD HEALTH ORGAN, V80, P282; Frongillo EA, 1997, J NUTR, V127, P2302, DOI 10.1093/jn/127.12.2302; Gardner SN, 2013, WHO CHILD GROWTH STA, V8; GHOSHJERATH S, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J4877; Gross R, 2006, LANCET, V367, P1209, DOI 10.1016/S0140-6736(06)68509-7; Hambidge KM, 2012, J PEDIATR GASTR NUTR, V54, P117, DOI 10.1097/MPG.0b013e3182331748; HILL K, 1995, POPUL DEV REV, V21, P127, DOI 10.2307/2137416; International Food Policy Research Institute, 2014, GLOB NUTR REP 2014 A; International Institute for Population Sciences (IIPS) and ICF, 2017, NAT FAM HLTH SURV 4; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Khan MN, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0181-0; Khara T, 2014, TECHNICAL BRIEFING P; King JC, 2016, J NUTR, V146, p1437S, DOI 10.3945/jn.115.223479; Kozuki N, 2015, J NUTR, V145, P2542, DOI 10.3945/jn.115.216374; Lenters LM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S23; Martorell R, 2012, ADV NUTR, V3, P227, DOI 10.3945/an.111.001107; McDonald C., 2010, SCALING NUTR WHAT WI; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Menon P, 2012, ADV NUTR, V3, P224, DOI 10.3945/an.111.001115; Ministry of Health Nepal New ERA ICF, 2017, DEM HLTH SURV 2016; Ministry of Public Health UNICEF Aga Khan University, 2014, NAT NUTR SURV AFGH 2; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; National Institute of Population Studies (NIPS) [Pakistan] Macro International Inc, 2013, PAK DEM HLTH SURV 20; Nel ED, 2016, CURR OPIN CLIN NUTR, V19, P234, DOI 10.1097/MCO.0000000000000269; Onis M. de, 2006, Acta Paediatrica, V95, P76; Pillai V. K., 2015, HLTH SCI J, V9; Raj A, 2015, MATERN CHILD HLTH J, V19, P217, DOI 10.1007/s10995-014-1513-0; Scrimshaw NS, 2003, J NUTR, V133, p316S, DOI 10.1093/jn/133.1.316S; Shekar M, 2017, INVESTMENT FRAMEWORK, DOI [10.1242/dev.134866, DOI 10.1242/DEV.134866]; Subramanian SV, 2009, JAMA-J AM MED ASSOC, V301, P1691, DOI 10.1001/jama.2009.548; Tickell KD, 2017, AM J TROP MED HYG, V97, P1337, DOI 10.4269/ajtmh.17-0139; UNICEF WHO World Bank, 2015, JOINT CHILD MAIN EST; UNICEF WHO World Bank, 2017, JOINT CHILD MAIN EST; Vollmer S, 2017, INT J EPIDEMIOL, V46, P312, DOI 10.1093/ije/dyw133; Vollmer S, 2014, LANCET GLOB HEALTH, V2, pE225, DOI 10.1016/S2214-109X(14)70025-7; WHO-WORLD HEALTH ORGANIZATION, 2014, GLOB NUTR TARG 2025; World Bank, 2016, INV NUTR FDN DEV INV; Wrottesley SV, 2016, J DEV ORIG HLTH DIS, V7, P144, DOI 10.1017/S2040174415001439	43	57	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0198749	10.1371/journal.pone.0198749	http://dx.doi.org/10.1371/journal.pone.0198749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969457	Green Submitted, Green Published, gold			2022-12-26	WOS:000437246700005
J	Schonfeld, MH; Ritzel, RM; Kemmling, A; Ernst, M; Fiehler, J; Gellissen, S				Schoenfeld, Michael H.; Ritzel, Robert M.; Kemmling, Andre; Ernst, Marielle; Fiehler, Jens; Gellissen, Susanne			Improved detectability of acute and subacute brainstem infarctions by combining standard axial and thin-sliced sagittal DWI	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MR; POSTERIOR-CIRCULATION STROKE; MAGNETIC-RESONANCE; ISCHEMIC-STROKE; NIHSS SCORE; SEQUENCES; DIAGNOSIS; PERFUSION; DEFICITS; LESION	Background and purpose Most false negative findings in DWI of ischemic stroke are in patients with minor deficits clinically localized to the brainstem. Our goal was to evaluate the benefit of a thin-sliced sagittal DWI in addition to conventional axial DWI at 1.5T for the detection of brainstem infarctions. Methods Data of patients with symptoms consistent with acute and subacute brainstem infarction and an MRI examination including standard axial DWI and thin-sliced sagittal DWI were retrospectively analyzed. Patients with the later diagnosis of a TIA, an inflammation or a tumor of the brainstem were excluded from analysis. Diffusion restrictions were identified by two independent raters blinded for the final clinical diagnosis in three separate reading steps: First, only axial DWI, secondly only sagittal DWI, and lastly both DWIs together. Presence and size of DWI-lesions were documented for each plane. Differences between the observers were settled in consensus in a separate joint reading. Results Of 73 included patients, 46 patients were clinically diagnosed with brainstem infarction. Inter-observer agreement was excellent for the detection of brainstem lesions in axial and sagittal DWI (kappa = 0.94 and 0.97). In 28/46 patients (60.9%) lesions were detected in the axial plane alone, whereas in 6 more patients (73.9%) lesions were detected in the review of both sequences together. All lesions undetectable in the axial plane were smaller than 5 mm in cranio-caudal direction. Conclusions Thin-sliced sagittal DWI in addition to axial DWI improves the detection rate of brainstem infarction with little additional expenditure of time.	[Schoenfeld, Michael H.; Ernst, Marielle; Fiehler, Jens; Gellissen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Ritzel, Robert M.] German Armed Forces Hosp Hamburg, Dept Radiol, Hamburg, Germany; [Kemmling, Andre] Univ Hosp Luebeck, Dept Neuroradiol, Lubeck, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck	Schonfeld, MH (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	m.schoenfeld@uke.de		Schonfeld, Michael/0000-0003-2096-3448				Ay H, 1999, NEUROLOGY, V52, P1784, DOI 10.1212/WNL.52.9.1784; Byeon J, 2015, CLIN IMAG, V39, P765, DOI 10.1016/j.clinimag.2015.06.001; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Engelter ST, 2004, NEUROLOGY, V62, P574, DOI 10.1212/01.WNL.0000110310.48162.F7; Etgen T, 2004, EUR NEUROL, V52, P145, DOI 10.1159/000081623; Felfeli P, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.666; Fitzek S, 2001, EUR J RADIOL, V39, P180, DOI 10.1016/S0720-048X(01)00372-2; Gerraty RP, 2002, STROKE, V33, P2019, DOI 10.1161/01.STR.0000020841.74704.5B; Hayashi S, 2009, NOSOTCHU, V31, P34, DOI [10.3995/jstroke.31.34, DOI 10.3995/JSTROKE.31.34]; Hong GS, 2017, EUR RADIOL, V27, P859, DOI 10.1007/s00330-016-4388-1; Huo J, 2016, CLIN NEURORADIOL, V26, P423, DOI 10.1007/s00062-015-0381-3; Kuker W, 2002, J NEUROL, V249, P33, DOI 10.1007/PL00007845; Lee H, 2014, J STROKE, V16, P124, DOI 10.5853/jos.2014.16.3.124; Linfante I, 2001, ARCH NEUROL-CHICAGO, V58, P621, DOI 10.1001/archneur.58.4.621; Linn J, 2011, ATLAS KLIN NEURORADI; Lovblad KO, 1998, AM J NEURORADIOL, V19, P1061; Marx JJ, 2002, J NEUROL NEUROSUR PS, V72, P572, DOI 10.1136/jnnp.72.5.572; Narisawa A, 2001, No To Shinkei, V53, P1021; Oppenheim C, 2000, AM J NEURORADIOL, V21, P1434; Pandya A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148106; Paul NLM, 2013, LANCET NEUROL, V12, P65, DOI 10.1016/S1474-4422(12)70299-5; Porter DA, 2009, MAGN RESON MED, V62, P468, DOI 10.1002/mrm.22024; Seeger A, 2016, CLIN NEURORADIOL, V26, P177, DOI 10.1007/s00062-014-0342-2; Seo Min-Jung, 2006, J Clin Neurol, V2, P107, DOI 10.3988/jcn.2006.2.2.107; Sorimachi T, 2008, NEUROL MED-CHIR, V48, P108, DOI 10.2176/nmc.48.108; Toi H, 2003, NEURORADIOLOGY, V45, P352, DOI 10.1007/s00234-002-0897-5; Tong DC, 1998, NEUROLOGY, V50, P864, DOI 10.1212/WNL.50.4.864; Wardlaw J, 2014, HEALTH TECHNOL ASSES, V18, P1; Westesson, 2009, DIFFUSION WEIGHTED M; Wilson CA, 2017, CLIN NEURORADIOL, V27, P31, DOI 10.1007/s00062-015-0409-8	30	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0200092	10.1371/journal.pone.0200092	http://dx.doi.org/10.1371/journal.pone.0200092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969485	Green Published, gold, Green Submitted			2022-12-26	WOS:000437246700042
J	Anderson, KM; Barback, CV; Qin, ZT; Hall, DJ; Hoh, CK; Vera, DR; McHale, MT				Anderson, Kristen M.; Barback, Christopher V.; Qin, Zhengtao; Hall, David J.; Hoh, Carl K.; Vera, David R.; McHale, Michael T.			Molecular Imaging of endometrial sentinel lymph nodes utilizing fluorescent-labeled Tilmanocept during robotic-assisted surgery in a porcine model	PLOS ONE			English	Article							SYSTEMATIC PELVIC LYMPHADENECTOMY; SQUAMOUS-CELL CARCINOMA; INDOCYANINE GREEN; BLUE-DYE; CANCER; IDENTIFICATION; RADIOTRACER; TRIAL	Molecular imaging with a fluorescent version of Tilmanocept may permit an accurate and facile detection of sentinel nodes of endometrial cancer. Tilmanocept accumulates in sentinel lymph nodes (SLN) by binding to a cell surface receptor unique to macrophages and dendritic cells. Four female Yorkshire pigs underwent cervical stromal injection of IRDye800-Tilmanocept, a molecular imaging agent tagged with near-infrared fluorescent dye and radiolabeled with gallium-68 and technetium-99m. PET/CT scans 1.5 hours post-injection provided preoperative SLN mapping. Robotic-assisted lymphadenectomy was performed two days after injection, using the FireFly imaging system to identify nodes demonstrating fluorescent signal. After removal of fluorescent nodes, pelvic and periaortic node dissections were performed. Nodes were assayed for technetium-99m activity, and SLNs were established using the "10%-rule", requiring that the radioactivity of additional SLNs be greater than 10% of the "hottest" SLN. Thirty-four nodal samples were assayed ex vivo for radioactivity. All the SLNs satisfying the "10%-rule" were detected using the FireF/ysystem. Five fluorescent nodes were detected, corresponding with preoperative PET/CT scan. Three pigs had one SLN and one pig had two SLNs, with 100% concordance between fluorescence and radioactivity. Fluorescent-labeled Tilmanocept permits real-time intraoperative detection of SLNs during robotic-assisted lymphadenectomy for endometrial cancer in a porcine model. When radiolabeled with gallium-68, Tilmanocept allows for preoperative localization of SLNs using PET/CT, and shows specificity to SLNs with persistent fluorescent signal, detectable using the FireF/ysystem, for two days post-injection. In conclusion, these findings suggest that a phase I trial in human subjects is warranted, and that a long-term goal of an intra-operative administration of non-radioactive fluorescent-labeled Tilmanocept is possible.	[Anderson, Kristen M.; McHale, Michael T.] Univ Calif San Diego, Dept Reprod Med, Div Gynecol Oncol, San Diego, CA 92103 USA; [Barback, Christopher V.; Qin, Zhengtao; Hall, David J.; Hoh, Carl K.; Vera, David R.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Barback, Christopher V.; Qin, Zhengtao; Hall, David J.; Hoh, Carl K.; Vera, David R.] Univ Calif San Diego, UCSD Mol Imaging Program, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Anderson, KM (corresponding author), Univ Calif San Diego, Dept Reprod Med, Div Gynecol Oncol, San Diego, CA 92103 USA.	kranderson@ucsd.edu						Abu-Rustum NR, 2014, J NATL COMPR CANC NE, V12, P288, DOI 10.6004/jnccn.2014.0026; Abu-Rustum NR, 2009, GYNECOL ONCOL, V113, P163, DOI 10.1016/j.ygyno.2009.01.003; Agrawal A, 2015, ANN SURG ONCOL, V22, P3708, DOI 10.1245/s10434-015-4382-x; Barlin JN, 2012, GYNECOL ONCOL, V125, P531, DOI 10.1016/j.ygyno.2012.02.021; Barton DPJ, 2009, INT J GYNECOL CANCER, V19, P1465, DOI 10.1111/IGC.0b013e3181b89f95; Buda A, 2017, J MINIM INVAS GYN, V24, P165, DOI 10.1016/j.jmig.2016.09.006; CHOI HJ, 2016, J GYNECOL ONCOL, V27; Emerson DK, 2012, RADIOLOGY, V265, P186, DOI 10.1148/radiol.12120638; Holloway RW, 2016, GYNECOL ONCOL, V141, P206, DOI 10.1016/j.ygyno.2016.02.018; Hosseini A, 2014, J SURG RES, V190, P528, DOI 10.1016/j.jss.2014.05.012; Imboden S, 2015, ANN SURG ONCOL, V22, P4198, DOI 10.1245/s10434-015-4701-2; Lee HJ, 2017, J NUCL MED, V58, P547, DOI 10.2967/jnumed.116.178582; LISS MA, 2014, UROLOGY, V84, DOI DOI 10.1016/J.JACI.2014.07.006; Liss MA, 2014, J NUCL MED, V55, P1552, DOI 10.2967/jnumed.114.140871; Marcinow AM, 2013, JAMA OTOLARYNGOL, V139, P895, DOI 10.1001/jamaoto.2013.4239; NCCN, 2017, CLIN PRACT GUID UT N; Panici PB, 2008, JNCI-J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Papadia A, 2017, J CANCER RES CLIN, V143, P2039, DOI 10.1007/s00432-017-2501-8; Papadia A, 2017, J CANCER RES CLIN, V143, P475, DOI 10.1007/s00432-016-2297-y; Qin ZT, 2015, NUCL MED BIOL, V42, P917, DOI 10.1016/j.nucmedbio.2015.07.011; Qin ZT, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.101315; Rossi EC, 2017, LANCET ONCOL, V18, P384, DOI 10.1016/S1470-2045(17)30068-2; Seamon LG, 2010, GYNECOL ONCOL, V117, P6, DOI 10.1016/j.ygyno.2009.12.025; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sondak VK, 2013, ANN SURG ONCOL, V20, P680, DOI 10.1245/s10434-012-2612-z; Stroup SP, 2012, CLIN EXP METASTAS, V29, P673, DOI 10.1007/s10585-012-9498-9; Todo Y, 2010, LANCET, V375, P1165, DOI 10.1016/S0140-6736(09)62002-X; Unkart JT, 2015, ANN SURG ONCOL, V22, pS559, DOI 10.1245/s10434-015-4802-y; Vera DR, 2001, J NUCL MED, V42, P951; Wallace AM, 2003, ANN SURG ONCOL, V10, P531, DOI 10.1245/ASO.2003.07.012; Wallace AM, 2013, ANN SURG ONCOL, V20, P2590, DOI 10.1245/s10434-013-2887-8; Wallace AM, 2009, NUCL MED BIOL, V36, P687, DOI 10.1016/j.nucmedbio.2009.04.007	32	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0197842	10.1371/journal.pone.0197842	http://dx.doi.org/10.1371/journal.pone.0197842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965996	Green Submitted, gold, Green Published			2022-12-26	WOS:000437224100003
J	Steinhard, J; Entenmann, A; van der Valk, E; Schmitz, R; Heinig, J; Laser, KT; Michel, M				Steinhard, Johannes; Entenmann, Andreas; van der Valk, Elise; Schmitz, Ralf; Heinig, Joerg; Laser, Kai Thorsten; Michel, Miriam			The transverse four-chamber view for the assessment of atrial tissue deformation in the fetus	PLOS ONE			English	Article							ATRIOVENTRICULAR TIME INTERVALS; SPECKLE-TRACKING; DOPPLER-ECHOCARDIOGRAPHY; FETAL HEART; STRAIN; DIAGNOSIS; CARDIOVERSION; FIBRILLATION; ARRHYTHMIAS	Aims To determine if atrial tissue deformation (peak strain, PS) and time to peak strain (TTPS) can be assessed in the fetus, with identification of best echocardiographic plane. Materials and methods Pulsed-wave tissue Doppler study of a longitudinal and a transverse four-chamber view (FCV) in each of 20 healthy fetuses. Determination of PS and TTPS in regions of interest (ROI), viz., lateral walls of the right and left atria (RA, LA); comparison of values depending on section plane, with results-based discussion of the physiology of fetal atrial deformation and of possible clinical uses. Results PS and TTPS could be determined on transverse FCV in 91% of subjects and in 61% on longitudinal FCV. Transverse PS and TTPS were significantly higher than longitudinal (p = 0.0001). Transverse PS was significantly higher in RA than in LA (26.9% vs. 17.3%, p = 0.034), and transverse TTPS was significantly shorter in RA than in LA (p = 0.034). Conclusion Atrial radial PS and TTPS determinations are possible in the fetus. The transverse FCV is best suited for these. The highest PS values and shortest TTPS values are found in ROI representing the RA. Our findings may contribute to detailed intrauterine assessment of atrial and ventricular myocardial function.	[Steinhard, Johannes; Laser, Kai Thorsten; Michel, Miriam] Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia, Ctr Pediat Cardiol & Congenital Heart Dis, Bochum, Germany; [Entenmann, Andreas] Innsbruck Med Univ, Dept Pediat Pediat 1, Innsbruck, Austria; [van der Valk, Elise] St Franziskus Hosp, Dept Obstet & Gynecol, Munster, Germany; [Schmitz, Ralf; Heinig, Joerg] Univ Munster, Dept Obstet & Gynaecol, Prenatal Med, Munster, Germany; [Michel, Miriam] Innsbruck Med Univ, Dept Pediat Cardiol Pediat 2, Innsbruck, Austria	Ruhr University Bochum; Medical University of Innsbruck; St. Franziskus-Hospital; University of Munster; Medical University of Innsbruck	Michel, M (corresponding author), Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia, Ctr Pediat Cardiol & Congenital Heart Dis, Bochum, Germany.; Michel, M (corresponding author), Innsbruck Med Univ, Dept Pediat Cardiol Pediat 2, Innsbruck, Austria.	miriam.michel@i-med.ac.at	Laser, Kai Thorsten/B-8698-2015	Michel, Miriam/0000-0002-3626-3270				Antoni ML, 2011, J AM SOC ECHOCARDIOG, V24, P1126, DOI 10.1016/j.echo.2011.06.017; Bergman G, 2006, ULTRASOUND OBST GYN, V28, P57, DOI 10.1002/uog.2712; Cameli M, 2011, ECHOCARDIOGR-J CARD, V28, P327, DOI 10.1111/j.1540-8175.2010.01329.x; Cameli M, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-14; Carovac Aladin, 2011, Acta Inform Med, V19, P168, DOI 10.5455/aim.2011.19.168-171; Cotton JL, 2001, CIRCULATION, V104, P1206, DOI 10.1161/hc3501.094231; Crispi F, 2012, FETAL DIAGN THER, V32, P96, DOI 10.1159/000337329; D'hooge J, 2000, Eur J Echocardiogr, V1, P154, DOI 10.1053/euje.2000.0031; Dahlback C, 2015, PRENATAL DIAG, V35, P605, DOI 10.1002/pd.4580; Di Salvo G, 2005, J AM SOC ECHOCARDIOG, V18, P930, DOI 10.1016/j.echo.2005.01.029; Cianciulli TF, 2010, WORLD J CARDIOL, V2, P163, DOI 10.4330/wjc.v2.i7.163; Herling L, 2015, CARDIOVASC ULTRASOUN, V13, DOI 10.1186/s12947-015-0034-3; Ho SY, 2009, CLIN ANAT, V22, P52, DOI 10.1002/ca.20634; Jaeggi E, 1998, HEART, V79, P582, DOI 10.1136/hrt.79.6.582; Kaya EB, 2008, EUR J ECHOCARDIOGR, V9, P472, DOI 10.1016/j.euje.2007.07.003; Kurt M, 2012, EUR HEART J-CARD IMG, V13, P524, DOI 10.1093/ejechocard/jer283; Larsen LU, 2006, ULTRASOUND OBST GYN, V27, P210, DOI 10.1002/uog.2669; LI S, 1993, ULTRASOUND MED BIOL, V19, P593, DOI 10.1016/0301-5629(93)90083-Z; Muller P, 2014, J CARDIOVASC ELECTR, V25, P161, DOI 10.1111/jce.12306; Nii M, 2006, HEART, V92, P1831, DOI 10.1136/hrt.2006.093070; O'Connor K, 2011, EUR J ECHOCARDIOGR, V12, P299, DOI 10.1093/ejechocard/jer006; Paladini D, 2003, PRENATAL DIAG, V23, P1052, DOI 10.1002/pd.753; Paladini D, 2000, ULTRASOUND OBST GYN, V16, P530, DOI 10.1046/j.1469-0705.2000.00251.x; Rein AJJT, 2002, CIRCULATION, V106, P1827, DOI 10.1161/01.CIR.0000031571.92807.CC; STEWART JM, 1991, CARDIOVASC RES, V25, P784, DOI 10.1093/cvr/25.9.784; STRASBURGER JF, 1986, J AM COLL CARDIOL, V7, P1386, DOI 10.1016/S0735-1097(86)80161-9; Vieira MJ, 2014, J AM SOC ECHOCARDIOG, V27, P463, DOI 10.1016/j.echo.2014.01.021; Willruth AM, 2018, ULTRASCHALL MED, V39, P56, DOI 10.1055/s-0041-107765; Yu CM, 2005, INT J CARDIOL, V105, P178, DOI 10.1016/j.ijcard.2004.12.077	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199581	10.1371/journal.pone.0199581	http://dx.doi.org/10.1371/journal.pone.0199581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965971	Green Published, gold, Green Submitted			2022-12-26	WOS:000437224100015
J	Wieben, ED; Aleff, RA; Tang, XJ; Kalari, KR; Maguire, LJ; Patel, SV; Baratz, KH; Fautsch, MP				Wieben, Eric D.; Aleff, Ross A.; Tang, Xiaojia; Kalari, Krishna R.; Maguire, Leo J.; Patel, Sanjay V.; Baratz, Keith H.; Fautsch, Michael P.			Gene expression in the corneal endothelium of Fuchs endothelial corneal dystrophy patients with and without expansion of a trinucleotide repeat in TCF4	PLOS ONE			English	Article							MISSENSE MUTATIONS; MYOTONIC-DYSTROPHY; ASSOCIATION; PROTEIN	Fuchs Endothelial Corneal Dystrophy (FECD) is a late onset, autosomal dominant eye disease that can lead to loss of vision. Expansion of a CTG trinucleotide repeat in the third intron of the transcription factor 4 (TCF4) gene is highly associated with FECD. However, only about 75% of FECD patients in the northern European population possess an expansion of this repeat. The remaining FECD cases appear to be associated with variants in other genes. To better understand the pathophysiology of this disease, we compared gene expression profiles of corneal endothelium from FECD patients with an expanded trinucleotide repeat (RE+) to those that do not have a repeat expansion (RE-). Comparative analysis of these two cohorts showed widespread RNA mis-splicing in RE+, but not in RE- samples. Quantitatively, we identified 39 genes in which expression was significantly different between RE+ and RE- samples. Examination of the mutation profiles in the RE- samples did not find any mutations in genes previously associated with FECD, but did reveal one sample with a rare variant of laminin subunit gamma 1 (LAMC1) and three samples with rare variants in the gene coding for the mitochondrial protein peripheral-type benzodiazepine receptor-associated protein 1 (TSPOAP1).	[Wieben, Eric D.; Aleff, Ross A.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Tang, Xiaojia; Kalari, Krishna R.] Mayo Clin, Div Biostat & Bioinformat, Rochester, MN USA; [Tang, Xiaojia; Kalari, Krishna R.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Maguire, Leo J.; Patel, Sanjay V.; Baratz, Keith H.; Fautsch, Michael P.] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Fautsch, MP (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA.	fautsch@mayo.edu		Wieben, Eric/0000-0002-8708-0968; Fautsch, Michael/0000-0002-9115-2485	National Eye Institute [EY26490, EY25071]; Minnesota Partnership for Biotechnology and Medical Genomics TPDF [15.21]; Research to Prevent Blindness; Mayo Foundation; NATIONAL EYE INSTITUTE [R01EY026490] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Minnesota Partnership for Biotechnology and Medical Genomics TPDF; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Mayo Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute grants EY26490 (MPF) and EY25071 (KHB); Minnesota Partnership for Biotechnology and Medical Genomics TPDF #15.21 (MPF); Research to Prevent Blindness (MPF, KHB, SVP, LJM); and Mayo Foundation (MPF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari NA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14898; Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Benischke AS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06523-2; Du JT, 2015, J BIOL CHEM, V290, P5979, DOI 10.1074/jbc.M114.621607; Gatliff J, 2014, AUTOPHAGY, V10, P2279, DOI 10.4161/15548627.2014.991665; Gattey D, 2014, CORNEA, V33, P96, DOI 10.1097/ICO.0000000000000018; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; Kalari KR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-224; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kuot A, 2012, EUR J HUM GENET, V20, P632, DOI 10.1038/ejhg.2011.248; Mootha VV, 2017, INVEST OPHTH VIS SCI, V58, P4579, DOI 10.1167/iovs.17-22350; Mootha VV, 2014, INVEST OPHTH VIS SCI, V55, P33, DOI 10.1167/iovs.13-12611; Riazuddin SA, 2012, AM J HUM GENET, V90, P533, DOI 10.1016/j.ajhg.2012.01.013; Riazuddin SA, 2010, HUM MUTAT, V31, P1261, DOI 10.1002/humu.21356; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; Selvaraj V, 2015, TRENDS ENDOCRIN MET, V26, P341, DOI 10.1016/j.tem.2015.02.007; Vasanth S, 2015, INVEST OPHTH VIS SCI, V56, P4531, DOI 10.1167/iovs.14-16122; Wieben ED, 2017, INVEST OPHTH VIS SCI, V58, P343, DOI 10.1167/iovs.16-20900; Wieben ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049083	19	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0200005	10.1371/journal.pone.0200005	http://dx.doi.org/10.1371/journal.pone.0200005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966009	Green Published, gold, Green Submitted			2022-12-26	WOS:000437224100036
J	Yi, SY; Tuot, S; Chhoun, P; Pal, K; Chhim, K; Ngin, C; Brody, C				Yi, Siyan; Tuot, Sovannary; Chhoun, Pheak; Pal, Khuondyla; Chhim, Kolab; Ngin, Chanrith; Brody, Carinne			Sexual behaviors, HIV knowledge, HIV testing attitudes and recent HIV testing among female entertainment workers in Cambodia: A cross-sectional study	PLOS ONE			English	Article							HEALTH	Background In Cambodian context, female entertainment workers (FEWs) are young women working at establishments such as karaoke bars, restaurants, beer gardens or massage parlors. FEWs may sell sex to male patrons and are considered a high-risk group for HIV. This study aimed to identify factors associated with recent HIV testing among FEWs in Cambodia to inform future prevention activities. Methods Data were collected in 2014 as part of the evaluation of a larger HIV prevention project. A two-stage cluster sampling method was used to select participants from Phnom Penh and Siem Reap for face-to-face interviews using a structured questionnaire. A logistic regression model was constructed to identify independent factors associated with recent HIV testing. Results Data were collected from 667 FEWs with a mean age of 25.6 (SD = 5.5). Of total, 81.7% reported ever having had an HIV test, and 52.8% had at least one test in the past six months. After adjustment for other covariates, factors independently associated with recent HIV testing included living in Phnom Penh (AOR = 2.17, 95% CI = 1.43-3.28), having received HIV education in the past six months (AOR = 3.48, 95% CI = 2.35-5.15), disagreeing with a statement that 'I would rather not know if I have HIV' (AOR = 2.15, 95% CI = 1.41-3.30), agreeing with a statement that 'getting tested for HIV helps people feel better' (AOR = 0.32, 95% CI = 0.13-0.81) and not using a condom in the last sexual intercourse with a non-commercial partner (AOR = 0.48, 95% CI = 0.26-0.88). Conclusions FEWs with greater knowledge and positive attitudes towards HIV testing got tested for HIV more frequently than those with lesser knowledge and less positive attitudes. These findings suggest that future interventions should focus on disseminating tailored health messages around testing practices as well as specific topics such as condom use with non-commercial partners.	[Yi, Siyan; Tuot, Sovannary; Chhoun, Pheak; Pal, Khuondyla; Chhim, Kolab; Ngin, Chanrith] KHANA Ctr Populat Hlth Res, Phnom Penh, Cambodia; [Yi, Siyan; Brody, Carinne] Touro Univ Calif, Coll Educ & Hlth Sci, Publ Hlth Program, Vallejo, CA 94592 USA	Touro University California	Yi, SY (corresponding author), KHANA Ctr Populat Hlth Res, Phnom Penh, Cambodia.; Yi, SY (corresponding author), Touro Univ Calif, Coll Educ & Hlth Sci, Publ Hlth Program, Vallejo, CA 94592 USA.	siyan@doctor.com	Chhoun, Pheak/AAR-3361-2021	Chhoun, Pheak/0000-0001-6369-0190	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	Data used for this study were collected as part of the impact evaluation of the Sustainable Action against HIV and AIDS in Communities that was funded by the United States Agency for International Development (USAID). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Tran BX, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.20690; Cai R, 2015, SEX HEALTH, V12, P257, DOI 10.1071/SH14189; Carey MP, 2002, AIDS EDUC PREV, V14, P172, DOI 10.1521/aeap.14.2.172.23902; Chhim S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015390; Heng S, 2013, MID TERM REV SUSTAIN; Hong Y, 2012, AIDS BEHAV, V16, P44, DOI 10.1007/s10461-011-9960-8; International Labor Organization (ILO), 2011, CAMB D ADDR HIV VULN; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2011, CAMB COUNTR PROC REP; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; KHANA, 2017, ANN REP 2017 PARTN U; Maher L, 2015, HEALTH HUM RIGHTS, V17, P102, DOI 10.2307/healhumarigh.17.1.102; Ministry of Education Youth and Sport, 2012, EX LIF EXP HIV RISKS; Mun M, 2016, NATL HIV SENTINEL SU; National Center for HIV/ AIDS Dermatology and STD (NCHADS) Ministry of Health Cambodia, 2016, STRAT PLAN HIV AIDS; National Center for HIV/ AIDS Dermatology and STDs (NCHADS), 2011, BEH SENT SURV 2010; National Center for HIV/ AIDS Dermatology and STDs (NCHADS), 2013, ANN REPORT; National Institute of Statistics Directorate General for Health and ORC Macro, 2014, CAMB DEM HLTH SURV 2; Nishigaya K, 2002, WOMEN HEALTH, V35, P27, DOI 10.1300/J013v35n04_03; Page K, 2013, BMJ OPEN, V3; Saphonn V, 2004, AIDS EDUC PREV, V16, P64, DOI 10.1521/aeap.16.3.5.64.35522; Sopheab H, 2009, AIDS, V23, P1389, DOI 10.1097/QAD.0b013e32832cd95a; UNAIDS, 2010, CAMB TAK MDG PRIZ EX; Wang C, 2007, SEX TRANSM INFECT, V83, P534, DOI 10.1136/sti.2007.027151; Weissman A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152906; Xu JJ, 2011, SEX TRANSM DIS, V38, P89, DOI 10.1097/OLQ.0b013e3181f0bc5e; Yi S, 2014, END PROJECT EVALUATI; Yi S, 2014, AM J PUBLIC HLTH RES, V2, P211, DOI DOI 10.12691/AJPHR-2-5-5; Yi S., 2016, AM J EPIDEMIOLOGY IN, V4, P91; Yi SY, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0122-6; Yi SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136114; Yi SY, 2015, BMC INFECT DIS, V15, DOI [10.1186/s12879-015-0954-4, 10.1186/s12889-015-2096-4]; Yi SY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-477	32	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0198095	10.1371/journal.pone.0198095	http://dx.doi.org/10.1371/journal.pone.0198095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965968	Green Published, Green Submitted, gold			2022-12-26	WOS:000437224100005
J	Pohjoismaki, JLO; Lampi, S; Donner, J; Anderson, H				Pohjoismaki, Jaakko L. O.; Lampi, Sara; Donner, Jonas; Anderson, Heidi			Origins and wanderings of the Finnish hunting spitzes	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; DOG DOMESTICATION; MITOCHONDRIAL-DNA; GENETIC-MARKERS; INFERENCE; HYBRIDIZATION; GENOMICS; SUGGEST; TREES	Deducing the evolutionary histories of dog breeds can be challenging due to convergent traits and frequent admixture. In this report, we have explored the relationships of indigenous Finnish hunting spitz breeds among other northern Eurasian hunting breeds using commercially available SNP analysis (the MyDogDNA panel test). We find that Nordic hunting breeds Finnish Spitz, Nordic Spitz and the Karelian Bear Dog, as well as the reindeer herding Lapphund and Lapponian herder are all closely related and have common origins with the northeastern Eurasian Laika breeds, rather than with other Scandinavian Spitz breeds, such as Elkhounds and Swedish Vallhund. By tracing admixture events and direction of gene flow, we also elucidate the complex interactions between the breeds and provide new insight into the history of Swedish Elkhound and Russian-European Laika. The findings, together with an analysis of genetic differentiation between the populations, not only help to understand the origins of the breeds but also provide interesting possibilities to revive genetic diversity, lost during the breeding history, by backcrossing breeds to their hypothetical ancestry.	[Pohjoismaki, Jaakko L. O.; Lampi, Sara] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland; [Donner, Jonas; Anderson, Heidi] Genoscoper Labs Oy, Helsinki, Finland	University of Eastern Finland	Pohjoismaki, JLO (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland.	Jaakko.Pohjoismaki@uef.fi	Pohjoismaeki, Jaakko L. O./AAC-7995-2019	Pohjoismaeki, Jaakko L. O./0000-0002-1185-3610; Donner, Jonas/0000-0002-9874-8484	Genoscoper Laboratories Ltd	Genoscoper Laboratories Ltd	HA and JD represent Genoscoper Laboratories Ltd, a private company providing dog genotyping services. The company provided support in the form of salaries for authors HA and JD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Brown TA, 2006, CELL CYCLE, V5, P917, DOI 10.4161/cc.5.9.2710; Bryant D, 2012, MOL BIOL EVOL, V29, P1917, DOI 10.1093/molbev/mss086; Buja A, 2008, J COMPUT GRAPH STAT, V17, P444, DOI 10.1198/106186008X318440; COCKERHAM CC, 1993, EVOLUTION, V47, P855, DOI 10.1111/j.1558-5646.1993.tb01239.x; Donner J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161005; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Foote AD, 2016, HEREDITY, V117, P316, DOI 10.1038/hdy.2016.54; Hodel RGJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16810-7; Kettunen A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170039; Klutsch CFC, 2011, ANIM GENET, V42, P100, DOI 10.1111/j.1365-2052.2010.02069.x; Kumpulainen M, 2017, J ANIM BREED GENET; Kyostila K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002759; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Mortlock SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147941; Moura AE, 2015, HEREDITY, V114, P48, DOI 10.1038/hdy.2014.67; MyDogDNA, 2017, MYDOGDNA TECHNICAL D; Palo JU, 2009, EUR J HUM GENET, V17, P1336, DOI 10.1038/ejhg.2009.53; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Parker HG, 2017, CELL REP, V19, P697, DOI 10.1016/j.celrep.2017.03.079; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pilot M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2189; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2017, GRAPHICAL VIEWER PHY; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schopen GCB, 2008, ANIM GENET, V39, P451, DOI 10.1111/j.1365-2052.2008.01736.x; Simonlinna J, 1990, SUOMENPYSTYKORVA 100; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Uutela PZ L., 1987, SUOMEN PYSTYKORVAJAR; Wayne RK, 2012, MAMM GENOME, V23, P3, DOI 10.1007/s00335-011-9386-7; Wiener P, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3933-x	35	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0199992	10.1371/journal.pone.0199992	http://dx.doi.org/10.1371/journal.pone.0199992			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0PZ	29958296	gold, Green Submitted, Green Published			2022-12-26	WOS:000436793500025
J	Baines, PM; Schwab, AL; van Soest, AJ				Baines, Patricia M.; Schwab, A. L.; van Soest, A. J.			Experimental estimation of energy absorption during heel strike in human barefoot walking	PLOS ONE			English	Article							MECHANICAL WORK REQUIREMENTS; ANKLE PLANTAR FLEXORS; CENTER-OF-MASS; NEPTUNE ET-AL.; SWING INITIATION; INVERTED PENDULUM; STROKE PATIENTS; FOOT STRIKE; MUSCLE; COST	Metabolic energy expenditure during human gait is poorly understood. Mechanical energy loss during heel strike contributes to this energy expenditure. Previous work has estimated the energy absorption during heel strike as 0.8 J using an effective foot mass model. The aim of our study is to investigate the possibility of determining the energy absorption by more directly estimating the work done by the ground reaction force, the force-integral method. Concurrently another aim is to compare this method of direct determination of work to the method of an effective foot mass model. Participants of our experimental study were asked to walk barefoot at preferred speed. Ground reaction force and lower leg kinematics were collected at high sampling frequency (3000 Hz; 1295 Hz), with tight synchronization. The work done by the ground reaction force is 3.8 J, estimated by integrating this force over the foot-ankle deformation. The effective mass model is improved by dropping the assumption that foot-ankle deformation is maximal at the instant of the impact force peak. On theoretical grounds it is clear that in the presence of substantial damping that peak force and peak deformation do not occur simultaneously. The energy absorption results, due the vertical force only, corresponding to the force-integral method is similar to the results of the improved application of the effective mass model (2.7 J; 2.5 J). However the total work done by the ground reaction force calculated by the force-integral method is significantly higher than that of the vertical component alone. We conclude that direct estimation of the work done by the ground reaction force is possible and preferable over the use of the effective foot mass model. Assuming that energy absorbed is lost, the mechanical energy loss of heel strike is around 3.8 J for preferred walking speeds (approximate to 1.3(m/s)), which contributes to about 15-20% of the overall metabolic cost of transport.	[Baines, Patricia M.; Schwab, A. L.] Delft Univ Technol, Dept Mech Engn, Delft, Netherlands; [van Soest, A. J.] Vrije Univ Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands; [van Soest, A. J.] Res Inst Amsterdam Movement Sci, Amsterdam, Netherlands	Delft University of Technology; Vrije Universiteit Amsterdam	Baines, PM (corresponding author), Delft Univ Technol, Dept Mech Engn, Delft, Netherlands.	p.m.baines@tudelft.nl	Schwab, Arend/Q-4387-2016	Schwab, Arend/0000-0001-5897-9790				AERTS P, 1995, J BIOMECH, V28, P1299, DOI 10.1016/0021-9290(95)00009-7; Aerts P., 1993, Journal of Sports Sciences, V11, P449, DOI 10.1080/02640419308730011; ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; Baines PM, 2018, PMBAINES EXPT DATA E; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; Cappozzo A, 1996, CLIN BIOMECH, V11, P90, DOI 10.1016/0268-0033(95)00046-1; Cavanagh P., 1984, BIOL ASPECT MODELLIN, P24; Challis JH, 2008, J APPL BIOMECH, V24, P377, DOI 10.1123/jab.24.4.377; Chi KJ, 2005, J BIOMECH, V38, P1387, DOI 10.1016/j.jbiomech.2004.06.020; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; DECLERCQ D, 1994, J BIOMECH, V27, P1213, DOI 10.1016/0021-9290(94)90275-5; Eng JJ, 2002, STROKE, V33, P756, DOI 10.1161/hs0302.104195; Greenwood D T, 2006, ADV DYNAMICS; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Ker R F, 1989, Proc Inst Mech Eng H, V203, P191, DOI 10.1243/PIME_PROC_1989_203_038_01; Kinoshita H., 1992, J BIOMECH, V25, P806, DOI [10.1016/0021-9290(92)90565-I, DOI 10.1016/0021-9290(92)90565-I]; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Kuo AD, 2007, HUM MOVEMENT SCI, V26, P617, DOI 10.1016/j.humov.2007.04.003; Kuo AD, 2009, J BIOMECH, V42, P1783, DOI 10.1016/j.jbiomech.2009.03.054; Kwon YH., 1998, CTR OF PRESSURE; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; Neptune RR, 2009, J BIOMECH, V42, P1786, DOI [10.1016/j.jbiomech.2009.04.029, 10.1016/S0021-9290(01)00105-1]; Neptune RR, 2004, J BIOMECH, V37, P817, DOI 10.1016/j.jbiomech.2003.11.001; Neptune RR, 2001, J BIOMECH, V34, P1387, DOI 10.1016/S0021-9290(01)00105-1; OLNEY SJ, 1986, ARCH PHYS MED REHAB, V67, P92, DOI 10.1016/0003-9993(86)90109-7; PASSMORE R, 1955, PHYSIOL REV, V35, P801, DOI 10.1152/physrev.1955.35.4.801; Platts MM, 2006, MED SCI SPORT EXER, V38, P1041, DOI 10.1249/01.mss.0000222829.34111.9c; Rao SS., 2010, MECH VIBRATIONS; Riddick RC, 2016, J BIOMECH, V49, P436, DOI 10.1016/j.jbiomech.2016.01.001; Valiant G.A., 1984, DETERMINATION MECH C; WHIPP BJ, 1969, J APPL PHYSIOL, V26, P644, DOI 10.1152/jappl.1969.26.5.644; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Zajac FE, 2003, GAIT POSTURE, V17, P1, DOI 10.1016/S0966-6362(02)00069-3; Zelik KE, 2015, J EXP BIOL, V218, P876, DOI 10.1242/jeb.115451	35	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0197428	10.1371/journal.pone.0197428	http://dx.doi.org/10.1371/journal.pone.0197428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953479	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400003
J	Blanc-Durand, P; Van der Gucht, A; Verger, A; Langen, KJ; Dunet, V; Bloch, J; Brouland, JP; Nicod-Lalonde, M; Schaefer, N; Prior, JO				Blanc-Durand, Paul; Van der Gucht, Axel; Verger, Antoine; Langen, Karl-Josef; Dunet, Vincent; Bloch, Jocelyne; Brouland, Jean-Philippe; Nicod-Lalonde, Marie; Schaefer, Niklaus; Prior, John O.			Voxel-based F-18-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas	PLOS ONE			English	Article							RESPONSE ASSESSMENT; GRADE II; FET PET; NEUROONCOLOGY; CLASSIFICATION; EXPRESSION; BIOMARKERS; DIAGNOSIS; POINT	Introduction Aim was to develop a full automatic clustering approach of the time-activity curves (TAC) from dynamic F-18-FET PET and evaluate its association with IDH1 mutation status and survival in patients with gliomas. Methods Thirty-seven patients (mean age: 45 +/- 13 y) with newly diagnosed gliomas and dynamic F-18-FET PET before any histopathologic investigation or treatment were retrospectively included. Each dynamic F-18-FET PET was realigned to the first image and spatially normalized in the Montreal Neurological Institute template. A tumor mask was semi-automatically generated from Z-score maps. Each brain tumor voxel was clustered in one of the 3 following centroids using dynamic time warping and k-means clustering (centroid #1: slowly increasing slope; centroid #2: rapidly increasing followed by slowly decreasing slope; and centroid #3: rapidly increasing followed by rapidly decreasing slope). The percentage of each dynamic F-18-FET TAC within tumors and other conventional F-18-FET PET parameters (maximum and mean tumor-to-brain ratios [TBRmax and TBRmean], time-to-peak [TTP] and slope) was compared between wild-type and IDH1 mutant tumors. Their prognostic value was assessed in terms of progression free-survival (PFS) and overall survival (OS) by Kaplan-Meier estimates. Results Twenty patients were IDH1 wild-type and 17 IDH1 mutant. Higher percentage of centroid #1 and centroid #3 within tumors were positively (P = 0.016) and negatively (P = 0.01) correlated with IDH1 mutated status. Also, TBRmax, TBRmean, TTP, and slope discriminated significantly between tumors with and without IDH1 mutation (P range 0.01 to 0.04). Progression occurred in 22 patients (59%) at a median of 13.1 months (7.6-37.6 months) and 13 patients (35%) died from tumor progression. Patients with a percentage of centroid #1 > 90% had a longer survival compared with those with a percentage of centroid #1 < 90% (P = 0.003 for PFS and P = 0.028 for OS). This remained significant after stratification on IDH1 mutation status (P = 0.029 for PFS and P = 0.034 for OS). Compared to other conventional F-18-FET PET parameters, TTP and slope were associated with PFS and OS (P range 0.009 to 0.04). Conclusions Based on dynamic F-18-FET PET acquisition, we developed a full automatic clustering approach of TAC which appears to be a valuable noninvasive diagnostic and prognostic marker in patients with gliomas.	[Blanc-Durand, Paul; Van der Gucht, Axel; Nicod-Lalonde, Marie; Schaefer, Niklaus; Prior, John O.] Lausanne Univ Hosp, Dept Nucl Med & Mol Imaging, Lausanne, Switzerland; [Verger, Antoine] Nancy Univ Hosp, Dept Nucl Med & Mol Imaging, Nancy, France; [Langen, Karl-Josef] Univ Aachen, Dept Nucl Med, Aachen, Germany; [Dunet, Vincent] Lausanne Univ Hosp, Dept Diagnost & Intervent Radiol, Lausanne, Switzerland; [Bloch, Jocelyne] Lausanne Univ Hosp, Dept Neurosurg, Lausanne, Switzerland; [Brouland, Jean-Philippe] Lausanne Univ Hosp, Dept Pathol & Lab Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); CHU de Nancy; RWTH Aachen University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Blanc-Durand, P (corresponding author), Lausanne Univ Hosp, Dept Nucl Med & Mol Imaging, Lausanne, Switzerland.	paul.blancdurand@gmail.com	PRIOR, John O/I-5364-2017; Verger, Antoine/AAA-2066-2022; Langen, Karl-Josef/H-4396-2013; Bloch, Jocelyne/A-9668-2017	PRIOR, John O/0000-0003-1429-1374; Langen, Karl-Josef/0000-0003-1101-5075; Bloch, Jocelyne/0000-0002-6405-1590; Schaefer, Niklaus/0000-0002-9732-7696	Lionel Perrier Foundation (Montreux, Switzerland)	Lionel Perrier Foundation (Montreux, Switzerland)	This work was supported by a grant from the Lionel Perrier Foundation (Montreux, Switzerland). The authors would like to acknowledge the help of the Pr. Adrien Depeursinge (Institute of Information Systems, University of Applied Sciences Western Switzerland [HES-SO], Sierre, Switzerland).	Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Albert NL, 2016, NEURO-ONCOLOGY, V18, P1199, DOI 10.1093/neuonc/now058; Borght TV, 2006, EUR J NUCL MED MOL I, V33, P1374, DOI 10.1007/s00259-006-0206-3; Calcagni ML, 2011, CLIN NUCL MED, V36, P841, DOI 10.1097/RLU.0b013e3182291b40; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Ceccon G, 2017, NEURO-ONCOLOGY, V19, P281, DOI 10.1093/neuonc/now149; Cohen AL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0345-4; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Ducray F, 2011, EXPERT REV ANTICANC, V11, P781, DOI [10.1586/era.10.202, 10.1586/ERA.10.202]; Dunet V, 2016, NEURO-ONCOLOGY, V18, P426, DOI 10.1093/neuonc/nov148; Galldiks N, 2015, NEURO-ONCOLOGY, V17, P1293, DOI 10.1093/neuonc/nov088; Herzog H, 2011, NUKLEARMED-NUCL MED, V50, P74, DOI 10.3413/Nukmed-0347-10-09; Ikawa M, 2015, NEUROLOGY, V84, P2033, DOI 10.1212/WNL.0000000000001588; Jansen NL, 2012, NEURO-ONCOLOGY, V14, P1473, DOI 10.1093/neuonc/nos259; Janvier L, 2015, CLIN NUCL MED, V40, pE429, DOI 10.1097/RLU.0000000000000897; Kaira K, 2011, AM J TRANSL RES, V3, P468; Keogh E, 2003, DATA MIN KNOWL DISC, V7, P349, DOI 10.1023/A:1024988512476; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kunz M, 2011, NEURO-ONCOLOGY, V13, P307, DOI 10.1093/neuonc/noq196; la Fougere C, 2011, NEURO-ONCOLOGY, V13, P806, DOI 10.1093/neuonc/nor054; Langen KJ, 2006, NUCL MED BIOL, V33, P287, DOI 10.1016/j.nucmedbio.2006.01.002; Lohmann P, 2015, EUR RADIOL, V25, P3017, DOI 10.1007/s00330-015-3691-6; Lopci E, 2017, EUR J NUCL MED MOL I, V44, P1155, DOI 10.1007/s00259-017-3618-3; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Metellus P, 2011, J NEURO-ONCOL, V105, P591, DOI 10.1007/s11060-011-0625-2; Papin-Michault C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157139; Popperl G, 2007, EUR J NUCL MED MOL I, V34, P1933, DOI 10.1007/s00259-007-0534-y; Rakthanmanon T, 2013, ACM T KNOWL DISCOV D, V7, DOI 10.1145/2500489; Stockhammer F, 2008, J NEURO-ONCOL, V88, P205, DOI 10.1007/s11060-008-9551-3; SUCHORSKA B, 2015, J CLIN ONCOL S, V33, P82431; Thon N, 2015, INT J CANCER, V136, P2132, DOI 10.1002/ijc.29259; Verger A, 2017, EUR J NUCL MED MOL I, V44, P1408, DOI 10.1007/s00259-017-3710-8; Verger A, 2017, EUR J NUCL MED MOL I, V44, P1306, DOI 10.1007/s00259-017-3668-6; Verger A, 2018, EUR J NUCL MED MOL I, V45, P443, DOI 10.1007/s00259-017-3846-6; Weller M, 2013, LANCET ONCOL, V14, pE370, DOI 10.1016/S1470-2045(13)70168-2; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Xiong J, 2016, J MAGN RESON IMAGING, V43, P45, DOI 10.1002/jmri.24958; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhang K, 2014, NUCL MED COMMUN, V35, P245, DOI 10.1097/MNM.0000000000000036; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	42	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199379	10.1371/journal.pone.0199379	http://dx.doi.org/10.1371/journal.pone.0199379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953478	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400028
J	Sandlesh, P; Juang, T; Safina, A; Higgins, MJ; Gurova, KV				Sandlesh, Poorva; Juang, Thierry; Safina, Alfiya; Higgins, Michael J.; Gurova, Katerina V.			Uncovering the fine print of the CreER(T2)-LoxP system while generating a conditional knockout mouse model of Ssrpl gene	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; CRE RECOMBINASE; INNER-EAR; FACT SUBUNITS; STEM-CELLS; IN-VIVO; EXPRESSION; GENOME; CANCER; MICE	FAcilitates Chromatin Transcription (FACT) is a complex of SSRP1 and SPT16 that is involved in chromatin remodeling during transcription, replication, and DNA repair. FACT has been mostly studied in cell-free or single cell model systems because general FACT knockout (KO) is embryonically lethal (E3.5). FACT levels are limited to the early stages of development and stem cell niches of adult tissues. FACT is upregulated in poorly differentiated aggressive tumors. Importantly, FACT inhibition (RNAi) is lethal for tumors but not normal cells, making FACT a lucrative target for anticancer therapy. To develop a better understanding of FACT function in the context of the mammalian organism under normal physiological conditions and in disease, we aimed to generate a conditional FACT KO mouse model. Because SPT16 stability is dependent on the SSRP1-SPT16 association and the presence of SSRP1 mRNA, we targeted the Ssrp1 gene using a CreER(T2)-LoxP approach to generate the FACT KO model. Here, we highlight the limitations of the CreER(T2)-LoxP (Rosa26) system that we encountered during the generation of this model. In vitro studies showed an inefficient excision rate of ectopically expressed CreER(T2) (retroviral CreER(T2)) in fibroblasts with homozygous floxed Ssrp1. In vitro and in vivo studies showed that the excision efficiency could only be increased with germline expression of two alleles of Rosa26CreER(T2). The expression of one germline Rosa26CreER(T2) allele led to the incomplete excision of Ssrp1. The limited efficiency of the CreER(T2)-LoxP system may be sufficient for studies involving the deletion of genes that interfere with cell growth or viability due to the positive selection of the phenotype. However, it may not be sufficient for studies that involve the deletion of genes supporting growth, or those crucial for development. Although CreERT2-LoxP is broadly used, it has limitations that have not been widely discussed. This paper aims to encourage such discussions.	[Sandlesh, Poorva; Juang, Thierry; Safina, Alfiya; Gurova, Katerina V.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Higgins, Michael J.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Gurova, KV (corresponding author), Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA.	Katerina.Gurova@roswellpark.org	Sandlesh, Poorva/AAA-3322-2022	Gurova, Katerina/0000-0001-9189-0712	Incuron LLC; National Cancer Institute [R01CA197967, P30CA016056, R21CA198395]; Komen Foundation award [CCR13264604]; NATIONAL CANCER INSTITUTE [R01CA197967, R21CA198395, P30CA016056] Funding Source: NIH RePORTER	Incuron LLC; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Komen Foundation award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Incuron LLC (to K.G.); National Cancer Institute [R01CA197967 to K.G. and P30CA016056 to Roswell Park Cancer Center]; National Cancer Institute [R21CA198395 to K.G.] Komen Foundation award [CCR13264604 to K.G.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Akbudak MA, 2011, MOL BIOTECHNOL, V49, P82, DOI 10.1007/s12033-011-9381-y; Attwood K, 2017, BREAST CANCER-TARGET, V9, P301, DOI 10.2147/BCTT.S126390; Burkhart C, 2014, ONCOTARGET, V5, P11038, DOI 10.18632/oncotarget.2701; Cao S, 2003, MOL CELL BIOL, V23, P5301, DOI 10.1128/MCB.23.15.5301-5307.2003; Carter DR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1803; Casanova E, 2002, GENESIS, V34, P208, DOI 10.1002/gene.10153; Chow LML, 2006, DEV DYNAM, V235, P2991, DOI 10.1002/dvdy.20948; Cox BC, 2012, JARO-J ASSOC RES OTO, V13, P295, DOI 10.1007/s10162-012-0324-5; Dai JL, 1996, STEROIDS, V61, P531; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Formosa T, 2012, BBA-GENE REGUL MECH, V1819, P247, DOI 10.1016/j.bbagrm.2011.07.009; Garcia H, 2013, CELL REP, V4, P159, DOI 10.1016/j.celrep.2013.06.013; Garcia H, 2011, ONCOTARGET, V2, P783; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Gui YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046076; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jo DW, 2001, NAT BIOTECHNOL, V19, P929, DOI 10.1038/nbt1001-929; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Kristianto J, 2017, TRANSGENIC RES, V26, P411, DOI 10.1007/s11248-017-0018-1; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Safina A, 2013, CELL CYCLE, V12, P2423, DOI 10.4161/cc.25452; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; Tian Y, 2006, BRAIN RES, V1091, P243, DOI 10.1016/j.brainres.2006.01.040; Vincent SD, 2003, GENESIS, V37, P54, DOI 10.1002/gene.10226; Zhang J, 2012, J ZHEJIANG UNIV-SC B, V13, P511, DOI 10.1631/jzus.B1200042; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458	38	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199785	10.1371/journal.pone.0199785	http://dx.doi.org/10.1371/journal.pone.0199785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953487	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400068
J	Gladstone, M; Phuka, J; Mirdamadi, S; Chidzalo, K; Chitimbe, F; Koenraads, M; Maleta, K				Gladstone, Melissa; Phuka, John; Mirdamadi, Shirin; Chidzalo, Kate; Chitimbe, Fatima; Koenraads, Marianne; Maleta, Kenneth			The care, stimulation and nutrition of children from 0-2 in Malawi-Perspectives from caregivers; "Who's holding the baby?"	PLOS ONE			English	Article							QUALITATIVE RESEARCH; FOUNDATION; GROWTH	Introduction Universal access to quality early childhood development and care is a fundamental part of Sustainable Development Goal 4.2.1. Research from diverse settings, including that in low and middle income countries, now demonstrates the positive impact that interventions to promote play, stimulation, early communication and responsiveness can have, not just on child development, but on long term gains in education and economic growth. International agencies have recently produced the Nurturing Care Framework for Early Child Development in order to promote this and to encourage countries to move the focus from child survival to child thrival. Research on the best methods of integration of these programmes into present care practices, particularly in African settings is still very limited. Methods We used qualitative methods to gain an understanding of care practices (play, developmental stimulation, early communication and responsive feeding) for children 0-2 years. We conducted 18 focus groups (FGDs), six PFGDs (Participatory Research focus groups), 18 in depth interviews (IDIs) and 20 observations with caregivers in rural and urban settings of Malawi. We used a topic guide, audio-recorded the FGDs and IDIS and transcribed them in Chichewa or Yao and then into English. We coded data using an inductive approach to thematic analysis. We placed the data within a framework with the emerging major and minor themes. We conducted quality assurance for translations and coding frameworks through cross comparison of data and used respondent validation to check our results. Results Malawian caregivers see children's play as a consequence of good health and wellbeing, less an interaction that a parent undertakes to promote wellbeing and learning. Non-verbal communication and responsiveness with infants is clearly present and caregivers have many one-on-one interactions with young infants. Furthermore, many caregivers have good knowledge of feeding recommendations but cannot always follow these due to constraints on money. When children become mobile (toddlers), play is an activity done more often between children or with other caregivers such as siblings or grandparents. Community members consider that caring for children from 0-2 years is a woman's domain. Despite this, both men and women acknowledge the importance of maternal wellbeing in enabling good care of children. The present socioeconomic situation of most families in our study means that income generation and food security come first. Many mothers spend most of their time managing the responsibilities of daily living and have limited time to dedicate to children's play, responsiveness and communication with their children. Discussion Programmes promoted as part of the Nurturing Care Framework which provide advice on developmental stimulation, play, early communication and responsive feeding should ensure that topics within these programmes are culturally appropriate for the setting. Furthermore, programmes must not be an added burden to parents but be supportive to parents managing many responsibilities of daily living. Multi-sectorial approaches where both men and women are provided with knowledge but are also supported through programmes which address family finances, safe spaces for children whilst families are working, and family mental health and relationships may enable programmes to work more effectively.	[Gladstone, Melissa; Mirdamadi, Shirin; Koenraads, Marianne] Univ Liverpool, Dept Women & Childrens Hlth, Inst Translat Med, Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England; [Phuka, John; Chidzalo, Kate; Chitimbe, Fatima; Maleta, Kenneth] Univ Malawi, Sch Publ Hlth & Family Med, Dept Publ Hlth, Blantyre, Malawi	Alder Hey Children's NHS Foundation Trust; University of Liverpool; University of Malawi	Gladstone, M (corresponding author), Univ Liverpool, Dept Women & Childrens Hlth, Inst Translat Med, Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England.	M.J.Gladstone@liverpool.ac.uk	Maleta, Ken M/J-2821-2016; Gladstone, Melissa J./L-6535-2018	Maleta, Ken M/0000-0002-2536-3938; Gladstone, Melissa J./0000-0002-2579-9301; Phuka, John/0000-0003-4951-8145	NIHR; Academy of Medical Sciences Clinical Lecturer Starter Grant [SGCU2011Dec/round6]; Wellcome Trust; British Heart Foundation; Arthritis Research UK; Wellcome Trust Biosciences fellowship [097826/Z/11/Z]	NIHR(National Institute for Health Research (NIHR)); Academy of Medical Sciences Clinical Lecturer Starter Grant; Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Arthritis Research UK(Versus Arthritis); Wellcome Trust Biosciences fellowship(Wellcome Trust)	M.G. was a clinical lecturer funded by NIHR at the time of conducting this research. She gratefully acknowledges support from an Academy of Medical Sciences Clinical Lecturer Starter Grant (SGCU2011Dec/round6) supported by the Wellcome Trust, British Heart Foundation and Arthritis Research UK as well as a Wellcome Trust Biosciences fellowship (097826/Z/11/Z).	Abebe Z, 2017, APPETITE, V116, P132, DOI 10.1016/j.appet.2017.04.033; Bannister D, 1994, QUALITATIVE METHODS; Bentley ME, 2014, ANN NY ACAD SCI, V1308, P54, DOI 10.1111/nyas.12290; Black MM, 2017, LANCET, V389, P77, DOI 10.1016/S0140-6736(16)31389-7; Boivin MJ, 2013, J PEDIATR-US, V163, P1409, DOI 10.1016/j.jpeds.2013.06.055; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Bronfenbrenner U, 2005, MAKING HUMAN BEINGS, P3; Corsaro William A., 2008, ANTHR CHILD DEV CROS, P227; Daelmans B, 2017, LANCET, V389, P9, DOI 10.1016/S0140-6736(16)31659-2; DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107; Flax VL, 2013, MATERN CHILD NUTR, V9, P369, DOI 10.1111/j.1740-8709.2011.00377.x; Hurley KM, 2016, ADV NUTR, V7, P357, DOI 10.3945/an.115.010363; ISABELLA RA, 1993, CHILD DEV, V64, P605, DOI 10.2307/1131272; Kimani-Murage EW, 2015, MATERN CHILD NUTR, V11, P314, DOI 10.1111/mcn.12161; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Lancy DF, 2010, BEHAV BRAIN SCI, V33, P99, DOI 10.1017/S0140525X10000154; Lancy DF., 2015, ANTHR CHILDHOOD CHER; Legard R, 2004, QUALITATIVE RES PRAC, P138; LeVine R.A., 1994, CHILD CARE CULTURE L; Lingam R, 2014, ANN NY ACAD SCI, V1308, P204, DOI 10.1111/nyas.12326; Makusha T, 2014, CHILD ABUSE NEGLECT, V38, P982, DOI 10.1016/j.chiabu.2014.05.003; Munthali AC, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-305; Penn H, 2004, 8 CHRON POV CTR SAV; Rempel LA, 2017, DEV PSYCHOL, V53, P1844, DOI 10.1037/dev0000390; Richards E, 2013, SOC SCI MED, V95, P24, DOI 10.1016/j.socscimed.2012.06.015; Richardson J, 2006, HDB QUALITATIVE RES; Richter L., 2006, Where the heart is: meeting the psychosocial needs of young children in the context of HIV/AIDS; Richter LM, 2017, LANCET, V389, P103, DOI 10.1016/S0140-6736(16)31698-1; Richter LM, 2003, J PAEDIATR CHILD H, V39, P243, DOI 10.1046/j.1440-1754.2003.00145.x; Rogoff B., 1990, APPRENTICESHIP THINK; Rogoff B., 2003, CULTURAL NATURE HUMA; Scotland J., 2012, ENGLISH LANGUAGE TEA, V5, P9, DOI [DOI 10.5539/ELT.V5N9P9, 10.5539/elt.v5n9p9]; Serpell R, 1976, CULTURES INFLUENCE B; Sharma R, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.011002; Spencer L, 2004, QUALITATIVE RES PRAC, P199; Sylva K., 1980, CHILD WATCHING PLAYG; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNICEF, 2018, MOD 5 ENG FATH; Vazir S, 2013, MATERN CHILD NUTR, V9, P99, DOI 10.1111/j.1740-8709.2012.00413.x; Whiting B. B., 1975, CHILDREN 6 CULTURES; WHO/UNICEF, 2012, CAR CHILD DEV IMPR C; World Bank UNICEF World Health Organisation, 2018, NURT CAR EARLY CHILD; Yousafzai AK, 2015, PEDIATRICS, V135, pE1247, DOI 10.1542/peds.2014-2335; Yousafzai AK, 2014, ANN NY ACAD SCI, V1308, P33, DOI 10.1111/nyas.12313	45	9	10	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199757	10.1371/journal.pone.0199757	http://dx.doi.org/10.1371/journal.pone.0199757			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK9FZ	29949636	Green Published, gold, Green Submitted			2022-12-26	WOS:000436549200066
J	Shi, YP; Su, C; Hu, HX; Yan, H; Li, W; Chen, GH; Xu, DH; Du, XH; Zhang, P				Shi, Yunpeng; Su, Chang; Hu, Haixia; Yan, He; Li, Wei; Chen, Guohui; Xu, Dahai; Du, Xiaohong; Zhang, Ping			Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-2; COLORECTAL-CANCER; PROGNOSTIC-SIGNIFICANCE; EXPRESSION; THERAPY; PROTEIN; PLASMA	Objective The prevalence of papillary thyroid carcinoma (PTC) is rising rapidly. However, there are no reliable serum biomarkers for PTC. This study aimed to investigate the validity of preoperative serum matrix metalloproteinase-2 (MMP-2) as a biomarker for predicting prognosis of PTC after total or partial thyroidectomy. Methods Male patients with PTC or a benign thyroid nodule (BTN) and healthy controls (HCs) were retrospectively included. Receiver operating characteristic (ROC) curves were constructed to evaluate the performance of preoperative serum MMP-2 in diagnosing PTC, predicting lymph node metastasis (LNM), and predicting structurally persistent/recurrent disease (SPRD). Multivariate logistic regression and Cox regression were applied to identify independent risk factors for SPRD. Results The preoperative serum MMP-2 concentration in the PTC group was higher than those in BTN and HC groups. The concentration of postoperative serum MMP-2 decreased in comparison with pre-operation. ROC curves showed that serum MMP-2 could differentially diagnose PTC from BTN at the cutoff value of 86.30 ng/ml with an area under the curve (AUC) of 0.905 and could predict central LNM (CLNM) at the cutoff value of 101.55 ng/ml with an AUC of 0.711. Serum MMP-2 >101.55 ng/ml, age >45 years, and advanced TNM stage were independent risk factors for CLNM. Patients with SPRD had a higher median MMP-2 level (149.22 ng/ml) than patients without SPRD (104.55 ng/ml). Serum MMP-2 at the cutoff value of 144.04 ng/ml could predict SPRD in PTC patients with an AUC of 0.803. Advanced TNM stage and serum MMP-2 >144.04 ng/ml were independent risk factors for SPRD. Patients with serum MMP-2 >144.04 ng/ml had a worse clinical outcome than those with MMP-2 <144.04 ng/ml. Conclusion Preoperative serum MMP-2 may serve as a biomarker for diagnosing PTC and a predictive indicator for LNM and SPRD in male patients with PTC.	[Shi, Yunpeng; Du, Xiaohong; Zhang, Ping] Jilin Univ, Hosp 1, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China; [Su, Chang] Jilin Univ, Hosp 1, Dept Thyroid Surg, Changchun, Jilin, Peoples R China; [Hu, Haixia; Yan, He; Li, Wei; Xu, Dahai] Jilin Univ, Hosp 1, Dept Emergency, Changchun, Jilin, Peoples R China; [Chen, Guohui] Jilin City Peoples Hosp, Dept Pathol, Jilin, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Du, XH; Zhang, P (corresponding author), Jilin Univ, Hosp 1, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China.; Xu, DH (corresponding author), Jilin Univ, Hosp 1, Dept Emergency, Changchun, Jilin, Peoples R China.	yangzhouxux@sina.com; duxiaohong_6@sina.com; jdyyzhangping@163.com			Project of Education Department of Jilin Province [20150125, 2016453, 2016482]; Project of Health Department of Jilin Province [20150125]; Special Project for Health in Jilin Province [2018SCZWSZX-050]	Project of Education Department of Jilin Province; Project of Health Department of Jilin Province; Special Project for Health in Jilin Province	This work was supported by Project of Education Department of Jilin Province: #20150125, #2016453, #2016482 (Yunpeng Shi); Project of Health Department of Jilin Province: #20150125 (Yunpeng Shi); and Special Project for Health in Jilin Province: #2018SCZWSZX-050 (Dr. Dahai Xu).	Apostol DC, 2017, ROM J MORPHOL EMBRYO, V58, P439; Babula D, 2017, CLIN NEUROL NEUROSUR, V158, P90, DOI 10.1016/j.clineuro.2017.05.005; ben Nejima D, 2017, APPL IMMUNOHISTO M M, V25, P64, DOI 10.1097/PAI.0000000000000263; Chen YY, 2017, ENVIRON TOXICOL, V30, P74; Cymbaluk-Ploska A, 2017, ONCOTARGETS THER, V10, P3169, DOI 10.2147/OTT.S136750; Dawood FA, 2017, INT J PHARM BIO SCI, V8, pB622; Giganti MG, 2016, ONCOL LETT, V12, P2119, DOI 10.3892/ol.2016.4887; He J, 2017, BIOMED RES-INDIA, V28, P6711; Huang LL, 2017, INT J ONCOL, V51, P812, DOI 10.3892/ijo.2017.4074; Jia ZL, 2015, J XIAN JIAOTONG U ME, V36, P382; [贾宗良 Jia Zongliang], 2015, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V36, P362; Jonsson A, 2016, BRIT J CANCER, V115, P703, DOI 10.1038/bjc.2016.127; Jung CW, 2017, HISTOPATHOLOGY, V70, P301, DOI 10.1111/his.13065; Kim Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174737; Kumara HMCS, 2016, GASTROENTEROLOGY, V150, pS1219, DOI 10.1016/S0016-5085(16)34124-5; Lee JJ, 2017, J CLIN ENDOCRINOL ME; Liu C, 2016, CLIN EXP MED, V16, P375, DOI 10.1007/s10238-015-0369-y; Lukaszewicz-Zaja c M, 2015, CLIN CHEM LAB MED, V53, pS420; Marecko I, 2012, CANCER BIOMARK, V11, P49, DOI 10.3233/CBM-2012-0258; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Mikulova V, 2016, PREDICTIVE POTENTIAL, V76; Pang L, 2016, ONCOTARGET, V7, P77854, DOI 10.18632/oncotarget.12835; Pisamai S, 2017, J COMP PATHOL, V157, P150, DOI 10.1016/j.jcpa.2017.07.004; Ren FH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135544; Ricci S, 2017, J NEURO-ONCOL, V131, P223, DOI 10.1007/s11060-016-2297-4; Saffar H, 2013, PATHOL RES PRACT, V209, P195, DOI 10.1016/j.prp.2012.06.011; Song M, 2016, SERUM MMP2 MMP7 MMP9, P159; Tabouret E, 2015, EFFECT HIGH MMP2 LOW; Wehland M, 2013, INT J MOL SCI, V14, P9338, DOI 10.3390/ijms14059338; Wu G, 2013, J INT MED RES, V41, P816, DOI 10.1177/0300060513481923; Xie TC, 2016, BIOMED REP, V4, P241, DOI 10.3892/br.2015.553; Zhang DY, 2015, INT J CLIN EXP MED, V8, P20391; Zhang Q, 2016, BIOMED REP, V36; Zhao QJ, 2017, TUMOR BIOL, V39, P1, DOI 10.1177/1010428317707881; Zhou SF, 2013, CHINESE J CANC PREVE, V20, P942; Zhou SF, 2013, CHINESE MED J-PEKING, V126, P1925, DOI 10.3760/cma.j.issn.0366-6999.20130172; Zhu XL, 2016, INT J ONCOL, V48, P2321, DOI 10.3892/ijo.2016.3485; Zhu YC, 2017, INT J CLIN EXP MED, V10, P11488	38	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198896	10.1371/journal.pone.0198896	http://dx.doi.org/10.1371/journal.pone.0198896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949618	Green Submitted, Green Published, gold			2022-12-26	WOS:000436549200029
J	Yaya, S; Ghose, B				Yaya, Sanni; Ghose, Bishwajit			Patterns of computer and Internet use and its association with HIV knowledge in selected countries in sub-Saharan Africa	PLOS ONE			English	Article							HEALTH-CARE; BEHAVIOR-CHANGE; INTERVENTIONS; DISPARITIES; INFORMATION	Background Healthcare systems in Sub-Saharan Africa (SSA) are fraught with numerous governance and infrastructural issues including lack of access to quality care and health worker shortage. Policy makers are becoming increasingly interested in adopting novel technologies such as web-based interventions within the scope of e-Health to bridge the gaps in care delivery in a cost-effective and sustainable manner. Successful implementation of these policies is reliant on evidences regarding people's access to these technologies, which are scarce for countries in SSA. Objectives To 1) investigate the variation in the prevalence of accessing computer and internet across regional and socioeconomic groups, and 2) assess association between ever accessing computer and internet and knowledge of routes and risk factors of HIV transmission in selected SSA countries. Methods We analyzed cross-sectional datasets from UNICEF Multiple Indicator Cluster Surveys. Participants were 16,194 men and 39,121 women from Ghana, Guinea Bissau, Malawi and Zimbabwe. Main outcome variable was ever-accessing computer and Internet for any purpose. Associations were assessed by multivariable regression methods. Results Lifetime computer usage in Ghana, Guinea Bissau, Malawi and Zimbabwe was respectively 21.5%, 13.4%, 12.3%, 28.4% among men, and 12.5%, 8.3%, 4.8%, 20.5% among women, and that of internet was 14.9%, 11.7%, 10.8%, 34% among men, and 6.4%, 6.9%, 4.2%, 21.6% among women in the aforementioned order. Participants who reported ever using computer and Internet were more likely to have higher knowledge regarding the transmission of HIV compared to those who did not. Conclusions Prevalence of lifetime access to computer and Internet was considerably low in all four countries. Several socioeconomic factors appeared to be associated with the access to computer and Internet, addressing which might prove beneficial for the successful expansion e-Health in these countries.	[Yaya, Sanni; Ghose, Bishwajit] Univ Ottawa, Fac Social Sci, Sch Int Dev & Global Studies, Ottawa, ON, Canada	University of Ottawa	Yaya, S (corresponding author), Univ Ottawa, Fac Social Sci, Sch Int Dev & Global Studies, Ottawa, ON, Canada.	sanni.yaya@uOttawa.ca	Yaya, Sanni/C-1079-2019	Yaya, Sanni/0000-0002-4876-6043				Abubakar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071998; Afarikumah Ebenezer, 2014, Online J Public Health Inform, V5, P230, DOI 10.5210/ojphi.v5i3.4943; Alpay LL, 2010, TELEMED J E-HEALTH, V16, P787, DOI 10.1089/tmj.2009.0156; Bender MS, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3710; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Chuma J, 2007, TROP MED INT HEALTH, V12, P673, DOI 10.1111/j.1365-3156.2007.01825.x; Dubay LC, 2012, INT J HEALTH SERV, V42, P607, DOI 10.2190/HS.42.4.c; Ghana Statistical Service, 2011, MULT IND CLUST SURV; Hieftje K, 2013, JAMA PEDIATR, V167, P574, DOI 10.1001/jamapediatrics.2013.1095; Kind T, 2005, AMBUL PEDIATR, V5, P117, DOI 10.1367/A04-107R.1; Landis-Lewis Z, 2015, INT J MED INFORM, V84, P868, DOI 10.1016/j.ijmedinf.2015.07.003; Latkin CA, 2015, BEHAV MED, V41, P90, DOI 10.1080/08964289.2015.1034645; Lee K, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4345; Lettieri E, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0983-0; Mills EJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7031; Ministerio da Economia e Financas Direccao Geral do Plano/ Instituto Nacional de Estatistica (INE), 2014, INQ AOS IND MULT MIC; Naicker S, 2010, CLIN NEPHROL, V74, pS129; National Statistical Office, 2015, MAL MDG ENDL SURV 20; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Santana S, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1281; Wamala Dan S, 2013, J Pathol Inform, V4, P6, DOI 10.4103/2153-3539.112686; Willcox ML, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0073-8; Yaya S, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1846-6; Yaya S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196896; Yaya S, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000085; ZIMSTAT, 2015, ZIMB MULT IND CLUST	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199236	10.1371/journal.pone.0199236	http://dx.doi.org/10.1371/journal.pone.0199236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949601	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200039
J	L'Honneur, AS; Leh, H; Laurent-Tchenio, F; Hazan, U; Rozenberg, F; Bury-Mone, S				L'Honneur, Anne-Sophie; Leh, Herve; Laurent-Tchenio, Fanny; Hazan, Uriel; Rozenberg, Flore; Bury-Mone, Stephanie			Exploring the role of NCCR variation on JC polyomavirus expression from dual reporter minicircles	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; TRANSCRIPTIONAL CONTROL REGION; NONCODING CONTROL REGION; GENE-EXPRESSION; CEREBROSPINAL-FLUID; REGULATORY REGION; VIRUS-DNA; REARRANGEMENT PATTERNS; TRANSGENE EXPRESSION; TONSIL TISSUE	JC virus (JCV), a ubiquitous human polyomavirus, can cause fatal progressive multifocal leukoencephalopathy (PML) in immune compromised patients. The viral genome is composed of two conserved coding regions separated by a highly variable non-coding control region (NCCR). We analyzed the NCCR sequence from 10 PML JCV strains and found new mutations. Remarkably, the NCCR f section was mutated in most cases. We therefore explored the importance of this section in JCV expression in renal (HEK293H) and glioblastoma (U-87MG) cell lines, by adapting the emerging technology of DNA minicircles. Using bidirectional fluorescent reporters, we revealed that impaired NCCR-driven late expression in glioblastoma cells was restored by a short deletion overlapping e and f sections. This study evidenced a relevant link between JCV NCCR polymorphism and cell-type dependent expression. The use of DNA minicircles opens new insights for monitoring the impact of NCCR variation.	[L'Honneur, Anne-Sophie; Rozenberg, Flore] Univ Paris 05, INSERM Paris, Paris, France; [L'Honneur, Anne-Sophie; Rozenberg, Flore] Hop Cochin, AP HP, Serv Virol, Paris, France; [Leh, Herve; Laurent-Tchenio, Fanny; Hazan, Uriel] Univ Paris Saclay, LBPA, CNRS, ENS Paris Saclay, Cachan, France; [Bury-Mone, Stephanie] Univ Paris Saclay, I2BC, CEA, CNRS,Univ Paris Sud, Gif Sur Yvette, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Rozenberg, F (corresponding author), Univ Paris 05, INSERM Paris, Paris, France.; Rozenberg, F (corresponding author), Hop Cochin, AP HP, Serv Virol, Paris, France.; Bury-Mone, S (corresponding author), Univ Paris Saclay, I2BC, CEA, CNRS,Univ Paris Sud, Gif Sur Yvette, France.	flore.rozenberg@aphp.fr; stephanie.bury-mone@i2bc.paris-saclay.fr		Bury-Mone, Stephanie/0000-0003-2535-2208				ACHESON NH, 1981, J VIROL, V37, P628, DOI 10.1128/JVI.37.2.628-635.1981; Agostini HT, 1997, J GEN VIROL, V78, P659, DOI 10.1099/0022-1317-78-3-659; Agostini HT, 1996, J CLIN MICROBIOL, V34, P159, DOI 10.1128/JCM.34.1.159-164.1996; Ajuh ET, 2018, J VIROL, V92, DOI 10.1128/JVI.02231-17; Akan I, 2006, VIROLOGY, V349, P66, DOI 10.1016/j.virol.2006.01.025; AMEMIYA K, 1992, J BIOL CHEM, V267, P14204; ASTROM KE, 1958, BRAIN, V81, P93, DOI 10.1093/brain/81.1.93; Ault GS, 1997, J GEN VIROL, V78, P163, DOI 10.1099/0022-1317-78-1-163; AULT GS, 1993, J GEN VIROL, V74, P1499, DOI 10.1099/0022-1317-74-8-1499; BERGER JR, 1987, ANN INTERN MED, V107, P78, DOI 10.7326/0003-4819-107-1-78; Bofill-Mas S, 2001, J NEUROVIROL, V7, P345, DOI 10.1080/13550280152537210; BRADY J, 1984, P NATL ACAD SCI-BIOL, V81, P2040, DOI 10.1073/pnas.81.7.2040; BROOKS BR, 1984, NEUROL CLIN, V2, P299, DOI 10.1016/S0733-8619(18)31105-8; Carson KR, 2009, LANCET ONCOL, V10, P816, DOI 10.1016/S1470-2045(09)70161-5; Casado JL, 2014, EUR J CLIN MICROBIOL, V33, P179, DOI 10.1007/s10096-013-1941-6; Daniel AM, 1996, VIROLOGY, V216, P90, DOI 10.1006/viro.1996.0037; Delbue S, 2005, J NEUROVIROL, V11, P51, DOI 10.1080/13550280590900382; Delbue S, 2012, J CELL PHYSIOL, V227, P3511, DOI 10.1002/jcp.24051; Dominguez-Mozo MI, 2016, EUR J NEUROL, V23, P182, DOI 10.1111/ene.12834; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Ferenczy MW, 2012, CLIN MICROBIOL REV, V25, P471, DOI 10.1128/CMR.05031-11; Ferrante P, 2003, J NEUROVIROL, V9, P42, DOI 10.1080/13550280390195405; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; Gosert R, 2010, J VIROL, V84, P10448, DOI 10.1128/JVI.00614-10; HOLMAN RC, 1991, NEUROLOGY, V41, P1733, DOI 10.1212/WNL.41.11.1733; HOUFF SA, 1988, NEW ENGL J MED, V318, P301, DOI 10.1056/NEJM198802043180507; Jensen PN, 2001, J NEUROVIROL, V7, P280; Johnson EM, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/197807; Kang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029800; Kato A, 2004, J NEUROVIROL, V10, P244, DOI 10.1080/13550280490468663; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; KELLER JM, 1984, CELL, V36, P381, DOI 10.1016/0092-8674(84)90231-9; KENNEY S, 1986, J VIROL, V58, P216, DOI 10.1128/JVI.58.1.216-219.1986; KHALILI K, 1987, VIROLOGY, V158, P469, DOI 10.1016/0042-6822(87)90224-8; KITAMURA T, 1990, J INFECT DIS, V161, P1128, DOI 10.1093/infdis/161.6.1128; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Low J, 2004, VIROLOGY, V323, P182, DOI 10.1016/j.virol.2004.03.027; Lu JM, 2017, HUM GENE THER, V28, P125, DOI 10.1089/hum.2016.140; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; MARKOWITZ RB, 1991, J VIROL, V65, P4515, DOI 10.1128/JVI.65.8.4515-4519.1991; Marshall LJ, 2014, J VIROL, V88, P5177, DOI 10.1128/JVI.03221-13; Marshall LJ, 2012, J GEN VIROL, V93, P651, DOI 10.1099/vir.0.035832-0; Marzocchetti A, 2008, J NEUROVIROL, V14, P455, DOI 10.1080/13550280802356837; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; Moens U, 2017, J GEN VIROL, V98, P1159, DOI 10.1099/jgv.0.000839; Monaco MCG, 1996, J VIROL, V70, P7004, DOI 10.1128/JVI.70.10.7004-7012.1996; Monao MCG, 1998, J VIROL, V72, P9918, DOI 10.1128/JVI.72.12.9918-9923.1998; Nakamichi K, 2014, ARCH VIROL, V159, P1687, DOI 10.1007/s00705-014-1988-4; Nakamichi K, 2013, ARCH VIROL, V158, P639, DOI 10.1007/s00705-012-1532-3; Newman JT, 1997, J MED VIROL, V52, P243, DOI 10.1002/(SICI)1096-9071(199707)52:3<243::AID-JMV2>3.0.CO;2-2; PADGETT BL, 1971, LANCET, V1, P1257; Pietropaolo V, 2003, J NEUROVIROL, V9, P603, DOI 10.1080/714044482; Ravichandran V, 2008, J GEN VIROL, V89, P1396, DOI 10.1099/vir.0.2008/000059-0; Reid CE, 2011, J INFECT DIS, V204, P237, DOI 10.1093/infdis/jir256; Riu ER, 2007, MOL THER, V15, P1348, DOI 10.1038/sj.mt.6300177; Sadowska B, 2003, J VIROL, V77, P665, DOI 10.1128/JVI.77.1.665-672.2003; Sariyer IK, 2009, J VIROL METHODS, V159, P122, DOI 10.1016/j.jviromet.2009.02.023; Schnodt M, 2016, MOL THER-NUCL ACIDS, V5, DOI [10.1038/mtna.016.60, 10.1038/mtna.2016.60]; Seppala H, 2017, J INFECT DIS, V215, P889, DOI 10.1093/infdis/jiw399; Sock E, 1996, J VIROL, V70, P1512, DOI 10.1128/JVI.70.3.1512-1520.1996; Takahashi K, 2017, J VIROL, V91, DOI [10.1128/JVI.01335-16, 10.1128/jvi.01335-16]; Tan CS, 2010, J VIROL, V84, P9200, DOI 10.1128/JVI.00609-10; Team RDC, 2019, R LANG ENV STAT COMP; Van Loy T, 2015, J VIROL, V89, P1340, DOI 10.1128/JVI.02565-14; Van Loy T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070950; Vaz B, 2000, J NEUROVIROL, V6, P398, DOI 10.3109/13550280009018304; Weber K, 2011, NAT MED, V17, P504, DOI 10.1038/nm.2338; Wollebo HS, 2015, ANN NEUROL, V77, P560, DOI 10.1002/ana.24371; Yan ZP, 2017, J HEPATOL, V66, P1149, DOI 10.1016/j.jhep.2017.02.004; YOGO Y, 1990, J VIROL, V64, P3139, DOI 10.1128/JVI.64.6.3139-3143.1990; Yogo Y, 2008, VIROLOGY, V380, P118, DOI 10.1016/j.virol.2008.07.016; Zheng HY, 2005, J GEN VIROL, V86, P2035, DOI 10.1099/vir.0.80863-0; Zheng HY, 2004, ARCH PATHOL LAB MED, V128, P275	74	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199171	10.1371/journal.pone.0199171	http://dx.doi.org/10.1371/journal.pone.0199171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944671	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800022
J	Xiao, N; Li, H; Yu, WR; Gu, C; Fang, HS; Peng, YB; Mao, HS; Fang, Y; Ni, W; Yao, M				Xiao, Ning; Li, Hui; Yu, Weirong; Gu, Chuan; Fang, Houshun; Peng, Yinbo; Mao, Heshui; Fang, Yong; Ni, Wei; Yao, Min			SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation	FASEB JOURNAL			English	Article						STK38; LLL; MAPK activation	KINASE; PROTEINS; PHOSPHORYLATION; CONJUGATION; PATHWAY; SHAPE; SITE	A key member of the sentrin/small ubiquitin-like modifier (SUMO)-specific protease (SENP) family, SENP2 has been shown to implicate embryonic development, fatty acid metabolism, atherosclerosis, and neurodegenerative diseases. However, other biologic functions of SENP2 and its specific targets are incompletely understood. Here, we uncovered a novel role of SENP2 in negative regulation of keratinocyte migration, a process crucial to wound epithelialization. Defects in this function are often associated with the clinical phenotypes of chronic nonhealing wounds. Mechanistically, SENP2 as a specific de-SUMOylase targets NDR1 (nuclear Dbf2-related 1), also called STK38 (serine-threonine kinase 38), for de-SUMOylation and SUMO conjugation of NDR1 on Lys-465 attenuates its inhibition of p38/ERK1/2 activation by decreasing the association of NDR1 with MEK kinase 1/2. Significantly, low-level laser (LLL) irradiation increases NDR1 SUMOylation and subsequent p38/ERK1/2 activation via down-regulation of SENP2, leading to faster keratinocyte migration. Our findings fill the gaps that linger in the basic mechanisms underlying LLL therapy.Xiao, N., Li, H., Yu, W., Gu, C., Fang, H., Peng, Y., Mao, H., Fang, Y., Ni, W., Yao, M. SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation.	[Xiao, Ning] Shanghai Univ Tradit Chinese Med, Canc Inst Tradit Chinese Med, Longhua Hosp, 725 South Wanping Rd, Shanghai 200032, Peoples R China; [Xiao, Ning; Yu, Weirong; Gu, Chuan; Peng, Yinbo; Mao, Heshui; Fang, Yong; Ni, Wei; Yao, Min] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Burns & Plast Surg, 280 Mohe Rd, Shanghai 201900, Peoples R China; [Xiao, Ning; Yu, Weirong; Gu, Chuan; Peng, Yinbo; Mao, Heshui; Fang, Yong; Ni, Wei; Yao, Min] Shanghai Jiao Tong Univ, Sch Med, Inst Traumat Med, Shanghai, Peoples R China; [Li, Hui; Fang, Houshun] Shanghai Jiao Tong Univ, Sch Med, Minist Hlth, Key Lab Pediat Hematol & Oncol, Shanghai, Peoples R China; [Li, Hui; Fang, Houshun] Shanghai Jiao Tong Univ, Sch Med, Pediat Translat Med Inst, Shanghai Childrens Med Ctr, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xiao, N (corresponding author), Shanghai Univ Tradit Chinese Med, Canc Inst Tradit Chinese Med, Longhua Hosp, 725 South Wanping Rd, Shanghai 200032, Peoples R China.; Yao, M (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Burns & Plast Surg, 280 Mohe Rd, Shanghai 201900, Peoples R China.	dynas1986@163.com; my058@vip.sina.com			National Natural Science Foundation of China [81501670, 81272113, 81500112]; China Postdoctoral Science Foundation [2016T90375]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors thank Dr. Jinke Cheng, Dr. Jun Tu, Dr. Xian Huang, and Dr. Ping Wang for plasmids and reagents. The authors are grateful to Dr. Xiujun Fu for checking the usage of English in this paper. This study was supported by grants from the National Natural Science Foundation of China (81501670, 81272113, and 81500112) as well as funding from the China Postdoctoral Science Foundation (2016T90375). The authors declare no conflicts of interest.	Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Cornils H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000681; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; Enomoto A, 2008, ONCOGENE, V27, P1930, DOI 10.1038/sj.onc.1210828; Farivar S, 2014, J LASERS MED SCI, V5, P58; Fu J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004579; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Heo KS, 2015, J CLIN INVEST, V125, P1299, DOI 10.1172/JCI76453; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Hergovich A, 2016, GENES-BASEL, V7, DOI 10.3390/genes7050021; Hirabayashi S, 2008, ONCOGENE, V27, P4281, DOI 10.1038/onc.2008.66; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Koo YD, 2015, DIABETES, V64, P2420, DOI 10.2337/db15-0115; Li BS, 2015, NAT MED, V21, P563, DOI 10.1038/nm.3840; Li W, 2004, J INVEST DERMATOL, V123, P622, DOI 10.1111/j.0022-202X.2004.23416.x; Li W, 2001, J INVEST DERMATOL, V117, P1601, DOI 10.1046/j.0022-202x.2001.01608.x; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; Paul I, 2017, SCI REP-UK, V7, DOI 10.1038/srep42800; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Raja, 2007, Front Biosci, V12, P2849; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Takeuchi T, 2006, BIOCHEM BIOPH RES CO, V348, P473, DOI 10.1016/j.bbrc.2006.07.076; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Wen MY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8167; Xiao N, 2015, J BIOL CHEM, V290, P1927, DOI 10.1074/jbc.M114.608703; Xiao N, 2012, BIOCHEM J, V441, P979, DOI 10.1042/BJ20111358; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhang L, 2015, CURR BIOL, V25, P296, DOI 10.1016/j.cub.2014.11.054	37	7	9	3	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					163	174		10.1096/fj.201800353R	http://dx.doi.org/10.1096/fj.201800353R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29969578				2022-12-26	WOS:000457401500013
J	Kumar, V; Chaudhuri, TK				Kumar, Vipul; Chaudhuri, Tapan K.			Spontaneous refolding of the large multidomain protein malate synthase G proceeds through misfolding traps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIM BARREL PROTEIN; ESCHERICHIA-COLI; FOLDING INTERMEDIATE; TRYPTOPHAN SYNTHASE; ALPHA-SUBUNIT; MYCOBACTERIUM-TUBERCULOSIS; DIHYDROFOLATE-REDUCTASE; ANGSTROM RESOLUTION; CONTACT ORDER; OFF-PATHWAY	Most protein folding studies until now focus on single domain or truncated proteins. Although great insights in the folding of such systems has been accumulated, very little is known regarding the proteins containing multiple domains. It has been shown that the high stability of domains, in conjunction with interdomain interactions, manifests as a frustrated energy landscape, causing complexity in the global folding pathway. However, multidomain proteins despite containing independently foldable, loosely cooperative sections can fold into native states with amazing speed and accuracy. To understand the complexity in mechanism, studies were conducted previously on the multidomain protein malate synthase G (MSG), an enzyme of the glyoxylate pathway with four distinct and adjacent domains. It was shown that the protein refolds to a functionally active intermediate state at a fast rate, which slowly produces the native state. Although experiments decoded the nature of the intermediate, a full description of the folding pathway was not elucidated. In this study, we use a battery of biophysical techniques to examine the protein's folding pathway. By using multiprobe kinetics studies and comparison with the equilibrium behavior of protein against urea, we demonstrate that the unfolded polypeptide undergoes conformational compaction to a misfolded intermediate within milliseconds of refolding. The misfolded product appears to be stabilized under moderate denaturant concentrations. Further folding of the protein produces a stable intermediate, which undergoes partial unfolding-assisted large segmental rearrangements to achieve the native state. This study reveals an evolved folding pathway of the multidomain protein MSG, which involves surpassing the multiple misfolding traps during refolding.	[Kumar, Vipul; Chaudhuri, Tapan K.] Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi 110016, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Chaudhuri, TK (corresponding author), Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi 110016, India.	tkchaudhuri@bioschool.iitd.ac.in			University Grants Commission, India; Indian Institute of Technology, Delhi, India	University Grants Commission, India(University Grants Commission, India); Indian Institute of Technology, Delhi, India	Recipient of a Research Fellowship from the University Grants Commission, India.; Supported by funding from the Indian Institute of Technology, Delhi, India.	Acharya N, 2016, J PHYS CHEM LETT, V7, P173, DOI 10.1021/acs.jpclett.5b02545; Andersen CB, 2010, PROTEIN SCI, V19, P279, DOI 10.1002/pro.309; Anstrom DM, 2003, PROTEIN SCI, V12, P1822, DOI 10.1110/ps.03174303; Arai M, 2011, J MOL BIOL, V410, P329, DOI 10.1016/j.jmb.2011.04.057; Batey S, 2006, P NATL ACAD SCI USA, V103, P18113, DOI 10.1073/pnas.0604580103; Borgia A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9861; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; CHRUNYK BA, 1990, BIOCHEMISTRY-US, V29, P2149, DOI 10.1021/bi00460a027; Dahiya V, 2014, J BIOL CHEM, V289, P286, DOI 10.1074/jbc.M113.518373; Dahiya V, 2013, BIOCHEMISTRY-US, V52, P4517, DOI 10.1021/bi400328a; DAS BK, 1995, BIOCHEMISTRY-US, V34, P5242, DOI 10.1021/bi00015a038; Fan YX, 1998, PROTEIN SCI, V7, P2631, DOI 10.1002/pro.5560071217; Ferreiro DU, 2014, Q REV BIOPHYS, V47, P285, DOI 10.1017/S0033583514000092; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Forsyth WR, 2007, J MOL BIOL, V372, P236, DOI 10.1016/j.jmb.2007.06.018; Garcia-Manyes S, 2016, J BIOL CHEM, V291, P4226, DOI 10.1074/jbc.M115.673871; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; Gu ZY, 2007, J MOL BIOL, V368, P582, DOI 10.1016/j.jmb.2007.02.027; Hagen SJ, 2010, CURR PROTEIN PEPT SC, V11, P385; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; HOLZMAN TF, 1990, BIOCHEMISTRY-US, V29, P1255, DOI 10.1021/bi00457a022; Howard BR, 2000, BIOCHEMISTRY-US, V39, P3156, DOI 10.1021/bi992519h; Huang HL, 2016, J BIOL CHEM, V291, P27421, DOI 10.1074/jbc.M116.750877; HURLE MR, 1987, PROTEINS, V2, P54, DOI 10.1002/prot.340020107; Inanami T, 2014, P NATL ACAD SCI USA, V111, P15969, DOI 10.1073/pnas.1406244111; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jacob M, 1999, BIOCHEMISTRY-US, V38, P13773, DOI 10.1021/bi991503o; JONES BE, 1994, BIOCHEMISTRY-US, V33, P15250, DOI 10.1021/bi00255a005; Kathuria SV, 2008, J MOL BIOL, V382, P467, DOI 10.1016/j.jmb.2008.06.054; Kathuria SV, 2016, PROTEIN SCI, V25, P662, DOI 10.1002/pro.2860; Krieger IV, 2012, CHEM BIOL, V19, P1556, DOI 10.1016/j.chembiol.2012.09.018; KUBISTA M, 1994, ANALYST, V119, P417, DOI 10.1039/an9941900417; Liu P, 2005, NATURE, V437, P159, DOI 10.1038/nature03926; MANN CJ, 1993, BIOCHEMISTRY-US, V32, P5282, DOI 10.1021/bi00071a002; Mayr EM, 1997, J MOL BIOL, V269, P260, DOI 10.1006/jmbi.1997.1033; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Saluja A, 2014, PHARM RES-DORDR, V31, P1575, DOI 10.1007/s11095-013-1263-5; Scott KA, 2002, J MOL BIOL, V315, P819, DOI 10.1006/jmbi.2001.5260; Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084; Smith CV, 2003, J BIOL CHEM, V278, P1735, DOI 10.1074/jbc.M209248200; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Souillac PO, 2005, J PHARM SCI-US, V94, P2069, DOI 10.1002/jps.20423; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Teichmann SA, 1999, CURR OPIN STRUC BIOL, V9, P390, DOI 10.1016/S0959-440X(99)80053-0; Tian PF, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004933; Tugarinov V, 2005, P NATL ACAD SCI USA, V102, P622, DOI 10.1073/pnas.0407792102; Vanhove M, 1998, BIOCHEMISTRY-US, V37, P1941, DOI 10.1021/bi972143c; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Wani AH, 2009, J MOL BIOL, V387, P348, DOI 10.1016/j.jmb.2009.01.060; Wu Y, 2007, J MOL BIOL, V366, P1624, DOI 10.1016/j.jmb.2006.12.005; Zheng WH, 2013, P NATL ACAD SCI USA, V110, P1680, DOI 10.1073/pnas.1222130110	53	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13270	13283		10.1074/jbc.RA118.003903	http://dx.doi.org/10.1074/jbc.RA118.003903			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29959230	Green Published, hybrid			2022-12-26	WOS:000442730200025
J	Lau, YTK; Baytshtok, V; Howard, TA; Fiala, BM; Johnson, JM; Carter, LP; Baker, D; Lima, CD; Bahl, CD				Lau, Yue-Ting K.; Baytshtok, Vladimir; Howard, Tessa A.; Fiala, Brooke M.; Johnson, JayLee M.; Carter, Lauren P.; Baker, David; Lima, Christopher D.; Bahl, Christopher D.			Discovery and engineering of enhanced SUMO protease enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION TECHNOLOGY; STRUCTURAL BASIS; SOLUBILITY; COMPLEX; DESIGN; GENOME; SENP2	Small ubiquitin-like modifier (SUMO) is commonly used as a protein fusion domain to facilitate expression and purification of recombinant proteins, and a SUMO-specific protease is then used to remove SUMO from these proteins. Although this protease is highly specific, its limited solubility and stability hamper its utility as an in vitro reagent. Here, we report improved SUMO protease enzymes obtained via two approaches. First, we developed a computational method and used it to re-engineer WT Ulp1 from Saccharomyces cerevisiae to improve protein solubility. Second, we discovered an improved SUMO protease via genomic mining of the thermophilic fungus Chaetomium thermophilum, as proteins from thermophilic organisms are commonly employed as reagent enzymes. Following expression in Escherichia coli, we found that these re-engineered enzymes can be more thermostable and up to 12 times more soluble, all while retaining WT-or-better levels of SUMO protease activity. The computational method we developed to design solubility-enhancing substitutions is based on the RosettaScripts application for the macromolecular modeling suite Rosetta, and it is broadly applicable for the improvement of solution properties of other proteins. Moreover, we determined the X-ray crystal structure of a SUMO protease from C. thermophilum to 1.44 A resolution. This structure revealed that this enzyme exhibits structural and functional conservation with the S. cerevisiae SUMO protease, despite exhibiting only 28% sequence identity. In summary, by re-engineering the Ulp1 protease and discovering a SUMO protease from C. thermophilum, we have obtained proteases that are more soluble, more thermostable, and more efficient than the current commercially available Ulp1 enzyme.	[Lau, Yue-Ting K.; Howard, Tessa A.; Fiala, Brooke M.; Johnson, JayLee M.; Carter, Lauren P.; Baker, David; Bahl, Christopher D.] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Baker, David; Bahl, Christopher D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Baytshtok, Vladimir; Lima, Christopher D.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA; [Lima, Christopher D.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Howard Hughes Med Inst, New York, NY 10065 USA; [Bahl, Christopher D.] Inst Prot Innovat, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Bahl, CD (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.; Bahl, CD (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Bahl, CD (corresponding author), Inst Prot Innovat, Boston, MA 02115 USA.	chris.bahl@proteininnovation.org	Bahl, Christopher D/B-9410-2016	Bahl, Christopher D/0000-0002-3652-3693; Lima, Christopher/0000-0002-9163-6092	National Institutes of Health (NIH), NIGMS [P41 GM103403]; DOE Office of Science [DE-AC02-06CH11357]; NIH-ORIP HEI Grant [S10 RR029205]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118080, R01GM065872, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); NIH-ORIP HEI Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Lance Stewart and Dr. Ruud van Deursen for helpful discussions. Work was based in part upon research conducted at NE-CAT beamlines (National Institutes of Health (NIH), NIGMS, Grant P41 GM103403 and NIH-ORIP HEI Grant S10 RR029205). Beamline research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Bhardwaj G, 2016, NATURE, V538, P329, DOI 10.1038/nature19791; Bock T, 2014, NUCLEIC ACIDS RES, V42, P13525, DOI 10.1093/nar/gku1147; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Clegg Robert M., 1995, Current Opinion in Biotechnology, V6, P103, DOI 10.1016/0958-1669(95)80016-6; DEVORE JL, 1987, PROBABILITY STAT ENG; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Jacak R, 2012, PROTEINS, V80, P825, DOI 10.1002/prot.23241; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kellner N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20937; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kramer RM, 2012, BIOPHYS J, V102, P1907, DOI 10.1016/j.bpj.2012.01.060; Li L, 2013, PROTEIN SCI, V22, P1118, DOI 10.1002/pro.2289; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lima C. D., 2011, United States of America Patent, Patent No. [7910364B2, 7910364]; Lima CD, 2008, J BIOL CHEM, V283, P32045, DOI 10.1074/jbc.M805655200; Marblestone JG, 2006, PROTEIN SCI, V15, P182, DOI 10.1110/ps.051812706; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIDDAUGH CR, 1979, J BIOL CHEM, V254, P367; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Raghunathan G, 2013, MOL BIOSYST, V9, P2379, DOI 10.1039/c3mb70068b; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Shen LN, 2006, NAT STRUCT MOL BIOL, V13, P1069, DOI 10.1038/nsmb1172	32	13	13	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13224	13233		10.1074/jbc.RA118.004146	http://dx.doi.org/10.1074/jbc.RA118.004146			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29976752	hybrid, Green Published			2022-12-26	WOS:000442730200021
J	Kumar, P; Smith, T; Raeman, R; Chopyk, DM; Brink, H; Liu, YS; Sulchek, T; Anania, FA				Kumar, Pradeep; Smith, Tekla; Raeman, Reben; Chopyk, Daniel M.; Brink, Hannah; Liu, Yunshan; Sulchek, Todd; Anania, Frank A.			Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatic stellate cell (HSC); fibrosis; lysyl oxidase (LOX); extracellular matrix protein; transforming growth factor beta (TGF-beta); collagen; fibronectin; inflammation; POSTN; SMAD2; 3; fibronectin; POSTN; fibrogenesis; inflammation	EPITHELIAL-MESENCHYMAL TRANSITION; MATRICELLULAR PROTEIN; PULMONARY-FIBROSIS; SERUM PERIOSTIN; KIDNEY-DISEASE; CANCER CELLS; HEPATOCYTES; EXPRESSION; COLLAGEN; MICE	Liver fibrosis arises from dysregulated wound healing due to persistent inflammatory hepatic injury. Periostin is a nonstructural extracellular matrix protein that promotes organ fibrosis in adults. Here, we sought to identify the molecular mechanisms in periostin-mediated hepatic fibrosis. Hepatic fibrosis in periostin(-/-) mice was attenuated as evidenced by significantly reduced collagen fibril density and liver stiffness compared with those in WT controls. A single dose of carbon tetrachloride caused similar acute liver injury in periostin(-/-) and WT littermates, and we did not detect significant differences in transaminases and major fibrosis-related hepatic gene expression between these two genotypes. Activated hepatic stellate cells (HSCs) are the major periostin-producing liver cell type. We found that in primary rat HSCs in vitro, periostin significantly increases the expression levels and activities of lysyl oxidase (LOX) and lysyl oxidase-like (LOXL) isoforms 1-3. Periostin also induced expression of intra- and extracellular collagen type 1 and fibronectin in HSCs. Interestingly, periostin stimulated phosphorylation of SMAD2/3, which was sustained despite short hairpin RNA-mediated knockdown of transforming growth factor beta(TGF beta) receptor I and II, indicating that periostin-mediated SMAD2/3 phosphorylation is independent of TGF receptors. Moreover, periostin induced the phosphorylation of focal adhesion kinase (FAK) and AKT in HSCs. Notably, siRNA-mediated FAK knockdown failed to block periostin-induced SMAD2/3 phosphorylation. These results suggest that periostin promotes enhanced matrix stiffness in chronic liver disease by activating LOX and LOXL, independently of TGF receptors. Hence, targeting periostin may be of therapeutic benefit in combating hepatic fibrosis.	[Kumar, Pradeep; Smith, Tekla; Chopyk, Daniel M.; Liu, Yunshan; Anania, Frank A.] Emory Univ, Sch Med, Dept Med, Div Digest, Atlanta, GA 30322 USA; [Raeman, Reben] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Brink, Hannah; Sulchek, Todd] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA	Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; Georgia Institute of Technology	Kumar, P (corresponding author), Emory Univ, Dept Med, Div Digest Dis, 615 Michael St NE,Suite 265, Atlanta, GA 30322 USA.	pkuma23@emory.edu	Raeman, Reben/AAF-7282-2021; Chopyk, Daniel/ABD-3591-2020	Raeman, Reben/0000-0002-3914-1797; Chopyk, Daniel/0000-0003-4207-1360	NIDDK, National Institutes of Health [RO1 DK062092, DK111678, DK113147]; Emory University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK110264, R01DK062092, R56DK113147, R01DK111678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Emory University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIDDK, National Institutes of Health, Grants RO1 DK062092, DK111678, and DK113147 (all to F. A. A.). A portion of this work was also supported by funds from Emory University. The authors declare that they have no conflicts of interest with the contents of this article. This article was prepared while Frank A. Anania was employed at Emory University School of Medicine. The opinions expressed in this article are the author's own and do not reflect the views of the Food and Drug Administration, the Department of Health and Human Services, or the United States government. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfieri C, 2015, NEPHROL DIAL TRANSPL, V30, P1965, DOI 10.1093/ndt/gfv074; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Brown AC, 2013, J PATHOL, V229, P25, DOI 10.1002/path.4114; Carden MA, 2017, MICROCIRCULATION, V24, DOI 10.1111/micc.12353; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Das SK, 2008, SCAND J CLIN LAB INV, V68, P260, DOI 10.1080/00365510701668516; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Egbert M, 2014, J DERMATOL SCI, V73, P40, DOI 10.1016/j.jdermsci.2013.08.010; Friedman SL, 2015, DIGEST DIS, V33, P504, DOI 10.1159/000374098; Gao AE, 2016, BIOCHEM BIOPH RES CO, V475, P70, DOI 10.1016/j.bbrc.2016.05.037; Hasegawa D, 2015, J CELL PHYSIOL, V230, P2647, DOI 10.1002/jcp.24950; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Hong L, 2015, J CELL MOL MED, V19, P2462, DOI 10.1111/jcmm.12636; Honsawek S, 2015, BIOMARKERS, V20, P157, DOI 10.3109/1354750X.2015.1045032; Hu QF, 2015, CELL PHYSIOL BIOCHEM, V36, P799, DOI 10.1159/000430139; Hu WW, 2017, ONCOTARGET, V8, P62248, DOI 10.18632/oncotarget.19273; Huang YM, 2015, AM J PATHOL, V185, P786, DOI 10.1016/j.ajpath.2014.11.002; Iwasaki A, 2016, J BIOL CHEM, V291, P72, DOI 10.1074/jbc.M115.691519; Kaur H, 2016, CIRC RES, V118, P1906, DOI 10.1161/CIRCRESAHA.116.308643; Khurana S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13500; Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x; Kong DS, 2015, LAB INVEST, V95, P1234, DOI 10.1038/labinvest.2015.107; Kumar P, 2014, FASEB J, V28, P5172, DOI 10.1096/fj.14-253229; Lee WR, 2014, BIOCHEM BIOPH RES CO, V450, P195, DOI 10.1016/j.bbrc.2014.05.089; Liu CX, 2018, CANCER SCI, V109, P688, DOI 10.1111/cas.13479; Liu SB, 2016, FASEB J, V30, P1599, DOI 10.1096/fj.14-268425; Lorts A, 2012, P NATL ACAD SCI USA, V109, P10978, DOI 10.1073/pnas.1204708109; Lv Y, 2013, EJSO-EUR J SURG ONC, V39, P1129, DOI 10.1016/j.ejso.2013.06.023; Lv Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0385-7; Martinez-Martinez E, 2016, J MOL CELL CARDIOL, V92, P96, DOI 10.1016/j.yjmcc.2016.01.012; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Matsuzawa M, 2015, J PERIODONTAL RES, V50, P855, DOI 10.1111/jre.12277; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Mesarwi OA, 2015, SLEEP, V38, P1583, DOI 10.5665/sleep.5052; Mino M, 2017, HEPATOL COMMUN, V1, P1099, DOI 10.1002/hep4.1114; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Mosher DF, 2015, CRIT REV BIOCHEM MOL, V50, P427, DOI 10.3109/10409238.2015.1069791; Perepelyuk M, 2013, AM J PHYSIOL-GASTR L, V304, pG605, DOI 10.1152/ajpgi.00222.2012; Popov Y, 2011, GASTROENTEROLOGY, V140, P1642, DOI 10.1053/j.gastro.2011.01.040; Prakoura N, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00052; Romanos GE, 2014, J CELL PHYSIOL, V229, P1, DOI 10.1002/jcp.24407; Severgnini M, 2012, CYTOTECHNOLOGY, V64, P187, DOI 10.1007/s10616-011-9407-0; Siddikuzzaman, 2011, Inflammopharmacology, V19, P117, DOI 10.1007/s10787-010-0073-1; Tajiri M, 2015, RESPIR INVESTIG, V53, P73, DOI 10.1016/j.resinv.2014.12.003; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Takeda K, 2017, MOL MED REP, V16, P5752, DOI 10.3892/mmr.2017.7356; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Terao M, 2015, DERM-ENDOCRINOL, V7, DOI 10.1080/19381980.2015.1010983; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Uchida M, 2012, AM J RESP CELL MOL, V46, P677, DOI 10.1165/rcmb.2011-0115OC; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Wallace DP, 2014, KIDNEY INT, V85, P845, DOI 10.1038/ki.2013.488; Wallace MC, 2015, SEMIN LIVER DIS, V35, P107, DOI 10.1055/s-0035-1550060; Wu SQ, 2013, MOL MED REP, V7, P875, DOI 10.3892/mmr.2013.1267; Wu TT, 2018, MATRIX BIOL, V66, P81, DOI 10.1016/j.matbio.2017.09.004; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	56	36	38	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12781	12792		10.1074/jbc.RA117.001601	http://dx.doi.org/10.1074/jbc.RA117.001601			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29941453	hybrid, Green Published			2022-12-26	WOS:000442203500012
J	Fischbein, R; Nicholas, L; Aultman, J; Baughman, K; Falletta, L				Fischbein, Rebecca; Nicholas, Lauren; Aultman, Julie; Baughman, Kristin; Falletta, Lynn			Twin-twin transfusion syndrome screening and diagnosis in the United States: A triangulation design of patient experiences	PLOS ONE			English	Article							CARE TEAMS	Objective Using patient-reported experiences, this study: 1) quantitatively evaluated TTTS screening trends, 2) examined screening and diagnostic experiences using a mixed methods approach, and 3) determined gaps in clinical care experiences. Design This was a cross-sectional study. Data was collected using a self-report, retrospective survey. A triangulation design was used to validate quantitative survey data with thematically analyzed qualitative data. Setting Participants were recruited through social media and national foundations and completed the survey online. Participants Participants were 312 women who completed a TTTS pregnancy in the United States, representing the largest survey of participants who have experienced TTTS. Methods Descriptive statistics and bivariate analyses were conducted. Multivariate logistic regression examined predictors of ultrasound frequency. Qualitative data were initially coded by hand and checked using qualitative software. Results The percentages of participants reporting guideline recommended screening, including identification of pregnancy type by gestational week 13 and timely receipt of ultrasounds, increased over time. However, 44.6% of participants diagnosed in recent years (2014 and later), reported that prior to TTTS diagnosis, they did not receive biweekly or more frequent ultrasounds. Three patient-reported provider practices were related to receiving ultrasounds at the recommended frequency: (1) determining MCDA status prior to gestational week 14, (2) providing participants with early warnings about the risk of TTTS to their pregnancies after MCDA status had been determined, and (3) referring participants to a Maternal-Fetal Medicine Specialist after MCDA identification, as validated by qualitative data. Our qualitative data revealed gaps in effective clinical care experiences among OB/GYN and specialist providers. Conclusion These findings indicate screening and diagnosis for TTTS, as reported by patients, is improving in the United States; however, further efforts are required to ensure all patients receive appropriate screening, education and a team-based approach to comprehensive and supportive clinical care.	[Fischbein, Rebecca; Aultman, Julie; Baughman, Kristin] Northeast Ohio Med Univ, Dept Family & Community Med, Rootstown, OH 44272 USA; [Nicholas, Lauren] DYouville Coll, New York, NY USA; [Falletta, Lynn] Kent State Univ, Coll Publ Hlth, Kent, OH 44242 USA	Northeast Ohio Medical University (NEOMED); D'Youville College; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Fischbein, R (corresponding author), Northeast Ohio Med Univ, Dept Family & Community Med, Rootstown, OH 44272 USA.	rfischbein@neomed.edu	Fischbein, Rebecca/AAH-7838-2019; Baughman, Kristin R/B-8991-2009; Fischbein, Rebecca L/X-1024-2018; Aultman, Julie/AAM-3491-2020	Fischbein, Rebecca/0000-0002-4373-2039; Baughman, Kristin R/0000-0002-3128-3627; Fischbein, Rebecca L/0000-0002-4373-2039; 				[Anonymous], 2016, OBSTET GYNECOL, V128, P1459, DOI 10.1097/AOG.0000000000001815; [Anonymous], 2005, INTERNET J EPIDEMIOL; [Anonymous], 2016, 2015 NATL HEALTHCARE; Beck Rainer S, 2002, J Am Board Fam Pract, V15, P25; Chmait RH, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.001; Creswell J.W., 2003, HDB MIXED METHODS SO, V209, P209, DOI DOI 10.4135/9781506335193; Danon D, 2013, OBSTET GYNECOL, V121, P1318, DOI 10.1097/AOG.0b013e318292766b; Davies W, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0532-x; Diemert A, 2010, ULTRASOUND OBST GYN, V35, P71, DOI 10.1002/uog.7328; Farah N, 2012, ACTA OBSTET GYN SCAN, V91, P382, DOI 10.1111/j.1600-0412.2011.01288.x; GITHENS PB, 1993, BIRTH-ISS PERINAT C, V20, P136, DOI 10.1111/j.1523-536X.1993.tb00438.x; Grumbach K, 2004, JAMA-J AM MED ASSOC, V291, P1246, DOI 10.1001/jama.291.10.1246; Pew Research Center, 2017, SOC MED FACT SHEET; Simpson LL, 2013, AM J OBSTET GYNECOL, V208, P3, DOI 10.1016/j.ajog.2012.10.880; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Thorson HL, 2011, OBSTET GYNECOL, V117, P131, DOI 10.1097/AOG.0b013e31820292ec; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; Wee Ling Y, 2002, Semin Neonatol, V7, P187, DOI 10.1053/siny.2002.0106	19	2	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200087	10.1371/journal.pone.0200087	http://dx.doi.org/10.1371/journal.pone.0200087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975770	gold, Green Published, Green Submitted			2022-12-26	WOS:000437424500066
J	Sigmund, IK; Gamper, J; Weber, C; Holinka, J; Panotopoulos, J; Funovics, PT; Windhager, R				Sigmund, Irene Katharina; Gamper, Jutta; Weber, Christine; Holinka, Johannes; Panotopoulos, Joannis; Funovics, Philipp Theodor; Windhager, Reinhard			Efficacy of different revision procedures for infected megaprostheses in musculoskeletal tumour surgery of the lower limb	PLOS ONE			English	Article							SILVER-COATED MEGAPROSTHESES; 2-STAGE REVISION; LOWER-EXTREMITY; PERIPROSTHETIC INFECTION; HIP-ARTHROPLASTY; SALVAGE SURGERY; BONE SARCOMA; ONE-STAGE; ENDOPROSTHESES; RESECTION	Purpose The incidence of recurrent infections in patients following one or two stage revision for infected megaprostheses after resection of bone tumours was investigated. The difference between retaining at least one well fixed stem and a complete removal of the megaprosthesis during a two stage revision was also analysed. Methods 627 patients who experienced a replacement of a musculoskeletal tumour by megaprostheses were recorded. An infection occurred in 83 of 621 patients available for follow-up. 61 patients underwent one stage revision, and 16 patients two stage revision for the first revision surgery. In the entire study period, two stage revision was performed 32 times (first, second, and third revision). Results The cumulative incidence analysis showed a reinfection probability after one stage revision of 18% at one year, 30% at two years, 39% at five years, 46% at ten years, and 56% at 15 years. After two stage revision, a reinfection probability of 28% at two years, and 48% at five years was calculated. Cumulative incidence curves did not differ significantly (Gray's test; p = 0.51) between one and two stage revision (with and without complete removal of the stems). In two stage revision (n = 32), a statistically significant difference in infection rates between patients treated with complete removal of the megaprosthesis (n = 18) including anchorage stems and patients with at least one retained stem (n = 14) was shown (Fisher's exact test, p = 0.029). Conclusion Two stage revisions with complete removal of the megaprosthesis showed the best results among limb salvage procedures for the treatment of infected megaprosthesis.	[Sigmund, Irene Katharina; Weber, Christine; Holinka, Johannes; Panotopoulos, Joannis; Funovics, Philipp Theodor; Windhager, Reinhard] Med Univ Vienna, Dept Orthopaed & Trauma Surg, Vienna, Austria; [Gamper, Jutta] Med Univ Vienna, Sect Med Stat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Windhager, R (corresponding author), Med Univ Vienna, Dept Orthopaed & Trauma Surg, Vienna, Austria.	reinhard.windhager@meduniwien.ac.at		Windhager, Reinhard/0000-0002-6321-1804; Sigmund, Irene Katharina/0000-0002-5068-2738				Biau D, 2006, J BONE JOINT SURG AM, V88A, P1285, DOI 10.2106/JBJS.E.00553; Bindiganavile S, 2015, 28 ANN EMSOS EUR MUS, P47; CAPANNA R, 1994, J BONE JOINT SURG BR, V76B, P178, DOI 10.1302/0301-620X.76B2.8113272; CAPANNA R, 1991, CLIN ORTHOP RELAT R, P186; Cochran AR, 2016, J ARTHROPLASTY, V31, pS156, DOI 10.1016/j.arth.2016.03.028; COVENTRY MB, 1975, ORTHOP CLIN N AM, V6, P991; Donati F, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9079041; Ercolano LB, 2013, CLIN ORTHOP RELAT R, V471, P3204, DOI 10.1007/s11999-013-2852-7; FITZGERALD RH, 1977, J BONE JOINT SURG AM, V59, P847, DOI 10.2106/00004623-197759070-00001; Flint MN, 2007, J ARTHROPLASTY, V22, P859, DOI 10.1016/j.arth.2006.11.003; Funovics PT, 2011, INT ORTHOP, V35, P1437, DOI 10.1007/s00264-010-1054-0; Gosheger G, 2006, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000223978.36831.39; Grimer RJ, 2002, CLIN ORTHOP RELAT R, P193; Ham SJ, 1998, ANN SURG ONCOL, V5, P423, DOI 10.1007/BF02303861; Hanssen AD, 2000, CLIN ORTHOP RELAT R, P91; Hardes J, 2010, J SURG ONCOL, V101, P389, DOI 10.1002/jso.21498; Holzer G, 1997, J BONE JOINT SURG BR, V79B, P31, DOI 10.1302/0301-620X.79B1.7139; Ilyas I, 2001, INT ORTHOP, V25, P375, DOI 10.1007/s002640100290; Jeys LM, 2008, J BONE JOINT SURG AM, V90A, P1265, DOI 10.2106/JBJS.F.01324; Jeys LM, 2005, J BONE JOINT SURG AM, V87A, P842, DOI 10.2106/JBJS.C.01222; Kotz R, 2010, ORTHOPADE, V39, P922, DOI 10.1007/s00132-009-1567-7; MALAWER MM, 1995, J BONE JOINT SURG AM, V77A, P1154, DOI 10.2106/00004623-199508000-00003; Mavrogenis AF, 2015, SURG INFECT, V16, P267, DOI 10.1089/sur.2014.085; Mittermayer F, 2001, CLIN ORTHOP RELAT R, P167; Munjal S, 2001, Instr Course Lect, V50, P367; Orlic D, 2006, INT ORTHOP, V30, P458, DOI 10.1007/s00264-006-0193-9; Pala E, 2015, CLIN ORTHOP RELAT R, V473, P891, DOI 10.1007/s11999-014-3699-2; Perka C, 2011, Z GEBIETE OPERATIVEN, V82, P218, DOI [10.1007/s00104-010-2014-3, DOI 10.1007/S00104-010-2014-3]; Plotz W, 2002, CLIN ORTHOP RELAT R, P207; Politano AD, 2013, SURG INFECT, V14, P8, DOI 10.1089/sur.2011.097; Romano CL, 2012, KNEE SURG SPORT TR A, V20, P2445, DOI 10.1007/s00167-012-1885-x; Schmidt-Braekling Tom, 2017, Eur J Orthop Surg Traumatol, V27, P483, DOI 10.1007/s00590-017-1933-9; Schmolders J, 2017, ARCH ORTHOP TRAUM SU, V137, P149, DOI 10.1007/s00402-016-2584-8; Wirganowicz PZ, 1999, CLIN ORTHOP RELAT R, P64	34	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200304	10.1371/journal.pone.0200304	http://dx.doi.org/10.1371/journal.pone.0200304			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975769	Green Submitted, gold, Green Published			2022-12-26	WOS:000437424500083
J	Lee, AL; Dafforn, KA; Hutchings, PA; Johnston, EL				Lee, Aria L.; Dafforn, Katherine A.; Hutchings, Pat A.; Johnston, Emma L.			Reproductive strategy and gamete development of an invasive fanworm, Sabella spallanzanii (Polychaeta: Sabellidae), a field study in Gulf St Vincent, South Australia	PLOS ONE			English	Article							PORT-PHILLIP BAY; OFFSPRING SIZE; INTRODUCED POLYCHAETE; R-SELECTION; EGG SIZE; MARINE; VICTORIA; BIOLOGY; GAMETOGENESIS; FERTILIZATION	Several reproductive strategies have been identified as key factors that contribute to the establishment and dispersal of invasive species in new environments. These strategies include early maturity, high reproductive capacity and flexibility in timing of reproduction. It is therefore critical to investigate the reproductive biology of target exotic species to understand their potential for population increase and invasive spread, and to inform management control strategies. The European fanworm, Sabella spallanzanii (Gmelin 1791), has established invasive populations along the southern coast of Australia. Gamete development and reproductive periodicity of this worm were investigated in two populations in Gulf St Vincent in South Australia over a 1 year period (July 2012 to June 2013). Samples of worms were collected monthly and dissected for histological analysis. Most individuals reached reproductive maturity at 70 mm body length (thorax and abdomen). Individuals from both populations contained mature and developing gametes year-round and a distinct spawning season was not observed. This may indicate sustained spawning by the population over the year, which provides a constant supply of new recruits to the area. Body length and egg size of worms from these populations were smaller than conspecifics in its native range and other invasive locations. Reproduction and development of S. spallanzanii differs not only between native and invasive locations, but also within invasive locations. This study has shown that S. spallanzanii exhibits a higher phenotypic plasticity and reproductive flexibility than previously known.	[Lee, Aria L.; Johnston, Emma L.] Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Dafforn, Katherine A.; Hutchings, Pat A.] Macquarie Univ, Dept Environm Sci, N Ryde, NSW, Australia; [Dafforn, Katherine A.; Johnston, Emma L.] Sydney Inst Marine Sci, Mosman, NSW, Australia; [Hutchings, Pat A.] Australian Museum, Res Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Macquarie University; Sydney Institute of Marine Science; Australian Museum	Lee, AL (corresponding author), Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	aria.lee@unsw.edu.au	Johnston, Emma/AAC-2878-2022; Dafforn, Katherine/J-9647-2013	Johnston, Emma/0000-0002-2117-366X; Dafforn, Katherine/0000-0001-8848-377X	Biosecurity South Australia, a division of Primary Industries and Regions SA (PIRSA) [GRP0191014]	Biosecurity South Australia, a division of Primary Industries and Regions SA (PIRSA)	This study was funded by Biosecurity South Australia, a division of Primary Industries and Regions SA (PIRSA), grant no. GRP0191014.	Ahyong ST, 2017, J MAR BIOL ASSOC UK, V97, P985, DOI 10.1017/S0025315417000261; Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Tovar-Hernandez MA, 2011, MAR BIOL RES, V7, P710, DOI 10.1080/17451000.2010.547201; Tovar-Hernandez MA, 2009, SYST BIODIVERS, V7, P319, DOI 10.1017/S1477200009990041; Barrett SCH, 1996, PHILOS T R SOC B, V351, P725, DOI 10.1098/rstb.1996.0067; Bernardo J, 1996, AM ZOOL, V36, P216; Buhle ER, 2005, ECOL ECON, V52, P355, DOI 10.1016/j.ecolecon.2004.07.018; BURGER WC, 1981, BIOSCIENCE, V31, P572, DOI 10.2307/1308218; Bybee DR, 2007, MAR BIOL, V151, P639, DOI 10.1007/s00227-006-0504-0; Campbell M., 2001, 23 CSIRO MAR RES, V23, P1; Capa M, 2013, ZOOL SCR, V42, P637, DOI 10.1111/zsc.12028; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen CA, 2002, MAR BIOTECHNOL, V4, P17, DOI 10.1007/s10126-001-0069-3; Chuang A, 2016, GLOBAL CHANGE BIOL, V22, P494, DOI 10.1111/gcb.13107; Clapin Geordie, 1995, Centre for Research on Introduced Marine Pests Technical Report, V2, P1; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Currie DR, 1999, MAR POLLUT BULL, V38, P36, DOI 10.1016/S0025-326X(98)00083-6; Currie DR, 2000, MAR BIOL, V136, P645, DOI 10.1007/s002270050724; Dafforn KA, 2009, BIOFOULING, V25, P277, DOI 10.1080/08927010802710618; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Nogueira JMD, 2006, ZOOL STUD, V45, P586; [Department of the Environment and New Zealand Ministry for Primary Industries Australian Government D of A], 2015, ANT INW CLEAN GUID; Floerl O, 2003, AUSTRAL ECOL, P28; Gambi MC, 2000, B MAR SCI, V67, P299; Giangrande A, 2010, MEDITERR MAR SCI, V11, P373, DOI 10.12681/mms.86; Giangrande A, 2000, MAR BIOL, V136, P847, DOI 10.1007/s002279900251; Giangrande Adriana, 1997, Oceanography and Marine Biology an Annual Review, V35, P323; Giangrande Adriana, 1994, Memoires du Museum National d'Histoire Naturelle, V162, P51; Glasby TM, 1999, ESTUAR COAST SHELF S, V48, P281, DOI 10.1006/ecss.1998.0417; Grabowski M, 2007, HYDROBIOLOGIA, V590, P75, DOI 10.1007/s10750-007-0759-6; Grosholz ED, 2003, ECOL LETT, V6, P700, DOI 10.1046/j.1461-0248.2003.00495.x; Hay M., 1997, SCIENCE, P275; Hayes K, 2005, NATL PRIORITY PES 2, V18; Hedge LH, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-000375.1; Hewitt CL, 2004, MAR BIOL, V144, P183, DOI 10.1007/s00227-003-1173-x; Holloway MG, 2002, ECOL APPL, V12, P1803, DOI 10.2307/3099939; Holloway MG, 2002, MAR ECOL PROG SER, V236, P137, DOI 10.3354/meps236137; Hollows CF, 2007, MAR ECOL PROG SER, V333, P51, DOI 10.3354/meps333051; Honkoop PJC, 1999, MAR ECOL PROG SER, V180, P297, DOI 10.3354/meps180297; Johnston EL, 2011, MAR POLLUT BULL, V62, P2137, DOI 10.1016/j.marpolbul.2011.07.009; Johnston EL, 2002, ECOL APPL, V12, P1212; Johnston Emma L., 2009, V204, P133; Knight-Jones P, 1998, ZOOL J LINN SOC-LOND, V123, P385, DOI 10.1006/zjls.1997.0133; Lagos ME, 2017, FUNCT ECOL, V31, P2080, DOI 10.1111/1365-2435.12913; Licciano M, 2002, INVERTEBR BIOL, V121, P55; Marina Industries Association, 2018, INT CLEAN MAR PROGR; Marshall DJ, 2008, ADV MAR BIOL, V53, P1, DOI 10.1016/S0065-2881(07)53001-4; Marshall DJ, 2007, BIOL BULL-US, V212, P6, DOI 10.2307/25066575; MCEUEN FS, 1983, MAR BIOL, V76, P301, DOI 10.1007/BF00393033; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moran AL, 2001, ECOLOGY, V82, P1597, DOI 10.2307/2679803; Morrisey DJ, 2016, BIOFOULING, V32, P135, DOI 10.1080/08927014.2015.1126713; Murray JM, 2011, INVERTEBR REPROD DEV, V55, P183, DOI 10.1080/07924259.2011.555619; Nash R, 2003, MAR BIOL, V143, P919, DOI 10.1007/s00227-003-1146-0; O'Brien AL, 2006, MAR FRESHWATER RES, V57, P363, DOI 10.1071/MF05141; PARRY GD, 1981, OECOLOGIA, V48, P260, DOI 10.1007/BF00347974; Read GB, 2011, AQUAT INVASIONS, V6, P273, DOI 10.3391/ai.2011.6.3.04; Rivero NK, 2013, BIOFOULING, V29, P803, DOI 10.1080/08927014.2013.805751; Rollinson N, 2013, ECOLOGY, V94, P315, DOI 10.1890/2-0552.1; Ross DJ, 2007, MAR ECOL PROG SER, V340, P41, DOI 10.3354/meps340041; ROUSE G, 1994, ZOOL SCR, V23, P271, DOI 10.1111/j.1463-6409.1994.tb00390.x; Ruiz GM, 1997, AM ZOOL, V37, P621; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Simon CA, 2005, MAR BIOL, V147, P135, DOI 10.1007/s00227-005-1552-6; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stearns S.C., 1992, pi; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; STRATHMANN RR, 1990, AM ZOOL, V30, P197; Styan CA, 2002, T ROY SOC SOUTH AUST, V126, P117; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Tyrrell MC, 2007, J EXP MAR BIOL ECOL, V342, P54, DOI 10.1016/j.jembe.2006.10.014; van Woesik R, 2006, ECOL LETT, V9, P390, DOI 10.1111/j.1461-0248.2006.00886.x; Venebles WilliamN., 2002, MODERN APPL STAT S; Wells FE, 2010, 207 W AUST DEP FISH; WILSON WH, 1991, B MAR SCI, V48, P500; Wotton DM, 2004, NEW ZEAL J MAR FRESH, V38, P553, DOI 10.1080/00288330.2004.9517260; Yates CJ, 2005, CONSERV BIOL, V19, P239, DOI 10.1111/j.1523-1739.2005.00286.x	77	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0200027	10.1371/journal.pone.0200027	http://dx.doi.org/10.1371/journal.pone.0200027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969489	gold, Green Published, Green Submitted			2022-12-26	WOS:000437246700038
J	Strelcyk, O; Singh, G				Strelcyk, Olaf; Singh, Gurjit			TV listening and hearing aids	PLOS ONE			English	Article							SPEECH-INTELLIGIBILITY; AMPLIFICATION; REVERBERATION; SATISFACTION; COMPRESSION; NOISE; AGE	TV listening plays a large role in the lives of hearing-impaired (HI) individuals. Yet, few studies have examined TV listening in this group. In this paper, we report the findings of an online survey on TV listening conducted among HI individuals with and without hearing aids (HAs) in the United States in 2015. The research investigated if and in what form TV listening experiences of unaided and aided HI individuals might differ with regard to their viewing habits, difficulties they experience, and compensation strategies they employ. 515 HI people of ages 50+ years participated, 260 of whom owned HAs. HA users reported that they watched TV or video on average for 6 hours 10 min per day, 57 minutes longer than the duration reported by non-HA owners. Furthermore, HA users indicated fewer difficulties when watching TV than non-HA owners, suggesting that HA usage alleviated difficulties with TV listening. Nevertheless, the most frequent problems were still encountered by more than 39% of the HA users. Difficulties increased with greater self-reported unaided hearing disability, and female participants indicated more problems than male participants. Finally, those with carpeted floors reported fewer difficulties than those without carpets. The most frequently used compensation strategies were changing TV or HA volumes and using closed captioning. Only few HA users used audio streaming accessories. Given the exploratory nature of this study, further research is needed to inform interventions and improve the TV listening experiences of HI viewers.	[Strelcyk, Olaf] Sonova US Corp Serv, Warrenville, IL 60555 USA; [Singh, Gurjit] Phonak Canada Ltd, Mississauga, ON, Canada; [Singh, Gurjit] Univ Toronto, Dept Speech Language Pathol, Toronto, ON, Canada; [Singh, Gurjit] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Singh, Gurjit] Ryerson Univ, Dept Psychol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; Toronto Metropolitan University	Strelcyk, O (corresponding author), Sonova US Corp Serv, Warrenville, IL 60555 USA.	olaf.strelcyk@sonova.com		Strelcyk, Olaf/0000-0002-7644-3049	Sonova U.S. Corporate Services; Phonak Canada Ltd	Sonova U.S. Corporate Services; Phonak Canada Ltd	Sonova U.S. Corporate Services (O.S.) and Phonak Canada Ltd (G.S.) provided the funding for this work in the form of salaries for the authors O.S. and G.S. as well as research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abrams HB, 2015, AM AC AUD PRACT MAN; Adank P, 2010, PSYCHOL AGING, V25, P736, DOI 10.1037/a0020054; APPA, 2015, 2015 2016 NAT PET OW; Armstrong M., 2016, THE BBC; AVMA, 2012, US PET OWN DEM SOURC; Bates D., 2017, LME4 LINEAR MIXED EF, P1, DOI DOI 10.2307/2533043>; BBC, 2011, THE BBC; Benjamini Y, 2001, ANN STAT, V29, P1165; Bogdan J., 2014, PROVIDENCE J    1226; Bosse I., 2016, MEDIENNUTZUNG MENSCH; Bronkhorst AW, 2000, ACUSTICA, V86, P117; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Burrell I., 2009, INDEPENDENT; CEA, 2015, 17 ANN CE OWN MARK P; Cox R M, 2000, J Am Acad Audiol, V11, P368; Cox RM, 1999, EAR HEARING, V20, P306, DOI 10.1097/00003446-199908000-00004; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Edwards Brent, 2007, Trends Amplif, V11, P31, DOI 10.1177/1084713806298004; Everest F.A., 2009, MASTER HDB ACOUSTICS; FCC, 2017, Q REP CONS INQ COMPL; Gagne JP, 2017, TRENDS HEAR, V21, DOI 10.1177/2331216516687287; Google Trends, GOOGL TRENDS SEARCH; Gordon-Salant S, 2009, EAR HEARING, V30, P458, DOI 10.1097/AUD.0b013e3181a26ef4; HARRIS RW, 1985, AUDIOLOGY, V24, P319; Hasan SS, 2017, IEEE 6 ANN INT WORKS; Hasan SS., 2014, P 8 INT C PERV COMP; Hauser DJ, 2016, BEHAV RES METHODS, V48, P400, DOI 10.3758/s13428-015-0578-z; HELFER KS, 1990, J SPEECH HEAR RES, V33, P149, DOI 10.1044/jshr.3301.149; Hildebrandt E., 2014, THESIS; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Holman T., 1996, AUDIO ENG SOC 100 CO; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Hosford-Dunn H, 2000, J Am Acad Audiol, V11, P523; Humes LE, 2002, EAR HEARING, V23, P422, DOI 10.1097/00003446-200210000-00004; Iacus SM, 2016, COARSENED EXACT MATC; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Iacus SM, 2009, J STAT SOFTW, V30, P1; Kochkin S., 2009, HEARING REV, V16, P12; Kochkin S., 2005, HEARING J, V58, P30; Kochkin S., 2002, HEAR REV, V9, P14; Kochkin S., 2010, HEAR J, V63, P19, DOI [10.1097/01.HJ.0000366912.40173.76, DOI 10.1097/01.HJ.0000366912.40173.76]; Lenth R., 2018, EMMEANS ESTIMATED MA; Liebl T, 2016, 29 TONM VDT INT CONV; Marrone N, 2008, J ACOUST SOC AM, V124, P3064, DOI 10.1121/1.2980441; Marrone Nicole, 2008, Trends Amplif, V12, P300, DOI 10.1177/1084713808325880; Mathers CD, 1991, THE BBC; NEWMAN CW, 1991, EAR HEARING, V12, P355, DOI 10.1097/00003446-199110000-00009; Nielsen, 2016, Q12016 NIELS CO; Nielsen, 2017, Q12017 NIELS CO; PLOMP R, 1994, EAR HEARING, V15, P2, DOI 10.1097/00003446-199402000-00002; RNID, 2008, ANN SURV REP 2008; Shilling RD, HDB VIRTUAL ENV DESI; Shirley B., 2013, THESIS; Shirley B, 2017, J AUDIO ENG SOC, V65, P293, DOI 10.17743/jaes.2017.0005; Singh G, 2015, EAR HEARING, V36, P664, DOI 10.1097/AUD.0000000000000182; Skagerstrand A, 2014, INT J AUDIOL, V53, P259, DOI 10.3109/14992027.2013.876108; Sommers MS, 1997, J ACOUST SOC AM, V101, P2278, DOI 10.1121/1.418208; Standaert L, 2017, AUDIOLOGY; Timmer BHB, 2017, THESIS; Valter T., 2013, LOUDNESS STATUS EURO; VERSCHUURE H, 1994, EAR HEARING, V15, P13; VLV, 2011, VOIC LIST VIEW NEWS; Williger B, 2017, Z AUDIOL, V56, P94	64	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0200083	10.1371/journal.pone.0200083	http://dx.doi.org/10.1371/journal.pone.0200083			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL0PZ	29958299	Green Published, Green Submitted, gold			2022-12-26	WOS:000436793500028
J	Ali, SM; Vega-Rua, A; Driouich, JS; de Lamballerie, X; Failloux, AB; Nougairede, A				Ali, Souand Mohamed; Vega-Rua, Anubis; Driouich, Jean-Selim; de Lamballerie, Xavier; Failloux, Anna-Bella; Nougairede, Antoine			Comparison of chikungunya viruses generated using infectious clone or the Infectious Subgenomic Amplicons (ISA) method in Aedes mosquitoes	PLOS ONE			English	Article							RNA VIRUSES; CONSTRUCTION; THROUGHPUT; SYSTEMS; CDNA	Reverse genetics systems provide the opportunity to manipulate viral genomes and have been widely used to study RNA viruses and to develop new antiviral compounds and vaccine strategies. The recently described method called ISA (Infectious Subgenomic Amplicons) gives the possibility to rescue RNA viruses in days. We demonstrated in cell culture that the use of the ISA method led to a higher genetic diversity of viral populations than that observed using infectious clone technology. However, no replicative fitness difference was observed. In the present study, we used the chikungunya virus as a model to compare in Aedes aegypti and Aedes albopictus mosquitoes the genotypic and phenotypic characteristics of viruses produced either from an infectious clone or using the ISA method. We confirmed the results found in cellulo corroborating that the use of the ISA method was associated with higher genetic diversity of viral populations in mosquitoes but did not affect the vector competence validating its use for in vivo experiments.	[Ali, Souand Mohamed; Driouich, Jean-Selim; de Lamballerie, Xavier; Nougairede, Antoine] Aix Marseille Univ, INSERM, Inserm 1207, IRD 190,IHU Mediterranee Infect,UVE, Marseille, France; [Vega-Rua, Anubis; Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France; [Vega-Rua, Anubis] Inst Pasteur Guadeloupe, Lab Entomol Med, Abymes, Guadeloupe, France	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nougairede, A (corresponding author), Aix Marseille Univ, INSERM, Inserm 1207, IRD 190,IHU Mediterranee Infect,UVE, Marseille, France.	antoine.nougairede@univ-amu.fr	Driouich, Jean-Selim/T-4625-2019	Driouich, Jean-Selim/0000-0003-2326-2938	French "Agence Nationale de la Recherche" [ANR-14-CE14-0001]; European Union [653316]	French "Agence Nationale de la Recherche"(French National Research Agency (ANR)); European Union(European Commission)	This work was supported by the French "Agence Nationale de la Recherche" under grant agreement no. ANR-14-CE14-0001 (RNA Cacci-Code) and by the European Union's Horizon 2020 Research and Innovation Programme under grants agreements no. 653316 (European Virus Archive goes global project: https://www.european-virus-archive.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138703; Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007; Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0; Chambers TJ, 1999, J VIROL, V73, P3095, DOI 10.1128/JVI.73.4.3095-3101.1999; Ciota AT, 2007, J GEN VIROL, V88, P865, DOI 10.1099/vir.0.82606-0; Domingo E, 2005, ARCH VIROL, P59; Driouich JS, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0040-2; Edmonds J, 2013, J VIROL, V87, P2367, DOI 10.1128/JVI.03162-12; Gritsun TS, 1995, VIROLOGY, V214, P611, DOI 10.1006/viro.1995.0072; Holmes EC, 2002, J VIROL, V76, P460, DOI 10.1128/JVI.76.1.460-462.2002; Neumann G, 2004, CURR TOP MICROBIOL, V283, P43; Nougairede A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003172; RCore Team, 2020, R LANG ENV STAT COMP; REED L. J., 1938, AMER JOUR HYG, V27, P493; RICE C M, 1989, New Biologist, V1, P285; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6; Siridechadilok B, 2013, J VIROL, V87, P12667, DOI 10.1128/JVI.02261-13; Yang CC, 2014, ANTIMICROB AGENTS CH, V58, P110, DOI 10.1128/AAC.01281-13	19	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199494	10.1371/journal.pone.0199494	http://dx.doi.org/10.1371/journal.pone.0199494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953474	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400033
J	Gao, LX; Bao, WZ; Zhang, HB; Yuan, CA; Huang, DS				Gao, Liangxin; Bao, Wenzhen; Zhang, Hongbo; Yuan, Chang-An; Huang, De-Shuang			Fast sequence analysis based on diamond sampling	PLOS ONE			English	Article							BINDING-SITES; PROTEIN; METHODOLOGY; PREDICTION; PATTERNS	Both in DNA and protein contexts, an important method for modelling motifs is to utilize position weight matrix (PWM) in biological sequences. With the development of genome sequencing technology, the quantity of the sequence data is increasing explosively, so the faster searching algorithms which have the ability to meet the increasingly need are desired to develop. In this paper, we proposed a method for speeding up the searching process of candidate transcription factor binding sites (TFBS), and the users can be allowed to specify p threshold to get the desired trade-off between speed and sensitivity for a particular sequence analysis. Moreover, the proposed method can also be generalized to large-scale annotation and sequence projects.	[Gao, Liangxin; Bao, Wenzhen; Zhang, Hongbo; Huang, De-Shuang] Tongji Univ, Sch Elect & Informat Engn, Inst Machine Learning & Syst Biol, Shanghai, Peoples R China; [Yuan, Chang-An] Guangxi Teachers Educ Univ, Sci Comp & Intelligent Informat Proc GuangXi High, Nanning, Guangxi, Peoples R China	Tongji University; Nanning Normal University	Huang, DS (corresponding author), Tongji Univ, Sch Elect & Informat Engn, Inst Machine Learning & Syst Biol, Shanghai, Peoples R China.	dshuang@tongji.edu.cn			National Science Foundation of China [61732012, 61520106006, 31571364, 61672382, 61772370, U1611265, 61532008, 61472280, 61472173, 61702371, 61772357]; China Postdoctoral Science Foundation [2016M601646, 2017M611619]; "BAGUI Scholar" Program of Guangxi Province of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); "BAGUI Scholar" Program of Guangxi Province of China	This work was supported by the grants of the National Science Foundation of China, Nos. 61732012, 61520106006, 31571364, 61672382, 61772370, U1611265, 61532008, 61472280, 61472173, 61702371, and 61772357, China Postdoctoral Science Foundation Grant, Nos. 2016M601646 and 2017M611619, and supported by "BAGUI Scholar" Program of Guangxi Province of China. De-Shuang Huang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the grants of the National Science Foundation of China, Nos. 61732012, 61520106006, 31571364, 61672382, 61772370, U1611265, 61532008, 61472280, 61472173, 61702371, and 61772357, China Postdoctoral Science Foundation Grant, Nos. 2016M601646 and 2017M611619, and supported by "BAGUI Scholar" Program of Guangxi Province of China.	Ballard G, 2015, DAT MIN ICDM 2015 IE; Beckstette M, 2004, GERM C BIOINF; Beckstette M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-389; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deng SP, 2014, IEEE INT C BIOINFORM; Deng SP, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S3-S4; Dorohonceanu B, 2000, ACCELERATING PROTEIN; Freschi V, 2005, BIOINFORMATICS, V21, P2225, DOI 10.1093/bioinformatics/bti323; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Henikoff JG, 2000, NUCLEIC ACIDS RES, V28, P228, DOI 10.1093/nar/28.1.228; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Huang D.S., 1996, SYSTEMATIC THEORY NE, P201; Huang D. S, 2016, PREDICTING HUB GENES; Huang DS, 2006, BIOINFORMATICS, V22, P1855, DOI 10.1093/bioinformatics/btl190; Huang DS, 2014, CURR PROTEIN PEPT SC, V15, P553, DOI 10.2174/1389203715666140724084019; Huang DS, 2013, IEEE ACM T COMPUT BI, V10, P457, DOI 10.1109/TCBB.2013.10; Huang DS, 2012, IEEE T SYST MAN CY B, V42, P1489, DOI 10.1109/TSMCB.2012.2192475; Huang DS, 2008, IEEE T NEURAL NETWOR, V19, P2099, DOI 10.1109/TNN.2008.2004370; Huang DS, 1999, INT J PATTERN RECOGN, V13, P1083, DOI 10.1142/S0218001499000604; Liefooghe A, 2006, ANN S COMB PATT MATC; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MCLACHLAN AD, 1983, J MOL BIOL, V169, P15, DOI 10.1016/S0022-2836(83)80173-9; PAPP PP, 1993, J MOL BIOL, V233, P219, DOI 10.1006/jmbi.1993.1501; Pierce JR, 2012, INTRO INFORM THEORY; Pietrokovski S, 1996, NUCLEIC ACIDS RES, V24, P3836, DOI 10.1093/nar/24.19.3836; Rajasekaran S, 2002, J COMPUT BIOL, V9, P23, DOI 10.1089/10665270252833172; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Spellerberg IF, 2003, GLOBAL ECOL BIOGEOGR, V12, P177, DOI 10.1046/j.1466-822X.2003.00015.x; STADEN R, 1989, COMPUT APPL BIOSCI, V5, P89; Wang B, 2014, IEEE T NANOBIOSCI, V13, P118, DOI 10.1109/TNB.2014.2316997; Wu TD, 2000, BIOINFORMATICS, V16, P233, DOI 10.1093/bioinformatics/16.3.233; Yu CP, 2016, SCI REP-UK, V6, DOI 10.1038/srep25164; Zhu L, 2016, IEEE ACM T COMPUT BI, V13, P55, DOI 10.1109/TCBB.2015.2465893; Zhu L, 2015, IEEE T NANOBIOSCI, V14, P528, DOI 10.1109/TNB.2015.2420754; Zhu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058368	38	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0198922	10.1371/journal.pone.0198922	http://dx.doi.org/10.1371/journal.pone.0198922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953448	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400011
J	Kang, JH; Kao, LT; Lin, HC; Wang, TJ; Yang, TY				Kang, Jiunn-Horng; Kao, Li-Ting; Lin, Herng-Ching; Wang, Ta-Jung; Yang, Tsung-Yeh			Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CONVERTING ENZYME-INHIBITORS; INSURANCE RESEARCH DATABASE; ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CLINICAL-TRIAL; ACE-INHIBITORS; RECEPTOR BLOCKERS; MORTALITY; OUTCOMES; SYSTEM	Whether statins and an angiotensin-converting enzyme inhibitors (ACEIs) / angiotensin receptor blockors (ARBs) are associated with reduced risks of infection events is still inconclusive. This study aimed to explore the risk of hospitalization for pneumonia among patients who had received treatment with ACEIs/ARBs and/or statins using a population-based data-set. This study included 19,281 patients as cases who were hospitalized for pneumonia and 19,281 controls. We used a logistic regression to compute the odds ratio (OR) and 95% confidence interval (CI) for having previously used statins or an ACEI/ARB between patients who were hospitalized for pneumonia treatment and controls. We found there were significant associations between hospitalization for pneumonia and statin-only users (p<0.001), ACEI/ARB-only users (p<0.001), and statin and ACEI/ARB users (p<0.001). The logistic regression analysis suggested that statin-only users (adjusted OR = 0.38, 95% CI = 0.34 similar to 0.43), ACEI/ARB-only users (adjusted OR = 0.86, 95% CI = 0.82 similar to 0.91), and statin and ACEI/ARB users (adjusted OR = 0.47, 95% CI = 0.44 similar to 0.50) were all less likely to be hospitalized for pneumonia treatment than were non-users. Furthermore, we found that statin-only users (adjusted OR = 0.44, 95% CI = 0.40 similar to 0.50) and statin and ACEI/ARB users (adjusted OR = 0.55, 95% CI = 0.52 similar to 0.58) were less likely to be hospitalized for pneumonia treatment compared to ACEI-only users. However, combined statin and ACEI/ARB users (adjusted OR = 1.24, 95% CI = 1.10 similar to 1.40) were more likely to have been hospitalized for pneumonia treatment compared to statin-only users. Although we found use of both statins and ACEI/ARB were significantly associated with a lower risk of pneumonia, the combination of the two medications did not provide additional protection against pneumonia risk.	[Kang, Jiunn-Horng] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan; [Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Kao, Li-Ting] Triserv Gen Hosp, Dept Pharm Practice, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Wang, Ta-Jung; Yang, Tsung-Yeh] Taipei Med Univ Hosp, Shuang Ho Hosp, Div Cardiol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University Hospital	Lin, HC (corresponding author), Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan.; Lin, HC (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.	henry11111@tmu.edu.tw	Kao, Li-Ting/W-9287-2018	Kao, Li-Ting/0000-0003-0692-7408				Almirall J, 2014, ARCH BRONCONEUMOL, V50, P250, DOI 10.1016/j.arbres.2013.11.016; Brassard P, 2017, PHARMACOEPIDEM DR S, V26, P63, DOI 10.1002/pds.4112; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng HH, 2014, EUR REV MED PHARMACO, V18, P2294; Chung SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111268; Citgez E, 2016, BMJ OPEN RESPIR RES, V3, DOI 10.1136/bmjresp-2016-000142; de Groot MCH, 2014, EUR J EPIDEMIOL, V29, P767, DOI 10.1007/s10654-014-9941-0; Di Raimondo D, 2012, CURR PHARM DESIGN, V18, P4385, DOI 10.2174/138161212802481282; Fedson DS, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.11.03; Grau I, 2014, INT J INFECT DIS, V25, P59, DOI 10.1016/j.ijid.2013.12.013; Gunnell AS, 2013, HEART, V99, P1353, DOI 10.1136/heartjnl-2013-304348; Hemila H, 2016, CLIN INTERV AGING, V11, P1379, DOI 10.2147/CIA.S114515; Hoang V, 2016, CARDIOVASC DRUG THER, V30, P189, DOI 10.1007/s10557-016-6652-7; Kahlon S, 2013, CLIN MICROBIOL INFEC, V19, P709, DOI 10.1111/j.1469-0691.2012.04003.x; Kang JH, 2015, J NEUROL SCI, V348, P89, DOI 10.1016/j.jns.2014.11.013; Kim J, 2016, INT J CHRONIC OBSTR, V11, P2159, DOI 10.2147/COPD.S104097; Lin CF, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0202-x; McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285; Mortensen EM, 2012, CLIN INFECT DIS, V55, P1466, DOI 10.1093/cid/cis733; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P269, DOI 10.1002/pds.1715; Oesterle A, 2017, CIRC RES, V120, P229, DOI 10.1161/CIRCRESAHA.116.308537; Papazian L, 2013, JAMA-J AM MED ASSOC, V310, P1692, DOI 10.1001/jama.2013.280031; Phung DT, 2013, OBES REV, V14, P839, DOI 10.1111/obr.12055; Polgreen LA, 2015, CLIN INFECT DIS, V60, P1760, DOI 10.1093/cid/civ190; Radaelli A, 2007, ARTERIOSCL THROM VAS, V27, P2750, DOI 10.1161/ATVBAHA.107.149039; Sekizawa K, 1998, LANCET, V352, P1069, DOI 10.1016/S0140-6736(05)60114-6; Shankar-Hari M, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-106; Shin JY, 2017, BRIT J CLIN PHARMACO, V83, P1319, DOI 10.1111/bcp.13208; Shinohara Y, 2012, ADV THER, V29, P900, DOI 10.1007/s12325-012-0049-1; Shokouhi S, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.9456; Shrikrishna D, 2012, CLIN SCI, V123, P487, DOI 10.1042/CS20120081; Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520; Viasus D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006251; Wang HC, 2015, MOVEMENT DISORD, V30, P593, DOI 10.1002/mds.26136; Wieczorek-Surdacka E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020106; Wzgarda A, 2017, EUR J PHARMACOL, V797, P9, DOI 10.1016/j.ejphar.2016.12.031	37	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199981	10.1371/journal.pone.0199981	http://dx.doi.org/10.1371/journal.pone.0199981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953536	Green Submitted, gold, Green Published			2022-12-26	WOS:000436645400106
J	Borges, AC; Lima, GDG; Nishime, TMC; Gontijo, AVL; Kostov, KG; Koga-Ito, CY				Borges, Aline Chiodi; Gouvea Lima, Gabriela de Morais; Castaldelli Nishime, Thalita Mayumi; Lacerda Gontijo, Aline Vidal; Kostov, Konstantin Georgiev; Koga-Ito, Cristiane Yumi			Amplitude-modulated cold atmospheric pressure plasma jet for treatment of oral candidiasis: In vivo study	PLOS ONE			English	Article							VIRULENCE FACTORS; ALBICANS; CANDIDOSIS; COLONIZATION; MECHANISMS; INFECTION; MUCOSA	The aim of this study was to establish an effective and safe protocol for in vivo oral candidiasis treatment with atmospheric plasma jets. A novel amplitude-modulated cold atmospheric pressure plasma jet (AM-CAPPJ) device, operating with Helium, was tested. In vitro assays with Candida albicans biofilms and Vero cells were performed in order to determine the effective parameters with low cytotoxicity. After the determination of such parameters, the protocol was evaluated in experimentally induced oral candidiasis in mice. AM-CAPPJ could significantly reduce the viability of C. albicans biofilms after 5 minutes of plasma exposure when compared to the non-exposed group (p = 0.0033). After this period of exposure, high viability of Vero cells was maintained (86.33 +/- 10.45%). Also, no late effects on these cells were observed after 24 and 48 hours (83.24 +/- 15.23% and 88.96 +/- 18.65%, respectively). Histological analyses revealed significantly lower occurrence of inflammatory alterations in the AM-CAPPJ group when compared to non-treated and nystatin-treated groups (p < 0.0001). Although no significant differences among the values of CFU/tongue were observed among the non-treated group and the groups treated with AM-CAPPJ or nystatin (p = 0.3201), histological analyses revealed marked reduction in candidal tissue invasion. In conclusion, these results point out to a clinical applicability of this protocol, due to the simultaneous anti-inflammatory and inhibitory effects of AM-CAPPJ with low cytotoxicity.	[Borges, Aline Chiodi; Gouvea Lima, Gabriela de Morais; Lacerda Gontijo, Aline Vidal; Koga-Ito, Cristiane Yumi] Sao Paulo State Univ UNESP, Dept Environm Engn, Inst Sci & Technol, Sao Jose Dos Campos, Brazil; [Borges, Aline Chiodi; Gouvea Lima, Gabriela de Morais; Lacerda Gontijo, Aline Vidal; Koga-Ito, Cristiane Yumi] Sao Paulo State Univ UNESP, Oral Biopathol Grad Program, Inst Sci & Technol, Sao Jose Dos Campos, Brazil; [Castaldelli Nishime, Thalita Mayumi; Kostov, Konstantin Georgiev] Sao Paulo State Univ UNESP, Guaratingueta Fac Engn, Dept Chem & Phys, Guaratingueta, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Koga-Ito, CY (corresponding author), Sao Paulo State Univ UNESP, Dept Environm Engn, Inst Sci & Technol, Sao Jose Dos Campos, Brazil.; Koga-Ito, CY (corresponding author), Sao Paulo State Univ UNESP, Oral Biopathol Grad Program, Inst Sci & Technol, Sao Jose Dos Campos, Brazil.	cristiane@ict.unesp.br	Koga-Ito, Cristiane/ABC-6537-2020; Borges, Aline/AAH-7429-2021; Gontijo, Aline/G-9909-2013; Koga-Ito, Cristiane Y/D-7999-2012; Nishime, Thalita/H-7372-2014; Lima, Gabriela M G/I-5491-2012; Kostov, Konstantin G/C-2666-2012	Gontijo, Aline/0000-0002-4122-7610; Koga-Ito, Cristiane Y/0000-0002-2416-2173; Nishime, Thalita/0000-0003-2844-3156; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Sao Paulo Research Foundation (FAPESP) [2016/07196-6, 2015/21989-6, 2014/02354-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); www.fapesp.br: Grants #2016/07196-6 (CYKI); #2015/21989-6 (KGK) and PhD. fellowship #2014/02354-7 (ACB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Sao Paulo Research Foundation (FAPESP): Grants #2016/07196-6 (CY Koga-Ito); #2015/21989-6 (KG Kostov) and fellowship #2014/02354-7 (AC Borges).	[Anonymous], 2009, 109935 ISO; Bekeschus S, 2016, CLIN PLASMA MED, V4, P19, DOI 10.1016/j.cpme.2016.01.001; Bekeschus S, 2013, PLASMA PROCESS POLYM, V10, P706, DOI 10.1002/ppap.201300008; Borges AC, 2017, CLIN PLASMA MED, V7-8, P9, DOI 10.1016/j.cpme.2017.06.002; Boxhammer V, 2013, MUTAT RES-GEN TOX EN, V753, P23, DOI 10.1016/j.mrgentox.2012.12.015; Brun P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104397; Carmello JC, 2017, PHOTODIAGN PHOTODYN, V17, P194, DOI 10.1016/j.pdpdt.2016.11.013; de la Rosa-Garcia E, 2013, NEFROLOGIA, V33, P764, DOI 10.3265/Nefrologia.pre2013.Aug.11790; Ellepola ANB, 2001, ORAL DIS, V7, P211, DOI 10.1034/j.1601-0825.2001.70402.x; Emmert S, 2013, CLIN PLASMA MED, V1, P24, DOI 10.1016/j.cpme.2012.11.002; da Silva LCF, 2012, J CRANIOFAC SURG, V23, pE214, DOI 10.1097/SCS.0b013e31824de388; Fricke K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042539; Hebecker B, 2014, EXPERT REV ANTI-INFE, V12, P867, DOI 10.1586/14787210.2014.916210; Hofs S, 2016, J MICROBIOL, V54, P149, DOI 10.1007/s12275-016-5514-0; Junqueira JC, 2005, MICROBIOL IMMUNOL, V49, P199, DOI 10.1111/j.1348-0421.2005.tb03721.x; Kostov KG, 2015, PLASMA PROCESS POLYM, V12, P1383, DOI 10.1002/ppap.201500125; Kostov KG, 2015, PLASMA SOURCES SCI T, V24, DOI 10.1088/0963-0252/24/2/025038; Kostov KG, 2015, IEEE T PLASMA SCI, V43, P770, DOI 10.1109/TPS.2014.2360645; Laroussi M., 2018, PLASMA, V1, P47, DOI [10.3390/plasma1010005, DOI 10.3390/PLASMA1010005]; Lewis JS, 2008, EXPERT OPIN PHARMACO, V9, P927, DOI 10.1517/14656566.9.6.927; Liu DX, 2011, J HUAZHONG U SCI-MED, V31, P852, DOI 10.1007/s11596-011-0690-y; Lu X, 2016, PHYS REP, V630, P1, DOI 10.1016/j.physrep.2016.03.003; Matthes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070462; Merenstein D, 2013, AIDS RES HUM RETROV, V29, P30, DOI [10.1089/aid.2012.0269, 10.1089/AID.2012.0269]; Mohamed AAH, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/19/195401; Nittayananta W, 2016, ORAL DIS, V22, P107, DOI 10.1111/odi.12394; Okada M, 2013, ARCH ORAL BIOL, V58, P444, DOI 10.1016/j.archoralbio.2012.09.014; Ouf SA, 2016, CLEAN-SOIL AIR WATER, V44, DOI 10.1002/clen.201400575; Panngom K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.168; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Bianchi CMPD, 2016, REV INST MED TROP SP, V58, DOI [10.1590/S1678-9946201658017, 10.1590/s1678-9946201658017]; Rahimi-Verki N, 2016, PHOTODIAGN PHOTODYN, V13, P66, DOI 10.1016/j.pdpdt.2015.12.007; Reuter S, 2013, PHYS REP, P30; Robbins N, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.FUNK-0002-2016; Rossoni RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131700; Sanglard D, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00011; Sanguinetti M, 2015, MYCOSES, V58, P2, DOI 10.1111/myc.12330; Soysa NS, 2008, ORAL DIS, V14, P138, DOI 10.1111/j.1601-0825.2006.01357.x; Spellberg B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040038; Sun YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037178; Tournu Helene, 2012, Int J Microbiol, V2012, P845352, DOI 10.1155/2012/845352; Williams DW, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.22434; Yamazaki H, 2011, DENT MATER J, V30, P384, DOI 10.4012/dmj.2010-190; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176	44	25	25	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199832	10.1371/journal.pone.0199832	http://dx.doi.org/10.1371/journal.pone.0199832			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949638	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200070
J	de Araujo, LA; De Paula, AAP; de Paula, HDC; Ramos, JEP; de Oliveira, BR; De Carvalho, KPA; Guimaraes, RA; de Alencar, RDG; Duarte, ECB; Santos, SHR; Saddi, VA; Carneiro, MAD				de Araujo, Lyriane Apolinario; Peclat De Paula, Adriano Augusto; Cintra de Paula, Hellen da Silva; Porto Ramos, Jessica Enocencio; de Oliveira, Brunna Rodrigues; Almeida De Carvalho, Keila Patricia; Guimaraes, Rafael Alves; Goncalves de Alencar, Rita de Cassia; Barroso Duarte, Eliza Carla; Rabelo Santos, Silvia Helena; Saddi, Vera Aparecida; dos Santos Carneiro, Megmar Aparecida			Human papillomavirus (HPV) genotype distribution in penile carcinoma: Association with clinic pathological factors	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; P16(INK4A) EXPRESSION; NATURAL-HISTORY; CANCER; PREVALENCE; LESIONS; DNA; EPIDEMIOLOGY; INFECTION; VIRUS	Background Penile carcinoma (PC) is a rare, highly mutilating disease, common in developing countries. The evolution of penile cancer includes at least two independent carcinogenic pathways, related or unrelated to HPV infection. Objectives To estimate the prevalence, identify HPV genotypes, and correlate with clinicopathological data on penile cancer. Methods A retrospective cohort study involving 183 patients with PC undergoing treatment in a referral hospital in Goiania, Goias, in Midwestern Brazil, from 2003 to 2015. Samples containing paraffin embedded tumor fragments were subjected to detection and genotyping by INNO-LiPA HPV. The clinicopathological variables were subjected to analysis with respect to HPV positivity and used prevalence ratio (PR), adjusted prevalence ratio (PRa) and 95% confidence interval (CI) as statistical measures. Results The prevalence of HPV DNA in PC was 30.6% (95% CI: 24.4 to 37.6), high-risk HPV 24.9% (95% CI: 18.9 to 31.3), and 62.5% were HPV 16. There was a statistical association between the endpoints HPV infection and HPV high risk, and the variable tumor grade II-III (p = 0.025) (p = 0.040), respectively. There was no statistical difference in disease specific survival at 10 years between the HPV positive and negative patients (p = 0.143), and high and low risk HPV (p = 0.325). Conclusions The prevalence of HPV infection was 30.6%, and 80.3% of the genotypes were identified as preventable by anti-HPV quadrivalent or nonavalent vaccine. HPV infections and high-risk HPV were not associated with penile carcinoma prognosis in this study.	[de Araujo, Lyriane Apolinario; Cintra de Paula, Hellen da Silva; de Oliveira, Brunna Rodrigues; Almeida De Carvalho, Keila Patricia; Guimaraes, Rafael Alves; dos Santos Carneiro, Megmar Aparecida] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Peclat De Paula, Adriano Augusto; Saddi, Vera Aparecida] Araujo Jorge Hosp, Dept Urol Oncol, Goiania, Go, Brazil; [Porto Ramos, Jessica Enocencio] Pontifical Catholic Univ Goias, Dept Biol & Biomed Sci, Goiania, Go, Brazil; [Goncalves de Alencar, Rita de Cassia] Araujo Jorge Hosp, Pathol Dept, Goiania, Go, Brazil; [Barroso Duarte, Eliza Carla] Univ Brasilia, Dept Pathol, Brasilia, DF, Brazil; [Rabelo Santos, Silvia Helena] Univ Fed Goias, Fac Pharm, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade de Brasilia; Universidade Federal de Goias	Carneiro, MAD (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.	megmar242@gmail.com	Araújo, Lyriane/ABA-8755-2020; Rabelo-Santos, Silvia Helena/S-1912-2017; Carneiro, Megmar/O-6482-2018	Carneiro, Megmar/0000-0003-0569-477X; Enocencio Porto Ramos, Jessica/0000-0001-7961-1151; SADDI, VERA/0000-0001-9949-9988; Cintra de Paula, Hellen/0000-0003-2083-3651	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [483935/2013-1]; Fundacao de Amparo a Pesquisa do Estado de Goias [2014/10267000324]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Goias	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (483935/2013-1), <http://cnpq.br/web/guest/pagina-inicial> MASC; Fundacao de Amparo a Pesquisa do Estado de Goias (2014/10267000324), <http://www.fapeg.go.gov.br/> MASC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso LA, 2016, J UROLOGY, V195, P1784, DOI 10.1016/j.juro.2015.12.096; Afonso LA, 2012, MEM I OSWALDO CRUZ, V107, P18, DOI 10.1590/S0074-02762012000100003; Alemany L, 2016, EUR UROL, V69, P953, DOI 10.1016/j.eururo.2015.12.007; Backes DM, 2009, CANCER CAUSE CONTROL, V20, P449, DOI 10.1007/s10552-008-9276-9; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Barzon L, 2014, AM J PATHOL, V184, P3376, DOI 10.1016/j.ajpath.2014.08.004; Beech B, 2015, CUAJ-CAN UROL ASSOC, V9, P315, DOI 10.5489/cuaj.3230; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bezerra ALR, 2001, CANCER, V91, P2315, DOI 10.1002/1097-0142(20010615)91:12<2315::AID-CNCR1263>3.0.CO;2-C; Bezerra SM, 2015, HUM PATHOL, V46, P532, DOI 10.1016/j.humpath.2014.12.004; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Bleeker MCG, 2009, WORLD J UROL, V27, P141, DOI 10.1007/s00345-008-0302-z; de Sousa IDB, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0007-8; Bozzini G, 2016, UROLOGY, V90, P131, DOI 10.1016/j.urology.2016.01.003; Brasil. Ministerio da Saude, 2009, SECR AT SAUD DEP AC; Calmon MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053260; da Silva RJC, 2017, BRAZ J INFECT DIS, V21, P376, DOI 10.1016/j.bjid.2017.03.004; Christodoulidou M, 2015, CURR PROB CANCER, V39, P126, DOI 10.1016/j.currproblcancer.2015.03.010; Costa S, 2013, CADERNO GRADUACAO CI, V1, P23; Coutinho Leticia M S, 2008, Rev. Saúde Pública, V42, P992, DOI 10.1590/S0034-89102008000600003; Cubilla AL, 2004, INT J SURG PATHOL, V12, P351, DOI 10.1177/106689690401200408; Cubilla AL, 2010, AM J SURG PATHOL, V34, P104, DOI 10.1097/PAS.0b013e3181c76a49; da Fonseca AG, 2013, INT BRAZ J UROL, V39, P542, DOI 10.1590/S1677-5538.IBJU.2013.04.12; Diorio GJ, 2016, UROL CLIN N AM, V43, P419, DOI 10.1016/j.ucl.2016.06.003; Djajadiningrat RS, 2015, J UROLOGY, V193, P526, DOI 10.1016/j.juro.2014.08.087; Downes MR, 2015, J CLIN PATHOL, V68, P333, DOI 10.1136/jclinpath-2015-202911; Favorito LA, 2008, INT BRAZ J UROL, V34, P587, DOI 10.1590/S1677-55382008000500007; Ferrandiz-Pulido C, 2013, J AM ACAD DERMATOL, V68, P73, DOI 10.1016/j.jaad.2012.05.029; Garcia-Espinosa B, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-31; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; GREGOIRE L, 1995, JNCI-J NATL CANCER I, V87, P1705, DOI 10.1093/jnci/87.22.1705; Hernandez BY, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00009; Instituto Nacional De Cancer, 2016, CANC DE PEN; Kidd LC, 2017, TRANSL ANDROL UROL, V6, P791, DOI 10.21037/tau.2017.06.27; Langkamp DL, 2010, ACAD PEDIATR, V10, P205, DOI 10.1016/j.acap.2010.01.005; Larke NL, 2011, CANCER CAUSE CONTROL, V22, P1097, DOI 10.1007/s10552-011-9785-9; Lobrigatte MFP, 2015, BRAZILIAN J SURG CLI, V9, P20; Lopez-Romero R, 2013, INT J CLIN EXP PATHO, V6, P1409; Mannweiler S, 2013, J AM ACAD DERMATOL, V69, P73, DOI 10.1016/j.jaad.2012.12.973; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; Moch H, 2016, EUR UROL, V70, P93, DOI 10.1016/j.eururo.2016.02.029; Morrison BF, 2014, W INDIAN MED J, V63, P559, DOI 10.7727/wimj.2015.381; De Paula AAP, 2012, J UROLOGY, V187, P134, DOI 10.1016/j.juro.2011.09.027; Pow-Sang MR, 2010, UROLOGY, V76, pS2, DOI 10.1016/j.urology.2010.03.003; Rubin Leah H, 2007, J Undergrad Neurosci Educ, V5, pA71; Scheiner MA, 2008, INT BRAZ J UROL, V34, P467, DOI 10.1590/S1677-55382008000400009; Spiess PE, 2016, CA-CANCER J CLIN, V66, P482, DOI 10.3322/caac.21354; Steinau M, 2011, J MOL DIAGN, V13, P377, DOI 10.1016/j.jmoldx.2011.03.007; Steinestel J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1268-z; Stratton KL, 2016, ONCOLOGY-NY, V30, P245; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050	51	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199557	10.1371/journal.pone.0199557	http://dx.doi.org/10.1371/journal.pone.0199557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949632	gold, Green Submitted, Green Published			2022-12-26	WOS:000436549200056
J	Shahshahani, PM; Lipps, DB; Galecki, AT; Ashton-Miller, JA				Shahshahani, Payam Mirshams; Lipps, David B.; Galecki, Andrzej T.; Ashton-Miller, James A.			On the apparent decrease in Olympic sprinter reaction times	PLOS ONE			English	Article							BRAIN-STEM RESPONSE; GENDER; AGE	Reaction times of Olympic sprinters provide insights into the most rapid of human response times. To determine whether minimum reaction times have changed as athlete training has become ever more specialized, we analyzed the results from the Olympic Games between 2004 and 2016. The results for the 100 m and 110 m hurdle events show that minimum reaction times have systematically decreased between 2004 and 2016 for both sexes, with women showing a marked decrease since 2008 that eliminated the sex difference in 2012. Because overall race times have not systematically decreased between 2004 and 2016, the most likely explanation for the apparent decrease in reaction times is a reduction in the proprietary force thresholds used to calculate the reaction times based on force sensors in starting blocks-and not the result of more specialized or effective training.	[Shahshahani, Payam Mirshams; Ashton-Miller, James A.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Lipps, David B.; Ashton-Miller, James A.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Galecki, Andrzej T.; Ashton-Miller, James A.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Galecki, Andrzej T.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shahshahani, PM (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	mirshams@umich.edu		Mirshams Shahshahani, Payam/0000-0001-6930-6225	Claude Pepper Center Grant [AG024824]; National Institute of Aging; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	Claude Pepper Center Grant; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Claude Pepper Center Grant AG024824 from the National Institute of Aging, (JAAM and ATG), https://www.nia.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL DG, 1986, MED SCI SPORT EXER, V18, P31; Brosnan KC, 2017, J SPORT SCI, V35, P929, DOI 10.1080/02640414.2016.1201213; DON M, 1993, J ACOUST SOC AM, V94, P2135, DOI 10.1121/1.407485; Lipps DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026141; Pain MTG, 2007, J SPORT SCI, V25, P79, DOI 10.1080/02640410600718004; Thelen DG, 1996, J GERONTOL A-BIOL, V51, pM226, DOI 10.1093/gerona/51A.5.M226; TRUNE DR, 1988, HEARING RES, V32, P165, DOI 10.1016/0378-5955(88)90088-3; Uth N, 2005, J SPORT SCI MED, V4, P608; Willwacher S, 2013, PROCEDIA ENGINEER, V60, P124, DOI 10.1016/j.proeng.2013.07.073	9	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198633	10.1371/journal.pone.0198633	http://dx.doi.org/10.1371/journal.pone.0198633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949576	Green Submitted, Green Published, gold			2022-12-26	WOS:000436549200018
J	Zhao, Q; Liu, YN; Zhang, N; Hu, MH; Zhang, H; Joshi, TT; Xu, D				Zhao, Qi; Liu, Yuanning; Zhang, Ning; Hu, Menghan; Zhang, Hao; Joshi, Trupti; Xu, Dong			Evidence for plant-derived xenomiRs based on a large-scale analysis of public small RNA sequencing data from human samples	PLOS ONE			English	Article							RESPONSIVE MAMMALIAN MIRNAS; GENOME ANNOTATION; GENE-EXPRESSION; MICRORNAS; DIET; DELIVERY; CONTAMINATION; INGESTION; MECHANISM; EXOSOMES	In recent years, an increasing number of studies have reported the presence of plant miRNAs in human samples, which resulted in a hypothesis asserting the existence of plant-derived exogenous microRNA (xenomiR). However, this hypothesis is not widely accepted in the scientific community due to possible sample contamination and the small sample size with lack of rigorous statistical analysis. This study provides a systematic statistical test that can validate (or invalidate) the plant-derived xenomiR hypothesis by analyzing 388 small RNA sequencing data from human samples in 11 types of body fluids/tissues. A total of 166 types of plant miRNAs were found in at least one human sample, of which 14 plant miRNAs represented more than 80% of the total plant miRNAs abundance in human samples. Plant miRNA profiles were characterized to be tissue-specific in different human samples. Meanwhile, the plant miRNAs identified from microbiome have an insignificant abundance compared to those from humans, while plant miRNA profiles in human samples were significantly different from those in plants, suggesting that sample contamination is an unlikely reason for all the plant miRNAs detected in human samples. This study also provides a set of testable synthetic miRNAs with isotopes that can be detected in situ after being fed to animals.	[Zhao, Qi; Liu, Yuanning; Zhang, Hao; Xu, Dong] Jilin Univ, Dept Comp Sci & Technol, Changchun, Jilin, Peoples R China; [Zhao, Qi; Joshi, Trupti; Xu, Dong] Univ Missouri, Dept Elect Engn & Comp Sci, Columbia, MO USA; [Zhao, Qi; Joshi, Trupti; Xu, Dong] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA; [Zhao, Qi] Northeastern Univ, Sinodutch Biomed & Informat Engn Sch, Shenyang, Liaoning, Peoples R China; [Zhang, Ning; Joshi, Trupti; Xu, Dong] Univ Missouri, MU Informat Inst, Columbia, MO USA; [Hu, Menghan] Brown Univ, Dept Biostat, Providence, RI 02912 USA; [Joshi, Trupti] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA	Jilin University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Northeastern University - China; University of Missouri System; University of Missouri Columbia; Brown University; University of Missouri System; University of Missouri Columbia	Xu, D (corresponding author), Jilin Univ, Dept Comp Sci & Technol, Changchun, Jilin, Peoples R China.; Xu, D (corresponding author), Univ Missouri, Dept Elect Engn & Comp Sci, Columbia, MO USA.; Xu, D (corresponding author), Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA.; Xu, D (corresponding author), Univ Missouri, MU Informat Inst, Columbia, MO USA.	xudong@missouri.edu	Zhang, Ning/ABH-9679-2020; Zhang, Hao/AAR-8325-2020; Xu, Dong/Y-8605-2018	Zhang, Ning/0000-0001-6643-6980; Zhang, Hao/0000-0002-2058-7123; 	National Natural Science Foundation of China [61471181]; Natural Science Foundation of Jilin Province [20140101194JC, 20150101056JC]; US National Institutes of Health [GM100701]; Fundamental Research Funds for the Central Universities [02120022118016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/) under Grant No. 61471181, Natural Science Foundation of Jilin Province (http://kjt.jl.gov.cn/) under Grant No. 20140101194JC and No. 20150101056JC and US National Institutes of Health (https://www.nih.gov/) under Grant No. GM100701, and The Fundamental Research Funds for the Central Universities to Qi Zhao (02120022118016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Baier SR, 2014, J NUTR, V144, P1881, DOI 10.3945/jn.114.202606; Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cavalieri D, 2016, SCI REP-UK, V6, DOI 10.1038/srep25761; Chan SY, 2017, RNA BIOL, V14, P402, DOI 10.1080/15476286.2016.1248329; Chan SY, 2014, MICRORNA DIAGNOSTICS, V1; Chin AR, 2016, CELL RES, V26, P217, DOI 10.1038/cr.2016.13; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; Du JC, 2019, SCI CHINA LIFE SCI, V62, P309, DOI 10.1007/s11427-017-9026-7; EL Andaloussi S, 2013, ADV DRUG DELIVER REV, V65, P391, DOI 10.1016/j.addr.2012.08.008; Fabris L, 2016, MOL ONCOL, V10, P503, DOI 10.1016/j.molonc.2016.01.005; Guo L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154955; Guo L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23700; Han L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01113; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hirschi KD, 2015, TRENDS BIOTECHNOL, V33, P431, DOI 10.1016/j.tibtech.2015.06.003; Hirschi KD, 2012, TRENDS PLANT SCI, V17, P123, DOI 10.1016/j.tplants.2012.01.004; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jia L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12290; Jiang MX, 2012, BIOESSAYS, V34, P280, DOI 10.1002/bies.201100181; Kang WJ, 2017, RNA, V23, P433, DOI 10.1261/rna.059725.116; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lefebvre FA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00377; Lefebvre FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27680; Li J, 2015, PROTEIN CELL, V6, P391, DOI 10.1007/s13238-015-0156-2; Li Y, 2014, NUCLEIC ACIDS RES, V42, pD1070, DOI 10.1093/nar/gkt1023; Liang Gf, 2014, FOOD SCI NUTR, V2, P380, DOI 10.1002/fsn3.113; Liang HW, 2015, J NUTR BIOCHEM, V26, P505, DOI 10.1016/j.jnutbio.2014.12.002; Liang HW, 2013, RNA BIOL, V10, P373, DOI 10.4161/rna.23663; Lukasik A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010009; Lukasik A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099963; Luo Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00488-y; Ma JD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03707-8; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Masood M, 2016, RNA BIOL, V13, P109, DOI 10.1080/15476286.2015.1128063; Mico V, 2016, PLANT FOOD HUM NUTR, V71, P102, DOI 10.1007/s11130-016-0534-9; Mlotshwa S, 2015, CELL RES, V25, P521, DOI 10.1038/cr.2015.25; Munafo DB, 2010, RNA, V16, P2537, DOI 10.1261/rna.2242610; Nolte-'t Hoen ENM, 2015, J INTERN MED, V278, P99, DOI 10.1111/joim.12372; Oja H, 2004, STAT SCI; Pardridge William M, 2005, NeuroRx, V2, P3; Pastrello C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32773; Perge P, 2017, RNA BIOL, V14, P391, DOI 10.1080/15476286.2016.1251001; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Petrick JS, 2013, REGUL TOXICOL PHARM, V66, P167, DOI 10.1016/j.yrtph.2013.03.008; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Snow JW, 2013, RNA BIOL, V10, P1107, DOI 10.4161/rna.24909; Tosar JP, 2014, RNA, V20, P754, DOI 10.1261/rna.044263.114; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vaucheret H, 2012, CELL RES, V22, P3, DOI 10.1038/cr.2011.164; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051009; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Witwer KW, 2017, GENES NUTR, V12, DOI 10.1186/s12263-017-0564-4; Witwer KW, 2015, J NUTR BIOCHEM, V26, P1685, DOI 10.1016/j.jnutbio.2015.09.004; Witwer KW, 2014, J NUTR, V144, P1880, DOI 10.3945/jn.114.202523; Witwer KW, 2014, BIOESSAYS, V36, P394, DOI 10.1002/bies.201300150; Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246; Witwer KW, 2012, RNA BIOL, V9, P1147, DOI 10.4161/rna.21619; Xie WY, 2016, PLANTA MED, V82, P1153, DOI 10.1055/s-0042-108450; Yang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137516; Yang J, 2015, CELL RES, V25, P517, DOI 10.1038/cr.2015.26; Zhang H, 2017, BRIEFINGS BIOINFORMA; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-381; Zhao Yang, 2017, Cereal & Food Industry, P1; Zheng LL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00126; Zhou Z, 2015, CELL RES, V25, P39, DOI 10.1038/cr.2014.130; Zhu KA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006946; Zou Q, 2014, COMPUT BIOL MED, V45, P157, DOI 10.1016/j.compbiomed.2013.12.007	82	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0187519	10.1371/journal.pone.0187519	http://dx.doi.org/10.1371/journal.pone.0187519			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949574	Green Published, gold, Green Submitted			2022-12-26	WOS:000436549200001
J	Hwang, A; Shi, C; Zhu, E; Naaz, F; Zhou, P; Rasheed, Z; Liu, M; Jung, LS; Duan, B; Li, JS; Jiang, K; Paka, L; Gadhiya, SV; Dana, D; Ali, Q; Yamin, MA; Goldberg, ID; Narayan, P				Hwang, Anne; Shi, Christopher; Zhu, Edward; Naaz, Farha; Zhou, Ping; Rasheed, Zainab; Liu, Michelle; Jung, Lindsey S.; Duan, Bin; Li, Jingsong; Jiang, Kai; Paka, Latha; Gadhiya, Satishkumar, V; Dana, Dibyendu; Ali, Quaisar; Yamin, Michael A.; Goldberg, Itzhak D.; Narayan, Prakash			Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ALPHA-FETOPROTEIN; MOUSE MODEL; FIBROSIS; ASSOCIATION; MANAGEMENT	Although cirrhosis is a key risk factor for the development of hepatocellular carcinoma (HCC), mounting evidence indicates that in a subset of patients presenting with non-alcoholic steatohepatitis (NASH) HCC manifests in the absence of cirrhosis. Given the sheer size of the ongoing non-alcoholic fatty liver disease (NAFLD) epidemic and the dismal prognosis associated with late-stage primary liver cancer there is an urgent need for HCC surveillance in the NASH population. Using serum levels of HCC biomarkers as vectors and biopsy-proven HCC or no HCC as outputs / binary classifier, a supervised learning campaign was undertaken to develop a minimally invasive technique for making a diagnosis of HCC in a clinically relevant model of NASH. Adult mice randomized to control diet or a fast food diet (FFD) were followed for up to 14 mo and serum level of a panel of HCC-relevant biomarkers was compared with liver biopsies at 3 and 14 mo. Both NAFLD Activity Score (NAS) and hepatic hydroxyproline content were elevated at 3 and 14 mo on FFD. Picrosirius red staining of liver sections revealed a filigree pattern of fibrillar collagen deposition with no cirrhosis at 14 mo on FFD. Nevertheless, 46% of animals bore one or more tumors on their livers confirmed as HCC in hematoxylin-eosin-stained liver sections. In this training set, receiver operating characteristic (ROC) curves analysis for serum levels of the HCC biomarkers osteopontin (OPN), alpha-fetoprotein (AFP) and Dickkopf-1 (DKK1) returned con-cordance-statistic/area under ROC curve of >= 0.89. Serum levels of OPN (threshold, 218 ng/mL; sensitivity, 82%; specificity, 86%), AFP (136 ng/mL; 91%; 97%) and DKK1 (2.4 ng/mL; 82%; 81%) diagnostic for HCC were confirmed in a test set comprising mice on control diet or FFD and mice subjected to hepatic ischemia-reperfusion injury. These data suggest that levels of circulating OPN, AFP and DKK1 can be used to make a diagnosis of HCC in a clinically relevant model of NASH.	[Hwang, Anne; Shi, Christopher; Zhu, Edward; Naaz, Farha; Zhou, Ping; Rasheed, Zainab; Liu, Michelle; Jung, Lindsey S.; Duan, Bin; Li, Jingsong; Jiang, Kai; Paka, Latha; Gadhiya, Satishkumar, V; Dana, Dibyendu; Ali, Quaisar; Yamin, Michael A.; Goldberg, Itzhak D.; Narayan, Prakash] Angion Biomed Corp, Dept Preclin Res, Uniondale, NY 11553 USA		Narayan, P (corresponding author), Angion Biomed Corp, Dept Preclin Res, Uniondale, NY 11553 USA.	pnarayanan@angion.com			Angion Biomedica Corp	Angion Biomedica Corp	Angion Biomedica Corp provided support in the form of salaries for authors PZ, JL, KJ, LP, SVG, DD, QA, MAY, IDG, PN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Berhane S, 2016, CLIN GASTROENTEROL H, V14, P875, DOI 10.1016/j.cgh.2015.12.042; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cabibbo G, 2009, WORLD J HEPATOL, V1, P62, DOI 10.4254/wjh.v1.i1.62; Calderaro J, 2017, J HEPATOL, V67, P727, DOI 10.1016/j.jhep.2017.05.014; Chauhan Ranjit, 2016, Biomark Cancer, V8, P37, DOI 10.4137/BIC.S34413; Chen CB, 2013, J CHIN MED ASSOC, V76, P299, DOI 10.1016/j.jcma.2013.01.004; Cholankeril G, 2017, WORLD J HEPATOL, V9, P533, DOI 10.4254/wjh.v9.i11.533; Dyson JK, 2013, FRONTLINE GASTROENTE; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Friedman SL, 2014, J HEPATOL, V60, P1, DOI 10.1016/j.jhep.2013.10.003; Gonzalez Stevan A, 2014, Hepatobiliary Surg Nutr, V3, P410, DOI 10.3978/j.issn.2304-3881.2014.07.06; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Hankey BF, 1999, CANCER EPIDEM BIOMAR, V8, P1117; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Hewitson TD, 2014, NEPHROLOGY, V19, P721, DOI 10.1111/nep.12321; Kishida N, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0477-5; Kolly P, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6020022; Lau WY, 2008, HEPATOB PANCREAT DIS, V7, P237; Liedtke C, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-19; Lin DC, 2017, CANCER RES, V77, P2255, DOI 10.1158/0008-5472.CAN-16-2822; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Neuschwander-Tetri BA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0806-8; Paka L, 2017, WORLD J GASTROENTERO, V23, P4181, DOI 10.3748/wjg.v23.i23.4181; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734; Perumpail RB, 2015, DIGEST DIS SCI, V60, P3142, DOI 10.1007/s10620-015-3821-7; Pons Fernando, 2005, HPB (Oxford), V7, P35, DOI 10.1080/13651820410024058; Sanyal AJ, 2015, HEPATOLOGY, V61, P1392, DOI 10.1002/hep.27678; Shafizadeh Nafis, 2013, Surg Pathol Clin, V6, P367, DOI 10.1016/j.path.2013.03.007; Shi YJ, 2012, J HEPATOL, V56, P137, DOI 10.1016/j.jhep.2011.05.025; Takeuchi M, 2001, EUR J GASTROEN HEPAT, V13, P951, DOI 10.1097/00042737-200108000-00013; Tsuchiya N, 2015, WORLD J GASTROENTERO, V21, P10573, DOI 10.3748/wjg.v21.i37.10573; Xu P, 2014, WORLD J GASTROENTERO, V20, P11865, DOI 10.3748/wjg.v20.i33.11865; Yoshimine Y, 2015, ONCOL REP, V33, P1657, DOI 10.3892/or.2015.3745	34	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0198937	10.1371/journal.pone.0198937	http://dx.doi.org/10.1371/journal.pone.0198937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944670	Green Submitted, Green Published, gold			2022-12-26	WOS:000436377800016
J	Kelly, PJ; Allison, M; Ramaswamy, M				Kelly, Patricia J.; Allison, Molly; Ramaswamy, Megha			Cervical cancer screening among incarcerated women	PLOS ONE			English	Article							CHILDHOOD EXPERIENCES; SEXUAL-ABUSE; ADOLESCENCE; VACCINATION; BEHAVIORS; VIOLENCE; HISTORY; BREAST; MODEL	Background Women with a history of incarceration bear a disproportionate burden of cervical disease and have special characteristics that affect their intent and/or ability to adhere to cervical screening and follow-up recommendations. The goal of this study was to identify factors associated with cervical cancer screening and screening outcomes among incarcerated women. Methods We applied a framework of predisposing factors, enabling factors and population-specific characteristics that could impact screening behaviors and outcomes for this population. We used bivariate chi-square tests and Wilcoxon signed-rank tests to analyze data previously collected from 290 incarcerated women. Results Cervical cancer screening belief score, as a predisposing factor, was associated with women who had an up-to-date Pap test and who had a cervical cancer diagnosis ever in their life. Both a sexual history containing high-risk behaviors and a history of abuse, population +/- specific factors, were each associated with having had an abnormal pap; mental health, incarceration, and substance use histories were each associated with having a diagnosis of cervical cancer. Conclusions The significant differences in outcomes for these population-specific factors suggest the need for a health services approach that addresses the challenges to the cervical cancer preventive health needs of incarcerated women. Implications for practice Providers working with vulnerable populations such as women who have been incarcerated should be aware that their risk histories have an influence on their follow-up behaviors. These women will need extra support for cervical cancer screening and follow-up care.	[Kelly, Patricia J.] Univ Missouri, Kansas City, MO 64110 USA; [Allison, Molly; Ramaswamy, Megha] Univ Kansas, Sch Med, Kansas City, KS USA	University of Missouri System; University of Missouri Kansas City; University of Kansas; University of Kansas Medical Center	Kelly, PJ (corresponding author), Univ Missouri, Kansas City, MO 64110 USA.	kellypj@umkc.edu			American Cancer Society Institutional Research Grant; NATIONAL CANCER INSTITUTE [R01CA181047] Funding Source: NIH RePORTER	American Cancer Society Institutional Research Grant(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an American Cancer Society Institutional Research Grant to the University of Kansas School of Medicine (Principal Investigator of present study, Megha Ramaswamy; Principal Investigator of Institutional Research Grant, Bruce Kimler).	Aggarwal A, 2013, AM J PREV MED, V44, P392, DOI 10.1016/j.amepre.2012.12.006; Alcala HE, 2017, J WOMENS HEALTH, V26, P58, DOI 10.1089/jwh.2016.5823; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Binswanger IA, 2011, J WOMENS HEALTH, V20, P1839, DOI 10.1089/jwh.2011.2864; Brotherton JML, 2015, CURR OPIN ONCOL, V27, P399, DOI 10.1097/CCO.0000000000000211; Cadman L, 2012, J FAM PLAN REPROD H, V38, P214, DOI 10.1136/jfprhc-2012-100378; CHAMPION VL, 1993, NURS RES, V42, P139; Chan D, 2017, CANC NURS, V40, pe3; Draucker CB, 2013, NURS OUTLOOK, V61, P291, DOI 10.1016/j.outlook.2012.12.003; Farley MS, 2002, J FAM PRACTICE, V51, P827; Gomez D.T., 2007, COMMUNICATING CURREN, V1, P680; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Kelly PJ, 2014, PUBLIC HEALTH NURS, V31, P118, DOI 10.1111/phn.12056; Lofters A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1441-y; Marlow LAV, 2015, J FAM PLAN REPROD H, V41, P248, DOI 10.1136/jfprhc-2014-101082; McKnight B, 2006, J OBSTET GYNAECOL CA, V28, P695, DOI 10.1016/S1701-2163(16)32237-X; Ramaswamy M, 2015, J HEALTH CARE POOR U, V26, P1265, DOI 10.1353/hpu.2015.0130; Ramaswamy M, 2011, WOMEN HEALTH, V51, P423, DOI 10.1080/03630242.2011.590875; Rauscher GH, 2008, CANCER EPIDEM BIOMAR, V17, P748, DOI 10.1158/1055-9965.EPI-07-2629; Sherin K M, 1998, Fam Med, V30, P508; Singer M., 2009, GLOBAL HLTH TIME VIO; Walsh CA, 2008, CHILD ABUSE NEGLECT, V32, P1037, DOI 10.1016/j.chiabu.2008.05.003; Webb S, REV J WOMENS H	23	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199220	10.1371/journal.pone.0199220	http://dx.doi.org/10.1371/journal.pone.0199220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK7JR	29944694	gold, Green Published, Green Submitted			2022-12-26	WOS:000436377800023
J	Zarnitsyna, VI; Bulusheva, I; Handel, A; Longini, IM; Halloran, ME; Antia, R				Zarnitsyna, Veronika, I; Bulusheva, Irina; Handel, Andreas; Longini, Ira M.; Halloran, M. Elizabeth; Antia, Rustom			Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks	PLOS ONE			English	Article							CROSS-PROTECTIVE IMMUNITY; A VIRUS; IMMUNOLOGICAL DETERMINANTS; ANTIVIRAL RESISTANCE; LETHAL INFECTION; DYNAMICS; STRAIN; MODEL; EVOLUTION; IMPACT	For most pathogens, vaccination reduces the spread of the infection and total number of cases; thus, public policy usually advocates maximizing vaccination coverage. We use simple mathematical models to explore how this may be different for pathogens, such as influenza, which exhibit strain variation. Our models predict that the total number of seasonal influenza infections is minimized at an intermediate (rather than maximal) level of vaccination, and, somewhat counter-intuitively, further increasing the level of the vaccination coverage may lead to higher number of influenza infections and be detrimental to the public interest. This arises due to the combined effects of: competition between multiple co-circulating strains; limited breadth of protection afforded by the vaccine; and short-term strain-transcending immunity following natural infection. The study highlights the need for better quantification of the components of vaccine efficacy and longevity of strain-transcending cross-immunity in order to generate nuanced recommendations for influenza vaccine coverage levels.	[Zarnitsyna, Veronika, I] Emory Univ, Dept Microbiol & Immunol, Sch Med, Atlanta, GA 30322 USA; [Bulusheva, Irina] Moscow Inst Phys & Technol, Dept Biol & Med Phys, Dolgoprudnyi 141701, Russia; [Handel, Andreas] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Longini, Ira M.] Univ Florida, Dept Biostat, Gainesville, FL 32611 USA; [Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Antia, Rustom] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University; Moscow Institute of Physics & Technology; University System of Georgia; University of Georgia; State University System of Florida; University of Florida; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Emory University	Zarnitsyna, VI (corresponding author), Emory Univ, Dept Microbiol & Immunol, Sch Med, Atlanta, GA 30322 USA.; Antia, R (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	vizarni@emory.edu; rantia@emory.edu	Булушева, Ирина/AAL-8302-2020	Zarnitsyna, Veronika/0000-0003-3096-3695; Handel, Andreas/0000-0002-4622-1146; Bulusheva, Irina/0000-0001-8980-8425	National Institute of General Medical Sciences [MIDAS-U54GM111274]; National Institute of Allergy and Infectious Diseases [U19 AI117891, R37 AI32042]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117891, R37AI032042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM111274] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MIDAS-U54GM111274 National Institute of General Medical Sciences U19 AI117891 National Institute of Allergy and Infectious Diseases R37 AI32042 National Institute of Allergy and Infectious Diseases The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079; ANTIA R, 1994, J THEOR BIOL, V168, P141, DOI 10.1006/jtbi.1994.1094; Bedford T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-38; Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; Boni MF, 2006, P ROY SOC B-BIOL SCI, V273, P1307, DOI 10.1098/rspb.2006.3466; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; CASTILLOCHAVEZ C, 1989, J MATH BIOL, V27, P233, DOI 10.1007/BF00275810; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Couch RB, 2013, J INFECT DIS, V207, P974, DOI 10.1093/infdis/jis935; DAVENPORT F, 1961, AM REV RESPIR DIS, V83, P146; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Flannery B, 2016, J INFECT DIS, V214, P1010, DOI 10.1093/infdis/jiw181; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Fung ICH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036573; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Gupta S, 1996, NAT MED, V2, P437, DOI 10.1038/nm0496-437; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hamilton JR, 2016, P NATL ACAD SCI USA, V113, P3861, DOI 10.1073/pnas.1522376113; Handel A, 2007, P ROY SOC B-BIOL SCI, V274, P833, DOI 10.1098/rspb.2006.0015; Handel A, 2009, EPIDEMICS-NETH, V1, P185, DOI 10.1016/j.epidem.2009.09.001; Handel A, 2009, J THEOR BIOL, V256, P117, DOI 10.1016/j.jtbi.2008.09.021; Hillaire MLB, 2011, J GEN VIROL, V92, P2339, DOI 10.1099/vir.0.033076-0; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Koelle K, 2010, J R SOC INTERFACE, V7, P1257, DOI 10.1098/rsif.2010.0007; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Kreijtz JHCM, 2009, VACCINE, V27, P4983, DOI 10.1016/j.vaccine.2009.05.079; Kryazhimskiy S, 2007, PLOS COMPUT BIOL, V3, P1513, DOI 10.1371/journal.pcbi.0030159; LIANG SH, 1994, J IMMUNOL, V152, P1653; Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; MAY RM, 1982, NATURE, V300, P481, DOI 10.1038/300481a0; McCullers JA, 2012, HUM VACC IMMUNOTHER, V8, P34, DOI 10.4161/hv.8.1.18214; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P419, DOI 10.1017/S0950268800067170; McMaster SR, 2015, J IMMUNOL, V195, P203, DOI 10.4049/jimmunol.1402975; Meeyai A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001829; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Mina MJ, 2014, LANCET RESP MED, V2, P750, DOI 10.1016/S2213-2600(14)70131-6; Moghadas SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001839; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Park AW, 2009, SCIENCE, V326, P726, DOI 10.1126/science.1175980; Recker M, 2007, P NATL ACAD SCI USA, V104, P7711, DOI 10.1073/pnas.0702154104; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Slutter B, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2031; Smith AM, 2018, VIRAL IMMUNOL, V31, P159, DOI 10.1089/vim.2017.0138; SONOGUCHI T, 1985, J INFECT DIS, V151, P81, DOI 10.1093/infdis/151.1.81; Subramanian R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005204; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tria F, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07008; US CDC, 2008, 2007 2008 INFL SEAS; US CDC, VACC INFL VACC SUMM; van de Sandt CE, 2014, J VIROL, V88, P1684, DOI 10.1128/JVI.02843-13; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103; Worby CJ, 2017, EPIDEMICS-NETH, V19, P74, DOI 10.1016/j.epidem.2017.02.008; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Zarnitsyna VI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00165	66	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199674	10.1371/journal.pone.0199674	http://dx.doi.org/10.1371/journal.pone.0199674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944709	Green Submitted, Green Published, gold			2022-12-26	WOS:000436377800053
J	Martina, JA; Puertollano, R				Martina, Jose A.; Puertollano, Rosa			Protein phosphatase 2A stimulates activation of TFEB and TFE3 transcription factors in response to oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription factor; phosphatase; protein phosphatase 2 (PP2A); oxidative stress; nuclear translocation; mTORC1; okadaic acid; sodium arsenite; transcription factor binding to IGHM enhancer 3; transcription factor EB	LYSOSOMAL BIOGENESIS; LINKS AUTOPHAGY; CELL-SURVIVAL; PP2A; FTY720; DEGRADATION; CALCINEURIN; MTORC1; DEPHOSPHORYLATION; METABOLISM	Adaptations and responses to stress conditions are fundamental processes that all cells must accomplish to maintain or restore cellular homeostasis. Cells have a plethora of response pathways to mitigate the effect of different environmental stressors. The transcriptional regulators transcription factor EB (TFEB) and transcription factor binding to IGHM enhancer 3 (TFE3) play a key role in the control of these stress pathways. Therefore, understanding their regulation under different stress conditions is of great interest. Here, using a range of human and murine cells, we show that TFEB and TFE3 are activated upon induction of acute oxidative stress by sodium arsenite via an mTOR complex 1 (mTORC1)-independent process. We found that the mechanism of arsenite-stimulated TFEB and TFE3 activation instead involves protein phosphatase 2A (PP2A)-mediated dephosphorylation at Ser-211 and Ser-321, respectively. Depletion of either the catalytic (PPP2CA+B) or regulatory (PPP2R2A/B55) subunits of PP2A, as well as PP2A inactivation with the specific inhibitor okadaic acid, abolished TFEB and TFE3 activation in response to sodium arsenite. Conversely, PP2A activation by ceramide or the sphingosine-like compound FTY720 was sufficient to induce TFE3 nuclear translocation. MS analysis revealed that PP2A dephosphorylates TFEB at several residues, including Ser-109, Ser-114, Ser-122, and Ser-211, thus facilitating TFEB activation. Overall, this work identifies a critical mechanism that activates TFEB and TFE3 without turning off mTORC1 activity. We propose that this mechanism may enable some cell types such as immune or cancer cells that require simultaneous TFEB/TFE3 and mTORC1 signaling to survive and achieve robust cell growth in stressful environments.	[Martina, Jose A.; Puertollano, Rosa] NHLBI, Cell Biol & Physiol Ctr, NIH, 9000 Rockville Pike,Bldg 50-3537, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Puertollano, R (corresponding author), NHLBI, Cell Biol & Physiol Ctr, NIH, 9000 Rockville Pike,Bldg 50-3537, Bethesda, MD 20892 USA.	puertolr@mail.nih.gov	Martina, Jose A/C-2772-2013	Martina, Jose/0000-0001-5814-8807	Intramural Research Program of the National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006151] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the National Institutes of Health, NHLBI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Campbell GR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005018; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Cianfanelli V, 2015, NAT CELL BIOL, V17, P20, DOI 10.1038/ncb3072; Di Conza G, 2017, CELL REP, V18, P1699, DOI 10.1016/j.celrep.2017.01.051; Gong XZ, 2015, ARCH TOXICOL, V89, P1057, DOI 10.1007/s00204-014-1302-y; Gray MA, 2016, CURR BIOL, V26, P1955, DOI 10.1016/j.cub.2016.05.070; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Hogan PG, 2005, CURR BIOL, V15, pR442, DOI 10.1016/j.cub.2005.06.006; Hsu CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03340-7; Kelly SM, 2007, MOL BIOL CELL, V18, P4279, DOI 10.1091/mbc.E07-05-0487; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; Li Y, 2016, NAT CELL BIOL, V18, P1065, DOI 10.1038/ncb3407; Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003; Martina JA, 2016, EMBO J, V35, P479, DOI 10.15252/embj.201593428; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Nezich CL, 2015, J CELL BIOL, V210, P435, DOI 10.1083/jcb.201501002; Ouimet M, 2016, NAT IMMUNOL, V17, P677, DOI 10.1038/ni.3434; Palmieri M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14338; Pastore N, 2017, EMBO MOL MED, V9, P605, DOI 10.15252/emmm.201607204; Pastore N, 2016, AUTOPHAGY, V12, P1240, DOI 10.1080/15548627.2016.1179405; Raben N, 2016, ANNU REV CELL DEV BI, V32, P255, DOI 10.1146/annurev-cellbio-111315-125407; Rahman MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37297; Reid MA, 2013, MOL CELL, V50, P200, DOI 10.1016/j.molcel.2013.02.008; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Saddoughi SA, 2013, EMBO MOL MED, V5, P105, DOI 10.1002/emmm.201201283; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sha YB, 2017, EMBO J, V36, P2544, DOI 10.15252/embj.201796699; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Sun HN, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00286; Supinski GS, 1997, J APPL PHYSIOL, V82, P1119, DOI 10.1152/jappl.1997.82.4.1119; Swingle Mark, 2007, V365, P23; Vega-Rubin-de-Celis S, 2017, AUTOPHAGY, V13, P464, DOI 10.1080/15548627.2016.1271514; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wang CS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02332-3; Wong PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9048; Zhang XC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10293; Zheng CY, 2015, INT J ONCOL, V46, P1067, DOI 10.3892/ijo.2015.2826; Zhu XX, 2014, FOOD CHEM TOXICOL, V70, P144, DOI 10.1016/j.fct.2014.05.006	48	65	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12525	12534		10.1074/jbc.RA118.003471	http://dx.doi.org/10.1074/jbc.RA118.003471			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29945972	Green Published, hybrid			2022-12-26	WOS:000441408500018
J	Bataille, Y; Costerousse, O; Bertrand, OF; Moranne, O; Pottel, H; Delanaye, P				Bataille, Yoann; Costerousse, Olivier; Bertrand, Olivier F.; Moranne, Olivier; Pottel, Hans; Delanaye, Pierre			One-year mortality of patients with ST-Elevation myocardial infarction: Prognostic impact of creatinine-based equations to estimate glomerular filtration rate	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; COCKCROFT-GAULT EQUATIONS; ESTIMATING RENAL-FUNCTION; CHRONIC TOTAL OCCLUSION; CKD-EPI EQUATION; SERUM CREATININE; HEART-FAILURE; CYSTATIN-C; RISK PREDICTION; EPIDEMIOLOGY COLLABORATION	Background Renal dysfunction is associated with worse outcomes after primary percutaneous coronary intervention (PCI). However, whether glomerular filtration rate (GFR) estimated with various equations can equally predict outcomes after ST-Elevation Myocardial Infarction (STEMI) is still debated. Methods We compared the clinical impact of 3 different creatinine-based equations (Cockcroft and Gault (CG), CKD-epidemiology (CKD-EPI) and Full Age Spectrum (FAS)) to predict 1-year mortality in STEMI patients. Results Among 1755 consecutive STEMI patients who had undergone primary PCI included between 2006 and 2011, median estimated GFR was 79 (61; 96) with the CG, 81 (65; 95) with CKD-EPI and 75 (60; 91) mL/min/1.73 m(2) with FAS equation. Reduced GFR values were independently associated with 1-year mortality risk with the 3 equations. Receiver operating curves (ROC) of CG and FAS equations were significantly superior to the CKD-EPI equation, p = 0.03 and p = 0.01, respectively. Better prediction with FAS and CG equations was confirmed by net reclassification index. Conclusions Our results suggest that in STEMI patients who have undergone primary PCI, 1-year mortality is better predicted by CG or FAS equations compared to CKD-EPI.	[Bataille, Yoann; Costerousse, Olivier; Bertrand, Olivier F.] Quebec Heart Lung Inst, Quebec City, PQ, Canada; [Bataille, Yoann] Ctr Hosp Reg Citadelle, Dept Cardiol, Liege, Belgium; [Moranne, Olivier] Univ Montpellier Nimes, Dept Nephrol Dialysis Apheresis, CHU Nimes, Sch Med, Nimes, France; [Pottel, Hans] Univ Leuven, Dept Publ Hlth & Primary Care, Kortrijk, Belgium; [Delanaye, Pierre] Univ Liege CHU ULg, Dept Nephrol, Dialysis, Transplantat, Liege, Belgium	Quebec Heart & Lung Institute; University of Liege; Universite de Franche-Comte; Universite de Montpellier; CHU de Nimes; KU Leuven; University of Liege	Delanaye, P (corresponding author), Univ Liege CHU ULg, Dept Nephrol, Dialysis, Transplantat, Liege, Belgium.	pierre_delanaye@yahoo.fr	Pottel, Hans/AAD-9444-2019; Delanaye, Pierre/T-4225-2019; moranne, olivier/AAA-3056-2019	Pottel, Hans/0000-0003-0074-8919; Delanaye, Pierre/0000-0002-1480-5761; moranne, olivier/0000-0002-3127-1415				Abu-Assi E, 2013, INT J CARDIOL, V168, P4300, DOI 10.1016/j.ijcard.2013.04.194; Abu-Assi E, 2013, INT J CARDIOL, V167, P2325, DOI 10.1016/j.ijcard.2012.11.014; Akerblom A, 2013, CLIN CHEM, V59, P1369, DOI 10.1373/clinchem.2012.200709; Almeida I, 2016, EUR HEART J-ACUTE CA, V5, P223, DOI 10.1177/2048872615576219; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Barra Sergio, 2013, J Atr Fibrillation, V6, P896, DOI 10.4022/jafib.896; Bataille Y, 2013, AM J CARDIOL, V112, P194, DOI 10.1016/j.amjcard.2013.03.010; Bataille Y, 2012, HEART, V98, P1732, DOI 10.1136/heartjnl-2012-302376; Berger JS, 2009, JAMA-J AM MED ASSOC, V302, P874, DOI 10.1001/jama.2009.1227; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Bjork J, 2018, CLIN CHEM LAB MED, V56, P422, DOI 10.1515/cclm-2017-0563; Bjork J, 2018, NEPHROL DIAL TRANSPL, V33, P1380, DOI 10.1093/ndt/gfx272; Campbell NG, 2012, HEART, V98, P42, DOI 10.1136/heartjnl-2011-300024; CHRISTENSEN E, 1987, HEPATOLOGY, V7, P1346, DOI 10.1002/hep.1840070628; Coceani M, 2008, EUR J CARDIOV PREV R, V15, P423, DOI 10.1097/HJR.0b013e3282fa40da; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Delanaye P, 2017, NEPHRON, V136, P302, DOI 10.1159/000469669; Delanaye P, 2016, CLIN KIDNEY J, V9, P700, DOI 10.1093/ckj/sfw071; Delanaye P, 2016, CLIN KIDNEY J, V9, P682, DOI 10.1093/ckj/sfw070; Delanaye Pierre, 2016, Clin Biochem Rev, V37, P17; Delanaye P, 2013, NAT REV NEPHROL, V9, P513, DOI 10.1038/nrneph.2013.143; Delanaye P, 2012, NEPHROL DIAL TRANSPL, V27, P2664, DOI 10.1093/ndt/gfs265; Ferreira JP, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0731-2; Flores-Blanco PJ, 2016, CLIN CARDIOL, V39, P507, DOI 10.1002/clc.22556; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; GEHAN EA, 1970, CANCER CHEMOTH REP 1, V54, P225; Gibson CM, 2003, J AM COLL CARDIOL, V42, P1535, DOI 10.1016/j.jacc.2003.06.001; Glassock R, 2015, JAMA-J AM MED ASSOC, V314, P559, DOI 10.1001/jama.2015.6731; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kontos MC, 2008, AM J CARDIOL, V102, P140, DOI 10.1016/j.amjcard.2008.03.023; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawesson SS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008188; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lin TH, 2015, HEART VESSELS, V30, P441, DOI 10.1007/s00380-014-0504-9; Mandelli S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136039; Matsushita K, 2017, LANCET DIABETES ENDO, V5, P718, DOI 10.1016/S2213-8587(17)30183-3; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Muhlenbruch K, 2015, EUR J EPIDEMIOL, V30, P299, DOI 10.1007/s10654-015-0001-1; Orvin K, 2015, AM HEART J, V169, P702, DOI 10.1016/j.ahj.2015.01.012; Osadnik T, 2014, CLIN RES CARDIOL, V103, P569, DOI 10.1007/s00392-014-0687-1; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pieroni L, 2011, CLIN CHIM ACTA, V412, P2070, DOI 10.1016/j.cca.2011.07.012; Plischke M, 2013, EUR J HEART FAIL, V15, P763, DOI 10.1093/eurjhf/hft022; Pottel H, 2008, CLIN CHIM ACTA, V396, P49, DOI 10.1016/j.cca.2008.06.017; Pottel H, 2017, CLIN KIDNEY J, V10, P545, DOI 10.1093/ckj/sfx026; Pottel H, 2017, CLIN CHIM ACTA, V471, P164, DOI 10.1016/j.cca.2017.06.005; Pottel H, 2016, NEPHROL DIAL TRANSPL, V31, P798, DOI 10.1093/ndt/gfv454; Leston LR, 2018, EUR HEART J-ACUTE CA, V7, P703, DOI 10.1177/2048872617730040; Sabroe JE, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-15; Schei J, 2016, CLIN J AM SOC NEPHRO, V11, P280, DOI 10.2215/CJN.07360715; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Smilde TDJ, 2006, CIRCULATION, V114, P1572, DOI 10.1161/CIRCULATIONAHA.105.610642; Szummer K, 2017, OPEN HEART, V4, DOI 10.1136/openhrt-2016-000568; Szummer K, 2010, AM HEART J, V159, P979, DOI 10.1016/j.ahj.2010.03.028; Tomaszuk-Kazberuk A, 2011, RENAL FAILURE, V33, P983, DOI 10.3109/0886022X.2011.618922; Weidmann ZM, 2015, INT J CARDIOL, V201, P650, DOI 10.1016/j.ijcard.2015.08.097; Zamora E, 2012, J AM COLL CARDIOL, V59, P1709, DOI 10.1016/j.jacc.2011.11.066	61	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199773	10.1371/journal.pone.0199773	http://dx.doi.org/10.1371/journal.pone.0199773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979700	Green Published, gold, Green Submitted			2022-12-26	WOS:000437809500032
J	Mikula, L; Sahnoun, S; Pisella, L; Blohm, G; Khan, AZ				Mikula, Laura; Sahnoun, Sofia; Pisella, Laure; Blohm, Gunnar; Khan, Aarlenne Zein			Vibrotactile information improves proprioceptive reaching target localization	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; FREQUENCY CUTANEOUS VIBRATION; VISUAL POSITION-INFORMATION; ACTIVE ARM MOVEMENTS; TACTILE ACTIVITY; HAND; PERCEPTION; SENSE; INTEGRATION; AFFERENTS	When pointing to parts of our own body (e.g., the opposite index finger), the position of the target is derived from proprioceptive signals. Consistent with the principles of multisensory integration, it has been found that participants better matched the position of their index finger when they also had visual cues about its location. Unlike vision, touch may not provide an additional information about finger position in space, since fingertip tactile information theoretically remains the same irrespective of the postural configuration of the upper limb. However, since tactile and proprioceptive information are ultimately coded within the same population of posterior parietal neurons within high-level spatial representations, we nevertheless hypothesized that additional tactile information could benefit the processing of proprioceptive signals. To investigate the influence of tactile information on proprioceptive localization, we asked 19 participants to reach with the right hand towards the opposite unseen index finger (proprioceptive target). Vibrotactile stimuli were applied to the target index finger prior to movement execution. We found that participants made smaller errors and more consistent reaches following tactile stimulation. These results demonstrate that transient touch provided at the proprioceptive target improves subsequent reaching precision and accuracy. Such improvement was not observed when tactile stimulation was delivered to a distinct body part (the shoulder). This suggests a specific spatial integration of touch and proprioception at the level of high-level cortical body representations, resulting in touch improving position sense.	[Mikula, Laura; Pisella, Laure] Univ Claude Bernard Lyon 1, CRNL, ImpAct Team, Inserm,U1028,CNRS,UMR 5292, Bron, France; [Mikula, Laura; Sahnoun, Sofia; Khan, Aarlenne Zein] Univ Montreal, Sch Optometry, Montreal, PQ, Canada; [Blohm, Gunnar] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Universite de Montreal; Queens University - Canada	Khan, AZ (corresponding author), Univ Montreal, Sch Optometry, Montreal, PQ, Canada.	aarlenne.khan@umontreal.ca		Blohm, Gunnar/0000-0002-2297-3271; Mikula, Laura/0000-0002-6964-8046	Faculte des Etudes Superieures et Postdoctorales; Ecole d'Optometrie de l'Universite de Montreal; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair program; Centre National de la Recherche Scientifique; Laboratoires d'excellence; Initiatives d'excellence [ANR-11-LABX-0042]	Faculte des Etudes Superieures et Postdoctorales; Ecole d'Optometrie de l'Universite de Montreal; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair program(Canada Research Chairs); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Laboratoires d'excellence; Initiatives d'excellence	LM received support from a PhD excellence scholarship from Faculte des Etudes Superieures et Postdoctorales and Ecole d'Optometrie de l'Universite de Montreal. AZK and GB were funded by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). AZK was additionally supported by the Canada Research Chair program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). LP was supported by the Centre National de la Recherche Scientifique and the Laboratoires d'excellence and the Initiatives d'excellence (ANR-11-LABX-0042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti S, 1996, EXP BRAIN RES, V109, P92; COHEN DAD, 1994, J NEUROPHYSIOL, V71, P161, DOI 10.1152/jn.1994.71.1.161; de Vignemont F, 2005, CURR BIOL, V15, P1286, DOI 10.1016/j.cub.2005.06.067; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Godfroy-Cooper M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00311; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gordon AM, 1995, EXP BRAIN RES, V107, P281; Hairston WD, 2003, J COGNITIVE NEUROSCI, V15, P20, DOI 10.1162/089892903321107792; Kim SS, 2015, NEURON, V86, P555, DOI 10.1016/j.neuron.2015.03.020; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Macefield VG, 2005, CLIN EXP PHARMACOL P, V32, P135, DOI 10.1111/j.1440-1681.2005.04143.x; MOBERG E, 1983, BRAIN, V106, P1, DOI 10.1093/brain/106.1.1; Mountcastle V. B., 2005, SENSORY HAND NEURAL; O'Reilly JX, 2012, EUR J NEUROSCI, V35, P1169, DOI 10.1111/j.1460-9568.2012.08010.x; PAILLARD J, 1983, ARCH NEUROL-CHICAGO, V40, P548, DOI 10.1001/archneur.1983.04050080048008; PRUDHOMME MJL, 1994, J NEUROPHYSIOL, V71, P173, DOI 10.1152/jn.1994.71.1.173; Rao AK, 2001, EXP BRAIN RES, V138, P438, DOI 10.1007/s002210100717; Rincon-Gonzalez L, 2012, J MOTOR BEHAV, V44, P391, DOI 10.1080/00222895.2012.746281; Rincon-Gonzalez L, 2011, IEEE T NEUR SYS REH, V19, P490, DOI 10.1109/TNSRE.2011.2166808; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; ROSSETTI Y, 1994, EXP BRAIN RES, V101, P323, DOI 10.1007/BF00228753; ROSSETTI Y, 1995, NEUROREPORT, V6, P506, DOI 10.1097/00001756-199502000-00025; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; TILLERY SIH, 1994, NEUROREPORT, V6, P177; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Beers RJ, 1999, EXP BRAIN RES, V125, P43, DOI 10.1007/s002210050656; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; vanBeers RJ, 1996, EXP BRAIN RES, V111, P253, DOI 10.1007/BF00227302; Warren JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018073; Weber DJ, 2011, IEEE T NEUR SYS REH, V19, P501, DOI 10.1109/TNSRE.2011.2163145; Weerakkody NS, 2007, J PHYSIOL-LONDON, V581, P971, DOI 10.1113/jphysiol.2006.126854; Weerakkody NS, 2009, EXP BRAIN RES, V197, P347, DOI 10.1007/s00221-009-1921-3	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199627	10.1371/journal.pone.0199627	http://dx.doi.org/10.1371/journal.pone.0199627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979697	gold, Green Published			2022-12-26	WOS:000437809500024
J	Sciuto, KJ; Deng, SW; Venable, PW; Warren, M; Warren, JS; Zaitsev, AV				Sciuto, Katie J.; Deng, Steven W.; Venable, Paul W.; Warren, Mark; Warren, Junco S.; Zaitsev, Alexey, V			Cyclosporine-insensitive mode of cell death after prolonged myocardial ischemia: Evidence for sarcolemmal permeabilization as the pivotal step	PLOS ONE			English	Article							REPERFUSION INJURY; INFARCT SIZE; TRANSITION PORE; CARDIAC ISCHEMIA; TRANSIENT PERIOD; OXIDATIVE STRESS; HEART-DISEASE; RAT HEARTS; MITOCHONDRIAL; CARDIOPROTECTION	A prominent theory of cell death in myocardial ischemia/reperfusion (I/R) posits that the primary and pivotal step of irreversible cell injury is the opening of the mitochondrial permeability transition (MPT) pore. However, the predominantly positive evidence of protection against infarct afforded by the MPT inhibitor, Cyclosporine A (CsA), in experimental studies is in stark contrast with the overall lack of benefit found in clinical trials of CsA. One reason for the discrepancy might be the fact that relatively short experimental ischemic episodes (<1 hour) do not represent clinically-realistic durations, usually exceeding one hour. Here we tested the hypothesis that MPT is not the primary event of cell death after prolonged (60-80 min) episodes of global ischemia. We used confocal microcopy in Langendorff-perfused rabbit hearts treated with the electromechanical uncoupler, 2,3-Butanedione monoxime (BDM, 20 mM) to allow tracking of MPT and sarcolemmal permeabilization (SP) in individual ventricular myocytes. The time of the steepest drop in fluorescence of mitochondrial membrane potential (Delta Psi(m))-sensitivedye, TMRM, was used as the time of MPT (T-MPT). The time of 20% uptake of the normally cell-impermeable dye, YO-PRO1, was used as the time of SP (T-SP). We found that during reperfusion MPT and SP were tightly coupled, with MPT trending slightly ahead of SP (T-SP T-MPT = 0.76 +/- 1.31 min; p = 0.07). These coupled MPT/SP events occurred in discrete myocytes without crossing cell boundaries. CsA (0.2 mu M) did not reduce the infarct size, but separated SP and MPT events, such that detectable SP was significantly ahead of MPT (T-SP T-MPT = -1.75 +/- 1.28 min, p = 0.006). Mild permeabilization of cells with digitonin (2.5-20 mu M) caused coupled MPT/SP events which occurred in discrete myocytes similar to those observed in Control and CsA groups. In contrast, deliberate induction of MPT by titration with H2O2 (200-800 mu M), caused propagating waves of MPT which crossed cell boundaries and were uncoupled from SP. Taken together, these findings suggest that after prolonged episodes of ischemia, SP is the primary step in myocyte death, of which MPT is an immediate and unavoidable consequence.	[Sciuto, Katie J.; Venable, Paul W.; Warren, Mark; Warren, Junco S.; Zaitsev, Alexey, V] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA; [Sciuto, Katie J.; Deng, Steven W.; Venable, Paul W.; Warren, Mark; Zaitsev, Alexey, V] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Warren, Junco S.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Venable, Paul W.] Biosci Webster Inc, South Diamond Bar, CA USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Zaitsev, AV (corresponding author), Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA.; Zaitsev, AV (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.	Alexey.Zaitsev@utah.edu		Zaitsev, Alexey/0000-0002-8139-1378; Zaitsev, Artem/0000-0002-2314-0482	Nora Eccles Treadwell Foundation; United States National Science Foundation [1256065]; University of Utah	Nora Eccles Treadwell Foundation; United States National Science Foundation(National Science Foundation (NSF)); University of Utah	This work was supported by a Research Grant from Nora Eccles Treadwell Foundation (no web site; no grant ID) to A.V.Z., by a United States National Science Foundation Graduate Research Fellowship Grant #1256065 to K.J.S., and by a University of Utah Undergraduate Research Opportunities Program Grant (www.our.utah.edu; no grant ID) to S.W.D.	Andrienko T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167300; Ascah A, 2011, AM J PHYSIOL-HEART C, V300, pH144, DOI 10.1152/ajpheart.00522.2010; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023; Campbell MD, 2016, AM J PHYSIOL-HEART C, V310, pH1140, DOI 10.1152/ajpheart.00521.2015; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; CORR PB, 1989, J CLIN INVEST, V83, P927, DOI 10.1172/JCI113978; CROMPTON M, 1988, EUR J BIOCHEM, V178, P489, DOI 10.1111/j.1432-1033.1988.tb14475.x; Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489; Davidson SM, 2012, CARDIOVASC RES, V93, P445, DOI 10.1093/cvr/cvr349; De Paulis D, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0379-4; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Garcia-Dorado D, 2012, CARDIOVASC RES, V94, P168, DOI 10.1093/cvr/cvs116; GARCIADORADO D, 1992, CIRCULATION, V85, P1160, DOI 10.1161/01.CIR.85.3.1160; Goldlust EJ, 1996, STROKE, V27, P1657, DOI 10.1161/01.STR.27.9.1657; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Halestrap AP, 2015, J MOL CELL CARDIOL, V78, P129, DOI 10.1016/j.yjmcc.2014.08.018; Hausenloy DJ, 2017, EUR HEART J, V38, P935, DOI 10.1093/eurheartj/ehw145; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Karlsson LO, 2010, J CARDIOVASC PHARM T, V15, P182, DOI 10.1177/1074248410362074; KLONER RA, 1974, AM J PATHOL, V74, P399; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Kyoi S, 2006, CARDIOVASC RES, V70, P354, DOI 10.1016/j.cardiores.2006.01.004; Lim WY, 2012, BRIT J PHARMACOL, V165, P2034, DOI 10.1111/j.1476-5381.2011.01691.x; Liu JX, 2015, J MOL CELL CARDIOL, V80, P10, DOI 10.1016/j.yjmcc.2014.12.010; Martindale JJ, 2014, J MOL CELL CARDIOL, V67, P26, DOI 10.1016/j.yjmcc.2013.12.008; Matsumoto-Ida M, 2006, CIRCULATION, V114, P1497, DOI 10.1161/CIRCULATIONAHA.106.628834; McGehee JT, 2007, J ELECTROCARDIOL, V40, P26, DOI 10.1016/j.jelectrocard.2006.06.001; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; NAZARETH W, 1991, J MOL CELL CARDIOL, V23, P1351, DOI 10.1016/0022-2828(91)90181-K; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; Patel D, 2014, FEBS LETT, V588, P1372, DOI 10.1016/j.febslet.2013.12.023; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Piper HM, 1999, ANN THORAC SURG, V68, P1913, DOI 10.1016/S0003-4975(99)01025-5; Ruiz-Meana M, 2011, BASIC RES CARDIOL, V106, P1259, DOI 10.1007/s00395-011-0225-5; Sanada S, 2004, CIRCULATION, V110, P51, DOI 10.1161/01.CIR.0000133390.12306.C7; Smith K.C, 2011, UNIFIED MODEL ELECTR; Song KX, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/287058; Stoner JD, 2007, AM J PHYSIOL-HEART C, V292, pH109, DOI 10.1152/ajpheart.00925.2006; Venable PW, 2015, AM J PHYSIOL-HEART C, V308, pH485, DOI 10.1152/ajpheart.00257.2014; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Weinbrenner C, 1998, CARDIOVASC RES, V38, P676, DOI 10.1016/S0008-6363(98)00064-9; WHALEN DA, 1974, AM J PATHOL, V74, P381; Zhu H, 2018, J MOL CELL CARDIOL, V116, P125, DOI 10.1016/j.yjmcc.2018.01.018; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	46	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200301	10.1371/journal.pone.0200301	http://dx.doi.org/10.1371/journal.pone.0200301			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975744	Green Submitted, gold, Green Published			2022-12-26	WOS:000437424500082
J	Berendes, DM; Kirby, AE; Clennon, JA; Agbemabiese, C; Ampofo, JA; Armah, GE; Baker, KK; Liu, PB; Reese, HE; Robb, KA; Wellington, N; Yakubu, H; Moe, CL				Berendes, David M.; Kirby, Amy E.; Clennon, Julie A.; Agbemabiese, Chantal; Ampofo, Joseph A.; Armah, George E.; Baker, Kelly K.; Liu, Pengbo; Reese, Heather E.; Robb, Katharine A.; Wellington, Nii; Yakubu, Habib; Moe, Christine L.			Urban sanitation coverage and environmental fecal contamination: Links between the household and public environments of Accra, Ghana	PLOS ONE			English	Article							CHILDHOOD DIARRHEA; SHARED SANITATION; HUMAN ADENOVIRUS; INDICATOR BACTERIA; SLUDGE MANAGEMENT; YOUNG-CHILDREN; ANIMAL FECES; WATER; HEALTH; IMPACT	Exposure to fecal contamination in public areas, especially in dense, urban environments, may significantly contribute to enteric infection risk. This study examined associations between sanitation and fecal contamination in public environments in four low-income neighborhoods in Accra, Ghana. Soil (n = 72) and open drain (n = 90) samples were tested for E. coli, adenovirus, and norovirus. Sanitation facilities in surveyed households (n = 793) were categorized by onsite fecal sludge containment ("contained" vs. "uncontained") using previous Joint Monitoring Program infrastructure guidelines. Most sanitation facilities were shared by multiple households. Associations between spatial clustering of household sanitation coverage and fecal contamination were examined, controlling for neighborhood and population density (measured as enumeration areas in the 2010 census and spatially matched to sample locations). E. coli concentrations in drains within 50m of clusters of contained household sanitation were more than 3 log-units lower than those outside of clusters. Further, although results were not always statistically significant, E. coli concentrations in drains showed consistent trends with household sanitation coverage clusters: concentrations were lower in or near clusters of high coverage of household sanitation facilities-especially contained facilities-and vice versa. Virus detection in drains and E. coli concentrations in soil were not significantly associated with clustering of any type of household sanitation and did not exhibit consistent trends. Population density alone was not significantly associated with any of the fecal contamination outcomes by itself and was a significant, yet inconsistent, effect modifier of the association between sanitation clusters and E. coli concentrations. These findings suggest clustering of contained household sanitation, even when shared, may be associated with lower levels of fecal contamination within drains in the immediate public domain. Further research is needed to better quantify these relationships and examine impacts on health.	[Berendes, David M.; Reese, Heather E.] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Berendes, David M.; Kirby, Amy E.; Clennon, Julie A.; Baker, Kelly K.; Liu, Pengbo; Reese, Heather E.; Robb, Katharine A.; Yakubu, Habib; Moe, Christine L.] Emory Univ, Ctr Global Safe Water Sanitat & Hyg, Atlanta, GA 30322 USA; [Clennon, Julie A.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Agbemabiese, Chantal; Armah, George E.] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Accra, Ghana; [Ampofo, Joseph A.] CSIR, Water Res Inst, Accra, Ghana; [Wellington, Nii] TREND Grp, Accra, Ghana; [Berendes, David M.; Kirby, Amy E.] Ctr Dis Control & Prevent, Waterborne Dis Prevent Branch, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Baker, Kelly K.] Univ Iowa, Dept Occupat & Environm Hlth, Coll Publ Hlth, Iowa City, IA USA	Emory University; Rollins School Public Health; Emory University; Emory University; Rollins School Public Health; University of Ghana; Centers for Disease Control & Prevention - USA; University of Iowa	Berendes, DM (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.; Berendes, DM (corresponding author), Emory Univ, Ctr Global Safe Water Sanitat & Hyg, Atlanta, GA 30322 USA.; Berendes, DM (corresponding author), Ctr Dis Control & Prevent, Waterborne Dis Prevent Branch, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	dberendes@cdc.gov		Reese, Heather/0000-0002-5571-1614; Baker, Kelly/0000-0002-3774-2628; Agbemabiese, Chantal/0000-0003-1862-9408; Yakubu, Habib/0000-0001-5858-6962	Bill & Melinda Gates Foundation [OPP1016151]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by the Bill & Melinda Gates Foundation, OPP1016151 (https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database#q/k=OPP1016151) to CLM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1; [Anonymous], WATERLINES; [Anonymous], 2003, CHALL SLUMS; Armah GE, 2006, J MED VIROL, V78, P1480, DOI 10.1002/jmv.20722; Barreto ML, 2007, LANCET, V370, P1622, DOI 10.1016/S0140-6736(07)61638-9; Bateman OS, 1991, COMP HLTH EFFECTS WA; Baum R, 2013, ENVIRON SCI TECHNOL, V47, P1994, DOI 10.1021/es304284f; Brown J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008215; Cairncross S, 1996, TROP MED INT HEALTH, V1, P27, DOI 10.1046/j.1365-3156.1996.d01-9.x; CHF International, 2010, ACCR POV MAP GUID UR; Chow MF, 2013, WATER SCI TECHNOL, V67, P1822, DOI 10.2166/wst.2013.048; Diallo MBC, 2009, J WATER HEALTH, V7, P133, DOI 10.2166/wh.2009.010; DSouza RM, 1997, J BIOSOC SCI, V29, P271, DOI 10.1017/S002193209700271X; Eisenberg JNS, 2012, ANNU REV PUBL HEALTH, V33, P239, DOI 10.1146/annurev-publhealth-031811-124530; Ekklesia E, 2015, WATER RES, V75, P270, DOI 10.1016/j.watres.2015.02.037; Ekklesia E, 2015, WATER RES, V68, P171, DOI 10.1016/j.watres.2014.09.049; Ercumen A, 2017, ENVIRON SCI TECHNOL, V51, P8725, DOI 10.1021/acs.est.7b01710; Exley JLR, 2015, ENVIRON SCI TECHNOL, V49, P1086, DOI 10.1021/es503945x; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Fuller JA, 2014, AM J TROP MED HYG, V91, P173, DOI 10.4269/ajtmh.13-0503; Genser B, 2008, INT J EPIDEMIOL, V37, P831, DOI 10.1093/ije/dyn101; Ghana Statistical Service, 2014, 2010 POP HOUS CENS A, V78; Gretsch SR, 2016, J WATER HEALTH, V14, P255, DOI 10.2166/wh.2015.138; Gruber JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107429; Heijnen M, 2015, AM J TROP MED HYG, V93, P263, DOI 10.4269/ajtmh.14-0812; Heijnen M, 2014, TROP MED INT HEALTH, V19, P1334, DOI 10.1111/tmi.12375; Heijnen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093300; Hewitt J, 2013, WATER RES, V47, P6750, DOI 10.1016/j.watres.2013.09.001; Hundesa A, 2006, APPL ENVIRON MICROB, V72, P7886, DOI 10.1128/AEM.01090-06; Isunju JB, 2011, PUBLIC HEALTH, V125, P368, DOI 10.1016/j.puhe.2011.03.008; Jarquin C, 2016, AM J TROP MED HYG, V94, P912, DOI 10.4269/ajtmh.15-0555; Jiang SC, 2006, ENVIRON SCI TECHNOL, V40, P7132, DOI 10.1021/es060892o; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P3131, DOI 10.1128/AEM.71.6.3131-3136.2005; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kanungo S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-830; Katukiza AY, 2014, J APPL MICROBIOL, V116, P447, DOI 10.1111/jam.12368; Katukiza AY, 2013, J WATER HEALTH, V11, P358, DOI 10.2166/wh.2013.184; Katukiza AY, 2012, BIOTECHNOL ADV, V30, P964, DOI 10.1016/j.biotechadv.2012.02.007; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Labite H, 2010, J WATER HEALTH, V8, P417, DOI 10.2166/wh.2010.021; Leclerc H, 2001, ANNU REV MICROBIOL, V55, P201, DOI 10.1146/annurev.micro.55.1.201; Mara D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000363; Milroy CA, 2001, ENVIRON URBAN, V13, P235, DOI 10.1177/095624780101300117; Munjita SM, 2015, J TROP MED-US, V2015, DOI 10.1155/2015/309648; Norman G, 2010, LANCET INFECT DIS, V10, P536, DOI 10.1016/S1473-3099(10)70123-7; Nshimyimana JP, 2014, J APPL MICROBIOL, V116, P1369, DOI 10.1111/jam.12455; Peal A, 2014, J WATER SANIT HYG DE, V4, P563, DOI 10.2166/washdev.2014.026; Peal A, 2014, J WATER SANIT HYG DE, V4, P371, DOI 10.2166/washdev.2014.139; Penakalapati G, 2017, ENVIRON SCI TECHNOL, V51, P11537, DOI 10.1021/acs.est.7b02811; Peprah D, 2015, ENVIRON URBAN, V27, P589, DOI 10.1177/0956247815595918; Philipsborn R, 2016, J INFECT DIS, V214, P6, DOI 10.1093/infdis/jiw081; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P5736, DOI 10.1021/es300022c; Pina S, 1998, APPL ENVIRON MICROB, V64, P3376; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Rego RF, 2013, CAD SAUDE PUBLICA, V29, P1173, DOI 10.1590/S0102-311X2013001000014; Reither K, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-104; Rheinlander T, 2015, B WORLD HEALTH ORGAN, P1; Robb K, 2017, AM J TROP MED HYG, V97, P1020, DOI 10.4269/ajtmh.16-0508; Rochelle-Newall E, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.DD3D8, 10.3389/fmicb.2015.00308]; Rodriguez-Diaz J, 2009, APPL ENVIRON MICROB, V75, P387, DOI 10.1128/AEM.02045-08; Root GPM, 2001, J HEALTH POPUL NUTR, V19, P73; Seitz SR, 2011, APPL ENVIRON MICROB, V77, P6884, DOI 10.1128/AEM.05806-11; SHUVAL HI, 1981, B WORLD HEALTH ORGAN, V59, P243; Sidhu JPS, 2013, SCI TOTAL ENVIRON, V463, P488, DOI 10.1016/j.scitotenv.2013.06.020; Silverman AI, 2013, J WATER HEALTH, V11, P473, DOI 10.2166/wh.2013.025; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Szanto GL, 2012, WATER POLICY, V14, P613, DOI 10.2166/wp.2012.093; Turley R, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010067.pub2; UNICEF/WHO, 2017, PROGR DRINKING WATER, DOI DOI 10.1111/TMI.12329; United Nations, 2015, WORLD URB PROSP 2014; USEPA, 2002, 1604 USEPA; VICTORA CG, 1988, INT J EPIDEMIOL, V17, P651, DOI 10.1093/ije/17.3.651; Wagner E. G., 1958, MONOGRAPH SERIES; Wang Y, 2017, AM J TROP MED HYG, P1; WHO and UNICEF, 2015, 2015 UPD MDG ASS; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331	78	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199304	10.1371/journal.pone.0199304	http://dx.doi.org/10.1371/journal.pone.0199304			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL5XD	29969466	Green Published, Green Submitted, gold			2022-12-26	WOS:000437246700014
J	Bhatti, F; Kung, JW; Vieira, F				Bhatti, Faizah; Kung, Johannes W.; Vieira, Frederico			Retinal degeneration mutation in Sftpa1(tm1Kor/J) and Sftpd(-/-) targeted mice	PLOS ONE			English	Article							SURFACTANT PROTEIN-A; CGMP PHOSPHODIESTERASE; RODLESS RETINA; MOUSE RETINA; BETA-SUBUNIT; GENE; CELLS; MODEL; FLUID	Surfactant proteins are important coiiectin immune molecules with a wide distribution throughout the body, including the ocular system. Mice with gene deletions for the surfactant protein genes Sftpal and Sftpdwere observed to have visual impairment and thinning of the outer nuclear layers of the retina. We hypothesized that gene deletion of Sftpal and Sftpd (Sftpa1(tm1Kor/J) and Sftpd(-/-)) results in early retinal degeneration in these mice. Sftpa1(tm1Kor/J) and Sftpd(-/-) retinas were evaluated by histopathology and optical coherence tomography (OCT). Retinas from Sftpa1(tm1Kor/J) and Sftpd(-/-) mice showed early retinal degeneration with loss of the outer nuclear layer. After screening of mice for known retinal degeneration mutations, the mice were found to carry a previously unrecognized Pde6b(rd1) genotype which resulted from earlier breeding of the strain with Black Swiss mice during their generation. The mutation was outbred and the genotype of Sftpa7(tm1Kor/J) and Sftpd'' was confirmed. Outbreeding of the Pde6b(rd1) mutation resulted in restoration of normal retinal architecture confirmed by in vivo and in vitro examination. We can therefore conclude that loss of Sftpal and Sftpd do not result in retinal degeneration. We have now generated retinal Sftpal and Sftpd targeted mice that exhibit normal retinal histology.	[Bhatti, Faizah; Kung, Johannes W.; Vieira, Frederico] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Neonatal Perinatal Med, Oklahoma City, OK 73104 USA; [Bhatti, Faizah] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Bhatti, Faizah] Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Oklahoma City, OK 73104 USA; [Bhatti, Faizah] Univ Oklahoma, Oklahoma Ctr Neurosci, Hlth Sci Ctr, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Bhatti, F (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Neonatal Perinatal Med, Oklahoma City, OK 73104 USA.; Bhatti, F (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA.; Bhatti, F (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Oklahoma City, OK 73104 USA.; Bhatti, F (corresponding author), Univ Oklahoma, Oklahoma Ctr Neurosci, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.	faizah_bhatti@ouhse.edu		Bhatti, Faizah/0000-0001-7945-5291	COBRE [P20 RR017703-10, P30 EY021725]; Knights Templar Eye Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY021725] Funding Source: NIH RePORTER	COBRE; Knights Templar Eye Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by COBRE P20 RR017703-10, P30 EY021725 and The Knights Templar Eye Foundation Research Grant 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatti F, 2015, INVEST OPHTH VIS SCI, V56, P232, DOI 10.1167/iovs.13-13652; Blazek JD, 2010, DEV DYNAM, V239, P1645, DOI 10.1002/dvdy.22295; BOWES C, 1993, P NATL ACAD SCI USA, V90, P2955, DOI 10.1073/pnas.90.7.2955; Braeuer L, 2007, INVEST OPHTH VIS SCI, V48, P3945, DOI 10.1167/iovs.07-0201; Chabot S, 2003, J IMMUNOL, V171, P995, DOI 10.4049/jimmunol.171.2.995; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Clapcote SJ, 2005, COMPARATIVE MED, V55, P310; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; DeSilva NS, 2003, AM J RESP CELL MOL, V29, P757, DOI 10.1165/rcmb.2003-0186OC; Gidvani MR, 2014, PEDIATR RES, V76, P135, DOI 10.1038/pr.2014.75; Gowdy KM, 2012, J IMMUNOL, V188, P4897, DOI 10.4049/jimmunol.1103558; Grimm C, 2004, J NEUROSCI, V24, P5651, DOI 10.1523/JNEUROSCI.1288-04.2004; Hashimoto J, 2017, J IMMUNOL, V198, P2898, DOI 10.4049/jimmunol.1502626; KEELER C, 1966, J HERED, V57, P47, DOI 10.1093/oxfordjournals.jhered.a107462; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Korfhagen TR, 1998, BBA-MOL BASIS DIS, V1408, P296, DOI 10.1016/S0925-4439(98)00075-1; Korfhagen TR, 1998, J BIOL CHEM, V273, P28438, DOI 10.1074/jbc.273.43.28438; Lin ZW, 2001, PEDIATR PATHOL MOL M, V20, P367, DOI 10.1080/15513810109168621; Luo JM, 2004, INT J MOL MED, V14, P343; MacNeill C, 2004, IMMUNOLOGY, V111, P91, DOI 10.1111/j.1365-2567.2004.01782.x; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mukherjee S, 2012, J IMMUNOL, V188, P4376, DOI 10.4049/jimmunol.1101775; PITTLER SJ, 1993, P NATL ACAD SCI USA, V90, P9616, DOI 10.1073/pnas.90.20.9616; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Schob S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074412; Tian SJ, 2017, BBA-MOL BASIS DIS, V1863, P509, DOI 10.1016/j.bbadis.2016.11.032; Vieira F, 2017, ANN ANAT, V211, P184, DOI 10.1016/j.aanat.2017.03.002; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Wu WH, 2016, MOL THER, V24, P1388, DOI 10.1038/mt.2016.107	29	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199824	10.1371/journal.pone.0199824	http://dx.doi.org/10.1371/journal.pone.0199824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969487	gold, Green Submitted, Green Published			2022-12-26	WOS:000437246700030
J	Koolen, MKE; Pouran, B; Oner, FC; Zadpoor, AA; van der Jagt, OP; Weinans, H				Koolen, Marianne K. E.; Pouran, Behdad; Oner, Fetullah C.; Zadpoor, Amir A.; van der Jagt, Olav P.; Weinans, Harrie			Unfocused shockwaves for osteoinduction in bone substitutes in rat cortical bone defects	PLOS ONE			English	Article							WAVE THERAPY; REGENERATION; SCAFFOLDS	Bone substitutes are frequently used in clinical practice but often exhibit limited osteoinductivity. We hypothesized that unfocused shockwaves enhance the osteoinductivity of bone substitutes and improve osteointegration and angiogenesis. Three different bone substitutes, namely porous tricalcium phosphate, porous hydroxyapatite and porous titanium alloy, were implanted in a critical size (i.e. 6-mm) femoral defect in rats. The femora were treated twice with 1500 shockwaves at 2 and 4 weeks after surgery and compared with nontreated controls. The net volume of de novo bone in the defect was measured by microCTscanning during 11 -weeks follow-up. Bone ingrowth and angiogenesis in the bone substitutes was examined at 5 and 11 weeks using histology. It was shown that hydroxyapatite and titanium both had an increase of bone ingrowth with more bone in the Shockwave group compared to the control group, whereas resorption was seen in tricalcium phosphate bone substitutes over time and this was insensitive to Shockwave treatment. In conclusion, hydroxyapatite and titanium bone substitutes favour from Shockwave treatment, whereas tricalcium phosphate does not. This study shows that osteoinduction and osteointegration of bone substitutes can be influenced with unfocused Shockwave therapy, but among other factors depend on the type of bone substitute, likely reflecting its mechanical and biological properties.	[Koolen, Marianne K. E.; Pouran, Behdad; Oner, Fetullah C.; Weinans, Harrie] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands; [Pouran, Behdad; Zadpoor, Amir A.; Weinans, Harrie] Delft Univ Technol, Fac Mech Maritime & Mat Engn, Dept Biomech Engn, Delft, Netherlands; [van der Jagt, Olav P.] Elisabeth TweeSteden Hosp, Dept Orthopaed, Tilburg, Netherlands; [Weinans, Harrie] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Delft University of Technology; Elisabeth-TweeSteden Ziekenhuis (ETZ); Utrecht University; Utrecht University Medical Center	Koolen, MKE (corresponding author), Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.	m.k.e.koolen@umcutrecht.nl	Zadpoor, Amir/A-8510-2008	Zadpoor, Amir/0000-0003-3234-2112; Weinans, Harrie/0000-0002-2275-6170	AO Foundation [S13-155V]; Netherlands Institute of Regenerative Medicine [FES0908]	AO Foundation; Netherlands Institute of Regenerative Medicine	This work was supported by AO Foundation grant number S13-155V (recipient: O. van der Jagt, https://www.aofoundation.org/Structure/research/research-funding/Pages/research-funding.aspx) and the Netherlands Institute of Regenerative Medicine grant number FES0908 (recipeint: H. Weinans, www.nirmresearch.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	d'Agostino MC, 2015, INT J SURG, V24, P147, DOI 10.1016/j.ijsu.2015.11.030; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007; Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2; Holfeld J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103982; Ioppolo F, 2014, EUR J PHYS REHAB MED, V50, P217; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; McClure SR, 2004, VET SURG, V33, P40, DOI 10.1111/j.1532-950x.2004.04013.x; Mittermayr R, 2012, WOUND REPAIR REGEN, V20, P456, DOI 10.1111/j.1524-475X.2012.00796.x; Ogden JA, 2001, CLIN ORTHOP RELAT R, P8; Poldervaart MT, 2015, EUR CELLS MATER, V29, P35, DOI 10.22203/eCM.v029a03; Sheikh Z, 2015, MATERIALS, V8, P5671, DOI 10.3390/ma8095269; Tuchman A, 2016, GLOB SPINE J, V6, P592, DOI 10.1055/s-0035-1570749; van der Jagt OP, 2011, J BONE JOINT SURG AM, V93A, P38, DOI 10.2106/JBJS.I.01535; van der Jagt OP, 2013, J ORTHOP RES, V31, P768, DOI 10.1002/jor.22258; van der Jagt OP, 2009, J ORTHOP RES, V27, P1528, DOI 10.1002/jor.20910; van der Stok J, 2015, EUR CELLS MATER, V29, P141, DOI 10.22203/eCM.v029a11; van der Stok J, 2014, EUR CELLS MATER, V27, P137, DOI 10.22203/eCM.v027a11; van der Stok J, 2014, EUROPEAN CELLS MAT, V27, P148, DOI DOI 10.22203/ECM.V027A11; Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293; Van der Stok J, 2011, ACTA BIOMATER, V7, P739, DOI 10.1016/j.actbio.2010.07.035; Yavari SA, 2014, BIOMATERIALS, V35, P6172, DOI 10.1016/j.biomaterials.2014.04.054; Zelle BA, 2010, J ORTHOP TRAUMA, V24, pS66, DOI 10.1097/BOT.0b013e3181cad510	23	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0200020	10.1371/journal.pone.0200020	http://dx.doi.org/10.1371/journal.pone.0200020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969479	Green Published, Green Submitted, gold			2022-12-26	WOS:000437246700036
J	Cheng, MR; Mei, B; Zhou, Q; Zhang, ML; Huang, H; Han, LC; Huang, QY				Cheng, Mengrong; Mei, Bing; Zhou, Qian; Zhang, Manling; Huang, Han; Han, Lanchun; Huang, Qingyang			Computational analyses of obesity associated loci generated by genome-wide association studies	PLOS ONE			English	Article							BODY-MASS INDEX; DIET-INDUCED OBESITY; MELANOCORTIN-4 RECEPTOR; ADIPOGENESIS; DISEASE; MTCH2; MICE; PHOSPHORYLATION; DIFFERENTIATION; HOMEOSTASIS	Objectives Genome-wide association studies (GWASs) have discovered associations of numerous SNPs and genes with obesity. However, the underlying molecular mechanisms through which these SNPs and genes affect the predisposition to obesity remain not fully understood. Aims of our study are to comprehensively characterize obesity GWAS SNPs and genes through computational approaches. Methods For obesity GWAS identified SNPs, functional annotation, effects on miRNAs binding and impact on protein phosphorylation were performed via RegulomeDB and 3DSNP, miRNASNP, and the PhosSNP 1.0 database, respectively. For obesity associated genes, protein-protein interaction network construction, gene ontology and pathway enrichment analyses were performed by STRING, PANTHER and STRING, respectively. Results A total of 445 SNPs are significantly associated with obesity related phenotypes at threshold P < 5x10(-8). A number of SNPs were eQTLs for obesity associated genes, some SNPs located at binding sites of obesity related transcription factors. SNPs that might affect miRNAs binding and protein phosphorylation were identified. Protein-protein interaction network analysis identified the highly-interconnected "hub" genes. Obesity associated genes mainly involved in metabolic process and catalytic activity, and significantly enriched in 15 signal pathways. Conclusions Our results provided the targets for follow-up experimental testing and further shed new light on obesity pathophysiology.	[Cheng, Mengrong; Mei, Bing; Zhou, Qian; Zhang, Manling; Huang, Han; Han, Lanchun; Huang, Qingyang] Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China	Central China Normal University	Huang, QY (corresponding author), Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China.	huangqy@mail.ccnu.edu.cn			National Basic Research Program of China (973 Program) [2011CB504004]; National Natural Science Foundation of China [31371275, 30971635]; self-determined research funds of CCNU from the colleges' basic research and operation of MOE [CCNU14Z01003]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); self-determined research funds of CCNU from the colleges' basic research and operation of MOE	This work was supported by the National Basic Research Program of China (973 Program, No. 2011CB504004), the National Natural Science Foundation of China (Nos. 31371275 and 30971635) and self-determined research funds of CCNU from the colleges' basic research and operation of MOE (No. CCNU14Z01003) to QH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeza-Raja B, 2016, CELL REP, V14, P255, DOI 10.1016/j.celrep.2015.12.028; Bar-Lev Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157850; Bernhard F, 2013, DIABETOLOGIA, V56, P311, DOI 10.1007/s00125-012-2773-0; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buzaglo-Azriel L, 2016, CELL REP, V14, P1602, DOI 10.1016/j.celrep.2016.01.046; Carter CJ, 2013, J PATHOG, V2013, DOI 10.1155/2013/965046; Cheng MR, 2017, J DIABETES, V9, P362, DOI 10.1111/1753-0407.12421; Chiappini F, 2011, J BIOL CHEM, V286, P8094, DOI 10.1074/jbc.M110.178186; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; da Cunha DF, 2009, REV SOC BRAS MED TRO, V42, P494, DOI 10.1590/S0037-86822009000500004; Deng FY, 2013, J BONE MINER RES, V28, P2498, DOI 10.1002/jbmr.1997; Ekstrom S, 2017, AM J EPIDEMIOL, V186, P255, DOI 10.1093/aje/kwx081; Fuji S, 2009, BIOL BLOOD MARROW TR, V15, P73, DOI 10.1016/j.bbmt.2008.10.029; Han ZP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179677; Huang QY, 2015, J GENET GENOMICS, V42, P87, DOI 10.1016/j.jgg.2015.02.001; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Landgraf K, 2016, FEBS LETT, V590, P2852, DOI 10.1002/1873-3468.12330; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; Lu YM, 2017, NUCLEIC ACIDS RES, V45, pD643, DOI 10.1093/nar/gkw1022; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Merkestein M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7792; Molinero LL, 2016, TRANSPLANTATION, V100, P1015, DOI 10.1097/TP.0000000000001141; Naour N, 2010, J CLIN ENDOCR METAB, V95, P1861, DOI 10.1210/jc.2009-1894; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Niu TH, 2016, J BONE MINER RES, V31, P358, DOI 10.1002/jbmr.2687; Qin LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150070; Rathjen T, 2017, NAT NEUROSCI, V20, P1096, DOI 10.1038/nn.4590; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Rottiers V, 2017, OBESITY, V25, P616, DOI 10.1002/oby.21751; Singh S, 2017, NAT REV GASTRO HEPAT, V14, P110, DOI 10.1038/nrgastro.2016.181; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Sonne SB, 2017, ADIPOCYTE, V6, P124, DOI 10.1080/21623945.2017.1320002; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Tong T, 2016, SCI REP-UK, V6, DOI 10.1038/srep34179; Wang F, 2008, AM J PHYSIOL-CELL PH, V295, pC213, DOI 10.1152/ajpcell.00422.2007; Wu L, 2016, OBES REV, V17, P907, DOI 10.1111/obr.12430; Xu BJ, 2016, NAT REV NEUROSCI, V17, P282, DOI 10.1038/nrn.2016.24; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Zhang HR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41933; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200	42	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199987	10.1371/journal.pone.0199987	http://dx.doi.org/10.1371/journal.pone.0199987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966015	Green Published, gold, Green Submitted			2022-12-26	WOS:000437224100035
J	De Nardo, P; Gentilotti, E; Vairo, F; Nguhuni, B; Chaula, Z; Nicastri, E; Ismail, A; Ippolito, G				De Nardo, Pasquale; Gentilotti, Elisa; Vairo, Francesco; Nguhuni, Boniface; Chaula, Zainab; Nicastri, Emanuele; Ismail, Abbas; Ippolito, Giuseppe			A retrospective evaluation of bites at risk of rabies transmission across 7 years: The need to improve surveillance and reporting systems for rabies elimination	PLOS ONE			English	Article							TANZANIA; VACCINATION; INJURIES	The vast majority of rabies deaths occur in developing countries and rural areas. Due to the absence of surveillance and the lack of reliable information, many endemic countries are not able to assess their rabies burden and implement appropriate solutions. This study reports the incidence of animal bites considered at risk of rabies transmission, along with rates and determinants of the adherence to post-exposure prophylaxis (PEP) between 2008 and 2014 in Dodoma Region, Tanzania. A retrospective analysis of rabid animal bites considered at risk of rabies transmission at Dodoma Regional Referral Hospital (DRRH) during 2008-2014 was conducted. Data were collected from the registers of patients presenting to the hospital because of a potential rabies exposure. The patients were assessed by a trained health worker and each bite was considered as "at risk of rabies" based on the victim's description of the event. Overall, 10,771 patients coming from Dodoma Region attended DRRH because of a bite from a suspected rabid animal, giving a mean incidence of 74 bites at risk of rabies transmission per 100,000 persons per year. Overall, only 46.0% of people exposed received a complete course of PEP and 61.6% attended the clinic within 48 hours after the bite. Multivariate analysis shows that people age >15 years, residence in rural areas and occurrence during the rainy season were independently associated to delayed access to care. Male gender, age below 15 years. and bites occurring during the dry season were associated with completion of PEP. In this area with a high rate of at-risk bites, several factors-mainly related to health care access and to the affordability and delivery of rabies vaccines-still need to be addressed in order to reduce gender and social inequalities in rabies prevention and control. Further efforts are required to establish an efficient rabies surveillance system in Dodoma Region.	[De Nardo, Pasquale; Gentilotti, Elisa; Nguhuni, Boniface; Chaula, Zainab] Dodoma Reg Referral Hosp, Resource Ctr Infect Dis, Dept Internal Med, Dodoma, Tanzania; [De Nardo, Pasquale; Vairo, Francesco; Nguhuni, Boniface; Nicastri, Emanuele; Ippolito, Giuseppe] IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis INMI, Rome, Italy; [Gentilotti, Elisa] Tor Vergata Univ Hosp, Dept Infect Dis, Rome, Italy; [Ismail, Abbas] Univ Dodoma UDOM, Dept Stat, Dodoma, Tanzania	University of Rome Tor Vergata; Policlin Tor Vergata	Nguhuni, B (corresponding author), Dodoma Reg Referral Hosp, Resource Ctr Infect Dis, Dept Internal Med, Dodoma, Tanzania.; Nguhuni, B (corresponding author), IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis INMI, Rome, Italy.	bonellias@gmail.com	nicastri, emanuele/K-7780-2016; De Nardo, Pasquale/K-8933-2016	nicastri, emanuele/0000-0002-5606-8712; De Nardo, Pasquale/0000-0002-4433-0138; Ippolito, Giuseppe/0000-0002-1076-2979; PERNO, CARLO FEDERICO/0000-0002-0825-5388	Resource Center for Infectious Diseases of Dodoma Regional Referral Hospital - Tanzania; Italian Development Cooperation - Ministry of Foreign Affairs [AID9562]; 'Ricerca Corrente' of the Italian Ministry of Health	Resource Center for Infectious Diseases of Dodoma Regional Referral Hospital - Tanzania; Italian Development Cooperation - Ministry of Foreign Affairs; 'Ricerca Corrente' of the Italian Ministry of Health	This survey was supported by the Resource Center for Infectious Diseases of Dodoma Regional Referral Hospital - Tanzania and the Italian Development Cooperation - Ministry of Foreign Affairs AID9562 and 'Ricerca Corrente' of the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela-Ridder B, 2015, VET REC, V177, P148, DOI 10.1136/vr.h4196; [Anonymous], 2015, RAB RAT INV GLOB EL; [Anonymous], HUM RAB 2016 UPD CAL; [Anonymous], 2 APPSWHOINT; [Anonymous], RAB VACC IMM WHO POS; [Anonymous], RAB FACT SHEET 2017; [Anonymous], HOUS BUDG SURV 2011; [Anonymous], 2014, 6 M INT COORD GROUP; Bharti Omesh Kumar OK, 2012, WORLD J VACCINES, V2, P121; Cleaveland S, 2003, VACCINE, V21, P1965, DOI 10.1016/S0264-410X(02)00778-8; Cleaveland S, 2002, B WORLD HEALTH ORGAN, V80, P304; Fitzpatrick MC, 2014, ANN INTERN MED, V160, P91, DOI 10.7326/M13-0542; Hampson K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000339; Hemachudha T, 2013, LANCET NEUROL, V12, P498, DOI 10.1016/S1474-4422(13)70038-3; Johnson N, 2010, J GLOB INFECT DIS, V2, P201, DOI 10.4103/0974-777X.68523; Mallewa M, 2007, EMERG INFECT DIS, V13, P136, DOI 10.3201/eid1301.060810; Mazigo HD, 2010, J GLOB INFECT DIS, V2, P216, DOI 10.4103/0974-777X.68530; National Bureau of Statistics, 2013, 2012 POP HOUS CENS; Neville J., 2004, Historical perspective of rabies in Europe and the Mediterranean Basin: a testament to rabies by Dr Arthur A. King, P1; Sambo M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003310; Sambo M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002510; Tepsumethanon Veera, 2005, Journal of the Medical Association of Thailand, V88, P419	22	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0197996	10.1371/journal.pone.0197996	http://dx.doi.org/10.1371/journal.pone.0197996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965994	Green Published, Green Submitted, gold			2022-12-26	WOS:000437224100004
J	Navratna, V; Tosh, DK; Jacobson, KA; Gouaux, E				Navratna, Vikas; Tosh, Dilip K.; Jacobson, Kenneth A.; Gouaux, Eric			Thermostabilization and purification of the human dopamine transporter (hDAT) in an inhibitor and allosteric ligand bound conformation	PLOS ONE			English	Article							X-RAY STRUCTURES; MEMBRANE-TRANSPORT; BACTERIAL HOMOLOG; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; NEUROTRANSMITTER; LEUT; MECHANISM; RECEPTOR; EXPRESSION	The human dopamine transporter (hDAT) plays a major role in dopamine homeostasis and regulation of neurotransmission by clearing dopamine from the extracellular space using secondary active transport. Dopamine is an essential monoamine chemical messenger that regulates reward seeking behavior, motor control, hormonal release, and emotional response in humans. Psychostimulants such as cocaine primarily target the central binding site of hDAT and lock the transporter in an outward-facing conformation, thereby inhibiting dopamine reuptake. The inhibition of dopamine reuptake leads to accumulation of dopamine in the synapse causing heightened signaling. In addition, hDAT is implicated in various neurological disorders and disease-associated neurodegeneration. Despite its significance, the structural studies of hDAT have proven difficult. Instability of hDAT in detergent micelles has been a limiting factor in its successful biochemical, biophysical, and structural characterization. To overcome this hurdle, we identified ligands that stabilize hDAT in detergent micelles. We then screened similar to 200 single residue mutants of hDAT using a high-throughput scintillation proximity assay and identified a thermostable variant (1248Y). Here we report a robust strategy to overexpress and successfully purify a thermostable variant of hDAT in an inhibitor and allosteric ligand bound conformation.	[Navratna, Vikas; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA; [Tosh, Dilip K.; Jacobson, Kenneth A.] NIDDK, Mol Recognit Sect, Lab Bioorgan Chem, NIH, Bethesda, MD 20892 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA	Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Jacobson, Kenneth Alan/A-1530-2009; Navratna, Vikas/AAI-1331-2019; Navratna, Vikas/AAD-5036-2021	Gouaux, Eric/0000-0002-8549-2360; Jacobson, Kenneth Alan/0000-0001-8104-1493; 	NIMH/NIH [5R37MH070039]; Intramural Research Program of NIDDK, National Institutes of Health, Bethesda, MD, USA [ZIADK031127]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070039, R01MH070039] Funding Source: NIH RePORTER	NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural Research Program of NIDDK, National Institutes of Health, Bethesda, MD, USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research reported in this paper was funded by NIMH/NIH 5R37MH070039 (to EG) (https://www.nimh.nih.gov/index.shtml). EG is a Howard Hughes Medical Institute (HHMI) investigator (https://www.hhmi.org/). Synthesis of MRS compounds was supported in part by the Intramural Research Program of NIDDK, National Institutes of Health, Bethesda, MD, USA (ZIADK031127) (to KAJ) (https://www.niddk.nih.gov). The funding bodies did not play any role in experimental design, data collection and analysis, or preparation and publication of the manuscript.	Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Boudanova E, 2008, MOL CELL NEUROSCI, V39, P211, DOI 10.1016/j.mcn.2008.06.011; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Cherezov V, 2007, FARADAY DISCUSS, V136, P195, DOI 10.1039/b618173b; Coleman JA, 2016, JOVE-J VIS EXP, DOI 10.3791/54792; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Davis GL, 2018, BEHAV BRAIN RES, V337, P61, DOI 10.1016/j.bbr.2017.09.043; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Focke PJ, 2013, STRUCTURE, V21, P694, DOI 10.1016/j.str.2013.03.002; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Green EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145688; Harder D, 2012, NAT PROTOC, V7, P1569, DOI 10.1038/nprot.2012.090; Janowsky A, 2016, J PHARMACOL EXP THER, V357, P24, DOI 10.1124/jpet.115.229666; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Khelashvili G, 2015, BBA-BIOMEMBRANES, V1848, P1765, DOI 10.1016/j.bbamem.2015.03.025; Khelashvili G, 2015, PROTEINS, V83, P952, DOI 10.1002/prot.24792; Kimple ME, 2013, CURR PROTOC PROTEIN, V73, DOI [10.1002/0471140864.ps0909s73, DOI 10.1002/0471140864.PS0909S73]; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kroncke BM, 2010, BIOCHEMISTRY-US, V49, P10045, DOI 10.1021/bi101148w; Kurian MA, 2011, LANCET NEUROL, V10, P721, DOI 10.1016/S1474-4422(11)70141-7; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Malinauskaite L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11673; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Penmatsa A, 2015, NAT STRUCT MOL BIOL, V22, P506, DOI 10.1038/nsmb.3029; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Piscitelli CL, 2012, EMBO J, V31, P228, DOI 10.1038/emboj.2011.353; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rudnick G, 2014, PFLUG ARCH EUR J PHY, V466, P25, DOI 10.1007/s00424-013-1410-1; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Tate CG, 2012, TRENDS BIOCHEM SCI, V37, P343, DOI 10.1016/j.tibs.2012.06.003; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Tosh DK, 2017, J MED CHEM, V60, P3109, DOI 10.1021/acs.jmedchem.7b00141; UDENFRIEND S, 1987, ANAL BIOCHEM, V161, P494, DOI 10.1016/0003-2697(87)90479-9; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	48	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0200085	10.1371/journal.pone.0200085	http://dx.doi.org/10.1371/journal.pone.0200085			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965988	Green Submitted, gold, Green Published			2022-12-26	WOS:000437224100047
J	Senn, O; Kilchenmann, L; Bechtold, T; Hoesl, F				Senn, Olivier; Kilchenmann, Lorenz; Bechtold, Toni; Hoesl, Florian			Groove in drum patterns as a function of both rhythmic properties and listeners' attitudes	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; PARTICIPATORY DISCREPANCIES; PERCEIVED GROOVE; MUSICAL GROOVE; PERCEPTION; ENTRAINMENT; KIT; VARIABILITY; MOVEMENT; SOUNDS	Music psychology defines groove as humans' pleasureable urge to move their body in synchrony with music. Past research has found that rhythmic syncopation, event density, beat salience, and rhythmic variability are positively associated with groove. This exploratory study investigates the groove effect of 248 reconstructed drum patterns from different popular music styles (pop, rock, funk, heavy metal, rock'n'roll, hip hop, soul, R&B). It aims at identifying factors that might be relevant for groove and worth investigating in a controlled setting in the future. Drum patterns of eight bars duration, chosen from 248 popular music tracks, have been transcribed and audio reconstructions have been created on the basis of sound samples. During an online listening experiment, 665 participants rated the reconstructions a total of 8,329 times using a groove questionnaire. Results show that, among 15 tested variables, syncopation (R-2 = 0.010) and event density (R-2 = 0.011) were positively associated with the groove ratings. These effects were stronger in participants who were music professionals, compared to amateur musicians or mere listeners. A categorisation of the stimuli according to structural aspects was also associated with groove (R-2 = 0.018). Beat salience, residual microtiming and rhythmic variability showed no effect on the groove ratings. Participants' familiarity with a drum pattern had a positive influence on the groove ratings (R-2 = 0.051). The largest isolated effect was measured for participants' style bias (R-2 = 0.123): groove ratings tended to be high if participants had the impression that the drum pattern belonged to a style they liked. Combined, the effects of style bias and familiarity (R-2 = 0.152) exceeded the other effects as predictors for groove by a wide margin. We conclude that listeners' taste, musical biographies and expertise have a strong effect on their groove experience. This motivates groove research not to focus on the music alone, but to take the listeners into account as well.	[Senn, Olivier; Kilchenmann, Lorenz; Bechtold, Toni; Hoesl, Florian] Lucerne Univ Appl Sci & Arts, Sch Music, Luzern, Switzerland		Senn, O (corresponding author), Lucerne Univ Appl Sci & Arts, Sch Music, Luzern, Switzerland.	olivier.senn@hslu.ch		Bechtold, Toni Amadeus/0000-0002-4768-5997; Senn, Olivier/0000-0002-4944-3115	Schweizerischer Nationalfonds zur Forderung der wissenschaftlichen Forschung [100016_162504/1]	Schweizerischer Nationalfonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF))	This work was supported by Schweizerischer Nationalfonds zur Forderung der wissenschaftlichen Forschung (www.snf.ch), grant number: 100016_162504/1 to OS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles H, 2009, J RES MUSIC EDUC, V57, P127, DOI 10.1177/0022429409335878; ALEN O, 1995, ETHNOMUSICOLOGY, V39, P55, DOI 10.2307/852200; Avanti P, 2013, POP MUSIC SOC, V36, P476, DOI 10.1080/03007766.2012.681111; BADDELEY AD, 1993, MEM COGNITION, V21, P146, DOI 10.3758/BF03202726; Baur S., 2002, EVERY SOUND THERE IS, P171; Benadon F., 2006, ETHNOMUSICOLOGY; Benadon F, 2009, POP MUSIC, V28, P19, DOI 10.1017/S0261143008001578; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; Brooks K, 2010, J EXER PHYS ONLINE, V13, P52; Burger B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00903; Butler Mark J., 2006, UNLOCKING GROOVE RHY; Butterfield M.W., 2006, MUSIC THEORY ONLINE, V12, P2, DOI [10.30535/mto.12.4.2, DOI 10.30535/MTO.12.4.2]; Butterfield M, 2010, MUSIC PERCEPT, V27, P157, DOI 10.1525/MP.2010.27.3.157; Clayton M., 2005, EUR MEET ETHNOMUSICO, V11, P3, DOI DOI 10.1093/ACPROF:OSO/9780195339680.001.0001; Clayton M, 2012, EMPIR MUSICOL REV, V7, P49, DOI 10.18061/1811/52979; Coelho T, 2005, FLUTIST Q, P44; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dahl S, 2014, J NEW MUSIC RES, V43, P214, DOI 10.1080/09298215.2014.884144; Danielsen A, 2010, ASHG POP FOLK MUSIC, P1; Danielsen Anne, 2006, PRESENCE PLEASURE FU, P144; Davies M, 2013, MUSIC PERCEPT, V30, P497, DOI 10.1525/MP.2013.30.5.497; Dittmar C., 2015, P ISMIR 2015, P271; Doffman M. R., 2008, THESIS; Eros John., 2008, UPDATE APPL RES MUSI, V27, P57, DOI [10.1177/8755123308322379, DOI 10.1177/8755123308322379]; Etani T, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00462; Feld Steven, 1994, MUSIC GROOVES ESSAYS, P109; Fitch WT, 2007, MUSIC PERCEPT, V25, P43, DOI 10.1525/mp.2007.25.1.43; Fitch WT, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00064; Fleet P, 2014, POP MUSIC, V33, P293, DOI 10.1017/S0261143014000269; FOX JG, 1972, APPL ERGON, V3, P202, DOI 10.1016/0003-6870(72)90101-9; Friberg A, 2002, MUSIC PERCEPT, V19, P333, DOI 10.1525/mp.2002.19.3.333; Fritz TH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00921; Fruhauf J, 2013, MUSIC SCI, V17, P246, DOI 10.1177/1029864913486793; Fujii S, 2011, MUSIC PERCEPT, V28, P491, DOI 10.1525/mp.2011.28.5.491; Gerischer C., 2003, SUINGUE BAIANO MIKRO; Gioia Ted, 2006, WORK SONGS; Graf LKM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00015; Greenberg DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131151; Hallam S, 2008, INT J MUSIC EDUC, V26, P7, DOI 10.1177/0255761407085646; Hargreaves DJ, 2018, MUSIC SCI, V22, P161, DOI 10.1177/1029864917697783; Heckman J.J., 2010, MICROECONOMETRICS NE, P242, DOI [DOI 10.1057/9780230280816_29, http://doi.org/10.1057/9780230280816_29]; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hellmer K, 2015, MUSIC PERCEPT, V33, P147, DOI 10.1525/MP.2015.33.2.147; Hodeir A, 1980, UOMINI PROBLEMI JAZZ; Hodson R., 2007, INTERACTION IMPROVIS, DOI DOI 10.4324/9780203944103; Hofmann A, 2017, J NEW MUSIC RES, V46, P329, DOI 10.1080/09298215.2017.1355394; Janata P, 2012, J EXP PSYCHOL GEN, V141, P54, DOI 10.1037/a0024208; Karageorghis CI, 2010, PSYCHOL SPORT EXERC, V11, P551, DOI 10.1016/j.psychsport.2010.06.004; Karageorghis CI, 2012, INT REV SPORT EXER P, V5, P67, DOI 10.1080/1750984X.2011.631027; Katz Mark, 2012, GROOVE MUSIC ART CUL; KEIL C, 1995, ETHNOMUSICOLOGY, V39, P1, DOI 10.2307/852198; KEIL C., 2010, POPSCRIPTUM, V11; Keil Charles, 1987, CULTURAL ANTHR, V2, P275, DOI [DOI 10.1525/CAN.1987.2.3.02A00010, 10.1525/can.1987.2.3.02a00010]; Keil Charles M. H., 1966, J AESTHETICS ART CRI, V24, P337, DOI [DOI 10.2307/427969, 10.2307/427969]; Kilchenmann L., 2011, P INT S PERF SCI ISP, P593; Kilchenmann L, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01232; Kvifte T., 2004, STUD MUSICOL, V30, P54; Lesiuk T., 2005, PSYCHOL MUSIC, V33, P173, DOI [10.1177/0305735605050650, DOI 10.1177/0305735605050650]; LONGUETHIGGINS HC, 1984, MUSIC PERCEPT, V1, P424; Lucas G, 2011, EMPIR MUSICOL REV, V6, P75, DOI 10.18061/1811/51203; Madison G., 2001, P 7 INT S SYST COMP, P108; Madison G, 2006, MUSIC PERCEPT, V24, P201, DOI 10.1525/mp.2006.24.2.201; Madison G, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00147; Madison G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00894; Madison G, 2014, ACTA PSYCHOL, V147, P10, DOI 10.1016/j.actpsy.2013.10.002; Madison G, 2011, J EXP PSYCHOL HUMAN, V37, P1578, DOI 10.1037/a0024323; Matsushita S, 2016, MUSIC PERCEPT, V34, P123, DOI 10.1525/MP.2016.34.2.123; McCoach DB, 2013, INSTRUMENT DEVELOPMENT IN THE AFFECTIVE DOMAIN: SCHOOL AND CORPORATE APPLICATIONS, THIRD EDITION, P1, DOI 10.1007/978-1-4614-7135-6; McNeill W.H., 1997, KEEPING TOGETHER TIM; Merker B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00454; Miles J., 2001, APPL REGRESSION CORR; Moelants D, 2002, P 7 INT C MUSIC PERC, P1, DOI DOI 10.1044/1059-0889(2002/ER01); Monson Ingrid, 1996, SAYING SOMETHING JAZ; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; Naveda L, 2011, J NEW MUSIC RES, V40, P225, DOI 10.1080/09298215.2011.603833; Neuhoff H, 2017, MUSIC PERCEPT, V34, P438, DOI 10.1525/MP.2017.34.4.438; OGDEN C. K., 1948, SYSTEM BASIC ENGLISH; Pfleiderer M., 2006, RHYTHMUS PSYCHOL THE; Phillips-Silver J, 2010, MUSIC PERCEPT, V28, P3, DOI 10.1525/MP.2010.28.1.3; Polak R., 2010, MUSIC THEORY ONLINE, V16, DOI [10.30535/mto.16.4.4, DOI 10.30535/MTO.16.4.4]; Polak R, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00285; Pressing J, 2002, MUSIC PERCEPT, V19, P285, DOI 10.1525/mp.2002.19.3.285; PROGLER JA, 1995, ETHNOMUSICOLOGY, V39, P21, DOI 10.2307/852199; Rentfrow PJ, 2011, J PERS SOC PSYCHOL, V100, P1139, DOI 10.1037/a0022406; Rentfrow PJ, 2003, J PERS SOC PSYCHOL, V84, P1236, DOI 10.1037/0022-3514.84.6.1236; Ringli D., 2006, SCHWEIZER VOLKSMUSIK; Rose RF, 1989, THESIS; Ross JM, 2016, J EXP PSYCHOL HUMAN, V42, P308, DOI 10.1037/xhp0000198; Schafer T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00511; Senn O, 2018, HDB MUSIKPSYCHOLOGIE, P543; Senn O, 2011, MUSIK RAUM AKKORD BI, P799; Senn O, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01709; Senn O, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01487; SHAW RG, 1993, ECOLOGY, V74, P1638, DOI 10.2307/1939922; Sioros G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01036; Stewart Alexander, 2000, POP MUSIC, V19, P293, DOI [10.1017/S0261143000000180, DOI 10.1017/S0261143000000180]; Stupacher J, 2016, MUSIC PERCEPT, V33, P571, DOI 10.1525/MP.2016.33.5.571; Stupacher J, 2013, BRAIN COGNITION, V82, P127, DOI 10.1016/j.bandc.2013.03.003; Styns F, 2007, HUM MOVEMENT SCI, V26, P769, DOI 10.1016/j.humov.2007.07.007; Tamlyn GN, 1998, THESIS; Tan P.-N., 2014, INTRO DATA MINING, VFirst; Temperley D., 1999, POP MUSIC, V18, P19, DOI [10.1017/S0261143000008710, DOI 10.1017/S0261143000008710]; Trost W, 2014, NEUROIMAGE, V103, P55, DOI 10.1016/j.neuroimage.2014.09.009; Van Dyck E, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0025-9; van Noorden L, 1999, J NEW MUSIC RES, V28, P43, DOI 10.1076/jnmr.28.1.43.3122; Washburne C, 1998, LAT AM MUSIC REV, V19, P160, DOI 10.2307/779989; Weinberg N., 1998, GUIDE STANDARDIZED D; Wesolowski BC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163938; Wikioo, 2021, THINKING JAZZ INFINI; Witek MAG, 2017, MUSIC ANAL, V36, P138, DOI 10.1111/musa.12082; Witek MAG, 2017, EXP BRAIN RES, V235, P995, DOI 10.1007/s00221-016-4855-6; Witek MAG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139409; Witek MAG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094446; Yeats J, 2011, SPORT SCI REV, V20, P127; Zagorski-Thomas S., 2007, ETHNOMUSICOL FORUM, V16, P327, DOI DOI 10.1080/17411910701554013; Zbikowski LM, 2004, J ROY MUSIC ASSN, V129, P272, DOI 10.1093/jrma/129.2.272	116	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0199604	10.1371/journal.pone.0199604	http://dx.doi.org/10.1371/journal.pone.0199604			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL0PZ	29958289	Green Published, Green Submitted, gold			2022-12-26	WOS:000436793500011
J	Williams, BK; Johnson, FA				Williams, Byron K.; Johnson, Fred A.			Value of sample information in dynamic, structurally uncertain resource systems	PLOS ONE			English	Article							ADAPTIVE-MANAGEMENT; POPULATION; ROBUSTNESS; QUALITY	Few if any natural resource systems are completely understood and fully observed. Instead, there almost always is uncertainty about the way a system works and its status at any given time, which can limit effective management. A natural approach to uncertainty is to allocate time and effort to the collection of additional data, on the reasonable assumption that more information will facilitate better understanding and lead to better management. But the collection of more data, either through observation or investigation, requires time and effort that often can be put to other conservation activities. An important question is whether the use of limited resources to improve understanding is justified by the resulting potential for improved management. In this paper we address directly a change in value from new information collected through investigation. We frame the value of information in terms of learning through the management process itself, as well as learning through investigations that are external to the management process but add to our base of understanding. We provide a conceptual framework and metrics for this issue, and illustrate them with examples involving Florida scrub-jays (Aphelocoma coerulescens).	[Williams, Byron K.] Renewable Resources Associates, Oakton, VA 22124 USA; [Johnson, Fred A.] US Geol Survey, Wetland & Aquat Res Ctr, Gainesville, FL USA	United States Department of the Interior; United States Geological Survey	Williams, BK (corresponding author), Renewable Resources Associates, Oakton, VA 22124 USA.	bkenw111@yahoo.com	Johnson, Fred/GLU-6494-2022		U.S. Geological Survey	U.S. Geological Survey(United States Geological Survey)	Funding for this research was provided by the U.S. Geological Survey. Renewable Resources Associates provided support in the form of salaries for authors (BKW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contribution" section.	Berger J.O., 1995, STAT DECISION THEORY, V2nd ed; Breininger DR, 1995, CONSERV BIOL, V9, P1442, DOI 10.1046/j.1523-1739.1995.09061442.x; Breininger DR, 2004, ECOL APPL, V14, P1079, DOI 10.1890/03-5002; Breininger DR, 2003, ECOL APPL, V13, P516, DOI 10.1890/1051-0761(2003)013[0516:TQTASS]2.0.CO;2; Breininger DR, 1998, WILDLIFE SOC B, V26, P118; Canessa S, 2015, METHODS ECOL EVOL, V6, P1219, DOI 10.1111/2041-210X.12423; Conroy MJ, 2008, WILDLIFE RES, V35, P93, DOI 10.1071/WR07147; Dakins ME, 1996, RISK ANAL, V16, P67, DOI 10.1111/j.1539-6924.1996.tb01437.x; Doremus Holly, 2011, NC L REV, V89, P1455; Fackler PL, 2013, INT REV ENVIRON RESO, V7, P109, DOI 10.1561/101.00000058; Foster TE, 2003, P 2 INT WILDL FIR EC; Grantham HS, 2008, CONSERV LETT, V1, P190, DOI 10.1111/j.1755-263X.2008.00029.x; Johnson FA, 2015, ADAPTIVE MANAGEMENT; Johnson FA, 2017, ECOL ECON, V137, P83, DOI 10.1016/j.ecolecon.2017.03.004; Johnson FA, 2014, J WILDLIFE MANAGE, V78, P531, DOI 10.1002/jwmg.682; Johnson FA, 2014, ECOL MODEL, V273, P186, DOI 10.1016/j.ecolmodel.2013.10.031; Keisler Jeffrey M., 2014, Environment Systems & Decisions, V34, P3, DOI 10.1007/s10669-013-9439-4; Lee PM, 1989, BAYESIAN STAT; Mantyniemi S, 2009, ICES J MAR SCI, V66, P2278, DOI 10.1093/icesjms/fsp206; Maxwell SL, 2015, J APPL ECOL, V52, P12, DOI 10.1111/1365-2664.12373; McAllister MK, 1998, ICES J MAR SCI, V55, P1031, DOI 10.1006/jmsc.1998.0425; McAllister MK, 1996, CANADIAN J FISHERIES, V54, P301; McDonald A. David, 1997, Natural Resource Modeling, V10, P185; Moore AL, 2017, ECOL APPL, V27, P1210, DOI 10.1002/eap.1515; Moore AL, 2010, CONSERV BIOL, V24, P984, DOI 10.1111/j.1523-1739.2009.01443.x; Moore JL, 2012, CONSERV BIOL, V26, P810, DOI 10.1111/j.1523-1739.2012.01907.x; Nichols JD, 2015, J APPL ECOL, V52, P539, DOI 10.1111/1365-2664.12406; Nichols JD, 2012, ENCY ENV; Puterman ML., 2014, MARKOV DECISION PROC; Quirk JP, 1976, INTERMEDIATE MICROEC; Root KV, 1998, ECOL APPL, V8, P854, DOI 10.1890/1051-0761(1998)008[0854:ETEOHQ]2.0.CO;2; Runge MC, 2011, BIOL CONSERV, V144, P1214, DOI 10.1016/j.biocon.2010.12.020; Schlaifer R., 1961, APPL STAT DECISION T; Schwartz MW, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12385; Shea K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001970; Stith Bradley M., 1996, P187; Walters C., 1986, ADAPTIVE MANAGEMENT; Williams B.K., 2002, ANAL MANAGEMENT ANIM; Williams BK, 2011, J ENVIRON MANAGE, V2011, P1346, DOI DOI 10.1016/J.JENVMAN.2010.10.041; Williams BK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182934; Williams BK, 2015, WILDLIFE SOC B, V39, P488, DOI 10.1002/wsb.575; Williams BK, 2015, ECOL EVOL, V5, P466, DOI 10.1002/ece3.1363; Williams BK, 2015, J WILDLIFE MANAGE, V79, P148, DOI 10.1002/jwmg.814; Williams BK, 2014, ENVIRON MANAGE, V53, P465, DOI 10.1007/s00267-013-0205-7; Williams BK, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025004; Williams BK, 2011, ECOL MODEL, V222, P3429, DOI 10.1016/j.ecolmodel.2011.07.003; Williams BK, 2011, J ENVIRON MANAGE, V92, P1371, DOI 10.1016/j.jenvman.2010.10.039; Williams BK, 2009, ECOL MODEL, V220, P830, DOI 10.1016/j.ecolmodel.2008.12.023; Yokota F, 2004, RISK ANAL, V24, P635, DOI 10.1111/j.0272-4332.2004.00464.x; Yokota F, 2004, MED DECIS MAKING, V24, P287, DOI 10.1177/0272989X04263157	50	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0199326	10.1371/journal.pone.0199326	http://dx.doi.org/10.1371/journal.pone.0199326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0PZ	29958290	Green Published, gold			2022-12-26	WOS:000436793500009
J	Singh, N; Sundar, S				Singh, Neetu; Sundar, Shyam			Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis	PLOS ONE			English	Article							IFN-GAMMA; MURINE MACROPHAGES; HOST-DEFENSE; INDUCTION; CYTOKINES; INFECTION; RELEASE; MOUSE; CELLS	Immune activating cytokines Interferon (IFN)-gamma and Tumor necrosis factor (TNF)-alpha are known to activate macrophages for killing of Leishmania parasite. IFN-gamma provides therapeutic potential while TNF-alpha has been recognized to mediate protection in visceral model of infection. In the present study we investigated whether combination of IFN-gamma and TNF-alpha has better therapeutic strength than individually using one of these cytokines in Visceral Leishmaniasis (VL) patients. We performed combined blockade of IFN-gamma and TNF-alpha in VL splenic biopsies and demonstrated it's impact on number of viable amastigotes and cytokine production. Additionally, selective depletion of splenic cell subsets was performed to establish the cellular sources of IFN-gamma and TNF-alpha. Treatment of splenic aspirate cells with combination of anti-IFN-gamma and anti-TNF-alpha monoclonal antibodies for 72 hours enabled no direct additive impact of these cytokines on parasite replication and IL-10 secretion, but IL-4 production was induced. Further assessment of splenic biopsies put forward CD4(+) T cells as a source of IFN-gamma whereas CD14(+) cells contribute towards TNF-alpha production. Overall our results suggest, the interplay of pro-inflammatory cytokines IFN-gamma derived from CD4(+) T lymphocytes and TNF-alpha from CD14(+) cells has no direct additive impact on parasite replication but induces IL-4 production. Our data does not support direct targeting of IFN-gamma and TNF-alpha for combination therapy but targeting these cytokines as an adjuvant in patients with exaggerated tissue inflammatory responses can have favourable patient outcome.	[Singh, Neetu; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi, Uttar Pradesh, India	Banaras Hindu University (BHU)	Sundar, S (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi, Uttar Pradesh, India.	drshyamsundar@hotmail.com		Sundar, Shyam/0000-0001-9988-582X; Singh, Neetu/0000-0002-2110-9748	Extramural Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) Tropical Medicine Research Centres [TMRC] [P50AI074321]; UGC-CSIR, New Delhi, India; Sitaram Memorial Trust, Muzaffarpur, Bihar, India; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI074321, U19AI074321] Funding Source: NIH RePORTER	Extramural Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) Tropical Medicine Research Centres [TMRC]; UGC-CSIR, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India); Sitaram Memorial Trust, Muzaffarpur, Bihar, India; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Extramural Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) Tropical Medicine Research Centres [TMRC Grant No P50AI074321]. Neetu Singh thanks UGC-CSIR, New Delhi, India for providing Research Fellowship.; We thank hospital staffs at the Kala-azar Medical Research Centre, Muzaffarpur, Bihar, India, for their assistance in the collection of patient samples. The care of patients was supported by the Sitaram Memorial Trust, Muzaffarpur, Bihar, India.	Alexander J, 2000, EUR J IMMUNOL, V30, P2935, DOI 10.1002/1521-4141(200010)30:10&lt;2935::AID-IMMU2935&gt;3.0.CO;2-Q; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; BADARO R, 1993, J INFECT DIS, V167, pS13, DOI 10.1093/infdis/167.Supplement_1.S13; BOGDAN C, 1990, EUR J IMMUNOL, V20, P1131, DOI 10.1002/eji.1830200528; CARTER KC, 1989, EUR J IMMUNOL, V19, P779, DOI 10.1002/eji.1830190432; CRAWFORD RM, 1987, J IMMUNOL, V139, P135; Cunningham AC, 2002, EXP MOL PATHOL, V72, P132, DOI 10.1006/exmp.2002.2418; DING AH, 1988, J IMMUNOL, V141, P2407; Gautam S, 2011, J INFECT DIS, V204, P1134, DOI 10.1093/infdis/jir461; GREEN SJ, 1990, J IMMUNOL, V145, P4290; Kumar R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003198; LIEW FY, 1990, J IMMUNOL, V145, P4306; MARCINKIEWICZ J, 1993, CELL IMMUNOL, V146, P406, DOI 10.1006/cimm.1993.1036; MAUEL J, 1991, J LEUKOCYTE BIOL, V49, P73, DOI 10.1002/jlb.49.1.73; Maurya R, 2010, J CLIN MICROBIOL, V48, P1932, DOI 10.1128/JCM.01733-09; Melby PC, 2001, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1902S28; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Murray HW, 2000, INFECT IMMUN, V68, P6289, DOI 10.1128/IAI.68.11.6289-6293.2000; Murray HW, 2005, INFECT IMMUN, V73, P3903, DOI 10.1128/IAI.73.7.3903-3911.2005; MURRAY HW, 1987, J IMMUNOL, V138, P2290; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; NobenTrauth N, 1996, SCIENCE, V271, P987, DOI 10.1126/science.271.5251.987; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Nylen S, 2010, J GLOB INFECT DIS, V2, P135, DOI 10.4103/0974-777X.62876; Sacks DL, 2015, CURR PROTOC IMMUNOL, V108; SCOTT P, 1991, J IMMUNOL, V147, P3149; Singh N, 2016, CYTOKINE, V85, P184, DOI 10.1016/j.cyto.2016.06.013; Singh OP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00296; SQUIRES KE, 1989, J IMMUNOL, V143, P4244; Stager S, 2003, INFECT IMMUN, V71, P4804, DOI 10.1128/IAI.71.8.4804-4807.2003; Sundar S, 1997, J INFECT DIS, V176, P1117, DOI 10.1086/516526; SUNDAR S, 1995, J INFECT DIS, V172, P1627, DOI 10.1093/infdis/172.6.1627; Sundar S, 2013, EXPERT OPIN PHARMACO, V14, P53, DOI 10.1517/14656566.2013.755515; TUMANG MCT, 1994, J IMMUNOL, V153, P768; Vouldoukis I, 1997, EUR J IMMUNOL, V27, P860, DOI 10.1002/eji.1830270409; Wilhelm P, 2001, J IMMUNOL, V166, P4012, DOI 10.4049/jimmunol.166.6.4012	36	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199817	10.1371/journal.pone.0199817	http://dx.doi.org/10.1371/journal.pone.0199817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953494	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400076
J	Ti, ZY; Zhang, F; Pan, J; Ma, XF; Shang, Z				Ti, Zhengyi; Zhang, Feng; Pan, Jin; Ma, Xiaofei; Shang, Zheng			Permeability enhancement of deep hole pre-splitting blasting in the low permeability coal seam of the Nanting coal mine	PLOS ONE			English	Article							FRACTURE PROPAGATION; GAS; BOREHOLE; DRIVEN; MODEL	To solve the hidden danger of high methane and low permeability gas in the coal mining process, potentially affecting the safety production in an orderly way, we propose the use of deep hole blasting technology to improve the permeability of the coal seam gas drainage, increase the quantity and rate of extraction, and reduce methane output. Taking the geological conditions of the 201 working surface of Tingnan Coal Mine as an example, it is calculated that the single drilled fracture crack extension range is 3.11 similar to 5.24 m according to the coal seam deep-hole pre-splitting blasting joint mechanism and fracture propagation mechanics model, providing a theoretical basis for choosing the appropriate hole spacing. Using COM-SOL simulation software to simulate the effective gas drainage radius of a coal seam from a two-dimensional perspective on a single borehole radial, the least squares fitting method was used to analyze the simulated data, and obtained the effective drilling extraction radius after pre-split blasting in a deep hole that is 3.6 m, which is in accordance with the theoretical calculations. In order to obtain accurate and scientific calculations, Fast lagrangian analysis of continua (FLAC3D) numerical simulation software was used. After simulating the distribution of plastic zone between two blast holes at different intervals from a three-dimensional angle, and evaluating the development of cracks in the blasting hole, the white zone of the blasting space was completely eliminated when the interval between blasting holes was 7 m, and the cracks could be propagated throughout the surroundings. Therefore, a blasting hole spacing of 7 m is optimal. On-site monitoring in the Nanting coal mine showed that the quantity and rate of extraction of the single hole after pre-splitting blasting were 2.36 times and 1.62 times as much as before. By integrating the borehole drainage amount and the optimized calculation equation, it could be concluded that the permeability coefficient of the coal seam after blasting was 7.78 times as much as before. The function of time-variated drilling methane emission was obtained using multivariate statistical regressions based on the on-site monitored borehole methane emission (q(t)), and the drilling limit after pre-splitting blasting revealed that the limitation of methane extraction volume was 5.27 times as much as before.	[Ti, Zhengyi; Zhang, Feng; Pan, Jin; Ma, Xiaofei] Liaoning Tech Univ, Coll Min Engn, Fu Xin, Liaoning, Peoples R China; [Shang, Zheng] China Univ Min & Technol, Natl Engn Res Ctr Coal Mine Gas Control, Xuzhou, Jiangsu, Peoples R China	Liaoning Technical University; China University of Mining & Technology	Zhang, F (corresponding author), Liaoning Tech Univ, Coll Min Engn, Fu Xin, Liaoning, Peoples R China.	ln_zns@163.com		Zhang, Feng/0000-0002-1460-3633	National natural science foundation [china] [51704148]	National natural science foundation [china](National Natural Science Foundation of China (NSFC))	This work was supported by National natural science foundation [china], https://isisn.nsfc.gov.cn/egrantweb/, Fund number: 51704148, for the author: Zhu zhijie, Ti zhengyi. Funders give financial support to research projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, T I MIN METALL; BADAL R, 1994, INT J ROCK MECH MIN, V31, P79, DOI 10.1016/0148-9062(94)92317-5; Brent GF, 2000, J S AFR I MIN METALL, V100, P17; Cai F, 2009, J LIANGNING TECHNICA, V28; [蔡峰 Cai Feng], 2016, [煤炭学报, Journal of China Coal Society], V41, P113; [蔡峰 Cai Feng], 2015, [采矿与安全工程学报, Journal of Mining & Safety Engineering], V32, P840; [蔡峰 CAI Feng], 2007, [煤炭学报, Journal of China Coal Society], V32, P499; Chu HB., 2011, J MINING SAFETY ENG, V28, P644; DUNCAN C W, 2004, ROCK SLOPE ENG CIVIL; [龚敏 GONG Min], 2008, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V27, P1674; Hagan T O, 2001, J S AFR I MIN METALL, V01, P217; Konya C.J., 2018, ENERGY EFFICIENCY MI, P31, DOI [10.1007/978-3-319-54199-0_3, DOI 10.1007/978-3-319-54199-0_3]; Liang B, 2013, J MINING SAFETY ENG, V30; Mohammadi S, 2012, FINITE ELEM ANAL DES, V50, P48, DOI 10.1016/j.finel.2011.08.016; Mohammadi S, 2007, NONUNIFORM ISENTROPI, DOI [10.1016/j.finel.2006.11.005, DOI 10.1016/J.FINEL.2006.11.005]; NILSON RH, 1986, INT J NUMER ANAL MET, V10, P191, DOI 10.1002/nag.1610100207; NILSON RH, 1985, INT J ROCK MECH MIN, V22, P3, DOI 10.1016/0148-9062(85)92589-6; PAINE AS, 1994, INT J ROCK MECH MIN, V31, P699, DOI 10.1016/0148-9062(94)90009-4; Sang H C, 2004, INT J ROCK MECH MIN, V41, P433, DOI [10.1016/j.ijrmms.2004.03.079, DOI 10.1016/J.IJRMMS.2004.03.079]; Wang H. D, 2012, HA ERBIN I ENG MECH; [王岩 Wang Yan], 2013, [重庆大学学报. 自然科学版, Journal of Chongqing University. Natural Science Edition], V36, P101; [杨小林 Yang Xiaolin], 2011, [爆破, Blasting], V28, P1	22	19	20	6	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199835	10.1371/journal.pone.0199835	http://dx.doi.org/10.1371/journal.pone.0199835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953519	gold, Green Submitted, Green Published			2022-12-26	WOS:000436645400080
J	Dorji, J; Tamang, S; Tshewang, T; Dorji, T; Dorji, TY				Dorji, Jigme; Tamang, Sonam; Tshewang, Tshewang; Dorji, Tshering; Dorji, Tashi Yangzome			Genetic diversity and population structure of three traditional horse breeds of Bhutan based on 29 DNA microsatellite markers	PLOS ONE			English	Article							ALLELE FREQUENCY DATA; COMPUTER-PROGRAM; SOFTWARE; POLYMORPHISMS	The genetic variability and population structure of three Bhutanese traditional horse breeds were assessed through genotyping of 74 horses (Boeta 25, Sharta 14 and Yuta 35) for 29 microsatellite DNA loci. Altogether, 282 alleles were detected across 29 polymorphic loci. The allelic diversity (N-E) (Boeta 4.94; Sharta 4.65; Yuta 5.30) and gene diversities (H-E) (Boeta 0.78; Sharta 0.77; Yuta 0.79) were high. None of the breeds deviated significantly from the Hardy-Weinberg equilibrium. There was no sign of significant population bottleneck for all the breeds. The inbreeding estimates (F-IS) of the breeds were low (Boeta 0.023; Sharta 0.001; Yuta 0.021). Analysis of molecular variance showed 0.6% of the total genetic variation among breeds, 1.9% among individuals and 97.5% within individuals. The global F-IT, F-ST, and F-IS estimates for the population were 0.025, 0.006 and 0.019 respectively. The analysis of population structure failed to distinguish subpopulations in traditional horses and this was supported by a high genetic exchange among the breeds. Overall, the results of this study suggest a rich genetic diversity in the traditional horse despite a very low genetic differentiation among the breeds in Bhutan.	[Dorji, Jigme; Tamang, Sonam; Tshewang, Tshewang; Dorji, Tshering; Dorji, Tashi Yangzome] Minist Agr & Forests, Natl Biodivers Ctr, Thimphu, Bhutan		Dorji, J (corresponding author), Minist Agr & Forests, Natl Biodivers Ctr, Thimphu, Bhutan.	jigmedorjik@gmail.com		Dorji, Jigme/0000-0003-4057-8918	Royal Government of Bhutan; AFACI-AnGR project, Korea	Royal Government of Bhutan; AFACI-AnGR project, Korea	This study was funded by the Royal Government of Bhutan and the cost of referral of samples for genotyping was also supported by AFACI-AnGR project, Korea.	Behl R, 2007, ANIMAL, V1, P483, DOI 10.1017/S1751731107694178; Canon J, 2000, ANIM GENET, V31, P39, DOI 10.1046/j.1365-2052.2000.00591.x; Cortes O, 2017, J ANIM BREED GENET, V134, P340, DOI 10.1111/jbg.12255; Department of Livestock (DoL), 2016, LIV STAT 2016; Department of Livestock (DoL), 2007, LIV STAT 2007; Dorji J, 2017, BHUTAN J ANIMAL SCI, V1, P22; Eden A, 1837, POLITICAL MISSIONS B, P68; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Francis RM, 2017, MOL ECOL RESOUR, V17, P27, DOI 10.1111/1755-0998.12509; Glowatzki-Mullis ML, 2006, ANIM GENET, V37, P33, DOI 10.1111/j.1365-2052.2005.01376.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gurung PB, 1999, EQUINE GENOTYPE SURV; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Kakoi H, 2005, EQUINE VET J, V37, P143, DOI 10.2746/0425164054223787; Kakoi Hironaga, 2001, Animal Science Journal, V72, P453; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Ling YH, 2011, ANIM GENET, V42, P56, DOI 10.1111/j.1365-2052.2010.02067.x; Luethi NB., 1999, BOVINE EQUINE BHUTAN; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petersen JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054997, 10.1371/journal.pone.0069819]; Pires D.A.F., 2014, Arch. zootec., V63, P349; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sarkar R., 2012, J BHUTAN STUDIES, V26, P100; Senju N, 2017, J VET MED SCI, V79, DOI 10.1292/jvms.16-0040; Senju N, 2017, J VET MED SCI, V79, P218, DOI 10.1292/jvms.16-0111; Seo Joo-Hee, 2016, Journal of Animal Science and Technology, V58, P40, DOI 10.1186/s40781-016-0120-6; Takasu M, 2012, J VET MED SCI, V74, P161, DOI 10.1292/jvms.11-0025; Takezaki N, 2014, MOL BIOL EVOL, V31, P1622, DOI 10.1093/molbev/msu093; Tozaki T, 2001, J VET MED SCI, V63, P1191, DOI 10.1292/jvms.63.1191; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	36	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199376	10.1371/journal.pone.0199376	http://dx.doi.org/10.1371/journal.pone.0199376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949614	gold, Green Published, Green Submitted			2022-12-26	WOS:000436549200046
J	Horowitz, JF; Ortega, JF; Hinko, A; Li, MH; Nelson, RK; Mora-Rodriguez, R				Horowitz, Jeffrey F.; Ortega, Juan F.; Hinko, Alexander; Li, Minghua; Nelson, Rachael K.; Mora-Rodriguez, Ricardo			Changes in markers for cardio-metabolic disease risk after only 1-2 weeks of a high saturated fat diet in overweight adults	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INSULIN SENSITIVITY; ACID-COMPOSITION; SECULAR TRENDS; BODY DENSITY; PLASMA; CHOLESTEROL; QUALITY; VALIDATION; EXTRACTION	Purpose Diets high in saturated fat acids (SFA) have been linked with cardio-metabolic disease risk. The purpose of this study was to determine whether only 1-2 weeks of a high SFA diet could impact disease risk factors in overweight adults who normally eat a relatively low proportion of SFA (i.e., <40% of dietary fat). Methods Twelve overweight (BMI: 27 +/- 1 kg/m(2)) young adults were studied before and after a 2-week diet that increased the proportion of SFA (<40% to 60% of dietary fat), while maintaining their daily intake of total fat, carbohydrate, protein, and calories. Insulin resistance, blood pressure, plasma markers of liver damage, total plasma cholesterol concentrations, and fatty acid profile within plasma and skeletal muscle lipid pools were assessed before and after the intervention. Results Total plasma cholesterol concentration increased (148 +/- 5 vs. 164 +/- 8 mg/dl; P<0.05) after only one week, due exclusively to an increase in LDL-cholesterol (78 +/- 4 vs. 95 +/- 7 mg/dl; P<0.05). After two weeks, plasma aspartate amino transferase (AST) concentration increased (P<0.05) but we found no change in insulin resistance, or resting blood pressure. The diet increase the proportion of SFA in plasma (35 +/- 1% vs. 39 +/- 2%; P<0.05) and the intramyocellular triglyceride pool (32 +/- 1% vs. 37 +/- 1%; P<0.05) suggesting the fatty acids in these pools may readily exchange. Conclusions Although blood lipids remain within normal clinical range, increasing saturated fat in diet for only 2 weeks raises plasma markers of cardiovascular risk (LDL-cholesterol) and liver damage (AST). In overweight, but healthy-young adults SFA accumulate in plasma and muscle after only 1-2 weeks of dietary increase.	[Horowitz, Jeffrey F.; Hinko, Alexander; Li, Minghua] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Ortega, Juan F.; Mora-Rodriguez, Ricardo] Univ Castilla La Mancha, Exercise Physiol Lab, Toledo, Spain; [Nelson, Rachael K.] Cent Michigan Univ, Hlth Sci Dept, Coll Hlth Profess, Mt Pleasant, MI 48859 USA	University of Michigan System; University of Michigan; Universidad de Castilla-La Mancha; Central Michigan University	Horowitz, JF (corresponding author), Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA.	jeffhoro@umich.edu	Ortega, Juan Fernando F/L-4973-2014; Mora-Rodriguez, Ricardo/AAC-9096-2022	Ortega, Juan Fernando F/0000-0003-3884-923X; Mora-Rodriguez, Ricardo/0000-0001-9252-4933; Nelson, Rachael/0000-0002-3559-1766	National Institutes of Health (JFH) [R01 DK077966, P30-DK089503]; Spanish Ministry of Economy, Industry y Competitivity (RMR) [DEP-2017-83244-R]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, R01DK077966] Funding Source: NIH RePORTER	National Institutes of Health (JFH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Economy, Industry y Competitivity (RMR); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from National Institutes of Health (JFH, grant numbers R01 DK077966, P30-DK089503) and the Spanish Ministry of Economy, Industry y Competitivity (RMR grant numbers DEP-2017-83244-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2015, OBESITY, V23, P720, DOI 10.1002/oby.21031; Andersson A, 1998, AM J PHYSIOL-ENDOC M, V274, pE432, DOI 10.1152/ajpendo.1998.274.3.E432; Andersson A, 2002, AM J CLIN NUTR, V76, P1222, DOI 10.1093/ajcn/76.6.1222; Arner P, 2011, NATURE, V478, P110, DOI 10.1038/nature10426; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodennec J, 2000, ANAL BIOCHEM, V279, P245, DOI 10.1006/abio.2000.4454; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Chiu S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170664; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de la Fuente-Arrillaga C, 2010, PUBLIC HEALTH NUTR, V13, P1364, DOI 10.1017/S1368980009993065; Drouin-Chartier JP, 2016, ADV NUTR, V7, P1041, DOI 10.3945/an.115.011619; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Fasching P, 1996, ANN NUTR METAB, V40, P116, DOI 10.1159/000177904; Ortega JF, 2014, APPL PHYSIOL NUTR ME, V39, P787, DOI 10.1139/apnm-2013-0507; Ortega JF, 2013, APPL PHYSIOL NUTR ME, V38, P42, DOI [10.1139/, 10.1139/apnm-2012-0123]; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Galgani JE, 2008, BRIT J NUTR, V100, P471, DOI 10.1017/S0007114508894408; GINSBERG BH, 1982, BIOCHIM BIOPHYS ACTA, V690, P157, DOI 10.1016/0005-2736(82)90318-2; GRUNFELD C, 1981, BIOCHEM BIOPH RES CO, V103, P219, DOI 10.1016/0006-291X(81)91682-X; Holloway GP, 2009, AM J PHYSIOL-ENDOC M, V296, pE738, DOI 10.1152/ajpendo.90896.2008; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; Jebb SA, 2010, AM J CLIN NUTR, V92, P748, DOI 10.3945/ajcn.2009.29096; Jones PJH, 1998, J LIPID RES, V39, P1111; Kanaley JA, 2009, J PHYSIOL-LONDON, V587, P5939, DOI 10.1113/jphysiol.2009.180695; Kien CL, 2011, OBESITY, V19, P305, DOI 10.1038/oby.2010.135; KUO P, 1990, BIOCHEMISTRY-US, V29, P6626, DOI 10.1021/bi00480a011; Lottenberg AM, 2012, J NUTR BIOCHEM, V23, P1027, DOI 10.1016/j.jnutbio.2012.03.004; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTSON FH, 1985, J LIPID RES, V26, P194; MayerDavis EJ, 1997, AM J CLIN NUTR, V65, P79, DOI 10.1093/ajcn/65.1.79; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mensink RP, 2020, EFFECTS SATURATED FA; Moon JH, 2010, LIPIDS, V45, P1109, DOI 10.1007/s11745-010-3475-3; Mora-Rodriguez R, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050252; Nishida C, 2004, PUBLIC HEALTH NUTR, V7, P245, DOI 10.1079/PHN2003592; Patterson BW, 1999, J LIPID RES, V40, P2118; Petyaev IM, 2012, MED HYPOTHESES, V79, P746, DOI 10.1016/j.mehy.2012.08.018; Phillips CM, 2013, NUTRIENTS, V5, P32, DOI 10.3390/nu5010032; Pilon M, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0342-0; Rivellese AA, 2003, BIOMED PHARMACOTHER, V57, P84, DOI 10.1016/S0753-3322(03)00003-9; Ruiz E, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030177; Storlien LH, 1996, DIABETOLOGIA, V39, P621, DOI 10.1007/BF00418533; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; TRIPODI A, 1991, BIOCHIM BIOPHYS ACTA, V1083, P298, DOI 10.1016/0005-2760(91)90086-W; Valdes J, 2009, ANN NUTR METAB, V54, P177, DOI 10.1159/000217814; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wright Jacqueline D, 2010, NCHS Data Brief, P1; Zong G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5796	52	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198372	10.1371/journal.pone.0198372	http://dx.doi.org/10.1371/journal.pone.0198372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949578	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200015
J	Madut, NA; Nasinyama, GW; Muma, JB; Sube, KLL; Ocan, M; Muwonge, A; Godfroid, J; Jubara, AS; Kankya, C				Madut, Nuol Aywel; Nasinyama, George William; Muma, John Bwalya; Sube, Kenneth L. L.; Ocan, Moses; Muwonge, Adrian; Godfroid, Jacques; Jubara, Ambrose Samuel; Kankya, Clovice			Prevalence of brucellosis among patients attending Wau Hospital, South Sudan	PLOS ONE			English	Article							RISK OCCUPATIONAL GROUPS; INFECTION; DISTRICT; REGION; UGANDA; AREAS; TESTS	Brucellosis is a zoonotic disease of public health importance; its prevalence varies globally. In low-income countries, brucellosis is an endemic and neglected disease affecting both animals and humans. This study was intended to establish brucellosis sero-prevalence among patients attending Wau hospital, South Sudan. Across sectional study, was done among randomly selected patients attending Wau hospital. Data was collected using questionnaires and laboratory investigations. Rose Bengal plate Test (RBPT), Serum agglutination test (SAT) and Competitive Enzyme Linked Immuno Sorbent Assay (c-ELISA) was used in the analysis of blood samples serially starting with RBPT which is more sensitive and least specific then SAT. c-ELISA test which is most specific and less sensitive compared to RBPT and SAT was then used to confirm presence of Brucella antibodies in the samples. A total of 416 participants out of 1664 were enrolled to this study. The majority of participants were between 7-to-76 years of age with mean age of 30.72 (SD+/- 12.83). The sero-positivity of patient's blood samples for brucellosis using c-ELISA was 23.3% (97/416) among patients presenting to Wau hospital. Socio-demographic characteristics, occupation, clinical signs of disease and types of animals reared by animal owners showed no significant correlation with occurrence of sero-positivity among patient's blood samples for brucellosis. While ethnicity (Nilotic), knowledge of zoonotic disease, and consumption of animal urine were statistically significant (p<0.05). The study found a high prevalence of brucellosis among febrile patients attending Wau hospital general outpatient clinic. There is need for co-ordination and collaboration between veterinary and health sectors of government to help prevent and control brucellosis in the region.	[Madut, Nuol Aywel; Jubara, Ambrose Samuel] Univ Bahr el Ghazal, Fac Vet Sci, Dept Clin Studies, Wau, South Sudan; [Madut, Nuol Aywel; Nasinyama, George William; Kankya, Clovice] Makerere Univ, Dept Biosecur Ecosyste & Vet Publ Hlth BEP, Coll Vet Anim Resources & Biosecur COVAB, Kampala, Uganda; [Muma, John Bwalya] Univ Zambia, Dept Dis Control, Sch Vet Med, Lusaka, Zambia; [Sube, Kenneth L. L.] Univ Juba, Coll Med, Dept Biochem, Juba, South Sudan; [Ocan, Moses] Makerere Univ, Coll Hlth Sci, Dept Pharmacol & Therapeut, Kampala, Uganda; [Muwonge, Adrian] Univ Edinburgh, Dept Genet & Genom, Roslin Inst, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Godfroid, Jacques] Univ Tromso, Arctic Univ Norway, Dept Arctic & Marine Biol, Fac Biosci Fisheries & Econ, Tromso, Norway	Makerere University; University of Zambia; Makerere University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; UiT The Arctic University of Tromso	Madut, NA (corresponding author), Univ Bahr el Ghazal, Fac Vet Sci, Dept Clin Studies, Wau, South Sudan.; Madut, NA (corresponding author), Makerere Univ, Dept Biosecur Ecosyste & Vet Publ Hlth BEP, Coll Vet Anim Resources & Biosecur COVAB, Kampala, Uganda.	nmadut@gmail.com	Nasinyama, George/AAN-3148-2020; Godfroid, Jacques/HCI-7835-2022; NASINYAMA, GEORGE/GVS-7396-2022; Muma, John/R-9602-2019; godfroid, jacques/U-3524-2017	Muma, John/0000-0001-6180-4051; ADRIAN, MUWONGE/0000-0002-8579-0384; Ocan, Moses/0000-0002-8852-820X; godfroid, jacques/0000-0002-0782-7858	Makerere University-NORHED-CAPAZOMANINTECO Project [UGA-13/0031]; BBSRC [BBS/E/D/20002173, BB/P007767/1] Funding Source: UKRI	Makerere University-NORHED-CAPAZOMANINTECO Project; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Makerere University-NORHED-CAPAZOMANINTECO Project UGA-13/0031 to NAM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MO, 2010, EUROSURVEILLANCE, V15, P19; Al-Anazi Khalid Ahmed, 2007, J Med Case Rep, V1, P144, DOI 10.1186/1752-1947-1-144; Almuneef MA, 2004, EPIDEMIOL INFECT, V132, P533, DOI 10.1017/S0950268803001857; [Anonymous], 2012, EFFICACY IMMUNOLOGIC; Dinka H., 2009, EURASIAN J AGR ENV S, V6, P508; Donev D, 2010, Prilozi, V31, P33; EDWARDS JMB, 1970, J CLIN PATHOL, V23, P161, DOI 10.1136/jcp.23.2.161; GRUNER E, 1994, INFECTION, V22, P33, DOI 10.1007/BF01780762; Kunda J, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-315; Lado D, 2012, East Afr Med J, V89, P28; McDermott JJ, 2002, VET MICROBIOL, V90, P111, DOI 10.1016/S0378-1135(02)00249-3; Muma JB, 2007, PREV VET MED, V80, P306, DOI 10.1016/j.prevetmed.2007.03.003; Muriuki SMK, 1997, E AFR MED J, V74, P317; Mutanda LN, 1998, E AFR MED J, V75, P68; Nour BY, 2015, CLIN MICROBIOLOGY OP; Omer MK, 2002, EPIDEMIOL INFECT, V129, P85, DOI 10.1017/S0950268802007215; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Ramos TRR, 2008, BRAZ J INFECT DIS, V12, P133, DOI 10.1590/S1413-86702008000200007; Refai M, 2002, VET MICROBIOL, V90, P81, DOI 10.1016/S0378-1135(02)00248-1; Thrusfield M, 1995, VET EPIDEMIOLOGY, P266; Tumwine G, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2242-z; Zein AM, 2016, NOVA J MED BIOL SCI, V4; Zheludkov MM, 2010, BIOL BULL+, V37, P709, DOI 10.1134/S106235901007006X	23	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199315	10.1371/journal.pone.0199315	http://dx.doi.org/10.1371/journal.pone.0199315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949605	Green Submitted, Green Published, gold			2022-12-26	WOS:000436549200043
J	Torres, LG; Rodrigues, MC; Lima, NL; Trindade, TFH; Silva, FFE; Azevedo, CF; DeLima, RO				Torres, Livia Gomes; Rodrigues, Mateus Cupertino; Lima, Nathan Lamounier; Horta Trindade, Tatiane Freitas; Fonseca e Silva, Fabyano; Azevedo, Camila Ferreira; DeLima, Rodrigo Oliveira			Multi-trait multi-environment Bayesian model reveals G x E interaction for nitrogen use efficiency components in tropical maize	PLOS ONE			English	Article							GENETIC-VARIATION; SELECTION; HERITABILITY; LINES	Identifying maize inbred lines that are more efficient in nitrogen (N) use is an important strategy and a necessity in the context of environmental and economic impacts attributed to the excessive N fertilization. N-uptake efficiency (NUpE) and N-utilization efficiency (NUtE) are components of N-use efficiency (NUE). Despite the most maize breeding data have a mult-itrait structure, they are often analyzed under a single-trait framework. We aimed to estimate the genetic parameters for NUpE and NUtE in contrasting N levels, in order to identify superior maize inbred lines, and to propose a Bayesian multi-trait multi-environment (MIME) model. Sixty-four tropical maize inbred lines were evaluated in two experiments: at high (HN) and low N (LN) levels. The MIME model was compared to single-trait multi-environment (STME) models. Based on deviance information criteria (DIC), both multi- and single-trait models revealed genotypes x environments (G x E) interaction. In the MIME model, NUpE was found to be weakly heritable with posterior modes of heritability of 0.016 and 0.023 under HN and LN, respectively. NUtE at HN was found to be highly heritable (0.490), whereas under LN condition it was moderately heritable (0.215). We adopted the MIME model, since combined analysis often presents more accurate breeding values than single models. Superior inbred lines for NUpE and NUtE were identified and this information can be used to plan crosses to obtain maize hybrids that have superior nitrogen use efficiency.	[Torres, Livia Gomes; Rodrigues, Mateus Cupertino; Lima, Nathan Lamounier; Horta Trindade, Tatiane Freitas; DeLima, Rodrigo Oliveira] Univ Fed Vicosa, Dept Plant Sci, Vicosa, MG, Brazil; [Fonseca e Silva, Fabyano] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Azevedo, Camila Ferreira] Univ Fed Vicosa, Dept Stat, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	DeLima, RO (corresponding author), Univ Fed Vicosa, Dept Plant Sci, Vicosa, MG, Brazil.	rodrigoodelima@ufv.br	Silva, Fabyano Fonseca/D-8158-2017; Silva, Fabyano/Y-9223-2019; Azevedo, Camila Ferreira/AGE-4725-2022	Azevedo, Camila Ferreira/0000-0003-0438-5123; Lima, Rodrigo O. de/0000-0001-9291-8422	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) for financial support.	Arriagada O, 2012, EUPHYTICA, V186, P907, DOI 10.1007/s10681-012-0696-y; Azevedo CF, 2013, CIENC RURAL, V43, P1642, DOI 10.1590/S0103-84782013000900017; Banziger M., 1997, Crop Science, V37, P1103, DOI 10.2135/cropsci1997.0011183X003700040012x; Bertin P, 2000, MAYDICA, V45, P53; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Cane-Retamales C, 2011, EUPHYTICA, V178, P177, DOI 10.1007/s10681-010-0292-y; Ciampitti IA, 2014, AGRON J, V106, P2107, DOI 10.2134/agronj14.0025; Coque M, 2006, THEOR APPL GENET, V112, P1205, DOI 10.1007/s00122-006-0222-5; Elis HT, 2000, PESQUI AGROPECU BRAS, V35, P1135, DOI 10.1590/S0100-204X2000000600009; Gallais A, 2005, MAYDICA, V50, P531; Gallais A, 2004, J EXP BOT, V55, P295, DOI 10.1093/jxb/erh006; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Han M, 2015, ANNU REV GENET, V49, P269, DOI 10.1146/annurev-genet-112414-055037; Hayashi T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-34; Hirel B, 2001, PLANT PHYSIOL, V125, P1258, DOI 10.1104/pp.125.3.1258; Junqueira VS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157038; Liu JG, 2010, P NATL ACAD SCI USA, V107, P8035, DOI 10.1073/pnas.0913658107; Machado AT, 1992, BRAZ J PLANT PHYSIOL, V4, P45; Malosetti M, 2008, EUPHYTICA, V161, P241, DOI 10.1007/s10681-007-9594-0; Medici LO, 2005, J PLANT NUTR, V28, P903, DOI 10.1081/PLN-200055586; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; MOLL RH, 1987, CROP SCI, V27, P181, DOI 10.2135/cropsci1987.0011183X002700020007x; Mora F, 2014, TREE GENET GENOMES, V10, P711, DOI 10.1007/s11295-014-0716-2; NASPOLINI V, 1981, REV BRAS GENET, V4, P571; Piepho HP, 2007, GENETICS, V177, P1881, DOI 10.1534/genetics.107.074229; Pingali P.L., 2001, CIMMYT 1999 2000 WOR; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Presterl T, 2003, CROP SCI, V43, P1259, DOI 10.2135/cropsci2003.1259; Ranum P, 2014, ANN NY ACAD SCI, V1312, P105, DOI 10.1111/nyas.12396; Santos MX, 1992, RELATORIO TECINO ANU, P137; Silva FF, 2011, LIVEST SCI, V142, P210, DOI 10.1016/j.livsci.2011.07.012; Smith BJ, 2007, J STAT SOFTW, V21, P1; Sorensen DA., 2002, STAT BIOL HEALTH; Viana JMS, 2012, AGRON J, V104, P722, DOI 10.2134/agronj2011.0358; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; VanTassell CP, 1996, J ANIM SCI, V74, P2586; Viana JMS, 2010, PLANT BREEDING, V129, P599, DOI 10.1111/j.1439-0523.2009.01745.x; Worku M, 2007, CROP SCI, V47, P519, DOI 10.2135/cropsci2005.05.0070; Wu YS, 2011, EUPHYTICA, V180, P281, DOI 10.1007/s10681-011-0409-y	41	20	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199492	10.1371/journal.pone.0199492	http://dx.doi.org/10.1371/journal.pone.0199492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949626	gold, Green Published, Green Submitted			2022-12-26	WOS:000436549200054
J	Hao, JY; Wan, Y; Yao, XH; Zhao, WG; Hu, RZ; Chen, C; Li, L; Zhang, DY; Wu, GH				Hao, Jing-Yi; Wan, Yi; Yao, Xiao-Hui; Zhao, Wei-Guo; Hu, Run-Ze; Chen, Cong; Li, Long; Zhang, Dong-Yang; Wu, Guo-Hua			Effect of different planting areas on the chemical compositions and hypoglycemic and antioxidant activities of mulberry leaf extracts in Southern China	PLOS ONE			English	Article							MORUS-ALBA L.; BLOOD-GLUCOSE; ALPHA-GLUCOSIDASE; 1-DEOXYNOJIRIMYCIN; LEAVES; ATHEROSCLEROSIS; FAGOMINE	Guangdong, Guangxi and Chongqing are emerging sericulture areas in China where the production of mulberry leaves is huge. In order to identity high quality mulberry leaves that are suitable for healthy products to expand planting, 24 samples from three regions (Guangdong, Guangxi, Chongqing) in the south of China were quantified for two alkaloids (1-deoxynojirimycin and fagomine) and five phenols (chlorogenic acid, rutin, isoquercitrin, etc.) using high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS). Additionally, the total phenolic and total flavonoid contents, antioxidant and glycosidase inhibitory activities (hypoglycemic activity) were tested using different assays (DPPH, ABTS, FRAP) to comprehensively evaluate the quality of the mulberry leaves. The contents of DNJ and fagomine ranged from 0.401 +/- 0.003 to 5.309 +/- 0.036 mg/g and from 0.279 +/- 0.031 to 2.300 +/- 0.060 mg/g, respectively. The main phenolic constituents were chlorogenic acid, rutin and isoquercitrin, with chlorogenic acid present in the highest concentrations, ranging from 3.104 +/- 0.191 to 10.050 +/- 0.143 mg/g. The antioxidant activity exhibited a tendency as follows: Guangxi > Guangdong > Chongqing, except for two samples from Chongqing, which showed the highest antioxidant activity. Based on our study, mulberry leaves from Guangdong and Guangxi could be future sources of natural hypoglycemic and antioxidant products.	[Hao, Jing-Yi; Wan, Yi; Yao, Xiao-Hui; Zhao, Wei-Guo; Hu, Run-Ze; Chen, Cong; Li, Long; Zhang, Dong-Yang; Wu, Guo-Hua] Jiangsu Univ Sci & Technol, Coll Biotechnol, Zhenjiang, Peoples R China; [Hao, Jing-Yi; Wan, Yi; Yao, Xiao-Hui; Zhao, Wei-Guo; Hu, Run-Ze; Chen, Cong; Li, Long; Zhang, Dong-Yang; Wu, Guo-Hua] Jiangsu Univ Sci & Technol, Sericulture Res Inst, Zhenjiang, Peoples R China; [Hao, Jing-Yi; Wan, Yi; Yao, Xiao-Hui; Zhao, Wei-Guo; Hu, Run-Ze; Chen, Cong; Li, Long; Zhang, Dong-Yang; Wu, Guo-Hua] Minist Agr, Lab Qual & Safty Risk Assessment Sericulture Prod, Zhenjiang, Peoples R China; [Hao, Jing-Yi; Wan, Yi; Yao, Xiao-Hui; Zhao, Wei-Guo; Hu, Run-Ze; Chen, Cong; Li, Long; Zhang, Dong-Yang; Wu, Guo-Hua] Minist Agr, Qual Inspect Ctr Sericultutal Prod, Zhenjiang, Peoples R China	Jiangsu University of Science & Technology; Jiangsu University of Science & Technology; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs	Li, L; Zhang, DY (corresponding author), Jiangsu Univ Sci & Technol, Coll Biotechnol, Zhenjiang, Peoples R China.; Li, L; Zhang, DY (corresponding author), Jiangsu Univ Sci & Technol, Sericulture Res Inst, Zhenjiang, Peoples R China.; Li, L; Zhang, DY (corresponding author), Minist Agr, Lab Qual & Safty Risk Assessment Sericulture Prod, Zhenjiang, Peoples R China.; Li, L; Zhang, DY (corresponding author), Minist Agr, Qual Inspect Ctr Sericultutal Prod, Zhenjiang, Peoples R China.	lilong10029@126.com; zhangdongyang1987@126.com	wu, george/HHC-8454-2022		Sericulture Industry Technology in China Agriculture Research System [CARS-22-ZJ0308]; Project of National Agricultural Product Quality Safety Risk Assessment [GJFP201801003]; Natural Science Foundation of Jiangsu Province [BK201605553]; National Natural Science Foundation of China [31600461]; Scientific Research Start-up Funding of New Teacher at Jiangsu University of Science and Technology [1732931607, 1732921407]; Graduate Education Teaching Reform Research and Practice of Jiangsu University of Science [1102151504]	Sericulture Industry Technology in China Agriculture Research System; Project of National Agricultural Product Quality Safety Risk Assessment; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Start-up Funding of New Teacher at Jiangsu University of Science and Technology; Graduate Education Teaching Reform Research and Practice of Jiangsu University of Science	This work was supported by the Sericulture Industry Technology in China Agriculture Research System (project no. CARS-22-ZJ0308), Project of National Agricultural Product Quality Safety Risk Assessment (GJFP201801003), Natural Science Foundation of Jiangsu Province (BK201605553), National Natural Science Foundation of China (31600461), Scientific Research Start-up Funding of New Teacher at Jiangsu University of Science and Technology (1732931607), Scientific Research Start-up Funding of New Teacher at Jiangsu University of Science and Technology (1732921407), and Graduate Education Teaching Reform Research and Practice of Jiangsu University of Science (1102151504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2013, LIFE SCI, V92, P202, DOI 10.1016/j.lfs.2012.11.020; Amezqueta S, 2012, ANAL BIOANAL CHEM, V402, P1953, DOI 10.1007/s00216-011-5639-2; Andallu B, 2003, CLIN CHIM ACTA, V338, P3, DOI 10.1016/S0009-8981(03)00322-X; Andallu B, 2014, J HERB MED, V4, P10, DOI 10.1016/j.hermed.2013.10.002; Asano N, 2001, J AGR FOOD CHEM, V49, P4208, DOI 10.1021/jf010567e; Bae SH, 2007, LWT-FOOD SCI TECHNOL, V40, P955, DOI 10.1016/j.lwt.2006.06.007; Chan KC, 2013, J AGR FOOD CHEM, V61, P2780, DOI 10.1021/jf305328d; Chang YC, 2016, J FUNCT FOODS, V21, P249, DOI 10.1016/j.jff.2015.11.033; Chen CC, 2005, FOOD CHEM, V91, P601, DOI 10.1016/j.foodchem.2004.06.039; Chen PN, 2006, CANCER LETT, V235, P248, DOI 10.1016/j.canlet.2005.04.033; Chen XW, 2005, CHIN J PHARMACOEPIDE, V14, P70; [韩世玉 HAN Shiyu], 2006, [贵州农业科学, Guizhou Agricultural Sciences], V34, P118; Hu XQ, 2013, IND CROP PROD, V49, P782, DOI 10.1016/j.indcrop.2013.06.030; Jia FQ, 2007, QILU PHARM AFFAIR, V1; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kim JW, 2003, J CHROMATOGR A, V1002, P93, DOI 10.1016/S0021-9673(03)00728-3; Kimura T, 2007, J AGR FOOD CHEM, V55, P5869, DOI 10.1021/jf062680g; Liu C, 2015, IND CROP PROD, V70, P309, DOI 10.1016/j.indcrop.2015.02.046; Liu L, 2008, CHIN ARG SCI B, V24, P488; Mart?nez, 2017, J FOOD NUTR RES, V5, P253, DOI [10.12691/jfnr-5-4-7, DOI 10.12691/jfnr-5-4-7]; Masoodsadiq B, 2008, TRENDS FOOD SCI TECH, V19, P505; Mudra M, 2007, DIABETES CARE, V30, P1272, DOI 10.2337/dc06-2120; Ou-yang Z, 2013, REV BRAS FARMACOGN, V23, P776, DOI 10.1590/S0102-695X2013000500009; Riche DM, 2017, COMPLEMENT THER MED, V32, P105, DOI 10.1016/j.ctim.2017.04.006; Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035; Shin SO, 2016, EUR J INTEGR MED, V8, P602, DOI 10.1016/j.eujim.2016.06.008; Shivanna Yogisha, 2009, Journal of Natural Products (India), V2, P64; Sugiyama M, 2016, J SCI FOOD AGR, V96, P3915, DOI 10.1002/jsfa.7614; Taniguchi S, 1998, HORM METAB RES, V30, P679, DOI 10.1055/s-2007-978957; Wang F, 2010, J FOOD PROCESS ENG, V33, P39, DOI 10.1111/j.1745-4530.2008.00258.x; Yang NC, 2012, FOOD CHEM, V132, P1796, DOI 10.1016/j.foodchem.2011.11.143; Yang ZZ, 2012, FOOD CHEM, V131, P617, DOI 10.1016/j.foodchem.2011.09.040; Yu XF, FOOD SCI; Zhang DY, 2013, FOOD CHEM, V141, P2213, DOI 10.1016/j.foodchem.2013.05.045; 杨兵, 2012, [中药材, Journal of Chinese Medicinal Materials], V35, P876	35	23	29	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0198072	10.1371/journal.pone.0198072	http://dx.doi.org/10.1371/journal.pone.0198072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944667	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800004
J	Mansfield, L; Hall, J; Smith, L; Rasch, M; Reeves, E; Dewitt, S; Gardner, B				Mansfield, Louise; Hall, Jennifer; Smith, Lee; Rasch, Molly; Reeves, Emily; Dewitt, Stephen; Gardner, Benjamin			"Could you sit down please?" A qualitative analysis of employees' experiences of standing in normally-seated workplace meetings	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; PHYSICAL-ACTIVITY; SITTING TIME; VARICOSE-VEINS; INTERVENTION STRATEGIES; ENERGY-EXPENDITURE; PUBLIC-HEALTH; OFFICE; WORK; ADULTS	Office workers spend most of their working day sitting, and prolonged sitting has been associated with increased risk of poor health. Standing in meetings has been proposed as a strategy by which to reduce workplace sitting but little is known about the standing experience. This study documented workers' experiences of standing in normally seated meetings. Twenty-five participants (18+ years), recruited from three UK universities, volunteered to stand in 3 separate, seated meetings that they were already scheduled to attend. They were instructed to stand when and for however long they deemed appropriate, and gave semi-structured interviews after each meeting. Verbatim transcripts were analysed using Framework Analysis. Four themes, central to the experience of standing in meetings, were extracted: physical challenges to standing; implications of standing for meeting engagement; standing as norm violation; and standing as appropriation of power. Participants typically experienced some physical discomfort from prolonged standing, apparently due to choosing to stand for as long as possible, and noted practical difficulties of fully engaging in meetings while standing. Many participants experienced marked psychological discomfort due to concern at being seen to be violating a strong perceived sitting norm. While standing when leading the meeting was felt to confer a sense of power and control, when not leading the meeting participants felt uncomfortable at being misperceived to be challenging the authority of other attendees. These findings reveal important barriers to standing in normally- seated meetings, and suggest strategies for acclimatising to standing during meetings. Physical discomfort might be offset by building standing time slowly and incorporating more sit-stand transitions. Psychological discomfort may be lessened by notifying other attendees about intentions to stand. Organisational buy-in to promotional strategies for standing may be required to dispel perceptions of sitting norms, and to progress a wider workplace health and wellbeing agenda.	[Mansfield, Louise; Hall, Jennifer] Brunel Univ, Coll Hlth & Life Sci, Dept Life Sci, Uxbridge, Middx, England; [Hall, Jennifer; Reeves, Emily; Dewitt, Stephen; Gardner, Benjamin] Kings Coll London, Dept Psychol, Inst Psychiat Psychol & Neurosci, London, England; [Smith, Lee] Anglia Ruskin Univ, Cambridge Ctr Sport & Exercise Sci, Dept Life Sci, Cambridge, England; [Rasch, Molly] UCL, Dept Epidemiol & Publ Hlth, London, England	Brunel University; University of London; King's College London; Anglia Ruskin University; University of London; University College London	Gardner, B (corresponding author), Kings Coll London, Dept Psychol, Inst Psychiat Psychol & Neurosci, London, England.	benjamin.gardner@kcl.ac.uk	Reeves, Emily/GSO-0062-2022; Hall, Jennifer/D-3453-2019; Reeves, Emily/GVT-5690-2022; Gardner, Benjamin/C-1565-2008	Hall, Jennifer/0000-0001-8379-5555; Gardner, Benjamin/0000-0003-1223-5934; Smith, Lee/0000-0002-5340-9833	Medical Research Council [MR/N008979/1]; MRC [MR/N008979/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (grant number MR/N008979/1; mw.mrc.ac.uk) to Benjamin Gardner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Alkhajah TA, 2012, AM J PREV MED, V43, P298, DOI 10.1016/j.amepre.2012.05.027; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Bluedorn AC, 1999, J APPL PSYCHOL, V84, P277, DOI 10.1037/0021-9010.84.2.277; Buckley JP, 2015, BRIT J SPORT MED, V49, P1357, DOI 10.1136/bjsports-2015-094618; Buckley JP, 2014, OCCUP ENVIRON MED, V71, P109, DOI 10.1136/oemed-2013-101823; Carrier DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019630; Chaudhury M, 2009, HLTH SURVEY ENGLAND, P59; Danquah IH, 2017, INT J EPIDEMIOL, V46, P128, DOI 10.1093/ije/dyw009; De Cocker K, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0177-5; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Eley J., 2000, OFFICE SPACE PLANNIN; Elmer SJ, 2014, APPL ERGON, V45, P1240, DOI 10.1016/j.apergo.2014.03.001; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gardner B, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3974-0; Gardner B, 2016, HEALTH PSYCHOL REV, V10, P89, DOI 10.1080/17437199.2015.1082146; Gilson ND, 2011, HEALTH PROMOT J AUST, V22, P38, DOI 10.1071/HE11038; Gorman E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076723; Grunseit AC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-365; Hadgraft NT, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3611-y; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; John D, 2011, J PHYS ACT HEALTH, V8, P1034, DOI 10.1123/jpah.8.8.1034; Kontosic I, 2000, ACTA MED OKAYAMA, V54, P33; Kwasnicka D, 2016, HEALTH PSYCHOL REV, V10, P277, DOI 10.1080/17437199.2016.1151372; Laurikka JO, 2002, WORLD J SURG, V26, P648, DOI 10.1007/s00268-001-0283-1; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Mackenzie K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2635-z; Mansoubi M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1851-x; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Neuhaus M, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-21; Pronk N, 2012, PREVENTING CHRONIC D, V9; Rothman AJ, 2000, HEALTH PSYCHOL, V19, P64, DOI 10.1037/0278-6133.19.Suppl1.64; Ryde GC, 2014, J PHYS ACT HEALTH, V11, P1318, DOI 10.1123/jpah.2012-0480; Shrestha N, 2016, COCH DATABASE SYS RE, V3; Smith L, 2015, SPORTS MED, V45, P449, DOI 10.1007/s40279-015-0310-2; Smith L, 2015, BMC PUBLIC HEALTH, V15, DOI [10.1186/s12889-014-1338-1, 10.1186/s12889-015-1459-1]; Straker L, 2013, APPL ERGON, V44, P517, DOI 10.1016/j.apergo.2012.11.001; Takahashi Masaki, 2015, Asian J Sports Med, V6, pe24902, DOI 10.5812/asjsm.24902; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Townsend N., 2015, PHYS ACTIVITY STAT 2; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; Triandis H, 1977, INTERPERSONAL BEHAV; Tuchsen F, 2005, OCCUP ENVIRON MED, V62, P847, DOI 10.1136/oem.2005.020537; van der Ploeg HP, 2014, PREV MED, V69, P187, DOI 10.1016/j.ypmed.2014.10.004; Waters CN, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3023-z; Waters TR, 2015, REHABIL NURS, V40, P148, DOI 10.1002/rnj.166	49	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0198483	10.1371/journal.pone.0198483	http://dx.doi.org/10.1371/journal.pone.0198483			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK7JR	29944662	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000436377800010
J	Kara, E; Marks, JD; Roe, AD; Commins, C; Fan, ZY; Calvo-Rodriguez, M; Wegmann, S; Hudry, E; Hyman, BT				Kara, Eleanna; Marks, Jordan D.; Roe, Allyson D.; Commins, Caitlin; Fan, Zhanyun; Calvo-Rodriguez, Maria; Wegmann, Susanne; Hudry, Eloise; Hyman, Bradley T.			A flow cytometry-based in vitro assay reveals that formation of apolipoprotein E (ApoE)-amyloid beta complexes depends on ApoE isoform and cell type	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC AMYLOID-BETA; ALZHEIMERS-DISEASE BRAIN; TRANSGENIC MOUSE MODEL; ENERGY-TRANSFER ASSAY; A-BETA; STABLE COMPLEXES; CULTURED-CELLS; PEPTIDE; PROTEIN; RESONANCE	Apolipoprotein E (ApoE) is a secreted apolipoprotein with three isoforms, E2, E3, and FA, that binds to lipids and facilitates their transport in the extracellular environment of the brain and the periphery. The E4 allele is a major genetic risk factor for the sporadic form of Alzheimer's disease (AD), and studies of human brain and mouse models have revealed that E4 significantly exacerbates the deposition of amyloid beta (A beta). It has been suggested that this deposition could be attributed to the formation of soluble ApoE isoform-specific ApoE-A beta complexes. However, previous studies have reported conflicting results regarding the directionality and strength of those interactions. In this study, using a series of flow cytometry assays that maintain the physiological integrity of ApoE-A beta complexes, we systematically assessed the association of A beta with ApoE2, E3, or E4. We used ApoE secreted from HEK cells or astrocytes overexpressing ApoE fused with a GFP tag. As a source of soluble A beta peptide, we used synthetic A beta 40 or A beta 42 or physiological A beta secreted from CHO cell lines overexpressing WT or V717F variant amyloid precursor protein (APP). We observed significant interactions between the different ApoE isoforms and A beta, with E4 interacting with A beta more strongly than the E2 and E3 isoforms. We also found subtle differences depending on the A beta type and the ApoE-producing cell type. In conclusion, these results indicate that the strength of the ApoE-A beta association depends on the source of A beta or ApoE.	[Kara, Eleanna; Marks, Jordan D.; Roe, Allyson D.; Commins, Caitlin; Fan, Zhanyun; Calvo-Rodriguez, Maria; Wegmann, Susanne; Hudry, Eloise; Hyman, Bradley T.] Harvard Med Sch, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Alzheimers Dis Res Lab, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Hyman, BT (corresponding author), MassGen Inst Neurodegenerat Dis, Alzheimers Dis Res Lab, 114 16th St, Charlestown, MA 02129 USA.	BHYMAN@mgh.harvard.edu	Calvo-Rodriguez, Maria/B-9308-2019	Calvo-Rodriguez, Maria/0000-0001-6947-5547; Kara, Eleanna/0000-0001-5428-6743	EMBO Long-Term Fellowship [ATLF-815-2014]; Marie Curie Actions of the European Commission (LTFCOFUND2013) [GA-2013-609409]; JPB Foundation; F Prime; Abbvie; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020936, S10RR023440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG047336] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012027, S10OD016372] Funding Source: NIH RePORTER	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Actions of the European Commission (LTFCOFUND2013); JPB Foundation; F Prime; Abbvie(AbbVie); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by EMBO Long-Term Fellowship ATLF-815-2014, which is co-funded by the Marie Curie Actions of the European Commission (LTFCOFUND2013, GA-2013-609409) (to E. K.) and the JPB Foundation (to B. T. H.). This work was also supported by a grant from F Prime. Financial support was partially obtained from a sponsored research agreement from Abbvie. Abbvie was not involved in assay design, data acquisition, data analysis, preparation of the manuscript or decision to publish the results. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arbel-Ornath M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0169-9; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Bentley NM, 2002, BIOCHEM J, V366, P273, DOI 10.1042/BJ20020207; Chan W, 1996, BIOCHEMISTRY-US, V35, P7123, DOI 10.1021/bi952852v; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Drzezga A, 2009, NEUROLOGY, V72, P1487, DOI 10.1212/WNL.0b013e3181a2e8d0; Esbjorner EK, 2014, CHEM BIOL, V21, P732, DOI 10.1016/j.chembiol.2014.03.014; Golabek AA, 1996, J BIOL CHEM, V271, P10602, DOI 10.1074/jbc.271.18.10602; Grimmer T, 2010, BIOL PSYCHIAT, V68, P879, DOI 10.1016/j.biopsych.2010.05.013; Gylys KH, 2003, J NEUROCHEM, V84, P1442, DOI 10.1046/j.1471-4159.2003.01643.x; Hahn S, 2011, J NEUROCHEM, V116, P385, DOI 10.1111/j.1471-4159.2010.07118.x; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hudry E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007000; Hudry E, 2012, J NEUROSCI, V32, P3176, DOI 10.1523/JNEUROSCI.6439-11.2012; Irizarry MC, 2000, ANN NY ACAD SCI, V920, P171; Jones PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014586; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Kara E, 2017, J BIOL CHEM, V292, P14720, DOI 10.1074/jbc.M117.784264; Kim J, 2012, J EXP MED, V209, P2149, DOI 10.1084/jem.20121274; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; KOO EH, 1994, J BIOL CHEM, V269, P17386; LaDu MJ, 1997, J NEUROSCI RES, V49, P9, DOI 10.1002/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Liao F, 2014, J NEUROSCI, V34, P7281, DOI 10.1523/JNEUROSCI.0646-14.2014; Manelli AM, 2004, J MOL NEUROSCI, V23, P235, DOI 10.1385/JMN:23:3:235; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; NASLUND J, 1995, NEURON, V15, P219, DOI 10.1016/0896-6273(95)90079-9; Pillot T, 1997, EUR J BIOCHEM, V243, P650, DOI 10.1111/j.1432-1033.1997.00650.x; REBECK GW, 1993, NEURON, V11, P575; Sarkar G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097655; Shankar GM, 2011, METHODS MOL BIOL, V670, P33, DOI 10.1007/978-1-60761-744-0_3; Shuvaev VV, 1996, FEBS LETT, V383, P9, DOI 10.1016/0014-5793(96)00206-2; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Tai LM, 2013, J BIOL CHEM, V288, P5914, DOI 10.1074/jbc.M112.442103; Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; UTERMANN G, 1984, HUM GENET, V65, P232, DOI 10.1007/BF00286508; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Wellnitz S, 2005, J NEUROCHEM, V94, P1351, DOI 10.1111/j.1471-4159.2005.03295.x; Welzel AT, 2014, BIOCHEMISTRY-US, V53, P3908, DOI 10.1021/bi5003053; WISNIEWSKI T, 1993, BIOCHEM BIOPH RES CO, V192, P359, DOI 10.1006/bbrc.1993.1423; Wood SJ, 1996, BIOCHEMISTRY-US, V35, P12623, DOI 10.1021/bi961074j; Wood SJ, 1996, CHEM BIOL, V3, P949, DOI 10.1016/S1074-5521(96)90183-0; Wu HY, 2012, J NEUROSCI, V32, P5298, DOI 10.1523/JNEUROSCI.0227-12.2012	48	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13247	13256		10.1074/jbc.RA117.001388	http://dx.doi.org/10.1074/jbc.RA117.001388			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29950521	Green Published, hybrid			2022-12-26	WOS:000442730200023
J	Shridas, P; De Beer, MC; Webb, NR				Shridas, Preetha; De Beer, Maria C.; Webb, Nancy R.			High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABDOMINAL AORTIC-ANEURYSM; ACUTE-PHASE PROTEIN; PEPTIDE RECEPTOR 2; PERITONEAL-MACROPHAGES; CHOLESTEROL CRYSTALS; NALP3 INFLAMMASOME; PHYSIOLOGICAL-ROLE; CCL2 PRODUCTION; ROS PRODUCTION; CUTTING EDGE	Serum amyloid A (SAA) is a high-density apolipoprotein whose plasma levels can increase more than 1000-fold during a severe acute-phase inflammatory response and are more modestly elevated in chronic inflammation. SAA is thought to play important roles in innate immunity, but its biological activities have not been completely delineated. We previously reported that SAA deficiency protects mice from developing abdominal aortic aneurysms (AAAs) induced by chronic angiotensin II (AngII) infusion. Here, we report that SAA is required for AngII-induced increases in interleukin-1 beta (IL-1 beta), a potent proinflammatory cytokine that is tightly controlled by the Nod-like receptor protein 3 (NLRP3) inflammasome and caspase-1 and has been implicated in both human and mouse AAAs. We determined that purified SAA stimulates IL-1 beta secretion in murine J774 and bone marrow-derived macrophages through a mechanism that depends on NLRP3 expression and caspase-1 activity, but is independent of P2X7 nucleotide receptor (P2X7R) activation. Inhibiting reactive oxygen species (ROS) by N-acetyl-L-cysteine or mito-TEMPO and inhibiting activation of cathepsin B by CA-074 blocked SAA-mediated inflammasome activation and IL-1 beta secretion. Moreover, inhibiting cellular potassium efflux with glyburide or increasing extracellular potassium also significantly reduced SAA-mediated IL-1 beta secretion. Of note, incorporating SAA into high-density lipoprotein (HDL) prior to its use in cell treatments completely abolished its ability to stimulate ROS generation and inflammasome activation. These results provide detailed insights into SAA-mediated IL-1 beta production and highlight HDL's role in regulating SAA's proinflammatory effects.	[Shridas, Preetha] Univ Kentucky, Dept Internal Med, 537 CT Wethington Bldg,900 S Limestone St, Lexington, KY 40536 USA; [De Beer, Maria C.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [De Beer, Maria C.; Webb, Nancy R.] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA; [Webb, Nancy R.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Shridas, Preetha; De Beer, Maria C.; Webb, Nancy R.] Univ Kentucky, Barnstable Brown Diabet Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Shridas, P (corresponding author), Univ Kentucky, Dept Internal Med, 537 CT Wethington Bldg,900 S Limestone St, Lexington, KY 40536 USA.	pshri2@uky.edu	Webb, Nancy/AAL-7030-2021	shridas, Preetha/0000-0002-2532-4007	National Institutes of Health [HL134731]; Institutional Development Award (IDeA), National Institute of Health NIGMS [P20 GM103527]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL134731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527, P30GM127211] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Development Award (IDeA), National Institute of Health NIGMS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant HL134731 (to N. R. W) and Institutional Development Award (IDeA), National Institute of Health NIGMS Grant P20 GM103527. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amstad PA, 2001, BIOTECHNIQUES, V31, P608, DOI 10.2144/01313pf01; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Anderberg RJ, 2015, LAB INVEST, V95, P250, DOI 10.1038/labinvest.2014.163; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bjorkman L, 2008, J LEUKOCYTE BIOL, V83, P245, DOI 10.1189/jlb.0607-408; Bjorkman L, 2010, ARTHRITIS RHEUM-US, V62, P1660, DOI 10.1002/art.27440; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; Calero C, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-95; Chen MJ, 2014, IMMUNOBIOLOGY, V219, P916, DOI 10.1016/j.imbio.2014.08.002; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Claus S, 2017, EMBO REP, V18, P1352, DOI 10.15252/embr.201643411; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Connolly M, 2010, J IMMUNOL, V184, P6427, DOI 10.4049/jimmunol.0902941; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; de Beer MC, 2010, J LIPID RES, V51, P3117, DOI 10.1194/jlr.M005413; DEBEER MC, 1995, J LIPID RES, V36, P526; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Gombault A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00414; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Han CY, 2016, J CLIN INVEST, V126, P796, DOI 10.1172/JCI86401; Hatanaka E, 2011, CLIN EXP IMMUNOL, V163, P362, DOI 10.1111/j.1365-2249.2010.04300.x; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Jabaut J, 2013, FREE RADICAL BIO MED, V60, P233, DOI 10.1016/j.freeradbiomed.2013.01.025; Jayaraman S, 2015, J LIPID RES, V56, P1531, DOI 10.1194/jlr.M059162; Jin CC, 2011, P NATL ACAD SCI USA, V108, P14867, DOI 10.1073/pnas.1111101108; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Johnston WF, 2014, CIRCULATION, V130, pS51, DOI 10.1161/CIRCULATIONAHA.113.006800; Johnston WF, 2013, ARTERIOSCL THROM VAS, V33, P294, DOI 10.1161/ATVBAHA.112.300432; Juvonen J, 1997, ARTERIOSCL THROM VAS, V17, P2843, DOI 10.1161/01.ATV.17.11.2843; Kim MH, 2013, CYTOKINE, V61, P506, DOI 10.1016/j.cyto.2012.10.019; Kluve-Beckerman B, 1999, AM J PATHOL, V155, P123, DOI 10.1016/S0002-9440(10)65107-3; Kluve-Beckerman B, 2001, SCAND J IMMUNOL, V53, P393, DOI 10.1046/j.1365-3083.2001.00879.x; KLUVEBECKERMAN B, 1991, DNA CELL BIOL, V10, P651, DOI 10.1089/dna.1991.10.651; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee HY, 2008, J IMMUNOL, V181, P4332, DOI 10.4049/jimmunol.181.6.4332; Lee HY, 2010, EXP MOL MED, V42, P302, DOI 10.3858/emm.2010.42.4.029; Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lopez-Campos JL, 2013, INT J MED SCI, V10, P938, DOI 10.7150/ijms.6152; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; Migita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096703; Navab Mohamad, 2007, Curr Atheroscler Rep, V9, P244, DOI 10.1007/s11883-007-0026-3; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Pannell M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0735-z; Patel MN, 2017, TRENDS MOL MED, V23, P165, DOI 10.1016/j.molmed.2016.12.007; Patke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064974; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; PRECIADOPATT L, 1994, EUR J BIOCHEM, V223, P35, DOI 10.1111/j.1432-1033.1994.tb18963.x; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ren SW, 2014, INT J OPHTHALMOL-CHI, V7, P187, DOI 10.3980/j.issn.2222-3959.2014.02.01; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Roberts RL, 2011, ATHEROSCLEROSIS, V218, P123, DOI 10.1016/j.atherosclerosis.2011.04.043; Rocken C, 2005, ANN RHEUM DIS, V64, P808, DOI 10.1136/ard.2004.030429; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Simons JP, 2013, P NATL ACAD SCI USA, V110, P16115, DOI 10.1073/pnas.1306621110; Song CJ, 2009, ATHEROSCLEROSIS, V207, P374, DOI 10.1016/j.atherosclerosis.2009.05.007; Srinivasan S, 2013, J BIOL CHEM, V288, P2744, DOI 10.1074/jbc.M112.394155; STRACHAN AF, 1989, BIOCHEM J, V263, P365, DOI 10.1042/bj2630365; Sun WL, 2015, J MOL CELL CARDIOL, V81, P96, DOI 10.1016/j.yjmcc.2015.02.005; Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200; Tannock LR, 2018, J LIPID RES, V59, P339, DOI 10.1194/jlr.M080887; Thacker SG, 2016, IMMUNOLOGY, V149, P306, DOI 10.1111/imm.12638; Tolle M, 2012, CARDIOVASC RES, V94, P154, DOI 10.1093/cvr/cvs089; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Usui F, 2015, ARTERIOSCL THROM VAS, V35, P127, DOI 10.1161/ATVBAHA.114.303763; van den Brand B, 2013, ARTHRITIS RHEUM-US, V65, P283, DOI 10.1002/art.37737; Webb NR, 2015, ARTERIOSCL THROM VAS, V35, P1156, DOI 10.1161/ATVBAHA.114.304776; Witting PK, 2011, FREE RADICAL BIO MED, V51, P1390, DOI 10.1016/j.freeradbiomed.2011.06.031; Wu D, 2017, ARTERIOSCL THROM VAS, V37, P694, DOI 10.1161/ATVBAHA.116.307648	80	42	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13257	13269		10.1074/jbc.RA118.002428	http://dx.doi.org/10.1074/jbc.RA118.002428			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29976759	Green Published, hybrid			2022-12-26	WOS:000442730200024
J	Li, WJ; Nie, L; Zhang, TW				Li, Wenjun; Nie, Lei; Zhang, Tianwei			Electric multiple unit circulation plan optimization based on the branch-and-price algorithm under different maintenance management schemes	PLOS ONE			English	Article							RAILWAY ROLLING STOCK; COLUMN GENERATION	For railway operators, one of many important goals is to improve the utilization efficiency of electric multiple units (EMUs). When operators design EMU circulation plans, EMU type restrictions are critical factors when assigning EMUs to the correct depots for maintenance. However, existing studies only consider that EMUs are maintained at their home depots. However, targeting that problem, in this paper, an optimization model for the EMU circulation planning problem that allows depots to be selected for EMU maintenance is proposed. This model aims at optimizing the number of used EMUs and the number of EMU maintenance tasks and simultaneously incorporates other important constraints, including type restrictions, on EMU maintenance and night accommodation capacity at depots. In order to solve the model, a branch-and-price algorithm is also developed. A case study of a realworld high-speed railway was conducted to compare and analyze the effects of different maintenance location constraints. The results show that the number of EMUs used will decrease under the maintenance sharing scheme, the number of EMU maintenance tasks can be reduced, and the time occupied in EMU maintenance will be released. In addition, the scheme of maintenance resources sharing and increases to mileage limits can effectively decrease the number of EMU maintenance tasks significantly. The model and algorithm can be used as an effective quantitative analysis tool for railway operators' decision-making processes in the EMU circulation planning problem.	[Li, Wenjun; Nie, Lei] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China; [Zhang, Tianwei] Shijiazhuang Tiedao Univ, Sch Traff & Transportat, Shijiazhuang, Hebei, Peoples R China	Beijing Jiaotong University; Shijiazhuang Tiedao University	Nie, L (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China.	lnie8509@yahoo.com			project entitled "EMU Circulation and Operation Plan for Optimizing the High Speed Railway" [2013X014-C]; National Natural Science Foundation of China [U1434207]; Science and Technology Department of the China Railway Corporation [2011X014-E]; Hebei Province University Science and Technology Research Project [QN2015154]	project entitled "EMU Circulation and Operation Plan for Optimizing the High Speed Railway"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of the China Railway Corporation; Hebei Province University Science and Technology Research Project	This research is jointly supported by the project entitled "EMU Circulation and Operation Plan for Optimizing the High Speed Railway" (grant no. 2013X014-C to L.N.), the National Natural Science Foundation of China (grant no. U1434207 to W.L.), the Science and Technology Department of the China Railway Corporation (grant no. 2011X014-E to L.N.), and Hebei Province University Science and Technology Research Project (grant no. QN2015154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Barnhart C, 1998, OPER RES, V46, P316, DOI 10.1287/opre.46.3.316; Budai G, 2010, J SCHEDULING, V13, P281, DOI 10.1007/s10951-009-0133-9; Cacchiani V, 2013, DISCRETE APPL MATH, V161, P1707, DOI 10.1016/j.dam.2011.10.035; Cacchiani V, 2012, TRANSPORT SCI, V46, P217, DOI 10.1287/trsc.1110.0388; Cadarso L, 2011, COMPUT OPER RES, V38, P1131, DOI 10.1016/j.cor.2010.10.029; Chen Ran, 2016, China Railway Science, V37, P108, DOI 10.3969/j.issn.1001-4632.2016.01.15; Desrosiers J, 2005, PRIMER COLUMN GENERA, P1; He B, 2014, CN RAILWAY SCI, V35, P0122; Hong SP, 2009, OMEGA-INT J MANAGE S, V37, P637, DOI 10.1016/j.omega.2008.03.003; Lin ZY, 2016, TRANSPORT RES B-METH, V94, P97, DOI 10.1016/j.trb.2016.09.007; Lubbecke ME, 2005, OPER RES, V53, P1007, DOI 10.1287/opre.1050.0234; Nielsen LK, 2012, EUR J OPER RES, V220, P496, DOI 10.1016/j.ejor.2012.01.037; Peeters M, 2008, COMPUT OPER RES, V35, P538, DOI 10.1016/j.cor.2006.03.019; Tsuji Y, 2012, 2012 IEEE/SICE INTERNATIONAL SYMPOSIUM ON SYSTEM INTEGRATION (SII), P716, DOI 10.1109/SII.2012.6427319; Wang Zhongkai, 2012, China Railway Science, V33, P102, DOI 10.3969/j.issn.1001-4632.2012.03.17; Wolsey L.A., 1998, INTEGER PROGRAMMING	17	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199910	10.1371/journal.pone.0199910	http://dx.doi.org/10.1371/journal.pone.0199910			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979743	Green Submitted, gold, Green Published			2022-12-26	WOS:000437809500043
J	Lippi, G; Cadamuro, J; Danese, E; Gelati, M; Montagnana, M; von Meyer, A; Salvagno, GL; Simundic, AM				Lippi, Giuseppe; Cadamuro, Janne; Danese, Elisa; Gelati, Matteo; Montagnana, Martina; von Meyer, Alexander; Salvagno, Gian Luca; Simundic, Ana-Maria			Internal quality assurance of HIL indices on Roche Cobas c702	PLOS ONE			English	Article							HEMOLYSIS INDEX	Automatic assessment of hemoglobin (H), lipaemia (L) and icterus (I) in serum or plasma (HIL indices) is the mainstay for evaluating sample quality. We planned this study to verify whether in-house prepared internal quality control (IQC) materials may be suitable for quality assurance of HIL indices. Pools containing different values of each of the three HIL indices were prepared from routine plasma samples, divided in aliquots and frozen at -20 degrees C. Stability of frozen materials was assessed by thawing one aliquot of each pool after different days of freezing (1, 4, 8, 15, 22 and 29), and by measuring HIL indices on baseline fresh samples and frozen-thawed aliquots with Roche Cobas c702. Five fresh liquid IQCs materials were also measured at the same time points. Intra-assay and inter-assay imprecision of HIL indices calculated with commercial IQC materials ranged between 1.1-2.0% and 1.6-3.3%, respectively. When target values of HIL indices were calculated using frozen-thawed aliquots, the inter-assay imprecision of in-house prepared materials was optimal, even better than that of commercial liquid IQCs (H-index, 0.8% versus 1.6%; L-index, 2.2% versus 2.5%; I-index, 0.8% versus 3.3%). In conclusion, in-house prepared IQC materials are cost-effective alternatives to commercial liquid IQCs for HIL quality assurance.	[Lippi, Giuseppe; Danese, Elisa; Gelati, Matteo; Montagnana, Martina; Salvagno, Gian Luca] Univ Verona, Clin Biochem Sect, Verona, Italy; [Cadamuro, Janne] Paracelsus Med Univ, Dept Lab Med, Salzburg, Austria; [von Meyer, Alexander] Kliniken Nordoberpfalz AG, Inst Lab Med, Weiden, Germany; [von Meyer, Alexander] Klinikum St Marien, Inst Lab Med, Amberg, Germany; [Simundic, Ana-Maria] Univ Hosp Sveti Duh, Dept Med Lab Diagnost, Zagreb, Croatia	University of Verona; Paracelsus Private Medical University	Danese, E (corresponding author), Univ Verona, Clin Biochem Sect, Verona, Italy.	elisa.danese@univr.it	Gelati, Matteo/AAR-1692-2020; Lippi, Giuseppe/X-7198-2018; Salvagno, Gian Luca/R-3857-2016	Lippi, Giuseppe/0000-0001-9523-9054; SALVAGNO, GIAN LUCA/0000-0003-0487-9051; Danese, Elisa/0000-0002-2454-0410				Antonelli G, 2017, CLIN CHEM LAB MED, V55, P1501, DOI 10.1515/cclm-2016-0894; CLSI guideline EP05-A3, 2018, CLSI DOCUMENT EP05 A, V3rd Ed; Dimeski G., 2008, REV AUST ASS CLIN S1, V29, pS43; Dolci A, 2014, CLIN CHIM ACTA, V432, P38, DOI 10.1016/j.cca.2013.10.012; Farrell CJL, 2016, ANN CLIN BIOCHEM, V53, P527, DOI 10.1177/0004563216643557; FRASER CG, 1980, CRC CR REV CL LAB SC, V12, P59, DOI 10.3109/10408368009108726; Gabaj NN, 2018, CLIN CHEM LAB MED, V56, P776, DOI 10.1515/cclm-2017-0889; Gils C, 2017, J APPL LAB MED, V1, P450, DOI 10.1373/jalm.2016.021972; KRONENBERG F, 1994, J LIPID RES, V35, P1318; Lippi G, 2018, BLOOD TRANSFUS-ITALY, V16, P433, DOI 10.2450/2018.0045-18; Lippi G, 2018, CLIN CHEM LAB MED, V56, P718, DOI 10.1515/cclm-2017-1104; Lippi G, 2018, CLIN BIOCHEM, V54, P112, DOI 10.1016/j.clinbiochem.2018.02.018; Lippi G, 2018, CLIN CHEM LAB MED, V56, P513, DOI 10.1515/cclm-2017-0867; Lippi G, 2017, CLIN CHEM LAB MED, V55, P962, DOI 10.1515/cclm-2016-0810; Lippi G, 2010, BIOCHEM MEDICA, V20, P5, DOI 10.11613/BM.2010.001; Lippi G, 2009, CLIN CHEM LAB MED, V47, P934, DOI 10.1515/CCLM.2009.218; Miller WG, 2018, CLIN CHEM, V64, P447, DOI 10.1373/clinchem.2017.277525; Miller WG, 2011, CLIN CHEM, V57, P76, DOI 10.1373/clinchem.2010.148106; Petrova DT, 2013, CLIN BIOCHEM, V46, P1298, DOI 10.1016/j.clinbiochem.2013.06.018; Plebani M, 2009, CLIN CHEM LAB MED, V47, P899, DOI 10.1515/CCLM.2009.229; Sciacovelli L, 2007, CLIN CHEM LAB MED, V45, P756, DOI 10.1515/CCLM.2007.165; Smith MB., 2012, CLIN LAB STAND I, V32, P1; Westgard J., 2009, WESTGARD RULES; Westgard JO, 2003, ANN CLIN BIOCHEM, V40, P593, DOI 10.1258/000456303770367199; Zivkovic AM, 2009, METABOLOMICS, V5, P507, DOI 10.1007/s11306-009-0174-2	25	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200088	10.1371/journal.pone.0200088	http://dx.doi.org/10.1371/journal.pone.0200088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979722	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500057
J	Powell, L; Chia, D; McGreevy, P; Podberscek, AL; Edwards, KM; Neilly, B; Guastella, AJ; Lee, V; Stamatakis, E				Powell, Lauren; Chia, Debbie; McGreevy, Paul; Podberscek, Anthony L.; Edwards, Kate M.; Neilly, Brendon; Guastella, Adam J.; Lee, Vanessa; Stamatakis, Emmanuel			Expectations for dog ownership: Perceived physical, mental and psychosocial health consequences among prospective adopters	PLOS ONE			English	Article							COMPANION ANIMALS; BEHAVIOR PROBLEMS; PET OWNERSHIP; AGGRESSIVE-BEHAVIOR; ATTACHMENT; RELINQUISHMENT; ASSOCIATION; AUSTRALIA; SHELTERS; FRIENDS	Dog ownership is popular worldwide, with most human-dog dyads forming successful attachment bonds. However, millions of dogs are surrendered to animal shelters annually, possibly due to mismatches between owner expectations and the realities of dog ownership. The aim of the current study was to explore the benefits and challenges people expect from dog ownership and how these expectations vary with previous ownership history. An Australian-wide sample of 3465 prospective adopters completed a self-administered online questionnaire about the physical, mental and psychosocial health benefits and challenges they associated with dog ownership. Among the potential benefits, respondents expected increased walking (89%), happiness (89%) and companionship (61%) and decreased stress (74%) and loneliness (61%). Among the challenges, they expected increased responsibility (64%) and dog training (62%). Ownership history influenced respondents' expectations, with previous/current dog owners having consistently greater odds of expecting benefits and reduced odds of expecting challenges than non-owners. A possible explanation is that previous/current dog owners' exhibit bias when considering dog ownership by selectively recalling positive experiences from previous ownership. Our findings support the need for education of prospective dog owners to ensure their expectations align with the reality of ownership, based on current scientific evidence.	[Powell, Lauren; Chia, Debbie; Lee, Vanessa; Stamatakis, Emmanuel] Univ Sydney, Sydney Sch Publ Hlth, Fac Med & Hlth, Charles Perkins Ctr,Prevent Res Collaborat, Sydney, NSW, Australia; [McGreevy, Paul] Univ Sydney, Sydney Sch Vet Sci, Sydney, NSW, Australia; [Podberscek, Anthony L.] Univ Sydney, Sydney Sch Vet Sci, Charles Perkins Ctr, Sydney, NSW, Australia; [Edwards, Kate M.] Univ Sydney, Charles Perkins Ctr, Fac Hlth Sci, Sydney, NSW, Australia; [Neilly, Brendon] Royal Soc Prevent Cruelty Anim RSPCA NSW, Sydney, NSW, Australia; [Guastella, Adam J.] Univ Sydney, Autism Clin Translat Res, Brain & Mind Ctr, Cent Clin Sch,Sydney Med Sch, Camperdown, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Powell, L (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Fac Med & Hlth, Charles Perkins Ctr,Prevent Res Collaborat, Sydney, NSW, Australia.	lauren.powell@sydney.edu.au	Stamatakis, Emmanuel/C-4958-2009; Edwards, Kate M/A-2609-2013	Stamatakis, Emmanuel/0000-0001-7323-3225; Edwards, Kate M/0000-0003-3429-5989; Chia, Debbie/0000-0001-7711-6202; McGreevy, Paul/0000-0001-7220-8378; Podberscek, Anthony/0000-0001-7692-8057	 [183100]		This work was supported by a research donation offered by Ms Lynne Cattell [grant ID: 183100] (ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 2002, PSYCHOSOM MED, V64, P727, DOI 10.1097/01.PSY.0000024236.11538.41; American Society for the Prevention of Cruelty to Animals (ASPCA), 2017, SHELT INT SURR PET S; Animal Medicines Australia, 2016, PET OWN AUSTR 2016; Bao KJ, 2016, ANTHROZOOS, V29, P283, DOI 10.1080/08927936.2016.1152721; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; Chia Debbie, 2018, BMC Res Notes, V11, P169, DOI 10.1186/s13104-018-3277-x; Christensen E, 2007, APPL ANIM BEHAV SCI, V106, P85, DOI 10.1016/j.applanim.2006.07.002; Christian HE, 2013, J PHYS ACT HEALTH, V10, P750, DOI 10.1123/jpah.10.5.750; Chua D, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7070050; Coe JB, 2014, J APPL ANIM WELF SCI, V17, P253, DOI 10.1080/10888705.2014.899910; Col R, 2016, J VET BEHAV, V15, P1, DOI 10.1016/j.jveb.2016.07.001; Dall PM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4422-5; Diesel G, 2010, J APPL ANIM WELF SCI, V13, P15, DOI 10.1080/10888700903369255; DiGiacomo N, 1998, ANTHROZOOS, V11, P41, DOI 10.2752/089279398787000878; El-Alayli A, 2006, BASIC APPL SOC PSYCH, V28, P131, DOI 10.1207/s15324834basp2802_3; ENDENBURG N, 1994, J ECON PSYCHOL, V15, P191, DOI 10.1016/0167-4870(94)90037-X; Fiocco AJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070707; GfK, 2016, GLOB GFK SURV PET OW; Gilbey A, 2015, ANTHROZOOS, V28, P181, DOI 10.2752/089279315X14219211661615; Gillum RF, 2010, INT J ENV RES PUB HE, V7, P2452, DOI 10.3390/ijerph7062452; Ramirez MTG, 2014, J VET BEHAV, V9, P311, DOI 10.1016/j.jveb.2014.08.002; Hemy M, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7090067; Jagoe A, 1996, APPL ANIM BEHAV SCI, V47, P31, DOI 10.1016/0168-1591(95)01008-4; Kerswell KJ, 2013, ANTHROZOOS, V26, P5, DOI 10.2752/175303713X13534238631317; Kobelt AJ, 2003, APPL ANIM BEHAV SCI, V82, P137, DOI 10.1016/S0168-1591(03)00062-5; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Kwan JY, 2013, J APPL ANIM WELF SCI, V16, P168, DOI 10.1080/10888705.2013.768923; Lambert K, 2015, PREV VET MED, V118, P148, DOI 10.1016/j.prevetmed.2014.11.002; Levine GN, 2013, CIRCULATION, V127, P2353, DOI 10.1161/CIR.0b013e31829201e1; Marder A, 2008, VET CLIN N AM-SMALL, V38, P1145, DOI 10.1016/j.cvsm.2008.04.011; Marston LC, 2003, APPL ANIM BEHAV SCI, V83, P227, DOI 10.1016/S0168-1591(03)00135-7; McGreevy P, 2017, VET J; McNicholas J, 2000, BRIT J PSYCHOL, V91, P61, DOI 10.1348/000712600161673; Meyer I, 2014, J VET BEHAV, V9, P143, DOI 10.1016/j.jveb.2014.03.002; Mondelli Francesca, 2004, Journal of Applied Animal Welfare Science, V7, P253, DOI 10.1207/s15327604jaws0704_3; Mubanga M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16118-6; Neidhart Laura, 2002, Journal of Applied Animal Welfare Science, V5, P175, DOI 10.1207/S15327604JAWS0503_02; New J. C. Jr., 2000, Journal of Applied Animal Welfare Science, V3, P179, DOI 10.1207/S15327604JAWS0303_1; O'Connor R, 2017, SOC ANIM, V25, P362, DOI 10.1163/15685306-12341451; O'Connor R, 2016, J APPL ANIM WELF SCI, V19, P157, DOI 10.1080/10888705.2015.1125295; Payne E, 2015, PSYCHOL RES BEHAV MA, V8, P71, DOI 10.2147/PRBM.S74972; Perez-Guisado J, 2009, J ANIM VET ADV, V8, P336; Podberscek AL, 1997, APPL ANIM BEHAV SCI, V52, P215, DOI 10.1016/S0168-1591(96)01124-0; Polheber JP, 2014, J BEHAV MED, V37, P860, DOI 10.1007/s10865-013-9546-1; RSPCA Australia, 2007, WALK THE DOG; Salman M D, 1998, J Appl Anim Welf Sci, V1, P207, DOI 10.1207/s15327604jaws0103_2; Salman M. D., 2000, Journal of Applied Animal Welfare Science, V3, P93, DOI 10.1207/S15327604JAWS0302_2; Salmon J, 2010, RES Q EXERCISE SPORT, V81, P264; Scarlett J M, 1999, J Appl Anim Welf Sci, V2, P41, DOI 10.1207/s15327604jaws0201_4; SERPELL J, 1991, J ROY SOC MED, V84, P717, DOI 10.1177/014107689108401208; Stamatakis E, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0280-7; Tami G, 2009, APPL ANIM BEHAV SCI, V120, P159, DOI 10.1016/j.applanim.2009.06.009; Torske MO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179832; Wu Y-T, 2017, J EPIDEMIOLOGY COMMU	54	26	26	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200276	10.1371/journal.pone.0200276	http://dx.doi.org/10.1371/journal.pone.0200276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM1FJ	29979749	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500088
J	Tydecks, L; Jeschke, JM; Wolf, M; Singer, G; Tockner, K				Tydecks, Laura; Jeschke, Jonathan M.; Wolf, Max; Singer, Gabriel; Tockner, Klement			Spatial and topical imbalances in biodiversity research	PLOS ONE			English	Article							CHALLENGES; EXTINCTION; THREATS	The rapid erosion of biodiversity is among the biggest challenges human society is facing. Concurrently, major efforts are in place to quantify changes in biodiversity, to understand the consequences for ecosystem functioning and human wellbeing, and to develop sustainable management strategies. Based on comprehensive bibliometric analyses covering 134,321 publications, we report systematic spatial biases in biodiversity-related research. Research is dominated by wealthy countries, while major research deficits occur in regions with disproportionately high biodiversity as well as a high share of threatened species. Similarly, core scientists, who were assessed through their publication impact, work primarily in North America and Europe. Though they mainly exchange and collaborate across locations of these two continents, the connectivity among them has increased with time. Finally, biodiversity-related research has primarily focused on terrestrial systems, plants, and the species level, and is frequently conducted in Europe and Asia by researchers affiliated with European and North American institutions. The distinct spatial imbalances in biodiversity research, as demonstrated here, must be filled, research capacity built, particularly in the Global South, and spatially-explicit biodiversity data bases improved, curated and shared.	[Tydecks, Laura; Jeschke, Jonathan M.; Wolf, Max; Singer, Gabriel; Tockner, Klement] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany; [Tydecks, Laura; Jeschke, Jonathan M.; Tockner, Klement] Free Univ Berlin, Inst Biol, Berlin, Germany; [Jeschke, Jonathan M.; Tockner, Klement] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany; [Tockner, Klement] Wissenschaftsfond FWF, Vienna, Austria	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Free University of Berlin	Tydecks, L (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany.; Tydecks, L (corresponding author), Free Univ Berlin, Inst Biol, Berlin, Germany.	tydecks@igb-berlin.de	Jeschke, Jonathan M/A-2707-2008; Singer, Gabriel/C-6285-2012	Jeschke, Jonathan M/0000-0003-3328-4217; Singer, Gabriel/0000-0002-7389-9788; Wolf, Max/0000-0001-8878-0504	Deutsche Forschungsgemeinschaft (DFG) [JE 288/9-1]; Cross-Cutting Research Domain Aquatic Biodiversity of the Leibniz-Institute of Freshwater Ecology and Inland Fisheries (IGB); Leibniz Open Access Publishing Fund	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cross-Cutting Research Domain Aquatic Biodiversity of the Leibniz-Institute of Freshwater Ecology and Inland Fisheries (IGB); Leibniz Open Access Publishing Fund	JMJ received financial support from the Deutsche Forschungsgemeinschaft (DFG; JE 288/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Anna Koska for collecting data on core scientists, and the participants of the workshop 'Scientific Writing' at the Leibniz-Institute of Freshwater Ecology and Inland Fisheries for helpful discussion in an early stage of the manuscript. JMJ received financial support from the Deutsche Forschungsgemeinschaft (DFG; JE 288/9-1). The publication of this article was supported by the Cross-Cutting Research Domain Aquatic Biodiversity of the Leibniz-Institute of Freshwater Ecology and Inland Fisheries (IGB) and the Leibniz Open Access Publishing Fund. We are very grateful for the comments by Maud Bernard-Verdier, Thomas Mehner and an anonymous reviewer.	Ahrends A, 2011, DIVERS DISTRIB, V17, P191, DOI 10.1111/j.1472-4642.2010.00737.x; AmphibiaWeb, 2014, AMPHIBIAWEB INF AMPH; Baron JS, 2017, BIOSCIENCE, V67, P750, DOI 10.1093/biosci/bix053; Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; Bellard C, 2016, CONSERV BIOL, V30, P230, DOI 10.1111/cobi.12611; BirdLife International, 2014, COUNTR PROF; Boshoff N, 2009, SCIENTOMETRICS, V81, P413, DOI 10.1007/s11192-008-2211-8; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Collen B, 2004, GLOBAL ECOL BIOGEOGR, V13, P459, DOI 10.1111/j.1466-822X.2004.00121.x; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Dorai-Raj S, 2014, BINOM BINOMIAL CONDE; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; Fleming PA, 2016, MAMMAL REV, V46, P241, DOI 10.1111/mam.12066; France Robert, 1998, Diversity and Distributions, V4, P77, DOI 10.1046/j.1472-4642.1998.00018.x; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Grandjean P, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-96; Habel JC, 2014, BIODIVERS CONSERV, V23, P3143, DOI 10.1007/s10531-014-0761-z; Harrison AL, 2006, CONSERV BIOL, V20, P652, DOI 10.1111/j.1523-1739.2006.00448.x; Harvey E, 2017, J APPL ECOL, V54, P371, DOI 10.1111/1365-2664.12769; Hassan R, 2005, ECOSYSTEMS HUMAN WEL, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Hendriks IE, 2008, J EXP MAR BIOL ECOL, V360, P15, DOI 10.1016/j.jembe.2008.03.004; Huggel C, 2016, NAT CLIM CHANGE, V6, P901, DOI 10.1038/NCLIMATE3104; IUCN, IUCN RED LIST THREAT; Jackson MC, 2016, ADV ECOL RES, V55, P615, DOI 10.1016/bs.aecr.2016.08.008; Jeschke JM, 2012, FRONT ECOL ENVIRON, V10, P349, DOI 10.1890/12.WB.016; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Jongman R.H.G., 2017, GEO HDB BIODIVERSITY, P19, DOI [10.1007/978-3-319-27288-7_2, DOI 10.1007/978-3-319-27288-7_2]; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; LAPIN M, 1995, CONSERV BIOL, V9, P1148, DOI 10.1046/j.1523-1739.1995.9051134.x-i1; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; LUUKKONEN T, 1992, SCI TECHNOL HUM VAL, V17, P101, DOI 10.1177/016224399201700106; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Meyer C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9221; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; Pasgaard M, 2015, GLOBAL ENVIRON CHANG, V35, P279, DOI 10.1016/j.gloenvcha.2015.09.018; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pond R, 2007, PAP REG SCI, V86, P423, DOI 10.1111/j.1435-5957.2007.00126.x; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; QGIS Development Team, 2015, QGIS GEOGR INF SYST; R Core Team, 2013, R LANG ENV STAT COMP; Reichman OJ, 2011, SCIENCE, V331, P703, DOI 10.1126/science.1197962; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Rozsa L, 2015, ORYX, V49, P107, DOI 10.1017/S0030605313000628; Scholes R.J., 2017, GEO HDB BIODIVERSITY, P1, DOI [10.1007/978-3-319-27288-7_1, DOI 10.1007/978-3-319-27288-7_1]; Strayer DL, 2006, J N AM BENTHOL SOC, V25, P271, DOI 10.1899/0887-3593(2006)25[271:CFFIC]2.0.CO;2; The World Bank, 2015, TERR MAR PROT AR; Vaidyanathan R., 2013, RCHARTS INTERACTIVE; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; Willis KJ, 2005, TRENDS ECOL EVOL, V20, P107, DOI 10.1016/j.tree.2004.12.003; WWF. [World Wildlife Fund], LIST OF EC	55	35	36	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199327	10.1371/journal.pone.0199327	http://dx.doi.org/10.1371/journal.pone.0199327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL7YG	29975719	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500028
J	Hedderson, MM; Xu, F; Sridhar, SB; Han, ES; Quesenberry, CP; Crites, Y				Hedderson, Monique M.; Xu, Fei; Sridhar, Sneha B.; Han, Emily S.; Quesenberry, Charles P.; Crites, Yvonne			A cohort study of maternal cardiometabolic risk factors and primary cesarean delivery in an integrated health system	PLOS ONE			English	Article							US ADULTS; PREPREGNANCY OVERWEIGHT; NULLIPAROUS WOMEN; OBESITY; POPULATION; TRENDS; PREVALENCE; WEIGHT; ASSOCIATION; IMPACT	Background Maternal cardiometabolic risk factors (i.e., hyperglycemia, pre-existing hypertension and high body mass index) impact fetal growth and risk of having a cesarean delivery. However, the independent and joint contribution of maternal cardiometabolic risk factors to primary cesarean section is unclear. We aimed to elucidate the degree to which maternal cardiometabolic risk factors contribute to primary cesarean deliveries and whether associations vary by infant size at birth in an integrated health system. Methods A cohort study of 185,045 singleton livebirths from 2001 to 2010. Poisson regression with robust standard errors provided crude and adjusted relative risks (RR) and 95% confidence intervals (CIs) for cesarean delivery risk associated with risk factors. We then estimated the proportion of cesarean sections that could be prevented if the cardiometabolic risk factor in pregnant women were eliminated (the population-attributable risk [PAR]). Results In a single multivariable model, maternal cardiometabolic risk factors were independently associated with cesarean delivery: RR (95% CI) abnormal glucose screening 1.04 (1.011.08); gestational diabetes 1.18 (1.11-1.18) and pre-existing diabetes 1.60 (1.49-1.71); pre-existing hypertension 1.16 (1.10-1.23); overweight 1.27 (1.24-1.30); obese class I 1.46 (1.42-1.51); obese class II 1.73 (1.67-1.80); and obese class III 1.97 (1.88-2.07); adjusting for established risk factors, medical facility and year. The associations between maternal cardiometabolic risk factors and primary cesarean delivery remained among infants with appropriate weights for gestational age. The PARs were 17.4% for overweight/obesity, 7.0% for maternal hyperglycemia, 2.0% for pre-existing hypertension and 20.5% for any cardiometabolic risk factor. Conclusions Maternal cardiometabolic risk factors were independently associated with risk of primary cesarean delivery, even among women delivering infants born at an appropriate size for gestational age. Effective strategies to increase the proportion of women entering pregnancy at an optimal weight with normal blood pressure and glucose before pregnancy could potentially eliminate up to 20% of cesarean deliveries.	[Hedderson, Monique M.; Xu, Fei; Sridhar, Sneha B.; Han, Emily S.; Quesenberry, Charles P.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA 94611 USA; [Crites, Yvonne] Kaiser Permanente Northern Calif Med Grp, Oakland, CA 94611 USA	Kaiser Permanente	Hedderson, MM (corresponding author), Kaiser Permanente Northern Calif, Div Res, Oakland, CA 94611 USA.	Monique.M.Hedderson@kp.org		Hedderson, Monique/0000-0003-1768-0412	Kaiser Permanente Community Benefit grant	Kaiser Permanente Community Benefit grant	This research was supported by a Kaiser Permanente Community Benefit grant (MMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 2017, EPIDEMIOLOGY, V28, P567, DOI 10.1097/EDE.0000000000000658; [Anonymous], 2011, Obstet Gynecol, V118, P751, DOI 10.1097/AOG.0b013e3182310cc3; Buhimschi CS, 2004, OBSTET GYNECOL, V103, P225, DOI 10.1097/01.AOG.000102706.84063.C7; Clark SL, 1998, AM J OBSTET GYNECOL, V179, P841, DOI 10.1016/S0002-9378(98)70175-9; Commission TJ, SPEC MAN JOINT COMM; Conroy Kelley, 2012, Rev Obstet Gynecol, V5, P69; Crane SS, 1997, OBSTET GYNECOL, V89, P213, DOI 10.1016/S0029-7844(96)00449-8; Dempsey JC, 2005, J MATERN-FETAL NEO M, V17, P179, DOI 10.1080/14767050500073456; Dietz PM, 2005, MATERN CHILD HLTH J, V9, P237, DOI 10.1007/s10995-005-0003-9; Dubay L, 1999, J HEALTH ECON, V18, P491, DOI 10.1016/S0167-6296(99)00004-1; Escobar G J, 1997, Qual Manag Health Care, V5, P19; Ferrara A, 2004, OBSTET GYNECOL, V103, P526, DOI 10.1097/01.AOG.0000113623.18286.20; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gordon N., 2015, SIMILARITY ADULT KAI; Gordon NP, 2012, SIMILARITY ADULT KAI; Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Liston FA, 2008, ARCH DIS CHILD-FETAL, V93, pF176, DOI 10.1136/adc.2006.112565; Martin Joyce A, 2006, Natl Vital Stat Rep, V55, P1; Naylor CD, 1996, JAMA-J AM MED ASSOC, V275, P1165, DOI 10.1001/jama.275.15.1165; Nuthalapaty FS, 2004, OBSTET GYNECOL, V103, P452; Osterman Michelle J K, 2014, Natl Vital Stat Rep, V63, P1; Remsberg KE, 1999, DIABETES CARE, V22, P1561, DOI 10.2337/diacare.22.9.1561; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Vahratian A, 2005, ANN EPIDEMIOL, V15, P467, DOI 10.1016/j.annepidem.2005.02.005; World Health Organization, INT CLASS AD UND OV; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199932	10.1371/journal.pone.0199932	http://dx.doi.org/10.1371/journal.pone.0199932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969472	Green Published, gold, Green Submitted			2022-12-26	WOS:000437246700035
J	Mattingly, M; Weineck, K; Costa, J; Cooper, RL				Mattingly, Matthew; Weineck, Kristin; Costa, Jennifer; Cooper, Robin L.			Hyperpolarization by activation of halorhodopsin results in enhanced synaptic transmission: Neuromuscular junction and CNS circuit	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; OPTOGENETIC CONTROL; GENE-EXPRESSION; NEURAL ACTIVITY; MODULATION; GLUTAMATE; CHANNELS; DOPAMINE; BEHAVIOR; CHANNELRHODOPSIN-2	Optogenetics offers a unique method to regulate the activity of select neural circuits. However, the electrophysiological consequences of targeted optogenetic manipulation upon the entire circuit remain poorly understood. Analysis of the sensory-CNS-motor circuit in Drosophila larvae expressing eHpHR and ChR2-XXL revealed unexpected patterns of excitability. Optical stimulation of motor neurons targeted to express eNpHR resulted in inhibition followed by excitation of body wall contraction with repetitive stimulation in intact larvae. In situ preparations with direct electrophysiological measures showed an increased responsiveness to excitatory synaptic activity induced by sensory stimulation within a functional neural circuit. To ensure proper function of eNpHR and ChR2-XXL they were expressed in body wall muscle and direct electrophysiological measurements were obtained. Under eNpHR induced hyperpolarization the muscle remained excitable with increased amplitude of excitatory postsynaptic synaptic potentials. Theoretical models to explain the observations are presented. This study aids in increasing the understanding of the varied possible influences with light activated proteins within intact neural circuits.	[Mattingly, Matthew; Weineck, Kristin; Costa, Jennifer; Cooper, Robin L.] Univ Kentucky, Dept Biol, Lexington, KY 40506 USA; [Mattingly, Matthew; Weineck, Kristin; Costa, Jennifer; Cooper, Robin L.] Univ Kentucky, Ctr Muscle Biol, Lexington, KY 40506 USA; [Weineck, Kristin] Goethe Univ Frankfurt Main, Frankfurt, Germany	University of Kentucky; University of Kentucky; Goethe University Frankfurt	Cooper, RL (corresponding author), Univ Kentucky, Dept Biol, Lexington, KY 40506 USA.; Cooper, RL (corresponding author), Univ Kentucky, Ctr Muscle Biol, Lexington, KY 40506 USA.	RLCOOP1@UKY.EDU	Cooper, Robin/L-7362-2019	Cooper, Robin/0000-0001-7234-4361	DADD: German Academic Exchange Service, RISE - Program (Research Internships in Science and Engineering); Kentucky Science and Engineering Foundation at the Kentucky Science and Technology Corporation [KSEF-3712-RDE-019]	DADD: German Academic Exchange Service, RISE - Program (Research Internships in Science and Engineering); Kentucky Science and Engineering Foundation at the Kentucky Science and Technology Corporation	KW had a summer fellowship from DADD: German Academic Exchange Service, RISE - Program (Research Internships in Science and Engineering) to work in the USA on this project. RLC received funding from the Kentucky Science and Engineering Foundation (KSEF-3712-RDE-019) at the Kentucky Science and Technology Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BD, 2015, LEARN MEMORY, V22, P232, DOI 10.1101/lm.038026.114; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bass CE, 2010, J NEUROCHEM, V114, P1344, DOI 10.1111/j.1471-4159.2010.06850.x; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burmeister JJ, 2018, NEUROMETHODS, V130, P327, DOI 10.1007/978-1-4939-7228-9_11; Burmeister JJ, 2002, J NEUROSCI METH, V119, P163, DOI 10.1016/S0165-0270(02)00172-3; Busskamp V, 2011, CURR OPIN NEUROBIOL, V21, P942, DOI 10.1016/j.conb.2011.06.001; Caldwell JH, 2008, J BIOL CHEM, V283, P24300, DOI 10.1074/jbc.M802593200; CamposOrtega J. A., 1985, EMBRYONIC DEV DROSOP, P9, DOI DOI 10.1007/978-3-662-22489-2_2; Chai ZY, 2017, NEURON, V96, P1317, DOI 10.1016/j.neuron.2017.10.028; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Danjo T, 2014, P NATL ACAD SCI USA, V111, P6455, DOI 10.1073/pnas.1404323111; Dasari S, 2004, NEUROSCI RES, V48, P221, DOI 10.1016/j.neures.2003.10.005; Dawydow A, 2014, P NATL ACAD SCI USA, V111, P13972, DOI 10.1073/pnas.1408269111; de Castro C, 2014, J COMP PHYSIOL A, V200, P83, DOI 10.1007/s00359-013-0864-0; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; DUDEL J, 1961, J PHYSIOL-LONDON, V155, P514, DOI 10.1113/jphysiol.1961.sp006644; El-Shamayleh Y, 2017, NEURON, V95, P51, DOI 10.1016/j.neuron.2017.06.002; Eliopoulos Nicoletta, 2002, Methods Mol Biol, V183, P353; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Falgairolle M, 2017, ELIFE, V6, DOI 10.7554/eLife.26622; Frank CA, 2014, NEUROPHARMACOLOGY, V78, P63, DOI 10.1016/j.neuropharm.2013.06.015; Giachello CNG, 2015, CURR BIOL, V25, P2964, DOI 10.1016/j.cub.2015.09.040; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Grosenick L, 2015, NEURON, V86, P106, DOI 10.1016/j.neuron.2015.03.034; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Guru A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv079; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han YC, 2015, IEEE ENG MED BIO, P6606, DOI 10.1109/EMBC.2015.7319907; Herman AM, 2014, ELIFE, V3, DOI 10.7554/eLife.01481; Higgins J, 2017, NEUROSCI RES, V125, P1, DOI 10.1016/j.neures.2017.07.001; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Huguenard JR, 1998, J SLEEP RES, V7, P24, DOI 10.1046/j.1365-2869.7.s1.5.x; Hunsberger HC, 2017, JOVE-J VIS EXP, DOI 10.3791/55418; Inada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029019; Jin I, 2012, P NATL ACAD SCI USA, V109, P9137, DOI 10.1073/pnas.1206846109; Kavalali ET, 2015, NAT REV NEUROSCI, V16, P5, DOI 10.1038/nrn3875; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Kito H, 2014, J PHARMACOL SCI, V125, P227, DOI 10.1254/jphs.14002SC; Knopfel T, 2010, J NEUROSCI, V30, P14998, DOI 10.1523/JNEUROSCI.4190-10.2010; Lee AT, 2014, NEURON, V81, P61, DOI 10.1016/j.neuron.2013.10.031; Lee D, 2017, NAT BIOTECHNOL, V35, P858, DOI 10.1038/nbt.3902; Lin John Y, 2013, Methods Mol Biol, V998, P401, DOI 10.1007/978-1-62703-351-0_31; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Majeed Z, 2017, F1000RESEARCH, V6, P117, DOI [10.12688/f1000research.10632.1, DOI 10.12688/F1000RESEARCH.10632.1]; Majeed ZR, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7291438; Malloy C, 2017, J COMP PHYSIOL A, V203, P791, DOI 10.1007/s00359-017-1191-7; Mauss AS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14076-7; Miyashita T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00045; Mohammad F, 2017, NAT METHODS, V14, P271, DOI [10.1038/NMETH.4148, 10.1038/nmeth.4148]; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Ordaz JD, 2017, NEURAL REGEN RES, V12, P1197, DOI 10.4103/1673-5374.213532; Parrot S, 2015, ACS CHEM NEUROSCI, V6, P948, DOI 10.1021/acschemneuro.5b00003; Quinn TA, 2016, P NATL ACAD SCI USA, V113, P14852, DOI 10.1073/pnas.1611184114; Rajasethupathy P, 2016, CELL, V165, P524, DOI 10.1016/j.cell.2016.03.047; Rama S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10163; Riemensperger T, 2016, METHODS MOL BIOL, V1408, P167, DOI 10.1007/978-1-4939-3512-3_11; Rost BR, 2017, NEURON, V96, P572, DOI 10.1016/j.neuron.2017.09.047; Ruffner ME, 1999, J NEUROPHYSIOL, V81, P788, DOI 10.1152/jn.1999.81.2.788; Schmidt-Hieber C, 2010, J NEUROSCI, V30, P10233, DOI 10.1523/JNEUROSCI.6335-09.2010; Scholl HPN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2838; Sengupta A, 2016, EMBO MOL MED, V8, P1248, DOI 10.15252/emmm.201505699; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Tamura K, 2017, SCIENCE, V357, P687, DOI 10.1126/science.aan4800; Titlow J.S., 2014, SCI TEACH, V81, P3; Titlowa JS, 2014, NEUROSCI RES, V83, P54, DOI 10.1016/j.neures.2014.04.003; Towne Chris, 2016, Curr Protoc Pharmacol, V75, DOI 10.1002/cpph.13; Ueda Y, 2018, BIOCHEM BIOPH RES CO, V506, P387, DOI 10.1016/j.bbrc.2017.11.091; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7; ZHONG Y, 1992, J NEUROSCI, V12, P644; Zhu YC, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12695	78	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0200107	10.1371/journal.pone.0200107	http://dx.doi.org/10.1371/journal.pone.0200107			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969493	Green Published, Green Submitted, gold			2022-12-26	WOS:000437246700046
J	Majors, AK; Chakravarti, R; Ruple, LM; Leahy, R; Stuehr, DJ; Lauer, M; Erzurum, SC; Janocha, A; Aronica, MA				Majors, Alana K.; Chakravarti, Ritu; Ruple, Lisa M.; Leahy, Rachel; Stuehr, Dennis J.; Lauer, Mark; Erzurum, Serpil C.; Janocha, Allison; Aronica, Mark A.			Nitric oxide alters hyaluronan deposition by airway smooth muscle cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; EXTRACELLULAR-MATRIX; EXPERIMENTAL ASTHMA; EPITHELIAL-CELLS; GENE-EXPRESSION; SYNTHASE; INFLAMMATION; CD44; ACID; LEUKOCYTES	Asthma is a chronic inflammatory disease that is known to cause changes in the extracellular matrix, including changes in hyaluronan (HA) deposition. However, little is known about the factors that modulate its deposition or the potential consequences. Asthmatics with high levels of exhaled nitric oxide (NO) are characterized by greater airway reactivity and greater evidence of airway inflammation. Based on these data and our previous work we hypothesized that excessive NO promotes the pathologic production of HA by airway smooth muscle cells (SMCs). Exposure of cultured SMCs to various NO donors results in the accumulation of HA in the form of unique, cable-like structures. HA accumulates rapidly after exposure to NO and can be seen as early as one hour after NO treatment. The cable-like HA in NO-treated SMC cultures supports the binding of leukocytes. In addition, NO produced by murine macrophages (RAW cells) and airway epithelial cells also induces SMCs to produce HA cables when grown in co-culture. The modulation of HA by NO appears to be independent of soluble guanylate cyclase. Taken together, NO-induced production of leukocyte-binding HA by SMCs provides a new potential mechanism for the non-resolving airway inflammation in asthma and suggests a key role of non-immune cells in driving the chronic inflammation of the submucosa. Modulation of NO, HA and the consequent immune cell interactions may serve as potential therapeutic targets in asthma.	[Majors, Alana K.; Chakravarti, Ritu; Ruple, Lisa M.; Leahy, Rachel; Stuehr, Dennis J.; Janocha, Allison; Aronica, Mark A.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44106 USA; [Erzurum, Serpil C.; Aronica, Mark A.] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA; [Erzurum, Serpil C.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Lauer, Mark] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA; [Chakravarti, Ritu] Univ Toledo, Dept Surg, 2801 W Bancroft St, Toledo, OH 43606 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; University of Toledo	Majors, AK (corresponding author), Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44106 USA.	majorsa@ccf.org	Chakravarti, Ritu/K-8928-2019	Chakravarti, Ritu/0000-0003-4680-8374	National Heart, Lung, and Blood Institute [HL081064, HL103453, HL107147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064, U10HL109250, P01HL103453] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute grants HL081064 (SCE and MAE); HL103453 (SCE and DJS) and HL107147 (ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike T, 2010, NITRIC OXIDE-BIOL CH, V23, P166, DOI 10.1016/j.niox.2010.06.006; Al-Alawi M, 2014, RESP MED, V108, P1409, DOI 10.1016/j.rmed.2014.08.008; Ayars AG, 2013, INT ARCH ALLERGY IMM, V161, P65, DOI 10.1159/000343031; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; BELVISI MG, 1992, EUR J PHARMACOL, V210, P221, DOI 10.1016/0014-2999(92)90676-U; Binia A, 2011, J HUM GENET, V56, P97, DOI 10.1038/jhg.2010.134; Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; BOUSQUET J, 1991, J ALLERGY CLIN IMMUN, V88, P649, DOI 10.1016/0091-6749(91)90159-L; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Casalino-Matsuda SM, 2004, J BIOL CHEM, V279, P21606, DOI 10.1074/jbc.M309950200; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; Chou LW, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3365; Colavita AM, 2000, CLIN CHEST MED, V21, P263, DOI 10.1016/S0272-5231(05)70265-3; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Dicker KT, 2014, ACTA BIOMATER, V10, P1558, DOI 10.1016/j.actbio.2013.12.019; Dweik RA, 2010, AM J RESP CRIT CARE, V181, P1033, DOI 10.1164/rccm.200905-0695OC; Edwards MR, 2012, NAT REV MICROBIOL, V10, P459, DOI 10.1038/nrmicro2801; Eszes N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094678; Evanko SP, 1999, J HISTOCHEM CYTOCHEM, V47, P1331, DOI 10.1177/002215549904701013; Evanko SP, 2014, MATRIX BIOL; Evora PRB, 2012, CURR DRUG TARGETS, V13, P1207; Fajt ML, 2015, J ALLERGY CLIN IMMUN, V135, P299, DOI 10.1016/j.jaci.2014.12.1871; Feldman AS, 2015, AM J RESP CRIT CARE, V191, P34, DOI 10.1164/rccm.201405-0901PP; Fernandez-Bustamante A, 2014, ANESTHESIOLOGY, V121, P469, DOI 10.1097/ALN.0000000000000301; Forteza R, 1999, AM J RESP CELL MOL, V21, P666, DOI 10.1165/ajrcmb.21.6.3651; FOSANG AJ, 1990, MATRIX, V10, P306, DOI 10.1016/S0934-8832(11)80186-1; Garantziotis S, 2016, AM J PHYSIOL-LUNG C, V310, pL785, DOI 10.1152/ajplung.00168.2015; Ghosh S., 2014, IMMUNOBIOLOGY; Ghosh S, 2015, IMMUNOBIOLOGY; Ghosh Sudakshina, 2012, Drug Discov Today Dis Mech, V9, pe89; Ghosh S, 2011, BBA-GEN SUBJECTS, V1810, P1008, DOI 10.1016/j.bbagen.2011.06.009; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Hoffman SM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-141; HOGMAN M, 1993, AM REV RESPIR DIS, V148, P1474; Hsu KJ, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-4; Iacob S, 2006, INT J BIOCHEM CELL B, V38, P123, DOI 10.1016/j.biocel.2005.08.011; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Johnson PRA, 2004, CURR ALLERGY ASTHM R, V4, P102, DOI 10.1007/s11882-004-0054-9; Johnson PRA, 2001, CLIN EXP PHARMACOL P, V28, P233, DOI 10.1046/j.1440-1681.2001.03426.x; Kim SR, 2015, ALLERGY ASTHMA IMMUN, V7, P106, DOI 10.4168/aair.2015.7.2.106; Kim SR, 2013, J ALLERGY CLIN IMMUN, V132, P1397, DOI 10.1016/j.jaci.2013.08.041; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lauer ME, 2015, J BIOL CHEM, V290, P23124, DOI 10.1074/jbc.M115.663823; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Lee YT, 2010, J ORTHOP RES, V28, P492, DOI 10.1002/jor.21029; Lee-Sayer SSM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00150; Liang JR, 2016, ADV DRUG DELIVER REV, V97, P186, DOI 10.1016/j.addr.2015.10.017; Lo Faro ML, 2014, NITRIC OXIDE-BIOL CH, V41, P38, DOI 10.1016/j.niox.2014.05.014; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Makhija L, 2014, AM J RESP CELL MOL, V50, P923, DOI 10.1165/rcmb.2013-0320OC; Marozkina NV, 2012, BBA-GEN SUBJECTS, V1820, P722, DOI 10.1016/j.bbagen.2011.06.017; McDonald B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00068; McKee CM, 1997, J BIOL CHEM, V272, P8013, DOI 10.1074/jbc.272.12.8013; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Nakamura T, 2015, NEUROBIOL DIS; Park TJ, 2014, ALLERGY ASTHMA IMMUN, V6, P142, DOI 10.4168/aair.2014.6.2.142; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; ROBBINS RA, 1994, BIOCHEM BIOPH RES CO, V198, P835, DOI 10.1006/bbrc.1994.1119; Rockey DC, 1998, HEPATOLOGY, V27, P86, DOI 10.1002/hep.510270115; Roughley PJ, 2011, SPINE, V36, pE914, DOI 10.1097/BRS.0b013e3181f1e84f; SAHU S, 1978, BIOCHEM J, V173, P565, DOI 10.1042/bj1730565; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Sawa T, 2013, NITRIC OXIDE-BIOL CH, V34, P10, DOI 10.1016/j.niox.2013.04.004; Simmers P, 2015, TISSUE ENG PT A, V21, P1455, DOI [10.1089/ten.tea.2014.0363, 10.1089/ten.TEA.2014.0363]; STUEHR DJ, 1987, CANCER RES, V47, P5590; Vigetti D, 2014, MATRIX BIOL, V35, P8, DOI 10.1016/j.matbio.2013.10.002; Waheed SM, 2010, FREE RADICAL BIO MED, V48, P1548, DOI 10.1016/j.freeradbiomed.2010.02.038; Walker JKL, 2017, AM J RESP CELL MOL B; Wan YI, 2012, THORAX, V67, P762, DOI 10.1136/thoraxjnl-2011-201262; Wang CT, 2006, OSTEOARTHR CARTILAGE, V14, P1237, DOI 10.1016/j.joca.2006.05.009; Wang MJ, 2004, J NEUROIMMUNOL, V146, P50, DOI 10.1016/j.jneuroim.2003.10.034; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Wight TN, 2017, CELL IMMUNOL, V312, P1, DOI 10.1016/j.cellimm.2016.12.003; Xu WL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183066; Yamauchi Kohei, 2007, Allergol Int, V56, P321, DOI 10.2332/allergolint.R-07-151; Yang TB, 2002, CANCER RES, V62, P2583; Yatagai Y, 2014, CLIN EXP ALLERGY, V44, P1327, DOI 10.1111/cea.12415	82	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0200074	10.1371/journal.pone.0200074	http://dx.doi.org/10.1371/journal.pone.0200074			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966020	Green Published, Green Submitted, gold			2022-12-26	WOS:000437224100043
J	Hay, CE; Gonzalez, GA; Ewing, LE; Reichard, EE; Hambuchen, MD; Nanaware-Kharade, N; Alam, S; Bolden, CT; Owens, SM; Margaritis, P; Peterson, EC				Hay, Charles E.; Gonzalez, Guillermo A., III; Ewing, Laura E.; Reichard, E. Elizabeth; Hambuchen, Michael D.; Nanaware-Kharade, Nisha; Alam, Sinthia; Bolden, Chris T.; Owens, S. Michael; Margaritis, Paris; Peterson, Eric C.			Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse	PLOS ONE			English	Article							ANTI-(+)-METHAMPHETAMINE MONOCLONAL-ANTIBODY; RECOMBINANT ADENOASSOCIATED VIRUS; MEDIATED GENE-TRANSFER; DISRUPTED ADENOVIRUS; HEMOPHILIA-B; THERAPY; (+)-METHAMPHETAMINE; RATS; EXPRESSION; MICE	Methamphetamine (METH) substance abuse disorders have major impact on society, yet no medications have proven successful at preventing METH relapse or cravings. Anti-METH monoclonal antibodies can reduce METH brain concentrations; however, this therapy has limitations, including the need for repeated dosing throughout the course of addiction recovery. An adeno-associated viral (AAV)-delivered DNA sequence for a single-chain variable fragment could offer long-term, continuous expression of anti-METH antibody fragments. For these studies, we injected mice via tail vein with 1 x 10(12) vector genomes of two AAV8 scFv constructs and measured long-term expression of the antibody fragments. Mice expressed each scFv for at least 212 days, achieving micromolar scFv concentrations in serum. In separate experiments 21 days and 50 days after injecting mice with AAV-scFvs mice were challenged with METH in vivo. The circulating scFvs were capable of decreasing brain METH concentrations by up to 60% and sequestering METH in serum for 2 to 3 hrs. These results suggest that AAV-delivered scFv could be a promising therapy to treat methamphetamine abuse.	[Hay, Charles E.; Gonzalez, Guillermo A., III; Ewing, Laura E.; Reichard, E. Elizabeth; Hambuchen, Michael D.; Nanaware-Kharade, Nisha; Alam, Sinthia; Bolden, Chris T.; Owens, S. Michael; Peterson, Eric C.] Univ Arkansas Med Sci, Coll Med, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Margaritis, Paris] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Margaritis, Paris] Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Margaritis, Paris] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Peterson, EC (corresponding author), Univ Arkansas Med Sci, Coll Med, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA.	epeterson@uams.edu	Ewing, Laura/AAG-3877-2021	Ewing, Laura/0000-0001-8496-8518; Hay, Charles/0000-0003-2069-3871	NIH/NIDA [R01-DA036600, T32-DA022981]; NIH/NIGMS [T32-GM106999, R25GM083297]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM106999, R21GM083297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036600, T32DA022981] Funding Source: NIH RePORTER	NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by NIH/NIDA: R01-DA036600 and T32-DA022981, NIH/NIGMS: T32-GM106999 and R25GM083297. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], US Patent Office, Patent No. [US9023353, 9023353]; Barash S, 2002, BIOCHEM BIOPH RES CO, V294, P835, DOI 10.1016/S0006-291X(02)00566-1; Bell P, 2011, MOL GENET METAB, V104, P395, DOI 10.1016/j.ymgme.2011.06.002; Byrnes-Blake KA, 2005, EUR J PHARMACOL, V521, P86, DOI 10.1016/j.ejphar.2005.08.016; Byrnes-Blake KA, 2003, EUR J PHARMACOL, V461, P119, DOI 10.1016/S0014-2999(03)01313-X; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Chen SJ, 2013, HUM GENE THER CL DEV, V24, P154, DOI 10.1089/humc.2013.082; Chen YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep46301; Chen YH, 2013, CURR GENE THER, V13, P39, DOI 10.2174/156652313804806552; Cherner M, 2010, J INT NEUROPSYCH SOC, V16, P890, DOI 10.1017/S1355617710000779; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; Galloway GP, 2010, AM J ADDICTION, V19, P510, DOI 10.1111/j.1521-0391.2010.00082.x; Gentry WB, 2009, HUM VACCINES, V5, P206, DOI 10.4161/hv.5.4.7456; Gentry WB, 2006, INT IMMUNOPHARMACOL, V6, P968, DOI 10.1016/j.intimp.2006.01.008; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Hambuchen MD, 2016, HUM VACC IMMUNOTHER, V12, P2240, DOI 10.1080/21645515.2016.1179407; Hambuchen MD, 2015, J MED CHEM, V58, P4665, DOI 10.1021/acs.jmedchem.5b00220; Hicks MJ, 2012, SCI TRANSL MED, V4; Hillhouse MP, 2007, ADDICTION, V102, P84, DOI 10.1111/j.1360-0443.2007.01768.x; Koob G, 2011, CNS NEUROL DISORD-DR, V10, P899, DOI 10.2174/187152711799219334; Laurenzana EM, 2003, DRUG METAB DISPOS, V31, P1320, DOI 10.1124/dmd.31.11.1320; Lisowski L, 2015, CURR OPIN PHARMACOL, V24, P59, DOI 10.1016/j.coph.2015.07.006; Liu YL, 2003, BIOTECHNIQUES, V34, P184, DOI 10.2144/03341dd07; Margaritis P, 2009, BLOOD, V113, P3682, DOI 10.1182/blood-2008-07-168377; McMillan DE, 2004, J PHARMACOL EXP THER, V309, P1248, DOI 10.1124/jpet.103.061762; Nanaware-Kharade N, 2015, SCI REP-UK, V5, DOI 10.1038/srep12060; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; NICOSIA N, 2009, EC COST METHAMPHETAM; Owens SM, 2011, CNS NEUROL DISORD-DR, V10, P892; Owens SM, 2011, CNS NEUROLOGICAL; Pasi KJ, 2017, NEW ENGL J MED, V377, P819, DOI [10.1056/NEJMoa1616569, 10.1056/NEJMoa1708483]; Peterson EC, 2008, J PHARMACOL EXP THER, V325, P124, DOI 10.1124/jpet.107.134395; Peterson EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082690; Reichard EE, 2016, PHARM RES-DORDR, V33, P2954, DOI 10.1007/s11095-016-2017-y; Riviere GJ, 2000, J PHARMACOL EXP THER, V292, P1042; Rosenberg JB, 2013, HUM GENE THER, V24, P595, DOI 10.1089/hum.2012.245; Rosenberg JB, 2012, HUM GENE THER, V23, P451, DOI 10.1089/hum.2011.178; Sands MS, 2011, METHODS MOL BIOL, V807, P141, DOI 10.1007/978-1-61779-370-7_6; Smalley E, 2017, NAT BIOTECHNOL, V35, P998, DOI 10.1038/nbt1117-998; Stevens MW, 2014, MABS-AUSTIN, V6, P1649, DOI 10.4161/19420862.2014.976431; Stevens MW, 2014, MABS-AUSTIN, V6, P547, DOI 10.4161/mabs.27620; Thakkar S, 2014, SCI REP-UK, V4, DOI 10.1038/srep03673; Unverdorben F, 2016, MABS-AUSTIN, V8, P120, DOI 10.1080/19420862.2015.1113360; Valentine JL, 1996, J PHARMACOL EXP THER, V278, P717; VIEIRA P, 1988, EUR J IMMUNOL, V18, P313, DOI 10.1002/eji.1830180221; Wang LL, 2015, MOL THER, V23, P1877, DOI 10.1038/mt.2015.179; Wee S, 2012, NEUROPSYCHOPHARMACOL, V37, P1083, DOI 10.1038/npp.2011.200; White SJ, 2014, DRUG METAB DISPOS, V42, P1285, DOI 10.1124/dmd.114.056879; Wright JF, 2009, HUM GENE THER, V20, P698, DOI 10.1089/hum.2009.064; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	51	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0200060	10.1371/journal.pone.0200060	http://dx.doi.org/10.1371/journal.pone.0200060			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL0PZ	29958300	gold, Green Published, Green Submitted			2022-12-26	WOS:000436793500026
J	Park, M; Han, J; Jang, MJ; Suh, MW; Lee, JH; Oh, SH; Park, MK				Park, Mina; Han, Jiyeon; Jang, Myoung-jin; Suh, Myung-Whan; Lee, Jun Ho; Oh, Seung Ha; Park, Moo Kyun			Air pollution influences the incidence of otitis media in children: A national population-based study	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; CHILDHOOD EAR INFECTION; MIDDLE-EAR; ASSOCIATION; POLLUTANTS; PREVALENCE; PARTICLES; EXPOSURE; QUALITY; HEALTH	Background Otitis media (OM) is a major reason for children's visits to physicians and a major cause of their being treated with antibiotics. It not only causes economic burdens but also influences hearing, speech, and education. To our knowledge, no nationwide population-based study has assessed the association between air pollution and OM. Therefore, this study evaluated the association between air pollution levels and the incidence of OM. Methods We identified cases of OM that occurred in South Korea between January 2011 and December 2012 from the Korea National Health Insurance Service-National Sample Cohort database, and evaluated its relationship with five air pollutants: particulate matter (PM10, particulates <= 10 mu m in diameter), nitrogen dioxide (NO2), ozone (O-3), sulfur dioxide, and carbon monoxide. Associations between the weekly incidence of OM and the five air pollutants were analyzed using generalized estimating equations. Conditional logistic regression analysis was used to obtain odds ratios (ORs) and their 99.9% Bonferroni-corrected confidence intervals after adjusting for gender, age, season, and region. Results We based our analysis on 160,875 hospital visits for OM by children aged <15 years. Correlations with higher concentrations of the five pollutants showed higher ORs than did the reference values at most time lags. PM10 had the largest influence on the OM incidence at a time lag of 0 weeks, whereas NO2 and O-3 had the largest impacts on OM incidence at time lags of 1 and 4 weeks, respectively. Conclusion These findings support the notion that the incidence of OM is associated with ambient air pollution.	[Park, Mina] Seoul Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Han, Jiyeon; Jang, Myoung-jin] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea; [Suh, Myung-Whan; Lee, Jun Ho; Oh, Seung Ha; Park, Moo Kyun] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Suh, Myung-Whan; Lee, Jun Ho; Oh, Seung Ha; Park, Moo Kyun] Seoul Natl Univ, Med Res Ctr, Sensory Organ Res Inst, Seoul, South Korea	Seoul Medical Center; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Park, MK (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.; Park, MK (corresponding author), Seoul Natl Univ, Med Res Ctr, Sensory Organ Res Inst, Seoul, South Korea.	entpmk@gmail.com	Suh, Myung-Whan/AAZ-9615-2020	Park, Moo Kyun/0000-0002-8635-797X; Suh, Myung-Whan/0000-0003-1301-2249	Korea Ministry of Environment (MOE) [2016001360009]; Korea Ministry of Environment as part of "The Environmental Health Action Program" [2016001360009]	Korea Ministry of Environment (MOE); Korea Ministry of Environment as part of "The Environmental Health Action Program"	This subject was supported by Korea Ministry of Environment (MOE) as "The Environmental Health Action Program" (2016001360009) to Moo Kyun Park.; This study was supported by the Korea Ministry of Environment as part of "The Environmental Health Action Program" (2016001360009).	BC KJ, 1983, PEDIAT OTOLARYNGOLOG; Bondy J, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e72; Bondy J, 2000, VITAL HLTH STAT, V105, pE72; BOTHNER H, 1987, ACTA OTO-LARYNGOL, P25; Brauer M, 2006, ENVIRON HEALTH PERSP, V114, P1414, DOI 10.1289/ehp.9089; Caceres Udina Ma J, 2004, An Pediatr (Barc), V60, P133; Chun BC, 2013, J KOREAN MED ASSOC, V56, P62, DOI 10.5124/jkma.2013.56.1.62; Daly KA, 1999, PEDIATRICS, V103, P1158, DOI 10.1542/peds.103.6.1158; Deng QH, 2017, ATMOS ENVIRON, V157, P18, DOI 10.1016/j.atmosenv.2017.03.005; Deng QH, 2017, CHEMOSPHERE, V169, P288, DOI 10.1016/j.chemosphere.2016.11.079; Gestro M, 2017, INT J BIOMETEOROL, V61, P1749, DOI 10.1007/s00484-017-1356-7; Heikkinen T, 1999, NEW ENGL J MED, V340, P260, DOI 10.1056/NEJM199901283400402; Heinrich J, 2004, CURR ALLERGY ASTHM R, V4, P302, DOI 10.1007/s11882-004-0075-4; Heinrich J, 2002, EPIDEMIOLOGY, V13, P394, DOI 10.1097/00001648-200207000-00006; Kang SH, 2016, INT J CARDIOL, V203, P1086, DOI 10.1016/j.ijcard.2015.11.100; Kim C, 2010, AM J PSYCHIAT, V167, P1100, DOI 10.1176/appi.ajp.2010.09050706; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117929; Kousha T, 2016, J NURS SCHOLARSHIP, V48, P163, DOI 10.1111/jnu.12195; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lee WH, 2016, SCI TOTAL ENVIRON, V565, P271, DOI 10.1016/j.scitotenv.2016.03.163; MacIntyre EA, 2011, EPIDEMIOLOGY, V22, P81, DOI 10.1097/EDE.0b013e3181fdb60f; Minovi Amir, 2014, GMS Curr Top Otorhinolaryngol Head Neck Surg, V13, pDoc11, DOI 10.3205/cto000114; Noh Juhwan, 2016, J Prev Med Public Health, V49, P329; OHASHI Y, 1989, ANN OTO RHINOL LARYN, V98, P479; Park MK, 2014, INT J PEDIATR OTORHI, V78, P2193, DOI 10.1016/j.ijporl.2014.10.011; Ribeiro H, 2003, SOC SCI MED, V57, P2013, DOI 10.1016/S0277-9536(03)00068-6; Rim TH, 2015, OPHTHALMOLOGY, V122, P1187, DOI 10.1016/j.ophtha.2015.01.020; Song JJ, 2012, INT J PEDIATR OTORHI, V76, P334, DOI 10.1016/j.ijporl.2011.12.003; SPREM N, 1993, EUR ARCH OTO-RHINO-L, V250, P286, DOI 10.1007/BF00186227; Vergison A, 2008, VACCINE, V26, pG5, DOI 10.1016/j.vaccine.2008.11.006; Zemek R, 2010, ENVIRON HEALTH PERSP, V118, P1631, DOI 10.1289/ehp.0901675	31	8	8	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199296	10.1371/journal.pone.0199296	http://dx.doi.org/10.1371/journal.pone.0199296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953484	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400021
J	Rattay, S; Graf, D; Kislat, A; Homey, B; Herebian, D; Haussinger, D; Hengel, H; Zimmermann, A; Schupp, AK				Rattay, Stephanie; Graf, Dirk; Kislat, Andreas; Homey, Bernhard; Herebian, Diran; Haeussinger, Dieter; Hengel, Hartmut; Zimmermann, Albert; Schupp, Anna-Kathrin			Anti-inflammatory consequences of bile acid accumulation in virus-infected bile duct ligated mice	PLOS ONE			English	Article							MURINE CYTOMEGALOVIRUS-INFECTION; INNATE IMMUNE-SYSTEM; INTERFERON-GAMMA; GENE-EXPRESSION; LIVER-INJURY; INFLAMMATION; RESPONSES; REPLICATION; CHOLESTASIS; RECRUITMENT	Cholestatic patients exhibiting high bile acid serum levels were reported to be more susceptible to bacterial and viral infections. Animal studies in bile duct ligated (BDL) mice suggest that cholestasis leads to an aggravation of hepatic bacterial infections. We have investigated the impact of cholestasis on mouse cytomegalovirus (MCMV)-induced immune responses and viral replication. While MCMV did not aggravate BDL-induced liver damage, BDL markedly reduced MCMV-triggered chemokine expression and immune cell recruitment to the liver. MCMV-infected BDL mice showed diminished trafficking of Ly6C(+)/F4/80(+) myeloid cells and NK1.1(+) NK cells to the liver compared to MCMV infected control mice. Moreover, virus-driven expression of CCL7, CCL12, CXCL9 and CXCL10 was clearly impaired in BDL-compared to sham-operated mice. Furthermore, production of the anti-inflammatory cytokine IL-10 was massively augmented in infected BDL mice. In contrast, intra- and extrahepatic virus replication was unaltered in BDL-MCMV mice when compared to sham-MCMV mice. Cholestasis in the BDL model severely impaired pathogen-induced chemokine expression in the liver affecting CCR2- and CXCR3-dependent cell trafficking. Cholestasis resulted in reduced recruitment of inflammatory monocytes and NK cells to the liver.	[Rattay, Stephanie; Zimmermann, Albert] Heinrich Heine Univ, Univ Hosp, Inst Virol, Dusseldorf, Germany; [Rattay, Stephanie] Univ Hosp, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Graf, Dirk; Haeussinger, Dieter; Schupp, Anna-Kathrin] Heinrich Heine Univ, Univ Hosp, Dept Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Kislat, Andreas; Homey, Bernhard] Heinrich Heine Univ, Univ Hosp, Dept Dermatol, Dusseldorf, Germany; [Herebian, Diran] Heinrich Heine Univ, Dept Gen Pediat Neonatol & Pediat Cardiol, Univ Hosp, Dusseldorf, Germany; [Hengel, Hartmut] Albert Ludwigs Univ, Inst Virol, Med Ctr, Freiburg, Germany; [Hengel, Hartmut] Albert Ludwigs Univ, Dept Med Microbiol & Hyg, Inst Virol, Fac Med, Freiburg, Germany	Heinrich Heine University Dusseldorf; University of Bonn; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Freiburg; University of Freiburg	Zimmermann, A (corresponding author), Heinrich Heine Univ, Univ Hosp, Inst Virol, Dusseldorf, Germany.	albert.zimmermann@uni-duesseldorf.de		Rattay, Stephanie/0000-0002-9341-1911; Dr. Herebian, Diran/0000-0002-8528-0122; Zimmermann, Albert/0000-0002-0273-7992	German Research Foundation (DFG) [Sonderforschungsbereich 974]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was funded by the German Research Foundation (DFG) through Sonderforschungsbereich 974 'Communication and system relevance in liver damage and regeneration', Project A09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, HEPATOLOGY, V40, P414, DOI 10.1002/hep.20301; Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026; Alnouti Y, 2008, J CHROMATOGR B, V873, P209, DOI 10.1016/j.jchromb.2008.08.018; Bardina SV, 2015, J IMMUNOL, V195, P4306, DOI 10.4049/jimmunol.1500352; Ben-Ari Z, 2003, LIVER TRANSPLANT, V9, P1005, DOI 10.1053/jlts.2003.50212; Bouabe H, 2011, J IMMUNOL, V187, P3165, DOI 10.4049/jimmunol.1101477; Brune W, 1999, CURRENT PROTOCOLS IM; Carlquist JF, 1999, J INFECT DIS, V179, P1094, DOI 10.1086/314734; Chen JP, 2006, J IMMUNOL, V177, P3185, DOI 10.4049/jimmunol.177.5.3185; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Cortez VS, 2015, CURR OPIN IMMUNOL, V32, P71, DOI 10.1016/j.coi.2015.01.004; Crane MJ, 2009, J IMMUNOL, V183, P2810, DOI 10.4049/jimmunol.0900205; Daley-Bauer LP, 2012, IMMUNITY, V37, P122, DOI 10.1016/j.immuni.2012.04.014; Delale T, 2005, J IMMUNOL, V175, P6723, DOI 10.4049/jimmunol.175.10.6723; Ehlting C, 2016, J HEPATOL, V64, P380, DOI 10.1016/j.jhep.2015.08.012; Georgiev P, 2007, GUT, V56, P121, DOI 10.1136/gut.2006.097170; Graf D, 2006, HEPATOLOGY, V44, P1206, DOI 10.1002/hep.21368; Graf D, 2010, BIOL CHEM, V391, P1175, DOI 10.1515/BC.2010.108; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Grzimek NKA, 1999, J VIROL, V73, P5043, DOI 10.1128/JVI.73.6.5043-5055.1999; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Harada K, 2010, EMS SER LECT MATH, P1, DOI 10.4171/090; Haselow K, 2013, J LEUKOCYTE BIOL, V94, P1253, DOI 10.1189/jlb.0812396; Hokeness KL, 2007, J VIROL, V81, P1241, DOI 10.1128/JVI.01937-06; Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549; Hokeness-Antonelli KL, 2007, J IMMUNOL, V179, P6176, DOI 10.4049/jimmunol.179.9.6176; Jeyarajah DR, 2006, AM J PHYSIOL-GASTR L, V291, pG91, DOI 10.1152/ajpgi.00095.2004; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Jordan S, 2011, J VIROL, V85, P10346, DOI 10.1128/JVI.00545-11; Kahraman A, 2008, HEPATOLOGY, V47, P1317, DOI 10.1002/hep.22136; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; Keitel V, 2008, WORLD J GASTROENTERO, V14, P5620, DOI 10.3748/wjg.14.5620; Kim HY, 2010, FEBS J, V277, P2791, DOI 10.1111/j.1742-4658.2010.07695.x; Laschke MW, 2010, J SURG RES, V159, P666, DOI 10.1016/j.jss.2008.08.023; Le VTK, 2008, J GEN VIROL, V89, P1131, DOI 10.1099/vir.0.83538-0; LUCIN P, 1994, J GEN VIROL, V75, P101, DOI 10.1099/0022-1317-75-1-101; MAGGIORE G, 1982, J PEDIATR GASTR NUTR, V1, P385, DOI 10.1097/00005176-198201030-00019; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Morita Y, 2008, J SURG RES, V146, P262, DOI 10.1016/j.jss.2007.05.040; Muse M, 2008, VIROLOGY, V382, P132, DOI 10.1016/j.virol.2008.09.032; Noriega VM, 2014, J VIROL, V88, P9391, DOI 10.1128/JVI.00934-14; ORANGE JS, 1995, J EXP MED, V182, P1045, DOI 10.1084/jem.182.4.1045; Quinones MP, 2007, PARASITE IMMUNOL, V29, P211, DOI 10.1111/j.1365-3024.2006.00935.x; Ramiere C, 2008, J VIROL, V82, P10832, DOI 10.1128/JVI.00883-08; Saiman Y, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00213; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; Scholtes C, 2008, J HEPATOL, V48, P192, DOI 10.1016/j.jhep.2007.09.015; Schupp AK, 2016, J VIROL, V90, P6686, DOI 10.1128/JVI.00299-16; Serbina NV, 2012, ADV IMMUNOL, V113, P119, DOI 10.1016/B978-0-12-394590-7.00003-8; Sinzger C, 1999, J INFECT DIS, V180, P976, DOI 10.1086/315032; Stacey MA, 2014, CELL HOST MICROBE, V15, P471, DOI 10.1016/j.chom.2014.03.003; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tag Carmen G, 2015, J Vis Exp, DOI 10.3791/52438; Tomita K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28786; Trilling M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002069; Walsh KB, 2007, J IMMUNOL, V179, P1155, DOI 10.4049/jimmunol.179.2.1155; Wammers M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18305-x; Woolbright BL, 2012, WORLD J GASTROENTERO, V18, P4985, DOI 10.3748/wjg.v18.i36.4985; Zhang YC, 2012, LIVER INT, V32, P58, DOI 10.1111/j.1478-3231.2011.02662.x; Zhu JG, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89880	61	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199863	10.1371/journal.pone.0199863	http://dx.doi.org/10.1371/journal.pone.0199863			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953538	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400082
J	Salinas, MJ; Cases, JJ; Rubio-Rios, J; Lopez-Carrique, E; Ramos-Miras, JJ; Gil, C				Salinas, Maria J.; Jesus Cases, J.; Rubio-Rios, Juan; Lopez-Carrique, Enrique; Ramos-Miras, Jose J.; Gil, Carlos			Climate-driven changes of riparian plant functional types in permanent headwater streams. Implications for stream food webs	PLOS ONE			English	Article							LITTER DECOMPOSITION RATES; LEAF ECONOMICS SPECTRUM; PHRAGMITES-AUSTRALIS; SPECIES RICHNESS; SOIL-SALINITY; TRAITS; ECOSYSTEMS; VEGETATION; WORLDWIDE; ECOLOGY	Little is known regarding consequences of climate change on riparian plant functional types (PFTs) related to leaf traits, with putative domino effects on stream food webs, plausible even if the tipping point of stream-desiccation is not reached. We hypothesized that, as stream food-webs are highly dependent on riparian subsidies, climate change might alter PFTs to the point of weakening terrestrial-aquatic linkages. We conducted a gradient analysis to assess the relative effects of climate, soil and riparian physical characteristics on PFTs. If PFTs differ significantly in leaf traits and climate had major influences on them, we could assume space-for-time interchangeability forward in time to predict leaf traits changes, and consequences for stream food webs under future climate change scenarios. Results indicated a clear distinction in leaf traits among PFTs: woody deciduous plants showed leaf traits associated to high decomposability and nutritional value for invertebrate shredders compared to evergreen woody and giant graminoid groups. We found a prime role of climate predicting changes in abundance and diversity of PFTs: 1) a warming and precipitation-decline scenario, coupled with soil characteristics related to aridification, would have detrimental effects on deciduous plants, while fostering giant graminoids; 2) in a scenario of no precipitation-reduction in wetter areas, warming might promote the expansion of evergreen to the detriment of deciduous plants. In both scenarios the net outcome implies increasing recalcitrance of leaf litter inputs, potentially weakening terrestrial-aquatic linkages in headwater streams.	[Salinas, Maria J.; Jesus Cases, J.; Rubio-Rios, Juan] Univ Almeria, Dept Biol & Geol, Almeria, Spain; [Salinas, Maria J.; Jesus Cases, J.] Univ Almeria, Andalusian Ctr Evaluat & Monitoring Global Change, Almeria, Spain; [Lopez-Carrique, Enrique] Univ Almeria, Dept Educ, Almeria, Spain; [Ramos-Miras, Jose J.; Gil, Carlos] Univ Almeria, Dept Agron, Almeria, Spain	Universidad de Almeria; Universidad de Almeria; Universidad de Almeria; Universidad de Almeria	Salinas, MJ (corresponding author), Univ Almeria, Dept Biol & Geol, Almeria, Spain.; Salinas, MJ (corresponding author), Univ Almeria, Andalusian Ctr Evaluat & Monitoring Global Change, Almeria, Spain.	mjsalina@ual.es	RUBIO-RÍOS, JUAN/AAT-1967-2021; Ramos-Miras, J. J./AAO-7818-2021; SALINAS, MARIA-JACOBA/K-1193-2012; Miras, José Joaquín Ramos/J-2678-2018	RUBIO-RÍOS, JUAN/0000-0002-5335-1766; SALINAS, MARIA-JACOBA/0000-0001-6931-6677; Miras, José Joaquín Ramos/0000-0001-6194-7191; Casas Jimenez, Jose Jesus/0000-0003-0928-0080	Spanish Ministry of Science and Innovation, project RIBARID [CGL2012-39635]; Spanish Ministry of Science and Innovation, project RIBARID [MICINN]; Spanish Ministry of Science and Innovation, project RIBARID [EU FEDER]	Spanish Ministry of Science and Innovation, project RIBARID(Ministry of Science and Innovation, Spain (MICINN)); Spanish Ministry of Science and Innovation, project RIBARID [MICINN](Ministry of Science and Innovation, Spain (MICINN)); Spanish Ministry of Science and Innovation, project RIBARID [EU FEDER]	This study was supported by a grant from the Spanish Ministry of Science and Innovation, project RIBARID [CGL2012-39635; MICINN; EU FEDER].	Adams WW, 2004, BIOSCIENCE, V54, P41, DOI 10.1641/0006-3568(2004)054[0041:PSOOE]2.0.CO;2; AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; Aguiar FC, 2013, J VEG SCI, V24, P628, DOI 10.1111/jvs.12009; Andersen CM, 2010, J CHEMOMETR, V24, P728, DOI 10.1002/cem.1360; ARNDT JL, 1989, SOIL SCI SOC AM J, V53, P848, DOI 10.2136/sssaj1989.03615995005300030037x; ARROYO J, 1990, J BIOGEOGR, V17, P163, DOI 10.2307/2845324; Barlocher F, 2002, FRESHWATER BIOL, V47, P1123, DOI 10.1046/j.1365-2427.2002.00836.x; Blanca G., 2009, FLORA VASCULAR ANDAL; Blois JL, 2013, P NATL ACAD SCI USA, V110, P9374, DOI 10.1073/pnas.1220228110; Bonan GB, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001360; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Boulton AJ, 2006, AUST J BOT, V54, P133, DOI 10.1071/BT05074; Boyero L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10640-3; Bui EN, 2013, J ARID ENVIRON, V92, P14, DOI 10.1016/j.jaridenv.2012.12.014; BUSCH DE, 1995, ECOL MONOGR, V65, P347, DOI 10.2307/2937064; Carrion JS, 2010, J ARID ENVIRON, V74, P731, DOI 10.1016/j.jaridenv.2008.11.014; Catford JA, 2013, ECOSYSTEMS, V16, P382, DOI 10.1007/s10021-012-9566-7; Condes S, 2012, FOREST ECOL MANAG, V284, P59, DOI 10.1016/j.foreco.2012.07.030; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornelissen JHC, 2004, FUNCT ECOL, V18, P779, DOI 10.1111/j.0269-8463.2004.00900.x; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; de la Riva EG, 2016, OIKOS, V125, P354, DOI 10.1111/oik.01875; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Fenoy E, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw169; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Gil C, 2004, CHEMOSPHERE, V55, P1027, DOI 10.1016/j.chemosphere.2004.01.013; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Givnish TJ, 2002, SILVA FENN, V36, P703, DOI 10.14214/sf.535; Goering H.K., 1970, AGR HDB USDA; Graca MAS, 2014, OECOLOGIA, V174, P1021, DOI 10.1007/s00442-013-2825-2; Graca MAS, 2010, INT REV HYDROBIOL, V95, P27, DOI 10.1002/iroh.200911173; Handa IT, 2014, NATURE, V509, P218, DOI 10.1038/nature13247; Hladyz S, 2011, J APPL ECOL, V48, P443, DOI 10.1111/j.1365-2664.2010.01924.x; Hladyz S, 2009, FRESHWATER BIOL, V54, P957, DOI 10.1111/j.1365-2427.2008.02138.x; Casas JJ, 2013, SCI TOTAL ENVIRON, V458, P197, DOI 10.1016/j.scitotenv.2013.04.004; Kennedy TA, 2005, ECOL APPL, V15, P2072, DOI 10.1890/04-1533; Kent M., 2012, VEGETATION DESCRIPTI, V2nd ed.; Lambert AM, 2010, INVAS PLANT SCI MANA, V3, P489, DOI 10.1614/IPSM-D-10-00031.1; Lecerf A, 2008, BASIC APPL ECOL, V9, P598, DOI 10.1016/j.baae.2007.11.003; Maestre FT, 2004, DIVERS DISTRIB, V10, P21, DOI 10.1111/j.1472-4642.2004.00057.x; Mahlman JD, 1997, SCIENCE, V278, P1416, DOI 10.1126/science.278.5342.1416; Maire V, 2015, GLOBAL ECOL BIOGEOGR, V24, P706, DOI 10.1111/geb.12296; Martinez A, 2013, FOREST ECOL MANAG, V310, P147, DOI 10.1016/j.foreco.2013.08.024; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; Meerhoff M, 2012, ADV ECOL RES, V46, P259, DOI 10.1016/B978-0-12-396992-7.00004-6; Nackley LL, 2015, GCB BIOENERGY, V7, P752, DOI 10.1111/gcbb.12184; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; Nohara D, 2006, J HYDROMETEOROL, V7, P1076, DOI 10.1175/JHM531.1; Oliveira G, 2004, PLANT ECOL, V175, P179, DOI 10.1007/s11258-005-4876-x; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Pagter M, 2009, AQUAT BOT, V90, P43, DOI 10.1016/j.aquabot.2008.05.005; Pakeman RJ, 2009, J VEG SCI, V20, P148, DOI 10.1111/j.1654-1103.2009.05548.x; Latorre AVP, 2006, PLANT ECOL, V187, P227, DOI 10.1007/s11258-005-6574-0; PICKETT S T A, 1989, P110; Reich P. B., 2003, International Journal of Plant Sciences, V164, pS143, DOI 10.1086/374368; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Renofalt BM, 2005, J BIOGEOGR, V32, P2025, DOI 10.1111/j.1365-2699.2005.01328.x; Salinas MJ, 2007, WETLANDS, V27, P831, DOI 10.1672/0277-5212(2007)27[831:RVOTSM]2.0.CO;2; Sardans J, 2013, GLOBAL ECOL BIOGEOGR, V22, P494, DOI 10.1111/geb.12015; Schaller J, 2014, ECOLOGY, V95, P3181, DOI 10.1890/13-2104.1; Schaller J, 2013, HYDROBIOLOGIA, V709, P201, DOI 10.1007/s10750-013-1449-1; Schaller J, 2012, ENVIRON EXP BOT, V77, P283, DOI 10.1016/j.envexpbot.2011.12.009; Scholes R.J., 1993, AFRICAN SAVANNA SYNT; Shipley B, 2006, ECOLOGY, V87, P535, DOI 10.1890/05-1051; Stocker T. F., 2013, CLIMATE CHANGE 2013; Stromberg JC, 2013, ECOSYSTEMS, V16, P411, DOI 10.1007/s10021-012-9606-3; Tenenhaus M, 1998, RE GRESSION PLS A OR; Valdes B., 1987, FLORA VASCULAR ANDAL; Vicente-Serrano SM, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/4/044001; Wallace JB, 2015, ECOLOGY, V96, P1213, DOI 10.1890/14-1589.1; Wilcox KL, 2003, J GREAT LAKES RES, V29, P664, DOI 10.1016/S0380-1330(03)70469-9; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wullschleger SD, 2014, ANN BOT-LONDON, V114, P1, DOI 10.1093/aob/mcu077	76	10	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199898	10.1371/journal.pone.0199898	http://dx.doi.org/10.1371/journal.pone.0199898			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953530	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400089
J	Tao, Y; Liu, ZJ; Hou, YY; Wang, SL; Liu, SH; Jiang, YH; Tan, D; Ge, QL; Li, CF; Hu, YM; Liu, Z; Chen, X; Wang, Q; Wang, ML; Zhang, XR				Tao, Yu; Liu, Zhanjie; Hou, Yingyong; Wang, Shouli; Liu, Sanhong; Jiang, Yuhang; Tan, Dan; Ge, Qiulin; Li, Cuifeng; Hu, Yiming; Liu, Zhi; Chen, Xi; Wang, Qi; Wang, Mingliang; Zhang, Xiaoren			Alternative NF-kappa B signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3	ONCOGENE			English	Article							FAMILY-MEMBER BCL-3; C-MYC; CANCER STATISTICS; PROSTATE-CANCER; ACTIVATION; INFLAMMATION; ANGIOGENESIS; EXPRESSION; BINDING; KINASE	Multiple studies have shown that chronic inflammation is closely related to the occurrence and development of colorectal cancer (CRC). Classical NF-kappa B signaling, the key factor in controlling inflammation, has been found to be of great importance to CRC development. However, the role of alternative NF-kappa B signaling in CRC is still elusive. Here, we found aberrant constitutive activation of alternative NF-kappa B signaling both in CRC tissue and CRC cells. Knockdown of RelB downregulates c-Myc and upregulates p27(Kip1) protein level, which inhibits CRC cell proliferation and retards CRC xenograft growth. Conversely, overexpression of RelB increases proliferation of CRC cells. In addition, we revealed a significant correlation between Bcl-3 and RelB in CRC tissues. The expression of RelB was consistent with the expression of Bcl-3 and the phosphorylation of Bcl-3 downstream proteins p-Akt (S473) and p-GSK3 beta (S9). Bcl-3 overexpression can restore the phenotype changes caused by RelB knockdown. Importantly, we demonstrated that alternative NF-kappa B transcriptional factor (p52:RelB) can directly bind to the promoter region of Bcl-3 gene and upregulate its transcription. Moreover, the expression of RelB, NF-kappa B2 p52, and Bcl-3 was associated with poor survival of CRC patients. Taken together, these results represent that alternative NF-kappa B signaling may function as an oncogenic driver in CRC, and also provide new ideas and research directions for the pathogenesis, prevention, and treatment of other inflammatory-related diseases.	[Tao, Yu; Liu, Zhanjie; Liu, Sanhong; Jiang, Yuhang; Li, Cuifeng; Hu, Yiming; Liu, Zhi; Chen, Xi; Wang, Qi; Zhang, Xiaoren] Shanghai Jiao Tong Univ, Inst Hlth Sci, Key Lab Stem Cell Biol, Sch Med, Shanghai 200025, Peoples R China; [Tao, Yu; Liu, Zhanjie; Liu, Sanhong; Jiang, Yuhang; Li, Cuifeng; Hu, Yiming; Liu, Zhi; Chen, Xi; Wang, Qi; Zhang, Xiaoren] Chinese Acad Sci, SIBS, Shanghai 200025, Peoples R China; [Hou, Yingyong] Fudan Univ, Zhongshan Hosp, Dept Pathol, 180 Fenglin Rd, Shanghai 200032, Peoples R China; [Wang, Shouli] Soochow Univ, Dept Pathol, Sch Med, Suzhou 215123, Peoples R China; [Liu, Sanhong] Shanghai Tech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai, Peoples R China; [Tan, Dan; Wang, Mingliang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gen Surg, Shanghai 200025, Peoples R China; [Ge, Qiulin] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Zhang, Xiaoren] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Guangzhou 510000, Guangdong, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Soochow University - China; ShanghaiTech University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Guangzhou Medical University	Zhang, XR (corresponding author), Shanghai Jiao Tong Univ, Inst Hlth Sci, Key Lab Stem Cell Biol, Sch Med, Shanghai 200025, Peoples R China.; Zhang, XR (corresponding author), Chinese Acad Sci, SIBS, Shanghai 200025, Peoples R China.; Wang, ML (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gen Surg, Shanghai 200025, Peoples R China.; Zhang, XR (corresponding author), Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Guangzhou 510000, Guangdong, Peoples R China.	mingliang-99@hotmail.com; xrzhang@sibs.ac.cn	wang, mingliang/GXF-2439-2022	Liu, Sanhong/0000-0002-8695-0343; zhang, xiaoren/0000-0003-4080-433X	National Program on Key Research [2016YFC1302400]; National Basic Research Program [2014CB541904, 2014CB943600]; National Natural Science Foundation of China [91742113, 31570902, 31370881]; Natural Science Foundation of Shanghai [14ZR1426300, 18ZR1424400, 18ZR1446400]	National Program on Key Research; National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was supported by the National Program on Key Research (2016YFC1302400), the National Basic Research Program (2014CB541904, 2014CB943600), National Natural Science Foundation of China (91742113, 31570902, 31370881), and Natural Science Foundation of Shanghai (14ZR1426300, 18ZR1424400, 18ZR1446400).	Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Amati B, 1998, FRONT BIOSCI, V3, pd250, DOI [10.2741/a239, DOI 10.2741/A239]; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; Brasier AR, 2001, J BIOL CHEM, V276, P32080, DOI 10.1074/jbc.M102949200; Bretones G, 2011, J BIOL CHEM, V286, P9815, DOI 10.1074/jbc.M110.165977; Chandramohan V, 2008, J CELL BIOCHEM, V104, P2091, DOI 10.1002/jcb.21765; Chen C, 2013, BIOCHEM BIOPH RES CO, V430, P505, DOI 10.1016/j.bbrc.2012.12.006; Dejardin E, 1999, ONCOGENE, V18, P2567, DOI 10.1038/sj.onc.1202599; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Franzoso G, 1997, IMMUNITY, V6, P479, DOI 10.1016/S1074-7613(00)80291-5; Ge QL, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.309; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jacque E, 2013, ONCOGENE, V32, P2661, DOI 10.1038/onc.2012.282; Karin M, 2006, MOL CARCINOGEN, V45, P355, DOI 10.1002/mc.20217; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Liu SH, 2014, GASTROENTEROLOGY, V147, P847, DOI 10.1053/j.gastro.2014.06.006; Liu ZJ, 2013, J MOL CELL BIOL, V5, P280, DOI 10.1093/jmcb/mjt020; Maldonado V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-152; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; NAUMANN M, 1993, EMBO J, V12, P213, DOI 10.1002/j.1460-2075.1993.tb05647.x; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Nottingham LK, 2014, ONCOGENE, V33, P1135, DOI 10.1038/onc.2013.49; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; PerezRoger I, 1997, ONCOGENE, V14, P2373, DOI 10.1038/sj.onc.1201197; Poljak L, 1999, J IMMUNOL, V163, P6581; Saamarthy K, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1342-6; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; TANAKA S, 1990, CANCER GENET CYTOGEN, V49, P219, DOI 10.1016/0165-4608(90)90144-Y; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Urban BC, 2016, GUT, V65, P1151, DOI 10.1136/gutjnl-2014-308270; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vallabhapurapu SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9428; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Wang Y, 2016, ONCOGENE, V35, P4080, DOI 10.1038/onc.2015.470; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; Wen DY, 2006, J PHARMACOL EXP THER, V317, P989, DOI 10.1124/jpet.105.097584; Wharry CE, 2009, CANCER BIOL THER, V8, P1567, DOI 10.4161/cbt.8.16.8961; Xu Y, 2009, CANCER RES, V69, P3267, DOI 10.1158/0008-5472.CAN-08-4635; Xue G, 2015, ONCOGENE, V34, P1393, DOI 10.1038/onc.2014.82; Zhang JP, 2007, ENDOCRINOLOGY, V148, P268, DOI 10.1210/en.2006-0500; Zhang XR, 2007, IMMUNITY, V27, P438, DOI 10.1016/j.immuni.2007.07.017	51	8	8	2	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 1	2018	37	44					5887	5900		10.1038/s41388-018-0363-4	http://dx.doi.org/10.1038/s41388-018-0363-4			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GY9EX	29973688				2022-12-26	WOS:000448943100006
J	Coussens, NP; Kales, SC; Henderson, MJ; Lee, OW; Horiuchi, KY; Wang, YR; Chen, Q; Kuznetsova, E; Wu, J; Chakka, SH; Cheff, DM; Cheng, KCC; Shinn, P; Brimacombe, KR; Shen, M; Simeonov, A; Lal-Nag, M; Ma, HC; Jadhav, A; Hall, MD				Coussens, Nathan P.; Kales, Stephen C.; Henderson, Mark J.; Lee, Olivia W.; Horiuchi, Kurumi Y.; Wang, Yuren; Chen, Qing; Kuznetsova, Ekaterina; Wu, Jianghong; Chakka, Sirisha; Cheff, Dorian M.; Cheng, Ken Chih-Chien; Shinn, Paul; Brimacombe, Kyle R.; Shen, Min; Simeonov, Anton; Lal-Nag, Madhu; Ma, Haiching; Jadhav, Ajit; Hall, Matthew D.			High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; cancer; high-throughput screening (HTS); histone methylation; nucleosome; oncogene; small molecule; lysine methyltransferase inhibitor; MMSET; NSD2; WHSC1	ACUTE LYMPHOBLASTIC-LEUKEMIA; T(4/14) MULTIPLE-MYELOMA; PROTEIN METHYLTRANSFERASES; FGFR3 EXPRESSION; GENE-EXPRESSION; KINASE ASSAYS; CANCER-CELLS; MMSET; OVEREXPRESSION; DOMAIN	The histone lysine methyltransferase nuclear receptor-binding SET domain protein 2 (NSD2, also known as WHSC1/MMSET) is an epigenetic modifier and is thought to play a driving role in oncogenesis. Both NSD2 overexpression and point mutations that increase its catalytic activity are associated with several human cancers. Although NSD2 is an attractive therapeutic target, no potent, selective, and bioactive small molecule inhibitors of NSD2 have been reported to date, possibly due to the challenges of developing high-throughput assays for NSD2. Here, to establish a platform for the discovery and development of selective NSD2 inhibitors, we optimized and implemented multiple assays. We performed quantitative high-throughput screening with full-length WT NSD2 and a nucleosome substrate against a diverse collection of bioactive small molecules comprising 16,251 compounds. We further interrogated 174 inhibitory compounds identified in the primary screen with orthogonal and counter assays and with activity assays based on the clinically relevant NSD2 variants E1099K and T1150A. We selected five confirmed inhibitors for follow-up, which included a radiolabeled validation assay, surface plasmon resonance studies, methyltransferase profiling, and histone methylation in cells. We found that all five NSD2 inhibitors bind the catalytic SET domain and one exhibited apparent activity in cells, validating the workflow and providing a template for identifying selective NSD2 inhibitors. In summary, we have established a robust discovery pipeline for identifying potent NSD2 inhibitors from small-molecule libraries.	[Coussens, Nathan P.; Kales, Stephen C.; Henderson, Mark J.; Lee, Olivia W.; Chakka, Sirisha; Cheff, Dorian M.; Cheng, Ken Chih-Chien; Shinn, Paul; Brimacombe, Kyle R.; Shen, Min; Simeonov, Anton; Lal-Nag, Madhu; Jadhav, Ajit; Hall, Matthew D.] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA; [Horiuchi, Kurumi Y.; Wang, Yuren; Chen, Qing; Kuznetsova, Ekaterina; Wu, Jianghong; Ma, Haiching] React Biol Corp, Malvern, PA 19355 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Hall, MD (corresponding author), NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA.	hallma@mail.nih.gov		Jadhav, Ajit/0000-0001-7955-1451; Lee, Olivia/0000-0001-5389-6267; Kales, Stephen C./0000-0002-8702-5766; Henderson, Mark/0000-0001-8590-7338	National Center for Advancing Translational Sciences (NCATS) Division of Pre-Clinical Innovation Intramural Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000252, ZICTR000041] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS) Division of Pre-Clinical Innovation Intramural Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Center for Advancing Translational Sciences (NCATS) Division of Pre-Clinical Innovation Intramural Program. K.Y.H., Y.W., Q.C., E.K., J.W., and H.M. are employed by Reaction Biology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allali-Hassani A, 2014, J BIOMOL SCREEN, V19, P928, DOI 10.1177/1087057114525854; Allali-Hassani A, 2012, J BIOMOL SCREEN, V17, P71, DOI 10.1177/1087057111422256; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Auld D, 2004, ASSAY INTERFERENCE C; Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; Auld DS, 2010, P NATL ACAD SCI USA, V107, P4878, DOI 10.1073/pnas.0909141107; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Bea S, 2013, P NATL ACAD SCI USA, V110, P18250, DOI 10.1073/pnas.1314608110; Bennett RL, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026708; Benoit YD, 2013, J CELL PHYSIOL, V228, P764, DOI 10.1002/jcp.24224; Brito JLR, 2009, HAEMATOL-HEMATOL J, V94, P78, DOI 10.3324/haematol.13426; Cain C., 2013, SCIBX SCI BUSINESS E, V6, DOI 10.1038/scibx.2013.1083; Cherblanc FL, 2013, J MED CHEM, V56, P8616, DOI 10.1021/jm401063r; Cherblanc FL, 2013, NAT CHEM BIOL, V9, P136, DOI 10.1038/nchembio.1187; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Chi HF, 2014, BIOORGAN MED CHEM, V22, P1268, DOI 10.1016/j.bmc.2014.01.011; Dahlin JL, 2015, J MED CHEM, V58, P2091, DOI 10.1021/jm5019093; di Luccio Eric, 2015, J Cancer Prev, V20, P113, DOI 10.15430/JCP.2015.20.2.113; Drake KM, 2014, ASSAY DRUG DEV TECHN, V12, P258, DOI 10.1089/adt.2014.583; Ezponda T, 2013, ONCOGENE, V32, P2882, DOI 10.1038/onc.2012.297; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Giannetti AM, 2008, J MED CHEM, V51, P574, DOI 10.1021/jm700952v; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V135, P688, DOI 10.1016/0006-291X(86)90048-3; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Horiuchi KY, 2013, ASSAY DRUG DEV TECHN, V11, P227, DOI 10.1089/adt.2012.480; Hsiao K, 2016, EPIGENOMICS-UK, V8, P321, DOI 10.2217/epi.15.113; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Huang Z, 2013, CANCER RES, V73, P6277, DOI 10.1158/0008-5472.CAN-13-1000; Hudlebusch HR, 2011, CANCER RES, V71, P4226, DOI 10.1158/0008-5472.CAN-10-3810; Hudlebusch HR, 2011, CLIN CANCER RES, V17, P2919, DOI 10.1158/1078-0432.CCR-10-1302; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Johnston PA, 2008, ASSAY DRUG DEV TECHN, V6, P505, DOI 10.1089/adt.2008.151; Kassambara A, 2009, BIOCHEM BIOPH RES CO, V379, P840, DOI 10.1016/j.bbrc.2008.12.093; Keats JJ, 2005, BLOOD, V105, P4060, DOI 10.1182/blood-2004-09-3704; Keats JJ, 2003, BLOOD, V101, P1520, DOI 10.1182/blood-2002-06-1675; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Kimos M, 2016, J BIOMOL SCREEN, V21, P490, DOI 10.1177/1087057115616793; Kozian DH, 2012, BIOORG MED CHEM LETT, V22, P5239, DOI 10.1016/j.bmcl.2012.06.057; Kumar M., 2015, ASSAY DRUG DEV TECHN, V13, P200, DOI 10.1089/adt.2014.60925710335; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Lazo JS, 2001, J MED CHEM, V44, P4042, DOI 10.1021/jm0102046; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Li J, 2008, NEURO-ONCOLOGY, V10, P45, DOI 10.1215/15228517-2007-036; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Liu Q, 2016, ACTA PHARMACOL SIN, V37, P1273, DOI 10.1038/aps.2016.64; Luo MK, 2012, ACS CHEM BIOL, V7, P443, DOI 10.1021/cb200519y; Ma H., 2015, EPIGENETICS DRUG DIS, P267; Ma HC, 2008, EXPERT OPIN DRUG DIS, V3, P607, DOI 10.1517/17460441.3.6.607; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573; McGrath J, 2015, PHARMACOL THERAPEUT, V150, P1, DOI 10.1016/j.pharmthera.2015.01.002; Michael S, 2008, ASSAY DRUG DEV TECHN, V6, P637, DOI 10.1089/adt.2008.150; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Morrison MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197082; Okabe H, 2001, CANCER RES, V61, P2129; Orena S, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00115; Oyer JA, 2014, LEUKEMIA, V28, P198, DOI 10.1038/leu.2013.204; Popovic R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004566; Qian J, 2013, ASSAY DRUG DEV TECHN, V11, P449, DOI 10.1089/adt.2013.515; Quinn AM, 2010, MOL BIOSYST, V6, P782, DOI 10.1039/b921912a; Richon VM, 2011, CHEM BIOL DRUG DES, V78, P199, DOI 10.1111/j.1747-0285.2011.01135.x; Saloura V, 2015, MOL CANCER RES, V13, P293, DOI 10.1158/1541-7786.MCR-14-0292-T; Sankaran SM, 2016, J BIOL CHEM, V291, P8465, DOI 10.1074/jbc.M116.720748; Santra M, 2003, BLOOD, V101, P2374, DOI 10.1182/blood-2002-09-2801; Schnitzler G. R., 2001, CURR PROTOC MOL BIOL, V2001, DOI 10.1002/0471142727.mb2105s5018265197; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Soares KM, 2010, ASSAY DRUG DEV TECHN, V8, P152, DOI 10.1089/adt.2009.0247; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tanega C, 2009, ASSAY DRUG DEV TECHN, V7, P606, DOI 10.1089/adt.2009.0230; Tisi D, 2016, ACS CHEM BIOL, V11, P3093, DOI 10.1021/acschembio.6b00308; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xiao M, 2013, J SURG ONCOL, V107, P428, DOI 10.1002/jso.23234; Yang SS, 2013, BIOMARKERS, V18, P257, DOI 10.3109/1354750X.2013.773082; Zheng YP, 2016, MOL CELL PROTEOMICS, V15, P776, DOI 10.1074/mcp.M115.053819; Zheng YP, 2012, P NATL ACAD SCI USA, V109, P13549, DOI 10.1073/pnas.1205707109	84	31	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13750	13765		10.1074/jbc.RA118.004274	http://dx.doi.org/10.1074/jbc.RA118.004274			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29945974	hybrid, Green Published			2022-12-26	WOS:000443375500033
J	Zhao, WK; Liu, MJ; Ji, HJ; Zhu, YR; Wang, CC; Huang, YK; Ma, XQ; Xing, GD; Xia, Y; Jiang, Q; Qin, JZ				Zhao, Wukui; Liu, Mengjie; Ji, Haijing; Zhu, Yaru; Wang, Congcong; Huang, Yikai; Ma, Xiaoqi; Xing, Guangdong; Xia, Yin; Jiang, Qing; Qin, Jinzhong			The polycomb group protein Yaf2 regulates the pluripotency of embryonic stem cells in a phosphorylation-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; polycomb; phosphorylation; epigenetics; differentiation; H2AK119ub1; PRC1; Yaf2	YY1 DNA-BINDING; H2A UBIQUITYLATION; PCG RECRUITMENT; REPO DOMAIN; IN-VIVO; COMPLEX; TRANSCRIPTION; CHROMATIN; RING1B; FAMILY	The polycomb group (PcG) proteins are key epigenetic regulators in stem cell maintenance. PcG proteins have been thought to act through one of two polycomb repressive complexes (PRCs), but more recent biochemical analyses have challenged this model in the identification of noncanonical PRC1 (nc-PRC1) complexes characterized by the presence of Rybp or Yaf2 in place of the canonical Chromobox proteins. However, the biological significance of these nc-PRC1s and the potential mechanisms by which they mediate gene repression are largely unknown. Here, we explore the functional consequences of Yaf2 disruption on stem cell regulation. We show that deletion of Yaf2 results in compromised proliferation and abnormal differentiation of mouse embryonic stem cells (mESCs). Genome-wide profiling indicates Yaf2 functions primarily as a transcriptional repressor, particularly impacting genes associated with ectoderm cell fate in a manner distinct from Rybp. We confirm that Yaf2 assembles into a noncanonical PRC complex, with deletion analysis identifying the region encompassing amino acid residues 102-150 as required for this assembly. Furthermore, we identified serine 166 as a Yaf2 phosphorylation site, and we demonstrate that mutation of this site to alanine (S166A) compromises Ring1B-mediated H2A monoubiquitination and in turn its ability to repress target gene expression. We therefore propose that Yaf2 and its phosphorylation status serve as dual regulators to maintain the pluripotent state in mESCs.	[Zhao, Wukui; Liu, Mengjie; Zhu, Yaru; Wang, Congcong; Huang, Yikai; Ma, Xiaoqi; Qin, Jinzhong] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, 12 Xuefu Rd, Nanjing 210032, Jiangsu, Peoples R China; [Zhao, Wukui; Liu, Mengjie; Zhu, Yaru; Wang, Congcong; Huang, Yikai; Ma, Xiaoqi; Qin, Jinzhong] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210032, Jiangsu, Peoples R China; [Ji, Haijing] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China; [Xing, Guangdong] Jiangsu Acad Agr Sci, Inst Anim Sci, Nanjing 210014, Jiangsu, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Jiang, Qing] Nanjing Univ, Med Sch, Nanjing Drum Tower Hosp, Dept Sports Med & Adult Reconstruct Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Chinese University of Hong Kong; Nanjing University	Qin, JZ (corresponding author), Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, 12 Xuefu Rd, Nanjing 210032, Jiangsu, Peoples R China.; Qin, JZ (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210032, Jiangsu, Peoples R China.	qinjz@nicemice.cn	zhao, wukui/AAI-9846-2020; Xia, Yin/M-5440-2018	Xia, Yin/0000-0003-0315-7532	National Natural Science Foundation of China [31671532, 31471387]; 2015 Shuangchuang Program of Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 2015 Shuangchuang Program of Jiangsu Province	This work was supported by National Natural Science Foundation of China Grants 31671532 and 31471387 and the 2015 Shuangchuang Program of Jiangsu Province (to J. Q.). The authors declare that they have no conflicts of interest with the contents of this article.	Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Atlasi Y, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.57; Bannasch D, 2001, ONCOGENE, V20, P5913, DOI 10.1038/sj.onc.1204747; Basu A, 2014, NUCLEIC ACIDS RES, V42, P2208, DOI 10.1093/nar/gkt1187; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Huang YK, 2018, CELL REP, V22, P3032, DOI 10.1016/j.celrep.2018.02.072; Kalenik JL, 1997, NUCLEIC ACIDS RES, V25, P843, DOI 10.1093/nar/25.4.843; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Rose NR, 2016, ELIFE, V5, DOI [10.7554/elife.18591, 10.7554/eLife.18591]; Sawa C, 2002, J BIOL CHEM, V277, P22484, DOI 10.1074/jbc.M203060200; Schwartz YB, 2014, CELL REP, V8, P321, DOI 10.1016/j.celrep.2014.07.001; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sim YJ, 2017, STEM CELL REP, V8, P1312, DOI 10.1016/j.stemcr.2017.04.001; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Stanton SE, 2006, J BIOL CHEM, V281, P28782, DOI 10.1074/jbc.M603348200; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Turner SA, 2013, CELL STEM CELL, V12, P145, DOI 10.1016/j.stem.2013.01.014; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang RJ, 2010, STRUCTURE, V18, P966, DOI 10.1016/j.str.2010.04.013; Wilkinson F, 2010, J CELL BIOCHEM, V109, P478, DOI 10.1002/jcb.22424; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Yan Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep46276; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhao WK, 2017, J BIOL CHEM, V292, P21527, DOI 10.1074/jbc.M117.804054; Zhao WK, 2017, J BIOL CHEM, V292, P2773, DOI 10.1074/jbc.M116.763961	47	7	7	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12793	12804		10.1074/jbc.RA118.003299	http://dx.doi.org/10.1074/jbc.RA118.003299			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29959227	Green Published, hybrid			2022-12-26	WOS:000442203500013
J	Svidritskiy, E; Demo, G; Korostelev, AA				Svidritskiy, Egor; Demo, Gabriel; Korostelev, Andrei A.			Mechanism of premature translation termination on a sense codon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						translation release factor; translation regulation; ribosome structure; ribosome function; RNA-protein interaction; 70S ribosome; hot-spot sense codon; hydrophobic interactions; near-stop codon; -stacking	NUCLEIC-ACID BASES; 23S RIBOSOMAL-RNA; RELEASE FACTOR; STRUCTURAL BASIS; STOP-CODON; CRYSTAL-STRUCTURES; PEPTIDE; RECOGNITION; INSIGHTS; STACKING	Accurate translation termination by release factors (RFs) is critical for the integrity of cellular proteomes. Premature termination on sense codons, for example, results in truncated proteins, whose accumulation could be detrimental to the cell. Nevertheless, some sense codons are prone to triggering premature termination, but the structural basis for this is unclear. To investigate premature termination, we determined a cryo-EM structure of the Escherichia coli 70S ribosome bound with RF1 in response to a UAU (Tyr) sense codon. The structure reveals that RF1 recognizes a UAU codon similarly to a UAG stop codon, suggesting that sense codons induce premature termination because they structurally mimic a stop codon. Hydrophobic interaction between the nucleobase of U3 (the third position of the UAU codon) and conserved Ile-196 in RF1 is important for misreading the UAU codon. Analyses of RNA binding in ribonucleoprotein complexes or by amino acids reveal that Ile-U packing is a frequent protein-RNA-binding motif with key functional implications. We discuss parallels with eukaryotic translation termination by the release factor eRF1.	[Svidritskiy, Egor; Demo, Gabriel; Korostelev, Andrei A.] Univ Massachusetts, Sch Med, RNA Therapeut Inst, 368 Plantat St, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Korostelev, AA (corresponding author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, 368 Plantat St, Worcester, MA 01605 USA.	andrei.korostelev@umassmed.edu	Demo, Gabriel/D-7261-2012	Demo, Gabriel/0000-0002-5472-9249; Korostelev, Andrei/0000-0003-1588-717X	National Institutes of Health [R01 GM107465]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM107465. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amort M, 2007, NUCLEIC ACIDS RES, V35, P5130, DOI 10.1093/nar/gkm539; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bouakaz L, 2006, J BIOL CHEM, V281, P4548, DOI 10.1074/jbc.M510433200; Brown A, 2015, NATURE, V524, P493, DOI 10.1038/nature14896; Brown RF, 2015, J CHEM THEORY COMPUT, V11, P2315, DOI 10.1021/ct501170h; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; CHAPMAN MS, 1995, ACTA CRYSTALLOGR A, V51, P69, DOI 10.1107/S0108767394007130; Chavatte L, 2003, J MOL BIOL, V331, P745, DOI 10.1016/S0022-2836(03)00813-1; Chavatte L, 2002, EMBO J, V21, P5302, DOI 10.1093/emboj/cdf484; CHEN L, 1995, P NATL ACAD SCI USA, V92, P5077, DOI 10.1073/pnas.92.11.5077; CULLIS PM, 1981, BIOCHEMISTRY-US, V20, P3024, DOI 10.1021/bi00514a006; de Ruiter A, 2015, NUCLEIC ACIDS RES, V43, P708, DOI 10.1093/nar/gku1344; Delano WL., 2002, PYMOL MOL GRAPHICS S; Demo G, 2017, ELIFE, V6, DOI 10.7554/eLife.23687; Dunkle JA, 2010, ANNU REV BIOPHYS, V39, P227, DOI 10.1146/annurev.biophys.37.032807.125954; Florian J, 1999, J PHYS CHEM B, V103, P884, DOI 10.1021/jp983699s; Florin T, 2017, NAT STRUCT MOL BIOL, V24, P752, DOI 10.1038/nsmb.3439; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; FRIEDMAN RA, 1995, BIOPHYS J, V69, P1528, DOI 10.1016/S0006-3495(95)80023-8; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Frolova L, 2002, RNA, V8, P129, DOI 10.1017/S1355838202013262; Frolova L, 1996, RNA, V2, P334; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Grant T, 2018, ELIFE, V7, DOI 10.7554/eLife.35383; Grigorieff N, 2016, METHOD ENZYMOL, V579, P191, DOI 10.1016/bs.mie.2016.04.013; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Huter P, 2017, NATURE, V541, P546, DOI 10.1038/nature20821; Jafilan S, 2012, J PHYS CHEM B, V116, P3613, DOI 10.1021/jp209986y; James NR, 2016, SCIENCE, V354, P1437, DOI 10.1126/science.aai9127; Jin H, 2010, P NATL ACAD SCI USA, V107, P8593, DOI 10.1073/pnas.1003995107; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; Keeling KM, 2011, WIRES RNA, V2, P837, DOI 10.1002/wrna.95; Korkmaz G, 2017, J BIOL CHEM, V292, P15134, DOI 10.1074/jbc.M117.785238; Korostelev A, 2002, ACTA CRYSTALLOGR D, V58, P761, DOI 10.1107/S0907444902003402; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Korostelev AA, 2011, RNA, V17, P1409, DOI 10.1261/rna.2733411; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kryuchkova P, 2013, NUCLEIC ACIDS RES, V41, P4573, DOI 10.1093/nar/gkt113; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Loveland AB, 2017, NATURE, V546, P113, DOI 10.1038/nature22397; Lozupone C, 2003, RNA, V9, P1315, DOI 10.1261/rna.5114503; Luo R, 2001, BIOPHYS J, V80, P140, DOI 10.1016/S0006-3495(01)76001-8; Ma CY, 2017, NATURE, V541, P550, DOI 10.1038/nature20822; Majerfeld I, 1998, RNA, V4, P471; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Matheisl S, 2015, NUCLEIC ACIDS RES, V43, P8615, DOI 10.1093/nar/gkv909; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; Moras D, 1996, CURR BIOL, V6, P530, DOI 10.1016/S0960-9822(02)00534-1; Nakamura Y, 2011, WIRES RNA, V2, P647, DOI 10.1002/wrna.81; Noeske J, 2015, NAT STRUCT MOL BIOL, V22, P336, DOI 10.1038/nsmb.2994; Norberg J, 1998, BIOPHYS J, V74, P394, DOI 10.1016/S0006-3495(98)77796-3; Oshima K, 2018, ACTA CRYSTALLOGR F, V74, P57, DOI 10.1107/S2053230X17018039; Oshima K, 2016, BIOCHEM BIOPH RES CO, V474, P541, DOI 10.1016/j.bbrc.2016.04.118; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierson WE, 2016, CELL REP, V17, P11, DOI 10.1016/j.celrep.2016.08.085; Polacek N, 2003, MOL CELL, V11, P103, DOI 10.1016/S1097-2765(02)00825-0; Polikanov YS, 2015, NAT STRUCT MOL BIOL, V22, P342, DOI 10.1038/nsmb.2992; Ramakrishnan V, 2011, RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS, P19; Rawat U, 2006, J MOL BIOL, V357, P1144, DOI 10.1016/j.jmb.2006.01.038; Salas-Marco J, 2004, MOL CELL BIOL, V24, P7769, DOI 10.1128/MCB.24.17.7769-7778.2004; Shao SC, 2016, CELL, V167, P1229, DOI 10.1016/j.cell.2016.10.046; Shih P, 1998, J MOL BIOL, V280, P421, DOI 10.1006/jmbi.1998.1880; Sund J, 2010, NATURE, V465, P947, DOI 10.1038/nature09082; Svidritskiy E, 2018, STRUCTURE, V26, P821, DOI 10.1016/j.str.2018.04.001; Svidritskiy E, 2018, J MOL BIOL, V430, P591, DOI 10.1016/j.jmb.2018.01.007; Svidritskiy E, 2016, J MOL BIOL, V428, P2228, DOI 10.1016/j.jmb.2016.04.018; Svidritskiy E, 2014, STRUCTURE, V22, P1210, DOI 10.1016/j.str.2014.06.003; TATE WP, 1984, J BIOL CHEM, V259, P7317; TSUKADA K, 1984, CHEM PHARM BULL, V32, P1929; Van Dyke N, 2003, J MOL BIOL, V330, P9, DOI 10.1016/S0022-2836(03)00537-0; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Wilson KA, 2016, RNA, V22, P696, DOI 10.1261/rna.054924.115; WOESE CR, 1966, P NATL ACAD SCI USA, V55, P966, DOI 10.1073/pnas.55.4.966; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zeng FX, 2017, NATURE, V541, P554, DOI 10.1038/nature21053; Zhu CQ, 2016, P NATL ACAD SCI USA, V113, P12946, DOI 10.1073/pnas.1616138113	84	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12472	12479		10.1074/jbc.AW118.003232	http://dx.doi.org/10.1074/jbc.AW118.003232			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29941456	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000441408500013
J	Lai, WS; Wen, LM; Li, YB; Huang, XH; Qing, ZZ				Lai, Weisi; Wen, Lieming; Li, Yinbo; Huang, Xinghua; Qing, Zhenzhen			Concordance of tomographic ultrasound and multiplanar ultrasound in detecting levator ani muscle injury in patients with pelvic organ prolapse	PLOS ONE			English	Article							CYSTOCELE RECURRENCE; FLOOR ULTRASOUND; AVULSION; TRAUMA; ANATOMY; REPAIR; IMPACT; WOMEN	Aim To compare the evaluations of evaluate levator ani muscle injury (LAMI) by tomographic ultrasound imaging (TUI) and multiplanar (MP) ultrasound in patients with pelvic organ prolapse (POP). Method This retrospective analysis studied women who underwent International Continence Society POP quantification examination between October 2015 and June 2016. LAMI was assessed by both TUI and MP ultrasounds. Concordance of these two testing results was analyzed. Their correlations with clinical symptoms were also studied. Results A total of 135 women were included. All the patients with POP had a minimal LAMI depth >= 7 mm. Two examinations, TUI and MP, had satisfactory concordance (k = 0.71, P < 0.01). Depth of LAMI in the coronal plane demonstrated good agreement with TUI scores (r = 0.84; P < 0.01). After controlling for age, BMI, and parity, to have clinically significant POP and POP symptoms, the odds ratios (ORs) for the depth of LAMI in the coronal plane were 1.31 (95% CI 1.19-1.44) and 1.25 (95% CI 1.14-1.36), and for TUI scores were 1.72 (95% CI 1.37-2.17) and 1.63 (95% CI 1.31-2.03). Receiver operating characteristic curve analyses showed a cutoff depth of 7 mm of LAMI yielded a sensitivity of 62% and specificity of 80% for POP symptoms. Conclusions TUI and MP had satisfactory concordance in detecting LAMI and correlated with clinical symptoms of POP.	[Lai, Weisi] Cent South Univ, Xiangya Hosp 2, Dept Obstet & Gynecol, Changsha, Hunan, Peoples R China; [Wen, Lieming; Huang, Xinghua; Qing, Zhenzhen] Cent South Univ, Xiangya Hosp 2, Dept Ultrasound Diag, Changsha, Hunan, Peoples R China; [Li, Yinbo] Food & Drug Adm, Dept Drug Evaluat & ADR Monitoring, Changsha, Hunan, Peoples R China	Central South University; Central South University	Wen, LM (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Ultrasound Diag, Changsha, Hunan, Peoples R China.	wen_lieming@csu.edu.cn		Wen, Lieming/0000-0003-3283-888X				Abdool Z, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.005; Chan SSC, 2012, ULTRASOUND OBST GYN, V39, P704, DOI 10.1002/uog.10132; DELANCEY JOL, 1994, CURR OPIN OBSTET GYN, V6, P313; Dietz HP, 2008, INT UROGYNECOL J, V19, P1097, DOI 10.1007/s00192-008-0575-1; Dietz HP, 2007, ULTRASOUND OBST GYN, V29, P329, DOI 10.1002/uog.3951; Dietz HP, 2016, ULTRASOUND OBST GYN, V47, P363, DOI 10.1002/uog.14872; Dietz HP, 2014, INT UROGYNECOL J, V25, P451, DOI 10.1007/s00192-013-2307-4; Dietz HP, 2012, ULTRASOUND OBST GYN, V40, P693, DOI 10.1002/uog.11190; Dietz HP, 2011, INT UROGYNECOL J, V22, P699, DOI 10.1007/s00192-010-1329-4; Dietz HP, 2017, CLIN OBSTET GYNECOL, V60, P58, DOI 10.1097/GRF.0000000000000264; Dietz HP, 2016, INT UROGYNECOL J, V27, P909, DOI 10.1007/s00192-015-2909-0; Dietz HP, 2013, AUST NZ J OBSTET GYN, V53, P220, DOI 10.1111/ajo.12059; Dietz HP, 2011, INT UROGYNECOL J, V22, P1085, DOI 10.1007/s00192-011-1402-7; Dietz HP, 2016, NONCOMMERCIAL NO DER, P83; Durnea CM, 2015, ULTRASOUND OBST GYN, V46, P356, DOI 10.1002/uog.14711; Eickmeyer SM, 2017, PHYS MED REH CLIN N, V28, P455, DOI 10.1016/j.pmr.2017.03.003; Friedman T, 2018, INT UROGYNECOL J, V29, P13, DOI 10.1007/s00192-017-3475-4; Graybum PA, 2015, AM J CARDIOL, V116, P913, DOI 10.1016/j.amjcard.2015.06.015; Rojas RG, 2014, INT UROGYNECOL J, V25, P375, DOI 10.1007/s00192-013-2226-4; Lammers K, 2012, INT UROGYNECOL J, V23, P1653, DOI 10.1007/s00192-012-1805-0; Notten KJB, 2014, OBSTET GYNECOL, V124, P1190, DOI 10.1097/AOG.0000000000000560; Rostaminia G, 2016, INT UROGYNECOL J, V27, P261, DOI 10.1007/s00192-015-2827-1; Rostaminia G, 2013, INT UROGYNECOL J, V24, P1237, DOI 10.1007/s00192-012-1912-y; Shobeiri SA, 2013, BJOG-INT J OBSTET GY, V120, P205, DOI 10.1111/1471-0528.12055; Svabik K, 2014, ULTRASOUND OBST GYN, V43, P365, DOI 10.1002/uog.13305; Thibault-Gagnon S, 2014, INT UROGYNECOL J, V25, P1389, DOI 10.1007/s00192-014-2331-z; Wen LM, 2018, J ULTRAS MED, V37, P1001, DOI 10.1002/jum.14445; Wong V, 2013, ULTRASOUND OBST GYN, V42, P230, DOI 10.1002/uog.12433; Wong V, 2014, EUR J OBSTET GYN R B, V172, P131, DOI 10.1016/j.ejogrb.2013.11.001; Xiong Y, 2010, ULTRASOUND OBST GYN, V36, P136, DOI 10.1002/uog.7613	30	0	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199864	10.1371/journal.pone.0199864	http://dx.doi.org/10.1371/journal.pone.0199864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979693	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500037
J	Vitale, MG; Scagliarini, S; Galli, L; Pignata, S; Lo Re, G; Berruti, A; Defferrari, C; Spada, M; Masini, C; Santini, D; Ciuffreda, L; Ruggeri, EM; Bengala, C; Livi, L; Fagnani, D; Bonetti, A; Giustini, L; Hamzaj, A; Procopio, G; Caserta, C; Sabbatini, R				Vitale, Maria Giuseppa; Scagliarini, Sarah; Galli, Luca; Pignata, Sandro; Lo Re, Giovanni; Berruti, Alfredo; Defferrari, Carlotta; Spada, Massimiliano; Masini, Cristina; Santini, Daniele; Ciuffreda, Libero; Ruggeri, Enzo Maria; Bengala, Carmelo; Livi, Lorenzo; Fagnani, Daniele; Bonetti, Andrea; Giustini, Lucio; Hamzaj, Alketa; Procopio, Giuseppe; Caserta, Claudia; Sabbatini, Roberto			Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy	PLOS ONE			English	Article							EVEROLIMUS; CANCER	Background Results from phase III clinical trial CheckMate 025 have established nivolumab as the standard of care for treatment of metastatic renal-cell carcinoma (mRCC) after VEGF inhibitor failure; however, elderly patients are under-represented in the registration trial and little is known about the activity of nivolumab in this subgroup. The purpose of the Expanded Access Program was to provide nivolumab to patients with mRCC who had progressed despite treatment with other agents that were considered standard of care. Methods Nivolumab 3 mg/kg was administered intravenously every 2 weeks to a maximum of 24 months or until progression or unacceptable toxicity. The current analysis included all patients from the EAP Italian cohort who had received >= 1 dose of nivolumab. Adverse events (AEs) were monitored using Common Terminology Criteria for Adverse Events v4.0. Results A total of 389 patients with advanced RCC were enrolled in the Italian cohort of the EAP and treated with nivolumab. Of these patients, 125 (32%) were at least 70 years of age and 70 (18%) were at least 75 years of age. Efficacy with nivolumab in the elderly patients was similar to that observed in the overall EAP population and in the CheckMate 025 trial. Safety was comparable between the elderly patients and the overall EAP population, and was consistent with what previously reported. Conclusion The final results suggest that elderly patients with pretreated metastatic RCC may benefit from therapy with nivolumab.	[Vitale, Maria Giuseppa; Sabbatini, Roberto] Azienda Osped Univ Modena, Modena, Italy; [Scagliarini, Sarah] AORN A Cardarelli, Naples, Italy; [Galli, Luca] Azienda Osped Univ Pisana, Pisa, Italy; [Pignata, Sandro] Ist Nazl Tumori IRCCS Fdn Pascale, Naples, Italy; [Lo Re, Giovanni] Azienda Osped Santa Maria Angeli, Pordenone, Italy; [Berruti, Alfredo] Azienda Socio Sanit Terr Spedali Civili Brescia, Brescia, Italy; [Defferrari, Carlotta] Osped Galliera, Genoa, Italy; [Spada, Massimiliano] Fdn Ist Giglio, Cefalu, Italy; [Masini, Cristina] Arcispedale Santa Maria Nuova Reggio Emilia, Reggio Emilia, Italy; [Santini, Daniele] Policlin Univ Campus Biomed, Rome, Italy; [Ciuffreda, Libero] Azienda Osped Univ Citta Salute & Sci, Turin, Italy; [Ruggeri, Enzo Maria] Osped Belcolle, Viterbo, Italy; [Bengala, Carmelo] USL 9 Presidio Osped Misericordia, Grosseto, Italy; [Livi, Lorenzo] Univ Firenze, Florence, Italy; [Fagnani, Daniele] ASST DI Vimercate, Vimercate, Italy; [Bonetti, Andrea] Mater Salutis Hosp, Legnago, Italy; [Giustini, Lucio] Area Vasta 4, Fermo, Italy; [Hamzaj, Alketa] Azienda USL 8 Arezzo, Arezzo, Italy; [Procopio, Giuseppe] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Caserta, Claudia] Azienda Osped Santa Maria Terni, Terni, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; University of Pisa; Azienda Ospedaliero Universitaria Pisana; IRCCS Fondazione Pascale; Azienda Ospedaliera Santa Maria degli Angeli Pordenone; Ente Ospedaliero Ospedali Galliera; IRCCS Arcispedale S. Maria Nuova; University Campus Bio-Medico - Rome Italy; A.O.U. Citta della Salute e della Scienza di Torino; University of Florence; ULSS 9 Scaligera; Ospedale Mater Salutis di Legnago; Fondazione IRCCS Istituto Nazionale Tumori Milan	Vitale, MG (corresponding author), Azienda Osped Univ Modena, Modena, Italy.	vitalemariag@gmail.com	Sabbatini, Roberto/AAC-5398-2022; Berruti, Alfredo/AAC-2069-2019; Sabbatini, Roberto/AAC-5739-2022; Re, Giovanni Lo/ABE-1780-2020; Vitale, Maria Giuseppa/ABA-3200-2020; Bonetti, Andrea/AAL-6623-2020	Sabbatini, Roberto/0000-0002-8943-7545; Re, Giovanni Lo/0000-0003-1169-2359; pignata, sandro/0000-0002-8836-2633; Vitale, Maria Giuseppa/0000-0001-8551-266X; Galli, Luca/0000-0001-6008-0266				Choueiri TK, 2016, LANCET ONCOL, V17, P917, DOI 10.1016/S1470-2045(16)30107-3; Coppin C., 2005, COCHRANE DB SYST REV, V25; De Giorgi U, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.4577; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Hamid O, 2013, EXPERT OPIN BIOL TH, V13, P847, DOI 10.1517/14712598.2013.770836; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Nurieva RI, 2011, IMMUNOL REV, V241, P133, DOI 10.1111/j.1600-065X.2011.01012.x; Quivy A, 2013, CLIN INTERV AGING, V8, P433, DOI 10.2147/CIA.S30765; Ramos-Barcelo E, 2009, CRIT REV ONCOL HEMAT, V72, P83, DOI 10.1016/j.critrevonc.2009.02.005	9	20	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199642	10.1371/journal.pone.0199642	http://dx.doi.org/10.1371/journal.pone.0199642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979712	Green Published, gold, Green Submitted			2022-12-26	WOS:000437809500025
J	Berhanu, H; Kiflie, Z; Miranda, I; Lourenco, A; Ferreira, J; Feleke, S; Yimam, A; Pereira, H				Berhanu, Hanna; Kiflie, Zebene; Miranda, Isabel; Lourenco, Ana; Ferreira, Joana; Feleke, Sisay; Yimam, Abubeker; Pereira, Helena			Characterization of crop residues from false banana /Ensete ventricosum/ in Ethiopia in view of a full-resource valorization	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; VEGETABLE WASTES; PLANT; DEGRADABILITY; BEHAVIOR; FIBERS; YIELD; STRAW; FRUIT; PARTS	False banana /Ensete ventricosum [Welw.] Cheesman/ is exploited as a food crop in Ethiopia where it represents an important staple food. The plant is harvested and large amounts of biomass residues are originated, mainly from the pseudo stem (i.e., fiber bundles obtained from the leaf sheaths after being scrapped to produce starchy food) and the inflorescence stalk. These materials were studied in relation to their summative chemical composition, composition of lignin, lipophilic and polar extracts. Moreover, their structural characteristics, in view of their valorization, were scrutinized. The analytical studies were performed with the aid of FTIR, GC/MS, Py-GC/MS and SEM. The fiber bundles are aggregates of mainly long and slender fibers with low ash, extractives and lignin contents (3.8%. 4.4% and 10.5% respectively) and high holocellulose and alpha-cellulose contents (87.5% and 59.6% respectively). The hemicelluloses in the fibers are mostly highly acetylated xylans and the lignin is of the H-type (H:G:S, 1:0.7:0.8). This lignin composition is in line with the FTIR peaks at 1670 cm(-1) and 1250 cm(-1).The inflorescence stalk has high ash content (12.3% in the main stalk and 24.6% in fines) with a major proportion of potassium, high extractives (25.9%), and low lignin and alpha-cellulose contents (5.8% and 17.9% respectively). The stalk includes numerous starch granules in the cellular structure with the predominant presence of parenchyma. The potential valorization routes for these materials are clearly different. The fiber bundles could be used as a fiber source for paper pulp production with the possibility of a prior hemicelluloses removal while the inflorescence stalk has nutritional value for food and fodder. Furthermore, it can also be used for sugar fermentation products.	[Berhanu, Hanna; Kiflie, Zebene; Yimam, Abubeker] Addis Ababa Inst Technol, Sch Chem & Bioengn, Addis Ababa, Ethiopia; [Miranda, Isabel; Lourenco, Ana; Ferreira, Joana; Pereira, Helena] Univ Lisbon, Ctr Estudos Florestais, Inst Super Agron, Lisbon, Portugal; [Feleke, Sisay] Ethiopian Environm & Forest Res Inst, Addis Ababa, Ethiopia	Universidade de Lisboa	Berhanu, H (corresponding author), Addis Ababa Inst Technol, Sch Chem & Bioengn, Addis Ababa, Ethiopia.; Pereira, H (corresponding author), Univ Lisbon, Ctr Estudos Florestais, Inst Super Agron, Lisbon, Portugal.	berhanu.hanna@yahoo.com; hpereira@ulisboa.pt	Lourenço, Ana/A-5901-2011; Kiflie, Zebene/AAE-1721-2019; Pereira, Helena/V-5236-2019; Ferreira, Joana/I-6369-2019; Kiflie, Zebene/ABD-6122-2021	Lourenço, Ana/0000-0003-4896-344X; Pereira, Helena/0000-0002-5393-4443; Ferreira, Joana/0000-0002-7637-3466; Kiflie, Zebene/0000-0001-5511-9808; Lemma, Hanna Berhanu/0000-0002-7260-276X; Miranda, Isabel/0000-0003-0280-5219	Addis Ababa University, Institute of Technology, Ethiopia by SIDA; Portuguese Science Foundation (FCT) [SFRH/BPD/95385/2013, UID/AGR/00239/2013]; Instituto superior de Agronomia	Addis Ababa University, Institute of Technology, Ethiopia by SIDA; Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology); Instituto superior de Agronomia	HB is funded by Addis Ababa University, Institute of Technology, Ethiopia who is funded by SIDA Short-term research visit to Instituto superior de Agronomia. AL is funded by a post-doctoral grant (SFRH/BPD/95385/2013) from the Portuguese Science Foundation (FCT) who also financed the Forest Research Center (CEF) under UID/AGR/00239/2013. All the expenses related to this research and publication fee was covered by Instituto superior de Agronomia.	Abdalla S, 2014, BIORESOURCES, V9, P3396; Abrham Wondimu, 2014, Journal of Drug Delivery and Therapeutics, V4, P1; [Anonymous], 1997, TREE HUNGER ENSET BA; Ayalew A, 2011, INNOVATIVE SYS DES E, V2, P26; BAKER R. E. D., 1953, Kew Bulletin, P405, DOI 10.2307/4115529; Bhatnagar R, 2015, INT J SCI ENG RES, V6; Bilba K, 2007, BIORESOURCE TECHNOL, V98, P58, DOI 10.1016/j.biortech.2005.11.030; Bridgeman TG, 2007, FUEL, V86, P60, DOI 10.1016/j.fuel.2006.06.022; Buranov AU, 2008, IND CROP PROD, V28, P237, DOI 10.1016/j.indcrop.2008.03.008; Carvalheiro F, 2009, APPL BIOCHEM BIOTECH, V153, P84, DOI 10.1007/s12010-008-8448-0; Chen H, 2010, CARBOHYD POLYM, V82, P772, DOI 10.1016/j.carbpol.2010.05.052; Cordeiro N, 2004, IND CROP PROD, V19, P147, DOI 10.1016/j.indcrop.2003.09.001; Cordeiro N, 2006, CONTACT ANGLE, WETTABILITY AND ADHESION, VOL 4, P387; del Rio JC, 2007, J ANAL APPL PYROL, V79, P39, DOI 10.1016/j.jaap.2006.09.003; Fahn A., 1974, PLANT ANATOMY; Fekadu D, 1997, LIVEST PROD SCI, V49, P249, DOI 10.1016/S0301-6226(97)00047-X; Forsido SF, 2013, INT J FOOD SCI NUTR, V64, P915, DOI 10.3109/09637486.2013.806448; Gominho J, 2009, IND CROP PROD, V29, P116, DOI 10.1016/j.indcrop.2008.04.022; Jackson M. L., 1958, Soil Chemical Analysis.; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Li K, 2010, BIORESOURCES, V5, P576; Liu XL, 2011, FUEL PROCESS TECHNOL, V92, P1273, DOI 10.1016/j.fuproc.2011.01.016; Lourenco A, 2013, J ANAL APPL PYROL, V101, P142, DOI 10.1016/j.jaap.2013.01.018; Mizera C., 2016, Scientia Agriculturae Bohemica, V47, P90; Mizera C., 2015, Agronomy Research, V13, P680; Mizera C, 2017, J NAT FIBERS, V14, P187; Mohammed B., 2013, African Journal of Agricultural Research, V8, P2326; Moniz P, 2014, IND CROP PROD, V62, P460, DOI 10.1016/j.indcrop.2014.09.020; Moniz P, 2013, IND CROP PROD, V50, P145, DOI 10.1016/j.indcrop.2013.06.037; Nurfeta A, 2008, ANIM FEED SCI TECH, V146, P55, DOI 10.1016/j.anifeedsci.2007.12.003; Nurfeta A, 2008, TROP ANIM HEALTH PRO, V40, P299, DOI 10.1007/s11250-007-9095-0; Oliveira L, 2009, IND CROP PROD, V29, P86, DOI 10.1016/j.indcrop.2008.04.012; Oliveira L, 2007, IND CROP PROD, V26, P163, DOI 10.1016/j.indcrop.2007.03.002; Oliveira L, 2005, IND CROP PROD, V22, P187, DOI 10.1016/j.indcrop.2004.10.001; Panda SK, 2018, CRIT REV BIOTECHNOL, V38, P1, DOI 10.1080/07388551.2017.1311295; Panda SK, 2016, ENVIRON RES, V146, P161, DOI 10.1016/j.envres.2015.12.035; Quilho T, 2004, IAWA J, V25, P217, DOI 10.1163/22941932-90000362; Quinlan RJ, 2015, J ETHNOBIOL, V35, P314, DOI 10.2993/etbi-35-02-314-336.1; Rahman M.M., 2014, INT J LIGNOCELLULOSI, V1, P93; RALPH J, 1991, J AGR FOOD CHEM, V39, P1426, DOI 10.1021/jf00008a014; Ramadevi P, 2012, BIORESOURCES, V7, P3515; Rowell R.M., 2005, HDB WOOD CHEM WOOD C; Sartori C, 2016, HOLZFORSCHUNG, V70, P819, DOI 10.1515/hf-2015-0258; Sharma OP, 2009, FOOD CHEM, V113, P1202, DOI 10.1016/j.foodchem.2008.08.008; Shumbulo A., 2012, FOOD SCI QUALITY MAN, V7, P24; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Smeds H, 1955, ACTA GEOGR, P1; Solomon Zewdie, 2008, Sinet, Ethiopian Journal of Science, V31, P81; Tsegaye A, 2001, NETH J AGR SCI, V49, P81, DOI 10.1016/S1573-5214(01)80017-8; Tsegaye A, 1992, PLANT RESOURCES TROP; Yemane Tsehaye, 2006, Ethnobotany Research and Applications, V4, P147	51	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199422	10.1371/journal.pone.0199422	http://dx.doi.org/10.1371/journal.pone.0199422			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975715	Green Published, gold			2022-12-26	WOS:000437424500032
J	Kim, TH; Lee, EJ; Choi, JH; Yim, SY; Lee, S; Kang, J; Lee, YR; Lee, HA; Choi, HS; Kim, ES; Keum, B; Seo, YS; Vim, HJ; Jeen, YT; Chun, HJ; Lee, HS; Kim, CD; Woo, HG; Um, SH				Kim, Tae Hyung; Lee, Eun-Ju; Choi, Ji-Hye; Yim, Sun Young; Lee, Sunwon; Kang, Jaewoo; Lee, Yoo Ra; Lee, Han Ah; Choi, Hyuk Soon; Kim, Eun Sun; Keum, Bora; Seo, Yeon Seok; Vim, Hyung Joon; Jeen, Yoon Tee; Chun, Hoon Jai; Lee, Hong Sik; Kim, Chang Duck; Woo, Hyun Goo; Um, Soon Ho			Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B	PLOS ONE			English	Article							VIRUS X PROTEIN; GENOME-WIDE ASSOCIATION; 7 AGONIST GS-9620; HBSAG SEROCLEARANCE; DISEASE PROGRESSION; DELAYED CLEARANCE; CHRONIC CARRIERS; SERUM HBSAG; FOLLOW-UP; INFECTION	Background/Aims The seroclearance of hepatitis B virus (HBV) surface antigen (HBsAg) is regarded as a functional cure of chronic hepatitis B (CHB) although it occurs rarely. Recently, several genome-wide association studies (GWASs) revealed various genetic alterations related to the clinical course of HBV infection. However, all of these studies focused on the progression of HBV infection to chronicity and had limited application because of the heterogeneity of HBV genotypes. In the present study, we aimed to determine susceptibility genetic markers for seroclearance of HBsAg in CHB patients with a homogenous viral genotype. Methods One hundred patients with CHB who had experienced HBsAg seroclearance before 60 years of age and another 100 with CHB showing high serum levels of HBsAg even after 60 years of age were enrolled. Extreme-phenotype GWAS was conducted using blood samples of participants. Results We identified three single nucleotide polymorphisms, rs7944135 (P=4.17 x 10(-6), odds ratio [OR] = 4.16, 95% confidence interval [CI] = 2.27-7.63) at 11q12.1, rs171941 (P=3.52x10(-6), OR = 3.69, 95% CI = 2.13-6.42) at 5q14.1, and rs6462008 (P = 3.40 x 10(-6), OR = 0.34, 95% CI = 0.22-0.54) at 7p15.2 as novel susceptibility loci associated with HBsAg seroclearance in patients with CHB. The flanking genes at these loci including MPEG1, DTX4, MTX3, and HOXA13 were suggested to have functional significance. In addition, through functional analysis, CXCL13 was also presumed to be related. Conclusions To the best of our knowledge, this study is the first GWAS regarding the seroclearance of HBsAg in CHB patients. We identify new susceptibility loci for cure of CHB, providing new insights into its pathophysiology.	[Kim, Tae Hyung; Yim, Sun Young; Lee, Yoo Ra; Lee, Han Ah; Choi, Hyuk Soon; Kim, Eun Sun; Keum, Bora; Seo, Yeon Seok; Vim, Hyung Joon; Jeen, Yoon Tee; Chun, Hoon Jai; Lee, Hong Sik; Kim, Chang Duck; Um, Soon Ho] Korea Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Lee, Eun-Ju; Choi, Ji-Hye; Woo, Hyun Goo] Ajou Univ, Sch Med, Dept Physiol, Suwon, South Korea; [Choi, Ji-Hye; Woo, Hyun Goo] Ajou Univ, Grad Sch, Dept Biomed Sci, Suwon, South Korea; [Lee, Sunwon; Kang, Jaewoo] Korea Univ, Dept Comp Sci & Engn, Coll Informat, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Ajou University; Ajou University; Korea University	Um, SH (corresponding author), Korea Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Woo, HG (corresponding author), Ajou Univ, Sch Med, Dept Physiol, Suwon, South Korea.; Woo, HG (corresponding author), Ajou Univ, Grad Sch, Dept Biomed Sci, Suwon, South Korea.	hg@ajou.ac.kr; umsh@korea.ac.kr	Yim, Sun Young/AAX-8128-2020; Woo, Hyun Goo | 우현구/I-8954-2019; Woo, Hyun Goo/AEJ-7372-2022	Yim, Sun Young/0000-0001-7346-5974; Woo, Hyun Goo | 우현구/0000-0002-0916-893X; Woo, Hyun Goo/0000-0002-0916-893X; Kim, Eun Sun/0000-0003-1820-459X; Lee, Hong Sik/0000-0001-9726-5416; Kim, Taehyung/0000-0002-7747-4293	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2012R1A5A2048183]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was funded in full by the National Research Foundation of Korea (NRF; https://www.nrf.re.kr) funded by the Korea government (MSIP), grant number NRF-2012R1A5A2048183. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bae SH, 2005, J KOREAN MED SCI, V20, P816, DOI 10.3346/jkms.2005.20.5.816; Bertoletti A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00441; BRUNETTO MR, 1991, P NATL ACAD SCI USA, V88, P4186, DOI 10.1073/pnas.88.10.4186; Chen YC, 2002, GASTROENTEROLOGY, V123, P1084, DOI 10.1053/gast.2002.36026; Cho EJ, 2017, CLIN MOL HEPATOL, V23, P205, DOI 10.3350/cmh.2017.0104; Cho IR, 2012, INT J MOL MED, V29, P581, DOI 10.3892/ijmm.2012.879; Chu CM, 2007, HEPATOLOGY, V45, P1187, DOI 10.1002/hep.21612; Chu CM, 2010, ANTIVIR THER, V15, P133, DOI 10.3851/IMP1497; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Ferreira SC, 2014, ANN HEPATOL, V13, P762, DOI 10.1016/S1665-2681(19)30978-0; Goodman AG, 2010, J VIROL, V84, P2027, DOI 10.1128/JVI.01595-09; Hu ZB, 2013, NAT GENET, V45, P1499, DOI 10.1038/ng.2809; Jiang JY, 2010, PROTEIN CELL, V1, P1106, DOI 10.1007/s13238-010-0141-8; Jilkova ZM, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3214917; Kato Y, 2000, J GASTROENTEROL, V35, P201, DOI 10.1007/s005350050331; Kim YJ, 2013, HUM MOL GENET, V22, P4233, DOI 10.1093/hmg/ddt266; Li L, 2018, J HEPATOL, V68, P912, DOI 10.1016/j.jhep.2017.12.008; Li YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11664; Liang KH, 2016, SCI REP-UK, V6, DOI 10.1038/srep34088; LIAW YF, 1991, HEPATOLOGY, V13, P627, DOI 10.1002/hep.1840130403; Liu C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00323; Liu J, 2010, GASTROENTEROLOGY, V139, P474, DOI 10.1053/j.gastro.2010.04.048; Nam Soon Woo, 2007, Korean Journal of Internal Medicine, V22, P73; Nishida N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086449; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; Niu CG, 2018, J HEPATOL, V68, P922, DOI 10.1016/j.jhep.2017.12.007; Ono K, 2010, PROTEIN CELL, V1, P161, DOI 10.1007/s13238-010-0017-y; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Park YM, 2016, WORLD J GASTROENTERO, V22, P9836, DOI 10.3748/wjg.v22.i44.9836; Publicover J, 2013, J CLIN INVEST, V123, P3728, DOI 10.1172/JCI68182; Quagliata L, 2014, HEPATOLOGY, V59, P911, DOI 10.1002/hep.26740; SPILSBURY K, 1995, BLOOD, V85, P1620, DOI 10.1182/blood.V85.6.1620.bloodjournal8561620; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Tseng TC, 2013, J GASTROENTEROL, V48, P13, DOI 10.1007/s00535-012-0668-y; Tseng TC, 2012, HEPATOLOGY, V55, P68, DOI 10.1002/hep.24615; Tseng TC, 2011, GASTROENTEROLOGY, V141, P517, DOI 10.1053/j.gastro.2011.04.046; Wang SH, 2015, J GASTROEN HEPATOL, V30, P1237, DOI 10.1111/jgh.12934; Wang XM, 2010, CELL MOL IMMUNOL, V7, P341, DOI 10.1038/cmi.2010.36; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Wieland SF, 2003, J VIROL, V77, P1227, DOI 10.1128/JVI.77.2.1227-1236.2003; Zhang KL, 2015, PROTEIN CELL, V6, P221, DOI 10.1007/s13238-014-0114-4	44	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199094	10.1371/journal.pone.0199094	http://dx.doi.org/10.1371/journal.pone.0199094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975729	Green Published, gold, Green Submitted			2022-12-26	WOS:000437424500022
J	Ngala, RA; Awe, MA; Nsiah, P				Ngala, Robert Amadu; Awe, Martin Akilla; Nsiah, Paul			The effects of plasma chromium on lipid profile, glucose metabolism and cardiovascular risk in type 2 diabetes mellitus. A case - control study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HUMAN ENDOTHELIAL-CELLS; INSULIN-RESISTANCE; CONTROLLED-TRIALS; ATHEROSCLEROSIS; DISEASE; SUPPLEMENTATION; SECRETION; KINASE; ADULTS	Background The study was aimed at determining the effect of plasma chromium concentration on the metabolism of glucose, and lipids and their subsequent cardiovascular risk in patients with type 2 diabetes in the Bolgatanga district of Ghana. Material and methods Fasting blood glucose and lipids profile were determined by enzymatic assay using the BT 5000 (R) Random Access Chemistry Analyzer. Fasting serum insulin and High sensitive C-reactive protein were determined by ELISA, a solid phase direct sandwich immunoassay method. HOMA-IR, which is based on fasting blood sample for insulin and glucose concentrations measured in a single blood sample, was used to calculate insulin resistance. Plasma chromium was measured using an atomic Absorption Spectrometer. Results Patientswith diabeteshad significantly (p<0.0001) increased LDL, TC, TG, VLDL, insulin, CRP and HOMAIR and a significantly reduced plasma chromium (p<0.0001) (0.53 +/- 0.02 mu g/I and 0.11 +/- 0.01 mu g/I control and case respectively). Low Cr (p <= 0.001) was associated with high blood pressure, obesity and lipid dysregulation. Plasma Cr significantly correlated negatively with blood pressure and LDL. Conclusion Lower plasma Cr level was associated with hyperglycaemia, hyperinsulinemia, hypertension, insulin resistance and high inflammation marker HsCRP.	[Ngala, Robert Amadu; Awe, Martin Akilla] KNUST, Sch Med Sci, Dept Mol Med, Kumasi, Ghana; [Nsiah, Paul] Univ Cape Coast, Dept Chem Pathol, Cape Coast, Ghana	Kwame Nkrumah University Science & Technology; University of Cape Coast	Ngala, RA (corresponding author), KNUST, Sch Med Sci, Dept Mol Med, Kumasi, Ghana.	mgala2000@yahoo.com	Nsiah, Paul/Y-7880-2019; Nsiah, Paul/GON-7685-2022	Nsiah, Paul/0000-0002-9925-1015; Ngala, Robert/0000-0001-6915-5914				Albarracini CA, 2008, DIABETES-METAB RES, V24, P41, DOI 10.1002/dmrr.755; AMOIKON EK, 1995, J ANIM SCI, V73, P1123; Anderson R.A., 1994, STRESS EFFECTS CHROM, P267; Anderson RA, 1997, J AM COLL NUTR, V16, P404, DOI 10.1080/07315724.1997.10718705; Anderson RA, 2000, DIABETES METAB, V26, P22; Anderson RA, 1997, DIABETES, V46, P1786, DOI 10.2337/diabetes.46.11.1786; Avramoglu RK, 2003, FRONT BIOSCI, V8, pD464, DOI 10.2741/1022; Bahijri SM, 2011, J CLIN BIOCHEM NUTR, V49, P164, DOI 10.3164/jcbn.10-148; Balk EM, 2007, DIABETES CARE, V30, P2154, DOI 10.2337/dc06-0996; Blake GJ, 2002, ARTERIOSCL THROM VAS, V22, P1512, DOI 10.1161/01.ATV.0000038145.59548.85; Cefalu WT, 2002, J NUTR, V132, P1107, DOI 10.1093/jn/132.6.1107; Davis CM, 1997, BIOCHEMISTRY-US, V36, P4382, DOI 10.1021/bi963154t; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Eriksson UK, LOW C REACTIVE PROTE, P26, DOI [10.1371/journal.pone.0070076, DOI 10.1371/JOURNAL.PONE.0070076]; ESCHWEGE E, 1985, REV EPIDEMIOL SANTE, V33, P352; Feng WW, 2015, J DIABETES INVEST, V6, P396, DOI 10.1111/jdi.12350; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; GINSBERG HN, 1991, DIABETES CARE, V14, P839, DOI 10.2337/diacare.14.9.839; Halbert JA, 1999, EUR J CLIN NUTR, V53, P514, DOI 10.1038/sj.ejcn.1600784; Horton F, 2014, DIABETIC MED, V31, P559, DOI 10.1111/dme.12360; Houldsworth A, 2017, INT J ENDOCRINOL MET, V3, DOI [10.16966/2380-548X.13, DOI 10.16966/2380-548X.13]; Hummel M, 2007, HORM METAB RES, V39, P743, DOI 10.1055/s-2007-985847; Jain SK, 2012, MOL NUTR FOOD RES, V56, P1333, DOI 10.1002/mnfr.201100719; Joseph E, 2015, INT J NUTR METABOLIS, V7, P24; Kelley-Hedgepeth A, 2008, CLIN CHEM, V54, P1027, DOI 10.1373/clinchem.2007.098996; KOZLOVSKY AS, 1986, METABOLISM, V35, P515, DOI 10.1016/0026-0495(86)90007-7; Lai MH, 2006, INT J VITAM NUTR RES, V76, P391, DOI 10.1024/0300-9831.76.6.391; Pasceri V, 2000, CIRCULATION, V102, P2165; Pasceri V, 2001, CIRCULATION, V103, P2531; Peng M, 2015, J INORG BIOCHEM, V146, P97, DOI 10.1016/j.jinorgbio.2015.01.002; Sahin K, 2007, METABOLISM, V56, P1233, DOI 10.1016/j.metabol.2007.04.021; SPARKS JD, 1994, BBA-LIPID LIPID MET, V1215, P9, DOI 10.1016/0005-2760(94)90088-4; STRIFFLER JS, 1995, METABOLISM, V44, P1314, DOI 10.1016/0026-0495(95)90036-5; Sundaram B, 2012, BIOFACTORS, V38, P59, DOI 10.1002/biof.194; Torzewski J, 1998, ARTERIOSCL THROM VAS, V18, P1386, DOI 10.1161/01.ATV.18.9.1386; Via Michael, 2012, ISRN Endocrinol, V2012, P103472, DOI 10.5402/2012/103472; Vincent JB, 2015, BIOL TRACE ELEM RES, V166, P7, DOI 10.1007/s12011-015-0231-9; Wang H, 2005, BIOCHEMISTRY-US, V44, P8167, DOI 10.1021/bi0473152; YANG J, 2016, IEEE T PATTERN ANAL, VPP, P1; Yin RV, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-14; Zwaka TP, 2001, CIRCULATION, V103, P1194	41	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0197977	10.1371/journal.pone.0197977	http://dx.doi.org/10.1371/journal.pone.0197977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975702	Green Submitted, Green Published, gold			2022-12-26	WOS:000437424500006
J	Xu, J; Lin, DI				Xu, Jia; Lin, Douglas, I			Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas	PLOS ONE			English	Article							NUCLEAR EXPORT; BREAST-CANCER; PHOSPHORYLATION; PALBOCICLIB; PROTEOLYSIS; CARCINOMA	Cyclin D1 (CCND1) is a core cell cycle regulator and is frequently overexpressed in human cancers, often via amplification, translocation or post-transcription regulation. Accumulating evidence suggests that mutations of the CCND1 gene that result in nuclear retention and constitutive activation of CDK4/6 kinases are oncogenic drivers in cancer. However, the spectrum of CCND1 mutations across human cancers has not been systematically investigated. Here, we retrospectively mined whole-exome sequencing data from 124 published studies representing up to 29,432 cases from diverse cancer types and sites of origin, including carcinoma, melanoma, sarcoma and lymphoma/leukemia, via online tools to determine the frequency and spectrum of CCND1 mutations in human cancers and their associated clinico-pathological characteristics. Overall, in contrast to gene amplification, which occurred at a frequency of 4.8% (1,419 of 28,769 cases), CCND1 mutations were of very low frequency (0.5%, 151 of 29,432 cases) across all cancers, but were predominantly enriched in uterine endometrioid-type adenocarcinoma (6.5%, 30 of 458 cases) in both primary tumors and in advanced, metastatic endometrial cancer samples. CCND1 mutations in endometrial endometrioid adenocarcinoma occurred most commonly in the c-terminus of cyclin D1, as putative driver mutations, in a region thought to result in oncogenic activation of cyclin D1 via inhibition of Thr-286 phosphorylation and nuclear export, thereby resulting in nuclear retention and protein overexpression. Our findings implicate oncogenic c-terminal mutations of CCND1 in the pathogenesis of a subset of human cancers and provide a key resource to guide future preclinical and clinical investigations.	[Xu, Jia; Lin, Douglas, I] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Lin, DI (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	dilin@bidmc.harvard.edu		Lin, Douglas/0000-0003-0105-9760				Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Dosil MA, 2017, J PATHOL, V242, P152, DOI 10.1002/path.4896; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Benzeno S, 2006, ONCOGENE, V25, P6291, DOI 10.1038/sj.onc.1209644; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011; Chandran UR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165395; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gladden AB, 2006, ONCOGENE, V25, P998, DOI 10.1038/sj.onc.1209147; Hardisson D, 2003, EUR ARCH OTO-RHINO-L, V260, P502, DOI 10.1007/s00405-003-0581-3; Ikeda Y, 2013, ONCOL REP, V30, P584, DOI 10.3892/or.2013.2515; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Lin DI, 2008, ONCOGENE, V27, P1231, DOI 10.1038/sj.onc.1210738; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; LUKAS J, 1994, ONCOGENE, V9, P2159; Mohanty A, 2016, ONCOTARGET, V7, P73558, DOI 10.18632/oncotarget.12434; Moreno-Bueno G, 2003, ONCOGENE, V22, P6115, DOI 10.1038/sj.onc.1206868; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Qie S, 2016, J MOL MED, V94, P1313, DOI 10.1007/s00109-016-1475-3; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Tanaka T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177019; Verma S, 2016, ONCOLOGIST, V21, P1165, DOI 10.1634/theoncologist.2016-0097; Vose Julie M, 2013, Am J Hematol, V88, P1082, DOI 10.1002/ajh.23615; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333	30	20	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199688	10.1371/journal.pone.0199688	http://dx.doi.org/10.1371/journal.pone.0199688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969496	Green Published, Green Submitted, gold			2022-12-26	WOS:000437246700023
J	Gilbert, MK; Mack, BM; Moore, GG; Downey, DL; Lebar, MD; Joardar, V; Losada, L; Yu, JJ; Nierman, WC; Bhatnagar, D				Gilbert, Matthew K.; Mack, Brian M.; Moore, Geromy G.; Downey, Darlene L.; Lebar, Matthew D.; Joardar, Vinita; Losada, Liliana; Yu, JiuJiang; Nierman, William C.; Bhatnagar, Deepak			Whole genome comparison of Aspergillus flavus L-morphotype strain NRRL 3357 (type) and S-morphotype strain AF70	PLOS ONE			English	Article							POPULATION GENETIC-ANALYSIS; AFLATOXIN PRODUCTION; CLUSTER; ORYZAE; BIOSYNTHESIS; SEQUENCE; PARASITICUS; EXPRESSION; MYCOTOXIN; ALIGNMENT	Aspergillus flavus is a saprophytic fungus that infects corn, peanuts, tree nuts and other agriculturally important crops. Once the crop is infected the fungus has the potential to secrete one or more mycotoxins, the most carcinogenic of which is aflatoxin. Aflatoxin contaminated crops are deemed unfit for human or animal consumption, which results in both food and economic losses. Within A. flavus, two morphotypes exist: the S strains (small sclerotia) and L strains (large sclerotia). Significant morphological and physiological differences exist between the two morphotypes. For example, the S-morphotypes produces sclerotia that are smaller (< 400 mu m), greater in quantity, and contain higher concentrations of aflatoxin than the L-morphotypes (>400 mu m). The morphotypes also differ in pigmentation, pH homeostasis in culture and the number of spores produced. Here we report the first full genome sequence of an A. flavus S morphotype, strain AF70. We provide a comprehensive comparison of the A. flavus S-morphotype genome sequence with a previously sequenced genome of an L-morphotype strain (NRRL 3357), including an in-depth analysis of secondary metabolic clusters and the identification SNPs within their aflatoxin gene clusters.	[Gilbert, Matthew K.; Mack, Brian M.; Moore, Geromy G.; Downey, Darlene L.; Lebar, Matthew D.; Bhatnagar, Deepak] USDA, Food & Feed Safety Unit, New Orleans, LA 70124 USA; [Joardar, Vinita; Losada, Liliana; Nierman, William C.] J Craig Venter Inst, Rockville, MD USA; [Yu, JiuJiang] USDA, Food Qual Lab, Beltsville, MD USA; [Joardar, Vinita] Natl Ctr Biotechnol Informat, Bethesda, MD USA; [Losada, Liliana] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA	United States Department of Agriculture (USDA); J. Craig Venter Institute; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gilbert, MK (corresponding author), USDA, Food & Feed Safety Unit, New Orleans, LA 70124 USA.	matthew.gilbert@ars.usda.gov		Lebar, Matthew/0000-0003-4910-1438; Gilbert, Matthew/0000-0002-8416-0217	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was funded by the United States Department of Agriculture.	Abbas HK, 2011, FOOD ADDIT CONTAM A, V28, P198, DOI 10.1080/19440049.2010.544680; Abbas HK, 2005, EUR J PLANT PATHOL, V112, P283, DOI 10.1007/s10658-004-4888-8; Amaike S, 2011, ANNU REV PHYTOPATHOL, V49, P107, DOI 10.1146/annurev-phyto-072910-095221; Aylor DL, 2006, BIOINFORMATICS, V22, P1399, DOI 10.1093/bioinformatics/btl136; Baan R, 2009, LANCET ONCOL, V10, P1143, DOI 10.1016/S1470-2045(09)70358-4; Baidya S, 2014, EUKARYOT CELL, V13, P1095, DOI 10.1128/EC.00099-14; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; BAYMAN P, 1993, CAN J BOT, V71, P23, DOI 10.1139/b93-003; Benvenuti M.E., 2010, RAPID ANAL AFLATOXIN; Bushnell B., 2014, BBMAP FAST ACCURATE; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Cary JW, 2015, EUKARYOT CELL, V14, P983, DOI 10.1128/EC.00092-15; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chitarrini G, 2014, INT J FOOD MICROBIOL, V189, P1, DOI 10.1016/j.ijfoodmicro.2014.07.029; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; COTTY PJ, 1989, PHYTOPATHOLOGY, V79, P808, DOI 10.1094/Phyto-79-808; CUMMINGS B, 1989, GENE ANAL TECH, V6, P89, DOI 10.1016/0735-0651(89)90013-7; Donner M, 2010, FOOD ADDIT CONTAM A, V27, P576, DOI 10.1080/19440040903551954; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrlich KC, 2004, APPL ENVIRON MICROB, V70, P6518, DOI 10.1128/AEM.70.11.6518-6524.2004; Ehrlich KC, 2014, TOXINS, V6, P1916, DOI 10.3390/toxins6061916; FILTENBORG O, 1990, NATO ADV SCI I A-LIF, V185, P433; Garrison E, 2012, HAPLOTYPE BASED VARI; Geiser DM, 1998, P NATL ACAD SCI USA, V95, P388, DOI 10.1073/pnas.95.1.388; Geiser DM, 2000, FUNGAL GENET BIOL, V31, P169, DOI 10.1006/fgbi.2000.1215; Gilbert MK, 2016, MICROBIOL RES, V182, P150, DOI 10.1016/j.micres.2015.08.007; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; HORN BW, 1995, MYCOLOGIA, V87, P324, DOI 10.2307/3760829; Horn BW, 1999, APPL ENVIRON MICROB, V65, P1444; Hruska Z, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00122; KAFER E, 1977, CAN J GENET CYTOL, V19, P723; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Kim JH, 2008, INT J FOOD MICROBIOL, V122, P49, DOI 10.1016/j.ijfoodmicro.2007.11.058; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; LESLIE JF, 1993, ANNU REV PHYTOPATHOL, V31, P127, DOI 10.1146/annurev.py.31.090193.001015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linz JE, 2014, EUKARYOT CELL, V13, P1113, DOI 10.1128/EC.00108-14; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; MATELES RI, 1965, APPL MICROBIOL, V13, P208, DOI 10.1128/AEM.13.2.208-211.1965; Medema MH, 2015, NAT CHEM BIOL, V11, P625, DOI 10.1038/nchembio.1890; Medema MH, 2013, MOL BIOL EVOL, V30, P1218, DOI 10.1093/molbev/mst025; Moore GG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1719-6; Moore GG, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003574; Mylroie JE, 2016, TOXINS, V8, DOI 10.3390/toxins8010015; Nierman WC, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00168-15; Pabinger S, 2014, BRIEF BIOINFORM, V15, P256, DOI 10.1093/bib/bbs086; Payne GA, 2006, MED MYCOL, V44, pS9, DOI 10.1080/13693780600835716; Payne GA, 2010, ASPERGILLUS: MOLECULAR BIOLOGY AND GENOMICS, P157; Pechanova O, 2013, PROTEOMICS, V13, P1513, DOI 10.1002/pmic.201100659; Price EW, 2005, BIOINFORMATICS, V21, P402, DOI 10.1093/bioinformatics/bti003; Rank C, 2012, METABOLITES, V2, P39, DOI 10.3390/metabo2010039; Saito M., 1993, Proceedings of the Japanese Association of Mycotoxicology, P31; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; VARDON P, 2003, 139 CAST; Varga J, 1996, APPL ENVIRON MICROB, V62, P4461, DOI 10.1128/AEM.62.12.4461-4464.1996; Wu F, 2006, TRANSGENIC RES, V15, P277, DOI 10.1007/s11248-005-5237-1; Wu F, 2014, ANNU REV FOOD SCI T, V5, P351, DOI 10.1146/annurev-food-030713-092431; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	60	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199169	10.1371/journal.pone.0199169	http://dx.doi.org/10.1371/journal.pone.0199169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966003	Green Published, Green Submitted, gold			2022-12-26	WOS:000437224100010
J	Thomas, Y; Scott, DC; Kristariyanto, YA; Rinehart, J; Clark, K; Cohen, P; Kurz, T				Thomas, Yann; Scott, Daniel C.; Kristariyanto, Yosua Adi; Rinehart, Jesse; Clark, Kristopher; Cohen, Philip; Kurz, Thimo			The NEDD8 E3 ligase DCNL5 is phosphorylated by IKK alpha during Toll-like receptor activation	PLOS ONE			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; EDITING ENZYME A20; CELL-CYCLE; INTERFERON-PRODUCTION; CULLIN NEDDYLATION; SIGNALING PATHWAY; ESCHERICHIA-COLI; SCCRO DCUN1D1; KINASE-ALPHA	The activity of Cullin-RING ubiquitin E3 ligases (CRL) is regulated by NEDD8 modification. DCN-like proteins promote Cullin neddylation as scaffold-like E3s. One DCNL, DCNL5, is highly expressed in immune tissue. Here, we provide evidence that DCNL5 may be involved in innate immunity, as it is a direct substrate of the kinase IKK alpha during immune signalling. We find that upon activation of Toll-like receptors, DCNL5 gets rapidly and transiently phosphorylated on a specific N-terminal serine residue (S41). This phosphorylation event is specifically mediated by IKK alpha and not IKK beta. Our data for the first time provides evidence that DCNL proteins are post-translationally modified in an inducible manner. Our findings also provide the first example of a DCNL member as a kinase substrate in a signalling pathway, indicating that the activity of at least some DCNLs may be regulated.	[Thomas, Yann; Kristariyanto, Yosua Adi; Clark, Kristopher; Cohen, Philip; Kurz, Thimo] Univ Dundee, Med Res Council Prot Phosphorylat, Sch Life Sci, Dundee, Scotland; [Thomas, Yann; Kristariyanto, Yosua Adi; Clark, Kristopher; Cohen, Philip; Kurz, Thimo] Univ Dundee, Ubiquitylat Unit, Sch Life Sci, Dundee, Scotland; [Scott, Daniel C.] St Jude Childrens Res Hosp, Dept Biol Struct, Howard Hughes Med Inst, 332 N Lauderdale St, Memphis, TN 38105 USA; [Rinehart, Jesse] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT USA; [Rinehart, Jesse] Yale Univ, Syst Biol Inst, West Haven, CT USA; [Thomas, Yann] Paris Diderot Univ, Inst Jacques Monod, UMR7592, CNRS, Paris, France; [Kurz, Thimo] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Dundee; University of Dundee; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Yale University; Yale University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Glasgow	Kurz, T (corresponding author), Univ Dundee, Med Res Council Prot Phosphorylat, Sch Life Sci, Dundee, Scotland.; Kurz, T (corresponding author), Univ Dundee, Ubiquitylat Unit, Sch Life Sci, Dundee, Scotland.; Kurz, T (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	thimo.kurz@glasgow.ac.uk		Kurz, Thimo/0000-0003-0700-6993	Medical Research Council [MC_UU_12016/7]; ERC Starting Investigator Grant; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck; Janssen Pharmaceutica; Pfizer; MRC [MC_UU_12016/7, MR/R021406/1, MR/K000985/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC Starting Investigator Grant; AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MC_UU_12016/7), an ERC Starting Investigator Grant (to TK), as well as the pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck, Janssen Pharmaceutica and Pfizer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkhi MY, 2010, CELL SIGNAL, V22, P117, DOI 10.1016/j.cellsig.2009.09.021; Campbell David G, 2002, J Biomol Tech, V13, P119; Chang FM, 2012, J BIOL CHEM, V287, P35756, DOI 10.1074/jbc.M112.397703; Clark K, 2013, NAT REV MOL CELL BIO, V14, P673, DOI 10.1038/nrm3644; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Enesa K, 2012, J BIOL CHEM, V287, P34825, DOI 10.1074/jbc.M112.367557; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Heinemann IU, 2012, FEBS LETT, V586, P3716, DOI 10.1016/j.febslet.2012.08.031; Hjerpe R, 2016, CELL, V166, P935, DOI 10.1016/j.cell.2016.07.001; Hjerpe R, 2012, J MOL BIOL, V421, P27, DOI 10.1016/j.jmb.2012.05.013; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Huang GC, 2014, J BIOL CHEM, V289, P34728, DOI 10.1074/jbc.M114.585505; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Kaileh M, 2012, IMMUNOL REV, V246, P254, DOI 10.1111/j.1600-065X.2012.01106.x; Keuss MJ, 2016, J CELL SCI, V129, P1441, DOI 10.1242/jcs.181784; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Liu B, 2010, SCIENCE, V330, P521, DOI 10.1126/science.1193787; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Liu M, 2012, MOL CELL, V45, P171, DOI 10.1016/j.molcel.2011.11.018; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Meyer-Schaller N, 2009, P NATL ACAD SCI USA, V106, P12365, DOI 10.1073/pnas.0812528106; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Ordureau A, 2013, J BIOL CHEM, V288, P24569, DOI 10.1074/jbc.M113.479550; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prajapati S, 2006, CELL CYCLE, V5, P2371, DOI 10.4161/cc.5.20.3359; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2011, NAT IMMUNOL, V12, P834, DOI 10.1038/ni.2066; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tu Z, 2006, J BIOL CHEM, V281, P6699, DOI 10.1074/jbc.M512439200; Wu K, 2011, J BIOL CHEM, V286, P34060, DOI 10.1074/jbc.M111.273045; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zhu F, 2007, MOL CELL, V27, P214, DOI 10.1016/j.molcel.2007.05.042	57	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0199197	10.1371/journal.pone.0199197	http://dx.doi.org/10.1371/journal.pone.0199197			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0PZ	29958295	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000436793500007
J	Njikan, S; Manning, AJ; Ovechkina, Y; Awasthi, D; Parish, T				Njikan, Samuel; Manning, Alyssa J.; Ovechkina, Yulia; Awasthi, Divya; Parish, Tanya			High content, high-throughput screening for small molecule inducers of NF-kappa B translocation	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; NUCLEAR TRANSLOCATION; STATISTICAL-METHODS; IMMUNE-SYSTEM; ACTIVATION; EXPRESSION; ADJUVANT; ASSAY	NF-kappa B is an important mediator of immune activity and its activation is essential in mounting immune response to pathogens. Here, we describe the optimization and implementation of a high-throughput screening platform that utilizes high content imaging and analysis to monitor NF-kappa B nuclear translocation. We screened 38,991 compounds from three different small molecule libraries and identified 103 compound as hits; 31% of these were active in a dose response assay. Several of the molecules lacked cytotoxicity or had a selectivity index of more than 2-fold. Our image-based approach provides an important first step towards identifying small molecules with immunomodulatory activity.	[Njikan, Samuel; Manning, Alyssa J.; Ovechkina, Yulia; Awasthi, Divya; Parish, Tanya] Infect Dis Res Inst, TB Discovery Res, Seattle, WA 98102 USA		Parish, T (corresponding author), Infect Dis Res Inst, TB Discovery Res, Seattle, WA 98102 USA.	tanya.parish@idri.org		Manning, Alyssa/0000-0001-7212-7420	Life Sciences Discovery Fund [19547899]; M. J. Murdock Charitable Trust; Washington Research Foundation	Life Sciences Discovery Fund; M. J. Murdock Charitable Trust; Washington Research Foundation	This work was supported by the Life Sciences Discovery Fund [Grant Number 19547899], the M. J. Murdock Charitable Trust, and the Washington Research Foundation. http://www.Isdfa.org/; https://murdocktrust.org/; http://www.wrfseattle.org/. The funders had no role in study design, data collection and analysis, decision o publish, or preparation of the manuscript.	Andreakos E, 2006, P NATL ACAD SCI USA, V103, P14459, DOI 10.1073/pnas.0603493103; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Deptala A, 1998, CYTOMETRY, V33, P376, DOI 10.1002/(SICI)1097-0320(19981101)33:3<376::AID-CYTO13>3.0.CO;2-Q; Fitzner N, 2008, CLIN VACCINE IMMUNOL, V15, P138, DOI 10.1128/CVI.00257-07; Fuseler JW, 2006, MICROSC MICROANAL, V12, P269, DOI 10.1017/S1431927606060260; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Green TL, 2014, EXP MOL PATHOL, V97, P44, DOI 10.1016/j.yexmp.2014.05.003; Haney SA, 2006, DRUG DISCOV TODAY, V11, P889, DOI 10.1016/j.drudis.2006.08.015; Hellweg CE, 2006, ANN NY ACAD SCI, V1091, P191, DOI 10.1196/annals.1378.066; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; Kaufmann SHE, 2018, NAT REV DRUG DISCOV, V17, P35, DOI 10.1038/nrd.2017.162; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; LAWRENCE R, 1994, J BIOL CHEM, V269, P28913; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075144; Maiga M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030749; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Malo N, 2010, J BIOMOL SCREEN, V15, P990, DOI 10.1177/1087057110377497; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003; Nicholls EF, 2010, ANN NY ACAD SCI, V1213, P46, DOI 10.1111/j.1749-6632.2010.05787.x; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; Oh DR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/406514; Rogers JA, 2007, NITRIC OXIDE-BIOL CH, V16, P379, DOI 10.1016/j.niox.2007.02.001; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Trask O.J., 2004, ASSAY GUIDANCE MANUA; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Xiaohua Douglas, 2008, BMC Res Notes, V1, P33, DOI 10.1186/1756-0500-1-33; Zhang XD, 2008, NUCLEIC ACIDS RES, V36, P4667, DOI 10.1093/nar/gkn435; Zhu T, 2013, J MED CHEM, V56, P6560, DOI 10.1021/jm301916b	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199966	10.1371/journal.pone.0199966	http://dx.doi.org/10.1371/journal.pone.0199966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953522	gold, Green Published, Green Submitted			2022-12-26	WOS:000436645400105
J	Songok, AC; Panta, P; Doerrler, WT; Macnaughtan, MA; Taylor, CM				Songok, Abigael C.; Panta, Pradip; Doerrler, William T.; Macnaughtan, Megan A.; Taylor, Carol M.			Structural modification of the tripeptide KPV by reductive "glycoalkylation" of the lysine residue	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; ALPHA-MSH PEPTIDES; ANTIMICROBIAL PEPTIDES; ANTICANDIDA ACTIVITY; ACID; OLIGOMERS; FUTURE; GENES; CELLS; VAL	Peptides that exhibit enzymatic or hormonal activities are regulatory factors and desirable therapeutic drugs because of their high target specificity and minimal side effects. Unfortunately, these drugs are susceptible to enzymatic degradation, leading to their rapid elimination and thereby demanding frequent dosage. Structurally modified forms of some peptide drugs have shown enhanced pharmacokinetics, improving their oral bioavailability. Here, we discuss a novel glycomimetic approach to modify lysine residues in peptides. In a model system, the epsilon-amine of Ts-Lys-OMe was reductively alkylated with a glucose derivative to afford a dihydroxylated piperidine in place of the amine. A similar modification was applied to H-KPV-NH2, a tripeptide derived from the alpha-melanocyte stimulating hormone (alpha-MSH) reported to have antimicrobial and anti-inflammatory properties. Antimicrobial assays, under a variety of conditions, showed no activity for Ac-KPV-NH2 or the alpha-or epsilon-glycoalkylated analogs. Glycoalkylated peptides did, however, show stability toward proteolytic enzymes.	[Songok, Abigael C.; Macnaughtan, Megan A.; Taylor, Carol M.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA; [Panta, Pradip; Doerrler, William T.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Taylor, CM (corresponding author), Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA.	cmtaylor@isu.edu	Taylor, Carol/B-4841-2012	Taylor, Carol/0000-0002-6262-0796; SONGOK, ABIGAEL/0000-0002-4761-0477; Macnaughtan, Megan/0000-0003-4626-0062; Panta, Pradip/0000-0001-7413-4464				Barcellini W, 2000, J LEUKOCYTE BIOL, V68, P693; BARTON DHR, 1975, J CHEM SOC PERK T 1, P1574, DOI 10.1039/p19750001574; BAUER AW, 1959, ARCH INTERN MED, V104, P208, DOI 10.1001/archinte.1959.00270080034004; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Brzoska T, 2008, ENDOCR REV, V29, P581, DOI 10.1210/er.2007-0027; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Catania A, 2009, J LEUKOCYTE BIOL, V85, P373, DOI 10.1189/jlb.1008654; Charnley M, 2008, PEPTIDES, V29, P1004, DOI 10.1016/j.peptides.2008.02.004; Chetyrkin SV, 2008, BIOCHEMISTRY-US, V47, P997, DOI 10.1021/bi701190s; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Cui LN, 2014, CARBOHYD RES, V383, P1, DOI 10.1016/j.carres.2013.10.012; Cutuli M, 2000, J LEUKOCYTE BIOL, V67, P233, DOI 10.1002/jlb.67.2.233; Elliott RJ, 2004, J INVEST DERMATOL, V122, P1010, DOI 10.1111/j.0022-202X.2004.22404.x; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Grieco P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061614; Gurjar MK, 2005, ARKIVOC, P237, DOI 10.3998/ark.5550190.0006.326; Haddad JJE, 2001, BIOCHEM J, V355, P29, DOI 10.1042/bj3550029; HILTZ ME, 1991, PEPTIDES, V12, P767, DOI 10.1016/0196-9781(91)90131-8; Iacono S., 1986, ORG SYNTH, V64, P57, DOI DOI 10.15227/ORGSYN.064.0057; Ikeda Y, 2013, BIOCONJUGATE CHEM, V24, P1824, DOI 10.1021/bc400169s; Latham PW, 1999, NAT BIOTECHNOL, V17, P755, DOI 10.1038/11686; Lau QY, 2015, INT J PEPT RES THER, V21, P21, DOI 10.1007/s10989-014-9440-x; Mahajan A, 2014, INDIAN J PHARM EDUC, V48, P34, DOI 10.5530/ijper.48.3.6; MANNA S, 1986, TETRAHEDRON LETT, V27, P2679, DOI 10.1016/S0040-4039(00)84615-8; Matassini C, 2014, EUR J ORG CHEM, V2014, P5419, DOI 10.1002/ejoc.201402427; Matassini C, 2012, EUR J ORG CHEM, V2012, P3920, DOI 10.1002/ejoc.201200587; Mereyala HB, 2012, SYNTHETIC COMMUN, V42, P1278, DOI 10.1080/00397911.2010.539753; Meyer JD, 1998, PHARMACEUT RES, V15, P188, DOI 10.1023/A:1011998014474; MILLER SM, 1995, DRUG DEVELOP RES, V35, P20, DOI 10.1002/ddr.430350105; POOLE S, 1992, BRIT J PHARMACOL, V106, P489, DOI 10.1111/j.1476-5381.1992.tb14361.x; Rauch I, 2009, J LEUKOCYTE BIOL, V85, P371, DOI 10.1189/jlb.1008614; Rauter AP, 2001, TETRAHEDRON-ASYMMETR, V12, P1131, DOI 10.1016/S0957-4166(01)00197-5; SCHLIMME E, 1988, NUCLEOS NUCLEOT, V7, P577, DOI 10.1080/07328318808056288; Singh M, 2011, ANTIMICROB AGENTS CH, V55, P1920, DOI 10.1128/AAC.00957-10; Steiner AJ, 2009, AUST J CHEM, V62, P553, DOI 10.1071/CH09040; TROP M, 1970, BIOCHEM J, V116, P19, DOI 10.1042/bj1160019; Ung P, 2011, J MED CHEM, V54, P1111, DOI 10.1021/jm1012984; Violette A, 2006, CHEM BIOL, V13, P531, DOI 10.1016/j.chembiol.2006.03.009; Wang J, 2002, PHARMACEUT RES, V19, P609, DOI 10.1023/A:1015397811161; White TR, 2011, NAT CHEM BIOL, V7, P810, DOI 10.1038/nchembio.664; Yang XM, 2015, ORG BIOMOL CHEM, V13, P9364, DOI 10.1039/c5ob01278c	42	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199686	10.1371/journal.pone.0199686	http://dx.doi.org/10.1371/journal.pone.0199686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953505	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400053
J	Rajaratanam, DD; Ariffin, H; Hassan, MA; Abd Rahman, NMAN; Nishida, H				Rajaratanam, Dhurga Devi; Ariffin, Hidayah; Hassan, Mohd Ali; Abd Rahman, Nik Mohd Afizan Nik; Nishida, Haruo			In vitro cytotoxicity of superheated steam hydrolyzed oligo((R)-3-hydroxybutyrate-co-(R)-3-hydroxyhexanoate) and characteristics of its blend with poly(L-lactic acid) for biomaterial applications	PLOS ONE			English	Article							POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE); BIODEGRADATION; GROWTH; WETTABILITY; FIBROBLAST; ADHESION	In order to clarify the in vitro cytotoxicity effect of superheated steam (SHS) treated poly((R)-3-hydroxybutyrate-co-(R)-3-hydroxyhexanoate) (PHBHHx) for biomaterial applications, SHS-treated PHBHHx oligoester samples: P(HB-co-6%-HHx) and P(HB-co-11%-HHx) with low and high percentages of unsaturated chain ends were evaluated for their cytotoxicity effects toward the growth of mouse fibroblast cell line NIH 3T3. From the results obtained after 24 and 48 h of the growth test, the SHS-treated PHBHHx oligoesters were found to be nontoxic to the growth of mouse fibroblast NIH 3T3 cell line with cell viability percentages of more than 95%. In order to serve as a potential resorbable medical suture, PHBHHx oligoesters were blended with poly(L-lactic acid) (PLLA) with a weight ratio of PHBHHx oligoester/PLLA = 20: 80 (wt/wt) to improve mechanical properties of PHBHHx oligoesters. The PHBHHx oligoesters/PLLA blend films were evaluated for their thermal, mechanical, and surface wetting properties. Thermal properties of the blend films suggested a good compatibility between PHBHHx oligoesters and PLLA components. Mechanical properties of the blend films were determined to be close enough to a desirable strength range of medical sutures. Moreover, contact angle range of 65 < theta < 70 degrees for the blend samples could provide desirable cell adhesion when used as biomaterials. Therefore, the blend of SHS-treated PHBHHx oligoesters and PLLA would be an ideal choice to be used as biomedical materials.	[Rajaratanam, Dhurga Devi; Ariffin, Hidayah; Hassan, Mohd Ali] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Bioproc Technol, Upm Serdang, Malaysia; [Rajaratanam, Dhurga Devi; Nishida, Haruo] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka, Japan; [Ariffin, Hidayah] Univ Putra Malaysia, Inst Trop Forestry & Forest Prod INTROP, Upm Serdang, Selangor, Malaysia; [Abd Rahman, Nik Mohd Afizan Nik] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Upm Serdang, Malaysia	Universiti Putra Malaysia; Kyushu Institute of Technology; Universiti Putra Malaysia; Universiti Putra Malaysia	Ariffin, H (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Bioproc Technol, Upm Serdang, Malaysia.; Ariffin, H (corresponding author), Univ Putra Malaysia, Inst Trop Forestry & Forest Prod INTROP, Upm Serdang, Selangor, Malaysia.	hidayah@upm.edu.my	Ariffin, Hidayah/B-2934-2010; Hassan, Mohd Ali/AAL-2510-2020; Hassan, Mohammad/GZA-7507-2022	Ariffin, Hidayah/0000-0002-9381-6767; Hassan, Mohammad/0000-0002-1712-0004; Nik Abd Rahman, Nik Mohd Afizan/0000-0003-4835-4687; M. Hassan, Ali/0000-0001-9509-9266; Hassan, Mohd Ali/0000-0002-5073-1536	Ministry of Higher Education, Malaysia [5524483]; Ministry of Higher Education, Malaysia; Japan Student Services Organization (JASSO)	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); Japan Student Services Organization (JASSO)(Japan Student Services Organization)	This project was funded by Ministry of Higher Education, Malaysia through Fundamental Research Grant Scheme (FRGS) (vot no. 5524483 to H.A.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the Ministry of Higher Education, Malaysia for MyPhD financial support to the first author. This project was funded by the Ministry of Higher Education, Malaysia through Fundamental Research Grant Scheme (FRGS) (vot no. 5524483). The authors also would like to extend deepest gratitude to Kaneka Corporation, Japan for the provision of PHBHHx samples; and Japan Student Services Organization (JASSO) for scholarship to conduct short-term study in Japan. The authors are grateful to Associate Professor Dr. Noorjahan Banu Alitheen for allowing us to use the facilities and to conduct research works at the Animal Tissue Culture Laboratory (ATCL) of Universiti Putra Malaysia (UPM). Hereby, the authors declare that there is no conflict of interest.	Brigham C.J., 2012, INT J BIOTECHNOL WEL, V1, P52, DOI [10.6000/1927-3037.2012.01.01.03, DOI 10.6000/1927-3037.2012.01.01.03]; Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036; DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007; Furukawa Taichi, 2016, Sessile Organisms, V33, P1; He Y, 2014, J MATER SCI-MATER M, V25, P561, DOI 10.1007/s10856-013-5073-4; Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688; Lim J, 2016, MACROMOL RES, V24, P9, DOI 10.1007/s13233-016-4004-x; Manavitehrani I, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8010020; Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015; Qu XH, 2006, BIOMATERIALS, V27, P2944, DOI 10.1016/j.biomaterials.2006.01.013; Rajaratanam DD, 2017, POLYM DEGRAD STABIL, V137, P58, DOI 10.1016/j.polymdegradstab.2017.01.007; Rezvanian M, 2016, CARBOHYD POLYM, V137, P295, DOI 10.1016/j.carbpol.2015.10.091; Scandola M, 2011, PROCESS CONTROLLED D, Patent No. PCT/IT2008/000646; Sun J, 2007, BIOMATERIALS, V28, P3896, DOI 10.1016/j.biomaterials.2007.05.011; TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V; Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023; Wang YW, 2004, POLYM DEGRAD STABIL, V85, P815, DOI 10.1016/j.polymdegradstab.2004.02.010; Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032; Yang HX, 2009, POLYMER, V50, P1533, DOI 10.1016/j.polymer.2009.01.038; Yang QX, 2014, CURR STEM CELL RES T, V9, P215, DOI 10.2174/1574888X09666140213160853; Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5; Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X; Zhao Q, 2012, J BIOMED MATER RES B, V100B, P23, DOI 10.1002/jbm.b.31915; Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041; Zulkifli FH, 2014, POLYM DEGRAD STABIL, V110, P473, DOI 10.1016/j.polymdegradstab.2014.10.017	25	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199742	10.1371/journal.pone.0199742	http://dx.doi.org/10.1371/journal.pone.0199742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944726	Green Published, gold, Green Submitted			2022-12-26	WOS:000436377800058
J	Thampy, LK; Remy, KE; Walton, AH; Hong, Z; Liu, K; Liu, R; Burnham, CAD; Hotchkiss, RS				Thampy, Lukose K.; Remy, Kenneth E.; Walton, Andrew H.; Hong, Zachery; Liu, Kelilah; Liu, Rebecca; Burnham, Carey-Ann D.; Hotchkiss, Richard S.			Restoration of T Cell function in multi-drug resistant bacterial sepsis after interleukin-7, anti-PD-L1, and OX-40 administration	PLOS ONE			English	Article							ORGAN FAILURE; IMMUNOSUPPRESSION; INFECTIONS; IL-7; EXPRESSION; THERAPIES; SURVIVAL; IMMUNITY; INNATE; CANCER	Background Multidrug resistant (MDR) bacterial pathogens are a serious problem of increasing importance facing the medical community. MDR bacteria typically infect the most immunologically vulnerable: patients in intensive care units, patients with extensive comorbidities, oncology patients, hemodialysis patients, and other immune suppressed individuals are likely to fall victim to these pathogens. One promising novel approach to treatment of MDR bacteria is immuno-adjuvant therapy to boost patient immunity. Success with this strategy would have the major benefit of providing protection against a number of MDR pathogens. Objectives This study had two main objectives. First, immunophenotyping of peripheral blood mononuclear cells from patients with sepsis associated with MDR bacteria was performed to examine for findings indicative of immunosuppression. Second, the ability of three immunoadjuvants with distinct mechanisms of action to reverse CD4 and CD8 T cell dysfunction, a pathophysiological hallmark of sepsis, was evaluated. Results Septic patients with MDR bacteria had increased expression of the inhibitory receptor PD-1 and its ligand PD-L1 and decreased monocyte HLA-DR expression compared to non-septic patients. All three immuno-adjuvants, IL-7, anti-PD-L1, and OX-40L, increased T cell production of IFN-gamma in a subset of septic patients with MDR bacteria: IL-7 was most efficacious. There was a strong trend toward increased mortality in patients whose T cells failed to increase IFN-gamma production in response to the three treatments. Conclusion Immuno-adjuvant therapy reversed T cell dysfunction, a key pathophysiological mechanism in septic patients with MDR bacteria.	[Thampy, Lukose K.; Walton, Andrew H.; Hong, Zachery; Liu, Kelilah; Liu, Rebecca; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Remy, Kenneth E.] Washington Univ, Sch Med, Dept Pediat, Div Crit Care Med, St Louis, MO 63110 USA; [Burnham, Carey-Ann D.] Washington Univ, Sch Med, Dept Immunol & Pathol, St Louis, MO USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.; Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.	hotch@wustl.edu	Remy, Kenneth/AAA-2587-2021	Remy, Kenneth/0000-0001-5222-9884; Yi, Victoria N./0000-0002-3385-5430	National Institute of Health [GM 44118]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM129763, R01GM044118] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RSH was supported by National Institute of Health grant GM 44118. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstadhaug KB, 2014, JAMA NEUROL, V71, P1030, DOI 10.1001/jamaneurol.2014.825; Arias CA, 2010, CLIN MICROBIOL INFEC, V16, P555, DOI 10.1111/j.1469-0691.2010.03214.x; Benner Kim W, 2014, J Pediatr Pharmacol Ther, V19, P83, DOI 10.5863/1551-6776-19.2.83; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Caldwell CC, 2011, CRIT CARE, V15, DOI 10.1186/cc9397; Curti BD, 2013, CANCER RES, V73, P7189, DOI 10.1158/0008-5472.CAN-12-4174; Drewry AM, 2014, SHOCK, V42, P383, DOI 10.1097/SHK.0000000000000234; Efron PA, 2004, SHOCK, V21, P566, DOI 10.1097/01.shk.0000126648.58732.8c; Francois B, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98960; Grimaldi D, 2017, LANCET INFECT DIS, V17, P18, DOI 10.1016/S1473-3099(16)30541-2; Hotchkiss RS, 2014, NEW ENGL J MED, V371, P380, DOI 10.1056/NEJMcibr1404664; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2003, P NATL ACAD SCI USA, V100, P6724, DOI 10.1073/pnas.1031788100; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Kasten KR, 2010, INFECT IMMUN, V78, P4714, DOI 10.1128/IAI.00456-10; Kaufmann SHE, 2018, NAT REV DRUG DISCOV, V17, P35, DOI 10.1038/nrd.2017.162; Van Nguyen K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1158; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Marston HD, 2016, JAMA-J AM MED ASSOC, V316, P1193, DOI 10.1001/jama.2016.11764; Nseir S, 2011, CLIN MICROBIOL INFEC, V17, P1201, DOI 10.1111/j.1469-0691.2010.03420.x; Nseir S, 2010, CLIN MICROBIOL INFEC, V16, P902, DOI 10.1111/j.1469-0691.2009.03027.x; Nseir S, 2007, CRIT CARE MED, V35, P1318, DOI 10.1097/01.CCM.0000261885.50604.20; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Patera AC, 2016, J LEUKOCYTE BIOL, V100, P1239, DOI 10.1189/jlb.4HI0616-255R; Patil NK, 2018, J LEUKOCYTE BIOL, V103, P23, DOI 10.1002/JLB.5HI0917-360R; Ribeiro VB, 2014, ANTIMICROB AGENTS CH, V58, P622, DOI 10.1128/AAC.02271-13; Salgado CD, 2005, CRIT CARE MED, V33, P2373, DOI 10.1097/01.CCM.0000181727.04501.F3; Shindo Y, 2017, J LEUKOCYTE BIOL, V101, P543, DOI 10.1189/jlb.4A1215-581R; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; Venet F, 2018, NAT REV NEPHROL, V14, P121, DOI 10.1038/nrneph.2017.165; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; Willoughby J, 2017, MOL IMMUNOL, V83, P13, DOI 10.1016/j.molimm.2017.01.006; Zavascki AP, 2013, EXPERT REV ANTI-INFE, V11, P1333, DOI 10.1586/14787210.2013.845523	37	32	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199497	10.1371/journal.pone.0199497	http://dx.doi.org/10.1371/journal.pone.0199497			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944697	Green Published, gold, Green Submitted			2022-12-26	WOS:000436377800037
J	Kanugula, AK; Adapala, RK; Midha, P; Cappelli, HC; Meszaros, JG; Paruchuri, S; Chilian, WM; Thodeti, CK				Kanugula, Anantha K.; Adapala, Ravi K.; Midha, Priya; Cappelli, Holly C.; Meszaros, J. Gary; Paruchuri, Sailaja; Chilian, William M.; Thodeti, Charles K.			Novel noncanonical regulation of soluble VEGF/VEGFR2 signaling by mechanosensitive ion channel TRPV4	FASEB JOURNAL			English	Article						angiogenesis; endothelial cell; phosphorylation	ENDOTHELIAL-CELLS; ANGIOGENESIS; VEGF; TRANSDUCTION; ACTIVATION; MECHANISMS; PATHWAYS; CALCIUM	VEGF signaling via VEGF receptor-2 (VEGFR2) is a major regulator of endothelial cell (EC) functions, including angiogenesis. Although most studies of angiogenesis focus on soluble VEGF signaling, mechanical signaling also plays a critical role. Here, we examined the consequence of disruption of mechanical signaling on soluble signaling pathways. Specifically, we observed that small interfering RNA (siRNA) knockdown of a mechanosensitive ion channel, transient receptor potential vanilloid 4 (TRPV4), significantly reduced perinuclear (Golgi) VEGFR2 in human ECs with a concomitant increase in phosphorylation at Y1175 and membrane translocation. TRPV4 knockout (KO) ECs exhibited increased plasma membrane localization of phospho-VEGFR2 compared with normal ECs. The knockdown also increased phospho-VEGFR2 in whole cell lysates and membrane fractions compared with control siRNA-treated cells. siRNA knockdown of TRPV4 enhanced nuclear localization of mechanosensitive transcription factors, yes-associated protein/transcriptional coactivator with PDZ-binding motif via rho kinase, which were shown to increase VEGFR2 trafficking to the plasma membrane. Furthermore, TRPV4 deletion/knockdown enhanced VEGF-mediated migration in vitro and increased expression of VEGFR2 in vivo in the vasculature of TRPV4 KO tumors compared with wild-type tumors. Our results thus show that TRPV4 channels regulate VEGFR2 trafficking and activation to identify novel cross-talk between mechanical (TRPV4) and soluble (VEGF) signaling that controls EC migration and angiogenesis.Kanugula, A. K., Adapala, R. K., Midha, P., Cappelli, H. C., Meszaros, J. G., Paruchuri, S., Chilian, W. M., Thodeti, C. K., Novel noncanonical regulation of soluble VEGF/VEGFR2 signaling by mechanosensitive ion channel TRPV4.	[Kanugula, Anantha K.; Midha, Priya; Thodeti, Charles K.] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Adapala, Ravi K.; Cappelli, Holly C.; Meszaros, J. Gary; Chilian, William M.; Thodeti, Charles K.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Paruchuri, Sailaja] Univ Akron, Dept Chem, Akron, OH 44325 USA	Northeast Ohio Medical University (NEOMED); University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; University of Akron	Thodeti, CK (corresponding author), Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA.	cthodeti@neomed.edu	Adapala, Ravi kumar/AAD-1282-2020	Adapala, Ravi kumar/0000-0002-4082-5301	U.S. National Institutes of Health (NIH)-National Cancer Institute [R15CA202847]; National Heart, Lung, and Blood Institute [R01HL119705]; NATIONAL CANCER INSTITUTE [R15CA202847] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL135024, R01HL119705, R01HL135110] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH)-National Cancer Institute (R15CA202847) and National Heart, Lung, and Blood Institute (R01HL119705). The authors declare no conflicts of interest.	Adapala RK, 2016, ONCOGENE, V35, P314, DOI 10.1038/onc.2015.83; Adapala RK, 2013, J MOL CELL CARDIOL, V54, P45, DOI 10.1016/j.yjmcc.2012.10.016; Adapala RK, 2011, AM J PHYSIOL-HEART C, V301, pH757, DOI 10.1152/ajpheart.00142.2011; Baratchi S, 2016, CELL MOL LIFE SCI, V73, P649, DOI 10.1007/s00018-015-2018-8; Caporarello N, 2017, MOL MED REP, V16, P4393, DOI 10.3892/mmr.2017.7179; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cheng HW, 2006, ARTERIOSCL THROM VAS, V26, P1768, DOI 10.1161/01.ATV.0000231518.86795.0f; Conway Daniel, 2012, F1000 Biol Rep, V4, P1, DOI 10.3410/B4-1; Coon BG, 2015, J CELL BIOL, V208, P975, DOI 10.1083/jcb.201408103; Domigan CK, 2015, ARTERIOSCL THROM VAS, V35, P30, DOI 10.1161/ATVBAHA.114.303215; Dragoni S, 2013, STEM CELLS DEV, V22, P2561, DOI 10.1089/scd.2013.0032; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Hamdollah Zadeh MA, 2008, MICROCIRCULATION, V15, P605, DOI 10.1080/10739680802220323; Harry BL, 2008, ARTERIOSCL THROM VAS, V28, P2003, DOI 10.1161/ATVBAHA.108.164707; Ingber D E, 1992, Semin Cancer Biol, V3, P57; Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5; Khan K, 2017, CURR DRUG TARGETS, V18, P56, DOI 10.2174/1389450116666150325231555; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Koehler Ralf, 2007, P377; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Liedtke W., 2007, V179, P473; Lupo G, 2017, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00519; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Moccia F, 2018, J CELL PHYSIOL, V233, P3901, DOI 10.1002/jcp.26152; Morrow D, 2007, ARTERIOSCL THROM VAS, V27, P1289, DOI 10.1161/ATVBAHA.107.142778; Pocock TM, 2004, AM J PHYSIOL-HEART C, V286, pH1015, DOI 10.1152/ajpheart.00826.2003; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Tamura R, 2017, BRAIN TUMOR PATHOL, V34, P62, DOI 10.1007/s10014-017-0284-x; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Thoppil RJ, 2016, ONCOTARGET, V7, P25849, DOI 10.18632/oncotarget.8405; Thoppil RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14257; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Wang XH, 2017, DEV CELL, V42, P462, DOI 10.1016/j.devcel.2017.08.002; Yamada KH, 2014, J CELL SCI, V127, P4518, DOI 10.1242/jcs.156109	36	23	23	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					195	203		10.1096/fj.201800509R	http://dx.doi.org/10.1096/fj.201800509R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29957061	Green Published			2022-12-26	WOS:000457401500016
J	Bloecher, N; Powell, M; Hytterod, S; Gjessing, M; Wiik-Nielsen, J; Mohammad, SN; Johansen, J; Hansen, H; Floerl, O; Gjevre, AG				Bloecher, Nina; Powell, Mark; Hytterod, Sigurd; Gjessing, Mona; Wiik-Nielsen, Jannicke; Mohammad, Saima N.; Johansen, Joachim; Hansen, Haakon; Floerl, Oliver; Gjevre, Anne-Gerd			Effects of cnidarian biofouling on salmon gill health and development of amoebic gill disease	PLOS ONE			English	Article							FARMED ATLANTIC SALMON; LOUSE LEPEOPHTHEIRUS-SALMONIS; SALAR L.; NEOPARAMOEBA-PERURANS; N. GEN.; AGD; FISH; EPITHELIOCYSTIS; AQUACULTURE; MANAGEMENT	This study examines the potential implications of biofouling management on the development of an infectious disease in Norwegian farmed salmon. The hydroid Ectopleura larynx frequently colonises cage nets at high densities (thousands of colonies per m(2)) and is released into the water during regular in-situ net cleaning. Contact with the hydroids' nematocysts has the potential to cause irritation and pathological damage to salmon gills. Amoebic gill disease (AGD), caused by the amoeba Paramoeba perurans, is an increasingly international health challenge in Atlantic salmon farming. AGD often occurs concomitantly with other agents of gill disease. This study used laboratory challenge trials to: (1) characterise the gill pathology resulting from the exposure of salmon to hydroids, and (2) investigate if such exposure can predispose the fish to secondary infections-using P. perurans as an example. Salmon in tanks were exposed either to freshly 'shredded' hydroids resembling waste material from net cleaning, or to authentic concentrations of free-living P. perurans, or first to 'shredded' hydroids and then to P. perurans. Gill health (AGD gill scores, non-specific gill scores, lamellar thrombi, epithelial hyperplasia) was monitored over 5 weeks and compared to an untreated control group. Nematocysts of E. larynx contained in cleaning waste remained active following high-pressure cleaning, resulting in higher non-specific gill scores in salmon up to 1 day after exposure to hydroids. Higher average numbers of gill lamellar thrombi occurred in fish up to 7 days after exposure to hydroids. However, gill lesions caused by hydroids did not affect the infection rates of P. perurans or the disease progression of AGD. This study discusses the negative impacts hydroids and current net cleaning practices can have on gill health and welfare of farmed salmon, highlights existing knowledge gaps and reiterates the need for alternative approaches to net cleaning.	[Bloecher, Nina; Floerl, Oliver] SINTEF Ocean, Trondheim, Norway; [Powell, Mark; Johansen, Joachim] Norwegian Inst Water Res, Bergen, Norway; [Hytterod, Sigurd; Gjessing, Mona; Wiik-Nielsen, Jannicke; Mohammad, Saima N.; Hansen, Haakon; Gjevre, Anne-Gerd] Norwegian Vet Inst, Oslo, Norway; [Powell, Mark] Inst Marine Res, Bergen, Norway	SINTEF; Norwegian Institute for Water Research (NIVA); Norwegian Veterinary Institute; Institute of Marine Research - Norway	Bloecher, N (corresponding author), SINTEF Ocean, Trondheim, Norway.	Nina.Bloecher@sintef.no	Hansen, Haakon/F-3763-2010	Hansen, Haakon/0000-0003-1400-9615; Bloecher, Nina/0000-0002-8009-331X	Research Council of Norway [NFR 244444/E40]; Norwegian Veterinary Institute [NFR 233858/E40]; Norwegian Institute for Water Research NIVA	Research Council of Norway(Research Council of Norway); Norwegian Veterinary Institute; Norwegian Institute for Water Research NIVA	This study was funded by the Research Council of Norway through a postdoctoral grant (NFR 244444/E40) for NB, and a research grant (NFR 233858/E40) for the members of the Norwegian Veterinary Institute (AGG, SH, MG, JWN, SNM, HH) and the Norwegian Institute for Water Research NIVA (MP, JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MB, 2009, AQUACULTURE, V290, P28, DOI 10.1016/j.aquaculture.2009.02.007; Adams MB, 2004, J FISH DIS, V27, P151, DOI 10.1111/j.1365-2761.2004.00526.x; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Baxter EJ, 2011, AQUACULT ENV INTERAC, V1, P245, DOI 10.3354/aei00024; Baxter EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018529; Bloecher N, 2015, BIOFOULING, V31, P163, DOI 10.1080/08927014.2015.1012713; Bloecher N, 2013, AQUACULTURE, V416, P302, DOI 10.1016/j.aquaculture.2013.09.025; Bosch-Belmar M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154239; Braithwaite RA, 2005, ADV MAR BIOL, V47, P215; Carl C, 2011, AQUAC RES, V42, P1056, DOI 10.1111/j.1365-2109.2010.02659.x; Cegolon L, 2013, MAR DRUGS, V11, P523, DOI 10.3390/md11020523; Colin SP, 2007, J EXP MAR BIOL ECOL, V351, P114, DOI 10.1016/j.jembe.2007.06.033; Crosbie PBB, 2012, INT J PARASITOL, V42, P511, DOI 10.1016/j.ijpara.2012.04.002; de Nys R, 2009, WOODHEAD PUBL MATER, P177, DOI 10.1533/9781845696313.1.177; Downes JK, 2015, AQUACULT ENV INTERAC, V7, P239, DOI 10.3354/aei00150; Draghi A, 2004, J CLIN MICROBIOL, V42, P5286, DOI 10.1128/JCM.42.11.5286-5297.2004; Fitridge I, 2012, BIOFOULING, V28, P649, DOI 10.1080/08927014.2012.700478; Floerl O, 2016, AQUACULT ENV INTERAC, V8, P407, DOI 10.3354/aei00187; Fore M, 2018, BIOSYST ENG, V173, P176, DOI 10.1016/j.biosystemseng.2017.10.014; Freeman MA, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-58; Gjessing MC, 2017, J FISH DIS, V40, P1253, DOI 10.1111/jfd.12608; Gjessing MC, 2015, J VIROL, V89, P9348, DOI 10.1128/JVI.01174-15; GOLDES SA, 1988, J FISH DIS, V11, P23, DOI 10.1111/j.1365-2761.1988.tb00520.x; Guenther J, 2010, AQUACULTURE, V300, P120, DOI 10.1016/j.aquaculture.2010.01.005; Gunnarsson GS, 2017, AQUACULTURE, V468, P126, DOI 10.1016/j.aquaculture.2016.10.011; Haukaas A., 2017, HLTH SITUATION NORWE; Hellebo A, 2017, J FISH DIS, V40, P661, DOI 10.1111/jfd.12546; Helmholz H, 2010, HYDROBIOLOGIA, V645, P223, DOI 10.1007/s10750-010-0216-9; KENT ML, 1988, DIS AQUAT ORGAN, V5, P163, DOI 10.3354/dao005163; Kotob MH, 2016, VET RES, V47, DOI 10.1186/s13567-016-0383-4; Kvellestad A, 2013, THESIS; Lader P, 2015, CHINA OCEAN ENG, V29, P369, DOI 10.1007/s13344-015-0026-y; Marcos-Lopez M, 2016, J FISH DIS, V39, P111, DOI 10.1111/jfd.12267; Marine-Harvest, 2017, SALM FARM IND HDB 20; Mitchell SO, 2011, J FISH DIS, V34, P411, DOI 10.1111/j.1365-2761.2011.01251.x; Mitchell SO, 2010, J FISH DIS, V33, P665, DOI 10.1111/j.1365-2761.2010.01171.x; Mitchell SO, 2011, VET RECORD CASE REPO, V1; Mitchell SO, 2013, DIS AQUAT ORGAN, V103, P35, DOI 10.3354/dao02563; Moreira M, 2017, J FISH DIS, V40, P1545, DOI 10.1111/jfd.12623; Morrison RN, 2004, J FISH DIS, V27, P445, DOI 10.1111/j.1365-2761.2004.00561.x; Nowak B. F., 1994, Bulletin of the European Association of Fish Pathologists, V14, P77; Nylund S, 2015, ARCH MICROBIOL, V197, P17, DOI 10.1007/s00203-014-1038-3; Nylund S, 2010, J EUKARYOT MICROBIOL, V57, P95, DOI 10.1111/j.1550-7408.2009.00451.x; Olafsen T., 2006, SFH80A066041 SINTEF; Oldham T, 2016, AQUACULTURE, V457, P35, DOI 10.1016/j.aquaculture.2016.02.013; OSTMAN C, 1995, SCI MAR, V59, P165; Lhorente JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095397; Powell MD, 2008, J FISH BIOL, V73, P2161, DOI 10.1111/j.1095-8649.2008.02053.x; Powell MD, 2018, J FISH DIS, P1, DOI [10.1111/jfd.12727, DOI 10.1111/JFD.12727]; Rodger HD, 2011, REV FISH BIOL FISHER, V21, P423, DOI 10.1007/s11160-010-9182-6; Ruane N. M., 2012, FISH VET J, V13, P17; Stachowicz JJ, 2000, OECOLOGIA, V124, P280, DOI 10.1007/s004420000372; Steinum T, 2008, J FISH DIS, V31, P205, DOI 10.1111/j.1365-2761.2007.00893.x; Steinum T, 2010, DIS AQUAT ORGAN, V91, P201, DOI 10.3354/dao02266; Taylor RS, 2009, AQUACULTURE, V290, P1, DOI 10.1016/j.aquaculture.2009.01.030; Toenshoff ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032696; Wiik-Nielsen J, 2016, J FISH DIS, V39, P1113, DOI 10.1111/jfd.12444; Zilberg D, 2001, J FISH DIS, V24, P79, DOI 10.1046/j.1365-2761.2001.00271.x	58	22	22	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199842	10.1371/journal.pone.0199842	http://dx.doi.org/10.1371/journal.pone.0199842			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979703	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000437809500036
J	Jardim, TV; Gaziano, TA; Nascente, FM; Carneiro, CD; Morais, P; Roriz, V; Mendonca, KL; Povoa, TIR; Barroso, WKS; Sousa, ALL; Jardim, PCBV				Jardim, Thiago Veiga; Gaziano, Thomas A.; Nascente, Flavia Miquetichuc; Carneiro, Carolina de Souza; Morais, Polyana; Roriz, Vanessa; Mendonca, Karla Lorena; Rolim Povoa, Thais Inacio; Sebba Barroso, Weimar Kunz; Lima Sousa, Ana Luiza; Brandao Veiga Jardim, Paulo Cesar			Multiple cardiovascular risk factors in adolescents from a middle-income country: Prevalence and associated factors	PLOS ONE			English	Article							WAIST CIRCUMFERENCE PERCENTILES; PHYSICAL-ACTIVITY; BLOOD-PRESSURE; ARTERIAL-HYPERTENSION; BRAZILIAN ADOLESCENTS; ALCOHOL-USE; CHILDREN; DISEASE; BURDEN; SURVEILLANCE	Multiple cardiovascular risk factors are directly related to the severity of atherosclerosis, even in children and adolescents. In this context accurate assessment of risk factors at the individual level play a decisive role in cardiovascular disease (CVD) prevention. The objective of this study was to estimate the prevalence of cardiovascular risk factors, the frequency of their coexistence in individuals, and identify possible determinants associated with this coexistence in Brazilian adolescents. A cross-sectional study with 1170 students (12-17 years) from public and private schools of a large city was conducted. In addition to family history, modifiable cardiovascular risk factors were assessed including: tobacco use, alcohol consumption, sedentary lifestyle, overweight/obesity, increased waist circumference, and high blood pressure (office and home). We built a linear regression model to identify determinants associated with increasing number of modifiable risk factors. Mean study population age was 14.7 +/- 1.6 years, 67% were enrolled in public schools and 33% in private ones. The majority of the adolescents had at least two risk factors (68.9%), more than 10% had more than 4 risk factors, and in only 6.7% of the sample no risk factor was identified. Family history of CVD (beta-coefficient = 1.20; 95%CI 1.07-1.34; p<0.001), increasing age (beta-coefficient = 0.08; 95%CI 0.04-0.11; p<0.001), and being enrolled in private schools (beta-coefficient = 0.16; 95%CI 0.02-0.30; p = 0.023) were directly associated with the modifiable CV risk factors. In conclusion, the prevalence of multiple cardiovascular risk factors was high in the population of adolescents studied. School based interventions should be addressed to change this scenario.	[Jardim, Thiago Veiga; Nascente, Flavia Miquetichuc; Carneiro, Carolina de Souza; Morais, Polyana; Roriz, Vanessa; Mendonca, Karla Lorena; Rolim Povoa, Thais Inacio; Sebba Barroso, Weimar Kunz; Lima Sousa, Ana Luiza; Brandao Veiga Jardim, Paulo Cesar] Hypertens League Fed Univ Goias, S-N Setor Univ, Goiania, Go, Brazil; [Jardim, Thiago Veiga; Gaziano, Thomas A.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Jardim, Thiago Veiga; Gaziano, Thomas A.] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Dept Hlth Policy & Management, Boston, MA USA; [Rolim Povoa, Thais Inacio] State Univ Goias UEG, Sch Phys Educ & Therapy ESEFFEGO, Goiania, Go, Brazil	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Universidade Estadual de Goias	Jardim, TV (corresponding author), Hypertens League Fed Univ Goias, S-N Setor Univ, Goiania, Go, Brazil.; Jardim, TV (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.; Jardim, TV (corresponding author), Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Dept Hlth Policy & Management, Boston, MA USA.	thiagoloirin@hotmail.com	Jardim, Thiago V/I-9095-2018; Sousa, Ana Luiza/AAO-4239-2020; Sousa, Ana Luiza L/G-2936-2017	Jardim, Thiago V/0000-0002-7750-2792; Sousa, Ana Luiza L/0000-0002-7566-3541	National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq)	National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The project was funded by the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq).	Andersen LB, 2003, PREV MED, V37, P363, DOI 10.1016/S0091-7435(03)00145-2; [Anonymous], 2012, BRAZ DEM CENS 2010; [Anonymous], 2011, ARQ BRAS CARDIOL S3, V97, P1; Barreto Sandhi Maria, 2014, Rev. bras. epidemiol., V17, P62, DOI 10.1590/1809-4503201400050006; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bloch Katia Vergetti, 2016, Rev. Saúde Pública, V50, p9s, DOI 10.1590/s01518-8787.2016050006685; Cureau FV, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S01518-8787.2016050006683, 10.1590/s01518-8787.2016050006683]; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Estatstica IBdGe, 2013, PESQ NAC SAUD ESC PE; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; de Moraes ACF, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000232; Figueiredo Valeska Carvalho, 2016, Rev. Saúde Pública, V50, p12s, DOI 10.1590/s01518-8787.2016050006741; Coutinho ESF, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S01518-8787.2016050006684, 10.1590/s01518-8787.2016050006684]; Guedes DP., 2005, REV BRASILEIRA MED E, V11, P151, DOI [10.1590/S1517-86922005000200011, DOI 10.1590/S1517-86922005000200011]; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Jardim TV, 2018, J HYPERTENS, V36, P61, DOI 10.1097/HJH.0000000000001495; Jardim TV, 2018, BLOOD PRESSURE, V27, P151, DOI 10.1080/08037051.2017.1422388; Jardim TV, 2017, BLOOD PRESSURE, V26, P272, DOI 10.1080/08037051.2017.1312279; Jardim TV, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2477-8; Kann L, 2014, MMWR SURVEILL SUMM, V63, P1; Kuschnir MCC, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S01518-8787.2016050006701, 10.1590/s01518-8787.2016050006701]; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Lai CC, 2014, J AM COLL CARDIOL, V64, P1580, DOI 10.1016/j.jacc.2014.05.072; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Magliano ES, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-833; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; May AL, 2012, PEDIATRICS, V129, P1035, DOI 10.1542/peds.2011-1082; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; Moreira NF, 2013, ARQ BRAS ENDOCRINOL, V57, P520, DOI 10.1590/S0004-27302013000700004; Nascente FMN, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3836-9; Paavola M, 2004, J ADOLESCENT HEALTH, V35, P238, DOI 10.1016/j.jadohealth.2003.12.004; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Prendergast C, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-013-0454-0; Schmidt MI., 2011, LANCET, V377, P1949, DOI [10.1016/S0140-6736%2811%2960135-9, DOI 10.1016/S0140-6736%2811%2960135-9]; [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI 10.1590/S0066-782X2010001700001; Stergiou GS, 2006, BLOOD PRESS MONIT, V11, P229, DOI 10.1097/01.mbp.0000209074.38331.16; Strauch ES, 2009, REV SAUDE PUBL, V43, P647, DOI 10.1590/S0034-89102009005000044; Wong SL, 2012, HEALTH REP, V23, P47	41	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200075	10.1371/journal.pone.0200075	http://dx.doi.org/10.1371/journal.pone.0200075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975756	gold, Green Submitted, Green Published			2022-12-26	WOS:000437424500065
J	Massiceti, D; Hicks, SL; van Rheede, JJ				Massiceti, Daniela; Hicks, Stephen Lloyd; van Rheede, Joram Jacob			Stereosonic vision: Exploring visual-to-auditory sensory substitution mappings in an immersive virtual reality navigation paradigm	PLOS ONE			English	Article							MOBILITY PERFORMANCE; OLDER-ADULTS; BLIND INDIVIDUALS; RETINITIS-PIGMENTOSA; IMPAIRMENT; REHABILITATION; ECHOLOCATION; PERCEPTION; PEOPLE; REPRESENTATION	Sighted people predominantly use vision to navigate spaces, and sight loss has negative consequences for independent navigation and mobility. The recent proliferation of devices that can extract 3D spatial information from visual scenes opens up the possibility of using such mobility-relevant information to assist blind and visually impaired people by presenting this information through modalities other than vision. In this work, we present two new methods for encoding visual scenes using spatial audio: simulated echolocation and distance-dependent hum volume modulation. We implemented both methods in a virtual reality (VR) environment and tested them using a 3D motion-tracking device. This allowed participants to physically walk through virtual mobility scenarios, generating data on real locomotion behaviour. Blindfolded sighted participants completed two tasks: maze navigation and obstacle avoidance. Results were measured against a visual baseline in which participants performed the same two tasks without blindfolds. Task completion time, speed and number of collisions were used as indicators of successful navigation, with additional metrics exploring detailed dynamics of performance. In both tasks, participants were able to navigate using only audio information after minimal instruction. While participants were 65% slower using audio compared to the visual baseline, they reduced their audio navigation time by an average 21% over just 6 trials. Hum volume modulation proved over 20% faster than simulated echolocation in both mobility scenarios, and participants also showed the greatest improvement with this sonification method. Nevertheless, we do speculate that simulated echolocation remains worth exploring as it provides more spatial detail and could therefore be more useful in more complex environments. The fact that participants were intuitively able to successfully navigate space with two new visual-to-audio mappings for conveying spatial information motivates the further exploration of these and other mappings with the goal of assisting blind and visually impaired individuals with independent mobility.	[Massiceti, Daniela] Univ Oxford, Dept Engn Sci, Oxford, England; [Hicks, Stephen Lloyd] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [van Rheede, Joram Jacob] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Massiceti, D (corresponding author), Univ Oxford, Dept Engn Sci, Oxford, England.	daniela@robots.ox.ac.uk	van Rheede, Joram/AAI-9097-2020	van Rheede, Joram/0000-0001-8164-8594	University of Oxford Clarendon Fund; University of Oxford	University of Oxford Clarendon Fund; University of Oxford	Daniela Massiceti was supported by University of Oxford Clarendon Fund (http://www.ox.ac.uk/clarendon/about). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Stephen Hicks and Joram van Rheede: Salary and research expenses were supported by a private donor into the University of Oxford titled "EVE: Expanded Visual Enhancement." The donor, Mr Jiangong Zhang, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2014, RESTOR NEUROL NEUROS, V32, P247, DOI 10.3233/RNN-130338; Amedi A, 2017, TRENDS COGN SCI, V21, P307, DOI 10.1016/j.tics.2017.03.007; [Anonymous], 2005, BAT K SONAR CANE; [Anonymous], 2005, MINIGUIDE; [Anonymous], 2005, ULTRACANE; Arnab A, 2016, BRIT MACH VIS C; BACH P, 1969, NATURE, V221, P963, DOI 10.1038/221963a0; Bach-y-Rita P, 1998, J REHABIL RES DEV, V35, P427; Bach-Y-Rita P, 2004, ANN NY ACAD SCI, V1013, P83, DOI 10.1196/annals.1305.006; Begault D. R., 1994, 3D SOUND VIRTUAL RE; Black A., 1997, CLIN EXP OPTOM, V80, P1, DOI [10.1111/j.1444-0938.1997.tb04841.x, DOI 10.1111/J.1444-0938.1997.TB04841.X]; Blasch, 2010, FDN ORIENTATION MOBI, P45; BROWN B, 1986, AM J OPTOM PHYS OPT, V63, P733; Chance SS, 1998, PRESENCE-TELEOP VIRT, V7, P168, DOI 10.1162/105474698565659; Chebat DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126307; Colwell C., 1998, ASSETS'98. Third International ACM Conference on Assistive Technologies, P92, DOI 10.1145/274497.274515; Cushman LA, 2008, NEUROLOGY, V71, P888, DOI 10.1212/01.wnl.0000326262.67613.fe; Fine I, 2015, VISION RES, V111, P115, DOI 10.1016/j.visres.2015.04.012; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Garcia-Betances RI, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00080; Geruschat DR, 1998, OPTOMETRY VISION SCI, V75, P525, DOI 10.1097/00006324-199807000-00022; Giudice N.A., 2008, ENGI HDB SMART TECHN, V8, P479, DOI DOI 10.1002/9780470379424.CH25; Giudice NA, 2018, HANDBOOK OF BEHAVIORAL AND COGNITIVE GEOGRAPHY, P260; Giudice NA, 2010, ACM T APPL PERCEPT, V7, DOI 10.1145/1658349.1658352; GOLLEDGE RG, 1993, T I BRIT GEOGR, V18, P63, DOI 10.2307/623069; Goodrich G. L., 2003, VISUAL IMPAIRMENT RE, V5, P57, DOI DOI 10.1076/VIMR.5.2.57.26265; Gougoux F, 2005, PLOS BIOL, V3, P324, DOI 10.1371/journal.pbio.0030027; Gougoux F, 2004, NATURE, V430, P309, DOI 10.1038/430309a; Gould NF, 2007, AM J PSYCHIAT, V164, P516, DOI 10.1176/appi.ajp.164.3.516; GUTH D, 1995, J VISUAL IMPAIR BLIN, V89, P28; Hartcher-O'Brien J, 2015, 2015 IEEE WORLD HAPTICS CONFERENCE (WHC), P7, DOI 10.1109/WHC.2015.7177683; Haymes S, 1996, OPTOMETRY VISION SCI, V73, P621, DOI 10.1097/00006324-199610000-00001; Haymes SA, 2002, OPHTHAL PHYSL OPT, V22, P79, DOI 10.1046/j.1475-1313.2002.00016.x; Hicks SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067695; Hughes B, 2001, HUM MOVEMENT SCI, V20, P371, DOI 10.1016/S0167-9457(01)00059-8; Iachini T, 2014, BEHAV BRAIN RES, V273, P73, DOI 10.1016/j.bbr.2014.07.032; IFUKUBE T, 1991, IEEE T BIO-MED ENG, V38, P461, DOI 10.1109/10.81565; Iglesias R, 2004, 3RD IEEE INTERNATIONAL WORKSHOP ON HAPTIC, AUDIO AND VISUAL ENVIRONMENTS AND THEIR APPLICATIONS - HAVE 2004, P13, DOI 10.1109/HAVE.2004.1391874; Ivers RQ, 1998, J AM GERIATR SOC, V46, P58; Jetley S, 2017, IEEE C COMP VIS PATT; Kay L., 1974, Radio and Electronic Engineer, V44, P605, DOI 10.1049/ree.1974.0148; Kay L., 1964, ULTRASONICS, V2, P53, DOI 10.1016/0041-624X(64)90382-8; Kempen GIJM, 2012, QUAL LIFE RES, V21, P1405, DOI 10.1007/s11136-011-0061-y; Kish CD, 1995, THESIS; Kish D, 2009, HUMAN ECHOLOCATION S; Kolarik AJ, 2014, HEARING RES, V310, P60, DOI 10.1016/j.heares.2014.01.010; Kurniawan S.., 2012, ASSIST TECHNOL; Kuyk T, 1998, OPTOMETRY VISION SCI, V75, P538, DOI 10.1097/00006324-199807000-00023; Lamoureux EL, 2008, OPHTHALMOLOGY, V115, P1973, DOI 10.1016/j.ophtha.2008.05.005; Lamoureux EL, 2004, AM J OPHTHALMOL, V137, P265, DOI 10.1016/j.ajo.2003.08.003; Lapointe JF, 2011, COMPUT HUM BEHAV, V27, P2186, DOI 10.1016/j.chb.2011.06.014; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Liao JT, 2017, IEEE T IMAGE PROCESS, V26, P1089, DOI 10.1109/TIP.2016.2636661; LONG RG, 1990, PEABODY J EDUC, V67, P89, DOI 10.1080/01619569009538683; Loomis JM, 1998, PRESENCE-TELEOP VIRT, V7, P193, DOI 10.1162/105474698565677; Loomis JM, 2001, OPTOMETRY VISION SCI, V78, P282, DOI 10.1097/00006324-200105000-00011; MacDonald JA, 2006, INT J AUDIOL, V45, P595, DOI 10.1080/14992020600876519; Maidenbaum Shachar, 2014, Universal Access in Human-Computer Interaction. Design and Development Methods for Universal Access. 8th International Conference, UAHCI 2014, Held as Part of HCI International 2014. Proceedings: LNCS 8513, P398, DOI 10.1007/978-3-319-07437-5_38; Maidenbaum S, 2014, NEUROSCI BIOBEHAV R, V41, P3, DOI 10.1016/j.neubiorev.2013.11.007; Maidenbaum S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072555; Manduchi R., 2011, RES PRACTICE VISUAL, V4, P44; MARRON JA, 1982, AM J OPTOM PHYS OPT, V59, P413; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; MEIJER PBL, 1992, IEEE T BIO-MED ENG, V39, P112, DOI 10.1109/10.121642; Mihajlik P, 2001, IEEE IMTC P, P1535, DOI 10.1109/IMTC.2001.929462; Mohler BJ, 2007, EXP BRAIN RES, V181, P221, DOI 10.1007/s00221-007-0917-0; Newcombe RA, 2011, INT SYM MIX AUGMENT, P127, DOI 10.1109/ISMAR.2011.6092378; Novich S.D., 2014, P IEEE HAPT S HAPTIC, P1; Oertel D., 2013, PRINCIPLES NEURAL SC, V5th, P682; Pasqualotto A, 2013, BEHAV BRAIN RES, V236, P175, DOI 10.1016/j.bbr.2012.08.042; PASSINI R, 1988, ENVIRON BEHAV, V20, P227, DOI 10.1177/0013916588202006; Patla AE, 1997, GAIT POSTURE, V5, P54, DOI 10.1016/S0966-6362(96)01109-5; Picinali L, 2014, INT J HUM-COMPUT ST, V72, P393, DOI 10.1016/j.ijhcs.2013.12.008; Prisacariu VA, 2017, CORR; Redmon J, 2016, PROC CVPR IEEE, P779, DOI 10.1109/CVPR.2016.91; Reed-Jones RJ, 2013, MATURITAS, V75, P22, DOI 10.1016/j.maturitas.2013.01.019; Reich L, 2012, CURR OPIN NEUROL, V25, P86, DOI 10.1097/WCO.0b013e32834ed723; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Roentgen UR, 2008, J VISUAL IMPAIRMENT, V102, P702; Rosen S., 2010, FDN ORIENTATION MOBI, V1, P138; Ruddle RA, 2013, ACM T APPL PERCEPT, V10, DOI 10.1145/2465780.2465785; Sanchez Jaime, 2010, Ext Abstr Hum Factors Computing Syst, V2010, P3409, DOI 10.1145/1753846.1753993; Sauzeon H, 2012, EXP PSYCHOL, V59, P99, DOI 10.1027/1618-3169/a000131; Schinazi VR, 2016, WIRES COGN SCI, V7, P37, DOI 10.1002/wcs.1375; SMITH AJ, 1992, J VISUAL IMPAIR BLIN, V86, P58; Sohl-Dickstein J, 2015, IEEE T BIO-MED ENG, V62, P1526, DOI 10.1109/TBME.2015.2393371; Stelmack J, 2001, OPTOMETRY VISION SCI, V78, P335, DOI 10.1097/00006324-200105000-00017; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; Supa M, 1944, AM J PSYCHOL, V57, P133, DOI 10.2307/1416946; Teng S, 2012, EXP BRAIN RES, V216, P483, DOI 10.1007/s00221-011-2951-1; Thaler L, 2016, WIRES COGN SCI, V7, P382, DOI 10.1002/wcs.1408; Turano KA, 2004, OPTOMETRY VISION SCI, V81, P298, DOI 10.1097/01.opx.0000134903.13651.8e; Turano KA, 1999, INVEST OPHTH VIS SCI, V40, P2803; Usoh M, 1999, COMP GRAPH, P359, DOI 10.1145/311535.311589; van Rheede JJ, 2015, INVEST OPHTH VIS SCI, V56, P4802, DOI 10.1167/iovs.14-16311; VERAART C, 1987, PERCEPT PSYCHOPHYS, V42, P132, DOI 10.3758/BF03210501; Vercillo T, 2018, COGNITION, V170, P263, DOI 10.1016/j.cognition.2017.10.013; Vineet V, 2015, IEEE INT CONF ROBOT, P75, DOI 10.1109/ICRA.2015.7138983; Voss P, 2004, CURR BIOL, V14, P1734, DOI 10.1016/j.cub.2004.09.051; Walker BN, 2005, ASSIST TECHNOL, V17, P72, DOI 10.1080/10400435.2005.10132097; Walker BN, 2005, INT C AUD DISPL GEOR; Walker BN, 2006, HUM FACTORS, V48, P265, DOI 10.1518/001872006777724507; Waters DA, 2007, INT J HUM-COMPUT ST, V65, P873, DOI 10.1016/j.ijhcs.2007.06.001; Whelan T, 2016, INT J ROBOT RES, V35, P1697, DOI 10.1177/0278364916669237; White G. R., 2008, P 3 INT C DIG INT ME, P134, DOI DOI 10.1145/1413634.1413663; Wilson J, 2007, ELEVENTH IEEE INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, PROCEEDINGS, P91; WORCHEL P, 1950, J EXP PSYCHOL, V40, P746, DOI 10.1037/h0060950; Yang MD, 2013, AUTOMAT CONSTR, V33, P48, DOI 10.1016/j.autcon.2012.09.017; Zhang ZY, 2012, IEEE MULTIMEDIA, V19, P4, DOI 10.1109/MMUL.2012.24	109	22	22	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199389	10.1371/journal.pone.0199389	http://dx.doi.org/10.1371/journal.pone.0199389			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL7YG	29975734	gold, Green Submitted, Green Published			2022-12-26	WOS:000437424500030
J	Medina, SG; Hyde, C; Lovera, I; Piercy, RJ				Medina, Sonia Gonzalez; Hyde, Carolyne; Lovera, Imogen; Piercy, Richard J.			Detection of equine atypical myopathy-associated hypoglycin A in plant material: Optimisation and validation of a novel LC-MS based method without derivatisation	PLOS ONE			English	Article							ACKEE BLIGHIA-SAPIDA; JAMAICAN VOMITING SICKNESS; METHYLENECYCLOPROPYLGLYCINE; TOXICITY; FRUIT; QUANTIFICATION; METABOLISM; INGESTION; SEEDS; ACID	Hypoglycin A (HGA) toxicity, following ingestion of material from certain plants, is linked to an acquired multiple acyl-CoA dehydrogenase deficiency known as atypical myopathy, a commonly fatal form of equine rhabdomyolysis seen worldwide. Whilst some plants are known to contain this toxin, little is known about its function or the mechanisms that lead to varied HGA concentrations between plants. Consequently, reliable tools to detect this amino acid in plant samples are needed. Analytical methods for HGA detection have previously been validated for the food industry, however, these techniques rely on chemical derivatisation to obtain accurate results at low HGA concentrations. In this work, we describe and validate a novel method, without need for chemical derivatisation (accuracy = 84-94%; precision = 3-16%; reproducibility = 3-6%; mean linear range R-2 = 0.999). The current limit of quantitation for HGA in plant material was halved (from 1 mu g/g in previous studies) to 0.5 mu g/g. The method was tested in Acer pseudoplatanus material and other tree and plant species. We confirm that A. pseudoplatanus is most likely the only source of HGA in trees found within European pastures.	[Medina, Sonia Gonzalez; Piercy, Richard J.] Royal Vet Coll, Comparat Neuromuscular Dis Lab, London, England; [Hyde, Carolyne; Lovera, Imogen] Bioanal Ctr, London, England	University of London; University of London Royal Veterinary College	Medina, SG (corresponding author), Royal Vet Coll, Comparat Neuromuscular Dis Lab, London, England.	sgonzalezmedina@rvu.ac.uk			Horse Trust; Royal Veterinary College's Animal Care Trust [G6015]	Horse Trust; Royal Veterinary College's Animal Care Trust	Financial support was provided by The Horse Trust with a contribution from the Royal Veterinary College's Animal Care Trust, G6015 (The Horse trust). The manuscript was approved by the Royal Veterinary College's research office and assigned the following unique reference number: CSS_01754. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS D E, 1969, West Indian Medical Journal, V18, P147; Blake OA, 2006, FOOD CHEM TOXICOL, V44, P207, DOI 10.1016/j.fct.2005.07.002; Bochnia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136785; Bowen-Forbes CS, 2011, J AGR FOOD CHEM, V59, P3869, DOI 10.1021/jf104623c; BROWN M, 1992, J FOOD SAFETY, V12, P167, DOI 10.1111/j.1745-4565.1991.tb00075.x; Carlier J, 2015, J CHROMATOGR B, V978, P70, DOI 10.1016/j.jchromb.2014.11.029; CHASE GW, 1988, J CHROMATOGR, V456, P431, DOI 10.1016/0021-9673(86)80044-9; Cheeke PR., 1989, TOXICANTS PLANT ORIG, P230; Committee RAM, 2013, M S GUID ACH REL QUA; Cortinovis C, 2013, VET J, V197, P163, DOI 10.1016/j.tvjl.2013.03.007; Deng P, 2012, BIOANALYSIS, V4, P49, DOI [10.4155/BIO.11.298, 10.4155/bio.11.298]; ELOFF JN, 1970, PHYTOCHEMISTRY, V9, P2423, DOI 10.1016/S0031-9422(00)85756-8; European Medicines Agency (EMA), 2006, NOT GUID VAL AN PROC; FENG PC, 1955, BRIT J NUTR, V9, P368, DOI 10.1079/BJN19550052; FOWDEN L, 1973, PHYTOCHEMISTRY, V12, P1677, DOI 10.1016/0031-9422(73)80387-5; Gaillard Y, 2011, FORENSIC SCI INT, V206, pE103, DOI 10.1016/j.forsciint.2011.01.018; GHISLA S, 1990, PROG CLIN BIOL RES, V321, P185; GOLDEN KD, 1984, CLIN CHIM ACTA, V142, P293, DOI 10.1016/0009-8981(84)90265-1; Gonzalez-Medina S, 2016, UNDER REVISION; HASSALL CH, 1954, NATURE, V173, P356, DOI 10.1038/173356b0; Isenberg SL, 2016, J AGR FOOD CHEM, V64, P5607, DOI 10.1021/acs.jafc.6b02478; Isenberg SL, 2015, CHEM RES TOXICOL, V28, P1753, DOI 10.1021/acs.chemrestox.5b00205; Iwasaki Y, 2011, J CHROMATOGR B, V879, P1159, DOI 10.1016/j.jchromb.2011.02.008; Li D, 1999, J AM CHEM SOC, V121, P9034, DOI 10.1021/ja991908w; MCGOWAN C, 1989, Biochromatography, V4, P161; MELDE K, 1991, BIOCHEM J, V274, P395, DOI 10.1042/bj2740395; Moore RE, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-30; PATRICK SJ, 1962, CAN J BIOCHEM PHYS, V40, P1195; Qi BL, 2014, TRAC-TREND ANAL CHEM, V59, P121, DOI 10.1016/j.trac.2014.03.013; Sander J, 2017, J AGR FOOD CHEM, V65, P2603, DOI 10.1021/acs.jafc.7b00224; SARWAR G, 1994, J AOAC INT, V77, P1175; Shrivastava A, 2017, LANCET GLOB HEALTH, V5, pE458, DOI [10.1016/S2214-109X(17)30035-9, 10.1016/s2214-109x(17)30035-9]; Stegelmeier BL, 1999, J NAT TOXINS, V8, P95; TANAKA K, 1972, SCIENCE, V175, P69, DOI 10.1126/science.175.4017.69; Unger L, 2014, J VET INTERN MED, V28, P1289, DOI 10.1111/jvim.12367; Valberg SJ, 2013, EQUINE VET J, V45, P419, DOI 10.1111/j.2042-3306.2012.00684.x; van Galen G, 2012, EQUINE VET J, V44, P614, DOI 10.1111/j.2042-3306.2012.00556.x; VONHOLT C, 1966, BIOCHIM BIOPHYS ACTA, V125, P11, DOI 10.1016/0005-2760(66)90139-1; Votion DM, 2014, EQUINE VET J, V46, P146, DOI 10.1111/evj.12117; Ware GM, 2002, J AOAC INT, V85, P933; Westermann CM, 2016, J VET INTERN MED, V30, P880, DOI 10.1111/jvim.13927; Whitaker TB, 2007, J AOAC INT, V90, P1060; WITTE L, 1992, PHYTOCHEMISTRY, V31, P559, DOI 10.1016/0031-9422(92)90038-R; Zuraw A, 2016, EQUINE VET J, V48, P418, DOI 10.1111/evj.12460	44	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199521	10.1371/journal.pone.0199521	http://dx.doi.org/10.1371/journal.pone.0199521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969503	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000437246700017
J	Buzas, R; Tautu, OF; Dorobantu, M; Ivan, V; Lighezan, D				Buzas, Roxana; Tautu, Oana-Florentina; Dorobantu, Maria; Ivan, Vlad; Lighezan, Daniel			Serum uric acid and arterial hypertension-Data from Sephar III survey	PLOS ONE			English	Article							DISEASE; RISK	Objectives This paper aims to evaluate the association between serum uric acid (SUA) levels, arterial hypertension (HT) prevalence, blood pressure values control, kidney function and intima media thickness (IMT), as a surrogate marker of early atherosclerosis, in a representative group of Romanian adult population. Materials and methods The study sample consists in 1920 adults included in SEPHAR III (Study for the Evaluation of Prevalence of Hypertension and cArdiovascular Risk in Romania) survey (mean age 48.63 years, 52.76% females) collecting data for SUA levels, blood pressure (BP) measurements, kidney function by estimated glomerular filtration rate (eGFR) and carotid IMT. SUA levels between 2,40-5,70mg/dI in females and 3,40-7,00mg/dI in males respectively were considered normal. HT and HT control were defined according to the current guidelines. IMT evaluation was assessed by B-mode Doppler ultrasound evaluation. Results Hypertensive subjects had significantly higher values of SUA compared with normotensive subjects, hypertensive patients were 1.713 times more likely to have higher values of SUA. Among treated hypertensive patients, those without optimal BP control had significantly higher SUA levels compared with those with optimal BP control, the presence of hyperuricemia increasing the odds of suboptimal BP control by 1.023. Hyperuricemic subjects had significantly lower eGFR values compared with normouricemic ones, on an average with 14.28ml/min/1.73m2 by Modification of Diet in Renal Disease formula (MDRD) and with 16.64ml/min/1.73m2 by Chronic Kidney Disease Epidemiology Collaboration formula (CKDEPI), with an indirect association between SUA levels and eGFR values (rs = -0.319/-0.347), independent of age. IMT values recorded in hyperuricemic subjects were significantly increased, on an average with 0.08mm, compared with normouricemic subjects, with a direct association between SUA levels and IMT values (rs = 0.263), independent of BP values. Conclusion The results of our study offers support that increased SUA levels are associated with arterial hypertension and with suboptimal BP control in treated hypertensive subjects. The decline in kidney function, independent of age, and also increased IMT values as a marker of atherosclerosis, were also correlated with elevated SUA values. Hyperuricemia screening may have a role in identifying patients at risk of developing HT and lowering SUA levels may improve not only BP control in treated HT patients but also decrease total cardiovascular mortality by slowing the progression of atherosclerosis and renal failure in hypertensive patients.	[Buzas, Roxana; Ivan, Vlad; Lighezan, Daniel] Victor Babes Univ Med & Pharm, Internal Med Dept, Timisoara, Romania; [Tautu, Oana-Florentina; Dorobantu, Maria] Carol Davila Univ Med & Pharm, Cardiothorac Pathol Dept, Bucharest, Romania	Victor Babes University of Medicine & Pharmacy, Timisoara; Carol Davila University of Medicine & Pharmacy	Buzas, R (corresponding author), Victor Babes Univ Med & Pharm, Internal Med Dept, Timisoara, Romania.	roxanabuzas@yahoo.com	Buzas, Roxana/AAB-4197-2020; Buzas, Roxana/ABF-1665-2021; DOROBANTU, MARIA/AAS-2934-2020	Buzas, Roxana/0000-0001-7476-6584; Vlad, Ivan/0000-0001-8781-4178	Romanian Society of Hypertension; SERVIER PHARMA - Romanian Branch through a non-restrictive research grant	Romanian Society of Hypertension; SERVIER PHARMA - Romanian Branch through a non-restrictive research grant	SEPHAR III survey was realized with the financial support of Romanian Society of Hypertension and SERVIER PHARMA - Romanian Branch through a non-restrictive research grant.	Ahn Jae Joong Lee Jeonghoon, 2015, CLIN HYPERTENS, P21; Borghi C, 2015, J HYPERTENS, V33, P1729, DOI 10.1097/HJH.0000000000000701; Dorobantu M, J HYPERTENSION PERSP; Dorobantu M, 2014, HYPERTONIA NEPHROLOG, V18; Dorobantu M, 2016, J HYPERTENS RES, V2, P143; Feig DI, 2014, CURR OPIN RHEUMATOL, V26, P176, DOI 10.1097/BOR.0000000000000033; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Kuwabara M, 2015, PULSE, V3, P242, DOI 10.1159/000443769; Li X, 2017, ANN RHEUM DIS, V76, P547, DOI 10.1136/annrheumdis-2017-eular.4032; Li X, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2376; Tsai CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170393; Valaiyapathi B, HIGH URIC ACID LEVEL, V70; Verdecchia P, 2000, HYPERTENSION, V36, P1072, DOI 10.1161/01.HYP.36.6.1072	13	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199865	10.1371/journal.pone.0199865	http://dx.doi.org/10.1371/journal.pone.0199865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966019	Green Submitted, Green Published, gold			2022-12-26	WOS:000437224100025
J	Negroni, MP; Stern, LJ				Negroni, Maria Pia; Stern, Lawrence J.			The N-terminal region of photocleavable peptides that bind HLA-DR1 determines the kinetics of fragment release	PLOS ONE			English	Article							CLASS-II MHC; MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELL EPITOPES; INDUCED CONFORMATIONAL-CHANGE; HLA-DM; PROTEIN HLA-DR1; ANTIGEN PRESENTATION; ESCHERICHIA-COLI; CROSS-REACTIVITY; HYDROGEN-BONDS	Major Histocompatibility Complex class II (MHC-II) molecules bind peptides and present them to receptors on CD4(+) T cells as part of the immune system's surveillance of pathogens and malignancy. In the absence of peptide, MHC-II equilibrates between peptide-receptive and peptide-averse conformations. The conversion between these forms has been postulated to be important in regulating cellular antigen presentation but has been difficult to study. In order to generate the MHC-II molecule HLA-DR1 in the peptide-receptive form, we designed and tested a series of photocleavable peptides that included the UV-sensitive 3-amino-3-(2-nitrophenyl)-propionate amino acid analog. They were intended to bind tightly to the HLA-DR1 MHC molecule, but to generate low-affinity fragments after UV exposure that would be released to yield HLA-DR1 in the peptide-receptive conformation. We were able to identify photocleavable peptides that bound tightly to HLA-DR1 and generated the peptide-receptive conformation after UV exposure. However, slow release of photocleaved peptide fragments from the binding site limited the rate of binding of an incoming labeled peptide and complicated kinetic measurements of the individual steps of the overall peptide binding reaction. Modification of the N-terminal region of the photocleavable peptide to reduce MHC-II pocket or H-bonding interactions allowed for generation of the peptide receptive form immediately after UV exposure with peptide fragments neither retained within the site nor interfering with binding of an incoming peptide. However this was achieved only at the expense of a substantial reduction in overall peptide binding affinity, and these peptides had such weak interaction with HLA-DR1 that they were easily exchanged by incoming peptide without UV exposure. These results show that photocleavable peptides can be used to generate peptide-receptive HLA-DR1 and to facilitate peptide exchange in generation of specific peptide-MHC-II complexes, but that usage of these peptides for kinetic studies can be constrained by slow fragment release.	[Negroni, Maria Pia; Stern, Lawrence J.] Univ Massachusetts, Med Sch, Program Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Stern, LJ (corresponding author), Univ Massachusetts, Med Sch, Program Biochem & Mol Pharmacol, Worcester, MA 01605 USA.; Stern, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	Lawrence.stern@umassmed.edu		Stern, Lawrence/0000-0001-9870-8557	National Institute of Allergy and Infectious Diseases [AI-38996]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038996] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institute of Allergy and Infectious Diseases to LJ Stern. Grant number: AI-38996. www.niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, IDENTIFICATION MOTIF, P176; Ausubel LJ, 1996, P NATL ACAD SCI USA, V93, P15317, DOI 10.1073/pnas.93.26.15317; Baker BM, 2012, IMMUNOL REV, V250, P10, DOI 10.1111/j.1600-065X.2012.01165.x; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; Bandyopadhyay A, 2008, MOL IMMUNOL, V45, P1248, DOI 10.1016/j.molimm.2007.09.011; Bolin DR, 2000, J MED CHEM, V43, P2135, DOI 10.1021/jm000034h; Carven GJ, 2005, BIOCHEMISTRY-US, V44, P13625, DOI 10.1021/bi050972p; Carven GJ, 2004, J BIOL CHEM, V279, P16561, DOI 10.1074/jbc.M314315200; Celie PHN, 2009, J AM CHEM SOC, V131, P12298, DOI 10.1021/ja9037559; Ferrante A, 2010, J IMMUNOL, V184, P1153, DOI 10.4049/jimmunol.0902878; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garrett TP, 1989, NATURE; Gelder C, 1998, INT IMMUNOL, V10, P211, DOI 10.1093/intimm/10.2.211; Grotenbreg GM, 2008, P NATL ACAD SCI USA, V105, P3831, DOI 10.1073/pnas.0711504105; Grotenbreg GM, 2007, J BIOL CHEM, V282, P21425, DOI 10.1074/jbc.M702844200; HILL CM, 1994, J IMMUNOL, V152, P2890; Hoppes R, 2014, J IMMUNOL, V193, P4803, DOI 10.4049/jimmunol.1400800; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; Jardetzky TS, 1991, NATURE; Jensen K. L., 2018, IEEE T PLASMA SCI, P1; Ji NN, 2013, J IMMUNOL, V191, P5074, DOI 10.4049/jimmunol.1300407; Joshi RV, 2000, BIOCHEMISTRY-US, V39, P3751, DOI 10.1021/bi9923656; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; McFarland BJ, 1999, J IMMUNOL, V163, P3567; McFarland BJ, 2002, MED RES REV, V22, P168, DOI 10.1002/med.10006; McFarland BJ, 2001, P NATL ACAD SCI USA, V98, P9231, DOI 10.1073/pnas.151131498; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Natarajan SK, 1999, J IMMUNOL, V162, P4030; Natarajan SK, 1999, J IMMUNOL, V162, P3463; NEWTONNASH DK, 1993, J IMMUNOL, V150, P1813; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; ROCHE PA, 1990, J IMMUNOL, V144, P1849; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; Sloan VS, 1995, NATURE; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Toebes Mireille, 2009, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1816s87; van Buuren MM, 2014, J IMMUNOL, V192, P641, DOI 10.4049/jimmunol.1301770; van Kasteren SI, 2014, CURR OPIN IMMUNOL, V26, P21, DOI 10.1016/j.coi.2013.10.005; Wieboldt R, 2002, J ORG CHEM, V67, P8827, DOI 10.1021/jo0201373; WINDHAGEN A, 1995, IMMUNITY, V2, P373, DOI 10.1016/1074-7613(95)90145-0; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; Yin L, 2014, CURR PROTOC IMMUNOL, V2014; Yin LS, 2014, J BIOL CHEM, V289, P23449, DOI 10.1074/jbc.M114.585539; Zarutskie JA, 2001, P NATL ACAD SCI USA, V98, P12450, DOI 10.1073/pnas.211439398	49	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199704	10.1371/journal.pone.0199704	http://dx.doi.org/10.1371/journal.pone.0199704			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965980	Green Published, Green Submitted, gold			2022-12-26	WOS:000437224100020
J	Tan, C; Ekambaram, M; Yiu, CKY				Tan, Chiewee; Ekambaram, Manikandan; Yiu, Cynthia Kar Yung			Prevalence, characteristic features, and complications associated with the occurrence of unerupted permanent incisors	PLOS ONE			English	Article							MAXILLARY CENTRAL INCISOR; SUPERNUMERARY TEETH; MANAGEMENT; MESIODENS; ODONTOMA; PATIENT; TRAUMA	This study examined the prevalence, characteristic features, and complications associated with the occurrence of unerupted permanent incisors among children and adolescents attending a university dental teaching hospital. A retrospective review was performed of the clinical records of children and adolescents who attended the Prince Philip Dental Hospital, Hong Kong between 2005 and 2014. All patients who had at least one unerupted permanent incisor tooth were included. A total of 266 subjects with 320 unerupted permanent incisors were identified. The prevalence of unerupted permanent incisors among children and adolescents was 2.0%. Permanent maxillary central incisors (70.6%) were the most commonly affected teeth. The most common cause for unerupted incisors were dilacerations (n = 83, 36.7%) for maxillary central incisors; developmental dental anomalies (n = 22; 30.6%) together with unfavorable root development (n = 22; 30.6%) for maxillary laterals incisors; and abnormal tooth/tissue ratio (n = 11, 50.0%) for mandibular incisors. A majority of unerupted incisors presented with complications the most common being ectopic/displacement/ rotation of the unerupted incisors (46.6%), loss of space (36.9%) and midline shift (27.5%). In conclusion, the causes were distinct for different manifestations of unerupted permanent incisors. As the majority of unerupted incisors presented with complications, a systematic and organized method of history taking as well as clinical and radiographic examinations is mandatory in the diagnosis of unerupted permanent incisors.	[Tan, Chiewee; Ekambaram, Manikandan; Yiu, Cynthia Kar Yung] Univ Hong Kong, Fac Dent, Paediat Dent, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Yiu, CKY (corresponding author), Univ Hong Kong, Fac Dent, Paediat Dent, Pokfulam, Hong Kong, Peoples R China.	ckyyiu@hkucc.hku.hk	Yiu, Cynthia/B-2183-2009; Ekambaram, Manikandan/AAQ-9550-2020	Ekambaram, Manikandan/0000-0002-9156-3727				American Academy of Pediatric Dentistry. Ad Hoc Committee on Pedodontic Radiology, 2012, Pediatr Dent, V34, P189; Ayers E, 2014, EUR ARCH PAEDIATR DE, V15, P421, DOI 10.1007/s40368-014-0132-1; Bartolo A, 2010, EUR J ORTHODONT, V32, P297, DOI 10.1093/ejo/cjp094; Betts A, 1999, Int J Paediatr Dent, V9, P285, DOI 10.1046/j.1365-263X.1999.00147.x; Ferrazzano GF, 2014, EUR J PAEDIATR DENT, V15, P187; Ferres-Amat E, 2015, EUR J PAEDIATR DENT, V16, P19; Flores MT, 2007, DENT TRAUMATOL, V23, P196, DOI 10.1111/j.1600-9657.2007.00627.x; Gungormus M, 2010, MED ORAL PATOL ORAL, V15, pE398, DOI 10.4317/medoral.15.e398; Jacobs SG, 2000, AM J ORTHOD DENTOFAC, V118, P432, DOI 10.1067/mod.2000.108783; Jena AK, 2015, J DENT CHILD, V82, P157; Jeremias Fabiano, 2016, Dent Res J (Isfahan), V13, P85, DOI 10.4103/1735-3327.174723; Kobayashi H, 1999, Int J Paediatr Dent, V9, P277, DOI 10.1111/j.1365-263X.1999.00146.x; Leyland Leila, 2006, J Clin Pediatr Dent, V30, P225; Lygidakis NN, 2015, EUR ARCH PAEDIATR DE, V16, P153, DOI 10.1007/s40368-014-0150-z; MacPhee CG, 1935, BR DENT J, V58, P59; Mason C, 2000, BRIT J ORAL MAX SURG, V38, P62, DOI 10.1054/bjom.1999.0210; Mitchell L, 1992, Br J Orthod, V19, P41; Nuvvula S, 2012, PEDIATR DENT, V34, P70; Pavoni C, 2013, PEDIATR DENT, V35, P364; Pinho T, 2011, AM J ORTHOD DENTOFAC, V140, P256, DOI 10.1016/j.ajodo.2009.11.018; Punde PA, 2014, ETHIOP J HEALTH SCI, V24, P273, DOI 10.4314/ejhs.v24i3.12; Rohilla M, 2011, J Indian Soc Pedod Prev Dent, V29, P244, DOI 10.4103/0970-4388.85834; Sant'Anna EF, 2012, AM J ORTHOD DENTOFAC, V142, P863, DOI 10.1016/j.ajodo.2011.07.030; Shaked I, 2008, DENT TRAUMATOL, V24, P395, DOI 10.1111/j.1600-9657.2008.00564.x; Sharma D, 2010, DENT TRAUMATOL, V26, P289, DOI 10.1111/j.1600-9657.2010.00882.x; Shun Y, 2008, J DENT CHILD, V75, P104; Society, 2010, MAN DEV OCC GUID DEN; TAYLOR NG, 1995, BRIT DENT J, V179, P377, DOI 10.1038/sj.bdj.4808931; Topkara A, 2012, EUR J PAEDIATR DENT, V13, P311; Topouzelis N, 2010, DENT TRAUMATOL, V26, P335, DOI 10.1111/j.1600-9657.2010.00915.x; Torres JN, 2012, AM J ORTHOD DENTOFAC, V141, P773, DOI 10.1016/j.ajodo.2010.08.019; Yaqoob O., 2016, MANAGEMENT UNERUPTED	32	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199501	10.1371/journal.pone.0199501	http://dx.doi.org/10.1371/journal.pone.0199501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953473	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400034
J	Asiki, G; Newton, R; Kibirige, L; Kamali, A; Marions, L; Smedman, L				Asiki, Gershim; Newton, Robert; Kibirige, Leonard; Kamali, Anatoli; Marions, Lena; Smedman, Lars			Feasibility of using smartphones by village health workers for pregnancy registration and effectiveness of mobile phone text messages on reduction of homebirths in rural Uganda	PLOS ONE			English	Article							CARE	Introduction Homebirths are common in low and middle income countries and are associated with poor child survival. We assessed the feasibility of using smartphones by village health workers for pregnancy registration and the effectiveness of health text messages (SMS) sent to pregnant women through village health workers in reducing homebirths in rural Uganda. Methods A non-randomised intervention study was undertaken in 26 villages. In the intervention arm, village health workers registered pregnant women (n = 262) in 13 villages using a smartphone app (doForm) and paper forms and gestation age-timed SMS were sent through village health workers to the pregnant women. In 13 control villages, (n = 263) pregnant women were registered on paper forms only and no SMS was sent. The main outcome was place of birth measured through a self-report. Logistic regression with generalised estimating equations was used to explore the effect of the intervention. Results Comparing 795 corresponding data fields on phone and paper revealed that numeric variable fields were 86%-95% similar while text fields were 38%-48% similar. Of the 525 pregnant women followed, 83 (15.8%) delivered at home. In the adjusted analysis, the intervention was associated with lower odds of homebirths [AOR = 0.38, 95%CI (0.15-0.97)]. Muslim religion [AOR = 4.0, 95%CI (1.72-9.34)], primary or no maternal education [AOR = 2.51, 95%CI (1.00-6.35)] and health facility distance >= 2 km [AOR = 2.26, 95%CI (0.955.40)] were independently associated with homebirths. Conclusion Village health workers can register pregnant women at home using phones and relay gestation age specific SMS to them to effectively reduce homebirths.	[Asiki, Gershim; Smedman, Lars] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Asiki, Gershim; Newton, Robert; Kibirige, Leonard; Kamali, Anatoli] Med Res Council Uganda Virus Res Council, Uganda Res Unit AIDS, Entebbe, Uganda; [Asiki, Gershim] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Newton, Robert] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Marions, Lena] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden	Karolinska Institutet; African Population & Health Research Centre; University of York - UK; Karolinska Institutet	Asiki, G (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.; Asiki, G (corresponding author), Med Res Council Uganda Virus Res Council, Uganda Res Unit AIDS, Entebbe, Uganda.; Asiki, G (corresponding author), African Populat & Hlth Res Ctr, Nairobi, Kenya.	gershim@gmail.com		Asiki, Gershim/0000-0002-9966-1153	Medical Research/Uganda Virus Research Institute, Uganda Research Unit	Medical Research/Uganda Virus Research Institute, Uganda Research Unit	This work was nested within the General Population Cohort supported by Medical Research/Uganda Virus Research Institute, Uganda Research Unit and we gratefully acknowledge and thank the study team, the participants, community leaders for their tremendous contributions.	Asiki G, 2013, INT J EPIDEMIOL; Asiki G, 2015, ACTA PAEDIAT; Asiki G, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0708-8; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Chib A, 2013, GLOB HEALTH PROMOT, V20, P26, DOI 10.1177/1757975912462419; Crowe S, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-4; Gabriel SA, 2009, BE J ECON ANAL POLI, V9, DOI 10.1186/1471-2393-9-34; Hayes RJ, CLUSTER RANDOMIZED T; Hurt K, 2016, GLOB J HLTH SCI, V8, P183, DOI DOI 10.5539/GJHS.V8N9P183; Labrique AB, 2012, REPROD HEALTH MATTER, V20, P113, DOI 10.1016/S0968-8080(12)39631-6; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lund S, 2012, BJOG-INT J OBSTET GY, V119, P1256, DOI 10.1111/j.1471-0528.2012.03413.x; MAMA, POW HLTH EV MAM HAND; Mobile Technology for Community Health in Ghana (MOTECH), 2011, WHAT IT IS WHAT GRAM; Ngabo F, 2012, PAN AFR MED J, V13; Orinda V, 2005, INT J GYNECOL OBSTET, V91, P285, DOI 10.1016/j.ijgo.2005.07.023; Rajput ZA, 2012, J AM MED INFORM ASSN, V19, P655, DOI 10.1136/amiajnl-2011-000476; Rutaremwa G, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1611-y; Tesfaye S, 2014, J MIDWIFERY WOM HEAL, V59, pS55, DOI 10.1111/jmwh.12168; UMC, 2018, MAKING PREGNANCY SAF; Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x	21	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198653	10.1371/journal.pone.0198653	http://dx.doi.org/10.1371/journal.pone.0198653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949593	Green Published, gold, Green Accepted			2022-12-26	WOS:000436549200019
J	Mac Sweeney, A; Chambovey, A; Wicki, M; Muller, M; Artico, N; Lange, R; Bijelic, A; Breibeck, J; Rompel, A				Mac Sweeney, Aengus; Chambovey, Alain; Wicki, Micha; Mueller, Manon; Artico, Nadia; Lange, Roland; Bijelic, Aleksandar; Breibeck, Joscha; Rompel, Annette			The crystallization additive hexatungstotellurate promotes the crystallization of the HSP70 nucleotide binding domain into two different crystal forms	PLOS ONE			English	Article							PROTEIN CRYSTALLOGRAPHY; LATENT	The use of the tellurium-centered Anderson-Evans polyoxotungstate [TeW6O24](6-) (TEW) as a crystallization additive has been described. Here, we present the use of TEW as an additive in the crystallization screening of the nucleotide binding domain (NBD) of HSP70. Crystallization screening of the HSP70 NBD in the absence of TEW using a standard commercial screen resulted in a single crystal form. An identical crystallization screen of the HSP70 NBD in the presence of TEW resulted in both the "TEW free" crystal form and an additional crystal form with a different crystal packing. TEW binding was observed in both crystal forms, either as a well-defined molecule or in overlapping alternate positions suggesting translational disorder. The structures were solved by both molecular replacement and single wavelength anomalous diffraction (SAD) using the anomalous signal of a single bound molecule of TEW. This study adds one more example of TEW binding to a protein and influencing its crystallization behavior.	[Mac Sweeney, Aengus; Chambovey, Alain; Wicki, Micha; Mueller, Manon; Artico, Nadia; Lange, Roland] Idorsia Pharmaceut Ltd, Drug Discovery Biol, Allschwil, Switzerland; [Bijelic, Aleksandar; Breibeck, Joscha; Rompel, Annette] Univ Vienna, Dept Biophys Chem, Fac Chem, Vienna, Austria	Idorsia Pharmaceuticals Ltd; University of Vienna	Mac Sweeney, A (corresponding author), Idorsia Pharmaceut Ltd, Drug Discovery Biol, Allschwil, Switzerland.; Rompel, A (corresponding author), Univ Vienna, Dept Biophys Chem, Fac Chem, Vienna, Austria.	aengus.mac-sweeney@idorsia.com; annette.rompel@univie.ac.at		Breibeck, Joscha/0000-0002-7210-5261; Rompel, Annette/0000-0002-5919-0553	Austrian Science Fund [P27534]; University of Vienna; Idorsia Pharmaceuticals Ltd.	Austrian Science Fund(Austrian Science Fund (FWF)); University of Vienna; Idorsia Pharmaceuticals Ltd.	This work was supported by the Austrian Science Fund grant number P27534 was provided to A.R. (https://www.fwf.ac.at/). Funding was also provided by the University of Vienna. https://www.bpc.univie.ac.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Idorsia Pharmaceuticals Ltd. provided support in the form of salaries for authors AMS, AC, MM, MM, NA AND RL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; We acknowledge the Paul Scherrer Institut, Villigen, Switzerland for provision of synchrotron radiation beamtime at beamline X06DA of the SLS and would like to thank the beamline staff for assistance. This research was funded by the Austrian Science Fund (FWF) P27534 (A.R.) and the University of Vienna.	Arakawa A, 2011, PROTEIN SCI, V20, P1367, DOI 10.1002/pro.663; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bijelic A, 2017, ACCOUNTS CHEM RES, V50, P1441, DOI 10.1021/acs.accounts.7b00109; Bijelic A, 2015, COORDIN CHEM REV, V299, P22, DOI 10.1016/j.ccr.2015.03.018; Bijelic A, 2015, CHEMBIOCHEM, V16, P233, DOI 10.1002/cbic.201402597; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engilberge S, 2017, CHEM SCI, V8, P5909, DOI 10.1039/c7sc00758b; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Kranz JK, 2011, METHOD ENZYMOL, V493, P277, DOI 10.1016/B978-0-12-381274-2.00011-X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Layton CJ, 2010, BIOCHEMISTRY-US, V49, P10831, DOI 10.1021/bi101414z; Mauracher SG, 2014, ACTA CRYSTALLOGR D, V70, P2301, DOI 10.1107/S1399004714013777; Mauracher SG, 2014, ACTA CRYSTALLOGR F, V70, P263, DOI 10.1107/S2053230X14000582; Molitor C, 2017, IUCRJ, V4, P734, DOI 10.1107/S2052252517012349; Molitor C, 2016, CHEM COMMUN, V52, P12286, DOI 10.1039/c6cc07004c; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naskar B, 2015, J PHYS CHEM C, V119, P20985, DOI 10.1021/acs.jpcc.5b06273; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Osipiuk J, 1999, ACTA CRYSTALLOGR D, V55, P1105, DOI 10.1107/S0907444999002103; Potterton L, 2018, ACTA CRYSTALLOGR D, V74, P68, DOI 10.1107/S2059798317016035; Redhead M, 2017, BIOCHEMISTRY-US, V56, P6187, DOI 10.1021/acs.biochem.7b00860; Reinhard L, 2013, ACTA CRYSTALLOGR F, V69, P209, DOI 10.1107/S1744309112051858; Shida M, 2010, ACTA CRYSTALLOGR D, V66, P223, DOI 10.1107/S0907444909053979; Skubak P, 2018, ACTA CRYSTALLOGR D, V74, P117, DOI 10.1107/S2059798317014462; Skubak P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3777; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	30	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199639	10.1371/journal.pone.0199639	http://dx.doi.org/10.1371/journal.pone.0199639			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949628	gold, Green Published, Green Submitted			2022-12-26	WOS:000436549200060
J	Manabe, A; Yamakawa, T; Ohnishi, S; Akamine, T; Narimatsu, Y; Tanaka, H; Funamoto, T; Ueda, Y; Yamamote, T				Manabe, Akihiro; Yamakawa, Takashi; Ohnishi, Shuhei; Akamine, Tatsuro; Narimatsu, Yoji; Tanaka, Hiroshige; Funamoto, Tetsuichiro; Ueda, Yuji; Yamamote, Takeo			A novel growth function incorporating the effects of reproductive energy allocation	PLOS ONE			English	Article							OPTIMAL RESOURCE-ALLOCATION; LIFE-HISTORY INVARIANTS; INDETERMINATE GROWTH; MODEL; MATURATION; PATTERNS; ANIMALS; ECOLOGY; FISHES; COST	Ontogenetic growth functions provide basic information in biological and ecological studies. Various growth functions classified into the Putter model have been used historically, regardless of controversies over their appropriateness. Here, we present a novel growth function for fish and aquatic organisms (generalised q-VBGF) by considering an allocation schedule of allometrically produced surplus energy between somatic growth and reproduction. The generalised q-VBGF can track growth trajectories in different life history strategies from determinate to indeterminate growth by adjusting the value of the 'growth indeterminacy exponent' q. The timing of maturation and attainable body size can be adjusted by the 'maturation timing parameter' tau while maintaining a common growth trajectory before maturation. The generalised q-VBGF is a comprehensive growth function in which exponentials in the traditional monomolecular, von Bertalanffy, Gompertz, logistic, and Richards functions are replaced with q-exponentials defined in the non-extensive Tsallis statistics, and it fits to actual data more adequately than these conventional functions. The relationship between the estimated parameter values tau and rq forms a unique hyperbola, which provides a new insight into the continuum of life history strategies of organisms.	[Manabe, Akihiro; Yamakawa, Takashi] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Ohnishi, Shuhei] Tokai Univ, Sch Marine Sci & Technol, Shizuoka, Shizuoka, Japan; [Akamine, Tatsuro] Japan Fisheries Res & Educ Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Narimatsu, Yoji] Japan Fisheries Res & Educ Agcy, Hachinohe Lab, Tohoku Natl Fisheries Res Inst, Hachinohe, Aomori, Japan; [Tanaka, Hiroshige] Japan Fisheries Res & Educ Agcy, Natl Res Inst Far Seas Fisheries, Shimizu, Shizuoka, Japan; [Tanaka, Hiroshige; Funamoto, Tetsuichiro] Japan Fisheries Res & Educ Agcy, Hokkaido Natl Fisheries Res Inst, Kushiro, Hokkaido, Japan; [Ueda, Yuji] Japan Fisheries Res & Educ Agcy, Japan Sea Natl Fisheries Res Inst, Niigata, Niigata, Japan; [Yamamote, Takeo] Japan Fisheries Res & Educ Agcy, Obama Lab, Japan Sea Natl Fisheries Res Inst, Obama, Fukui, Japan	University of Tokyo; Tokai University; Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA)	Manabe, A; Yamakawa, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	manabe@aqua.fs.a.u-tokyo.ac.jp; ayamakw@mail.ecc.u-tokyo.ac.jp	Tanaka, Hiroshige/ACK-1566-2022	Tanaka, Hiroshige/0000-0003-2883-8270; Yamamoto, Takeo/0000-0002-0872-4260; Manabe, Akihiro/0000-0002-6336-0260	Fisheries Agency; Japan Fisheries Research and Education Agency	Fisheries Agency; Japan Fisheries Research and Education Agency	Part of this study was conducted as the project 'Assessment of Fisheries Stocks in the Waters around Japan' and was financially supported by the Fisheries Agency and Japan Fisheries Research and Education Agency. The Fisheries Agency is not responsible for the contents of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; AKAMINE T, 1993, NIPPON SUISAN GAKK, V59, P1857; Alonso-Fernandez A, 2009, FISH RES, V99, P47, DOI 10.1016/j.fishres.2009.04.011; Amari S, 2011, ENTROPY, V13, P1070; Boukal DS, 2014, J THEOR BIOL, V359, P199, DOI 10.1016/j.jtbi.2014.05.022; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Chapman EW, 2011, CAN J FISH AQUAT SCI, V68, P1934, DOI 10.1139/F2011-109; Czarnoleski M, 1998, ECOL LETT, V1, P5, DOI 10.1046/j.1461-0248.1998.0007b.x; Economo EP, 2005, ECOL LETT, V8, P353, DOI 10.1111/j.1461-0248.2005.00737.x; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Fujita S., 1965, Bulletin of the Japanese Society of Scientific Fisheries, V31, P258; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; IWASA Y, 1989, AM NAT, V133, P480, DOI 10.1086/284931; JONSSON B, 1993, REV FISH BIOL FISHER, V3, P348, DOI 10.1007/BF00043384; Jusup M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021903; Karkach AS, 2006, DEMOGR RES, V15, P348; Katsukawa Y, 2002, POPUL ECOL, V44, P265, DOI 10.1007/s101440200030; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Kooijman SALM, 2008, BIOL REV, V83, P533, DOI 10.1111/j.1469-185X.2008.00053.x; Kozlowski J, 1996, P ROY SOC B-BIOL SCI, V263, P559, DOI 10.1098/rspb.1996.0084; Kozlowski J, 1999, EVOL ECOL RES, V1, P423; Lester NP, 2004, P ROY SOC B-BIOL SCI, V271, P1625, DOI 10.1098/rspb.2004.2778; MAC ARTHUR ROBERT H., 1967; Ohnishi S, 2014, J THEOR BIOL, V343, P174, DOI 10.1016/j.jtbi.2013.10.017; Ohnishi S, 2012, FISH B-NOAA, V110, P223; Picoli S, 2009, BRAZ J PHYS, V39, P468, DOI 10.1590/S0103-97332009000400023; Prince J, 2015, ICES J MAR SCI, V72, P194, DOI 10.1093/icesjms/fsu011; Putter A, 1920, PFLUG ARCH GES PHYS, V180, P298, DOI 10.1007/BF01755094; Quince C, 2008, J THEOR BIOL, V254, P197, DOI 10.1016/j.jtbi.2008.05.029; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; Sheehan RJ, 1999, T AM FISH SOC, V128, P491, DOI 10.1577/1548-8659(1999)128&lt;0491:BGIAFD&gt;2.0.CO;2; SIBLY R, 1985, J THEOR BIOL, V112, P553, DOI 10.1016/S0022-5193(85)80022-9; Spillman W. J., 1924, LAW DIMINISHING RETU; TAYLOR BE, 1992, AM NAT, V139, P248, DOI 10.1086/285326; Tsallis C, 1994, QUIM NOVA, V17, P468; Tsallis C., 2009, SPRINGER; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Wang ZP, 2002, AQUACULTURE, V204, P337, DOI 10.1016/S0044-8486(01)00845-6; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; WOOTTON RJ, 1976, J FISH BIOL, V8, P385, DOI 10.1111/j.1095-8649.1976.tb03967.x; YOKLAVICH MM, 1990, MAR ECOL PROG SER, V64, P13, DOI 10.3354/meps064013	44	9	9	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199346	10.1371/journal.pone.0199346	http://dx.doi.org/10.1371/journal.pone.0199346			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944689	Green Submitted, gold, Green Published			2022-12-26	WOS:000436377800031
J	Wroblewska, B; Szyc, AM; Markiewicz, LH; Zakrzewska, M; Romaszko, E				Wroblewska, Barbara; Szyc, Anna Maria; Markiewicz, Lidia Hanna; Zakrzewska, Magdalena; Romaszko, Ewa			Increased prevalence of eating disorders as a biopsychosocial implication of food allergy	PLOS ONE			English	Article							BODY-MASS INDEX; ATOPIC-DERMATITIS; CELIAC-DISEASE; ADIPOSE-TISSUE; GUT MICROBIOTA; CHILDREN; ASTHMA; INFLAMMATION; POPULATION; CHILDHOOD	Introduction The study evaluates the impact of biopsychosocial factors involved in food allergy (FA) on the prevalence of eating disorders (ED). For the 5-year follow-up studies, 75 participants (aged 1 +/- 14 years) with early-onset FA and 81 healthy peers were included. Method Participants were diagnosed with FA using antibody/cytokine content immunoassay tests. Medical history, including BMI z-scores, was completed using data obtained in response to a validated allergic questionnaire that incorporated the SCOFF and EAT-8 screening questionnaires for ED. FA was confirmed if total IgE was elevated, specific sIgE to food allergens exceeded 0.7 kUA/L and if manifestations were observed. Screening for ED was considered positive if two or more SCOFF and EAT-8 items were confirmed. Results In the FA(+) group, 50% of female participants and 6.7% of their healthy female peers reported ED. An ED+ result was more frequent in FA(+) individuals than in their healthy peers (p = 0.046) although the association is weak. In the FA(+)/ED+ group, 25.3% of the participants were underweight, and 14.7% were overweight compared to their peers where this reached respectively 4.2% and 2.8% (p< 0.005). 74% of the FA(+)/ED+ individuals reported elimination diet implementation and only 15% declared it was medically consulted. The prevalence of ED in the FA(+) male group was consistently correlated with lack of confidence in FA issues (r = 0.5424) and in the FA(+) female group with applied medical procedures (r = 0.7069; p<0.005). Conclusion These findings suggest that participants with FA especially struggling with lack of confidence in FA issues and those following an uncontrolled, restrictive elimination diet are more prone to food aversion and ED than their healthy peers. Applied procedures are necessary, and their neglect is associated with FA deterioration; however, the possibility of ED and biopsychosocial implications development should not be underestimated.	[Wroblewska, Barbara; Szyc, Anna Maria; Markiewicz, Lidia Hanna] Polish Acad Sci, Dept Immunol & Food Microbiol, Inst Anim Reprod & Food Res, Olsztyn, Poland; [Zakrzewska, Magdalena] Nonpubl Hlth Care Clin Allergy ALLERGICA, Olsztyn, Poland; [Romaszko, Ewa] Nonpubl Hlth Care Clin ATARAX, Olsztyn, Poland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Szyc, AM (corresponding author), Polish Acad Sci, Dept Immunol & Food Microbiol, Inst Anim Reprod & Food Res, Olsztyn, Poland.	a.szyc@pan.olsztyn.pl	Ogrodowczyk, Anna/AAS-4520-2021; Ogrodowczyk, Anna M/J-2200-2016; Markiewicz, Lidia H./H-7221-2017; OGRODOWCZYK, Anna M./AAW-7873-2020; WROBLEWSKA, Barbara/H-7270-2017	Ogrodowczyk, Anna M/0000-0001-7350-4072; Markiewicz, Lidia H./0000-0003-0109-5710; OGRODOWCZYK, Anna M./0000-0001-7350-4072; WROBLEWSKA, Barbara/0000-0002-7383-7819	National Science Centre Poland [N312 311939]; European Social Fund	National Science Centre Poland(National Science Centre, Poland); European Social Fund(European Social Fund (ESF))	This work was supported by The National Science Centre Poland, URL: https://www.ncn.gov. pl [grant number N312 311939 to BM], and the European Social Fund (DRINNO 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; [Anonymous], 2011, WHO ANTHR V 3 2 2; Dourado LPA, 2011, CELL IMMUNOL, V270, P198, DOI 10.1016/j.cellimm.2011.05.008; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Bachle C, 2016, INT J EAT DISORDER, V49, P193, DOI 10.1002/eat.22463; BELL IR, 1993, J AM COLL NUTR, V12, P693; Berstad A, 2005, PSYCHONEUROENDOCRINO, V30, P983, DOI 10.1016/j.psyneuen.2005.04.010; Bharadwaj S, 2016, GASTROENTEROL REP, V4, P272, DOI 10.1093/gastro/gow013; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Bollinger ME, 2017, ANN ALLERG ASTHMA IM, V96, P415; Bryant-Waugh R, 2010, INT J EAT DISORDER, V43, P98, DOI 10.1002/eat.20795; Byberg KK, 2016, CLIN TRANSL ALLERGY, V6, DOI 10.1186/s13601-016-0124-9; Carper JL, 2000, APPETITE, V35, P121, DOI 10.1006/appe.2000.0343; Chung BY, 2011, ANN DERMATOL, V23, pS91, DOI 10.5021/ad.2011.23.S1.S91; Ciprandi G, 2009, RESP MED, V103, P289, DOI 10.1016/j.rmed.2008.08.008; Ciriaco M, 2013, J PHARMACOL PHARMACO, V4, pS94, DOI 10.4103/0976-500X.120975; Ellegard L., 2011, 33 ESPEN C GOTH; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Fiocchi A., 2010, WORLD ALLERGY ORG WA; Flammarion S, 2011, PEDIAT ALLERG IMM-UK, V22, P161, DOI 10.1111/j.1399-3038.2010.01028.x; Fortunato JE, 2007, CLIN PEDIAT PHILA, V5, P496; Hill LS, 2010, INT J EAT DISORDER, V43, P344, DOI 10.1002/eat.20679; ISOLAURI E, 1995, J PEDIATR-US, V127, P550, DOI 10.1016/S0022-3476(95)70111-7; Kacik J, 2017, SERUM DIAMINE OXIDAS, P1; Kilpelainen M, 2006, RESP MED, V100, P1518, DOI 10.1016/j.rmed.2006.01.011; Klewicka E, 2011, POL J MICROBIOL, V60, P329, DOI 10.33073/pjm-2011-047; KOSKY N, 1993, INT J EAT DISORDER, V14, P117, DOI 10.1002/1098-108X(199307)14:1&lt;117::AID-EAT2260140116&gt;3.0.CO;2-H; Kurz S, 2016, INT J EAT DISORDER, V49, P102, DOI 10.1002/eat.22461; Madden S, 2009, MED J AUSTRALIA, V190, P410, DOI 10.5694/j.1326-5377.2009.tb02487.x; Malmlof K, 2005, INT J OBESITY, V29, P1402, DOI 10.1038/sj.ijo.0803036; Marcos A, 2003, EUR J CLIN NUTR, V57, pS66, DOI 10.1038/sj.ejcn.1601819; Mascola A., 2011, EAT BEHAV, V11, P253; McLachlan CR, 2007, J ALLERGY CLIN IMMUN, V119, P634, DOI 10.1016/j.jaci.2006.10.029; Meyer R, 2014, J HUM NUTR DIET, V27, P227, DOI 10.1111/jhn.12149; Million M, 2013, INT J OBESITY, V37, P1460, DOI 10.1038/ijo.2013.20; Mollet A, 2003, PEPTIDES, V24, P155, DOI 10.1016/S0196-9781(02)00288-7; Morgan JF, 1999, BRIT MED J, V319, P1467, DOI 10.1136/bmj.319.7223.1467; Nowak-Wegrzyn A, 2009, J ALLERGY CLIN IMMUN, V123, pS365, DOI 10.1016/j.jaci.2009.03.042; Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423; Ogrodowczyk A, 2013, CENT EUR J IMMUNOL, V38, P403, DOI 10.5114/ceji.2013.37747; Okada Y, 2017, ALLERGY ASTHMA IMMUN, V9, P322, DOI 10.4168/aair.2017.9.4.322; Patten SB, 2007, INT J PSYCHIAT MED, V37, P11, DOI 10.2190/L811-0738-10NG-7157; Pawankar R, 2013, WHITE BOOK ALLERGY U; Primeau MN, 2000, CLIN EXP ALLERGY, V30, P1135, DOI 10.1046/j.1365-2222.2000.00889.x; Ricca V, 2000, INT J EAT DISORDER, V27, P119; Richter F, 2016, EAT BEHAV, V21, P198, DOI 10.1016/j.eatbeh.2016.03.006; Santamaria F, 2007, J ALLERGY CLIN IMMUN, V120, P965, DOI 10.1016/j.jaci.2007.06.002; Shanahan L, 2014, J PSYCHOSOM RES, V77, P468, DOI 10.1016/j.jpsychores.2014.10.005; Sideleva O, 2012, AM J RESP CRIT CARE, V186, P598, DOI 10.1164/rccm.201203-0573OC; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P518, DOI 10.1111/j.1365-2222.2008.03156.x; Stoma M, 2016, POSTEP DERM ALERGOL, V33, P281, DOI 10.5114/ada.2016.61604; Teufel M, 2007, WORLD J GASTROENTERO, V13, P3456, DOI 10.3748/wjg.v13.i25.3456; van Huisstede A, 2015, THORAX, V70, P659, DOI 10.1136/thoraxjnl-2014-206712; WHO, 2006, WHO CHILD GROWTH STA; WHO & UNICEF, 2009, STAT WORLDS CHILDR; Wilczynska-Kwiatek A, 2009, EUR J MED RES, V14, P248, DOI 10.1186/2047-783X-14-S4-248; Yoshizawa M, 2009, BIOL PSYCHIAT, V65, P329, DOI 10.1016/j.biopsych.2008.08.012; YOUNG E, 1994, LANCET, V343, P1127, DOI 10.1016/S0140-6736(94)90234-8; Yucel B, 2006, INT J EAT DISORDER, V39, P530, DOI 10.1002/eat.20294	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0198607	10.1371/journal.pone.0198607	http://dx.doi.org/10.1371/journal.pone.0198607			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK7JR	29944672	Green Published, gold, Green Submitted			2022-12-26	WOS:000436377800012
J	Cui, YH; Kim, H; Lee, M; Yi, JM; Kim, RK; Uddin, N; Yoo, KC; Kang, JH; Choi, MY; Cha, HJ; Kwon, OS; Bae, IH; Kim, MJ; Kaushik, N; Lee, SJ				Cui, Yan-Hong; Kim, Hyeonmi; Lee, Minyoung; Yi, Joo Mi; Kim, Rae-Kwon; Uddin, Nizam; Yoo, Ki-Chun; Kang, Jae Hyeok; Choi, Mi-Young; Cha, Hyuk-Jin; Kwon, Ok-Seon; Bae, In-Hwa; Kim, Min-Jung; Kaushik, Neha; Lee, Su-Jae			FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation	ONCOGENE			English	Article							DOMAIN-CONTAINING PROTEIN-1; F-BOX PROTEINS; GENE FAMILY; CELL; EXPRESSION; SURVIVAL; PHOSPHORYLATION; METASTASIS; MICRORNAS; MIGRATION	Understanding the molecular mechanisms that underlie the aggressive behavior and relapse of breast cancer may help in the development of novel therapeutic interventions. CUB-domain-containing protein 1 (CDCP1), a transmembrane adaptor protein, is highly maintained and required in the context of cellular metastatic potential in triple-negative breast cancer (TNBC). For this reason, gene expression levels of CDCP1 have been considered as a prognostic marker in TNBC. However, not rarely, transcript levels of genes do not reflect always the levels of proteins, due to the post-transcriptional regulation. Here we show that miR-17/20a control the FBXL14 E3 ligase, establishing FBXL14 as an upstream regulator of the CDCP1 pathway. FBXL14 acts as an novel interaction partner of CDCP1, and facilitates its ubiquitination and proteasomal degradation with an enhanced capacity to suppress CDCP1 protein stability that eventually prevents CDCP1 target genes involved in breast cancer metastasis. Our findings first time uncovers the regulatory mechanism of CDCP-1 protein stabilization, more predictable criteria than gene expression levels for prognosis of breast cancer patients.	[Cui, Yan-Hong; Kim, Hyeonmi; Kim, Rae-Kwon; Uddin, Nizam; Yoo, Ki-Chun; Kang, Jae Hyeok; Choi, Mi-Young; Kaushik, Neha; Lee, Su-Jae] Hanyang Univ, Res Inst Nat Sci, Dept Life Sci, Seoul 04763, South Korea; [Lee, Minyoung] Korea Inst Radiol & Med Sci, Div Radiat Effect, Seoul 01812, South Korea; [Yi, Joo Mi] Dongnam Inst Radiol & Med Sci, Res Inst, Busan, South Korea; [Cha, Hyuk-Jin; Kwon, Ok-Seon] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Bae, In-Hwa] Korea Inst Radiol & Med Sci, Div Basic Radiat Biosci, Seoul, South Korea; [Kim, Min-Jung] Korea Inst Radiol & Med Sci, Lab Radiat Exposure & Therapeut, Natl Radiat Emergency Med Ctr, Seoul, South Korea	Hanyang University; Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Seoul National University (SNU); Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences	Kaushik, N; Lee, SJ (corresponding author), Hanyang Univ, Res Inst Nat Sci, Dept Life Sci, Seoul 04763, South Korea.	neha.bioplasma@gmail.com; sj0420@hanyang.ac.kr	Cui, Yanhong/ABB-1148-2021; Cha, Hyuk-Jin/AAB-8508-2020; Kaushik, Neha/AAL-8177-2020; Kaushik, Neha/AAY-5982-2020	Cui, Yanhong/0000-0002-4169-6521; Cha, Hyuk-Jin/0000-0001-9277-2662; Kaushik, Neha/0000-0001-8671-6779; Ud Din, Nizam/0000-0002-9845-3109	National Research Foundation (NRF); Ministry of Science, ICT and Future Planning, Korean Government, through its National Nuclear Technology Program [NRF-2016R1E1A1A01942075, NRF-2015M2A2A7A01044998]	National Research Foundation (NRF); Ministry of Science, ICT and Future Planning, Korean Government, through its National Nuclear Technology Program	This work was supported by the National Research Foundation (NRF) and Ministry of Science, ICT and Future Planning, Korean Government, through its National Nuclear Technology Program NRF-2016R1E1A1A01942075 and NRF-2015M2A2A7A01044998.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Alajati A, 2015, CELL REP, V11, P564, DOI 10.1016/j.celrep.2015.03.044; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brock M, 2011, J BIOL CHEM, V286, P40142, DOI 10.1074/jbc.M111.251793; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Busino L, 2004, ONCOGENE, V23, P2050, DOI 10.1038/sj.onc.1207394; Cao MQ, 2016, TUMOR BIOL, V37, P1651, DOI 10.1007/s13277-015-3527-7; Casar B, 2014, ONCOGENE, V33, P255, DOI 10.1038/onc.2012.547; Chen CL, 2010, J CELL SCI, V123, P2901, DOI 10.1242/jcs.069765; Chou CT, 2015, ANN SURG ONCOL, V22, P4335, DOI 10.1245/s10434-015-4505-4; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Cui YH, 2015, ONCOGENE, V34, P5372, DOI 10.1038/onc.2014.466; Dai XF, 2017, J CANCER, V8, P3131, DOI 10.7150/jca.18457; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Diaz VM, 2016, SEMIN CANCER BIOL, V36, P71, DOI 10.1016/j.semcancer.2015.10.003; Dong Y, 2012, J BIOL CHEM, V287, P9792, DOI 10.1074/jbc.M111.335448; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Emerling BM, 2013, P NATL ACAD SCI USA, V110, P3483, DOI 10.1073/pnas.1222435110; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Heo JH, 2016, SEMIN CANCER BIOL, V36, P33, DOI 10.1016/j.semcancer.2015.09.015; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Labidi-Galy SI, 2015, ONCOGENE, V34, P299, DOI 10.1038/onc.2013.562; Law ME, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0741-1; Liu R, 2009, J BIOL CHEM, V284, P16791, DOI 10.1074/jbc.M808919200; Mazzucotelli E, 2006, CURR GENOMICS, V7, P509, DOI 10.2174/138920206779315728; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Shostak K, 2014, NAT COMMUN, V287, P9792; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Sun Y, 2001, ANTIOXID REDOX SIGN, V3, P635, DOI 10.1089/15230860152542989; Turdo F, 2016, ONCOTARGET, V7, P69649, DOI 10.18632/oncotarget.11935; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Wong CH, 2009, CLIN CANCER RES, V15, P2311, DOI 10.1158/1078-0432.CCR-08-2533; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; Wright HJ, 2016, ONCOGENE, V35, P4762, DOI 10.1038/onc.2016.7; Wright HJ, 2017, P NATL ACAD SCI USA, V114, pE6556, DOI 10.1073/pnas.1703791114; Yi JM, 2013, CLIN CANCER RES, V19, P6544, DOI 10.1158/1078-0432.CCR-12-3224; Zhu HQ, 2014, AM J PATHOL, V184, P2828, DOI 10.1016/j.ajpath.2014.06.024	43	13	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 25	2018	37	43					5794	5809		10.1038/s41388-018-0372-3	http://dx.doi.org/10.1038/s41388-018-0372-3			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GY1KL	29973690				2022-12-26	WOS:000448288200007
J	Teran-Melo, JL; Pena-Sandoval, GR; Silva-Jimenez, H; Rodriguez, C; Alvarez, AF; Georgellis, D				Teran-Melo, Juan L.; Pena-Sandoval, Gabriela R.; Silva-Jimenez, Hortencia; Rodriguez, Claudia; Alvarez, Adrian F.; Georgellis, Dimitris			Routes of phosphoryl group transfer during signal transmission and signal decay in the dimeric sensor histidine kinase ArcB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; 2-COMPONENT SYSTEM; TRANSDUCTION SYSTEM; IN-VITRO; INTERMOLECULAR COMPLEMENTATION; REGULATOR PROTEIN; GENE-EXPRESSION; REDOX SIGNAL; PAS DOMAIN; VIVO	The Arc (anoxic redox control) two-component system of Escherichia coli, comprising ArcA as the response regulator and ArcB as the sensor histidine kinase, modulates the expression of numerous genes in response to respiratory growth conditions. Under reducing growth conditions, ArcB autophosphorylates at the expense of ATP, and transphosphorylates ArcA via a His(292) -> Asp(576) -> His(717) -> Asp(54) phosphorelay, whereas under oxidizing growth conditions, ArcB catalyzes the dephosphorylation of ArcA-P by a reverse Asp(54 )-> His(717) -> Asp(576) -> P-i phosphorelay. However, the exact phosphoryl group transfer routes and the molecular mechanisms determining their directions are unclear. Here, we show that, during signal propagation, the His(292) -> Asp(576) and Asp(576) -> His(717) phosphoryl group transfers within ArcB dimers occur intra- and intermolecularly, respectively. Moreover, we report that, during signal decay, the phosphoryl group transfer from His(717) to Asp(576) takes place intramolecularly. In conclusion, we present a mechanism that dictates the direction of the phosphoryl group transfer within ArcB dimers and that enables the discrimination of the kinase and phosphatase activities of ArcB.	[Teran-Melo, Juan L.; Rodriguez, Claudia; Alvarez, Adrian F.; Georgellis, Dimitris] Univ Nacl AutOnoma Mexico, Dept Genet Mol, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Pena-Sandoval, Gabriela R.] Univ Autonoma Nayarit, Unidad Acad Agr, Tepic 63190, Nayarit, Mexico; [Silva-Jimenez, Hortencia] Univ Autonoma Baja California, Inst Invest Oceanol, Area Oceanog Quim, Ensenada 22860, Baja California, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma de Baja California	Georgellis, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	dimitris@ifc.unam.mx	Alvarez, Adrian F./L-4656-2019; Silva-Jiménez, Hortencia/AAK-8730-2021; Alvarez, Adrian F./L-7575-2013; Silva-Jiménez, Hortencia/GPX-7834-2022	Alvarez, Adrian F./0000-0003-4381-5691; Silva-Jiménez, Hortencia/0000-0002-0091-7738; Alvarez, Adrian F./0000-0003-4381-5691; 	Consejo Nacional de Ciencia y Tecnologia (CONACyT); DGAPA-PAPIIT, UNAM [IN208718, IN209918]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-PAPIIT, UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was supported by a doctoral fellowship from the Consejo Nacional de Ciencia y Tecnologia (CONACyT) (to J. L. T. M.) as well as DGAPA-PAPIIT, UNAM, Grants IN208718 and IN209918 (to A. F. A. and D. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez AF, 2016, ENVIRON MICROBIOL, V18, P3210, DOI 10.1111/1462-2920.13397; Alvarez AF, 2013, J BACTERIOL, V195, P3054, DOI 10.1128/JB.00406-13; Alvarez AF, 2010, METHOD ENZYMOL, V471, P205, DOI 10.1016/S0076-6879(10)71012-0; Alvarez AF, 2010, J BACTERIOL, V192, P391, DOI 10.1128/JB.00881-09; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; DONG JM, 1993, J BACTERIOL, V175, P6671, DOI 10.1128/jb.175.20.6671-6678.1993; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; FU HA, 1991, MOL GEN GENET, V226, P209, DOI 10.1007/BF00273605; Georgellis D, 1999, J BIOL CHEM, V274, P35950, DOI 10.1074/jbc.274.50.35950; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Georgellis D, 2001, J BACTERIOL, V183, P7206, DOI 10.1128/JB.183.24.7206-7212.2001; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Goulian M, 2010, CURR OPIN MICROBIOL, V13, P184, DOI 10.1016/j.mib.2010.01.009; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; ISHIGE K, 1994, EMBO J, V13, P5195, DOI 10.1002/j.1460-2075.1994.tb06850.x; IUCHI S, 1990, MOL MICROBIOL, V4, P715, DOI 10.1111/j.1365-2958.1990.tb00642.x; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Jourlin C, 1997, J MOL BIOL, V267, P770, DOI 10.1006/jmbi.1997.0919; Jovanovic G, 2015, MOL BIOSYST, V11, P1348, DOI 10.1039/c4mb00720d; Jung WS, 2008, FEMS MICROBIOL LETT, V284, P109, DOI 10.1111/j.1574-6968.2008.01187.x; Kinoshita-Kikuta E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148294; Kwon O, 2003, J BIOL CHEM, V278, P13192, DOI 10.1074/jbc.M210647200; Kwon O, 2000, J BACTERIOL, V182, P3858, DOI 10.1128/JB.182.13.3858-3862.2000; Kwon O, 2000, J BACTERIOL, V182, P2960, DOI 10.1128/JB.182.10.2960-2966.2000; Lin ECC, 1996, ESCHERICHIA COLI SAL, P1526; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; Malpica R, 2006, ANTIOXID REDOX SIGN, V8, P781, DOI 10.1089/ars.2006.8.781; Miller JH., 1972, EXPT MOL GENETICS; NINFA EG, 1993, J BACTERIOL, V175, P7024, DOI 10.1128/jb.175.21.7024-7032.1993; Oreza LAN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038187; Pena-Sandoval GR, 2010, J BACTERIOL, V192, P1735, DOI 10.1128/JB.01401-09; Pena-Sandoval GR, 2005, J BACTERIOL, V187, P3267, DOI 10.1128/JB.187.9.3267-3272.2005; Rodriguez C, 2004, J BACTERIOL, V186, P2085, DOI 10.1128/JB.186.7.2085-2090.2004; Soo VWC, 2011, P NATL ACAD SCI USA, V108, P1484, DOI 10.1073/pnas.1012108108; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; SWANSON RV, 1993, MOL MICROBIOL, V8, P435, DOI 10.1111/j.1365-2958.1993.tb01588.x; Tanaka T, 1998, NATURE, V396, P88, DOI 10.1038/23968; Tomomori C, 1999, NAT STRUCT BIOL, V6, P729; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9	48	12	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13214	13223		10.1074/jbc.RA118.003910	http://dx.doi.org/10.1074/jbc.RA118.003910			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29945971	Green Published, hybrid			2022-12-26	WOS:000442730200020
J	Lv, JL; Ding, YZ; Liu, XS; Pan, L; Zhang, ZW; Zhou, P; Zhang, YG; Hu, YH				Lv, Jianliang; Ding, Yaozhong; Liu, Xinsheng; Pan, Li; Zhang, Zhongwang; Zhou, Peng; Zhang, Yongguang; Hu, Yonghao			Gene expression analysis of porcine whole blood cells infected with foot-and-mouth disease virus using high-throughput sequencing technology	PLOS ONE			English	Article							RNA-SEQ; TRANSCRIPTOMES; COMPLEXES; PROTEINS; PACKAGE; FMDV	Foot-and-mouth disease virus (FMDV) is a single-stranded positive RNA virus that belongs to the family Picornaviridae. FMDV infects cloven-hoofed animals, such as pigs, sheep, goats, cattle and diverse wildlife species, and remains a major threat to the livestock industry worldwide. In this study, a transcriptome analysis of whole blood from pigs infected with FMDV was performed using the paired-end Illumina sequencing technique to understand the interactions between the pathogen and its host cells. During infection with FMDV, a total of 120 differentially expressed genes (DEGs) were identified, including 110 up-regulated genes and 10 down-regulated genes. To further investigate the DEGs involved in interactions between the virus and its host, gene ontology (GO) annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment were conducted. GO annotation indicated that a number of DEGs were enriched in categories involved in host-virus interactions, such as response to stimulus, immune system process and regulation of biological process. KEGG enrichment analysis indicated that the DEGs were primarily involved in the ribosome signaling pathway and immune-related signaling pathways. Ten DEGs, including the immune-related genes BTK1, C1QB, TIMD4 and CXCL10, were selected and validated using quantitative PCR, which showed that the expression patterns of these genes are consistent with the results of the in silico expression analysis. In conclusion, this study presents the first transcriptome analysis of pig whole blood cells infected with FMDV, and the results obtained in this study improve our understanding of the interactions between FMDV and host cells as well as the diagnosis and control of FMD.	[Lv, Jianliang; Zhang, Yongguang; Hu, Yonghao] Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China; [Lv, Jianliang; Ding, Yaozhong; Liu, Xinsheng; Pan, Li; Zhang, Zhongwang; Zhou, Peng; Zhang, Yongguang] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Zhang, Yongguang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Gansu Agricultural University; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Zhang, YG; Hu, YH (corresponding author), Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China.; Zhang, YG (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.; Zhang, YG (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	zhangyongguang@caas.cn; yhh0817@126.com		Ding, Yao-zhong/0000-0003-3684-8217	National Key Research and Development Program in "the 13th Five-Year Plan" of China [2016YFD0501503]; Science and Technology Support Program of Gansu Province [1504NKCA054-5, 1604NKCA045-2]; National Pig Industrial System [CARS-35]	National Key Research and Development Program in "the 13th Five-Year Plan" of China; Science and Technology Support Program of Gansu Province; National Pig Industrial System	All research described in this manuscript was funded by the National Key Research and Development Program in "the 13th Five-Year Plan" of China (2016YFD0501503), the Science and Technology Support Program of Gansu Province (1504NKCA054-5, 1604NKCA045-2) and the National Pig Industrial System (CARS-35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S, FASTQC QUALITY CONTR, DOI [10.1186/gb-2013-14-4-r36, DOI 10.1186/GB-2013-14-4-R36]; Bao H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12620; Bieganowski P, 2004, J BIOL CHEM, V279, P44656, DOI 10.1074/jbc.M406151200; Brown F, 2003, VIRUS RES, V91, P3, DOI 10.1016/S0168-1702(02)00268-X; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; Domingo E, 2002, COMP IMMUNOL MICROB, V25, P297, DOI 10.1016/S0147-9571(02)00027-9; El-Bacha T, 2013, INT J BIOCHEM CELL B, V45, P41, DOI 10.1016/j.biocel.2012.09.021; Gao Y, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0561-z; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Gunderson AJ, 2016, CANCER DISCOV, V6, P270, DOI 10.1158/2159-8290.CD-15-0827; Ho NI, 2017, J IMMUNOL, V198, P4235, DOI 10.4049/jimmunol.1602169; Jaing C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10186-4; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knowles NJ, 2001, VET REC, V148, P258; Kohda M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005679; Lee EY, 2009, AUTOIMMUN REV, V8, P379, DOI 10.1016/j.autrev.2008.12.002; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mason PW, 2003, VIRUS RES, V91, P9, DOI 10.1016/S0168-1702(02)00257-5; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; ROBERTSON BH, 1985, J VIROL, V54, P651, DOI 10.1128/JVI.54.3.651-660.1985; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salguero F. J, 2015, VIROLOGY, V332, P384; SANGAR DV, 1987, NUCLEIC ACIDS RES, V15, P3305, DOI 10.1093/nar/15.8.3305; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Sobrino F, 2001, VET RES, V32, P1, DOI 10.1051/vetres:2001106; TAMKUN JW, 1986, CELL, V46, P271, DOI 10.1016/0092-8674(86)90744-0; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhao FR, 2017, ACTA TROP, V173, P69, DOI 10.1016/j.actatropica.2017.05.009	31	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200081	10.1371/journal.pone.0200081	http://dx.doi.org/10.1371/journal.pone.0200081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979724	gold, Green Published, Green Submitted			2022-12-26	WOS:000437809500056
J	Rauf, S; Ali, Y; Hussain, S; Ullah, F; Hayat, A				Rauf, Sajid; Ali, Yaqeen; Hussain, Sabir; Ullah, Fakhar; Hayat, Akhtar			Design of a novel filter paper based construct for rapid analysis of acetone	PLOS ONE			English	Article							GAS SENSOR; STABILIZED ZIRCONIA; SENSING PROPERTIES; BREATH ACETONE; EXHALED BREATH; NANOCOMPOSITES; DIAGNOSIS; NANOPARTICLES; PERFORMANCE; REMOVAL	The present work was focused to design a cheap, rapid, portable and easy to use filter paper based assay for the qualitative and quantitate analysis of acetone. Sodium alginate gel was loaded with the acetone specific optical signal probe, and subsequently coated onto filter paper surface to design portable colorimetric assays for acetone monitoring. The color of the paper sensor strip was observed to change from dark yellow to light yellowish in the presence of varying concentrations of acetone. Three different color analyzing models including RGB, HSV, and LAB were employed to probe the output optical signal, and their performance was compared in terms of better interpretation of the generated signal. The LAB model was found to provide better analytical figures of merit with a linear response for the acetone concentration ranging from 2.5 to 1500 ppm, and a limit of detection of 0.5 ppm. Furthermore, the specificity of the designed filter paper based sensor was demonstrated against different common interfering compounds. The results demonstrated the potential of our proposed filter paper based sensor as a novel tool for the analysis of acetone.	[Rauf, Sajid; Hayat, Akhtar] COMSATS Inst Informat Technol, IRCBM, Lahore, Pakistan; [Ali, Yaqeen] COMSATS Inst Informat Technol, Dept Comp Sci, Lahore, Pakistan; [Ali, Yaqeen; Hussain, Sabir; Ullah, Fakhar] Univ Sargodha, Dept Comp Sci & Informat Technol, Sargodha, Pakistan	COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI); University of Sargodha	Hayat, A (corresponding author), COMSATS Inst Informat Technol, IRCBM, Lahore, Pakistan.	akhtarhayat@ciitlahore.edu.pk	Hayat, Akhtar/AAI-7518-2020		Higher education commission Pakistan-National research program for universities [20-4286/RD/HEC/2014]; HEC-NRPU [20-4286/RD/HEC/2014, 204286/RD/HEC/2014]	Higher education commission Pakistan-National research program for universities; HEC-NRPU	The work was performed under the financial support from the Higher education commission Pakistan-National research program for universities; no. 20-4286/R&D/HEC/2014 of Akhtar Hayat. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sajid Rauf thanks the financial support from the HEC-NRPU project No. 20-4286/R&D/HEC/2014 of Akhtar Hayat. This work was carried out as part of the HEC-NRPU project No. 204286/R&D/HEC/2014 of Akhtar Hayat.	Aparicio-Martinez E, 2018, J NANOMATERIALS, V2018; Bai SL, 2010, SENSOR ACTUAT B-CHEM, V150, P749, DOI 10.1016/j.snb.2010.08.007; BASHIR WA, 1983, MICROCHEM J, V28, P77, DOI 10.1016/0026-265X(83)90030-9; Boots AW, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/2/027108; Choi SJ, 2013, ANAL CHEM, V85, P1792, DOI 10.1021/ac303148a; Choi SW, 2013, SENSOR ACTUAT B-CHEM, V176, P585, DOI 10.1016/j.snb.2012.09.035; Dong CJ, 2016, SENSOR ACTUAT B-CHEM, V224, P193, DOI 10.1016/j.snb.2015.09.107; Gouma P, 2012, AM CERAM SOC BULL, V91, P26; Jan YH, 2009, J AIR WASTE MANAGE, V59, P1186, DOI 10.3155/1047-3289.59.10.1186; Joshi N, 2016, RSC ADV, V6; Joshi N, 2018, MICROCHIM ACTA, V185, DOI 10.1007/s00604-018-2750-5; Joshi N, 2018, SENSOR ACTUAT B-CHEM, V257, P906, DOI 10.1016/j.snb.2017.11.041; Kakati N, 2010, THIN SOLID FILMS, V519, P494, DOI 10.1016/j.tsf.2010.08.005; Kamat PC, 2007, APPL OPTICS, V46, P3969, DOI 10.1364/AO.46.003969; Kao KW, 2012, SENSORS-BASEL, V12, P7157, DOI 10.3390/s120607157; Kharitonov S, 1997, EUR RESPIR J, V10, P1683, DOI 10.1183/09031936.97.10071683; Kim D, 2017, J HAZARD MATER, V326, P69, DOI 10.1016/j.jhazmat.2016.12.007; Kim S, 2015, SENSOR ACTUAT B-CHEM, V209, P180, DOI 10.1016/j.snb.2014.11.106; Liu FM, 2017, SENSOR ACTUAT B-CHEM, V248, P9, DOI 10.1016/j.snb.2017.03.133; Liu FM, 2016, SENSOR ACTUAT B-CHEM, V229, P200, DOI 10.1016/j.snb.2016.01.128; Liu X., 2017, ADV FUNCTIONAL MAT, V27; Lupan O, 2014, J PHYS CHEM C, V118, P15068, DOI 10.1021/jp5038415; Madhi I, 2015, CERAM INT, V41, P6552, DOI 10.1016/j.ceramint.2015.01.098; MANOLIS A, 1983, CLIN CHEM, V29, P5; Minh TDC, 2011, AM J PHYSIOL-ENDOC M, V300, pE1166, DOI 10.1152/ajpendo.00634.2010; Mishra YK, 2017, MAT TODAY, DOI 10.1016/j.mattod.2017.11.003; Moseley PT, 2017, MEAS SCI TECHNOL, V28, DOI 10.1088/1361-6501/aa7443; Murade PA, 2011, CURR APPL PHYS, V11, P451, DOI 10.1016/j.cap.2010.08.020; Narasimhan LR, 2001, P NATL ACAD SCI USA, V98, P4617, DOI 10.1073/pnas.071057598; ONEILL HJ, 1988, CLIN CHEM, V34, P1613; Park S, 2017, J ALLOY COMPD, V696, P655, DOI 10.1016/j.jallcom.2016.11.298; Park SY, 2015, J ASIAN CERAM SOC, V2, P339; Phillips M, 1999, LANCET, V353, P1930, DOI 10.1016/S0140-6736(98)07552-7; Ping W, 1997, BIOSENS BIOELECTRON, V12, P1031, DOI 10.1016/S0956-5663(97)00059-6; Salehi S, 2014, SENSOR ACTUAT B-CHEM, V205, P261, DOI 10.1016/j.snb.2014.08.082; Shi GL, 2018, SENSOR ACTUAT B-CHEM, V257, P451, DOI 10.1016/j.snb.2017.10.154; Smith D, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/2/022001; Tang HX, 2006, SENSOR ACTUAT B-CHEM, V114, P910, DOI 10.1016/j.snb.2005.08.010; Tao WY, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010194; Teleki A, 2006, SENSOR ACTUAT B-CHEM, V119, P683, DOI 10.1016/j.snb.2006.01.027; Turner C, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/4/046004; Ueta I, 2009, J CHROMATOGR B, V877, P2551, DOI 10.1016/j.jchromb.2009.06.039; Vomiero A, 2007, CRYST GROWTH DES, V7, P2500, DOI 10.1021/cg070209p; Wang CJ, 2010, IEEE SENS J, V10, P54, DOI 10.1109/JSEN.2009.2035730; Wang L, 2008, CHEM MATER, V20, P4794, DOI 10.1021/cm800761e; Wang YR, 2016, ACS APPL MATER INTER, V8, P9674, DOI 10.1021/acsami.5b12857; Woo HS, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/24/245501; Xing RQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10717; Xu XL, 2015, SENSOR ACTUAT B-CHEM, V213, P222, DOI 10.1016/j.snb.2015.02.073; Yu H, 2003, SENS 2003 P IEEE; Yu QX, 2015, SENSOR ACTUAT B-CHEM, V213, P27, DOI 10.1016/j.snb.2015.01.130; Zhang J, 2016, ADV MATER, V28, P795, DOI 10.1002/adma.201503825; Zhang S, 2017, SENSOR ACTUAT B-CHEM, V242, P983, DOI 10.1016/j.snb.2016.09.155	53	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199978	10.1371/journal.pone.0199978	http://dx.doi.org/10.1371/journal.pone.0199978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979737	gold, Green Published, Green Submitted			2022-12-26	WOS:000437809500047
J	Roth, JA; Carter-Harris, L; Brandzel, S; Buist, DSM; Wernli, KJ				Roth, Joshua A.; Carter-Harris, Lisa; Brandzel, Susan; Buist, Diana S. M.; Wernli, Karen J.			A qualitative study exploring patient motivations for screening for lung cancer	PLOS ONE			English	Article							PERCEPTIONS	Background Low-dose computed tomography (LDCT) of the chest for lung cancer screening of heavy smokers was given a 'B' rating by the U.S. Preventive Services Task Force (USPSTF) in 2013, and gained widespread insurance coverage in the U.S. in 2015. Lung cancer screening has since had low uptake. However, for those that do choose to screen, little is known about patient motivations for completing screening in real-world practice. Objective To explore the motivations for screening-eligible patients to screen for lung cancer. Methods Semi-structured qualitative interviews were conducted with 20 LDCT screen-completed men and women who were members of an integrated mixed-model healthcare system in Washington State. From June to September 2015, participants were recruited and individual interviews performed about motivations to screen for lung cancer. Audio-recorded interviews were transcribed and analyzed using inductive content analysis by three investigators. Results Four primary themes emerged as motivations for completing LDCT lung cancer screening: 1) trust in the referring clinician; 2) early-detection benefit; 3) low or limited harm perception; and 4) friends or family with advanced cancer. Conclusion Participants in our study were primarily motivated to screen for lung cancer based on perceived benefit of early-detection, absence of safety concerns, and personal relationships. Our findings provide new insights about patient motivations to screen, and can potentially be used to improve lung cancer screening uptake and shared decision-making processes.	[Roth, Joshua A.] Fred Hutchinson Canc Res Ctr, Hutchinson Inst Canc Outcomes Res, 1124 Columbia St, Seattle, WA 98104 USA; [Roth, Joshua A.] Univ Washington, Comparat Hlth Outcomes Policy & Econ Inst, Seattle, WA 98195 USA; [Carter-Harris, Lisa] Indiana Univ, Sch Nursing, Indianapolis, IN 46204 USA; [Brandzel, Susan] Hlth Stories Project Insights, Seattle, WA USA; [Buist, Diana S. M.; Wernli, Karen J.] Kaiser Permanente Washington, Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Indiana University System; Indiana University-Purdue University Indianapolis; Kaiser Permanente	Roth, JA (corresponding author), Fred Hutchinson Canc Res Ctr, Hutchinson Inst Canc Outcomes Res, 1124 Columbia St, Seattle, WA 98104 USA.; Roth, JA (corresponding author), Univ Washington, Comparat Hlth Outcomes Policy & Econ Inst, Seattle, WA 98195 USA.	jroth@fredhutch.org	Wernli, Karen/ABF-6379-2021; Alizadeh/AAK-1398-2021; Wernli, Karen/AAM-2671-2020; , M/AAD-2633-2019	Roth, Joshua/0000-0001-6621-8342	Agency for Healthcare Research and Quality [1K12HS022982]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS022982] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by grant number 1K12HS022982 from the Agency for Healthcare Research and Quality to JAR. The Agency for Healthcare Research and Quality had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Agency for Healthcare Research and Quality, LUNG CANC SCREEN TOO; Carter-Harris L, 2017, FAM PRACT, V34, P239, DOI 10.1093/fampra/cmw146; Carter-Harris L, 2017, HEALTH EXPECT, V20, P59, DOI 10.1111/hex.12433; Carter-Harris L, 2016, PATIENT EDUC COUNS, V99, P1772, DOI 10.1016/j.pec.2016.05.014; FRIEDMAN LC, 1995, AM J PREV MED, V11, P218, DOI 10.1016/S0749-3797(18)30449-5; Fyffe DC, 2008, J NATL MED ASSOC, V100, P1161, DOI 10.1016/S0027-9684(15)31478-4; Graff S, 2017, JNCI-J NATL CANCER I, V109; Howlader N, 2012, SEER CANC STAT REV; Huo JH, 2017, JAMA INTERN MED, V177, P439, DOI 10.1001/jamainternmed.2016.9016; Lau YK, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.4039; Lillie SE, 2017, LUNG CANCER, V104, P38, DOI 10.1016/j.lungcan.2016.11.021; McCunney RJ, 2014, CHEST, V145, P618, DOI 10.1378/chest.13-1420; McKee Brady J, 2016, J Am Coll Radiol, V13, pR25, DOI 10.1016/j.jacr.2015.12.009; Memorial Sloan Kettering Cancer Center, LUNG CANC SCREEN DEC; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Noone A, 2016, CANC INCIDENCE SURVI, DOI [10.1158/1055-9965.epi-16-0520, DOI 10.1158/1055-9965.EPI-16-0520]; Park ER, 2014, NICOTINE TOB RES, V16, P166, DOI 10.1093/ntr/ntt133; Park ER, 2009, ANN BEHAV MED, V37, P268, DOI 10.1007/s12160-009-9112-9; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Schapira MM, 2016, ANN AM THORAC SOC, V13, P1969, DOI 10.1513/AnnalsATS.201604-290OC; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Zapka Jane, 2012, Journal of the National Cancer Institute Monographs, P11, DOI 10.1093/jncimonographs/lgs005; Zeliadt SB, 2015, JAMA INTERN MED, V175, P1530, DOI 10.1001/jamainternmed.2015.3558	24	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0196758	10.1371/journal.pone.0196758	http://dx.doi.org/10.1371/journal.pone.0196758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL7YG	29975709	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500002
J	Franzo, G; Segales, J; Tucciarone, CM; Cecchinato, M; Drigo, M				Franzo, Giovanni; Segales, Joaquim; Tucciarone, Claudia Maria; Cecchinato, Mattia; Drigo, Michele			The analysis of genome composition and codon bias reveals distinctive patterns between avian and mammalian circoviruses which suggest a potential recombinant origin for Porcine circovirus 3	PLOS ONE			English	Article							NUCLEOTIDE COMPOSITION; MUTATION PRESSURE; USAGE; DNA; VIRUS; HOST; SELECTION; BATS; METHYLATION; ACTIVATION	Members of the genus Circovirus are host-specific viruses, which are totally dependent on cell machinery for their replication. Consequently, certain mimicry of the host genome features is expected to maximize cellular replicative system exploitation and minimize the recognition by the innate immune system. In the present study, the analysis of several genome composition and codon bias parameters of circoviruses infecting avian and mammalian species demonstrated the presence of quite distinctive patterns between the two groups. Remarkably, a higher deviation from the expected values based only on mutational patterns was observed for mammalian circoviruses both at dinucleotide and codon levels. Accordingly, a stronger selective pressure was estimated to shape the genome of mammalian circoviruses, particularly in the Cap encoding gene, compared to avian circoviruses. These differences could be attributed to different physiological and immunological features of the two host classes and suggest a trade-off between a tendency to optimize the capsid protein translation while minimizing the recognition of the genome and the transcript molecules. Interestingly, the recently identified Porcine circovirus 3(PCV-3) had an intermediate pattern in terms of genome composition and codon bias. Particularly, its Rep gene appeared closely related to other mammalian circoviruses (especially bat circoviruses) while the Cap gene more closely resembled avian circoviruses. These evidences, coupled with the high selective forces apparently modelling the PCV-3 Cap gene composition, suggest the potential recombinant origin, followed or preceded by a host jump, of this virus.	[Franzo, Giovanni; Tucciarone, Claudia Maria; Cecchinato, Mattia; Drigo, Michele] Univ Padua, Dept Anim Med Prod & Hlth MAPS, Padua, Italy; [Segales, Joaquim] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Barcelona, Spain; [Segales, Joaquim] UAB, IRTA, Ctr Recerca Sanitat Anim CReSA, Campus Univ Autonoma Barcelona, Barcelona, Spain	University of Padua; Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA	Franzo, G (corresponding author), Univ Padua, Dept Anim Med Prod & Hlth MAPS, Padua, Italy.	giovanni.franzo@unipd.it	Segalés, Joaquim/A-4933-2011; Segalés, Joaquim/AAB-4815-2020	Segalés, Joaquim/0000-0002-1539-7261; Segalés, Joaquim/0000-0002-1539-7261; Tucciarone, Claudia Maria/0000-0002-0340-8920; Franzo, Giovanni/0000-0003-2991-217X; Drigo, Michele/0000-0002-7267-9388; Cecchinato, Mattia/0000-0002-2269-7879				Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71; Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Bonvicini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033316; Brownlie R, 2011, CELL TISSUE RES, V343, P121, DOI 10.1007/s00441-010-1026-0; Brownlie R, 2009, MOL IMMUNOL, V46, P3163, DOI 10.1016/j.molimm.2009.06.002; Campbell A, 1999, P NATL ACAD SCI USA, V96, P9184, DOI 10.1073/pnas.96.16.9184; Carlini DB, 2004, J EVOLUTION BIOL, V17, P779, DOI 10.1111/j.1420-9101.2004.00725.x; Chaney JL, 2015, ANNU REV BIOPHYS, V44, P143, DOI 10.1146/annurev-biophys-060414-034333; Charif D, 2008, SEQINR 2 0 1 CONTRIB, P268; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Chen Y, 2014, ARCH VIROL, V159, P2145, DOI 10.1007/s00705-014-2015-5; Chothe SK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00793-6; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Dalpke A, 2006, INFECT IMMUN, V74, P940, DOI 10.1128/IAI.74.2.940-946.2006; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; Di Giallonardo F, 2017, J VIROL, V91, DOI 10.1128/JVI.02381-16; Dobson AP, 2005, SCIENCE, V310, P628, DOI 10.1126/science.1120872; Franzo G, 2018, VET REC, V182, P83, DOI 10.1136/vr.k91; Franzo G, 2017, MOL PHYLOGENET EVOL, V114, P82, DOI 10.1016/j.ympev.2017.05.019; Freidl GS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127035; Gentles AJ, 2001, GENOME RES, V11, P540, DOI 10.1101/gr.163101; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Han HJ, 2015, VIRUS RES, V205, P1, DOI 10.1016/j.virusres.2015.05.006; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hoelzer K, 2008, NUCLEIC ACIDS RES, V36, P2825, DOI 10.1093/nar/gkn121; Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; King AMQ, 2018, ARCH VIROL, V163, P2601, DOI 10.1007/s00705-018-3847-1; KNIGHT RD, 2001, GENOME BIOL, V2; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Ku X, 2017, TRANSBOUND EMERG DIS, V64, P703, DOI 10.1111/tbed.12638; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kumar N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154376; Kwon T, 2017, VET MICROBIOL, V207, P178, DOI 10.1016/j.vetmic.2017.06.013; Liu XS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-68; Ma MR, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-544; Myers P, ANIMAL DIVERSITY WEB, V12, P2; Nasrullah I, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0456-4; Novembre J, 2006, USER DOCUMENTATION E, P1; Novembre JA., 2000, AMINO ACIDS, V2, P1390, DOI DOI 10.1093/0XF0RDJ0URNALS.M0LBEV.A004201; Palinski R, 2017, J VIROL, V91, DOI [10.1128/JVI.01879-16, 10.1128/jvi.01879-16]; Parmley JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000548; Rosario K, 2017, ARCH VIROL, V162, P1447, DOI 10.1007/s00705-017-3247-y; Roth A, 2012, CODON EVOLUTION: MECHANISMS AND MODELS, P189; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Shah P, 2011, P NATL ACAD SCI USA, V108, P10231, DOI 10.1073/pnas.1016719108; Sturkie P.D., 1986, AVIAN PHYSIOL, DOI DOI 10.1007/978-1-4612-4862-0_5; Su MW, 2009, J COMPUT BIOL, V16, P1539, DOI 10.1089/cmb.2009.0046; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Team RC, 2011, R LANG ENV STAT COMP; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; TISCHER I, 1974, ZBL BAKT-INT J MED M, V226, P153; TISCHER I, 1982, NATURE, V295, P64, DOI 10.1038/295064a0; Todd D, 2004, VET MICROBIOL, V98, P169, DOI 10.1016/j.vetmic.2003.10.010; Phan TG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0642-z; Turmelle AS, 2009, ECOHEALTH, V6, P522, DOI 10.1007/s10393-009-0263-8; van Hemert FJ, 2007, VIROLOGY, V361, P447, DOI 10.1016/j.virol.2006.11.021; WANG AHJ, 1984, CELL, V37, P321, DOI 10.1016/0092-8674(84)90328-3; Wang JM, 2016, J AM CERAM SOC, V99, P3371, DOI 10.1111/jace.14358; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; Xu Y, 2015, GENE, V557, P138, DOI 10.1016/j.gene.2014.12.019; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Zheng S, 2017, TRANSBOUND EMERG DIS, V64, P1337, DOI 10.1111/tbed.12667	67	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0199950	10.1371/journal.pone.0199950	http://dx.doi.org/10.1371/journal.pone.0199950			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0PZ	29958294	Green Published, Green Submitted, gold			2022-12-26	WOS:000436793500024
J	Li, HJ; Kuo, CC; Yao, YC; Tsai, CH; Chow, PC; Li, YC				Li, Hsing-Jung; Kuo, Chao-Chan; Yao, Yi-Chien; Tsai, Ching-Hong; Chow, Philip C.; Li, Ying-Chun			Outpatient rehabilitation resources and medical expenditure in children with attention-deficit hyperactivity disorder in Taiwan	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; ECONOMIC-IMPACT; PREVALENCE; CHILDHOOD; COSTS; ADHD; ADOLESCENTS; BURDEN; YOUTH; CARE	Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder in children. This study investigated the use of rehabilitation treatment in Taiwan. We selected children aged 3 - 12 years from the National Health Insurance Research Database from 2008 to 2012 and included them in the analysis. The children who received a diagnosis according to the International Classification of Diseases, Ninth Revision, Clinical Modification were divided into two groups: ADHD and non-ADHD. We used the chi-squared test, independent sample t test, and multiple regression analysis to conduct the analysis. The utilisation of rehabilitation resources was higher in the ADHD group than in the non-ADHD group. The number of school-aged children with ADHD was higher than the number of preschool-aged children (p < 0.001). The highest utilisation of rehabilitation resources was observed in clinics (p < 0.001). In terms of region, Taipei exhibited the highest utilisation of rehabilitation resources, and the East exhibited the lowest resource utilisation (p < 0.001). Prediction of the use of rehabilitation resources, average cost, average frequency of visits, and total annual cost was affected by factors such as the average frequency of rehabilitation use, demographic characteristics, and the hospital characteristics and location (p < 0.001). The number of children with ADHD and rehabilitation use are increasing yearly; however, limitations in payment restrict the growth of rehabilitation resource use in hospitals. Supplementation of rehabilitation resources at clinics accounts for more than 60%, however, the total annual cost is less than what is observed for hospitals (p < 0.001). Policies should be established to aid in the early detection and treatment of children with ADHD to improve treatment outcomes and reduce the family burden and treatment expenditure in the future.	[Li, Hsing-Jung; Tsai, Ching-Hong] Kai Syuan Psychiat Hosp, Dept Child & Adolescent Psychiat, Kaohsiung, Taiwan; [Li, Hsing-Jung; Yao, Yi-Chien; Li, Ying-Chun] Natl Sun Yat Sen Univ, Inst Hlth Care Management, Dept Business Management, Kaohsiung, Taiwan; [Kuo, Chao-Chan] Kai Syuan Psychiat Hosp, Dept Adult Psychiat, Kaohsiung, Taiwan; [Chow, Philip C.] Conde Sao Januario Cent Hosp, Dept Psychiat, Macau, Peoples R China	National Sun Yat Sen University	Li, YC (corresponding author), Natl Sun Yat Sen Univ, Inst Hlth Care Management, Dept Business Management, Kaohsiung, Taiwan.	ycli@mail.nsysy.edu.tw		Li, Ying-Chun/0000-0001-8516-970X				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Austerman J, 2015, CLEV CLIN J MED, V82, pS2, DOI 10.3949/ccjm.82.s1.01; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Birnbaum HG, 2005, CURR MED RES OPIN, V21, P195, DOI 10.1185/030079904X20303; Burd L, 2003, J CHILD NEUROL, V18, P555, DOI 10.1177/08830738030180080101; Chien IC, 2012, SOC PSYCH PSYCH EPID, V47, P1885, DOI 10.1007/s00127-012-0501-1; Chorozoglou M, 2015, J CHILD PSYCHOL PSYC, V56, P966, DOI 10.1111/jcpp.12437; Dopheide JA, 2009, PHARMACOTHERAPY, V29, P656, DOI 10.1592/phco.29.6.656; Doshi JA, 2012, J AM ACAD CHILD PSY, V51, P990, DOI 10.1016/j.jaac.2012.07.008; Gau SSF, 2010, AUST NZ J PSYCHIAT, V44, P135, DOI 10.3109/00048670903282733; Guevara J, 2001, PEDIATRICS, V108, P71, DOI 10.1542/peds.108.1.71; Klassen A, 1999, CAN J PSYCHIAT, V44, P1007, DOI 10.1177/070674379904401007; Klora M, 2015, HEALTH ECON REV, V5, DOI 10.1186/s13561-015-0078-y; Kooij SJJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-67; Korsgaard HO, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0871-0; Larson K, 2011, PEDIATRICS, V127, P462, DOI 10.1542/peds.2010-0165; Le HH, 2014, EUR CHILD ADOLES PSY, V23, P587, DOI 10.1007/s00787-013-0477-8; Leibson CL, 2001, JAMA-J AM MED ASSOC, V285, P60, DOI 10.1001/jama.285.1.60; Lin JD, 2013, RES DEV DISABIL, V34, P2127, DOI 10.1016/j.ridd.2013.03.034; Marks DJ, 2009, J PEDIATR PSYCHOL, V34, P681, DOI 10.1093/jpepsy/jsn112; Page TF, 2016, J CLIN CHILD ADOLESC, V45, P416, DOI 10.1080/15374416.2015.1055859; Pelham WE, 2007, AMBUL PEDIATR, V7, P121, DOI 10.1016/j.ambp.2006.08.002; Remschmidt H, 2005, EUR CHILD ADOLES PSY, V14, P127, DOI 10.1007/s00787-005-0439-x; Rowe Donald L., 2004, Journal of Integrative Neuroscience, V3, P453, DOI 10.1142/S0219635204000592; Schoffski O, 2008, GESUNDHEITSWESEN, V70, P398, DOI 10.1055/s-0028-1082049; Tai YM, 2013, RES DEV DISABIL, V34, P1100, DOI 10.1016/j.ridd.2012.11.027; Tsai CC, 2009, TAWAN J PSYCHIAT, V23, P296; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8	28	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199877	10.1371/journal.pone.0199877	http://dx.doi.org/10.1371/journal.pone.0199877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL0GK	29953532	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400085
J	Zheng, HB; Liu, WR; Zheng, JY; Luo, Y; Li, RP; Wang, H; Qi, H				Zheng, Hongbing; Liu, Wuren; Zheng, Jinyu; Luo, Yang; Li, Ruiping; Wang, Hao; Qi, Hua			Effect of long-term tillage on soil aggregates and aggregate-associated carbon in black soil of Northeast China	PLOS ONE			English	Article							ORGANIC-MATTER; MICROAGGREGATE; MANAGEMENT; MECHANISMS; DYNAMICS; SYSTEMS	Soil tillage can affect the stability and formation of soil aggregates by disrupting soil structure. Frequent tillage deteriorates soil structure and weakens soil aggregates, causing them to be susceptible to decay. Different types of tillage systems affect soil physical properties and organic matter content, in turn influencing the formation of aggregates. The objective of this study was to evaluate the effect of long-term tillage on soil aggregates and aggregate-associated carbon in a black soil of Northeast China and to identify the optimal conservation tillage in this system. This research was conducted on a long-term tillage experimental field established in 1983 at the Jilin Academy of Agricultural Sciences, Gongzhuling, China. Plots were treated with four tillage systems including no tillage (NT), spacing tillage (ST), mold-board plowing (MP), and conventional tillage (CT). We took samples every 10cm from 0-60cm depth and demonstrated that water-stable soil aggregates >0.25mm in diameter accounted for over 66.0% of total aggregates for all tillage treatments, and the percentage for the ST treatment was 34.5% higher than in the other treatments. The NT treatment had the highest effect at 0-10cm depth, while the effect for the ST treatment was highest at 0-30cm. SOC storage decreased with soil depth, with a significant accumulation at 0-20cm depth. Across treatments, aggregate-associated C at a depth of 0-10cm was higher in the NT and ST treatments than in the MP and CT treatments. The advantage of the NT treatment weakened with soil depth, while the amount of aggregate-associated C remained higher for the ST treatment. There were more macro-aggregates in the ST and NT treatments than in the MP and CT treatments, while the MP and CT treatments had more micro-aggregates. The sum of macro-aggregate contributing rates for soil organic C (SOC) was significantly superior to that of the micro-aggregates. Water-stable aggregates increased by 34.5% in the ST treatment, effectively improving the soil structure. Furthermore, 0.25-1.00 and 1-2mm aggregates had the highest SOC storage and responded rapidly to the various tillage treatments. Hence, they can serve as indicators for the long-term influence of different tillage treatments on the distribution of aggregates and SOC.	[Zheng, Hongbing; Qi, Hua] Agr Univ Shenyang, Agron Coll, Shenyang, Liaoning, Peoples R China; [Zheng, Hongbing; Liu, Wuren; Zheng, Jinyu; Luo, Yang; Li, Ruiping; Wang, Hao] Jilin Acad Agr Sci, Res Inst Agr Resources & Environm, Changchun, Jilin, Peoples R China; [Zheng, Hongbing; Liu, Wuren; Zheng, Jinyu; Luo, Yang; Li, Ruiping; Wang, Hao] Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Northeast, Changchun, Jilin, Peoples R China	Shenyang Agricultural University; Jilin Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Qi, H (corresponding author), Agr Univ Shenyang, Agron Coll, Shenyang, Liaoning, Peoples R China.	Qihua09@163.com		zheng, hongbing/0000-0002-2870-3467	National Natural Science Foundation Program [31501248]; National Key Research and Development Program of China [2016YFD03002]; Agricultural Science and Technology Innovation Program of Jilin Province [CXGC2017ZY009]; Special Fund for Agro-scientific Research in the Public Interest [201503116]	National Natural Science Foundation Program(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Agricultural Science and Technology Innovation Program of Jilin Province; Special Fund for Agro-scientific Research in the Public Interest	This study was supported by the National Natural Science Foundation Program (31501248), the National Key Research and Development Program of China (2016YFD03002), Agricultural Science and Technology Innovation Program of Jilin Province (CXGC2017ZY009), Special Fund for Agro-scientific Research in the Public Interest (201503116).	Al-Kaisi MM, 2014, J SOIL WATER CONSERV, V69, P574, DOI 10.2489/jswc.69.6.574; An TingTing, 2007, Journal of Shenyang Agricultural University, V38, P407; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Caesar-TonThat T, 2011, BIOL FERT SOILS, V47, P157, DOI 10.1007/s00374-010-0508-2; [蔡立群 CAI Li-Qun], 2009, [中国生态农业学报, Chinese Journal of Eco-Agriculture], V17, P1; Dou Sen, 2011, Acta Pedologica Sinica, V48, P412; Ellert BH, 1995, CAN J SOIL SCI, V75, P529, DOI 10.4141/cjss95-075; Hamza MA, 2005, SOIL TILL RES, V82, P121, DOI 10.1016/j.still.2004.08.009; Hillel D., 1982, INTRO SOIL PHYS; [黄丹丹 Huang Dandan], 2012, [农业环境科学学报, Journal of Agro-Environment Science], V31, P1560; Humberto BC, 2004, PLANT SCI, V23, P481; ISMAIL I, 1994, SOIL SCI SOC AM J, V58, P193, DOI 10.2136/sssaj1994.03615995005800010028x; Jastrow JD, 1996, SOIL SCI SOC AM J, V60, P801, DOI 10.2136/sssaj1996.03615995006000030017x; Karunatilake U, 2000, SOIL TILL RES, V55, P31, DOI 10.1016/S0167-1987(00)00096-9; Kemper W. D., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P425; Kladivko EJ, 2001, SOIL TILL RES, V61, P61, DOI 10.1016/S0167-1987(01)00179-9; Lal R, 2007, SOIL TILL RES, V94, P1, DOI 10.1016/j.still.2007.02.002; Lal R, 2009, SOIL TILL RES, V102, P1, DOI 10.1016/j.still.2008.08.001; [李爱宗 LI Aizong], 2008, [土壤通报, Journal of Soil Science], V39, P480; Liang Ai-zhen, 2008, Yingyong Shengtai Xuebao, V19, P1052; Liang AiZhen, 2009, Scientia Agricultura Sinica, V42, P2801; Liu XiaoLi, 2009, Acta Pedologica Sinica, V46, P255; OADES JM, 1984, PLANT SOIL, V76, P319, DOI 10.1007/BF02205590; Pan GX, 2005, ADV EARTH SCI, V20, P327; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Triplett GB, 2008, AGRON J, V100, pS153, DOI 10.2134/agronj2007.0005c; Varsa EC, 1997, SOIL TILL RES, V43, P219, DOI 10.1016/S0167-1987(97)00041-X; Wang Yan, 2008, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V16, P766; Wen D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146757; Wu ChengZhen, 1999, Acta Pedologica Sinica, V36, P162; YODER ROBERT E., 1936, JOUR AMER SOC AGRON, V28, P337; [张凤华 Zhang Fenghua], 2014, [干旱地区农业研究, Agricultural Research in the Arid Areas], V32, P113; [张赛 Zhang Sai], 2013, [水土保持学报, Journal of Soil and Water Conservation], V27, P263; Zhang SX, 2012, SOIL TILL RES, V124, P196, DOI 10.1016/j.still.2012.06.007; [郑子成 Zheng Zicheng], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P1827; [郑子成 Zheng Zicheng], 2011, [自然资源学报, Journal of Natural Resources], V26, P119; Zhou Hu, 2009, Acta Pedologica Sinica, V46, P501; [周萍 ZHOU Ping], 2007, [土壤通报, Journal of Soil Science], V38, P256	44	62	67	9	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199523	10.1371/journal.pone.0199523	http://dx.doi.org/10.1371/journal.pone.0199523			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953462	gold, Green Submitted, Green Published			2022-12-26	WOS:000436645400038
J	Crane, NL; Tariel, J; Caselle, JE; Friedlander, AM; Robertson, DR; Bernardi, G				Crane, Nicole L.; Tariel, Juliette; Caselle, Jennifer E.; Friedlander, Alan M.; Ross Robertson, D.; Bernardi, Giacomo			Clipperton Atoll as a model to study small marine populations: Endemism and the genomic consequences of small population size	PLOS ONE			English	Article							CORAL-REEF FISH; TROPICAL EASTERN PACIFIC; MULTILOCUS GENOTYPE DATA; GENETIC DIVERSITY; LINKAGE DISEQUILIBRIUM; INFORM CONSERVATION; SELF-RECRUITMENT; ACINONYX-JUBATUS; N-E; POMACANTHIDAE	Estimating population sizes and genetic diversity are key factors to understand and predict population dynamics. Marine species have been a difficult challenge in that respect, due to the difficulty in assessing population sizes and the open nature of such populations. Small, isolated islands with endemic species offer an opportunity to groundtruth population size estimates with empirical data and investigate the genetic consequences of such small populations. Here we focus on two endemic species of reef fish, the Clipperton damselfish, Stegastes baldwini, and the Clipperton angelfish, Holacanthus limbaughi, on Clipperton Atoll, tropical eastern Pacific. Visual surveys, performed over almost two decades and four expeditions, and genetic surveys based on genomic RAD sequences, allowed us to estimate kinship and genetic diversity, as well as to compare population size estimates based on visual surveys with effective population sizes based on genetics. We found that genetic and visual estimates of population numbers were remarkably similar. S. baldwini and H. limbaughi had population sizes of approximately 800,000 and 60,000, respectively. Relatively small population sizes resulted in low genetic diversity and the presence of apparent kinship. This study emphasizes the importance of small isolated islands as models to study population dynamics of marine organisms.	[Crane, Nicole L.] Cabrillo Coll, Dept Biol, Aptos, CA USA; [Tariel, Juliette; Bernardi, Giacomo] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Caselle, Jennifer E.] Univ Calif Santa Barbara, Marine Sci Inst, Santa Barbara, CA 93106 USA; [Friedlander, Alan M.] Natl Geog Soc, Pristine Seas, Washington, DC USA; [Friedlander, Alan M.] Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Ross Robertson, D.] Smithsonian Trop Res Inst, Balboa, Panama	University of California System; University of California Santa Cruz; University of California System; University of California Santa Barbara; National Geographic Society; University of Hawaii System; Smithsonian Institution; Smithsonian Tropical Research Institute	Bernardi, G (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	bernardi@ucsc.edu	Bernardi, Giacomo/F-6346-2011; Tariel-Adam, Juliette/AAH-4363-2021	Bernardi, Giacomo/0000-0002-8249-4678; Tariel-Adam, Juliette/0000-0003-1552-4088	National Geographic Society Grant [5831-96]; Smithsonian Tropical Research Institute; National Geographic Society Pristine Seas program	National Geographic Society Grant(National Geographic Society); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); National Geographic Society Pristine Seas program	Work at Clipperton by DRR and JEC in 1998 was financed by National Geographic Society Grant 5831-96 and the Smithsonian Tropical Research Institute. Work by JEC and AMF in 2016 was financed by the National Geographic Society Pristine Seas program.	Adam TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023717; Allen G. R., 1994, FISHES TROPICAL E PA; Allen GR, 1997, REV BIOL TROP, V45, P813; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Alva-Campbell Y, 2010, MOL PHYLOGENET EVOL, V56, P456, DOI 10.1016/j.ympev.2010.02.014; [Anonymous], CLIPPERTON ENV BIODI; Arellano-Martinez M, 1999, B MAR SCI, V65, P677; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barbato M, 2015, FRONT GENET, V6, P1, DOI DOI 10.3389/FGENE.2015.00001; Barbato M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07382-7; Bellwood DR, 2004, MOL PHYLOGENET EVOL, V33, P140, DOI 10.1016/j.ympev.2004.04.015; Bernardi G, 2014, B MAR SCI, V90, P533, DOI 10.5343/bms.2013.1036; Berumen ML, 2012, ECOL EVOL, V2, P444, DOI 10.1002/ece3.208; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Candy JR, 2015, MOL ECOL RESOUR, V15, P1421, DOI 10.1111/1755-0998.12400; Cariou M, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0791-0; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Charpy L., 2009, CLIPPERTON ENV BIODI; Coscia I, 2016, HEREDITY, V117, P251, DOI 10.1038/hdy.2016.50; Crane NL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177083; Deck J, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002925; Delrieu-Trottin E, 2017, SCI REP-UK, V7, DOI 10.1038/srep40519; Delrieu-Trottin E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1068; DeMartini EE, 2004, MAR ECOL PROG SER, V271, P281, DOI 10.3354/meps271281; Dias EA, 2007, GENET MOL RES, V6, P1097; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Do Kyoung-Tag, 2014, Journal of Animal Science and Technology, V56, P28, DOI 10.1186/2055-0391-56-28; Dobrynin P, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0837-4; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fourriere M, 2014, PAC SCI, V68, P375, DOI 10.2984/68.3.7; FROESE R, 2000, FISHBASE 2000 CONCEP; Furlan E, 2012, ECOL EVOL, V2, P844, DOI 10.1002/ece3.195; Garbe JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160496; Gasca-Pineda J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078120; Gomez-Uchida D, 2006, J HERED, V97, P603, DOI 10.1093/jhered/esl042; Hague MTJ, 2016, HEREDITY, V116, P92, DOI 10.1038/hdy.2015.76; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hedgecock D, 2011, B MAR SCI, V87, P971, DOI 10.5343/bms.2010.1051; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Hutchinson WF, 2003, P ROY SOC B-BIOL SCI, V270, P2125, DOI 10.1098/rspb.2003.2493; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Kaiser K. L., 2007, FESTIVUS S, V39, P1, DOI DOI 10.5962/BHL.TITLE.129868; Kimura M., 1983, NEUTRAL THEORY MOL E; Larson WA, 2014, EVOL APPL, V7, P355, DOI 10.1111/eva.12128; Le Port A, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1300; Lester SE, 2007, ECOL LETT, V10, P745, DOI 10.1111/j.1461-0248.2007.01070.x; Liu W, 2004, ANN HUM GENET, V68, P606, DOI 10.1046/j.1529-8817.2004.00121.x; Liu XM, 2015, NAT GENET, V47, P555, DOI 10.1038/ng.3254; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Longo G, 2015, MOL PHYLOGENET EVOL, V88, P55, DOI 10.1016/j.ympev.2015.03.027; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Matthies D, 2004, OIKOS, V105, P481, DOI 10.1111/j.0030-1299.2004.12800.x; Meekan MG, 2001, MAR ECOL PROG SER, V212, P223, DOI 10.3354/meps212223; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Miller MR, 2012, MOL ECOL, V21, P237, DOI 10.1111/j.1365-294X.2011.05305.x; MOYER JT, 1983, ENVIRON BIOL FISH, V9, P25, DOI 10.1007/BF00001056; Ovenden JR, 2016, J FISH BIOL, V89, P2505, DOI 10.1111/jfb.13129; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Paris JR, 2017, METHODS ECOL EVOL, V8, P1360, DOI 10.1111/2041-210X.12775; Peel D, 2013, MOL ECOL RESOUR, V13, P243, DOI 10.1111/1755-0998.12049; Pinheiro HT, 2017, NATURE, V549, P82, DOI 10.1038/nature23680; Pritchard JK, 2000, GENETICS, V155, P945; Puebla O, 2014, MOL ECOL, V23, P5291, DOI 10.1111/mec.12926; Ricart AM, 2016, SCI MAR, V80, P479, DOI 10.3989/scimar.04301.12B; Robertson DR, 2009, MAR ECOL PROG SER, V380, P1, DOI 10.3354/meps07925; ROBERTSON DR, 1990, ECOL MONOGR, V60, P311, DOI 10.2307/1943060; Robertson DR, 2001, P NATL ACAD SCI USA, V98, P5667, DOI 10.1073/pnas.091367798; ROBERTSON DR, 1990, J EXP MAR BIOL ECOL, V144, P49; Saenz-Agudelo P, 2015, MOL ECOL, V24, P6241, DOI 10.1111/mec.13471; Sakai Y, 2003, ZOOL SCI, V20, P627, DOI 10.2108/zsj.20.627; Stockwell BL, 2016, CONSERV GENET, V17, P239, DOI 10.1007/s10592-015-0776-3; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; TAJIMA F, 1983, GENETICS, V105, P437; Tariel J, 2016, MOL PHYLOGENET EVOL, V98, P84, DOI 10.1016/j.ympev.2016.01.010; Tenggardjaja Kimberly A., 2016, Journal of Marine Biology, P3251814; Terrell KA, 2016, BIOL CONSERV, V200, P192, DOI 10.1016/j.biocon.2016.05.034; Turner TF, 2002, GENETICS, V162, P1329; Victor BC, 2000, MAR ECOL PROG SER, V205, P241, DOI 10.3354/meps205241; Vucetich JA, 1997, EVOLUTION, V51, P2017, DOI 10.1111/j.1558-5646.1997.tb05123.x; Waples RS, 2016, J FISH BIOL, V89, P2479, DOI 10.1111/jfb.13143; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Zhang BD, 2016, MOL ECOL RESOUR, V16, P755, DOI 10.1111/1755-0998.12476	91	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198901	10.1371/journal.pone.0198901	http://dx.doi.org/10.1371/journal.pone.0198901			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949612	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200030
J	Park, AJ; Battaglino, RA; Nguyen, NMH; Morse, LR				Park, Andrew J.; Battaglino, Ricardo A.; Nguyen, Nguyen M. H.; Morse, Leslie R.			Associations between lean mass and leptin in men with chronic spinal cord injury: Results from the FRASCI-muscle study	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; SERUM LEPTIN; CANDIDATE BIOMARKER; SEDENTARY BEHAVIOR; CIRCULATING LEPTIN; METABOLIC SYNDROME; FAT; EXPRESSION; OBESITY; INFLAMMATION	Leptin is an adipo-myokine that regulates appetite and energy expenditure by a neuroendocrine feedback loop. Leptin levels are positively correlated with BMI in the spinal cord injury population and leptin levels are greater in individuals with spinal cord injury compared to uninjured controls. Leptin is produced in multiple tissues, including fat, bone, and skeletal muscle and is a putative biomarker of sedentary behavior in older adults. We assessed body composition leptin, adiponectin, and IL-6 levels in 205 men with chronic spinal cord injury. We found no association between age, injury duration, injury level, injury completeness, or walking status and leptin. There was a significant positive association between lean mass and leptin in men with SCI that was independent of fat. Adjusting for body composition, leptin levels were positively associated with IL-6 and negatively associated with adiponectin levels. When considering men with SCI and sarcopenic obesity, only fat mass remained positively associated with leptin. We found no association between IL-6, adiponectin, or lean mass and leptin in the sarcopenic obesity group. Our findings suggest that lean mass is an under recognized, but substantial, source of circulating leptin. Furthermore, SCI-related sarcopenic obesity may result in dysregulated adipo-myokine metabolism with local and systemic physiologic effects.	[Park, Andrew J.; Battaglino, Ricardo A.; Morse, Leslie R.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO 80045 USA; [Nguyen, Nguyen M. H.; Morse, Leslie R.] Craig Rehabil Hosp, Rocky Mt Reg Spinal Injury Syst, Englewood, CO 80113 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Morse, LR (corresponding author), Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO 80045 USA.; Morse, LR (corresponding author), Craig Rehabil Hosp, Rocky Mt Reg Spinal Injury Syst, Englewood, CO 80113 USA.	lmorse@craighospital.org	Morse, Leslie/AAU-5608-2020	Park, Andrew J/0000-0003-0249-5353	National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR059270-01]; Department of Health and Human Services [90SI5015-01-00]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064793, R01AR059270] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Department of Health and Human Services; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funded by National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR059270-01] https://www.niams.nih.gov/ LRM and RAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript Department of Health and Human Services [90SI5015-01-00] https://www.hhs.gov/ LRM and RAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison MA, 2012, AM J PREV MED, V42, P8, DOI 10.1016/j.amepre.2011.09.023; Arounleut P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072330; Bartell SM, 2011, J BONE MINER RES, V26, P1710, DOI 10.1002/jbmr.406; Bigford GE, 2013, ASN NEURO, V5, P243, DOI 10.1042/AN20130021; Bigford GE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041073; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bucci L, 2013, BIOGERONTOLOGY, V14, P261, DOI 10.1007/s10522-013-9428-5; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Doherty AL, 2014, J BONE MINER RES, V29, P251, DOI 10.1002/jbmr.2020; Fernandez-Real JM, 2000, EUR J ENDOCRINOL, V142, P25, DOI 10.1530/eje.0.1420025; Gorgey AS, 2007, SPINAL CORD, V45, P304, DOI 10.1038/sj.sc.3101968; Groah SL, 2011, J CARDIOPULM REHABIL, V31, P73, DOI 10.1097/HCR.0b013e3181f68aba; Guerra B, 2007, J APPL PHYSIOL, V102, P1786, DOI 10.1152/japplphysiol.01313.2006; Hamrick MW, 2015, EXP GERONTOL, V70, P92, DOI 10.1016/j.exger.2015.07.014; Hamrick Mark W, 2017, J Bone Metab, V24, P1, DOI 10.11005/jbm.2017.24.1.1; Henson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078350; Hoppeler H, 2016, J EXP BIOL, V219, P205, DOI 10.1242/jeb.128207; Huang TS, 2000, ARCH PHYS MED REHAB, V81, P1582, DOI 10.1053/apmr.2000.9173; Jeon JY, 2010, ARCH PHYS MED REHAB, V91, P1957, DOI 10.1016/j.apmr.2010.08.024; Jeon JY, 2003, J CLIN ENDOCR METAB, V88, P402, DOI 10.1210/jc.2002-020939; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Kelley DE, 2015, DIABETES, V64, P3055, DOI 10.2337/db15-0403; Krzysik-Walker SM, 2008, ENDOCRINOLOGY, V149, P1543, DOI 10.1210/en.2007-1301; Larsen BA, 2014, MED SCI SPORT EXER, V46, P520, DOI 10.1249/MSS.0b013e3182a77220; Latifi S, 2013, SPINAL CORD, V51, P728, DOI 10.1038/sc.2013.82; Li YH, 2014, MOL BIOL REP, V41, P7543, DOI 10.1007/s11033-014-3646-z; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; Maimoun L, 2004, METABOLISM, V53, P989, DOI 10.1016/j.metabol.2004.03.005; Mark AL, 2002, J HYPERTENS, V20, P1245, DOI 10.1097/00004872-200207000-00001; Maruyama Y, 2008, SPINAL CORD, V46, P494, DOI 10.1038/sj.sc.3102171; Moore CD, 2015, J MUSCULOSKEL NEURON, V15, P32; Morse LR, 2013, OSTEOPOROSIS INT, V24, P961, DOI 10.1007/s00198-012-2072-0; Nakamura K, 2014, J CARDIOL, V63, P250, DOI 10.1016/j.jjcc.2013.11.006; Ojima K, 2014, EUPA OPEN PROTEOM, V5, DOI DOI 10.1016/J.EUPR0T.2014.08.001; Pareja-Galeano H, 2017, MECH AGEING DEV, V162, P129, DOI 10.1016/j.mad.2016.02.014; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pellegrinelli V, 2015, DIABETES, V64, P3121, DOI 10.2337/db14-0796; Pelletier CA, 2016, ARCH PHYS MED REHAB, V97, P1931, DOI 10.1016/j.apmr.2016.04.026; Rosety-Rodriguez M, 2014, ARCH PHYS MED REHAB, V95, P297, DOI 10.1016/j.apmr.2013.08.246; Sainz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006808; Solberg R, 2005, J CELL BIOCHEM, V96, P89, DOI 10.1002/jcb.20521; Spungen AM, 2003, J APPL PHYSIOL, V95, P2398, DOI 10.1152/japplphysiol.00729.2002; Villanueva EC, 2008, INT J OBESITY, V32, pS8, DOI 10.1038/ijo.2008.232; Wang JL, 1999, NAT MED, V5, P895, DOI 10.1038/11335; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Wang YH, 2005, ARCH PHYS MED REHAB, V86, P1964, DOI 10.1016/j.apmr.2005.04.017; Wolsk E, 2012, CYTOKINE, V60, P667, DOI 10.1016/j.cyto.2012.08.021	48	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198969	10.1371/journal.pone.0198969	http://dx.doi.org/10.1371/journal.pone.0198969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949600	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200033
J	Yoon, H; Kim, YS; Lee, JH; Gi, MY; Cha, JA; Seong, JM				Yoon, Hyun; Kim, Yoon Sik; Lee, Jun Ho; Gi, Mi Young; Cha, Ju Ae; Seong, Jeong Min			Gender difference in the relationship between the ferritin and homeostasis model assessment of insulin resistance in non-diabetic Korean adults	PLOS ONE			English	Article							BETA-CELL FUNCTION; NECROSIS-FACTOR-ALPHA; SERUM FERRITIN; METABOLIC SYNDROME; DIABETES-MELLITUS; IRON-METABOLISM; FREE-RADICALS; WOMEN; MEN; HEALTH	Background The present study was conducted to assess gender difference in the relationship between the ferritin and homeostasis model assessment of insulin resistance (HOMA-IR) and beta cell function (HOMA-B) in non-diabetic Korean adults. Materials and methods A sample including 5,414 adults (2,279 men, 1,529 postmenopausal women, and 1,606 premenopausal women) aged & nbsp;>= 20 years from the fifth Korean National Health and Nutrition Examination Survey (KNHANES V-1, 2010) was analyzed. Results There were several key findings in the present study. First, in men, HOMA-IR (beta = 0.119, 95% confidence interval [CI], 3.304 to 8.003) constituted the independent factor determining ferritin, but this was not the case for HOMA-B (beta = -0.042, 95% CI, -0.100 to 0.011). Second, in postmenopausal women, HOMA-IR (beta = 0.087, 95% CI, 0.899 to 5.238) was the independent factor determining ferritin, but this was not the case for HOMA-B (beta = -0.043, 95% CI, -0.065 to 0.010). Third, in premenopausal women, neither HOMA-IR (beta = -0.050, 95% CI, -3.056 to 0.364) nor HOMA-B (beta = -0.009, 95% CI, -0.028 to 0.020) constituted the independent factors determining ferritin. Conclusions Ferritin was positively associated with insulin resistance in non-diabetic Korean men and postmenopausal women, but not in non-diabetic Korean premenopausal women.	[Yoon, Hyun] Hanlyo Univ, Dept Biomed Lab Sci, Gwangyang Si, Jeollanam Do, South Korea; [Kim, Yoon Sik] Dongkang Coll, Dept Biomed Lab Sci, Gwangju, South Korea; [Lee, Jun Ho] Wonkwang Hlth Sci Univ, Dept Biomed Lab Sci, Iksan Si, South Korea; [Gi, Mi Young] Christian Coll Nursing, Dept Nursing, Gwangju, South Korea; [Cha, Ju Ae] Chosun Nursing Coll, Dept Nursing, Gwangju, South Korea; [Seong, Jeong Min] Kangwon Natl Univ, Dept Dent Hyg, Coll Hlth Sci, Samcheok Si, Gangwon Do, South Korea	Chosun University; Kangwon National University	Seong, JM (corresponding author), Kangwon Natl Univ, Dept Dent Hyg, Coll Hlth Sci, Samcheok Si, Gangwon Do, South Korea.	jmseong@kangwon.ac.kr	yoon, hyun/E-6542-2015	yoon, hyun/0000-0002-4741-9664				Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Belfort IK Pereira, 2016, INT ARCH MED, V9, P172; Bonfils L, 2015, DIABETOLOGIA, V58, P523, DOI 10.1007/s00125-014-3469-4; Chen J, 2004, DIABETES CARE, V27, P2960, DOI 10.2337/diacare.27.12.2960; Cho YS, 2015, KOREAN J OBES, V14, P76; Conrad ME, 1999, AM J MED SCI, V318, P213, DOI 10.1097/00000441-199910000-00002; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Dekker LH, 2013, DIABETES CARE, V36, P965, DOI 10.2337/dc12-1243; Elsammak M, 2005, CURR MED RES OPIN, V21, P527, DOI 10.1185/030079905X38141; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; Fradin D, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/647514; Ganz T, 2005, BEST PRACT RES CL HA, V18, P171, DOI 10.1016/j.beha.2004.08.020; Guo JJ, 2013, PAK J MED SCI, V29, P809, DOI 10.12669/pjms.293.2982; GUYATT GH, 1992, J GEN INTERN MED, V7, P145, DOI 10.1007/BF02598003; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Jian JL, 2009, ANTIOXID REDOX SIGN, V11, P2939, DOI [10.1089/ars.2009.2576, 10.1089/ARS.2009.2576]; Kalantar-Zadeh K, 2006, CLIN J AM SOC NEPHRO, V1, pS9, DOI 10.2215/CJN.01390406; Kunutsor SK, 2013, DIABETES-METAB RES, V29, P308, DOI 10.1002/dmrr.2394; Lee JY, 2012, KOREAN J FAM MED, V33, P205, DOI 10.4082/kjfm.2012.33.4.205; Li BQ, 2014, EXP THER MED, V7, P1671, DOI 10.3892/etm.2014.1668; Li J, 2015, ACTA DIABETOL, V52, P417, DOI 10.1007/s00592-015-0719-y; Liu BW, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/642194; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meyer MR, 2011, ACTA PHYSIOL, V203, P259, DOI 10.1111/j.1748-1716.2010.02237.x; Nagpal J, 2009, DIABETIC MED, V26, P19, DOI 10.1111/j.1464-5491.2008.02636.x; Pham NM, 2013, METABOLISM, V62, P561, DOI 10.1016/j.metabol.2012.07.025; Rasheed H, 2013, SKIN PHARMACOL PHYS, V26, P101, DOI 10.1159/000346698; Regitz-Zagrosek V, 2012, EMBO REP, V13, P596, DOI 10.1038/embor.2012.87; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Rushton DH, 2010, CRIT REV ONCOL HEMAT, V73, P1, DOI 10.1016/j.critrevonc.2009.03.010; Sarac F, 2014, JDM, V4, P242; Sheu WHH, 2003, CLIN ENDOCRINOL, V58, P380, DOI 10.1046/j.1365-2265.2003.01729.x; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang HY, 2014, DIABETES, V63, P1506, DOI 10.2337/db13-1195; Wang W, 2010, BBA-GEN SUBJECTS, V1800, P760, DOI 10.1016/j.bbagen.2010.03.011; Williams MJA, 2002, ATHEROSCLEROSIS, V165, P179, DOI 10.1016/S0021-9150(02)00233-2; WOLFF SP, 1993, BRIT MED BULL, V49, P642, DOI 10.1093/oxfordjournals.bmb.a072637; World Health Organization, 2000, AS PAC PERSP RED OB, P15; Yoon H, 2016, ENDOCR J, V63, P785, DOI 10.1507/endocrj.EJ16-0106; Zafar Uzma, 2015, J Ayub Med Coll Abbottabad, V27, P307; Zandman-Goddard G, 2007, AUTOIMMUN REV, V6, P457, DOI 10.1016/j.autrev.2007.01.016	43	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							0199465	10.1371/journal.pone.0199465	http://dx.doi.org/10.1371/journal.pone.0199465			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949646	gold, Green Published, Green Submitted			2022-12-26	WOS:000436549200053
J	Adebanjo, T; Lessa, FC; Mucavele, H; Moiane, B; Chauque, A; Pimenta, F; Massora, S; Carvalho, MD; Whitney, CG; Sigauque, B				Adebanjo, Tolulope; Lessa, Fernanda C.; Mucavele, Helio; Moiane, Benild; Chauque, Alberto; Pimenta, Fabiana; Massora, Sergio; Carvalho, Maria da Gloria; Whitney, Cynthia G.; Sigauque, Betuel			Pneumococcal carriage and serotype distribution among children with and without pneumonia in Mozambique, 2014-2016	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; DISEASE; COLONIZATION; SURVEILLANCE; POPULATION; HEALTHY	Background Pneumococcal colonization is a precursor to pneumonia, and pneumococcal conjugate vaccines (PCV) can decrease vaccine-type (VT) colonization. Pneumococcal colonization studies are traditionally done among healthy children in the community; however, VT colonization prevalence may differ between these children and those with pneumonia. We assessed overall and VT pneumococcal colonization and factors associated with colonization among children with and without pneumonia after Mozambique introduced 10-valent PCV (PCV10) in 2013. Methods We used data from ongoing pneumonia surveillance in children aged <5 years and from cross-sectional nasopharyngeal colonization surveys conducted in October 2014-April 2015 and October 2015-May 2016. Pneumonia was defined using WHO standard criteria for radiologically confirmed pneumonia. Children with pneumonia enrolled from January 2014-April 2016 were compared to children without pneumonia enrolled from the cross-sectional surveys. Clinical data and nasopharyngeal (NP) swabs were collected from each child. NP specimens were cultured for pneumococci, and culture-negative specimens from children with pneumonia underwent polymerase chain reaction (PCR). Results Of 778 and 927 children with and without pneumonia, 97.4% and 27.0% were exposed to antibiotics before swab collection, respectively. Based on culture, pneumococcal colonization was 45.1% for children with and 84.5% for children without pneumonia (P<0.001); VT pneumococcal colonization was 18.6% for children with and 23.4% for children without pneumonia (P = 0.02). The addition of PCR in children with pneumonia increased overall and VT-pneumococcal colonization to 79.2% and 31.1%, respectively. In multivariable analysis including PCR results, pneumonia was associated with VT pneumococcal colonization (adjusted OR: 1.4, 95% CI: 1.10-1.78). Conclusion Vaccine-type pneumococcal colonization remains common among children with and without pneumonia post-PCV10 introduction in Mozambique. In a population of children with high antibiotic exposure, the use of PCR for culture-negative NP swabs can improve assessment of pneumococcal colonization and circulating serotypes.	[Adebanjo, Tolulope] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Adebanjo, Tolulope; Lessa, Fernanda C.; Pimenta, Fabiana; Carvalho, Maria da Gloria; Whitney, Cynthia G.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Bacterial Dis, Resp Dis Branch, Atlanta, GA 30333 USA; [Mucavele, Helio; Moiane, Benild; Chauque, Alberto; Massora, Sergio; Sigauque, Betuel] CISM, Fundacao Manhica, Maputo, Mozambique; [Sigauque, Betuel] JSI, MCSP, USAID Grantee, Maputo, Mozambique	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centro de Investigacao em Saude de Manhica; United States Agency for International Development (USAID)	Adebanjo, T (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.; Adebanjo, T (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Bacterial Dis, Resp Dis Branch, Atlanta, GA 30333 USA.	vnx2@cdc.gov			GAVI; Vaccine Alliance; US Agency for International Development (USAID) in Mozambique; Agencia Espanhola de Cooperacao Internacional para o Desenvolvimento (AECID)	GAVI; Vaccine Alliance; US Agency for International Development (USAID) in Mozambique(United States Agency for International Development (USAID)); Agencia Espanhola de Cooperacao Internacional para o Desenvolvimento (AECID)	This project was funded by GAVI, the Vaccine Alliance, the US Agency for International Development (USAID) in Mozambique, and the Agencia Espanhola de Cooperacao Internacional para o Desenvolvimento (AECID). The funding agencies had no role in the study design, implementation, analysis and interpretation.	Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787; Balsells E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177113; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brandileone MCD, 2016, VACCINE, V34, P5604, DOI 10.1016/j.vaccine.2016.09.027; Carvalho MDG, 2013, PEERJ, V1, DOI 10.7717/peerj.97; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chan KCC, 2016, VACCINE, V34, P3867, DOI 10.1016/j.vaccine.2016.05.047; Chappuy H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-357; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Desai AP, 2015, PEDIATR INFECT DIS J, V34, P1168, DOI 10.1097/INF.0000000000000849; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; Fleming-Dutra KE, 2014, PEDIATR INFECT DIS J, V33, pS152, DOI 10.1097/INF.0000000000000083; Grant LR, 2016, PEDIATR INFECT DIS J, V35, P907, DOI 10.1097/INF.0000000000001207; GRAY BM, 1982, AM J EPIDEMIOL, V116, P692, DOI 10.1093/oxfordjournals.aje.a113452; Greenberg D, 2011, PEDIATR INFECT DIS J, V30, P227, DOI 10.1097/INF.0b013e3181f87802; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Jroundi I, 2017, J INFECT PUBLIC HEAL, V10, P165, DOI 10.1016/j.jiph.2016.02.012; Kobayashi M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2103-0; Magomani V, 2014, J CLIN MICROBIOL, V52, P3271, DOI 10.1128/JCM.01061-14; Mirzaei Ghazi Kalayeh H, 2014, IRAN J PUBLIC HEALTH, V43, P1284; O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Olwagen CP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04915-y; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Resti M, 2009, CLIN THER, V31, P1266, DOI 10.1016/j.clinthera.2009.06.010; Ritchie ND, 2012, FUTURE MICROBIOL, V7, P33, DOI [10.2217/fmb.11.146, 10.2217/FMB.11.146]; Rutebemberwa E, 2015, UPSALA J MED SCI, V120, P249, DOI 10.3109/03009734.2015.1072606; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Sigauque B MS, 2016, INT S PNEUM PNEUM DI; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; UNICEF, 2016, MOZ WHO UNICEF EST I; Usuf E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085001; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; Verani JR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191113; WHO, 2009, HIV ASS OP CHAR 2009; Wyllie AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23809	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199363	10.1371/journal.pone.0199363	http://dx.doi.org/10.1371/journal.pone.0199363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944695	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800032
J	Cheek, M; Alvarez-Aguirre, MG; Grall, A; Sonke, B; Howes, MJR; Larridon, I				Cheek, Martin; Alvarez-Aguirre, Maria G.; Grall, Aurelie; Sonke, Bonaventure; Howes, Melanie-Jayne R.; Larridon, Isabel			Kupeantha (Coffeeae, Rubiaceae), a new genus from Cameroon and Equatorial Guinea	PLOS ONE			English	Article							SOUTHERN CAMEROON; TRICALYSIA; PHYLOGENY; ALIGNMENT; DWARF	Two new coffee relatives (tribe Coffeeae, Rubiaceae), discovered during botanical expeditions to Cameroon, are examined for generic placement, and the placement of three previously known species (Argocoffeopsis fosimondi, A. spathulata and Calycosiphonia pentamera) is reinvestigated using plastid sequence (accD-psa1, rpl16, trnL-F) and morphological data. Seed biochemistry of the new species and pollen micromorphology (only one of the two species) are also studied. Based on the plastid sequence data, the new taxa are nested in a wellsupported monophyletic group that includes Argocoffeopsis and Calycosiphonia. Within this clade, three well-supported subclades are recovered that are morphologically easy to diagnose: (1) Calycosiphonia (excluding C. pentamera), (2) Argocoffeopsis (excluding A. fosimondi and A. spathulata), and (3) a clade including the above excluded species, in addition to the new species. Based on the results, Kupeantha, a new genus of five species, is described, including two new Critically Endangered taxa from the Highlands of Cameroon: Kupeantha ebo and K. kupensis. Phytochemical analysis of Kupeantha seeds reveals compounds assigned as hydroxycinnamic acid derivatives, amino acids and ent-kaurane diterpenoids; caffeine was not detected. Kupeantha is the first new genus described in tribe Coffeeae in 40 years.	[Cheek, Martin; Alvarez-Aguirre, Maria G.; Grall, Aurelie; Howes, Melanie-Jayne R.; Larridon, Isabel] Royal Bot Gardens, Herbarium, Richmond, Surrey, England; [Sonke, Bonaventure] Univ Yaounde I, Higher Teachers Training Coll, Plant Systemat & Ecol Lab, Yaounde, Cameroon; [Sonke, Bonaventure] Univ Libre Bruxelles, Herbarium & Bibliotheque Bot Africaine, Brussels, Belgium; [Sonke, Bonaventure] Missouri Bot Garden, St Louis, MO USA; [Larridon, Isabel] Univ Ghent, Dept Biol, Res Grp Spermatophytes, Campus Ledeganck, Ghent, Belgium	Royal Botanic Gardens, Kew; University of Yaounde I; Universite Libre de Bruxelles; Missouri Botanical Gardens; Ghent University	Cheek, M; Larridon, I (corresponding author), Royal Bot Gardens, Herbarium, Richmond, Surrey, England.; Larridon, I (corresponding author), Univ Ghent, Dept Biol, Res Grp Spermatophytes, Campus Ledeganck, Ghent, Belgium.	m.cheek@kew.org; i.larridon@kew.org	Larridon, Isabel/ABH-5407-2020; Larridon, Isabel/J-8631-2013	GRALL, Aurelie/0000-0002-1613-4703; Larridon, Isabel/0000-0003-0285-722X	Earthwatch Europe; Darwin Initiative of the UK Government; Fonds de la Recherche Scientifique (FNRS; Belgium); Institut de Recherche pour le Developpement (IRD; Cameroon, France); Royal Botanic Gardens, Kew through the Bentham-Moxon Trust; French Ministry of Foreign Affairs [375]	Earthwatch Europe; Darwin Initiative of the UK Government; Fonds de la Recherche Scientifique (FNRS; Belgium)(Fonds de la Recherche Scientifique - FNRS); Institut de Recherche pour le Developpement (IRD; Cameroon, France); Royal Botanic Gardens, Kew through the Bentham-Moxon Trust; French Ministry of Foreign Affairs	Earthwatch Europe (http://eu.earthwatch.org/) and the Darwin Initiative of the UK Government (https://www.gov.uk/government/groups/the-darwin-initiative) are acknowledged for part-funding the fieldwork and research which led to this paper under the Red Data Plants, Cameroon project. BS's activities in Africa and in Europe received financial support from various institutions, namely Fonds de la Recherche Scientifique (FNRS; Belgium, http://www.fnrs.be/), Institut de Recherche pour le Developpement (IRD; Cameroon, France, http://www.cameroun.ird.fr/), Royal Botanic Gardens, Kew through the Bentham-Moxon Trust (https://www.kew.org/about-our-organisation/our-people-and-departments/bentham-moxon-trust), and "Sud Expert Plantes - projet # 375" project under the French Ministry of Foreign Affairs (http://www.sud-expert-plantes.ird.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abwe Ekwoge E., 2008, Pan Africa News, V15, P26; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; BARTHLOTT W, 1996, ERDKUNDE, V50, P317, DOI [DOI 10.3112/ERDKUNDE.1996.04.03, 10.1007/s004250050096, DOI 10.1007/S004250050096]; Cable S., 1997, AFRICAN RAINFORESTS, P29; CCD, COMB CHEM DICT ONL C; Cheek M., 2004, Kew Bulletin, V59, P605, DOI 10.2307/4110919; Cheek M., 2003, Kew Bulletin, V58, P225, DOI 10.2307/4119366; CHEEK M, 2008, KEW BULL, V63, P243; Cheek M, 2010, PLANTS LEBIALEM HIGH, P53; Cheek M., 2004, PLANTS KUPE MWANENGU; Cheek Martin, 2006, Kew Bulletin, V61, P591; Cheek Martin, 2005, Kew Bulletin, V60, P293; Cheek Martin, 2002, Kew Bulletin, V57, P375, DOI 10.2307/4111113; Cheek Martin, 1999, Kew Bulletin, V54, P471, DOI 10.2307/4115828; Cheek Martin, 2000, Kew Bulletin, V55, P871, DOI 10.2307/4113632; Cheek M, 2017, PEERJ, V5, DOI 10.7717/peerj.4137; Cheek M, 2009, NORD J BOT, V27, P456, DOI 10.1111/j.1756-1051.2009.00576.x; Cheek Martin, 2008, Kew Bulletin, V63, P405, DOI 10.1007/s12225-008-9056-4; Davis AP, 2007, AM J BOT, V94, P313, DOI 10.3732/ajb.94.3.313; Davis AP, 2008, BLUMEA, V53, P527, DOI 10.3767/000651908X607486; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gosline George, 1998, Kew Bulletin, V53, P461, DOI 10.2307/4114512; Harvey Y, 2010, PLANTS LEBIALEM HIGH; Jaiswal R, 2010, J AGR FOOD CHEM, V58, P8722, DOI 10.1021/jf1014457; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Litt A, 2002, BRITTONIA, V54, P13, DOI 10.1663/0007-196X(2002)054[0013:KSANGA]2.0.CO;2; Martins D, 2015, MOLECULES, V20, P13422, DOI 10.3390/molecules200713422; McNeill J., 2011, 18 INT BOT C MELB AU; Miller M.A., 2010, P GAT COMP ENV WORKS; Monente C, 2015, J AGR FOOD CHEM, V63, P4327, DOI 10.1021/acs.jafc.5b01619; Muller J, 2010, PHYDE PHYLOGENETIC D; Mwachala G., 2007, Kew Bulletin, V62, P613; Nieber K, 2017, PLANTA MED, V83, P1256, DOI 10.1055/s-0043-115007; Nishimura K, 2006, TETRAHEDRON, V62, P1512, DOI 10.1016/j.tet.2005.11.024; Onana J.M., 2011, RED DATA BOOK FLOWER; Otsuka H, 2007, CHEM PHARM BULL, V55, P1600, DOI 10.1248/cpb.55.1600; Perry E, 2011, CNS NEUROSCI THER, V17, P683, DOI 10.1111/j.1755-5949.2010.00202.x; Rambaut A., 2007, TRACE 1 4; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105; Shorthouse DP, 2010, SIMPLEMAPPR ONLINE T; Sonke A B, 2005, ADANSONIA 3, V3, P309; Sonke B, 2008, BLUMEA, V53, P533, DOI 10.3767/000651908X607495; Sonke B, 2007, NORD J BOT, V25, P275, DOI 10.1111/j.0107-055X.2007.00141.x; Sonke B, 2006, BOT J LINN SOC, V151, P425, DOI 10.1111/j.1095-8339.2006.00508.x; Sonke B, 2009, NORD J BOT, V27, P305, DOI 10.1111/j.1756-1051.2009.00415.x; Sosef MSM, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0356-8; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Stone R.D., 2008, KEW BULL, V63, P227; Thiers B., INDEX HERBARIORUM GL; Tosh J, 2009, ANN MO BOT GARD, V96, P194, DOI 10.3417/2006202; Xu WH, 2010, CHEM PHARM BULL, V58, P261, DOI 10.1248/cpb.58.261	56	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199324	10.1371/journal.pone.0199324	http://dx.doi.org/10.1371/journal.pone.0199324			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944676	gold, Green Published, Green Submitted			2022-12-26	WOS:000436377800030
J	Beyrakhova, K; Li, L; Xu, CS; Gagarinova, A; Cygler, M				Beyrakhova, Ksenia; Li, Lei; Xu, Caishuang; Gagarinova, Alla; Cygler, Miroslaw			Legionella pneumophila effector Lem4 is a membrane-associated protein tyrosine phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE; PHOSPHOTYROSINE PHOSPHATASE; LEGIONNAIRES-DISEASE; ACTIVATION; MDP-1; SUPERFAMILY; VALIDATION; REGULATOR; SUBSTRATE; INSIGHTS	Legionella pneumophila is a Gram-negative pathogenic bacterium that causes severe pneumonia in humans. It establishes a replicative niche called Legionella containing vacuole (LCV) that allows bacteria to survive and replicate inside pulmonary macrophages. To hijack host cell defense systems, L pneumophila injects over 300 effector proteins into the host cell cytosol. The Lem4 effector (lpg1101) consists of two domains: an N-terminal haloacid dehalogenase (HAD) domain with unknown function and a C-terminal phosphatidylinositol 4-phosphate-binding domain that anchors Lem4 to the membrane of early LCVs. Herein, we demonstrate that the HAD domain (Lem4-N) is structurally similar to mouse MDP-1 phosphatase and displays phosphotyrosine phosphatase activity. Substrate specificity of Lem4 was probed using a tyrosine phosphatase substrate set, which contained a selection of 360 phosphopeptides derived from human phosphorylation sites. This assay allowed us to identify a consensus pTyr-containing motif. Based on the localization of Lem4 to lysosomes and to some extent to plasma membrane when expressed in human cells, we hypothesize that this protein is involved in protein-protein interactions with an LCV or plasma membrane-associated tyrosine-phosphorylated host target.	[Beyrakhova, Ksenia; Li, Lei; Xu, Caishuang; Gagarinova, Alla; Cygler, Miroslaw] Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada; [Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	University of Saskatchewan; McGill University	Cygler, M (corresponding author), Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	miroslaw.cygler@usask.ca		Cygler, Miroslaw/0000-0003-4579-1881	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research; DOE Office of Science [DE-AC02-06CH11357]	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); DOE Office of Science(United States Department of Energy (DOE))	We acknowledge the Protein Characterization and Crystallization Facility, College of Medicine, University of Saskatchewan, for access to the crystallization robot and the 08ID-1 beamline at the Canadian Light Source for diffraction data collection. The Canadian Light Source is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly, which operates the facility.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Babu M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004120; Baccarini M, 1991, Receptor, V1, P243; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; DAUM G, 1993, ANAL BIOCHEM, V211, P50, DOI 10.1006/abio.1993.1231; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Declerck P, 2010, ENVIRON MICROBIOL, V12, P557, DOI 10.1111/j.1462-2920.2009.02025.x; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldheim YS, 2016, MOL MICROBIOL, V99, P1059, DOI 10.1111/mmi.13290; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fields BS, 1996, TRENDS MICROBIOL, V4, P286, DOI 10.1016/0966-842X(96)10041-X; Fontana MF, 2012, INFECT IMMUN, V80, P3570, DOI 10.1128/IAI.00557-12; Gagnaire A, 2017, NAT REV MICROBIOL, V15, P109, DOI 10.1038/nrmicro.2016.171; Gomez-Valero L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00208; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Haneburger I, 2014, CURR TOP MICROBIOL, V376, P155, DOI 10.1007/82_2013_341; Hempstead AD, 2014, CURR TOP MICROBIOL, V376, P249, DOI 10.1007/82_2013_342; Hilbi H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00091; Hoffmann C, 2014, CELL MICROBIOL, V16, P1034, DOI 10.1111/cmi.12256; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Hu GC, 2012, CRIT REV IMMUNOL, V32, P127, DOI 10.1615/CritRevImmunol.v32.i2.20; Huang H, 2015, P NATL ACAD SCI USA, V112, pE1974, DOI 10.1073/pnas.1423570112; Hubber A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004222; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Huynh J, 2012, CELL SIGNAL, V24, P1753, DOI 10.1016/j.cellsig.2012.04.022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lau AW, 2008, J CELL SCI, V121, P4008, DOI 10.1242/jcs.033522; Li J, 2015, BOUND VALUE PROBL, DOI 10.1186/s13661-014-0269-1; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Liu Y, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006186; Losick VP, 2010, CELL MICROBIOL, V12, P1083, DOI 10.1111/j.1462-5822.2010.01452.x; Lu ZB, 2009, J BIOL CHEM, V284, P1224, DOI 10.1074/jbc.M807056200; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; O'Shea JP, 2013, NAT METHODS, V10, P1211, DOI [10.1038/NMETH.2646, 10.1038/nmeth.2646]; Peisach E, 2004, BIOCHEMISTRY-US, V43, P12770, DOI 10.1021/bi0490688; Pinotsis N, 2017, J BIOL CHEM, V292, P9240, DOI 10.1074/jbc.M117.781948; Prevost MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10249-6; Quaile AT, 2018, J BIOL CHEM, V293, P3307, DOI 10.1074/jbc.M117.812727; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schoebel S, 2010, EMBO REP, V11, P598, DOI 10.1038/embor.2010.97; Selengut JD, 2001, BIOCHEMISTRY-US, V40, P12704, DOI 10.1021/bi011405e; Selengut JD, 2000, BIOCHEMISTRY-US, V39, P8315, DOI 10.1021/bi0005052; Shin S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000220; So EC, 2015, CAN J MICROBIOL, V61, P617, DOI 10.1139/cjm-2015-0166; Stanley ER, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a021857; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tanner JR, 2016, MOL MICROBIOL, V100, P1017, DOI 10.1111/mmi.13365; Urbanus ML, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167381; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Yu WF, 2012, J BIOL CHEM, V287, P13694, DOI 10.1074/jbc.M112.355610; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	66	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13044	13058		10.1074/jbc.RA118.003845	http://dx.doi.org/10.1074/jbc.RA118.003845			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29976756	Green Published, hybrid			2022-12-26	WOS:000442730200007
J	Oda, M; Nishida, I; Miyamoto, I; Saeki, K; Tanaka, T; Kito, S; Yamamoto, N; Yada, N; Yoshiga, D; Matsumoto-Takeda, S; Wakasugi-Sato, N; Habu, M; Kodama, M; Kokuryo, S; Osawa, K; Nishimura, S; Joujima, T; Miyamura, Y; Matsuo, K; Tominaga, K; Yoshioka, I; Maki, K; Morimoto, Y				Oda, Masafumi; Nishida, Ikuko; Miyamoto, Ikuya; Saeki, Katsura; Tanaka, Tatsurou; Kito, Shinji; Yamamoto, Noriaki; Yada, Naomi; Yoshiga, Daigo; Matsumoto-Takeda, Shinobu; Wakasugi-Sato, Nao; Habu, Manabu; Kodama, Masaaki; Kokuryo, Shinya; Osawa, Kenji; Nishimura, Shun; Joujima, Takaaki; Miyamura, Yuichi; Matsuo, Kou; Tominaga, Kazuhiro; Yoshioka, Izumi; Maki, Kenshi; Morimoto, Yasuhiro			Significance and usefulness of imaging characteristics of gubernaculum tracts for the diagnosis of odontogenic tumors or cysts	PLOS ONE			English	Article								We aimed to determine the significance and usefulness of imaging characteristics of gubernaculum tracts (GT) for the diagnosis of odontogenic tumors or cysts. This was a retrospective analysis of relationships between odontogenic or non-odontogenic tumors or cysts and the GT that were visualized using multi-detector computed tomography (MDCT). The relationship between the size of a mass and expansion of the GT in all odontogenic tumors or cysts to which GTs were contiguous on MDCT, was statistically analyzed. Intact or expanded GTs were detected in MDCT images on the top of almost all odontogenic tumors or cysts, but not on non-odontogenic tumors or cysts. Characteristic image findings regarding the relationship between the GT and the odontogenic mass were detected for the respective odontogenic tumors or cysts in which the GTs were contiguous to the mass on MDCT. In ameloblastomas, expansion of the GTs significantly and very strongly correlated with tumor size (r = 0.741, p = 0.0001), but this correlation was very weak in dentigerous cysts (r = 0.167, p = 0.028) and there was no correlation between these parameters in odontogenic keratocysts (r = -0.089, p = 0.557). The imaging characteristics of GTs at the top of masses should be very useful for both the differential diagnosis of the pathological diagnosis of odontogenic masses and for differentiation between odontogenic and non-odontogenic masses.	[Oda, Masafumi; Tanaka, Tatsurou; Kito, Shinji; Matsumoto-Takeda, Shinobu; Wakasugi-Sato, Nao; Nishimura, Shun; Joujima, Takaaki; Miyamura, Yuichi; Morimoto, Yasuhiro] Kyushu Dent Univ, Div Oral & Maxillofacial Radiol, Kitakyushu, Fukuoka, Japan; [Nishida, Ikuko; Saeki, Katsura; Maki, Kenshi] Kyushu Dent Univ, Div Dev Stomatognath Funct Sci, Kitakyushu, Fukuoka, Japan; [Miyamoto, Ikuya; Kokuryo, Shinya; Osawa, Kenji; Yoshioka, Izumi] Kyushu Dent Univ, Div Oral Med, Kitakyushu, Fukuoka, Japan; [Yamamoto, Noriaki] Oita Univ, Dept Oral & Maxillofacial Surg, Oita, Japan; [Yada, Naomi; Matsuo, Kou] Kyushu Dent Univ, Div Oral Pathol, Kitakyushu, Fukuoka, Japan; [Yoshiga, Daigo; Habu, Manabu; Kodama, Masaaki; Tominaga, Kazuhiro] Kyushu Dent Univ, Div Maxillofacial Surg, Kitakyushu, Fukuoka, Japan	Kyushu Dental University; Kyushu Dental University; Kyushu Dental University; Oita University; Kyushu Dental University; Kyushu Dental University	Morimoto, Y (corresponding author), Kyushu Dent Univ, Div Oral & Maxillofacial Radiol, Kitakyushu, Fukuoka, Japan.	rad-mori@kyu-dent.ac.jp	YOSHIGA, Daigo/GZM-9352-2022	YOSHIGA, Daigo/0000-0001-9603-3138				Bump WS., 1927, SURG GYNECOL OBSTET, V44, P173; CAROLLO DA, 1971, ANGLE ORTHOD, V41, P300; Ide F, 2011, HEAD NECK PATHOL, V5, P123, DOI 10.1007/s12105-011-0253-3; Nanci A., 2013, 10 CATES ORAL HISTOL, P233; Nishida I, 2015, OR SURG OR MED OR PA, V120, pE109, DOI 10.1016/j.oooo.2015.05.001; Oda M, 2016, OR SURG OR MED OR PA, V122, P511, DOI 10.1016/j.oooo.2016.07.006; Oda M, 2016, OR SURG OR MED OR PA, V121, P91, DOI 10.1016/j.oooo.2015.10.014; PHILIPSEN HP, 1992, J ORAL PATHOL MED, V21, P348, DOI 10.1111/j.1600-0714.1992.tb01363.x; TOLLER PAUL, 1967, ANN ROY COLL SURG ENGL, V40, P306	9	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199285	10.1371/journal.pone.0199285	http://dx.doi.org/10.1371/journal.pone.0199285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979687	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500012
J	Sato, T; Yuki, H; Ogura, K; Honma, T				Sato, Tomohiro; Yuki, Hitomi; Ogura, Keiji; Honma, Teruki			Construction of an integrated database for hERG blocking small molecules	PLOS ONE			English	Article							DRUG DISCOVERY; CHEMICAL SPACE; PREDICTION; MODELS; CLASSIFICATION; DETERMINANTS; TERFENADINE; BLOCKADE; QSAR	The inhibition of the hERG potassium channel is closely related to the prolonged QT interval, and thus assessing this risk could greatly facilitate the development of therapeutic compounds and the withdrawal of hazardous marketed drugs. The recent increase in SAR information about hERG inhibitors in public databases has led to many successful applications of machine learning techniques to predict hERG inhibition. However, most of these reports constructed their prediction models based on only one SAR database because the differences in the data format and ontology hindered the integration of the databases. In this study, we curated the hERG-related data in ChEMBL, PubChem, GOSTAR, and hERGCentral, and integrated them into the largest database about hERG inhibition by small molecules. Assessment of structural diversity using Murcko frameworks revealed that the integrated database contains more than twice as many chemical scaffolds for hERG inhibitors than any of the individual databases, and covers 18.2% of the Murcko framework-based chemical space occupied by the compounds in ChEMBL. The database provides the most comprehensive information about hERG inhibitors and will be useful to design safer compounds for drug discovery. The database is freely available at http://drugdesign.riken.jp/hERGdb/.	[Sato, Tomohiro; Yuki, Hitomi; Ogura, Keiji; Honma, Teruki] RIKEN, Ctr Life Sci Technol, Tsurumi ku, Suehiro Cho, Yokohama, Kanagawa, Japan	RIKEN	Honma, T (corresponding author), RIKEN, Ctr Life Sci Technol, Tsurumi ku, Suehiro Cho, Yokohama, Kanagawa, Japan.	honma.teruki@riken.jp	YUKI, Hitomi/C-5044-2012	YUKI, Hitomi/0000-0002-8778-8261	AMED Japan Agency for Medical Research and Development; Program: Development of a Drug Discovery Informatics System	AMED Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Program: Development of a Drug Discovery Informatics System	This work was supported by AMED Japan Agency for Medical Research and Development (https://www.amed.go.jp/en/); Program: Development of a Drug Discovery Informatics System (https://www.amed.go.jp/en/program/list/06/03/001_02-02.html); Recipient: Teruki Honma. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braga RC, 2015, MOL INFORM, V34, P698, DOI 10.1002/minf.201500040; Chemi G, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00007; Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032; Czodrowski P, 2013, J CHEM INF MODEL, V53, P2240, DOI 10.1021/ci400308z; De Ponti F, 2001, EUR J CLIN PHARMACOL, V57, P185, DOI 10.1007/s002280100290; Du F, 2015, PLOS ONE, V10, P1; Du F, 2011, ASSAY DRUG DEV TECHN, V9, P580, DOI 10.1089/adt.2011.0425; Fernandez-de Gortari E, 2015, RSC ADV, V5, P87465, DOI 10.1039/c5ra19611f; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; GOSTAR (GVK BIO Online Structure Activity Relationship Database) GVK Biosciences Private Limited, 2010, GOST GVK BIO ONL STR; Jia L, 2008, BIOORGAN MED CHEM, V16, P6252, DOI 10.1016/j.bmc.2008.04.028; Kamiya K, 2006, MOL PHARMACOL, V69, P1709, DOI 10.1124/mol.105.020990; Kamiya K, 2008, J PHARMACOL SCI, V108, P301, DOI 10.1254/jphs.08102FP; Karawajczyk A, 2015, DRUG DISCOV TODAY, V20, P1310, DOI 10.1016/j.drudis.2015.09.009; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Korotcov A, 2017, MOL PHARMACEUT, V14, P4462, DOI 10.1021/acs.molpharmaceut.7b00578; Kratz JM, 2014, J CHEM INF MODEL, V54, P2887, DOI 10.1021/ci5001955; Langdon SR, 2013, SCAFFOLD HOPPING MED, V58, P39; O'Brien SE, 2005, J MED CHEM, V48, P1287, DOI 10.1021/jm049254b; Pearlstein RA, 2003, BIOORG MED CHEM LETT, V13, P1829, DOI 10.1016/S0960-894X(03)00196-3; Prieto-Martinez FD, 2016, RSC ADV, V6, P56225, DOI 10.1039/c6ra07224k; Rampe D, 1997, FEBS LETT, V417, P28, DOI 10.1016/S0014-5793(97)01249-0; Roy ML, 1996, CIRCULATION, V94, P817, DOI 10.1161/01.CIR.94.4.817; Schyman P, 2016, J CHEM INF MODEL, V56, P213, DOI 10.1021/acs.jcim.5b00616; Song MH, 2006, J CHEM INF MODEL, V46, P392, DOI 10.1021/ci050308f; Su BH, 2010, J CHEM INF MODEL, V50, P1304, DOI 10.1021/ci100081j; Suessbrich H, 1996, FEBS LETT, V385, P77, DOI 10.1016/0014-5793(96)00355-9; Sun HM, 2017, MOL INFORM, V36, DOI 10.1002/minf.201600126; Tobita M, 2005, BIOORG MED CHEM LETT, V15, P2886, DOI 10.1016/j.bmcl.2005.03.080; Villoutreix BO, 2015, ADV DRUG DELIVER REV, V86, P72, DOI 10.1016/j.addr.2015.03.003; Wang SQ, 2016, MOL PHARMACEUT, V13, P2855, DOI 10.1021/acs.molpharmaceut.6b00471; Wang SC, 2013, CURR TOP MED CHEM, V13, P1317; Xu CY, 2012, J CHEM INF MODEL, V52, P2840, DOI 10.1021/ci300400a; Yu PL, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-29; Zhou Z., 1996, J CARDIOVASC ELECTR, V10, P836	36	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199348	10.1371/journal.pone.0199348	http://dx.doi.org/10.1371/journal.pone.0199348			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979714	gold, Green Published, Green Submitted			2022-12-26	WOS:000437809500014
J	Tomono, T; Machida, T; Kamioka, H; Shibasaki, Y; Yano, K; Ogihara, T				Tomono, Takumi; Machida, Tatsuya; Kamioka, Hiroki; Shibasaki, Yumi; Yano, Kentaro; Ogihara, Takuo			Entinostat reverses P-glycoprotein activation in snail-overexpressing adenocarcinoma HCC827 cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; RANDOMIZED PHASE-II; DEACETYLASE INHIBITOR; LUNG-CANCER; MULTIDRUG-RESISTANCE; CARCINOMA-CELLS; IN-VITRO; BREAST; METASTASIS	Epithelial-to-mesenchymal transition (EMT) in cancer cells facilitates tumor progression by promoting invasion and metastasis. Snail is a transcriptional factor that induces EMT, while P-glycoprotein (P-gp) is an efflux transporter involved in anticancer drug resistance, and P-gp efflux activity is stimulated in Snail-overexpressing lung cancer cells with EMT characteristics. Since the histone deacetylase (HDAC) inhibitor entinostat (Ent) reverses EMT features, our aim in this study was to determine whether Ent also suppresses P-gp activation in Snail-induced cells. First, we confirmed that Ent treatment reduced migration activity, down-regulated E-cadherin and upregulated vimentin at the mRNA level in Snail-overexpressing cells, thus inhibiting EMT. Efflux and uptake assays using rhodamine123 (Rho123), a fluorescent P-gp substrate, showed that Ent also inhibited Snail-induced activation of P-gp. Moreover, P-gp activity was more strongly inhibited by Ent in Snail-overexpressing cells than in Mock cells. When we evaluated the uptakes of Rho123 by LLC-PK1 cells and P-gp-overexpressing LLC-GA5COL150 cells, Rho123 accumulation in LLC-GA5COL150 cells was significantly decreased compared with that in LLC-PK1 cells. Coincubation with Ent had no effect on Rho123 accumulation in either of the cell lines. Thus, Ent appears to be an inhibitor, but not a substrate, of P-gp at low concentration. Our results suggest that Ent treatment might suppress not only Snail-induced cancer malignant alteration, but also P-gp-mediated multidrug resistance.	[Tomono, Takumi; Kamioka, Hiroki; Ogihara, Takuo] Takasaki Univ Hlth & Welf, Grad Sch Pharmaceut Sci, Clin Pharmacokinet Lab, Takasaki, Gunma, Japan; [Machida, Tatsuya; Shibasaki, Yumi; Yano, Kentaro; Ogihara, Takuo] Takasaki Univ Hlth & Welf, Fac Pharm, Lab Biopharmaceut, Takasaki, Gunma, Japan		Ogihara, T (corresponding author), Takasaki Univ Hlth & Welf, Grad Sch Pharmaceut Sci, Clin Pharmacokinet Lab, Takasaki, Gunma, Japan.; Ogihara, T (corresponding author), Takasaki Univ Hlth & Welf, Fac Pharm, Lab Biopharmaceut, Takasaki, Gunma, Japan.	togihara@takasaki-u.ac.jp			Nagai Memorial Research Scholarship from the Pharmaceutical Society of Japan [N-161101]; Japan Society for the Promotion of Science (JSPS) KAKENHI [15K08078, 16K18956, 18K06793]	Nagai Memorial Research Scholarship from the Pharmaceutical Society of Japan; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Nagai Memorial Research Scholarship from the Pharmaceutical Society of Japan, N-161101 (TT), and by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 15K08078 (TO), 16K18956 (KY) and 18K06793 (TO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin ML, 2013, DRUG TARGET INSIGHT, V7, P27, DOI 10.4137/DTI.S12519; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bill R, 2015, FEBS LETT, V589, P1577, DOI 10.1016/j.febslet.2015.05.002; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; Collins DM, 2010, INVEST NEW DRUG, V28, P433, DOI 10.1007/s10637-009-9266-0; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Gonzalez ML, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00205; Hauschild A, 2008, MELANOMA RES, V18, P274, DOI 10.1097/CMR.0b013e328307c248; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kagalwalla AF, 2012, J ALLERGY CLIN IMMUN, V129, P1387, DOI 10.1016/j.jaci.2012.03.005; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lillico R, 2016, J PROTEOMICS, V133, P125, DOI 10.1016/j.jprot.2015.12.018; Lioni M, 2007, AM J PATHOL, V170, P709, DOI 10.2353/ajpath.2007.060343; Lorenz KJ, 2015, HEAD NECK-J SCI SPEC, V37, P530, DOI 10.1002/hed.23622; Marchetti S, 2008, MOL CANCER THER, V7, P2280, DOI 10.1158/1535-7163.MCT-07-2250; Ngamphaiboon N, 2015, INVEST NEW DRUG, V33, P225, DOI 10.1007/s10637-014-0174-6; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Sanchez-Tillo E, 2013, CLIN CANCER RES, V19, P1071, DOI 10.1158/1078-0432.CCR-12-2675; Schouten LJ, 2002, CANCER, V94, P2698, DOI 10.1002/cncr.10541; Shah P, 2014, BREAST CANCER RES TR, V143, P99, DOI 10.1007/s10549-013-2784-7; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Tabe Y, 2006, BLOOD, V107, P1546, DOI 10.1182/blood-2004-10-4126; Tomono T, 2017, J PHARM SCI-US, V106, P2642, DOI 10.1016/j.xphs.2017.03.011; Tsou SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116747; Witta SE, 2012, J CLIN ONCOL, V30, P2248, DOI 10.1200/JCO.2011.38.9411; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Xu YC, 2012, EXP CELL RES, V318, P177, DOI 10.1016/j.yexcr.2011.11.010; Yardley DA, 2013, J CLIN ONCOL, V31, P2128, DOI 10.1200/JCO.2012.43.7251; Zhu YH, 2010, ENDOCRINOLOGY, V151, P5497, DOI 10.1210/en.2010-0486	31	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200015	10.1371/journal.pone.0200015	http://dx.doi.org/10.1371/journal.pone.0200015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979729	Green Submitted, gold, Green Published			2022-12-26	WOS:000437809500053
J	Jiang, Y; Song, HY; He, JR; Wang, Q; Liu, J				Jiang, Yu; Song, Hai-Yan; He, Jun-Rong; Wang, Qiang; Liu, Jia			Comparative transcriptome analysis provides global insight into gene expression differences between two orchid cultivars	PLOS ONE			English	Article							FLAVONOID BIOSYNTHESIS; CAROTENOID BIOSYNTHESIS; CHLOROPLAST DEVELOPMENT; CHALCONE SYNTHASE; COLOR FORMATION; ARABIDOPSIS; EVOLUTION; GENOME; ANTHOCYANIN; DEGRADATION	The orchids GL and YL are two cultivars of Cymbidium longibracteatum. YL displays an obviously yellowing rhizome and yellow leaves, while GL ('Longchangsu') shows dark green leaves and greenish rhizome. But the molecular mechanism for the differences between the two cultivars is poorly understood. In the present study, we showed that the structure of chloroplasts was significantly damaged in YL. Biochemical analysis uncovered the contents of chlorophyll a, chlorophyll b, total chlorophyll and carotenoid were notably decreased in YL. Using RNA-Seq technology, more than 38 million clean reads were generated in each pool, and 116,422 unigenes were assembled de novo. 6,660 unigenes with differential expression patterns (FDR <= 0.01 and vertical bar log2 ratio vertical bar >= 1) were totally identified between the two cultivars. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of differentially expressed unigenes (DEGs) suggested 33 KEGG pathways were notably enriched, including biological processes such as "phenylpropanoid biosynthesis", "phagosome", "starch and sucrose metabolism", "drug metabolism-cytochrome P450", "fatty acid elongation", and "flavone and flavonol biosynthesis". Further analysis revealed that chlorophyll degeneration related unigene (c48794_g1) and flavonoid biosynthesis related unigenes (c16388_g1, c48963_g1, c63571_g1, c4492_g1, c52282_g1, c78740_g1, c4645_g1) were up-regulated while carotenoid biosynthesis related unigene (c7212_g1) were down-regulated in YL. Additionally, six of NAC, R2R3-MYB, bHLH transcription factors (c42861_g1, c105949_g1, c61265_g1, c42659_g1, c82171_g1, c19158_g1) might be involved in regulation of pigment biosynthesis. The chlorophyll degeneration and the flavonoid biosynthesis related unigenes up-regulation together with the carotenoid biosynthesis related unigenes down-regulation may contribute to the yellowing phenotype of YL.	[Jiang, Yu; Wang, Qiang] Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China; [Jiang, Yu; Song, Hai-Yan; He, Jun-Rong; Liu, Jia] Sichuan Acad Agr Sci, Inst Hort, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Academy of Agricultural Sciences (SAAS)	Wang, Q (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China.	qwang@sicau.edu.cn	Wang, Qiang/GOE-4599-2022		Applied Basic Research Programs of Sichuan province [2017JY0287]; Sichuan Agricultural University	Applied Basic Research Programs of Sichuan province; Sichuan Agricultural University	This work was supported by the grant from the Applied Basic Research Programs of Sichuan province (no. 2017JY0287 to Yu Jiang) and the Start-up Funds from Sichuan Agricultural University to Qiang Wang.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cai J, 2015, NAT GENET, V47, P65, DOI 10.1038/ng.3149; Chao YT, 2017, PLANT CELL PHYSIOL, V58, DOI 10.1093/pcp/pcw220; Costa-Silva J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190152; Duan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134824; Fraser Christopher M, 2011, Arabidopsis Book, V9, pe0152, DOI 10.1199/tab.0152; Fu CC, 2017, PLANT CELL PHYSIOL, V58, P2155, DOI 10.1093/pcp/pcx149; Fu CC, 2016, J AGR FOOD CHEM, V64, P5454, DOI 10.1021/acs.jafc.6b01020; Gilkerson J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-102; Gonzalez-Jorge S, 2016, PLANT PHYSIOL, V171, P1837, DOI 10.1104/pp.16.00604; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guengerich FP, 2013, J BIOL CHEM, V288, P17065, DOI 10.1074/jbc.R113.462275; Hu ZH, 2014, J EXP BOT, V65, P1111, DOI 10.1093/jxb/ert463; Huang WT, 2012, INT J MOL SCI, V13, P11385, DOI 10.3390/ijms130911385; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Jiang Y., 2015, NOR HORTICUL, P65, DOI [10.11937/BFYY.201507021, DOI 10.11937/BFYY.201507021]; Kim HT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187318; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Lai B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086293; Lee WB, 2017, BIOCHEM BIOPH RES CO, V493, P1491, DOI 10.1016/j.bbrc.2017.10.018; Li CF, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0885-2; Li PH, 2016, NEW PHYTOL, V210, P905, DOI 10.1111/nph.13816; Li ST, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27522; Li X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169838; Li XB, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0124-5; Lin YS, 2015, PLANT PHYSIOL, V169, P1917, DOI 10.1104/pp.15.00953; Luo YB, 2003, BIODIVERS SCI, V11, P70, DOI DOI 10.3321/J.ISSN:1005-0094.2003.01.010; Ma NN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0351-y; MANN V, 1994, PLANT MOL BIOL, V24, P429, DOI 10.1007/BF00024111; Natale DA, 2000, GENOME BIOL, V1; Niu ZT, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00715; Ohmiya A, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1156-6; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Park HY, 2008, BIOCHEM BIOPH RES CO, V375, P80, DOI 10.1016/j.bbrc.2008.07.128; Podzimska-Sroka Dagmara, 2015, Plants-Basel, V4, P412, DOI 10.3390/plants4030412; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Ren GD, 2007, PLANT PHYSIOL, V144, P1429, DOI 10.1104/pp.107.100172; Renault H, 2014, CURR OPIN PLANT BIOL, V19, P27, DOI 10.1016/j.pbi.2014.03.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sagawa JM, 2016, NEW PHYTOL, V209, P1049, DOI 10.1111/nph.13647; Schijlen EGWM, 2007, PLANT PHYSIOL, V144, P1520, DOI 10.1104/pp.107.100305; Song LB, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00803; Sun YY, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3089-1; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wong DCJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01955; Wong DCJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01260; Xiang LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143892; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu HY, 2017, CURR BIOL, V27, P1867, DOI 10.1016/j.cub.2017.05.065; Xu WJ, 2013, NEW PHYTOL, V198, P59, DOI 10.1111/nph.12142; Yang FX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142434; Yang KY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23195; Yang YX, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00139; Zhang GQ, 2017, NATURE, V549, P379, DOI 10.1038/nature23897; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhang XB, 2017, PLANT CELL, V29, P1157, DOI 10.1105/tpc.16.00855; Zhang Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00897; Zhao L, 2013, FUNCT INTEGR GENOMIC, V13, P75, DOI 10.1007/s10142-012-0301-4; Zhu MK, 2014, PLANT CELL PHYSIOL, V55, P119, DOI 10.1093/pcp/pct162	59	7	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200155	10.1371/journal.pone.0200155	http://dx.doi.org/10.1371/journal.pone.0200155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975782	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500072
J	Langlois, AC; Marinach, C; Manzoni, G; Silvie, O				Langlois, Anne-Claire; Marinach, Carine; Manzoni, Giulia; Silvie, Olivier			Plasmodium sporozoites can invade hepatocytic cells independently of the Ephrin receptor A2	PLOS ONE			English	Article							HEPATITIS-C VIRUS; MALARIA CIRCUMSPOROZOITE PROTEIN; HEPARAN-SULFATE; INFECTION; ENTRY; CD81; PARASITES; IMMUNITY; BINDING; EPHA2	Sporozoite forms of the malaria parasite Plasmodium are transmitted by mosquitoes and first infect the liver for an initial round of replication before parasite proliferation in the blood. The molecular mechanisms involved during sporozoite invasion of hepatocytes remain poorly understood. In previous studies, two receptors of the Hepatitis C virus (HCV), the tetraspanin CD81 and the Scavenger Receptor BI (SR-BI), were shown to play an important role during entry of Plasmodium sporozoites into hepatocytic cells. In contrast to HCV entry, which requires both CD81 and SR-BI together with additional host factors, CD81 and SR-BI operate independently during malaria liver infection, as sporozoites can use CD81 and/or SR-BI, depending on the Plasmodium species, to invade hepatocytes. However, the molecular function of CD81 and SR-BI during parasite entry remains unknown. Another HCV entry factor, the Ephrin receptor A2 (EphA2), was recently reported to play a key role as a host cell entry factor during malaria liver infection. Here, we investigated the contribution of EphA2 during CD81-dependent and SR-BI-dependent sporozoite infection. Using small interfering RNA (siRNA) and antibodies against EphA2, combined with direct detection of parasites by flow cytometry or microscopy, we show that blocking EphA2 has no significant impact on P. yoelii or P. berghei host cell infection, irrespective of the entry route. Thus, our findings argue against an important role of EphA2 during malaria liver infection.	[Langlois, Anne-Claire; Marinach, Carine; Manzoni, Giulia; Silvie, Olivier] Sorbonne Univ, Ctr Immunol & Malad Infect, CIMI Paris, INSERM,CNRS, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Silvie, O (corresponding author), Sorbonne Univ, Ctr Immunol & Malad Infect, CIMI Paris, INSERM,CNRS, Paris, France.	olivier.silvie@inserm.fr	Langlois, Anne-Claire/GZX-5048-2022; Silvie, Olivier/AAF-5437-2021; Silvie, Olivier/K-7290-2017	Silvie, Olivier/0000-0002-0525-6940; Silvie, Olivier/0000-0002-0525-6940; Langlois, Anne-Claire/0000-0002-9001-2667	European Union (FP7 PathCo Collaborative Project) [HEALTH-F3-2012-305578]; Laboratoire d'Excellence ParaFrap [ANR-11-LABX-0024]; Agence Nationale de la Recherche [ANR-16-CE15-0004]; "DIM Malinf" doctoral fellowship - Conseil Regional d'Ile-de-France	European Union (FP7 PathCo Collaborative Project); Laboratoire d'Excellence ParaFrap; Agence Nationale de la Recherche(French National Research Agency (ANR)); "DIM Malinf" doctoral fellowship - Conseil Regional d'Ile-de-France	This work was funded by grants from the European Union (FP7 PathCo Collaborative Project HEALTH-F3-2012-305578), the Laboratoire d'Excellence ParaFrap (ANR-11-LABX-0024), and the Agence Nationale de la Recherche (ANR-16-CE15-0004) to OS. GM was supported by a "DIM Malinf" doctoral fellowship awarded by the Conseil Regional d'Ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredondo SA, 2012, P NATL ACAD SCI USA, V109, P6692, DOI 10.1073/pnas.1204363109; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Hugel FU, 1996, MOL BIOCHEM PARASIT, V81, P151, DOI 10.1016/0166-6851(96)02701-6; Ishino T, 2005, MOL MICROBIOL, V58, P1264, DOI 10.1111/j.1365-2958.2005.04801.x; Kaushansky A, 2015, SCIENCE, V350, P1089, DOI 10.1126/science.aad3318; Labaied M, 2007, INFECT IMMUN, V75, P3758, DOI 10.1128/IAI.00225-07; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Manzoni G, 2014, SCI REPORTS, V4, P1; Manzoni G, 2017, ELIFE, V6, DOI [10.7554/eLife.25903, 10.7554/elife.25903]; Morikawa K, 2007, J MED VIROL, V79, P714, DOI 10.1002/jmv.20842; Mota MM, 2001, ANN REV MICROBIOLOGY; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2012, CURR OPIN VIROL, V2, P14, DOI 10.1016/j.coviro.2011.12.007; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; Ramakrishnan C, 2012, LAB MAINTENANCE RODE, V923, P51; Risco-Castillo V, 2015, CELL HOST MICROBE, V18, P593, DOI 10.1016/j.chom.2015.10.006; Rodrigues CD, 2008, CELL HOST MICROBE, V4, P271, DOI 10.1016/j.chom.2008.07.012; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Silvie O, 2007, INT J PARASITOL, V37, P173, DOI 10.1016/j.ijpara.2006.10.005; Silvie O, 2006, CELL MICROBIOL, V8, P1134, DOI 10.1111/j.1462-5822.2006.00697.x; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; World Health Organization, 2017, INTEGRATED CARE OLDE, P1; Yalaoui S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000010	30	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200032	10.1371/journal.pone.0200032	http://dx.doi.org/10.1371/journal.pone.0200032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975762	Green Published, gold, Green Submitted			2022-12-26	WOS:000437424500062
J	Otero, A				Otero, Alejandro			Forelimb musculature and osteological correlates in Sauropodomorpha (Dinosauria, Saurischia)	PLOS ONE			English	Article							SP-NOV DINOSAURIA; PECTORAL GIRDLE; ALLIGATOR-MISSISSIPPIENSIS; PHYLOGENETIC-RELATIONSHIPS; POSTCRANIAL ANATOMY; APPENDICULAR SKELETON; THEROPOD DINOSAUR; SOUTH-AFRICA; MANUS SHAPE; 1ST RECORD	This contribution presents the forelimb muscular arrangement of sauropodomorph dinosaurs as inferred by comparisons with living archosaurs (crocodiles and birds) following the Extant Phylogenetic Bracket approach. Forty-one muscles were reconstructed, including lower limb and manus musculature, which prior information available was scarce for sauropodomorphs. A strong emphasis was placed on osteological correlates (such as tubercles, ridges and striae) and comparisons with primitive archosauromorphs are included in order to track these correlates throughout the Glade. This should help to elucidate how widespread among other archosaurian groups are these osteological correlates identified in Sauropodomorpha. The ultimate goal of this contribution was to provide an exhaustive guide to muscular identification in fossil archosaurs and to offer solid anatomical bases for future studies based on osteology, myology, functional morphology and systematics.	[Otero, Alejandro] Consejo Nacl Invest Cient & Tecn, Div Paleontol Vertebrados, Museo La Plata, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata	Otero, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Div Paleontol Vertebrados, Museo La Plata, La Plata, Buenos Aires, Argentina.	alexandros.otero@gmail.com			Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2011-2482, PICT 2015-0504]; Subsidio para Viajes y Estadias (La Plata University); Whittingtton Award; Research Grant (The Palaeontological Association); Theodore Roosevelt Memorial Grant (AMNH); Short Term Visitor Award (The Smithsonian Institution); Visiting Scholarships (FMNH); Ostrom Fund (Yale University); Deutscher Akademischer Austausch Dienst (DAAD); Programa de Cooperacion Cientifico-Tecnologica MINCyT (Argentina)	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Subsidio para Viajes y Estadias (La Plata University); Whittingtton Award; Research Grant (The Palaeontological Association); Theodore Roosevelt Memorial Grant (AMNH); Short Term Visitor Award (The Smithsonian Institution); Visiting Scholarships (FMNH); Ostrom Fund (Yale University); Deutscher Akademischer Austausch Dienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Programa de Cooperacion Cientifico-Tecnologica MINCyT (Argentina)	Traveling in the context of the present study was possible thanks to the following financial support: Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2011-2482 and PICT 2015-0504), Subsidio para Viajes y Estadias (La Plata University), Whittingtton Award and Research Grant (The Palaeontological Association), Theodore Roosevelt Memorial Grant (AMNH), Short Term Visitor Award (The Smithsonian Institution), Visiting Scholarships (FMNH), Ostrom Fund (Yale University), and Deutscher Akademischer Austausch Dienst (DAAD) to A.O., and Programa de Cooperacion Cientifico-Tecnologica MINCyT (Argentina).	Alcober OA, 2010, ZOOKEYS, P55, DOI 10.3897/zookeys.63.550; Allen V, 2014, J ANAT, V225, P569, DOI 10.1111/joa.12245; Apaldetti C, 2013, PALAEONTOLOGY, V56, P277, DOI 10.1111/j.1475-4983.2012.01198.x; Apaldetti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026964; Baier DB, 2013, J ANAT, V223, P462, DOI 10.1111/joa.12102; Bates KT, 2012, J R SOC INTERFACE, V9, P1339, DOI 10.1098/rsif.2011.0687; Bates KT, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150636; Benson RBJ, 2010, ZOOL J LINN SOC-LOND, V158, P882, DOI 10.1111/j.1096-3642.2009.00569.x; Benton MJ, 2004, DINOSAURIA, 2ND EDITION, P7; Bittencourt JS, 2015, J SYST PALAEONTOL, V13, P189, DOI 10.1080/14772019.2013.878758; Blob RW, 1999, J EXP BIOL, V202, P1023; Blob RW, 2001, PALEOBIOLOGY, V27, P14, DOI 10.1666/0094-8373(2001)027<0014:EOHPIN>2.0.CO;2; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; Bonaparte JF, 2006, CRETACEOUS RES, V27, P364, DOI 10.1016/j.cretres.2005.07.004; Bonaparte Jose F., 1993, Ameghiniana, V30, P271; Bonnan MF, 2007, SPEC PAP PALAEONTOL, P157; Bonnan MF, 2003, J VERTEBR PALEONTOL, V23, P595, DOI 10.1671/A1108; Borsuk-Bialynicka M, 1977, PALAENTOL POL, V37, P1; BROCHU C. A., 2002, MEMOIR SOC VERTEBRAT, V22, P1; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; Burch SH, 2017, J ANAT, V231, P515, DOI 10.1111/joa.12660; Burch SH, 2014, J ANAT, V225, P271, DOI 10.1111/joa.12216; Burch SH, 2012, J VERTEBR PALEONTOL, V32, P1, DOI 10.1080/02724634.2012.622027; Butler RJ, 2010, ZOOL J LINN SOC-LOND, V160, P648, DOI 10.1111/j.1096-3642.2009.00631.x; Carballido JL, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1219; Carballido JL, 2011, J VERTEBR PALEONTOL, V31, P93, DOI 10.1080/02724634.2011.539651; Carrano MT, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P229; Carrano MT, 2005, J VERTEBR PALEONTOL, V25, P835, DOI 10.1671/0272-4634(2005)025[0835:NIOSHA]2.0.CO;2; Carrano MT, 1998, PALEOBIOLOGY, V24, P450, DOI 10.1017/S0094837300020108; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; Carrano MT, 2000, PALEOBIOLOGY, V26, P489, DOI 10.1666/0094-8373(2000)026<0489:HATEOD>2.0.CO;2; Cerda IA, 2012, PALAEONTOL Z, V86, P441, DOI 10.1007/s12542-012-0140-6; Cerda IA, 2012, NATURWISSENSCHAFTEN, V99, P83, DOI 10.1007/s00114-011-0869-x; CHIAPPE LM, 1995, NATURE, V378, P349, DOI 10.1038/378349a0; Clark JM, 2004, DINOSAURIA, 2ND EDITION, P151; Cong L., 1998, GROSS ANATOMY ALLIGA; COOMBS WP, 1978, J PALEONTOL, V52, P642; Cooper M. R, 1981, NATURAL SCI, V6, P689; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Diogo R, 2010, MUSCLES VERTEBRATES; Ezcurra MD, 2016, PEERJ, V4, DOI 10.7717/peerj.1778; Filippi LS, 2011, GEOL ACTA, V9, P1, DOI 10.1344/105.000001648; Gallina PA, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.924957; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; GATESY SM, 1991, J ZOOL, V224, P577, DOI 10.1111/j.1469-7998.1991.tb03786.x; Gilmore C. W., 1936, Memoirs of the Carnegie Museum, V11, P175; Godoy PL, 2016, PEERJ, V4, DOI 10.7717/peerj.2075; Riga BJG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19165; Gower DJ, 2009, J VERTEBR PALEONTOL, V29, P103, DOI 10.1080/02724634.2009.10010365; Harris JD, 2004, ANAT REC PART A, V281A, P1240, DOI 10.1002/ar.a.20078; Harris JD, 2007, GEOBIOS-LYON, V40, P501, DOI 10.1016/j.geobios.2006.02.002; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Hutchinson JR, 2005, PALEOBIOLOGY, V31, P676; Hutchinson JR, 2000, PALEOBIOLOGY, V26, P734, DOI 10.1666/0094-8373(2000)026<0734:AAATEO>2.0.CO;2; Jasinoski SC, 2006, ZOOL J LINN SOC-LOND, V146, P301, DOI 10.1111/j.1096-3642.2006.00200.x; JENKINS FA, 1993, AM J SCI, V293A, P253, DOI 10.2475/ajs.293.A.253; Klinkhamer AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175079; Langer MC, 2007, SPEC PAP PALAEONTOL, P113; Langer MC, 2013, GEOLOGICAL SOC SPECI, P379; Leardi JM., 2013, EVOLUCION FUNCION LO, P620; Madsen Jr JR, 1993, UTAH GEOLOGICAL SURV, V109, P163; Maidment SCR, 2011, J VERTEBR PALEONTOL, V31, P1265, DOI 10.1080/02724634.2011.606857; Maidment SCR, 2008, J SYST PALAEONTOL, V6, P367, DOI 10.1017/S1477201908002459; Mannion PD, 2017, PEERJ, V5, DOI 10.7717/peerj.3217; Mannion PD, 2012, J VERTEBR PALEONTOL, V32, P614, DOI 10.1080/02724634.2012.660898; Mannion PD, 2011, BIOL REV, V86, P157, DOI 10.1111/j.1469-185X.2010.00139.x; Marsh OC, AM J SCI, V183, p[152, 81]; Leardi JM, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.995187; Martin Valerie, 1999, Oryctos, V2, P39; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Martinez RN, 2009, J VERTEBR PALEONTOL, V29, P142, DOI 10.1671/039.029.0102; Mateus O, 2014, J VERTEBR PALEONTOL, V34, P618, DOI 10.1080/02724634.2013.822875; Mateus O, 2011, AN ACAD BRAS CIENC, V83, P221, DOI 10.1590/S0001-37652011000100012; MCINTOSH JS, 1989, AGE DINOSAURS SHORT, V2, P85; MCKITRICK MC, 1991, ZOOL J LINN SOC-LOND, V102, P115, DOI 10.1111/j.1096-3642.1991.tb00285.x; Meers MB, 2003, ANAT REC PART A, V274A, P891, DOI 10.1002/ar.a.10097; MEYERS RA, 1992, ZOOMORPHOLOGY, V112, P91, DOI 10.1007/BF01673810; Nesbitt SJ., 2011, B AM MUS NAT HIST, V352, P292; Nesbitt SJ, 2009, ZOOL J LINN SOC-LOND, V157, P814, DOI 10.1111/j.1096-3642.2009.00530.x; NICHOLLS EL, 1985, PALAEONTOLOGY, V28, P643; Osborn H. F., 1921, Memoirs from the American Museum of Natural History New York NS, V3, P247; Osborn HF, 1899, MEMOIRS AM MUSEUM NA, V30, P1; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; Ostrom JH., 1974, POSTILLA, V165, P10; Otero A, 2017, PEERJ, V5, DOI 10.7717/peerj.3976; Otero A, 2015, ZOOL J LINN SOC-LOND, V174, P589, DOI 10.1111/zoj.12247; Otero A, 2013, J VERTEBR PALEONTOL, V33, P1138, DOI 10.1080/02724634.2013.769444; Otero A, 2010, ACTA PALAEONTOL POL, V55, P399, DOI 10.4202/app.2009.0099; PARRISH JM, 1987, PALEOBIOLOGY, V13, P396; Pol D, 2005, AMEGHINIANA, V42, P21; Pol D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014572; Poropat SF, 2015, GONDWANA RES, V27, P995, DOI 10.1016/j.gr.2014.03.014; Reese A. M., 1915, ALLIGATOR ITS ALLIES; Reilly SM, 1998, J EXP BIOL, V201, P2559; Remes K, 2008, THESIS; Rogers KC, 2009, J VERTEBR PALEONTOL, V29, P1046, DOI 10.1671/039.029.0432; Romer AS, 1923, B AM MUS NAT HIST, V48, P533; Russell Anthony P., 2008, P1; Santa Luca AP, 1980, ANN S AFR MUS, V79, P15; Schwarz D, 2007, ANAT REC, V290, P32, DOI 10.1002/ar.20405; Sereno PC, 2012, J VERTEBR PALEONTOL, V32, P83, DOI 10.1080/02724634.2013.820113; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; Sertich JJW, 2010, J VERTEBR PALEONTOL, V30, P122, DOI 10.1080/02724634.2010.516902; Sertich JJW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009789; Smith ND, 2007, ACTA PALAEONTOL POL, V52, P657; Suzuki Daisuke, 2010, Fossils (Tokyo), P83; Taylor MP, 2009, J VERTEBR PALEONTOL, V29, P787, DOI 10.1671/039.029.0309; Fernandez-Baldor FT, 2017, PEERJ, V5, DOI 10.7717/peerj.3409; Tschopp E., 2015, PALAEONTOL ELECTRON, V18, P1; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; VanBuren CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074842; Vanden Berge James C., 1993, Publications of the Nuttall Ornithological Club, V23, P189; von Huene F, 1929, SAURISQUIOS ORNITISQ, V3; von Huene F., 1926, GEOL PALAEONTOL ABHA, V15, P139; Wedel M, 2007, SPEC PAP PALAEONTOL, P207; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wedel Mathew J., 2002, Paleobios, V22, P1; Wedel MJ, 2009, J EXP ZOOL PART A, V311A, P611, DOI 10.1002/jez.513; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Wilhite R, 2003, THESIS LOUISIANA STA, P185; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; WILSON JA, 1998, MEMOIR SOC VERTEBRAT, V5, P1, DOI DOI 10.2307/3889325; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Yates AM, 2010, P ROY SOC B-BIOL SCI, V277, P787, DOI 10.1098/rspb.2009.1440; Yates AM, 2005, J VERTEBR PALEONTOL, V25, P466, DOI 10.1671/0272-4634(2005)025[0466:FCITPD]2.0.CO;2; You HL., 2008, GANSU GEOLOGY, V17, P1; Zaaf A, 1999, ZOOMORPHOLOGY, V119, P9, DOI 10.1007/s004350050077	133	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0198988	10.1371/journal.pone.0198988	http://dx.doi.org/10.1371/journal.pone.0198988			65	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975691	Green Published, gold, Green Submitted			2022-12-26	WOS:000437424500015
J	Sumi, M; Nakamura, T				Sumi, Misa; Nakamura, Takashi			Salivary gland carcinoma: Prediction of cancer death risk based on apparent diffusion coefficient histogram profiles	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; INTRAVOXEL INCOHERENT MOTION; PROGNOSTIC-SIGNIFICANCE; NECK-CARCINOMA; HEAD; TUMORS; KI-67; DIFFERENTIATION; METASTASES; MANAGEMENT	We evaluated apparent diffusion coefficient (ADC) histogram parameters for predicting the outcomes of patients with salivary gland carcinoma. Diffusion-weighted MR imaging was performed in 20 patients with salivary gland carcinoma, and ADCs were determined using b-values of 500 and 1000 s/mm(2). ADC histogram parameters (mean, median, percentage tumor area with distinctive ADC values [pADC], skewness, and kurtosis) were analyzed. The patients were followed for 5-136 months after primary surgery. The ADC histogram parameters and T (pT), N(pN), and M categories of the primary tumors were assessed for the prognostic importance using Cox proportional hazards models, logistic regression analysis, and receiver operating characteristic (ROC) analysis. Cohen's d was determined for evaluating the importance of differences in the parameters between two patient groups with different outcomes. Six patients died of cancer (DOC) within 3 years after the primary surgery. Cox proportional hazards models indicated that ADC mean (95% CI = 0.494-0.977, p = 0.034), ADC median (95% CI = 0.511-0.997, p = 0.048), pADC with extremely low (<0.6 mm(2)/s) ADC (95% CI = 1.013-1.082, p = 0.007), kurtosis (95% CI = 1.166-7.420, p = 0.023), and pN classification (95% CI = 1.196-4.836, p = 0.012) were important factors of cancer death risk. ROC analyses indicated that the pADC <0.6 x10(-3) mm(2)/s was the best prognostic predictor (p <0.001; AUC = 0.929) among the ADC and TNM classification parameters that were significant in a univariate logistic regression analysis. Cohen's d values between the DOC and survived patients for the ADC mean, ADC median, pADC with extremely low ADC, and kurtosis were 1.06, 1.04, 2.12, and 1.13, respectively. These results suggest that ADC histogram analysis may be helpful for predicting the outcomes of patients with salivary gland carcinoma.	[Sumi, Misa; Nakamura, Takashi] Nagasaki Univ, Dept Radiol & Canc Biol, Grad Sch Biomed Sci, Nagasaki, Japan	Nagasaki University	Nakamura, T (corresponding author), Nagasaki Univ, Dept Radiol & Canc Biol, Grad Sch Biomed Sci, Nagasaki, Japan.	taku@nagasaki-u.ac.jp						Ahn SJ, 2012, ACAD RADIOL, V19, P1233, DOI 10.1016/j.acra.2012.04.019; Amit M, 2017, HEAD NECK-J SCI SPEC, V39, P1008, DOI 10.1002/hed.24740; Dinh AH, 2016, RADIOLOGY, V280, P117, DOI 10.1148/radiol.2016151406; Baddour HM, 2016, J SURG ONCOL, V113, P248, DOI 10.1002/jso.24134; Barnes L, 2005, PATHOLOGY GENETICS H; Bradley PJ, 2015, CURR OPIN OTOLARYNGO, V23, P91, DOI 10.1097/MOO.0000000000000139; Durr ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010828; Eida S, 2007, AM J NEURORADIOL, V28, P116; Eida S, 2010, J MAGN RESON IMAGING, V31, P673, DOI 10.1002/jmri.22091; Feinstein TM, 2011, HEAD NECK-J SCI SPEC, V33, P318, DOI 10.1002/hed.21444; Fujima N, 2017, EUR RADIOL, V27, P956, DOI 10.1007/s00330-016-4440-1; Huang ZQ, 2015, EUR J RADIOL, V84, P2464, DOI 10.1016/j.ejrad.2015.09.013; Iima M, 2016, RADIOLOGY, V278, P13, DOI 10.1148/radiol.2015150244; King AD, 2013, RADIOLOGY, V266, P531, DOI 10.1148/radiol.12120167; Langendijk JA, 2005, CANCER-AM CANCER SOC, V104, P1408, DOI 10.1002/cncr.21340; Larsen SR, 2012, J ORAL PATHOL MED, V41, P598, DOI 10.1111/j.1600-0714.2012.01148.x; Lewis AG, 2016, OTOLARYNG CLIN N AM, V49, P343, DOI 10.1016/j.otc.2015.11.001; Lindgren A, 2017, EUR RADIOL, V27, P4002, DOI 10.1007/s00330-017-4786-z; Ljumanovic R, 2006, EUR J RADIOL, V60, P58, DOI 10.1016/j.ejrad.2006.05.019; Luukkaa H, 2006, ACTA ONCOL, V45, P669, DOI 10.1080/02841860500543208; McHugh CH, 2012, CANCER-AM CANCER SOC, V118, P3928, DOI 10.1002/cncr.26697; Mermod M, 2016, ORAL ONCOL, V62, P60, DOI 10.1016/j.oraloncology.2016.10.003; Murase R, 2016, CANCER LETT, V377, P11, DOI 10.1016/j.canlet.2016.04.021; Nakamura T, 2010, METHODS CANCER DIAGN, V7, P255; Pereira ER, 2015, SEMIN CELL DEV BIOL, V38, P98, DOI 10.1016/j.semcdb.2015.01.008; Stodulski D, 2016, EUR ARCH OTO-RHINO-L, V273, P3937, DOI 10.1007/s00405-016-4048-8; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248; Wang K, 2016, CLIN CANCER RES, V22, P6061, DOI 10.1158/1078-0432.CCR-15-2568; Wittekind C, 2017, UICC TNM CLASSIFICAT	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200291	10.1371/journal.pone.0200291	http://dx.doi.org/10.1371/journal.pone.0200291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975742	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500080
J	Rice, CA; Campbell, SJ; Bisson, C; Owen, HJ; Sedelnikova, SE; Baker, PJ; Rice, DW; Henriquez, FL; Roberts, CW				Rice, Christopher A.; Campbell, Sara J.; Bisson, Claudine; Owen, Hayley J.; Sedelnikova, Svetlana E.; Baker, Patrick J.; Rice, David W.; Henriquez, Fiona L.; Roberts, Craig W.			Structural and functional studies of histidine biosynthesis in Acanthamoeba spp. demonstrates a novel molecular arrangement and target for antimicrobials	PLOS ONE			English	Article							IMIDAZOLEGLYCEROL-PHOSPHATE DEHYDRATASE; KERATITIS DIAGNOSIS; INHIBITORS; PATHWAY; UPDATE; ALIGNMENT; MECHANISM; DESIGN; TOOL	Acanthamoeba is normally free-living, but sometimes facultative and occasionally opportunistic parasites. Current therapies are, by necessity, arduous and yet poorly effective due to their inabilities to kill cyst stages or in some cases to actually induce encystation. Acanthamoeba can therefore survive as cysts and cause disease recurrence. Herein, in pursuit of better therapies and to understand the biochemistry of this understudied organism, we characterize its histidine biosynthesis pathway and explore the potential of targeting this with antimicrobials. We demonstrate that Acanthamoeba is a histidine autotroph, but with the ability to scavenge preformed histidine. It is able to grow in defined media lacking this amino acid, but is inhibited by 3-amino-1,2,4-triazole (3AT) that targets Imidazoleglycerol-Phosphate Dehydratase (IGPD) the rate limiting step of histidine biosynthesis. The structure of Acanthamoeba IGPD has also been determined in complex with 2-hydroxy-3-(1,2,4-triazol-1-yl) propylphosphonate [(R)-C348], a recently described novel inhibitor of Arabidopsis thaliana IGPD. This compound inhibited the growth of four Acanthamoeba species, having a 50% inhibitory concentration (IC50) ranging from 250-526 nM. This effect could be ablated by the addition of 1 mM exogenous free histidine, but importantly not by physiological concentrations found in mammalian tissues. The ability of 3AT and (R)-C348 to restrict the growth of four strains of Acanthamoeba spp. including a recently isolated clinical strain, while not inducing encystment, demonstrates the potential therapeutic utility of targeting the histidine biosynthesis pathway in Acanthamoeba.	[Rice, Christopher A.; Campbell, Sara J.; Henriquez, Fiona L.] Univ West Scotland, Sch Sci & Sport, Inst Biomed & Environm Hlth Res, Paisley, Renfrew, Scotland; [Rice, Christopher A.; Roberts, Craig W.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Bisson, Claudine; Owen, Hayley J.; Sedelnikova, Svetlana E.; Baker, Patrick J.; Rice, David W.] Univ Sheffield, Krebs Inst Biomol Res, Dept Mol Biol & Biotechnol, Court 5,Western Bank, Sheffield, S Yorkshire, England; [Rice, Christopher A.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Bisson, Claudine] Univ London, Birkbeck Coll, Dept Biol Sci, London, England	University of West Scotland; University of Strathclyde; University of Sheffield; University System of Georgia; University of Georgia; University of London; Birkbeck University London	Henriquez, FL (corresponding author), Univ West Scotland, Sch Sci & Sport, Inst Biomed & Environm Hlth Res, Paisley, Renfrew, Scotland.; Roberts, CW (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	fiona.henriquez@uws.ac.uk; c.w.roberts@strath.ac.uk	Roberts, Craig William/B-8016-2008	Roberts, Craig William/0000-0002-0653-835X; Owen, Hayley/0000-0002-6274-0560; Baker, Patrick/0000-0003-1995-5643; Rice, Christopher/0000-0003-0672-9604; Henriquez, Fiona/0000-0002-5534-1019; Bisson, Claudine/0000-0002-9430-6822	Biotechnology and Biological Sciences Research Council BAG [MX7423]; BBSRC; UWS studentship	Biotechnology and Biological Sciences Research Council BAG(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UWS studentship	This work was supported by Biotechnology and Biological Sciences Research Council BAG allocation MX7423 to Dr. David W. Rice, University of the West of Scotland to Dr. Fiona L. Henriquez.; We thank BBSRC for financial support, the Diamond Light Source for beam time under BAG allocation MX7423 and the beamline scientists on I03 for assistance with data collection. We also thank Syngenta for providing a sample of R-C348 for this study. CAR was funded by a UWS studentship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahangar MS, 2013, ACTA CRYSTALLOGR D, V69, P2461, DOI 10.1107/S0907444913022579; Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; [Anonymous], 1990, HDB PESTICIDE TOXICO; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bisson C, 2016, ANGEW CHEM INT EDIT, V55, P13485, DOI 10.1002/anie.201607185; Bisson C, 2015, STRUCTURE, V23, P1236, DOI 10.1016/j.str.2015.05.012; Casarett LJ, 1980, CASARETT DOULLS TOXI, V2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clarke M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r11; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cox JM, 1997, PESTIC SCI, V50, P297, DOI 10.1002/(SICI)1096-9063(199708)50:4&lt;297::AID-PS592&gt;3.0.CO;2-2; Dart JKG, 2009, AM J OPHTHALMOL, V148, P487, DOI 10.1016/j.ajo.2009.06.009; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fani R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S4; Fondi M, 2009, J MOL EVOL, V69, P512, DOI 10.1007/s00239-009-9286-6; Glynn SE, 2005, STRUCTURE, V13, P1809, DOI 10.1016/j.str.2005.08.012; Henriquez FL, 2015, PROTIST, V166, P93, DOI 10.1016/j.protis.2014.12.001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kwon YH, 2005, EYE, V19, P455, DOI 10.1038/sj.eye.6701546; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Lindell SD, 1996, BIOORG MED CHEM LETT, V6, P547, DOI 10.1016/0960-894X(96)00076-5; Lunardi J, 2013, CURR TOP MED CHEM, V13, P2866, DOI 10.2174/15680266113136660203; Mattana A, 2016, INFECT IMMUN, V84, P2944, DOI 10.1128/IAI.00345-16; Maycock NJR, 2016, CORNEA, V35, P713, DOI 10.1097/ICO.0000000000000804; McBride J, 2005, J CLIN MICROBIOL, V43, P629, DOI 10.1128/JCM.43.2.629-634.2005; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; READ RJ, 1988, J APPL CRYSTALLOGR, V21, P490, DOI 10.1107/S002188988800562X; Schweitzer BA, 1999, BIOORG MED CHEM LETT, V9, P2053, DOI 10.1016/S0960-894X(99)00338-8; Seal DV, 2003, EYE, V17, P893, DOI 10.1038/sj.eye.6700563; Shimizu M, 2006, ORG LETT, V8, P3585, DOI 10.1021/ol0615634; SHUKLA OP, 1990, J PROTOZOOL, V37, P237, DOI 10.1111/j.1550-7408.1990.tb01134.x; Sinha SC, 2004, J BIOL CHEM, V279, P15491, DOI 10.1074/jbc.M312733200; Stepansky A, 2006, AMINO ACIDS, V30, P121, DOI 10.1007/s00726-005-0246-1; U. S. Environmental Protection Agency, 1992, FED REGISTER, V57, P46448; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yanai I, 2002, GENOME BIOL, V3	39	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0198827	10.1371/journal.pone.0198827	http://dx.doi.org/10.1371/journal.pone.0198827			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969448	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000437246700007
J	Wang, Y; Liu, K; Bi, D; Zhou, SB; Shao, JW				Wang, Ying; Liu, Kun; Bi, De; Zhou, Shoubiao; Shao, Jianwen			Molecular phylogeography of East Asian Boea clarkeana (Gesneriaceae) in relation to habitat restriction	PLOS ONE			English	Article							CHLOROPLAST DNA PHYLOGEOGRAPHY; DYSOSMA-VERSIPELLIS BERBERIDACEAE; 2 REFUGE AREAS; GENETIC DIVERSITY; DESICCATION TOLERANCE; POPULATION-STRUCTURE; QUATERNARY CLIMATE; COMPUTER-PROGRAM; CPDNA HAPLOTYPES; CHINA	Subfamily Cyrtandroideae (Gesneriaceae) comprises a broadly distributed group of rockyslope herbs, with China being the center of its distributional range. The normal growth of many species within the family is particularly dependent on special habitats. Due to the paucity of molecular studies, very little is known regarding East Asian herb phylogeographic pattern. Here, we investigate the molecular phylogeography of Boea clarkeana Hemsl., a unique resurrection herb endemic to China, focusing on geographically restrictive effects of habitat distribution on evolutionary history. Variation in three chloroplast DNA (cpDNA) intergenic spacers (psbA-trnH, rps12-rpl20, and trnL-trnF), the ribosomal internal transcribed spacer (ITS) and simple sequence repeats in expressed sequence tags (EST-SSRs) was investigated across 18 populations to assess genetic diversity, genetic structure and historical dynamics. Genetic diversity was low within populations (cpDNA, h(s) = 0.03,pi(s)x10(3) = 0.17; ITS, h(s) = 0.16,pi(s)x10(3) = 0.43) but high for species (cpDNA, h(T) = 0.82, pi(T)x10(3) = 3.12; ITS, h(T) = 0.88,pi(T)x10(3) = 6.39); 76 alleles were detected in this highly inbred species (F-IS = 0.22), with a significantly low average of 1.34 alleles per locus. No cpDNA or ITS haplotypes were shared between regions. Based on cpDNA results, the Mt. Huangshan-Tianmu and Mt. Qinling-Daba haplotypes are ancestral; these two regions represent potential refugia. Although no evidence of significant retreat-migration phenomena during glacial cycles was detected, interglacial range expansion from northern Mt. Qinling-Daba was identified (121,457 yr BP). Rapid agricultural growth caused bottlenecks in many populations, especially on Mt. Huang-Tianmu. Habitat restriction and fragmentation, weak seed and pollen dispersal abilities, and long-term isolation caused by human-induced or environmental changes are considered the main causes of extinction of several populations and low genetic diversity within populations and regions. These analyses clarify the effects of habitat restriction on B.clarkeana, representing an evolutionary reference for similar gesneriads, and enrich our understanding of the molecular phylogeography of East Asian rocky-slope herbs.	[Wang, Ying; Liu, Kun; Bi, De; Zhou, Shoubiao; Shao, Jianwen] Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China; [Wang, Ying; Liu, Kun; Shao, Jianwen] Anhui Prov Key Lab Conservat & Exploitat Biol Res, Wuhu, Anhui, Peoples R China; [Zhou, Shoubiao] Anhui Normal Univ, Coll Environm Sci & Engn, Wuhu, Anhui, Peoples R China	Anhui Normal University; Anhui Normal University	Zhou, SB; Shao, JW (corresponding author), Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China.; Shao, JW (corresponding author), Anhui Prov Key Lab Conservat & Exploitat Biol Res, Wuhu, Anhui, Peoples R China.; Zhou, SB (corresponding author), Anhui Normal Univ, Coll Environm Sci & Engn, Wuhu, Anhui, Peoples R China.	zhoushoubiao@vip.163.com; 545491044@qq.com			National Natural Science Foundation of China [31400291, 31570336]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	K.L. was supported in part by the National Natural Science Foundation of China (No. 31400291). J.S. was supported in part by the National Natural Science Foundation of China (No. 31570336). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anmarkrud JA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-138; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Axelrod DI, 1959, BRIT J CLIN PHARMACO, V4, P141; Bai WN, 2010, NEW PHYTOL, V188, P892, DOI 10.1111/j.1469-8137.2010.03407.x; Beaumont MA, 1999, GENETICS, V153, P2013; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Cai BQ, 2006, J XIAMEN U, V1, P49; Cao YJ, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0257-x; Chao Tian-cai, 2013, Shengtaixue Zazhi, V32, P1161; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; CRAWFORD DJ, 1992, AM J BOT, V79, P962, DOI 10.2307/2445008; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farrant JM, 2007, PLANT STRESS, V1, P72, DOI [DOI 10.1002/9780470376881.CH3, DOI 10.1002/9780470376881.ch3]; Fu YX, 1996, GENETICS, V143, P557; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gechev TS, 2012, CELL MOL LIFE SCI, V69, P3175, DOI 10.1007/s00018-012-1088-0; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Gong W, 2008, MOL PHYLOGENET EVOL, V48, P1094, DOI 10.1016/j.ympev.2008.05.003; Graur D., 1999, FUNDAMENTALS MOL EVO; Guan BC, 2010, AM J BOT, V97, P111, DOI 10.3732/ajb.0900160; Hamilton MB, 1999, MOL ECOL, V8, P521; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hancock JM, 1999, MICROSATELLITES EVOL; Hawk JD, 2005, P NATL ACAD SCI USA, V102, P8639, DOI 10.1073/pnas.0503415102; Huang DQ, 2014, J SYST EVOL, V52, P341, DOI 10.1111/jse.12050; Jiang GQ, 2007, PLANTA, V225, P1405, DOI 10.1007/s00425-006-0449-z; KARRON JD, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P87; Karron JD, 1987, EVOL ECOL, V1, P47, DOI 10.1007/BF02067268; Koch M, 2004, AM J BOT, V91, P115, DOI 10.3732/ajb.91.1.115; Kou YX, 2016, J BIOGEOGR, V43, P351, DOI 10.1111/jbi.12635; Lande R., 2003, OXFORD SERIES ECOLOG; Li EX, 2008, MOL PHYLOGENET EVOL, V49, P702, DOI 10.1016/j.ympev.2008.09.012; Li Z.-Y., 1996, ACTA PHYTOTAX SINICA, V34, P341; Li ZY, 2005, PLANTS GESNERIACEAE; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; [刘戈宇 LIU Geyu], 2007, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V43, P446; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu ZW, 2016, INDIAN J GENET PL BR, V76, P57, DOI 10.5958/0975-6906.2016.00008.0; Lowe A., 2004, ECOLOGICAL GENETICS; Ma Q, 2015, SYST BOT, V40, P796, DOI 10.1600/036364415X689267; MANTEL N, 1967, CANCER RES, V27, P209; NEI M, 1974, GENETICS, V76, P379; Ni XW, 2006, GENETICA, V127, P177, DOI 10.1007/s10709-005-3227-0; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Ota T., 1993, DISPAN VERSION 1 1 G; Palme AE, 2003, MOL ECOL, V12, P201, DOI 10.1046/j.1365-294X.2003.01724.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pons O, 1996, GENETICS, V144, P1237; Qi XS, 2012, NEW PHYTOL, V196, P617, DOI 10.1111/j.1469-8137.2012.04242.x; Qiu YX, 2006, BIOCHEM SYST ECOL, V34, P745, DOI 10.1016/j.bse.2006.06.001; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Qiu YX, 2009, NEW PHYTOL, V183, P480, DOI 10.1111/j.1469-8137.2009.02876.x; Qiu YX, 2009, MOL PHYLOGENET EVOL, V51, P281, DOI 10.1016/j.ympev.2009.01.016; Rambaut A., 2007, TRACER V1 4; Ren GY, 2002, QUATERNARY SCI REV, V21, P1395, DOI 10.1016/S0277-3791(01)00119-6; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sun YX, 2014, J BIOGEOGR, V41, P1721, DOI 10.1111/jbi.12323; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian B, 2009, J BIOGEOGR, V36, P2148, DOI 10.1111/j.1365-2699.2009.02157.x; Tian S, 2008, ANN BOT-LONDON, V102, P69, DOI 10.1093/aob/mcn068; Trewick SA, 2002, MOL ECOL, V11, P2003, DOI 10.1046/j.1365-294X.2002.01583.x; Udupa SM, 2001, MOL GENET GENOMICS, V265, P1097, DOI 10.1007/s004380100508; Wan SM, 2007, PALAEOGEOGR PALAEOCL, V254, P561, DOI 10.1016/j.palaeo.2007.07.009; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Wang J, 2009, J BIOGEOGR, V36, P2156, DOI 10.1111/j.1365-2699.2009.02165.x; Wang XQ, 1998, ACTA PHYTOTAX SINICA, V36, P97; Wang YH, 2015, NEW PHYTOL, V206, P852, DOI 10.1111/nph.13261; Wang Y, 2017, PEERJ, V5, DOI 10.7717/peerj.3422; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wen F., 2006, CHINESE WILD PLANT R, V25, P1; Wilson GA, 2003, GENETICS, V163, P1177; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Xiao LH, 2015, P NATL ACAD SCI USA, V112, P5833, DOI 10.1073/pnas.1505811112; Xie XF, 2012, J SYST EVOL, V50, P284, DOI 10.1111/j.1759-6831.2012.00204.x; Yi S, 2003, QUATERNARY SCI REV, V22, P1501, DOI 10.1016/S0277-3791(03)00080-5; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; Yu H, 2013, NEW PHYTOL, V197, P276, DOI 10.1111/j.1469-8137.2012.04383.x; Yuan N, 2014, AM J BOT, V101, P521, DOI 10.3732/ajb.1400043; Zhai PM, 2005, J CLIMATE, V18, P1096, DOI 10.1175/JCLI-3318.1; Zhang D., 2011, STUDY BIOL CHARACTER; Zhang Dan-dan, 2016, Shengtaixue Zazhi, V35, P72; Zhang JJ, 2015, ANN BOT-LONDON, V116, P727, DOI 10.1093/aob/mcv112; Zhang XP, 2006, BIOCHEM SYST ECOL, V34, P38, DOI 10.1016/j.bse.2005.05.007; Zhang YH., 2016, PHYLOGEOGRAPHY LANDS; Zhu Y, 2015, PLANT CELL PHYSIOL, V56, P1429, DOI 10.1093/pcp/pcv059; Zimmer EA, 2002, AM J BOT, V89, P296, DOI 10.3732/ajb.89.2.296	93	3	5	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199780	10.1371/journal.pone.0199780	http://dx.doi.org/10.1371/journal.pone.0199780			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969490	Green Published, gold, Green Submitted			2022-12-26	WOS:000437246700026
J	Perkin, OJ; McGuigan, PM; Thompson, D; Stokes, KA				Perkin, Oliver J.; McGuigan, Polly M.; Thompson, Dylan; Stokes, Keith A.			Habitual physical activity levels do not predict leg strength and power in healthy, active older adults	PLOS ONE			English	Article							MUSCLE POWER; SKELETAL-MUSCLE; CONTRACTILE PROPERTIES; PERFORMANCE; MASS; ASSOCIATION; RESISTANCE; DETERMINANT; MORTALITY; EXERCISE	Physical activity is considered crucial in attenuating losses in strength and power associated with ageing. However, in well-functioning, active older adults the relationship between habitual physical activity and muscle function is surprisingly unclear. Leg press velocity, force, and power, were compared between 50 older and 30 younger healthy individuals, and associations with habitual physical activity explored. An incremental power test was performed on a pneumatic leg press, with theoretical maximum velocity, force, and power calculated. Vastus lateralis muscle thickness was measured by ultrasound, and participants wore a combined accelerometer and heart rate monitor for 6-days of free-living. Older individuals produced lower absolute maximum velocity, force, and power, than younger individuals. When accounting for smaller muscle size, older individual's maximum force and power remained markedly lower. Both groups were active, however using age specific thresholds for classifying physical activity, the older individuals engaged in twice the amount of moderate-to-vigorous physical activity in comparison to the younger individuals. There were no associations between any characteristics of muscle function and physical activity. These data support that the ability to generate force and power deteriorates with age, however habitual physical activity levels do not explain inter-individual differences in muscle function in active older individuals.	[Perkin, Oliver J.; McGuigan, Polly M.; Thompson, Dylan; Stokes, Keith A.] Univ Bath, Dept Hlth, Bath, Avon, England; [Perkin, Oliver J.; Stokes, Keith A.] Arthrit Res UK, Ctr Sport Exercise & Osteoarthrit, Bath, Avon, England	University of Bath	Perkin, OJ (corresponding author), Univ Bath, Dept Hlth, Bath, Avon, England.; Perkin, OJ (corresponding author), Arthrit Res UK, Ctr Sport Exercise & Osteoarthrit, Bath, Avon, England.	O.J.Perkin@bath.ac.uk	Stokes, Keith/C-2605-2009	Stokes, Keith/0000-0002-5049-2838; Perkin, Oliver/0000-0001-8921-8708	University of Bath	University of Bath	The authors received funding from their own institution (University of Bath) in the form of a PhD studentship (OJP).	Alcazar J, 2018, EXP GERONTOL, V108, P1, DOI 10.1016/j.exger.2018.03.015; Bean JF, 2002, J AM GERIATR SOC, V50, P461; Bobbert MF, 2012, J APPL PHYSIOL, V112, P1975, DOI 10.1152/japplphysiol.00787.2011; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Breen L, 2013, J CLIN ENDOCR METAB, V98, P2604, DOI 10.1210/jc.2013-1502; Brooks George A, 2004, Am J Clin Nutr, V79, p921S; Buchman AS, 2007, MUSCLE NERVE, V35, P354, DOI 10.1002/mus.20702; Clark DJ, 2013, J GERONTOL A-BIOL, V68, P1419, DOI 10.1093/gerona/glt036; Cooper C, 2013, CALCIFIED TISSUE INT, V93, P201, DOI 10.1007/s00223-013-9757-z; D'Antona G, 2007, EUR J APPL PHYSIOL, V100, P603, DOI 10.1007/s00421-007-0402-2; de Vos NJ, 2005, J GERONTOL A-BIOL, V60, P638, DOI 10.1093/gerona/60.5.638; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; den Ouden MEM, 2013, GERIATR GERONTOL INT, V13, P274, DOI 10.1111/j.1447-0594.2012.00890.x; Foldvari M, 2000, J GERONTOL A-BIOL, V55, pM192, DOI 10.1093/gerona/55.4.M192; Fukunaga T, 2001, ACTA PHYSIOL SCAND, V172, P249, DOI 10.1046/j.1365-201x.2001.00867.x; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hughes VA, 2001, J GERONTOL A-BIOL, V56, pB209, DOI 10.1093/gerona/56.5.B209; Izquierdo M, 1999, ACTA PHYSIOL SCAND, V167, P57; Jantunen H, 2017, AGE AGEING, V46, P232, DOI 10.1093/ageing/afw194; Kortebein P, 2008, J GERONTOL A-BIOL, V63, P1076, DOI 10.1093/gerona/63.10.1076; Kubo K, 2007, MED SCI SPORT EXER, V39, P541, DOI 10.1249/01.mss.0000247006.24965.74; Liu CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002759.pub2; Macaluso A, 2003, EUR J APPL PHYSIOL, V90, P458, DOI 10.1007/s00421-003-0866-7; Manini TM, 2009, BRIT J SPORT MED, V43, P28, DOI 10.1136/bjsm.2008.053736; Mitchell WK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00260; Morie M, 2010, J AM GERIATR SOC, V58, P1727, DOI 10.1111/j.1532-5415.2010.03012.x; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Peterson MD, 2010, AGEING RES REV, V9, P226, DOI 10.1016/j.arr.2010.03.004; Reid KF, 2012, EXERC SPORT SCI REV, V40, P4, DOI 10.1097/JES.0b013e31823b5f13; Samozino P, 2012, MED SCI SPORT EXER, V44, P313, DOI 10.1249/MSS.0b013e31822d757a; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; SKELTON DA, 1994, AGE AGEING, V23, P371, DOI 10.1093/ageing/23.5.371; Straight CR, 2016, WOMEN HEALTH, V56, P871, DOI 10.1080/03630242.2016.1141828; Thom JM, 2007, EUR J APPL PHYSIOL, V100, P613, DOI 10.1007/s00421-007-0481-0; Walston JD, 2012, CURR OPIN RHEUMATOL, V24, P623, DOI 10.1097/BOR.0b013e328358d59b; Yu F, 2007, ACTA PHYSIOL, V190, P229, DOI 10.1111/j.1748-1716.2007.01699.x; Zampieri S, 2015, J GERONTOL A-BIOL, V70, P163, DOI 10.1093/gerona/glu006	42	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0200089	10.1371/journal.pone.0200089	http://dx.doi.org/10.1371/journal.pone.0200089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL5QR	29965998	Green Published, gold, Green Submitted			2022-12-26	WOS:000437224100048
J	Wang, SM; Tickle-Degnen, L				Wang, Shu-Mei; Tickle-Degnen, Linda			Emotional cues from expressive behavior of women and men with Parkinson's disease	PLOS ONE			English	Article							FACIAL EXPRESSIONS; GENDER-DIFFERENCES; ALEXITHYMIA; VALIDATION; LAUGHTER; PEOPLE; REHABILITATION; COMMUNICATION; IMPRESSIONS; PERSONALITY	Objective Emotional experience of people with Parkinson's disease is prone to being misunderstood by observers and even healthcare practitioners, which affects treatment effectiveness and makes clients suffer distress in their social lives. This study was designed to identify reliable emotional cues from expressive behavior in women and men with Parkinson's disease. Method Videotaped expressive behavior of 96 participants during an interview of discussing enjoyable events was rated using the Interpersonal Communication Rating Protocol. Indices from emotional measures were represented in three components. Correlational analyses between expressive behavior domains and emotional components were conducted for the total sample and by gender separately. Results More gross motor expressivity and smiling/laughing indicated more positive affect in the total sample. Less conversational engagement indicated more negative affect in women. However, women with more negative affect and depression appeared to smile and laugh more. Conclusion This study identified reliable cues from expressive behavior that could be used for assessment of emotional experience in people with Parkinson's disease. For women, because smiling/laughing may convey two possible meanings, that is, more positive and more negative affect, this cue needs to be interpreted cautiously and be used for detecting the intensity, not the type, of emotional experience. Healthcare practitioners should be sensitive to valid cues to make an accurate evaluation of emotion in people with Parkinson's disease.	[Wang, Shu-Mei] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China; [Tickle-Degnen, Linda] Tufts Univ, Sch Arts & Sci, Dept Occupat Therapy, Medford, MA 02155 USA	Hong Kong Polytechnic University; Tufts University	Wang, SM (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.	shumei.wang@polyu.edu.hk	Wang, Shu-Mei/AAY-6677-2021	Wang, Shu-Mei/0000-0001-5960-3314	Ministry of Science and Technology in Taiwan [103-2917-I-006-006]; Doctoral Dissertation Fulbright Research grant [15141395]; National Institute on Aging of the U.S. National Institutes of Health [R01NAG21152]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); Doctoral Dissertation Fulbright Research grant; National Institute on Aging of the U.S. National Institutes of Health	The study was supported by the graduate students study abroad program (no. 103-2917-I-006-006) from Ministry of Science and Technology in Taiwan (https://secure-web.cisco.com/1rL6o8n3LZg2BLfflV28AUZd0L7-VupupAVJOXXzcSkmpR1iQ8Oq-87anXUNBfBcXiN_agh7_DdGETNzL36WHXhxS4JbW5_fQXwXqi21_AvqoGNqfQhiC05OEZQnOG7cyX7ww1A8u9T7aAXAkOKxB2RN58u9OTtkKTHWrJez76Snmh6KTKNFVHueK8NlIeJjhIellbiWJL_DzwPMV5bR9XaYpQxM4v8U9I6pMjRyio5gaL0OMQ0h8VH-B7MkJ8sXfWwWuaPCJD YMrVejZaEOmVOZcfYeb_qVISxWb8Z0VxBm3kk MZa5ckYcQ9NhLEJlGGsXRWv3WGNK5Aeej37ox_ 2womk83JSo0zBrcHlJEtYWo/https%3A%2F% 2Fwww.most.gov.tw%2Fen%2Fpublic%29 and by the Doctoral Dissertation Fulbright Research grant (no. 15141395) (http://secure-web.cisco.com/1fFa Q0MG3k4jdMs0zRbxi735Qz0bAW6HjGGOyYu2HD wl0wpD-TQ01SwNav_lR71nsvTWMm-Q20I1TZve 9iSqI9GX8kMEQVQ7nOutC4uxmIAAwXKZiQEup 7ow3AfBk0ayx5FSGX55lTSaLokdyxVMGo4sS 5Xh_jK_JtPHFXo4ch6GQVVCKqjZyT2Yhohrbw 9fvZAtlWfeS9mzJmmPIuTvQMFF5mIsFQAK1gH MLK5CvsZpS7B3czIKOe9VgzhQEgYQHKiU6fTI psL07B69Jwa2F7CglFl9l5jt1c9URBzzZuAVcsSfdN sC4vW2W6kY7HN6xEJl-lQ5YLo_Bh7QDM8q TQMVL-5CSsYg6A1FpqjkJ_B8/http%3A%2F% 2Fwww.fulbright.org.tw%2FdispPageBox% 2FMainEn.aspx%3FddsPageID%3DFOSEENGHP% 26) awarded to SMW. The database used in this study was supported partially by the National Institute on Aging of the U.S. National Institutes of Health (https://secure-web.cisco.com/1tnBppNk ZREfwJibc2ZhNtYow_BhZzumawJFO4K4mT3An_ hIcMUmJiP3pOZP4A4PI1mC4LaeeJJe6jrvLuY w47ni14cJsJklNKsnjV3Iz0w31CsLnOJ-xBEOt3rG O9syl2ZYxiFyXSou5j5ESeVrVYxQ9Wyqy_4uBb4 rcolhLPZjR6gjxY-iGplJSbW8t9WKNmP2ST9m_ D66FyDtQfU6Qo5ehHYhVCnyg8NBMhNZ_ ENLR02LZz8Ivb +/- b3m1SwBEgBLDLH2IK8_ mrqbiF-yHAQpg28-Bm04-OrfNTUNiCwnl WS9sgc13FZwMb172BdMrW_8wzyYzEZMnoec Xpm9YlaB-9KlG3FTQKxfLBjw5IcJc/https%3A%2F %2Fprojectreporter.nih.gov%2Fproject_info_ description.cfm%3Faid%3D6612029%26icde% 3D39971180%26ddparam%3D%26ddvalue%3D %26ddsub%3D%26cr%3D3%26csb%3Ddefault %26cs%3DASC%26pball%3D) under Award Number R01NAG21152 to Robert Wagenaar (PI, deceased) and LTD (Co-I). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport GW, 1933, STUDIES EXPRESSIVE M; Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; Argaud S, 2018, MOVEMENT DISORD, V33, P554, DOI 10.1002/mds.27305; Assogna F, 2016, PARKINSONISM RELAT D, V28, P1, DOI 10.1016/j.parkreldis.2016.03.021; Assogna F, 2012, AM J GERIAT PSYCHIAT, V20, P133, DOI 10.1097/JGP.0b013e318209de07; Bandini A, 2017, J NEUROSCI METH, V281, P7, DOI 10.1016/j.jneumeth.2017.02.006; Bodden ME, 2010, PARKINSONISM RELAT D, V16, P466, DOI 10.1016/j.parkreldis.2010.04.014; Bologna M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00230; Brozgold A Z, 1998, Appl Neuropsychol, V5, P15, DOI 10.1207/s15324826an0501_2; Caap-Ahlgren M, 2002, J ADV NURS, V39, P87, DOI 10.1046/j.1365-2648.2002.02245.x; Coats EJ, 1996, PERS SOC PSYCHOL B, V22, P1014, DOI 10.1177/01461672962210004; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa A, 2016, NEURODEGENER DIS MAN, V6, P215, DOI 10.2217/nmt-2016-0001; DEPAULO BM, 1992, PSYCHOL BULL, V111, P203, DOI 10.1037/0033-2909.111.2.203; Dodd DK, 1999, PSYCHOL REC, V49, P543, DOI 10.1007/BF03395325; EKMAN P, 1980, J PERS SOC PSYCHOL, V39, P1125, DOI 10.1037/h0077722; EKMAN P, 1982, J NONVERBAL BEHAV, V6, P238, DOI 10.1007/BF00987191; EKMAN P, 1990, J PERS SOC PSYCHOL, V58, P342, DOI 10.1037/0022-3514.58.2.342; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frith C, 2005, CURR BIOL, V15, pR644, DOI 10.1016/j.cub.2005.08.041; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; GILES H, 1970, B BRIT PSYCHOL SOC, V23, P97; GRIFFIN WA, 1994, PSYCHIATRY, V57, P269; Gunnery SD, 2017, COGENT PSYCHOL, V4, DOI 10.1080/23311908.2017.1376425; Hall J.A., 2006, HDB NONVERBAL COMMUN, P201, DOI [10.4135/9781412976152.n11, DOI 10.4135/9781412976152.N11]; Jones JD, 2014, PARKINSONISM RELAT D, V20, P1236, DOI 10.1016/j.parkreldis.2014.09.014; Knapp ML, 2006, NONVERBAL COMMUNICAT, P295; Knapp ML, 2006, NONVERBAL COMMUNICAT, P225; Lang F, 2000, ARCH FAM MED, V9, P222, DOI 10.1001/archfami.9.3.222; Lyons KD, 2004, REHABIL PSYCHOL, V49, P328, DOI 10.1037/0090-5550.49.4.328; Lyons KD, 2004, DISABIL REHABIL, V26, P463, DOI 10.1080/09638280410001663030; Miller IN, 2010, MOVEMENT DISORD, V25, P2695, DOI 10.1002/mds.23388; Miller N, 2006, AGE AGEING, V35, P235, DOI 10.1093/ageing/afj053; Olanow CW, 2008, THERAPEUTICS PARKINS, P3; Pell MD, 2006, BRAIN LANG, V97, P123, DOI 10.1016/j.bandl.2005.08.010; Pentland B., 1987, CLIN REHABIL, V1, P307, DOI DOI 10.1177/026921558700100410; PETO V, 1995, QUAL LIFE RES, V4, P241, DOI 10.1007/BF02260863; PITCAIRN TK, 1990, BRIT J CLIN PSYCHOL, V29, P177, DOI 10.1111/j.2044-8260.1990.tb00867.x; Poletti M, 2012, NEUROSCI BIOBEHAV R, V36, P2147, DOI 10.1016/j.neubiorev.2012.07.004; Portney LG, 2009, FDN CLIN RES APPL PR, p[77, 644]; POYATOS F, 1993, SEMIOTICA, V93, P61, DOI 10.1515/semi.1993.93.1-2.61; Ricciardi A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176881; Rosenthal R, 2008, ESSENTIALS BEHAV RES, P663; Rosenthal Robert, 2005, P NEW HDB METHODS NO, P199; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; Schroder C, 2010, J NEUROL SCI, V289, P32, DOI 10.1016/j.jns.2009.08.038; Schwertman NC, 2004, COMPUT STAT DATA AN, V47, P165, DOI 10.1016/j.csda.2003.10.012; Simons G, 2004, J INT NEUROPSYCH SOC, V10, P521, DOI 10.1017/S135561770410413X; Simons G, 2003, COGNITION EMOTION, V17, P759, DOI 10.1080/02699930302280; Smith M C, 1996, J Int Neuropsychol Soc, V2, P383; Szameitat DP, 2009, EMOTION, V9, P397, DOI 10.1037/a0015692; Takahashi K, 2010, AM J OCCUP THER, V64, P484, DOI 10.5014/ajot.2010.09078; Thordardottir B, 2014, DISABIL REHABIL, V36, P2216, DOI 10.3109/09638288.2014.898807; Tickle-Degnen L, 2004, SOC SCI MED, V58, P603, DOI 10.1016/S0277-9536(03)00213-2; Tickle-Degnen L., INTERPERSONAL COMMUN; Tickle-Degnen L, 2011, SOC SCI MED, V73, P95, DOI 10.1016/j.socscimed.2011.05.008; Tickle-Degnen L, 2010, MOVEMENT DISORD, V25, P194, DOI 10.1002/mds.22940; Wallbott HG, 1998, EUR J SOC PSYCHOL, V28, P879, DOI 10.1002/(SICI)1099-0992(1998110)28:6<879::AID-EJSP901>3.0.CO;2-W; Wang SF, 2013, IEEE T AFFECT COMPUT, V4, P34, DOI 10.1109/T-AFFC.2012.32; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	62	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199896	10.1371/journal.pone.0199886	http://dx.doi.org/10.1371/journal.pone.0199886			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL5QR	29965984	Green Submitted, Green Published, gold			2022-12-26	WOS:000437224100027
J	Buontempo, F; Orsini, E; Zironi, I; Stolen, L; Cappellini, A; Rapino, S; Tartari, A; Mostacci, D; Cucchi, G; Martelli, AM; Sumini, M; Castellani, G				Buontempo, Francesca; Orsini, Ester; Zironi, Isabella; Stolen, Lorenzo; Cappellini, Alessandra; Rapino, Stefania; Tartari, Agostino; Mostacci, Domiziano; Cucchi, Giorgio; Martelli, Alberto Maria; Sumini, Marco; Castellani, Gastone			Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device	PLOS ONE			English	Article							DNA-DAMAGE; E-CADHERIN; RADIATION; RADIOTHERAPY; RESISTANCE; SENESCENCE; P53; MECHANISMS; CHECKPOINT; STRATEGIES	Radiation therapy is a useful and standard tumor treatment strategy. Despite recent advances in delivery of ionizing radiation, survival rates for some cancer patients are still low because of recurrence and radioresistance. This is why many novel approaches have been explored to improve radiotherapy outcome. Some strategies are focused on enhancement of accuracy in ionizing radiation delivery and on the generation of greater radiation beams, for example with a higher dose rate. In the present study we proposed an in vitro research of the biological effects of very high dose rate beam on SK-Me128 and A375, two radioresistant human melanoma cell lines. The beam was delivered by a pulsed plasma device, a "Mather type" Plasma Focus for medical applications. We hypothesized that this pulsed X-rays generator is significantly more effective to impair melanoma cells survival compared to conventional X-ray tube. Very high dose rate treatments were able to reduce clonogenic efficiency of SK-Me128 and A375 more than the X-ray tube and to induce a greater, less easy-to-repair DNA double-strand breaks. Very little is known about biological consequences of such dose rate. Our characterization is preliminary but is the first step toward future clinical considerations.	[Buontempo, Francesca; Orsini, Ester; Martelli, Alberto Maria] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Zironi, Isabella; Castellani, Gastone] Univ Bologna, Dept Phys & Astron, Bologna, Italy; [Zironi, Isabella; Sumini, Marco; Castellani, Gastone] Univ Bologna, Dept Chem G Ciamician, Bologna, Italy; [Zironi, Isabella; Rapino, Stefania; Castellani, Gastone] Interdept Ctr L Galvani CIG Integrated Studies Bi, Bologna, Italy; [Stolen, Lorenzo; Tartari, Agostino; Mostacci, Domiziano; Cucchi, Giorgio; Sumini, Marco] European Inst Oncol, Milan, Italy; [Stolen, Lorenzo; Tartari, Agostino; Mostacci, Domiziano; Cucchi, Giorgio; Sumini, Marco] Monzino Cardiac Ctr Fdn IEO CCM, Milan, Italy; [Stolen, Lorenzo] Univ Bologna, Dept Ind Engn, Bologna, Italy; [Cappellini, Alessandra] Univ Cassino & Southern Lazio, Dept Human Social & Hlth Sci, Cassino, Italy; [Rapino, Stefania] Natl Inst Nucl Phys INFN, Bologna, Italy	University of Bologna; University of Bologna; University of Bologna; IRCCS European Institute of Oncology (IEO); University of Bologna; University of Cassino; Gran Sasso Science Institute (GSSI); Istituto Nazionale di Fisica Nucleare (INFN)	Buontempo, F (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.	francesca.buontempo3@unibo.it	isolan, lorenzo/S-5285-2018; Zironi, Isabella/AAA-7451-2020	isolan, lorenzo/0000-0003-2320-5925; Zironi, Isabella/0000-0001-7870-0267	MIUR FIRB [RBAP11ZJFA_001]; COMECER S.p.A. (Alberazzo-Canalvecchio, RA, Italy); Alma Mater Foundation (FAM) of the University of Bologna	MIUR FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); COMECER S.p.A. (Alberazzo-Canalvecchio, RA, Italy); Alma Mater Foundation (FAM) of the University of Bologna	This work was supported by MIUR FIRB 2011 (RBAP11ZJFA_001) to Alberto Maria Martelli. INFN ETHICS 2015 (Pre-clinical experimental and theoretical studies to improve treatment and protection by charged particles) to Dr. Giorgio Cucchi.; The authors wish to thank Mr. S. Zanella, for his kind collaboration in the X-rays experiments carried out in COMECER S.p.A. (Alberazzo-Canalvecchio, RA, Italy), the Alma Mater Foundation (FAM) of the University of Bologna, for the support given to the setting up of the Plasma Focus Laboratory of the Industrial Engineering Department. We also thank Professor R. Orecchia, Dr. Marta Cremonesi, Dr. Cristina Garibaldi and Prof. Ugo Cavallaro from IEO (European Institute for Oncology) for the A375 cell line.	Abend M, 2003, INT J RADIAT BIOL, V79, P927, DOI 10.1080/09553000310001632958; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Auer S, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-139; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Baumann M, 2016, NAT REV CANCER, V16, P234, DOI 10.1038/nrc.2016.18; BEDFORD JS, 1973, RADIAT RES, V54, P316, DOI 10.2307/3573709; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Bentzen SM, 2005, RADIOTHER ONCOL, V76, P1, DOI 10.1016/j.radonc.2005.06.009; Bhide SA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-25; Borgmann K, 2004, INT J RADIAT ONCOL, V58, P445, DOI 10.1016/j.ijrobp.2003.09.036; Bravata V, 2015, ANTICANCER RES, V35, P2577; BRENNER DJ, 1991, INT J RADIAT ONCOL, V20, P181, DOI 10.1016/0360-3016(91)90158-Z; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Ceccolini E, 2012, J APPL PHYS, V112, DOI 10.1063/1.4748179; Ceccolini E, 2011, AIP CONF PROC, V1412, DOI 10.1063/1.3665299; Ceccolini E, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3622523; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Delaney G, 2005, CANCER-AM CANCER SOC, V104, P1129, DOI 10.1002/cncr.21324; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; EPP ER, 1968, RADIAT RES, V34, P320, DOI 10.2307/3572557; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Favaudon V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008973; FitzGerald TJ, 2008, EXPERT REV ANTICANC, V8, P967, DOI 10.1586/14737140.8.6.967; Gregoire V, 2015, J CLIN ONCOL, V33, P3277, DOI 10.1200/JCO.2015.61.2994; Grimaldi C, 2012, LEUKEMIA, V26, P91, DOI 10.1038/leu.2011.269; HALL EJ, 1972, BRIT J RADIOL, V45, P81, DOI 10.1259/0007-1285-45-530-81; HALL EJ, 1991, INT J RADIAT ONCOL, V21, P1403, DOI 10.1016/0360-3016(91)90314-T; Holler M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154745; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; Kim BM, 2015, INT J MOL SCI, V16, P26880, DOI 10.3390/ijms161125991; Klein LE, 2005, CELL CYCLE, V4, P501, DOI 10.4161/cc.4.3.1550; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Ling CC, 2010, RADIOTHER ONCOL, V95, P261, DOI 10.1016/j.radonc.2010.03.014; Lonetti A, 2015, ONCOTARGET, V6, P10399, DOI 10.18632/oncotarget.3295; Luo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079940; Maier P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010102; MITCHELL JB, 1979, RADIAT RES, V79, P552, DOI 10.2307/3575180; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Nunez MI, 1996, RADIOTHER ONCOL, V39, P155, DOI 10.1016/0167-8140(96)01732-X; Qureshi HS, 2006, AM J CLIN PATHOL, V125, P377, DOI 10.1309/WMX7DRWTFVQP2LOT; Rao SS, 2014, RADIOTHER ONCOL, V111, P88, DOI 10.1016/j.radonc.2014.02.010; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; RICE GC, 1986, CANCER RES, V46, P6105; Rodriguez Luis G., 2004, V294, P23; Sambade MJ, 2011, RADIOTHER ONCOL, V98, P394, DOI 10.1016/j.radonc.2010.12.017; Schick U, 2015, RADIOTHER ONCOL, V117, P364, DOI 10.1016/j.radonc.2015.06.026; Selzer E, 2013, EXPERT REV CLIN PHAR, V6, P663, DOI 10.1586/17512433.2013.841540; Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63; Sobol WT, 2002, MED PHYS, V29, P132, DOI 10.1118/1.1445415; Sorensen BS, 2011, RADIOTHER ONCOL, V101, P223, DOI 10.1016/j.radonc.2011.06.018; STEIN GH, 1995, BIOESSAYS, V17, P537, DOI 10.1002/bies.950170610; Sumini M, 2017, RADIAT PHYS CHEM, V140, P452, DOI 10.1016/j.radphyschem.2017.03.022; Sumini M, 2015, X-RAY SPECTROM, V44, P289, DOI 10.1002/xrs.2621; Tian X, 2015, NANOSCALE, V7, P20211, DOI 10.1039/c5nr05869d; Virelli A, 2015, RADIAT PROT DOSIM, V166, P383, DOI 10.1093/rpd/ncv163; Wambersie A, 1996, CERN REPORT, V96, P610; Wang T, 2011, FRONT ONCOL, V1, DOI 10.3389/fonc.2011.00017; Wilson P, 2012, BRIT J RADIOL, V85, pE933, DOI 10.1259/bjr/17827549; Yue GZ, 2002, APPL PHYS LETT, V81, P355, DOI 10.1063/1.1492305; Zahnreich S, 2010, MUTAT RES-GEN TOX EN, V701, P60, DOI 10.1016/j.mrgentox.2010.03.010	61	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0199312	10.1371/journal.pone.0199312	http://dx.doi.org/10.1371/journal.pone.0199312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0PZ	29958291	Green Submitted, Green Published, gold			2022-12-26	WOS:000436793500008
J	Skagenholt, M; Traff, U; Vastfjall, D; Skagerlund, K				Skagenholt, Mikael; Traff, Ulf; Vastfjall, Daniel; Skagerlund, Kenny			Examining the Triple Code Model in numerical cognition: An fMRI study	PLOS ONE			English	Article							FUNCTIONAL NEUROIMAGING METAANALYSIS; NUMBER FORM AREA; PARIETAL CORTEX; INTRAPARIETAL SULCUS; NONSYMBOLIC NUMBER; ANGULAR GYRUS; FRONTOPARIETAL NETWORK; HYPER-CONNECTIVITY; LETTER RECOGNITION; BRAIN ACTIVITY	The Triple Code Model (TCM) of numerical cognition argues for the existence of three representational codes for number: Arabic digits, verbal number words, and analog nonsymbolic magnitude representations, each subserved by functionally dissociated neural substrates. Despite the popularity of the TCM, no study to date has explored all three numerical codes within one fMRI paradigm. We administered three tasks, associated with each of the aforementioned numerical codes, in order to explore the neural correlates of numerosity processing in a sample of adults (N=46). Independent task-control contrast analyses revealed task-dependent activity in partial support of the model, but also highlight the inherent complexity of a distributed and overlapping fronto-parietal network involved in all numerical codes. The results indicate that the TCM correctly predicts the existence of some functionally dissociated neural substrates, but requires an update that accounts for interactions with attentional processes. Parametric contrasts corresponding to differences in task difficulty revealed specific neural correlates of the distance effect, where closely spaced numbers become more difficult to discriminate than numbers spaced further apart. A conjunction analysis illustrated overlapping neural correlates across all tasks, in line with recent proposals for a fronto-parietal network of number processing. We additionally provide tentative results suggesting the involvement of format-independent numerosity-sensitive retinotopic maps in the early visual stream, extending previous findings of nonsymbolic stimulus selectivity. We discuss the functional roles of the components associated with the model, as well as the purported fronto-parietal network, and offer arguments in favor of revising the TCM.	[Skagenholt, Mikael; Traff, Ulf; Vastfjall, Daniel; Skagerlund, Kenny] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Skagenholt, Mikael; Vastfjall, Daniel; Skagerlund, Kenny] Linkoping Univ, JEDI Lab, Div Econ, Dept Management & Engn, Linkoping, Sweden; [Vastfjall, Daniel] Decis Res, Eugene, OR USA; [Vastfjall, Daniel] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Vastfjall, Daniel; Skagerlund, Kenny] Linkoping Univ, CSAN, Linkoping, Sweden	Linkoping University; Linkoping University; University of Oregon; Linkoping University	Skagenholt, M (corresponding author), Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden.; Skagenholt, M (corresponding author), Linkoping Univ, JEDI Lab, Div Econ, Dept Management & Engn, Linkoping, Sweden.	mikael.skagenholt@liu.se	Västfjäll, Daniel/F-9629-2014; Skagenholt, Mikael/K-3971-2019	Skagenholt, Mikael/0000-0001-8554-1858; Vastfjall, Daniel/0000-0003-2873-4500	Linkoping University [LiU-2009-01356]; Marianne and Marcus Wallenberg Foundation [2014-0173]	Linkoping University; Marianne and Marcus Wallenberg Foundation	This research was partially supported by a grant from Linkoping University (Dnr: LiU-2009-01356; http://liu.se/en) awarded to U. T. and partially supported by a grant from the Marianne and Marcus Wallenberg Foundation (Dnr: 2014-0173; https://www.wallenberg.com/mmw/en) awarded to D. V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7026; Amalric M, 2016, P NATL ACAD SCI USA, V113, P4909, DOI 10.1073/pnas.1603205113; Ansari D, 2006, BRAIN RES, V1067, P181, DOI 10.1016/j.brainres.2005.10.083; Ansari D, 2005, NEUROREPORT, V16, P1769, DOI 10.1097/01.wnr.0000183905.23396.f1; Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Ansari D, 2006, J COGNITIVE NEUROSCI, V18, P1820, DOI 10.1162/jocn.2006.18.11.1820; Arsalidou M, 2018, DEV COGN NEUROS-NETH, V30, P239, DOI 10.1016/j.dcn.2017.08.002; Arsalidou M, 2011, NEUROIMAGE, V54, P2382, DOI 10.1016/j.neuroimage.2010.10.009; Ashby F Gregory, 2004, Behav Cogn Neurosci Rev, V3, P101, DOI 10.1177/1534582304270782; Bloechle J, 2016, HUM BRAIN MAPP, V37, P3061, DOI 10.1002/hbm.23226; Brannon Elizabeth M., 2010, P144; Bulthe J, 2014, NEUROIMAGE, V87, P311, DOI 10.1016/j.neuroimage.2013.10.049; Bulthe J, 2015, J COGNITIVE NEUROSCI, V27, P1376, DOI 10.1162/jocn_a_00787; Butterworth B, 2011, SCIENCE, V332, P1049, DOI 10.1126/science.1201536; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2012, TRENDS COGN SCI, V16, P338, DOI 10.1016/j.tics.2012.04.008; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Cavdaroglu S, 2015, NEUROIMAGE, V116, P135, DOI 10.1016/j.neuroimage.2015.04.019; Chang TT, 2016, NEUROIMAGE, V126, P184, DOI 10.1016/j.neuroimage.2015.11.053; CIPOLOTTI L, 1995, CORTEX, V31, P73, DOI 10.1016/S0010-9452(13)80106-2; Cloutman LL, 2013, BRAIN LANG, V127, P251, DOI 10.1016/j.bandl.2012.08.003; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Collins E, 2017, P NATL ACAD SCI USA, V114, pE2806, DOI 10.1073/pnas.1613982114; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dehaene S, 1996, NEUROPSYCHOLOGIA, V34, P1097, DOI 10.1016/0028-3932(96)00027-9; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 2003, TRENDS COGN SCI, V7, P145, DOI 10.1016/S1364-6613(03)00055-X; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Dehaene Stanislas, 2011, NUMBER SENSE MIND CR, DOI 10.1016/C2010-0-66570-9; DeWind NK, 2015, COGNITION, V142, P247, DOI 10.1016/j.cognition.2015.05.016; Douw L, 2016, NEUROSCIENCE, V339, P12, DOI 10.1016/j.neuroscience.2016.09.034; Dowker A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00508; Dufor O, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00781; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Emerson RW, 2012, DEV COGN NEUROS-NETH, V2, pS139, DOI 10.1016/j.dcn.2011.11.003; Fayol M, 2005, NUMERICAL REPRESENTA, P3; Fornaciai M, 2017, NEUROIMAGE, V157, P429, DOI 10.1016/j.neuroimage.2017.05.069; Fornaciai M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00021; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Gevers W, 2006, ACTA PSYCHOL, V122, P221, DOI 10.1016/j.actpsy.2005.11.004; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Grabner RH, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00130; Gross J., 2009, LONG TERM COSTS NUME; Grotheer M, 2016, NEUROIMAGE, V132, P314, DOI 10.1016/j.neuroimage.2016.02.069; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Hannagan T, 2015, TRENDS COGN SCI, V19, P374, DOI 10.1016/j.tics.2015.05.006; Harvey BM, 2017, NATURE HUMAN BEHAV, V4, P1; He LX, 2014, CEREB CORTEX, V24, P2199, DOI 10.1093/cercor/bht074; Henson R, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P193, DOI 10.1016/B978-012372560-8/50015-2; Hermes D, 2015, CEREB CORTEX, V27, P567; Hyde DC, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00150; James KH, 2005, COGN AFFECT BEHAV NE, V5, P452, DOI 10.3758/CABN.5.4.452; Jefferies E, 2005, NEUROPSYCHOLOGIA, V43, P887, DOI 10.1016/j.neuropsychologia.2004.09.009; Jolles D, 2016, DEVELOPMENTAL SCI, V19, P613, DOI 10.1111/desc.12399; Kadosh RC, 2005, NEUROPSYCHOLOGIA, V43, P1238, DOI 10.1016/j.neuropsychologia.2004.12.017; Kadosh RC, 2009, BEHAV BRAIN SCI, V32, P313, DOI 10.1017/S0140525X09990938; Kaufmann L, 2005, NEUROIMAGE, V25, P888, DOI 10.1016/j.neuroimage.2004.12.041; Kaufmann L, 2008, CORTEX, V44, P376, DOI 10.1016/j.cortex.2007.08.003; Kaufmann L, 2011, DEV NEUROPSYCHOL, V36, P763, DOI 10.1080/87565641.2010.549884; Klein E, 2016, BRAIN STRUCT FUNCT, V221, P979, DOI 10.1007/s00429-014-0951-1; Krinzinger H, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00373; Leibovich T, 2017, BEHAV BRAIN SCI, V40, P1, DOI 10.1017/S0140525X16000960; Leibovich T, 2016, CAN J EXP PSYCHOL, V70, P12, DOI 10.1037/cep0000070; Libertus ME, 2014, DEV PSYCHOL, V50, P108, DOI 10.1037/a0032986; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lyons IM, 2015, HUM BRAIN MAPP, V36, P475, DOI 10.1002/hbm.22641; McCaskey U, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00102; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mix KS, 2002, PSYCHOL BULL, V128, P278, DOI 10.1037//0033-2909.128.2.278; Moeller K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00227; Morosan P, 2005, ANAT EMBRYOL, V210, P401, DOI 10.1007/s00429-005-0029-1; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Mussolin C, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00663, 10.3389/fpsyt.2013.00179]; Mussolin C, 2011, ACTA PSYCHOL, V138, P193, DOI 10.1016/j.actpsy.2011.06.004; Nieder A, 2016, NAT REV NEUROSCI, V17, P366, DOI 10.1038/nrn.2016.40; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Park J, 2016, CEREB CORTEX, V26, P748, DOI 10.1093/cercor/bhv017; Park J, 2013, CEREB CORTEX, V23, P2127, DOI 10.1093/cercor/bhs193; Park J, 2012, J COGNITIVE NEUROSCI, V24, P39, DOI 10.1162/jocn_a_00085; Parsons S., 2005, DOES NUMERACY MATTER; Peters L, 2016, NEUROPSYCHOLOGIA, V86, P19, DOI 10.1016/j.neuropsychologia.2016.04.001; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Piazza M, 2010, TRENDS COGN SCI, V14, P542, DOI 10.1016/j.tics.2010.09.008; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Polk TA, 2002, J COGNITIVE NEUROSCI, V14, P145, DOI 10.1162/089892902317236803; PRICE CJ, 1994, BRAIN, V117, P1255, DOI 10.1093/brain/117.6.1255; Price GR, 2018, DEV COGN NEUROS-NETH, V30, P280, DOI 10.1016/j.dcn.2017.02.006; Price GR, 2011, NEUROIMAGE, V57, P1205, DOI 10.1016/j.neuroimage.2011.05.035; Ptak R, 2017, TRENDS COGN SCI, V21, P589, DOI 10.1016/j.tics.2017.05.002; Roggeman C, 2011, J NEUROSCI, V31, P7168, DOI 10.1523/JNEUROSCI.4503-10.2011; Rosenberg-Lee M, 2015, DEVELOPMENTAL SCI, V18, P351, DOI 10.1111/desc.12216; Rouder JN, 2014, DEVELOPMENTAL SCI, V17, P525, DOI 10.1111/desc.12166; Roux FE, 2008, NEUROLOGY, V70, P210, DOI 10.1212/01.wnl.0000297194.14452.a0; Sato M, 2007, J COGNITIVE NEUROSCI, V19, P684, DOI 10.1162/jocn.2007.19.4.684; Scheperjans F, 2008, CEREB CORTEX, V18, P2141, DOI 10.1093/cercor/bhm241; Schmithorst VJ, 2004, NEUROIMAGE, V22, P1414, DOI 10.1016/j.neuroimage.2004.03.021; Schweizer R, 2008, NEUROIMAGE, V42, P28, DOI 10.1016/j.neuroimage.2008.04.184; Shum J, 2013, J NEUROSCI, V33, P6709, DOI 10.1523/JNEUROSCI.4558-12.2013; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Skagerlund K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00500; Sokolowski HM, 2017, NEUROIMAGE, V146, P376, DOI 10.1016/j.neuroimage.2016.10.028; Sokolowski HM, 2016, SYMBOLIC NONSYMBOLIC, P327; STARKEY P, 1980, SCIENCE, V210, P1033, DOI 10.1126/science.7434014; Szucs D, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-35; Uddin LQ, 2010, CEREB CORTEX, V20, P2636, DOI 10.1093/cercor/bhq011; Van Opstal F, 2008, PSYCHON B REV, V15, P419, DOI 10.3758/PBR.15.2.419; Venkatraman V, 2005, NEUROPSYCHOLOGIA, V43, P744, DOI 10.1016/j.neuropsychologia.2004.08.005; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wimmer H, 2016, PSYCHOL SCI, V27, P1240, DOI 10.1177/0956797616657319; Xu F, 2003, COGNITION, V89, pB15, DOI 10.1016/S0010-0277(03)00050-7; Yeo DJ, 2017, NEUROSCI BIOBEHAV R, V78, P145, DOI 10.1016/j.neubiorev.2017.04.027; Zhao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049565	119	14	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199247	10.1371/journal.pone.0199247	http://dx.doi.org/10.1371/journal.pone.0199247			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953456	Green Published, Green Submitted, gold			2022-12-26	WOS:000436645400019
J	Wu, CH; Yang, YH; Chen, MR; Tsai, CH; Cheng, AL; Doong, SL				Wu, Chun-Hsien; Yang, Yu-Hsuan; Chen, Mei-Ru; Tsai, Ching-Hwa; Cheng, Ann-Lii; Doong, Shin-Lian			Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-kappa B signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells	PLOS ONE			English	Article							T-CELLS; PROTEOLYTIC ACTIVITY; PROTEASE ACTIVITY; UBIQUITIN LIGASE; ABC-DLBCL; CLEAVAGE; INFLAMMATION; TARGETS; BCL10; DETERMINANTS	MALT1 controls several receptors-mediated signaling to nuclear factor KB (NF-kappa B) through both its scaffold and protease function. MALT1 protease activity is shown to inactivate several negative regulators of NF-kappa B signaling and augment NF-kappa B activation ability. In this study, MALT1 was demonstrated to autoprocess itself in the presence of oligomerizationcompetent BCL10. Cleavage occurred after Arginine 781 located in the C-terminus of MALT1. Shortened MALT1 cleavage products showed attenuated binding ability with TRAF6. Its NF-kappa B activation ability was also weakened. Various MALT1 constructs including wild type, catalytically-inactive (MALT1_C464A), cleavage-defective (MALT1_R781L), or truncated (MALT1_1-781) form of MALT1 was introduced into MALT1-knocked-down-Jurkat T cells. Cleavage-defective MALT1_R781L retained its proteolytic and initial IKBa phosphorylation activity as MALT1. Truncated MALT1_1-781 mutant showed weakness in IKBa phosphorylation and the expression of NF-kappa B targets IL-2 and IFN-gamma. Cleavage at R781 was detectable but marginal after activation with TPA/ionomycin or anti-CD3 antibody in lymphocytes. However, cleavage at R781 was evident in ABC-DLBCL cells such as OCI-Ly3, HBL1. HBL-1 cells with induced expression of catalytically-inactive MALT1_C464A or cleavage defective MALT1_R781 L exhibited characteristic of retarded-growth. These findings suggested that cleavage at R781 of MALT1 played a role in the survival of ABC-DLBCL cells.	[Wu, Chun-Hsien; Yang, Yu-Hsuan; Chen, Mei-Ru; Tsai, Ching-Hwa; Doong, Shin-Lian] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei, Taiwan; [Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol & Internal Med, Taipei, Taiwan; [Cheng, Ann-Lii] Natl Taiwan Univ, Coll Med, Canc Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Doong, SL (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei, Taiwan.	sldoong@ntu.edu.tw		DOONG, SHIN-LIAN/0000-0002-0936-3858	Ministry of Science and Technology, Taiwan [NSC-102-2320-6-002-024]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The work was supported by grant NSC-102-2320-6-002-024 from Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/) to SLD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baens M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103774; Bornancin F, 2015, J IMMUNOL, V194, P3723, DOI 10.4049/jimmunol.1402254; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Demeyer A, 2016, TRENDS MOL MED, V22, P135, DOI 10.1016/j.molmed.2015.12.004; Douanne T, 2016, J CELL SCI, V129, P1775, DOI 10.1242/jcs.185025; Elton L, 2016, FEBS J, V283, P403, DOI 10.1111/febs.13597; Ferch U, 2009, J EXP MED, V206, P2313, DOI 10.1084/jem.20091167; Fontan L, 2012, CANCER CELL, V22, P812, DOI 10.1016/j.ccr.2012.11.003; Gewies A, 2014, CELL REP, V9, P1292, DOI 10.1016/j.celrep.2014.10.044; Ginster S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169026; Guiet C, 2000, J CELL BIOL, V148, P1131, DOI 10.1083/jcb.148.6.1131; Hachmann J, 2012, BIOCHEM J, V443, P287, DOI 10.1042/BJ20120035; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; Jaworski M, 2016, CELL MOL LIFE SCI, V73, P459, DOI 10.1007/s00018-015-2059-z; Jaworski M, 2014, EMBO J, V33, P2765, DOI 10.15252/embj.201488987; Jeltsch KM, 2014, NAT IMMUNOL, V15, P1079, DOI 10.1038/ni.3008; Jou SY, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-85; Klein T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9777; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Meininger I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11292; Nagel D, 2012, CANCER CELL, V22, P825, DOI 10.1016/j.ccr.2012.11.002; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Nie ZL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6908; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Wegener Elmar, 2007, Sci STKE, V2007, ppe21, DOI 10.1126/stke.3842007pe21; Wiesmann C, 2012, J MOL BIOL, V419, P4, DOI 10.1016/j.jmb.2012.02.018; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Yu JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127083	36	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199779	10.1371/journal.pone.0199779	http://dx.doi.org/10.1371/journal.pone.0199779			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953499	Green Submitted, Green Published, gold			2022-12-26	WOS:000436645400065
J	Yen, YH; Kuo, FY; Kee, KM; Chang, KC; Tsai, MC; Hu, TH; Lu, SN; Wang, JH; Hung, CH; Chen, CH				Yen, Yi-Hao; Kuo, Fang-Ying; Kee, Kwong-Ming; Chang, Kuo-Chin; Tsai, Ming-Chao; Hu, Tsung-Hui; Lu, Sheng-Nan; Wang, Jing-Houng; Hung, Chao-Hung; Chen, Chien-Hung			APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level	PLOS ONE			English	Article							SIMPLE NONINVASIVE INDEX; TRANSIENT ELASTOGRAPHY; VIRUS-INFECTION; CIRRHOSIS; MANAGEMENT; CARCINOMA; DIAGNOSIS; PREDICT; BIOPSY; PLOTS	Background and aim The aspartate aminotransferase (AST)-to-platelet ratio index (APRI) and fibrosis-4 index (FIB-4) are commonly used compound surrogates for advanced fibrosis in chronic hepatitis C (CHC) patients. However, the use of APRI and FIB-4 entails a risk of overestimating the fibrosis stage due to the impact of necroinflammatory activity on transaminases. We sought to investigate the optimal cutoff values of the two compound surrogates for predicting cirrhosis stratified by AST level. Methods This retrospective study enrolled 1716 treatment-naive CHC patients who underwent liver biopsy prior to interferon therapy from 1997-2010. Fibrosis was scored according to the modified Knodell classification. The upper limit for normal AST in our hospital is 37 IU/L. We stratified the enrolled patients into the categories of AST <= 37 IU/L (N = 132), 37<AST <= 74, (N = 501), 74<AST <= 148 IU/L (N = 737), and AST>148 IU/L (N = 346). Results 436 patients had cirrhosis (F4). The area under receiver operating characteristic (AUROC) analysis results distinguishing cirrhosis (F4) from non-cirrhosis (F0-F3) were 0.81 for APRI and 0.85 for FIB-4 in patients with AST-37 IU/L; 0.71 for APRI and 0.72 for FIB-4 in patients with 37< AST <= 74IU/L; 0.72 for APRI and 0.73 for FIB-4 in patients with 74<AST <= 148 IU/L; and 0.68 for APRI and 0.70 for FIB-4 in patients with AST>148 IU/L. The optimal cutoff values of APRI and FIB-4 for the diagnosis of cirrhosis were 0.6 and 1.4, respectively, in patients with AST <= 37 IU/L; 1.1 and 2.2, respectively, in patients with 37< AST-74 IU/L; 2.2 and 3.4, respectively, in patients with 74<AST <= 148 IU/L; and 3.4 and 5.5, respectively, in patients with AST>148 IU/L. Conclusions We provide optimal cutoff values of both APRI and FIB-4 to predict cirrhosis stratified by AST levels, which should be more feasible compared with the single cutoff values proposed in previous studies.	[Yen, Yi-Hao; Kee, Kwong-Ming; Chang, Kuo-Chin; Tsai, Ming-Chao; Hu, Tsung-Hui; Lu, Sheng-Nan; Wang, Jing-Houng; Hung, Chao-Hung; Chen, Chien-Hung] Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Yen, Yi-Hao; Kuo, Fang-Ying; Kee, Kwong-Ming; Chang, Kuo-Chin; Tsai, Ming-Chao; Hu, Tsung-Hui; Lu, Sheng-Nan; Wang, Jing-Houng; Hung, Chao-Hung; Chen, Chien-Hung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Kuo, Fang-Ying] Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Hu, TH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Kaohsiung, Taiwan.; Hu, TH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	dr.hu@msa.hinet.net	Tsai, Ming Chao/ABA-9806-2020	, Ming-Chao/0000-0002-3613-2051	Chang Gung Memorial Hospital-Kaohsiung Medical Center, Taiwan [CMRPG8E1301]	Chang Gung Memorial Hospital-Kaohsiung Medical Center, Taiwan	This study was supported by Grant CMRPG8E1301 from the Chang Gung Memorial Hospital-Kaohsiung Medical Center, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Dienstag JL, 2011, HEPATOLOGY, V54, P396, DOI 10.1002/hep.24370; EASL recommendations on treatment of hepatitis C, 2018, J HEPATOL; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; European Association for Study of Liver, 2015, J HEPATOL, V63; Everhart JE, 2010, HEPATOLOGY, V51, P585, DOI 10.1002/hep.23315; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Houot M, 2016, ALIMENT PHARM THER, V43, P16, DOI 10.1111/apt.13446; KAMIMOTO Y, 1985, HEPATOLOGY, V5, P367, DOI 10.1002/hep.1840050305; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x; Shiha G, 2017, HEPATOL INT, V11, P1, DOI 10.1007/s12072-016-9760-3; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Tapper EB, 2012, CLIN GASTROENTEROL H, V10, P932, DOI 10.1016/j.cgh.2012.01.015; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; ZWEIG MH, 1993, CLIN CHEM, V39, P561	29	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199760	10.1371/journal.pone.0199760	http://dx.doi.org/10.1371/journal.pone.0199760			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953518	gold, Green Published, Green Submitted			2022-12-26	WOS:000436645400061
J	Lobba, ARM; Carreira, ACO; Cerqueira, OLD; Fujita, A; DeOcesano-Pereira, C; Osorio, CAB; Soares, FA; Rameshwar, P; Sogayar, MC				Maia Lobba, Aline Ramos; Oliveira Carreira, Ana Claudia; Dutra Cerqueira, Otto Luiz; Fujita, Andre; DeOcesano-Pereira, Carlos; Bueno Osorio, Cynthia Aparecida; Soares, Fernando Augusto; Rameshwar, Pranela; Sogayar, Mari Cleide			High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; N-CADHERIN; STEM-CELLS; CARCINOMA; PANCREAS; LOCALIZATION; RECEPTOR; BIOLOGY; MARKERS	Breast cancer is the most prevalent cancer among women, with the basal-like triple negative (TNBC) being the most agressive one, displaying the poorest prognosis within the ductal carcinoma subtype. Due to the lack of adequate molecular targets, the diagnosis and treatment of patients with the TNBC phenotype has been a great challenge. In a previous work, we identified CD90/Thy-1 as being highly expressed in the aggressive high malignancy grade Hs578T basal-like breast tumor cell line, pointing to this molecule as a promising breast tumor marker, which should be further investigated. Here, CD90 expression was analyzed in human breast cancer samples and its functional role was investigated to better assess the oncogenic nature of CD90 in mammary cells. Quantification of CD90 expression in human breast cancer samples, by tissue microarray, showed that high CD90 positivity correlates with metastasis and poor patient survival in the basal-like subtype. The functional genetic approach, by overexpression in the CD90 cDNA in a basal-like normal mammary cell line (MCF10A) and knockdown in a highly malignant cell line (Hs578T), allowed us to demonstrate that CD90 is involved with several cellular processes that lead to malignant transformation, such as: morphological change, increased cell proliferation, invasiveness, metastasis and activation of the EGFR pathway. Therefore, our results reveal that CD90 is involved with malignant transformation in breast cancer cell lines and is correlated with metastasis and poor patient survival in the basal-like subtype, being considered as a promising new breast cancer target.	[Maia Lobba, Aline Ramos; Oliveira Carreira, Ana Claudia; Dutra Cerqueira, Otto Luiz; DeOcesano-Pereira, Carlos; Sogayar, Mari Cleide] Univ Sao Paulo, Internal Med Dept, Sch Med, NUCEL Cell & Mol Therapy Ctr, Sao Paulo, Brazil; [Maia Lobba, Aline Ramos; Oliveira Carreira, Ana Claudia; Sogayar, Mari Cleide] Univ Sao Paulo, Chem Inst, Biochem Dept, Sao Paulo, Brazil; [Fujita, Andre] Univ Sao Paulo, Inst Math & Stat, Dept Comp Sci, Sao Paulo, Brazil; [Bueno Osorio, Cynthia Aparecida; Soares, Fernando Augusto] AC Camargo Hosp, Dept Anat Pathol, Sao Paulo, Brazil; [Rameshwar, Pranela] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; A.C.Camargo Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Sogayar, MC (corresponding author), Univ Sao Paulo, Internal Med Dept, Sch Med, NUCEL Cell & Mol Therapy Ctr, Sao Paulo, Brazil.; Sogayar, MC (corresponding author), Univ Sao Paulo, Chem Inst, Biochem Dept, Sao Paulo, Brazil.	mcsoga@iq.usp.br	Fujita, Andre/Q-1271-2019; Carreira, Ana Claudia Oliveira/B-7655-2012; de Toledo Osório, Cynthia Bueno/J-9282-2015; Osório, Cynthia/AAI-7427-2020; Carreira, Ana Claudia Oliveira/AAR-4474-2021; Sogayar, Mari C/B-3980-2017; DeOcesano-Pereira, Carlos/O-2022-2015	Fujita, Andre/0000-0002-7756-7051; Carreira, Ana Claudia Oliveira/0000-0002-9142-1155; de Toledo Osório, Cynthia Bueno/0000-0002-7675-9780; Carreira, Ana Claudia Oliveira/0000-0002-9142-1155; Sogayar, Mari C/0000-0003-4805-4609; Soares, Fernando/0000-0002-1212-9093; DeOcesano-Pereira, Carlos/0000-0002-8933-4474	FAPESP (Fundacao de Apoio a Pesquisa do Estado de Sao Paulo) [2008/53972-1]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FINEP (Financiadora de Estudo e Projetos); BNDES (Banco Nacional de Desenvolvimento Economico e Social); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); Ministerio da Saude/Departamento de Ciencia e Tecnologia (MS-DECIT)	FAPESP (Fundacao de Apoio a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FINEP (Financiadora de Estudo e Projetos); BNDES (Banco Nacional de Desenvolvimento Economico e Social); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); Ministerio da Saude/Departamento de Ciencia e Tecnologia (MS-DECIT)	This work was supported by FAPESP (Fundacao de Apoio a Pesquisa do Estado de Sao Paulo) [grant number 2008/53972-1] http://fapesp.br/; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) http://www.cnpq.br/; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) http://www.capes.gov.br/; FINEP (Financiadora de Estudo e Projetos) http://www.finep.gov.br/; BNDES (Banco Nacional de Desenvolvimento Economico e Social) https://www.bndes.gov.br/; Ministerio da Ciencia, Tecnologia e Inovacao (MCTI) http://www.mctic.gov.br/; Ministerio da Saude/Departamento de Ciencia e Tecnologia (MS-DECIT) http://www.ms.gov.br/.	Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Audard V, 2008, PANCREAS, V36, P80, DOI 10.1097/mpa.0b013e318137a9da; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Cerqueira OLD, 2015, ONCOTARGET, V6, P9397, DOI 10.18632/oncotarget.3351; Changavi Arathi A, 2015, J Lab Physicians, V7, P79, DOI 10.4103/0974-2727.163129; Chetty R, 2008, HISTOPATHOLOGY, V52, P325, DOI 10.1111/j.1365-2559.2007.02949.x; Chetty R, 2008, ADV ANAT PATHOL, V15, P234, DOI 10.1097/PAP.0b013e31817bf566; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Donnenberg VS, 2010, CYTOM PART B-CLIN CY, V78B, P287, DOI 10.1002/cyto.b.20530; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Figueira RCS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-20; Gomes LR, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1666-2; Hazan RB, CELL ADHESION COMMUN, V4, P399; He JT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010744; Jiang J, 2012, ONCOGENE, V31, P671, DOI 10.1038/onc.2011.282; Kumar A, 2016, TUMOR BIOL, V37, P11611, DOI 10.1007/s13277-016-5112-0; Lobba ARM, 2012, CYTOM PART A, V81A, P1084, DOI 10.1002/cyto.a.22220; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Maria-Engler SS, 2004, J ENDOCRINOL, V183, P455, DOI 10.1677/joe.1.05703; Martinazzi M., 1993, Pathologica (Genoa), V85, P637; Nakai K, 2016, AM J CANCER RES, V6, P1609; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petersen OW, 2001, BREAST CANCER RES, V3, P213; Podo F, 2010, MOL ONCOL, V4, P209, DOI 10.1016/j.molonc.2010.04.006; SAINSBURY JRC, 1987, LANCET, V1, P1398; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Serra S, 2007, J PANCREAS, V8, P296; Sharp JA, 1999, LAB INVEST, V79, P869; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Tang KH, 2013, CANCER RES, V73, P2322, DOI 10.1158/0008-5472.CAN-12-2991; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Trombetta-Lima M, 2015, ONCOTARGET, V6, P33120, DOI 10.18632/oncotarget.5305; Vincent-Salomon A, 2003, BREAST CANCER RES, V5, P101, DOI 10.1186/bcr578; Wang XL, 2015, INT J CLIN EXP PATHO, V8, P5105; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zarrella ER, 2016, LAB INVEST, V96, P1016, DOI 10.1038/labinvest.2016.73; Zeichner SB, 2016, BREAST CANCER-BASIC, V10, DOI 10.4137/BCBCR.S32783	44	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199254	10.1371/journal.pone.0199254	http://dx.doi.org/10.1371/journal.pone.0199254			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949609	Green Submitted, Green Published, gold			2022-12-26	WOS:000436549200040
J	Le Bourgot, C; Ferret-Bernard, S; Apper, E; Taminiau, B; Cahu, A; Le Normand, L; Respondek, F; Le Huerou-Luron, I; Blat, S				Le Bourgot, Cindy; Ferret-Bernard, Stephanie; Apper, Emmanuelle; Taminiau, Bernard; Cahu, Armelle; Le Normand, Laurence; Respondek, Frederique; Le Huerou-Luron, Isabelle; Blat, Sophie			Perinatal short-chain fructooligosaccharides program intestinal microbiota and improve enteroinsular axis function and inflammatory status in high-fat diet-fed adult pigs	FASEB JOURNAL			English	Article						nutritional programming; prebiotic; GLP-1; Prevotella	GLUCAGON-LIKE PEPTIDE-1; MATERNAL HIGH-PROTEIN; GUT MICROBIOTA; INSULIN SENSITIVITY; GENE-EXPRESSION; DELIVERY MODE; GLUCOSE; OBESE; CONSEQUENCES; SECRETION	Perinatal nutrition programs physiologic and metabolic functions, with consequences on the susceptibility to develop metabolic diseases in adulthood. The microbiota represents a key factor of such programming. We investigated whether perinatal prebiotic [short-chain fructooligosaccharides (scFOS)] supplementation improved adult metabolic health in association with microbiota changes in pigs used as human model. Sows were supplemented with scFOS or not during the end of gestation and the entire lactation, and offspring received scFOS accordingly during 1 mo after weaning. Pigs were then fed a standard diet for 5 mo, followed by a high-fat diet for 3 mo once adults. Perinatal scFOS supplementation induced a persistent modulation of the composition of the fecal microbiota in adulthood, notably by increasing the Prevotella genus. Meanwhile, scFOS animals displayed improved capacity to secrete glucagon-like peptide-1 and improved pancreas sensitivity to glucose without any changes in peripheral insulin sensitivity. Perinatal scFOS supplementation also increased ileal secretory IgA secretion and alkaline phosphatase activity and decreased TNF- expression in adipose tissue. In conclusion, perinatal scFOS supplementation induced long-lasting modulation of intestinal microbiota and had beneficial consequences on the host physiology in adulthood. Our results highlight the key role of perinatal nutrition on later microbiota and host metabolic adaptation to an unbalanced diet.Le Bourgot, C., Ferret-Bernard, S., Apper, E., Taminiau, B., Cahu, A., Le Normand, L., Respondek, F., Le Huerou-Luron, I., Blat, S. Perinatal short-chain fructooligosaccharides program intestinal microbiota and improve enteroinsular axis function and inflammatory status in high-fat diet-fed adult pigs.	[Le Bourgot, Cindy; Apper, Emmanuelle; Respondek, Frederique] Tereos, Marckolsheim, France; [Le Bourgot, Cindy; Ferret-Bernard, Stephanie; Cahu, Armelle; Le Normand, Laurence; Le Huerou-Luron, Isabelle; Blat, Sophie] Univ Rennes, INSERM, INRA, Nutr Metab & Canc,NuMeCan, Rennes, France; [Taminiau, Bernard] Univ Liege, Liege, Belgium	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; University of Liege	Blat, S (corresponding author), Univ Rennes, INSERM, INRA, NuMeCan, 16 Le Clos, F-35590 St Gilles, France.	sophie.blat@inra.fr	Ferret-Bernard, Stéphanie/AAD-4465-2019	Ferret-Bernard, Stéphanie/0000-0002-1439-9206; Luron, Isabelle/0000-0002-1769-5246	Tereos, a company producing scFOS	Tereos, a company producing scFOS	The authors thank the technical staff of Nutrition Metabolisms and Cancer (NuMeCan) for its expert assistance during the course of this project. They also acknowledge all of the staff of Rennes Porcine Experimental Facilities (UEPR) for animal care and feeding. This study received funding from Tereos, a company producing scFOS. F.R. and E.A. are employed by Tereos. A French patent application has been filed (FR 17/0035). C.L.B., S.F.B., B.T., A.C., L.L.N., I.L.H.L., and S.B. declare no conflict of interest.	Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Atkinson BJ, 2013, DIABETES, V62, P2249, DOI 10.2337/db12-1146; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Bergman RN, 2005, HORM RES, V64, P8, DOI 10.1159/000089312; Bindels LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131009; Blat S, 2012, BRIT J NUTR, V108, P102, DOI 10.1017/S0007114511005253; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2007, BRIT J NUTR, V98, P32, DOI 10.1017/S0007114507691648; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; Cani PD, 2004, BRIT J NUTR, V92, P521, DOI 10.1079/BJN20041225; Chan HM, 2011, AM J PHYSIOL-REG I, V300, pR1126, DOI 10.1152/ajpregu.00687.2010; Chatelais L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019594; CHEN TT, 2017, SCI REP UK, V0007; Christoffersen B, 2009, AM J PHYSIOL-REG I, V297, pR1195, DOI 10.1152/ajpregu.90851.2008; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Delamaire E, 2012, CLIN NUTR, V31, P741, DOI 10.1016/j.clnu.2012.02.005; Delmee E, 2006, LIFE SCI, V79, P1007, DOI 10.1016/j.lfs.2006.05.013; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Fujiwara R, 2008, BRIT J NUTR, V99, P1174, DOI 10.1017/S0007114507862349; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Hallam MC, 2014, OBESITY, V22, P2344, DOI 10.1002/oby.20849; Hallam MC, 2013, BRIT J NUTR, V110, P1732, DOI 10.1017/S0007114513000998; JOUANY JP, 1981, REPROD NUTR DEV, V21, P871, DOI 10.1051/rnd:19810701; Kaji I, 2011, J MOL HISTOL, V42, P27, DOI 10.1007/s10735-010-9304-4; Kampmann U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027854; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; Le Bourgot C, 2017, BRIT J NUTR, V117, P83, DOI 10.1017/S0007114516004268; Le Bourgot C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107508; Liu TW, 2016, J NUTR, V146, P949, DOI 10.3945/jn.115.227504; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mach N, 2015, ENV MICROBIOL REP, V7, P554, DOI 10.1111/1758-2229.12285; Maurer AD, 2011, BRIT J NUTR, V105, P329, DOI 10.1017/S0007114510003533; Mosnier E, 2010, J ANIM SCI, V88, P612, DOI 10.2527/jas.2008-1768; Mourot J, 2004, B ACAD VET FR, V157, P29; Ohland CL, 2015, CELL MOL GASTROENTER, V1, P28, DOI 10.1016/j.jcmgh.2014.11.004; Pan XD, 2009, J ZHEJIANG UNIV-SC B, V10, P258, DOI 10.1631/jzus.B0820261; Pannaraj PS, 2017, JAMA PEDIATR, V171, P647, DOI 10.1001/jamapediatrics.2017.0378; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Respondek F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071026; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Russell ARB, 2006, BJOG-INT J OBSTET GY, V113, P758, DOI 10.1111/j.1471-0528.2006.00952.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schokker D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116523; Swanson KS, 2002, J NUTR, V132, P3721, DOI 10.1093/jn/132.12.3721; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132	58	19	19	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					301	313		10.1096/fj.201800108R	http://dx.doi.org/10.1096/fj.201800108R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29975568	Green Submitted			2022-12-26	WOS:000457401500025
J	Paschen, M; Moede, T; Valladolid-Acebes, I; Leibiger, B; Moruzzi, N; Jacob, S; Garcia-Prieto, CF; Brismar, K; Leibiger, IB; Berggren, PO				Paschen, Meike; Moede, Tilo; Valladolid-Acebes, Ismael; Leibiger, Barbara; Moruzzi, Noah; Jacob, Stefan; Garcia-Prieto, Concha F.; Brismar, Kerstin; Leibiger, Ingo B.; Berggren, Per-Olof			Diet-induced -cell insulin resistance results in reversible loss of functional -cell mass	FASEB JOURNAL			English	Article						in vivo imaging; diabetes mellitus; fluorescence microscopy; biosensor; diet intervention	BETA-CELL; CA2+ CHANNELS; GLUCOSE-HOMEOSTASIS; GENE-TRANSCRIPTION; HIGH-RESOLUTION; MOUSE MODELS; RECEPTOR; SECRETION; MICE; DISSOCIATION	Although convincing in genetic models, the relevance of -cell insulin resistance in diet-induced type 2 diabetes (T2DM) remains unclear. Exemplified by diabetes-prone, male, C57B1/6J mice being fed different combinations of Western-style diet, we show that -cell insulin resistance occurs early during T2DM progression and is due to a combination of lipotoxicity and increased -cell workload. Within 8 wk of being fed a high-fat, high-sucrose diet, mice became obese, developed impaired insulin and glucose tolerances, and displayed noncompensatory insulin release, due, at least in part, to reduced expression of syntaxin-1A. Through reporter islets transplanted to the anterior chamber of the eye, we demonstrated a concomitant loss of functional -cell mass. When mice were changed from diabetogenic diet to normal chow diet, the diabetes phenotype was reversed, suggesting a remarkable plasticity of functional -cell mass in the early phase of T2DM development. Our data reinforce the relevance of diet composition as an environmental factor determining different routes of diabetes progression in a given genetic background. Employing the in vivo reporter islet-monitoring approach will allow researchers to define key times in the dynamics of reversible loss of functional -cell mass and, thus, to investigate the underlying, molecular mechanisms involved in the progression toward T2DM manifestation.Paschen, M., Moede, T., Valladolid-Acebes, I., Leibiger, B., Moruzzi, N., Jacob, S., Garcia-Prieto, C. F., Brismar, K., Leibiger, I. B., Berggren, P.-O. Diet-induced -cell insulin resistance results in reversible loss of functional -cell mass.	[Paschen, Meike; Moede, Tilo; Valladolid-Acebes, Ismael; Leibiger, Barbara; Moruzzi, Noah; Jacob, Stefan; Garcia-Prieto, Concha F.; Brismar, Kerstin; Leibiger, Ingo B.; Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, L1 03, SE-17176 Stockholm, Sweden	Karolinska Institutet	Leibiger, IB; Berggren, PO (corresponding author), Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, L1 03, SE-17176 Stockholm, Sweden.	ingo.leibiger@ki.se; per-olof.berggren@ki.se	Moruzzi, Noah/AAC-8875-2019	Moede, Tilo/0000-0002-2045-9244; Berggren, Per-Olof/0000-0001-8991-413X; Moruzzi, Noah/0000-0001-6868-1488; Jacob, Stefan/0000-0001-8456-3924; Valladolid-Acebes, Ismael/0000-0002-7699-9207	Karolinska Institutet (KID programme); Swedish Research Council; Family Erling-Persson Foundation; Novo Nordisk Foundation; Novo Nordisk A/S; Stichting af Jochnick Foundation; Swedish Diabetes Association; Scandia Insurance Company Limited; Diabetes Research and Wellness Foundation; Berth von Kantzow's Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; ERC-2013 [AdG 338936 BetaImage]; ERC-2017 [PoC 727306 BETASCREEN]; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; Novo Nordisk; Karolinska Institutet	Karolinska Institutet (KID programme); Swedish Research Council(Swedish Research CouncilEuropean Commission); Family Erling-Persson Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk A/S(Novo Nordisk); Stichting af Jochnick Foundation; Swedish Diabetes Association; Scandia Insurance Company Limited; Diabetes Research and Wellness Foundation; Berth von Kantzow's Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; ERC-2013; ERC-2017; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk(Novo Nordisk); Karolinska Institutet(Karolinska Institutet)	This work was supported by funds from the Karolinska Institutet (KID programme), the Swedish Research Council, the Family Erling-Persson Foundation, the Novo Nordisk Foundation, Novo Nordisk A/S, the Stichting af Jochnick Foundation, the Swedish Diabetes Association, Scandia Insurance Company Limited, the Diabetes Research and Wellness Foundation, the Berth von Kantzow's Foundation, the Strategic Research Program in Diabetes at Karolinska Institutet, the ERC-2013-AdG 338936 BetaImage, the ERC-2017-PoC 727306 BETASCREEN, the Swedish Foundation for Strategic Research, and the Knut and Alice Wallenberg Foundation. N.M. was supported by a Novo Nordisk postdoctoral fellowship run in partnership with the Karolinska Institutet. P.-O.B. is cofounder of Biocrine AB, I.B.L. and B.L. are consultants for Biocrine AB, and S.J. is employed by Biocrine AB.	Abdulreda MH, 2011, P NATL ACAD SCI USA, V108, P12863, DOI 10.1073/pnas.1105002108; Alquier T, 2018, DIABETOLOGIA, V61, P526, DOI 10.1007/s00125-017-4495-9; Avall K, 2015, P NATL ACAD SCI USA, V112, pE2611, DOI 10.1073/pnas.1423849112; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Chen CG, 2016, DIABETES, V65, P2676, DOI 10.2337/db15-1718; Chmelova H, 2015, DIABETES, V64, P2148, DOI 10.2337/db14-1055; Collins SC, 2010, DIABETES, V59, P1192, DOI 10.2337/db09-0791; de Monvel JB, 2001, BIOPHYS J, V80, P2455, DOI 10.1016/S0006-3495(01)76214-5; Diez JA, 2017, CELL REP, V20, P1490, DOI 10.1016/j.celrep.2017.07.039; Drewnowski A, 1998, NUTR REV, V56, P347, DOI 10.1111/j.1753-4887.1998.tb01677.x; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Gerdes JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6308; Goldfine AB, 2012, DIABETES OBES METAB, V14, P152, DOI 10.1111/j.1463-1326.2012.01647.x; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Hoppa MB, 2009, CELL METAB, V10, P455, DOI 10.1016/j.cmet.2009.09.011; Hughey CC, 2014, MAMM GENOME, V25, P522, DOI 10.1007/s00335-014-9533-z; Ilegems E, 2015, SCI REP-UK, V5, DOI 10.1038/srep10740; Ilegems E, 2013, P NATL ACAD SCI USA, V110, P20581, DOI 10.1073/pnas.1313696110; Kaneko K, 2010, CELL METAB, V12, P619, DOI 10.1016/j.cmet.2010.11.005; Kaneto H, 2015, INT J MOL SCI, V16, P6281, DOI 10.3390/ijms16036281; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kluth O, 2011, DIABETOLOGIA, V54, P605, DOI 10.1007/s00125-010-1973-8; Kroon D.-J., 2011, SEGMENTATION MANDIBU; Kubota T, 2017, CELL METAB, V25, P797, DOI 10.1016/j.cmet.2017.03.004; Kulkarni RN, 2003, DIABETES, V52, P1528, DOI 10.2337/diabetes.52.6.1528; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lam PPL, 2005, DIABETES, V54, P2744, DOI 10.2337/diabetes.54.9.2744; Laurent D, 2016, DIABETES OBES METAB, V18, P6, DOI 10.1111/dom.12544; Lawrence MC, 2001, MOL ENDOCRINOL, V15, P1758, DOI 10.1210/me.15.10.1758; Leibiger B, 2004, FRONT DIABETES, V16, P249; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; Leibiger B., 1994, INSULIN SECRETION PA, P15; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Leibiger IB, 2017, MOL METAB, V6, P1002, DOI 10.1016/j.molmet.2017.03.014; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Li L, 2013, CLIN EXP PHARMACOL P, V40, P841, DOI 10.1111/1440-1681.12160; Lindqvist A, 2005, REGUL PEPTIDES, V130, P123, DOI 10.1016/j.regpep.2005.05.002; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Moede T, 2001, DIABETES, V50, pS15, DOI 10.2337/diabetes.50.2007.S15; Mosser RE, 2015, AM J PHYSIOL-ENDOC M, V308, pE573, DOI 10.1152/ajpendo.00460.2014; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Paschen M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21448; Rorsman P, 2018, PHYSIOL REV, V98, P117, DOI 10.1152/physrev.00008.2017; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sellmann C, 2015, J NUTR BIOCHEM, V26, P1183, DOI 10.1016/j.jnutbio.2015.05.011; Softic S, 2017, J CLIN INVEST, V127, P4059, DOI 10.1172/JCI94585; Speier S, 2008, NAT PROTOC, V3, P1278, DOI 10.1038/nprot.2008.118; Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Thorens B, 2015, DIABETOLOGIA, V58, P558, DOI 10.1007/s00125-014-3468-5; Uhles S, 2003, J CELL BIOL, V163, P1327, DOI 10.1083/jcb.200306093; Uhles S, 2007, FASEB J, V21, P1609, DOI 10.1096/fj.06-7589com; van Krieken PP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12124-w; Yang SN, 1999, P NATL ACAD SCI USA, V96, P10164, DOI 10.1073/pnas.96.18.10164; Yoo T, 2018, DIABETES, V67, P360, DOI 10.2337/db17-0499; Zanella R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02523; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012	64	17	17	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					204	218		10.1096/fj.201800826R	http://dx.doi.org/10.1096/fj.201800826R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29957055	Green Published, hybrid			2022-12-26	WOS:000457401500017
J	Wang, L; Fan, Y; Zhang, LA; Li, LL; Kuang, GY; Luo, C; Li, C; Xiang, TX; Tao, Q; Zhang, Q; Ying, JM				Wang, Lu; Fan, Yu; Zhang, Lian; Li, Lili; Kuang, Guanyu; Luo, Cheng; Li, Chen; Xiang, Tingxiu; Tao, Qian; Zhang, Qian; Ying, Jianming			Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma	FASEB JOURNAL			English	Article						SRY-related high mobility group; promoter; CpG methylation; epithelial to mesenchymal transition; renal cancer	PROMOTER METHYLATION; TRANSCRIPTION FACTOR; DNA METHYLATION; EXPRESSION; CANCER; PROGENITORS; SEQUENCE	SOX7 (SRY-related high mobility group box 7), a high mobility group protein, is reported to be down-regulated in several cancer types, which indicates an important role in tumorigenesis; however, its biologic role in renal cell carcinoma (RCC) pathogenesis remains unknown. We studied the alterations and functions of SOX7 in RCC. We detected its broad expression in multiple human normal tissues, including kidney, but frequent down-regulation in RCC cell lines and primary tumors. Promoter CpG methylation seems to directly mediate SOX7 silencing in RCC cells, which could be reversed by demethylation treatment. SOX7 methylation was detected in primary RCC tumors, but rarely in normal kidney tissues. Restoration of SOX7 in silenced 786-O and A498 RCC cell lines inhibited their cell growth by inducing G(0)/G(1) arrest, whereas SOX7 knockdown promoted RCC cell proliferation. We also found that SOX7 silencing resulted in the activation of WNT signaling and the induction of epithelial to mesenchymal transition. In conclusion, the current study demonstrates that SOX7 is frequently inactivated by promoter CpG methylation in RCC and functions as a tumor suppressor by regulating WNT signaling.Wang, L., Fan, Y., Zhang, L., Li, L., Kuang, G., Luo, C., Li, C., Xiang, T., Tao, Q., Zhang, Q., Ying, J. Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma.	[Wang, Lu; Fan, Yu; Zhang, Lian; Kuang, Guanyu; Luo, Cheng; Zhang, Qian] Peking Univ, Hosp 1, Natl Res Ctr Genitourinary Oncol, Dept Urol, Beijing, Peoples R China; [Wang, Lu; Fan, Yu; Zhang, Lian; Kuang, Guanyu; Luo, Cheng; Zhang, Qian] Inst Urol, Beijing, Peoples R China; [Li, Lili; Li, Chen; Tao, Qian] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, Canc Epigenet Lab,State Key Lab Oncol South China, Hong Kong, Peoples R China; [Li, Lili; Li, Chen; Tao, Qian] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China; [Li, Lili; Li, Chen; Tao, Qian] Chinese Univ Hong Kong, Shenzhen Res Inst, Hong Kong, Peoples R China; [Xiang, Tingxiu] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Mol Oncol & Epigenet, Chongqing, Peoples R China; [Ying, Jianming] Chinese Acad Med Sci, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr,Dept Pathol, Beijing, Peoples R China; [Ying, Jianming] Peking Union Med Coll, Beijing, Peoples R China	Peking University; Chinese University of Hong Kong; State Key Lab Oncology South China; Chinese University of Hong Kong; Chinese University of Hong Kong; Chongqing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, Q (corresponding author), Inst Urol, Beijing, Peoples R China.; Zhang, Q (corresponding author), Peking Univ, Hosp 1, Dept Urol, Beijing, Peoples R China.; Ying, JM (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing, Peoples R China.	zhangqianbmu@vip.sina.com; jmying@hotmail.com	Tao, Qian/T-4743-2018; Li, Lili/Q-5750-2018	Tao, Qian/0000-0001-5383-4808; Li, Lili/0000-0002-0292-5889	National Natural Science Foundation [81272290, 81572510, 81772869]; National Key Research and Development Program of China [2017YFE0191700]; Vice-Chancellor special research fund from The Chinese University of Hong Kong	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Vice-Chancellor special research fund from The Chinese University of Hong Kong	This work was supported by the National Natural Science Foundation (Grants 81272290, 81572510, and 81772869), the National Key Research and Development Program of China (Grant 2017YFE0191700), and the Vice-Chancellor special research fund from The Chinese University of Hong Kong. The authors declare no conflicts of interest.	Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Brabletz T, 2018, NAT REV CANCER, V18, P128, DOI 10.1038/nrc.2017.118; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Du ZF, 2016, ONCOTARGET, V7, P21618, DOI 10.18632/oncotarget.7822; Fenner A, 2017, NAT REV UROL, V14, P8, DOI 10.1038/nrurol.2016.226; Fisel P, 2013, CLIN CANCER RES, V19, P5170, DOI 10.1158/1078-0432.CCR-13-1180; Francois M, 2010, INT J BIOCHEM CELL B, V42, P445, DOI 10.1016/j.biocel.2009.08.017; Gandillet A, 2009, BLOOD, V114, P4813, DOI 10.1182/blood-2009-06-226290; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Guo LH, 2008, MOL CANCER RES, V6, P1421, DOI 10.1158/1541-7786.MCR-07-2175; Han KR, 2003, J UROLOGY, V169, P899, DOI 10.1097/01.ju.0000051480.62175.35; Hayano T, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-17; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hirata H, 2009, CLIN CANCER RES, V15, P5678, DOI 10.1158/1078-0432.CCR-09-0558; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; LIU H, 2016, SCI REP UK, V6; Liu HD, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0087-1; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Nelson TJ, 2009, DIFFERENTIATION, V77, P248, DOI 10.1016/j.diff.2008.10.012; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Shiozawa M, 1996, BBA-GENE STRUCT EXPR, V1309, P73, DOI 10.1016/S0167-4781(96)00145-5; Slater AA, 2013, EPIGENETICS-US, V8, P252, DOI 10.4161/epi.23817; Takash W, 2001, NUCLEIC ACIDS RES, V29, P4274, DOI 10.1093/nar/29.21.4274; Taniguchi K, 1999, BBA-GENE STRUCT EXPR, V1445, P225, DOI 10.1016/S0167-4781(99)00047-0; Tao Q, 1999, AM J PATHOL, V155, P619, DOI 10.1016/S0002-9440(10)65157-7; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Zhang Q, 2014, CANCER LETT, V354, P227, DOI 10.1016/j.canlet.2014.07.040; Zhang QA, 2010, J UROLOGY, V184, P731, DOI 10.1016/j.juro.2010.03.108; Zhang Q, 2007, CANCER LETT, V249, P220, DOI 10.1016/j.canlet.2006.08.019; Zhang Y, 2009, CANCER LETT, V277, P29, DOI 10.1016/j.canlet.2008.11.014; Zhao TS, 2016, CANCER LETT, V375, P100, DOI 10.1016/j.canlet.2016.02.044; Zhu YT, 2014, NAT METHODS, V11, P599, DOI 10.1038/nmeth.2956	40	16	17	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					254	263		10.1096/fj.201701453RR	http://dx.doi.org/10.1096/fj.201701453RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29957056				2022-12-26	WOS:000457401500021
J	Damgaard, ALD; Gregersen, R; Lange, T; Buchvald, F; Hansen, BM; Greisen, G				Damgaard, Anne Louise de Barros; Gregersen, Rasmus; Lange, Theis; Buchvald, Frederik; Hansen, Bo Molholm; Greisen, Gorm			The increased purchase of asthma medication for individuals born preterm seems to wane with age: A register-based longitudinal national cohort study	PLOS ONE			English	Article							CHILDREN; BIRTH; PREVALENCE	Introduction Preterm birth is associated with increased risk of respiratory symptoms in childhood, often treated with asthma medication. We designed a follow-up study to previous research and investigated whether the association of gestational age with purchasing asthma medication diminishes in adulthood. Methods We conducted a register-based study of a national cohort of all infants born in Denmark in 1980-2009 evaluating longitudinal data on individually prescribed asthma medication (both inhaled 13-2 receptor agonist and different controller treatment over 2-year periods) available from 1995-2011. We analyzed the effect of gestational age considering age, birth year, and perinatal variables using logistic regression with a Generalized Estimating Equations model. All data were unambiguously linked through the Civil Registration System. Results We included 1,819,743 individuals in our study population. We found an inverse doseresponse relationship between gestational age and asthma medication in earlier age-groups with a gradual decrease in odds ratios with increasing age and loss of statistical significance in early adulthood (18-31 years). For our oldest generations, there was a significant effect of gestational age (p-value = 0.04), which became insignificant when adjusting for confounding and mediating factors (p = 0.44). There were significant interactions between gestational age and age (p<0.0001) and gestational age and birth year, but these were most important during childhood (0-11 years) and for our youngest generations (born after 1995). Conclusion The strong association between gestational age and purchase of prescription asthma medication weakens with age into early adulthood, in consistence with the results from our previous study. The risk for purchasing medication to treat asthma-like symptoms was higher in more recent birth years, but the effect of gestational age was small beyond 11 years of age. Gestational age per se did not seem to be significant for the development of asthma-like symptoms: most of its effect could be explained by other perinatal factors.	[Damgaard, Anne Louise de Barros; Gregersen, Rasmus; Greisen, Gorm] Copenhagen Univ Hosp, Dept Neonatol, Rigshosp, Copenhagen, Denmark; [Lange, Theis] Peking Univ, Ctr Stat Sci, Beijing, Peoples R China; [Lange, Theis] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Buchvald, Frederik] Copenhagen Univ Hosp, Rigshosp, Dept Pediat, Pulm Serv, Copenhagen, Denmark; [Hansen, Bo Molholm] Copenhagen Univ Hosp Herlev, Dept Pediat, Neonatol Serv, Herlev, Denmark	Rigshospitalet; University of Copenhagen; Peking University; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Damgaard, ALD (corresponding author), Copenhagen Univ Hosp, Dept Neonatol, Rigshosp, Copenhagen, Denmark.	aldamgaard@me.com	de Barros Garioud, Anne Louise/AAQ-3868-2021; Greisen, Gorm/AAA-6463-2022	de Barros Garioud, Anne Louise/0000-0003-1149-9946; Greisen, Gorm/0000-0001-8042-3262; Hansen, Bo Molholm/0000-0002-3087-3983; Gregersen, Rasmus/0000-0001-9439-4933; Lange, Theis/0000-0001-6807-8347				Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Baraldi E, 2005, AM J RESP CRIT CARE, V171, P68, DOI 10.1164/rccm.200403-298Oc; Been JV, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001596; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Costeloe KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7976; Damgaard AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117253; Fortuna M, 2016, PEDIATR PULM, V51, P1057, DOI 10.1002/ppul.23422; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Jobe AH, 2016, AM J PERINAT, V33, P1076, DOI 10.1055/s-0036-1586107; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P303, DOI 10.2147/CLEP.S37587; Keyes KM, 2010, SOC SCI MED, V70, P1100, DOI 10.1016/j.socscimed.2009.12.018; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Lo J, 2018, PEDIATR PULM, V53, P324, DOI 10.1002/ppul.23933; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Martinez FD, 2016, NEW ENGL J MED, V375, P871, DOI 10.1056/NEJMra1603287; Moth G, 2007, EUR J CLIN PHARMACOL, V63, P605, DOI 10.1007/s00228-007-0286-4; Narayanan M, 2013, AM J RESP CRIT CARE, V187, P1104, DOI 10.1164/rccm.201210-1850OC; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pottegard A, 2017, INT J EPIDEMIOL, V46, P798, DOI 10.1093/ije/dyw213; Priante E, 2016, AM J PERINAT, V33, P1040, DOI 10.1055/s-0036-1586172; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; UNESCO Institute for Statistics, INT STAND CLASS ED I; Vogt H, 2011, PEDIATRICS, V127, P1052, DOI 10.1542/peds.2010-3083; Wogelius P, 2005, EUR J EPIDEMIOL, V20, P17, DOI 10.1007/s10654-004-1501-6	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199884	10.1371/journal.pone.0199884	http://dx.doi.org/10.1371/journal.pone.0199884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975752	Green Published, gold, Green Submitted			2022-12-26	WOS:000437424500054
J	Humphries, T; Chauhan, BS; Florentine, SK				Humphries, Talia; Chauhan, Bhagirath S.; Florentine, Singarayer K.			Environmental factors effecting the germination and seedling emergence of two populations of an aggressive agricultural weed; Nassella trichotoma	PLOS ONE			English	Article							BURIAL DEPTH; NASSELLA TUSSOCK; DORMANCY; ECOLOGY; WEED; SOIL; MANAGEMENT; HALOPHYTE; LIGHT; TEMPERATURES	Nassella trichotoma (Nees) Hack. ex Arechav. (Serrated tussock) is an aggressive globally significant weed to agricultural and natural ecosystems. Herbicide resistant populations of this C3 perennial weed have emerged, increasing the need for effective wide-scale cultural control strategies. A thorough seed ecology study on two spatially distinct populations of N. trichotoma was conducted on this weed to identify differences in important environmental factors (drought, salinity, alternating temperature, photoperiod, burial depth, soil pH, artificial seed aging, and radiant heat) which influence seed dormancy. Seeds were collected from two spatially distinct populations; Gnarwarre (38(O) 9' 8.892 '' S, 144(O) 7' 38.784 '' E) and Ingliston (37(O) 40' 4.44 '' S, 144(O) 18' 39.24 '' E) in December 2016 and February 2017, respectively. Twenty sterilized seeds were placed into Petri dishes lined with a single Whatman (R) No. 10 filter paper dampened with the relevant treatments solution and then incubated under the identified optimal alternating temperature and photoperiod regime of 25 degrees C/15 degrees C (light/dark, 12h/12h). For the burial depth treatment, 20 seeds were placed into plastic containers (10cm in diameter and 6cm in depth) and buried to the relevant depth in sterilized soil. All trials were monitored for 30 days and germination was indicated by 5mm exposure of the radicle and emergence was indicated by the exposure of the cotyledon. Each treatment had three replicates for each population, and each treatment was repeated to give a total of six replicates per treatment, per population. Nassella trichotoma was identified to be non-photoblastic, with germination (%) being similar under alternating light and dark and complete darkness conditions. With an increase of osmotic potential and salinity, a significant decline in germination was observed. There was no effect of pH on germination. Exposure to a radiant heat of 120 degrees C for 9 minutes resulted in the lowest germination in the Ingliston population (33%) and the Gnarwarre population (60%). In the burial depth treatment, the Ingliston population and the Gnarwarre population had highest emergence of 75% and 80%, respectively at a depth of 1cm. Variation between the two populations was observed for the burial depth treatments; Gnarwarre had greater emergence than Ingliston from the 4cm burial depth, while Ingliston had greater emergence at the soil surface than Gnarwarre. The Gnarwarre population had greater overall germination than Ingliston, which could be attributed to the greater seed mass (0.86mg compared to 0.76mg, respectively). This study identifies that spatial variations in N. trichotoma's seed ecology are present between spatially distinct populations.	[Humphries, Talia; Florentine, Singarayer K.] Federat Univ Australia, Fac Sci & Technol, Ctr Environm Management, Mt Helen, Vic, Australia; [Chauhan, Bhagirath S.] Univ Queensland, QAAFI, Ctr Plant Sci, Toowoomba, Qld, Australia	Federation University Australia; University of Queensland	Florentine, SK (corresponding author), Federat Univ Australia, Fac Sci & Technol, Ctr Environm Management, Mt Helen, Vic, Australia.	s.florentine@federation.edu.au	Florentine, Singarayer/Q-7198-2019; Florentine, Singarayer/ABA-7740-2020; Chauhan, Bhagirath/G-8892-2014	Florentine, Singarayer/0000-0002-5734-3421; Chauhan, Bhagirath/0000-0003-1540-4668				Ahmed S, 2015, WEED SCI, V63, P491, DOI 10.1614/WS-D-14-00115.1; Amini R, 2017, WEED RES, V57, P247, DOI 10.1111/wre.12259; Atak Mehmet, 2006, Turkish Journal of Agriculture and Forestry, V30, P39; Atwell B. J., 1999, PLANTS ACTION ADAPTI; Badgery WB, 2008, AUST J AGR RES, V59, P226, DOI 10.1071/AR07112; Bajji M, 2002, CAN J BOT, V80, P297, DOI [10.1139/B02-008, 10.1139/b02-008]; Bajwa AA, 2016, ENVIRON SCI POLLUT R, V23, P24694, DOI 10.1007/s11356-016-7794-7; Baruch Z, 1999, OECOLOGIA, V119, P510, DOI 10.1007/s004420050814; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Batlla D, 2007, CROP PROT, V26, P189, DOI 10.1016/j.cropro.2005.07.014; Bentsink Leonie, 2008, Arabidopsis Book, V6, pe0119, DOI 10.1199/tab.0119; Benvenuti S, 2004, WEED RES, V44, P87, DOI 10.1111/j.1365-3180.2003.00376.x; Bittencourt HVH, 2017, S AFR J BOT, V109, P246, DOI 10.1016/j.sajb.2017.01.009; Bond W, 2001, WEED RES, V41, P383, DOI 10.1046/j.1365-3180.2001.00246.x; Bureau of Meteorology, 2017, CLIM DAT ONL; Chachalis D, 2000, WEED SCI, V48, P212, DOI 10.1614/0043-1745(2000)048[0212:FACRSG]2.0.CO;2; Chauhan BS, 2008, WEED SCI, V56, P383, DOI 10.1614/WS-07-154.1; Chauhan BS, 2006, WEED SCI, V54, P1004, DOI 10.1614/WS-06-087R.1; Chauhan BS, 2009, WEED SCI, V57, P36, DOI 10.1614/WS-08-015.1; CRC, 2013, WEED MAN GUID SERR T, P1; Cuneo P, 2010, AUST J BOT, V58, P342, DOI 10.1071/BT10061; Dalling JW, 2011, J ECOL, V99, P89, DOI 10.1111/j.1365-2745.2010.01739.x; De Cauwer B, 2014, WEED RES, V54, P38, DOI 10.1111/wre.12055; Department of Primary Industries, 2016, PARKS WAT ENV INV SP; Department of Primary Industries, 2006, SAL CONV; Department of Primary Industries, NSW WEEDWISE SERR TU; Ebrahimi E, 2012, WEED RES, V52, P50, DOI 10.1111/j.1365-3180.2011.00896.x; Fennor M, 2005, ECOLOGY SEEDS; Ferrari FN, 2015, J ARID ENVIRON, V113, P1, DOI 10.1016/j.jaridenv.2014.09.002; Florentine SK, 2016, RANGELAND J, V38, P417, DOI 10.1071/RJ16022; Guillemin JP, 2011, WEED BIOL MANAG, V11, P217, DOI 10.1111/j.1445-6664.2011.00423.x; Han CC, 2013, WEED SCI, V61, P549, DOI 10.1614/WS-D-13-00015.1; Hao JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170297; Javaid MM, 2014, WEED RES, V54, P565, DOI 10.1111/wre.12111; JOUBERT DC, 1982, S AFR J BOT, V1, P142, DOI 10.1016/S0022-4618(16)30165-6; Jung J. S., 1998, Korean Journal of Weed Science, V18, P128; Kolodziejek J, 2015, NOT BOT HORTI AGROBO, V43, P439; Kriticos DJ, 2004, N Z PLANT PROTECT-SE, P81, DOI 10.30843/nzpp.2004.57.6976; Li Jigang, 2011, Arabidopsis Book, V9, pe0148, DOI 10.1199/tab.0148; Limon A, 2016, ACTA OECOL, V71, P8, DOI 10.1016/j.actao.2016.01.001; Lin JX, 2017, CROP PASTURE SCI, V68, P188, DOI [10.1071/CP16402, 10.1071/cp16402]; Lu P, 2011, PROCEDIA ENVIRON SCI, V10, P1741, DOI 10.1016/j.proenv.2011.09.273; Mahmoudi A, 2016, INT J FUZZY SYST, V18, P1117, DOI 10.1007/s40815-016-0173-1; Malcolm CV, 2003, PLANT SOIL, V253, P171, DOI 10.1023/A:1024578002235; McElroy JS, 2004, WEED SCI, V52, P47, DOI 10.1614/P2002-090; MILBERG P, 1995, BIOL CONSERV, V73, P45, DOI 10.1016/0006-3207(95)90061-6; Oduor AMO, 2016, J ECOL, V104, P957, DOI 10.1111/1365-2745.12578; Osmond R., 2008, SERRATED TUSSOCK NAT; Presotto A, 2014, ANN APPL BIOL, V164, P373, DOI 10.1111/aab.12104; Qu XX, 2008, ANN BOT-LONDON, V101, P293, DOI 10.1093/aob/mcm047; Ramasamy S, 2010, 17 AUSTR WEEDS C, P210; Rezvani M, 2016, PLANT SPEC BIOL, V31, P280, DOI 10.1111/1442-1984.12113; Saatkamp A, 2011, ANN BOT-LONDON, V107, P415, DOI 10.1093/aob/mcq255; Shinomura T, 1997, J PLANT RES, V110, P151, DOI 10.1007/BF02506854; SLAVICH PG, 1993, AUST J SOIL RES, V31, P73, DOI 10.1071/SR9930073; The Grassland Society of NSW Inc, 2006, 21 ANN C WAGG WAGG N, P40; Thiam M, 2013, ISNR BIOTECHNOLOGY, V382417, P1; Van Acker RC, 2009, WEED RES, V49, P1, DOI 10.1111/j.1365-3180.2008.00656.x; Vandelook F, 2008, FUNCT ECOL, V22, P470, DOI 10.1111/j.1365-2435.2008.01385.x; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Willis Anthony J., 2003, Ecological Management & Restoration, V4, P55, DOI 10.1046/j.1442-8903.2003.00131.x	61	20	20	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199491	10.1371/journal.pone.0199491	http://dx.doi.org/10.1371/journal.pone.0199491			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975730	gold, Green Published, Green Submitted			2022-12-26	WOS:000437424500033
J	Savy, A; Kaikkonen, MU; Leger, A; Dickx, Y; Galibert, L; Merten, OW				Savy, Adrien; Kaikkonen, Minna U.; Leger, Adrien; Dickx, Yohann; Galibert, Lionel; Merten, Otto-Wilhelm			Genetics instability of wtAAV2 genome and AAV promoter activities in the Baculovirus/Sf9 cells system	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS TYPE-2; EXPRESSION STRATEGY; INSECT CELLS; VECTORS; DNA; HELICASE; ENCAPSIDATION; ORGANIZATION; INFECTIVITY; EFFICIENT	The human Adeno-Associated Virus serotype 2 (wtAAV2) is a common non-pathological virus and its recombinant form (rAAV) is widely used as gene therapy vector. Although rAAVs are routinely produced in the Baculovirus/Sf9 cell system, wtAAV2 has never been studied in this context. We tried to produce wtAAV2 in the baculovirus/Sf9 cell system hypothesizing that the wtAAV2 may be considered as a normal recombinant AAV transgene. Through our attempts to produce wtAAV2 in Baculovirus/Sf9, we found that wtAAV2 p5 promoter, which controls the expression of large Rep proteins in mammalian cells, was active in this system. p5 promoter activity in the baculovirus/Sf9 cell system leads to the expression of Rep78 that finally excises wtAAV2 genome from the baculovirus genome during the earliest phases of baculovirus stock production. Via p5 promoter expression kinetics and strand specific RNA-Seq analysis of wtAAV2, rAAV and Rep2/Cap2 cassettes in the baculovirus context we could demonstrate that wtAAV2 native promoters, p5, p19 and p40 are all active in the context of the baculovirus system and lead to the expression of different proteins and peptides. In addition, this study has proven that the baculovirus brings at least some of the helper functions needed in the AAV replication/life cycle.	[Savy, Adrien; Dickx, Yohann; Galibert, Lionel; Merten, Otto-Wilhelm] Genethon, Evry, France; [Savy, Adrien] Univ Evry Val Essonne, Evry, France; [Savy, Adrien] Synpromics Ltd, Edinburgh, Midlothian, Scotland; [Kaikkonen, Minna U.] Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland; [Leger, Adrien] Atlantic Gene Therapies, Nantes, France; [Leger, Adrien] Inserm, U1089, Nantes, France; [Leger, Adrien] EMBL EBI, Cambridge, England; [Galibert, Lionel] FinVector Vis Therapies, Kuopio, Finland	UDICE-French Research Universities; Universite Paris Saclay; University of Eastern Finland; Institut National de la Sante et de la Recherche Medicale (Inserm); European Molecular Biology Laboratory (EMBL)	Merten, OW (corresponding author), Genethon, Evry, France.	omerten@genethon.fr	Kaikkonen, Minna U/AAK-3612-2020	Kaikkonen, Minna U/0000-0001-6294-0979; Savy, Adrien/0000-0003-3663-9909; Leger, Adrien/0000-0001-8772-6776	Academy of Finland; Sigrid JuseAlius Foundation; Jane and Aatos Erkko Foundation	Academy of Finland(Academy of Finland); Sigrid JuseAlius Foundation; Jane and Aatos Erkko Foundation	M.U.K. was supported by grants from Academy of Finland, Sigrid JuseAlius Foundation and Jane and Aatos Erkko Foundation.; We thank the Sequencing Service GeneCore Sequencing Facility for RNA-Seq library sequencing (EMBL, http://www.genecore.embl.de). M.U.K. was supported by grants from Academy of Finland, Sigrid Juse A lius Foundation and Jane and Aatos Erkko Foundation.	ATCHISON RW, 1965, SCIENCE, V149, P754, DOI 10.1126/science.149.3685.754; BECERRA SP, 1988, J VIROL, V62, P2745, DOI 10.1128/JVI.62.8.2745-2754.1988; BERNS KI, 1990, MICROBIOL REV, V54, P316, DOI 10.1128/MMBR.54.3.316-329.1990; Cao M, 2015, VIROLOGY, V482, P84, DOI 10.1016/j.virol.2015.03.007; Cao MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104596; Chen YR, 2013, J VIROL, V87, P6391, DOI 10.1128/JVI.00194-13; Herson S, 2012, BRAIN, V135, P483, DOI 10.1093/brain/awr342; IM DS, 1990, CELL, V61, P447, DOI 10.1016/0092-8674(90)90526-K; James JA, 2003, STRUCTURE, V11, P1025, DOI 10.1016/S0969-2126(03)00152-7; Kaikkonen MU, 2014, NUCLEIC ACIDS RES, V42, P12570, DOI 10.1093/nar/gku1036; Kakumani PK, 2014, GENOMICS, V104, P134, DOI 10.1016/j.ygeno.2014.06.005; King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282; Kohlbrenner E, 2005, MOL THER, V12, P1217, DOI 10.1016/j.ymthe.2005.08.018; Kotin RM, 2011, HUM MOL GENET, V20, pR2, DOI 10.1093/hmg/ddr141; Liu KY, 2011, J VIROL, V85, P10069, DOI 10.1128/JVI.00625-11; Liu XL, 2015, TRENDS BIOCHEM SCI, V40, P516, DOI 10.1016/j.tibs.2015.07.003; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; McCarthy CB, 2008, J VIROL METHODS, V148, P286, DOI 10.1016/j.jviromet.2007.11.004; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; Merten O.-W., 2016, CELL GENE THER INSIG, V2, P521, DOI [10.18609/cgti.2016.067, DOI 10.18609/CGTI.2016.067]; Mietzsch M, 2015, HUM GENE THER, V26, P688, DOI 10.1089/hum.2015.050; Mietzsch M, 2014, HUM GENE THER, V25, P212, DOI 10.1089/hum.2013.184; Pereira DJ, 1997, J VIROL, V71, P1079, DOI 10.1128/JVI.71.2.1079-1088.1997; Samulski RJ, 2014, ANNU REV VIROL, V1, P427, DOI 10.1146/annurev-virology-031413-085355; Smith RH, 2009, MOL THER, V17, P1888, DOI 10.1038/mt.2009.128; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; SRIVASTAVA A, 1983, J VIROL, V45, P555, DOI 10.1128/JVI.45.2.555-564.1983; Steinbach S, 1997, J GEN VIROL, V78, P1453, DOI 10.1099/0022-1317-78-6-1453; Stutika C, 2016, J VIROL, V90, P1278, DOI 10.1128/JVI.02750-15; Tijssen P, 2003, J VIROL, V77, P10357, DOI 10.1128/JVI.77.19.10357-10365.2003; Timpe J, 2005, CURR GENE THER, V5, P273, DOI 10.2174/1566523054065011; Urabe M, 2002, HUM GENE THER, V13, P1935, DOI 10.1089/10430340260355347; WOOD HA, 1977, J INVERTEBR PATHOL, V29, P304, DOI 10.1016/S0022-2011(77)80035-9; Zarate-Perez F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002764; Zeltner N, 2010, GENE THER, V17, P872, DOI 10.1038/gt.2010.27	35	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199866	10.1371/journal.pone.0199866	http://dx.doi.org/10.1371/journal.pone.0199866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975713	gold, Green Submitted, Green Published			2022-12-26	WOS:000437424500050
J	Angwenyi, V; Aantjes, C; Kajumi, M; De Man, J; Criel, B; Bunders-Aelen, J				Angwenyi, Vibian; Aantjes, Carolien; Kajumi, Murphy; De Man, Jeroen; Criel, Bart; Bunders-Aelen, Joske			Patients experiences of self-management and strategies for dealing with chronic conditions in rural Malawi	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CHRONIC DISEASE; CARE; HIV; RELEVANCE; PEOPLE	Background The high burden of chronic communicable diseases such as HIV/AIDS, and an escalating rise of non-communicable diseases (NCDs) in Malawi and other sub-Saharan African countries, calls for a shift in how health care services are designed and delivered. Patient-centred care and patient self-management are critical elements in chronic care, and are advocated as universal strategies. In sub-Saharan Africa, there is need for more evidence around the practice of patient self-management, and how to best support patients with chronic conditions in the African context. Our study explored self-management practices of patients with different chronic conditions, and their strategies to overcome care challenges in a resource-constrained setting in Malawi. Methods This is primarily a qualitative study, involving patients with different chronic conditions from one rural district in Malawi. Data are drawn from semi-structured questions of a survey with 129 patients (from the third of four-part data collection series), 14 in-depth interviews, and four focus-group discussions with patients (n = 31 respondents). A framework approach was used for qualitative analysis, and descriptive statistical analysis was performed on survey data. Results Patients demonstrated ability to self-manage their conditions, though this varied between conditions, and was influenced by individual and external factors. Factors included: 1) ability to acquire appropriate disease knowledge; 2) poverty level; 3) the presence of support from family caregivers and community-based support initiatives; 4) the nature of one's social relations; and 5) the ability to deal with stressors and stigma. NCD and HIV comorbid patients were more disadvantaged in their access to care, as they experienced frequent drug stock-outs and incurred additional costs when referred. These barriers contributed to delayed care, poorer treatment adherence, and likelihood of poorer treatment outcomes. Patients proved resourceful and made adjustments in the face of (multiple) care challenges. Conclusion Our findings complement other research on self-management experiences in chronically ill patients with its analysis on factors and barriers that influence patient self-management capacity in a resource-constrained setting. We recommend expanding current peer-patient and support group initiatives to patients with NCDs, and further investments in the decentralisation of integrated health services to primary care level in Malawi.	[Angwenyi, Vibian; Aantjes, Carolien; Bunders-Aelen, Joske] Vrije Univ, Fac Sci, Athena Inst Res Innovat & Commun Hlth & Life Sci, Amsterdam, Netherlands; [Angwenyi, Vibian; De Man, Jeroen; Criel, Bart] Inst Trop Med, Dept Publ Hlth, Unit Equ & Hlth, Antwerp, Belgium; [Angwenyi, Vibian] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain; [Aantjes, Carolien; Kajumi, Murphy] Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa	Vrije Universiteit Amsterdam; Institute of Tropical Medicine (ITM); ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; University of Kwazulu Natal	Angwenyi, V (corresponding author), Vrije Univ, Fac Sci, Athena Inst Res Innovat & Commun Hlth & Life Sci, Amsterdam, Netherlands.; Angwenyi, V (corresponding author), Inst Trop Med, Dept Publ Hlth, Unit Equ & Hlth, Antwerp, Belgium.; Angwenyi, V (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain.	v.angwenyi@vu.nl	De Man, Jeroen/AAI-2108-2019	De Man, Jeroen/0000-0002-3196-8757; Aantjes, Carolien/0000-0001-5727-8271; Angwenyi, Vibian/0000-0002-7554-6265	European Commission, through the Erasmus Mundus Joint Doctorate Fellowship [2015-1595]	European Commission, through the Erasmus Mundus Joint Doctorate Fellowship	This work was supported by funding from the European Commission, through the Erasmus Mundus Joint Doctorate Fellowship, Specific Grant Agreement 2015-1595, awarded to VA (Vibian Angwenyi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aantjes C, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0085-5; Aantjes CJ, 2014, PATIENT EDUC COUNS, V95, P185, DOI 10.1016/j.pec.2014.01.007; Abiiro GA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-234; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Bemelmans M, 2014, TROP MED INT HEALTH, V19, P968, DOI 10.1111/tmi.12332; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Decroo T, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/749718; Dube L, 2017, J COMMUN HEALTH NURS, V34, P21, DOI 10.1080/07370016.2017.1260983; Elissen A, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-117; Government of Malawi, 2011, NAT COMM HOM BAS CAR; Government of the Republic of Malawi, 2017, HLTH SECT STRAT PLAN; Green J., 2018, QUALITATIVE METHODS, VFourth; Grimsrud A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19984; Haldane V, 2018, AIDS CARE, V30, P103, DOI 10.1080/09540121.2017.1344350; Haregu TN., 2015, INT J HEALTHCARE, V1, P21, DOI [10.5430/ijh.v1n1p21, DOI 10.5430/IJH.V1N1P21]; Jahn A, 2016, B WORLD HEALTH ORGAN, V94, P772, DOI 10.2471/BLT.15.166074; Kayira G. W., 2013, SOC MALAWI J, V66, P39; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Lorig K., 2007, PRIMER EVALUATING OU; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; Maddux J.E., 1995, SELF EFFICACY ADAPTA; Malawi Ministry of Health, 2013, PHAL DISTRCT HLTH SE; Malawi Ministry of Health, 2016, MAL POP BAS HIV IMP; Martin F, 2013, AIDS PATIENT CARE ST, V27, P697, DOI 10.1089/apc.2013.0254; Masanjala W, 2013, MULTI COUNTRY RES CO; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; Murphy K, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0969-y; Mwangome MN, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0345-5; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; Richard AA, 2011, J NURS SCHOLARSHIP, V43, P255, DOI 10.1111/j.1547-5069.2011.01404.x; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Russell S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147896; Schulman-Green D, 2016, J ADV NURS, V72, P1469, DOI 10.1111/jan.12902; SMRC, ENGL EV TOOLS; Tenthani L, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-140; van Olmen J, 2012, J TROPICAL MED, V2012; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; WHO, 2002, INNOVATIVE CARE CHRO; World Health Organization, 2014, NONC DIS COUNTR PROF; Wroe EB, 2015, HEALTHCARE, V3, P270, DOI 10.1016/j.hjdsi.2015.08.002	42	44	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199977	10.1371/journal.pone.0199977	http://dx.doi.org/10.1371/journal.pone.0199977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL5QR	29965990	Green Published, gold			2022-12-26	WOS:000437224100034
J	Heiden, BT; Chen, GA; Hermann, M; Brown, RKJ; Orringer, MB; Lin, J; Chang, AC; Carrott, PW; Lynch, WR; Zhao, LL; Beer, DG; Reddy, RM				Heiden, Brendan T.; Chen, Guoan; Hermann, Matthew; Brown, Richard K. J.; Orringer, Mark B.; Lin, Jules; Chang, Andrew C.; Carrott, Philip W.; Lynch, William R.; Zhao, Lili; Beer, David G.; Reddy, Rishindra M.			F- 18-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; METABOLIC SWITCH; PROGNOSTIC VALUE; F-18-FDG PET/CT; EXPRESSION; PI3K; ADAPTATION; PREDICTION; MYC	Background F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) is critical for staging non-small-cell lung cancer (NSCLC). While PET intensity carries prognostic significance, the genetic abnormalities associated with increased intensity remain unspecified. Methods NSCLC samples (N = 34) from 1999 to 2011 for which PET data were available were identified from a prospectively collected tumor bank. PET intensity was classified as mild, moderate, or intense based on SUVmax measurement or radiology report. Associations between genome-wide expression (RNAseq) and PET intensity were determined. Associations with overall survival were then validated in two external NSCLC cohorts. Results Overall survival was significantly worse in patients with PET-intense (N = 11) versus mild (N = 10) tumors (p = 0.039). Glycolytic gene expression patterns were markedly similar between intense and mild tumors. Gene ontology analysis demonstrated significant enhancement of cell-cycle and proliferative processes in FDG-intense tumors (p<0.001). Gene set enrichment analysis (GSEA) suggested associations between PET-intensity and canonical oncogenic signaling pathways including MYC, NF-kappa B, and HIF-1. Using an external cohort of 25 tumors with PET and genomic profiling data, common genes and gene sets were validated for additional study (P<0.05). Of these common gene sets, 20% were associated with hypoxia or HIF-1 signaling. While HIF-1 expression did not correlate with poor survival in the NSCLC validation cohort (N = 442), established targets of hypoxia signaling (PLAUR, ADM, CA9) were significantly associated with poor overall survival. Conclusions PET-intensity is associated with a variety of oncogenic alterations in operable NSCLC. Adjuvant targeting of these pathways may improve survival among patients with PET-intense tumors.	[Heiden, Brendan T.; Chen, Guoan; Orringer, Mark B.; Lin, Jules; Chang, Andrew C.; Carrott, Philip W.; Lynch, William R.; Beer, David G.; Reddy, Rishindra M.] Univ Michigan, Dept Surg, Thorac Surg Sect, Ann Arbor, MI 48109 USA; [Hermann, Matthew; Brown, Richard K. J.] Univ Michigan, Dept Radiol, Div Nucl Med, Ann Arbor, MI 48109 USA; [Zhao, Lili] Univ Michigan, Ctr Comprehens Canc, Biostat Unit, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Reddy, RM (corresponding author), Univ Michigan, Dept Surg, Thorac Surg Sect, Ann Arbor, MI 48109 USA.	reddyrm@med.umich.edu	Lin, Jules/AAK-3200-2021; Chen, Guoan/J-9140-2018	Chen, Guoan/0000-0001-5608-6761; Lin, Jules/0000-0003-4733-0659; Chang, Andrew/0000-0001-9506-0425; Heiden, Brendan/0000-0002-0116-7377	American Association for Thoracic Surgery (AATS); American Federation for Aging Research (AFAR)	American Association for Thoracic Surgery (AATS); American Federation for Aging Research (AFAR)	This work was supported in part by the American Association for Thoracic Surgery (AATS, www.aats.org) and the American Federation for Aging Research (AFAR, www.afar.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Casali C, 2010, LUNG CANCER, V69, P187, DOI 10.1016/j.lungcan.2009.10.015; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; de Geus-Oei LF, 2007, LUNG CANCER, V55, P79, DOI 10.1016/j.lungcan.2006.08.018; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Goldstraw P, 2006, J THORAC ONCOL, V1, P281, DOI 10.1097/01243894-200605000-00002; Goodgame B, 2008, J THORAC ONCOL, V3, P130, DOI 10.1097/JTO.0b013e318160c122; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lee HY, 2010, ANN SURG ONCOL, V17, P2787, DOI 10.1245/s10434-010-1107-z; Little AG, 2007, LUNG CANCER, V57, P253, DOI 10.1016/j.lungcan.2007.03.012; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Marom EM, 2001, LUNG CANCER-J IASLC, V33, P99, DOI 10.1016/S0169-5002(00)00250-6; Nadal E, 2014, J THORAC ONCOL, V9, P1513, DOI 10.1097/JTO.0000000000000305; Nair VS, 2014, LUNG CANCER, V83, P189, DOI 10.1016/j.lungcan.2013.11.001; Nair VS, 2012, CANCER RES, V72, P3725, DOI 10.1158/0008-5472.CAN-11-3943; Paesmans M, 2010, J THORAC ONCOL, V3, P1; Palaskas N, 2011, CANCER RES, V71, P5164, DOI 10.1158/0008-5472.CAN-10-4633; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Park SY, 2015, J NUCL MED, V56, P45, DOI 10.2967/jnumed.114.147561; Pastorek J, 2015, SEMIN CANCER BIOL, V31, P52, DOI 10.1016/j.semcancer.2014.08.002; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shiono S, 2011, J THORAC ONCOL, V6, P43, DOI 10.1097/JTO.0b013e3181f9abca; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song XR, 2006, CANCER CHEMOTH PHARM, V58, P776, DOI 10.1007/s00280-006-0224-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uehara H, 2013, ANN THORAC SURG, V96, P1958, DOI 10.1016/j.athoracsur.2013.06.086; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Younes M, 1997, CANCER-AM CANCER SOC, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7	37	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199970	10.1371/journal.pone.0199970	http://dx.doi.org/10.1371/journal.pone.0199970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966011	gold, Green Published, Green Submitted			2022-12-26	WOS:000437224100032
J	Kuki, MC; Scapim, CA; Rossi, ES; Mangolin, CA; do Amaral, AT; Pinto, RJB				Kuki, Mauricio Carlos; Scapim, Carlos Alberto; Rossi, Evandrei Santos; Mangolin, Claudete Aparecida; do Amaral Junior, Antonio Teixeira; Barth Pinto, Ronald Jose			Genome wide association study for gray leaf spot resistance in tropical maize core	PLOS ONE			English	Article							LOCI CONTROLLING RESISTANCE; DISEASE; MARKERS; REPEAT; BLIGHT; ATLAS	Gray leaf spot is a maize foliar disease with worldwide distribution and can drastically reduce the production in susceptible genotypes. Published works indicate that resistance to gray leaf spot is a complex trait controlled by multiple genes, with additive effect and influenced by environment. The aim of this study was to identify genomic regions, including putative genes, associated with resistance to gray leaf spot under natural conditions of disease occurrence. A genome wide association study was conducted with 355,972 single nucleotide polymorphism markers on a phenotypic data composed by 157 tropical maize inbred lines, evaluated at Maringa-Brazil. Seven single nucleotide polymorphisms were significantly associated with gray leaf spot, some of which were localized to previously reported quantitative trait loci regions. Three gene models linked to the associated single nucleotide polymorphism were expressed at flowering time and tissue related with gray leaf spot infection, explaining a considerable proportion of the phenotypic variance, ranging from 0.34 to 0.38. The gene model GRMZM2G073465 (bin 10.07) encodes a cysteine protease3 protein, gene model GRMZM2G007188 (bin 1.02) expresses a rybosylation factor-like protein and the gene model GRMZM2G476902 (bin 4.08) encodes an armadillo repeat protein. These three proteins are related with plant defense pathway. Once these genes are validated in next studies, they will be useful for marker-assisted selection and can help improve the understanding of maize resistance to gray leaf spot.	[Kuki, Mauricio Carlos; Scapim, Carlos Alberto; Rossi, Evandrei Santos; Mangolin, Claudete Aparecida; Barth Pinto, Ronald Jose] Univ Estadual Maringa, Dept Agron, Maringa, Parana, Brazil; [do Amaral Junior, Antonio Teixeira] Univ Estadual Norte Fluminense, Lab Melhoramento Genet Vegetal, Campos Dos Goytacazes, RJ, Brazil	Universidade Estadual de Maringa; Universidade Estadual do Norte Fluminense	Kuki, MC (corresponding author), Univ Estadual Maringa, Dept Agron, Maringa, Parana, Brazil.	mcarloskuki@gmail.com	mangolin, claudete a/F-3643-2015; do Amaral, Antônio Teixeira/AAD-6291-2021; scapim, Carlos/ABE-6461-2020	mangolin, claudete a/0000-0002-1653-3106; do Amaral, Antônio Teixeira/0000-0003-4831-7878; Kuki, Mauricio Carlos/0000-0002-6401-2313	CAPES-Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior; CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; State University of Maringa (UEM)	CAPES-Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State University of Maringa (UEM)	This work was supported by CAPES-Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (URL: http://www.capes.gov.br/), CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (URL: http://cnpq.br/web/guest/pagina-inicial), and the State University of Maringa (UEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agroceres, 1992, GUIA AGR SANID; [Anonymous], 2021, LANG ENV STAT COMP; Benson JM, 2015, PLOS GENET, V11, P1; Berger DK, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-60; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brito André Humberto, 2013, Rev. Ceres, V60, P629, DOI 10.1590/S0034-737X2013000500005; BUBECK DM, 1993, CROP SCI, V33, P838, DOI 10.2135/cropsci1993.0011183X003300040041x; Casela CR, 2006, DOENC E CULTURA MILH; Clements MJ, 2000, PHYTOPATHOLOGY, V90, P1018, DOI 10.1094/PHYTO.2000.90.9.1018; Companhia Nacional de Abastecimento-Conab, 2017, AC SAFR BRAS GRAOS 2; Crous PW, 2006, STUD MYCOL, P189, DOI 10.3114/sim.55.1.189; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Harper LC, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar016; Korsman J, 2012, EUR J PLANT PATHOL, V133, P461, DOI 10.1007/s10658-011-9920-1; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lee WY, 2003, PHYSIOL PLANTARUM, V119, P573, DOI 10.1046/j.1399-3054.2003.00215.x; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu L, 2016, PLANT DIS, V100, P304, DOI 10.1094/PDIS-08-14-0825-RE; Liu XL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005767; Mammadov J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2171-3; Maroof MAS, 1996, THEOR APPL GENET, V93, P539, DOI 10.1007/BF00417945; Money D, 2015, G3-GENES GENOM GENET, V5, P2383, DOI 10.1534/g3.115.021667; Olukolu BA, 2016, PHYTOPATHOLOGY, V106, P745, DOI 10.1094/PHYTO-11-15-0305-R; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Sharma M, 2014, DNA RES, V21, P267, DOI 10.1093/dnares/dst056; Shi LY, 2014, CROP J, V2, P132, DOI 10.1016/j.cj.2014.02.001; Shi LiYu, 2007, Agricultural Sciences in China, V6, P1411, DOI 10.1016/S1671-2927(08)60002-4; Sibov ST, 2003, HEREDITAS, V139, P96, DOI 10.1111/j.1601-5223.2003.01666.x; Stelpflug SC, 2015, PLANT GENOME, V9, P1; Tehon L.R., 1925, MYCOLOGIA, V17, P240, DOI [10.2307/3753890, DOI 10.2307/3753890]; van der Linde K, 2012, PLANT CELL, V24, P1285, DOI 10.1105/tpc.111.093732; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Walley JW, 2016, SCIENCE, V353, P814, DOI 10.1126/science.aag1125; Wang CL, 2014, MOL GENET GENOMICS, V289, P745, DOI 10.1007/s00438-014-0848-y; Ward JMJ, 1999, PLANT DIS, V83, P884, DOI 10.1094/PDIS.1999.83.10.884; Weng JF, 2012, PHYTOPATHOLOGY, V102, P692, DOI 10.1094/PHYTO-12-11-0330; Yin ZC, 2000, MOL PLANT MICROBE IN, V13, P869, DOI 10.1094/MPMI.2000.13.8.869; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171	42	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199539	10.1371/journal.pone.0199539	http://dx.doi.org/10.1371/journal.pone.0199539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953466	gold, Green Published, Green Submitted			2022-12-26	WOS:000436645400040
J	Kiertiburanakul, S; Wongprasit, P; Phuphuakrat, A; Chotiprasitsakul, D; Sungkanuparph, S				Kiertiburanakul, Sasisopin; Wongprasit, Pawinee; Phuphuakrat, Angsana; Chotiprasitsakul, Darunee; Sungkanuparph, Somnuek			Prevalence of HIV infection, access to HIV care, and response to antiretroviral therapy among partners of HIV-infected individuals in Thailand	PLOS ONE			English	Article							TRANSMISSION RISK; KNOWLEDGE; MEN; PREVENTION; SEROSTATUS; SEX	Background Health care providers usually focus on index HIV-infected patients and seldom obtain information from their partners. We aimed to determine HIV-preventative measures among couples, the prevalence of HIV infection, and treatment outcomes of partners. Methods This cross-sectional study was conducted in two hospital settings, a university hospital in Bangkok and a general hospital in northeastern Thailand, from January 2011-October 2015. Factors associated with serodiscordant relationships were determined by logistic regression. Results A total of 393 couples were enrolled for analysis; 156 (39.7%) were serodiscordant. The median relationship duration of serodiscordant couples was shorter than that of seroconcordant couples (6.4 years vs 11.6 years, p<0.001). Of 237 HIV-infected partners, 17.7% had AIDS-defining illness, the median nadir CD4 count (interquartile range) was 240 (96-427) cells/mm(3), 83.5% received antiretroviral therapy (ART), 98.3% had adherence > 95%, 90.3% had undetectable HIV RNA, and 22.9% had a prior history of treatment failure. There was no significant difference in condom usage in the prior 30 days between serodiscordant and seroconcordant couples. Factors of index HIV-infected patients associated with serodiscordant relationships were younger age (odds ratio [OR] 1.04 per 5 years; 95% confidence interval [CI] 1.01-1.06), receiving care at the general hospital (OR 1.73; 95% CI 1.08-2.78), a shorter duration of relationship (OR 1.04 per year; 95% CI 1.01-1.07), a higher nadir CD4 count (OR 1.06 per 50 cells/mm 3 ; 95% CI 1.1-1.13), and not receiving a protease inhibitor-based regimen (OR 2.04; 95% CI 1.06-3.96). Conclusions A high number of serodiscordant couples was determined. Partners' information should be retrieved as a holistic approach. Interventions for minimizing HIV transmission within serodiscordant couples should be evaluated and implemented.	[Kiertiburanakul, Sasisopin; Phuphuakrat, Angsana; Chotiprasitsakul, Darunee; Sungkanuparph, Somnuek] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok, Thailand; [Wongprasit, Pawinee] Buriram Hosp, Dept Med, Muang, Buriram, Thailand	Mahidol University	Kiertiburanakul, S (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok, Thailand.	sasisopin.kie@mahidol.ac.th	Phuphuakrat, Angsana/AAI-2492-2019	Phuphuakrat, Angsana/0000-0003-2474-1850; Chotiprasitsakul, Darunee/0000-0003-2669-0372	Office of the Higher Education Commission (Thailand); Faculty of Medicine Ramathibodi Hospital, Mahidol University	Office of the Higher Education Commission (Thailand); Faculty of Medicine Ramathibodi Hospital, Mahidol University	This study was funded by Office of the Higher Education Commission (Thailand). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the governments or institutions mentioned above. We would like to thank Dr. Gillian Campbell, University of Edinburgh, for editing the manuscript. She was paid by Faculty of Medicine Ramathibodi Hospital, Mahidol University.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2013, CONGUID UANT DRU; Bienzle D, 2000, J INFECT DIS, V182, P123, DOI 10.1086/315670; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Conserve D, 2013, AM J MENS HEALTH, V7, P450, DOI 10.1177/1557988312468146; Department of Disease Control Ministry of Public Health, THAIL NAT GUID HIV A; Hallal Ronaldo Campos, 2015, Rev. bras. epidemiol., V18, P169, DOI 10.1590/1809-4503201500050013; Jacobs RJ, 2013, AM J MENS HEALTH, V7, P186, DOI 10.1177/1557988312463417; Jennings L, 2015, AIDS BEHAV, V19, P291, DOI 10.1007/s10461-014-0884-y; Jiwatram-Negron T, 2014, AIDS BEHAV, V18, P1864, DOI 10.1007/s10461-014-0827-7; Kiertiburanakul S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147945; Kiertiburanakul S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062057; Nagaraj S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-181; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Phuphuakrat A, 2014, SEX HEALTH, V11, P119, DOI 10.1071/SH13045; Ravikumar Bc, 2013, Indian J Dermatol, V58, P405, DOI 10.4103/0019-5154.117304; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; The Joint United Nation Programme on HIV/AIDS, 2014, 90 90 90 AMB TREATM; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7; Wilson LE, 2011, AIDS CARE, V23, P971, DOI 10.1080/09540121.2010.543878; World Health Organization, 2015, GUID START ANT THER; Xia Q, 2006, AIDS, V20, P2081, DOI 10.1097/01.aids.0000247566.57762.b2	23	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198654	10.1371/journal.pone.0198654	http://dx.doi.org/10.1371/journal.pone.0198654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949594	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200020
J	Zhen, CG; Tan, Y; Miao, L; Wu, J; Gao, XW				Zhen, Congai; Tan, Yao; Miao, Ling; Wu, Jie; Gao, Xiwu			Overexpression of cytochrome P450s in a lambda-cyhalothrin resistant population of Apolygus lucorum (Meyer-Dur)	PLOS ONE			English	Article							TRANSGENIC BT COTTON; FENPROPATHRIN RESISTANCE; PYRETHROID RESISTANCE; MOLECULAR-CLONING; GENE-EXPRESSION; MESSENGER-RNA; LYGUS-LUCORUM; IDENTIFICATION; MIRIDAE; CARBOXYLESTERASE	The mirid bug, Apolygus lucorum Meyer-Dur, has been an important pest of cotton crop in China, and is primarily controlled with insecticides, such as pyrethroids. To elucidate the potential resistant mechanisms of A. lucorum to lambda-cyhalothrin, a series of biological, biochemical, and molecular assays were conducted in the reference (AL-S) and lambda-cyhalothrin-resistant (AL-R) populations. Comparison of the molecular target of pyrethroid insecticides, voltage-gated sodium channel, revealed that there were no mutation sites in the resistant population, indicating target insensitivity is not responsible for increased resistance of AL-R to lambda-cyhalothrin. Furthermore, the synergism assays and the activities of detoxification enzymes were performed to determine detoxification mechanism conferring the lambda-cyhalothrin resistance. In the tested synergists, the piperonyl butoxide had the highest synergism ratio against lambda-cyhalothrin, which was up to five-fold in both populations. In addition, the result also showed that only cytochrome P450 had significantly higher O-deethylase activity with 7-ethoxycoumarin (1.78-fold) in AL-R population compared with AL-S population. Seven cytochrome P450 genes were found to be significantly overexpressed in the resistant AL-R population compared with AL-S population. Taken together, these results demonstrate that multiple over-transcribed cytochrome P450 genes would be involved in the development of lambda-cyhalothrin resistance in AL-R population.	[Zhen, Congai; Tan, Yao; Miao, Ling; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing, Peoples R China; [Zhen, Congai; Wu, Jie] Chinese Acad Agr Sci, Inst Apicultural Res, Key Lab Pollinating Insect Biol, Minist Agr, Beijing, Peoples R China; [Tan, Yao] Inner Mongolia Agr Univ, Res Ctr Grassland Entomol, Hohhot, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs; Inner Mongolia Agricultural University	Gao, XW (corresponding author), China Agr Univ, Dept Entomol, Beijing, Peoples R China.; Wu, J (corresponding author), Chinese Acad Agr Sci, Inst Apicultural Res, Key Lab Pollinating Insect Biol, Minist Agr, Beijing, Peoples R China.	apis@vip.sina.com; gaoxiwu@263.net.cn	Tan, Yao/GZH-2907-2022	Tan, Yao/0000-0002-8450-9888				Arouri R, 2015, PEST MANAG SCI, V71, P1281, DOI 10.1002/ps.3924; Bautista MAM, 2007, PESTIC BIOCHEM PHYS, V87, P85, DOI 10.1016/j.pestbp.2006.06.004; Berge JB, 1998, PHILOS T R SOC B, V353, P1701, DOI 10.1098/rstb.1998.0321; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang J, 2010, PESTIC BIOCHEM PHYS, V98, P296, DOI 10.1016/j.pestbp.2010.06.021; Cong J, 2006, B ENVIRON CONTAM TOX, V76, P914, DOI 10.1007/s00128-006-1005-z; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; Grosso CG, 2016, INFECT GENET EVOL, V44, P459, DOI 10.1016/j.meegid.2016.07.027; Guzov VM, 1998, ARCH BIOCHEM BIOPHYS, V359, P231, DOI 10.1006/abbi.1998.0901; Holloway J. W., 1998, 1998 Proceedings Beltwide Cotton Conferences, San Diego, California, USA, 5-9 January 1998. Volume 2., P947; Huang Y, 2013, PESTIC BIOCHEM PHYS, V106, P1, DOI 10.1016/j.pestbp.2013.03.001; Jiang RZ, 2005, CROP BIOL DISASTER R; Kasai S, 2000, INSECT BIOCHEM MOLEC, V30, P163, DOI 10.1016/S0965-1748(99)00114-9; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Li GP, 2011, CROP PROT, V30, P1573, DOI 10.1016/j.cropro.2011.08.015; Liu Jia, 2015, Chinese Journal of Applied Entomology, V52, P616, DOI 10.7679/j.issn.2095-1353.2015.072; Liu NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023403; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y. H., 2008, BIOL CONTROL MIRIDS; Lu YH, 2007, ENVIRON ENTOMOL, V36, P1007, DOI 10.1603/0046-225X(2007)36[1007:FPOLLM]2.0.CO;2; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lu YanHui, 2011, Outlooks on Pest Management, V22, P248, DOI 10.1564/22dec02; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Ranasinghe C, 1998, PESTIC SCI, V54, P195, DOI 10.1002/(SICI)1096-9063(1998110)54:3&lt;195::AID-PS813&gt;3.0.CO;2-8; Rasool Akhtar, 2014, Insect Biochemistry and Molecular Biology, V53, P54, DOI 10.1016/j.ibmb.2014.07.006; Santo-Orihuela Pablo Luis, 2011, Acta toxicol. argent., V19, P32; Scott JG, 1999, GENE, V226, P347, DOI 10.1016/S0378-1119(98)00545-9; Shen ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079443, 10.1371/journal.pone.0054520]; Shi L, 2016, INSECT MOL BIOL, V25, P653, DOI 10.1111/imb.12251; Shi L, 2015, PESTIC BIOCHEM PHYS, V119, P33, DOI 10.1016/j.pestbp.2015.02.009; Stevens JL, 2000, INSECT BIOCHEM MOLEC, V30, P559, DOI 10.1016/S0965-1748(00)00024-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Vontas JG, 2002, BIOCHEM J, V362, P329, DOI 10.1042/bj3620329; Wheelock CE, 2005, J PESTIC SCI, V30, P75, DOI 10.1584/jpestics.30.75; Wu K, 2002, CROP PROT, V21, P997, DOI 10.1016/S0261-2194(02)00080-7; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Xi J, 2015, PESTIC BIOCHEM PHYS, V118, P77, DOI 10.1016/j.pestbp.2014.12.002; Xu Xin-Xin, 2012, Chinese Journal of Applied Entomology, V49, P324; Yang YH, 2008, PESTIC BIOCHEM PHYS, V92, P101, DOI 10.1016/j.pestbp.2008.07.001; Zhang P, 2015, CROP PROT, V76, P127, DOI 10.1016/j.cropro.2015.03.013; Zhen CG, 2016, PESTIC BIOCHEM PHYS, V127, P82, DOI 10.1016/j.pestbp.2015.09.011; Zhu YC, 2003, INSECT MOL BIOL, V12, P39, DOI 10.1046/j.1365-2583.2003.00385.x	48	10	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198671	10.1371/journal.pone.0198671	http://dx.doi.org/10.1371/journal.pone.0198671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949596	gold, Green Submitted, Green Published			2022-12-26	WOS:000436549200021
J	Garnett, ST; Ainsworth, GB; Zander, KK				Garnett, Stephen T.; Ainsworth, Gillian B.; Zander, Kerstin K.			Are we choosing the right flagships? The bird species and traits Australians find most attractive	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; HUMAN PREFERENCES; PHYSICAL ATTRACTIVENESS; SYSTEMATIC-APPROACH; RESPONSE RATES; CONSERVATION; INTERNET; VALUATION; ANIMALS; VALUES	Understanding what people like about birds can help target advocacy for bird conservation. However, testing preferences for characteristics of birds is methodologically challenging, with bias difficult to avoid. In this paper we test whether preferred characteristics of birds in general are shared by the individual bird species the same people nominate as being those they consider most attractive. We then compare these results with the birds which appear most frequently in the imagery of conservation advocates. Based on a choice model completed by 638 general public respondents from around Australia, we found a preference for small colourful birds with a melodious call. However, when the same people were asked which five birds they found most attractive, 48% named no more than three, mostly large well-known species. Images displayed by a leading Australian bird conservation organisation also favoured large colourful species. The choice model results suggest conservation advocates can promote a much wider range of bird types as flagships, particularly smaller species that might otherwise be neglected.	[Garnett, Stephen T.; Ainsworth, Gillian B.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT, Australia; [Ainsworth, Gillian B.] Ctr Ecol & Hydrol, Coastal Seas Ecol Team, Penicuik, Midlothian, Scotland; [Zander, Kerstin K.] Charles Darwin Univ, Northern Inst, Darwin, NT, Australia	Charles Darwin University; UK Centre for Ecology & Hydrology (UKCEH); Charles Darwin University	Zander, KK (corresponding author), Charles Darwin Univ, Northern Inst, Darwin, NT, Australia.	kerstin.zander@cdu.edu.au	Ainsworth, Gill/P-3013-2019; Zander, Kerstin/M-2888-2013	Ainsworth, Gill/0000-0003-0460-6563; Zander, Kerstin/0000-0002-2237-1801				Alberini A, 2006, GLOBAL ENVIRON CHANG, V16, P123, DOI 10.1016/j.gloenvcha.2006.02.001; Amiot CE, 2015, PSYCHOL BULL, V141, P6, DOI 10.1037/a0038147; [Anonymous], 1995, GLOBAL BIODIVERSITY; [Anonymous], 1994, HDB AUSTR NZ ANTARCT, V1-7; Australia Maps, 2012, STREET DIR COM AU; Australian Bureau of Statistics, 2007, 2006 CENS POP HOUS; Barrett G.W., 2003, NEW ATLAS AUSTR BIRD; Bowen-Jones E, 2002, ORYX, V36, P189, DOI 10.1017/S0030605302000261; Boxall PC, 2002, ENVIRON RESOUR ECON, V23, P421, DOI 10.1023/A:1021351721619; Boyle KJ, 2016, ENVIRON RESOUR ECON, V64, P401, DOI 10.1007/s10640-015-9876-2; Brambilla M, 2013, BIOL CONSERV, V160, P209, DOI 10.1016/j.biocon.2013.02.006; Burton M., 2016, AUST J AGR RESOUR EC, V59, P1, DOI DOI 10.5194/AMT-2015-380; Choi Bernard C K, 2005, Prev Chronic Dis, V2, pA16; Clucas B, 2008, BIODIVERS CONSERV, V17, P1517, DOI 10.1007/s10531-008-9361-0; Cluley RJ, 1990, UNIT BADGES ROYAL AU; Cocker M., 2013, BIRDS AND PEOPLE; Cole J., 1999, HUMAN DIMENSIONS WIL, V4, P44, DOI [https://doi.org/10.1080/10871209909359164, DOI 10.1080/10871209909359164]; Colleony A, 2017, BIOL CONSERV, V206, P263, DOI 10.1016/j.biocon.2016.11.035; Correia RA, 2016, PEERJ, V4, DOI 10.7717/peerj.1728; Coupey E, 1998, J CONSUM RES, V24, P459, DOI 10.1086/209521; Cozzolino M., 1980, SYMBOLS OF AUSTR; Douglas LR, 2014, BIODIVERS CONSERV, V23, P979, DOI 10.1007/s10531-014-0647-0; Echeverri A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170973; Entwistle A, 2000, ORYX, V34, P239, DOI 10.1046/j.1365-3008.2000.00140.x; Fleming CM, 2009, J ENVIRON MANAGE, V90, P284, DOI 10.1016/j.jenvman.2007.09.011; Garnett S. T., 2003, NATL LAND WATER RESO, P63; Garnett ST, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.61; Gunnthorsdottir A, 2001, ANTHROZOOS, V14, P204, DOI 10.2752/089279301786999355; Jacobsen JB, 2012, BIODIVERS CONSERV, V21, P543, DOI 10.1007/s10531-011-0200-3; Jepson P, 2015, CONSERV SOC, V13, P95, DOI 10.4103/0972-4923.161228; Jobson C., 2009, LOOKING FORWARD LOOK; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; La Fountain-Stokes L, 2007, CENTRO J, V19, P192; Legge S., 2004, KOOKABURRA KING BUSH; Lindhjem H, 2011, ECOL ECON, V70, P1628, DOI 10.1016/j.ecolecon.2011.04.002; Liskova S, 2015, EVOL PSYCHOL-US, V13, P339, DOI 10.1177/147470491501300203; Liskova S, 2013, ANTHROZOOS, V26, P27, DOI 10.2752/175303713X13534238631399; Lloyd S, 2013, J MARKET MANAG-UK, V29, P5, DOI 10.1080/0267257X.2013.765498; Lorimer J., 2009, INT ENCY HUMAN GEOGR, P324; MacDonald Donald, 1908, THE ARGUS; Martin-Collado D, 2014, ANIMAL, V8, P1373, DOI 10.1017/S1751731114000676; Nielsen JS, 2011, RESOUR ENERGY ECON, V33, P119, DOI 10.1016/j.reseneeco.2010.01.006; Olsen SB, 2009, ENVIRON RESOUR ECON, V44, P591, DOI 10.1007/s10640-009-9303-7; Pahl K., 2006, ENGLISH IN EDUCATION, V40, P20, DOI [10.1111/j.1754-8845.2006.tb00780.x, DOI 10.1111/J.1754-8845.2006.TB00780.X]; Sagoff M., 1988, EC EARTH; Sax LJ, 2003, RES HIGH EDUC, V44, P409, DOI 10.1023/A:1024232915870; Scarpa R, 2008, AUST J AGR RESOUR EC, V52, P253, DOI 10.1111/j.1467-8489.2007.00436.x; Serpell JA, 2004, ANIM WELFARE, V13, pS145; Shih TH, 2009, EDUC RES REV-NETH, V4, P26, DOI 10.1016/j.edurev.2008.01.003; Skibins J, 2016, J SUSTAIN TOUR, V24, P1024, DOI 10.1080/09669582.2015.1101126; Skibins JC, 2017, HUM DIMENS WILDL, V22, P157, DOI 10.1080/10871209.2016.1276233; Smith A. M., 2008, Human Dimensions of Wildlife, V13, P127, DOI 10.1080/10871200701883408; Smith RJ, 2012, CONSERV LETT, V5, P205, DOI 10.1111/j.1755-263X.2012.00229.x; SPASH CL, 1995, ECOL ECON, V12, P191, DOI 10.1016/0921-8009(94)00056-2; Spash CL, 2009, ECOL ECON, V68, P955, DOI 10.1016/j.ecolecon.2006.09.013; Spears NE, 1996, J BUS RES, V37, P87, DOI 10.1016/0148-2963(96)00060-4; Steven R, 2017, CONSERV BIOL, V31, P818, DOI 10.1111/cobi.12849; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Su S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127482; Teschke K, 2000, AM J IND MED, V38, P385, DOI 10.1002/1097-0274(200010)38:4<385::AID-AJIM3>3.0.CO;2-Q; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Vall-Llosera M, 2017, ECOL ECON, V131, P407, DOI 10.1016/j.ecolecon.2016.07.015; van Zanten BT, 2016, ECOSYST SERV, V17, P87, DOI 10.1016/j.ecoser.2015.11.011; Vaske JJ, 1999, SOC NATUR RESOUR, V12, P523, DOI 10.1080/089419299279425; Verissimo D, 2009, ANIM CONSERV, V12, P549, DOI 10.1111/j.1469-1795.2009.00282.x; Verissimo D, 2017, BIOL CONSERV, V211, P95, DOI 10.1016/j.biocon.2017.04.018; Verissimo D, 2014, CONSERV LETT, V7, P263, DOI 10.1111/conl.12070; Verissimo D, 2014, CONSERV BIOL, V28, P269, DOI 10.1111/cobi.12142; Verissimo D, 2011, CONSERV LETT, V4, P1, DOI 10.1111/j.1755-263X.2010.00151.x; Walpole MJ, 2002, BIODIVERS CONSERV, V11, P543, DOI 10.1023/A:1014864708777; Wilson C, 2005, BIRD CONSERV INT, V15, P225, DOI 10.1017/S0959270905000419; Wilson C, 2007, CONTEMP ECON POLICY, V25, P226, DOI 10.1111/j.1465-7287.2006.00021.x; Windle J, 2011, ECON ANAL POLICY, V41, P83, DOI 10.1016/S0313-5926(11)50006-2; Zander KK, 2014, CONSERV SOC, V12, P27, DOI 10.4103/0972-4923.132126; Zander KK, 2008, ECOL ECON, V68, P34, DOI 10.1016/j.ecolecon.2008.01.023; Zmihorski M, 2013, OIKOS, V122, P183, DOI 10.1111/j.1600-0706.2012.20486.x; Zorloni A, 2016, ART WEALTH MANAGEMEN, P67	77	15	17	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199253	10.1371/journal.pone.0199253	http://dx.doi.org/10.1371/journal.pone.0199253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK7JR	29944681	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000436377800024
J	Widrick, JJ; Gibbs, DE; Sanchez, B; Gupta, VA; Pakula, A; Lawrence, C; Beggs, AH; Kunkel, LM				Widrick, Jeffrey J.; Gibbs, Devin E.; Sanchez, Benjamin; Gupta, Vandana A.; Pakula, Anna; Lawrence, Christian; Beggs, Alan H.; Kunkel, Louis M.			An open source microcontroller based flume for evaluating swimming performance of larval, juvenile, and adult zebrafish	PLOS ONE			English	Article							LOCOMOTOR PERFORMANCE; DANIO-RERIO; MORPHOLOGY; BEHAVIOR; MODEL	Zebrafish are a preferred vertebrate model for delineating genotype-phenotype relationships. One of the most studied features of zebrafish is their exceptional swimming ability. By 7 days postfertilization (dpf), zebrafish spend over two-thirds of their time engaged in spontaneous swimming activity and several months later they are capable of attaining some of the fastest swimming velocities relative to body length ever recorded in the laboratory. However, laboratory-assembled flumes capable of achieving the slow flow velocities characteristics of larvae as well as the relatively fast maximal velocities of adults have not been described in sufficient detail to allow easy replication. Here we describe an easily assembled, open-source zebrafish-scaled flume for assessing swimming performance. The flume uses two independent spherical-impeller pumps modulated by a microcontroller to achieve flow velocities ranging from 1 to 70 cm s(-1). The microcontroller also monitors water temperature and flow velocity and sends these data to a personal computer for real-time display and storage. Incremental protocols for assessing maximal swimming speed (U-max) were developed, stored in custom software, and then uploaded to the microcontroller in order to assess performance of larval (14, 21, 28 dpf), juvenile (35, 42 dpf), and adult (8, 22 month) zebrafish. The flume had sufficient range and sensitivity to detect developmental changes in U-max of larvae and juveniles, an 18-24% faster U-max of adult males vs. females, and a 14-20% age-related reduction in U-max for the oldest zebrafish. Detailed information is provided to assemble and operate this low-cost, versatile, and reliable tool for assessing zebrafish swimming performance.	[Widrick, Jeffrey J.; Gibbs, Devin E.; Pakula, Anna; Beggs, Alan H.; Kunkel, Louis M.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA 02115 USA; [Widrick, Jeffrey J.; Gibbs, Devin E.; Pakula, Anna; Beggs, Alan H.; Kunkel, Louis M.] Harvard Med Sch, Boston, MA 02115 USA; [Sanchez, Benjamin] Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neuromuscular Dis, Boston, MA 02215 USA; [Gupta, Vandana A.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Lawrence, Christian] Boston Childrens Hosp, Aquat Resources Program, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Widrick, JJ (corresponding author), Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA 02115 USA.; Widrick, JJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	jeffrey.widrick@childrens.harvard.edu	; Sanchez, Benjamin/K-8148-2015	Gupta, Vandana/0000-0002-4057-8451; Widrick, Jeffrey/0000-0002-5597-1141; Beggs, Alan/0000-0001-8818-0568; Sanchez, Benjamin/0000-0002-1594-9847	National Institutes of Health [R01AR064300, R01AR044345]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD075802]; Muscular Dystrophy Association of U.S.A [MDA383249]; RYR-1 Foundation; AUism Charitable Foundation; Pfizer, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064300, R01AR044345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Muscular Dystrophy Association of U.S.A(Muscular Dystrophy Association); RYR-1 Foundation; AUism Charitable Foundation; Pfizer, Inc.(Pfizer); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funded by the National Institutes of Health R01AR064300 (LMK) and R01AR044345 (AHB), the Eunice Kennedy Shriver National Institute of Child Health and Human Development R01HD075802 (AHB), the Muscular Dystrophy Association of U.S.A MDA383249 (AHB), the RYR-1 Foundation (AHB), the AUism Charitable Foundation (AHB), and Pfizer, Inc. (LMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAZKA PM, 1960, PHYSIOL BOHEMOSLOV, V9, P553; BRETT JR, 1962, J FISH RES BOARD CAN, V19, P1025, DOI 10.1139/f62-067; Buss RR, 2001, J NEUROPHYSIOL, V86, P197, DOI 10.1152/jn.2001.86.1.197; Carneiro MC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005798; Conradsen C, 2015, J FISH BIOL, V87, P1219, DOI 10.1111/jfb.12784; Conradsen C, 2016, J EXP BIOL, V219, P2888, DOI 10.1242/jeb.141259; Ellerby David J., 2013, P345; Fiaz AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034072; Gerhard GS, 2002, EXP GERONTOL, V37, P1055, DOI 10.1016/S0531-5565(02)00088-8; Gilbert MJH, 2014, EXP GERONTOL, V50, P106, DOI 10.1016/j.exger.2013.11.013; Granato M, 1996, DEVELOPMENT, V123, P399; Gupta V, 2011, HUM MOL GENET, V20, P1712, DOI 10.1093/hmg/ddr047; James RS, 1998, J FISH BIOL, V53, P485, DOI 10.1006/jfbi.1998.0722; Lange M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070172; Leris I, 2013, J FISH BIOL, V83, P1381, DOI 10.1111/jfb.12210; Lindsey BW, 2010, ZEBRAFISH, V7, P85, DOI 10.1089/zeb.2009.0616; McHenry MJ, 2006, J MORPHOL, V267, P1099, DOI 10.1002/jmor.10462; Muggeo V.M., 2008, R NEWS, V8, P20; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Pearce JM, 2012, SCIENCE, V337, P1303, DOI 10.1126/science.1228183; Plaut I, 2000, J EXP BIOL, V203, P813; R Core Team, 2021, R LANGUAGE ENV STAT; Reidy SP, 2000, J EXP BIOL, V203, P347; Rombough P, 2002, J EXP BIOL, V205, P1787; Seebacher F, 2012, J EXP BIOL, V215, P663, DOI 10.1242/jeb.066712; Smith LL, 2013, JOVE-J VIS EXP, DOI 10.3791/50925; Spence R, 2007, J FISH BIOL, V71, P304, DOI 10.1111/j.1095-8649.2007.01492.x; VANRAAMSDONK W, 1982, ANAT EMBRYOL, V164, P63; Winata CL, 2009, DEV BIOL, V331, P222, DOI 10.1016/j.ydbio.2009.04.035	29	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199712	10.1371/journal.pone.0199712	http://dx.doi.org/10.1371/journal.pone.0199712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944715	Green Published, gold, Green Submitted			2022-12-26	WOS:000436377800056
J	Zmora, P; Hoffmann, M; Kollmus, H; Moldenhauer, AS; Danov, O; Braun, A; Winkler, M; Schughart, K; Pohlmann, S				Zmora, Pawel; Hoffmann, Markus; Kollmus, Heike; Moldenhauer, Anna-Sophie; Danov, Olga; Braun, Armin; Winkler, Michael; Schughart, Klaus; Poehlmann, Stefan			TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						influenza virus; protease; protease inhibitor; virus entry; virology; TMPRSS11A	HOST-CELL ENTRY; RESPIRATORY SYNDROME CORONAVIRUS; HUMAN AIRWAY EPITHELIUM; PROTEOLYTIC ACTIVATION; SERINE PROTEASES; MATRIPTASE; INHIBITOR; CLEAVAGE; IDENTIFICATION; TRYPSIN	The influenza virus hemagglutinin (HA) facilitates viral entry into target cells. Cleavage of HA by host cell proteases is essential for viral infectivity, and the responsible enzymes are potential targets for antiviral intervention. The type II transmembrane serine protease (TTSP) TMPRSS2 has been identified as an HA activator in cell culture and in the infected host. However, it is less clear whether TMPRSS2-related enzymes can also activate HA for spread in target cells. Moreover, the activity of cellular serine protease inhibitors against HA-activating TTSPs is poorly understood. Here, we show that TMPRSS11A, another member of the TTSP family, cleaves and activates the influenza A virus (FLUAV) HA and the Middle East respiratory syndrome coronavirus spike protein (MERS-S). Moreover, we demonstrate that TMPRSS11A is expressed in murine tracheal epithelium, which is a target of FLUAV infection, and in human trachea, suggesting that the protease could support FLUAV spread in patients. Finally, we show that HA activation by the TMPRSS11A-related enzymes human airway tryptase and DESC1, but not TMPRSS11A itself, is blocked by the cellular serine protease inhibitor hepatocyte growth factor activator inhibitor type-1 (HAI-1). Our results suggest that TMPRSS11A could promote FLUAV spread in target cells and that HA-activating TTSPs exhibit differential sensitivity to blockade by cellular serine protease inhibitors.	[Zmora, Pawel; Hoffmann, Markus; Moldenhauer, Anna-Sophie; Winkler, Michael; Poehlmann, Stefan] German Primate Ctr, Leibniz Inst Primate Res, Infect Biol Unit, D-37077 Gottingen, Germany; [Kollmus, Heike; Schughart, Klaus] Helmholtz Ctr Infect Res, Dept Infect Genet, D-38124 Braunschweig, Germany; [Schughart, Klaus] Univ Vet Med Hannover, D-30599 Hannover, Germany; [Schughart, Klaus] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Danov, Olga; Braun, Armin] German Ctr Lung Res DZL, Fraunhofer Inst Toxicol & Expt Med ITEM, Biomed Res Endstage & Obstruct Lung Dis Hannover, REBIRTH Cluster Excellence, D-30625 Hannover, Germany; [Poehlmann, Stefan] Univ Gottingen, Fac Biol & Psychol, D-37073 Gottingen, Germany	Deutsches Primatenzentrum (DPZ); Helmholtz Association; Helmholtz-Center for Infection Research; University of Veterinary Medicine Hannover, Foundation; University of Tennessee System; University of Tennessee Health Science Center; Fraunhofer Gesellschaft	Zmora, P (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Dept Bioproc Engn, Sandtorstr 1, D-39106 Magdeburg, Germany.; Pohlmann, S (corresponding author), German Primate Ctr, Infect Biol Unit, Kellnerweg 4, D-37077 Gottingen, Germany.	zmora@mpi-magdeburg.mpg.de; spoehlmann@dpz.eu	Zmora, Pawel/V-3843-2019; Hoffmann, Markus/J-7836-2018; Pöhlmann, Stefan/H-2395-2011; Braun, Armin/B-8750-2009	Zmora, Pawel/0000-0002-2012-7223; Hoffmann, Markus/0000-0003-4603-7696; Pöhlmann, Stefan/0000-0001-6086-9136; Braun, Armin/0000-0002-1142-1463; Winkler, Michael/0000-0002-6198-554X; Kollmus, Heike/0000-0002-9473-8676; Schughart, Klaus/0000-0002-6824-7523	Deutsche Forschungsgemeinschaft [PO 716/6-1]; Helmholtz Association; Leibniz Association	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Association(Helmholtz Association); Leibniz Association	This work was supported by Deutsche Forschungsgemeinschaft Grant PO 716/6-1 (to S. P.). This work was also supported by Intramural grants (Infection and Immunity Program) from the Helmholtz Association and by Intramural support from the Leibniz Association. The authors declare that they have no conflicts of interest with the contents of this article.	Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Baron J, 2013, J VIROL, V87, P1811, DOI 10.1128/JVI.02320-12; Beaulieu A, 2013, J VIROL, V87, P4237, DOI 10.1128/JVI.03005-12; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Bertram S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035876; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Bottcher E, 2009, VACCINE, V27, P6324, DOI 10.1016/j.vaccine.2009.03.029; Bottcher-Friebertshauser E, 2013, PATHOG DIS, V69, P87, DOI 10.1111/2049-632X.12053; Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Brauer R, 2015, JOVE-J VIS EXP, DOI 10.3791/52421; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Cheng ZS, 2015, J INFECT DIS, V212, P1214, DOI 10.1093/infdis/jiv246; Dittmann M, 2015, CELL, V160, P631, DOI 10.1016/j.cell.2015.01.040; Dunning J, 2014, LANCET INFECT DIS, V14, P1259, DOI 10.1016/S1473-3099(14)70821-7; Edinger TO, 2014, J GEN VIROL, V95, P263, DOI 10.1099/vir.0.059477-0; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Garten W, 2015, EUR J CELL BIOL, V94, P375, DOI 10.1016/j.ejcb.2015.05.013; Gierer S, 2015, J INFECT DIS, V211, P889, DOI 10.1093/infdis/jiu407; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Hamilton BS, 2014, BIOCHEM BIOPH RES CO, V450, P1070, DOI 10.1016/j.bbrc.2014.06.109; Hamilton BS, 2012, J VIROL, V86, P10579, DOI 10.1128/JVI.00306-12; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kato M, 2012, J BIOCHEM, V151, P179, DOI 10.1093/jb/mvr131; Kido H, 2007, CURR PHARM DESIGN, V13, P405, DOI 10.2174/138161207780162971; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Kuhn N, 2016, J VIROL, V90, P4298, DOI 10.1128/JVI.02693-15; Leist SR, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2483-y; Matthaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056659; Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Paules C, 2017, LANCET, V390, P697, DOI 10.1016/S0140-6736(17)30129-0; Richard M, 2016, FEMS MICROBIOL REV, V40, P68, DOI 10.1093/femsre/fuv039; Sakai K, 2015, J VIROL, V89, P5154, DOI 10.1128/JVI.00124-15; Sakai K, 2014, J VIROL, V88, P5608, DOI 10.1128/JVI.03677-13; Sales KU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023261; Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13; Sun XJ, 2013, ADV EXP MED BIOL, V790, P72, DOI 10.1007/978-1-4614-7651-1_4; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Tarnow C, 2014, J VIROL, V88, P4744, DOI 10.1128/JVI.03799-13; Watanabe T, 2015, CURR OPIN VIROL, V14, P71, DOI 10.1016/j.coviro.2015.08.008; Winkler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043337; Wrensch F, 2014, VIRUSES-BASEL, V6, P3683, DOI 10.3390/v6093683; Zmora P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138380; Zmora P, 2014, J VIROL, V88, P12087, DOI 10.1128/JVI.01427-14	52	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13863	13873		10.1074/jbc.RA118.001273	http://dx.doi.org/10.1074/jbc.RA118.001273			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29976755	Green Published, hybrid			2022-12-26	WOS:000444070700013
J	Rodriguez-Acebes, S; Mouron, S; Mendez, J				Rodriguez-Acebes, Sara; Mouron, Silvana; Mendez, Juan			Uncoupling fork speed and origin activity to identify the primary cause of replicative stress phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; molecular biology; cell division cycle 7-related protein kinase (Cdc7); DNA polymerase; DNA primase; fork speed; replication origin; replicative stress; stretched DNA fibers	DNA-REPLICATION; HUMAN-CELLS; S-PHASE; CANCER DEVELOPMENT; VERTEBRATE CELLS; INITIATION; CHK1; PROGRESSION; ACTIVATION; DYNAMICS	In growing cells, DNA replication precedes mitotic cell division to transmit genetic information to the next generation. The slowing or stalling of DNA replication forks at natural or exogenous obstacles causes "replicative stress" that promotes genomic instability and affects cellular fitness. Replicative stress phenotypes can be characterized at the single-molecule level with DNA combing or stretched DNA fibers, but interpreting the results obtained with these approaches is complicated by the fact that the speed of replication forks is connected to the frequency of origin activation. Primary alterations in fork speed trigger secondary responses in origins, and, conversely, primary alterations in the number of active origins induce compensatory changes in fork speed. Here, by employing interventions that temporally restrict either fork speed or origin firing while still allowing interrogation of the other variable, we report a set of experimental conditions to separate cause and effect in any manipulation that affects DNA replication dynamics. Using HeLa cells and chemical inhibition of origin activity (through a CDC7 kinase inhibitor) and of DNA synthesis (via the DNA polymerase inhibitor aphidicolin), we found that primary effects of replicative stress on velocity of replisomes (fork rate) can be readily distinguished from primary effects on origin firing. Identifying the primary cause of replicative stress in each case as demonstrated here may facilitate the design of methods to counteract replication stress in primary cells or to enhance it in cancer cells to increase their susceptibility to therapies that target DNA repair.	[Rodriguez-Acebes, Sara; Mouron, Silvana; Mendez, Juan] Spanish Natl Canc Res Ctr, Mol Oncol Programme, DNA Replicat Grp, 3 Melchor Fernandez Almagro, Madrid 28029, Spain; [Mouron, Silvana] Spanish Natl Canc Res Ctr, Clin Res Programme, Breast Canc Clin Res Unit, 3 Melchor Fernandez Almagro, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Mendez, J (corresponding author), Spanish Natl Canc Res Ctr, Mol Oncol Programme, DNA Replicat Grp, 3 Melchor Fernandez Almagro, Madrid 28029, Spain.	jmendez@cnio.es	Mendez, Juan/K-8001-2014; Rodriguez, Sara/AAA-8972-2019; Mouron, Silvana/L-7174-2014	Mendez, Juan/0000-0002-3235-2559; Rodriguez, Sara/0000-0002-9867-7591; Mouron, Silvana/0000-0001-6287-8001	Spanish Ministry of Science and Competitiveness [BFU2013-49153-P, BFU2016-80402-R, CSD2007-00015]	Spanish Ministry of Science and Competitiveness(Spanish Government)	This work was supported by Spanish Ministry of Science and Competitiveness Grants BFU2013-49153-P, BFU2016-80402-R, and CSD2007-00015 (to J.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahuja AK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10660; Alvarez S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9548; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Conti C, 2007, GENE CHROMOSOME CANC, V46, P724, DOI 10.1002/gcc.20448; Dorn ES, 2009, NUCLEIC ACIDS RES, V37, P60, DOI 10.1093/nar/gkn912; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Gallo David, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot085118; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Garcia-Muse T, 2016, NAT REV MOL CELL BIO, V17, P553, DOI 10.1038/nrm.2016.88; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Macheret M, 2018, NATURE, V555, P112, DOI 10.1038/nature25507; Malinsky J, 2001, J CELL SCI, V114, P747; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Mouron S, 2013, NAT STRUCT MOL BIOL, V20, P1383, DOI 10.1038/nsmb.2719; Munoz S, 2017, CHROMOSOMA, V126, P1, DOI 10.1007/s00412-016-0573-x; Neelsen KJ, 2013, GENE DEV, V27, P2537, DOI 10.1101/gad.226373.113; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Poli J, 2012, EMBO J, V31, P883, DOI 10.1038/emboj.2011.470; Puigvert JC, 2016, FEBS J, V283, P232, DOI 10.1111/febs.13574; Sarni D, 2016, CURR OPIN CELL BIOL, V40, P131, DOI 10.1016/j.ceb.2016.03.017; Schiavone D, 2016, MOL CELL, V61, P161, DOI 10.1016/j.molcel.2015.10.038; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Techer H, 2017, NAT REV GENET, V18, P535, DOI 10.1038/nrg.2017.46; Techer H, 2013, J MOL BIOL, V425, P4845, DOI 10.1016/j.jmb.2013.03.040; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Wan L, 2013, EMBO REP, V14, P1104, DOI 10.1038/embor.2013.159; Wheaton K, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00659-16; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhong Y, 2013, J CELL BIOL, V201, P373, DOI 10.1083/jcb.201208060	41	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12855	12861		10.1074/jbc.RA118.003740	http://dx.doi.org/10.1074/jbc.RA118.003740			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29959228	Green Published, hybrid			2022-12-26	WOS:000442203500018
J	Muhonja, CN; Makonde, H; Magoma, G; Imbuga, M				Muhonja, Christabel Ndahebwa; Makonde, Huxley; Magoma, Gabriel; Imbuga, Mabel			Biodegradability of polyethylene by bacteria and fungi from Dandora dumpsite Nairobi-Kenya	PLOS ONE			English	Article							LOW-DENSITY POLYETHYLENE	This study aimed at isolating and identifying bacteria and fungi with the capacity to degrade low density polyethylene (LDPE). The level of biodegradation of LDPE sheets with bacterial and fungal inoculums from different sampling points of Dandora dumpsite was evaluated under laboratory conditions. Incubation of the LDPE sheets was done for sixteen weeks at 37 degrees C and 28 degrees C for bacteria and fungi respectively in a shaker incubator. Isolation of effective candidates for biodegradation was done based on the recorded biodegradation outcomes. The extent of biodegradation on the polyethylene sheets was assessed by various techniques including weight loss analysis, Fourier Transform Infrared Spectroscopy (FTIR) and GC-MS. Fourier Transform Infra-Red spectroscopy (FTIR) analysis revealed the appearance of new functional groups attributed to hydrocarbon degradation after incubation with the bacteria and fungi. Analysis of the 16S rDNA and 18S rDNA sequences for bacteria and fungi respectively showed that bacteria belonging to genera Pseudomonas, Bacillus, Brevibacillus, Cellulosimicrobium, Lysinibacillus and fungi of genus Aspergillus were implicated as polyethylene degraders. An overall analysis confirmed that fungi are generally better degraders of polyethylene than bacteria. The highest fungal degradation activity was a mean weight reduction of 36.4 +/- 5.53% attributed to Aspergillus oryzae strain A5, 1 (MG779508). The highest degradation activity for bacteria was a mean of 35.72 +/- 4.01% and 20.28 +/- 2.30% attributed to Bacillus cereus strain A5, a (MG645264) and Brevibacillus borstelensis strain B2,2 (MG645267) respectively. Genus Aspergillus, Bacillus and Brevibacillus were confirmed to be good candidates for Low Density Poly Ethene bio-degradation. This was further confirmed by the appearance of the aldehyde, ether and carboxyl functional groups after FTIR analysis of the polythene sheets and the appearance of a ketone which is also an intermediary product in the culture media. To improve this degrading capacity through assessment of optimum conditions for microbial activity and enzyme production will enable these findings to be applied commercially and on a larger scale.	[Muhonja, Christabel Ndahebwa; Magoma, Gabriel] Pan African Univ Inst Sci Technol & Innovat, Nairobi, Kenya; [Makonde, Huxley] Tech Univ Mombasa, Dept Pure & Appl Sci, Mombasa, Kenya; [Imbuga, Mabel] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya	Technical University of Mombasa; Jomo Kenyatta University of Agriculture & Technology	Muhonja, CN (corresponding author), Pan African Univ Inst Sci Technol & Innovat, Nairobi, Kenya.	muhosh@gmail.com			African Union Commission [ADF/BD/WP/2013/68]; Japanese International Co-operation Agency (JICA) [00025]	African Union Commission; Japanese International Co-operation Agency (JICA)	This research is supported by the African Union Commission (ADF/BD/WP/2013/68 to CNM) and the Japanese International Co-operation Agency (JICA) (00025 to CNM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurah C.M., 2013, AM J ENV PROTECTION, V1, P96, DOI 10.12691/env-1-4-4.; Ausubel F.M., 1989, MOL BIOL, V1, P146, DOI [10.1002/mrd.1080010210, DOI 10.1002/MRD.1080010210]; Baud I, 2016, GEO J LIB, V76, DOI [10.1007/1-4020-2529-7_11, DOI 10.1007/1-4020-2529-7_11]; Bhatia M, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-497; Deepika S, 2015, J EXP BIOL AGRIC SCI, V3, P15; Esmaeili A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071720; Feng HK, 2009, POLYMER, V50, P3470, DOI 10.1016/j.polymer.2009.06.017; Gontia-Mishra I, 2014, INDIAN J BIOTECHNOL, V13, P536; Government of Kenya (GoK), 2017, KEN GAZ, VCXIX, P1077; Hadad D, 2005, J APPL MICROBIOL, V98, P1093, DOI 10.1111/j.1365-2672.2005.02553.x; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Ibiene A., 2014, NIGERIAN J BIOTECHNO, V26, P68, DOI [10.4314/njb.v26i1, DOI 10.4314/NJB.V26I1]; Kapri A, 2010, J MICROBIOL BIOTECHN, V20, P1032, DOI 10.4014/jmb.0912.12026; Khanam PN, 2015, ADV MANUF-POLYM COMP, V1, P63, DOI [10.1179/2055035915Y.0000000002, 10.1080/20550340.2016.1235768]; Kyaw BM, 2012, INDIAN J MICROBIOL, V52, P411, DOI 10.1007/s12088-012-0250-6; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lucas N, 2008, CHEMOSPHERE, V73, P429, DOI 10.1016/j.chemosphere.2008.06.064; Mahalakshmi V., 2012, International Journal of Pharmaceutical and Biological Archives, V3, P1190; Muller R., 2005, BIOPOLYMERS ONLINE, DOI [10.1002/3527600035.BPOLA012, DOI 10.1002/3527600035.BPOLA012, 10.1002/3527600035.bpola012]; Nanda S., 2010, N Y SCI J, V3, P95; Ojha N, 2017, SCI REP-UK, V7, DOI 10.1038/srep39515; Orhan Y, 2000, INT BIODETER BIODEGR, V45, P49, DOI 10.1016/S0964-8305(00)00048-2; Ramesh, 2015, AFR J BACTERIOL RES, V7, P24, DOI [10.5897/JBR2015.0152, DOI 10.5897/JBR2015.0152]; Sangale M. K., 2012, Journal of Bioremediation and Biodegradation, V3, P1000164; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Sheik S, 2015, INT BIODETER BIODEGR, V105, P21, DOI 10.1016/j.ibiod.2015.08.006; Shimao M, 2001, CURR OPIN BIOTECH, V12, P242, DOI 10.1016/S0958-1669(00)00206-8; Sudhakar M, 2008, INT BIODETER BIODEGR, V61, P203, DOI 10.1016/j.ibiod.2007.07.011; Suresh B., 2011, INT RES J MICROBIOLO, V2, P292; Vimala PP, 2016, PROC TECH, V24, P232, DOI 10.1016/j.protcy.2016.05.031; Vinay BR, 2016, INT J CURRENT RES, V8, P34752	31	116	123	27	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0198446	10.1371/journal.pone.0198446	http://dx.doi.org/10.1371/journal.pone.0198446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979708	Green Published, gold, Green Submitted			2022-12-26	WOS:000437809500008
J	Allam, I; Flatters, D; Caumes, G; Regad, L; Delos, V; Nuel, G; Camproux, AC				Allam, Ikram; Flatters, Delphine; Caumes, Geraldine; Regad, Leslie; Delos, Vincent; Nuel, Gregory; Camproux, Anne-Claude			SAFlex: A structural alphabet extension to integrate protein structural flexibility and missing data information	PLOS ONE			English	Article							STRUCTURE PREDICTION; DATA-BANK; CONFORMATIONAL-CHANGES; RECOGNITION; BACKBONE; MODELS; DEFORMATION; COMPLEXES; ENSEMBLES; SEQUENCES	In this paper, we describe SAFlex (Structural Alphabet Flexibility), an extension of an existing structural alphabet (HMM-SA), to better explore increasing protein three dimensional structure information by encoding conformations of proteins in case of missing residues or uncertainties. An SA aims to reduce three dimensional conformations of proteins as well as their analysis and comparison complexity by simplifying any conformation in a series of structural letters. Our methodology presents several novelties. Firstly, it can account for the encoding uncertainty by providing a wide range of encoding options: the maximum a posteriori, the marginal posterior distribution, and the effective number of letters at each given position. Secondly, our new algorithm deals with the missing data in the protein structure files (concerning more than 75% of the proteins from the Protein Data Bank) in a rigorous probabilistic framework. Thirdly, SAFlex is able to encode and to build a consensus encoding from different replicates of a single protein such as several homomer chains. This allows localizing structural differences between different chains and detecting structural variability, which is essential for protein flexibility identification. These improvements are illustrated on different proteins, such as the crystal structure of an eukaryotic small heat shock protein. They are promising to explore increasing protein redundancy data and obtain useful quantification of their flexibility.	[Allam, Ikram; Flatters, Delphine; Caumes, Geraldine; Regad, Leslie; Camproux, Anne-Claude] Univ Paris Diderot, Mol Therapeut Sil MTi, INSERM UMR S973, Paris 7, France; [Allam, Ikram; Delos, Vincent; Nuel, Gregory] Univ Paris 06, PSB, LPMA Lab, CNRS INSMI UMR 7599, Paris 6, France; [Allam, Ikram; Delos, Vincent; Nuel, Gregory] Univ Paris 05, CNRS UMR 8145, MAP5 Lab, Math Appl, Paris 5, France; [Allam, Ikram; Flatters, Delphine; Caumes, Geraldine; Regad, Leslie; Delos, Vincent; Nuel, Gregory; Camproux, Anne-Claude] Sorbonne Paris Cite, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Camproux, AC (corresponding author), Univ Paris Diderot, Mol Therapeut Sil MTi, INSERM UMR S973, Paris 7, France.; Nuel, G (corresponding author), Univ Paris 06, PSB, LPMA Lab, CNRS INSMI UMR 7599, Paris 6, France.; Nuel, G (corresponding author), Univ Paris 05, CNRS UMR 8145, MAP5 Lab, Math Appl, Paris 5, France.; Nuel, G; Camproux, AC (corresponding author), Sorbonne Paris Cite, Paris, France.	Gregory.Nuel@math.cnrs.fr; Anne-Claude.Camproux@univ-paris-diderot.fr		Camproux, Anne-Claude/0000-0001-8821-9952; Regad, Leslie/0000-0002-9292-5283	USPC grant (SA-Flex); ANR (BIP-BIP) [ANR-10-BINF-0003]	USPC grant (SA-Flex); ANR (BIP-BIP)(French National Research Agency (ANR))	This work was supported by a USPC grant (SA-Flex) and an ANR grant (ANR-10-BINF-0003, BIP-BIP).	Adams-Cioaba MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013559; Baeten L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000083; Baussand J, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-9; Bergendahl LT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05084-8; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERNSTEIN FC, 1978, ARCH BIOCHEM BIOPHYS, V185, P584, DOI 10.1016/0003-9861(78)90204-7; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Budowski-Tal I, 2010, P NATL ACAD SCI USA, V107, P3481, DOI 10.1073/pnas.0914097107; Camproux AC, 2005, BBA-GEN SUBJECTS, V1724, P394, DOI 10.1016/j.bbagen.2005.05.019; Camproux AC, 2004, J MOL BIOL, V339, P591, DOI 10.1016/j.jmb.2004.04.005; Camproux AC, 1999, PROTEIN ENG, V12, P1063, DOI 10.1093/protein/12.12.1063; Cho JH, 2014, P NATL ACAD SCI USA, V111, P12079, DOI 10.1073/pnas.1402054111; Craveur P, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00020; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; de Brevern AG, 2012, NUCLEIC ACIDS RES, V40, pW317, DOI 10.1093/nar/gks482; Deschavanne P, 2009, PROTEINS, V76, P129, DOI 10.1002/prot.22324; Dong QW, 2007, COMPUT BIOL MED, V37, P1610, DOI 10.1016/j.compbiomed.2007.03.002; Dong QW, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4628025; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Fix E., 1951, JOSEPH; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Frommlet F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148620; Gautier R, 2004, NUCLEIC ACIDS RES, V32, pW508, DOI 10.1093/nar/gkh388; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Griep S, 2010, NUCLEIC ACIDS RES, V38, pD318, DOI 10.1093/nar/gkp786; Grunberg R, 2004, STRUCTURE, V12, P2125, DOI 10.1016/j.str.2004.09.014; Guyon F, 2004, NUCLEIC ACIDS RES, V32, pW545, DOI 10.1093/nar/gkh467; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kalev I, 2011, BIOINFORMATICS, V27, P3110, DOI 10.1093/bioinformatics/btr541; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kolodny R, 2002, J MOL BIOL, V323, P297, DOI 10.1016/S0022-2836(02)00942-7; Lamiable A, 2016, J COMPUT CHEM, V37, P2006, DOI 10.1002/jcc.24422; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Le Gall T, 2007, J BIOMOL STRUCT DYN, V24, P325; Lensink MF, 2008, CURR PHARM BIOTECHNO, V9, P77, DOI 10.2174/138920108783955173; Mahajan S, 2014, J BIOMOL STRUCT DYN, V32, P751, DOI 10.1080/07391102.2013.789989; Marsh JA, 2015, ANNU REV BIOCHEM, V84, P551, DOI 10.1146/annurev-biochem-060614-034142; Marsh JA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001870; Martin J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-12; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Micheletti C, 2000, PROTEINS, V40, P662, DOI 10.1002/1097-0134(20000901)40:4<662::AID-PROT90>3.0.CO;2-F; Nuel G, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-15; Pandini A, 2016, J CHEM THEORY COMPUT, V12, P1368, DOI 10.1021/acs.jctc.5b00992; Pandini A, 2013, BIOINFORMATICS, V29, P2053, DOI 10.1093/bioinformatics/btt326; Pandini A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-97; Poulain P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009990; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Regad L, 2008, COMPUT STAT DATA AN, V52, P3198, DOI 10.1016/j.csda.2007.09.010; Regad L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182972; Regad L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-75; ROOMAN MJ, 1990, J MOL BIOL, V213, P327, DOI 10.1016/S0022-2836(05)80194-9; Sander O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-14; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sormanni P, 2017, NAT CHEM BIOL, V13, P339, DOI 10.1038/nchembio.2331; Tung C.H., 2013, INT J BIOSCI BIOCH B, V3, P433, DOI DOI 10.7763/IJBBB.2013.V3.250; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; UNGER R, 1989, PROTEINS, V5, P355, DOI 10.1002/prot.340050410; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Wang Sheng, 2008, Journal of Bioinformatics and Computational Biology, V6, P347, DOI 10.1142/S0219720008003461; Zhang X, 1993, Proc Int Conf Intell Syst Mol Biol, V1, P438	62	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0198854	10.1371/journal.pone.0198854	http://dx.doi.org/10.1371/journal.pone.0198854			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975698	Green Published, gold, Green Submitted			2022-12-26	WOS:000437424500011
J	Candyrine, SCL; Mahadzir, MF; Garba, S; Jahromi, MF; Ebrahimi, M; Goh, YM; Samsudin, AA; Sazili, AQ; Chen, WL; Ganesh, S; Ronimus, R; Muetzel, S; Liang, JB				Candyrine, Su Chui Len; Mahadzir, Mazrul Fahmi; Garba, Sani; Jahromi, Mohammad Faseleh; Ebrahimi, Mandi; Goh, Yong Meng; Samsudin, Anjas Asmara; Sazili, Awis Qurni; Chen, Wei Li; Ganesh, Siva; Ronimus, Ron; Muetzel, Stefan; Liang, Juan Boo			Effects of naturally-produced lovastatin on feed digestibility, rumen fermentation, microbiota and methane emissions in goats over a 12-week treatment period	PLOS ONE			English	Article							IN-VITRO; RUMINAL FERMENTATION; YUCCA-SCHIDIGERA; ENTERIC METHANE; STATINS; OPPORTUNITIES; BACTERIA; EXTRACT; PROTEIN; SETS	Twenty male Saanen goats were randomly assigned to four levels of lovastatin supplementation and used to determine the optimal dosage and sustainability of naturally produced lovastatin from fermentation of palm kernel cake (PKC) with Aspergillus terreus on enteric methane (CH4) mitigation. The effects on ruminal microbiota, rumen fermentation, feed digestibility and health of animal were determined over three measuring periods (4-, 8- and 12-weeks) and the accumulation of lovastatin in tissues was determined at the end of the experiment. The diets contained 50% rice straw, 22.8% concentrates and 27.2% of various proportions of untreated or treated PKC to achieve the target daily intake level of 0 (Control), 2, 4 or 6 mg lovastatin/kg body weight (BW). Enteric CH4 emissions per dry matter intake (DMI), decreased significantly (P<0.05) and equivalent to 11% and 20.4%, respectively, for the 2 and 4 mg/kg BW groups as compared to the Control. No further decrease in CH4 emission thereafter with higher lovastatin supplementation. Lovastatin had no effect on feed digestibility and minor effect on rumen microbiota, and specifically did not reduce the populations of total methanogens and Methanobacteriales (responsible for CH4 production). Similarly, lovastatin had little effect on rumen fermentation characteristics except that the proportion of propionate increased, which led to a decreasing trend (P<0.08) in acetic: propionate ratio with increasing dosage of lovastatin. This suggests a shift in rumen fermentation pathway to favor propionate production which serves as H+ sink, partly explaining the observed CH4 reduction. No adverse physiological effects were noted in the animals except that treated PKC (containing lovastatin) was less palatable at the highest inclusion level. Lovastatin residues were detected in tissues of goats fed 6 mg lovastatin/kg BW at between 0.01 to 0.03 mu g/g, which are very low.	[Candyrine, Su Chui Len; Mahadzir, Mazrul Fahmi; Garba, Sani; Goh, Yong Meng; Sazili, Awis Qurni; Chen, Wei Li; Liang, Juan Boo] Univ Putra Malaysia, Inst Trop Agr & Food Secur, Serdang, Selangor, Malaysia; [Candyrine, Su Chui Len] Univ Malaysia Sabah, Fac Sustainable Agr, Sandakan, Sabah, Malaysia; [Jahromi, Mohammad Faseleh] Agr Biotechnol Res Inst Iran, Mashhad, Iran; [Ebrahimi, Mandi; Goh, Yong Meng] Univ Putra Malaysia, Fac Vet Med, Serdang, Selangor, Malaysia; [Samsudin, Anjas Asmara; Sazili, Awis Qurni] Univ Putra Malaysia, Fac Agr, Serdang, Selangor, Malaysia; [Ganesh, Siva; Ronimus, Ron; Muetzel, Stefan] AgResearch, Rumen Microbiol, Palmerston North, New Zealand	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; AgResearch - New Zealand	Liang, JB (corresponding author), Univ Putra Malaysia, Inst Trop Agr & Food Secur, Serdang, Selangor, Malaysia.	jbliang@upm.edu.my	Garba, Sani/AAK-2704-2020; Ebrahimi, Mahdi/A-5042-2012; A., Samsudin A./AAJ-6659-2020; Goh, Y.M./B-2382-2010	Ebrahimi, Mahdi/0000-0002-3827-7369; A., Samsudin A./0000-0002-9758-7973; Goh, Y.M./0000-0003-1237-2170; Qurni, Awis/0000-0002-7362-0855; Chen, Wei Li/0000-0001-8936-6487	New Zealand Government [6386600]; Universiti Putra Malaysia [9300412]; New Zealand Government; Universiti Putra Malaysia	New Zealand Government; Universiti Putra Malaysia; New Zealand Government; Universiti Putra Malaysia	This study was funded by the New Zealand Government to support the objectives of Livestock Research Group of the Global Research Alliance on Agricultural Greenhouse Gases, Ministry of Primary Industries (6386600 to JBL) and Universiti Putra Malaysia (9300412 to JBL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the New Zealand Government to support the objectives of Livestock Research Group of the Global Research Alliance on Agricultural Greenhouse Gases and Universiti Putra Malaysia.	Adeniyi AF, 2010, CURR DIABETES REV, V6, P201, DOI 10.2174/157339910791658907; Antons KA, 2006, AM J MED, V119, P400, DOI 10.1016/j.amjmed.2006.02.007; AOAC, 1999, OFF METH AN ASS OFF; Azlan PM, 2018, TROP ANIM HEALTH PRO, V50, P565, DOI 10.1007/s11250-017-1470-x; Baird MF, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/960363; Benchaar C, 2011, ANIM FEED SCI TECH, V166-67, P338, DOI 10.1016/j.anifeedsci.2011.04.024; Boeckaert C, 2008, APPL ENVIRON MICROB, V74, P6923, DOI 10.1128/AEM.01473-08; Brancaccio P, 2007, BRIT MED BULL, V81-82, P209, DOI 10.1093/bmb/ldm014; Candyrine SCL, 2017, ANIM PROD SCI, V57, P1607, DOI 10.1071/AN15684; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Di Stasi SL, 2010, PHYS THER, V90, P1530, DOI 10.2522/ptj.20090251; Duncanson GR, 2012, VET TREATMENT SHEEP; Evans M, 2002, CURR OPIN LIPIDOL, V13, P415, DOI 10.1097/00041433-200208000-00009; Garnsworthy PC, 2012, J DAIRY SCI, V95, P3166, DOI 10.3168/jds.2011-4605; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Henderson G, 2018, ANIM PROD SCI, V58, P1017, DOI 10.1071/AN15757; Hristov AN, 1999, J ANIM SCI, V77, P2554; Huang XD, 2011, ANIM FEED SCI TECH, V166-67, P373, DOI 10.1016/j.anifeedsci.2011.04.026; Jahromi MF, 2013, AFR J PHARM PHARMACO, V7, P2106; Jahromi MF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/397934; Jahromi MF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/604721; KAKADE ML, 1972, J AGR FOOD CHEM, V20, P87, DOI 10.1021/jf60179a024; Klevenhusen F, 2011, ARCH ANIM NUTR, V65, P255, DOI 10.1080/1745039X.2011.588845; Knapp JR, 2014, J DAIRY SCI, V97, P3231, DOI 10.3168/jds.2013-7234; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Miller TL, 2001, J DAIRY SCI, V84, P1445, DOI 10.3168/jds.S0022-0302(01)70177-4; Miller TL, 1999, United States patent US, Patent No. [5,985,907, 5985907]; Mills JAN, 2003, J ANIM SCI, V81, P3141; Morgavi DP, 2013, J ANIM SCI, V91, P848, DOI 10.2527/jas.2012-5665; Muetzel S, 2015, NEW ZEAL J AGR RES, V58, P472, DOI 10.1080/00288233.2015.1090460; Oeztuerk H, 2010, J ANIM VET ADV, V9, P2752, DOI 10.3923/javaa.2010.2752.2758; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Pelchen A, 1998, SMALL RUMINANT RES, V27, P137, DOI 10.1016/S0921-4488(97)00031-X; Soares LFP, 2011, REV BRAS ZOOTECN, V40, P2005, DOI 10.1590/S1516-35982011000900023; Pinares-Patino C., 2012, TECHNICAL MANUAL RES; Ramirez-Restrepo CA, 2014, ANIM PROD SCI, V54, P1294, DOI 10.1071/AN14246; RUBINSTEIN A, 1991, AM J CARDIOL, V68, P1123, DOI 10.1016/0002-9149(91)90181-J; Seamamdg A., 2016, MERCK VET MANUAL; Sylvester JT, 2004, J NUTR, V134, P3378, DOI 10.1093/jn/134.12.3378; Syzdek J, 2009, J POWER SOURCES, V194, P66, DOI 10.1016/j.jpowsour.2009.01.070; Toral PG, 2016, J DAIRY SCI, V99, P301, DOI 10.3168/jds.2015-10292; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Vaughan CJ, 1996, LANCET, V348, P1079, DOI 10.1016/S0140-6736(96)05190-2; WALLACE RJ, 1994, APPL ENVIRON MICROB, V60, P1762, DOI 10.1128/AEM.60.6.1762-1767.1994; Wang LZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160198; Wang LZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154354; Wang Y, 2000, J APPL MICROBIOL, V88, P887, DOI 10.1046/j.1365-2672.2000.01054.x; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zhou M, 2009, APPL ENVIRON MICROB, V75, P6524, DOI 10.1128/AEM.02815-08	52	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199840	10.1371/journal.pone.0199840	http://dx.doi.org/10.1371/journal.pone.0199840			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975711	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000437424500048
J	Ezugwu, AE; Adeleke, OJ; Viriri, S				Ezugwu, Absalom E.; Adeleke, Olawale J.; Viriri, Serestina			Symbiotic organisms search algorithm for the unrelated parallel machines scheduling with sequence-dependent setup times	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; ECONOMIC-DISPATCH; TOTAL TARDINESS; MINIMIZE; MAKESPAN; FLOW	This paper addresses the problem of makespan minimization on unrelated parallel machines with sequence dependent setup times. The symbiotic organisms search (SOS) algorithm is a new and popular global optimization technique that has received wide acceptance in recent years from researchers in continuous and discrete optimization domains. An improved SOS algorithm is developed to solve the parallel machine scheduling problem. Since the standard SOS algorithm was originally developed to solve continuous optimization problems, a new solution representation and decoding procedure is designed to make the SOS algorithm suitable for the unrelated parallel machine scheduling problem (UPMSP). Similarly, to enhance the solution quality of the SOS algorithm, an iterated local search strategy based on combining variable numbers of insertion and swap moves is incorporated into the SOS algorithm. More so, to further improve the SOS optimization speed and performance, the longest processing time first (LPT) rule is used to design a machine assignment heuristic that assigns processing machines to jobs based on the machine dynamic load-balancing mechanism. Subsequently, the machine assignment scheme is incorporated into SOS algorithms and used to solve the UPMSP. The performances of the proposed methods are evaluated by comparing their solutions with other existing techniques from the literature. A number of statistical tests were also conducted to determine the variations in performance for each of the techniques. The experimental results showed that the SOS with LPT (SOSLPT) heuristic has the best performance compared to other tested method, which is closely followed by SOS algorithm, indicating that the two proposed algorithms' solution approaches are reasonable and effective for solving large-scale UPMSPs.	[Ezugwu, Absalom E.; Adeleke, Olawale J.; Viriri, Serestina] Univ Kwazulu Natal, Sch Math Stat & Comp Sci, Westville Campus, Durban, South Africa	University of Kwazulu Natal	Ezugwu, AE (corresponding author), Univ Kwazulu Natal, Sch Math Stat & Comp Sci, Westville Campus, Durban, South Africa.	Ezugwua@ukzn.ac.za	Viriri, Serestina/AAN-3882-2020; Ezugwu, Absalom El-Shamir/G-3015-2017	Viriri, Serestina/0000-0002-2850-8645; Ezugwu, Absalom El-Shamir/0000-0002-3721-3400				Agarwal R., 2004, WORKING PAPER; Anagnostopoulos GC, 2002, TSI PRESS S, V14, P115, DOI 10.1109/WAC.2002.1049430; Armentano VA, 2007, EUR J OPER RES, V183, P100, DOI 10.1016/j.ejor.2006.09.077; Arnaout JP, 2014, J INTELL MANUF, V25, P43, DOI 10.1007/s10845-012-0672-3; Arnaout JP, 2010, J INTELL MANUF, V21, P693, DOI 10.1007/s10845-009-0246-1; Balin S, 2011, INFORM SCIENCES, V181, P3551, DOI 10.1016/j.ins.2011.04.010; Baykasoglu A, 2018, J MANUF SYST, V46, P152, DOI 10.1016/j.jmsy.2017.12.005; Behnamian J, 2009, EXPERT SYST APPL, V36, P9637, DOI 10.1016/j.eswa.2008.10.007; Chang PC, 2011, APPL SOFT COMPUT, V11, P1263, DOI 10.1016/j.asoc.2010.03.003; Chen YY, 2013, INT J PROD ECON, V141, P66, DOI 10.1016/j.ijpe.2012.06.013; Cheng M. -Y., 2014, J CHIN I CIVIL HYDRA, V26, P293; Cheng MY, 2016, J COMPUT CIVIL ENG, V30, DOI 10.1061/(ASCE)CP.1943-5487.0000512; Cheng MY, 2014, COMPUT STRUCT, V139, P98, DOI 10.1016/j.compstruc.2014.03.007; Dell'Amico M, 2005, EUR J OPER RES, V160, P576, DOI 10.1016/j.ejor.2004.06.002; Dell'Amico M., 1995, ORSA Journal on Computing, V7, P191, DOI 10.1287/ijoc.7.2.191; Do DTT, 2017, APPL SOFT COMPUT, V61, P683, DOI 10.1016/j.asoc.2017.08.002; Ezugwu AE, 2017, FUTURE GENER COMP SY, V76, P33, DOI 10.1016/j.future.2017.05.024; Ezugwu AES, 2017, EXPERT SYST APPL, V87, P70, DOI 10.1016/j.eswa.2017.06.007; Ezugwu AES, 2017, EXPERT SYST APPL, V77, P189, DOI 10.1016/j.eswa.2017.01.053; Fleszar K, 2012, J INTELL MANUF, V23, P1949, DOI 10.1007/s10845-011-0522-8; Garey M.R., 1979, COMPUTERS INTRACTABI; Gatica Claudia R., ACO APPROACH PARALLE; Guo P, 2015, ENG OPTIMIZ, V47, P1564, DOI 10.1080/0305215X.2014.982634; Hao JH, 2010, CHINESE J ELECTRON, V19, P103; Jia J, 2009, INT J PROD RES, V47, P2565, DOI 10.1080/00207540701725042; Kashan AH, 2009, COMPUT IND ENG, V56, P216, DOI 10.1016/j.cie.2008.05.007; Keskinturk T, 2012, COMPUT OPER RES, V39, P1225, DOI 10.1016/j.cor.2010.12.003; Li XH, 2012, J INTELL MANUF, V23, P1179, DOI 10.1007/s10845-010-0428-x; Lin SW, 2014, COMPUT OPER RES, V51, P172, DOI 10.1016/j.cor.2014.05.013; Lin YK, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/409486; Marichelvam MK, 2014, APPL SOFT COMPUT, V19, P93, DOI 10.1016/j.asoc.2014.02.005; Mokotoff E, 2004, EUR J OPER RES, V152, P758, DOI [10.1016/S0377-2217(02)00726-9, 10.1016/S0377-2217(03)00726-9]; Mokotoff E, 2002, EUR J OPER RES, V141, P515, DOI 10.1016/S0377-2217(01)00270-3; Morton TE, 1993, HEURISTIC SCHEDULING; Pinedo M., 1995, SCHEDULING THEORY AL; Prasad D, 2016, ENG SCI TECHNOL, V19, P79, DOI 10.1016/j.jestch.2015.06.005; Ramezanian R, 2012, SCI IRAN, V19, P1887, DOI 10.1016/j.scient.2012.05.004; Secui DC, 2016, ENERGY, V113, P366, DOI 10.1016/j.energy.2016.07.056; Sonmez Y, 2017, J EXP THEOR ARTIF IN, V29, P495, DOI 10.1080/0952813X.2016.1198935; Tanaka S, 2008, INT J PROD ECON, V113, P446, DOI 10.1016/j.ijpe.2007.10.006; Torabi SA, 2013, APPL SOFT COMPUT, V13, P4750, DOI 10.1016/j.asoc.2013.07.029; Vallada E, 2011, EUR J OPER RES, V211, P612, DOI 10.1016/j.ejor.2011.01.011; Ying KC, 2010, EXPERT SYST APPL, V37, P2848, DOI 10.1016/j.eswa.2009.09.006; Yu VF, 2017, APPL SOFT COMPUT, V52, P657, DOI 10.1016/j.asoc.2016.10.006	44	29	29	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200030	10.1371/journal.pone.0200030	http://dx.doi.org/10.1371/journal.pone.0200030			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975783	Green Submitted, gold, Green Published			2022-12-26	WOS:000437424500061
J	Smirnov, MS; Garrett, TR; Yasuda, R				Smirnov, Michael S.; Garrett, Tavita R.; Yasuda, Ryohei			An open-source tool for analysis and automatic identification of dendritic spines using machine learning	PLOS ONE			English	Article							MICROSCOPY	Synaptic plasticity, the cellular basis for learning and memory, is mediated by a complex biochemical network of signaling proteins. These proteins are compartmentalized in dendritic spines, the tiny, bulbous, post-synaptic structures found on neuronal dendrites. The ability to screen a high number of molecular targets for their effect on dendritic spine structural plasticity will require a high-throughput imaging system capable of stimulating and monitoring hundreds of dendritic spines in various conditions. For this purpose, we present a program capable of automatically identifying dendritic spines in live, fluorescent tissue. Our software relies on a machine learning approach to minimize any need for parameter tuning from the user. Custom thresholding and binarization functions serve to "clean" fluorescent images, and a neural network is trained using features based on the relative shape of the spine perimeter and its corresponding dendritic backbone. Our algorithm is rapid, flexible, has over 90% accuracy in spine detection, and bundled with our user-friendly, open-source, MATLAB-based software package for spine analysis.	[Smirnov, Michael S.; Garrett, Tavita R.; Yasuda, Ryohei] Max Planck Florida Inst Neurosci, Neuronal Signal Transduct, Jupiter, FL 33458 USA; [Garrett, Tavita R.] Oregon Hlth & Sci Univ, Sch Med, Neurosci, Portland, OR 97201 USA	Max Planck Society; Oregon Health & Science University	Smirnov, MS (corresponding author), Max Planck Florida Inst Neurosci, Neuronal Signal Transduct, Jupiter, FL 33458 USA.	Michael.Smirnov@mpfi.org		Garrett, Tavita/0000-0002-2585-4251; Yasuda, Ryohei/0000-0001-6263-9297	National Institutes of Health-National Institute of Neurological Disorders and Stroke [5DP1NS096787]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP1NS096787] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All relevant work by Smirnov, Garrett, and Yasuda was supported by National Institutes of Health-National Institute of Neurological Disorders and Stroke - 5DP1NS096787.	Blumer C, 2015, MED IMAGE ANAL, V19, P87, DOI 10.1016/j.media.2014.09.004; Cheng J, 2009, AUTOMATED DETECTION; Cheng J, 2007, J NEUROSCI METH, V165, P122, DOI 10.1016/j.jneumeth.2007.05.020; Gala R, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00037; Hoover EE, 2013, NAT PHOTONICS, V7, P93, DOI [10.1038/nphoton.2013.361, 10.1038/nphoton.2012.361]; Jungblut D, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.076007; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim IH, 2014, ELIFE, V3, DOI 10.7554/eLife.02839; Kong T.Y., 1996, TOPOLOGICAL ALGORITH; LAM L, 1992, IEEE T PATTERN ANAL, V14, P869, DOI 10.1109/34.161346; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Sethian JA, 1996, P NATL ACAD SCI USA, V93, P1591, DOI 10.1073/pnas.93.4.1591; Smirnov MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170586; Soille P., 1999, MORPHOLOGICAL IMAGE, DOI 10.1007/978-3-662-05088-0; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Swanger SA, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-38; Tavita G, 2018, LABELED DENDRITIC SP, DOI [10.6084/m9.figshare.6149207.v1, DOI 10.6084/M9.FIGSHARE.6149207.V1]; Wang SH, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/454076; Zhang Y, 2010, NEUROIMAGE, V50, P1472, DOI 10.1016/j.neuroimage.2010.01.048	22	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199589	10.1371/journal.pone.0199589	http://dx.doi.org/10.1371/journal.pone.0199589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975722	Green Published, gold, Green Submitted			2022-12-26	WOS:000437424500040
J	Vasco, C; Bilsborrow, R; Torres, B; Griess, V				Vasco, Cristian; Bilsborrow, Richard; Torres, Bolier; Griess, Verena			Agricultural land use among mestizo colonist and indigenous populations: Contrasting patterns in the Amazon	PLOS ONE			English	Article							ECUADORIAN AMAZON; INTERNATIONAL MIGRATION; INCOME DIVERSIFICATION; COVER CHANGE; DEFORESTATION; DETERMINANTS; CONSERVATION; FERTILITY; FRONTIER; TENURE	This paper compares land use patterns of mestizo colonists and indigenous populations in the central Ecuadorian Amazon, based on data from a household survey covering mestizo colonist, Kichwa and Shuar households. As expected, colonists mostly engage in commercial agriculture and cattle ranching, but there are substantial differences in land use patterns between the Shuar and the Kichwa. The Shuar engage in cash cropping and cattle ranching, and on average, devote even more land to agricultural uses than mestizo colonists in this sample. In contrast, the Kichwa engage more in subsistence crop production and less in commercial agriculture. Such different patterns appear related to local conditions, earlier migratory and settlement patterns, and the level of exposure to markets. The implications of this for policy are explored in the conclusions.	[Vasco, Cristian] Univ Cent Ecuador, Fac Ciencias Agr, Quito, Ecuador; [Bilsborrow, Richard] Univ North Carol Chapel Hill, Carolina Populat Ctr, Chapel Hill, NC USA; [Torres, Bolier] Univ Estatal Amazon, Puyo, Ecuador; [Griess, Verena] Univ British Columbia, Dept Forest Resources Management, Vancouver, BC, Canada	Universidad Central del Ecuador; University of British Columbia	Vasco, C (corresponding author), Univ Cent Ecuador, Fac Ciencias Agr, Quito, Ecuador.	clvasco@uce.edu.ec	Griess, Verena/M-3343-2019; Vasco, Cristian/AAK-6842-2020	Griess, Verena/0000-0002-3856-3736; Torres, Bolier/0000-0002-9182-419X; Vasco, Cristian/0000-0001-7414-4910	Universidad Estatal Amazonica at Puyo, Ecuador [AMB-001-013]	Universidad Estatal Amazonica at Puyo, Ecuador	This paper was based upon work funded by Universidad Estatal Amazonica at Puyo, Ecuador (Award number: AMB-001-013 (https://www.uea.edu.ec/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Stoen M, 2016, J AGRAR CHANGE, V16, P123, DOI 10.1111/joac.12091; Alvarado M, 2012, NAPO PASTAZA DERECHO; Angelsen A, 1999, WORLD BANK RES OBSER, V14, P73, DOI 10.1093/wbro/14.1.73; [Anonymous], 2005, CONDITIONS AGR GROWT; [Anonymous], 2015, EL TELEGRAFO; Barbieri AF, 2005, POPUL ENVIRON, V27, P1, DOI 10.1007/s11111-005-0013-y; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Bilsborrow Richard E., 2004, Acta Amaz., V34, P635, DOI 10.1590/S0044-59672004000400015; Bremner J., 2006, CONSERV SOC, V4, P499; Bremner J, 2009, POPUL ENVIRON, V30, P93, DOI 10.1007/s11111-009-0078-0; Cavendish W., 2003, DO FOREST SUPPORT IN; Caviglia-Harris JL, 2005, AGR ECON-BLACKWELL, V32, P221, DOI 10.1111/j.1574-0862.2005.00238.x; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Davis J, 2015, INT PERSPECT SEX R H, V41, P1, DOI 10.1363/4100115; DAVIS SH, 1994, AMBIO, V23, P485; DUFOUR DL, 1990, BIOSCIENCE, V40, P652, DOI 10.2307/1311432; Ellis F, 2000, J AGR ECON, V51, P289, DOI 10.1111/j.1477-9552.2000.tb01229.x; Ellis F, 1999, RURAL LIVELIHOOD DIV; Ellis F., 1993, PEASANT EC FARM HOUS; FAO, 2005, STAT WORLDS FOR 2005; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Godoy R, 2005, J ANTHROPOL RES, V61, P157, DOI 10.3998/jar.0521004.0061.202; Godoy R, 1998, LAND ECON, V74, P162, DOI 10.2307/3147048; Gray CL, 2008, HUM ECOL, V36, P97, DOI 10.1007/s10745-007-9141-6; Grimaldi M, 2014, LANDSCAPE ECOL, V29, P311, DOI 10.1007/s10980-013-9981-y; Guzman-Gallegos, 1997, QUE YUCA BEBA NUESTR; Henrich J, 1997, HUM ECOL, V25, P319, DOI 10.1023/A:1021982324396; Hicks JF, 1990, ECUADORS AMAZON REGI; Hvalkof S., 2006, REIMAGINING POLITICA; INEC, 2010, CENS POBL VIV 2010; INIAP, 1997, MAN PAST AM EC; Kuntashula E, 2014, BIOMASS BIOENERG, V63, P187, DOI 10.1016/j.biombioe.2014.01.051; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Lonergan S, 1999, GLOBAL ENV CHANGE HU; Lu F, 2010, CONSERV BIOL, V24, P881, DOI 10.1111/j.1523-1739.2010.01463.x; Mainville N, 2006, SCI TOTAL ENVIRON, V368, P88, DOI 10.1016/j.scitotenv.2005.09.064; Martinez Novo Rodrigo, 2012, DESACATOS, V40, P111; Mejia E, 2015, INT FOREST REV, V17, P38, DOI 10.1505/146554815814668954; Murphy L, 1997, J DEV STUD, V34, P35, DOI 10.1080/00220389708422511; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Pan WKY, 2005, GLOBAL PLANET CHANGE, V47, P232, DOI 10.1016/j.gloplacha.2004.10.014; Pichon FJ, 1997, ECON DEV CULT CHANGE, V45, P707, DOI 10.1086/452305; Pichon FJ, 1997, WORLD DEV, V25, P67, DOI 10.1016/S0305-750X(96)00091-5; Porro R, 2014, TROPICS, V23, P47, DOI 10.3759/tropics.23.47; Prefectura de Pastaza, 2012, PLAN DES PROV PAST A; Restrepo M., 1998, CANELOS CUNA PASTAZA; Revelo J., 2003, FACTORES QUE AFECTAN; Rudel TK, 2002, LAT AM RES REV, V37, P144; Rudel TK, 2002, ANN ASSOC AM GEOGR, V92, P87, DOI 10.1111/1467-8306.00281; Schwartzman S, 2000, CONSERV BIOL, V14, P1351, DOI 10.1046/j.1523-1739.2000.99329.x; SENPLADES, 2012, PROC DESC EJ NIV ADM; SENPLADES, 2014, PROYECT EMBL PAST; SINGH I, 1986, WORLD BANK ECON REV, V1, P149, DOI 10.1093/wber/1.1.149; Siren AH, 2007, HUM ECOL, V35, P669, DOI 10.1007/s10745-006-9089-y; SOUTHGATE D, 1991, WORLD DEV, V19, P1145, DOI 10.1016/0305-750X(91)90063-N; Tandazo F, 2009, EFECTOS CONSTRUCCION; Taylor MJ, 2016, LAND USE POLICY, V54, P290, DOI 10.1016/j.landusepol.2016.02.024; Torres B, 2014, REV AMAZ CIENC TECNO, V3, P221; USIG, 2017, CART MAP COMM PAST; VADEZ V, 2003, FIELD METHOD, V15, P289; van Vliet N, 2013, SOC NATUR RESOUR, V26, P1454, DOI 10.1080/08941920.2013.820813; Vasco C, 2016, ANIM CONSERV, V19, P422, DOI 10.1111/acv.12259; VASCO C, 2014, J AGR RURAL DEV TROP, V115; Vasco C, 2017, DRIVERS MARKET INTEG; Vasco C, 2017, SOC NATUR RESOUR, V30, P1212, DOI 10.1080/08941920.2017.1331487; Vasco C, 2017, FOREST POLICY ECON, V78, P133, DOI 10.1016/j.forpol.2017.01.015; Perez CV, 2015, J RURAL STUD, V42, P1, DOI 10.1016/j.jrurstud.2015.09.003; von Thunen JH, 1966, THE ISOLATE STATE; Walker R, 2002, INT REGIONAL SCI REV, V25, P169, DOI 10.1177/016001702762481230; Wooldridge JM, 2002, INTRO ECONOMETRICS M; Zimmerman B, 2001, ENVIRON CONSERV, V28, P10, DOI 10.1017/S0376892901000029	72	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199518	10.1371/journal.pone.0199518	http://dx.doi.org/10.1371/journal.pone.0199518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL7YG	29975718	Green Submitted, Green Published, gold			2022-12-26	WOS:000437424500036
J	Scott, EM; Solomon, LA; Davidson, C; Storie, J; Palikhe, NS; Cameron, L				Scott, Emily MacLean; Solomon, Lauren A.; Davidson, Courtney; Storie, Jessica; Palikhe, Nami Shrestha; Cameron, Lisa			Activation of Th2 cells downregulates CRTh2 through an NFAT1 mediated mechanism	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; PROSTAGLANDIN D-2 RECEPTOR; TRANSCRIPTION FACTOR NFAT1; INNATE LYMPHOID-CELLS; HUMAN T-CELLS; CYTOKINE PRODUCTION; MAST-CELLS; GENE-TRANSCRIPTION; MICE LACKING; IN-VIVO	CRTh2 (encoded by PTGDR2) is a G-protein coupled receptor expressed by Th2 cells as well as eosinophils, basophils and innate lymphoid cells (ILC)2s. Activation of CRTh2, by its ligand prostaglandin (PG)D-2, mediates production of type 2 cytokines (IL-4, IL-5 and IL-13), chemotaxis and inhibition of apoptosis. As such, the PGD(2)-CRTh2 pathway is considered important to the development and maintenance of allergic inflammation. Expression of CRTh2 is mediated by the transcription factor GATA3 during Th2 cell differentiation and within ILC2s. Other than this, relatively little is known regarding the cellular and molecular mechanisms regulating expression of CRTh2. Here, we show using primary human Th2 cells that activation (24hrs) through TCR crosslinking (alpha CD3/alpha CD28) reduced expression of both mRNA and surface levels of CRTh2 assessed by flow cytometry and qRT-PCR. This effect took more than 4 hours and expression was recovered following removal of activation. EMSA analysis revealed that GATA3 and NFAT1 can bind independently to overlapping sites within a CRTh2 promoter probe. NFAT1 over-expression resulted in loss of GATA3-mediated CRTh2 promoter activity, while inhibition of NFAT using a peptide inhibitor (VIVIT) coincided with recovery of CRTh2 expression. Collectively these data indicate that expression of CRTh2 is regulated through the competitive action of GATA3 and NFAT1. Though prolonged activation led to NFAT1-mediated downregulation, CRTh2 was re-expressed when stimulus was removed suggesting this is a dynamic mechanism and may play a role in PGD(2)-CRTh2 mediated allergic inflammation.	[Scott, Emily MacLean; Davidson, Courtney; Storie, Jessica; Palikhe, Nami Shrestha; Cameron, Lisa] Univ Alberta, Dept Med, Pulm Res Grp, Edmonton, AB, Canada; [Solomon, Lauren A.; Cameron, Lisa] Western Univ, Dept Pathol & Lab Med, London, ON, Canada	University of Alberta; Western University (University of Western Ontario)	Cameron, L (corresponding author), Univ Alberta, Dept Med, Pulm Res Grp, Edmonton, AB, Canada.; Cameron, L (corresponding author), Western Univ, Dept Pathol & Lab Med, London, ON, Canada.	lisa.cameron@schulich.uwo.ca		Shrestha, Nami/0000-0002-9456-1145	Canadian Institute of Health Research [MOP111267]; Canadian Lung Association; Alberta Heritage Foundation for Medical Research [200700439]; GlaxoSmithKline-Canadian Institute of Health Research Chair in Airway Inflammation [233605]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Lung Association; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); GlaxoSmithKline-Canadian Institute of Health Research Chair in Airway Inflammation	Funded by Canadian Institute of Health Research (Grant #: MOP111267; LC, EMS), Canadian Lung Association (LC, EMS), Alberta Heritage Foundation for Medical Research (Grant #: 200700439; LC). LC also received funding from a GlaxoSmithKline-Canadian Institute of Health Research Chair in Airway Inflammation (Grant #: 233605; http://ca.gsk.com/en-ca/research/pathfinders-fund/) in the form of salary support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1999, GENE, V227, P71, DOI 10.1016/S0378-1119(98)00599-X; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Ahmed SR, 2011, J IMMUNOL, V187, P1432, DOI 10.4049/jimmunol.1100299; Alberto EC, 2012, ALLERGY, V67, P1357, DOI 10.1111/all.12003; Almishri W, 2005, J PHARMACOL EXP THER, V313, P64, DOI 10.1124/jpet.104.079079; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Barlic J, 2004, J BIOL CHEM, V279, P48520, DOI 10.1074/jbc.M406978200; Bates DL, 2008, J MOL BIOL, V381, P1292, DOI 10.1016/j.jmb.2008.06.072; Bingham CO, 2000, J ALLERGY CLIN IMMUN, V105, pS527, DOI 10.1016/S0091-6749(00)90056-3; Boehme SA, 2009, INT IMMUNOL, V21, P81, DOI 10.1093/intimm/dxn127; Brunner M, 2008, GENES IMMUN, V9, P640, DOI 10.1038/gene.2008.67; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; De Fanis U, 2007, BLOOD, V109, P4343, DOI 10.1182/blood-2006-05-025940; Dolganov G, 1996, BLOOD, V87, P3316, DOI 10.1182/blood.V87.8.3316.bloodjournal8783316; Dustin ML, 2004, IMMUNITY, V21, P305, DOI 10.1016/j.immuni.2004.08.016; Fajt ML, 2013, J ALLERGY CLIN IMMUN, V131, P1504, DOI 10.1016/j.jaci.2013.01.035; Fonseca BPF, 2009, AM J RESP CELL MOL, V40, P66, DOI 10.1165/rcmb.2007-0102OC; Fujitani Y, 2002, J IMMUNOL, V168, P443, DOI 10.4049/jimmunol.168.1.443; He R, 2010, J ALLERGY CLIN IMMUN, V126, P784, DOI 10.1016/j.jaci.2010.07.006; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Huang JL, 2004, HUM MOL GENET, V13, P2691, DOI 10.1093/hmg/ddh279; Iwasaki M, 2002, J INVEST DERMATOL, V119, P609, DOI 10.1046/j.1523-1747.2002.01862.x; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Kagawa S, 2011, INT ARCH ALLERGY IMM, V155, P6, DOI 10.1159/000327257; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lavenu-Bombled C, 2002, J BIOL CHEM, V277, P18313, DOI 10.1074/jbc.M110013200; Lukacs NW, 2008, AM J PHYSIOL-LUNG C, V295, pL767, DOI 10.1152/ajplung.90351.2008; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marelli-Berg FM, 2010, IMMUNOLOGY, V130, P158, DOI 10.1111/j.1365-2567.2010.03278.x; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Monticelli S, 2004, J BIOL CHEM, V279, P36210, DOI 10.1074/jbc.M406354200; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Mutalithas K, 2010, CLIN EXP IMMUNOL, V161, P34, DOI 10.1111/j.1365-2249.2010.04161.x; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Nagata K, 1999, J IMMUNOL, V162, P1278; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Nomiya R, 2008, J IMMUNOL, V180, P5680, DOI 10.4049/jimmunol.180.8.5680; Palikhe NS, 2016, CLIN EXP ALLERGY, V46, P825, DOI 10.1111/cea.12741; Peacock JW, 1999, J IMMUNOL, V162, P215; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Peters Stephen P, 2017, J Allergy Clin Immunol Pract, V5, pS15, DOI 10.1016/j.jaip.2017.07.008; Quapp R, 2007, BIOCHEM BIOPH RES CO, V363, P948, DOI 10.1016/j.bbrc.2007.09.076; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Santus P, 2016, EXPERT OPIN INV DRUG, V25, P1083, DOI 10.1080/13543784.2016.1212838; Satoh T, 2006, J IMMUNOL, V177, P2621, DOI 10.4049/jimmunol.177.4.2621; Scheinman EJ, 2009, J BIOL CHEM, V284, P3037, DOI 10.1074/jbc.M807302200; Shimura C, 2010, AM J PATHOL, V176, P227, DOI 10.2353/ajpath.2010.090111; Shiraishi Y, 2014, CLIN EXP ALLERGY, V44, P1076, DOI 10.1111/cea.12280; Shiraishi Y, 2008, J IMMUNOL, V180, P541, DOI 10.4049/jimmunol.180.1.541; Shirasaki H, 2009, ANN ALLERG ASTHMA IM, V102, P110, DOI 10.1016/S1081-1206(10)60239-6; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Son JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022042; Sundrud MS, 2003, J IMMUNOL, V171, P3542, DOI 10.4049/jimmunol.171.7.3542; Tan AHM, 2008, J BIOL CHEM, V283, P128, DOI 10.1074/jbc.M707693200; Tanaka K, 2004, BIOCHEM BIOPH RES CO, V316, P1009, DOI 10.1016/j.bbrc.2004.02.151; Viola JPB, 1998, BLOOD, V91, P2223, DOI 10.1182/blood.V91.7.2223.2223_2223_2230; Wambre E, 2012, J ALLERGY CLIN IMMUN, V129, P544, DOI 10.1016/j.jaci.2011.08.034; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Westhorpe CLV, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03181-4; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Xue L, 2009, CLIN EXP IMMUNOL, V156, P126, DOI 10.1111/j.1365-2249.2008.03871.x; Xue LZ, 2009, J IMMUNOL, V182, P7580, DOI 10.4049/jimmunol.0804090; Xue LZ, 2005, J IMMUNOL, V175, P6531, DOI 10.4049/jimmunol.175.10.6531; Yao X, 2010, CHINESE MED J-PEKING, V123, P739, DOI 10.3760/cma.j.issn.0366-6999.2010.06.019; Yu HX, 2007, CARDIOVASC DRUG REV, V25, P175, DOI 10.1111/j.1527-3466.2007.00011.x	73	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199156	10.1371/journal.pone.0199156	http://dx.doi.org/10.1371/journal.pone.0199156			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969451	Green Published, gold, Green Submitted			2022-12-26	WOS:000437246700009
J	Greene, BL; Nocera, DG; Stubbe, J				Greene, Brandon L.; Nocera, Daniel G.; Stubbe, JoAnne			Basis of dATP inhibition of RNRs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							HUMAN RIBONUCLEOTIDE REDUCTASE; ALLOSTERIC REGULATION	Ribonucleotide reductases (RNRs) are essential enzymes producing de novo deoxynucleotide (dNTP) building blocks for DNA replication and repair and regulating dNTP pools important for fidelity of these processes. A new study reveals that the class Ia Escherichia coli RNR is regulated by dATP via stabilization of an inactive 44 quaternary structure, slowing formation of the active 22 structure. The results support the importance of the regulatory 44 complex providing insight in design of experiments to understand RNR regulation in vivo.	[Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stubbe, JoAnne] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Greene, Brandon L.; Nocera, Daniel G.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Stubbe, J (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	stubbe@mit.edu			National Institutes of Health [GM029595, GM047274]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047274, R01GM029595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant GM029595. To whom correspondence may be addressed: Dept. of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139. Tel.: 617-253-1814; E-mail: stubbe@mit.edu.; Supported by National Institutes of Health Grant GM047274 (to D. G. N.).	Ahluwalia D, 2012, DNA REPAIR, V11, P480, DOI 10.1016/j.dnarep.2012.02.001; Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; Aye Y, 2012, CHEM BIOL, V19, P799, DOI 10.1016/j.chembiol.2012.05.015; Brignole EJ, 2018, ELIFE, V7, DOI [10.7554/eLife.3150, 10.7554/eLife.31502]; Chen PYT, 2018, J BIOL CHEM, V293, P10404, DOI 10.1074/jbc.RA118.002569; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Minnihan EC, 2013, ACCOUNTS CHEM RES, V46, P2524, DOI 10.1021/ar4000407; Minnihan EC, 2013, P NATL ACAD SCI USA, V110, P3835, DOI 10.1073/pnas.1220691110	10	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10413	10414		10.1074/jbc.H118.003717	http://dx.doi.org/10.1074/jbc.H118.003717			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29959279	Green Published, hybrid			2022-12-26	WOS:000437096700038
J	Griffen, BD				Griffen, Blaine D.			The timing of energy allocation to reproduction in an important group of marine consumers	PLOS ONE			English	Article							MANGROVE TREE CRAB; EUROPEAN GREEN CRAB; LIFE-HISTORY; HEMIGRAPSUS-SANGUINEUS; DECAPOD CRUSTACEANS; FEEDING SCHEDULE; HABITAT QUALITY; INVASIVE CRABS; BODY CONDITION; CLAW REMOVAL	Organisms may energetically finance reproductive effort using energy stored prior to the reproductive period (termed capital breeders) or using energy acquired during the reproductive period (termed income breeders). The specific strategy used has implications for population dynamics as well as for the response to environmental variation. Crabs and other crustaceans have generally been assumed to be capital breeders. Here I demonstrate an experimental procedure used to determine whether crabs are capable of using an income breeding strategy. I then examine data from several published studies from a range of crab species across a broad phylogenetic spectrum that conducted similar experiments to look for evidence of income breeding strategy. I show that income breeding does occur in crabs, but that it appears to be taxon-specific. In particular, I show that income breeding occurs in two species from the family Portunidae, but fail to find evidence for income breeding in other taxa examined. This finding has a range of implications for this ecologically and economically important group of consumers, including implications for their response to human-induced environmental change, their response to fishing pressure, and best practices for aquaculture. The implications of breeding strategy in crabs likely depends on phylogeny (morphology) and ecology, both of which influence the space available for energy storage inside the carapace.	[Griffen, Blaine D.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Brigham Young University	Griffen, BD (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	blaine_griffen@byu.edu	Griffen, Blaine/AAC-6384-2021		NSF [OCE-1129166]	NSF(National Science Foundation (NSF))	This work was supported by NSF grant (Directorate for Geosciences) #OCE-1129166 to BG; www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiyodi R.G., 1988, P139, DOI 10.1017/CBO9780511753428.006; Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; Anilkumar G, 1980, THESIS; Bearhop S, 2004, P ROY SOC B-BIOL SCI, V271, pS215, DOI 10.1098/rsbl.2003.0129; Belgrad BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145481; Bert TM, 2016, J SHELLFISH RES, V35, P241, DOI 10.2983/035.035.0127; Bonnet X, 1998, OIKOS, V83, P333, DOI 10.2307/3546846; Boretto JM, 2015, J ZOOL, V297, P77, DOI 10.1111/jzo.12245; Boudreau SA, 2012, MAR ECOL PROG SER, V469, P195, DOI 10.3354/meps09862; Briski E, 2012, BIOL INVASIONS, V14, P1843, DOI 10.1007/s10530-012-0194-0; Brockerhoff A, 2011, INVAD NAT SPRING SER, V6, P27, DOI 10.1007/978-94-007-0591-3_2; Brockman DK, 2005, CAM S BIO EVOL ANTHR, V44, P269, DOI 10.1017/CBO9780511542343.011; Carlton JT, 2003, J BIOGEOGR, V30, P1809, DOI 10.1111/j.1365-2699.2003.00962.x; Crocker DE, 2001, ECOLOGY, V82, P3541, DOI 10.2307/2680171; Culloch RM, 2016, MAR MAMMAL SCI, V32, P400, DOI 10.1111/mms.12259; DRENT RH, 1980, ARDEA, V68, P225; Drent RH, 2006, ARDEA, V94, P305; Duermit E, 2015, N AM J FISH MANAGE, V35, P895, DOI 10.1080/02755947.2015.1064836; Epifanio CE, 2013, J EXP MAR BIOL ECOL, V441, P33, DOI 10.1016/j.jembe.2013.01.010; GALLARDO PP, 1995, AQUACULTURE, V131, P239, DOI 10.1016/0044-8486(94)00321-E; GRAY IE, 1957, BIOL BULL, V112, P34, DOI 10.2307/1538877; Griffen BD, 2008, J ANIM ECOL, V77, P32, DOI 10.1111/j.1365-2656.2007.01304.x; Griffen BD, 2017, ECOL EVOL, V7, P2423, DOI 10.1002/ece3.2861; Griffen BD, 2015, BIOL INVASIONS, V17, P2533, DOI 10.1007/s10530-015-0890-7; Griffen BD, 2015, ECOL EVOL, V5, P1474, DOI 10.1002/ece3.1427; Griffen BD, 2015, MAR ECOL PROG SER, V522, P181, DOI 10.3354/meps11160; Griffen BD, 2014, OECOLOGIA, V174, P121, DOI 10.1007/s00442-013-2751-3; Griffen BD, 2012, BIOL INVASIONS, V14, P2545, DOI 10.1007/s10530-012-0251-8; Griffen BD, 2011, J EXP MAR BIOL ECOL, V406, P6, DOI 10.1016/j.jembe.2011.06.005; Griffen BD, 2011, J ANIM ECOL, V80, P854, DOI 10.1111/j.1365-2656.2011.01832.x; Griffen BD, 2009, BIOL INVASIONS, V11, P927, DOI 10.1007/s10530-008-9305-3; Grosholz ED, 1996, BIOL CONSERV, V78, P59, DOI 10.1016/0006-3207(94)00018-2; Hancock ER, 2017, MAR ECOL PROG SER, V582, P133, DOI 10.3354/meps12329; Heim KC, 2016, ECOL FRESHW FISH, V25, P156, DOI 10.1111/eff.12199; HINES AH, 1991, CAN J FISH AQUAT SCI, V48, P267, DOI 10.1139/f91-037; HINES AH, 1982, MAR BIOL, V69, P309, DOI 10.1007/BF00397496; Hogan JM, 2014, J SHELLFISH RES, V33, P795, DOI 10.2983/035.033.0314; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Juanes F, 1995, J EXP MAR BIOL ECOL, V193, P197, DOI 10.1016/0022-0981(95)00118-2; Kennish R, 1997, OECOLOGIA, V109, P209, DOI 10.1007/s004420050075; KYOMO J, 1988, MAR BIOL, V97, P87, DOI 10.1007/BF00391248; Lovrich GA, 2005, SCI MAR, V69, P183, DOI 10.3989/scimar.2005.69s2183; McDermott JJ, 1998, J CRUSTACEAN BIOL, V18, P308, DOI 10.2307/1549324; McDermott JJ, 2015, P BIOL SOC WASH, V128, P98, DOI 10.2988/0006-324X-128.1.98; MCDONALD J, 1982, MAR ECOL PROG SER, V8, P173, DOI 10.3354/meps008173; Mendo T, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2785-7; Ng Peter K.L., 2008, Raffles Bulletin of Zoology Supplement, V17, P1; Norris DR, 2005, OIKOS, V109, P178, DOI 10.1111/j.0030-1299.2005.13671.x; Packard GC, 1999, COMP BIOCHEM PHYS A, V122, P37, DOI 10.1016/S1095-6433(98)10170-8; PACKARD GC, 1988, PHYSIOL ZOOL, V61, P1; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pearse A. S., 1929, Journal of the Elisha Mitchell Scientific Society, V44, P230; Pettorelli N, 2002, P ROY SOC B-BIOL SCI, V269, P747, DOI 10.1098/rspb.2001.1791; POWELL GVN, 1986, BIOL CONSERV, V36, P101, DOI 10.1016/0006-3207(86)90001-7; Riley ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176263; Riley ME, 2014, SOUTHEAST NAT, V13, pN43, DOI 10.1656/058.013.0405; Riley ME, 2014, AQUAT BIOL, V20, P35, DOI 10.3354/ab00543; ROBLES C, 1987, ECOLOGY, V68, P1502, DOI 10.2307/1939234; Sanchez-Paz A, 2006, INSECT BIOCHEM MOLEC, V36, P241, DOI 10.1016/j.ibmb.2006.01.002; Schwemmer P, 2016, ECOL MODEL, V320, P322, DOI 10.1016/j.ecolmodel.2015.10.023; Silliman BR, 2002, P NATL ACAD SCI USA, V99, P10500, DOI 10.1073/pnas.162366599; Steneck RS, 2001, MARINE COMMUNITY ECOLOGY, P445; Steneck RS, 2004, ECOSYSTEMS, V7, P323, DOI 10.1007/s10021-004-0240-6; Steneck RS, 1977, P GULF MAIN EC DYN S; Stephens PA, 2009, ECOLOGY, V90, P2057, DOI 10.1890/08-1369.1; Suprayudi MA, 2002, FISHERIES SCI, V68, P1295, DOI 10.1046/j.1444-2906.2002.00567.x; Tacon AGJ., 2011, DEMAND SUPPLY FEED I; Tammaru T, 1996, OIKOS, V77, P561, DOI 10.2307/3545946; Tanaka H, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2773-y; Tepolt CK, 2014, J EXP BIOL, V217, P1129, DOI 10.1242/jeb.093849; TESHIMA S, 1986, B JPN SOC SCI FISH, V52, P519; Thatje S, 2005, ECOLOGY, V86, P619, DOI 10.1890/04-0620; Thomas V.G., 1988, P353; Varpe O, 2007, OIKOS, V116, P1331, DOI 10.1111/j.2007.0030-1299.15893.x; Wade NM, 2017, REV AQUACULT, V9, P141, DOI 10.1111/raq.12109; WARNER G F, 1977, P202; WARNER GF, 1967, J ZOOL, V153, P321, DOI 10.1111/j.1469-7998.1967.tb04066.x; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; WOLIN EM, 1973, DEV BIOL, V35, P160, DOI 10.1016/0012-1606(73)90013-4; Zeng YW, 2014, CRUSTACEANA, V87, P1648, DOI 10.1163/15685403-00003385	80	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199043	10.1371/journal.pone.0199043	http://dx.doi.org/10.1371/journal.pone.0199043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949621	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200036
J	Gruca-Rokosz, R; Koszelnik, P				Gruca-Rokosz, Renata; Koszelnik, Piotr			Production pathways for CH4 and CO2 in sediments of two freshwater ecosystems in south-eastern Poland	PLOS ONE			English	Article							ISOTOPE FRACTIONATION; METHANE OXIDATION; EUTROPHIC LAKE; METHANOGENESIS PATHWAYS; STABLE-ISOTOPES; CARBON-DIOXIDE; MASS-BALANCE; BIOGEOCHEMISTRY; ENVIRONMENTS; MARINE	This paper presents the results of research into pathways leading to the production of methane (CH4) and carbon dioxide (CO2) in sediments of two eutrophic reservoirs (Maziarnia and Nielisz), located in south-eastern Poland. In seeking to identify the pathways in question, use was made of analysis of stable carbon isotopes in CH4 and CO2 dissolved in pore water. This determined that CH4 is mainly produced through acetate fermentation, though the hydrogenotrophic methanogenic process may also be of importance, especially in deeper layers of sediments. Both the presence of autochthonous organic matter and increased pH values are shown to favour acetate fermentation. In turn, methanogenesis in sediments is assessed as capable of accounting for the generation of a considerable amount of CO2 . Indeed, the role of methanogenesis in CO2 production is increasingly important further down in the layers of sediment, where allochthonous organic matter is predominant.	[Gruca-Rokosz, Renata; Koszelnik, Piotr] Rzeszow Univ Technol, Dept Environm & Chem Engn, Fac Civil & Environm Engn & Architecture, Rzeszow, Poland	Rzeszow University of Technology	Gruca-Rokosz, R (corresponding author), Rzeszow Univ Technol, Dept Environm & Chem Engn, Fac Civil & Environm Engn & Architecture, Rzeszow, Poland.	renatagr@prz.edu.pl	Koszelnik, Piotr/D-4747-2013	Koszelnik, Piotr/0000-0001-6866-7432; Gruca-Rokosz, Renata/0000-0001-8222-2480	Poland's Ministry of Science [N N305 077836]; NCN [2011/03/B/ST10/04998]	Poland's Ministry of Science; NCN	The study was supported by Poland's Ministry of Science, via grant no. N N305 077836 (RG-R). Since 2010 the documentation has been archived in the National Science Centre (NCN). Part of the model research was funded by the NCN via grant no. 2011/03/B/ST10/04998. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, SYNTHESIS REPORT; BARKER H. ALBERT, 1936, ARCH MIKROBIOL, V7, P420, DOI 10.1007/BF00407414; Bartoszek L, 2007, ENVIRON PROT ENG, V33, P25; Bastviken D., 2009, ENCY INLAND WATERS, P783, DOI [10.1016/b978-012370626-3.00117-4, DOI 10.1016/B978-012370626-3.00117-4]; BENNER R, 1984, APPL ENVIRON MICROB, V47, P998, DOI 10.1128/AEM.47.5.998-1004.1984; Bergier I., 2011, OECOL AUST, V15, P666, DOI [10.4257/oeco.2011.1503.17, DOI 10.4257/0EC0.2011.1503.17, DOI 10.4257/OECO.2011.1503.17]; Boehme SE, 1996, GEOCHIM COSMOCHIM AC, V60, P3835, DOI 10.1016/0016-7037(96)00204-9; Chanton JP, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2008GB003274; Conrad R, 2005, ORG GEOCHEM, V36, P739, DOI 10.1016/j.orggeochem.2004.09.006; Conrad R, 2010, LIMNOL OCEANOGR, V55, P1932, DOI 10.4319/lo.2010.55.5.1932; Conrad R, 2010, LIMNOL OCEANOGR, V55, P689, DOI 10.4319/lo.2009.55.2.0689; Conrad R, 2009, LIMNOL OCEANOGR, V54, P457, DOI 10.4319/lo.2009.54.2.0457; Corbett JE, 2013, BIOGEOCHEMISTRY, V114, P327, DOI 10.1007/s10533-012-9813-1; DEVOL AH, 1988, J GEOPHYS RES-ATMOS, V93, P1583, DOI 10.1029/JD093iD02p01583; Furlanetto LM, 2012, LIMNOLOGICA, V42, P151, DOI 10.1016/j.limno.2011.09.009; Galand PE, 2010, BIOGEOSCIENCES, V7, P3893, DOI 10.5194/bg-7-3893-2010; Glissmann K, 2004, MICROB ECOL, V48, P389, DOI 10.1007/s00248-003-2027-2; Gruca-Rokosz R., 2011, INZYN EKOL, V26, P196; Gruca-Rokosz R, 2015, WATER AIR SOIL POLL, V226, DOI 10.1007/s11270-014-2268-3; Gruca-Rokosz R, 2011, ENVIRON PROT ENG, V37, P101; Gruca-Rokosz R, 2011, POL J ENVIRON STUD, V20, P81; Hershey AE, 2014, BIOGEOCHEMISTRY, V117, P325, DOI 10.1007/s10533-013-9864-y; Hornibrook ERC, 2000, GEOCHIM COSMOCHIM AC, V64, P1013, DOI 10.1016/S0016-7037(99)00321-X; JEDRYSEK MO, 1995, GEOCHIM COSMOCHIM AC, V59, P557, DOI 10.1016/0016-7037(94)00369-W; Jedrysek MO, 1999, CHEM GEOL, V159, P241, DOI 10.1016/S0009-2541(99)00040-6; Jedrysek MO, 1998, WATER-ROCK INTERACTION, P325; Jedrysek MO, 2014, ANN U M CURIE SKLODO, VLXIX, P29; Jedrysek MO, 1997, ACTA U VRATISLAVIENI, VLXIII, P1; KELLY CA, 1982, LIMNOL OCEANOGR, V27, P868, DOI 10.4319/lo.1982.27.5.0868; Lima IBT, 2005, CHEMOSPHERE, V59, P1697, DOI 10.1016/j.chemosphere.2004.12.011; Lojen S, 1999, CHEM GEOL, V159, P223, DOI 10.1016/S0009-2541(99)00032-7; Mandic-Mulec I, 2012, LIMNOL OCEANOGR, V57, P868, DOI 10.4319/lo.2012.57.3.0868; MIYAJIMA T, 1995, LIMNOL OCEANOGR, V40, P994, DOI 10.4319/lo.1995.40.5.0994; Murase J, 2001, GEOCHEM J, V35, P257, DOI 10.2343/geochemj.35.257; Nusslein B, 2000, ARCH HYDROBIOL, V149, P597; Nusslein B, 2003, LIMNOL OCEANOGR, V48, P1439; Ogrinc N, 2002, GLOBAL PLANET CHANGE, V33, P57, DOI 10.1016/S0921-8181(02)00061-9; Paull C.K., 2000, PROC OCEAN DRILLING, V164, P67, DOI DOI 10.2973/ODP.PROC.SR.164.207.2000; REEBURGH WS, 1967, LIMNOL OCEANOGR, V12, P163, DOI 10.4319/lo.1967.12.1.0163; REEBURGH WS, 1980, EARTH PLANET SC LETT, V47, P345, DOI 10.1016/0012-821X(80)90021-7; Takai Y., 1970, Soil Science and Plant Nutrition, V16, P238, DOI 10.1080/00380768.1970.10433371; Tomaszek J, 1991, SCI PAPERS RZESZOW U, V84; Valentine DL, 2004, GEOCHIM COSMOCHIM AC, V68, P1571, DOI 10.1016/j.gca.2003.10.012; Wand U, 2006, LIMNOL OCEANOGR, V51, P1180, DOI 10.4319/lo.2006.51.2.1180; Whiticar M.J., 1996, MITT INT VER LIMNOL, V25, P39, DOI [10.1080/05384680.1996.11904065, DOI 10.1080/05384680.1996.11904065]; WHITICAR MJ, 1986, ORG GEOCHEM, V10, P759, DOI 10.1016/S0146-6380(86)80013-4; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; Wu M, 2014, CIESC J, V65, P1606; Wu ZJ, 2008, J EARTH SYST SCI, V117, P935, DOI 10.1007/s12040-008-0078-y; Zimmermann C.F., 1997, 4400 USEPA NER LAB	51	15	15	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199755	10.1371/journal.pone.0199755	http://dx.doi.org/10.1371/journal.pone.0199755			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949634	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200065
J	Kaushik, P; Plazas, M; Prohens, J; Vilanova, S; Gramazio, P				Kaushik, Prashant; Plazas, Mariola; Prohens, Jaime; Vilanova, Santiago; Gramazio, Pietro			Diallel genetic analysis for multiple traits in eggplant and assessment of genetic distances for predicting hybrids performance	PLOS ONE			English	Article							COMBINING-ABILITY; SOLANUM-MELONGENA; AGRONOMIC TRAITS; YIELD; FRUIT; DIVERSITY; HETEROSIS; TOMATO; IDENTIFICATION; HYBRIDIZATION	Evaluation and prediction of the performance of hybrids is important in eggplant (Solanum melongena) breeding. A set of 10 morphologically highly diverse eggplant parents, including nine inbred S. melongena and one weedy S. insanum accessions, were intercrossed according to a half-diallel mating design without reciprocals to obtain 45 hybrids. Parents and hybrids were evaluated for 14 morphological and agronomic conventional descriptors and 14 fruit morphometric traits using Tomato Analyzer. Genetic distances among parents were estimated with 7,335 polymorphic SNP markers. Wide ranges of variation and significant differences were observed in the set of 55 genotypes for all traits, although the hybrids group had significantly higher vigour and yield than parents. General and specific combining abilities (GCA and SCA) were significant for most (GCA) or all (SCA) traits, although a wide variation was obtained for GCA/SCA ratios. Many relevant traits associated to vigour and yield had low GCA/SCA ratios and narrow-sense heritability (h(2)) values, while the reverse occurred for most fruit shape descriptors. Broad-sense heritability (H-2) values were generally high, irrespective of GCA/SCA ratios. Significant correlations were found between traits related to size of leaf, flower and fruit, as well as among many fruit morphometric traits. Genetic distances (GD) among parents were coherent with their phylogenetic relationships, but few significant and generally low correlations were found between GD and hybrid means, heterosis or SCA. The results provide relevant information for developing appropriate strategies for parent selection and hybrid development in eggplant and suggest that GD among parents have limited value to predict hybrid performance in this crop.	[Kaushik, Prashant; Prohens, Jaime; Vilanova, Santiago; Gramazio, Pietro] Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valencia, Valencia, Spain; [Plazas, Mariola] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain	Universitat Politecnica de Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Prohens, J (corresponding author), Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valencia, Valencia, Spain.	jprohens@btc.upv.es	Gramazio, Pietro/O-3143-2017; De La O Plazas Ávila, Maria/AAA-8711-2019; vilanova, santiago/AAA-5743-2019; Prohens, Jaime/ABF-1229-2021; Prohens, Jaime/H-2228-2015	Gramazio, Pietro/0000-0003-2226-7999; De La O Plazas Ávila, Maria/0000-0001-8090-7312; vilanova, santiago/0000-0003-4939-9713; Prohens, Jaime/0000-0003-1181-9065; Prohens, Jaime/0000-0003-1181-9065; Kaushik, Prashant/0000-0002-3145-2849	European Union [677379]; Spanish Ministerio de Economia, lndustria y Competitividad and Fondo Europeo de Desarrollo Regional (from MINECO/FEDER) [AGL2015-64755-R]; initiative "Adapting Agriculture to Climate Change: Collecting, Protecting and Preparing Crop Wild Relatives" [CROP/SC310-03]; Government of Norway; ICAR; Universitat Politecnica de Valencia; Spanish Ministerio de Economia, lndustria y Competitividad [FCJI-2015-24835]	European Union(European Commission); Spanish Ministerio de Economia, lndustria y Competitividad and Fondo Europeo de Desarrollo Regional (from MINECO/FEDER); initiative "Adapting Agriculture to Climate Change: Collecting, Protecting and Preparing Crop Wild Relatives"; Government of Norway; ICAR(Indian Council of Agricultural Research (ICAR)); Universitat Politecnica de Valencia; Spanish Ministerio de Economia, lndustria y Competitividad	This work has been funded by the European Union's Horizon 2020 Research and Innovation Programme under grant agreement No 677379 (G2P-SOL project: Linking genetic resources, genomes and phenotypes of Solanaceous crops) and from Spanish Ministerio de Economia, lndustria y Competitividad and Fondo Europeo de Desarrollo Regional (grant AGL2015-64755-R from MINECO/FEDER). Funding has also been received from the initiative "Adapting Agriculture to Climate Change: Collecting, Protecting and Preparing Crop Wild Relatives" (internal contract reference CROP/SC310-03), which is supported by the Government of Norway. The project is managed by the Global Crop Diversity Trust with the Millennium Seed Bank of the Royal Botanic Gardens, Kew and implemented in partnership with national and international gene banks and plant breeding institutes around the world. For further information see the project website: http://www.ourdiversiti.org/. Prashant Kaushik is grateful to ICAR for a pre-doctoral grant. Pietro Gramazio is grateful to Universitat Politecnica de Valencia for a pre-doctoral (Programa FPI de la UPV-Subprograma 1/2013 call) contract. Mariola Plazas is grateful to Spanish Ministerio de Economia, lndustria y Competitividad for a post-doctoral grant within the Juan de la Cierva programme (FCJI-2015-24835). Authors also thank the Italian Eggplant Genome Sequencing Consortium for providing access to an improved version of the eggplant genome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been funded by the European Union's Horizon 2020 Research and Innovation Programme under grant agreement No 677379 (G2P-SOL project: Linking genetic resources, genomes and phenotypes of Solanaceous crops) and from Spanish Ministerio de Economia, Industria y Competitividad and Fondo Europeo de Desarrollo Regional (grant AGL2015-64755R from MINECO/FEDER). Funding has also been received from the initiative "Adapting Agriculture to Climate Change: Collecting, Protecting and Preparing Crop Wild Relatives" (internal contract reference CROP/SC-310-03), which is supported by the Government of Norway. The project is managed by the Global Crop Diversity Trust with the Millennium Seed Bank of the Royal Botanic Gardens, Kew and implemented in partnership with national and international gene banks and plant breeding institutes around the world. For further information see the project website: http://www.cwrdiversity.org/. Prashant Kaushik is grateful to ICAR for a pre-doctoral grant. Pietro Gramazio is grateful to Universitat Politecnica de Valencia for a pre-doctoral (Programa FPI de la UPV-Subprograma 1/2013 call) contract. Mariola Plazas is grateful to Spanish Ministerio de Economia, Industria y Competitividad for a post-doctoral grant within the Juan de la Cierva programme (FCJI-2015-24835). Authors also thank the Italian Eggplant Genome Sequencing Consortium for providing access to an improved version of the eggplant genome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhinav Sao, 2010, Electronic Journal of Plant Breeding, V1, P783; Acquaah G., 2012, PRINCIPLES PLANT GEN, P617, DOI [10.1002/9781118313718.ch34, DOI 10.1002/9781118313718.CH34]; Acquadro A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180774; Akpan N, 2016, NOT SCI BIOL, DOI [10.15835/nsb.8.2.9783, DOI 10.15835/NSB.8.2.9783]; Augustinos AA, 2016, SPAN J AGRIC RES, V14, DOI 10.5424/sjar/2016144-9020; BAKER RJ, 1978, CROP SCI, V18, P533, DOI 10.2135/cropsci1978.0011183X001800040001x; Bebeli P.J., 2008, EUR J PLANT SCI BIOT, V2, P3; Bison O, 2007, GENET MOL BIOL, V30, P417, DOI 10.1590/S1415-47572007000300019; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Burgue?o, 2015, AGD R ANAL GENETIC D; Cericola F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073702; Chintan Mistry, 2016, Annals of Agricultural Science (Cairo), V61, P237; Damnjanovic J, 2002, ACTA HORTIC, P197, DOI 10.17660/ActaHortic.2002.579.32; Daunay M.-C., 2012, HDB VEGETABLES, P257, DOI DOI 10.1016/B978-0-08-040826-2.50028-X; Davidar P, 2015, AM J BOT, V102, P129, DOI 10.3732/ajb.1400404; Dhaka S.K., 2017, J PHARM PHYTOCHEM, V6, P181; Diaz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104188; do Nascimento NFF, 2014, GENET MOL RES, V13, P3237, DOI 10.4238/2014.April.29.2; Dranca F, 2017, J FOOD PROCESS ENG, V40, DOI 10.1111/jfpe.12312; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Frary A, 2012, GENOME MAPPING MOL B, V5, P287, DOI [10.1007/978-3-540-34536-7_9, DOI 10.1007/978-3-540-34536-7_9]; Frisch M, 2010, THEOR APPL GENET, V120, P441, DOI 10.1007/s00122-009-1204-1; Gaffney J, 2016, GLOB FOOD SECUR-AGR, V9, P36, DOI 10.1016/j.gfs.2016.06.001; Geleta LF, 2004, PLANT BREEDING, V123, P467, DOI 10.1111/j.1439-0523.2004.01017.x; Glover MA, 2005, CROP SCI, V45, P1096, DOI 10.2135/cropsci2004.0493; GOVINDARASU P, 1981, SCI HORTIC-AMSTERDAM, V14, P125, DOI 10.1016/0304-4238(81)90003-0; Gramazio P, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2631-4; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; HAYMAN BI, 1954, GENETICS, V39, P789; Hernandez-Bautista A, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2122-6; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hurtado M, 2013, SCI HORTIC-AMSTERDAM, V164, P625, DOI 10.1016/j.scienta.2013.10.028; Hurtado M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041748; IBPGR, 1990, DESCR EGGPL; Kakizaki Y, 1931, GENETICS, V16, P0001; Kaushik P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00677; Khan MMR, 2016, HORTICULT J, V85, P1, DOI 10.2503/hortj.MI-IR03; Khan MMR, 2014, SCI HORTIC-AMSTERDAM, V172, P149, DOI 10.1016/j.scienta.2014.04.013; Knapp S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057039; Knaus BJ, 2017, MOL ECOL RESOUR, V17, P44, DOI 10.1111/1755-0998.12549; Kouassi B, 2016, SCI HORTIC-AMSTERDAM, V213, P199, DOI 10.1016/j.scienta.2016.10.039; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Marin J., 2015, PORTAGRANO VADEMECUM; Meyer RS, 2012, MOL PHYLOGENET EVOL, V63, P685, DOI 10.1016/j.ympev.2012.02.006; Monforte AJ, 2000, THEOR APPL GENET, V100, P471, DOI 10.1007/s001220050061; Munoz-Falcon JE, 2008, EUPHYTICA, V164, P405, DOI 10.1007/s10681-008-9688-3; Munoz-Falcon JE, 2009, ANN APPL BIOL, V154, P453, DOI 10.1111/j.1744-7348.2009.00314.x; Park EJ, 2007, PLANT BIOTECHNOL J, V5, P422, DOI 10.1111/j.1467-7652.2007.00251.x; Patel AA, 2016, J PHARMACOGN PHYTOCH, V6, P975; Patel J.P., 2013, VEGETABLE SCI, V40, P61; PEDERSON DG, 1971, HEREDITY, V27, P247, DOI 10.1038/hdy.1971.88; Pessarakli MM, 2004, J FOOD AGRIC ENVIRON, V2, P218; Plazas M, 2016, J AM SOC HORTIC SCI, V141, P34, DOI 10.21273/JASHS.141.1.34; Plazas M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00318; Plazas M, 2013, NOT BOT HORTI AGROBO, V41, P26; Poehlman J M, 1977, BREEDING FIELD CROPS, P27; Portis E., 2016, Proceedings of XVIth EUCARPIA Capsicum and Eggplant Working Group Meeting in memoriam Dr. Alain Palloix, 12-14 September 2016, Kecskemet, Hungary, P221; Portis E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135200; Prohens J, 2005, J AM SOC HORTIC SCI, V130, P54, DOI 10.21273/JASHS.130.1.54; Prohens J, 2009, HORTSCIENCE, V44, P2017, DOI 10.21273/HORTSCI.44.7.2017; Ranil RHG, 2017, GENET RESOUR CROP EV, V64, P1707, DOI 10.1007/s10722-016-0467-z; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; RIGGS TJ, 1988, J HORTIC SCI, V63, P369, DOI 10.1080/14620316.1988.11515871; Rodriguez Gustavo R, 2010, J Vis Exp, DOI 10.3791/1856; Rodriguez-Burruezo A, 2008, EUR J HORTIC SCI, V73, P76; Shattuck V.I., 2010, PLANT BREEDING REV, P9; SHATTUCK VI, 1993, GENETICA, V90, P73, DOI 10.1007/BF01435180; Tian HY, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-016-1788-x; van der Knaap E, 2003, THEOR APPL GENET, V107, P139, DOI 10.1007/s00122-003-1224-1; van der Weerden GM, 2007, ACTA HORTIC, V745, P503, DOI DOI 10.17660/ACTAHORTIC; Vilanova S, 2012, MOL BREEDING, V30, P647, DOI 10.1007/s11032-011-9650-2; Vorontsova MS, 2013, BOT J LINN SOC, V173, P176, DOI 10.1111/boj.12053; Vuylsteke M, 2000, HEREDITY, V85, P208, DOI 10.1046/j.1365-2540.2000.00747.x; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Weber LC, 2013, HORTIC BRAS, V31, P461, DOI 10.1590/S0102-05362013000300019; Wricke G, 1986, QUANTITATIVE GENETIC, P355, DOI [10.1515/9783110837520.355, DOI 10.1515/9783110837520.355]; Xie FM, 2014, THEOR APPL GENET, V127, P407, DOI 10.1007/s00122-013-2227-1; Zhang JF, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2036-8	78	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199943	10.1371/journal.pone.0199943	http://dx.doi.org/10.1371/journal.pone.0199943			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949625	gold, Green Submitted, Green Published			2022-12-26	WOS:000436549200073
J	Miciak, JJ; Hirshberg, J; Bunz, F				Miciak, Jessica J.; Hirshberg, Jason; Bunz, Fred			Seamless assembly of recombinant adenoviral genomes from high-copy plasmids	PLOS ONE			English	Article							ESCHERICHIA-COLI; CONSTRUCTION; EFFICIENT; VECTORS; PROTEIN; SYSTEM; COMPLEX; DOMAIN; GENES; P53	The adenoviruses are essential tools for basic research and therapeutic development. Robust methods for the generation of mutant and recombinant viruses are crucial for these diverse applications. Here we describe a simple plasmid-based method that permits highly efficient modification of the adenoviral genome and rapid production of high-titer virus stocks. The 36-kilobase genome of adenovirus serotype 5 was divided into seven tractable blocks that could be individually modified in a single step and reassembled in vitro. Because the system is composed of compact modules, modifications at different loci can be readily recombined. Viral assemblies were delivered to packaging cells by electroporation, a strategy that consistently resulted in the de novo production of 10 8 infectious units in 3-5 days. In principle, a similar strategy could be applied to any other adenovirus serotype or to other double-strand DNA viruses.	[Miciak, Jessica J.; Hirshberg, Jason; Bunz, Fred] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Bunz, F (corresponding author), Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA.	fredbunz@jhmi.edu			National Institute of Allergy and Infectious Diseases [R21AI137726]; National Cancer Institute [R25CA171973, P30CA006973]; Allegheny Health Network; NATIONAL CANCER INSTITUTE [R25CA171973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI125961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Allegheny Health Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Institute of Allergy and Infectious Diseases grant R21AI137726 (FB), the National Cancer Institute grants R25CA171973 and P30CA006973 (FB) and the Allegheny Health Network (FB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berk AJ, 2007, FIELDS VIROLOGY, P2355; Berk AJ, 2016, P NATL ACAD SCI USA, V113, P801, DOI 10.1073/pnas.1525084113; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Chung JH, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.597203; Crouzet J, 1997, P NATL ACAD SCI USA, V94, P1414, DOI 10.1073/pnas.94.4.1414; Crystal RG, 2014, HUM GENE THER, V25, P3, DOI 10.1089/hum.2013.2527; Deryckere F, 1997, BIOTECHNIQUES, V22, P868, DOI 10.2144/97225bm18; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jager L, 2009, NAT PROTOC, V4, P547, DOI 10.1038/nprot.2009.4; KETNER G, 1994, P NATL ACAD SCI USA, V91, P6186, DOI 10.1073/pnas.91.13.6186; McSharry BP, 2008, J VIROL, V82, P4585, DOI 10.1128/JVI.02251-07; Muck-Hausl Martin, 2015, Nucleic Acids Res, V43, pe50, DOI 10.1093/nar/gkv031; Niemann J, 2017, VIRUS GENES; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Stanton RJ, 2008, BIOTECHNIQUES, V45, P659, DOI 10.2144/000112993; Tang XY, 2017, J VIROL, V91, DOI 10.1128/JVI.02462-16; Uusi-Kerttula H, 2015, HUM GENE THER, V26, P320, DOI 10.1089/hum.2015.015; WEINBERG DH, 1983, P NATL ACAD SCI-BIOL, V80, P5383, DOI 10.1073/pnas.80.17.5383; Yu D, 2011, J VIROL, V85, P13114, DOI 10.1128/JVI.05759-11; Yu DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054516; Yuan M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030072	25	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199563	10.1371/journal.pone.0199563	http://dx.doi.org/10.1371/journal.pone.0199563			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949649	Green Published, gold, Green Submitted			2022-12-26	WOS:000436549200057
J	Pausas, JG; Belliure, J; Minguez, E; Montagud, S				Pausas, Juli G.; Belliure, Josabel; Minguez, Eduardo; Montagud, Sergio			Fire benefits flower beetles in a Mediterranean ecosystem	PLOS ONE			English	Article							SMALL MAMMALS; FOREST-FIRES; MICE; DIET; COMMUNITIES; DYNAMICS; HISTORY; CLIMATE; REGIME	Despite the abundance of plants that benefit from fire in Mediterranean ecosystems, little is known about the possible presence of fire-favoured insects (other than bark beetles). For two years we sampled invertebrates after two large wildfires in eastern Spain and demonstrate that two flower beetle species, Protaetia morio and P. oblonga (Cetoniidae), show a pyrophilous behaviour. These beetles were much more numerous after the fires than in unburnt plots around the fire perimeter; in addition, these species tended to increase in number with the distance from the fire perimeter and with fire recurrence, especially P. morio. These results were maintained for the two postfire years sampled. The results for the beetles do not support the hypothesis of postfire colonization, but that local populations survived the fire as eggs or larvae protected in the soil (endogenous persistence). We propose that the increase in population size (compared with unburnt zones) could be driven by the reduction of their predator populations, as vertebrates that feed on these beetles were disfavoured by fire. That is, the results suggest that these flower beetle species benefit from fire because fire disrupts antagonistic interactions with their predators (predation release hypothesis). Given the omnipresence of small mammals, soil insects, and fires, the processes described here are likely to be general but unexplored.	[Pausas, Juli G.] CSIC, Ctr Invest Desertificac CIDE, Valencia, Spain; [Belliure, Josabel] Univ Alcala, Dept Ciencias Vida, Madrid, Spain; [Minguez, Eduardo] Ciudadanos Ciencia, Lalfas Del Pi, Alacant, Spain; [Montagud, Sergio] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE); Universidad de Alcala; University of Valencia	Pausas, JG (corresponding author), CSIC, Ctr Invest Desertificac CIDE, Valencia, Spain.	juli.g.pausas@uv.es	Pausas, Juli/C-5794-2008	Pausas, Juli/0000-0003-3533-5786; MONTAGUD ALARIO, SERGIO/0000-0002-0634-4643	FILAS project from the Spanish government (Ministerio de Economia y Competitividad) [CGL2015-64086-P]; Valencia government (Generalitat Valenciana) [PROMETEO/2016/021]	FILAS project from the Spanish government (Ministerio de Economia y Competitividad); Valencia government (Generalitat Valenciana)	This paper has been funded by the FILAS project (CGL2015-64086-P) from the Spanish government (Ministerio de Economia y Competitividad) and the PROMETEO/2016/021 project from the Valencia government (Generalitat Valenciana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnan X, 2013, ECOGRAPHY, V36, P1182, DOI 10.1111/j.1600-0587.2013.00155.x; BADAN D, 1986, NEW ZEAL J ECOL, V9, P137; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Bjornstad ON, 2009, NCF SPATIAL NONPARAM, P1; Boucher J, 2012, ECOSCIENCE, V19, P328, DOI 10.2980/19-4-3503; Bowman DMJS, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0058; Brennan KEC, 2011, AUSTRAL ECOL, V36, P131, DOI 10.1111/j.1442-9993.2010.02127.x; COOK SF, 1959, ECOLOGY, V40, P102, DOI 10.2307/1929926; Diffendorfer J, 2012, INT J WILDLAND FIRE, V21, P436, DOI 10.1071/WF10060; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Dosso K., 2011, Journal of Applied Biosciences, V39, P2607; Dugdale JS, 1996, J ROY SOC NEW ZEAL, V26, P251, DOI 10.1080/03014223.1996.9517513; EVANS WG, 1966, ECOLOGY, V47, P1061, DOI 10.2307/1935658; Falkenberg JC, 1998, J MAMMAL, V79, P558, DOI 10.2307/1382986; Fernandez-Munoz S, 1999, INCENDIOS HIST APROX, P111; Fuisz Tibor Istvan, 2013, Ornis Hungarica, V21, P38; Garcia Y, 2016, OECOLOGIA, V182, P1165, DOI 10.1007/s00442-016-3733-z; Keeley J. E., 2012, FIRE MEDITERRANEAN E; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Kiss L, 2006, BIODIVERS CONSERV, V15, P2925, DOI 10.1007/s10531-005-3430-4; Lanszki J, 2003, FOLIA ZOOL, V52, P367; Lawes MJ, 2015, INT J WILDLAND FIRE, V24, P712, DOI 10.1071/WF14163; Lee JE, 2014, ENTOMOL RES, V44, P244, DOI 10.1111/1748-5967.12075; Manson RH, 1998, OIKOS, V82, P37, DOI 10.2307/3546915; Moretti M, 2004, ECOGRAPHY, V27, P173, DOI 10.1111/j.0906-7590.2004.03660.x; Mutz J, 2017, J ANIM ECOL, V86, P1065, DOI 10.1111/1365-2656.12689; New TR, 2014, INSECTS FIRE CONSERV; Ostfeld RS, 1996, BIOSCIENCE, V46, P323, DOI 10.2307/1312946; OVERSKAUG K, 1995, J RAPTOR RES, V29, P137; Park JS, 2012, EUR J CARDIO-THORAC, V41, P41, DOI 10.1016/j.ejcts.2011.03.051; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pausas JG, 2018, EVOL ECOL, V32, P113, DOI 10.1007/s10682-018-9927-6; Pausas JG, 2012, CLIMATIC CHANGE, V110, P215, DOI 10.1007/s10584-011-0060-6; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Pinheiro J, R PACKAGE VERSION; Pons J, 2007, ECOL RES, V22, P535, DOI 10.1007/s11284-006-0053-5; Robinson NM, 2013, J APPL ECOL, V50, P1321, DOI 10.1111/1365-2664.12153; Santos X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088224; Schwarz Martin, 2013, Entomologist's Gazette, V64, P131; SGARDELIS SP, 1992, ISRAEL J ZOOL, V38, P1; Smith VR, 2002, POLAR BIOL, V25, P703, DOI 10.1007/s00300-002-0405-8; Stevens-Rumann C, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00443.1; Svensson GP, 2012, J INSECT CONSERV, V16, P549, DOI 10.1007/s10841-011-9440-5; Tauzin P, 2009, CETONIIMANIA B ASS P, V5, P3; Tauzin Pierre-Hubert, 2009, Cetoniimania, V6, P31	47	13	13	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198951	10.1371/journal.pone.0198951	http://dx.doi.org/10.1371/journal.pone.0198951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949613	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200031
J	O'Brien, CE; McCarthy, CGP; Walshe, AE; Shaw, DR; Sumski, DA; Krassowski, T; Fitzpatrick, DA; Butler, G				O'Brien, Caoimhe E.; McCarthy, Charley G. P.; Walshe, Annie E.; Shaw, Dennis R.; Sumski, Deirdre A.; Krassowski, Tadeusz; Fitzpatrick, David A.; Butler, Geraldine			Genome analysis of the yeast Diutina catenulata, a member of the Debaryomycetaceae/Metschnikowiaceae (CTG-Ser) clade	PLOS ONE			English	Article							CANDIDA-CATENULATA; GENETIC-CODE; SP NOV.; ANTIFUNGAL SUSCEPTIBILITY; DIVERSITY; RUGOSA; RECONSTRUCTION; REASSIGNMENT; MESORUGOSA; PHYLOGENY	Diutina catenulata (Candida catenulata) is an ascomycetous yeast that has been isolated from humans, animals and environmental sources. The species is a contaminant of dairy products, and has been linked to superficial and invasive infections in both humans and animals. Previous phylogenetic analyses have assigned the species to the Saccharomycetales, but failed to identify its specific clade. Here, we report the genome sequence of an environmental isolate of D. catenulata. Examination of the tRNA repertoire and coding potential of this species shows that it translates the CUG codon as serine and not leucine. In addition, two phylogenetic analyses using 204 ubiquitous gene family alignments and 3,826 single-copy genes both confirm the placement of the species in the Debaryomycetaceae/Metschnikowiaceae, or CTG-Ser clade. The sequenced isolate contains an MTL alpha idio-morph. However, unlike most MTL loci in related species, poly (A) polymerase (PAP) is not adjacent to MTL alpha 1.	[O'Brien, Caoimhe E.; Walshe, Annie E.; Shaw, Dennis R.; Sumski, Deirdre A.; Butler, Geraldine] Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst, Dublin, Ireland; [McCarthy, Charley G. P.; Fitzpatrick, David A.] Maynooth Univ, Dept Biol, Genome Evolut Lab, Maynooth, Kildare, Ireland; [Krassowski, Tadeusz] Univ Coll Dublin, Sch Med, Conway Inst, Dublin, Ireland	University College Dublin; Maynooth University; University College Dublin	Butler, G (corresponding author), Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst, Dublin, Ireland.	gbutler@ucd.ie		McCarthy, Charley/0000-0002-3880-9978; Butler, Geraldine/0000-0002-1770-5301; Fitzpatrick, David/0000-0001-7345-6998	University College Dubin, Science Foundation Ireland [12/IA/1343]; Wellcome Trust [109167/Z/15/Z]; Chris Todd Hittinger, University of Wisconsin	University College Dubin, Science Foundation Ireland(Science Foundation Ireland); Wellcome Trust(Wellcome TrustEuropean Commission); Chris Todd Hittinger, University of Wisconsin	This work was supported by University College Dubin, Science Foundation Ireland (grant number 12/IA/1343) (GB) and the Wellcome Trust (grant number 109167/Z/15/Z) (GB, COB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the help and support of Chris Todd Hittinger, University of Wisconsin, who stimulated this undergraduate research project. We also thank Anthony Murray who collected one Diutina isolate.	Akanni WA, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140436; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bennett RJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.FUNK-0005-2016; Butler Geraldine, 2007, P3; Butler G, 2010, CLIN MICROBIOL REV, V23, P140, DOI 10.1128/CMR.00053-09; Byrne KP, 2006, NUCLEIC ACIDS RES, V34, pD452, DOI 10.1093/nar/gkj041; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chaves GM, 2013, MED MYCOL, V51, P231, DOI 10.3109/13693786.2012.710345; Cogan TM, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.CM-0010-2012; Daniel HM, 2014, ANTON LEEUW INT J G, V106, P67, DOI 10.1007/s10482-014-0170-z; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de Almeida JMGCF, 2005, FEMS MICROBIOL ECOL, V53, P295, DOI 10.1016/j.femsec.2005.01.006; Delavenne E, 2011, INT J FOOD MICROBIOL, V151, P247, DOI 10.1016/j.ijfoodmicro.2011.08.029; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Facchin S, 2013, BRAZ J MICROBIOL, V44, P701, DOI 10.1590/S1517-83822013000300006; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Gkatzionis K, 2014, INT J FOOD MICROBIOL, V177, P109, DOI 10.1016/j.ijfoodmicro.2014.02.016; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Groenewald M, 2010, INT J SYST EVOL MICR, V60, P2675, DOI 10.1099/ijs.0.018580-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hittinger CT, 2015, CURR OPIN GENET DEV, V35, P100, DOI 10.1016/j.gde.2015.10.008; Janke T, 2013, CURR MICROBIOL, V67, P156, DOI 10.1007/s00284-013-0344-3; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Joo HS, 2008, ENVIRON POLLUT, V156, P891, DOI 10.1016/j.envpol.2008.05.026; Khunnamwong P, 2015, INT J SYST EVOL MICR, V65, P4701, DOI 10.1099/ijsem.0.000634; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; LACHANCE MA, 1976, CAN J MICROBIOL, V22, P1756, DOI 10.1139/m76-259; Lachance MA, 2016, YEAST, V33, P563, DOI 10.1002/yea.3208; Lachance MA, 2016, YEAST, V33, P261, DOI 10.1002/yea.3163; Lachance MA, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P987, DOI 10.1016/B978-0-444-52149-1.00090-2; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McCarthy CGP, 2017, ADV GENET, V100, P211, DOI 10.1016/bs.adgen.2017.09.006; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mendes JF, 2014, REV INST MED TROP SP, V56, P525, DOI 10.1590/S0036-46652014000600012; Morais CG, 2017, INT J SYST EVOL MICR, V67, P3798, DOI 10.1099/ijsem.0.002186; Muhlhausen S, 2016, GENOME RES, V26, P945, DOI 10.1101/gr.200931.115; Nobile CJ, 2003, MICROBIOL-SGM, V149, P3629, DOI 10.1099/mic.0.26640-0; Brilhante RSN, 2017, MED MYCOL, V55, P725, DOI 10.1093/mmy/myw144; Paredes K, 2012, J CLIN MICROBIOL, V50, P2397, DOI 10.1128/JCM.00688-12; Radosavljevic M, 1999, J CLIN MICROBIOL, V37, P475, DOI 10.1128/JCM.37.2.475-477.1999; Riley R, 2016, P NATL ACAD SCI USA, V113, P9882, DOI 10.1073/pnas.1603941113; Santin R, 2013, BRAZ J MICROBIOL, V44, P139, DOI 10.1590/S1517-83822013005000018; Santos MAS, 2011, CR BIOL, V334, P607, DOI 10.1016/j.crvi.2011.05.008; Santos MAS, 1997, MOL MICROBIOL, V26, P423, DOI 10.1046/j.1365-2958.1997.5891961.x; Sarbu Ionela, 2013, Roum Arch Microbiol Immunol, V72, P225; Shen XX, 2016, G3-GENES GENOM GENET, V6, P3927, DOI 10.1534/g3.116.034744; Srikantha T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002476; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Subramanya SH, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1024-4; Sylvester K, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov002; Urubschurov V, 2008, FEMS YEAST RES, V8, P1349, DOI 10.1111/j.1567-1364.2008.00444.x; VANDERWALT JP, 1977, A VAN LEEUW J MICROB, V43, P205, DOI 10.1007/BF00395675; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wolfe KH, 2017, ANNU REV MICROBIOL, V71, P197, DOI 10.1146/annurev-micro-090816-093403; YOKOGAWA T, 1992, P NATL ACAD SCI USA, V89, P7408, DOI 10.1073/pnas.89.16.7408	60	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0198957	10.1371/journal.pone.0198957	http://dx.doi.org/10.1371/journal.pone.0198957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944657	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000436377800017
J	Tykesson, E; Hassinen, A; Zielinska, K; Thelin, MA; Frati, G; Ellervik, U; Westergren-Thorsson, G; Malmstrom, A; Kellokumpu, S; Maccarana, M				Tykesson, Emil; Hassinen, Antti; Zielinska, Katarzyna; Thelin, Martin A.; Frati, Giacomo; Ellervik, Ulf; Westergren-Thorsson, Gunilla; Malmstrom, Anders; Kellokumpu, Sakari; Maccarana, Marco			Dermatan sulfate epimerase 1 and dermatan 4-O-sulfotransferase 1 form complexes that generate long epimerized 4-O-sulfated blocks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondroitin sulfate; dermatan sulfate; Golgi; glycosaminoglycan; glycobiology; D4ST1; DS-epi1; DS-epi2; epimerization; epimerase	EHLERS-DANLOS-SYNDROME; GROWTH FACTOR/SCATTER FACTOR; HEPARIN-COFACTOR-II; CHONDROITIN SULFATE; IDURONIC ACID; CANCER-CELLS; BIOSYNTHESIS; SUBSTRATE; N-ACETYLGALACTOSAMINYLTRANSFERASE-1; POLYMERIZATION	During the biosynthesis of chondroitin/dermatan sulfate (CS/DS), a variable fraction of glucuronic acid is converted to iduronic acid through the activities of two epimerases, dermatan sulfate epimerases 1 (DS-epi1) and 2 (DS-epi2). Previous in vitro studies indicated that without association with other enzymes, DS-epi1 activity produces structures that have only a few adjacent iduronic acid units. In vivo, concomitant with epimerization, dermatan 4-O-sulfotransferase 1 (D4ST1) sulfates the GalNAc adjacent to iduronic acid. This sulfation facilitates DS-epi1 activity and enables the formation of long blocks of sulfated iduronic acid-containing domains, which can be major components of CS/DS. In this report, we used recombinant enzymes to confirm the concerted action of DS-epi1 and D4ST1. Confocal microscopy revealed that these two enzymes colocalize to the Golgi, and FRET experiments indicated that they physically interact. Furthermore, FRET, immunoprecipitation, and cross-linking experiments also revealed that DS-epi1, DS-epi2, and D4ST1 form homomers and are all part of a hetero-oligomeric complex where D4ST1 directly interacts with DS-epi1, but not with DS-epi2. The cooperation of DS-epi1 with D4ST1 may therefore explain the processive mode of the formation of iduronic acid blocks. In conclusion, the iduronic acid-forming enzymes operate in complexes, similar to other enzymes active in glycosaminoglycan biosynthesis. This knowledge shed light on regulatory mechanisms controlling the biosynthesis of the structurally diverse CS/DS molecule.	[Tykesson, Emil; Zielinska, Katarzyna; Thelin, Martin A.; Frati, Giacomo; Westergren-Thorsson, Gunilla; Malmstrom, Anders; Maccarana, Marco] Lund Univ, Dept Expt Med Sci, SE-22100 Lund, Sweden; [Hassinen, Antti; Kellokumpu, Sakari] Univ Oulu, Fac Biochem & Mol Med, FIN-90570 Oulu, Finland; [Hassinen, Antti] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00014 Helsinki, Finland; [Ellervik, Ulf] Lund Univ, Dept Chem, SE-22100 Lund, Sweden	Lund University; University of Oulu; University of Helsinki; Lund University	Maccarana, M (corresponding author), BMC C12, S-22184 Lund, Sweden.	marco.maccarana@med.lu.se	maccarana, marco/AAB-4764-2021; Frati, Giacomo/ABE-5974-2021; Tykesson, Emil/F-9879-2014; Frati, Giacomo/ABI-7410-2020	Frati, Giacomo/0000-0001-5584-6060; Tykesson, Emil/0000-0002-0511-9831; Malmstrom, Anders/0000-0002-6691-146X; Maccarana, Marco/0000-0003-3549-8921; Thelin, Martin/0000-0002-2232-5514; Hassinen, Antti/0000-0001-9491-2868	Medical Faculty at Lund University; Lund University; Swedish Research Council; Swedish Cancer Society Grant [140530]; Mizutani Foundation for Glycoscience; Greta and Johan Kock Foundation; FLAK Research School; Albert Osterlund Foundation; Royal Physiographic Society; Lars Hierta Foundation; Academy of Finland Grant; Aaltonen Foundation	Medical Faculty at Lund University; Lund University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society Grant; Mizutani Foundation for Glycoscience; Greta and Johan Kock Foundation; FLAK Research School; Albert Osterlund Foundation; Royal Physiographic Society; Lars Hierta Foundation; Academy of Finland Grant(Academy of Finland); Aaltonen Foundation	This work was supported by the Medical Faculty at Lund University, Lund University, the Swedish Research Council, the Swedish Cancer Society Grant 140530 (to M.M.), the Mizutani Foundation for Glycoscience, the Greta and Johan Kock Foundation, the FLAK Research School, the Albert Osterlund Foundation, the Royal Physiographic Society, and the Lars Hierta Foundation. The work was also supported by an Academy of Finland Grant and the Aaltonen Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Bartolini B, 2012, GLYCOBIOLOGY, V22, P1007, DOI 10.1093/glycob/cws065; Catlow KR, 2008, J BIOL CHEM, V283, P5235, DOI 10.1074/jbc.M706589200; Deakin JA, 2009, J BIOL CHEM, V284, P6311, DOI 10.1074/jbc.M807671200; Dick G, 2008, GLYCOBIOLOGY, V18, P53, DOI 10.1093/glycob/cwm121; Eklund E, 2000, ARCH BIOCHEM BIOPHYS, V383, P171, DOI 10.1006/abbi.2000.2043; FRANSSON LA, 1982, J BIOL CHEM, V257, P6333; Gouignard N, 2016, DIS MODEL MECH, V9, P607, DOI 10.1242/dmm.024661; Hannesson HH, 1996, BIOCHEM J, V313, P589, DOI 10.1042/bj3130589; Hassinen A, 2014, J BIOL CHEM, V289, P26937, DOI 10.1074/jbc.M114.595058; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; He L, 2008, BLOOD, V111, P4118, DOI 10.1182/blood-2007-12-127928; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2015, J BIOL CHEM, V290, P5438, DOI 10.1074/jbc.M114.603266; Izumikawa T, 2012, BIOCHEM J, V441, P697, DOI 10.1042/BJ20111472; Kellokumpu S, 2016, CELL MOL LIFE SCI, V73, P305, DOI 10.1007/s00018-015-2066-0; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; Kosho T, 2016, PEDIATR INT, V58, P88, DOI 10.1111/ped.12878; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; Malmstrom A, 2012, J HISTOCHEM CYTOCHEM, V60, P916, DOI 10.1369/0022155412459857; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Miyake N, 2010, HUM MUTAT, V31, P966, DOI 10.1002/humu.21300; Muller T, 2013, HUM MOL GENET, V22, P3761, DOI 10.1093/hmg/ddt227; Pacheco B, 2009, GLYCOBIOLOGY, V19, P1197, DOI 10.1093/glycob/cwp110; Pacheco B, 2009, J BIOL CHEM, V284, P9788, DOI 10.1074/jbc.M809339200; Pacheco B, 2009, J BIOL CHEM, V284, P1741, DOI 10.1074/jbc.M805479200; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Radek KA, 2009, WOUND REPAIR REGEN, V17, P118, DOI 10.1111/j.1524-475X.2008.00449.x; Stachtea XN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140279; Syx D, 2015, HUM MUTAT, V36, P535, DOI 10.1002/humu.22774; Taylor KR, 2005, J BIOL CHEM, V280, P5300, DOI 10.1074/jbc.m410412200; Thelin MA, 2013, FEBS J, V280, P2431, DOI 10.1111/febs.12214; Thelin MA, 2012, CANCER RES, V72, P1943, DOI 10.1158/0008-5472.CAN-11-1351; Tykesson E, 2016, CHEM SCI, V7, P1447, DOI 10.1039/c5sc03798k; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zhou XX, 2011, GLYCOBIOLOGY, V21, P771, DOI 10.1093/glycob/cwr001	41	19	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13725	13735		10.1074/jbc.RA118.003875	http://dx.doi.org/10.1074/jbc.RA118.003875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29976758	Green Published, hybrid			2022-12-26	WOS:000443375500031
J	Willemse, D; Weber, B; Masino, L; Warren, RM; Adinolfi, S; Pastore, A; Williams, MJ				Willemse, Danicke; Weber, Brandon; Masino, Laura; Warren, Robin M.; Adinolfi, Salvatore; Pastore, Annalisa; Williams, Monique J.			Rv1460, a SufR homologue, is a repressor of the suf operon in Mycobacterium tuberculosis	PLOS ONE			English	Article							IRON-SULFUR CLUSTER; ESCHERICHIA-COLI; OXIDATIVE STRESS; CYSTEINE DESULFURASE; AZOTOBACTER-VINELANDII; SUFBCDS OPERON; PROTEIN; COMPLEX; BIOGENESIS; ISCS	Iron-sulphur (Fe-S) clusters are ubiquitous co-factors which require multi-protein systems for their synthesis. In Mycobacterium tuberculosis, the Rv1460-Rv1461-Rv1462-Rv1463csd- Rv1465-Rv1466 operon (suf operon) encodes the primary Fe-S cluster biogenesis system. The first gene in this operon, Rv1460, shares homology with the cyanobacterial SufR, which functions as a transcriptional repressor of the sufBCDS operon. Rv1460' s function in M. tuberculosis has however not been determined. In this study, we demonstrate that M. tuberculosis mutants lacking a functional Rv1460 protein are impaired for growth under standard culture conditions. Elevated expression of Rv1460 and Rv1461 was observed in the mutant, implicating Rv1460 in the regulation of the suf operon. Binding of an Fe-S cluster to purified recombinant Rv1460 was confirmed by UV-visible spectroscopy and circular dichroism. Furthermore, three conserved cysteine residues, C203, C216 and C244, proposed to provide ligands for the coordination of an Fe-S cluster, were shown to be required for the function of Rv1460 in M. tuberculosis. Rv1460 therefore seems to be functionally analogous to cyanobacterial SufR.	[Willemse, Danicke; Warren, Robin M.; Williams, Monique J.] Stellenbosch Univ, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, Tygerberg, South Africa; [Willemse, Danicke; Warren, Robin M.; Williams, Monique J.] Stellenbosch Univ, Fac Med & Hlth Sci, South African Med Res Council Ctr TB Res, Tygerberg, South Africa; [Willemse, Danicke; Warren, Robin M.; Williams, Monique J.] Stellenbosch Univ, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, Tygerberg, South Africa; [Weber, Brandon] Univ Cape Town, Electron Microscope Unit, Cape Town, South Africa; [Masino, Laura] Francis Crick Inst, Struct Biol Sci Technol Platform, London, England; [Adinolfi, Salvatore] Univ Turin, Pharmaceut Sci & Technol, Turin, Italy; [Pastore, Annalisa] Kings Coll London, Maurice Wohl Inst, Dept Basic & Clin Neurosci, London, England	National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University; Stellenbosch University; University of Cape Town; Francis Crick Institute; University of Turin; University of London; King's College London	Williams, MJ (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, Tygerberg, South Africa.; Williams, MJ (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, South African Med Res Council Ctr TB Res, Tygerberg, South Africa.; Williams, MJ (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, Tygerberg, South Africa.	moniquejw@sun.ac.za		Masino, Laura/0000-0002-5326-7003; Williams, Monique/0000-0002-6701-8403; Willemse, Danicke/0000-0003-3778-8738; Warren, Robin/0000-0001-5741-7358	South African Medical Research Council (SAMRC) Centre for Tuberculosis Research; Stellenbosch University node of the DST/National Research Foundation (NRF) Centre of Excellence for Biomedical TB Research; NRF [91424]; Newton fund; DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University,; BBSRC [BB/S001832/1] Funding Source: UKRI; MRC [MC_PC_13054, MC_U117584256] Funding Source: UKRI	South African Medical Research Council (SAMRC) Centre for Tuberculosis Research; Stellenbosch University node of the DST/National Research Foundation (NRF) Centre of Excellence for Biomedical TB Research; NRF; Newton fund; DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University,; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge the generous support of Professor Paul van Helden, the South African Medical Research Council (SAMRC) Centre for Tuberculosis Research and the Stellenbosch University node of the DST/National Research Foundation (NRF) Centre of Excellence for Biomedical TB Research. This work was supported by a Research Career Award (grant #91424 to MJW) from the NRF and a Researcher Links travel award from the Newton fund (to MJW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the SAMRC or NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the generous support of Professor Paul van Helden, DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa. This work was supported by a Research Career Award (grant # 91424 to MJW) from the NRF and a Researcher Links travel award from the Newton fund (to MJW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the SAMRC or NRF. We thank Prof B. Gicquel (Institute Pasteur) and Prof D Dean (Department of Biochemistry, Virginia Tech) who kindly provided the pJEM15 and pDB845 plasmids respectively. We also thank Dr J Brand and Ms E Malherbe at the Central Analytical Facility of Stellenbosch University, Nuclear Magnetic Resonance Unit.	Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Adrover M, 2015, BBA-MOL CELL RES, V1853, P1448, DOI 10.1016/j.bbamcr.2014.10.023; Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boyd JM, 2009, J BIOL CHEM, V284, P110, DOI 10.1074/jbc.M807003200; Colangeli R, 2007, PLOS PATHOG, V3, P780, DOI 10.1371/journal.ppat.0030087; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cortes T, 2013, CELL REP, V5, P1121, DOI 10.1016/j.celrep.2013.10.031; Dai YY, 2012, FEBS LETT, V586, P4016, DOI 10.1016/j.febslet.2012.10.001; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Fontecave M, 2006, NAT CHEM BIOL, V2, P171, DOI 10.1038/nchembio0406-171; Fox NG, 2015, BIOCHEMISTRY-US, V54, P3880, DOI 10.1021/bi5014497; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; Hirabayashi K, 2015, J BIOL CHEM, V290, P29717, DOI 10.1074/jbc.M115.680934; Huet G, 2006, J BACTERIOL, V188, P3412, DOI 10.1128/JB.188.9.3412-3414.2006; Huet G, 2005, J BACTERIOL, V187, P6137, DOI 10.1128/JB.187.17.6137-6146.2005; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Kumar MS, 2010, ADV BIOTECHNOL, V10, P3, DOI DOI 10.1016/J.MICPATH.2010.10.003; Kurthkoti K, 2017, MBIO, V8, DOI [10.1128/mBio.01092-17, 10.1128/mbio.01092-17]; Lee J. H, 2003, J MICROBIOL; Lee JH, 2004, MOL MICROBIOL, V51, P1745, DOI 10.1111/j.1365-2958.2003.03946.x; Mettert EL, 2014, J BACTERIOL, V196, P4315, DOI 10.1128/JB.01975-14; Minch KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6829; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Pandey R, 2014, MOL MICROBIOL, V91, P98, DOI 10.1111/mmi.12441; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Prischi F, 2010, PROTEIN EXPRES PURIF, V73, P161, DOI 10.1016/j.pep.2010.05.003; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Roback P, 2007, NUCLEIC ACIDS RES, V35, P5085, DOI 10.1093/nar/gkm518; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Rustad TR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0502-3; Rybniker J, 2014, BIOCHEM J, V459, P467, DOI 10.1042/BJ20130732; Saini A, 2010, BIOCHEMISTRY-US, V49, P9402, DOI 10.1021/bi1011546; Santos JA, 2014, P NATL ACAD SCI USA, V111, pE2251, DOI 10.1073/pnas.1322728111; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Saves I, 2002, J CLIN MICROBIOL, V40, P943, DOI 10.1128/JCM.40.3.943-950.2002; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Shen G, 2007, J BIOL CHEM, V282, P31909, DOI 10.1074/jbc.M705554200; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; Song H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11870; Springer B, 2001, INT J MED MICROBIOL, V290, P669; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; Tian T, 2014, BIOCHEM BIOPH RES CO, V443, P376, DOI 10.1016/j.bbrc.2013.11.131; Topilina NI, 2015, P NATL ACAD SCI USA, V112, P10348, DOI 10.1073/pnas.1512777112; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Tyagi P, 2015, FREE RADICAL BIO MED, V84, P344, DOI 10.1016/j.freeradbiomed.2015.03.008; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Wang Chao, 2012, Biotechniques, V52, DOI 10.2144/000113858; Wang T, 2004, J BACTERIOL, V186, P956, DOI 10.1128/JB.186.4.956-967.2004; Wayne L G, 2001, Methods Mol Med, V54, P247, DOI 10.1385/1-59259-147-7:247; Wayne L. G., 1998, Tubercle and Lung Disease, V79, P127, DOI 10.1054/tuld.1998.0015; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Yan R, 2015, BBA-PROTEINS PROTEOM, V1854, P1113, DOI 10.1016/j.bbapap.2015.02.002; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	65	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200145	10.1371/journal.pone.0200145	http://dx.doi.org/10.1371/journal.pone.0200145			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979728	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500064
J	Ferro, A; Qu, WH; Lukowicz, A; Svedberg, D; Johnson, A; Cvetanovic, M				Ferro, Austin; Qu, Wenhui; Lukowicz, Abigail; Svedberg, Daniel; Johnson, Andrea; Cvetanovic, Marija			Inhibition of NF-kappa B signaling in IKK beta(F/F);LysM Cre mice causes motor deficits but does not alter pathogenesis of Spinocerebellar ataxia type 1	PLOS ONE			English	Article							BETA LINKS INFLAMMATION; NECROSIS-FACTOR DEATH; CLIMBING FIBER; MOUSE MODEL; IKK-BETA; MICROGLIAL ACTIVATION; SYNAPSE ELIMINATION; TRANSGENIC MICE; KINASE COMPLEX; TNF-RECEPTORS	Spinocerebellar Ataxia type 1 (SCA1) is a fatal neurodegenerative genetic disease that is characterized by pronounced neuronal loss and gliosis in the cerebellum. We have previously demonstrated microglial activation, measured as an increase in microglial density in cerebellar cortex and an increase in the production of pro-inflammatory cytokines, including tumor necrosis factor alpha (TNF-alpha), in the cerebellum of the ATXN1[82Q]transgenic mouse model of SCA1. To examine the role of activated state of microglia in SCA1, we used a Cre-Lox approach with IKK beta(F/F);LysM Cre mice intended to reduce inflammatory NF-kappa B signaling, selectively in microglia. ATXN1[82Q],IKK beta(F/F); LysM Cre mice showed reduced cerebellar microglial density and production of TNF alpha compared to ATXN1[82Q] mice, yet reducing NF-kappa B did not ameliorate motor impairments and cerebellar cellular pathologies. Unexpectedly, at 12 weeks of age, control IKK beta(F/F); LysM Cre mice showed motor deficits equal to ATXN1[82Q] mice that were dissociated from any obvious neurodegenerative changes in the cerebellum, but were rather associated with a developmental impairment that presented as a retention of climbing fiber synaptic terminals on the soma of Purkinje neurons. These results indicate that NF-kappa B signaling is required for increase in microglial numbers and TNF-alpha production in the cerebella of ATXN1[82Q] mouse model of SCA1. Furthermore, these results elucidate a novel role of canonical NF-kappa B signaling in pruning of surplus synapses on Purkinje neurons in the cerebellum during development.	[Ferro, Austin; Qu, Wenhui; Lukowicz, Abigail; Svedberg, Daniel; Johnson, Andrea; Cvetanovic, Marija] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Cvetanovic, Marija] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA; [Svedberg, Daniel] Brandeis Univ, Dept Neurosci, Waltham, MA USA; [Johnson, Andrea] Univ S Florida, Med Sch, Tampa, FL USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Brandeis University; State University System of Florida; University of South Florida	Cvetanovic, M (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.; Cvetanovic, M (corresponding author), Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA.	mcvetano@umn.edu		Svedberg, Daniel/0000-0002-4605-9572; Cvetanovic, Marija/0000-0001-7744-736X	NIGMS NIH HHS [T32 GM008471] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008471] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Banfi S, 1996, HUM MOL GENET, V5, P33, DOI 10.1093/hmg/5.1.33; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Ben Haim Carrillo-de Sauvage BL, 2015, FRONTIERS CELLULAR N, V9, P1, DOI DOI 10.3389/FNCEL.2015.00001; Brambilla R, 2011, BRAIN, V134, P2736, DOI 10.1093/brain/awr199; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Cho IH, 2008, BRAIN, V131, P3019, DOI 10.1093/brain/awn230; Cho SH, 2015, J NEUROSCI, V35, P807, DOI 10.1523/JNEUROSCI.2939-14.2015; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; Cvetanovic M, 2015, NEUROSCIENCE, V289, P289, DOI 10.1016/j.neuroscience.2015.01.003; Cvetanovic M, 2015, CEREBELLUM, V14, P8, DOI 10.1007/s12311-014-0605-0; Cvetanovic M, 2011, NAT MED, V17, P1445, DOI 10.1038/nm.2494; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Duvick L, 2010, NEURON, V67, P929, DOI 10.1016/j.neuron.2010.08.022; Gennarino VA, 2015, CELL, V160, P1087, DOI 10.1016/j.cell.2015.02.012; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; Hashimoto K, 2005, NEUROSCI RES, V53, P221, DOI 10.1016/j.neures.2005.07.007; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Ingram M, 2016, NEURON, V89, P1194, DOI 10.1016/j.neuron.2016.02.011; Khoshnan A, 2004, J NEUROSCI, V24, P7999, DOI 10.1523/JNEUROSCI.2675-04.2004; Kwon SH, 2017, NEUROPSYCHOPHARMACOL, V42, P2072, DOI 10.1038/npp.2017.93; Lee MJ, 2016, MOL NEURODEGENER, V11, P1, DOI [10.1186/s13024-015-0066-z, DOI 10.1186/S13024-015-0066-Z]; Letellier M, 2008, DEV NEUROBIOL, V68, P997, DOI 10.1002/dneu.20639; Li R, 2004, J NEUROSCI, V24, P1760, DOI 10.1523/JNEUROSCI.4580-03.2004; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Lian H, 2016, J NEUROSCI, V36, P577, DOI 10.1523/JNEUROSCI.2117-15.2016; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu H, 2018, TNF GENE EXPRESSION, DOI 10.1016/j.cell.2008.01.020; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Matilla-Duenas A, 2008, CEREBELLUM, V7, P106, DOI 10.1007/s12311-008-0009-0; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Mincheva-Tasheva S, 2013, NEUROSCIENTIST, V19, P175, DOI 10.1177/1073858412444007; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Orthgiess J, 2016, EUR J IMMUNOL, V46, P1529, DOI 10.1002/eji.201546108; Oz G, 2010, MOVEMENT DISORD, V25, P1253, DOI 10.1002/mds.23067; Oz G, 2010, J NEUROSCI, V30, P3831, DOI 10.1523/JNEUROSCI.5612-09.2010; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038; Paulson HL, 2017, NAT REV NEUROSCI, V18, P613, DOI 10.1038/nrn.2017.92; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Perez-Pouchoulen M, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0036-15.2015; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Qu WH, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0880-z; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Ren LQ, 1999, MOL BRAIN RES, V65, P198, DOI 10.1016/S0169-328X(99)00016-9; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Seidel K, 2012, ACTA NEUROPATHOL, V124, P1, DOI 10.1007/s00401-012-1000-x; Sensitization B, 2016, NEURON, V90, P1, DOI [10.1016/j.neuron.2016.03.023, DOI 10.1016/J.NEURON.2016.03.023]; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; Sriram K, 2006, FASEB J, V20, P670, DOI 10.1096/fj.05-5106com; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stowell RD, 2018, DEV NEUROBIOL, P1; Wang XJ, 2005, MECH AGEING DEV, V126, P1241, DOI 10.1016/j.mad.2005.06.012; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; York EM, 2018, DEV NEUROBIOL, V78, P593, DOI 10.1002/dneu.22571; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	81	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200013	10.1371/journal.pone.0200013	http://dx.doi.org/10.1371/journal.pone.0200013			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975753	Green Submitted, Green Published, gold			2022-12-26	WOS:000437424500059
J	McNeill, RS; Stroobant, EE; Smithberger, E; Canoutas, DA; Butler, MK; Shelton, AK; Patel, SD; Limas, JC; Skinner, KR; Bash, RE; Schmid, RS; Miller, CR				McNeill, Robert S.; Stroobant, Emily E.; Smithberger, Erin; Canoutas, Demitra A.; Butler, Madison K.; Shelton, Abigail K.; Patel, Shrey D.; Limas, Juanita C.; Skinner, Kasey R.; Bash, Ryan E.; Schmid, Ralf S.; Miller, C. Ryan			PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition	PLOS ONE			English	Article							KINASE INHIBITOR; MEK INHIBITION; PATHWAY; ACTIVATION; RESISTANCE; TUMORS; MECHANISMS; BUPARLISIB; COOPERATIVITY; COMBINATION	Background Glioblastoma (GBM) is the most common adult primary brain tumor. Multimodal treatment is empiric and prognosis remains poor. Recurrent PIK3CA missense mutations (PIK3CA(mut)) in GBM are restricted to three functional domains: adaptor binding (ABD), helical, and kinase. Defining how these mutations influence gliomagenesis and response to kinase inhibitors may aid in the clinical development of novel targeted therapies in biomarker-stratified patients. Methods We used normal human astrocytes immortalized via expression of hTERT, E6, and E7 (NHA). We selected two PIK3CA(mut) from each of 3 mutated domains and induced their expression in NHA with (NHA(RAs)) and without mutant RAS using lentiviral vectors. We then examined the role of PIK3CA(mut) in gliomagenesis in vitro and in mice, as well as response to targeted P13K (PI3Ki) and MEK (MEKi) inhibitors in vitro. Results PIK3CA(mut), particularly helical and kinase domain mutations, potentiated proximal P13K signaling and migration of NHA and NHA(RAs) in vitro. Only kinase domain mutations promoted NHA colony formation, but both helical and kinase domain mutations promoted NHA(RAs) tumorigenesis in vivo. PIK3CA(mut) status had minimal effects on PI3Ki and MEKi efficacy. However, PI3Ki/MEKi synergism was pronounced in NHA and NHA(RAs) harboring ABD or helical mutations. Conclusion PIK3CA(mut) promoted differential gliomagenesis based on the mutated domain. While PIK3CA(mut) did not influence sensitivity to single agent PI3Ki, they did alter PI3Ki/MEKi synergism. Taken together, our results demonstrate that a subset of PIK3CA(mut) promote tumorigenesis and suggest that patients with helical domain mutations may be most sensitive to dual PI3Ki/MEKi treatment.	[McNeill, Robert S.; Smithberger, Erin; Shelton, Abigail K.; Miller, C. Ryan] Univ N Carolina, Sch Med, Pathobiol & Translat Sci Grad Program, Chapel Hill, NC 27515 USA; [Stroobant, Emily E.; Patel, Shrey D.] Univ N Carolina, Sch Med, Dept Chem, Chapel Hill, NC 27515 USA; [Canoutas, Demitra A.; Butler, Madison K.] Univ N Carolina, Sch Med, Dept Biol, Chapel Hill, NC 27515 USA; [Limas, Juanita C.; Miller, C. Ryan] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Skinner, Kasey R.; Schmid, Ralf S.; Miller, C. Ryan] Univ N Carolina, Sch Med, Neurosci Ctr, Chapel Hill, NC 27515 USA; [Bash, Ryan E.; Miller, C. Ryan] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA; [Schmid, Ralf S.; Miller, C. Ryan] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Miller, C. Ryan] Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Miller, CR (corresponding author), Univ N Carolina, Sch Med, Pathobiol & Translat Sci Grad Program, Chapel Hill, NC 27515 USA.; Miller, CR (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA.; Miller, CR (corresponding author), Univ N Carolina, Sch Med, Neurosci Ctr, Chapel Hill, NC 27515 USA.; Miller, CR (corresponding author), Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA.; Miller, CR (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.; Miller, CR (corresponding author), Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27515 USA.	miller@med.unc.edu	, Pathology Services Core/CEZ-2246-2022; Miller, Ryan/B-9365-2008	Miller, Ryan/0000-0002-0096-8762; Patel, Shrey/0000-0001-5008-7616; Limas, Juanita C./0000-0001-6384-8787; Skinner, Kasey/0000-0003-4316-5959; Butler, Madison/0000-0002-1031-2054	UNC University Cancer Research Fund (UCRF); National Center for Advancing Translational Sciences [UL1TR001111, 550KR61332]; National Cancer Institute [R01CA204136, P30CA016086]; UNC Graduate Training Program in Translational Medicine; National Institute of Environmental Health Sciences [P30ES010126]; UCRF; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA204136] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007431] Funding Source: NIH RePORTER	UNC University Cancer Research Fund (UCRF); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UNC Graduate Training Program in Translational Medicine; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); UCRF; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CRM was supported by the UNC University Cancer Research Fund (UCRF), National Center for Advancing Translational Sciences (UL1TR001111, subaward 550KR61332), and National Cancer Institute (R01CA204136). RSM is a Robert H. Wagner Scholar and AKS is a Bill Sykes Scholar in Pathobiology and Translational Science. RSM was supported by the UNC Graduate Training Program in Translational Medicine. Translational Pathology Laboratory (TPL) is supported by National Cancer Institute (P30CA016086), National Institute of Environmental Health Sciences (P30ES010126), and UCRF.	Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Barouch-Bentov R, 2011, EXPERT OPIN INV DRUG, V20, P153, DOI 10.1517/13543784.2011.546344; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Di Veroli GY, 2016, BIOINFORMATICS, V32, P2866, DOI 10.1093/bioinformatics/btw230; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Dymond AW, 2017, J CLIN PHARMACOL, V57, P592, DOI 10.1002/jcph.848; El Meskini R, 2015, DIS MODEL MECH, V8, P45, DOI 10.1242/dmm.018168; Filbin MG, 2013, NAT MED, V19, P1518, DOI 10.1038/nm.3328; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanker AB, 2013, P NATL ACAD SCI USA, V110, P14372, DOI 10.1073/pnas.1303204110; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Klempner SJ, 2013, CANCER DISCOV, V3, P1345, DOI 10.1158/2159-8290.CD-13-0063; Koren S, 2013, FEBS J, V280, P2758, DOI 10.1111/febs.12175; Koul D, 2012, CLIN CANCER RES, V18, P184, DOI 10.1158/1078-0432.CCR-11-1558; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; McNeill RS, 2017, NEURO-ONCOLOGY, V19, P1469, DOI 10.1093/neuonc/nox044; McNeill RS, 2014, JOVE-J VIS EXP, DOI [10.3791/51763, 10.3791/51753]; Mendelsohn J, 2013, J CLIN ONCOL, V31, P1904, DOI 10.1200/JCO.2012.45.3605; Netland IA, 2016, J NEURO-ONCOL, V129, P57, DOI 10.1007/s11060-016-2158-1; Ostrom QT, 2017, NEURO-ONCOLOGY, V19, pV1, DOI 10.1093/neuonc/nox158; Prados MD, 2015, NEURO-ONCOLOGY, V17, P1051, DOI 10.1093/neuonc/nov031; Quayle SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049466; Rodon J, 2014, INVEST NEW DRUG, V32, P670, DOI 10.1007/s10637-014-0082-9; Schmid RS, 2016, NEURO-ONCOLOGY, V18, P962, DOI 10.1093/neuonc/nov321; See WL, 2012, CANCER RES, V72, P3350, DOI 10.1158/0008-5472.CAN-12-0334; Song YR, 2013, P NATL ACAD SCI USA, V110, P17933, DOI 10.1073/pnas.1317026110; Sonoda Y, 2001, CANCER RES, V61, P4956; Sonoda Y, 2001, CANCER RES, V61, P6674; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Speranza MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep20189; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Tang Y, 2012, CANCER BIOL THER, V13, P379, DOI 10.4161/cbt.19240; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Turke AB, 2012, CANCER RES, V72, P3228, DOI 10.1158/0008-5472.CAN-11-3747; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vitucci M, 2013, NEURO-ONCOLOGY, V15, P1317, DOI 10.1093/neuonc/not084; Wachsberger PR, 2014, J CANCER RES CLIN, V140, P573, DOI 10.1007/s00432-014-1594-6; Wen PY, 2012, NEURO-ONCOLOGY, V14, P819, DOI 10.1093/neuonc/nos117; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	55	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200014	10.1371/journal.pone.0200014	http://dx.doi.org/10.1371/journal.pone.0200014			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975751	Green Published, gold, Green Submitted			2022-12-26	WOS:000437424500060
J	Mendonca, V; Madeira, C; Dias, M; Vermandele, F; Archambault, P; Dissanayake, A; Canning-Clode, J; Flores, AAV; Silva, A; Vinagre, C				Mendonca, Vanessa; Madeira, Carolina; Dias, Marta; Vermandele, Fanny; Archambault, Philippe; Dissanayake, Awantha; Canning-Clode, Joao; Flores, Augusto A., V; Silva, Ana; Vinagre, Catarina			What's in a tide pool? just as much food web network complexity as in large open ecosystems	PLOS ONE			English	Article							INTERTIDAL ROCK POOLS; NEW-SOUTH-WALES; COMMUNITY STRUCTURE; ORGANIC-MATTER; WEST-COAST; SCALE; MARINE; SHORE; CANNIBALISM; TIDEPOOLS	Understanding the fundamental laws that govern complex food web networks over large ecosystems presents high costs and oftentimes unsurmountable logistical challenges. This way, it is crucial to find smaller systems that can be used as proxy food webs. Intertidal rock pool environments harbour particularly high biodiversity over small areas. This study aimed to analyse their food web networks to investigate their potential as proxies of larger ecosystems for food web networks research. Highly resolved food webs were compiled for 116 intertidal rock pools from cold, temperate, subtropical and tropical regions, to ensure a wide representation of environmental variability. The network properties of these food webs were compared to that of estuaries, lakes and rivers, as well as marine and terrestrial ecosystems (46 previously published complex food webs). The intertidal rock pool food webs analysed presented properties that were in the same range as the previously published food webs. The niche model predictive success was remarkably high (73-88%) and similar to that previously found for much larger marine and terrestrial food webs. By using a large-scale sampling effort covering 116 intertidal rock pools in several biogeographic regions, this study showed, for the first time, that intertidal rock pools encompass food webs that share fundamental organizational characteristics with food webs from markedly different, larger, open and abiotically stable ecosystems. As small, self-contained habitats, intertidal rock pools are particularly tractable systems and therefore a large number of food webs can be examined with relatively low sampling effort. This study shows, for the first time that they can be useful models for the understanding of universal processes that regulate the complex network organization of food webs, which are harder or impossible to investigate in larger, open ecosystems, due to high costs and logistical difficulties.	[Mendonca, Vanessa; Madeira, Carolina; Dias, Marta; Vinagre, Catarina] Univ Lisbon, Fac Ciencias, MARE Marine & Environm Sci Ctr, Lisbon, Portugal; [Vermandele, Fanny] Univ Quebec Rimouski, Dept Biol Chim & Geog, Rimouski, PQ, Canada; [Archambault, Philippe] Univ Laval, Takuvik, Quebec Ocean, Dept Biol, Laval, PQ, Canada; [Dissanayake, Awantha] Plymouth Univ, Sch Biol Sci, Plymouth, Devon, England; [Canning-Clode, Joao] MARE Marine & Environm Sci Ctr, Quinta Lorde Marina, Canical, Madeira Island, Portugal; [Canning-Clode, Joao] Univ Azores, Dept Oceanog & Fisheries, Ctr IMAR, Rua Prof Dr Frederico Machado, Horta, Azores, Portugal; [Canning-Clode, Joao] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA; [Flores, Augusto A., V] Univ Sao Paulo, Ctr Biol Marinha, Rod Manoel Hipolito do Rego, Sao Sebastiao, SP, Brazil; [Silva, Ana] Univ Lisbon, Inst Super Tecn, CERIS, Lisbon, Portugal	Universidade de Lisboa; University of Quebec; Universite du Quebec a Rimouski; Laval University; University of Plymouth; Universidade dos Acores; Smithsonian Institution; Smithsonian Environmental Research Center; Universidade de Sao Paulo; Universidade de Lisboa; Instituto Superior Tecnico	Vinagre, C (corresponding author), Univ Lisbon, Fac Ciencias, MARE Marine & Environm Sci Ctr, Lisbon, Portugal.	cmvinagre@fc.ul.pt	Vinagre, Catarina/G-1965-2015; Madeira, Carolina/B-1531-2019; Silva, ACF/P-4202-2017; Flores, Augusto A. V./B-7092-2011; Canning-Clode, Joao/I-4343-2019; Dias, Marta/ABE-3178-2020; Mendonca, Vanessa/C-5774-2015; Dias, Marta/O-4112-2015	Vinagre, Catarina/0000-0003-2146-7948; Madeira, Carolina/0000-0003-1632-634X; Silva, ACF/0000-0003-4734-6538; Flores, Augusto A. V./0000-0001-9347-8860; Canning-Clode, Joao/0000-0003-2143-6535; Mendonca, Vanessa/0000-0002-3658-9502; Dias, Marta/0000-0003-0447-6009; Archambault, Philippe/0000-0001-5986-6149; Vermandele, Fanny/0000-0002-0239-3835	Portuguese 'Fundacao para a Ciencia e a Tecnologia' (FCT) [SFRH/BD/109618/2015, SFRH/BD/92975/2013, SFRH/BD/103047/2014]; FCT Investigator Program [IF/01606/2014/CP1230/CT0001]; Canadian Network for Research and Innovation in Machining Technology NSERC Undergraduate Student Research Awards;  [PTDC/AAG-REC/2139/2012];  [PTDC/MAR-EST/2141/2012];  [UID/MAR/04292/2013]	Portuguese 'Fundacao para a Ciencia e a Tecnologia' (FCT)(Portuguese Foundation for Science and Technology); FCT Investigator Program(Portuguese Foundation for Science and Technology); Canadian Network for Research and Innovation in Machining Technology NSERC Undergraduate Student Research Awards; ; ; 	This study had the support of the Portuguese 'Fundacao para a Ciencia e a Tecnologia' (FCT) through the PhD grant awarded to V. Mendonca SFRH/BD/109618/2015, to C. Madeira SFRH/BD/92975/2013 and M. Dias SFRH/BD/103047/2014; the researcher position awarded to C. Vinagre (Investigador FCT 2013) and the projects PTDC/AAG-REC/2139/2012, PTDC/MAR-EST/2141/2012 and UID/MAR/04292/2013. J. Canning-Clode was supported by a starting grant in the framework of the 2014 FCT Investigator Program (IF/01606/2014/CP1230/CT0001). F. Vermandele was supported by the Canadian Network for Research and Innovation in Machining Technology NSERC Undergraduate Student Research Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo R, 2006, ACTA OECOL, V30, P192, DOI 10.1016/j.actao.2006.04.002; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; BENNETT BA, 1987, S AFR J ZOOL, V22, P25; BRIAND F, 1984, NATURE, V307, P264, DOI 10.1038/307264a0; Bustamante RH, 1996, J EXP MAR BIOL ECOL, V196, P1, DOI 10.1016/0022-0981(95)00093-3; Camacho J, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.030901; Camacho J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.228102; CHAPMAN ARO, 1990, HYDROBIOLOGIA, V203, P191, DOI 10.1007/BF00005687; COHEN JE, 1993, ECOLOGY, V74, P252, DOI 10.2307/1939520; COHEN JE, 1994, PHILOS T R SOC B, V343, P57, DOI 10.1098/rstb.1994.0008; Coll M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022591; Delany J, 1998, J EXP MAR BIOL ECOL, V221, P221, DOI 10.1016/S0022-0981(97)00129-9; Dias M, 2014, J APPL ICHTHYOL, V30, P970, DOI 10.1111/jai.12450; Dias M, 2016, MAR BIOL RES, V12, P331, DOI 10.1080/17451000.2016.1143106; Dunne JA, 2004, MAR ECOL PROG SER, V273, P291, DOI 10.3354/meps273291; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; FAIRWEATHER PG, 1988, AUST J ECOL, V13, P401, DOI 10.1111/j.1442-9993.1988.tb00988.x; Firth LB, 2008, HYDROBIOLOGIA, V614, P233, DOI 10.1007/s10750-008-9509-7; Firth LB, 2014, MAR ENVIRON RES, V102, P122, DOI 10.1016/j.marenvres.2014.03.016; Firth LB, 2013, DIVERS DISTRIB, V19, P1275, DOI 10.1111/ddi.12079; Firth LB, 2010, OECOLOGIA, V162, P163, DOI 10.1007/s00442-009-1441-7; FITZGERALD GJ, 1992, BEHAV ECOL, V3, P141, DOI 10.1093/beheco/3.2.141; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; HAVENS K, 1992, SCIENCE, V257, P1107, DOI 10.1126/science.257.5073.1107; Hawkins SJ, 2008, CLIM RES, V37, P123, DOI 10.3354/cr00768; Hechinger R. F., 2011, Ecology, V92, P791, DOI 10.1890/10-1383.1; Huxham M, 1996, OIKOS, V76, P284, DOI 10.2307/3546201; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Link J, 2002, MAR ECOL PROG SER, V230, P1, DOI 10.3354/meps230001; LUBCHENCO J, 1982, J PHYCOL, V18, P544; LUBCHENCO J, 1983, ECOLOGY, V64, P1116, DOI 10.2307/1937822; LUBCHENCO J, 1984, J EXP MAR BIOL ECOL, V78, P23, DOI 10.1016/0022-0981(84)90069-8; Lubchenco J., 1986, COMMUNITY ECOLOGY, P537; MacPherson E, 1998, J EXP MAR BIOL ECOL, V220, P127, DOI 10.1016/S0022-0981(97)00086-5; MAHON R, 1994, ENVIRON BIOL FISH, V41, P171, DOI 10.1007/BF02197843; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; MARTINEZ ND, 1994, AM NAT, V144, P935, DOI 10.1086/285719; MARTINEZ ND, 1993, SCIENCE, V260, P242, DOI 10.1126/science.260.5105.242; Martins GM, 2007, MAR ECOL PROG SER, V329, P43, DOI 10.3354/meps329043; Memmott J, 2000, J ANIM ECOL, V69, P1, DOI 10.1046/j.1365-2656.2000.00367.x; Mendonca V, 2018, MAR ECOL PROG SER, V587, P17, DOI 10.3354/meps12401; MENGE BA, 1985, OECOLOGIA, V65, P394, DOI 10.1007/BF00378915; Menge BA, 1995, CONTROL INTERACTION, P258; METAXAS A, 1993, MAR ECOL PROG SER, V98, P187, DOI 10.3354/meps098187; Meziane T, 2000, MAR ECOL PROG SER, V200, P49, DOI 10.3354/meps200049; Montoya JM, 2002, J THEOR BIOL, V214, P405, DOI 10.1006/jtbi.2001.2460; Mouritsen K. N., 2011, ECOLOGY, V92, P2006, DOI DOI 10.1890/11-0371.1; Opitz S., 1996, 43 ICLARM; PARKER T, 1993, OPHELIA, V38, P69, DOI 10.1080/00785326.1993.10429889; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Reagan D. P., 1996, FOOD WEB TROPICAL RA; Romanuk TN, 2006, ECOGRAPHY, V29, P3, DOI 10.1111/j.2005.0906-7590.04181.x; Ryer CH, 1997, MAR ECOL PROG SER, V147, P77, DOI 10.3354/meps147077; Strydom NA, 2008, AFR ZOOL, V43, P256, DOI 10.3377/1562-7020-43.2.256; Thieltges D. W., 2011, ECOLOGY, V92, DOI DOI 10.1890/11-0351.1; THOMPSON GB, 1980, J EXP MAR BIOL ECOL, V45, P173, DOI 10.1016/0022-0981(80)90058-1; Townsend CR, 1998, ECOL LETT, V1, P200; UNDERWOOD AJ, 1984, J EXP MAR BIOL ECOL, V75, P71, DOI 10.1016/0022-0981(84)90024-8; UNDERWOOD AJ, 1980, OECOLOGIA, V46, P201, DOI 10.1007/BF00540127; Underwood AJ, 1996, J EXP MAR BIOL ECOL, V197, P63, DOI 10.1016/0022-0981(95)00145-X; vanTamelen PG, 1996, J EXP MAR BIOL ECOL, V201, P197, DOI 10.1016/0022-0981(95)00182-4; Vinagre C, 2014, MAR ECOL PROG SER, V503, P11, DOI 10.3354/meps10722; Vinagre C, 2015, MAR ENVIRON RES, V110, P53, DOI 10.1016/j.marenvres.2015.07.016; Vinagre C, 2015, BIOLOGIA, V70, P372, DOI 10.1515/biolog-2015-0046; Wai TC, 2006, MAR BIOL, V149, P1139, DOI 10.1007/s00227-006-0291-7; WARREN PH, 1989, OIKOS, V55, P299, DOI 10.2307/3565588; WHORISKEY FG, 1985, BEHAV ECOL SOCIOBIOL, V18, P15; Williams R. J., 2010, NETWORK3D SOFTWARE; Williams RJ, 2004, AM NAT, V163, P458, DOI 10.1086/381964; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Yodzis P, 1998, J ANIM ECOL, V67, P635, DOI 10.1046/j.1365-2656.1998.00224.x; Yoon I, 2004, P SOC PHOTO-OPT INS, V5295, P124, DOI 10.1117/12.526956; Zander C. D., 2011, ECOLOGY, V92, P2007, DOI DOI 10.1890/11-0374.1	74	16	16	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200066	10.1371/journal.pone.0200066	http://dx.doi.org/10.1371/journal.pone.0200066			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975745	Green Submitted, Green Published, gold			2022-12-26	WOS:000437424500064
J	Noda, M; Okayama, H; Kofunato, Y; Chida, S; Saito, K; Tada, T; Ashizawal, M; Nakajima, T; Aoto, K; Kikuchi, T; Sakamoto, W; Endo, H; Fujita, S; Saito, M; Momma, T; Ohki, S; Kono, K				Noda, Masaru; Okayama, Hirokazu; Kofunato, Yasuhide; Chida, Shun; Saito, Katsuharu; Tada, Takeshi; Ashizawal, Mai; Nakajima, Takahiro; Aoto, Keita; Kikuchi, Tomohiro; Sakamoto, Wataru; Endo, Hisahito; Fujita, Shotaro; Saito, Motonobu; Momma, Tomoyuki; Ohki, Shinji; Kono, Koji			Prognostic role of FUT8 expression in relation to p53 status in stage II and III colorectal cancer	PLOS ONE			English	Article							ALPHA-1-6 FUCOSYL-TRANSFERASE; SURVIVAL; TISSUES; ALPHA(1,6)FUCOSYLTRANSFERASE; GLYCOSYLATION; CHEMOTHERAPY; ASSOCIATION; PROGRESSION; METASTASIS; BIOMARKER	The expression of fucosyltransferase 8, an enzyme responsible for core fucosylation encoded by FUT8, influences tumor biology and correlates with patient prognosis in several solid cancers. We hypothesized that p53 alteration modifies prognostic associations of FUT8 expression in colorectal cancer (CRC), since FUT8 has recently been identified as a direct transcriptional target of wild-type p53. Utilizing multiple datasets of microarray and RNA sequence of CRC, FUT8 mRNA was found to be highly expressed in wild-type p53 tumors (n = 382) compared to those of mutant p53 (n = 437). Prognostic values of FUT8 expression in conjunction with the p53 status for disease-free survival (DFS) were analyzed using two independent cohorts of stage II and III CRC after curative surgery, including the immunohistochemistry (IHC) cohort (n = 123) and the microarray cohort (n = 357). In both cohorts, neither FUT8 expression nor the p53 status was associated with DFS. Strikingly, positive expression of FUT8 protein was significantly associated with better DFS only in tumors with negative p53, while it had no prognostic impact in tumors with positive p53 in the IHC cohort. Although not statistically significant, a similar prognostic trend was observed in the microarray cohort when patients were stratified by the p53 status. Our results suggest that the prognostic values of FUT8 expression on DFS may be modified by the p53 status, and the expression of FUT8 protein can be a prognostic biomarker for patients with stage II and III CRC.	[Noda, Masaru; Okayama, Hirokazu; Chida, Shun; Saito, Katsuharu; Tada, Takeshi; Ashizawal, Mai; Nakajima, Takahiro; Aoto, Keita; Kikuchi, Tomohiro; Sakamoto, Wataru; Endo, Hisahito; Fujita, Shotaro; Saito, Motonobu; Momma, Tomoyuki; Ohki, Shinji; Kono, Koji] Fukushima Med Univ, Sch Med, Dept Gastrointestinal Tract Surg, Fukushima, Japan; [Noda, Masaru] Fukushima Med Univ, Dept Breast Surg, Sch Med, Fukushima, Japan; [Kofunato, Yasuhide] Fukushima Med Univ, Dept Hepatobiliary Pancreat & Transplant Surg, Sch Med, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University; Fukushima Medical University	Okayama, H (corresponding author), Fukushima Med Univ, Sch Med, Dept Gastrointestinal Tract Surg, Fukushima, Japan.	okayama@fmu.ac.jp	Saito, Motonobu/AAQ-3633-2021	Saito, Motonobu/0000-0001-5072-3520; Nakajima, Takahiro/0000-0001-5576-4153; Okayama, Hirokazu/0000-0003-0966-4746	KAKENHI from the Japan Society for the Promotion of Science [17K10643, 15K10143, 25870582]	KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (Grants-in-Aid for Scientific Research) Grant numbers 17K10643, 15K10143 and 25870582, from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOYAGI Y, 1985, LANCET, V2, P1353; Baudot AD, 2016, CELL CYCLE, V15, P2299, DOI 10.1080/15384101.2016.1191714; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Chida S, 2016, CARCINOGENESIS, V37, P878, DOI 10.1093/carcin/bgw069; Ezawa I, 2016, CANCER SCI, V107, P734, DOI 10.1111/cas.12933; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kannagi R, 2010, CANCER SCI, V101, P586, DOI 10.1111/j.1349-7006.2009.01455.x; Katkoori VR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030020; Kirzin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103159; Kofunato Y, 2012, ONCOL REP, V28, P1997, DOI 10.3892/or.2012.2064; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Miyoshi E, 1997, INT J CANCER, V72, P1117; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Muinelo-Romay L, 2011, HUM PATHOL, V42, P1740, DOI 10.1016/j.humpath.2011.01.021; Muinelo-Romay L, 2008, INT J CANCER, V123, P641, DOI 10.1002/ijc.23521; Munro AJ, 2005, BRIT J CANCER, V92, P434, DOI 10.1038/sj.bjc.6602358; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Noda K, 1998, HEPATOLOGY, V28, P944, DOI 10.1002/hep.510280408; Noda K, 1998, INT J CANCER, V75, P444; Okagawa Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168355; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Robles AI, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026294; Robles AI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001016; Russo A, 2005, J CLIN ONCOL, V23, P7518, DOI 10.1200/JCO.2005.00.471; Saito M, 2017, ONCOL LETT, V14, P6184, DOI 10.3892/ol.2017.6956; Saldova R, 2014, J PROTEOME RES, V13, P2314, DOI 10.1021/pr401092y; Schlicker A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-66; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; Trinchera M, 2011, INT J BIOCHEM CELL B, V43, P130, DOI 10.1016/j.biocel.2010.10.004; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang XC, 2014, GLYCOBIOLOGY, V24, P935, DOI 10.1093/glycob/cwu051; Zlobec I, 2006, MODERN PATHOL, V19, P1236, DOI 10.1038/modpathol.3800642	38	19	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200315	10.1371/journal.pone.0200315	http://dx.doi.org/10.1371/journal.pone.0200315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975776	Green Published, gold			2022-12-26	WOS:000437424500084
J	Sato, S; Ueki, M				Sato, Shuntaro; Ueki, Masao		Alzheimers Dis Neuroimaging Initia	Fast score test with global null estimation regardless of missing genotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IMPUTATION; PLINK	In genome-wide association studies (GWASs) for binary traits (or case-control samples) in the presence of covariates to be adjusted for, researchers often use a logistic regression model to test variants for disease association. Popular tests include Wald, likelihood ratio, and score tests. For likelihood ratio test and Wald test, maximum likelihood estimation (MLE), which requires iterative procedure, must be computed for each single nucleotide polymorphism (SNP). In contrast, the score test only requires MLE under the null model, being lower in computational cost than other tests. Usually, genotype data include missing genotypes because of assay failures. It loses computational efficiency in the conventional score test (CST), which requires null estimation by excluding individuals with missing genotype for each SNP. In this study, we propose two new score tests, called PM1 and PM2, that use a single global null estimator for all SNPs regardless of missing genotypes, thereby enabling faster computation than CST. We prove that PM2 and CST have an equivalent asymptotic power and that the power of PM1 is asymptotically lower than that of PM2. We evaluate the performance of the proposed methods in terms of type I error rates and power by simulation studies and application to real GWAS data provided by the Alzheimer's Disease Neuroimaging Initiative (ADNI), confirming our theoretical results. ADNI-GWAS application demonstrated that the proposed score tests improve computational speed about 6-18 times faster than the existing tests, CST, Wald tests and likelihood ratio tests. Our score tests are general and applicable to other regression models.	[Sato, Shuntaro] Nagasaki Univ Hosp, Clin Res Ctr, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528501, Japan; [Sato, Shuntaro] Kurume Univ, Grad Sch Med, Biostat, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan; [Ueki, Masao] RIKEN Ctr Adv Intelligence Project, Stat Genet Team, Chuo Ku, 1-4-1 Nihonbashi, Tokyo 1030027, Japan	Nagasaki University; Kurume University; RIKEN	Sato, S (corresponding author), Nagasaki Univ Hosp, Clin Res Ctr, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528501, Japan.; Sato, S (corresponding author), Kurume Univ, Grad Sch Med, Biostat, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	shuntarosato@nagasaki-u.ac.jp	Sato, Shuntaro/AAN-8048-2020	Sato, Shuntaro/0000-0002-6055-3649	Japan Society for the promotion of science [JP16K00064, JP16K08638, JP16H05242, JP16H01528]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; EliLilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC; Johnson & Johnson Pharmaceutical Research & Development LLC; Lumosity; Meso Scale Diagnostics, LLC; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; Lundbeck; Merck Co., Inc.; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Japan Society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; EliLilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC; Johnson & Johnson Pharmaceutical Research & Development LLC(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Meso Scale Diagnostics, LLC; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Japan Society for the promotion of science (http://www.jsps.go.jp/english/), grant numbers JP16K00064, JP16K08638, JP16H05242, and JP16H01528 (received author is M.U.). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; EliLilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. This work was carried out under the ISM General Cooperative Research 1 (2015-ISM-CRP-1013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Japan Society for the promotion of science (http://www.jsps.go.jp/english/), grant numbers JP16K00064, JP16K08638, JP16H05242, and JP16H01528 (received author is M.U.).; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuro-imaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; EliLilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neuro-track Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Graffelman J, 2015, G3-GENES GENOM GENET, V5, P2365, DOI 10.1534/g3.115.022111; Graffelman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083316; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; Lee SM, 2013, GENET EPIDEMIOL, V37, P831, DOI 10.1002/gepi.21768; Lin DY, 2008, AM J HUM GENET, V82, P444, DOI 10.1016/j.ajhg.2007.11.004; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shen L, 2014, BRAIN IMAGING BEHAV, V8, P183, DOI 10.1007/s11682-013-9262-z; Ueki M, 2014, STAT MED, V33, P4934, DOI 10.1002/sim.6264; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199692	10.1371/journal.pone.0199692	http://dx.doi.org/10.1371/journal.pone.0199692			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975732	Green Published, gold, Green Submitted			2022-12-26	WOS:000437424500043
J	Sydykov, B; Oldenhof, H; Sieme, H; Wolkers, WF				Sydykov, Bulat; Oldenhof, Harriette; Sieme, Harald; Wolkers, Willem F.			Storage stability of liposomes stored at elevated subzero temperatures in DMSO/sucrose mixtures	PLOS ONE			English	Article							LONG-TERM STORAGE; MOLECULAR MOBILITY; STEM-CELLS; GLASS-TRANSITION; AMORPHOUS PHARMACEUTICALS; STRUCTURAL RELAXATION; ENTHALPY RELAXATION; PHYSICAL STABILITY; SOLID DISPERSIONS; AQUEOUS-SOLUTIONS	Cryopreservation of biological materials is predominantly done using liquid nitrogen, and its application involves high maintenance costs and the need for periodical refilling of liquid nitrogen. Stable storage in mechanical freezers at -80 degrees C would eliminate these issues and allow for shipment of frozen specimens using dry ice. In this work, the possibility of increasing the storage temperature of cryopreserved samples to -80 degrees C by using combinations of DMSO and sucrose has been studied. Preservation efficacy was studied by measuring stability of liposomes encapsulated with carboxyfluorescein during storage at -150, -80 and -25 degrees C for up to three months. Thermal and molecular mobility properties of the different DMSO-sucrose formulations were measured using differential scanning calorimetry, whereas hydrogen bonding interactions of the formulations were probed by Fourier transform infrared spectroscopy. It was found that addition of sucrose to DMSO solutions increases the T-g, and decreases molecular mobility in the glassy state at a particular temperature. Although it was expected that storage above or close to T-g at -80 degrees C would affect liposome stability, stability was found to be similar compared to that of samples stored at -150 degrees C. Higher molecular mobility in the glassy state could not be associated with faster CF-leakage rates. Distinct differences in storage stability at -25 degrees C, far above T-g, were found among the sucrose/DMSO formulations, which were explained by the differences in permeability of sucrose and DMSO resulting in different levels of osmotic stress in the formulations.	[Sydykov, Bulat; Wolkers, Willem F.] Leibniz Univ Hannover, Inst Multiphase Proc, Hannover, Germany; [Oldenhof, Harriette; Sieme, Harald] Univ Vet Med Hannover, Clin Horses, Unit Reprod Med, Hannover, Germany	Leibniz University Hannover; University of Veterinary Medicine Hannover, Foundation	Wolkers, WF (corresponding author), Leibniz Univ Hannover, Inst Multiphase Proc, Hannover, Germany.	wolkers@imp.uni-hannover.de	Wolkers, Wim/AAT-1110-2021	Wolkers, Willem/0000-0002-7406-4651	German Research Foundation (DFG: Deutsche Forschungsgemeinschaft) via Cluster of Excellence 'From regenerative biology to reconstructive therapy' (REBIRTH) [EXC 62/1, WO1735/6-1, SI1462/4-1]; Leibniz UniversitaEt Hannover	German Research Foundation (DFG: Deutsche Forschungsgemeinschaft) via Cluster of Excellence 'From regenerative biology to reconstructive therapy' (REBIRTH); Leibniz UniversitaEt Hannover	This work was financially supported by the German Research Foundation (DFG: Deutsche Forschungsgemeinschaft) via the Cluster of Excellence 'From regenerative biology to reconstructive therapy' (REBIRTH, EXC 62/1) and grants WO1735/6-1 to WW and SI1462/4-1 to HS, and the publication of this article was funded by the Open Access Fund of the Leibniz Universitat Hannover. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Fattah AM, 2007, J PHARM SCI-US, V96, P1983, DOI 10.1002/jps.20859; Andreasson A, 2013, BIOPRESERV BIOBANK, V11, P366, DOI 10.1089/bio.2013.0038; Bhattacharya S, 2009, J PHARM SCI-US, V98, P2935, DOI 10.1002/jps.21728; Brockbank KGM, 2011, ANN THORAC SURG, V91, P1829, DOI 10.1016/j.athoracsur.2011.02.043; Chinachoti P., 2008, MODERN MAGNETIC RESO, P1703, DOI 10.1007/1-4020-3910-7_191; Cicerone MT, 2015, ADV DRUG DELIVER REV, V93, P14, DOI 10.1016/j.addr.2015.05.006; Clarke GN, 1999, HUM REPROD, V14, P2941, DOI 10.1093/humrep/14.12.2941; CROWE JH, 1988, BIOCHIM BIOPHYS ACTA, V939, P327, DOI 10.1016/0005-2736(88)90077-6; Ediger MD, 1996, J PHYS CHEM-US, V100, P13200, DOI 10.1021/jp953538d; Elliott GD, 2017, CRYOBIOLOGY, V76, P74, DOI 10.1016/j.cryobiol.2017.04.004; Frank GA, 2007, J PHYS CHEM REF DATA, V36, P1279, DOI 10.1063/1.2779330; Grzybowska K, 2017, MOL PHARMACEUT, V14, P1154, DOI 10.1021/acs.molpharmaceut.6b01056; Grzybowska K, 2016, ADV DRUG DELIVER REV, V100, P158, DOI 10.1016/j.addr.2015.12.008; Gunawan L, 2006, PHARM RES-DORDR, V23, P967, DOI 10.1007/s11095-006-9898-0; Gurruchaga H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16134-6; Gutierrez-Perez O, 2009, CRYOBIOLOGY, V58, P287, DOI 10.1016/j.cryobiol.2009.02.003; HANCOCK BC, 1995, PHARMACEUT RES, V12, P799, DOI 10.1023/A:1016292416526; HODGE IM, 1995, SCIENCE, V267, P1945, DOI 10.1126/science.267.5206.1945; Hunt CJ, 2011, TRANSFUS MED HEMOTH, V38, P107, DOI 10.1159/000326623; Kakumanu VK, 2002, PHARMACEUT RES, V19, P1873, DOI 10.1023/A:1021453810624; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Kawai K, 2005, PHARM RES-DORDR, V22, P490, DOI 10.1007/s11095-004-1887-6; Kothari K, 2015, MOL PHARMACEUT, V12, P162, DOI 10.1021/mp5005146; KRISTIANSEN J, 1992, CRYOBIOLOGY, V29, P575, DOI 10.1016/0011-2240(92)90062-7; Luthra SA, 2008, J PHARM SCI-US, V97, P3865, DOI 10.1002/jps.21255; Mandumpal JB, 2011, PHYS CHEM CHEM PHYS, V13, P3839, DOI 10.1039/c0cp02326d; Mao C, 2007, J PHYS CHEM B, V111, P13243, DOI 10.1021/jp072577+; Mao C, 2006, PHARM RES, V23, P1906, DOI 10.1007/s11095-006-9008-3; Mathieson W, 2016, J CLIN PATHOL, V69, P1105, DOI 10.1136/jclinpath-2016-203697; MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5; McCullough J, 2010, TRANSFUSION, V50, P808, DOI 10.1111/j.1537-2995.2009.02482.x; Mehta M, 2016, MOL PHARMACEUT, V13, P1267, DOI 10.1021/acs.molpharmaceut.5b00853; Mistry P, 2015, MOL PHARMACEUT, V12, P3339, DOI 10.1021/acs.molpharmaceut.5b00333; Miyazaki T, 2004, J PHARM SCI-US, V93, P2710, DOI 10.1002/jps.20182; Rodrigues JP, 2008, CRYOBIOLOGY, V56, P144, DOI 10.1016/j.cryobiol.2008.01.003; Sahni EK, 2016, FOOD BIOPHYS, V11, P20, DOI 10.1007/s11483-015-9405-4; Shamblin SL, 2006, PHARM RES, V23, P2254, DOI 10.1007/s11095-006-9080-8; Shamblin SL, 1998, PHARMACEUT RES, V15, P1828, DOI 10.1023/A:1011997721086; Sun W.Q., 2004, CELL PRESERV TECHNOL, V2, P55, DOI [10.1089/153834404322708763, DOI 10.1089/153834404322708763]; Sun WQ, 1996, BIOPHYS J, V70, P1769, DOI 10.1016/S0006-3495(96)79740-0; Sun Y, 2008, J PHYS CHEM B, V112, P5594, DOI 10.1021/jp7120577; Sydykov B, 2018, BBA-BIOMEMBRANES, V1860, P467, DOI 10.1016/j.bbamem.2017.10.031; TAKAHASHI T, 1988, BIOPHYS J, V54, P509, DOI 10.1016/S0006-3495(88)82983-7; TALSMA H, 1991, INT J PHARM, V77, P119, DOI 10.1016/0378-5173(91)90309-C; Wallace VM, 2015, J PHYS CHEM B, V119, P14780, DOI 10.1021/acs.jpcb.5b09196; Wang BQ, 2009, J PHARM SCI-US, V98, P3145, DOI 10.1002/jps.21622; Yin HJ, 2017, ACS MACRO LETT, V6, P813, DOI 10.1021/acsmacrolett.7b00456; Yuan Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep34476	48	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199867	10.1371/journal.pone.0199867	http://dx.doi.org/10.1371/journal.pone.0199867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975741	Green Published, gold			2022-12-26	WOS:000437424500051
J	Finkelmeyer, A; He, JB; Maclachlan, L; Blamire, AM; Newton, JL				Finkelmeyer, Andreas; He, Jiabao; Maclachlan, Laura; Blamire, Andrew M.; Newton, Julia L.			Intracranial compliance is associated with symptoms of orthostatic intolerance in chronic fatigue syndrome	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; POSTURAL TACHYCARDIA SYNDROME; PERFUSION; MRI; AUTOREGULATION; BRAIN; SPECT; VARIABILITY; DEPRESSION	Symptoms of orthostatic intolerance (01) are common in Chronic Fatigue Syndrome (CFS) and similar disorders. These symptoms may relate to individual differences in intracranial compliance and cerebral blood perfusion. The present study used phase-contrast, quantitative flow magnetic resonance imaging (MRI) to determine intracranial compliance based on arterial inflow, venous outflow and cerebrospinal fluid flow along the spinal canal into and out of the cranial cavity. Flow-sensitive Alternating Inversion Recovery (FAIR) Arterial Spin Labelling was used to measure cerebral blood perfusion at rest. Forty patients with CFS and 10 age and gender matched controls were scanned. Severity of symptoms of Ol was determined from self-report using the Autonomic Symptom Profile. CFS patients reported significantly higher levels of Ol (p < .001). Within the patient group, higher severity of Ol symptoms were associated with lower intracranial compliance (r = -.346, p = .033) and higher resting perfusion (r = .337, p = .038). In both groups intracranial compliance was negatively correlated with cerebral perfusion. There were no significant differences between the groups in intracranial compliance or perfusion. In patients with CFS, low intracranial compliance and high resting cerebral perfusion appear to be associated with an increased severity of symptoms of Ol. This may signify alterations in the ability of the cerebral vasculature to cope with changes to systemic blood pressure due to orthostatic stress, but this may not be specific to CFS.	[Finkelmeyer, Andreas] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [He, Jiabao; Blamire, Andrew M.] Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [He, Jiabao] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland; [Maclachlan, Laura; Newton, Julia L.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Maclachlan, Laura] Gothenburg Univ, Dept Publ Hlth & Community Med, Gothenburg, Sweden	Newcastle University - UK; Newcastle University - UK; University of Aberdeen; Newcastle University - UK; University of Gothenburg	Finkelmeyer, A (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.; Newton, JL (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.	andreas.finkelmeyer@newcastle.ac.uk; julia.newton@newcastle.ac.uk	Blamire, Andrew/AAU-6100-2021	Finkelmeyer, Andreas/0000-0001-7491-5113; He, Jiabao/0000-0001-7794-7188; Newton, Julia/0000-0002-1249-5253; Maclachlan, Laura/0000-0002-8867-2201; Blamire, Andrew/0000-0002-8749-1257	UK Medical Research Council [MR/J002712/1]; MRC [MR/J002712/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded through a grant by the UK Medical Research Council (https://www.mrc.ac.uk/) awarded to JLN (MR/J002712/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperin N, 2005, J MAGN RESON IMAGING, V22, P591, DOI 10.1002/jmri.20427; Alperin N, 2003, MAGNET RESON MED, V49, P934, DOI 10.1002/mrm.10455; Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; Biswal B, 2011, J NEUROL SCI, V301, P9, DOI 10.1016/j.jns.2010.11.018; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Claassen JAHR, 2009, J APPL PHYSIOL, V106, P153, DOI 10.1152/japplphysiol.90822.2008; COSTA DC, 1995, QJM-INT J MED, V88, P767; First MB, 2002, STRUCTURED CLIN INTE; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Garland EM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0583-8; He JB, 2010, MAGN RESON MED, V63, P842, DOI 10.1002/mrm.22251; ICHISE M, 1992, NUCL MED COMMUN, V13, P767, DOI 10.1097/00006231-199213100-00011; LASSEN NA, 1964, CIRC RES, V15, P201; Lewis DH, 2001, RADIOLOGY, V219, P766, DOI 10.1148/radiology.219.3.r01jn18766; Lewis I, 2013, J INTERN MED, V273, P501, DOI 10.1111/joim.12022; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Machale SM, 2000, BRIT J PSYCHIAT, V176, P550, DOI 10.1192/bjp.176.6.550; MacIntosh BJ, 2010, MAGN RESON MED, V63, P641, DOI 10.1002/mrm.22256; Medow MS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00234; Miwa K, 2016, HEART VESSELS, V31, P1522, DOI 10.1007/s00380-015-0744-3; Moon J, 2016, J AM SOC HYPERTENS, V10, P263, DOI 10.1016/j.jash.2016.01.011; Perrin R, 2010, BRIT J RADIOL, V83, P419, DOI 10.1259/bjr/85621779; Reynolds GK, 2014, J INTERN MED, V275, P409, DOI 10.1111/joim.12161; Roberts DA, 1996, JMRI-J MAGN RESON IM, V6, P363, DOI 10.1002/jmri.1880060217; Roerink ME, 2017, J INTERN MED, V281, P179, DOI 10.1111/joim.12564; Schondorf R, 1999, J AUTONOM NERV SYST, V75, P192, DOI 10.1016/S0165-1838(98)00177-5; SCHWARTZ RB, 1994, AM J ROENTGENOL, V162, P943, DOI 10.2214/ajr.162.4.8141022; SCHWARTZ RB, 1994, AM J ROENTGENOL, V162, P935, DOI 10.2214/ajr.162.4.8141020; Spence VA, 2008, CLIN SCI, V114, P561, DOI 10.1042/CS20070274; Stewart JM, 2015, HYPERTENSION, V65, P636, DOI 10.1161/HYPERTENSIONAHA.114.04576; Suarez GA, 1999, NEUROLOGY, V52, P523, DOI 10.1212/WNL.52.3.523; Tain RW, 2009, J MAGN RESON IMAGING, V30, P878, DOI 10.1002/jmri.21925; Tain RW, 2009, IEEE T BIO-MED ENG, V56, P544, DOI 10.1109/TBME.2008.2006010; Tzeng YC, 2014, EUR J APPL PHYSIOL, V114, P545, DOI 10.1007/s00421-013-2667-y; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; Videbech P, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1034/j.1600-0447.2000.101001011.x; Yoshiuchi K, 2006, CLIN PHYSIOL FUNCT I, V26, P83, DOI 10.1111/j.1475-097X.2006.00649.x	37	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0200068	10.1371/journal.pone.0200068	http://dx.doi.org/10.1371/journal.pone.0200068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969498	gold, Green Published, Green Submitted			2022-12-26	WOS:000437246700040
J	Tikka, P; Kauttonen, J; Hlushchuk, Y				Tikka, Pia; Kauttonen, Janne; Hlushchuk, Yevhen			Narrative comprehension beyond language: Common brain networks activated by a movie and its script	PLOS ONE			English	Article							TEMPORAL RECEPTIVE WINDOWS; NEURAL RESPONSES; HIERARCHY; ANATOMY; SPOKEN; FMRI	Narratives surround us in our everyday life in different forms. In the sensory brain areas, the processing of narratives is dependent on the media of presentation, be that in audiovisual or written form. However, little is known of the brain areas that process complex narrative content mediated by various forms. To isolate these regions, we looked for the functional networks reacting in a similar manner to the same narrative content despite different media of presentation. We collected 3-T fMRI whole brain data from 31 healthy human adults during two separate runs when they were either viewing a movie or reading its screenplay text. The independent component analysis (ICA) was used to separate 40 components. By correlating the components' time-courses between the two different media conditions, we could isolate 5 functional networks that particularly related to the same narrative content. These TOP-5 components with the highest correlation covered fronto-temporal, parietal, and occipital areas with no major involvement of primary visual or auditory cortices. Interestingly, the top-ranked network with highest modality-invariance also correlated negatively with the dialogue predictor, thus pinpointing that narrative comprehension entails processes that are not language-reliant. In summary, our novel experiment design provided new insight into narrative comprehension networks across modalities.	[Tikka, Pia; Kauttonen, Janne; Hlushchuk, Yevhen] Aalto Univ, Sch Arts Design & Architecture, Dept Media, Helsinki, Finland; [Tikka, Pia] Tallinn Univ, Baltic Film Media Arts & Commun Sch, Tallinn, Estonia; [Kauttonen, Janne] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Espoo, Finland; [Kauttonen, Janne] Laurea Univ Appl Sci, NeuroLab, Espoo, Finland; [Hlushchuk, Yevhen] Aalto Univ, Adv Magnet Imaging Ctr, Aalto Neurolmaging, Sch Sci, Espoo, Finland; [Hlushchuk, Yevhen] Univ Helsinki, HUS Med Imaging Ctr, Radiol, Helsinki, Finland; [Hlushchuk, Yevhen] Helsinki Univ Hosp, Helsinki, Finland	Aalto University; Tallinn University; Aalto University; Laurea University of Applied Sciences; Aalto University; Hyvinkaan Sairaala; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Hlushchuk, Y (corresponding author), Aalto Univ, Sch Arts Design & Architecture, Dept Media, Helsinki, Finland.; Hlushchuk, Y (corresponding author), Aalto Univ, Adv Magnet Imaging Ctr, Aalto Neurolmaging, Sch Sci, Espoo, Finland.; Hlushchuk, Y (corresponding author), Univ Helsinki, HUS Med Imaging Ctr, Radiol, Helsinki, Finland.; Hlushchuk, Y (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	yevhen.hlushchuk@hus.fi		Hlushchuk, Yevhen/0000-0001-6869-6305	aivoAALTO (Aalto/aA) from the Aalto University; Aalto Starting Grant (Aalto/NC) from the Aalto University; aivoAALTO; Aalto Starting Grant from the Aalto University	aivoAALTO (Aalto/aA) from the Aalto University; Aalto Starting Grant (Aalto/NC) from the Aalto University; aivoAALTO; Aalto Starting Grant from the Aalto University	The research was funded by aivoAALTO (Aalto/aA2010) and Aalto Starting Grant (Aalto/NC2011; www.neurocine.net) from the Aalto University (www.aalto.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was funded by aivoAALTO and Aalto Starting Grant from the Aalto University. We thank Riitta Hari for valuable comments, Marita Kattelus for assistance in fMRI scanning, Eerik Puska for input in preprocessing, and producer Outi Rousu for the permission to use original film material. The authors declare no competing financial interests.	Aleman A, 2005, CEREB CORTEX, V15, P221, DOI 10.1093/cercor/bhh124; Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Bartels A, 2004, NEUROIMAGE, V22, P419, DOI 10.1016/j.neuroimage.2004.01.007; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carter RM, 2013, TRENDS COGN SCI, V17, P328, DOI 10.1016/j.tics.2013.05.007; Caulo M, 2011, AM J NEURORADIOL, V32, P1056, DOI 10.3174/ajnr.A2428; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Grossman ED, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.015.2010; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; Honey CJ, 2012, J NEUROSCI, V32, P15277, DOI 10.1523/JNEUROSCI.1800-12.2012; Jaaskelainen Iiro P, 2008, Open Neuroimag J, V2, P14, DOI 10.2174/1874440000802010014; Jung-Beeman M, 2005, TRENDS COGN SCI, V9, P512, DOI 10.1016/j.tics.2005.09.009; Kauttonen J, 2015, NEUROIMAGE, V110, P136, DOI 10.1016/j.neuroimage.2015.01.063; Kauttonen Janne, 2014, 5 WORKSH COMP MOD NA, P77, DOI DOI 10.4230/OASICS.CMN.2014.77; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; Lahnakoski JM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00233; Lahnakoski JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035215; Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011; Mars RB, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00189; Mazaika P., 2009, NEUROIMAGE, V47, pS58, DOI DOI 10.1016/S1053-8119(09)70238-1; Moreno DR, 2014, BRAIN CONNECT, V5, P1, DOI [10.1089/BRAIN.2013.0186, DOI 10.1089/BRAIN.2013.0186]; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Naci L, 2014, P NATL ACAD SCI USA, V111, P14277, DOI 10.1073/pnas.1407007111; Pamilo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042000; Perrone-Bertolotti M, 2012, J NEUROSCI, V32, P17554, DOI 10.1523/JNEUROSCI.2982-12.2012; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Regev M, 2013, J NEUROSCI, V33, P15978, DOI 10.1523/JNEUROSCI.1580-13.2013; Saxe Rebecca, 2010, HDB THEORY MIND; Scholz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004869; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; St George M, 1999, BRAIN, V122, P1317, DOI 10.1093/brain/122.7.1317; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Wolf I, 2010, NEUROIMAGE, V49, P894, DOI 10.1016/j.neuroimage.2009.08.060; Wu X, 2009, NEUROIMAGE, V45, P1347, DOI 10.1016/j.neuroimage.2008.12.050; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]	44	14	14	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0200134	10.1371/journal.pone.0200134	http://dx.doi.org/10.1371/journal.pone.0200134			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969491	Green Submitted, Green Published, gold			2022-12-26	WOS:000437246700047
J	Borelli, E; Crepaldi, D; Porro, CA; Cacciari, C				Borelli, Eleonora; Crepaldi, Davide; Porro, Carlo Adolfo; Cacciari, Cristina			The psycholinguistic and affective structure of words conveying pain	PLOS ONE			English	Article							AGE-OF-ACQUISITION; ATTENTION-GRABBING POWER; AFFECTIVE NORMS; AUTOMATIC VIGILANCE; LEXICAL DECISION; NEGATIVE WORDS; IMAGEABILITY RATINGS; CONTEXT AVAILABILITY; EMOTIONAL WORDS; FRENCH WORDS	Despite the flourishing research on the relationships between affect and language, the characteristics of pain-related words, a specific type of negative words, have never been systematically investigated from a psycholinguistic and emotional perspective, despite their psychological relevance. This study offers psycholinguistic, affective, and pain-related norms for words expressing physical and social pain. This may provide a useful tool for the selection of stimulus materials in future studies on negative emotions and/or pain. We explored the relationships between psycholinguistic, affective, and pain-related properties of 512 Italian words (nouns, adjectives, and verbs) conveying physical and social pain by asking 1020 Italian participants to provide ratings of Familiarity, Age of Acquisition, Imageability, Concreteness, Context Availability, Valence, Arousal, Pain-Relatedness, Intensity, and Unpleasantness. We also collected data concerning Length, Written Frequency (Subtlex-IT), N-Size, Orthographic Levenshtein Distance 20, Neighbor Mean Frequency, and Neighbor Maximum Frequency of each word. Interestingly, the words expressing social pain were rated as more negative, arousing, pain-related, and conveying more intense and unpleasant experiences than the words conveying physical pain.	[Borelli, Eleonora; Porro, Carlo Adolfo; Cacciari, Cristina] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy; [Borelli, Eleonora; Porro, Carlo Adolfo; Cacciari, Cristina] Univ Modena & Reggio Emilia, Ctr Neurosci & Neurotechnol, Modena, Italy; [Crepaldi, Davide] Int Sch Adv Studies SISSA, Dept Cognit Neurosci, Trieste, Italy; [Crepaldi, Davide] Univ Milano Bicocca, Dept Neurol & Neurosci, Milan Ctr Neurosci NeuroMi, Milan, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; International School for Advanced Studies (SISSA); University of Milano-Bicocca	Borelli, E (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy.; Borelli, E (corresponding author), Univ Modena & Reggio Emilia, Ctr Neurosci & Neurotechnol, Modena, Italy.	eleonora.borelli@unimore.it	Cacciari, Cristina/H-2463-2013; Borelli, Eleonora/AAU-9973-2021	Cacciari, Cristina/0000-0002-5506-244X; Crepaldi, Davide/0000-0002-6765-1516; Borelli, Eleonora/0000-0002-3391-4437	FAR2016 grant from the University of Modena and Reggio Emilia	FAR2016 grant from the University of Modena and Reggio Emilia	This research was supported by the FAR2016 grant from the University of Modena and Reggio Emilia (https://www.unimore.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi E, 2011, COGN AFFECT BEHAV NE, V11, P372, DOI 10.3758/s13415-011-0034-1; Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; Augustine AA, 2011, SOC PSYCHOL PERS SCI, V2, P508, DOI 10.1177/1948550611399154; Avenanti A, 2006, NEUROIMAGE, V32, P316, DOI 10.1016/j.neuroimage.2006.03.010; Baayen RH, 2006, ANAL LINGUISTIC DATA; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; Balota DA, 2004, J EXP PSYCHOL GEN, V133, P283, DOI 10.1037/0096-3445.133.2.283; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Baroni M, INTRO REPUBBLICA COR; Barrett LF, 2006, J RES PERS, V40, P35, DOI 10.1016/j.jrp.2005.08.006; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Bertinetto PM, CORPUS LESSICO FREQU; Betti V, 2016, NEUROSCI BIOBEHAV R, V63, P191, DOI 10.1016/j.neubiorev.2016.02.009; Biemiller A, 2014, SCI STUD READ, V18, P130, DOI 10.1080/10888438.2013.821992; Bird H, 2001, BEHAV RES METH INS C, V33, P73, DOI 10.3758/BF03195349; Bonin P, 2003, ANN PSYCHOL, V103, P655; Borsook D, 2009, NEURON, V61, P153, DOI 10.1016/j.neuron.2009.01.003; Bradley M. M., 2000, HDB PSYCHOPHYSIOLOGY, P581; Bradley M. M., 1999, PSYCHOLOGY; Bradshaw JL, 2001, J NEUROL NEUROSUR PS, V70, P135; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Briesemeister BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023743; Briesemeister BB, 2011, BEHAV RES METHODS, V43, P441, DOI 10.3758/s13428-011-0059-y; Brooks JA, 2017, SOC COGN AFFECT NEUR, V12, P169, DOI 10.1093/scan/nsw121; Brysbaert M, 2017, Q J EXP PSYCHOL, V70, P1129, DOI 10.1080/17470218.2016.1172097; Brysbaert M, 2014, BEHAV RES METHODS, V46, P904, DOI 10.3758/s13428-013-0403-5; Cacioppo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02027; CARROLL JB, 1973, J VERB LEARN VERB BE, V12, P563, DOI 10.1016/S0022-5371(73)80036-2; Citron FMM, 2016, BEHAV RES METHODS, V48, P91, DOI 10.3758/s13428-015-0581-4; Citron FMM, 2014, APPL PSYCHOLINGUIST, V35, P313, DOI 10.1017/S0142716412000409; Citron FMM, 2013, NEUROSCI LETT, V533, P90, DOI 10.1016/j.neulet.2012.10.054; Citron FMM, 2012, BRAIN LANG, V122, P211, DOI 10.1016/j.bandl.2011.12.007; Clinton H., 2006, CLINTONS EMOTIONAL C; Coltheart M., 1977, ATTENTION PERFORM, P535, DOI DOI 10.1006/BRLN.2001.2475; Cortese MJ, 2004, BEHAV RES METH INS C, V36, P384, DOI 10.3758/BF03195585; Crepaldi D., 2015, P ANN M IT ASS EXP P; Cristofori I, 2013, CEREB CORTEX, V23, P2437, DOI 10.1093/cercor/bhs236; Dahl M, 2001, SCAND J PSYCHOL, V42, P97, DOI 10.1111/1467-9450.00218; Della Rosa PA, 2010, BEHAV RES METHODS, V42, P1042, DOI 10.3758/BRM.42.4.1042; Duckworth KL, 2002, PSYCHOL SCI, V13, P513, DOI 10.1111/1467-9280.00490; Dworkin RH, 2002, CLIN J PAIN, V18, P343, DOI 10.1097/00002508-200211000-00001; Eilola TM, 2010, BEHAV RES METHODS, V42, P134, DOI 10.3758/BRM.42.1.134; Eisenberger NI, 2015, ANNU REV PSYCHOL, V66, P601, DOI 10.1146/annurev-psych-010213-115146; Eisenberger NI, 2012, PSYCHOSOM MED, V74, P126, DOI 10.1097/PSY.0b013e3182464dd1; Eisenberger NI, 2004, TRENDS COGN SCI, V8, P294, DOI 10.1016/j.tics.2004.05.010; Estes Z, 2008, EMOTION, V8, P453, DOI 10.1037/a0012887; Estes Z, 2008, EMOTION, V8, P441, DOI 10.1037/1528-3542.8.4.441; Fairfield B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169472; Feldman- Barrett L, 1988, J PERS SOC PSYCHOL, V74, p967 ; Ferrand L, 2010, BEHAV RES METHODS, V42, P488, DOI 10.3758/BRM.42.2.488; Ferre P, 2012, BEHAV RES METHODS, V44, P395, DOI 10.3758/s13428-011-0165-x; Fischer A., 2000, GENDER EMOTION SOCIA; Fitzgibbon BM, 2010, NEUROSCI BIOBEHAV R, V34, P500, DOI 10.1016/j.neubiorev.2009.10.007; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Garcia D, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds3; GERNSBACHER MA, 1984, J EXP PSYCHOL GEN, V113, P256, DOI 10.1037/0096-3445.113.2.256; GILHOOLY KJ, 1980, BEHAV RES METH INSTR, V12, P395, DOI 10.3758/BF03201693; Gracely RH, 2016, PAIN, V157, P1369, DOI 10.1097/j.pain.0000000000000589; Gu XS, 2007, BEHAV BRAIN RES, V181, P218, DOI 10.1016/j.bbr.2007.04.008; Guasch M, 2016, BEHAV RES METHODS, V48, P1358, DOI 10.3758/s13428-015-0684-y; Guida A, 2007, ITAL J LINGUIST, V19, P293; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Hofmann MJ, 2009, COGN AFFECT BEHAV NE, V9, P389, DOI 10.3758/9.4.389; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Horn C, 2012, PAIN RES MANAG, V17, P15, DOI 10.1155/2012/478019; IBM Corp, 2017, IBM SPSS STAT VERS 2; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Jaremka LM, 2011, SELF IDENTITY, V10, P44, DOI 10.1080/15298860903513881; Juhasz BJ, 2015, BEHAV RES METHODS, V47, P1004, DOI 10.3758/s13428-014-0523-6; Juhasz BJ, 2005, PSYCHOL BULL, V131, P684, DOI 10.1037/0033-2909.131.5.684; Kanske P, 2010, NEUROPSYCHOLOGIA, V48, P3661, DOI 10.1016/j.neuropsychologia.2010.07.021; Keuleers E, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00174; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kloumann IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029484; Knickerbocker H, 2015, COGNITION EMOTION, V29, P784, DOI 10.1080/02699931.2014.938023; Kousta ST, 2009, COGNITION, V112, P473, DOI 10.1016/j.cognition.2009.06.007; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kristensen Christian Haag, 2011, Trends Psychiatry Psychother., V33, P135; Kuperman V, 2014, J EXP PSYCHOL GEN, V143, P1065, DOI 10.1037/a0035669; Kuperman V, 2012, BEHAV RES METHODS, V44, P978, DOI 10.3758/s13428-012-0210-4; Kveraga K, 2015, SOC COGN AFFECT NEUR, V10, P28, DOI 10.1093/scan/nsu007; Lahl O, 2009, BEHAV RES METHODS, V41, P13, DOI 10.3758/BRM.41.1.13; Lai S, 2015, INTELLIGENT SYSTEMS, V31; Larsen R.J., 1992, EMOTION, P25; Larsen RJ, 2006, EMOTION, V6, P62, DOI 10.1037/1528-3542.6.1.62; Lebani G. E., 2015, J COGNITIVE SCI, V16, P399; Lindquist KA, 2016, CEREB CORTEX, V26, P1910, DOI 10.1093/cercor/bhv001; Luniewska M, 2016, BEHAV RES METHODS, V48, P1154, DOI 10.3758/s13428-015-0636-6; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Main CJ, 2016, PAIN, V157, P1387, DOI 10.1097/j.pain.0000000000000457; Marelli M, 2017, PSIHOLOGIJA, V50, P503, DOI 10.2298/PSI161208011M; Mather M, 2011, PERSPECT PSYCHOL SCI, V6, P114, DOI 10.1177/1745691611400234; McKenna FP, 2004, J EXP PSYCHOL LEARN, V30, P382, DOI 10.1037/0278-7393.30.2.382; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Melzack R, SKIN SENSES; Melzack R., 1983, PAIN MEASUREMENT ASS; MILLER GA, 1991, LANG COGNITIVE PROC, V6, P1, DOI 10.1080/01690969108406936; Mohammad S., 2010, P NAACL HLT 2010 WOR, P26; Monnier C, 2014, BEHAV RES METHODS, V46, P1128, DOI 10.3758/s13428-013-0431-1; Montefinese M, 2014, BEHAV RES METHODS, V46, P887, DOI 10.3758/s13428-013-0405-3; Montefinese M, 2013, BEHAV RES METHODS, V45, P440, DOI 10.3758/s13428-012-0263-4; Morrison CM, 1997, Q J EXP PSYCHOL-A, V50, P528, DOI 10.1080/027249897392017; Most SB, 2005, PSYCHOL REV, V112, P217, DOI 10.1037/0033-295X.112.1.217; Nasrallah M, 2009, EMOTION, V9, P609, DOI 10.1037/a0016305; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Osaka N, 2004, BEHAV BRAIN RES, V153, P123, DOI 10.1016/j.bbr.2003.11.013; Osborn Jody, 2010, Pain, V148, P268, DOI 10.1016/j.pain.2009.11.007; Osgood C. E., 1967, MEASUREMENT MEANING; PAIVIO A, 1968, CAN J PSYCHOLOGY, V22, P427, DOI 10.1037/h0082782; PAIVIO A, 1971, PERCEPT PSYCHOPHYS, V10, P408, DOI 10.3758/BF03210323; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; Paivio A, 1971, IMAGERY VERBAL PROCE; Paivio A, 2013, J EXP PSYCHOL GEN, V142, P282, DOI 10.1037/a0027004; Palazova M, 2011, NEUROPSYCHOLOGIA, V49, P2766, DOI 10.1016/j.neuropsychologia.2011.06.005; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; PRICE DD, 1987, PAIN, V28, P297, DOI 10.1016/0304-3959(87)90065-0; R Development Core Team, 2016, R LANG ENV STAT COMP; Rammstedt B, 2007, EUR J PSYCHOL ASSESS, V23, P32, DOI 10.1027/1015-5759.23.1.32; RATCLIFF R, 1985, J EXP PSYCHOL GEN, V114, P435, DOI 10.1037/0096-3445.114.4.435; Recio G, 2014, BRAIN LANG, V134, P34, DOI 10.1016/j.bandl.2014.03.009; Redondo J, 2007, BEHAV RES METHODS, V39, P600, DOI 10.3758/BF03193031; REISENZEIN R, 1994, J PERS SOC PSYCHOL, V67, P525, DOI 10.1037/0022-3514.67.3.525; Richter M, 2014, PAIN RES MANAG, V19, P69, DOI 10.1155/2014/425321; Richter M, 2010, PAIN, V148, P198, DOI 10.1016/j.pain.2009.08.009; Ritter A, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030054; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Rozin P, 2010, COGNITION EMOTION, V24, P536, DOI 10.1080/02699930902793462; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schmidtke DS, 2014, BEHAV RES METHODS, V46, P1108, DOI 10.3758/s13428-013-0426-y; SCHWANENFLUGEL PJ, 1983, J EXP PSYCHOL LEARN, V9, P82, DOI 10.1037/0278-7393.9.1.82; SCHWANENFLUGEL PJ, 1988, J MEM LANG, V27, P499, DOI 10.1016/0749-596X(88)90022-8; Semino E, 2010, METAPHOR SYMBOL, V25, P205, DOI 10.1080/10926488.2010.510926; Soares AP, 2012, BEHAV RES METHODS, V44, P256, DOI 10.3758/s13428-011-0131-7; Stadthagen-Gonzalez H, 2006, BEHAV RES METHODS, V38, P598, DOI 10.3758/BF03193891; Stanford EA, 2005, PAIN, V114, P278, DOI 10.1016/j.pain.2004.12.029; Strong J, 2009, PAIN, V145, P86, DOI 10.1016/j.pain.2009.05.018; Venables WN., 2002, MODERN APPL STAT S 4; Vigliocco G, 2014, CEREB CORTEX, V24, P1767, DOI 10.1093/cercor/bht025; Vinson D, 2014, COGNITION EMOTION, V28, P737, DOI 10.1080/02699931.2013.851068; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Vo MLH, 2006, BEHAV RES METHODS, V38, P606, DOI 10.3758/BF03193892; Wang W, 2016, SCIENCE, V353, P1502, DOI 10.1126/science.aaf6758; Warriner AB, 2013, BEHAV RES METHODS, V45, P1191, DOI 10.3758/s13428-012-0314-x; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; Wei WL, 2011, LECT NOTES COMPUT SC, V6975, P121, DOI 10.1007/978-3-642-24571-8_13; Wentura D, 2000, J PERS SOC PSYCHOL, V78, P1024, DOI 10.1037//0022-3514.78.6.1024; Wiemer- Hastings K, 2001, P ANN M COGN SCI SOC; Wierzbicka A, 2012, EMOT REV, V4, P307, DOI 10.1177/1754073912439761; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Witherell D, 2012, MENT LEX, V7, P183, DOI 10.1075/ml.7.2.03wit; WOODFORDE JM, 1972, J PSYCHOSOM RES, V16, P173, DOI 10.1016/0022-3999(72)90041-4; Wurm LH, 2007, PSYCHON B REV, V14, P1218, DOI 10.3758/BF03193116; Yao Z, 2017, BEHAV RES METHODS, V49, P1374, DOI 10.3758/s13428-016-0793-2; Yarkoni T, 2008, PSYCHON B REV, V15, P971, DOI 10.3758/PBR.15.5.971; Yee LTS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174569	158	10	11	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0199658	10.1371/journal.pone.0199658	http://dx.doi.org/10.1371/journal.pone.0199658			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL0PZ	29958269	Green Submitted, Green Published, gold			2022-12-26	WOS:000436793500014
J	Henscheid, N; Clarkson, E; Myers, KJ; Barrett, HH				Henscheid, Nick; Clarkson, Eric; Myers, Kyle J.; Barrett, Harrison H.			Physiological random processes in precision cancer therapy	PLOS ONE			English	Article							TUMOR-GROWTH; MATHEMATICAL-MODELS; AVASCULAR TUMOR; HETEROGENEITY; PENETRATION; DYNAMICS	Many different physiological processes affect the growth of malignant lesions and their response to therapy. Each of these processes is spatially and genetically heterogeneous; dynamically evolving in time; controlled by many other physiological processes, and intrinsically random and unpredictable. The objective of this paper is to show that all of these properties of cancer physiology can be treated in a unified, mathematically rigorous way via the theory of random processes. We treat each physiological process as a random function of position and time within a tumor, defining the joint statistics of such functions via the infinite-dimensional characteristic functional. The theory is illustrated by analyzing several models of drug delivery and response of a tumor to therapy. To apply the methodology to precision cancer therapy, we use maximum-likelihood estimation with Emission Computed Tomography (ECT) data to estimate unknown patient-specific physiological parameters, ultimately demonstrating how to predict the probability of tumor control for an individual patient undergoing a proposed therapeutic regimen.	[Henscheid, Nick; Clarkson, Eric; Barrett, Harrison H.] Univ Arizona, Ctr Gamma Ray Imaging, Tucson, AZ 85721 USA; [Henscheid, Nick; Clarkson, Eric; Barrett, Harrison H.] Univ Arizona, Program Appl Math, Tucson, AZ 85721 USA; [Clarkson, Eric; Barrett, Harrison H.] Univ Arizona, Dept Med Imaging, Tucson, AZ USA; [Clarkson, Eric; Barrett, Harrison H.] Univ Arizona, Coll Opt Sci, Tucson, AZ USA; [Myers, Kyle J.] Food & Drug Adm, Ctr Devices & Radiol Hlth, Silver Spring, MD USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; US Food & Drug Administration (FDA)	Henscheid, N (corresponding author), Univ Arizona, Ctr Gamma Ray Imaging, Tucson, AZ 85721 USA.; Henscheid, N (corresponding author), Univ Arizona, Program Appl Math, Tucson, AZ 85721 USA.	nhenscheid@math.arizona.edu		MYERS, KYLE/0000-0001-7394-4932; Henscheid, Nick/0000-0002-9361-6976	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [R01EB000803, P41EB002035]; ARCS foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000803, P41EB002035] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); ARCS foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under award numbers R01EB000803 and P41EB002035 to HHB. The first author, NH, was partially supported by the ARCS foundation for a portion of this work. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LH, 2006, BRIT J CANCER, V95, P1136, DOI 10.1038/sj.bjc.6603310; Abramson RG, 2015, ACAD RADIOL, V22, P25, DOI 10.1016/j.acra.2014.09.001; ADAM JA, 1986, MATH BIOSCI, V81, P229, DOI 10.1016/0025-5564(86)90119-7; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Baish JW, 2000, CANCER RES, V60, P3683; Barrett H H, 2004, FDN IMAGE SCI; Barrett HH, 2008, IEEE T MED IMAGING, V27, P775, DOI 10.1109/TMI.2007.913241; Barrett HH, 2016, J MED IMAGING, V3, DOI 10.1117/1.JMI.3.2.023502; Barrett HH, 2013, PHYS MED BIOL, V58, P8197, DOI 10.1088/0031-9155/58/22/8197; Barrett HH, 2010, PROC SPIE, V7627, DOI 10.1117/12.844189; BARRETT HH, 1994, PHYS MED BIOL, V39, P833, DOI 10.1088/0031-9155/39/5/004; Barrett HH, 2015, P SPIE INT SOC OPT E, V9412; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Caucci L, 2016, OPT ENG, V55, DOI [10.1117/1.OE.55.1.013102, 10.1117/1.oe.55.1.013102]; Clarkson E, 2016, J OPT SOC AM A, V33, P1464, DOI 10.1364/JOSAA.33.001464; Cristini V., 2010, MULTISCALE MODELING; Darne C, 2014, PHYS MED BIOL, V59, pR1, DOI 10.1088/0031-9155/59/1/R1; de Pillis LG, 2001, J THEO MED, V24, P79, DOI [10.1080/10273660108833067, DOI 10.1080/10273660108833067]; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ding YJ, 2017, MED PHYS, V44, P2478, DOI 10.1002/mp.12245; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; DREWINKO B, 1981, CANCER RES, V41, P2328; Ferreira SC, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021907; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gonzalez-Garcia I, 2002, P NATL ACAD SCI USA, V99, P13085, DOI 10.1073/pnas.202139299; GYLLENBERG M, 1990, J MATH BIOL, V28, P671, DOI 10.1007/BF00160231; GYLLENBERG M, 1989, GROWTH DEVELOP AGING, V53, P25; Hahnfeldt P, 1999, CANCER RES, V59, P4770; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Jackson TL, 2000, MATH BIOSCI, V164, P17, DOI 10.1016/S0025-5564(99)00062-0; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; Klauschen Frederick, 2014, Oncoscience, V1, P504; Kupinski MA, 2003, J OPT SOC AM A, V20, P421, DOI 10.1364/JOSAA.20.000421; MARUSIC M, 1994, B MATH BIOL, V56, P617, DOI 10.1007/BF02460714; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Michor F, 2011, NAT REV CANCER, V11, P657, DOI 10.1038/nrc3092; Miller BW, 2014, NUCL INSTRUM METH A, V767, P146, DOI 10.1016/j.nima.2014.05.070; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; NORTON L, 1988, CANCER RES, V48, P7067; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Peterson TE, 2011, PHYS MED BIOL, V56, pR145, DOI 10.1088/0031-9155/56/17/R01; Ribba B, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-7; Roose T, 2007, SIAM REV, V49, P179, DOI 10.1137/S0036144504446291; Sachs RK, 2001, MATH COMPUT MODEL, V33, P1297, DOI 10.1016/S0895-7177(00)00316-2; Sanga S, 2006, EXPERT REV ANTICANC, V6, P1361, DOI 10.1586/14737140.6.10.1361; Sevick-Muraca EM, 2002, CURR OPIN CHEM BIOL, V6, P642, DOI 10.1016/S1367-5931(02)00356-3; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shepp L A, 1982, IEEE Trans Med Imaging, V1, P113, DOI 10.1109/TMI.1982.4307558; Simon R, 2006, NAT CLIN PRACT ONCOL, V3, P406, DOI 10.1038/ncponc0560; SKIPPER HE, 1971, CANCER-AM CANCER SOC, V28, P1479, DOI 10.1002/1097-0142(197112)28:6<1479::AID-CNCR2820280622>3.0.CO;2-M; Smith R.C., 2013, UNCERTAINTY QUANTIFI, V12; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Thurber GM, 2008, ADV DRUG DELIVER REV, V60, P1421, DOI 10.1016/j.addr.2008.04.012; VAIDYA VG, 1982, INT J BIOMED COMPUT, V13, P19, DOI 10.1016/0020-7101(82)90048-4; Van der Vaart AW, 2000, ASYMPTOTIC STAT, V3; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WEINSTEIN JN, 1992, CANCER RES, V52, pS2747; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Wheldon TE, 1988, MATH MODELS CANC RES; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Wittrup KD, 2012, METHOD ENZYMOL, V503, P255, DOI 10.1016/B978-0-12-396962-0.00010-0; WONG WH, 1991, ANN STAT, V19, P603, DOI 10.1214/aos/1176348113; Zhu SC, 1998, INT J COMPUT VISION, V27, P107, DOI 10.1023/A:1007925832420	71	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0199823	10.1371/journal.pone.0199823	http://dx.doi.org/10.1371/journal.pone.0199823			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0PZ	29958271	Green Published, Green Submitted, gold			2022-12-26	WOS:000436793500019
J	Rockel, JS; Zhang, WD; Shestopaloff, K; Likhodii, S; Sun, G; Furey, A; Randell, E; Sundararajan, K; Gandhi, R; Zhai, GJ; Kapoor, M				Rockel, Jason S.; Zhang, Weidong; Shestopaloff, Konstantin; Likhodii, Sergei; Sun, Guang; Furey, Andrew; Randell, Edward; Sundararajan, Kale; Gandhi, Rajiv; Zhai, Guangju; Kapoor, Mohit			A classification modeling approach for determining metabolite signatures in osteoarthritis	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; PLASMA; HIP	Multiple factors can help predict knee osteoarthritis (OA) patients from healthy individuals, including age, sex, and BMI, and possibly metabolite levels. Using plasma from individuals with primary OA undergoing total knee replacement and healthy volunteers, we measured lysophosphatidylcholine (lysoPC) and phosphatidylcholine (PC) analogues by metabolomics. Populations were stratified on demographic factors and lysoPC and PC analogue signatures were determined by univariate receiver-operator curve (AUC) analysis. Using signatures, multivariate classification modeling was performed using various algorithms to select the most consistent method as measured by AUC differences between resampled training and test sets. Lists of metabolites indicative of OA [AUC > 0.5] were identified for each stratum. The signature from males age > 50 years old encompassed the majority of identified metabolites, suggesting lysoPCs and PCs are dominant indicators of OA in older males. Principal component regression with logistic regression was the most consistent multivariate classification algorithm tested. Using this algorithm, classification of older males had fair power to classify OA patients from healthy individuals. Thus, individual levels of lysoPC and PC analogues may be indicative of individuals with OA in older populations, particularly males. Our metabolite signature modeling method is likely to increase classification power in validation cohorts.	[Rockel, Jason S.; Shestopaloff, Konstantin; Sundararajan, Kale; Gandhi, Rajiv; Kapoor, Mohit] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Arthrit Program, Toronto, ON, Canada; [Rockel, Jason S.; Shestopaloff, Konstantin; Sundararajan, Kale; Gandhi, Rajiv; Kapoor, Mohit] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Zhang, Weidong; Zhai, Guangju] Mem Univ Newfoundland, Discipline Genet, Fac Med, St John, NF, Canada; [Zhang, Weidong] Jilin Univ, Sch Pharmaceut Sci, Changchun, Jilin, Peoples R China; [Likhodii, Sergei; Randell, Edward] Mem Univ Newfoundland, Dept Lab Med, Fac Med, St John, NF, Canada; [Sun, Guang] Mem Univ Newfoundland, Discipline Med, Fac Med, St John, NF, Canada; [Furey, Andrew] Mem Univ Newfoundland, Dept Surg, Fac Med, St John, NF, Canada; [Gandhi, Rajiv; Kapoor, Mohit] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Zhai, Guangju] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Kapoor, Mohit] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Memorial University Newfoundland; Jilin University; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; University of Toronto; University of Tasmania; Menzies Institute for Medical Research; University of Toronto	Kapoor, M (corresponding author), Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Arthrit Program, Toronto, ON, Canada.; Kapoor, M (corresponding author), Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada.; Zhai, GJ (corresponding author), Mem Univ Newfoundland, Discipline Genet, Fac Med, St John, NF, Canada.; Kapoor, M (corresponding author), Univ Toronto, Dept Surg, Toronto, ON, Canada.; Zhai, GJ (corresponding author), Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia.; Kapoor, M (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	guangju.zhai@med.mun.ca; mohit.Kapoor@uhnresearch.ca			Canadian Institute of Health Research [MOP 126016, FRN 132178, FRN 143058, FRN 153298]; RDC of the Newfoundland and Labrador Project [5404.1423.102]; Memorial University of Newfoundland; Campaign to Cure Arthritis via Toronto General and Western Foundation	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); RDC of the Newfoundland and Labrador Project; Memorial University of Newfoundland; Campaign to Cure Arthritis via Toronto General and Western Foundation	This work is supported by the Canadian Institute of Health Research Operating Grants: MOP 126016, FRN 132178; FRN 143058; FRN 153298, RDC of the Newfoundland and Labrador (Project No. 5404.1423.102), Memorial University of Newfoundland, and Campaign to Cure Arthritis via the Toronto General and Western Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Apold H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-217; Cuadra VMB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097690; Efron B., 1993, INTRO BOOTSTRAP, Vxvi; Fontaine-Bisson B, 2014, AM J CLIN NUTR, V99, P384, DOI 10.3945/ajcn.113.073387; Guo L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15126; Inoue R, 2011, J ORTHOP SCI, V16, P704, DOI 10.1007/s00776-011-0157-9; Kraus VB, 2017, ANN RHEUM DIS, V76, P179, DOI 10.1136/annrheumdis-2016-209253; Kremers HM, 2015, J BONE JOINT SURG AM, V97A, P1386, DOI 10.2106/JBJS.N.01141; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; Poddighe S, 2017, INT J BIOCHEM CELL B, V93, P148, DOI 10.1016/j.biocel.2017.07.004; Silverwood V, 2015, OSTEOARTHR CARTILAGE, V23, P507, DOI 10.1016/j.joca.2014.11.019; Singh JA, 2014, ARTHRIT CARE RES, V66, P897, DOI 10.1002/acr.22233; Sturmer T, 1998, J RHEUMATOL, V25, P1827; Sun L, 2016, J PROTEOME RES, V15, P3118, DOI 10.1021/acs.jproteome.6b00228; Zhang W, 2016, OSTEOARTHR CARTILAGE, V24, P827, DOI 10.1016/j.joca.2015.12.004; Zhang WD, 2016, RHEUMATOLOGY, V55, P1566, DOI 10.1093/rheumatology/kew207; Zhang WD, 2015, J RHEUMATOL, V42, P859, DOI 10.3899/jrheum.141252; Zhou M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10158-8	20	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0199618	10.1371/journal.pone.0199618	http://dx.doi.org/10.1371/journal.pone.0199618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0PZ	29958292	Green Accepted, Green Published, gold			2022-12-26	WOS:000436793500012
J	Debelmas, A; Picard, A; Kadlub, N; Boisson, J				Debelmas, Alexandre; Picard, Arnaud; Kadlub, Natacha; Boisson, Jean			Contribution of the periosteum to mandibular distraction	PLOS ONE			English	Article							OF-THE-LITERATURE; MECHANICAL-PROPERTIES; OSTEOGENESIS; COLLAGEN; BIOMECHANICS; CAPACITY; SKELETON; MODEL	Mandibular distraction is a surgical process that progressively lengthens bone. To improve the distraction procedure and devices, the load of distraction and the mechanical strain of soft tissues during the process must be determined. We tested the assumption that it could be the periosteum primarily opposing distraction. Therefore we assessed the mechanical properties of the human mandibular periosteum and compared the stress-strain data with the torque measured on the activator during a cadaveric mandibular distraction. A 20 mm horizontal mandibular distraction was performed in 7 cadavers using standard distractors. Torque was measured with a torquemeter placed on the activation rods of the devices, providing a load (L-t) for each millimeter of distraction. In parallel, 18 periosteum samples were harvested from 9 cadaver mandibles. Uniaxial tensile tests were performed on the specimens and an estimated load (L-c) was calculated using periosteal stress-strain data and mandibular dimensions. During the distraction process, we observed an increase of the load Lt from 11.6 to 50.6 N. The periosteum exhibited a nonlinear viscoelastic stress-strain relationship, typical of biological tissues composed of collagen and elastin. The median L-c and L-t were not significantly different for the first millimeter of distraction. We demonstrated the periosteum is primarily responsible for opposing the distraction load.	[Debelmas, Alexandre; Picard, Arnaud; Kadlub, Natacha] Necker Enfant Malades, AP HP, Unit Maxillofacial Surg & Plast Surg, Paris, France; [Debelmas, Alexandre; Boisson, Jean] ENSTA Paris Tech, IMSIA, Dept Mech Engn, Palaiseau, France; [Picard, Arnaud; Kadlub, Natacha] Paris Descartes Univ, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Cite	Boisson, J (corresponding author), ENSTA Paris Tech, IMSIA, Dept Mech Engn, Palaiseau, France.	jean.boisson@ensta-paristech.fr		Boisson, Jean/0000-0001-9979-1786	l'Ecole de chirurgie de l'APHP, Idex Paris Saclay grant; Strasbourg Osteosynthesis Research Group research grant; Coline Association; Association Francaises des Families ayant un enfant atteint du Syndrome Silver Russell (SSR) ou ne Petit pour l'Age Gestationnel (PAG) et leurs amis; l'Ecole de chirurgie de l'APHP	l'Ecole de chirurgie de l'APHP, Idex Paris Saclay grant; Strasbourg Osteosynthesis Research Group research grant; Coline Association; Association Francaises des Families ayant un enfant atteint du Syndrome Silver Russell (SSR) ou ne Petit pour l'Age Gestationnel (PAG) et leurs amis; l'Ecole de chirurgie de l'APHP	This cadaveric experiment was supported by l'Ecole de chirurgie de l'APHP, Idex Paris Saclay grant to JB, a Strasbourg Osteosynthesis Research Group research grant to NK, the Coline Association to NK, and Association Francaises des Families ayant un enfant atteint du Syndrome Silver Russell (SSR) ou ne Petit pour l'Age Gestationnel (PAG) et leurs amis to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This cadaveric experiment was supported by l'Ecole de chirurgie de l'APHP.	Adolphs N, 2014, J CRANIO MAXILL SURG, V42, P966, DOI 10.1016/j.jcms.2014.01.018; [Anonymous], 1993, BIOMECHANICS MECH PR, DOI DOI 10.1007/978-1-4757-2257-4_7; Bancelin S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17635; Bell WH, 2007, DISTRACTION OSTEGENE, P327; Bertram JEA, 1998, BONE, V22, P669, DOI 10.1016/S8756-3282(98)00035-0; Boisson J, 2016, J CRANIO MAXILL SURG, V44, P684, DOI 10.1016/j.jcms.2016.03.009; Burstein FD, 2008, J CRANIOFAC SURG, V19, P644, DOI 10.1097/SCS.0b013e31816ae1a8; COMNINOU M, 1976, J BIOMECH, V9, P427, DOI 10.1016/0021-9290(76)90084-1; Diner PA, 1996, J CRANIO MAXILL SURG, V24, P92, DOI 10.1016/S1010-5182(96)80019-9; Evans SF, 2013, TISSUE ENG PART B-RE, V19, P147, DOI [10.1089/ten.teb.2012.0216, 10.1089/ten.TEB.2012.0216]; Foolen J, 2010, J BIOMECH, V43, P3168, DOI 10.1016/j.jbiomech.2010.07.040; Goldwaser BR, 2012, J ORAL MAXIL SURG, V70, P407, DOI 10.1016/j.joms.2011.01.042; Gupta HS, 2010, J STRUCT BIOL, V169, P183, DOI 10.1016/j.jsb.2009.10.002; Lynch B, 2017, ACTA BIOMATER, V50, P302, DOI 10.1016/j.actbio.2016.12.051; MANSCHOT JFM, 1986, J BIOMECH, V19, P517, DOI 10.1016/0021-9290(86)90125-9; McBride SH, 2011, J BIOMECH, V44, P1954, DOI 10.1016/j.jbiomech.2011.04.036; McBride SH, 2011, ANN BIOMED ENG, V39, P1570, DOI 10.1007/s10439-010-0242-9; McCarthy JG, 2001, PLAST RECONSTR SURG, V107, P1812, DOI 10.1097/00006534-200106000-00029; Popowics TE, 2002, ARCH ORAL BIOL, V47, P733, DOI 10.1016/S0003-9969(02)00065-1; Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033; Robinson RC, 2001, J ORAL MAXIL SURG, V59, P539, DOI 10.1053/joms.2001.22688; Saman M, 2013, JAMA FACIAL PLAST SU, V15, P167, DOI 10.1001/jamafacial.2013.44; Saunders Marnie M, 2008, Atlas Oral Maxillofac Surg Clin North Am, V16, P147, DOI 10.1016/j.cxom.2008.04.006; Verlinden CRA, 2015, INT J ORAL MAX SURG, V44, P37, DOI 10.1016/j.ijom.2014.07.009; Yiannakopoulos CK, 2008, ARCH ORTHOP TRAUM SU, V128, P117, DOI 10.1007/s00402-007-0433-5; Zeng YJ, 2003, CLIN BIOMECH, V18, P760, DOI 10.1016/S0268-0033(03)00136-0	26	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199116	10.1371/journal.pone.0199116	http://dx.doi.org/10.1371/journal.pone.0199116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953443	Green Submitted, gold, Green Published			2022-12-26	WOS:000436645400015
J	Li, CF; Li, YF; Yuan, YH; Wu, XJ; Sang, QB				Li, Chaofeng; Li, Yifan; Yuan, Yunhao; Wu, Xiaojun; Sang, Qingbing			Quaternion wavelet transform based full reference image quality assessment for multiply distorted images	PLOS ONE			English	Article							SIMILARITY; EFFICIENT	Most of real-world image distortions are multiply distortion rather than single distortion. To address this issue, in this paper we propose a quaternion wavelet transform (QWT) based full reference image quality assessment (FR IQA) metric for multiply distorted images, which jointly considers the local similarity of phase and magnitude of each subband via QWT. Firstly, the reference images and distorted images are decomposed by QWT, and then the similarity of amplitude and phase are calculated on each subband, thirdly the IQA metric is constructed by the weighting method considering human visual system (HVS) characteristics, and lastly the scores of each subband are averaged to get the quality score of test image. Experimental results show that the proposed method outperforms the state of art in multiply distorted IQA.	[Li, Chaofeng] Shanghai Maritime Univ, Inst Logist Sci & Engn, Shanghai, Peoples R China; [Li, Yifan; Wu, Xiaojun; Sang, Qingbing] Jiangnan Univ, Sch Internet Things Engn, Wuxi, Peoples R China; [Yuan, Yunhao] Yangzhou Univ, Coll Informat Engn, Yangzhou, Jiangsu, Peoples R China	Shanghai Maritime University; Jiangnan University; Yangzhou University	Li, CF (corresponding author), Shanghai Maritime Univ, Inst Logist Sci & Engn, Shanghai, Peoples R China.	wxlichaofeng@126.com	Sang, Qingbing/AAB-4778-2022	Li, Chaofeng/0000-0002-3236-3143	National Natural Science Foundation of China [61771223]; NSF of Hebei Province [F2016202144]; Department of Education of Hebei Province [QN2016217]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF of Hebei Province(Natural Science Foundation of Hebei Province); Department of Education of Hebei Province	This work was supported by the National Natural Science Foundation of China (No. 61771223), and NSF of Hebei Province under Grant F2016202144, and the youth fund from the Department of Education of Hebei Province under grant QN2016217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (No. 61771223), and NSF of Hebei Province under Grant F2016202144, and the youth fund from the Department of Education of Hebei Province under grant QN2016217.	Chan WL, 2008, IEEE T IMAGE PROCESS, V17, P1069, DOI 10.1109/TIP.2008.924282; Chen Q, 2013, IEEE INT CON MULTI; Gu K, 2014, IEEE T BROADCAST, V60, P555, DOI 10.1109/TBC.2014.2344471; Jayaraman D, 2012, CONF REC ASILOMAR C, P1693, DOI 10.1109/ACSSC.2012.6489321; Kolaman A, 2012, IEEE T IMAGE PROCESS, V21, P1526, DOI 10.1109/TIP.2011.2181522; Liu AM, 2012, IEEE T IMAGE PROCESS, V21, P1500, DOI 10.1109/TIP.2011.2175935; Saad MA, 2011, IEEE IMAGE PROC; Soulard R, 2011, PATTERN RECOGN LETT, V32, P1669, DOI 10.1016/j.patrec.2011.06.028; Tang LJ, 2017, J VIS COMMUN IMAGE R, V49, P204, DOI 10.1016/j.jvcir.2017.09.010; Thirulogasanthar K, 2015, J MATH PHYS, V251, P21; Traore A, 2014, IEEE IMAGE PROC, P526, DOI 10.1109/ICIP.2014.7025105; Wang Z, 2003, CONF REC ASILOMAR C, P1398; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wu JJ, 2013, IEEE T IMAGE PROCESS, V22, P43, DOI 10.1109/TIP.2012.2214048; Xue WF, 2014, IEEE T IMAGE PROCESS, V23, P684, DOI 10.1109/TIP.2013.2293423; Zhang L, 2011, IEEE T IMAGE PROCESS, V20, P2582, DOI 10.1109/TIP.2011.2121080	16	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199430	10.1371/journal.pone.0199430	http://dx.doi.org/10.1371/journal.pone.0199430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949615	gold, Green Submitted, Green Published			2022-12-26	WOS:000436549200048
J	Tani, N; Ikeda, T; Watanabe, M; Toyomura, J; Ohyama, A; Ishikawa, T				Tani, Naoto; Ikeda, Tomoya; Watanabe, Miho; Toyomura, Junko; Ohyama, Akihiro; Ishikawa, Takaki			Prolactin selectively transported to cerebrospinal fluid from blood under hypoxic/ischemic conditions	PLOS ONE			English	Article							GROWTH-HORMONE; POSTMORTEM OXYMETRY; HYPOXIA; NEUROGENESIS; EXPRESSION; BRAIN; IMMUNOHISTOCHEMISTRY	Aim The aim of this study was to determine and to verify the correlation between the amount of prolactin (PRL) levels in the blood and in the cerebrospinal fluid (CSF) by various causes of death as an indicator for acute hypoxia in autopsy cases. It is to confirm the cause of the change in prolactin level in CSF by in vitro system. Materials and methods In autopsy materials, the PRL levels in blood from the right heart ventricle and in the CSF were measured by chemiluminescent enzyme immunoassay, and changes in the percentage of PRL-positive cells in the pituitary gland were examined using an immunohistochemical method. Furthermore, an inverted culture method was used as an in vitro model of the blood-CSF barrier using epithelial cells of the human choroid plexus (HIBCPP cell line) and SDR-P-1D5 or MSH-P3 (PRL-secreting cell line derived from miniature swine hypophysis) under normoxic or hypoxic (5% oxygen) conditions, and as an index of cell activity, we used Vascular Endothelial Growth Factor (VEGF). Results and discussion Serum PRL levels were not significantly different between hypoxia/ischemia cases and other causes of death. However, PRL levels in CSF were three times higher in cases of hypoxia/ischemia than in those of the other causes of death. In the cultured cell under the hypoxia condition, PRL and VEGF showed a high concentration at 10 min. We established a brain-CSF barrier model to clarify the mechanism of PRL transport to CSF from blood, the PRL concentrations from blood to CSF increased under hypoxic conditions from 5 min. These results suggested that PRL moves in CSF through choroidal epithelium from blood within a short time. PRL is hypothesized to protect the hypoxic/ischemic brain, and this may be because of the increased transportation of the choroid plexus epithelial cells.	[Tani, Naoto; Ikeda, Tomoya; Ishikawa, Takaki] Osaka City Univ, Dept Legal Med, Med Sch, Osaka, Japan; [Tani, Naoto; Ikeda, Tomoya; Ishikawa, Takaki] Med Legal Consultat & Postmortem Invest Support, Forens Autopsy Sect, Osaka, Japan; [Watanabe, Miho; Toyomura, Junko; Ohyama, Akihiro] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept NDU Life Sci, Tokyo, Japan; [Watanabe, Miho] Nippon Dent Univ, Grad Sch Life Dent Niigata, Course Clin Sci, Field Oral & Maxillofacial Surg & Syst Med, Niigata, Japan; [Watanabe, Miho; Toyomura, Junko; Ohyama, Akihiro] Univ Tsukuba, Lab Clin Regenerat Med, Fac Med, Tsukuba, Ibaraki, Japan	Osaka Metropolitan University; Nippon Dental University; Nippon Dental University; University of Tsukuba	Tani, N (corresponding author), Osaka City Univ, Dept Legal Med, Med Sch, Osaka, Japan.; Tani, N (corresponding author), Med Legal Consultat & Postmortem Invest Support, Forens Autopsy Sect, Osaka, Japan.	tani.naoto@med.osaka-cu.ac.jp	Ishikawa, Takaki/AAP-7005-2020; Tani, Naoto/AAX-1858-2021	Tani, Naoto/0000-0002-4981-0456				Adan A, 2016, CURR PHARM BIOTECHNO, V17, P1213, DOI 10.2174/1389201017666160808160513; Cabrera-Reyes EA, 2017, ENDOCRINE, V57, P199, DOI 10.1007/s12020-017-1346-x; Bozorgi Ali, 2016, Crit Pathw Cardiol, V15, P174; Brown RSE, 2016, FASEB J, V30, P1002, DOI 10.1096/fj.15-276519; Chang A, 1999, EUR J ENDOCRINOL, V141, P387, DOI 10.1530/eje.0.1410387; Clapp C, 2015, ADV EXP MED BIOL, V846, P83, DOI 10.1007/978-3-319-12114-7_4; Cosio G, 2003, LAB INVEST, V83, P1627, DOI 10.1097/01.LAB.0000098429.59348.36; Dalwadi Pradip P, 2017, Indian J Endocrinol Metab, V21, P80, DOI 10.4103/2230-8210.196018; Dewangan J, 2018, LIFE SCI, V193, P9, DOI 10.1016/j.lfs.2017.11.045; Dinner S, 2016, JOVE-J VIS EXP, DOI 10.3791/54061; DUBEY AK, 1983, LIFE SCI, V32, P1857, DOI 10.1016/0024-3205(83)90064-4; Gragnoli C, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.50; Harvey S, 2012, ENDOCRINE, V41, P19, DOI 10.1007/s12020-011-9557-z; Holst B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001542; Ishikawa T, 2008, FORENSIC SCI INT, V179, P147, DOI 10.1016/j.forsciint.2008.04.023; Ishikawa T, 2011, HUM CELL, V24, P74, DOI 10.1007/s13577-011-0012-5; Ishikawa Takaki, 2009, Leg Med (Tokyo), V11 Suppl 1, pS228, DOI 10.1016/j.legalmed.2009.02.049; Ishiwata Isamu, 2005, Hum Cell, V18, P67; Jang JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184339; KNUDTZON J, 1989, HORM METAB RES, V21, P453, DOI 10.1055/s-2007-1009260; Kulshreshtha Bindu, 2017, Indian J Endocrinol Metab, V21, P545, DOI 10.4103/ijem.IJEM_515_16; Larsen CM, 2012, BRAIN BEHAV IMMUN, V26, P201, DOI 10.1016/j.bbi.2011.07.233; Leegwater NC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171492; Maeda H, 1997, FORENSIC SCI INT, V87, P201, DOI 10.1016/S0379-0738(97)00050-9; Maeda H, 1996, FORENSIC SCI INT, V81, P201, DOI 10.1016/S0379-0738(96)01952-4; Maeda H, 2006, FORENSIC SCI INT, V161, P141, DOI 10.1016/j.forsciint.2006.01.016; Majumdar Abha, 2013, J Hum Reprod Sci, V6, P168, DOI 10.4103/0974-1208.121400; NOGAMI H, 1989, ENDOCRINOLOGY, V125, P964, DOI 10.1210/endo-125-2-964; Patubskal S, 2017, MENOPAUSE REV, V16, P1, DOI 10.5114/pm.2017.67364; Richalet JP, 2010, AM J PHYSIOL-REG I, V299, pR1685, DOI 10.1152/ajpregu.00484.2010; Schwerk C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030069; Shao Y, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-9; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Tani N, 2017, J HARD TISSUE BIOL, V26, P347, DOI 10.2485/jhtb.26.347; Tominaga M, 2015, FORENSIC SCI INT, V254, P118, DOI 10.1016/j.forsciint.2015.07.005; Torner L, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00025; Vanoye-Carlo A, 2008, HORM BEHAV, V53, P112, DOI 10.1016/j.yhbeh.2007.09.004; Veith NT, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.109; WALSH RJ, 1987, ENDOCRINOLOGY, V120, P1846, DOI 10.1210/endo-120-5-1846; Xu LX, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0824-x; Yoshida C, 2011, INT J LEGAL MED, V125, P11, DOI 10.1007/s00414-009-0374-3; Zhang YS, 2000, NEUROSCI LETT, V279, P137, DOI 10.1016/S0304-3940(99)00968-4; Zhao Dong, 2009, Leg Med (Tokyo), V11 Suppl 1, pS290, DOI 10.1016/j.legalmed.2009.01.094; Zhu Bao-Li, 2008, Legal Medicine, V10, P11, DOI 10.1016/j.legalmed.2007.06.002; Zhu BL, 2000, FORENSIC SCI INT, V113, P193, DOI 10.1016/S0379-0738(00)00264-4	45	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198673	10.1371/journal.pone.0198673	http://dx.doi.org/10.1371/journal.pone.0198673			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949606	Green Submitted, Green Published, gold			2022-12-26	WOS:000436549200022
J	Houy, N; Le Grand, F				Houy, Nicolas; Le Grand, Francois			Optimal dynamic regimens with artificial intelligence: The case of temozolomide	PLOS ONE			English	Article							METRONOMIC CHEMOTHERAPY; MODEL; PHARMACOKINETICS; CHILDREN; TRIAL	We determine an optimal protocol for temozolomide using population variability and dynamic optimization techniques inspired by artificial intelligence. We use a Pharmacokinetics/Pharmacodynamics (PK/PD) model based on Faivre and coauthors (Faivre, et al., 2013) for the pharmacokinetics of temozolomide, as well as the pharmacodynamics of its efficacy. For toxicity, which is measured by the nadir of the normalized absolute neutrophil count, we formalize the myelosuppression effect of temozolomide with the physiological model of Panetta and coauthors (Panetta, et al., 2003). We apply the model to a population with variability as given in Panetta and coauthors (Panetta, et al., 2003). Our optimization algorithm is a variant in the class of Monte-Carlo tree search algorithms. We do not impose periodicity constraint on our solution. We set the objective of tumor size minimization while not allowing more severe toxicity levels than the standard Maximum Tolerated Dose (MTD) regimen. The protocol we propose achieves higher efficacy in the sense that-compared to the usual MTD regimen-it divides the tumor size by approximately 7.66 after 336 days-the 95% confidence interval being [7.36-7.97]. The toxicity is similar to MTD. Overall, our protocol, obtained with a very flexible method, gives significant results for the present case of temozolomide and calls for further research mixing operational research or artificial intelligence and clinical research in oncology.	[Houy, Nicolas] Univ Lyon, F-69007 Lyon, France; [Houy, Nicolas] CNRS, GATE Lyon, F-69130 St Etienne, France; [Le Grand, Francois] Emlyon Business Sch, F-69130 Ecully, France; [Le Grand, Francois] ETH, CH-8092 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); EMLYON Business School; Swiss Federal Institutes of Technology Domain; ETH Zurich	Le Grand, F (corresponding author), Emlyon Business Sch, F-69130 Ecully, France.; Le Grand, F (corresponding author), ETH, CH-8092 Zurich, Switzerland.	legrand@em-lyon.com		Le Grand, Francois/0000-0002-1505-5851				Atkinson BJ, 2014, J UROLOGY, V191, P611, DOI 10.1016/j.juro.2013.08.090; Barbolosi D, 2016, NAT REV CLIN ONCOL, V13, P242, DOI 10.1038/nrclinonc.2015.204; Barbolosi D, 2014, CANCER CHEMOTH PHARM, V74, P647, DOI 10.1007/s00280-014-2546-1; Benzekry S, 2015, SEMIN CANCER BIOL, V35, P53, DOI 10.1016/j.semcancer.2015.09.002; Bocci G, 2016, NAT REV CLIN ONCOL, V13, P659, DOI 10.1038/nrclinonc.2016.64; Browne CB, 2012, IEEE T COMP INTEL AI, V4, P1, DOI 10.1109/TCIAIG.2012.2186810; Elishmereni M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002206; Engel C, 2004, BLOOD, V104, P2323, DOI 10.1182/blood-2004-01-0306; Faivre C, 2013, CANCER CHEMOTH PHARM, V71, P1013, DOI 10.1007/s00280-013-2095-z; Gieschke R, 2000, EUR J DRUG METAB PH, V25, P49, DOI 10.1007/BF03190058; Hammond LA, 1999, J CLIN ONCOL, V17, P2604, DOI 10.1200/JCO.1999.17.8.2604; Henin E, 2016, BREAST CANCER RES TR, V156, P331, DOI 10.1007/s10549-016-3760-9; Houy N, 2018, J THEOR BIOL, V446, P71, DOI 10.1016/j.jtbi.2018.02.034; Lakshman R, 2001, J CLIN PATHOL, V54, P7, DOI 10.1136/jcp.54.1.7; Ledzewicz U, 2013, MATH BIOSCI ENG, V10, P787, DOI 10.3934/mbe.2013.10.787; Martin R. B., 1994, OPTIMAL CONTROL DRUG; Meille C, 2008, J PHARMACOKINET PHAR, V35, P619, DOI 10.1007/s10928-008-9106-4; Meille C, 2016, CLIN PHARMACOKINET, V55, P1015, DOI 10.1007/s40262-016-0374-7; Panetta JC, 2003, CANCER CHEMOTH PHARM, V52, P435, DOI 10.1007/s00280-003-0670-4; Panetta JC, 2003, MATH BIOSCI, V186, P29, DOI 10.1016/j.mbs.2003.07.002; Silber JH, 1998, J CLIN ONCOL, V16, P2435, DOI 10.1200/JCO.1998.16.7.2435; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; SWAN GW, 1990, MATH BIOSCI, V101, P237, DOI 10.1016/0025-5564(90)90021-P; van Kesteren C, 2003, INVEST NEW DRUG, V21, P225, DOI 10.1023/A:1023577514605	24	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199076	10.1371/journal.pone.0199076	http://dx.doi.org/10.1371/journal.pone.0199076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944669	gold, Green Published, Green Submitted			2022-12-26	WOS:000436377800019
J	Maaz, D; Krucken, J; Blumke, J; Richter, D; McKay-Demeler, J; Matuschka, FR; Hartmann, S; von Samson-Himmelstjerna, G				Maaz, Denny; Kruecken, Juergen; Bluemke, Julia; Richter, Dania; McKay-Demeler, Janina; Matuschka, Franz-Rainer; Hartmann, Susanne; von Samson-Himmelstjerna, Georg			Factors associated with diversity, quantity and zoonotic potential of ectoparasites on urban mice and voles	PLOS ONE			English	Article							IXODES-RICINUS TICKS; SMALL MAMMALS; GEOGRAPHICAL-DISTRIBUTION; DERMANYSSUS-GALLINAE; BORRELIA-BURGDORFERI; OCCIDENTAL EUROPE; IMMATURE STAGES; MITES ACARI; S-STR; RODENTS	Wild rodents are important hosts for tick larvae but co-infestations with other mites and insects are largely neglected. Small rodents were trapped at four study sites in Berlin, Germany, to quantify their ectoparasite diversity. Host-specific, spatial and temporal occurrence of ectoparasites was determined to assess their influence on direct and indirect zoonotic risk due to mice and voles in an urban agglomeration. Rodent-associated arthropods were diverse, including 63 species observed on six host species with an overall prevalence of 99%. The tick Ixodes ricinus was the most prevalent species, found on 56% of the rodents. The trapping location clearly affected the presence of different rodent species and, therefore, the occurrence of particular host-specific parasites. In Berlin, fewer temporary and periodic parasite species as well as non-parasitic species (fleas, chiggers and nidicolous Gamasina) were detected than reported from rural areas. In addition, abundance of parasites with low host-specificity (ticks, fleas and chiggers) apparently decreased with increasing landscape fragmentation associated with a gradient of urbanisation. In contrast, stationary ectoparasites, closely adapted to the rodent host, such as the fur mites Myobiidae and Listrophoridae, were most abundant at the two urban sites. A direct zoonotic risk of infection for people may only be posed by Nosopsyllus fasciatus fleas, which were prevalent even in the city centre. More importantly, peridomestic rodents clearly supported the life cycle of ticks in the city as hosts for their subadult stages. In addition to trapping location, season, host species, body condition and host sex, infestation with fleas, gamasid Laelapidae mites and prostigmatic Myobiidae mites were associated with significantly altered abundance of I. ricinus larvae on mice and voles. Whether this is caused by predation, grooming behaviour or interaction with the host immune system is unclear. The present study constitutes a basis to identify interactions and vector function of rodent-associated arthropods and their potential impact on zoonotic diseases.	[Maaz, Denny; Kruecken, Juergen; Bluemke, Julia; McKay-Demeler, Janina; von Samson-Himmelstjerna, Georg] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [Maaz, Denny; Hartmann, Susanne] Free Univ Berlin, Inst Immunol, Berlin, Germany; [Richter, Dania] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geoecol, Braunschweig, Germany; [Matuschka, Franz-Rainer] Univ Potsdam, Outpatient Clin, Potsdam, Germany	Free University of Berlin; Free University of Berlin; Braunschweig University of Technology; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Potsdam	Maaz, D (corresponding author), Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany.; Maaz, D (corresponding author), Free Univ Berlin, Inst Immunol, Berlin, Germany.	denny.maaz@fu-berlin.de	Krücken, Jürgen/AAE-3133-2021; Krücken, Jürgen/CAF-6903-2022; Krücken, Jürgen/B-6794-2009; McKay-Demeler, Janina/AAO-4336-2020	Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Richter, Dania/0000-0002-4799-5389; Maaz, Denny/0000-0002-5005-4416	German Research Foundation [IRTG 1673]; Einstein Foundation (Berlin, Germany)	German Research Foundation(German Research Foundation (DFG)); Einstein Foundation (Berlin, Germany)	This study was supported by grants from the German Research Foundation in the framework of the International Research Training Group (IRTG 1673) and the Einstein Foundation (Berlin, Germany) to DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMCZEWSKA-ANDRZEJEWSKA K, 1973, Acta Theriologica, V18, P353; AMBROS M, 1984, Miscellanea Zoologica Hungarica, V2, P35; Ambros M., 1995, MILBEN KLEINSAUGERN, V82, P111; [Anonymous], 2004, P 4 INT S URB WILDL; ARTZ V, 1975, Entomologica Germanica, V1, P105; Baker EW., 1956, MANUAL PARASITIC MIT; BEAUCOURNU J-C, 1968, Annales de Parasitologie Humaine et Comparee, V43, P201; Bochkov A. V., 2009, Acarina, V17, P109; Bochkov AV, 2011, ZOOTAXA, P1; Bochkov AV, 2003, ACTA PARASITOL, V48, P24; Brinck-Lindroth G, 2007, FLEAS SIPHONAPTERA F; Dautel H, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.01.013; DIZIJ A, 1995, PARASITE IMMUNOL, V17, P177, DOI 10.1111/j.1365-3024.1995.tb00887.x; DUBININA E V, 1968, Parazitologiya (St. Petersburg), V2, P407; Dubinina HV, 1967, PARAZITOLOGIYA, V1, P480; DUDICH A, 1984, Miscellanea Zoologica Hungarica, V2, P29; EDLER A, 1973, Folia Parasitologica (Ceske Budejovice), V20, P75; Eisen RJ, 2012, ANNU REV ENTOMOL, V57, P61, DOI 10.1146/annurev-ento-120710-100717; ELTON CHARLES, 1931, PROC ZOOL SOC LONDON, V1931, P657; Fain A., 1993, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Entomologie, V63, P77; Fain A., 1970, Revue Zool. Bot. afr., V81, P271; FAIN A, 1969, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique, V45, P1; FAIN A, 1994, INT J PARASITOL, V24, P1273, DOI 10.1016/0020-7519(94)90194-5; FAIN A, 1981, ACAROLOGIA, V22, P305; Fain A., 2001, Acarina, V9, P47; Fain A, 1970, Acta Zool Pathol Antverp, V50, P67; Fain A., 1969, Revue de Zoologie et de Botanique Africaines, V79, P389; Fain A., 1968, Bulletin et Annales de la Societe Entomologique de Belgique, V104, P85; Fain A, 1967, ACTA ZOOLOGICA PATHO, V43, P79; Fain A, 1974, B CLASSE SCI, P1137; FAIN ALEX, 1956, ANN PARASITOL HUMAINE ET COMP, V31, P155; Ferrari N, 2009, PARASITOLOGY, V136, P305, DOI 10.1017/S0031182008005404; HAITLINGER R, 1986, Polskie Pismo Entomologiczne, V56, P423; HAITLINGER R, 1987, Polskie Pismo Entomologiczne, V57, P597; Haitlinger R., 1983, Acta Theriologica, V28, P55; Haitlinger R., 2010, Zeszyty Naukowe Uniwersytetu Przyrodniczego we Wroclawiu - Biologia i Hodowla Zwierzat, V61, P21; Haitlinger R., 2010, Zeszyty Naukowe Uniwersytetu Przyrodniczego we Wroclawiu - Biologia i Hodowla Zwierzat, V60, P31; Haitlinger R., 2009, Zeszyty Naukowe Uniwersytetu Przyrodniczego we Wroclawiu - Biologia i Hodowla Zwierzat, V59, P19; Haitlinger R., 2007, Zeszyty Naukowe Uniwersytetu Przyrodniczego we Wroclawiu - Biologia i Hodowla Zwierzat, V55, P23; Haitlinger R., 2008, Zeszyty Naukowe Uniwersytetu Przyrodniczego we Wroclawiu - Biologia i Hodowla Zwierzat, V57, P57; Haitlinger R., 1997, ZESZYTY NAUKOWE AKAD, V43, P48; Haitlinger R., 2006, ZESZYTY NAUKOWE U PR, V54, P7; Haitlinger Ryszard, 2015, Zeszyty Naukowe Uniwersytetu Przyrodniczego we Wroclawiu, V610, P35; Haitlinger Ryszard, 2011, Zeszyty Naukowe Uniwersytetu Przyrodniczego we Wroclawiu, V583, P59; HALLE S, 1987, Zeitschrift fuer Angewandte Zoologie, V74, P299; Halliday B, 2011, AUST J ENTOMOL, V50, P61, DOI 10.1111/j.1440-6055.2010.00776.x; Harrison A, 2010, OIKOS, V119, P1099, DOI 10.1111/j.1600-0706.2009.18072.x; Hauer S, 2009, ATLAS SAUGETIERE SAC; HORNOK S, 2015, PARASITE VECTOR, V8, P1, DOI DOI 10.1186/S13071-014-0630-3; Hughes S, 2006, PARASITE IMMUNOL, V28, P577, DOI 10.1111/j.1365-3024.2006.00897.x; Kampen H., 2002, AMOBEN BANDWURMER ZE; Karg W., 1993, RAUBMILBE DIE TIERWE; KEPKA OTTO, 1964, Z PARASITENK, V23, P548; Kiffner C, 2011, PARASITOL RES, V108, P323, DOI 10.1007/s00436-010-2065-x; Kim KC, 1985, COEVOLUTION PARASITI; Kolodziej P, 2014, ANN AGR ENV MED, V21, P510, DOI 10.5604/12321966.1120592; KOVACIK J, 1984, Miscellanea Zoologica Hungarica, V2, P39; Krantz G., 2009, MANUAL ACAROLOGY; Krczal H., BEITRAGE SYSTEMATIK, V1; Krucken J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172829; Krucken J, 2013, J CLIN MICROBIOL, V51, P1958, DOI 10.1128/JCM.00284-13; Kudryashova N.I., 1998, CHIGGER MITES ACARIF; Kutzscher Christian, 2003, Entomofauna Germanica, V6, P292; Labrzycka A, 2008, ANN ZOOL, V58, P383, DOI 10.3161/000345408X326717; Lesna I, 2009, EXP APPL ACAROL, V48, P63, DOI 10.1007/s10493-009-9239-1; LUKOSCHUS F S, 1972, Tijdschrift voor Entomologie, V115, P325; LUNDQVIST L, 1987, FOLIA PARASIT, V34, P357; Maaz D, 2016, INFECT IMMUN, V84, P1274, DOI 10.1128/IAI.01309-15; Macdonald D., 1993, MAMMALS BRITAIN EURO; Mahnert V., 1971, Mitteilungen der Schweizerischen Entomologischen Gessellschaft, V44, P333; MAHNERT V, 1972, OECOLOGIA, V8, P400, DOI 10.1007/BF00367541; MAHNERT V, 1971, Revue Suisse de Zoologie, V78, P909; MAHNERT V, 1971, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V44, P323; MARQUEZ FJ, 1992, ACAROLOGIA, V33, P325; MARSHALL AG, 1981, ECOLOGY ECTOPARASITI; Martinet L., 1966, Mammalia, V30, P425, DOI 10.1515/mamm.1966.30.3.425; MasuYn P., 2010, REV LAELAPID MITES A; MATUSCHKA FR, 1990, J MED ENTOMOL, V27, P385, DOI 10.1093/jmedent/27.3.385; Matuschka FR, 1996, J INFECT DIS, V174, P1108, DOI 10.1093/infdis/174.5.1108; McKINLEY D. J., 1963, ANN AND MAG NAT HIST, V6, P65; Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1; Mit'kova K, 2015, PARASITOL RES, V114, P2465, DOI 10.1007/s00436-015-4443-x; MOREL P-C, 1973, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V11, P275; MOREL P-C, 1972, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V10, P47; MOREL PC, 1978, ACAROLOGIA, V19, P579; MOREL PC, 1978, ACAROLOGIA, V19, P395; Moro CV, 2005, PARASITE, V12, P99, DOI 10.1051/parasite/2005122099; Mrciak M., 1964, Biologia Bratislava, V19, P159; NAUMOV RL, 1984, PARAZITOLOGIYA+, V18, P106; Niethammer J, 1982, HDB SAUGETIERE EUROP, V2, P649; Niethammer J., 1978, HDB SAUGETIERE EUROP, P325; Niethammer J, 1978, HDB SAUGETIERE EUROP, P337; NILSSON A, 1988, HOLARCTIC ECOL, V11, P161; OLIVER JH, 1986, J PARASITOL, V72, P811, DOI 10.2307/3281492; Paziewska A, 2010, EXP APPL ACAROL, V50, P79, DOI 10.1007/s10493-009-9269-8; Perez D, 2012, VECTOR-BORNE ZOONOT, V12, P633, DOI 10.1089/vbz.2011.0763; Randolph SE, 1999, J MED ENTOMOL, V36, P741, DOI 10.1093/jmedent/36.6.741; Reiczigel J., 2005, QUANTITATIVE PARASIT; Renvoise A, 2012, INT J INFECT DIS, V16, pE221, DOI 10.1016/j.ijid.2011.11.009; Rizzoli A, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00251; Rosen S, 2002, MED VET ENTOMOL, V16, P442, DOI 10.1046/j.1365-2915.2002.00386.x; Rossin MA, 2010, PARASITOLOGY, V137, P1569, DOI 10.1017/S0031182010000351; Samish M, 2001, J MED ENTOMOL, V38, P1, DOI 10.1603/0022-2585-38.1.1; SCHOBER W, 1958, Z Parasitenkd, V18, P270, DOI 10.1007/BF00259200; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Silaghi C, 2016, MICROB ECOL, V72, P965, DOI 10.1007/s00248-016-0787-8; Skuratowicz W., 1967, PCHLY SIPHONAPTERA A; SMETANA ALES, 1962, CESKOSLOV PARASITOL, V9, P375; SMILEY R L, 1984, International Journal of Acarology, V10, P59; SMITH M, 1985, J PARASITOL, V71, P481, DOI 10.2307/3281542; SONENSHINE DE, 1968, J MED ENTOMOL, V5, P49, DOI 10.1093/jmedent/5.1.49; SOSNINA EF, 1981, PARAZITOLOGIYA+, V15, P157; Spitalska E, 2015, PARASITOL RES, V114, P4333, DOI 10.1007/s00436-015-4713-7; Stammer H. J., 1956, Verhandlungen der Deutschen Zoologischen Gesellschaft, V19, P362; Stanko M, 2015, PARASITOLOGY, V142, P938, DOI 10.1017/S0031182015000037; STARK HAROLD E., 1962, PAN PACIFIC ENTOMOL, V38, P249; STENSETH NC, 1985, ANN ZOOL FENN, V22, P289; STRANDTMANN RW, 1970, J MED ENTOMOL, V7, P261, DOI 10.1093/jmedent/7.2.261; Talleklint L, 1997, EXP APPL ACAROL, V21, P755, DOI 10.1023/A:1018473122070; Timm RM, 1975, OCCASIONAL PAPERS BE, V14, P1; Tomaso H, 2001, CLIN MICROBIOL INFEC, V7, P639, DOI 10.1046/j.1198-743x.2001.00332.x; Turk E., 1957, BEITRAGE SYSTEMATIK, P1; Vandorpe E., 1980, Annales de la Societe Royale Zoologique de Belgique, V109, P133; Vercammen-Grandjean P. H., 1960, Acarologia, V2, P469; Viro P, 1982, HDB SAUGETIERE EUROP, V2, P109; Volgin V. I., 1989, ACARINA FAMILY CHEYL; Vollack K, 2017, INT J BIOMETEOROL, V61, P1787, DOI 10.1007/s00484-017-1362-9; WHARTON GW, 1957, J PARASITOL, V43, P45, DOI 10.2307/3274753; Whitaker A.P, 2007, FLEAS SIPHONAPTERA; Willmann C., 1952, Zeitschrift fuer Parasitenkunde, V15, P392; Zejda J., 1965, Zoologicke Listy, V14, P301	131	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199385	10.1371/journal.pone.0199385	http://dx.doi.org/10.1371/journal.pone.0199385			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940047	Green Published, Green Submitted, gold			2022-12-26	WOS:000436088700013
J	Tang, BJ; Lummis, SCR				Tang, Bijun; Lummis, Sarah C. R.			Multiple regions in the extracellular domain of the glycine receptor determine receptor activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycine receptor; electrophysiology; membrane biophysics; mutagenesis; mutant; aromatic amino acid; Cys-loop; ion channel; ligand-gated; pentameric ligand-gated ion channel; two-voltage electrode clamp	LIGAND-BINDING DOMAIN; NICOTINIC ACETYLCHOLINE-RECEPTORS; CATION-PI INTERACTION; CYS-LOOP RECEPTORS; CRYSTAL-STRUCTURE; SUBUNIT; SITE; RESIDUES; STRYCHNINE; AGONIST	Glycine receptors (GlyRs) are Cys-loop receptors that mediate fast synaptic inhibition in the brain stem and spinal cord. They are involved in the generation of motor rhythm, reflex circuit coordination, and sensory signal processing and therefore represent targets for therapeutic interventions. The extracellular domains (ECDs) of Cys-loop receptors typically contain many aromatic amino acids, but only those in the receptor binding pocket have been extensively studied. Here, we show that many Phe residues in the ECD that are not located in the binding pocket are also involved in GlyR function. We examined these Phe residues by creating several GlyR variants, characterizing these variants with the two-electrode voltage clamp technique in Xenopus oocytes, and interpreting changes in receptor parameters by using currently available structural information on the open and closed states of the GlyR. Substitution of six of the eight Phe residues in the ECD with Ala resulted in loss of function or significantly increased the EC50 and also altered the maximal response to the partial GlyR agonist taurine compared with glycine in those receptor variants that were functional. Substitutions with other amino acids, combined with examination of nearby residues that could potentially interact with these Phe residues, suggested interactions that could be important for GlyR function, and possibly similar interactions could contribute to the function of other members of the Cys-loop receptor family. Overall, our results suggest that many ECD regions are important for GlyR function and that these regions could inform the design of therapeutic agents targeting GlyR activity.	[Tang, Bijun; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Lummis, SCR (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England.	sl120@cam.ac.uk		Tang, Bijun/0000-0003-3689-0167	Medical Research Council [MR/L021676]; MRC [MR/L021676/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by Medical Research Council Grant MR/L021676.	Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Bhattacharyya R, 2004, PROTEIN ENG DES SEL, V17, P795, DOI 10.1093/protein/gzh093; Braun N, 2016, ACS CHEM NEUROSCI, V7, P339, DOI 10.1021/acschemneuro.5b00298; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Henault CM, 2017, BBA-BIOMEMBRANES, V1859, P218, DOI 10.1016/j.bbamem.2016.11.006; Henchman RH, 2003, BIOPHYS J, V85, P3007, DOI 10.1016/S0006-3495(03)74720-1; Hu XQ, 2003, J BIOL CHEM, V278, P46583, DOI 10.1074/jbc.M308974200; Huang X, 2017, NAT STRUCT MOL BIOL, V24, P108, DOI 10.1038/nsmb.3329; Huang X, 2015, NATURE, V526, P277, DOI 10.1038/nature14972; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lummis SCR, 2005, CHEM BIOL, V12, P993, DOI 10.1016/j.chembiol.2005.06.012; Luo J, 2009, J NEUROSCI, V29, P13898, DOI 10.1523/JNEUROSCI.2833-09.2009; Lynch JW, 2006, CURR OPIN INVEST DR, V7, P48; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Mu TW, 2003, J AM CHEM SOC, V125, P6850, DOI 10.1021/ja0348086; Padgett CL, 2007, J NEUROSCI, V27, P886, DOI 10.1523/JNEUROSCI.4791-06.2007; Pless SA, 2008, J NEUROSCI, V28, P10937, DOI 10.1523/JNEUROSCI.2540-08.2008; Pless SA, 2011, J BIOL CHEM, V286, P35129, DOI 10.1074/jbc.M111.269027; Pless SA, 2011, MOL PHARMACOL, V79, P742, DOI 10.1124/mol.110.069583; Purohit P, 2013, J GEN PHYSIOL, V141, P467, DOI 10.1085/jgp.201210946; Reeves DC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-27; SCHMIEDEN V, 1993, SCIENCE, V262, P256, DOI 10.1126/science.8211147; Schofield CM, 2004, BIOCHEMISTRY-US, V43, P10058, DOI 10.1021/bi036159g; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; TZARTOS SJ, 1991, MOL NEUROBIOL, V5, P1, DOI 10.1007/BF02935610; Vafa B, 1999, J NEUROCHEM, V73, P2158; VANDENBERG RJ, 1992, P NATL ACAD SCI USA, V89, P1765, DOI 10.1073/pnas.89.5.1765; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088; Zondlo NJ, 2013, ACCOUNTS CHEM RES, V46, P1039, DOI 10.1021/ar300087y	33	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13889	13896		10.1074/jbc.RA118.003088	http://dx.doi.org/10.1074/jbc.RA118.003088			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29941455	Green Published, hybrid			2022-12-26	WOS:000444070700015
J	Emendato, A; Milordini, G; Zacco, E; Sicorello, A; Dal Piaz, F; Guerrini, R; Thorogate, R; Picone, D; Pastore, A				Emendato, Alessandro; Milordini, Giulia; Zacco, Elsa; Sicorello, Alessandro; Dal Piaz, Fabrizio; Guerrini, Remo; Thorogate, Richard; Picone, Delia; Pastore, Annalisa			Glycation affects fibril formation of A beta peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID CASCADE HYPOTHESIS; HUMAN LENS PROTEINS; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; MAILLARD REACTION; END-PRODUCTS; THIOFLAVIN-T; METHYLGLYOXAL; AGGREGATION; RISK	Increasing evidence shows that beta-amyloid (A beta) peptides, which are associated with Alzheimer disease (AD), are heavily glycated in patients, suggesting a role of this irreversible nonenzymatic post-translational modification in pathology. Previous reports have shown that glycation increases the toxicity of the A beta peptides, although little is known about the mechanism. Here, we used the natural metabolic by-product methylglyoxal as a glycating agent and exploited various spectroscopic methods and atomic force microscopy to study how glycation affects the structures of the A beta 40 and A beta 42 peptides, the aggregation pathway, and the morphologies of the resulting aggregates. We found that glycation significantly slows down but does not prevent beta-conversion to mature fibers. We propose that the previously reported higher toxicity of the glycated A beta peptides could be explained by a longer persistence in an oligomeric form, usually believed to be the toxic species.	[Emendato, Alessandro; Picone, Delia] Univ Naples Federico II, Dept Chem Sci, Via Cintia, I-80126 Naples, Italy; [Milordini, Giulia; Zacco, Elsa; Sicorello, Alessandro; Pastore, Annalisa] Kings Coll London, Denmark Hill Campus, London SE5 9RT, England; [Milordini, Giulia; Zacco, Elsa; Sicorello, Alessandro; Pastore, Annalisa] Kings Coll London, UK Dementia Res Inst, Denmark Hill Campus, London SE5 9RT, England; [Dal Piaz, Fabrizio] Univ Salerno, I-84084 Fisciano, Italy; [Guerrini, Remo] Univ Ferrara, Dept Chem & Pharmaceut Sci, I-44121 Ferrara, Italy; [Thorogate, Richard] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Pastore, Annalisa] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy	University of Naples Federico II; University of London; King's College London; University of London; King's College London; University of Salerno; University of Ferrara; University of London; University College London; University of Pavia	Picone, D (corresponding author), Univ Naples Federico II, Dept Chem Sci, Via Cintia, I-80126 Naples, Italy.; Pastore, A (corresponding author), Kings Coll London, Denmark Hill Campus, London SE5 9RT, England.	delia.picone@unina.it; annalisa.pastore@crick.ac.uk	Emendato, Alessandro/GWQ-4371-2022; Zacco, Elsa/AAZ-5750-2021; Picone, Delia/L-2480-2015	Zacco, Elsa/0000-0002-3593-6023; Sicorello, Alessandro/0000-0003-1407-8039; Picone, Delia/0000-0002-7582-2581	Diabetes UK; Dementia Research Institute grant; MRC [MC_PC_13054, MC_U117584256, UKDRI-6002] Funding Source: UKRI	Diabetes UK(Diabetes UK); Dementia Research Institute grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a Diabetes UK and a Dementia Research Institute grant. To whom correspondence may be addressed: King's College London, Denmark Hill Campus, London SE5 9RT, United Kingdom. E-mail: annalisa.pastore@crick.ac.uk.	Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Baynes JW, 2000, FREE RADICAL BIO MED, V28, P1708, DOI 10.1016/S0891-5849(00)00228-8; Beisswenger PJ, 2012, DIABETES TECHNOL THE, V14, P285, DOI 10.1089/dia.2011.0108; Brion JP, 1998, EUR NEUROL, V40, P130, DOI 10.1159/000007969; Broersen K, 2011, PROTEIN ENG DES SEL, V24, P743, DOI 10.1093/protein/gzr020; Chen K, 2006, J NEUROCHEM, V99, P1413, DOI 10.1111/j.1471-4159.2006.04181.x; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; Culberson JW, 2017, PROG MOL BIOL TRANSL, V146, P1, DOI 10.1016/bs.pmbts.2016.12.011; Emendato A, 2016, FEBS LETT, V590, P582, DOI 10.1002/1873-3468.12082; Fernandez-Busquets X, 2010, CURR ALZHEIMER RES, V7, P428, DOI 10.2174/156720510791383787; Fica-Contreras SM, 2017, J BIOL INORG CHEM, V22, P1211, DOI 10.1007/s00775-017-1497-5; Frye EB, 1998, J BIOL CHEM, V273, P18714, DOI 10.1074/jbc.273.30.18714; Gandy S, 2010, ANN NEUROL, V68, P220, DOI 10.1002/ana.22052; Ganzinger KA, 2014, CHEMBIOCHEM, V15, P2515, DOI 10.1002/cbic.201402377; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Goate A M, 1990, Adv Neurol, V51, P197; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; Habchi J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501244; Han WP, 2010, P NATL ACAD SCI USA, V107, P6557, DOI 10.1073/pnas.1002555107; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2017, FEBS J, V284, P1040, DOI 10.1111/febs.14004; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Iannuzzi Clara, 2014, Front Mol Biosci, V1, P9, DOI 10.3389/fmolb.2014.00009; Jana AK, 2016, PHYS CHEM CHEM PHYS, V18, P31446, DOI 10.1039/c6cp05041g; Lapolla A, 2006, MASS SPECTROM REV, V25, P775, DOI 10.1002/mas.20090; Li XH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.180; Liao YH, 2015, PROTEIN EXPRES PURIF, V113, P63, DOI 10.1016/j.pep.2015.05.002; Luth HJ, 2005, CEREB CORTEX, V15, P211, DOI 10.1093/cercor/bhh123; LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Masino L, 2011, BIOPHYS J, V100, P2033, DOI 10.1016/j.bpj.2011.02.056; MATTSON MP, 1995, NATURE, V373, P481, DOI 10.1038/373481a0; Munch G, 2000, J CHEM NEUROANAT, V20, P253, DOI 10.1016/S0891-0618(00)00096-X; Nomoto K., 2013, ANTIAGING MED, V10, P92; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Pampati PK, 2011, ANAL BIOCHEM, V408, P59, DOI 10.1016/j.ab.2010.08.038; Paranjape GS, 2012, ACS CHEM NEUROSCI, V3, P302, DOI 10.1021/cn2001238; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; REICHARD GA, 1986, DIABETES, V35, P668, DOI 10.2337/diabetes.35.6.668; RICHARD JP, 1993, BIOCHEM SOC T, V21, P549, DOI 10.1042/bst0210549; Sabate R, 2013, CHEM COMMUN, V49, P5745, DOI 10.1039/c3cc42040j; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shea TB, 2018, J ALZHEIMERS DIS, V62, P1049, DOI 10.3233/JAD-170724; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Taylor CA, 2017, MMWR-MORBID MORTAL W, V66, pS21, DOI 10.15585/mmwr.mm6620a1; Thornalley PJ, 2005, ANN NY ACAD SCI, V1043, P111, DOI 10.1196/annals.1333.014; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; WOLF J, 1994, J ANIM BREED GENET, V111, P209, DOI 10.1111/j.1439-0388.1994.tb00459.x; Xu WL, 2009, DIABETOLOGIA, V52, P1031, DOI 10.1007/s00125-009-1323-x; Xue C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160696; Yang Y, 2013, NEUROSCIENCE, V250, P140, DOI 10.1016/j.neuroscience.2013.07.009	52	36	37	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13100	13111		10.1074/jbc.RA118.002275	http://dx.doi.org/10.1074/jbc.RA118.002275			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29959224	hybrid, Green Published			2022-12-26	WOS:000442730200011
J	Lu, WX; Tirumuru, N; St Gelais, C; Koneru, PC; Liu, C; Kvaratskhelia, M; He, C; Wu, L				Lu, Wuxun; Tirumuru, Nagaraja; St Gelais, Corine; Koneru, Pratibha C.; Liu, Chang; Kvaratskhelia, Mamuka; He, Chuan; Wu, Li			N-6-Methyladenosine- binding proteins suppress HIV-1 infectivity and viral production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; M(6)A RNA METHYLOMES; GENE-EXPRESSION; N6-METHYLADENOSINE; REVEALS; CELLS; RESTRICTION; TRANSLATION; METHYLATION; SPECIFICITY	The internal N-6-methyladenosine (m(6)A) modification of cellular mRNA regulates post-transcriptional gene expression. The YTH domain family proteins (YTHDF1-3 or Y1-3) bind to m(6)A-modified cellular mRNAs and modulate their metabolism and processing, thereby affecting cellular protein translation. We previously reported that HIV-1 RNA contains the m(6)A modification and that Y1-3 proteins inhibit HIV-1 infection by decreasing HIV-1 reverse transcription activity. Here, we investigated the mechanisms of Y1-3-mediated inhibition of HIV-1 infection in target cells and the effect of Y1-3 on viral production levels in virus-producing cells. We found that Y1-3 protein overexpression in HIV-1 target cells decreases viral genomic RNA (gRNA) levels and inhibits both early and late reverse transcription. Purified recombinant Y1-3 proteins preferentially bound to the m(6)A-modified 5' leader sequence of gRNA compared with its unmodified RNA counterpart, consistent with the strong binding of Y1-3 proteins to HIV-1 gRNA in infected cells. HIV-1 mutants with two altered m(6)A modification sites in the 5' leader sequence of gRNA exhibited significantly lower infectivity than WT, replication-competent HIV-1, confirming that these sites alter viral infection. HIV-1 produced from cells in which endogenous Y1, Y3, or Y1-3 proteins were (mocked down singly or together had increased viral infectivity compared with HIV-1 produced in control cells. Interestingly, we found that Y1-3 proteins and HIV-1 Gag protein formed a complex with RNA in HIV-1-producing cells. Overall, these results indicate that Y1-3 proteins inhibit HIV-1 infection and provide new insights into the mechanisms by which the m(6)A modification of HIV-1 RNA affects viral replication.	[Lu, Wuxun; Tirumuru, Nagaraja; St Gelais, Corine; Wu, Li] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, 1900 Coffey Rd, Columbus, OH 43210 USA; [Koneru, Pratibha C.; Kvaratskhelia, Mamuka] Univ Colorado, Div Infect Dis, Sch Med, Aurora, CO 80045 USA; [Liu, Chang; He, Chuan] Univ Chicago, Dept Chem & Biochem, Inst Biophys Dynam, Chicago, IL 60637 USA; [Liu, Chang; He, Chuan] Univ Chicago, Dept Mol Biol, Inst Biophys Dynam, Chicago, IL 60637 USA; [Liu, Chang; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University System of Ohio; Ohio State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Wu, L (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, 1900 Coffey Rd, Columbus, OH 43210 USA.	wu.840@osu.edu	Wu, Li/ABB-2813-2020	Wu, Li/0000-0002-5468-2487; Koneru, Pratibha Chowdary/0000-0003-3955-4548	National Institutes of Health [GM128212, AI062520, AI120209, AI104483]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM128212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM128212 (to L.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant AI062520.; Supported in part by National Institutes of Health Grants AI120209 and AI104483.	Abd El-Wahab EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5304; Antonucci JM, 2016, NAT MED, V22, P1072, DOI 10.1038/nm.4163; Arguello AE, 2017, J AM CHEM SOC, V139, P17249, DOI 10.1021/jacs.7b09213; BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X; Berkhout B, 2000, Adv Pharmacol, V48, P29; CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Courtney DG, 2017, CELL HOST MICROBE, V22, P377, DOI 10.1016/j.chom.2017.08.004; CUMMINS LM, 1991, BLOOD, V77, P1111; Das AT, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-59; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Eckwahl MJ, 2016, MBIO, V7, DOI 10.1128/mBio.02025-15; Edupuganti RR, 2017, NAT STRUCT MOL BIOL, V24, P870, DOI 10.1038/nsmb.3462; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gelais CS, 2015, AIDS RES HUM RETROV, V31, P806, DOI [10.1089/aid.2014.0313, 10.1089/AID.2014.0313]; Gelais CS, 2014, J VIROL, V88, P5834, DOI 10.1128/JVI.00155-14; Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015; Janas AM, 2008, VIROLOGY, V375, P442, DOI 10.1016/j.virol.2008.01.044; Keane SC, 2015, SCIENCE, V348, P917, DOI 10.1126/science.aaa9266; Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002; Kessl JJ, 2016, CELL, V166, P1257, DOI 10.1016/j.cell.2016.07.044; Kharytonchyk S, 2016, P NATL ACAD SCI USA, V113, P13378, DOI 10.1073/pnas.1616627113; KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Li FD, 2014, CELL RES, V24, P1490, DOI 10.1038/cr.2014.153; Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002; Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Pollom E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003294; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Tan B, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0056-8; Telesnitsky A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080235; Tirumuru N, 2016, ELIFE, V5, DOI [10.7554/eLife.15528, 10.7554/eLife.31482]; Wang JH, 2007, J VIROL, V81, P2497, DOI 10.1128/JVI.01970-06; Wang JH, 2009, J VIROL, V83, P4195, DOI 10.1128/JVI.00006-09; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Ye FC, 2017, J VIROL, V91, DOI 10.1128/JVI.00466-17; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	50	56	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					12992	13005		10.1074/jbc.RA118.004215	http://dx.doi.org/10.1074/jbc.RA118.004215			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29976753	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000442730200002
J	Kim, G; Park, YS; Lee, Y; Jin, YM; Choi, DH; Ryu, KH; Park, YJ; Park, KD; Jo, I				Kim, Gyungah; Park, Yoon Shin; Lee, Yunki; Jin, Yoon Mi; Choi, Da Hyeon; Ryu, Kyung-Ha; Park, Yoon Jeong; Park, Ki Dong; Jo, Inho			Tonsil-derived mesenchymal stem cell-embedded in situ crosslinkable gelatin hydrogel therapy recovers postmenopausal osteoporosis through bone regeneration	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; STROMAL CELLS; MOUSE MODEL; TISSUE; VITRO; MARROW; EXPRESSION; DELIVERY; HORMONE; CULTURE	We investigated therapeutic potential of human tonsil-derived mesenchymal stem cells (TMSC) subcutaneously delivered to ovariectomized (OVX) mice for developing more safe and effective therapy for osteoporosis. TMSC were isolated from tonsil tissues of children undergoing tonsillectomy, and TMSC-embedded in situ crosslinkable gelatin-hydroxyphenyl propionic acid hydrogel (TMSC-GHH) or TMSC alone were delivered subcutaneously to the dorsa of OVX mice. After 3 months, three-dimensionally reconstructed micro-computed tomographic images revealed better recovery of the femoral heads in OVX mice treated with TMSC-GHH. Serum osteocalcin and alkaline phosphatase were also recovered, indicating bone formation only in TMSC-GHH-treated mice, and absence in hypercalcemia or other severe macroscopic deformities showed biocompatibility of TMSC-GHH. Additionally, visceral fat reduction effects by TMSC-GHH further supported their therapeutic potential. TMSC provided therapeutic benefits toward osteoporosis only when embedded in GHH, and showed potential as a supplement or alternative to current therapies.	[Kim, Gyungah; Jin, Yoon Mi; Jo, Inho] Ewha Womans Univ, Coll Med, Dept Mol Med, Seoul, South Korea; [Kim, Gyungah; Jin, Yoon Mi; Ryu, Kyung-Ha; Jo, Inho] Ewha Womans Univ, Coll Med, Ewha Tonsil Derived Mesenchymal Stem Cells Res Ct, Seoul, South Korea; [Park, Yoon Shin; Choi, Da Hyeon] Chungbuk Natl Univ, Coll Nat Sci, Sch Biol Sci, Microbiol, Cheongju, South Korea; [Lee, Yunki; Park, Ki Dong] Ajou Univ, Dept Mol Sci & Technol, Suwon, South Korea; [Ryu, Kyung-Ha] Ewha Womans Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Park, Yoon Jeong] Seoul Natl Univ, Sch Dent, Dent Res Inst, Dept Dent Regenerat Biotechnol, Seoul, South Korea; [Park, Yoon Jeong] NIBEC, Cent Res Inst, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Chungbuk National University; Ajou University; Ewha Womans University; Seoul National University (SNU)	Jo, I (corresponding author), Ewha Womans Univ, Coll Med, Dept Mol Med, Seoul, South Korea.; Jo, I (corresponding author), Ewha Womans Univ, Coll Med, Ewha Tonsil Derived Mesenchymal Stem Cells Res Ct, Seoul, South Korea.	inhojo@ewha.ac.kr	Jo, Inho/R-3581-2019	Kim, Gyungah/0000-0002-1383-1394; Jo, Inho/0000-0001-6060-6416; Ryu, Kyung-Ha/0000-0001-8424-2303	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2017M3A9B303636, NRF-2017-R1A2B4002611]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C-2207]; Nano Intelligent Biomedical Engineering Corporation (NIBEC)	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Nano Intelligent Biomedical Engineering Corporation (NIBEC)	This study was supported in part by: 1. The Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2017M3A9B303636 to IJ) (URL http://www.nrf.re.kr); 2. The Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI16C-2207 to IJ) (URL - http://www.khidi.or.kr); and 3. The Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2017-R1A2B4002611 to YSP) (URL - http://www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Yoon Jeong Park is employed by Nano Intelligent Biomedical Engineering Corporation (NIBEC). Nano Intelligent Biomedical Engineering Corporation (NIBEC) provided support in the form of salary for author YJP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Agarwala S, 2016, INDIAN J ORTHOP, V50, P434, DOI 10.4103/0019-5413.185612; Bidwell JP, 2013, CURR OSTEOPOROS REP, V11, P117, DOI 10.1007/s11914-013-0139-2; Caffarelli C, 2014, CLIN INTERV AGING, V9, P1629, DOI 10.2147/CIA.S64625; Chen FP, 2013, CLIMACTERIC, V16, P154, DOI 10.3109/13697137.2012.672496; Cho KA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16788-2; Chung HJ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-184; Filipovic B, 2015, J ANAT, V226, P489, DOI 10.1111/joa.12298; Furlani D, 2009, MICROVASC RES, V77, P370, DOI 10.1016/j.mvr.2009.02.001; Gambacciani M, 2014, MENOPAUSE REV, V13, P213, DOI 10.5114/pm.2014.44996; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Gibbs DMR, 2016, J TISSUE ENG REGEN M, V10, P187, DOI 10.1002/term.1968; Gupta A, 2016, AUST PRESCR, V39, P40, DOI 10.18773/austprescr.2016.028; Janjanin S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2459; Jin GZ, 2017, TISSUE ENG REGEN MED, V14, P383, DOI 10.1007/s13770-017-0060-3; Jo YI, 2017, TISSUE ENG REGEN MED, V14, P411, DOI 10.1007/s13770-017-0042-5; Kashte S, 2017, TISSUE ENG REGEN MED, V14, P1, DOI 10.1007/s13770-016-0001-6; Kiernan J, 2016, STEM CELL TRANSL MED, V5, P683, DOI 10.5966/sctm.2015-0231; Kim JE, 2014, TISSUE ENG REGEN MED, V11, P24, DOI [10.1007/s13770-013-1123-8, 10.1007/s13770-014-0001-3]; Kim MH, 2016, AMINO ACIDS, V48, P791, DOI 10.1007/s00726-015-2127-6; Kim SY, 2015, DIFFERENTIATION, V90, P27, DOI 10.1016/j.diff.2015.08.001; Kim YH, 2016, STEM CELLS DEV, V25, P1161, DOI 10.1089/scd.2016.0063; Lee SH, 2014, ADV FUNCT MATER, V24, P6771, DOI 10.1002/adfm.201401110; Lee Y, 2014, J MATER CHEM B, V2, P7712, DOI 10.1039/c4tb01111b; Lee Y, 2013, J MATER CHEM B, V1, P2407, DOI [10.1039/c3tb00578j, 10.1039/C3TB00578J]; Letizia M, 1999, Am J Hosp Palliat Care, V16, P585, DOI 10.1177/104990919901600407; Li F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149400; Lim J, 2018, TISSUE ENG REGEN MED, V15, P75, DOI 10.1007/s13770-017-0086-6; Michael B, 2007, TOXICOL PATHOL, V35, P742, DOI 10.1080/01926230701595292; Moon HJ, 2016, ADV HEALTHC MATER, V5, P353, DOI 10.1002/adhm.201500558; Palermo A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060544; Park HS, 2018, HEAD NECK-J SCI SPEC, V40, P526, DOI 10.1002/hed.25004; Park MH, 2014, ADV HEALTHC MATER, V3, P1782, DOI 10.1002/adhm.201400140; Park M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08616; Park S, 2018, MUSCLE NERVE, V57, P478, DOI 10.1002/mus.25763; Park YS, 2018, J TISSUE ENG REGEN M, V12, pE1747, DOI 10.1002/term.2430; Park YS, 2016, ACTA BIOMATER, V35, P215, DOI 10.1016/j.actbio.2016.03.003; Park YS, 2015, BIOMATERIALS, V65, P140, DOI 10.1016/j.biomaterials.2015.06.044; Park YS, 2014, BIOMATERIALS, V35, P9747, DOI 10.1016/j.biomaterials.2014.08.007; Pettersson LF, 2017, TISSUE ENG REGEN MED, V14, P763, DOI 10.1007/s13770-017-0071-0; Ryu KH, 2014, EXP CELL RES, V326, P143, DOI 10.1016/j.yexcr.2014.06.007; Ryu KH, 2012, CYTOTHERAPY, V14, P1193, DOI 10.3109/14653249.2012.706708; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Samivel R, 2015, AM J RHINOL ALLERGY, V29, P262, DOI 10.2500/ajra.2015.29.4216; Singh S, 2015, J CLIN DIAGN RES, V9, pRC4, DOI 10.7860/JCDR/2015/14857.6318; Son Youngsook, 2017, Tissue Eng Regen Med, V14, P641, DOI 10.1007/s13770-017-0099-1; Spees JL, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0363-7; Thi TTH, 2016, MACROMOL BIOSCI, V16, P334, DOI 10.1002/mabi.201500327; Ullm S, 2014, BIOMATERIALS, V35, P9755, DOI 10.1016/j.biomaterials.2014.08.023; Williams LB, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00056; Yoon Y, 2018, TISSUE ENG REGEN MED, V15, P115, DOI 10.1007/s13770-017-0092-8; You L, 2016, CELL PHYSIOL BIOCHEM, V39, P253, DOI 10.1159/000445621; Yousefi AM, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6180487; Yu Y, 2016, TISSUE ENG REGEN MED, V13, P162, DOI 10.1007/s13770-016-9134-x; Yu Y, 2014, J ANAT, V225, P510, DOI 10.1111/joa.12229	54	18	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200111	10.1371/journal.pone.0200111	http://dx.doi.org/10.1371/journal.pone.0200111			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975738	Green Published, gold, Green Submitted			2022-12-26	WOS:000437424500067
J	Pokrant, E; Medina, F; Maddaleno, A; San Martin, B; Cornejo, J				Pokrant, Ekaterina; Medina, Francisca; Maddaleno, Aldo; San Martin, Betty; Cornejo, Javiera			Determination of sulfachloropyridazine residue levels in feathers from broiler chickens after oral administration using liquid chromatography coupled to tandem mass spectrometry	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; EDIBLE TISSUES; SULFONAMIDE RESIDUES; POULTRY SECTOR; ANIMAL ORIGIN; DEPLETION; MS/MS; OXYTETRACYCLINE; TRIMETHOPRIM; ENROFLOXACIN	Several antimicrobials are routinely used by the poultry farming industry on their daily operations, however, researchers have found for some antimicrobials that their residues persist for longer periods in feathers than they do in edible tissues, and at higher concentrations, as well. But this information is not known for other classes of antimicrobials, such as the sulfonamides. Therefore, this work presents an accurate and reliable analytical method for the detection of sulfachloropyridazine (SCP) in feathers and edible tissues from broiler chickens. This method was also validated in-house and then used to study the depletion of sulfachloropyridazine in those matrices. The experimental group comprised 54 broiler chickens, who were raised under controlled conditions and then treated with a commercial formulation of 10% sulfachloropyridazine for 5 days. Samples were analyzed via LC-MS/MS, using C-13(6)-sulfamethazine (SMZ-C-13(6)) as an internal standard. Aromatic sulfonic acid solid phase extraction (SPE) cartridges were used to clean up the samples. The Limit of Detection (LOD) for this method was set at 10 mu g kg(-1 )on feathers and liver; and at 5 mu g kg(-1) on muscle. Within the range of 10-100 mu g kg(-1), the calibration curves for all matrices presented a determination coefficient greater than 0.96. Our results show, with a 95% confidence level, that sulfachloropyridazine persisted in feathers for up to 55 days after ceasing treatment, and its concentrations were higher than in edible tissues. In consequence, to avoid re-entry of antimicrobial residues into the food-chain, we recommend monitoring and inspecting animal diets that contain feather derivatives, such as feathers meals, because they could be sourced from birds that might have been medicated with sulfachloropyridazine.	[Pokrant, Ekaterina; Medina, Francisca; Maddaleno, Aldo; Cornejo, Javiera] Univ Chile, Fac Vet & Anim Sci, Prevent Med Dept, Santiago, Chile; [San Martin, Betty] Univ Chile, Fac Vet & Anim Sci, Lab Vet Pharmacol, Santiago, Chile	Universidad de Chile; Universidad de Chile	Cornejo, J (corresponding author), Univ Chile, Fac Vet & Anim Sci, Prevent Med Dept, Santiago, Chile.	jacornej@uchile.cl	Cornejo, Javiera/H-7900-2013; Smith, Keely/AAL-4913-2020	Cornejo, Javiera/0000-0001-5641-9562; 	CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica) via the FONDECYT Initiation into Research [11140530]	CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica) via the FONDECYT Initiation into Research	This research was supported by CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica) via the FONDECYT Initiation into Research [grant number 11140530] to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anadon A, 2012, TOXICOLOGIA ALIMENTA, P394; [Anonymous], 2017, CACMRL22017; Babapour A., 2012, World Applied Sciences Journal, V19, P1417; Baert K, 2003, VET RES COMMUN, V27, P301, DOI 10.1023/A:1024084108803; Baran W, 2012, ECOL CHEM ENG A, V19, P1153, DOI 10.2428/ecea.2012.19(10)110; Bedendo GC, 2010, J CHROMATOGR A, V1217, P6449, DOI 10.1016/j.chroma.2010.08.030; Berendsen BJA, 2013, FOOD ADDIT CONTAM A, V30, P2102, DOI 10.1080/19440049.2013.843026; Cornejo J, 2017, FOOD ADDIT CONTAM A, V34, P469, DOI 10.1080/19440049.2016.1267876; Cornejo J, 2011, J VET PHARMACOL THER, V34, P168, DOI 10.1111/j.1365-2885.2010.01208.x; Cornejo J, 2018, FOOD ADDIT CONTAM A, V35, P448, DOI 10.1080/19440049.2017.1401740; Cornejo J, 2017, J FOOD PROTECT, V80, P619, DOI 10.4315/0362-028X.JFP-16-320; Cornejo-Kelly J., 2012, Residues of veterinary drugs in food. Proceedings of the EuroResidue VII Conference, Egmond aan Zee, The Netherlands, 14-16 May, 2012. Volume 1, 2 and 3, P683; Divakala KC, 2009, J ANIM SCI, V87, P1270, DOI 10.2527/jas.2008-1121; EMA] European Medicines Agency, 2016, EMEACVMPSWP735325201; [EMA] European Medicines Agency, 2015, EMACVMPVICH463199200; Fang GZ, 2006, J CHROMATOGR A, V1127, P12, DOI 10.1016/j.chroma.2006.06.024; Hindle R, 2013, VALIDATED ATMOSPHERI; Hofacre CL, 2013, ANTIMICROBIAL THERAPY IN VETERINARY MEDICINE, 5TH EDITION, P569; Jansen LJM, 2017, ANAL BIOANAL CHEM, V409, P4927, DOI 10.1007/s00216-017-0445-0; Jansen LJM, 2016, ANAL BIOANAL CHEM, V408, P495, DOI 10.1007/s00216-015-9118-z; Jin HS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172712; Kools SAE, 2008, REGUL TOXICOL PHARM, V50, P59, DOI 10.1016/j.yrtph.2007.06.003; Lebkowska-Wieruszewska B, 2013, FOOD ADDIT CONTAM A, V30, P272, DOI 10.1080/19440049.2012.747005; Lebkowska-Wieruszewska BI, 2010, J VET PHARMACOL THER, V33, P389, DOI 10.1111/j.1365-2885.2009.01147.x; Li YJ, 2015, J VET MED SCI, V77, P1555, DOI 10.1292/jvms.14-0605; Love DC, 2012, ENVIRON SCI TECHNOL, V46, P3795, DOI 10.1021/es203970e; Martin BS, 2007, J FOOD PROTECT, V70, P1952, DOI 10.4315/0362-028X-70.8.1952; Mensah SEP, 2014, REV SCI TECH OIE, V33, P987; Mund MD, 2017, INT J FOOD PROP, V20, P1433, DOI 10.1080/10942912.2016.1212874; National Research Council, US DRUG FOOD AN BEN; Pang GF, 2005, J AOAC INT, V88, P1304; Premarathne JMKJK, 2017, FOOD CONTROL, V72, P276, DOI 10.1016/j.foodcont.2015.12.012; Prescott JF, 2013, ANTIMICROBIAL THERAPY IN VETERINARY MEDICINE, 5TH EDITION, P279; Renew JE, 2004, J CHROMATOGR A, V1042, P113, DOI 10.1016/j.chroma.2004.05.056; Sentepe I, 2010, FOOD CHEM TOXICOL, V48, P448, DOI 10.1016/j.fct.2009.10.044; Shao B, 2005, ANAL CHIM ACTA, V546, P174, DOI 10.1016/j.aca.2005.05.007; Shukla G, 2008, EC ZOOLOGY; Stubbings G, 2009, ANAL CHIM ACTA, V637, P68, DOI 10.1016/j.aca.2009.01.029; Swisher K., 2008, RENDER MAGAZINE, P10; Vishnuraj M. R., 2016, COGENT FOOD AGR, V2, P1, DOI DOI 10.1080/23311932.2016.1235458; Yu H, 2011, J CHROMATOGR B, V879, P2653, DOI 10.1016/j.jchromb.2011.07.032	41	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200206	10.1371/journal.pone.0200206	http://dx.doi.org/10.1371/journal.pone.0200206			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975750	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500076
J	Li, LW; Gao, F; Zhen, H; Jiang, YF; Tong, W; Zhou, YJ; Tong, GZ				Li, Liwei; Gao, Fei; Zhen, Hao; Jiang, Yifeng; Tong, Wu; Zhou, Yanjun; Tong, Guangzhi			Utilizing host endogenous microRNAs to negatively regulate the replication of porcine reproductive and respiratory syndrome virus in MARC-145 cells	PLOS ONE			English	Article							STRUCTURAL PROTEINS; PRRSV INFECTION; CODING REGIONS; EXPRESSION; IDENTIFICATION; PATHOGENESIS; MIRNAS	MicroRNAs (miRNAs) contribute to gene regulation at the post-transcriptional level and are capable of mRNA silencing by binding to target sites exhibiting high degrees of complementarity. Therefore, cloning host miRNA-recognition sequences into the genome of RNA viruses represents a rational strategy for manipulating viral replication. Here, we performed deep sequencing to obtain small-RNA (sRNA)-expression profiles from in vitro-cultured MARC-145 cells post infection with porcine reproductive and respiratory syndrome virus (PRRSV) and chose six candidate miRNAs of different abundance (miR-21, miR-140-3p, miR-185, miR-26a, miR-505, and miR-199a) for further study. Based on the full-length cDNA clone p7USC, we constructed a number of PRRSV mutants that provided complementary base-pairing target sites for the miRNAs in 3' untranslated regions. Our results showed that all low- and moderate- abundant miRNA-target mutants showed similar growth properties, whereas the highest-abundant miRNA-target mutant blocked both viral transcription and replication. Discontinuous mutations in high-abundant miRNA-target sites subsequently recovered viral viability and propagation. These results demonstrated the copy number of endogenous miRNAs and the extent of sRNA complementarity were key factors to silence potential mRNA expression/translation, thereby determining PRRSV viability. Interestingly, the mutant containing miR-140-target sites (v140-t) showed strong suppression of viral replication from P1 to P3 in vitro, as shown by virus titer, plaque morphology, and qRT-PCR assays. To assess genetic stability, sequencing of v140-t (P1, P3, P5 and P10) revealed spontaneous mutations preferentially located among several nucleotides near the 3' end of the insertion region and corresponding to the "seed region" of miR-1403p, explaining the induced viral repression and the direction of virus evolution. This approach provided a general silencing strategy for limiting PRRSV replication by endogenous miRNAs in MARC-145 cells.	[Li, Liwei; Gao, Fei; Zhen, Hao; Jiang, Yifeng; Tong, Wu; Zhou, Yanjun; Tong, Guangzhi] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Gao, Fei; Zhen, Hao; Jiang, Yifeng; Tong, Wu; Zhou, Yanjun; Tong, Guangzhi] Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Yangzhou University	Tong, GZ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China.; Tong, GZ (corresponding author), Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	gztong@shvri.ac.cn	jiang, yifeng/GWM-9104-2022		National Natural Science foundation of China [31602052, 31670158]; National Key Research and Development Program of China [2016YFE0112500]; National Basic Research Program (973 Plan) [2014CB542700]; National Sci-Tech Support Plan Program [2015BAD12B01-1]; EU Horizon 2020 program project [SAPHIR-633184]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; National Basic Research Program (973 Plan)(National Basic Research Program of China); National Sci-Tech Support Plan Program; EU Horizon 2020 program project	This work was supported by the National Natural Science foundation of China (no. 31602052, no. 31670158), the National Key Research and Development Program of China (2016YFE0112500), the National Basic Research Program (973 Plan) (no.2014CB542700), the National Sci-Tech Support Plan Program (2015BAD12B01-1) and the EU Horizon 2020 program project (Grant Number: SAPHIR-633184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENFIELD DA, 1992, J VET DIAGN INVEST, V4, P127, DOI 10.1177/104063879200400202; Chand RJ, 2012, CURR OPIN VIROL, V2, P256, DOI 10.1016/j.coviro.2012.02.002; Chen J, 2017, J VIROL, V91, DOI 10.1128/JVI.01311-16; Cong PQ, 2014, MOL BIOL REP, V41, P5863, DOI 10.1007/s11033-014-3460-7; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Guo XK, 2013, J VIROL, V87, P1159, DOI 10.1128/JVI.02386-12; Guo YE, 2014, MOL CELL BIOL, V34, P3780, DOI 10.1128/MCB.00871-14; Hicks JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082054; Huang HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16132; Huang Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0376-8; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Li LW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17010; Li LW, 2015, VIRUS RES, V195, P86, DOI 10.1016/j.virusres.2014.08.012; Li N, 2016, SCI REP-UK, V6, DOI 10.1038/srep34332; Liu F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151546; Mollaie HR, 2013, ASIAN PAC J CANCER P, V14, P7045, DOI 10.7314/APJCP.2013.14.12.7045; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; Perez JT, 2009, NAT BIOTECHNOL, V27, P572, DOI 10.1038/nbt.1542; Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465; Prieto C, 2009, VET J, V180, P363, DOI 10.1016/j.tvjl.2008.01.005; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Sun Z, 2010, VIRUS RES, V154, P38, DOI 10.1016/j.virusres.2010.08.027; Tan FF, 2011, VIRUS RES, V158, P62, DOI 10.1016/j.virusres.2011.03.011; tenOever BR, 2013, NAT REV MICROBIOL, V11, P169, DOI 10.1038/nrmicro2971; Tian DB, 2011, VIROLOGY, V412, P1, DOI 10.1016/j.virol.2010.12.048; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Wang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055838; Xiao SQ, 2015, J VIROL, V89, P4494, DOI 10.1128/JVI.02810-14; Yu DD, 2009, VIROLOGY, V383, P22, DOI 10.1016/j.virol.2008.09.013; Yuan SS, 2008, SCI CHINA SER C, V51, P271, DOI 10.1007/s11427-008-0023-y; Zhang Q, 2016, J IMMUNOL, V196, P2272, DOI 10.4049/jimmunol.1502006; Zhou A, 2014, INFECT GENET EVOL, V27, P173, DOI 10.1016/j.meegid.2014.07.023	39	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0200029	10.1371/journal.pone.0200029	http://dx.doi.org/10.1371/journal.pone.0200029			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969475	Green Published, Green Submitted, gold			2022-12-26	WOS:000437246700039
J	Jacko, D; Bersiner, K; Friederichs, G; Ritter, P; Nirenberg, L; Eisenbraun, J; de Marees, M; Bloch, W; Gehlert, S				Jacko, Daniel; Bersiner, Kaethe; Friederichs, Gerrit; Ritter, Patrick; Nirenberg, Linnea; Eisenbraun, Jan; de Marees, Markus; Bloch, Wilhelm; Gehlert, Sebastian			Resistance exercise-induced muscle fatigue is not accompanied by increased phosphorylation of ryanodine receptor 1 at serine 2843	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNEL; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; ECCENTRIC CONTRACTIONS; INTRACELLULAR CALCIUM; PLASMA-CATECHOLAMINE; PROTEIN-KINASE; HEART-FAILURE; RESPONSES; STRESS	Skeletal muscle fatigue has been shown to be associated with hyperphosphorylation of the ryanodine receptor 1 at serine 2843 ((p)RyR1(Ser2843)), due to chronic overloading exercise. We investigated whether (p)RyR1(Ser2843), is a mechanism relevant for muscle fatigue also under acute, in contrast to chronic, muscle loading. 24 male subjects (age: 24,8 +/- 3,8; height: 182,8 +/- 7,2 cm; weight: 82,5 +/- 9,9 kg) were evenly (n = 6) assigned to the following four different resistance exercise (RE) groups: hypertrophy-(HYP), strength endurance-(SE), maximum power-(MAX) at the subjects' 10, 25 and 3 repetition maximum, respectively, and low intensity (LI) RE with 70% of the 10 repetition maximum. Each group completed three different RE volumes (1 set, 5, and 10 sets). Muscle biopsies from the vastus lateralis were taken before and after exercise, analyzed for (p)RyR1(Ser2843) and examined for association with RE-induced muscle fatigue which was determined as reduction in maximum isometric force (F-iso(max)) in the quadriceps femoris muscle also before and after exercise. The degree of RE-induced muscle fatigue was specific in terms of set volume as well as of RE mode. F-iso(max) was not reduced in any group after one set of RE. Five sets led to a significant reduction of F-iso(max) in HYP and SE but not in LI and MAX (p< 0,05). Ten sets of RE, as compared to five sets, exclusively induced further muscle fatigue in LI. In terms of RE mode differences, F-iso(max) reduction was generally higher in HYP and SE than in MAX and Li after five and ten sets of RE (p< 0,05). However, (p)RyR1(Ser2843) did not show any significant regulation, regardless of exercise condition. We conclude that despite its relevance in reducing muscle contractility in chronic overloading, (p)RyR1(Ser2843) does not reflect the degree of muscle fatigue exerted by acute hypertrophy-, strength endurance-, maximum power and low intensity-oriented exercise.	[Jacko, Daniel; Friederichs, Gerrit; Ritter, Patrick; Nirenberg, Linnea; Eisenbraun, Jan; Bloch, Wilhelm; Gehlert, Sebastian] German Sport Univ Cologne, Inst Cardiovasc Res & Sport Med, Sect Mol & Cellular Sport Med, Cologne, Germany; [Jacko, Daniel] Olymp Base Ctr Rhineland, Cologne, Germany; [Bersiner, Kaethe; Gehlert, Sebastian] Univ Hildesheim, Inst Sport Sci, Hildesheim, Germany; [de Marees, Markus] Ruhr Univ Bochum, Fac Sport Sci, Sect Sports Med & Sports Nutr, Bochum, Germany	German Sport University Cologne; University of Hildesheim; Ruhr University Bochum	Jacko, D (corresponding author), German Sport Univ Cologne, Inst Cardiovasc Res & Sport Med, Sect Mol & Cellular Sport Med, Cologne, Germany.; Jacko, D (corresponding author), Olymp Base Ctr Rhineland, Cologne, Germany.	d.jacko@dshs-koeln.de	Gehlert, Sebastian/AAU-7086-2021; Gehlert, Sebastian/P-7687-2016	Gehlert, Sebastian/0000-0001-6940-3084; Bersiner, Kaethe/0000-0002-8107-7899	Federal Institute of Sports Science (BISp) [AZ 070105/15-16]	Federal Institute of Sports Science (BISp)	This investigation was funded by the Federal Institute of Sports Science (BISp), Grant Number: AZ 070105/15-16 (www.bisp.de) to DJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2008, J APPL PHYSIOL, V104, P296, DOI 10.1152/japplphysiol.00908.2007; Allen DG, 2005, J PHYSIOL-LONDON, V567, P723, DOI 10.1113/jphysiol.2005.091694; Andersson DC, 2012, J PHYSIOL-LONDON, V590, P6381, DOI 10.1113/jphysiol.2012.237925; BAKER AJ, 1993, AM J PHYSIOL, V264, pC577, DOI 10.1152/ajpcell.1993.264.3.C577; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bellinger AM, 2008, J CLIN INVEST, V118, P445, DOI 10.1172/JCI34006; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bracken RM, 2009, AMINO ACIDS, V36, P209, DOI 10.1007/s00726-008-0049-2; Bush JA, 1999, MED SCI SPORTS EXERC, V31; Favero TG, 1995, J APPL PHYSL, V78; Friden J, 1983, INT J SPORTS MED; Gehlert S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049326; Goto K, 2009, EUR J APPL PHYSIOL, V106, P731, DOI 10.1007/s00421-009-1075-9; HAIN J, 1994, BIOPHYS J, V67, P1823, DOI 10.1016/S0006-3495(94)80664-2; Lamboley CR, 2016, J PHYSIOL-LONDON, V594, P469, DOI 10.1113/JP271382; MAYRLEITNER M, 1995, CELL CALCIUM, V18, P197, DOI 10.1016/0143-4160(95)90064-0; McBride TA, 2000, J APPL PHYSIOL, V88, P91, DOI 10.1152/jappl.2000.88.1.91; Pullinen T, 2002, MED SCI SPORT EXER, V34, P806, DOI 10.1097/00005768-200205000-00013; Pullinen T, 1999, EUR J APPL PHYSIOL, V80, P125, DOI 10.1007/s004210050568; Rebbeck RT, 2014, INT J BIOCHEM CELL B, V48, P28, DOI 10.1016/j.biocel.2013.12.001; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Rullman E, 2013, J HEART LUNG TRANSPL, V32, P925, DOI 10.1016/j.healun.2013.06.026; Sonobe T, 2008, AM J PHYSIOL-REG I, V294, pR1329, DOI 10.1152/ajpregu.00815.2007; SUKO J, 1993, BIOCHIM BIOPHYS ACTA, V1175, P193, DOI 10.1016/0167-4889(93)90023-I; WESTERBLAD H, 1991, J GEN PHYSIOL, V98, P615, DOI 10.1085/jgp.98.3.615; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhang B-T, 2012, J APPL PHYSIOL, V112, P2077	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199307	10.1371/journal.pone.0199307	http://dx.doi.org/10.1371/journal.pone.0199307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953482	gold, Green Published, Green Submitted			2022-12-26	WOS:000436645400024
J	Wilson, R; Ahmmed, AA; Poll, A; Sakaue, M; Laude, A; Sieber-Blum, M				Wilson, Rachel; Ahmmed, Afsara A.; Poll, Alistair; Sakaue, Motoharu; Laude, Alex; Sieber-Blum, Maya			Human peptidergic nociceptive sensory neurons generated from human epidermal neural crest stem cells (hEPI-NCSC)	PLOS ONE			English	Article							EXPRESSION; DIFFERENTIATION; SUBTYPES; SPECIFICATION; ANTAGONIST; COMMITMENT; BRN3A; TRPV1; NGF	Here we provide new technology for generating human peptidergic nociceptive sensory neurons in a straightforward and efficient way. The cellular source, human epidermal neural crest stem cells (hEPI-NCSC), consists of multipotent somatic stem cells that reside in the bulge of hair follicles. hEPI-NCSC and primary sensory neurons have a common origin, the embryonic neural crest. For directed differentiation, hEPI-NCSC were exposed to pertinent growth factors and small molecules in order to modulate master signalling networks involved in differentiation of neural crest cells into postmitotic peptidergic sensory neurons during embryonic development. The neuronal populations were homogenous in regard to antibody marker expression. Cells were immunoreactive for essential master regulatory genes, including NGN1/2, SOX10, and BRN3a among others, and for the pain-mediating genes substance P (SP), calcitonin gene related protein (CGRP) and the TRPV1 channel. Approximately 30% of total cells responded to capsaicin, indicating that they expressed an active TRPV1 channel. In summary, hEPI-NCSC are a biologically relevant and easily available source of somatic stem cells for generating human peptidergic nociceptive neurons without the need for genetic manipulation and cell purification. As no analgesics exist that specifically target TRPV1, a ready supply of high-quality human peptidergic nociceptive sensory neurons could open the way for new approaches, in a biologically relevant cellular context, to drug discovery and patient-specific disease modelling that is aimed at pain control, and as such is highly desirable.	[Wilson, Rachel; Ahmmed, Afsara A.; Sakaue, Motoharu; Sieber-Blum, Maya] Newcastle Univ, Inst Genet Med, Ctr Life, Newcastle Upon Tyne, Tyne & Wear, England; [Poll, Alistair] Newcastle Univ, Sch Biol, Newcastle Upon Tyne, Tyne & Wear, England; [Laude, Alex] Newcastle Univ, Med Sch, Bioimaging Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Sakaue, Motoharu] Azabu Univ, Sch Vet Med, Dept Vet Med, Lab Anat 2,Chuo Ku, Sagamihara, Kanagawa, Japan	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Azabu University	Sieber-Blum, M (corresponding author), Newcastle Univ, Inst Genet Med, Ctr Life, Newcastle Upon Tyne, Tyne & Wear, England.	epincsc@gmail.com		Laude, Alex/0000-0002-3853-1187	Medical Research Council UK [G0802547]; Innovative Medicines Initiative Joint Undertaking grant [115439]; European Union; Joint MRC/Wellcome Trust grant Human Developmental Biology Resource [099175/Z/12/Z]; MRC [G0700089, G0802547] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Innovative Medicines Initiative Joint Undertaking grant; European Union(European Commission); Joint MRC/Wellcome Trust grant Human Developmental Biology Resource(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research leading to these results has received support from the Medical Research Council UK Grant G0802547 (MSB) and from the Innovative Medicines Initiative Joint Undertaking under grant agreement no 115439, resources of which are composed of a financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution (MSB). This publication reflects only the authors' views and neither the IMI JU nor EFPIA nor the European Commission are liable for any use that may be made of the information contained therein and StemBANCC. The human foetal material was provided by the Joint MRC/Wellcome Trust (grant # 099175/Z/12/Z) Human Developmental Biology Resource (http://www.hdbr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 1999, CURR OPIN NEUROBIOL, V9, P517, DOI 10.1016/S0959-4388(99)00015-X; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Bareille P, 2013, INT J CLIN PHARM TH, V51, P576, DOI 10.5414/CP201890; Blanchard JW, 2015, NAT NEUROSCI, V18, P25, DOI 10.1038/nn.3887; Boisvert EM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16821; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Clewes O, 2011, STEM CELL REV REP, V7, P799, DOI 10.1007/s12015-011-9255-5; Dykes IM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-3; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Gascon E, 2010, J NEUROSCI, V30, P12414, DOI 10.1523/JNEUROSCI.3135-10.2010; George L, 2010, J COMP NEUROL, V15, P518; Geppetti P, 1996, NEUROGENIC INFLAMMAT; Gericota B, 2014, STEM CELL TRANSL MED, V3, P334, DOI 10.5966/sctm.2013-0129; Guan W, 2008, DEV BIOL, V314, P317, DOI 10.1016/j.ydbio.2007.11.030; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; Hu YF, 2006, STEM CELLS, V24, P2692, DOI 10.1634/stemcells.2006-0233; Ji RR, 2016, SCIENCE, V354, P572, DOI 10.1126/science.aaf8924; Kondo T, 2011, STEM CELLS, V29, P836, DOI 10.1002/stem.624; Lei L, 2006, DEV BIOL, V300, P758, DOI 10.1016/j.ydbio.2006.08.062; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; MALMBERG AB, 2005, TURNING HEAT PAIN TR; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Narytnyk A, 2014, STEM CELL REV REP, V10, P316, DOI 10.1007/s12015-013-9493-9; Ota M, 2006, DEV DYNAM, V235, P646, DOI 10.1002/dvdy.20673; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Rehberg S, 2002, MOL CELL BIOL, V22, P5826, DOI 10.1128/MCB.22.16.5826-5834.2002; Sakaue M, 2015, DEVELOPMENT, V142, P3188, DOI 10.1242/dev.123034; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; SIEBERBLUM M, 1989, SCIENCE, V243, P1608, DOI 10.1126/science.2564699; SIEBERBLUM M, 1991, NEURON, V6, P949, DOI 10.1016/0896-6273(91)90235-R; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Ungos JM, 2003, DEVELOPMENT, V130, P5351, DOI 10.1242/dev.00722; VERDI JM, 1994, NEURON, V13, P1359, DOI 10.1016/0896-6273(94)90421-9; Wainger BJ, 2015, NAT NEUROSCI, V18, P17, DOI 10.1038/nn.3886; Woodcock J, 2007, NAT REV DRUG DISCOV, V6, P703, DOI 10.1038/nrd2335; Wyatt S, 1998, MOL BRAIN RES, V55, P254, DOI 10.1016/S0169-328X(98)00006-0	41	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199996	10.1371/journal.pone.0199996	http://dx.doi.org/10.1371/journal.pone.0199996			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953534	gold, Green Published			2022-12-26	WOS:000436645400107
J	Sinha, CB; Bakshi, N; Ross, D; Krishnamurti, L				Sinha, Cynthia B.; Bakshi, Nitya; Ross, Diana; Krishnamurti, Lakshmanan			From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea	PLOS ONE			English	Article							TREATMENT FATIGUE; ANEMIA; BARRIERS; CHILDREN; THERAPY; MANAGEMENT; ADHERENCE; MORTALITY; BURDEN; HEALTH	Despite its efficacy, the uptake of HU in adults with sickle cell disease (SCD) is poor likely due to a combination of system, provider, and patient-related factors. We investigated attitudes of adult patients towards HU by conducting qualitative interviews with 95 adult SCD patients (age 18 to 67 years old, 71 were female). While 53% of all participants reported that they were currently taking HU, patients ranging in age 18-30 years (Group 1) were more likely to report current HU use as compared to those (Group 2) ranging in age 31-67 years (65% vs. 41% P = 0.01). Most Group 1 participants who reported currently taking HU indicated that the decision to start HU was made by a parent, though some made the decision themselves as a young adult. Group 1 participants expressed trust in the efficacy of HU as well as trust that their physician adequately shared risks and benefits for the medication. The Group 2 participants, who were not currently on HU, were skeptical that all the risks and benefits of HU were known, were concerned that the efficacy of HU was not proven, and that they were not receiving complete information about its potential side effects. Of Group 2 participants who reported currently being on HU, 25% were concerned about the side effects and efficacy of HU and reported continuing HU because of a lack of effective alternatives. These data suggest that there are significant differences by age in adult SCD patients' attitudes towards, utilization and understanding of the risks and benefits of HU.	[Sinha, Cynthia B.; Bakshi, Nitya; Ross, Diana; Krishnamurti, Lakshmanan] Emory Univ, Dept Pediat Hematol Oncol BMT, Atlanta, GA 30322 USA; [Bakshi, Nitya; Krishnamurti, Lakshmanan] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders, Atlanta, GA 30322 USA; [Bakshi, Nitya; Ross, Diana; Krishnamurti, Lakshmanan] Childrens Hosp Pittsburgh, Dept Pediat Hematol Oncol, Pittsburgh, PA 15213 USA; [Bakshi, Nitya; Ross, Diana; Krishnamurti, Lakshmanan] Univ Pittsburgh, Pittsburgh, PA 15260 USA	Emory University; Children's Healthcare of Atlanta (CHOA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Krishnamurti, L (corresponding author), Emory Univ, Dept Pediat Hematol Oncol BMT, Atlanta, GA 30322 USA.; Krishnamurti, L (corresponding author), Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders, Atlanta, GA 30322 USA.; Krishnamurti, L (corresponding author), Childrens Hosp Pittsburgh, Dept Pediat Hematol Oncol, Pittsburgh, PA 15213 USA.; Krishnamurti, L (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.	lkrishn@emory.edu		Krishnamurti, Lakshmanan/0000-0003-3242-0037	Patient Centered Outcomes Research Institute (PCORI) [ce-12-114318]	Patient Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI)	This work was supported by Patient Centered Outcomes Research Institute (PCORI) - ce-12-114318; https://www.pcon.org/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakanay SM, 2005, BLOOD, V105, P545, DOI 10.1182/blood-2004-01-0322; Brandow AM, 2010, AM J HEMATOL, V85, P611, DOI 10.1002/ajh.21749; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brawley OW, 2008, ANN INTERN MED, V148, P932, DOI 10.7326/0003-4819-148-12-200806170-00220; Charache S, 1996, MEDICINE, V75, P300, DOI 10.1097/00005792-199611000-00002; Charmaz K., 2012, MED SOCIOLOGY ONLINE, V6; Claborn K, 2017, J ASS NURSES AIDS CA; Claborn KR, 2015, PSYCHOL HEALTH MED, V20, P255, DOI 10.1080/13548506.2014.945601; Davis H, 1997, PUBLIC HEALTH REP, V112, P40; Freudenreich O, 2009, HARVARD REV PSYCHIAT, V17, P35, DOI 10.1080/10673220902724565; Fritschi C, 2010, J PSYCHOSOM RES, V69, P33, DOI 10.1016/j.jpsychores.2010.01.021; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hankins J, 2007, PEDIATR BLOOD CANCER, V48, P705, DOI 10.1002/pbc.20903; Haywood C, 2014, PATIENT EDUC COUNS, V96, P159, DOI 10.1016/j.pec.2014.05.013; Haywood C, 2011, AM J HEMATOL, V86, P85, DOI 10.1002/ajh.21883; Heckman BW, 2015, CURR OPIN PSYCHOL, V5, P31, DOI 10.1016/j.copsyc.2015.03.004; Jenerette CM, 2011, NURSING RES PRACTICE, V2011; Kanter J, 2013, BLOOD REV, V27, P279, DOI 10.1016/j.blre.2013.09.001; Kardas P, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00091; Lanzkron S, 2008, J NATL MED ASSOC, V100, P968; LEIKIN SL, 1989, PEDIATRICS, V84, P500; National Heart Lung and Blood Institute (NHLBI), 2014, EV BAS MAN SICKL CEL; Nottage KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072077; Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543; Smith WR, 2008, ANN INTERN MED, V148, P94, DOI 10.7326/0003-4819-148-2-200801150-00004; Smith WR, 2005, J NATL MED ASSOC, V97, P183; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Strauss A., 1998, BASICS QUALITATIVE R; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Ware RE, 2010, BLOOD, V115, P5300, DOI 10.1182/blood-2009-04-146852	31	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199375	10.1371/journal.pone.0199375	http://dx.doi.org/10.1371/journal.pone.0199375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK9FZ	29949647	Green Published, gold, Green Submitted			2022-12-26	WOS:000436549200045
J	Youn, H; Kirkhart, C; Chia, J; Scott, K				Youn, Hyesoo; Kirkhart, Colleen; Chia, Justine; Scott, Kristin			A subset of octopaminergic neurons that promotes feeding initiation in Drosophila melanogaster	PLOS ONE			English	Article							MUSHROOM BODIES; TASTE CIRCUIT; BITTER TASTE; BRAIN; RECEPTOR; FOOD; STARVATION; EXPRESSION; DOPAMINE; BEHAVIOR	Octopamine regulates feeding behavioral responses in Drosophila melanogaster, however the molecular and circuit mechanisms have not been fully elucidated. Here, we investigated the role of a subset of octopaminergic neurons, the OA-VPM4 cluster, in sucrose acceptance behavior. Thermogenetic activation of Gal4 lines containing OA-VPM4 promoted proboscis extension to sucrose, while optogenetic inactivation reduced extension. Anatomically, the presynaptic terminals of OA-VPM4 are in close proximity to the axons of sugar-responsive gustatory sensory neurons. Moreover, RNAi knockdown of a specific class of octopamine receptor, OAMB, selectively in sugar-sensing gustatory neurons decreased the behavioral response to sucrose. By calcium imaging experiments, we found that application of octopamine potentiates sensory responses to sucrose in satiated flies. Taken together, these findings suggest a model by which OA-VPM4 promotes feeding behavior by modulating the activity of sensory neurons.	[Youn, Hyesoo; Chia, Justine; Scott, Kristin] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Kirkhart, Colleen; Scott, Kristin] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Scott, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Scott, K (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	kscott@berkeley.edu			NIH NIDDK [DK098747]; NSF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098747] Funding Source: NIH RePORTER	NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by an NIH NIDDK award DK098747 to KS and an NSF award to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004356; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Bownes M, 1989, GENET RES, DOI DOI 10.1017/S0016672300028895; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Busch S, 2010, J COMP NEUROL, V518, P2355, DOI 10.1002/cne.22337; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Datta S, BIOMETRICS, P501, DOI [10.2307/25502086, DOI 10.2307/25502086]; DETHIER VG, 1976, P NATL ACAD SCI USA, V73, P3315, DOI 10.1073/pnas.73.9.3315; Dey S, 2015, CELL, V161, P1334, DOI 10.1016/j.cell.2015.04.052; El-Kholy S, 2015, CELL TISSUE RES, V361, P669, DOI 10.1007/s00441-015-2137-4; Ezak MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009487; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Farooqui Tahira, 2012, Open Access Insect Physiology, V4, P1; Flood TF, 2013, NATURE, V499, P83, DOI 10.1038/nature12208; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Han KA, 1998, J NEUROSCI, V18, P3650; Harris DT, 2015, NEURON, V86, P1449, DOI 10.1016/j.neuron.2015.05.026; Inagaki HK, 2014, NEURON, V84, P806, DOI 10.1016/j.neuron.2014.09.032; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Jiang Y, 2017, WILCOXON RANK BASED; Kain P, 2015, NEURON, V85, P819, DOI 10.1016/j.neuron.2015.01.005; Kirkhart C, 2015, J NEUROSCI, V35, P5950, DOI 10.1523/JNEUROSCI.3930-14.2015; Ko KI, 2015, ELIFE, V4, DOI 10.7554/eLife.08298; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lebreton S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13132; Ledue EE, 2016, CURR BIOL, V26, P2854, DOI 10.1016/j.cub.2016.08.028; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Manzo A, 2012, P NATL ACAD SCI USA, V109, P6307, DOI 10.1073/pnas.1120305109; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Marella S, 2012, NEURON, V73, P941, DOI 10.1016/j.neuron.2011.12.032; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Miyazaki T, 2015, J NEUROGENET, V29, P144, DOI 10.3109/01677063.2015.1054993; Mohammad F, 2017, NAT METHODS, V14, P271, DOI [10.1038/NMETH.4148, 10.1038/nmeth.4148]; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; ROEDER T, 1990, EUR J PHARMACOL, V191, P221, DOI 10.1016/0014-2999(90)94151-M; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Rosner B, 2006, BIOMETRICS, V62, P185, DOI 10.1111/j.1541-0420.2005.00389.x; SAUDOU F, 1990, EMBO J, V9, P3611, DOI 10.1002/j.1460-2075.1990.tb07572.x; Scheiner R, 2014, J INSECT PHYSIOL, V69, P107, DOI 10.1016/j.jinsphys.2014.03.011; Schwarz O, 2017, ELIFE, V6, DOI 10.7554/eLife.19892; Shearin HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077724; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Vosshall LB, 2007, MOL ARCHITECTURE SME, DOI [10.1146/annurev.neuro.30.051606.094306, DOI 10.1146/ANNUREV.NEURO.30.051606.094306]; Wang QP, 2016, CELL METAB, V24, P75, DOI 10.1016/j.cmet.2016.06.010; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Yang Z, 2015, P NATL ACAD SCI USA, V112, P5219, DOI 10.1073/pnas.1417838112; Yapici N, 2016, CELL, V165, P715, DOI 10.1016/j.cell.2016.02.061; Zhang T, 2013, P NATL ACAD SCI USA, V110, P15431, DOI 10.1073/pnas.1308816110; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	60	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198362	10.1371/journal.pone.0198362	http://dx.doi.org/10.1371/journal.pone.0198362			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949586	Green Submitted, Green Published, gold			2022-12-26	WOS:000436549200013
J	Lang, JF; Tian, XL; Shi, MW; Ran, LX				Lang, Jian-Feng; Tian, Xue-Liang; Shi, Ming-Wang; Ran, Long-Xian			Identification of endophytes with biocontrol potential from Ziziphus jujuba and its inhibition effects on Alternaria alternata, the pathogen of jujube shrunken-fruit disease	PLOS ONE			English	Article							BACILLUS-SUBTILIS; RESISTANCE; STABILITY; BACTERIA; STRAINS; CROPS; FIELD	Endophytic strains were isolated from different parts of a healthy "Dongzao" jujube (Ziziphus jujuba Mill. 'Dongzao') to find biocontrol agents against jujube shrunken-fruit disease caused by Alternaria alternata. The strains were screened using A. alternata strain CN193 as the target pathogen. The nutrient competition for all isolates was studied using the dual culture, and their inhibitive capability was tested by measuring the inhibition width of filter paper disks with filtrate. Influence of filtrate from the selected strains with strong inhibition of mycelial growth on spore germination was studied with hanging drop method on concavity slides. Colonization in the jujube leaves was assayed using a rifampicin-resistant mutant of strain St-zn-34 as the screening marker. Strains were identified based on their morphological, physiological, and biochemical characteristics, 16S rDNA sequencing, and phylogenetic analysis. A total of 81 endophytic strains were isolated from the stems, leaves, flowers, and fruits of winter jujube. Among these isolates, 14 strains showed strong antagonism against A. alternata. Further study showed that the filtrate of strains St-zn-9 and St-zn-34 could inhibit the mycelial growth of A. alternata, and the widths of their inhibition zone reached 6.14 +/- 0.03 mm and 8.27 +/- 0.09 mm, respectively. However, strain St-zn-34 showed stronger inhibition on spore germination than strain St-zn-9. St-zn-34 could significantly reduce the spore germination rate of A. alternata, and the spore did not germinate at all or the germ tube was very short. A rifampicin resistant-derivative of wild-type strain St-zn-34, which was designated as St-zn-34(r), was obtained by transferring the strains to media with stepwise-increased rifampicin. Colonization assays indicated that St-zn-34(r) could colonize in jujube leaves, and the population of St-zn-34(r) was 1.2x10(3) CFU/g FW after inoculation for 30 days. Except for its salt tolerance, St-zn-34 was the closest to those of Bacillus subtilis. Thus, the strain was identified as B. subtilis.	[Lang, Jian-Feng; Ran, Long-Xian] Hebei Agr Univ, Coll Forestry, Baoding, Hebei, Peoples R China; [Lang, Jian-Feng; Tian, Xue-Liang; Shi, Ming-Wang] Henan Inst Sci & Technol, Dept Plant Protect, Xinxiang, Henan, Peoples R China; [Ran, Long-Xian] Hebei Key Lab Forest Germplasm Resources & Protec, Baoding, Hebei, Peoples R China	Hebei Agricultural University; Henan Institute of Science & Technology	Ran, LX (corresponding author), Hebei Agr Univ, Coll Forestry, Baoding, Hebei, Peoples R China.; Shi, MW (corresponding author), Henan Inst Sci & Technol, Dept Plant Protect, Xinxiang, Henan, Peoples R China.; Ran, LX (corresponding author), Hebei Key Lab Forest Germplasm Resources & Protec, Baoding, Hebei, Peoples R China.	shimw888@126.com; longxianran@163.com			Natural Science Foundation of Hebei Province [C2016204202]; Science and Technology Project in Henan Province Department of Education [17A210006]	Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Science and Technology Project in Henan Province Department of Education	This study was supported by the Natural Science Foundation of Hebei Province (C2016204202, http://www.hebstd.gov.cn/) and the Science and Technology Project in Henan Province Department of Education (17A210006, http://www.haedu.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon CW, 2001, ENVIRON HEALTH PERSP, V109, P325, DOI 10.2307/3435026; Bochow H, 2001, Z PFLANZENK PFLANZEN, V108, P21; Buchanan R. E., 1984, BERGEYS MANUAL DETER, V8th; Cui Na, 2014, RES POPULATION DIVER; Dong XZ, 2001, COMMON BACTERIA SYST; FANG ZD, 1998, METHODS PLANT PATHOL; GLANDORF DCM, 1992, PLANT SOIL, V147, P135, DOI 10.1007/BF00009379; Gu ZhenRong, 2004, Acta Phytopathologica Sinica, V34, P166; Guo ZK, 2007, CHINESE J TROPICAL A, V27, P25; Han DY, 2012, IDENTIFICATION INITI; [贺珍 He Zhen], 2017, [华中农业大学学报, Journal of Huazhong Agricultural University], V36, P35; Huang Jing, 2010, Weishengwu Xuebao, V50, P710; Lang Jianfeng, 2016, Weishengwu Xuebao, V56, P1616, DOI 10.13343/j.cnki.wsxb.20150622; Li DX, 2010, ISOLATION IDENTIFICA; Li YH, 2009, STUDY ENDOPHYTIC BAC; Li Yong, 2013, Scientia Silvae Sinicae, V49, P90; [刘惠娟 LIU Huijuan], 2007, [山西农业科学, Journal of Shanxi Agricultural Sciences], V35, P66; Liu HuiLi, 2014, China Biotechnology, V34, P96; [马忠友 Ma Zhangyou], 2012, [食品与发酵工业, Food and Fermentation Industries], V38, P101; Park Joong-Hyeop, 2003, Mycobiology, V31, P179; Chung JY, 2015, BIOL CONTROL, V91, P71, DOI 10.1016/j.biocontrol.2015.07.012; Shi LingFang, 2016, Journal of Agricultural Biotechnology, V24, P1354; [苏林涓 Su Linjuan], 2012, [福建师范大学学报. 自然科学版, Journal of Fujian Normal University. Natural Science Edition], V28, P94; Sun X, 2011, FUNGAL DIVERS, V47, P85, DOI 10.1007/s13225-010-0086-5; [王树雪 Wang Shuxue], 2013, [中国生物防治学报, Chinese Journal of Biological Control], V29, P647; Wen CaiYi, 2011, Acta Phytophylacica Sinica, V38, P481; Wu H.X., 2012, SHANXI FORESTRY SCI, V41, P34; Wu T, 2011, ACTA AGR JIANGXI, V23, P91; [武自强 Wu Ziqiang], 2015, [微生物学通报, Microbiology China], V42, P1321; Xu XiangBin, 2009, Acta Phytopathologica Sinica, V39, P225; Xu Y., 2014, MOL DETECTION PRIMAR; Xu Ying, 1995, Acta Agriculturae Boreali-Sinica, V10, P139; Yang CP, 2008, STUDIES ENDOPHYTES S; Yin HanWen, 2006, Journal of Nanjing Agricultural University, V29, P18; Yuan GS, 2007, FOREST PEST DIS, V6, P28; Zhang BaoJun, 2010, Acta Phytophylacica Sinica, V37, P143; Zhang CH, 2015, BIOCONTROL SCI TECHN, V25, P573, DOI 10.1080/09583157.2014.997675; Zhang F, 2008, CHINESE AGR SCI B, V24, P384; [赵乐 Zhao Le], 2016, [林业科学, Scientia Silvae Sinicae], V52, P53	39	6	7	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199466	10.1371/journal.pone.0199466	http://dx.doi.org/10.1371/journal.pone.0199466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944684	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800036
J	Formaggio, F; Saracino, E; Mola, MG; Rao, SB; Amiry-Moghaddam, M; Muccini, M; Zamboni, R; Nicchia, GP; Caprini, M; Benfenati, V				Formaggio, Francesco; Saracino, Emanuela; Mola, Maria Grazia; Rao, Shreyas Balachandra; Amiry-Moghaddam, Mahmood; Muccini, Michele; Zamboni, Roberto; Nicchia, Grazia Paola; Caprini, Marco; Benfenati, Valentina			LRRC8A is essential for swelling-activated chloride current and for regulatory volume decrease in astrocytes	FASEB JOURNAL			English	Article						edema; ion channels; VRAC; central nervous system; volume regulation	EXCITATORY AMINO-ACIDS; ANION CHANNEL; BRAIN EDEMA; PHARMACOLOGICAL CHARACTERIZATION; ESSENTIAL COMPONENT; WATER TRANSPORT; TAURINE RELEASE; AQUAPORIN-4; POTASSIUM; ATP	Consolidated evidence indicates that astroglial cells are critical in the homeostatic regulation of cellular volume by means of ion channels and aquaporin-4. Volume-regulated anion channel (VRAC) is the chloride channel that is activated upon cell swelling and critically contributes to cell volume regulation in astrocytes. The molecular identity of VRAC has been recently defined, revealing that it belongs to the leucine-rich repeat-containing 8 (LRRC8) protein family. However, there is a lack of evidence demonstrating that LRRC8A underpins VRAC currents in astrocyte. Nonetheless, direct evidence of the role of LRRC8A in astrocytic regulatory volume decrease remains to be proved. Here, we aim to bridge this gap in knowledge by combining RNA interference specific for LRRC8A with patch-clamp analyses and a water-permeability assay. We demonstrated that LRRC8A molecular expression is essential for swelling-activated chloride current via VRAC in primary-cultured cortical astrocytes. The knockdown of LRRC8A with a specific short interference RNA abolished the recovery of the cell volume after swelling induced by hypotonic challenge. In addition, immunoblotting, immunofluorescence, confocal imaging, and immunogold electron microscopy demonstrated that LRRC8A is expressed in the plasma membrane of primary cortical astrocytes and in situ in astrocytes at the perivascular interface with endothelial cells. Collectively, our results suggest that LRRC8A is an essential subunit of VRAC and a key factor for astroglial volume homeostasis.Formaggio, F., Saracino, E., Mola, M. G., Rao, S. B., Amiry-Moghaddam, M., Muccini, M., Zamboni, R., Nicchia, G. P., Caprini, M., Benfenati, V. LRRC8A is essential for swelling-activated chloride current and for regulatory volume decrease in astrocytes.	[Formaggio, Francesco; Caprini, Marco] Univ Bologna, Dept Pharm & Biotechnol, Lab Human & Gen Physiol, Bologna, Italy; [Formaggio, Francesco; Muccini, Michele; Caprini, Marco; Benfenati, Valentina] Natl Res Council Italy, Inst Study Nanostruct Mat, Bologna, Italy; [Saracino, Emanuela; Zamboni, Roberto; Benfenati, Valentina] Natl Res Council Italy, Inst Organ Synth & Photoreact, Bologna, Italy; [Mola, Maria Grazia; Nicchia, Grazia Paola] Univ Bari Aldo Moro, Ctr Excellence Comparat Gen, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Rao, Shreyas Balachandra; Amiry-Moghaddam, Mahmood] Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway; [Nicchia, Grazia Paola] Yeshiva Univ, Albert Einstein Coll Med, Dept Neurosci, Bronx, NY USA	University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio dei Materiali Nanostrutturati (ISMN-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); Universita degli Studi di Bari Aldo Moro; University of Oslo; Yeshiva University; Albert Einstein College of Medicine	Caprini, M (corresponding author), Univ Bologna, Lab Human & Gen Physiol, Dept Pharm & Biotechnol FaBiT, Via S Donato 19-2, I-40127 Bologna, Italy.; Benfenati, V (corresponding author), Natl Res Council Italy CNR ISOF, Inst Organ Synth & Photoreact, Via P Gobetti 101, I-40129 Bologna, Italy.	m.caprini@unibo.it; valentina.benfenati@isof.cnr.it	Muccini, Michele/D-6935-2018; Benfenati, Valentina/AAD-1821-2019; Formaggio, Francesco/AAH-3521-2020; Mola, Maria Grazia/I-3507-2019; Saracino, Emanuela/Q-4385-2018	Muccini, Michele/0000-0003-0489-8316; Benfenati, Valentina/0000-0002-2858-8497; Mola, Maria Grazia/0000-0002-4421-9237; Formaggio, Francesco/0000-0002-7504-6607; Rao, Shreyas/0000-0001-6029-3018	Fondazione Del Monte di Bologna e Ravenna; Fund for Investment in Basic Research (FIRB)-Futuro in Ricerca [RBFR12SJA8_001, RBFR12SJA8_002]; University of Bologna [RFO2016/17]; FIRB-Futuro in Ricerca; U.S. Air Force Office of Scientific Research [FA9550 16 1 0502, FA9550-17-1-0502]	Fondazione Del Monte di Bologna e Ravenna(Fondazione del Monte di Bologna e Ravenna); Fund for Investment in Basic Research (FIRB)-Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); University of Bologna; FIRB-Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	The authors thank Alessia Minardi (University of Bologna) for assistance in astrocyte preparation; Bjorg Riber, Karen Marie Gujord and Nadia Skauli (University of Oslo) for technical assistance; and Wilson R. Adams (Vanderbilt University, Nashville, TN, USA) for the English proofreading of the manuscript. Special thanks are given to Prof. Stefano Ferroni (University of Bologna) for technical assistance in patch-clamp experiments, and Prof. Thomas Jentsch (Max Delbruck Center for Molecular Medicine, Berlin, Germany) for kindly providing the LRRC8A/pCMV6 clone and the HCT 116 LRRC8A-KO cell line. The authors thank the Fondazione Del Monte di Bologna e Ravenna and the Italian Minister for Education, University, and Research within the Fund for Investment in Basic Research (FIRB)-Futuro in Ricerca (RBFR12SJA8_001; RBFR12SJA8_002) for providing F.F. and E.S. a Ph.D. fellowship. This work was supported by grants from the University of Bologna (RFO2016/17; to M.C.) and the Italian Minister for Education, University, and Research within the FIRB-Futuro in Ricerca (to V.B. and G.P.N.). The U.S. Air Force Office of Scientific Research, Research Projects Advanced Nano-Structured Material Interfaces and Devices for In Vivo-like-In Vitro Monitoring of Astrocytes Physiology and Brain Toxicology (ASTROMAT; FA9550 16 1 0502) and Shedding Light on Glial Function (ASTRONIR; FA9550-17-1-0502) (both to V.B.) are acknowledged. The authors declare no conflicts of interest.	Abdullaev IF, 2006, J PHYSIOL-LONDON, V572, P677, DOI 10.1113/jphysiol.2005.103820; Akita T, 2014, NEUROSCIENCE, V275, P211, DOI 10.1016/j.neuroscience.2014.06.015; Akita T, 2011, CELL PHYSIOL BIOCHEM, V28, P1181, DOI 10.1159/000335867; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2004, FASEB J, V18, P542, DOI 10.1096/fj.03-0869fje; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; BARRON KD, 1988, ACTA NEUROPATHOL, V75, P295, DOI 10.1007/BF00690538; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Benfenati V, 2010, NEUROSCIENCE, V168, P926, DOI 10.1016/j.neuroscience.2009.12.017; Benfenati V, 2015, HOMEOSTATIC CONTROL, V1st, P3, DOI DOI 10.1093/MED/9780199322299.003.0001; Benfenati V, 2007, J NEUROCHEM, V100, P87, DOI 10.1111/j.1471-4159.2006.04164.x; Benfenati V, 2006, J NEUROCHEM, V98, P430, DOI 10.1111/j.1471-4159.2006.03877.x; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; Benfenati V, 2009, CHANNELS, V3, P323, DOI 10.4161/chan.3.5.9568; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Cardin V, 2003, GLIA, V44, P119, DOI 10.1002/glia.10271; Cardin V, 1999, J NEUROSCI RES, V56, P659; Crepel V, 1998, J NEUROSCI, V18, P1196; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; Decher T, 2001, BRIT J PHARMACOL, V134, P1467; Fabene PF, 2006, NEUROBIOL DIS, V21, P80, DOI 10.1016/j.nbd.2005.06.013; FERRONI S, 1995, FEBS LETT, V367, P319, DOI 10.1016/0014-5793(95)00588-Z; Feustel PJ, 2004, STROKE, V35, P1164, DOI 10.1161/01.STR.0000124127.57946.a1; Fisher SK, 2010, J PHYSIOL-LONDON, V588, P3355, DOI 10.1113/jphysiol.2010.190777; Gaitan-Penas H, 2016, BIOPHYS J, V111, P1429, DOI 10.1016/j.bpj.2016.08.030; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Haskew-Layton RE, 2005, J BIOL CHEM, V280, P3548, DOI 10.1074/jbc.M409803200; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hyzinski-Garcia MC, 2014, J PHYSIOL-LONDON, V592, P4855, DOI 10.1113/jphysiol.2014.278887; JACKSON PS, 1993, AM J PHYSIOL, V265, pC1489, DOI 10.1152/ajpcell.1993.265.6.C1489; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; KIMELBERG HK, 1995, J CEREBR BLOOD F MET, V15, P409, DOI 10.1038/jcbfm.1995.51; Kimelberg HK, 2003, J NEUROSURG, V99, P138, DOI 10.3171/jns.2003.99.1.0138; Kimelberg HK, 1998, CONTRIB NEPHROL, V123, P240, DOI 10.1159/000059916; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Milenkovic A, 2015, P NATL ACAD SCI USA, V112, pE2630, DOI 10.1073/pnas.1418840112; Minieri L, 2013, BRIT J PHARMACOL, V168, P1240, DOI 10.1111/bph.12011; Mola MG, 2016, GLIA, V64, P139, DOI 10.1002/glia.22921; Mola MG, 2009, ANAL CHEM, V81, P8219, DOI 10.1021/ac901526k; Mongin AA, 2005, AM J PHYSIOL-CELL PH, V288, pC204, DOI 10.1152/ajpcell.00330.2004; Mongin AA, 2002, AM J PHYSIOL-CELL PH, V283, pC569, DOI 10.1152/ajpcell.00438.2001; Mongin AA, 2016, PFLUG ARCH EUR J PHY, V468, P421, DOI 10.1007/s00424-015-1765-6; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Nielsen S, 1997, J NEUROSCI, V17, P171; Nilius B, 2004, NEUROCHEM RES, V29, P3, DOI 10.1023/B:NERE.0000010430.23137.be; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; OKADA Y, 1994, JPN J PHYSIOL, V44, P403, DOI 10.2170/jjphysiol.44.403; Olson JE, 1997, GLIA, V20, P254, DOI 10.1002/(SICI)1098-1136(199707)20:3<254::AID-GLIA9>3.0.CO;2-7; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Parkerson KA, 2004, GLIA, V46, P419, DOI 10.1002/glia.10361; Parkerson KA, 2003, AM J PHYSIOL-CELL PH, V284, pC1460, DOI 10.1152/ajpcell.00603.2002; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Pasantes-Morales H, 2010, NEUROSCIENCE, V168, P871, DOI 10.1016/j.neuroscience.2009.11.074; Pasantes-Morales H, 2006, AM J MED, V119, pS4, DOI 10.1016/j.amjmed.2006.05.002; PASANTESMORALES H, 1990, GLIA, V3, P427, DOI 10.1002/glia.440030514; Phillis JW, 1998, BRAIN RES, V780, P352, DOI 10.1016/S0006-8993(97)01352-8; Phillis JW, 1997, BRAIN RES, V758, P9, DOI 10.1016/S0006-8993(97)00155-8; Prydz A, 2017, NEUROSCIENCE, V359, P258, DOI 10.1016/j.neuroscience.2017.07.029; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Rutledge EM, 1998, AM J PHYSIOL-CELL PH, V274, pC1511, DOI 10.1152/ajpcell.1998.274.6.C1511; Schober AL, 2017, J PHYSIOL-LONDON, V595, P6939, DOI 10.1113/JP275053; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Sirianant L, 2016, PFLUG ARCH EUR J PHY, V468, P805, DOI 10.1007/s00424-016-1789-6; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Takano T, 2005, P NATL ACAD SCI USA, V102, P16466, DOI 10.1073/pnas.0506382102; Vessey JP, 2004, J NEUROPHYSIOL, V92, P1252, DOI 10.1152/jn.00148.2004; VITARELLA D, 1994, J NEUROCHEM, V63, P1143; Voets T, 1997, J GEN PHYSIOL, V110, P313, DOI 10.1085/jgp.110.3.313; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Walz W, 2002, GLIA, V40, P1, DOI 10.1002/glia.10125; Wang RP, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90632; Yamada T, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12940; Zhang YH, 2017, NAT CELL BIOL, V19, P504, DOI 10.1038/ncb3514	83	25	26	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					101	113		10.1096/fj.201701397RR	http://dx.doi.org/10.1096/fj.201701397RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29957062	Green Submitted			2022-12-26	WOS:000457401500008
J	Schoenauer, R; Larpin, Y; Babiychuk, EB; Drucker, P; Babiychuk, VS; Avota, E; Schneider-Schaulies, S; Schumacher, F; Kleuser, B; Koffel, R; Draeger, A				Schoenauer, Roman; Larpin, Yu; Babiychuk, Eduard B.; Drucker, Patrick; Babiychuk, Viktoriia S.; Avota, Elita; Schneider-Schaulies, Sibylle; Schumacher, Fabian; Kleuser, Burkhard; Koffel, Rene; Draeger, Annette			Down-regulation of acid sphingomyelinase and neutral sphingomyelinase-2 inversely determines the cellular resistance to plasmalemmal injury by pore-forming toxins	FASEB JOURNAL			English	Article						membrane repair; blebbing; calcium; bacterial toxins; annexins	ACTIVATED PROTEIN-KINASE; EPITHELIAL-CELLS; P38 MAPK; MEMBRANE; REPAIR; CERAMIDE; CHOLESTEROL; ENDOCYTOSIS; EXPRESSION; RECOVERY	Bacterial pore-forming toxins compromise plasmalemmal integrity, leading to Ca2+ influx, leakage of the cytoplasm, and cell death. Such lesions can be repaired by microvesicular shedding or by the endocytic uptake of the injured membrane sites. Cells have at their disposal an entire toolbox of repair proteins for the identification and elimination of membrane lesions. Sphingomyelinases catalyze the breakdown of sphingomyelin into ceramide and phosphocholine. Sphingomyelin is predominantly localized in the outer leaflet, where it is hydrolyzed by acid sphingomyelinase (ASM) after lysosomal fusion with the plasma membrane. The magnesium-dependent neutral sphingomyelinase (NSM)-2 is found at the inner leaflet of the plasmalemma. Because either sphingomyelinase has been ascribed a role in the cellular stress response, we investigated their role in plasma membrane repair and cellular survival after treatment with the pore-forming toxins listeriolysin O (LLO) or pneumolysin (PLY). Jurkat T cells, in which ASM or NSM-2 was down-regulated [ASM knockdown (KD) or NSM-2 KD cells], showed inverse reactions to toxin-induced membrane damage: ASM KD cells displayed reduced toxin resistance, decreased viability, and defects in membrane repair. In contrast, the down-regulation of NSM-2 led to an increase in viability and enhanced plasmalemmal repair. Yet, in addition to the increased plasmalemmal repair, the enhanced toxin resistance of NSM-2 KD cells also appeared to be dependent on the activation of p38/MAPK, which was constitutively activated, whereas in ASM KD cells, the p38/MAPK activation was constitutively blunted.Schoenauer, R., Larpin, Y., Babiychuk, E. B., Drucker, P., Babiychuk, V. S., Avota, E., Schneider-Schaulies, S., Schumacher, F., Kleuser, B., Koffel, R., Draeger, A. Down-regulation of acid sphingomyelinase and neutral sphingomyelinase-2 inversely determines the cellular resistance to plasmalemmal injury by pore-forming toxins.	[Schoenauer, Roman; Larpin, Yu; Babiychuk, Eduard B.; Drucker, Patrick; Babiychuk, Viktoriia S.; Koffel, Rene; Draeger, Annette] Univ Bern, Inst Anat, Dept Cell Biol, Bern, Switzerland; [Avota, Elita; Schneider-Schaulies, Sibylle] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Schumacher, Fabian; Kleuser, Burkhard] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany	University of Bern; University of Wurzburg; University of Potsdam	Koffel, R; Draeger, A (corresponding author), Univ Bern, Inst Anat, Baltzerstr 2, CH-3000 Bern 9, Switzerland.	rene.koeffel@ana.unibe.ch; draeger@ana.unibe.ch	Köffel, René/ABI-2028-2020; Babiychuk, Eduard/AAV-7223-2021; Schumacher, Fabian/ABC-1750-2020	Köffel, René/0000-0001-9477-4282; Schumacher, Fabian/0000-0001-8703-3275; Babiychuk, Eduard/0000-0003-1786-0085; Drucker, Patrick/0000-0003-3353-5880; Kleuser, Burkhard/0000-0002-1888-9595; Larpin, Yu/0000-0002-4313-5509	Swiss National Science Foundation [SNF 601 31003A_159414]; Gebert-Ruf Foundation [GRS-073/14]; Novartis [16B100]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gebert-Ruf Foundation; Novartis(Novartis)	The authors thank Andrea Hostettler and Adolfo Odriozola for technical assistance and Dr. Ioan Iacovache (all from Institute of Anatomy, University of Bern) for providing the pET29-LLO construct. Images were acquired on equipment supported by the Microscopy Imaging Center of the University of Bern. Funding was provided by the Swiss National Science Foundation (SNF 601 31003A_159414), the Gebert-Ruf Foundation (GRS-073/14) (to A.D.), and Novartis (16B100) (to E.B.B). The authors declare no conflicts of interest.	Aroian R, 2007, CURR OPIN MICROBIOL, V10, P57, DOI 10.1016/j.mib.2006.12.008; Atanassoff AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089743; Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Babiychuk EB, 2008, TRAFFIC, V9, P1757, DOI 10.1111/j.1600-0854.2008.00800.x; Babiychuk EB, 2015, SEMIN CELL DEV BIOL, V45, P39, DOI 10.1016/j.semcdb.2015.10.016; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Barth BM, 2012, J NEUROSCI RES, V90, P229, DOI 10.1002/jnr.22748; Bienias K, 2016, PHARMACOL REP, V68, P570, DOI 10.1016/j.pharep.2015.12.008; Bollinger CR, 2005, BBA-MOL CELL RES, V1746, P284, DOI 10.1016/j.bbamcr.2005.09.001; Cassidy SKB, 2013, TOXINS, V5, P618, DOI 10.3390/toxins5040618; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Clement AB, 2009, J NEUROCHEM, V111, P669, DOI 10.1111/j.1471-4159.2009.06360.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CORONEOS E, 1995, J BIOL CHEM, V270, P23305, DOI 10.1074/jbc.270.40.23305; Corrotte M, 2012, TRAFFIC, V13, P483, DOI 10.1111/j.1600-0854.2011.01323.x; Draeger A, 2014, BIOCHIMIE, V107, P66, DOI 10.1016/j.biochi.2014.08.008; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Dreschers S, 2007, CELL PHYSIOL BIOCHEM, V20, P241, DOI 10.1159/000104170; Eddleman CS, 1997, P NATL ACAD SCI USA, V94, P4745, DOI 10.1073/pnas.94.9.4745; Goni FM, 2012, PROG LIPID RES, V51, P238, DOI 10.1016/j.plipres.2012.03.002; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Gulbins E, 2002, BBA-MOL CELL BIOL L, V1585, P139, DOI 10.1016/S1388-1981(02)00334-7; Haubert D, 2007, EMBO J, V26, P3308, DOI 10.1038/sj.emboj.7601778; Henry BD, 2015, NAT BIOTECHNOL, V33, P81, DOI 10.1038/nbt.3037; Holopainen JM, 2000, BIOPHYS J, V78, P830, DOI 10.1016/S0006-3495(00)76640-9; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Husmann M, 2006, BIOCHEM BIOPH RES CO, V344, P1128, DOI 10.1016/j.bbrc.2006.03.241; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Larson EM, 1997, INVEST OPHTH VIS SCI, V38, P1929; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; Liu B, 1998, J BIOL CHEM, V273, P11313, DOI 10.1074/jbc.273.18.11313; LOIKE JD, 1983, J IMMUNOL METHODS, V57, P373, DOI 10.1016/0022-1759(83)90097-2; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; MORGAN BP, 1987, J IMMUNOL, V138, P246; Mueller N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004574; Niaudet C, 2017, CELL SIGNAL, V33, P10, DOI 10.1016/j.cellsig.2017.02.001; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ohanian J, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12015; Ohanian J, 2012, J VASC RES, V49, P353, DOI 10.1159/000336649; Perry DM, 2014, J BIOL CHEM, V289, P22401, DOI 10.1074/jbc.M114.589648; Podobnik M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09623; Potez S, 2011, J BIOL CHEM, V286, P17982, DOI 10.1074/jbc.M110.187625; Schoenauer R, 2014, BBA-MOL CELL RES, V1843, P915, DOI 10.1016/j.bbamcr.2014.01.024; Shamseddine Achraf A, 2015, Adv Biol Regul, V57, P24, DOI 10.1016/j.jbior.2014.10.002; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Valencia-Nunez DM, 2017, HEART VESSELS, V32, P1390, DOI 10.1007/s00380-017-1006-3; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Wolfmeier H, 2016, BBA-GEN SUBJECTS, V1860, P2498, DOI 10.1016/j.bbagen.2016.07.022; Wolfmeier H, 2015, BBA-MOL CELL RES, V1853, P2045, DOI 10.1016/j.bbamcr.2014.09.005	56	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					275	285		10.1096/fj.201800033R	http://dx.doi.org/10.1096/fj.201800033R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29979630				2022-12-26	WOS:000457401500023
J	King, MT; Huh, I; Shenai, A; Brooks, TM; Brooks, CL				King, Moeko Toride; Huh, Ian; Shenai, Akhilesh; Brooks, Teresa M.; Brooks, Cory L.			Structural basis of VHH-mediated neutralization of the food-borne pathogen Listeria monocytogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; single-domain antibody (sdAb; nanobody); structural biology; protein-protein interaction; virulence factor; Listeria; receptor endocytosis; virulence factor	MULTISTATE OUTBREAK; MAMMALIAN-CELLS; SURFACE PROTEIN; INIB PROTEIN; INVASION; ANTIBODY; ENTRY; INLB; INTERNALIN; RECEPTOR	Listeria monocytogenes causes listeriosis, a potentially fatal food-borne disease. The condition is especially harmful to pregnant women. Listeria outbreaks can originate from diverse foods, highlighting the need for novel strategies to improve food safety. The first step in Listeria invasion is internalization of the bacteria, which is mediated by the interaction of the internalin family of virulence factors with host cell receptors. A crucial interaction for Listeria invasion of the placenta, and thus a target for therapeutic intervention, is between internalin B (InlB) and the receptor c-Met. Single-domain antibodies (VHH, also called nanobodies, or sdAbs) from camel heavy-chain antibodies are a novel solution for preventing Listeria infections. The VHH R303, R330, and R326 all bind InlB with high affinity; however, the molecular mechanism behind their mode of action was unknown. We demonstrate that despite a high degree of sequence and structural diversity, the VHH bind a single epitope on InlB. A combination of gentamicin protection assays and florescent microscopy establish that InlB-specific VHH inhibit Listeria invasion of HeLa cells. A high-resolution X-ray structure of VHH R303 in complex with InlB showed that the VHH binds at the c-Met interaction site on InlB, thereby acting as a competitive inhibitor preventing bacterial invasion. These results point to the potential of VHH as a novel class of therapeutics for the prevention of listeriosis.	[King, Moeko Toride; Huh, Ian; Shenai, Akhilesh; Brooks, Teresa M.; Brooks, Cory L.] Calif State Univ Fresno, Dept Chem, 2555 E San Ramon Ave, Fresno, CA 93740 USA	California State University System; California State University Fresno	Brooks, CL (corresponding author), Calif State Univ Fresno, Dept Chem, 2555 E San Ramon Ave, Fresno, CA 93740 USA.	cbrooks@csufresno.edu			NIGMS, National Institutes of Health [SC3GM112532]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM112532] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant SC3GM112532. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adolf-Bryfogle J, 2015, NUCLEIC ACIDS RES, V43, pD432, DOI 10.1093/nar/gku1106; Agerer F, 2004, J MICROBIOL METH, V59, P23, DOI 10.1016/j.mimet.2004.05.008; Allerberger F, 2003, FEMS IMMUNOL MED MIC, V35, P183, DOI 10.1016/S0928-8244(02)00447-9; Angelo KM, 2017, EPIDEMIOL INFECT, V145, P848, DOI 10.1017/S0950268816003083; Banerjee M, 2004, MOL MICROBIOL, V52, P257, DOI 10.1111/j.1365-2958.2003.03968.x; Braun L, 1999, MOL MICROBIOL, V34, P10, DOI 10.1046/j.1365-2958.1999.01560.x; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Charlier C, 2017, LANCET INFECT DIS, V17, P510, DOI [10.1016/s1473-3099(16)30521-7, 10.1016/S1473-3099(16)30521-7]; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Dussurget O, 2004, ANNU REV MICROBIOL, V58, P587, DOI 10.1146/annurev.micro.57.030502.090934; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garner D, 2016, J FOOD PROTECT, V79, P337, DOI 10.4315/0362-028X.JFP-15-387; Gene RW, 2015, J IMMUNOL METHODS, V416, P29, DOI 10.1016/j.jim.2014.10.009; Greiffenberg L, 1998, INFECT IMMUN, V66, P5260, DOI 10.1128/IAI.66.11.5260-5267.1998; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Hof H, 1997, CLIN MICROBIOL REV, V10, P345, DOI 10.1128/CMR.10.2.345; Huh I, 2014, ACTA CRYSTALLOGR F, V70, P1532, DOI 10.1107/S2053230X1402010X; Janakiraman Vanitha, 2008, Rev Obstet Gynecol, V1, P179; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; Kumaran Jyothi, 2012, Methods Mol Biol, V911, P105, DOI 10.1007/978-1-61779-968-6_7; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Lo AWH, 2014, J BIOL CHEM, V289, P25374, DOI 10.1074/jbc.M114.566257; Ma LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026310; Madjunkov M, 2017, ARCH GYNECOL OBSTET, V296, P143, DOI 10.1007/s00404-017-4401-1; Malik AA, 2016, TOXINS, V8, DOI 10.3390/toxins8040099; Marino M, 1999, MOL CELL, V4, P1063, DOI 10.1016/S1097-2765(00)80234-8; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Mylonakis E, 2002, MEDICINE, V81, P260, DOI 10.1097/00005792-200207000-00002; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Puthiyakunnon S, 2017, CURR TOP MED CHEM, V17, P278, DOI 10.2174/1568026616666160829162313; Radoshevich L, 2018, NAT REV MICROBIOL, V16, P32, DOI 10.1038/nrmicro.2017.126; Schubert WD, 2003, CHEMBIOCHEM, V4, P1285, DOI 10.1002/cbic.200300624; Shali A, 2018, INT J BIOL MACROMOL, V114, P1267, DOI 10.1016/j.ijbiomac.2018.03.034; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Sulea T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20599-4; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Yao GR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07457-5; Zhang YZ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0796-y	47	13	15	4	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13626	13635		10.1074/jbc.RA118.003888	http://dx.doi.org/10.1074/jbc.RA118.003888			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29976754	hybrid, Green Published			2022-12-26	WOS:000443375500022
J	Douma, I; Rousseau, D; Sallit, R; Kodjikian, L; Denis, P				Douma, Ikrame; Rousseau, David; Sallit, Rebecca; Kodjikian, Laurent; Denis, Philippe			Toward quantitative and reproducible clinical use of OCT-Angiography	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY ANGIOGRAPHY; RETINAL VEIN OCCLUSION; FOVEAL AVASCULAR ZONE; DIABETIC-RETINOPATHY; PERIPAPILLARY RETINA; VESSEL DENSITY; SWEPT-SOURCE; GLAUCOMA; AREA	Optical coherence tomography angiography (OCT-A) is an ophthalmic imaging technique which has recently been introduced to clinical use. OCT-A provides visualization of the retinal vascularization in three dimensions, without injection of contrast agents. OCT-A could thus replace the current standard of opthalmic imaging, which is 2D only and requires contrast agents. However, quantitative studies remain to be carried out to assess the full potential of OCT-A. In this context, the present work proposes a methodology to perform OCT-A in a more reproducible and precise way. We introduce a procedure to automatically extract the area of interest in avascular regions, which we demonstrate on various avascular areas with a focus on the optic nerve extracted in 2-dimensional images for a selected depth. We then study the repeatability of OCT-A with our segmentation technique when implemented on various clinical devices. For illustration, we apply this segmentation to healthy control group and to patients presenting different stages of glaucoma, a disease of clinical interest. The variability observed between these two cohorts compares favorably to the variability due to instrumental limitations or the segmentation algorithm. Our results thus constitute a significant step toward a more quantitative use of OCT-A in a clinical context.	[Douma, Ikrame; Rousseau, David] Univ Angers, UMR INRA IRHS, LARIS, 62 Ave Notre Dame du Lac, F-49000 Angers, France; [Douma, Ikrame; Sallit, Rebecca; Kodjikian, Laurent; Denis, Philippe] Univ Lyon 1, Hosp Civils Lyon, Croix Rousse Univ Hosp, Dept Ophthalmol, Lyon, France	INRAE; Universite d'Angers; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Rousseau, D (corresponding author), Univ Angers, UMR INRA IRHS, LARIS, 62 Ave Notre Dame du Lac, F-49000 Angers, France.	david.rousseau@univ-angers.fr						Akil H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170476; Al-Sheikh M, 2017, OSLI RETINA, V48, P385, DOI 10.3928/23258160-20170428-04; Balaratnasingam C, 2016, OPHTHALMOLOGY, V123, P2352, DOI 10.1016/j.ophtha.2016.07.008; Bojikian KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154691; Cardoso JN, 2016, AM J OPHTHALMOL, V163, P93, DOI 10.1016/j.ajo.2015.11.025; Chalam K V, 2016, J Ophthalmic Vis Res, V11, P84, DOI 10.4103/2008-322X.180709; Chen C.-L, 2016, INVEST OPHTH VIS SCI, V57, DOI DOI 10.1167/IOVS.15-18909; Chen CL, 2017, BIOMED OPT EXPRESS, V8, P1056, DOI 10.1364/BOE.8.001056; Chu ZD, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.6.066008; de Carlo Talisa E, 2015, Int J Retina Vitreous, V1, P5; Guo JX, 2017, OPHTHALMOLOGICA, V237, P21, DOI 10.1159/000453112; Hodapp E., 1993, CLIN DECISIONS GLAUC, P52; Hwang TS, 2015, RETINA-J RET VIT DIS, V35, P2371, DOI 10.1097/IAE.0000000000000716; Ishibazawa A, 2015, AM J OPHTHALMOL, V160, P35, DOI 10.1016/j.ajo.2015.04.021; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Jia YL, 2015, P NATL ACAD SCI USA, V112, pE2395, DOI 10.1073/pnas.1500185112; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; Kim AY, 2016, AM J OPHTHALMOL, V171, P101, DOI 10.1016/j.ajo.2016.08.035; Kim AY, 2016, INVEST OPHTH VIS SCI, V57, pOCT362, DOI 10.1167/iovs.15-18904; Lang G, 2017, KLIN MONATSBLATTER A; Lee EJ, 2016, INVEST OPHTH VIS SCI, V57, P6265, DOI 10.1167/iovs.16-20287; Leveque PM, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6956717; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Lu CD, 2014, BIOMED OPT EXPRESS, V5, P293, DOI 10.1364/BOE.5.000293; Men SJ, 2017, SKIN RES TECHNOL, V23, P607, DOI 10.1111/srt.12379; Munk MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177059; Rao HL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173930; Roisman L, 2016, OPHTHALMOLOGY, V123, P1309, DOI 10.1016/j.ophtha.2016.01.044; Sakaguchi K, 2017, INVEST OPHTH VIS SCI, V58, P5251, DOI 10.1167/iovs.17-21955; Virgili G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186209; Yarmohammadi A, 2016, OPHTHALMOLOGY, V123, P2498, DOI 10.1016/j.ophtha.2016.08.041; Yarmohammadi A, 2016, INVEST OPHTH VIS SCI, V57, pOCT451, DOI 10.1167/iovs.15-18944; Zhang QQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22017	33	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0197588	10.1371/journal.pone.0197588	http://dx.doi.org/10.1371/journal.pone.0197588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979719	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500006
J	Maghbooli, Z; Hossein-nezhad, A; Adabi, E; Asadollah-pour, E; Sadeghi, M; Mohammad-nabi, S; Rad, LZ; Hosseini, AAM; Radmehr, M; Faghihi, F; Aghaei, A; Omidifar, A; Aghababei, Y; Behzadi, H				Maghbooli, Zhila; Hossein-nezhad, Arash; Adabi, Elham; Asadollah-pour, Effat; Sadeghi, Mahsa; Mohammad-nabi, Sara; Rad, Leila Zakeri; Hosseini, Ali-asghar Malek; Radmehr, Mehrnaz; Faghihi, Fatemeh; Aghaei, Atoosa; Omidifar, Abolfazl; Aghababei, Yasaman; Behzadi, Hadis			Air pollution during pregnancy and placental adaptation in the levels of global DNA methylation	PLOS ONE			English	Article							FETAL-GROWTH; IMPRINTED GENES; INFANT GROWTH	Background Health in early life is crucial for health later in life. Exposure to air pollution during embryonic and early-life development can result in placental epigenetic modification and foetus reprogramming, which can influence disease susceptibility in later life. Objectives: The aim of this paper was to investigate the placental adaptation in the level of global DNA methylation and differential gene expression in the methylation cycle in new-borns exposed to high fine particulate matter in the foetal stage. Study design This is a nested case-control study. We enrolled pregnant healthy women attending prenatal care clinics in Tehran, Iran, who were residents of selected polluted and unpolluted regions, before the 14th week of pregnancy. We calculated the regional background levels of particle mass-particles with aerodynamics diameter smaller than 2.5 mu m (PM2.5) and 10 mu m (PM10)-of two regions of interest. At the time of delivery, placental tissue was taken for gene expression and DNA methylation analyses. We also recorded birth outcomes (the new-born's sex, birth date, birth weight and length, head and chest circumference, gestational age, Apgar score, and level of neonatal care required). Results As regards PM2.5 and PM10 concentrations in different time windows of pregnancy, there were significantly independent positive correlations between PM10 and PM2.5 in the first trimester of all subjects and placental global DNA methylation levels (p-value = 0.01, p-value = 0.03, respectively). The gene expression analysis showed there was significant correlation between S-adenosylmethionine expression and PM2.5 (p = 0.003) and PM10 levels in the first trimester (p = 0.03). Conclusion Our data showed prenatal exposures to air pollutants in the first trimester could influence placental adaptation by DNA methylation.	[Maghbooli, Zhila; Aghababei, Yasaman] Univ Tehran Med Sci, MS Res Ctr, Neurosci Inst, Tehran, Iran; [Hossein-nezhad, Arash] Boston Univ, Med Ctr, Dept Med, Sect Endocrinol Nutr & Diabet,Vitamin D Skin & Bo, Boston, MA 02215 USA; [Adabi, Elham; Asadollah-pour, Effat; Sadeghi, Mahsa; Mohammad-nabi, Sara; Hosseini, Ali-asghar Malek] Univ Tehran Med Sci, Endocrinol & Metab Res Inst, Tehran, Iran; [Rad, Leila Zakeri] Univ Tehran Med Sci, Sch Nursing & Midwifery, Tehran, Iran; [Radmehr, Mehrnaz] Milad Hosp, Pregnancy & Gynecol Unit, Tehran, Iran; [Faghihi, Fatemeh; Aghaei, Atoosa; Behzadi, Hadis] Azad Univ Med Sci, Dept Genet, Tehran, Iran; [Omidifar, Abolfazl] Shahid Beheshti Univ Med Sci, Sch Allied Med Sci, Dept Med Lab Sci, Tehran, Iran	Tehran University of Medical Sciences; Boston University; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Islamic Azad University; Shahid Beheshti University Medical Sciences	Maghbooli, Z (corresponding author), Univ Tehran Med Sci, MS Res Ctr, Neurosci Inst, Tehran, Iran.; Hossein-nezhad, A (corresponding author), Boston Univ, Med Ctr, Dept Med, Sect Endocrinol Nutr & Diabet,Vitamin D Skin & Bo, Boston, MA 02215 USA.	z-maghbooli@sina.tums.ac.ir; hn@bu.edu	Shirvani, Arash H/A-2847-2010; Shirvani, Arash/AAD-6246-2020	Shirvani, Arash H/0000-0003-2847-4737; Maghbooli, Zhila/0000-0001-8858-6269; Asadolahpour, Effat/0000-0003-0512-7708; Omidifar, Abolfazl/0000-0001-5663-6065	National Institute for Medical Research Development of Iran [940173]	National Institute for Medical Research Development of Iran	The National Institute for Medical Research Development of Iran (grant no. 940173) provided financial support for the conduct of the research; in the collection, analysis and interpretation of data, http://nimad.ac.ir/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester F, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-6; Banister CE, 2011, EPIGENETICS-US, V6, P920, DOI 10.4161/epi.6.7.16079; Cai J, 2017, SCI TOTAL ENVIRON, V607, P1103, DOI 10.1016/j.scitotenv.2017.07.029; Fowden AL, 2011, PROG BIOPHYS MOL BIO, V106, P281, DOI 10.1016/j.pbiomolbio.2010.11.005; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; Glinianaia SV, 2004, EPIDEMIOLOGY, V15, P36, DOI 10.1097/01.ede.0000101023.41844.ac; Halek F, 2014, INT ARCH PHOTOGRAMM, V40, P141, DOI 10.5194/isprsarchives-XL-2-W3-141-2014; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Hochberg Z, 2011, ENDOCR REV, V32, P159, DOI 10.1210/er.2009-0039; Keravnou A, 2016, GENET RES, V98, DOI 10.1017/S0016672316000136; Kingsley SL, 2016, ENVIRON INT, V92-93, P43, DOI 10.1016/j.envint.2016.03.020; Koukoura O, 2012, MOL MED REP, V5, P883, DOI 10.3892/mmr.2012.763; Krzyzanowski M, 2008, AIR QUAL ATMOS HLTH, V1, P7, DOI 10.1007/s11869-008-0008-9; Maghbooli Z, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.7114; Maghbooli Z, 2015, DIABETES-METAB RES, V31, P183, DOI 10.1002/dmrr.2584; Maisonet M, 2004, ENVIRON RES, V95, P106, DOI 10.1016/j.envres.2004.01.001; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; Saenen ND, 2017, ENVIRON HEALTH PERSP, V125, P262, DOI 10.1289/EHP38; Saenen ND, 2015, ENVIRON HEALTH PERSP, V123, P834, DOI 10.1289/ehp.1408549; Sandovici I, 2012, REPROD BIOMED ONLINE, V25, P68, DOI 10.1016/j.rbmo.2012.03.017; SCHWARTZ J, 1994, AM J RESP CRIT CARE, V150, P1234, DOI 10.1164/ajrccm.150.5.7952546; Seigneur C, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P299, DOI 10.1007/978-94-007-0304-9_9; Su JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-12; Veras MM, 2008, BIOL REPROD, V79, P578, DOI 10.1095/biolreprod.108.069591; Wilhelm-Benartzi CS, 2012, ENVIRON HEALTH PERSP, V120, P296, DOI 10.1289/ehp.1103927	25	60	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199772	10.1371/journal.pone.0199772	http://dx.doi.org/10.1371/journal.pone.0199772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979694	gold, Green Submitted, Green Published			2022-12-26	WOS:000437809500031
J	Amadi, JA; Olago, DO; Ong'amo, GO; Oriaso, SO; Nanyingi, M; Nyamongo, IK; Estambale, BBA				Amadi, Jacinter A.; Olago, Daniel O.; Ong'amo, George O.; Oriaso, Silas O.; Nanyingi, Mark; Nyamongo, Isaac K.; Estambale, Benson B. A.			Sensitivity of vegetation to climate variability and its implications for malaria risk in Baringo, Kenya	PLOS ONE			English	Article							TIME-SERIES; SURFACE TEMPERATURES; TRENDS; SATELLITE; VECTORS; TRANSMISSION; DYNAMICS; MAXIMUM; MODELS; HORN	The global increase in vector borne diseases has been linked to climate change. Seasonal vegetation changes are known to influence disease vector population. However, the relationship is more theoretical than quantitatively defined. There is a growing demand for understanding and prediction of climate sensitive vector borne disease risks especially in regions where meteorological data are lacking. This study aimed at analyzing and quantitatively assessing the seasonal and year-to-year association between climatic factors (rainfall and temperature) and vegetation cover, and its implications for malaria risks in Baringo County, Kenya. Remotely sensed temperature, rainfall, and vegetation data for the period 2004-2015 were used. Poisson regression was used to model the association between malaria cases and climatic and environmental factors for the period 2009-2012, this being the period for which all datasets overlapped. A strong positive relationship was observed between the Normalized Difference Vegetation Index (NDVI) and monthly total precipitation. There was a strong negative relationship between NDVI and minimum temperature. The total monthly rainfall (between 94 -181mm), average monthly minimum temperatures (between 16-21 degrees C) and mean monthly NDVI values lower than 0.35 were significantly associated with malaria incidence rates. Results suggests that a combination of climatic and vegetation greenness thresholds need to be met for malaria incidence to be significantly increased in the county. Planning for malaria control can therefore be enhanced by incorporating these factors in malaria risk mapping.	[Amadi, Jacinter A.; Olago, Daniel O.; Oriaso, Silas O.] Univ Nairobi, Inst Climate Change & Adaptat, Nairobi, Kenya; [Amadi, Jacinter A.] Kenyatta Univ, Dept Plant Sci, Nairobi, Kenya; [Ong'amo, George O.] Univ Nairobi, Sch Biol Sci, Nairobi, Kenya; [Nanyingi, Mark] Univ Nairobi, Dept Publ Hlth Pharmacol & Toxicol, Nairobi, Kenya; [Nanyingi, Mark] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Nyamongo, Isaac K.] Cooperat Univ Kenya, Cooperat Dev Res & Innovat, Nairobi, Kenya; [Estambale, Benson B. A.] Jaramogi Oginga Odinga Univ Sci & Technol, Div Res Innovat & Outreach, Bondo, Kenya	University of Nairobi; Kenyatta University; University of Nairobi; University of Nairobi; Colorado State University; Cooperative University of Kenya; Jaramogi Oginga Odinga University of Science & Technology	Amadi, JA (corresponding author), Univ Nairobi, Inst Climate Change & Adaptat, Nairobi, Kenya.; Amadi, JA (corresponding author), Kenyatta Univ, Dept Plant Sci, Nairobi, Kenya.	aluochamadi@gmail.com	Amadi, Jacinter/AAB-8011-2022	Nyamongo, Isaac K./0000-0003-1796-9590; Amadi, Jacinter/0000-0003-3302-8387; Nanyingi, Mark/0000-0001-7485-6416	WHO's Special Programme for Research and Training in Tropical Diseases (TDR) through International Development Research Centre of Canada [10690500]; University of Nairobi [B20278]; Jaramogi Oginga Odinga University of Science and Technology, Kenya [B20278]	WHO's Special Programme for Research and Training in Tropical Diseases (TDR) through International Development Research Centre of Canada; University of Nairobi; Jaramogi Oginga Odinga University of Science and Technology, Kenya	The study received financial support from the WHO's Special Programme for Research and Training in Tropical Diseases (TDR) through a grant agreement with the International Development Research Centre of Canada (10690500). The funded Project No. B20278 was a collaborative research between the University of Nairobi and Jaramogi Oginga Odinga University of Science and Technology, Kenya.	Ageena I, 2014, THEOR APPL CLIMATOL, V117, P549, DOI 10.1007/s00704-013-1012-z; [Anonymous], 2016, KEN MAL IND SURV 201; Bi P, 2003, PUBLIC HEALTH REP, V118, P65, DOI 10.1016/S0033-3549(04)50218-2; Chirebvu E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0139843; Christensen J.H., 2007, CLIMATE CHANGE 2007; Dhimal M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-457; Division of Malaria Control [DOMC], 2011, 2010 KEN MAL IND SUR; Funk C., 2012, REMOTE SENS DROUGHT, P331, DOI DOI 10.1201/B11863; Fyfe JC, 2016, NAT CLIM CHANGE, V6, P224, DOI 10.1038/nclimate2938; Gavrilov MB, 2016, IDOJARAS, V120, P183; Githeko A.K., 2001, GLOB CHANGE HUM HLTH, V2, P54, DOI [10.1023/A:1011943131643, DOI 10.1023/A:1011943131643]; Githeko AK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-329; Goward SN, 1995, J BIOGEOGR, V22, P549, DOI 10.2307/2845953; Haque U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014341; Hashizume M, 2009, P NATL ACAD SCI USA, V106, P1857, DOI 10.1073/pnas.0806544106; HAUGH LD, 1976, J AM STAT ASSOC, V71, P378, DOI 10.2307/2285318; Hawinkel P, 2016, J GEOPHYS RES-BIOGEO, V121, P2422, DOI 10.1002/2016JG003436; Hay SI, 2000, ADV PARASIT, V47, P173, DOI 10.1016/S0065-308X(00)47009-0; Imai Chisato, 2015, Trop Med Health, V43, P1, DOI 10.2149/tmh.2014-21; IRI/LDO, 2016, IRI LDEO CLIM DAT; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jury MR, 2013, INT J CLIMATOL, V33, P1924, DOI 10.1002/joc.3560; Kabaria CW, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0051-y; King'uyu SM, 2000, J CLIMATE, V13, P2876, DOI 10.1175/1520-0442(2000)013&lt;2876:RTOMAM&gt;2.0.CO;2; KNBS, 2010, 2009 KEN POP HOUS CE; Kumar DS, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-14; Lacerda FF, 2015, J EARTH SCI CLIM CHA, V6; Landmann T, 2014, INT J APPL EARTH OBS, V33, P76, DOI 10.1016/j.jag.2014.04.020; Liebmann B, 2014, J CLIMATE, V27, P8630, DOI 10.1175/JCLI-D-13-00714.1; Lin Y, 2015, INT J REMOTE SENS, V36, P5031, DOI 10.1080/01431161.2015.1093196; Liu ZY, 2006, J CLIMATE, V19, P787, DOI 10.1175/JCLI3658.1; Lotsch A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017506; Lyon B, 2015, CLIMATE EXTREMES TRE; Midekisa A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-165; Minakawa N, 2002, J MED ENTOMOL, V39, P833, DOI 10.1603/0022-2585-39.6.833; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Muller GC, 2017, MALARIA J, P1, DOI [10.1186/s12936-016-1650-6, DOI 10.1186/S12936-016-1650-6]; Omondi PA, 2014, INT J CLIMATOL, V34, P1262, DOI 10.1002/joc.3763; Paaijmans KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-196; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Palaniyandi M., 2017, International Journal of Mosquito Research, V4, P9; Peters AJ, 2002, PHOTOGRAMM ENG REM S, V68, P71; R Core Team, 2021, R LANGUAGE ENV STAT; Rowell DP, 2015, J CLIMATE, V28, P9768, DOI 10.1175/JCLI-D-15-0140.1; Rueda LM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-55; Sewe MO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154204; Shah AD, 2014, AM J EPIDEMIOL, V179, P764, DOI 10.1093/aje/kwt312; Shankar S, 2016, J VECTOR DIS, V53, P54; Shongwe ME, 2011, J CLIMATE, V24, P3718, DOI 10.1175/2010JCLI2883.1; Ummenhofer CC, 2009, J CLIMATE, V22, P993, DOI 10.1175/2008JCLI2493.1; USAID, 2016, PRES MAL IN KEN MAL; Wandiga SO, 2010, CLIMATIC CHANGE, V99, P473, DOI 10.1007/s10584-009-9670-7; World Health Organization, 2015, WORLD MAL REP 2015; Yang WC, 2014, J CLIMATE, V27, P7185, DOI 10.1175/JCLI-D-13-00447.1; Ye Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-101	55	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199357	10.1371/journal.pone.0199357	http://dx.doi.org/10.1371/journal.pone.0199357			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975780	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500029
J	Cushman, SA; Elliott, NB; Bauer, D; Kesch, K; Bahaa-el-din, L; Bothwell, H; Flyman, M; Mtare, G; Macdonald, DW; Loveridge, AJ				Cushman, Samuel A.; Elliott, Nicholas B.; Bauer, Dominik; Kesch, Kristina; Bahaa-el-din, Laila; Bothwell, Helen; Flyman, Michael; Mtare, Godfrey; Macdonald, David W.; Loveridge, Andrew J.			Prioritizing core areas, corridors and conflict hotspots for lion conservation in southern Africa	PLOS ONE			English	Article							POPULATION; CONNECTIVITY	Conservation of large carnivores, such as the African lion, requires preservation of extensive core habitat areas, linkages between them, and mitigation of human-wildlife conflict. However, there are few rigorous examples of efforts that prioritized conservation actions for all three of these critical components. We used an empirically optimized resistance surface to calculate resistant kernel and factorial least cost path predictions of population connectivity and conflict risk for lions across the Kavango-Zambezi Transfrontier Conservation Area (KAZA) and surrounding landscape. We mapped and ranked the relative importance of (1) lion dispersal areas outside National Parks, (2) corridors between the key areas, and (3) areas of highest human-lion conflict risk. Spatial prioritization of conservation actions is critical given extensive land use redesignations that are reducing the extent and increasing the fragmentation of lion populations. While our example focuses on lions in southern Africa, it provides a general approach for rigorous, empirically based comprehensive conservation planning based on spatial prioritization.	[Cushman, Samuel A.] US Forest Serv, Rocky Mt Res Stn, Flagstaff, AZ USA; [Elliott, Nicholas B.; Bauer, Dominik; Macdonald, David W.; Loveridge, Andrew J.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney House, Tubney, Oxon, England; [Kesch, Kristina] Univ Hamburg, Dept Anim Ecol & Conservat, Hamburg, Germany; [Bahaa-el-din, Laila] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Bothwell, Helen] No Arizona Univ, Dept Biol, Flagstaff, AZ USA; [Flyman, Michael] Dept Wildlife & Natl Pk, Gaborone, Botswana; [Mtare, Godfrey] KAZA TFCA Secretariat, Zimbabwe Country Off, Victoria Falls, Zimbabwe	United States Department of Agriculture (USDA); United States Forest Service; University of Oxford; University of Hamburg; University of Kwazulu Natal; Northern Arizona University	Macdonald, DW (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney House, Tubney, Oxon, England.	david.macdonald@zoo.ox.ac.uk		Bothwell, Helen/0000-0003-0916-8355	Robertson Foundation; Kaplan Foundation; U.S. Forest Service, Rocky Mountain Research Station	Robertson Foundation; Kaplan Foundation; U.S. Forest Service, Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service)	This project was funded by grants to the University of Oxford Wildlife Conservation Research Unit from the Robertson Foundation and Kaplan Foundation. Additional support was provided by the U.S. Forest Service, Rocky Mountain Research Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer H, 2015, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2015-2.RLTS.T15951A50658092.en; Bjorklund M, 2003, CONSERV GENET, V4, P515, DOI 10.1023/A:1024737317695; Compton BW, 2007, CONSERV BIOL, V21, P788, DOI 10.1111/j.1523-1739.2007.00674.x; Cushman S.A., 2013, KEY TOPICS CONSERVAT, P384, DOI DOI 10.1002/9781118520178.CH21; Cushman SA, 2016, LANDSCAPE ECOL, V31, P1337, DOI 10.1007/s10980-015-0292-3; Cushman SA, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-12; Cushman SA, 2013, BIODIVERS CONSERV, V22, P2583, DOI 10.1007/s10531-013-0541-1; Cushman SA, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P369, DOI 10.1007/978-4-431-87771-4_20; Elliot NB, 2014, J APPL ECOL, V51, P1169, DOI 10.1111/1365-2664.12282; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; *INT UN CONS NAT, 2006, IUCN RED LIST THREAT; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Landguth EL, 2012, ECOGRAPHY, V35, P9, DOI 10.1111/j.1600-0587.2011.07149.x; Loveridge AJ, 2009, FINAL REPORT, P200; Loveridge AJ, 2017, PEERJ, V5, DOI 10.7717/peerj.2898; Macdonald DW, 2017, ANNU REV ENV RESOUR, V42, P1; Mbaiwa JE, 2017, S AFR GEOGR J, P1; Miller SM, 2013, S AFR J WILDL RES, V43, P138, DOI 10.3957/056.043.0202; Moqanaki EM, 2017, ANIM CONSERV, V20, P29, DOI 10.1111/acv.12281; PACKER C, 1991, CONSERV BIOL, V5, P219, DOI 10.1111/j.1523-1739.1991.tb00127.x; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Trinkel M, 2017, J ZOOL, V301, P41, DOI 10.1111/jzo.12387; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	26	47	47	8	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0196213	10.1371/journal.pone.0196213	http://dx.doi.org/10.1371/journal.pone.0196213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975694	gold, Green Published			2022-12-26	WOS:000437424500001
J	Hedman, C; Otero, A; Douet, JY; Lacroux, C; Lugan, S; Filali, H; Corbiere, F; Aron, N; Badiola, JJ; Andreoletti, O; Bolea, R				Hedman, Carlos; Otero, Alicia; Douet, Jean-Yves; Lacroux, Caroline; Lugan, Severine; Filali, Hicham; Corbiere, Fabien; Aron, Naima; Badiola, Juan Jose; Andreoletti, Olivier; Bolea, Rosa			Detection of PrPres in peripheral tissue in pigs with clinical disease induced by intracerebral challenge with sheep-passaged bovine spongiform encephalopathy agent	PLOS ONE			English	Article							NERVOUS-SYSTEM; PRION PROTEIN; INFECTIVITY; BSE; PATHOGENESIS; SCRAPIE; SPLEEN; PRP(D); ONSET	Bovine spongiform encephalopathy (BSE) can be efficiently transmitted to pigs via intracerebral inoculation. A clear link has been established between the consumption of products of bovine origin contaminated with the BSE agent and the development of variant Creutzfeldt-Jakob disease in humans. Small ruminants can also naturally develop BSE, and sheep-adapted BSE (Sh-BSE) propagates more efficiently than cattle BSE in pigs and in mouse models expressing porcine prion protein. In addition, Sh-BSE shows greater efficiency of transmission to human models than original cow BSE. While infectivity and/or abnormal PrP accumulation have been reported in the central nervous system in BSE-infected pigs, the ability of the agent to replicate in peripheral tissues has not been fully investigated. We previously characterized the presence of prions in a panel of tissues collected at the clinical stage of disease from pigs experimentally infected with Sh-BSE. Western blot revealed low levels of PrPres accumulation in lymphoid tissues, nerves, and skeletal muscles from 4 of the 5 animals analysed. Using protein misfolding cyclic amplification (PMCA), which we found to be 6 log fold more sensitive than direct WB for the detection of pig BSE, we confirmed the presence of the Sh-BSE agent in lymphoid organs, nerves, ileum, and striated muscles from all 5 inoculated pigs. Surprisingly, PrPres positivity was also detected in white blood cells from one pig using this method. The presence of infectivity in lymphoid tissues, striated muscles, and peripheral nerves was confirmed by bioassay in bovine PrP transgenic mice. These results demonstrate the ability of BSE-derived agents to replicate efficiently in various peripheral tissues in pigs. Although no prion transmission has been reported in pigs following oral BSE challenge, our data support the continuation of the Feed Ban measure implemented to prevent entry of the BSE agent into the feed chain.	[Hedman, Carlos; Otero, Alicia; Filali, Hicham; Badiola, Juan Jose; Bolea, Rosa] Univ Zaragoza, Vet Fac, Ctr Encefalopatias & Enfermedades Transmisibles E, Zaragoza, Spain; [Douet, Jean-Yves; Lacroux, Caroline; Lugan, Severine; Corbiere, Fabien; Aron, Naima; Andreoletti, Olivier] Ecole Natl Vet Toulouse, Interact Hotes Agents Pathogenes, UMR INRA ENVT 1225, Toulouse, France	University of Zaragoza; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Bolea, R (corresponding author), Univ Zaragoza, Vet Fac, Ctr Encefalopatias & Enfermedades Transmisibles E, Zaragoza, Spain.	rbolea@unizar.es	DOUET, Jean Yves/F-8208-2011; Filali, Hicham/D-1279-2014; García, Alicia Otero/AAA-9722-2021	DOUET, Jean Yves/0000-0002-0426-4957; Filali, Hicham/0000-0003-3352-740X; García, Alicia Otero/0000-0001-9075-2764	EU FEDER/INTERREG [EFA 282/13 TRANSPRION, 148/16 REDPRION]; Fondo Europeo de Desarrollo Regional (FEDER); European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA); Aragon Government; European Social Fund; POCTEFA	EU FEDER/INTERREG; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA); Aragon Government(Gobierno de Aragon); European Social Fund(European Social Fund (ESF)); POCTEFA	This work was financed by EU FEDER/INTERREG (EFA 282/13 TRANSPRION, 148/16 REDPRION) www.poctefa.eu, both co-financed by the Fondo Europeo de Desarrollo Regional (FEDER). The project has been 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020). CH and AO were supported by research grants from the Aragon Government, co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank POCTEFA for co-financing this project. POCTEFA aims to reinforce the economic and social integration of the French-Spanish-Andorran border. Its support is focused on developing economic, social and environmental cross-border activities through joint strategies favouring sustainable territorial development.	Andreoletti O, 2006, J GEN VIROL, V87, P1043, DOI 10.1099/vir.0.81318-0; Bellworthy SJ, 2005, VET REC, V156, P197, DOI 10.1136/vr.156.7.197; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2005, J INFECT DIS, V192, P934, DOI 10.1086/431602; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2004, J NEUROSCI, V24, P5063, DOI 10.1523/JNEUROSCI.5400-03.2004; Castilla J, 2003, ARCH VIROL, V148, P677, DOI 10.1007/s00705-002-0958-4; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; DAWSON M, 1990, VET REC, V127, P338; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; Espinosa JC, 2007, J GEN VIROL, V88, P1379, DOI 10.1099/vir.0.82647-0; Espinosa JC, 2009, EMERG INFECT DIS, V15, P1214, DOI 10.3201/eid1508.081218; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Foster JD, 1996, VET REC, V138, P546, DOI 10.1136/vr.138.22.546; Halliez S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104287; Hedman C, 2016, VET RES, V47, DOI 10.1186/s13567-015-0295-8; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hoffmann C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-21; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Jeffrey M, 2006, J COMP PATHOL, V134, P171, DOI 10.1016/j.jcpa.2005.10.003; Kaatz M, 2012, AM J PATHOL, V181, P515, DOI 10.1016/j.ajpath.2012.05.001; KIMBERLIN RH, 1988, CIBA F SYMP, V135, P37; Kimberlin RH, 1990, UNCONVENTIONAL SLOW, P671; Konold T, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-35; Lacroux C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004202; Lacroux C, 2012, J VIROL, V86, P2056, DOI 10.1128/JVI.06532-11; McGovern G, 2015, J COMP PATHOL, V152, P28, DOI 10.1016/j.jcpa.2014.09.004; MILLSON GC, 1979, VET MICROBIOL, V4, P89, DOI 10.1016/0378-1135(79)90045-2; Moudjou M, 2014, MBIO, V5, DOI 10.1128/mBio.00829-13; Padilla D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001319; Plinston C, 2011, J VIROL, V85, P1174, DOI 10.1128/JVI.01578-10; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Ryder SJ, 2000, J COMP PATHOL, V122, P131, DOI 10.1053/jcpa.1999.0349; Seuberlich T, 2010, EMERG INFECT DIS, V16, P164, DOI 10.3201/eid1601.091104; Siso S, 2008, J PATHOL, V215, P126, DOI 10.1002/path.2336; Spiropoulos J, 2011, EMERG INFECT DIS, V17, P2253, DOI 10.3201/eid1712.110333; Torres JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089722; van Keulen LJM, 2008, ARCH VIROL, V153, P445, DOI 10.1007/s00705-007-0007-4; Wells GAH, 1998, VET REC, V142, P103, DOI 10.1136/vr.142.5.103; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Wells GAH, 2005, VET REC, V156, P401, DOI 10.1136/vr.156.13.401; Wells GAH, 2003, J GEN VIROL, V84, P1021, DOI 10.1099/vir.0.18788-0	42	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199914	10.1371/journal.pone.0199914	http://dx.doi.org/10.1371/journal.pone.0199914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975760	Green Submitted, Green Published, gold			2022-12-26	WOS:000437424500055
J	Reed, CC; Winters, JM; Hart, SC; Hutchinson, R; Chandler, M; Venicx, G; Sullivan, BW				Reed, Cody C.; Winters, Julianne M.; Hart, Stephen C.; Hutchinson, Rachel; Chandler, Mark; Venicx, Gitte; Sullivan, Benjamin W.			Building flux capacity: Citizen scientists increase resolution of soil greenhouse gas fluxes	PLOS ONE			English	Article							SCIENCE	Though citizen science programs have been broadly successful in diverse scientific fields, their adoption has lagged in some disciplines, including soil science and ecosystem ecology. Collaborations with citizen scientists may be viewed as a conundrum in these disciplines, which often require substantial labor and technical experience; citizen scientists could improve sampling capacity but may reduce sample quality or require training and oversight prior to and while performing specialized tasks. To demonstrate the feasibility of incorporating citizen scientists into soil biogeochemistry research, we conducted a proof-of-concept study in high-elevation meadows of the Sierra Nevada in California. A collaboration between university researchers and citizen scientists allowed us to assess spatial and diel patterns of soil greenhouse gas (GHG) fluxes with an intensity and frequency that would otherwise be beyond the capacity of a typical research laboratory. This collaboration with citizen scientists increased our sampling intensity by over 700% while only doubling the sampling error relative to that of full-time researchers. With training and support from project scientists, citizen scientists collected data that demonstrate spatial independence of carbon dioxide, methane, and nitrous oxide at scales between 1 m and 175 m. Additionally, we found a lack of temporal variation over a 24-h period for all three GHGs. Citizen scientists participating in this one-day event reported levels of satisfaction commensurate with longer-term, immersive campaigns. The place-based event also proved an effective tool for teaching intangible concepts of soil biogeochemistry and promoting local conservation. Despite perceived barriers to entry, this study demonstrates the mutual benefits of citizen science collaborations in soil science and ecosystem ecology, encouraging adoption by disciplines that have been slow to take advantage of such collaborations. Short-term, local citizen science events can provide meaningful experiences for area residents and teach global biogeochemical cycles in a place-based context.	[Reed, Cody C.; Sullivan, Benjamin W.] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [Winters, Julianne M.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Hart, Stephen C.] Univ Calif Merced, Life & Environm Sci & Sierra Nevada Res Inst, Merced, CA USA; [Hutchinson, Rachel] South Yuba River Citizens League, Nevada City, CA USA; [Chandler, Mark; Venicx, Gitte] Earthwatch Inst, Allston, MA USA; [Sullivan, Benjamin W.] Univ Nevada, Global Water Ctr, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California Berkeley; University of California System; University of California Merced; Nevada System of Higher Education (NSHE); University of Nevada Reno	Reed, CC (corresponding author), Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA.	creed@cabnr.unr.edu			Earthwatch Institute; United States Department of Agriculture/Nevada Agricultural Experiment Station [NEV05292]; California Department of Fish and Wildlife [P1496002 00]	Earthwatch Institute; United States Department of Agriculture/Nevada Agricultural Experiment Station; California Department of Fish and Wildlife	This work was funded by a grant to S.C.H., R.H., and B.W.S. from the Earthwatch Institute (earthwatch.org) made possible by private donations. B.W.S. received additional support from the United States Department of Agriculture/Nevada Agricultural Experiment Station (NEV05292)(cabnr.unr.edu) and the California Department of Fish and Wildlife (P1496002 00) (dfg.ca.gov).	Amano T, 2016, BIOSCIENCE, V66, P393, DOI 10.1093/biosci/biw022; Bivand RS, 2008, USE R, P1; Blankinship JC, 2014, ARCT ANTARCT ALP RES, V46, P355, DOI 10.1657/1938-4246-46.2.355; Chandler M., 2016, BIOL CONSERVATION; Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5; Cooper CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106508; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Drew WM., 2016, SIERRA MEADOWS PARTN, V1, P40; Gibbs JP, 2000, CONSERV BIOL, V14, P314, DOI 10.1046/j.1523-1739.2000.98608.x; Hart S. C., 2005, Madrono, V52, P79, DOI 10.3120/0024-9637(2005)52[79:NPPOAW]2.0.CO;2; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Klausmeyer K, 2012, SCI CONSERVATION TEC; Likert R, 1932, ARCH PSYCHOL; Loheide SP, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005233; Loss SR, 2015, BIOL CONSERV, V184, P439, DOI 10.1016/j.biocon.2015.02.023; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; National Climatic Data Center, 1985, US ANN CLIM SUMM; Newman G, 2017, BIOL CONSERV, V208, P55, DOI 10.1016/j.biocon.2016.07.019; Paul Eldor Alvin, 2015, SOIL MICROBIOLOGY EC, Vfourth; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Prieme A, 1997, SOIL BIOL BIOCHEM, V29, P1165, DOI 10.1016/S0038-0717(97)00038-2; Rinne J, 2007, TELLUS B, V59, P449, DOI 10.1111/j.1600-0889.2007.00261.x; Sachs T, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000:505; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; Stoyan H, 2000, PLANT SOIL, V222, P203, DOI 10.1023/A:1004757405147; van den Pol-van Dasselaar A, 1998, SOIL SCI SOC AM J, V62, P810, DOI 10.2136/sssaj1998.03615995006200030039x; Velthof GL, 1996, SOIL BIOL BIOCHEM, V28, P1215, DOI 10.1016/0038-0717(96)00129-0; Weixelman DA, 2011, FIELD KEY MEADOW HYD; Whitelaw G, 2003, ENVIRON MONIT ASSESS, V88, P409, DOI 10.1023/A:1025545813057	29	4	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0198997	10.1371/journal.pone.0198997	http://dx.doi.org/10.1371/journal.pone.0198997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975686	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500016
J	Inoue, M; Uchida, Y; Edagawa, M; Hirata, M; Mitamura, J; Miyamoto, D; Taketani, K; Sekine, S; Kawauchi, J; Kitajima, S				Inoue, Makoto; Uchida, Yohei; Edagawa, Makoto; Hirata, Manabu; Mitamura, Jun; Miyamoto, Daiki; Taketani, Kenji; Sekine, Shigeki; Kawauchi, Junya; Kitajima, Shigetaka			The stress response gene ATF3 is a direct target of the Wnt/beta-catenin pathway and inhibits the invasion and migration of HCT116 human colorectal cancer cells	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; HUMAN COLON-CANCER; VASCULAR ENDOTHELIAL-CELLS; BETA-CATENIN; C-MYC; MATRIX METALLOPROTEINASES; SUPPRESSES METASTASIS; PROSTATE-CANCER; UP-REGULATION; DNA-DAMAGE	Aberrant Wnt/beta-catenin signaling is implicated in tumorigenesis and the progression of human colorectal cancers, and mutations in the components of the Wnt/beta-catenin signaling pathway are observed in the majority of patients. Therefore, extensive studies on the Wnt signaling pathway and its target genes are crucial to understand the molecular events of tumorigenesis and develop an efficacious therapy. In this study, we showed that the stress response gene ATF3 is transcriptionally activated by the binding of beta-catenin and TCF4 to the redundant TCF4 site at the proximal promoter region of the ATF3 gene, indicating that ATF3 is a direct target of the Wnt/beta-catenin pathway. The loss of function or overexpression studies showed that ATF3 inhibited the migration or invasion of HCT116 cells. The expression of some MMP and TIMP genes and the ratio of MMP2/9 to TIMP3/4 mRNAs was differentially regulated by ATF3. Therefore, though ATF3 is activated downstream of the Wnt/beta-catenin pathway, it acts as a negative regulator of the migration and invasion of HCT116 human colon cancer cells exhibiting aberrant Wnt/beta-catenin activity. ATF3 is a candidate biomarker and target for human colorectal cancer treatment and prevention.	[Inoue, Makoto; Uchida, Yohei; Edagawa, Makoto; Hirata, Manabu; Mitamura, Jun; Miyamoto, Daiki; Taketani, Kenji; Kawauchi, Junya; Kitajima, Shigetaka] Tokyo Med & Dent Univ, Med Res Inst, Dept Biochem Genet, Tokyo, Japan; [Edagawa, Makoto; Taketani, Kenji] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Fukuoka, Japan; [Sekine, Shigeki] Natl Canc Ctr, Res Inst, Pathol Div, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Kyushu University; National Cancer Center - Japan	Kitajima, S (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Biochem Genet, Tokyo, Japan.	kita.bgen@mri.tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25134708, 15K08300]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aids for Scientific Research 25134708 and 15K08300 to Shigetaka Kitajima from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Behrens J, 2004, INT J DEV BIOL, V48, P477, DOI 10.1387/ijdb.041815jb; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bottone FG, 2005, MOL CANCER THER, V4, P693, DOI 10.1158/1535-7163.MCT-04-0337; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Edagawa M, 2014, J BIOL CHEM, V289, P21544, DOI 10.1074/jbc.M114.558890; Gokulnath M, 2017, INT J BIOL MACROMOL, V94, P370, DOI 10.1016/j.ijbiomac.2016.10.026; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Guenzle J, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.6; Hackl C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-668; Hai T, 1999, GENE EXPRESSION, V7, P321; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hamdi M, 2008, DNA REPAIR, V7, P487, DOI 10.1016/j.dnarep.2007.12.004; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henderson LJ, 2012, J VIROL, V86, P9495, DOI 10.1128/JVI.00486-12; Horst D, 2012, CANCER RES, V72, P1547, DOI 10.1158/0008-5472.CAN-11-3222; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Inoue K, 2004, GENES CELLS, V9, P59, DOI 10.1111/j.1356-9597.2004.00707.x; Janz M, 2006, BLOOD, V107, P2536, DOI 10.1182/blood-2005-07-2694; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kawauchi J, 2013, J BIOL CHEM, V288, P24302, DOI 10.1074/jbc.M113.496703; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Lavergne E, 2011, ONCOGENE, V30, P423, DOI 10.1038/onc.2010.432; Lee SH, 2013, J NUTR BIOCHEM, V24, P664, DOI 10.1016/j.jnutbio.2012.03.016; Lemieux E, 2015, ONCOGENE, V34, P4914, DOI 10.1038/onc.2014.416; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2014, BIOCHEM BIOPH RES CO, V445, P320, DOI 10.1016/j.bbrc.2014.01.184; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu HS, 2014, TUMOR BIOL, V35, P9807, DOI 10.1007/s13277-014-2256-7; Mathiasen DP, 2012, ONCOGENE, V31, P390, DOI 10.1038/onc.2011.230; Matsuura K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1551; Milia-Argeiti E, 2012, INT J ANDROL, V35, P835, DOI 10.1111/j.1365-2605.2012.01289.x; Miyazaki K, 2009, NUCLEIC ACIDS RES, V37, P1438, DOI 10.1093/nar/gkn1082; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Pelzer AE, 2006, J UROLOGY, V175, P1517, DOI 10.1016/S0022-5347(05)00651-8; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Sadot E, 2002, J CELL SCI, V115, P2771; Said AH, 2014, CANCERS, V6, P366, DOI 10.3390/cancers6010366; Sasaki T, 2003, CANCER RES, V63, P801; Sekine S, 2002, ONCOGENE, V21, P5906, DOI 10.1038/sj.onc.1205756; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; STARR DB, 1991, CELL, V67, P1231, DOI 10.1016/0092-8674(91)90299-E; Taketani K, 2012, ONCOGENE, V31, P2210, DOI 10.1038/onc.2011.397; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vleminckx K, 1999, MECH DEVELOP, V81, P65, DOI 10.1016/S0925-4773(98)00225-1; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Wilson AJ, 2010, CANCER RES, V70, P609, DOI 10.1158/0008-5472.CAN-09-2327; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Xie JJ, 2014, ONCOTARGET, V5, P8569, DOI 10.18632/oncotarget.2322; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yan LQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016515; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879	67	27	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0194160	10.1371/journal.pone.0194160	http://dx.doi.org/10.1371/journal.pone.0194160			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966001	Green Published, Green Submitted, gold			2022-12-26	WOS:000437224100001
J	Quiroga, RE; Premoli, AC; Fernandez, RJ				Emiliano Quiroga, R.; Premoli, Andrea C.; Fernandez, Roberto J.			Climatic niche shift in the amphitropical disjunct grass Trichloris crinita	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; DATA SETS MATTER; GEOGRAPHIC DISTRIBUTIONS; POTENTIAL DISTRIBUTION; BIOLOGICAL INVASION; ECOLOGICAL NICHES; C-4 GRASSES; ARGENTINA; BIOGEOGRAPHY; CONSERVATISM	Plant species disjunctions have attracted the interest of ecologists for decades. We investigated Trichloris crinita, a native C4 perennial grass with disjunct distribution between subtropical regions of North and South America, testing the hypothesis that the species has a similar realized climatic niche in both subcontinents. The climatic niche of T. crinita in North and South America was characterized and compared using presence records and five uncorrelated bioclimatic variables selected according to their ecological importance for the species. We used reciprocal modeling to make geographic projections of the realized niche within each subcontinent. Niche overlap between T. crinita distributions in North and South America was intermediate for the individual climatic variables and the multivariate space. In all cases the test of equivalence between climates inhabited by T. crinita indicated that the realized niche of the species differ significantly between subcontinents. Also, the similarity test showed that in the majority of cases the realized niche in both subcontinents was significantly different than that expected by chance. T. crinita occupied a greater diversity of environments in South than in North America, while in the latter its distribution was displaced to drier and warmer environments. The modeled geographic distribution using the actual occurrences of the species in North America did not accurately predict the distribution in South America, and vice versa. Together, these results led us to reject the hypothesis of similar niche of T. crinita in both subcontinents. This information may be useful to manage restoration efforts by presenting the suitable areas and climates for the species, and suggesting that translocation of individuals between subcontinents could only be recommended with caution because introduced genotypes can be potentially maladaptive, and could colonize sites actually not occupied by the species within each subcontinent.	[Emiliano Quiroga, R.] INTA, Estn Expt Agr Catamarca, Valle Viejo, Catamarca, Argentina; [Premoli, Andrea C.] Univ Nacl Comahue, CONICET, INIBIOMA, San Carlos De Bariloche, Rio Negro, Argentina; [Fernandez, Roberto J.] Univ Buenos Aires, CONICET, Fac Agron, IFEVA,Catedra Ecol, Buenos Aires, DF, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Quiroga, RE (corresponding author), INTA, Estn Expt Agr Catamarca, Valle Viejo, Catamarca, Argentina.	quiroga.raul@inta.gob.ar	Quiroga, Emiliano/L-2904-2019	Quiroga, Emiliano/0000-0001-9785-451X; Fernandez, Roberto/0000-0003-3094-569X	Institute Nacional de Tecnologia Agropecuaria; Agencia de Promocion Cientifica y Tecnologica [PICT 2404, 1563]; Consejo Nacional de Investigaciones Cientificas y Tecnicas CONICET [PIP 626]; Universidad de Buenos Aires	Institute Nacional de Tecnologia Agropecuaria; Agencia de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	Funding for REQ was provided by the Institute Nacional de Tecnologia Agropecuaria. Financial support was provided by grants from Agencia de Promocion Cientifica y Tecnologica PICT 2404 and 1563 (ACP); Consejo Nacional de Investigaciones Cientificas y Tecnicas CONICET PIP 626 (ACP) and Universidad de Buenos Aires (RJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson DL, 1980, MANEJO PASTIZAL NATU; [Anonymous], 2010, R LANG ENV STAT COMP; Atwater DZ, 2018, NAT ECOL EVOL, V2, P34, DOI 10.1038/s41559-017-0396-z; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Bosso L, 2017, ENVIRON MANAGE, V60, P304, DOI 10.1007/s00267-017-0882-8; Bosso L, 2016, PHYTOPATHOL MEDITERR, V55, P62, DOI 10.14601/Phytopathol_Mediterr-16429; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Cabido M, 1997, J BIOGEOGR, V24, P197, DOI 10.1046/j.1365-2699.1997.00085.x; CAVAGNARO JB, 1988, OECOLOGIA, V76, P273, DOI 10.1007/BF00379962; Cavagnaro PF, 2006, GENOME, V49, P906, DOI 10.1139/G06-060; Dagnino D, 2017, PLANT BIOLOGY, V19, P1003, DOI 10.1111/plb.12600; Dai GH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19477-w; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ewen JG, 2012, REINTRODUCTION BIOL; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Fitzpatrick MC, 2008, GLOBAL ECOL BIOGEOGR, V17, P562, DOI 10.1111/j.1466-8238.2008.00389.x; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Greco SA, 2013, REV FAC CIENC AGRAR, V45, P197; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kozub PC, 2018, GRASS FORAGE SCI, V73, P257, DOI 10.1111/gfs.12337; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu P, 2017, PLANT DIVERSITY, V39, P111, DOI 10.1016/j.pld.2017.04.001; MacArthur R.H., 1969, POPULATION BIOL EVOL, P159; Marinoni L, 2018, PLANT ECOL DIVERS, V11, P173, DOI 10.1080/17550874.2018.1449262; Milesi Fernando A, 2005, Ecol. austral, V15, P131; ORIANS G, 1977, CONVERGENT EVOLUTION; Ortega-Huerta MA, 2008, REV MEX BIODIVERS, V79, P205; PASSERA CB, 1992, J RANGE MANAGE, V45, P480, DOI 10.2307/4002906; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pena-Gomez FT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105025; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2012, PLANT BIOSYST, V146, P789, DOI 10.1080/11263504.2012.740083; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson Paul M., 2007, Aliso, V23, P580; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Pezzani F, 2006, MYCORRHIZA, V16, P285, DOI 10.1007/s00572-006-0044-y; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Quiroga RE, 2010, ECOL APPL, V20, P1876, DOI 10.1890/09-0641.1; RAVEN PH, 1963, Q REV BIOL, V38, P151, DOI 10.1086/403797; Reside AE, 2018, BIODIVERS CONSERV, V27, P1, DOI 10.1007/s10531-017-1442-5; Scheldeman X, 2011, MANUAL CAPACITACIO; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Shipley JR, 2013, AUK, V130, P476, DOI 10.1525/auk.2013.12151; Silverman B.W., 1986, DENSITY ESTIMATION S; Simpson MG, 2017, AM J BOT, V104, P1600, DOI 10.3732/ajb.1700308; Smeraldo S, 2017, J NAT CONSERV, V37, P12, DOI 10.1016/j.jnc.2017.02.008; Sobek-Swant S, 2012, FOREST ECOL MANAG, V281, P23, DOI 10.1016/j.foreco.2012.06.017; Soberon J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175138; SOLBRIG OT, 1972, ANN MO BOT GARD, V59, P218, DOI 10.2307/2394754; THORNE RF, 1972, Q REV BIOL, V47, P365, DOI 10.1086/407399; Tingley R, 2014, P NATL ACAD SCI USA, V111, P10233, DOI 10.1073/pnas.1405766111; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wasof S, 2015, GLOBAL ECOL BIOGEOGR, V24, P1401, DOI 10.1111/geb.12375; WHITTAKER RH, 1973, AM NAT, V107, P321, DOI 10.1086/282837; Wiens JJ, 2011, PHILOS T R SOC B, V366, P2336, DOI 10.1098/rstb.2011.0059; Winkworth RC, 2015, J BIOGEOGR, V42, P1197, DOI 10.1111/jbi.12522	64	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199811	10.1371/journal.pone.0199811	http://dx.doi.org/10.1371/journal.pone.0199811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953506	gold, Green Submitted, Green Published			2022-12-26	WOS:000436645400075
J	Garcia-Vidal, C; Cardozo-Espinola, C; Puerta-Alcalde, P; Marco, F; Tellez, A; Aguero, D; Romero-Santana, F; Diaz-Beya, M; Gine, E; Morata, L; Rodriguez-Nunez, O; Martinez, JA; Mensa, J; Esteve, J; Soriano, A				Garcia-Vidal, Carolina; Cardozo-Espinola, Celia; Puerta-Alcalde, Pedro; Marco, Francesc; Tellez, Adrian; Aguero, Daiana; Romero-Santana, Francisco; Diaz-Beya, Marina; Gine, Eva; Morata, Laura; Rodriguez-Nunez, Olga; Antonio Martinez, Jose; Mensa, Josep; Esteve, Jordi; Soriano, Alex			Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GRAM-NEGATIVE BACILLI; PSEUDOMONAS-AERUGINOSA; HEMATOLOGICAL MALIGNANCIES; ANTIMICROBIAL RESISTANCE; NEUTROPENIC PATIENTS; CANCER-PATIENTS; BACTEREMIA; EPIDEMIOLOGY; BACTERIAL	Objectives We assess the epidemiology and risk factors for mortality of bloodstream infection (BSI) in patients with acute leukemia (AL). Methods Prospectively collected data of a cohort study from July 2004 to February 2016. Multivariate analyses were performed. Results 589 episodes of BSI were documented in 357 AL patients, 55% caused by gram-positive bacteria (coagulase-negative staphylococci 35.7%, Enterococcus spp 10.8%) and 43.5% by gram-negative bacteria (E. coli 21%, PA 12%). We identified 110 (18.7%) multidrug-resistant (MDR) microorganisms, especially MDR-Pseudomonas aeruginosa (7%) and extended-spectrum beta-lactamase producing Enterobacteriaceae (7%). The 30-day mortality was 14.8%. Age (OR 3.1; 95% CI 1.7-5.7); chronic lung disease (4.8; 1.1-21.8); fatal prognosis according to McCabe index (13.9; 6.4-30.3); shock (3.8; 1.9-7.7); pulmonary infection (3.6; 1.3-9.9); and MDR-PA infections with inappropriate treatment (12.8; 4.1-40.5) were related to mortality. MDR-PA BSI was associated to prior antipseudomonal cephalosporin use (9.31; 4.38-19.79); current use of betalactams (2.01; 1.01-4.3); shock (2.63; 1.03-6.7) and pulmonary source of infection (9.6; 3.4-27.21). Conclusions MDR organisms were commonly isolated in BSI in AL. Inappropriate empiric antibiotic treatment for MDR-PA is the primary factor related to mortality that can be changed. New treatment strategies to improve the coverage of MDR-PA BSI should be considered in those patients with risk factors for this infection.	[Garcia-Vidal, Carolina; Cardozo-Espinola, Celia; Puerta-Alcalde, Pedro; Tellez, Adrian; Aguero, Daiana; Romero-Santana, Francisco; Morata, Laura; Rodriguez-Nunez, Olga; Antonio Martinez, Jose; Mensa, Josep; Soriano, Alex] Hosp Clin IDIBAPS, Infect Dis Dept, Barcelona, Spain; [Marco, Francesc] Hosp Clin Barcelona, Ctr Diagnost Biomed, Microbiol Dept, Barcelona, Spain; [Marco, Francesc] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Romero-Santana, Francisco] Hosp Insular Univ Gran Canaria, Internal Med Dept, Las Palmas Gran Canaria, Spain; [Diaz-Beya, Marina; Gine, Eva; Esteve, Jordi] Hosp Clin DIBAPS, Hematol Dept, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Garcia-Vidal, C; Puerta-Alcalde, P (corresponding author), Hosp Clin IDIBAPS, Infect Dis Dept, Barcelona, Spain.	cgarciav@chnic.cat; pedro.puerta84@gmail.com	Morata, Laura/B-1817-2019; Soriano, Alex/I-1210-2017; Marco, Francesc/K-2900-2017	Morata, Laura/0000-0001-5795-0814; Soriano, Alex/0000-0002-9374-0811; Garcia-Vidal, Carolina/0000-0002-8915-0683; Marco, Francesc/0000-0002-1863-6379; Tellez, Adrian/0000-0003-3502-5999	Catalan Health Agency [PERIS (Pla estrategic de recerca i innovacio en salut 'Strategic Plan for Research and Innovation in HealthCare')]	Catalan Health Agency [PERIS (Pla estrategic de recerca i innovacio en salut 'Strategic Plan for Research and Innovation in HealthCare')]	Dra. Carolina Garcia-Vidal has received INTENSIFICACIO Grant-a grant supported by the Catalan Health Agency [PERIS (Pla estrategic de recerca i innovacio en salut 'Strategic Plan for Research and Innovation in HealthCare')]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dra. Carolina Garcia-Vidal has received INTENSIFICACIO Grant-a grant supported by the Catalan Health Agency [PERIS (Pla estrategic de recerca i innovacio en salut-'Strategic Plan for Research and Innovation in HealthCare')]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Ben-David D, 2010, INFECT CONT HOSP EP, V31, P620, DOI 10.1086/652528; Cattaneo C, 2012, ANN HEMATOL, V91, P1299, DOI 10.1007/s00277-012-1424-3; Collin BA, 2001, CLIN INFECT DIS, V33, P947, DOI 10.1086/322604; El Zowalaty ME, 2015, FUTURE MICROBIOL, V10, P1683, DOI 10.2217/fmb.15.48; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; Gudiol C, 2013, CLIN MICROBIOL INFEC, V19, P474, DOI 10.1111/j.1469-0691.2012.03879.x; Gudiol C, 2011, J ANTIMICROB CHEMOTH, V66, P657, DOI 10.1093/jac/dkq494; Gudiol C, 2016, RESPIROLOGY, V21, P1411, DOI 10.1111/resp.12848; Gudiol C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074734; Kara O, 2015, INFECT DIS-NOR, V47, P686, DOI 10.3109/23744235.2015.1051105; Madani TA, 2000, INFECTION, V28, P367, DOI 10.1007/s150100070007; Malagola M, 2008, EUR J HAEMATOL, V81, P354, DOI 10.1111/j.1600-0609.2008.01122.x; Marin M, 2015, CLIN MICROBIOL INFEC, V21, P583, DOI 10.1016/j.cmi.2015.01.029; Mikulska M, 2014, J INFECTION, V68, P321, DOI 10.1016/j.jinf.2013.12.006; Montassier E, 2013, EUR J CLIN MICROBIOL, V32, P841, DOI 10.1007/s10096-013-1819-7; Morata L, 2012, ANTIMICROB AGENTS CH, V56, P4833, DOI 10.1128/AAC.00750-12; Nesher L, 2015, TRANSPL INFECT DIS, V17, P33, DOI 10.1111/tid.12323; Norgaard M, 2006, CLIN MICROBIOL INFEC, V12, P217, DOI 10.1111/j.1469-0691.2005.01298.x; Norgaard M, 2006, BRIT J HAEMATOL, V132, P25, DOI 10.1111/j.1365-2141.2005.05845.x; Ortega M, 2016, J INFECTION, V72, P268, DOI 10.1016/j.jinf.2015.11.006; Ortega M, 2015, EPIDEMIOL INFECT, V143, P734, DOI 10.1017/S0950268814001654; Pena C, 2013, CLIN INFECT DIS, V57, P208, DOI 10.1093/cid/cit223; Ramphal R, 2004, CLIN INFECT DIS, V39, pS25, DOI 10.1086/383048; Rodriguez-Bano J, 2010, CLIN INFECT DIS, V50, P40, DOI 10.1086/649537; Schelenz S, 2013, J ANTIMICROB CHEMOTH, V68, P1431, DOI 10.1093/jac/dkt002; Serody JS, 2000, NEW ENGL J MED, V342, P217; Trecarichi EM, 2015, CLIN MICROBIOL INFEC, V21, P337, DOI 10.1016/j.cmi.2014.11.022; Tumbarello M, 2009, DIAGN MICR INFEC DIS, V64, P320, DOI 10.1016/j.diagmicrobio.2009.02.008; Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339; World Health Organization, 1997, WHO HDB REP RES CANC	31	42	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199531	10.1371/journal.pone.0199531	http://dx.doi.org/10.1371/journal.pone.0199531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953464	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400039
J	Ha, HJ; Koo, HJ; Huh, HK; Kim, GB; Kweon, J; Kim, N; Kim, YH; Kang, JW; Lim, TH; Song, JK; Lee, SJ; Yang, DH				Ha, Hojin; Koo, Hyun Jung; Huh, Hyung Kyu; Kim, Guk Bae; Kweon, Jihoon; Kim, Namkug; Kim, Young-Hak; Kang, Joon-Won; Lim, Tae-Hwan; Song, Jae-Kwan; Lee, Sang Joon; Yang, Dong Hyun			Effect of pannus formation on the prosthetic heart valve: In vitro demonstration using particle image velocimetry	PLOS ONE			English	Article							WALL SHEAR-STRESS; PULSATILE SWIRLING FLOW; AORTIC-VALVE; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; ASCENDING AORTA; CARDIAC CT; ECHOCARDIOGRAPHY; RECOMMENDATIONS; GUIDELINES	Although hemodynamic influence of the subprosthetic tissue, termed as pannus, may contribute to prosthetic aortic valve dysfunction, the relationship between pannus extent and hemodynamics in the prosthetic valve has rarely been reported. We investigated the fluid dynamics of pannus formation using in vitro experiments with particle image velocimetry. Subvalvular pannus formation caused substantial changes in prosthetic valve transvalvular peak velocity, transvalvular pressure gradient (TPG) and opening angle. Maximum flow velocity and corresponding TPG were mostly affected by pannus width. When the pannus width was 25% of the valve diameter, pannus formation elevated TPG to >2.5 times higher than that without pannus formation. Opening dysfunction was observed only for a pannus involvement angle of 360 degrees. Although circumferential pannus with an involvement angle of 360 degrees decreased the opening angle of the valve from approximately 82 degrees to 58 degrees, eccentric pannus with an involvement angle of 180 degrees did not induce valve opening dysfunction. The pannus involvement angle largely influenced the velocity flow field at the aortic sinus and corresponding hemodynamic indices, including wall shear stress, principal shear stress and viscous energy loss distributions. Substantial discrepancy between the velocity-based TPG estimation and direct pressure measurements was observed for prosthetic valve flow with pannus formation.	[Ha, Hojin] Kangwon Natl Univ, Dept Mech & Biomed Engn, Chunchon, South Korea; [Koo, Hyun Jung; Kang, Joon-Won; Lim, Tae-Hwan; Yang, Dong Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Huh, Hyung Kyu; Lee, Sang Joon] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang, South Korea; [Kim, Guk Bae] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Kweon, Jihoon; Kim, Young-Hak; Song, Jae-Kwan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul, South Korea; [Kim, Namkug] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med, Seoul, South Korea	Kangwon National University; University of Ulsan; Asan Medical Center; Pohang University of Science & Technology (POSTECH); University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Yang, DH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.	donghyun.yang@gmail.com	Kim, Namkug/E-3843-2012; Lee, Sang Joon/AAG-2448-2019	Kim, Namkug/0000-0002-3438-2217; Yang, Dong Hyun/0000-0001-5477-558X; Kweon, Jihoon/0000-0003-1831-7615	National Research Foundation of Korea (NRF) [NRF-2013R1A1A1058711, NRF-2015R1A2A2A04003034, NRF-2016R1A1A1A05921207, 2008-0061991]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This work was supported by grants from the National Research Foundation of Korea (NRF; http://www.nrf.re.kr, NRF-2013R1A1A1058711 and NRF-2015R1A2A2A04003034 to DHY, NRF-2016R1A1A1A05921207 to NK, no. 2008-0061991 to SJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbetseas J, 1998, J AM COLL CARDIOL, V32, P1410, DOI 10.1016/S0735-1097(98)00385-4; Barker AJ, 2014, MAGN RESON MED, V72, P620, DOI 10.1002/mrm.24962; Barker AJ, 2012, CIRC-CARDIOVASC IMAG, V5, P457, DOI 10.1161/CIRCIMAGING.112.973370; Baumgartner Helmut, 2008, EUROPEAN HEART J CAR; Berger SA, 2000, ANNU REV FLUID MECH, V32, P347, DOI 10.1146/annurev.fluid.32.1.347; Bouillot P, 2015, J NEUROINTERV SURG, DOI [10.1007/s10439-009-9697-y, DOI 10.1007/S10439-009-9697-Y]; Charonko J, 2009, ANN BIOMED ENG, V37, P1310, DOI 10.1007/s10439-009-9697-y; Chung MS, 2015, EUR HEART J-CARD IMG, V16, P458, DOI 10.1093/ehjci/jeu285; Dasi LP, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2743261; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Dyverfeldt P, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0174-5; Ha H, 2014, FLUID DYNAMIC OPTIMA; Ha H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151540; Ha H, 2016, MAGN RESON MED, V75, P1909, DOI 10.1002/mrm.25715; Ha H, 2015, MED ENG PHYS, V37, P272, DOI 10.1016/j.medengphy.2015.01.007; Ha HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111047; Ha HJ, 2014, MED ENG PHYS, V36, P1106, DOI 10.1016/j.medengphy.2014.06.004; Ha H, 2014, MED ENG PHYS, V36, P119, DOI 10.1016/j.medengphy.2013.10.008; Han K, 2015, RADIOLOGY; Han K, 2015, RADIOLOGY, V276, P724, DOI 10.1148/radiol.2015142400; Kim GH, 2015, J CARDIOVASCULAR COM; Kim YJ, 2015, KOREAN J RADIOL, V16, P251, DOI 10.3348/kjr.2015.16.2.251; Koo HJ, 2018, CLIN RES CARDIOL, P1, DOI [DOI 10.1007/S00392-017-1170-6, 10.1007/s00392-017-1170-6]; Lee SJ, 2003, J APPL PHYS, V94, P3620, DOI 10.1063/1.1599981; Meierhofer C, 2013, EUR HEART J-CARD IMG, V14, P797, DOI 10.1093/ehjci/jes273; Miron P, 2014, EXP FLUIDS, V55, DOI 10.1007/s00348-014-1814-5; Moore B, 2014, EXP FLUIDS, V55, DOI 10.1007/s00348-014-1770-0; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; PEACOCK JA, 1990, CIRC RES, V67, P448, DOI 10.1161/01.RES.67.2.448; REUL H, 1990, J BIOMECH, V23, P181, DOI 10.1016/0021-9290(90)90351-3; Suh YJ, 2016, INT J CARDIOL, V214, P455, DOI 10.1016/j.ijcard.2016.04.011; Thielicke W., 2014, J OPEN RES STW, V2, P30, DOI [10.5334/JORS.BL, DOI 10.5334/JORS.BL]; Yagi Takanobu, 2011, Journal of Biomechanical Science and Engineering, V6, P12, DOI 10.1299/jbse.6.64; Zoghbi WA, 2009, J AM SOC ECHOCARDIOG, V22, P975, DOI 10.1016/j.echo.2009.07.013	35	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199792	10.1371/journal.pone.0199792	http://dx.doi.org/10.1371/journal.pone.0199792			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953485	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400071
J	Lince-Deroche, N; Constant, D; Harries, J; Kluge, J; Blanchard, K; Sinanovic, E; Grossman, D				Lince-Deroche, Naomi; Constant, Deborah; Harries, Jane; Kluge, Judith; Blanchard, Kelly; Sinanovic, Edina; Grossman, Daniel			The costs and cost effectiveness of providing second-trimester medical and surgical safe abortion services in Western Cape Province, South Africa	PLOS ONE			English	Article							TERMINATION; PREGNANCY; MISOPROSTOL; EVACUATION; DILATION; COMPLICATIONS; PROVISION; INDUCTION; CHOICE; IMPACT	Background In South Africa, access to second-trimester abortion services, which are generally performed using medical induction with misoprostol alone, is challenging for many women. We aimed to estimate the costs and cost effectiveness of providing three safe second-trimester abortion services (dilation and evacuation (D&E)), medical induction with mifepristone and misoprostol (MI-combined), or medical induction with misoprostol alone (MI-misoprostol)) in Western Cape Province, South Africa to aid policymakers with planning for service provision in South Africa and similar settings. Methods We derived clinical outcomes data for this economic evaluation from two previously conducted clinical studies. In 2013-2014, we collected cost data from three public hospitals where the studies took place. We collected cost data from the health service perspective through micro-costing activities, including discussions with site staff. We used decision tree analysis to estimate average costs per patient interaction (e.g. first visit, procedure visit, etc.), the total average cost per procedure, and cost-effectiveness in terms of the cost per complete abortion. We discounted equipment costs at 3%, and present the results in 2015 US dollars. Results D&E services were the least costly and the most cost-effective at $91.17 per complete abortion. MI-combined was also less costly and more cost-effective (at $298.03 per complete abortion) than MI-misoprostol (at $375.31 per complete abortion), in part due to a shortened inpatient stay. However, an overlap in the plausible cost ranges for the two medical procedures suggests that the two may have equivalent costs in some circumstances. Conclusion D&E was most cost-effective in this analysis. However, due to resistance from health care providers and other barriers, these services are not widely available and scale-up is challenging. Given South Africa's reliance on medical induction, switching to the combined regimen could result in greater access to second-trimester services due to shorter inpatient stays without increasing costs.	[Lince-Deroche, Naomi] Ibis Reprod Hlth, Johannesburg, South Africa; [Constant, Deborah; Harries, Jane] Univ Cape Town, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa; [Kluge, Judith] Univ Stellenbosch, Dept Obstet & Gynaecol, Cape Town, South Africa; [Kluge, Judith] Tygerberg Hosp, Cape Town, South Africa; [Blanchard, Kelly] Ibis Reprod Hlth, Cambridge, MA USA; [Sinanovic, Edina] Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Econ Unit, Cape Town, South Africa; [Grossman, Daniel] Univ Calif San Francisco, Bixby Ctr Global Reprod Hlth, Dept Obstet Gynecol & Reprod Sci, Adv New Stand Reprod Hlth ANSIRH, Oakland, CA USA	University of Cape Town; Stellenbosch University; Tygerberg Hospital; University of Cape Town; University of California System; University of California San Francisco	Lince-Deroche, N (corresponding author), Ibis Reprod Hlth, Johannesburg, South Africa.	naomi.lince.deroche@gmail.com	KLUGE, Judith/GSM-7110-2022; Harries, Jane/R-6504-2019; Sinanovic, Edina/AAR-2590-2020	Harries, Jane/0000-0001-7359-8419; Lince-Deroche, Naomi/0000-0003-3689-4205	Safe Abortion Action Fund; Society of Family Planning; Medical Research Council of South Africa	Safe Abortion Action Fund; Society of Family Planning; Medical Research Council of South Africa(South African Medical Research Council)	Clinical data collection was funded through grants from the Safe Abortion Action Fund, the Society of Family Planning, and the Medical Research Council of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge Ntombomzi Mcanjana, Nomfundo Cishe, Mthokozisi Radebe, Adila Hargey and the hospital staff for assistance with carrying out the two clinical studies from which data for this analysis were drawn. This research was funded through grants from the Safe Abortion Action Fund, the Society of Family Planning, and the Medical Research Council of South Africa.	Amnesty International, 2017, BRIEF BARR SAF LEG A; [Anonymous], 2012, STAND TREATM GUID ES, V1st; [Anonymous], OBSTET GYNECOL; [Anonymous], 2015, STAND TREATM GUID ES; Ashok PW, 2004, CONTRACEPTION, V69, P51, DOI 10.1016/j.contraception.2003.09.006; Autry AM, 2002, AM J OBSTET GYNECOL, V187, P393, DOI 10.1067/mob.2002.123887; Constant D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161843; Cowett AA, 2006, AM J OBSTET GYNECOL, V194, P768, DOI 10.1016/j.ajog.2005.09.003; Creinin MD, 2005, CONTRACEPTION, V71, P26, DOI 10.1016/j.contraception.2004.07.011; Department of Health: Republic of South Africa, ESS DRUGS PROGR 2015; Department of Public Service and Administration: Republic of South Africa, 2015, SAL SCAL TRANSL KEYS; Grimes DA, 2008, REPROD HEALTH MATTER, V16, P183, DOI 10.1016/S0968-8080(08)31378-0; Grossman D, 2009, GYNECOL OBSTET, V107, pS93, DOI [10.1016/S0020-7292(09)60902-4, DOI 10.1016/S0020-7292(09)60902-4]; Grossman D, 2011, BMC HLTH SERV RES, V11; Grossman D, 2008, REPROD HEALTH MATTER, V16, P173, DOI 10.1016/S0968-8080(08)31379-2; Grossman D, 2014, CONTRACEPTION, V90, P234, DOI 10.1016/j.contraception.2014.05.003; Harries J, 2012, J BIOSOC SCI, V44, P197, DOI 10.1017/S0021932011000678; Harries Jane, 2007, Reprod Health, V4, P7, DOI 10.1186/1742-4755-4-7; Harries J, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-16; Harris LH, 2008, REPROD HEALTH MATTER, V16, P74, DOI 10.1016/S0968-8080(08)31396-2; International Monetary Fund, CONS PRIC IND WORLD; KALTREIDER NB, 1979, AM J OBSTET GYNECOL, V135, P235, DOI 10.1016/0002-9378(79)90351-X; Kerns J, 2012, INT J GYNECOL OBSTET, V116, P244, DOI 10.1016/j.ijgo.2011.10.016; Lince-Deroche N, 2015, CONTRACEPTION, V92, P339, DOI 10.1016/j.contraception.2015.06.029; Lohr PA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006714.pub2; Morroni C, 2006, SAJOG-S AFR J OBSTET, V12, P81; Morroni Chelsea, 2006, Reprod Health, V3, P7; National Health Laboratory Service, 2014, STAT PRIC LIST 2014; Ngo TD, 2011, B WORLD HEALTH ORGAN, V89, P360, DOI 10.2471/BLT.10.084046; Oanda, 2015, HIST EXCH RAT USD ZA; Patel A, 2006, CONTRACEPTION, V73, P420, DOI 10.1016/j.contraception.2005.10.004; Pazol K, 2015, MMWR SURVEILL SUMM, V64, P1, DOI 10.15585/ss6410a1; South African Department of Health, 2005, TERM PREGN UPD CUM S; South African National Department of Health, 2015, UN PAT FEE SCHED UPF; Turok DK, 2008, CONTRACEPTION, V77, P155, DOI 10.1016/j.contraception.2007.11.004; UK Department of Health and Social Care, 2022, AB STAT ENGL WAL 202; Winikoff B, 2012, INT PERSPECT SEX R H, V38, P164, DOI 10.1363/3816412	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0197485	10.1371/journal.pone.0197485	http://dx.doi.org/10.1371/journal.pone.0197485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953434	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400004
J	Savini, L; Tora, S; Di Lorenzo, A; Cioci, D; Monaco, F; Polci, A; Orsini, M; Calistri, P; Conte, A				Savini, Lara; Tora, Susanna; Di Lorenzo, Alessio; Cioci, Daniela; Monaco, Federica; Polci, Andrea; Orsini, Massimiliano; Calistri, Paolo; Conte, Annamaria			A Web Geographic Information System to share data and explorative analysis tools: The application to West Nile disease in the Mediterranean basin	PLOS ONE			English	Article							VIRUS	Background In the last decades an increasing number of West Nile Disease cases was observed in equines and humans in the Mediterranean basin and surveillance systems are set up in numerous countries to manage and control the disease. The collection, storage and distribution of information on the spread of the disease becomes important for a shared intervention and control strategy. To this end, a Web Geographic Information System has been developed and disease data, climatic and environmental remote sensed data, full genome sequences of selected isolated strains are made available. This paper describes the Disease Monitoring Dashboard (DMD) web system application, the tools available for the preliminary analysis on climatic and environmental factors and the other interactive tools for epidemiological analysis. Methods WNV occurrence data are collected from multiple official and unofficial sources. Whole genome sequences and metadata of WNV strains are retrieved from public databases or generated in the framework of the Italian surveillance activities. Climatic and environmental data are provided by NASA website. The Geographical Information System is composed by Oracle 10g Database and ESRI ArcGIS Server 10.03; the web mapping client application is developed with the ArcGIS API for Javascript and Phylocanvas library to facilitate and optimize the mash-up approach. ESRI ArcSDE 10.1 has been used to store spatial data. Results The DMD application is accessible through a generic web browser at https://netmed.izs.it/networkMediterraneo/. The system collects data through on-line forms and automated procedures and visualizes data as interactive graphs, maps and tables. The spatial and temporal dynamic visualization of disease events is managed by a time slider that returns results on both map and epidemiological curve. Climatic and environmental data can be associated to cases through python procedures and downloaded as Excel files. Conclusions The system compiles multiple datasets through user-friendly web tools; it integrates entomological, veterinary and human surveillance, molecular information on pathogens and environmental and climatic data. The principal result of the DMD development is the transfer and dissemination of knowledge and technologies to develop strategies for integrated prevention and control measures of animal and human diseases.	[Savini, Lara; Tora, Susanna; Di Lorenzo, Alessio; Cioci, Daniela; Monaco, Federica; Polci, Andrea; Orsini, Massimiliano; Calistri, Paolo; Conte, Annamaria] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Campo Boario Teramo, Italy	IZS Dell'abruzzo E Del Molise Giuseppe Caporale	Savini, L (corresponding author), Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Campo Boario Teramo, Italy.	l.savini@izs.it	Savini, Lara LS/C-2851-2018; Di Lorenzo, Alessio/I-3374-2016; Calistri, Paolo/E-4157-2015; Monaco, Federica/G-9282-2016; Monaco, Federica/ABC-9526-2021; Conte, Annamaria/H-5869-2016; Tora, Susanna/I-3371-2016	Savini, Lara LS/0000-0001-6175-7793; Di Lorenzo, Alessio/0000-0003-3222-2399; Calistri, Paolo/0000-0001-6004-9373; Monaco, Federica/0000-0002-7827-2642; Monaco, Federica/0000-0002-7827-2642; Conte, Annamaria/0000-0001-6975-2698; Tora, Susanna/0000-0001-8801-800X				Tran A, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-26; [Anonymous], 2010, NC B ENTR PROGR UT H; [Anonymous], 2012, FIGTREE; [Anonymous], 2006, NJTREE SOFTWARE; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Brault AC, 2009, VET RES, V40, DOI 10.1051/vetres/2009026; Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029; CDC, 2017, CDC WORKS 24 7; Chevalier V, 2014, INT J ENV RES PUB HE, V11, P67, DOI 10.3390/ijerph110100067; Conte A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146024; ECDC, ECDC WNF HUM CAS 201; Hahn MB, 2015, AM J TROP MED HYG, V92, P1013, DOI 10.4269/ajtmh.14-0737; Hurlbut HS, 1956, STUDY ECOLOGY W NILE; Monaco F, 2011, RES VET SCI, V91, P321, DOI 10.1016/j.rvsc.2011.01.008; Ozdenerol E, 2013, INT J ENV RES PUB HE, V10, P5399, DOI 10.3390/ijerph10115399; Paz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056398; Rizzo C, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.37.30340; Sotelo E, 2009, VIROLOGY, V395, P289, DOI 10.1016/j.virol.2009.09.013; Ward MP, 2009, PREV VET MED, V88, P205, DOI 10.1016/j.prevetmed.2008.10.003; Yamada KD, 2016, BIOINFORMATICS, V32, P3246, DOI 10.1093/bioinformatics/btw412	20	5	5	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0196429	10.1371/journal.pone.0196429	http://dx.doi.org/10.1371/journal.pone.0196429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949583	Green Submitted, gold, Green Published			2022-12-26	WOS:000436549200004
J	Wibisono, HT; Wahyudi, HA; Wilianto, E; Pinondang, IMR; Primajati, M; Liswanto, D; Linkie, M				Wibisono, Hariyo Tabah; Wahyudi, Hariyawan Agung; Wilianto, Erwin; Pinondang, Irene Margareth Romaria; Primajati, Mahendra; Liswanto, Darmawan; Linkie, Matthew			Identifying priority conservation landscapes and actions for the Critically Endangered Javan leopard in Indonesia: Conserving the last large carnivore in Java Island	PLOS ONE			English	Article							PANTHERA-PARDUS; NATIONAL-PARK; DISTRIBUTION MODELS; HABITAT USE; POPULATION; AFRICA; RANGE; SIZE; DISTRIBUTIONS; PREDATORS	With the extirpation of tigers from the Indonesian island of Java in the 1980s, the endemic and Critically Endangered Javan leopard is the island's last remaining large carnivore. Yet despite this, it has received little conservation attention and its population status and distribution remains poorly known. Using Maxent modeling, we predicted the locations of suitable leopard landscapes throughout the island of Java based on 228 verified Javan leopard samples and as a function of seven environmental variables. The identified landscapes covered over 1 million hectares, representing less than 9% of the island. Direct evidence of Javan leopard was confirmed from 22 of the 29 identified landscapes and included all national parks, which our analysis revealed as the single most important land type. Our study also emphasized the importance of maintaining connectivity between protected areas and human-modified landscapes because adjacent production forests and secondary forests were found to provide vital extensions for several Javan leopard subpopulations. Our predictive map greatly improves those previously produced by the Government of Indonesia's Javan Leopard Action Plan and the IUCN global leopard distribution assessment. It shares only a 32% overlap with the IUCN range predictions, adds six new priority landscapes, all with confirmed presence of Javan leopard, and reveals an island-wide leopard population that occurs in several highly fragmented landscapes, which are far more isolated than previously thought. Our study provides reliable information on where conservation efforts must be prioritized both inside and outside of the protected area network to safeguard Java's last remaining large carnivore.	[Wibisono, Hariyo Tabah] Univ Delaware, Coll Agr & Nat Resources, Dept Entomol & Wildlife Ecol, Newark, DE 19716 USA; [Wibisono, Hariyo Tabah] San Diego Zoo Inst Conservat Res, Populat Sustainabil, Escondido, CA 92027 USA; [Wibisono, Hariyo Tabah; Wilianto, Erwin] Forum HarimauKita, Bogor, West Java, Indonesia; [Wahyudi, Hariyawan Agung] Biodivers Soc, Banyumas, Central Java, Indonesia; [Pinondang, Irene Margareth Romaria; Primajati, Mahendra] Fauna & Flora Int Indonesia Programme, Jakarta, Indonesia; [Liswanto, Darmawan] Yayasan Titian Lestari, Pontianak, Kalimantan Bara, Indonesia; [Linkie, Matthew] Wildlife Conservat Soc Indonesia Program, Bogor, West Java, Indonesia	University of Delaware; Zoological Society of San Diego; Wildlife Conservation Society - Indonesia	Wibisono, HT (corresponding author), Univ Delaware, Coll Agr & Nat Resources, Dept Entomol & Wildlife Ecol, Newark, DE 19716 USA.; Wibisono, HT (corresponding author), San Diego Zoo Inst Conservat Res, Populat Sustainabil, Escondido, CA 92027 USA.; Wibisono, HT (corresponding author), Forum HarimauKita, Bogor, West Java, Indonesia.	beebach66@yahoo.com	Wibisono, Hariyo T/I-7511-2019	Wibisono, Hariyo T/0000-0002-0311-3700	Mohammed Bin Zayed Species Conservation Fund [13256220]; IdeaWild; PT Holchim Indonesia; Fauna & Flora International	Mohammed Bin Zayed Species Conservation Fund; IdeaWild; PT Holchim Indonesia; Fauna & Flora International	Projects in this study were partly funded by the Mohammed Bin Zayed Species Conservation Fund 13256220 (URL: https://www.speciesconservation.org/case-studies-projects/javan-leopard/6220) (EW), IdeaWild for a project titled "Initiating the protection of the last big carnivore of Java at Mount Slamet, Central Java" (HAW), and PT Holchim Indonesia and Fauna & Flora International for a biodiversity conservation planning in Nusakambangan Island (IP, MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Johany AMH, 2007, J ARID ENVIRON, V68, P20, DOI 10.1016/j.jaridenv.2006.04.002; [Anonymous], [No title captured]; Ario A., 2007, JAVAN LEOPARD PANTHE; Ario A., 2009, PROTECTION MONITORIN; Athreya V, 2016, ORYX, V50, P156, DOI 10.1017/S0030605314000106; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Bailey, 1993, AFRICAN LEOPARD ECOL; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Beyer H. L, 2012, GEOSPATIAL MODELLING; Biro Pusat Statistik, 2017, KEP PEND MEN PROP 20; Brashares JS, 2001, P ROY SOC B-BIOL SCI, V268, P2473, DOI 10.1098/rspb.2001.1815; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Chapron G, 2003, SNOW LEOPARD SURVIVA; Clements GR, 2012, INTEGR ZOOL, V7, P400, DOI 10.1111/j.1749-4877.2012.00314.x; Daly B, 2015, LEOPARD PANTHERA PAR, P105, DOI [10.13140/RG.2.1.1148.4649, DOI 10.13140/RG.2.1.1148.4649]; Dar NI, 2009, BIOL CONSERV, V142, P2076, DOI 10.1016/j.biocon.2009.04.003; Dutta T, 2013, DIVERS DISTRIB, V19, P760, DOI 10.1111/ddi.12024; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Erfanian B, 2013, WILDLIFE BIOL, V19, P170, DOI 10.2981/12-045; Evangelista P., 2011, MAXENT MODEL V3 3 3E; Gavashelishvili A, 2008, J APPL ECOL, V45, P579, DOI 10.1111/j.1365-2664.2007.01432.x; Geospatial Untuk Negeri, 2016, PETA RUPA BUMI INDON; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Gunawan H, 2012, PENELIT HUTAN DAN KO, V9, P49; Gunawan H., 2009, J PENELIT HUTAN KONS, VVII, P95; Harihar A, 2011, J APPL ECOL, V48, P806, DOI 10.1111/j.1365-2664.2011.01981.x; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hebblewhite M, 2011, BIOL CONSERV, V144, P2403, DOI 10.1016/j.biocon.2011.03.020; Hemery LG, 2016, DIVERS DISTRIB, V22, P1314, DOI 10.1111/ddi.12490; Hijmans RJ, 2005, MUSEUM VERTEBRATE ZO; IUCN (International Union for Conservation of Nature), 2017, PROT AR CAT; Jackson P., 1996, BIOL CONSERVATION; Jacobson AP, 2016, PEERJ, V4, DOI 10.7717/peerj.1974; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Kautz R, 2006, BIOL CONSERV, V130, P118, DOI 10.1016/j.biocon.2005.12.007; Kitchener A, 2017, CAT NEWS, V80; KLHK, 2016, STRAT DAN RENCANA AK; KLHK, 2011, LAND COV CLASS; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; McCarthy JL, 2015, GLOB ECOL CONSERV, V3, P210, DOI 10.1016/j.gecco.2014.11.009; Miquelle DG, 2015, INTEGR ZOOL, V10, P389, DOI 10.1111/1749-4877.12146; Mugiyono, 2009, PENYUSUNAN DATABASE; Ngoprasert D, 2007, ORYX, V41, P343, DOI 10.1017/S0030605307001102; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Raes N, 2009, ECOGRAPHY, V32, P180, DOI 10.1111/j.1600-0587.2009.05800.x; Rayan DM, 2016, BIOL CONSERV, V204, P360, DOI 10.1016/j.biocon.2016.11.009; Santiapillai C., 1992, TIGER PAPER, V19, P1; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Seidensticker J., 1987, P1; Simcharoen S, 2008, BIOL CONSERV, V141, P2242, DOI 10.1016/j.biocon.2008.06.015; Stein A. B., 2016, IUCN RED LIST THREAT; Sunquist Mel, 1999, P5; Suprapto E, 2010, SEM NAS KONTR PENG E, P1; Swanepoel LH, 2013, ANIM CONSERV, V16, P41, DOI 10.1111/j.1469-1795.2012.00566.x; Swanepoel LH, 2015, ORYX, V49, P595, DOI 10.1017/S0030605313001282; UNEP-WCMC, 2014, CHECKL CIT SPEC; United State Geological Survey, 2017, US DEP INT; Walston J, 2010, AVOIDING UNTHINKABLE; Wang SW, 2006, WILDLIFE SOC B, V34, P359, DOI 10.2193/0091-7648(2006)34[359:FPOCDB]2.0.CO;2; Wang SW, 2006, ENVIRON CONSERV, V33, P148, DOI 10.1017/S0376892906002931; Wang SW, 2009, BIOL CONSERV, V142, P606, DOI 10.1016/j.biocon.2008.11.023; Wibisono HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025931; Wibisono HT, 2012, MANAGING TIGER CONSE, P14	65	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198369	10.1371/journal.pone.0198369	http://dx.doi.org/10.1371/journal.pone.0198369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949588	gold, Green Published, Green Submitted			2022-12-26	WOS:000436549200014
J	Shibabaw, A; Gelaw, B; Wang, SH; Tessema, B				Shibabaw, Agumas; Gelaw, Baye; Wang, Shu-Hua; Tessema, Belay			Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia	PLOS ONE			English	Article							MDR-TB; PREDICTORS; IMPACT	Background Sputum smear and culture conversions are an important indicator of treatment efficacy and help to determine treatment duration in multidrug resistant tuberculosis (MDR-TB) patients. There are no published studies of sputum smear and culture conversion of MDR-TB patients in Ethiopia. The objective of this study is to evaluate and compare time to initial sputum smear and culture conversion and to identify factors influencing time to culture conversion. Methods A retrospective cohort study was conducted among all culture positive and rifampicin mono resistant (RR) or MDR-TB patients from September 2011 to August 2016 at University of Gondar Hospital. Sputum cultures were collected monthly and conversion was defined as two consecutive negative cultures taken at least 30 days apart. Data were entered using EpiData and exported to SPSS software for analysis. Cox proportional hazard model was used to determine the predictor variables for culture conversion. Results Overall, 85.5% (201/235) of the patients converted their cultures in a median of 72 days (inter-quartile range: 44 - 123). More than half (61.7%) of patients achieved culture conversion within three months. The median time for sputum smear conversion was 54 days (interquartile range: 31 - 72). The median time to culture conversion among HIV positive patients was significantly shorter at 67 days (95% CI, 55.4 - 78.6) compared to HIV negative patients, 77 days (95% CI, 63.9 - 90, p = 0.005). Independent predictors of significantly longer time to sputum culture conversion were underweight (aHR = 0.71, 95% CI, 0.52 - 0.97), HIV negative (aHR = 0.66, 95% CI, 0.47 - 0.94) and treatment regimen composition (aHR = 0.57, 95% CI, 0.37 - 0.88). Significantly higher rate of culture conversion was observed in 2015 (aHR = 1.86, 95% CI, 1.1 - 3.14) and in 2016 ( aHR = 3.7, 95% CI, 1.88 - 7.35) years of treatment compared to 2011. Conclusions Majority of patients achieved sputum culture conversion within three months and smear conversion within two months. Patients with identified risk factors were associated with delayed culture conversion. These factors should be considered during management of MDR-TB patients.	[Shibabaw, Agumas; Gelaw, Baye; Tessema, Belay] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Med Microbiol, Gondar, Ethiopia; [Wang, Shu-Hua] Ohio State Univ, Dept Internal Med, Div Infect Dis, Columbus, OH 43210 USA; [Shibabaw, Agumas] Wollo Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Dessie, Ethiopia	University of Gondar; University System of Ohio; Ohio State University	Shibabaw, A (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Med Microbiol, Gondar, Ethiopia.; Shibabaw, A (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Dessie, Ethiopia.	agumas2000@gmail.com	SHIBABAW, AGUMAS/GLV-0652-2022; Tes, Bel/L-3858-2019	SHIBABAW, AGUMAS/0000-0001-6286-7564; 	University of Gondar Mega Project Grant	University of Gondar Mega Project Grant	This work was funded by University of Gondar Mega Project Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basit A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093206; Brust JCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015841; California Department of Public Health Curry International TB Center, 2016, DRUG RES TUB SURV GU; Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Federal Ministry of Health, 2014, DRUG RSIST SURV 2014; Federal Ministry of Health, 2016, GUIDL CLIN PROGR MAN; Gupta KB, 2009, LUNG INDIA, V26, P9, DOI 10.4103/0970-2113.45198; Hafkin J, 2013, INT J TUBERC LUNG D, V17, P348, DOI 10.5588/ijtld.12.0100; Hickson M, 2006, POSTGRAD MED J, V82, P2, DOI 10.1136/pgmj.2005.037564; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Joseph P, 2011, INDIAN J MED RES, V133, P529; kim jamee, 2015, [The Journal of Korean Association of Computer Education, 컴퓨터교육학회 논문지], V18, P11; Kurbatova EV, 2012, INT J TUBERC LUNG D, V16, P1335, DOI 10.5588/ijtld.11.0811; Kurbatova EV, 2015, LANCET RESP MED, V3, P201, DOI 10.1016/S2213-2600(15)00036-3; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Lu P, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01558-2016; Magee MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094890; Park HO, 2016, INFECT CHEMOTHER, V48, P317, DOI 10.3947/ic.2016.48.4.317; Putri FA, 2014, INT J TUBERC LUNG D, V18, P564, DOI 10.5588/ijtld.13.0602; Rieu R, 2016, J ANTIMICROB CHEMOTH, V71, P803, DOI 10.1093/jac/dkv407; Rodriguez M, 2013, INT J TUBERC LUNG D, V17, P520, DOI 10.5588/ijtld.12.0481; Scrimshaw NS, 1997, AM J CLIN NUTR, V66, P464; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shah NS, 2008, JAMA-J AM MED ASSOC, V300, P2153, DOI 10.1001/jama.300.18.2153; Singla R, 2009, INT J TUBERC LUNG D, V13, P976; Tierney DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108035; Velayutham B, 2016, INT J TUBERC LUNG D, V20, P1671, DOI 10.5588/ijtld.16.0096; WHO, 2016, GLOB TUB REP	30	26	27	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0198080	10.1371/journal.pone.0198080	http://dx.doi.org/10.1371/journal.pone.0198080			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944658	Green Submitted, Green Published, gold			2022-12-26	WOS:000436377800005
J	Hattermann, D; Bernhardt-Romermann, M; Otte, A; Eckstein, RL				Hattermann, Dirk; Bernhardt-Roemermann, Markus; Otte, Annette; Eckstein, Rolf Lutz			New insights into island vegetation composition and species diversity-Consistent and conditional responses across contrasting insular habitats at the plot-scale	PLOS ONE			English	Article							PLANT DIVERSITY; VASCULAR PLANTS; LAND-USE; ENVIRONMENTAL-FACTORS; DISTRIBUTION PATTERNS; FINNISH ARCHIPELAGO; LANDSCAPE STRUCTURE; LOCAL FACTORS; RICHNESS; MANAGEMENT	Most island-ecology studies focus on the properties of entire island communities, thus neglecting species-environment relationships operating at the habitat-level. Habitat-specific variation in the strength and sign of these relationships will conceal patterns observed on the island scale and may preclude a mechanistic interpretation of patterns and processes. Habitat-specific species-environment relationships may also depend on the descriptor of ecological communities. This paper presents a comprehensive plot-based analysis of local vegetation composition and species diversity (species richness and species evenness) of (i) rocky shore, (ii) semi-natural grassland and (iii) coniferous forest habitats in three Baltic archipelagos in Sweden. To identify differences and consistencies between habitats and descriptors, we assessed the relative contributions of the variable-sets "region", "topography", "soil morphology", "soil fertility", "soil water", "light availability", "distance" and "island configuration" on local vegetation composition, species richness and species evenness. We quantified the impact of "management history" on the descriptors of local grassland communities by a newly introduced grazing history index (GHI). Unlike species diversity, changes in vegetation composition were related to most of the variable-sets. The relative contributions of the variable-sets were mostly habitat-specific and strongly contingent on the descriptor involved. Within each habitat, richness and evenness were only partly affected by the same variable-sets, and if so, their relative contribution varied between diversity proxies. Across all habitats, soil variable-sets showed highly consistent effects on vegetation composition and species diversity and contributed most to the variance explained. GHI was a powerful predictor, explaining high proportions of variation in all three descriptors of grassland species communities. The proportion of unexplained variance was habitat-specific, possibly reflecting a community maturity gradient. Our results reveal that species richness alone is an incomplete representation of local species diversity. Finally, we stress the need of including habitat-based approaches when analyzing complex species-environment relationships on islands.	[Hattermann, Dirk; Otte, Annette] Justus Liebig Univ, Inst Landscape Ecol & Resource Management, Res Ctr Biosystems Land Use & Nutr IFZ, Giessen, Germany; [Bernhardt-Roemermann, Markus] Friedrich Schiller Univ, Inst Ecol, Jena, Germany; [Eckstein, Rolf Lutz] Karlstad Univ, Dept Environm & Life Sci Biol, Karlstad, Sweden	Justus Liebig University Giessen; Friedrich Schiller University of Jena; Karlstad University	Hattermann, D (corresponding author), Justus Liebig Univ, Inst Landscape Ecol & Resource Management, Res Ctr Biosystems Land Use & Nutr IFZ, Giessen, Germany.	Dirk.Hattermann@umwelt.uni-giessen.de	Eckstein, Lutz/A-9241-2012; Bernhardt-Römermann, Markus/B-3027-2009	Bernhardt-Römermann, Markus/0000-0002-2740-2304	Deutsche Forschungsgemeinschaft (German Research Foundation) [EC 209/12-1, BE 4143/5-1]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation, www.dfg.de, EC 209/12-1 and BE 4143/5-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aavik T, 2008, J VEG SCI, V19, P475, DOI 10.3170/2008-8-18380; Aggemyr E, 2012, J BIOGEOGR, V39, P1645, DOI 10.1111/j.1365-2699.2012.02733.x; Barton K, 2015, MUMIN MULTIMODEL INT; Bernes C., 2011, BIODIVERSITY SWEDEN; Bernhardt-Romermann M, 2011, J APPL ECOL, V48, P1088, DOI 10.1111/j.1365-2664.2011.01968.x; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bock CE, 2007, ECOLOGY, V88, P1322, DOI 10.1890/06-0654; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE G; BUCKLEY RC, 1985, J BIOGEOGR, V12, P527, DOI 10.2307/2844908; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cooper A, 1997, J BIOGEOGR, V24, P483, DOI 10.1111/j.1365-2699.1997.00128.x; Corlett Richard T., 2016, Plant Diversity, V38, P10, DOI 10.1016/j.pld.2016.01.001; Cousins SAO, 2002, LANDSCAPE ECOL, V17, P517, DOI 10.1023/A:1021400513256; Cousins SAO, 2009, BIOL CONSERV, V142, P2752, DOI 10.1016/j.biocon.2009.07.001; Crawley MJ, 2013, R BOOK, P557; DESHAYE J, 1988, J BIOGEOGR, V15, P747, DOI 10.2307/2845337; DIEKMANN M, 1995, ECOGRAPHY, V18, P178, DOI 10.1111/j.1600-0587.1995.tb00339.x; Dupre C, 2002, J ECOL, V90, P796, DOI 10.1046/j.1365-2745.2002.00717.x; Ekebom J, 2003, ESTUAR COAST SHELF S, V57, P887, DOI 10.1016/S0272-7714(02)00419-5; Ekstam U, 1992, IF GRASSLAND MANAGEM; Ellenberg H, 2001, ZEIGERWERTE PFLANZEN, V3rd ed; Ellis JC, 2006, J ANIM ECOL, V75, P565, DOI 10.1111/j.1365-2656.2006.01077.x; Fleming-Lehtinen V, 2015, ECOL INDIC, V48, P380, DOI 10.1016/j.ecolind.2014.08.022; Froberg L., 2006, BLEKINGES FLORA; Gaston Kevin J., 2004, BIODIVERSITY INTRO; Glazkova E. A., 2009, Botanicheskii Zhurnal, V94, P989; GUREVITCH J, 2006, ECOLOGY PLANTS; GUSTAFSSON L, 1994, ECOGRAPHY, V17, P39, DOI 10.1111/j.1600-0587.1994.tb00075.x; Gustavsson E, 2007, BIOL CONSERV, V138, P47, DOI 10.1016/j.biocon.2007.04.004; Halle, 2013, ASSEMBLY RULES RESTO; Hannus JJ, 2008, J BIOGEOGR, V35, P1077, DOI 10.1111/j.1365-2699.2007.01862.x; He MZ, 2007, J ARID ENVIRON, V69, P473, DOI 10.1016/j.jaridenv.2006.10.005; Honnay O, 1999, BIOL CONSERV, V87, P73, DOI 10.1016/S0006-3207(98)00038-X; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; Iliadou E, 2014, J BIOL RES-THESSALON, V21, P1, DOI 10.1186/2241-5793-21-16; JARVINEN O, 1987, ANN ZOOL FENN, V24, P249; Jerling L, 2001, SVEN BOT TIDSKR, P212; Jerling L, 1999, SWEDISH PLANT GEOGRA, V84, P169; JOHANNESSON K, 1989, OIKOS, V54, P77, DOI 10.2307/3565899; Johnson M., 1974, J BIOGEOGR, V1, P149, DOI DOI 10.2307/3037964; KADMON R, 1993, ECOLOGY, V74, P977, DOI 10.2307/1940467; Kargar-Chigani H, 2017, J ARID LAND, V9, P161, DOI 10.1007/s40333-017-0050-2; Klimek S, 2007, BIOL CONSERV, V134, P559, DOI 10.1016/j.biocon.2006.09.007; KOHN DD, 1994, J ECOL, V82, P367, DOI 10.2307/2261304; Kuznetsova A., 2016, LMERTEST TESTS LINEA; Lantmateriet, 2015, SPOT 5 SAT IM SWED N; Lofgren A, 2002, FOLIA GEOBOT, V37, P297, DOI 10.1007/BF02805213; Losos JB, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P1; Ma M, 2005, OIKOS, V111, P192, DOI 10.1111/j.0030-1299.2005.13049.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Malhotra A, 2007, NOAA TECH MEMO NOS N, V65, P28; MANNY BA, 1994, HYDROBIOLOGIA, V279, P121, DOI 10.1007/BF00027847; Marini L, 2007, AGR ECOSYST ENVIRON, V119, P281, DOI 10.1016/j.agee.2006.07.015; Matthews JW, 2009, ECOL APPL, V19, P2108, DOI 10.1890/08-1836.1; Mazerolle MJ, 1999, ECOSCIENCE, V6, P117, DOI 10.1080/11956860.1999.11952204; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McMaster RT, 2005, J BIOGEOGR, V32, P475, DOI 10.1111/j.1365-2699.2004.01200.x; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; OKLAND RH, 1994, J VEG SCI, V5, P117, DOI 10.2307/3235645; Okland RH, 2006, LANDSCAPE ECOL, V21, P969, DOI 10.1007/s10980-006-0005-z; Pfadenhauer J., 1986, BER ANL, V10, P41; Raatikainen KM, 2007, PLANT ECOL, V189, P155, DOI 10.1007/s11258-006-9172-x; Reitalu T, 2009, BIOL CONSERV, V142, P899, DOI 10.1016/j.biocon.2008.12.020; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; Ricklefs RE, 2016, P NATL ACAD SCI USA, V113, P674, DOI 10.1073/pnas.1523683113; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schmucki R, 2012, J ECOL, V100, P1164, DOI 10.1111/j.1365-2745.2012.01988.x; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Stirling G, 2001, AM NAT, V158, P286, DOI 10.1086/321317; Sundblad G, 2014, AMBIO, V43, P1020, DOI 10.1007/s13280-014-0522-y; Swedish Meteorological and Hydrological Institute (SMHI), 2015, CLIM INF MAIN DRAIN; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Thiele J, 2010, J VEG SCI, V21, P213, DOI 10.1111/j.1654-1103.2009.01139.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tyler G, 1996, VEGETATIO, V127, P215, DOI 10.1007/BF00044642; von Numers M, 1998, GLOBAL ECOL BIOGEOGR, V7, P421, DOI 10.2307/2997713; von Numers M, 2007, ECOGRAPHY, V30, P789, DOI 10.1111/j.2007.0906-7590.05053.x; von Numers M, 2011, ANN BOT FENN, V48, P1; Walker JS, 2009, FRONT ECOL ENVIRON, V7, P465, DOI 10.1890/080084; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Wilsey BJ, 2005, ECOLOGY, V86, P1178, DOI 10.1890/04-0394; Wilsey B, 2007, PLANT ECOL, V190, P259, DOI 10.1007/s11258-006-9206-4; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049024	85	7	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200191	10.1371/journal.pone.0200191	http://dx.doi.org/10.1371/journal.pone.0200191			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979739	Green Published, gold			2022-12-26	WOS:000437809500075
J	Zheng, LP; He, Y; Yang, JX; Wu, LB				Zheng, Lan-Ping; He, You; Yang, Jun-Xing; Wu, Lun-Biao			A new genus and species of Labeonini (Teleostei: Cyprinidae) from the Pearl River in China	PLOS ONE			English	Article							GUANGXI; CYPRINIFORMES; FISH; PARASINILABEO; PHYLOGENY; NUCLEAR	Zuojiangia jingxiensis, both a new genus and species, is described from the Pearl River in China. It is distinguished from all other genera and species of Labeonini by the unique combination of modified oromandibular structures and head skeleton: a well-developed, pendulous, and conspicuously arched rostral fold, with an entirely crenulated margin; prominent papillae densely covering the margin of the rostral fold and anterior part of the lower lip; long postlabial grooves, partitioning the lower lip into three parts; transverse branch of dentary longer than half the length of the longitudinal branch; stubby lateral process present at the anterolateral margin of the longitudinal branch of the dentary, close to the corner; in the upper jaw, the premaxilla bears a triangular ascending process tapering to a point; maxilla exhibits a pair of articular heads at the anterodorsal margin, and a distinct fingerlike descending process posterior to the medial articular head embracing the ascending process of the premaxilla.	[Zheng, Lan-Ping; Yang, Jun-Xing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [He, You] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai Synchrotron Radiat Facil, Shanghai, Peoples R China; [Wu, Lun-Biao] Fishery Bur Beiliu City, Beiliu, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Yang, JX (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	yangjx@mail.kiz.ac.cn			National Natural Science Foundation of China [31201707, 31672250]; CAS "Light of West China" Program; State Key Laboratory of Genetic Resources and Evolution [GREKF16-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS "Light of West China" Program; State Key Laboratory of Genetic Resources and Evolution	This work was supported by National Natural Science Foundation of China (31201707) [http://www.nsfc.gov.cn/], and CAS "Light of West China" Program to LPZ; National Natural Science Foundation of China (31672250) [http://www.nsfc.gov.cn/], and State Key Laboratory of Genetic Resources and Evolution (GREKF16-06) to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chu X., 1989, P1; Ciccotto PJ, 2016, ZOOTAXA, V4127, P471, DOI 10.11646/zootaxa.4127.3.4; He AY, 2015, ICHTHYOL EXPLOR FRES, V25, P299; He You, 2013, Zoological Research, V34; Huang Yan-Fei, 2007, Zoological Research, V28, P531; Huang YF, 2014, ZOOTAXA, V3793, P379, DOI 10.11646/zootaxa.3793.3.6; Kottelat M., 2001, FRESHWATER FISHES NO, P1; Roberts TR., 1989, FRESHWATER FISHES W, P1; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, P1, DOI DOI 10.1007/BF02198856; Yang L, 2012, MOL PHYLOGENET EVOL, V65, P362, DOI 10.1016/j.ympev.2012.06.007; Yang L, 2010, MOL PHYLOGENET EVOL, V54, P254, DOI 10.1016/j.ympev.2009.09.027; Zhang E, 2008, ZOOTAXA, P33, DOI 10.11646/zootaxa.1682.1.3; Zhang E, 2004, HYDROBIOLOGIA, V527, P25, DOI 10.1023/B:HYDR.0000043315.64357.da; Zhang E., 2000, Ichthyological Exploration of Freshwaters, V11, P265; Zheng LP, 2016, ZOOKEYS, P133, DOI 10.3897/zookeys.612.9085; Zheng LP, 2016, ICHTHYOL EXPLOR FRES, V26, P299; Zheng LP, 2010, ZOOL SCR, V39, P559, DOI 10.1111/j.1463-6409.2010.00441.x; Zheng LP, 2010, ENVIRON BIOL FISH, V87, P93, DOI 10.1007/s10641-009-9555-7; Zheng LP, 2012, CURR ZOOL, V58, P837, DOI 10.1093/czoolo/58.6.837; Zhu DG, 2012, ZOOTAXA, P55; Zhu Yu, 2006, Acta Hydrobiologica Sinica, V30, P503; Zhu Y, 2011, ZOOTAXA, P39	22	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199973	10.1371/journal.pone.0199973	http://dx.doi.org/10.1371/journal.pone.0199973			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979725	Green Published, gold, Green Submitted			2022-12-26	WOS:000437809500045
J	Maraba, N; Hoffmann, CJ; Chihota, VN; Chang, LW; Ismail, N; Candy, S; Madibogo, E; Katzwinkel, M; Churchyard, GJ; McCarthy, K				Maraba, Noriah; Hoffmann, Christopher J.; Chihota, Violet N.; Chang, Larry W.; Ismail, Nazir; Candy, Sue; Madibogo, Edwin; Katzwinkel, Marc; Churchyard, Gavin J.; McCarthy, Kerrigan			Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot study	PLOS ONE			English	Article							INFECTION; START; CARE	Background Tuberculosis (TB) incidence in South Africa is among the highest globally. Initial loss to follow-up (ILFU), defined as not starting on TB treatment within 28 days of testing positive, is undermining control efforts. We assessed the feasibility, acceptability, and potential of a mHealth application to reduce ILFU. Methods An mHealth application was developed to capture patients TB investigation data, provide results and monitor treatment initiation. This was implemented in two primary health clinics (PHC) in inner-city Johannesburg. Feasibility was assessed by comparing documentation of personal details, specimen results for same individuals during implementation period (paper register and Mhealth application). Effectiveness was assessed by comparing proportion of patients with results within 48 hours, and proportion started on treatment within 28 days of testing TB positive during pre- implementation (paper register) and implementation (mHealth application) periods. In-depth interviews with patients and providers were conducted to assess acceptability of application. Results Pre-implementation, 457 patients were recorded in paper registers [195 (42.7%) male, median age 34 years (interquartile range IQR (28-40), 45 (10.5%) sputum Xpert positive]. During implementation, 319 patients were recorded in paper register and the mHealth application [131 (41.1%) male, median age 32 years (IQR 27-38), 33 (10.3%) sputum Xpert positive]. The proportion with complete personal details: [mHealth 95.0% versus paper register 94.0%, (p = 0.54)] and proportion with documented results: [mHealth 97.4% versus paper register 97.8%, (p = 0.79)] were not different in the two methods. The proportion of results available within 48 hours: [mHealth 96.8% versus paper register 68.6%), (p < 0.001)], and the proportion on treatment within 28 days [mHealth 28/33 (84.8%) versus paper register 30/44 (68.2%), (p = 0.08)] increased during implementation but was not statistically significant. In-depth interviews showed that providers easily integrated the mHealth application into routine TB investigation and patients positively received the delivery of results via text message. Time from sputum collection to TB treatment initiation decreased from 4 days (pre-implementation) to 3 days but was not statistically significant. Conclusions We demonstrated that implementation of the mHealth application was feasible, acceptable to health care providers and patients, and has potential to reduce the time to TB treatment initiation and ILFU in PHC settings.	[Maraba, Noriah; Hoffmann, Christopher J.; Chihota, Violet N.; Churchyard, Gavin J.; McCarthy, Kerrigan] Aurum Inst, Johannesburg, South Africa; [Maraba, Noriah; Chihota, Violet N.; Churchyard, Gavin J.; McCarthy, Kerrigan] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Hoffmann, Christopher J.; Chang, Larry W.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Ismail, Nazir; Candy, Sue; McCarthy, Kerrigan] Natl Inst Communicable Dis, Johannesburg, South Africa; [Madibogo, Edwin] City Johannesburg, Dept Hlth & Social Dev, Johannesburg, South Africa; [Katzwinkel, Marc] Mobenzi, Cape Town, South Africa; [Churchyard, Gavin J.] South African Med Res Council Collaborating Ctr H, Adv Treatment & Care TB&HIV, Johannesburg, South Africa; [Churchyard, Gavin J.] London Sch Trop & Hyg Med, London, England; [Maraba, Noriah] Fdn Innovat New Diagnost, Geneva, Switzerland	University of Witwatersrand; Johns Hopkins University; National Institute for Communicable Diseases (NICD); Foundation For Innovative New Diagnostics	Maraba, N (corresponding author), Aurum Inst, Johannesburg, South Africa.; Maraba, N (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.; Maraba, N (corresponding author), Fdn Innovat New Diagnost, Geneva, Switzerland.	nmaraba@auruminstitute.org	Chihota, Violet/DWH-9372-2022	McCarthy, Kerrigan/0000-0001-8958-9795; Chihota, Violet/0000-0003-1444-9266; Churchyard, Gavin/0000-0002-4269-3699; Hoffmann, Christopher/0000-0002-9422-0519	Fogarty International Center of the National Institutes of Health [5R21TW009894]; Mobenzi, South Africa; FOGARTY INTERNATIONAL CENTER [R21TW009894] Funding Source: NIH RePORTER	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Mobenzi, South Africa; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Research reported in this publication was supported by the Fogarty International Center of the National Institutes of Health (5R21TW009894) https://www.fic.nih.gov/Pages/Default.aspx. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KM received funding for this research. M. Katzwinkel is employed by Mobenzi, South Africa who were contracted and paid as a vendor to develop and maintain the mHealth application. Mobenzi, South Africa provided support in the form of salary for author MK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ansbro EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127728; Asiimwe C, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-5; Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P603, DOI 10.5588/ijtld.12.0505; Gurol-Urganci I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007456.pub2; Hirsch-Moverman Y, 2017, JAIDS-J ACQ IMM DEF, V74, pS37, DOI 10.1097/qai.0000000000001202; Jian WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044462; MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800; May C, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-148; Menon-Johansson AS, 2006, SEX TRANSM INFECT, V82, P49, DOI 10.1136/sti.2004.014381; Murray E, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-63; Mwansa-Kambafwile J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168659; Siedner MJ, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3859; Siedner MJ, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-56; South Africa National Department of Health, 2014, TUB MAN GUID; Wood R, 2010, CLIN INFECT DIS, V51, P401, DOI 10.1086/655129; World Health Organization, 2020, GLOBAL TUBERCULOSIS	18	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199687	10.1371/journal.pone.0199687	http://dx.doi.org/10.1371/journal.pone.0199687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969486	Green Submitted, Green Published, gold			2022-12-26	WOS:000437246700022
J	Siebers, M; Rohr, T; Ventura, M; Schutz, V; Thies, S; Kovacic, F; Jaeger, KE; Berg, M; Dormann, P; Schulz, M				Siebers, Meike; Rohr, Thomas; Ventura, Marina; Schuetz, Vadim; Thies, Stephan; Kovacic, Filip; Jaeger, Karl-Erich; Berg, Martin; Doermann, Peter; Schulz, Margot			Disruption of microbial community composition and identification of plant growth promoting microorganisms after exposure of soil to rapeseed-derived glucosinolates	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; FATTY-ACID-COMPOSITION; SP NOV.; BACTERIAL; DEGRADATION; IMPACT; RHIZOBACTERIA; BIOSYNTHESIS; PRODUCTIVITY; BIODIVERSITY	Land plants are engaged in intricate communities with soil bacteria and fungi indispensable for plant survival and growth. The plant-microbial interactions are largely governed by specific metabolites. We employed a combination of lipid-fingerprinting, enzyme activity assays, high-throughput DNA sequencing and isolation of cultivable microorganisms to uncover the dynamics of the bacterial and fungal community structures in the soil after exposure to isothiocyanates (ITC) obtained from rapeseed glucosinolates. Rapeseed-derived ITCs, including the cyclic, stable goitrin, are secondary metabolites with strong allelopathic affects against other plants, fungi and nematodes, and in addition can represent a health risk for human and animals. However, the effects of ITC application on the different bacterial and fungal organisms in soil are not known in detail. ITCs diminished the diversity of bacteria and fungi. After exposure, only few bacterial taxa of the Gammaproteobacteria, Bacteriodetes and Acidobacteria proliferated while Trichosporon (Zygomycota) dominated the fungal soil community. Many surviving microorganisms in ITC-treated soil where previously shown to harbor plant growth promoting properties. Cultivable fungi and bacteria were isolated from treated soils. A large number of cultivable microbial strains was capable of mobilizing soluble phosphate from insoluble calcium phosphate, and their application to Arabidopsis plants resulted in increased biomass production, thus revealing growth promoting activities. Therefore, inclusion of rapeseed-derived glucosinolates during biofumigation causes losses of microbiota, but also results in enrichment with ITC-tolerant plant microorganisms, a number of which show growth promoting activities, suggesting that Brassicaceae plants can shape soil microbiota community structure favoring bacteria and fungi beneficial for Brassica plants.	[Siebers, Meike; Rohr, Thomas; Ventura, Marina; Schuetz, Vadim; Doermann, Peter; Schulz, Margot] Univ Bonn, Inst Mol Physiol & Biotechnol Plants IMBIO, Bonn, Germany; [Thies, Stephan; Kovacic, Filip; Jaeger, Karl-Erich] Heinrich Heine Univ Dusseldorf, Forschungszentrum Julich, Inst Mol Enzyme Technol, Julich, Germany; [Jaeger, Karl-Erich] Forschungszentrum Julich, Inst Bio & Geosci IBG Biotechnol 1, Julich, Germany; [Berg, Martin] Univ Bonn, Inst Organ Agr, Bonn, Germany; [Berg, Martin] Univ Bonn, Expt Farm Wiesengut, Hennef, Germany	University of Bonn; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; University of Bonn; University of Bonn	Dormann, P (corresponding author), Univ Bonn, Inst Mol Physiol & Biotechnol Plants IMBIO, Bonn, Germany.	doermann@uni-bonn.de	jaeger, karl/ABB-1955-2020; Thies, Stephan/H-3749-2015; Kovacic, Filip/ABG-7585-2020; Filip, Kovacic/GRJ-3538-2022	Thies, Stephan/0000-0003-4240-9149; Filip, Kovacic/0000-0002-0313-427X; Rohr, Thomas/0000-0002-5856-0620; Dormann, Peter/0000-0002-5845-9370	BioScience Center Northrhine Westphalia BioSC [313/323-400-00213]; University of Bonn; Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence [EXC1028]	BioScience Center Northrhine Westphalia BioSC; University of Bonn; Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence(German Research Foundation (DFG))	This work was supported by the BioScience Center Northrhine Westphalia BioSC 313/323-400-00213 to MS, the University of Bonn, and Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence EXC1028 to K-EJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. P. Narf (University of Rostock) for valuable comments on soil handling. This work was supported by the BioScience Center Northrhine Westphalia BioSC 313/323-400-00213 to MS, the University of Bonn, and Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence EXC1028 to K-EJ.	Ahuja I, 2011, SUSTAINABLE AGRICULTURE, VOL 2, P623, DOI 10.1007/978-94-007-0394-0_28; Albaser A, 2016, J AGR FOOD CHEM, V64, P1520, DOI 10.1021/acs.jafc.5b05381; Alvarez-Ordonez A, 2008, INT J FOOD MICROBIOL, V123, P212, DOI 10.1016/j.ijfoodmicro.2008.01.015; Ambrosini A, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00245-15; [Anonymous], 2004, AGROINDUSTRIA; Becker D, 1997, LIEBIGS ANN-RECL, P767; Berg G, 2016, J EXP BOT, V67, P995, DOI 10.1093/jxb/erv466; Bitas V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01248; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOEDIJN K. B., 1959, MYCOPATH ET MYCOL APPL, V11, P354, DOI 10.1007/BF02089508; Bressan M, 2009, ISME J, V3, P1243, DOI 10.1038/ismej.2009.68; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Calmes B, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0462-0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carini P, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.242; CHAO A, 1984, SCAND J STAT, V11, P265; Chen F, 2013, INT J MOL SCI, V14, P17477, DOI 10.3390/ijms140917477; Chung EJ, 2012, INT J SYST EVOL MICR, V62, P3030, DOI 10.1099/ijs.0.036442-0; Cole BJ, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002860; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; DOWNEY RK, 1969, J AM OIL CHEM SOC, V46, P121, DOI 10.1007/BF02635712; Fang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048006; Fornasier F, 2011, SSSA BOOK S, V9, P371, DOI 10.2136/sssabookser9.c16; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Gao Y, 2015, AGR SCI, V3, P1, DOI [10.12735/as.v3i2p01, DOI 10.12735/AS.V3I2P01]; Gasulla F, 2013, PLANT J, V75, P726, DOI 10.1111/tpj.12241; Geiger O, 2013, BBA-MOL CELL BIOL L, V1831, P503, DOI 10.1016/j.bbalip.2012.08.009; Geiser DM, 2013, PHYTOPATHOLOGY, V103, P400, DOI 10.1094/PHYTO-07-12-0150-LE; Graber ER, 2010, PLANT SOIL, V337, P481, DOI 10.1007/s11104-010-0544-6; Grosser K, 2017, JOVE-J VIS EXP, DOI 10.3791/55425; Hausmann S, 2008, FEMS MICROBIOL LETT, V282, P65, DOI 10.1111/j.1574-6968.2008.01107.x; Herens KF-J, 2001, PLANT PHYSIOL, V125, P1688, DOI [10.1104/pp.125.4.1688, DOI 10.1104/PP.125.4.1688]; Hilton S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059859; Hollister EB, 2013, FEMS MICROBIOL ECOL, V83, P632, DOI 10.1111/1574-6941.12020; Hu Ping, 2014, Front Microbiol, V5, P729, DOI 10.3389/fmicb.2014.00729; HUBER J, 1983, NAHRUNG, V27, P257, DOI 10.1002/food.19830270319; HUG LA, 2016, NAT MICROBIOL, V1, DOI DOI 10.1038/NMICR0BIOL.2016.48; Ibekwe AM, 1998, FEMS MICROBIOL ECOL, V26, P151, DOI 10.1111/j.1574-6941.1998.tb00501.x; Ivanova EG, 2001, MICROBIOLOGY+, V70, P392, DOI 10.1023/A:1010469708107; Jaeger KE, 2014, METHODS MOL BIOL, V1149, P111, DOI 10.1007/978-1-4939-0473-0_12; Joergensen RG, 2008, SOIL BIOL BIOCHEM, V40, P2977, DOI 10.1016/j.soilbio.2008.08.017; Jorgensen ME, 2015, TRENDS PLANT SCI, V20, P508, DOI 10.1016/j.tplants.2015.04.006; Jousset A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600124; JURKOVA M, 1993, FEMS MICROBIOL LETT, V111, P245, DOI 10.1111/j.1574-6968.1993.tb06393.x; Kaiser C, 2010, SOIL BIOL BIOCHEM, V42, P1650, DOI 10.1016/j.soilbio.2010.05.019; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kennedy IR, 2004, SOIL BIOL BIOCHEM, V36, P1229, DOI 10.1016/j.soilbio.2004.04.006; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; Kottb M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00995; Kovacic F, 2016, FEBS OPEN BIO, V6, P484, DOI 10.1002/2211-5463.12061; Kruse J, 2015, J PLANT NUTR SOIL SC, V178, P43, DOI 10.1002/jpln.201400327; Lankau RA, 2012, P NATL ACAD SCI USA, V109, P11240, DOI 10.1073/pnas.1201343109; Lankau RA, 2011, OECOLOGIA, V165, P453, DOI 10.1007/s00442-010-1736-8; Lareen A, 2016, PLANT MOL BIOL, V90, P575, DOI 10.1007/s11103-015-0417-8; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lee CS, 2010, INT J SYST EVOL MICR, V60, P281, DOI 10.1099/ijs.0.013367-0; Lee S, 2012, J MICROBIOL, V50, P45, DOI 10.1007/s12275-012-1415-z; Lopez-Bucio J, 2007, MOL PLANT MICROBE IN, V20, P207, DOI 10.1094/MPMI-20-2-0207; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lupatini M, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02064; Ma MC, 2011, J BACTERIOL, V193, P311, DOI 10.1128/JB.01234-10; Madhaiyan M, 2010, INT J SYST EVOL MICR, V60, P2490, DOI 10.1099/ijs.0.015487-0; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; Neal AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035498; Nie M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09212; Nieto-Jacobo MF, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00102; Ogbo F., 2012, ADV MICROBIOL, V2, P368, DOI DOI 10.4236/AIM.2012.23046; Omirou M, 2011, MICROB ECOL, V61, P201, DOI 10.1007/s00248-010-9740-4; Page AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132062; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Robinson S, 2002, LANGMUIR, V18, P8743, DOI 10.1021/la020376l; Schubert K, 2007, STUD MYCOL, P105, DOI 10.3114/sim.2007.58.05; Sgroy V, 2009, APPL MICROBIOL BIOT, V85, P371, DOI 10.1007/s00253-009-2116-3; Sitkiewicz I, 2007, TRENDS MICROBIOL, V15, P63, DOI 10.1016/j.tim.2006.12.003; Smolinska U, 2003, PLANT DIS, V87, P407, DOI 10.1094/PDIS.2003.87.4.407; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Stursova M, 2014, ISME J, V8, P1920, DOI 10.1038/ismej.2014.37; TANI N, 1974, AGR BIOL CHEM TOKYO, V38, P1617, DOI 10.1080/00021369.1974.10861387; Turner TR, 2013, ISME J, V7, P2248, DOI 10.1038/ismej.2013.119; Tyson KS, 2005, NAT RENEW EN LABOR S, P1; van Dam NM, 2009, PHYTOCHEM REV, V8, P171, DOI 10.1007/s11101-008-9101-9; VARNAITE R, 2008, EKOLOGIYA, V54, P169, DOI DOI 10.2478/V10055-008-0026-9; Velasco P, 2008, J AM SOC HORTIC SCI, V133, P551, DOI 10.21273/JASHS.133.4.551; vom Dorp K, 2015, PLANT CELL, V27, P2846, DOI 10.1105/tpc.15.00395; Vuorela S, 2003, EUR FOOD RES TECHNOL, V217, P517, DOI 10.1007/s00217-003-0811-3; Wathelet JP, 1991, CERTIFICATION TOTAL, P1; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; White DC, 1996, J IND MICROBIOL, V17, P185, DOI 10.1007/BF01574692; WHITE DC, 1993, PHILOS T ROY SOC A, V344, P59, DOI 10.1098/rsta.1993.0075; Wittstock U., 2010, Arabidopsis Book, V8, pe0134, DOI 10.1199/tab.0134; Xie XG, 2016, FUNGAL BIOL-UK, V120, P402, DOI 10.1016/j.funbio.2015.11.010; Yasumoto S, 2010, PLANT PROD SCI, V13, P150, DOI 10.1626/pps.13.150; Yildirim E, 2011, HORTSCIENCE, V46, P932, DOI 10.21273/HORTSCI.46.6.932; Yu D, 2016, ANIM NUTR, V2, P57, DOI 10.1016/j.aninu.2016.02.002; Yurkov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120400; Zhang YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158351	99	34	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0200160	10.1371/journal.pone.0200160	http://dx.doi.org/10.1371/journal.pone.0200160			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969500	gold, Green Published			2022-12-26	WOS:000437246700050
J	Hartana, CA; Bergman, EA; Zirakzadeh, AA; Krantz, D; Winerdal, ME; Winerdal, M; Johansson, M; Alamdari, F; Jakubczyk, T; Glise, H; Riklund, K; Sherif, A; Winqvist, O				Hartana, Ciputra Adijaya; Bergman, Emma Ahlen; Zirakzadeh, A. Ali; Krantz, David; Winerdal, Malin E.; Winerdal, Max; Johansson, Markus; Alamdari, Farhood; Jakubczyk, Tomasz; Glise, Hans; Riklund, Katrine; Sherif, Amir; Winqvist, Ola			Urothelial bladder cancer may suppress perforin expression in CD8(+) T cells by an ICAM-1/TGF beta 2 mediated pathway	PLOS ONE			English	Article							DRAINING LYMPH-NODES; TGF-BETA; TUMOR MICROENVIRONMENT; EFFECTOR; PD-1; LYMPHOCYTES; GRANZYMES; GRANULES; TISSUE; AXIS	The immune system plays a significant role in urothelial bladder cancer (UBC) progression, with CD8(+) T cells being capable to directly kill tumor cells using perforin and granzymes. However, tumors avoid immune recognition by escape mechanisms. In this study, we aim to demonstrate tumor immune escape mechanisms that suppress CD8(+) T cells cytotoxicity. 42 patients diagnosed with UBC were recruited. CD8(+) T cells from peripheral blood (PB), sentinel nodes (SN), and tumor were analyzed in steady state and in vitro-stimulated conditions by flow cytometry, RT-qPCR, and ELISA. Mass spectrometry (MS) was used for identification of proteins from UBC cell line culture supernatants. Perforin was surprisingly found to be low in CD8(+) T cells from SN, marked by 1.8-fold decrease of PRF1 expression, with maintained expression of granzyme B. The majority of perforin-deficient CD8(+) T cells are effector memory T (T-EM) cells with exhausted Tc2 cell phenotype, judged by the presence of PD-1 and GATA-3. Consequently, perforin-deficient CD8(+) T cells from SN are low in T-bet expression. Supernatant from muscle invasive UBC induces perforin deficiency, a mechanism identified by MS where ICAM-1 and TGF beta 2 signaling were causatively validated to decrease perforin expression in vitro. Thus, we demonstrate a novel tumor escape suppressing perforin expression in CD8(+) T cells mediated by ICAM-1 and TGF beta 2, which can be targeted in combination for cancer immunotherapy.	[Hartana, Ciputra Adijaya; Bergman, Emma Ahlen; Zirakzadeh, A. Ali; Krantz, David; Winerdal, Malin E.; Winerdal, Max; Glise, Hans; Winqvist, Ola] Karolinska Inst, Dept Med Solna, Unit Immunol & Allergy, Stockholm, Sweden; [Zirakzadeh, A. Ali; Sherif, Amir] Umea Univ Hosp, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Johansson, Markus] Sundsvall Hosp, Dept Urol, Sundsvall, Sweden; [Alamdari, Farhood] Vastmanland Hosp, Dept Urol, Vasteras, Sweden; [Jakubczyk, Tomasz] Lanssjukhuset Ryhov, Dept Urol, Jonkoping, Sweden; [Riklund, Katrine] Umea Univ, Dept Radiat Sci, Umea, Sweden	Karolinska Institutet; Umea University; Vasteras Central Hospital; Umea University	Hartana, CA (corresponding author), Karolinska Inst, Dept Med Solna, Unit Immunol & Allergy, Stockholm, Sweden.	ciputra.adijaya.hartana@ki.se		Ahlen Bergman, Emma/0000-0002-6957-7129; Alamdari, Farhood/0000-0003-3589-7789; Hartana, Ciputra/0000-0001-5443-8292; Riklund, Katrine/0000-0001-5227-8117; Sherif, Amir/0000-0002-3675-3050; winqvist, Ola/0000-0003-0842-4441	Swedish Cancer Society (Cancerfonden); Center for Immune Modulatory Therapies for Autoimmunity and Cancer (IMTAC-Sweden); Regional Research Council in Uppsala-Orebro, Sweden; Swedish Research Council funding for clinical research in medicine (ALF) in Vasterbotten; Cancer Research Foundation in Norrland, Sweden	Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Center for Immune Modulatory Therapies for Autoimmunity and Cancer (IMTAC-Sweden); Regional Research Council in Uppsala-Orebro, Sweden; Swedish Research Council funding for clinical research in medicine (ALF) in Vasterbotten; Cancer Research Foundation in Norrland, Sweden	This work was supported by the Swedish Cancer Society (Cancerfonden) (OW); Center for Immune Modulatory Therapies for Autoimmunity and Cancer (IMTAC-Sweden) (OW); Regional Research Council in Uppsala-Orebro, Sweden (AS); the Swedish Research Council funding for clinical research in medicine (ALF) in Vasterbotten (AS); and the Cancer Research Foundation in Norrland, Sweden (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 1999, AIDS, V13, P1295, DOI 10.1097/00002030-199907300-00005; Andersson J, 2002, J INFECT DIS, V185, P1355, DOI 10.1086/340124; Andreev K, 2015, BRIT J CANCER, V113, P902, DOI 10.1038/bjc.2015.255; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Becht E, 2014, CANCER IMMUNOL IMMUN, V63, P991, DOI 10.1007/s00262-014-1590-3; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Csardi G, 2006, INTERJOURNAL; Cullen SP, 2010, CELL DEATH DIFFER, V17, P616, DOI 10.1038/cdd.2009.206; Das R, 2015, J IMMUNOL, V194, P950, DOI 10.4049/jimmunol.1401686; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Franciszkiewicz K, 2013, CANCER RES, V73, P617, DOI 10.1158/0008-5472.CAN-12-2569; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Humphrey PA, 2016, EUR UROL, V70, P106, DOI 10.1016/j.eururo.2016.02.028; Kawai K, 2013, CANCER SCI, V104, P22, DOI 10.1111/cas.12075; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Michaud DS, 2007, UROL ONCOL-SEMIN ORI, V25, P260, DOI 10.1016/j.urolonc.2006.10.002; Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001; Northrop JK, 2008, J IMMUNOL, V181, P865, DOI 10.4049/jimmunol.181.2.865; Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796; Preynat-Seauve O, 2007, CANCER RES, V67, P5009, DOI 10.1158/0008-5472.CAN-06-4494; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rosenblatt R, 2017, WORLD J UROL, V35, P921, DOI 10.1007/s00345-016-1952-x; Ruffell B, 2010, CYTOKINE GROWTH F R, V21, P3, DOI 10.1016/j.cytogfr.2009.11.002; Sanli O, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.22; Scharping NE, 2016, IMMUNITY, V45, P701, DOI 10.1016/j.immuni.2016.08.009; Schurich A, 2016, CELL REP, V16, P1243, DOI 10.1016/j.celrep.2016.06.078; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Sheu BC, 2001, J IMMUNOL, V167, P2972, DOI 10.4049/jimmunol.167.5.2972; Steer HJ, 2010, ONCOGENE, V29, P6301, DOI 10.1038/onc.2010.437; Swartz MA, 2012, NAT REV CANCER, V12, P210, DOI 10.1038/nrc3186; Taylor A, 2018, CANCER RES, V78, P706, DOI 10.1158/0008-5472.CAN-17-0491; Taylor A, 2016, IMMUNITY, V44, P274, DOI 10.1016/j.immuni.2016.01.018; Thaventhiran JED, 2013, CURR OPIN IMMUNOL, V25, P321, DOI 10.1016/j.coi.2013.05.010; Thiery Jerome, 2014, Subcell Biochem, V80, P197, DOI 10.1007/978-94-017-8881-6_10; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Thompson DB, 2015, EXPERT REV CLIN IMMU, V11, P265, DOI 10.1586/1744666X.2015.983082; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Trapani JA, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24185; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Wei SA, 2008, CANCER RES, V68, P5432, DOI 10.1158/0008-5472.CAN-07-6598; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wichert S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171205; Winerdal ME, 2011, BJU INT, V108, P1672, DOI 10.1111/j.1464-410X.2010.10020.x; Wu X, 2014, BRIT J CANCER, V111, P1391, DOI 10.1038/bjc.2014.416; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0200079	10.1371/journal.pone.0200079	http://dx.doi.org/10.1371/journal.pone.0200079			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29966014	Green Published, Green Submitted, gold			2022-12-26	WOS:000437224100046
J	Motz, M; Jung, K				Motz, Magdalena; Jung, Kirsten			The role of polyproline motifs in the histidine kinase EnvZ	PLOS ONE			English	Article							ELONGATION-FACTOR P; ENVZ/OMPR 2-COMPONENT REGULON; FACTOR EF-P; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; LINKER REGION; HAMP DOMAINS; PROTEIN; SEQUENCE; RIBOSOME	Although distinct amino acid motifs containing consecutive prolines (polyP) cause ribosome stalling, which necessitates recruitment of the translation elongation factor P (EF-P), they occur strikingly often in bacterial proteomes. For example, polyP motifs are found in more than half of all histidine kinases in Escherichia coli K-12, which raises the question of their role(s) in receptor function. Here we have investigated the roles of two polyP motifs in the osmosensor and histidine kinase EnvZ. We show that the I PPPL motif in the HAMP domain is required for dimerization of EnvZ. Moreover, replacement of the prolines in this motif by alanines disables the receptor's sensor function. The second motif, VVPPA, which is located in the periplasmic domain, was found to be required for interaction with the modulator protein MzrA. Our study also reveals that polyP-dependent stalling has little effect on EnvZ levels. Hence, both polyP motifs in EnvZ are primarily involved in protein-protein interaction. Furthermore, while the first motif occurs in almost all EnvZ homologues, the second motif is only found in species that have MzrA, indicating co-evolution of the two proteins.	[Motz, Magdalena; Jung, Kirsten] Ludwig Maximilians Univ Munchen, Ctr Integrated Prot Sci Munich, Dept Biol 1, Microbiol, Martinsried, Germany	University of Munich	Jung, K (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Integrated Prot Sci Munich, Dept Biol 1, Microbiol, Martinsried, Germany.	jung@lmu.de	Jung, Kirsten/K-4196-2014	Jung, Kirsten/0000-0003-0779-6841	Deutsche Forschungsgemeinschaft [Exc114/2, TRR174]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Exc114/2 and project P09 within the frame of TRR174) to K.J.	ADZHUBEI AA, 1987, BIOCHEM BIOPH RES CO, V146, P934, DOI 10.1016/0006-291X(87)90736-4; Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; Ashenberg O, 2011, J MOL BIOL, V413, P222, DOI 10.1016/j.jmb.2011.08.011; BARTIG D, 1992, EUR J BIOCHEM, V204, P751, DOI 10.1111/j.1432-1033.1992.tb16690.x; Batchelor E, 2006, MOL MICROBIOL, V59, P1767, DOI 10.1111/j.1365-2958.2006.05048.x; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Chakraborty S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02030-0; Chakraborty S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002116; Chevance FFV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004392; Dever TE, 2014, CRIT REV BIOCHEM MOL, V49, P413, DOI 10.3109/10409238.2014.939608; Doerfel LK, 2015, J AM CHEM SOC, V137, P12997, DOI 10.1021/jacs.5b07427; Dunin-Horkawicz S, 2010, J MOL BIOL, V397, P1156, DOI 10.1016/j.jmb.2010.02.031; Dutta R, 1996, J BIOL CHEM, V271, P1424, DOI 10.1074/jbc.271.3.1424; Dutta R, 1999, MOL MICROBIOL, V34, P633, DOI 10.1046/j.1365-2958.1999.01646.x; Egger LA, 1997, GENES CELLS, V2, P167, DOI 10.1046/j.1365-2443.1997.d01-311.x; Ferris HU, 2014, J STRUCT BIOL, V186, P376, DOI 10.1016/j.jsb.2014.03.014; Foo YH, 2015, PROG BIOPHYS MOL BIO, V118, P119, DOI 10.1016/j.pbiomolbio.2015.04.005; Gerken H, 2010, J BACTERIOL, V192, P6271, DOI 10.1128/JB.00855-10; Gerken H, 2009, MOL MICROBIOL, V72, P1408, DOI 10.1111/j.1365-2958.2009.06728.x; Ghosh M, 2017, BIOPHYS J, V112, P643, DOI 10.1016/j.bpj.2016.12.027; Heermann R, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-14; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; Hidaka Y, 1997, FEBS LETT, V400, P238, DOI 10.1016/S0014-5793(96)01396-8; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Hwang E, 2017, FEBS LETT, V591, P1419, DOI 10.1002/1873-3468.12658; Jha AK, 2005, BIOCHEMISTRY-US, V44, P9691, DOI 10.1021/bi0474822; Jung K, 2001, J BIOL CHEM, V276, P40896, DOI 10.1074/jbc.M107871200; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karimova G, 2001, US patent, Patent No. [US20020045237A1.200128.03.2001, 20020045237]; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; King ST, 2007, METHOD ENZYMOL, V422, P352, DOI 10.1016/S0076-6879(06)22017-2; Kishii R, 2007, J BIOL CHEM, V282, P26401, DOI 10.1074/jbc.M701342200; Kobayashi K, 2014, NUCLEIC ACIDS RES, V42, P12295, DOI 10.1093/nar/gku898; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Lassak J, 2016, MOL MICROBIOL, V99, P219, DOI 10.1111/mmi.13233; Lassak J, 2015, NAT CHEM BIOL, V11, P266, DOI [10.1038/nchembio.1751, 10.1038/NCHEMBIO.1751]; Lassak J, 2010, APPL ENVIRON MICROB, V76, P3263, DOI 10.1128/AEM.00512-10; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Libby EA, 2010, J BACTERIOL, V192, P4045, DOI 10.1128/JB.00344-10; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; Mandal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111800; MIZUNO T, 1982, J BIOL CHEM, V257, P13692; MURRAY NJ, 1994, EUR J BIOCHEM, V219, P923, DOI 10.1111/j.1432-1033.1994.tb18574.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NOEGEL AA, 1990, FEBS LETT, V266, P118, DOI 10.1016/0014-5793(90)81521-O; Park H, 1998, P NATL ACAD SCI USA, V95, P6728, DOI 10.1073/pnas.95.12.6728; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Parkinson JS, 2010, ANNU REV MICROBIOL, V64, P101, DOI 10.1146/annurev.micro.112408.134215; Peil L, 2013, P NATL ACAD SCI USA, V110, P15265, DOI 10.1073/pnas.1310642110; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi F, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005987; Qin L, 2003, J BACTERIOL, V185, P3429, DOI 10.1128/JB.185.11.3429-3435.2003; Rossi D, 2014, WIRES RNA, V5, P209, DOI 10.1002/wrna.1211; Starosta AL, 2014, CELL REP, V9, P476, DOI 10.1016/j.celrep.2014.09.008; Starosta AL, 2014, NUCLEIC ACIDS RES, V42, P10711, DOI 10.1093/nar/gku768; Stincone A, 2011, NUCLEIC ACIDS RES, V39, P7512, DOI 10.1093/nar/gkr338; Tanner DR, 2009, J BIOL CHEM, V284, P34809, DOI 10.1074/jbc.M109.039040; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Unnerstale S, 2011, BBA-BIOMEMBRANES, V1808, P2403, DOI 10.1016/j.bbamem.2011.06.018; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; VENKATAC.CM, 1969, ANNU REV BIOCHEM, V38, P45, DOI 10.1146/annurev.bi.38.070169.000401; Wang LC, 2012, EMBO J, V31, P2648, DOI 10.1038/emboj.2012.99; Williams SB, 1999, MOL MICROBIOL, V33, P1093, DOI 10.1046/j.1365-2958.1999.01562.x; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Woolstenhulme CJ, 2015, CELL REP, V11, P13, DOI 10.1016/j.celrep.2015.03.014; Yaku H, 1997, FEBS LETT, V417, P409, DOI 10.1016/S0014-5793(97)01329-X; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zhu Y, 2003, J BIOL CHEM, V278, P22812, DOI 10.1074/jbc.M300916200	73	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199782	10.1371/journal.pone.0199782	http://dx.doi.org/10.1371/journal.pone.0199782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953503	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400066
J	Muschol, M; Wenders, C; Wennemuth, G				Muschol, Michael; Wenders, Caroline; Wennemuth, Gunther			Four-dimensional analysis by high-speed holographic imaging reveals a chiral memory of sperm flagella	PLOS ONE			English	Article							SEA-URCHIN SPERM; MAMMALIAN SPERM; BEND PROPAGATION; MALE-FERTILITY; WAVE-FORM; MOTILITY; SPERMATOZOA; DYNEIN; BEAT; MICROSCOPY	Here high-speed Digital Holographic Microscopy (DHM) records sperm flagellar waveforms and swimming paths in 4 dimensions (X, Z, and t). We find flagellar excursions into the Z-plane nearly as large as the envelope of the flagellar waveform projected onto the XY-plane. These Z-plane excursions travel as waves down the flagellum each beat cycle. DHM also tracks the heads of free-swimming sperm and the dynamics and chirality of rolling of sperm around their long axis. We find that mouse sperm roll CW at the maximum positive Z-plane excursion of the head, then roll CCW at the subsequent maximum negative Z-plane excursion. This alternating chirality of rolling indicates sperm have a chiral memory. Procrustes alignments of path trajectories for sequences of roll-counterroll cycles show that path chirality is always CW for the cells analyzed in this study. Human and bull sperm lack distinguishable left and right surfaces, but DHM still indicates coordination of Z-plane excursions and rolling events. We propose that sperm have a chiral memory that resides in a hypothetical elastic linkage within the flagellar machinery, which stores some of the torque required for a CW or CCW roll to reuse in the following counter-roll. Separate mechanisms control path chirality.	[Muschol, Michael; Wenders, Caroline; Wennemuth, Gunther] Duisburg Essen Univ, Univ Hosp, Inst Anat, Essen, Germany	University of Duisburg Essen	Wennemuth, G (corresponding author), Duisburg Essen Univ, Univ Hosp, Inst Anat, Essen, Germany.	Gunther.Wennemuth@uk-essen.de		Wiesehofer, Caroline/0000-0002-7174-9954; Wennemuth, Gunther/0000-0003-3313-2475	Deutsche Forschungsgemeinschaft [WE 2344/9-1]; Open Access Publication Fund of the University of Duisburg-Essen; DFG [WE 2344/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of the University of Duisburg-Essen; DFG(German Research Foundation (DFG))	Support was provided by Deutsche Forschungsgemeinschaft; WE 2344/9-1 to G.W. We also acknowledge support by the Open Access Publication Fund of the University of Duisburg-Essen.; We are grateful to D. F. Babcock for technical and editorial assistance. We are grateful to A.G. of Wavemetrics, Inc. for help with the Procrustes alignments, to T. Colomb of Lyncee Tec SA for help with Spyder scripts, and to U. Janowitz of Rinder-Union West eG for providing bovine semen. We also thank C.J. Brokaw, California Institute of Technology, C.B. Lindemann of Oakland University and C.L. Asbury, University of Washington for helpful discussions, and J. Szczyrba, Duisburg-Essen University for critical and careful proofreading. Support was provided by DFG WE 2344/9-1 to G.W. We acknowledge support by the Open Access Publication Fund of the University of Duisburg-Essen.	Allen MJ, 2010, NANOMED-NANOTECHNOL, V6, P510, DOI 10.1016/j.nano.2009.12.003; Awata J, 2015, MOL BIOL CELL, V26, P2788, DOI 10.1091/mbc.E15-01-0018; Babcock DF, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0067-3; Bayly PV, 2010, CYTOSKELETON, V67, P56, DOI 10.1002/cm.20424; Brokaw CJ, 2014, CYTOSKELETON, V71, P273, DOI 10.1002/cm.21168; Brokaw CJ, 2009, CELL MOTIL CYTOSKEL, V66, P425, DOI 10.1002/cm.20313; Bukatin A, 2015, P NATL ACAD SCI USA, V112, P15904, DOI 10.1073/pnas.1515159112; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; Colomb T, 2010, OPT LETT, V35, P1840, DOI 10.1364/OL.35.001840; CUMMINS JM, 1985, J REPROD FERTIL, V75, P153, DOI 10.1530/jrf.0.0750153; Dudiki T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141961; ESHEL D, 1990, J EXP BIOL, V152, P441; Friedrich BM, 2010, J EXP BIOL, V213, P1226, DOI 10.1242/jeb.039800; Geyer VF, 2016, CURR BIOL, V26, P1098, DOI 10.1016/j.cub.2016.02.053; GIBBONS IR, 1987, NATURE, V325, P351, DOI 10.1038/325351a0; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Heuser T, 2012, MOL BIOL CELL, V23, P3143, DOI 10.1091/mbc.E12-05-0357; Heuser T, 2012, P NATL ACAD SCI USA, V109, pE2067, DOI 10.1073/pnas.1120690109; Hino T, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140400; Inaba K, 2011, MOL HUM REPROD, V17, P524, DOI 10.1093/molehr/gar034; ISHIJIMA S, 1992, CELL STRUCT FUNCT, V17, P319, DOI 10.1247/csf.17.319; ISHIJIMA S, 1992, J EXP BIOL, V163, P15; Ishijima S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148880; Ishikawa Y, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135418; Jansen V, 2015, ELIFE, V4, DOI 10.7554/eLife.05161; Jikeli JF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8985; Kantsler V, 2014, ELIFE, V3, DOI 10.7554/eLife.02403; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; Lesich KA, 2014, CYTOSKELETON, V71, P649, DOI 10.1002/cm.21199; Lindemann CB, 2016, CYTOSKELETON, V73, P652, DOI 10.1002/cm.21338; Lindemann CB, 2010, J CELL SCI, V123, P519, DOI 10.1242/jcs.051326; Mai A, 2002, MOL REPROD DEV, V63, P471, DOI 10.1002/mrd.10195; Miki K, 2013, CURR BIOL, V23, P443, DOI 10.1016/j.cub.2013.02.007; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Nosrati R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26669; Nosrati R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9703; Ounjai P, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101980; PHILLIPS DM, 1972, J CELL BIOL, V53, P561, DOI 10.1083/jcb.53.2.561; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Rappaz B, 2005, OPT EXPRESS, V13, P9361, DOI 10.1364/OPEX.13.009361; Rappaz B, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3147385; RIKMENSP.R, 1965, BIOPHYS J, V5, P365, DOI 10.1016/S0006-3495(65)86723-6; Sartori P, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.042426; Satir P, 2014, BIOSCIENCE, V64, P1073, DOI 10.1093/biosci/biu180; SHINGYOJI C, 1991, J CELL SCI, V98, P175; Su TW, 2016, ANIM REPROD SCI, V169, P45, DOI 10.1016/j.anireprosci.2015.12.012; Su TW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01664; Su TW, 2012, P NATL ACAD SCI USA, V109, P16018, DOI 10.1073/pnas.1212506109; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Wandernoth PM, 2015, J BIOL CHEM, V290, P29202, DOI 10.1074/jbc.M115.698597; Wennemuth G, 2000, J BIOL CHEM, V275, P21210, DOI 10.1074/jbc.M002068200; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; Woolley DM, 2010, BIOL REV, V85, P453, DOI 10.1111/j.1469-185X.2009.00110.x; Woolley DM, 2003, REPRODUCTION, V126, P259, DOI 10.1530/rep.0.1260259; WOOLLEY DM, 1984, J CELL SCI, V67, P159; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Xu G, 2016, BIOPHYS J, V110, P2759, DOI 10.1016/j.bpj.2016.05.017; Yanagimachi R, 1994, MAMMALIAN FERTILIZAT, P189; YEUNG CH, 1984, CELL MOTIL CYTOSKEL, V4, P215, DOI 10.1002/cm.970040306	60	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199678	10.1371/journal.pone.0199678	http://dx.doi.org/10.1371/journal.pone.0199678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953515	Green Published, gold			2022-12-26	WOS:000436645400050
J	Strachen, N; Booske, J; Behdad, N				Strachen, Nathan; Booske, John; Behdad, Nader			A mechanically based magneto-inductive transmitter with electrically modulated reluctance	PLOS ONE			English	Article								Magneto-inductive (MI) communication is a viable technology for wireless communications in underwater and underground environments. In this paper, a new design for an MI transmitter is presented. Unlike conventional MI transmitters that utilize coiled loops or solenoids to generate magnetic fields, we demonstrate the feasibility and advantages of using a rotating permanent magnet. We also present and experimentally verify a modulation technique that does not involve changing the rotational speed of the magnet. By electrically changing the permeability of a surrounding shield, the fields from the rotating magnet are amplitude modulated. Our findings suggest that increased efficiency and bandwidth can be realized compared to conventional MI transmitters.	[Strachen, Nathan; Booske, John; Behdad, Nader] Univ Wisconsin Madison, Dept Elect & Comp Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Strachen, N (corresponding author), Univ Wisconsin Madison, Dept Elect & Comp Engn, Madison, WI 53706 USA.	Strachen@wisc.edu		STRACHEN, NATHAN/0000-0001-8600-4544	Office of Naval Research under ONR award [N00014-11-1-0618]	Office of Naval Research under ONR award	The material presented in this work is supported in part by the Office of Naval Research under ONR award No. N00014-11-1-0618 (https://www.onr.navy.mil/). N. Strachen and N. Behdad are the recipients of this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrudan TE, 2015, IEEE J SEL AREA COMM, V33, P2404, DOI 10.1109/JSAC.2015.2430518; Ahmed N, 2017, MAGNETO INDUCTIVE CO; Arnold D. P., 2017, P IEEE INT S ANT PRO, P2; Balanis C., 2016, ANTENNA THEORY ANAL; Bickford JA, 2017, IEEE ANTENNAS PROP, P1475, DOI 10.1109/APUSNCURSINRSM.2017.8072780; Camacho J. M., 2013, Rev. mex. fís. E, V59, P8; Dinn D., 2008, UNDERWATER COMMUNICA; Fisher E, 2012, LOCKHEED MARTINS WIR; Gulbahar B, 2012, IEEE T WIREL COMMUN, V11, P3326, DOI 10.1109/TWC.2012.070912.111943; Hjelmstad WH, 1991, ULTRALOW FREQUENCY E; Markham Andrew, 2012, 2012 ACM/IEEE 11th International Conference on Information Processing in Sensor Networks (IPSN), P1, DOI 10.1109/IPSN.2012.6920946; McLyman WT, 1988, ELECT ENG ELECT, V49; Meybodi SA, 2011, IEEE ICC; Selvin S, 2017, IEEE ANTENNAS PROP, P1477, DOI 10.1109/APUSNCURSINRSM.2017.8072781; Sheinker A, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/10/105101; Sojdehei JJ, 2001, OCEANS 2001 MTS/IEEE: AN OCEAN ODYSSEY, VOLS 1-4, CONFERENCE PROCEEDINGS, P513, DOI 10.1109/OCEANS.2001.968775; Srinivas Prasad M. N., 2017, 2017 XXXIInd General Assembly and Scientific Symposium of the International Union of Radio Science (URSI GASS), DOI 10.23919/URSIGASS.2017.8105322; Sullivan CR, 2014, APPL POWER ELECT CO, P2667, DOI 10.1109/APEC.2014.6803681; Tal N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171982; Tan X, TESTBED MAGNETIC IND, P1; WOOTEN R, 2006, SAGO MINE EXPLOSION	22	14	15	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199934	10.1371/journal.pone.0199934	http://dx.doi.org/10.1371/journal.pone.0199934			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953525	gold, Green Published, Green Submitted			2022-12-26	WOS:000436645400098
J	Dolscheid, S; Penke, M				Dolscheid, Sarah; Penke, Martina			Quantifier comprehension is linked to linguistic rather than to numerical skills. Evidence from children with Down syndrome and Williams syndrome	PLOS ONE			English	Article							SEMANTIC DEMENTIA; LANGUAGE; ACQUISITION; NUMBER; ADOLESCENTS; COUNT	Comprehending natural language quantifiers (like many, all, or some) involves linguistic and numerical abilities. However, the extent to which both factors play a role is controversial. In order to determine the specific contributions of linguistic and number skills in quantifier comprehension, we examined two groups of participants that differ in their language abilities while their number skills appear to be similar: Participants with Down syndrome (DS) and participants with Williams syndrome (WS). Compared to rather poor linguistic skills of individuals with DS, individuals with WS display relatively advanced language abilities. Participants with WS also outperformed participants with DS in a quantifier comprehension task while number knowledge did not differ between the two groups. When compared to typically developing (TD) children of the same mental age, participants with WS displayed similar levels regarding quantifier abilities, but participants with DS performed worse than the control group. Language abilities but not number skills also significantly predicted quantifier knowledge in a linear regression analysis, stressing the importance of linguistic abilities for quantifier comprehension. In addition to determining the skills that are relevant for comprehending quantifiers, our findings provide the first demonstration of how quantifiers are acquired by individuals with DS and WS, an issue not investigated so far.	[Dolscheid, Sarah; Penke, Martina] Univ Cologne, Dept Special Educ & Rehabil, Cologne, Germany	University of Cologne	Dolscheid, S (corresponding author), Univ Cologne, Dept Special Educ & Rehabil, Cologne, Germany.	sarah.dolscheid@uni-koeln.de	Penke, Martina/W-7719-2019; Verlage, Sarah/AAI-9313-2021	Penke, Martina/0000-0003-4686-7673; Verlage, Sarah/0000-0001-9104-6386	Institutional Strategy of the University of Cologne within the German Excellence Initiative	Institutional Strategy of the University of Cologne within the German Excellence Initiative	This research was funded under the Institutional Strategy of the University of Cologne within the German Excellence Initiative (i.e. a 'UoC Postdoc Grant' which was awarded to the first author). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all of the children and adolescents who participated in this study. Thanks to their parents, day care centers, as well as the 'Bundesverband Williams-Beuren-Syndrom'. We thank Christina Winter and Lea Ostrowski for help with participant recruitment, data collection and archiving. This research was funded under the Institutional Strategy of the University of Cologne within the German Excellence Initiative (i.e. a 'UoC Postdoc Grant' which was awarded to the first author).	Abbeduto L, 2003, AM J MENT RETARD, V108, P149, DOI 10.1352/0895-8017(2003)108<0149:RLSOAA>2.0.CO;2; Ansari D, 2003, J EXP CHILD PSYCHOL, V85, P50, DOI 10.1016/S0022-0965(03)00026-2; Barner D, 2009, COGNITIVE PSYCHOL, V58, P195, DOI 10.1016/j.cogpsych.2008.07.001; BELLUGI U, 1990, AM J MED GENET, P115; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Bloom P, 1997, J CHILD LANG, V24, P511, DOI 10.1017/S0305000997003188; Brigstocke S., 2008, DOWN SYNDROME RES PR, DOI DOI 10.3104/REVIEWS.2070; Cappelletti M, 2006, NEUROCASE, V12, P136, DOI 10.1080/13554790600598782; Cappelletti M, 2012, NEUROPSYCHOLOGY, V26, P1, DOI 10.1037/a0026328; Carey S, 2004, DAEDALUS-US, V133, P59, DOI 10.1162/001152604772746701; Chapman R S, 2001, Downs Syndr Res Pract, V7, P1, DOI 10.3104/reviews.108; Chapman RS, 2000, J SPEECH LANG HEAR R, V43, P340, DOI 10.1044/jslhr.4302.340; Cheng DZ, 2013, NEUROPSYCHOLOGIA, V51, P2172, DOI 10.1016/j.neuropsychologia.2013.07.003; Dolscheid S, 2017, COGN DEV, V44; Donlan C, 2007, COGNITION, V103, P23, DOI 10.1016/j.cognition.2006.02.007; Durkin K, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00581; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Grimm H, 2003, SSV SPRACHSCREENING; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; Katsos N, 2016, P NATL ACAD SCI USA, V113, P9244, DOI 10.1073/pnas.1601341113; Katsos N, 2011, COGNITION, V120, P67, DOI 10.1016/j.cognition.2011.02.015; Katsos N, 2011, COGNITION, V119, P43, DOI 10.1016/j.cognition.2010.12.004; Krause M, 2002, BRAIN COGNITION, V48, P410, DOI 10.1006/brcg.2001.1388; McMillan CT, 2005, NEUROPSYCHOLOGIA, V43, P1729, DOI 10.1016/j.neuropsychologia.2005.02.012; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P380, DOI 10.1038/nrn1906; O'Hearn K, 2007, BRAIN COGNITION, V64, P238, DOI 10.1016/j.bandc.2007.03.005; Olm CA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00610; Paterson SJ, 2006, J CHILD PSYCHOL PSYC, V47, P190, DOI 10.1111/j.1469-7610.2005.01460.x; Pietroski P, 2009, MIND LANG, V24, P554, DOI 10.1111/j.1468-0017.2009.01374.x; Sarnecka BW, 2008, COGNITION, V108, P662, DOI 10.1016/j.cognition.2008.05.007; Sella F, 2013, RES DEV DISABIL, V34, P3798, DOI 10.1016/j.ridd.2013.07.038; Shikhare S, 2015, COGNITIVE SCI, V39, P1504, DOI 10.1111/cogs.12219; Tellegen P.J., 2007, SON R 2 7 NONVERBALE; Troiani V, 2009, NEUROPSYCHOLOGIA, V47, P104, DOI 10.1016/j.neuropsychologia.2008.08.015; Wei W, 2014, HUM BRAIN MAPP, V35, P444, DOI 10.1002/hbm.22190; Witecy B, 2016, SPRACHE-STIMME-GEHOR, P93; Wynn K., 1992, MIND LANG, V7, P367	38	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199743	10.1371/journal.pone.0199743	http://dx.doi.org/10.1371/journal.pone.0199743			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK9FZ	29949641	Green Published, gold			2022-12-26	WOS:000436549200063
J	Topor, LS; Bowerman, K; Machan, JT; Gilbert, CL; Kangarloo, T; Shaw, ND				Topor, Lisa Swartz; Bowerman, Kimberly; Machan, Jason T.; Gilbert, Courtney L.; Kangarloo, Tairmae; Shaw, Natalie D.			Central precocious puberty in Boston boys: A 10-year single center experience	PLOS ONE			English	Article							BODY-MASS INDEX; ASSOCIATIONS; GIRLS; PREVALENCE; MATURATION; CHILDREN; FAT	Objective Recent studies in the US and abroad suggest that boys are undergoing puberty at a younger age. It is unknown if this secular trend extends to boys with central precocious puberty (CPP), who sit at the extreme end of the pubertal spectrum, and if neuroimaging should remain a standard diagnostic tool. Study design Retrospective chart review of all boys with CPP seen by Endocrinology at a US pediatric hospital from 2001-2010. Results Fifty boys had pubertal onset at an average age of 7.31 years (95C1 6.83-7.89), though many did not present until nearly one year thereafter, by which time 30% were mid-to-late pubertal. Boys were predominantly non-Hispanic White and 64% were overweight/obese. The majority (64%) of boys had neurogenic CPP (CNS-CPP) with neurofibromatosis type I being the most common diagnosis. Diagnosis of CPP led to discovery of a neurogenic lesion in only 3 of 32 (9%) CNS-CPP cases. The remaining boys, with idiopathic CPP (36%), were indistinguishable from those with CNS-CPP aside from four boys who endorsed a family history of PP (22% vs. 0% among CNS-CPP cases). Importantly, there was no change in the incidence of male CPP after accounting for the increase in clinic volume during this time period. Conclusion In this contemporary Boston-based cohort of 50 boys with CPP, most cases were neurogenic, consistent with older literature. Several idiopathic cases had a family history of PP but were otherwise indistinguishable from CNS-CPP cases. Thus, neuroimaging remains a critical diagnostic tool. We find no evidence for an increase in the prevalence of male CPP.	[Topor, Lisa Swartz] Brown Univ, Alpert Med Sch, Div Pediat Endocrinol, Dept Pediat, Providence, RI 02912 USA; [Topor, Lisa Swartz] Hasbro Childrens Hosp, Providence, RI 02903 USA; [Bowerman, Kimberly; Machan, Jason T.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Machan, Jason T.] Rhode Isl Hosp, Lifespan Biostat Core, Providence, RI USA; [Machan, Jason T.] Univ Rhode Isl, Dept Psychol, South Kingston, RI USA; [Gilbert, Courtney L.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Kangarloo, Tairmae; Shaw, Natalie D.] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA; [Shaw, Natalie D.] NIEHS, Clin Res Branch, NIH, Durham, NC USA	Brown University; Hasbro Children's Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Rhode Island; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Topor, LS (corresponding author), Brown Univ, Alpert Med Sch, Div Pediat Endocrinol, Dept Pediat, Providence, RI 02912 USA.; Topor, LS (corresponding author), Hasbro Childrens Hosp, Providence, RI 02903 USA.	lisa_swartz_topor@brown.edu	Machan, Jason/D-3897-2013; Shaw, Natalie/C-3761-2019	Machan, Jason/0000-0003-2048-4914; Shaw, Natalie/0000-0002-0847-9170	Harvard Catalyst The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award) [UL1 TR001102]; Harvard University; Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [Z01-ES103315]; Warren Alpert Medical School of Brown University Summer Assistantship; Lasker Clinical Research Scholar [1SI2ES025429-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103315] Funding Source: NIH RePORTER	Harvard Catalyst The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award); Harvard University; Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Warren Alpert Medical School of Brown University Summer Assistantship; Lasker Clinical Research Scholar; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was conducted as part of a SHRINE Pilot Grant and was supported by Harvard Catalyst The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102 to LST) and financial contributions from Harvard University and its affiliated academic healthcare centers and, in part, by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01-ES103315 to NS) and the Warren Alpert Medical School of Brown University Summer Assistantship (to KB). NDS is supported as a Lasker Clinical Research Scholar (1SI2ES025429-01 to NS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, the National Center for Advancing Translational Science or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AP, 2013, NEW ENGL J MED, V368, P2467, DOI 10.1056/NEJMoa1302160; Alikasifoglu A, 2015, HORM RES PAEDIAT, V83, P340, DOI 10.1159/000377678; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Centers for Disease Control and Prevention (CDC), 2012, CLIN GROWTH CHARTS; Chemaitilly W, 2001, CLIN ENDOCRINOL, V54, P289, DOI 10.1046/j.1365-2265.2001.01229.x; Chen C, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014004; Choi Keun Hee, 2013, Ann Pediatr Endocrinol Metab, V18, P183, DOI 10.6065/apem.2013.18.4.183; Crocker MK, 2014, J CLIN ENDOCR METAB, V99, pE1519, DOI 10.1210/jc.2014-1384; Dauber A, 2017, J CLIN ENDOCR METAB, V102, P1557, DOI 10.1210/jc.2016-3677; De Sanctis V, 2000, J PEDIATR ENDOCR MET, V13, P687; Demerath EW, 2006, PEDIATRICS, V117, pE487, DOI 10.1542/peds.2005-0572; Faizah Mz, 2012, Biomed Imaging Interv J, V8, pe6, DOI 10.2349/biij.8.1.e6; Fukami M, 2017, J CELL MOL MED, V21, P2623, DOI 10.1111/jcmm.13146; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Greulich W. W., 1959, RADIOGRAPHIC ATLAS S, pxvi; Herman-Giddens ME, 2012, PEDIATRICS, V130, pE1058, DOI 10.1542/peds.2011-3291; Kaplowitz P, 1998, J PEDIATR-US, V133, P745, DOI 10.1016/S0022-3476(98)70144-1; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; Kaplowitz PB, 2001, PEDIATRICS, V108, P347, DOI 10.1542/peds.108.2.347; Kim SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141844; Lee JM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-0164; Lee JM, 2010, ARCH PEDIAT ADOL MED, V164, P139, DOI 10.1001/archpediatrics.2009.258; Louis GMB, 2008, PEDIATRICS, V121, pS192, DOI 10.1542/peds.1813E; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Murphy Shawn N, 2006, AMIA Annu Symp Proc, P1040; Osman Huda A, 2017, Sudan J Paediatr, V17, P19; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Rasmussen AR, 2015, PEDIATRICS, V135, P86, DOI 10.1542/peds.2014-0793; Shin Young-Lim, 2016, Ann Pediatr Endocrinol Metab, V21, P66, DOI 10.6065/apem.2016.21.2.66; Silveira LG, 2010, J CLIN ENDOCR METAB, V95, P2276, DOI 10.1210/jc.2009-2421; Sorensen K, 2010, J CLIN ENDOCR METAB, V95, P263, DOI 10.1210/jc.2009-1478; Soriano-Guillen L, 2010, J CLIN ENDOCR METAB, V95, P4305, DOI 10.1210/jc.2010-1025; Teilmann G, 2005, PEDIATRICS, V116, P1323, DOI 10.1542/peds.2005-0012; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Wang YF, 2002, PEDIATRICS, V110, P903, DOI 10.1542/peds.110.5.903	35	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199019	10.1371/journal.pone.0199019	http://dx.doi.org/10.1371/journal.pone.0199019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949619	Green Published, Green Submitted, gold			2022-12-26	WOS:000436549200034
J	Trost, JF; LeMasters, EH; Liu, F; Carney, P; Lu, XH; Sugawara, K; Hongo, S; Stevens, J; Steinhauer, DA; Tumpey, T; Katz, JM; Levine, MZ; Li, ZN				Trost, Jessica F.; LeMasters, Elizabeth H.; Liu, Feng; Carney, Paul; Lu, Xiuhua; Sugawara, Kanetsu; Hongo, Seiji; Stevens, James; Steinhauer, David A.; Tumpey, Terrence; Katz, Jacqueline M.; Levine, Min Z.; Li, Zhu-Nan			Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin	PLOS ONE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; STEM; PROTEINS; A(H3N2); EPITOPE; IDENTIFICATION; OPTIMUM; DOMAIN; SITES	Many broadly neutralizing antibodies (bnAbs) bind to conserved areas of the hemagglutinin (HA) stalk region and can inhibit the low pH induced HA conformational changes necessary for viral membrane fusion activity. We developed and evaluated a high-throughput virus-free and cell-free ELISA based low pH induced HA Conformational Change Inhibition Antibody Detection Assay (HCCIA) and a complementary proteinase susceptibility assay. Human serum samples (n = 150) were tested by HCCIA using H3 recombinant HA. Optical density (OD) ratios of mAb HC31 at pH 4.8 to pH 7.0 ranged from 0.87 to 0.09. Our results demonstrated that low pH induced HA conformational change inhibition antibodies (CCI) neutralized multiple H3 strains after removal of head-binding antibodies. The results suggest that HCCIA can be utilized to detect and characterize CCI in sera, that are potentially broadly neutralizing, and serves as a useful tool for evaluating universal vaccine candidates targeting the HA stalk.	[Trost, Jessica F.; LeMasters, Elizabeth H.; Liu, Feng; Carney, Paul; Lu, Xiuhua; Stevens, James; Tumpey, Terrence; Katz, Jacqueline M.; Levine, Min Z.; Li, Zhu-Nan] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Trost, Jessica F.; Steinhauer, David A.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Sugawara, Kanetsu; Hongo, Seiji] Yamagata Univ, Fac Med, Dept Infect Dis, Yamagata, Japan	Centers for Disease Control & Prevention - USA; Emory University; Yamagata University	Li, ZN (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	hix7@cdc.gov	Levine, Min/ABB-4350-2021; Stevens, James/GQH-1081-2022		Emerging Infectious Disease Fellowship Program; Centers for Disease Control and Prevention; National Institute for Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH) [T32AI106699]; US Department of Health and Human Services [HHSN272201400004C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI106699] Funding Source: NIH RePORTER	Emerging Infectious Disease Fellowship Program; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute for Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH); US Department of Health and Human Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the Emerging Infectious Disease Fellowship Program (JFT and EHL) administered by the Association of Public Health Laboratories (APHL) and funded by the Centers for Disease Control and Prevention. JFT is currently supported by National Institute for Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH) under Award Number T32AI106699, and DAS is supported by US Department of Health and Human Services contract HHSN272201400004C (NIAID Centers of Excellence for Influenza Research and Surveillance).	Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Barr IG, 2014, VACCINE, V32, P4713, DOI 10.1016/j.vaccine.2014.02.014; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Crowe Jr JE, 2017, COLD SPRING HARBOR P; DANIELS RS, 1983, J GEN VIROL, V64, P1657, DOI 10.1099/0022-1317-64-8-1657; DiLillo DJ, 2016, J CLIN INVEST, V126, P605, DOI 10.1172/JCI84428; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Dunand CJH, 2016, CELL HOST MICROBE, V19, P800, DOI 10.1016/j.chom.2016.05.014; Eggink D, 2014, J VIROL, V88, P699, DOI 10.1128/JVI.02608-13; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Flannery B, 2016, J INFECT DIS; Harris AK, 2013, P NATL ACAD SCI USA, V110, P4592, DOI 10.1073/pnas.1214913110; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Joyce MG, 2016, CELL; Kallewaard NL, 2016, CELL, V166, P596, DOI 10.1016/j.cell.2016.05.073; Kallewaard NL, 2016, CELL; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Khurana S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006366; Krammer F, 2017, COLD SPRING HARBOR P; Krammer F, 2016, CURR OPIN VIROL, V17, P95, DOI 10.1016/j.coviro.2016.02.002; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Laurie KL, 2015, CLIN VACCINE IMMUNOL, V22, P957, DOI 10.1128/CVI.00278-15; Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021; Leon PE, 2016, P NATL ACAD SCI USA, V113, pE5944, DOI 10.1073/pnas.1613225113; Li ZN, 2005, J VIROL, V79, P10003, DOI 10.1128/JVI.79.15.10003-10012.2005; Liu WC, 2016, J VIROL, V90, P8496, DOI 10.1128/JVI.00880-16; Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111; Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079; Nachbagauer R, 2017, CLIN MICROBIOLOGY IN; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Paborsky LR, 1996, ANAL BIOCHEM, V234, P60, DOI 10.1006/abio.1996.0050; Pappas C, 2015, VIROLOGY, V477, P61, DOI 10.1016/j.virol.2015.01.002; Shen CG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam5752; Skehel JJ, 2002, VACCINE, V20, pS51, DOI 10.1016/S0264-410X(02)00131-7; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan GS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005578; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tsuchiya E, 2001, J GEN VIROL, V82, P2475, DOI 10.1099/0022-1317-82-10-2475; Uyeki TM, 2017, LANCET, V389, P2172, DOI 10.1016/S0140-6736(17)31274-6; Valkenburg SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep22666; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wollacott AM, 2016, EBIOMEDICINE, V5, P147, DOI 10.1016/j.ebiom.2016.02.021; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu NC, 2017, J MOL BIOL, V429, P2694, DOI 10.1016/j.jmb.2017.06.015; Wu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028000; Yamayoshi S, 2017, EBIOMEDICINE, V17, P182, DOI 10.1016/j.ebiom.2017.03.007; Yang H, 2015, VIROLOGY, V477, P18, DOI 10.1016/j.virol.2014.12.024; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Zhu XY, 2013, J VIROL, V87, P12619, DOI 10.1128/JVI.01577-13	62	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199683	10.1371/journal.pone.0199683	http://dx.doi.org/10.1371/journal.pone.0199683			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949635	Green Published, gold, Green Submitted			2022-12-26	WOS:000436549200061
J	Al-Obaidi, N; Mohan, S; Liang, ST; Zhao, ZZ; Nayak, BK; Li, BJ; Sriramarao, P; Habib, SL				Al-Obaidi, Noor; Mohan, Sumathy; Liang, Sitai; Zhao, Zhenze; Nayak, Bijaya K.; Li, Boajie; Sriramarao, P.; Habib, Samy L.			Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes	FASEB JOURNAL			English	Article						renal fibrosis; IDDM; NIDDM; Gal-1	TUBULAR EPITHELIAL-CELLS; OXIDATIVE DNA-DAMAGE; BINDING PROTEIN; MATRIX PROTEIN; MECHANISM; GLUCOSE; FIBRONECTIN	Chronic exposure of tubular renal cells to high glucose contributes to tubulointerstitial changes in diabetic nephropathy. In the present study, we identified a new fibrosis gene called galectin-1 (Gal-1), which is highly expressed in tubular cells of kidneys of type 1 and type 2 diabetic mouse models. Gal-1 protein and mRNA expression showed significant increase in kidney cortex of heterozygous Akita(+/-) and db/db mice compared with wild-type mice. Mouse proximal tubular cells exposed to high glucose showed significant increase in phosphorylation of Akt and Gal-1. We cloned Gal-1 promoter and identified the transcription factor AP4 as binding to the Gal-1 promoter to up-regulate its function. Transfection of cells with plasmid carrying mutations in the binding sites of AP4 to Gal-1 promoter resulted in decreased protein function of Gal-1. In addition, inhibition of Gal-1 by OTX-008 showed significant decrease in p-Akt/AP4 and protein-promoter activity of Gal-1 and fibronectin. Moreover, down-regulation of AP4 by small interfering RNA resulted in a significant decrease in protein expression and promoter activity of Gal-1. We found that kidney of Gal-1(-/-) mice express very low levels of fibronectin protein. In summary, Gal-1 is highly expressed in kidneys of type 1 and 2 diabetic mice, and AP4 is a major transcription factor that activates Gal-1 under hyperglycemia. Inhibition of Gal-1 by OTX-008 blocks activation of Akt and prevents accumulation of Gal-1, suggesting a novel role of Gal-1 inhibitor as a possible therapeutic target to treat renal fibrosis in diabetes.Al-Obaidi, N., Mohan, S., Liang, S., Zhao, Z., Nayak, B. K., Li, B., Sriramarao, P., Habib, S. L. Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes.	[Al-Obaidi, Noor; Liang, Sitai; Zhao, Zhenze; Nayak, Bijaya K.; Habib, Samy L.] Univ Texas Hlth, Dept Cell Syst & Anat, San Antonio, TX USA; [Mohan, Sumathy] Univ Texas Hlth, Dept Pathol, San Antonio, TX USA; [Li, Boajie] Shanghai Jiao Tong Univ, Bio X Inst, Shanghai, Peoples R China; [Sriramarao, P.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Habib, Samy L.] Vet Healthcare Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Shanghai Jiao Tong University; University of Minnesota System; University of Minnesota Twin Cities; Geriatric Research Education & Clinical Center	Habib, SL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cell Syst & Anat, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	habib@uthscsa.edu	Zhao, Zhenze/AAW-5870-2020	Rao, Srirama/0000-0001-9082-1029	American Heart Association; South Texas Veterans Healthcare System; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [5RO1 DK096119]	American Heart Association(American Heart Association); South Texas Veterans Healthcare System; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the American Heart Association, a Merit Review Award from the South Texas Veterans Healthcare System (to S.L.H.), and a U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant 5RO1 DK096119 (to S.M.). The authors declare no conflicts of interest.	BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Fioretto P, 2006, J AM SOC NEPHROL, V17, pS86, DOI 10.1681/ASN.2005121343; Fryk E, 2016, METABOLISM, V65, P998, DOI 10.1016/j.metabol.2016.04.003; Ge XN, 2016, P NATL ACAD SCI USA, V113, pE4837, DOI 10.1073/pnas.1601958113; Ge XN, 2010, J IMMUNOL, V185, P1205, DOI 10.4049/jimmunol.1000039; Habib SL, 2008, AM J PHYSIOL-RENAL, V294, pF281, DOI 10.1152/ajprenal.00370.2007; Habib SL, 2016, CELL CYCLE, V15, P3048, DOI 10.1080/15384101.2016.1231259; Habib SL, 2015, CELL CYCLE, V14, P2598, DOI 10.1080/15384101.2015.1064204; Habib SL, 2014, ONCOTARGET, V5, P2542, DOI 10.18632/oncotarget.1833; Habib SL, 2013, J NEPHROL, V26, P865, DOI 10.5301/jn.5000287; Habib SL, 2012, J AM SOC NEPHROL, V23, P1652, DOI 10.1681/ASN.2012030285; Habib SL, 2010, EUR J CANCER, V46, P2806, DOI 10.1016/j.ejca.2010.06.117; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kolatsi-Joannou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018683; Lim MJ, 2014, EXP CELL RES, V326, P125, DOI 10.1016/j.yexcr.2014.06.001; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Liu YH, 2015, CELL BIOL INT, V39, P217, DOI 10.1002/cbin.10363; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; Martinez-Martinez E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166272; Morrisey K, 1999, KIDNEY INT, V55, P160, DOI 10.1046/j.1523-1755.1999.00248.x; Okamura DM, 2011, AM J PHYSIOL-RENAL, V300, pF245, DOI 10.1152/ajprenal.00326.2010; Okano K, 2010, EXP CELL RES, V316, P3282, DOI 10.1016/j.yexcr.2010.08.015; Pattabiraman DR, 2016, COLD SH Q B, V81, P11, DOI 10.1101/sqb.2016.81.030957; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Phillips AO, 2002, HISTOL HISTOPATHOL, V17, P247, DOI 10.14670/HH-17.247; Rao SP, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00068; Rebholz CM, 2018, KIDNEY INT, V93, P252, DOI 10.1016/j.kint.2017.06.028; Simone S, 2008, DIABETES, V57, P2626, DOI 10.2337/db07-1579; Tan KCB, 2018, DIABETOLOGIA, V61, P1212, DOI 10.1007/s00125-018-4552-z; Velagapudi C, 2011, J AM SOC NEPHROL, V22, P262, DOI 10.1681/ASN.2010040352; WELLS V, 1991, CELL, V64, P91, DOI 10.1016/0092-8674(91)90211-G; ZIYADEH FN, 1990, AM J PHYSIOL, V259, pF704, DOI 10.1152/ajprenal.1990.259.4.F704	37	24	24	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					373	387		10.1096/fj.201800555RR	http://dx.doi.org/10.1096/fj.201800555RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29975570	Green Published			2022-12-26	WOS:000457401500030
J	Chang, JM; Bhasin, SS; Bielenberg, DR; Sukhatme, VP; Bhasin, M; Huang, S; Kieran, MW; Panigrahy, D				Chang, Jaimie; Bhasin, Swati S.; Bielenberg, Diane R.; Sukhatme, Vikas P.; Bhasin, Manoj; Huang, Sui; Kieran, Mark W.; Panigrahy, Dipak			Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin	FASEB JOURNAL			English	Article						cancer; macrophage; angiogenesis	APOPTOTIC CELLS; CANCER-CELLS; CASPASE 3; MACROPHAGES; METASTASIS; EXPRESSION; PROMOTES; PROLIFERATION; MICROENVIRONMENT; TUMORIGENICITY	Colon cancer recurrence after therapy, such as 5-fluorouracil (5-FU), remains a challenge in the clinical setting. Chemotherapy reduces tumor burden by inducing cell death; however, the resulting dead tumor cells, or debris, may paradoxically stimulate angiogenesis, inflammation, and tumor growth. Here, we demonstrate that 5-FU-generated colon carcinoma debris stimulates the growth of a subthreshold inoculum of living tumor cells in subcutaneous and orthotopic models. Debris triggered the release of osteopontin (OPN) by tumor cells and host macrophages. Both coinjection of debris and systemic treatment with 5-FU increased plasma OPN levels in tumor-bearing mice. RNA expression levels of secreted phosphoprotein 1, the gene that encodes OPN, correlate with poor prognosis in patients with colorectal cancer and are elevated in chemotherapy-treated patients who experience tumor recurrence vs. no recurrence. Pharmacologic and genetic ablation of OPN inhibited debris-stimulated tumor growth. Systemic treatment with a combination of a neutralizing OPN antibody and 5-FU dramatically inhibited tumor growth. These results demonstrate a novel mechanism of tumor progression mediated by OPN released in response to chemotherapy-generated tumor cell debris. Neutralization of debris-stimulated OPN represents a potential therapeutic strategy to overcome the inherent limitation of cytotoxic therapies as a result of the generation of cell debris.Chang, J., Bhasin, S. S., Bielenberg, D. R., Sukhatme, V. P., Bhasin, M., Huang, S., Kieran, M. W., Panigrahy, D. Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin.	[Chang, Jaimie; Panigrahy, Dipak] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA USA; [Chang, Jaimie; Panigrahy, Dipak] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA USA; [Chang, Jaimie; Sukhatme, Vikas P.; Panigrahy, Dipak] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Canc, Boston, MA USA; [Bhasin, Swati S.; Bhasin, Manoj] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Interdisciplinary Med & Biol, Boston, MA USA; [Sukhatme, Vikas P.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA; [Bielenberg, Diane R.] Harvard Med Sch, Boston Childrens Hosp, Vasc Biol Program, Boston, MA USA; [Kieran, Mark W.] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat Hematol Oncol, Boston, MA USA; [Bielenberg, Diane R.] Harvard Med Sch, Dept Surg, Boston, MA USA; [Huang, Sui] Inst Syst Biol, Seattle, WA USA; [Kieran, Mark W.] Harvard Med Sch, Dana Farber Canc Inst, Div Pediat Oncol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Institute for Systems Biology (ISB); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Chang, JM; Panigrahy, D (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, 99 Brookline Ave, Boston, MA 02115 USA.	jchang10@rush.edu; dpanigra@bidmc.harvard.edu	Sukhatme, Vikas/W-2776-2019	Bhasin, Swati/0000-0001-8661-1459	U.S. National Institutes of Health, National Cancer Institute [R01-01CA170549-02, R01-CA148633-01A4]; Stop and Shop Pediatric Brain Tumor Fund; C. J. Buckley Pediatric Brain Tumor Fund; Alex Lemonade Stand; Molly's Magic Wand for Pediatric Brain Tumors; Markoff Foundation Art-In-Giving Foundation; Kamen Foundation; Jared Branfman Sunflowers for Life; Joe Andruzzi Foundation; Credit Unions Kids at Heart Team	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stop and Shop Pediatric Brain Tumor Fund; C. J. Buckley Pediatric Brain Tumor Fund; Alex Lemonade Stand; Molly's Magic Wand for Pediatric Brain Tumors; Markoff Foundation Art-In-Giving Foundation; Kamen Foundation; Jared Branfman Sunflowers for Life; Joe Andruzzi Foundation; Credit Unions Kids at Heart Team	The authors thank Steve Moskowitz (Advanced Medical Graphics, Boston, MA, USA) for preparation of the figures; Dr. David Zurakowski (Boston Children's Hospital, Boston, MA, USA) for guidance in statistical analyses; Ricasan Rowley Histology Consultants (Cambridge, MA, USA) for tissue sectioning services; and Drs. Allison Gartung (Beth Israel Deaconess Medical Center, Boston, MA, USA), Bruce Hammock (University of California Davis, Davis, CA, USA), Bruce Zetter, and Randy Watnick (both from Boston Children's Hospital, Boston, MA, USA) for their advice and discussion. This work was supported by U.S. National Institutes of Health, National Cancer Institute Grants R01-01CA170549-02 (to D.P.) and R01-CA148633-01A4 (to D.P.), the Stop and Shop Pediatric Brain Tumor Fund (to M.W.K.), the C. J. Buckley Pediatric Brain Tumor Fund (to M.W.K.), the Alex Lemonade Stand (to M.W.K.), Molly's Magic Wand for Pediatric Brain Tumors (to M.W.K.), the Markoff Foundation Art-In-Giving Foundation (to M.W.K.), the Kamen Foundation (to M.W.K.), Jared Branfman Sunflowers for Life (to M.W.K.), the Joe Andruzzi Foundation (to M.W.K.), and the Credit Unions Kids at Heart Team (to M.W.K.). D.P. has served as an unpaid scientific advisor for Tempest Therapeutics (formerly known as Inception 2, Inc.; San Francisco, CA, USA) since 2011, and owned stock options in the company from 2011 until August 8, 2018. The other authors declare no conflicts of interest.	Abubaker K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-24; Albertsson P, 2009, ACTA ONCOL, V48, P418, DOI 10.1080/02841860802409512; Alcaide J, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-24; Bandopadhyay M, 2014, EXPERT OPIN THER TAR, V18, P883, DOI 10.1517/14728222.2014.925447; Cao K, 2018, INT REV CEL MOL BIO, V337, P135, DOI 10.1016/bs.ircmb.2017.12.003; Cao L, 2015, ONCOTARGET, V6, P6627, DOI 10.18632/oncotarget.3113; Chang YS, 2017, P NATL ACAD SCI USA, V114, pE7159, DOI 10.1073/pnas.1700455114; Chaurio R, 2013, AUTOIMMUNITY, V46, P317, DOI 10.3109/08916934.2012.754433; Correa M, 2005, INT J CANCER, V114, P356, DOI 10.1002/ijc.20673; da Silva IA, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2016.90; Daenen LGM, 2011, CANCER RES, V71, P6976, DOI 10.1158/0008-5472.CAN-11-0627; de Jong JS, 2000, BRIT J CANCER, V82, P368; de Ruiter J, 1979, Eur J Cancer, V15, P1139, DOI 10.1016/0014-2964(79)90130-0; Feng X, 2017, CANCER LETT, V385, P12, DOI 10.1016/j.canlet.2016.10.042; Feng X, 2015, ONCOTARGET, V6, P32353, DOI 10.18632/oncotarget.5898; Flanagan L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.7; Ford CA, 2015, CURR BIOL, V25, P577, DOI 10.1016/j.cub.2014.12.059; Gregory CD, 2011, J PATHOL, V223, P177, DOI 10.1002/path.2792; Gunjal PM, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0141-7; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Himuro T, 2016, ANN SURG ONCOL, V23, P2235, DOI 10.1245/s10434-016-5164-9; Hsu HP, 2010, CANCER BIOL THER, V10, P144, DOI 10.4161/cbt.10.2.12160; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Ichim G, 2016, NAT REV CANCER, V16, P539, DOI 10.1038/nrc.2016.58; Imano M, 2011, AM SURGEON, V77, P1515; Imano M, 2010, WORLD J SURG, V34, P1930, DOI 10.1007/s00268-010-0582-5; Jalalinadoushan Mohammadreza, 2004, Urol J, V1, P177; Kale S, 2014, ONCOGENE, V33, P2295, DOI 10.1038/onc.2013.184; Karagiannis GS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan0026; Kindy MS, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-015-0757-9; Korbelik M, 2007, BRIT J CANCER, V97, P1381, DOI 10.1038/sj.bjc.6604059; LEOPOLD WR, 1981, CANCER RES, V41, P4368; Lin CN, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1114-3; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin HH, 2017, ONCOTARGET, V8, P13805, DOI 10.18632/oncotarget.14638; Liu J, 2014, INT J ONCOL, V45, P282, DOI 10.3892/ijo.2014.2393; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; MURRY CE, 1994, AM J PATHOL, V145, P1450; Naresh KN, 2001, CANCER, V91, P578, DOI 10.1002/1097-0142(20010201)91:3<578::AID-CNCR1037>3.3.CO;2-N; O'Connell MJ, 2008, J CLIN ONCOL, V26, P2336, DOI 10.1200/JCO.2007.15.8261; ORMEROD EJ, 1986, CANCER RES, V46, P884; ORR FW, 1986, CANCER RES, V46, P891; Panigrahy D, 2012, J CLIN INVEST, V122, P178, DOI 10.1172/JCI58128; Pisco AO, 2015, BRIT J CANCER, V112, P1725, DOI 10.1038/bjc.2015.146; Ramchandani D, 2015, BBA-REV CANCER, V1855, P202, DOI 10.1016/j.bbcan.2015.02.003; Rao GH, 2013, CLIN CANCER RES, V19, P785, DOI 10.1158/1078-0432.CCR-12-2788; REVESZ L, 1956, NATURE, V178, P1391, DOI 10.1038/1781391a0; Rittling SR, 1998, BIOCHEM BIOPH RES CO, V250, P287, DOI 10.1006/bbrc.1998.9306; Roca H, 2018, J CLIN INVEST, V128, P248, DOI 10.1172/JCI92466; Sahu RP, 2014, CANCER RES, V74, P7069, DOI 10.1158/0008-5472.CAN-14-2043; Shan CC, 2015, ONCOL LETT, V9, P1549, DOI 10.3892/ol.2015.2977; Sharp JA, 1999, LAB INVEST, V79, P869; Sinicrope FA, 1996, CLIN CANCER RES, V2, P1999; Stanford JC, 2014, J CLIN INVEST, V124, P4737, DOI 10.1172/JCI76375; Sulciner ML, 2018, J EXP MED, V215, P115, DOI 10.1084/jem.20170681; Sun BC, 2006, EUR J CANCER PREV, V15, P258, DOI 10.1097/01.cej.0000198896.02185.68; Volk-Draper L, 2014, CANCER RES, V74, P5421, DOI 10.1158/0008-5472.CAN-14-0067; Weber CE, 2015, ONCOGENE, V34, P4821, DOI 10.1038/onc.2014.410; Weigert A, 2016, ADV EXP MED BIOL, V930, P205, DOI 10.1007/978-3-319-39406-0_9; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xu ST, 2015, MOL MED REP, V11, P3701, DOI 10.3892/mmr.2015.3202; Yang L, 2012, MOL MED REP, V5, P373, DOI 10.3892/mmr.2011.679; Zhang H, 2014, CELL PHYSIOL BIOCHEM, V33, P991, DOI 10.1159/000358670	66	23	23	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					114	125		10.1096/fj.201800019RR	http://dx.doi.org/10.1096/fj.201800019RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29957058	Green Published, hybrid			2022-12-26	WOS:000457401500009
J	Boffito, M; Di Meglio, F; Mozetic, P; Giannitelli, SM; Carmagnola, I; Castaldo, C; Nurzynska, D; Sacco, AM; Miraglia, R; Montagnani, S; Vitale, N; Brancaccio, M; Tarone, G; Basoli, F; Rainer, A; Trombetta, M; Ciardelli, G; Chiono, V				Boffito, Monica; Di Meglio, Franca; Mozetic, Pamela; Giannitelli, Sara Maria; Carmagnola, Irene; Castaldo, Clotilde; Nurzynska, Daria; Sacco, Anna Maria; Miraglia, Rita; Montagnani, Stefania; Vitale, Nicoletta; Brancaccio, Mara; Tarone, Guido; Basoli, Francesco; Rainer, Alberto; Trombetta, Marcella; Ciardelli, Gianluca; Chiono, Valeria			Surface functionalization of polyurethane scaffolds mimicking the myocardial microenvironment to support cardiac primitive cells	PLOS ONE			English	Article							PROGENITOR CELLS; STEM-CELLS; IN-VITRO; LAMININ; HEART; DESIGN; NANOPARTICLES; EXPRESSION; PATCHES; GROWTH	Scaffolds populated with human cardiac progenitor cells (CPCs) represent a therapeutic opportunity for heart regeneration after myocardial infarction. In this work, square-grid scaffolds are prepared by melt-extrusion additive manufacturing from a polyurethane (PU), further subjected to plasma treatment for acrylic acid surface grafting/polymerization and finally grafted with laminin-1 (PU-LN1) or gelatin (PU-G) by carbodiimide chemistry. LN1 is a cardiac niche extracellular matrix component and plays a key role in heart formation during embryogenesis, while G is a low-cost cell-adhesion protein, here used as a control functionalizing molecule. X-ray photoelectron spectroscopy analysis shows nitrogen percentage increase after functionalization. O1s and C1s core-level spectra and static contact angle measurements show changes associated with successful functionalization. ELISA assay confirms LN1 surface grafting. PU-G and PU-LN1 scaffolds both improve CPC adhesion, but LN1 functionalization is superior in promoting proliferation, protection from apoptosis and expression of differentiation markers for cardiomyocytes, endothelial and smooth muscle cells. PU-LN1 and PU scaffolds are biodegraded into non-cytotoxic residues. Scaffolds subcutaneously implanted in mice evoke weak inflammation and integrate with the host tissue, evidencing a significant blood vessel density around the scaffolds. PU-LN1 scaffolds show their superiority in driving CPC behavior, evidencing their promising role in myocardial regenerative medicine.	[Boffito, Monica; Carmagnola, Irene; Ciardelli, Gianluca; Chiono, Valeria] Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy; [Di Meglio, Franca; Castaldo, Clotilde; Nurzynska, Daria; Sacco, Anna Maria; Miraglia, Rita; Montagnani, Stefania] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Mozetic, Pamela; Giannitelli, Sara Maria; Basoli, Francesco; Rainer, Alberto; Trombetta, Marcella] Univ Campus Biomed Roma, Tissue Engn Unit, Dept Engn, Rome, Italy; [Mozetic, Pamela] St Annes Univ Hosp, Int Clin Res Ctr, Ctr Translat Med, Brno, Czech Republic; [Vitale, Nicoletta; Brancaccio, Mara; Tarone, Guido] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Rainer, Alberto] CNR, Inst Photon & Nanotechnol, Rome, Italy	Polytechnic University of Turin; University of Naples Federico II; University Campus Bio-Medico - Rome Italy; St Anne's University Hospital Brno (FNUSA-ICRC); University of Turin; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR)	Chiono, V (corresponding author), Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy.	valeria.chiono@polito.it	Rainer, Alberto/G-8588-2011; Giannitelli, Sara Maria/AAC-1819-2019; Nurzynska, Daria/A-2161-2010; Mozetic, Pamela/AAE-3850-2021; Ciardelli, Gianluca/ABC-2531-2020; Basoli, Francesco/AAC-7390-2020	Rainer, Alberto/0000-0001-8971-551X; Giannitelli, Sara Maria/0000-0002-3616-5953; Nurzynska, Daria/0000-0003-1092-6168; Mozetic, Pamela/0000-0001-8641-0526; Ciardelli, Gianluca/0000-0003-0199-1427; Basoli, Francesco/0000-0003-0549-0048; Trombetta, Marcella/0000-0002-1357-4885; Chiono, Valeria/0000-0003-2067-7732; Castaldo, Clotilde/0000-0003-1475-5036; Vitale, Nicoletta/0000-0001-6677-2597; Boffito, Monica/0000-0001-7637-2001	MIUR-FIRB [RBFR10L0GK]; European Social Fund; European Regional Development Fund [CZ.02.1.01/0.0/0.0/15_003/0000492]	MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); European Social Fund(European Social Fund (ESF)); European Regional Development Fund(European Commission)	This work was entirely supported by MIUR-FIRB 2010 Future in Research (grant # RBFR10L0GK to VC). PM acknowledges funding from the European Social Fund and the European Regional Development Fund (CZ.02.1.01/0.0/0.0/15_003/0000492 "Unveiling the molecular determinants of aging to design new therapeutics - MAGNET").	Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Boccardo S, 2016, ACTA BIOMATER, V42, P127, DOI 10.1016/j.actbio.2016.07.041; Boffito M, 2016, POLYM INT, V65, P756, DOI 10.1002/pi.5080; Boffito M, 2015, J BIOMED MATER RES A, V103, P162, DOI 10.1002/jbm.a.35147; Boffito M, 2014, POLYM INT, V63, P2, DOI 10.1002/pi.4608; Cao F, 2007, STEM CELLS DEV, V16, P883, DOI 10.1089/scd.2007.0160; Castaldo C, 2008, STEM CELLS, V26, P1723, DOI 10.1634/stemcells.2007-0732; Castaldo C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/352370; Cauich-Rodriguez J.V., 2013, ADV BIOMATERIALS SCI, P51, DOI DOI 10.5772/53681; Chiono V, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0045; Chitteti BR, 2010, BLOOD, V115, P3239, DOI 10.1182/blood-2009-09-246173; Ciocci M, 2017, STEM CELLS DEV, V26, P1438, DOI 10.1089/scd.2017.0051; Cristallini C, 2014, BIOMATERIALS, V35, P92, DOI 10.1016/j.biomaterials.2013.09.058; De Arcangelis A, 1996, J CELL BIOL, V133, P417, DOI 10.1083/jcb.133.2.417; Desmet T, 2010, MACROMOL BIOSCI, V10, P1484, DOI 10.1002/mabi.201000147; Dubey G, 2011, ACTA BIOMATER, V7, P1114, DOI 10.1016/j.actbio.2010.11.010; Ferreira AM, 2014, J BIOMED MATER RES A, V102, P4394, DOI 10.1002/jbm.a.35121; Ferreira AM, 2013, SURF COAT TECH, V223, P92, DOI 10.1016/j.surfcoat.2013.02.035; Forte G, 2008, STEM CELLS, V26, P2093, DOI 10.1634/stemcells.2008-0061; Gaetani R, 2015, BIOMATERIALS, V61, P339, DOI 10.1016/j.biomaterials.2015.05.005; Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003; Gambini E, 2011, CARDIOVASC RES, V89, P362, DOI 10.1093/cvr/cvq292; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Giannitelli SM, 2015, MAT SCI ENG C-MATER, V51, P329, DOI 10.1016/j.msec.2015.03.002; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Hayashi M, 2004, CELL TRANSPLANT, V13, P639, DOI 10.3727/000000004783983558; Hsu SH, 2013, ACTA BIOMATER, V9, P6606, DOI 10.1016/j.actbio.2013.01.025; Itzhaki-Alfia A, 2009, CIRCULATION, V120, P2559, DOI 10.1161/CIRCULATIONAHA.109.849588; Kailasa SK, 2012, ANALYST, V137, P1629, DOI 10.1039/c2an16008k; Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177; Kim DH, 2012, INTEGR BIOL-UK, V4, P1019, DOI 10.1039/c2ib20067h; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Liau B, 2011, BIOMATERIALS, V32, P9180, DOI 10.1016/j.biomaterials.2011.08.050; Liu QH, 2015, ACTA BIOMATER, V26, P105, DOI 10.1016/j.actbio.2015.08.017; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Mauretti A, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/7471582; Mengsteab PY, 2016, BIOMATERIALS, V86, P1, DOI 10.1016/j.biomaterials.2016.01.062; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]; Oyama T, 2007, J CELL BIOL, V176, P329, DOI 10.1083/jcb.200603014; Rainer A, 2012, P 4 IEEE RAS EMBS IN; Rainer A, 2012, ANN BIOMED ENG, V40, P966, DOI 10.1007/s10439-011-0465-4; Rajabi-Zeleti S, 2014, BIOMATERIALS, V35, P970, DOI 10.1016/j.biomaterials.2013.10.045; Rangappa N, 2000, J BIOMED MATER RES, V51, P625, DOI 10.1002/1097-4636(20000915)51:4<625::AID-JBM10>3.0.CO;2-U; Sartori S, 2008, REACT FUNCT POLYM, V68, P809, DOI 10.1016/j.reactfunctpolym.2007.12.002; Sartori S, 2013, REACT FUNCT POLYM, V73, P1366, DOI 10.1016/j.reactfunctpolym.2013.01.006; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; Seyedmahmoud R, 2015, J BIOMED MATER RES A, V103, P91, DOI 10.1002/jbm.a.35153; Silvestri A, 2014, J BIOMED MATER RES B, V102, P1002, DOI 10.1002/jbm.b.33081; Silvestri A, 2013, MACROMOL BIOSCI, V13, P984, DOI 10.1002/mabi.201200483; Smith AST, 2017, CHEM COMMUN, V53, P7412, DOI 10.1039/c7cc01988b; Stoppel WL, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/034105; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Townsend N, 2015, EUR HEART J, V36, P2673; Tsui JH, 2017, ACS NANO, V11, P11954, DOI 10.1021/acsnano.7b00186; Xie JW, 2012, J BIOMED MATER RES A, V100A, P929, DOI 10.1002/jbm.a.34030; Xu CC, 2015, ACS APPL MATER INTER, V7, P20377, DOI 10.1021/acsami.5b06242; Zander NE, 2012, ACS APPL MATER INTER, V4, P2074, DOI 10.1021/am300045y; Zander NE, 2010, BIOINTERPHASES, V5, P149, DOI 10.1116/1.3526140	61	34	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199896	10.1371/journal.pone.0199896	http://dx.doi.org/10.1371/journal.pone.0199896			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979710	Green Published, gold			2022-12-26	WOS:000437809500042
J	Ding, Y; Li, HG; He, XJ; Liao, W; Yi, ZW; Yi, J; Chen, ZB; Moore, DJ; Yi, YJ; Xiang, W				Ding, Yan; Li, Hongai; He, Xiaojie; Liao, Wang; Yi, Zhuwen; Yi, Jia; Chen, Zhibin; Moore, Daniel J.; Yi, Yajun; Xiang, Wei			Identification of a gene-expression predictor for diagnosis and personalized stratification of lupus patients	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; PROSTATE-CANCER; ERYTHEMATOSUS; INTERFERON; SIGNATURES; NEPHRITIS; DISEASE; BLOOD; CELLS	Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by a wide spectrum of clinical manifestations and degrees of severity. Few genomic biomarkers for SLE have been validated and employed to inform clinical classifications and decisions. To discover and assess the gene-expression based SLE predictors in published studies, we performed a meta-analysis using our established signature database and a data similarity-driven strategy. From 13 training data sets on SLE gene-expression studies, we identified a SLE meta-signature (SLEmetaSig100) containing 100 concordant genes that are involved in DNA sensors and the IFN signaling pathway. We rigorously examined SLEmetaSig100 with both retrospective and prospective validation in two independent data sets. Using unsupervised clustering, we retrospectively elucidated that SLEmetaSig100 could classify clinical samples into two groups that correlated with SLE disease status and disease activities. More importantly, SLEmetaSig100 enabled personalized stratification demonstrating its ability to prospectively predict SLE disease at the individual patient level. To evaluate the performance of SLEmetaSig100 in predicting SLE, we predicted 1,171 testing samples to be either non-SLE or SLE with positive predictive value (97-99%), specificity (85%-84%), and sensitivity (60-84%). Our study suggests that SLEmetaSig100 has enhanced predictive value to facilitate current SLE clinical classification and provides personalized disease activity monitoring.	[Ding, Yan] Hainan Prov Dermatol Dis Hosp, Dept Dermatol, Haikou, Hainan, Peoples R China; [Li, Hongai] Univ South China, Pediat, Hainan Affiliated Hosp, Haikou, Hainan, Peoples R China; [He, Xiaojie; Yi, Zhuwen] Cent S Univ, Xiangya Hosp 2, Childrens Med Ctr, Dept Nephropathy, Changsha, Hunan, Peoples R China; [Liao, Wang] Hainan Gen Hosp, Dept Cardiol, Haikou, Hainan, Peoples R China; [Yi, Jia] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC USA; [Chen, Zhibin] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Moore, Daniel J.] Vanderbilt Univ, Dept Pediat & Pathol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Moore, Daniel J.] Vanderbilt Univ, Dept Microbiol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Moore, Daniel J.] Vanderbilt Univ, Dept Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Yi, Yajun] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA; [Xiang, Wei] Maternal & Child Hlth Care Hosp Hainan Prov, Dept Pediat, Haikou, Hainan, Peoples R China	University of South China; Central South University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Miami; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Yi, YJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA.; Xiang, W (corresponding author), Maternal & Child Hlth Care Hosp Hainan Prov, Dept Pediat, Haikou, Hainan, Peoples R China.	Yajun.Yi@vanderbilt.edu; 13907533529@163.com	Moore, Daniel/V-6145-2019; Moore, Daniel J/A-4924-2008	Moore, Daniel/0000-0002-6889-9345; Moore, Daniel J/0000-0002-6889-9345; Xiang, Wei/0000-0002-1897-3738; Yi, Yajun/0000-0002-7135-6325	Natural Science Foundation of China [81260139, 81060073, 81560275, 61562021, 30560161]; Hainan Natural Science Foundation Innovation Research Team Project [2018CXTD350]; Hainan special projects of Social Development [2015SF39, ZDYF2018103]; Hainan Association for academic excellence Youth Science and Technology Innovation Program [201515]; Hainan Natural Science Foundation of China [805106]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hainan Natural Science Foundation Innovation Research Team Project; Hainan special projects of Social Development; Hainan Association for academic excellence Youth Science and Technology Innovation Program; Hainan Natural Science Foundation of China	This study was supported by the grants (81260139, 81060073, 81560275, 61562021 to WX, 30560161 to YD) from Natural Science Foundation of China; the grant (2018CXTD350 to YD) from Hainan Natural Science Foundation Innovation Research Team Project; the grant (2015SF39 to YD, ZDYF2018103 to WX) from Hainan special projects of Social Development; the grant (201515 to YD) from Hainan Association for academic excellence Youth Science and Technology Innovation Program; and the grant (805106 to YD) from Hainan Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon-Levin N, 2012, AUTOIMMUN REV, V11, P593, DOI 10.1016/j.autrev.2011.10.020; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacob N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3349; Jin RJ, 2014, CANCER RES, V74, P2763, DOI 10.1158/0008-5472.CAN-13-2543; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Koenig KF, 2012, CYTOKINE, V60, P410, DOI 10.1016/j.cyto.2012.07.004; Komatsuda A, 2008, CLIN EXP IMMUNOL, V152, P482, DOI 10.1111/j.1365-2249.2008.03646.x; Lartigue A, 2009, J IMMUNOL, V183, P6207, DOI 10.4049/jimmunol.0803219; Lukes L, 2009, CANCER RES, V69, P310, DOI 10.1158/0008-5472.CAN-08-3520; Margolin AA, 2005, BIOINFORMATICS, V21, P3308, DOI 10.1093/bioinformatics/bti500; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Niewold TB, 2008, JCR-J CLIN RHEUMATOL, V14, P131, DOI 10.1097/RHU.0b013e318177627d; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Patole PS, 2006, NEPHROL DIAL TRANSPL, V21, P3062, DOI 10.1093/ndt/gfl336; Patole PS, 2005, J AM SOC NEPHROL, V16, P1326, DOI 10.1681/ASN.2004100820; Petri M, 2009, LUPUS, V18, P980, DOI 10.1177/0961203309105529; Qiu QC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054979; RONNBLOM LE, 1990, J INTERN MED, V227, P207; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wu J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-420; Wu YW, 2015, ACTA PHARMACOL SIN, V36, P1395, DOI 10.1038/aps.2015.91; Xiang YZ, 2013, MOL ONCOL, V7, P1019, DOI 10.1016/j.molonc.2013.07.008; Yi YJ, 2015, J UROLOGY, V194, P1762, DOI 10.1016/j.juro.2015.04.090; Yi YJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r133; Zhang HS, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0056-4; Zheng L, 2006, VIRCHOWS ARCH, V448, P172, DOI 10.1007/s00428-005-0061-9; Zheng L, 2008, J HISTOCHEM CYTOCHEM, V56, P517, DOI 10.1369/jhc.7A7368.2008	38	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0198325	10.1371/journal.pone.0198325	http://dx.doi.org/10.1371/journal.pone.0198325			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975701	gold, Green Submitted, Green Published			2022-12-26	WOS:000437424500007
J	Gelonch, O; Garolera, M; Valls, J; Castella, G; Varela, O; Rossello, L; Pifarre, J				Gelonch, Olga; Garolera, Maite; Valls, Joan; Castella, Gerard; Varela, Olalla; Rossello, Lluis; Pifarre, Josep			The effect of depressive symptoms on cognition in patients with fibromyalgia	PLOS ONE			English	Article							EXECUTIVE FUNCTION; MAJOR DEPRESSION; HEALTHY CONTROLS; WORKING-MEMORY; CHRONIC PAIN; DYSFUNCTION	Background Fibromyalgia (FM) patients frequently complain of cognitive problems, but it remains unclear whether these cognitive complaints can be attributed to a dysfunction of the central nervous system or if they can be explained by other factors associated with the disease, such as depression, anxiety and sleep dysfunction. Methods One hundred and ten patients with FM were compared with thirty-three patients diagnosed with a depressive disorder (DD) and fifty healthy controls (HC). Several measures of attention and executive functions were used to make these comparisons and the patients were also asked to complete questionnaires on depression, anxiety and sleep quality. Univariate analyses of covariance (ANCOVA) were performed to identify and control confounders and multiple linear models were used to examine the effects of fibromyalgia and depression on cognitive measures. Results FM and HC differed significantly with respect to depression, anxiety and sleep dysfunction, whereas FM and DD did not differ in terms of symptoms of depression and anxiety. However, FM was associated with a worse quality of sleep than DD. Comparisons of cognitive performance between groups showed that short-term and working memory and inattention measures were only associated with symptoms of depression, whereas selective attention was associated with both depression and fibromyalgia, and processing speed, cognitive flexibility and inhibitory control showed a significant interaction between depression and fibromyalgia. Moreover, cognitive flexibility and inhibition abilities were specifically associated with FM. Conclusion FM patients show a cluster of cognitive impairment in the attentional and executive domains, although some of the symptoms observed could be explained by the severity of the symptoms of depression, while others seem to depend on the effects of fibromyalgia. Implications of the findings for the understanding and management of cognitive impairment of FM patients are discussed.	[Gelonch, Olga; Pifarre, Josep] Univ Lleida, Lleida, Spain; [Gelonch, Olga; Garolera, Maite] Consorci Sanitari Terrassa, Brain Cognit & Behav Clin Res, Terrassa, Spain; [Garolera, Maite] Consorci Sanitari Terrassa, Neuropsychol Unit, Hosp Terrassa, Terrassa, Spain; [Valls, Joan; Castella, Gerard; Pifarre, Josep] Dr Pifarre Fdn, Lleida Inst Biomed Res, IRBLLEDA, Lleida, Spain; [Varela, Olalla] Hosp Arnau Vilanova, Lleida, Spain; [Rossello, Lluis] GSS Hosp Univ Santa Maria, Fibromyalgia & Chron Fatigue Syndrome Unit, Reumatol Sect, Lleida, Spain; [Pifarre, Josep] GSS Hosp Univ Santa Maria, Lleida, Spain; [Pifarre, Josep] St Joan de Deu Terres Lleida, Lleida, Spain	Universitat de Lleida; University Hospital Arnau de Vilanova	Pifarre, J (corresponding author), Univ Lleida, Lleida, Spain.; Pifarre, J (corresponding author), Dr Pifarre Fdn, Lleida Inst Biomed Res, IRBLLEDA, Lleida, Spain.; Pifarre, J (corresponding author), GSS Hosp Univ Santa Maria, Lleida, Spain.; Pifarre, J (corresponding author), St Joan de Deu Terres Lleida, Lleida, Spain.	pifarre1@comll.cat	Valls, Joan/GXM-6532-2022; GELONCH, OLGA/P-6406-2018; Garolera, Maite/A-3109-2015; Pifarre, Josep/B-5884-2009	GELONCH, OLGA/0000-0002-0788-2486; Garolera, Maite/0000-0001-7443-8249; Pifarre, Josep/0000-0001-6284-4709	Biomedical Research Institute of Lleida (IRB-Lleida) funds	Biomedical Research Institute of Lleida (IRB-Lleida) funds	This work was supported in part by Biomedical Research Institute of Lleida (IRB-Lleida) funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berryman C, 2014, CLIN PSYCHOL REV, V34, P563, DOI 10.1016/j.cpr.2014.08.003; Berryman C, 2013, PAIN, V154, P1181, DOI 10.1016/j.pain.2013.03.002; Dick BD, 2008, PAIN, V139, P610, DOI 10.1016/j.pain.2008.06.017; Gelonch O, 2016, COMPR PSYCHIAT, V66, P113, DOI 10.1016/j.comppsych.2016.01.002; Gelonch O, 2013, REV NEUROLOGIA, V56, P573, DOI 10.33588/rn.5611.2013016; Glass JM, 2009, RHEUM DIS CLIN N AM, V35, P299, DOI 10.1016/j.rdc.2009.06.002; Landro NI, 1997, J PSYCHOSOM RES, V42, P297, DOI 10.1016/S0022-3999(96)00301-7; Leavitt F, 2008, JCR-J CLIN RHEUMATOL, V14, P214, DOI 10.1097/RHU.0b013e31817a2472; Shmygalev S, 2014, PAIN THER, V3, P85, DOI 10.1007/s40122-014-0028-0; SLETVOLD H, 1995, J RHEUMATOL, V22, P137; Tesio V, 2015, ARTHRIT CARE RES, V67, P143, DOI 10.1002/acr.22403; Verdejo-Garcia A, 2009, ARCH CLIN NEUROPSYCH, V24, P113, DOI 10.1093/arclin/acp014; Walitt B, 2008, RHEUMATOL INT, V28, P561, DOI 10.1007/s00296-007-0487-2; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140	14	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0200057	10.1371/journal.pone.0200057	http://dx.doi.org/10.1371/journal.pone.0200057			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL7YG	29975749	Green Published, gold, Green Submitted			2022-12-26	WOS:000437424500063
J	Wang, QP; Browman, D; Herzog, H; Neely, GG				Wang, Qiao-Ping; Browman, Duncan; Herzog, Herbert; Neely, G. Gregory			Non-nutritive sweeteners possess a bacteriostatic effect and alter gut microbiota in mice	PLOS ONE			English	Article							STEVIA-REBAUDIANA BERTONI; WEIGHT-GAIN; BODY-WEIGHT; ARTIFICIAL SWEETENERS; FOOD-INTAKE; SUCRALOSE; SACCHARIN; GLUCOSE; OBESITY; GLYCOSIDES	Non-nutritive sweeteners (NNSs) are widely used in various food products and soft drinks. There is growing evidence that NNSs contribute to metabolic dysfunction and can affect body weight, glucose tolerance, appetite, and taste sensitivity. Several NNSs have also been shown to have major impacts on bacterial growth both in vitro and in vivo. Here we studied the effects of various NNSs on the growth of the intestinal bacterium, E. coli, as well as the gut bacterial phyla Bacteroidetes and Firmicutes, the balance between which is associated with gut health. We found that the synthetic sweeteners acesulfame potassium, saccharin and sucralose all exerted strong bacteriostatic effects. We found that rebaudioside A, the active ingredient in the natural NNS stevia, also had similar bacteriostatic properties, and the bacteriostatic effects of NNSs varied among different Escherichia coli strains. In mice fed a chow diet, sucralose increased Firmicutes, and we observed a synergistic effect on Firmicutes when sucralose was provided in the context of a high-fat diet. In summary, our data show that NNSs have direct bacteriostatic effects and can change the intestinal microbiota in vivo.	[Wang, Qiao-Ping; Neely, G. Gregory] Univ Sydney, Charles Perkins Ctr, Dr John & Anne Chong Lab Funct Genom, Camperdown, NSW, Australia; [Wang, Qiao-Ping; Neely, G. Gregory] Univ Sydney, Sch Life & Environm Sci, Camperdown, NSW, Australia; [Wang, Qiao-Ping] Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou, Guangdong, Peoples R China; [Browman, Duncan; Herzog, Herbert] Garvan Inst Med Res, Neurosci Div, Sydney, NSW, Australia	University of Sydney; University of Sydney; Sun Yat Sen University; Garvan Institute of Medical Research	Wang, QP; Neely, GG (corresponding author), Univ Sydney, Charles Perkins Ctr, Dr John & Anne Chong Lab Funct Genom, Camperdown, NSW, Australia.; Wang, QP; Neely, GG (corresponding author), Univ Sydney, Sch Life & Environm Sci, Camperdown, NSW, Australia.; Wang, QP (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou, Guangdong, Peoples R China.	wangqp7@mail.sysu.edu.cn; greg.neely@sydney.edu.au	Neely, Greg/AAB-4642-2020	Neely, Greg/0000-0002-1957-9732; , Herbert/0000-0002-1713-1029; Wang, Qiao-Ping/0000-0003-2809-6457	NHMRC [APP1026310, APP1029672, APP1028887, APP1046090, APP1042416, APP1086851]; NHMRC career development fellowship II [CDF1111940]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC career development fellowship II(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part through NHMRC project grants APP1026310, APP1029672, APP1028887, APP1046090, APP1042416, APP1086851. G.G.N. is supported by an NHMRC career development fellowship II CDF1111940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Donia MB, 2008, J TOXICOL ENV HEAL A, V71, P1415, DOI 10.1080/15287390802328630; ANDERSON RL, 1980, FOOD COSMET TOXICOL, V18, P353, DOI 10.1016/0015-6264(80)90188-1; Azad MB, 2017, CAN MED ASSOC J, V189, pE929, DOI 10.1503/cmaj.161390; Azad MB, 2016, JAMA PEDIATR, V170, P662, DOI 10.1001/jamapediatrics.2016.0301; Bian XM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178426; BOWEN WH, 1992, J DENT RES, V71, P1166, DOI 10.1177/00220345920710050701; Ceunen S, 2013, J NAT PROD, V76, P1201, DOI 10.1021/np400203b; de la Hunty A, 2006, NUTR BULL, V31, P115, DOI 10.1111/j.1467-3010.2006.00564.x; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Denina I, 2014, LETT APPL MICROBIOL, V58, P278, DOI 10.1111/lam.12187; Feijo FD, 2013, APPETITE, V60, P203, DOI 10.1016/j.appet.2012.10.009; Fowler SPG, 2016, PHYSIOL BEHAV, V164, P517, DOI 10.1016/j.physbeh.2016.04.047; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Lemus-Mondaca R, 2012, FOOD CHEM, V132, P1121, DOI 10.1016/j.foodchem.2011.11.140; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lohner S, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0278-x; McCaughey SA, 2008, NEUROSCI BIOBEHAV R, V32, P1024, DOI 10.1016/j.neubiorev.2008.04.002; Nettleton JE, 2016, PHYSIOL BEHAV, V164, P488, DOI 10.1016/j.physbeh.2016.04.029; Oksanen J., 2019, R PACKAGE VERSION; Omran A, 2013, J TOXICOL-US, V2013, DOI 10.1155/2013/372986; Omran AP, 2013, FASEB J, V27; Palmnas MSA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109841; PFEFFER M, 1985, Z ERNAHRUNGSWISS, V24, P231, DOI 10.1007/BF02023668; Prashant G M, 2012, J Contemp Dent Pract, V13, P749; Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721; Rogers PJ, 2016, INT J OBESITY, V40, P381, DOI 10.1038/ijo.2015.177; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; STELLMAN SD, 1988, APPETITE, V11, P85, DOI 10.1016/0195-6663(88)90048-7; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Swithers SE, 2008, BEHAV NEUROSCI, V122, P161, DOI 10.1037/0735-7044.122.1.161; Swithers SE, 2013, BEHAV NEUROSCI, V127, P262, DOI 10.1037/a0031717; Swithers SE, 2012, BEHAV BRAIN RES, V233, P1, DOI 10.1016/j.bbr.2012.04.024; Swithers SE, 2010, APPETITE, V55, P528, DOI 10.1016/j.appet.2010.08.021; Tomita T, 1997, MICROBIOL IMMUNOL, V41, P1005, DOI 10.1111/j.1348-0421.1997.tb01961.x; Uebanso T, 2017, NUTRIENTS, V9, DOI [10.3390/nu9060662, 10.3390/nu9060560]; Wang QP, 2017, CELL METAB, V26, P279, DOI 10.1016/j.cmet.2017.07.002; Wang QP, 2016, CELL METAB, V24, P75, DOI 10.1016/j.cmet.2016.06.010; YOUNG DA, 1990, J DENT RES, V69, P1480, DOI 10.1177/00220345900690080601; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27; Zhu YY, 2016, AM J CLIN NUTR, V103, P794, DOI 10.3945/ajcn.115.121780	43	71	73	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2018	13	7							e0199080	10.1371/journal.pone.0199080	http://dx.doi.org/10.1371/journal.pone.0199080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL7YG	29975731	Green Published, Green Submitted, gold			2022-12-26	WOS:000437424500021
J	Maier, MB; Schweiger, T; Lenz, CA; Vogel, RF				Maier, Maximilian B.; Schweiger, Tobias; Lenz, Christian A.; Vogel, Rudi F.			Inactivation of non-proteolytic Clostridium botulinum type E in low-acid foods and phosphate buffer by heat and pressure	PLOS ONE			English	Article							BACILLUS-AMYLOLIQUEFACIENS SPORES; BACTERIAL-SPORES; THERMAL INACTIVATION; STEAROTHERMOPHILUS SPORES; SPORULATION MEDIUM; HIGH-TEMPERATURE; SURVIVAL CURVES; KINETICS; STERILIZATION; ENDOSPORES	The effect of high pressure thermal (HPT) treatments on the inactivation of spores of nonproteolytic type E Clostridium botulinum TMW 2.990 was investigated at high pressures (300 to 600 MPa) and elevated temperatures (80 to 100 degrees C) in four low-acid foods (steamed sole, green peas with ham, vegetable soup, braised veal) and imidazole phosphate buffer (IPB). In addition, corresponding conventional thermal treatments at ambient pressure were performed to expose possible synergisms of pressure and temperature on spore inactivation. In general, spore count reduction was more efficient by combining pressure and temperatures < 100 degrees C and the overall process duration could be shortened due to accelerated heating rates (adiabatic effect). Processing at 90 degrees C and 600 MPa resulted in inactivation below the detection limit after 5 min in all foods except steamed sole. Traditional thermal processing of spores at 90 degrees C for 10 min, on the other hand, did not result in an estimated 6log reduction. Additional HPT treatments in steamed sole and IPB did not reveal pronounced food matrix dependent protective effects. Here, varying pressure levels did not appear to be the driving force for spore count reduction in steamed sole at any temperature. By applying a Weibull distribution on destruction kinetics of isobaric/isothermal holding times, 6D-values were calculated. Compression and decompression phase (1 s pressure holding time) had a considerable impact on spore count reduction (max. -2.9 log units) in both, foods and buffer. Hence, compression and decompression phases should directly be included into the total lethal effect of HPT treatments to avoid prolonged holding times and overprocessing.	[Maier, Maximilian B.; Schweiger, Tobias; Lenz, Christian A.; Vogel, Rudi F.] Tech Univ Munich, Lehrstuhl Tech Mikrobiol, Freising Weihenstephan, Germany	Technical University of Munich	Vogel, RF (corresponding author), Tech Univ Munich, Lehrstuhl Tech Mikrobiol, Freising Weihenstephan, Germany.	rudi.vogel@wzw.tum.de		Lenz, Christian/0000-0001-6700-5955	European Union's Horizon 2020 research and innovation program [635643]; German Research Foundation (DFG); Technical University of Munich (TUM)	European Union's Horizon 2020 research and innovation program; German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM)	This work was supported by the European Union's Horizon 2020 research and innovation program grant No 635643, https://ec.europa.eu/programmes/horizon2020/; German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. The funders did not have any influence on the setup and design of this study, nor in the discussion or representation of results.	ACMSF, 1995, REC PROD PREP CHILL; Ahn J, 2007, INT J FOOD MICROBIOL, V113, P321, DOI 10.1016/j.ijfoodmicro.2006.08.012; [Anonymous], THESIS; [Anonymous], THESIS; Artin I, 2008, APPL ENVIRON MICROB, V74, P2391, DOI 10.1128/AEM.02587-07; Bull MK, 2009, APPL ENVIRON MICROB, V75, P434, DOI 10.1128/AEM.01426-08; CERF O, 1977, J APPL BACTERIOL, V42, P1, DOI 10.1111/j.1365-2672.1977.tb00665.x; FSA, 2008, GUID SAF SHELF LIF V; Graham AF, 1997, LETT APPL MICROBIOL, V24, P95, DOI 10.1046/j.1472-765X.1997.00348.x; Hielm S, 1998, APPL ENVIRON MICROB, V64, P4161; Knoerzer K, 2010, J FOOD ENG, V96, P229, DOI 10.1016/j.jfoodeng.2009.07.017; Koutchma T, 2005, J FOOD PROCESS ENG, V28, P610, DOI 10.1111/j.1745-4530.2005.00043.x; Lenz CA, 2017, EFFECT HIGH HYDROSTA; Lenz CA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00652; Lenz CA, 2014, HIGH PRESSURE RES, V34, P412, DOI 10.1080/08957959.2014.975699; Lenz CA, 2015, FOOD MICROBIOL, V46, P434, DOI 10.1016/j.fm.2014.09.005; Lenz CA, 2014, FOOD MICROBIOL, V44, P156, DOI 10.1016/j.fm.2014.05.010; Lindstrom M, 2003, APPL ENVIRON MICROB, V69, P4029, DOI 10.1128/AEM.69.7.4029-4036.2003; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; Maier MB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187023; Margosch D, 2004, J FOOD PROTECT, V67, P2530, DOI 10.4315/0362-028X-67.11.2530; Margosch D, 2004, APPL ENVIRON MICROB, V70, P7321, DOI 10.1128/AEM.70.12.7321-7328.2004; Margosch D, 2006, APPL ENVIRON MICROB, V72, P3476, DOI 10.1128/AEM.72.5.3476-3481.2006; Mathys A, 2009, HIGH PRESSURE RES, V29, P3, DOI 10.1080/08957950802526469; Mathys A, 2007, J FOOD ENG, V81, P380, DOI 10.1016/j.jfoodeng.2006.11.012; Norton T, 2008, FOOD BIOPROCESS TECH, V1, P2, DOI 10.1007/s11947-007-0007-0; Patazca E, 2006, J FOOD SCI, V71, pM110, DOI 10.1111/j.1365-2621.2006.tb15633.x; Peck MW, 2006, J APPL MICROBIOL, V101, P556, DOI 10.1111/j.1365-2672.2006.02987.x; Peleg M, 1998, CRIT REV FOOD SCI, V38, P353, DOI 10.1080/10408699891274246; Rajan S, 2006, J FOOD PROTECT, V69, P853, DOI 10.4315/0362-028X-69.4.853; Rajan S, 2006, LWT-FOOD SCI TECHNOL, V39, P844, DOI 10.1016/j.lwt.2005.06.008; Ratphitagsanti W, 2009, J FOOD PROTECT, V72, P775, DOI 10.4315/0362-028X-72.4.775; Reddy NR, 2006, INNOV FOOD SCI EMERG, V7, P169, DOI 10.1016/j.ifset.2006.03.002; Reddy NR, 1999, J FOOD SAFETY, V19, P277, DOI 10.1111/j.1745-4565.1999.tb00252.x; Reineke K, 2013, TRENDS MICROBIOL, V21, P296, DOI 10.1016/j.tim.2013.03.001; Rodriguez AC, 2004, J FOOD SCI, V69, pE367, DOI 10.1111/j.1365-2621.2004.tb09897.x; SCHMIDT CF, 1961, J FOOD SCI, V26, P626, DOI 10.1111/j.1365-2621.1961.tb00807.x; Schnabel J, 2015, HIGH PRESSURE RES, V35, P78, DOI 10.1080/08957959.2014.999057; Setlow P., 2011, RESISTANCE BACTERIAL; Skinner GE, 2018, J FOOD PROTECT, V81, P261, DOI 10.4315/0362-028X.JFP-17-175; Skinner GE, 2014, J FOOD PROTECT, V77, P2054, DOI 10.4315/0362-028X.JFP-14-259; Syed QA, 2012, FOOD CONTROL, V25, P361, DOI 10.1016/j.foodcont.2011.10.061; van Asselt ED, 2006, INT J FOOD MICROBIOL, V107, P73, DOI 10.1016/j.ijfoodmicro.2005.08.014; Wei J, 2010, J BACTERIOL, V192, P1455, DOI 10.1128/JB.01497-09; Wilson DR, 2008, TRENDS FOOD SCI TECH, V19, P289, DOI 10.1016/j.tifs.2008.01.005	45	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0200102	10.1371/journal.pone.0200102	http://dx.doi.org/10.1371/journal.pone.0200102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969482	gold, Green Published, Green Submitted			2022-12-26	WOS:000437246700043
J	Nissen, NI; Anderson, KR; Wang, HX; Lee, HS; Garrison, C; Eichelberger, SA; Ackerman, K; Im, W; Miwa, JM				Nissen, Neel, I; Anderson, Kristin R.; Wang, Huaixing; Lee, Hui Sun; Garrison, Carly; Eichelberger, Samantha A.; Ackerman, Kasarah; Im, Wonpil; Miwa, Julie M.			Augmenting the antinociceptive effects of nicotinic acetylcholine receptor activity through lynx1 modulation	PLOS ONE			English	Article							ROOT GANGLION NEURONS; ACUTE PAIN MANAGEMENT; DORSAL RAPHE; TRYPTOPHAN-HYDROXYLASE; SUBUNIT-STOICHIOMETRY; ALLOSTERIC MODULATORS; POSTSURGICAL PAIN; MURINE ACUTE; EPIBATIDINE; MECHANISMS	Neuronal nicotinic acetylcholine receptors (nAChRs) of the cholinergic system have been linked to antinociception, and therefore could be an alternative target for pain alleviation. nAChR activity has been shown to be regulated by the nicotinic modulator, lynxl, which forms stable complexes with nAChRs and has a negative allosteric action on their function. The objective in this study was to investigate the contribution of lynxl to nicotine-mediated antinociception. Lynxl contribution was investigated by mRNA expression analysis and electrophysiological responses to nicotine in the dorsal raphe nucleus (DRN), a part of the pain signaling pathway. In vivo antinociception was investigated in a test of nociception, the hot-plate analgesia assay with behavioral pharmacology. Lynx1/alpha 4 beta 2 nAChR interactions were investigated using molecular dynamics computational modeling. Nicotine evoked responses in serotonergic and GABAergic neurons in the DRN are augmented in slices lacking lynx1(lynx1KO). The antinociceptive effect of nicotine and epibatidine is enhanced in lynx1KO mice and blocked by mecamylamine and DH beta E. Computer simulations predict preferential binding affinity of lynx1 to the alpha:alpha interface that exists in the stoichiometry of the low sensitivity (alpha 4)(3)(beta 2)(2) nAChRs. Taken together, these data point to a role of lynx1 in mediating pain signaling in the DRN through preferential affinity to the low sensitivity alpha 4 beta 2 nAChRs. This study suggests that lynx1 is a possible alternative avenue for nociceptive modulation outside of opioid-based strategies.	[Nissen, Neel, I; Anderson, Kristin R.; Wang, Huaixing; Lee, Hui Sun; Garrison, Carly; Eichelberger, Samantha A.; Ackerman, Kasarah; Im, Wonpil; Miwa, Julie M.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Nissen, Neel, I] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark	Lehigh University; Aalborg University	Miwa, JM (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	jmm312@lehigh.edu		Nissen, Neel Ingemann/0000-0002-8970-8798; Miwa, Julie/0000-0002-4418-3756; Anderson, Kristin/0000-0002-1842-0383	NIH [DA032464, 1R21DA033831, GM087519]; Lehigh Accelerator; PA CURE; Danish Research Foundation; XSEDE [MCB-070009]; HHMI; Lehigh University Mountaintop Project; Lehigh Presidential Scholar's program; CAS; Department of Biological Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R41DA032464, R44DA032464, R21DA033831] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lehigh Accelerator; PA CURE; Danish Research Foundation; XSEDE; HHMI(Howard Hughes Medical Institute); Lehigh University Mountaintop Project; Lehigh Presidential Scholar's program; CAS(Defence Research & Development Organisation (DRDO)Chinese Academy of Sciences); Department of Biological Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by NIH DA032464 and NIH 1R21DA033831 (to JMM), Lehigh Accelerator and PA CURE (to SAE and JMM), Danish Research Foundation (to NIN and KRA), and NIH GM087519 and XSEDE MCB-070009 (to WI), HHMI and Lehigh University Mountaintop Project (to KRA), Lehigh Presidential Scholar's program (to CG), CAS and the Department of Biological Sciences (to KA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlSharari SD, 2012, J PHARMACOL EXP THER, V342, P742, DOI 10.1124/jpet.112.194506; BADIO B, 1994, MOL PHARMACOL, V45, P563; Bannon AW, 1998, SCIENCE, V279, P77, DOI 10.1126/science.279.5347.77; Beck SG, 2004, J NEUROPHYSIOL, V91, P994, DOI 10.1152/jn.00744.2003; Bitner RS, 2000, BRAIN RES, V871, P66, DOI 10.1016/S0006-8993(00)02442-2; Changeux JP, 1998, BRAIN RES REV, V26, P198, DOI 10.1016/S0165-0173(97)00040-4; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Cucchiaro G, 2005, J PHARMACOL EXP THER, V313, P389, DOI 10.1124/jpet.104.079368; Damaj MI, 2007, J PHARMACOL EXP THER, V321, P1161, DOI 10.1124/jpet.106.112649; DAMAJ MI, 1995, PSYCHOPHARMACOLOGY, V117, P67, DOI 10.1007/BF02245100; Dawson A, 2013, ALCOHOL, V47, P85, DOI 10.1016/j.alcohol.2012.12.004; Debono DJ, 2013, J AM OSTEOPATH ASSOC, V113, P620, DOI 10.7556/jaoa.2013.023; Dube GR, 2005, NEUROSCI LETT, V376, P29, DOI 10.1016/j.neulet.2004.11.020; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Ernst F R, 2001, J Am Pharm Assoc (Wash), V41, P192; Freitas K, 2013, J PHARMACOL EXP THER, V344, P264, DOI 10.1124/jpet.112.197871; Freitas K, 2013, NEUROPHARMACOLOGY, V65, P156, DOI 10.1016/j.neuropharm.2012.08.022; Genzen JR, 2001, J NEUROPHYSIOL, V86, P1773, DOI 10.1152/jn.2001.86.4.1773; George AA, 2017, FASEB J, V31, P1398, DOI 10.1096/fj.201600733R; GERZANICH V, 1995, MOL PHARMACOL, V48, P774; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; GUIMARAES APC, 1994, BRAIN RES, V647, P220, DOI 10.1016/0006-8993(94)91321-8; Gurun MS, 2009, ANESTH ANALG, V108, P1680, DOI 10.1213/ane.0b013e31819dcd08; Hone AJ, 2017, CONTAINING NICOTINIC, DOI [10.1111/bph.13931, DOI 10.1111/BPH.13931]; Hooten WM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-78; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Huxtable CA, 2011, ANAESTH INTENS CARE, V39, P804, DOI 10.1177/0310057X1103900505; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Jackson KJ, 2010, J PHARMACOL EXP THER, V334, P137, DOI 10.1124/jpet.110.165738; Jareczek FJ, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0364-16.2017; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JOH TH, 1975, P NATL ACAD SCI USA, V72, P3575, DOI 10.1073/pnas.72.9.3575; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kobayashi A, 2014, J MOL NEUROSCI, V53, P525, DOI 10.1007/s12031-014-0352-1; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; LENOVERE N, 1995, J MOL EVOL, V40, P155, DOI 10.1007/BF00167110; Li XH, 2002, ANESTHESIOLOGY, V96, P1450, DOI 10.1097/00000542-200206000-00026; Li XY, 1998, J NEUROSCI, V18, P1904; Lyukmanova EN, 2013, J BIOL CHEM, V288, P15888, DOI 10.1074/jbc.M112.436576; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maiaru M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aab3376; Manchikanti L, 2008, PAIN PHYSICIAN, V11, pS63; Marubio LM, 1999, NATURE, V398, P805, DOI 10.1038/19756; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; Mazzaferro S, 2017, J BIOL CHEM, V292, P2729, DOI 10.1074/jbc.M116.764183; Mihailescu S, 2002, EUR J PHARMACOL, V452, P77, DOI 10.1016/S0014-2999(02)02244-6; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Miwa JM, 2012, PHYSIOLOGY, V27, P187, DOI 10.1152/physiol.00002.2012; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nichols WA, 2014, J BIOL CHEM, V289, P31423, DOI 10.1074/jbc.M114.573667; Ochoa V, 2016, FASEB J, V30, P1109, DOI 10.1096/fj.15-274548; Oderda G, 2012, PHARMACOTHERAPY, V32, p6S, DOI 10.1002/j.1875-9114.2012.01177.x; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Papke RL, 2015, NEUROPHARMACOLOGY, V91, P34, DOI 10.1016/j.neuropharm.2014.12.002; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prince RJ, 1998, BIOPHYS J, V75, P1817, DOI 10.1016/S0006-3495(98)77623-4; Rashid MH, 2006, PAIN, V125, P125, DOI 10.1016/j.pain.2006.05.011; ROBERTS MHT, 1984, NEUROPHARMACOLOGY, V23, P1529, DOI 10.1016/0028-3908(84)90097-2; Rockett M, 2013, ANAEST INTENS CARE M, V14, P477; Saika F, 2014, ACTA PHYSL OXF, V213, P462; Salas R, 2004, NEUROPHARMACOLOGY, V47, P401, DOI 10.1016/j.neuropharm.2004.05.002; Shih PY, 2014, J NEUROSCI, V34, P9789, DOI 10.1523/JNEUROSCI.0476-14.2014; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Sulaiman MR, 2004, FITOTERAPIA, V75, P667, DOI 10.1016/j.fitote.2004.07.002; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Traynor JR, 1998, BRIT J ANAESTH, V81, P69, DOI 10.1093/bja/81.1.69; Umana IC, 2013, BIOCHEM PHARMACOL, V86, P1208, DOI 10.1016/j.bcp.2013.08.001; Viguier F, 2013, EUR J PHARMACOL, V716, P8, DOI 10.1016/j.ejphar.2013.01.074; Vincler M, 2007, EXPERT OPIN THER TAR, V11, P891, DOI 10.1517/14728222.11.7.891; Waite ME, 2015, J AM ASSOC LAB ANIM, V54, P420; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; WANG QP, 1994, BRAIN RES BULL, V34, P575; WIESKOPF J, 2015, SCI TRANSL MED, V0007; World Health Organization Briefing note, 2008, ACC CONTR MED PROGR; Wu J, 2011, BIOCHEM PHARMACOL, V82, P800, DOI 10.1016/j.bcp.2011.07.067; Wu ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148215; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	83	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199643	10.1371/journal.pone.0199643	http://dx.doi.org/10.1371/journal.pone.0199643			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969495	Green Published, gold, Green Submitted			2022-12-26	WOS:000437246700021
J	Rahmani, B; Wong, CK; Norouzzadeh, P; Bodurka, J; McKinney, B				Rahmani, Bahareh; Wong, Chung Ki; Norouzzadeh, Payam; Bodurka, Jerzy; McKinney, Brett			Dynamical Hurst analysis identifies EEG channel differences between PTSD and healthy controls	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER	We employ a time-dependent Hurst analysis to identify EEG signals that differentiate between healthy controls and combat-related PTSD subjects. The Hurst exponents, calculated using a rescaled range analysis, demonstrate a significant differential response between healthy and PTSD samples which may lead to diagnostic applications. To overcome the non-stationarity of EEG data, we apply an appropriate window length wherein the EEG data displays stationary behavior. We then use the Hurst exponents for each channel as hypothesis test statistics to identify differences between PTSD cases and controls. Our study included a cohort of 12 subjects with half healthy controls. The Hurst exponent of the PTSD subjects is found to be significantly smaller than the healthy controls in channel F3. Our results indicate that F3 may be a useful channel for diagnostic applications of Hurst exponents in distinguishing PTSD and healthy subjects.	[Rahmani, Bahareh; McKinney, Brett] Univ Tulsa, Tandy Sch Comp Sci, Tulsa, OK 74104 USA; [Rahmani, Bahareh; McKinney, Brett] Univ Tulsa, Dept Math, Tulsa, OK 74104 USA; [Rahmani, Bahareh] Fontbonne Univ, Math & Comp Sci Dept, St Louis, MO 63105 USA; [Wong, Chung Ki; Bodurka, Jerzy] LIBR, Tulsa, OK USA; [Norouzzadeh, Payam] Oklahoma State Univ, Helmerich Adv Technol Res Ctr, Tulsa, OK USA; [Bodurka, Jerzy] Univ Oklahoma, Stephenson Sch Biomed Engn, Tulsa, OK USA	University of Tulsa; University of Tulsa; Laureate Institute for Brain Research, Inc.; Oklahoma State University System; Oklahoma State University - Tulsa; University of Oklahoma System; University of Oklahoma - Tulsa	Rahmani, B (corresponding author), Univ Tulsa, Tandy Sch Comp Sci, Tulsa, OK 74104 USA.; Rahmani, B (corresponding author), Univ Tulsa, Dept Math, Tulsa, OK 74104 USA.; Rahmani, B (corresponding author), Fontbonne Univ, Math & Comp Sci Dept, St Louis, MO 63105 USA.	Brahmani@fontbonne.edu	Rahmani, Bahareh/AAX-1888-2021; Norouzzadeh, Payam/T-2668-2018	Norouzzadeh, Payam/0000-0003-3006-6396	US Department of Defense [W81XWH-12-1-0697]; Tandy supercomputing center	US Department of Defense(United States Department of Defense); Tandy supercomputing center	This work was supported by W81XWH-12-1-0697 grant from the US Department of Defense to JB and CKW.; The authors would like to acknowledge Bill White for his helps in programming and Tandy supercomputing center for many hours of computing time and supports.	Abou B. Khalil, 2006, ATLAS EEG SEIZURE SE; Chae JH, 2004, PSYCHIAT RES-NEUROIM, V131, P79, DOI 10.1016/j.pscychresns.2003.05.002; Coben R, 2011, NEUROFEEDBACK AND NEUROMODULATION TECHNIQUES AND APPLICATIONS, P1; da Silva FL, 2010, EEG-FMRI: PHYSIOLOGICAL BASIS, TECHNIQUE AND APPLICATIONS, P19, DOI 10.1007/978-3-540-87919-0_2; Fan J, 2013, RES J APPL SCI ENG T, V5, P4489; Hurst H.E., 1965, LONG TERM STORAGE EX; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Ingber L, 1998, MATH COMPUT MODEL, V27, P33, DOI 10.1016/S0895-7177(97)00265-3; Jokic-Begic N, 2003, NORD J PSYCHIAT, V57, P351, DOI 10.1080/08039480310002688; Kim J, 2012, PSYCHIAT CLIN NEUROS, V66, P87, DOI 10.1111/j.1440-1819.2011.02300.x; Korolev V. Yu., 2006, STOCHASTIC MODELS ST; Metzger LJ, PTSD AROUSAL DEPRESS; Morales R, 2013, ARXIV12123195V2; Mulert C, 2010, EEG-FMRI: PHYSIOLOGICAL BASIS, TECHNIQUE AND APPLICATIONS, P1, DOI 10.1007/978-3-540-87919-0; Nason GP, 2008, USE R, P1; Niedermeyer E., 2004, ELECTROENCEPHALOGRAP; Norouzzadeh P, 2005, PHYSICA A, V356, P609, DOI 10.1016/j.physa.2005.02.046; Norouzzadeh P, 2007, INT J MODERN PHYS C; Rabe S, 2006, J ABNORM PSYCHOL, V115, P687, DOI 10.1037/0021-843X.115.4.687; Rose O., 1996, ESTIMATION HURST PAR; Rutter P., 2012, 5 CASE STUDIES USING; Subha DP, 2010, J MED SYST, V34, P195, DOI 10.1007/s10916-008-9231-z; Voss J., 2013, RESCALED RANGE ANAL; Wahbeh H, 2013, APPL PSYCHOPHYS BIOF, V38, P57, DOI 10.1007/s10484-012-9208-z; Zaremba W., 2012, THESIS	25	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2018	13	7							e0199144	10.1371/journal.pone.0199144	http://dx.doi.org/10.1371/journal.pone.0199144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5XD	29969467	Green Submitted, gold, Green Published			2022-12-26	WOS:000437246700008
J	Priprem, A; Lee, YC; Limphirat, W; Tiyaworanant, S; Saodaeng, K; Chotitumnavee, J; Kowtragoon, N				Priprem, Aroonsri; Lee, Yao-Chang; Limphirat, Wanwisa; Tiyaworanant, Suppachai; Saodaeng, Kedsarin; Chotitumnavee, Jiranan; Kowtragoon, Nuttanunth			Eucalyptus ash alters secondary protein conformation of human grey hair and facilitates anthocyanin dyeing	PLOS ONE			English	Article							RAY-ABSORPTION-SPECTROSCOPY; PURPLE WAXY CORN; SULFUR; EXCITATION; KERATIN; INNER; MODEL	Wood ashes infused with water have been traditionally used as hair cosmetics, but little or no research has examined the effects of ash on human hair. This study investigated the effect of eucalyptus ash on the structure and morphology of excised human grey hair and its potential use as a pretreatment in natural hair dyeing using anthocyanins extracted from purple cops of Zea mays. Tensile characteristics and surface morphology of ash-pretreated hair was monitored by texture analysis, scanning electron microscopy and atomic force microscopy. The biochemical characteristics of ash-treated hair were analyzed by synchrotron radiation-FTIR and sulfur K-edge X-ray absorption near edge. Dyeing with anthocyanins was analyzed by Lab color scale and adsorption of anthocyanins. Ash-treated hair was elastically and plastically deformed with microscopic alterations to the ridges of the cuticle cells, similar to ammonia-treated hair. The ash extract significantly changed the relative proportion of alpha-helices in the cuticle and cortex layers (p < 0.05), but did not affect the interaction of S-bonds with neighboring atoms (p > 0.05). Ash-treated hair showed significantly enhanced adsorption of anthocyanins (p < 0.05) which changed the color of the grey hair. The alteration of secondary proteins in the cuticle and cortex layers of the grey hair by ash extract pre-treatment, enhanced anthocyanin adsorption. The eucalyptus ash could potentially be useful as a natural hair dyeing pre-treatment.	[Priprem, Aroonsri] Khon Kaen Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Khon Kaen, Thailand; [Lee, Yao-Chang] Natl Synchrotron Radiat Res Ctr, Hsinchu, Taiwan; [Limphirat, Wanwisa] Natl Synchrotron Res Inst Thailand, Muang, Nakornratchasim, Thailand; [Tiyaworanant, Suppachai] Khon Kaen Univ, Fac Pharmaceut Sci, Dept Pharmacognosy & Toxicol, Khon Kaen, Thailand; [Saodaeng, Kedsarin] Khon Kaen Univ, Grad Sch, Pharmaceut Chem & Nat Prod, Postgrad program, Khon Kaen, Thailand; [Chotitumnavee, Jiranan; Kowtragoon, Nuttanunth] Khon Kaen Univ, Fac Pharmaceut Sci, Undergrad Program Doctor Pharm, Khon Kaen, Thailand; [Saodaeng, Kedsarin] Thai Elegant Cosmet Co Ltd, Chiang Mai, Thailand; [Chotitumnavee, Jiranan] Mahidol Univ, Dept Pharmacol, Fac Dent, Bangkok, Thailand; [Kowtragoon, Nuttanunth] Boots Retail, Bangkok, Thailand	Khon Kaen University; National Synchrotron Radiation Research Center; Khon Kaen University; Khon Kaen University; Khon Kaen University; Mahidol University	Priprem, A (corresponding author), Khon Kaen Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Khon Kaen, Thailand.	aroonsri@kku.ac.th		Priprem, Aroonsri/0000-0003-0107-395X	Thailand Research Fund (TRF); Mama Herb (99), through the management of TRF	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Mama Herb (99), through the management of TRF	The Thailand Research Fund (TRF) and Mama Herb (99), through the management of TRF, were the partial co-sponsors that provided support in the form of salaries for an author [KS] and materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors had no personal contact with Mama Herb (99). The specific roles of these authors are articulated in the 'author contributions' section.	Bantignies JL, 2000, J COSMET SCI, V51, P73; BEYAK R, 1969, J SOC COSMET CHEM, V20, P615; Bhushan B, 2005, WEAR, V259, P1012, DOI 10.1016/j.wear.2004.12.026; Bhushan B., 2010, BIOPHYSICS HUMAN HAI, DOI [10.1007/978-3-642-15901-5, DOI 10.1007/978-3-642-15901-5]; Blackburn RS, 2013, Patent No. [WO2010131049 A3, 2010131049]; Burton CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153372; Cao JN, 2002, J MOL STRUCT, V607, P69, DOI 10.1016/S0022-2860(01)00901-2; Castaneda-Ovando A, 2009, FOOD CHEM, V113, P859, DOI 10.1016/j.foodchem.2008.09.001; CHAO J, 1979, J SOC COSMET CHEM, V30, P401; Chen N, 2005, J MICROSC-OXFORD, V220, P96, DOI 10.1111/j.1365-2818.2005.01517.x; Wagner RDC, 2007, J MICROSC-OXFORD, V226, P54, DOI 10.1111/j.1365-2818.2007.01747.x; Corbett JF, 1999, DYES PIGMENTS, V41, P127, DOI 10.1016/S0143-7208(98)00075-8; Dario MF, 2015, J PHOTOCH PHOTOBIO B, V153, P240, DOI 10.1016/j.jphotobiol.2015.09.025; Dorin RJ, 2014, COSMET TOILETRIES, V129, P34; Dumas P, 2003, J BIOL PHYS, V29, P201, DOI 10.1023/A:1024448910761; GEORGE GN, 1989, J AM CHEM SOC, V111, P3182, DOI 10.1021/ja00191a012; Harakotr B, 2016, SABRAO J BREED GENET, V48, P230; Harakotr B, 2014, FOOD CHEM, V164, P510, DOI 10.1016/j.foodchem.2014.05.069; HARKEY MR, 1993, FORENSIC SCI INT, V63, P9, DOI 10.1016/0379-0738(93)90255-9; HITCHCOCK AP, 1986, J CHEM PHYS, V85, P4835, DOI 10.1063/1.451718; Jalilehvand F, 2006, CHEM SOC REV, V35, P1256, DOI 10.1039/b417595f; Kuzuhara A, 2007, BIOPOLYMERS, V87, P134, DOI 10.1002/bip.20805; Lambert MJ, 1981, 45 FOR COMM NEW S WA; LaTorre C, 2005, ULTRAMICROSCOPY, V105, P155, DOI 10.1016/j.ultramic.2005.06.032; Lee J, 2005, J AOAC INT, V88, P1269; Leonti M, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00092; Li JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002688; Miller LM, 2006, BBA-BIOMEMBRANES, V1758, P846, DOI 10.1016/j.bbamem.2006.04.010; Morel O, 2008, COLOR TECHNOL, V124, P301, DOI 10.1111/j.1478-4408.2008.00157.x; Mukherjeea PK, 2008, J ETHNOPHARMACOL, V120, P291, DOI 10.1016/j.jep.2008.09.009; Mukkanna KS, 2017, J ASTHMA ALLERGY, V10, P9, DOI 10.2147/JAA.S90265; Nagyvary J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004245; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Oh K, 1997, J SOC DYERS COLOUR, V113, P243; Pereira P, 2012, GEODERMA, V191, P105, DOI 10.1016/j.geoderma.2012.02.005; Petibois C, 2006, TRENDS BIOTECHNOL, V24, P455, DOI 10.1016/j.tibtech.2006.08.005; Pitman RM, 2006, FORESTRY, V79, P563, DOI 10.1093/forestry/cpl041; Prange A, 2002, MICROBIOL-SGM, V148, P267, DOI 10.1099/00221287-148-1-267; Puthongking P, 2016, IJAAEE, V3, P73, DOI [10.15242/ijaaee.er0116037, DOI 10.15242/IJAAEE.ER0116037]; Rai R K, 2003, INDIAN J TRADIT KNOW, V2, P15; Robbins C, 2009, J COSMET SCI, V60, P437; Seshadri IP, 2008, ACTA MATER, V56, P3585, DOI 10.1016/j.actamat.2008.03.039; Singh AJA., 2004, INDIAN J TRADIT KNOW, V3, P442; SZE KH, 1988, CHEM PHYS, V121, P279, DOI 10.1016/0301-0104(88)90034-1; Vadivel E, 2014, INT J PHARMACEUT, V4, P226; WEATHERALL IL, 1992, J INVEST DERMATOL, V99, P468, DOI 10.1111/1523-1747.ep12616156; Wis-Surel Gabriela M., 1999, International Journal of Cosmetic Science, V21, P327, DOI 10.1046/j.1467-2494.1999.186183.x; Yao S, 2012, ANAL BIOANAL CHEM, V404, P1311, DOI 10.1007/s00216-012-6223-0	48	2	2	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2018	13	7							e0199696	10.1371/journal.pone.0199696	http://dx.doi.org/10.1371/journal.pone.0199696			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL5QR	29965982	Green Submitted, Green Published, gold			2022-12-26	WOS:000437224100019
J	De Brabandere, A; De Beeck, TO; Schutte, KH; Meert, W; Vanwanseele, B; Davis, J				De Brabandere, Arne; De Beeck, Tim Op; Schutte, Kurt H.; Meert, Wannes; Vanwanseele, Benedicte; Davis, Jesse			Data fusion of body-worn accelerometers and heart rate to predict VO2max during submaximal running	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; AEROBIC POWER; OXYGEN-UPTAKE; EXERCISE; FITNESS; REGRESSION; VO(2)MAX; SENSORS; MODEL; AGE	Maximal oxygen uptake (VO2max) is often used to assess an individual's cardiorespiratory fitness. However, measuring this variable requires an athlete to perform a maximal exercise test which may be impractical, since this test requires trained staff and specialized equipment, and may be hard to incorporate regularly into training programs. The aim of this study is to develop a new model for predicting VO2max by exploiting its relationship to heart rate and accelerometer features extracted during submaximal running. To do so, we analyzed data collected from 31 recreational runners (15 men and 16 women) aged 19-26 years who performed a maximal incremental test on a treadmill. During this test, the subjects' heart rate and acceleration at three locations (the upper back, the lower back and the tibia) were continuously measured. We extracted a wide variety of features from the measurements of the warm-up and the first three stages of the test and employed a data-driven approach to select the most relevant ones. Furthermore, we evaluated the utility of combining different types of features. Empirically, we found that combining heart rate and accelerometer features resulted in the best model with a mean absolute error of 2.33 ml.kg(-1).min(-l) and a mean absolute percentage error of 4.92%. The model includes four features: gender, body mass, the inverse of the average heart rate and the inverse of the variance of the total tibia acceleration during the warm-up stage of the treadmill test. Our model provides a practical tool for recreational runners in the same age range to estimate their VO2max from submaximal running on a treadmill. It requires two body-worn sensors: a heart rate monitor and an accelerometer positioned on the tibia.	[De Brabandere, Arne; De Beeck, Tim Op; Meert, Wannes; Davis, Jesse] Katholieke Univ Leuven, Dept Comp Sci, Leuven, Belgium; [Schutte, Kurt H.; Vanwanseele, Benedicte] Katholieke Univ Leuven, Dept Movement Sci, Leuven, Belgium; [Schutte, Kurt H.] Stellenbosch Univ, Dept Sport Sci, Stellenbosch, South Africa	KU Leuven; KU Leuven; Stellenbosch University	De Brabandere, A (corresponding author), Katholieke Univ Leuven, Dept Comp Sci, Leuven, Belgium.	arne.debrabandere@kuleuven.be	Vanwanseele, Benedicte/AAQ-1706-2021; Meert, Wannes/C-7019-2013	Vanwanseele, Benedicte/0000-0002-6158-9483; Meert, Wannes/0000-0001-9560-3872; De Brabandere, Arne/0000-0002-1918-5805; Davis, Jesse/0000-0002-3748-9263	EU lnterreg VA project Nano4Sports; KU Leuven Research Fund [C22/15/015, C32/17/036, C14/17/07]; Fonds Wetenschappelijk Onderzoek Vlaanderen [SBO-150033]	EU lnterreg VA project Nano4Sports; KU Leuven Research Fund(KU Leuven); Fonds Wetenschappelijk Onderzoek Vlaanderen(FWO)	ADB, TODB, KHS, BV and JD are partially supported by the EU lnterreg VA project Nano4Sports (http://www.grensregio.eu/ projecten/nano4sports). TODB, KHS, BV and JD are partially supported by the KU Leuven Research Fund (C22/15/015, C32/17/036, https://www.kuleuven.be/). JD is partially supported by the KU Leuven Research Fund (C14/17/07, https://www.kuleuven.be/) and Fonds Wetenschappelijk Onderzoek Vlaanderen (SBO-150033, http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abut F, 2015, P 8 ENG TECHN S ANK, P367; Abut F, 2016, COMPUT BIOL MED, V79, P182, DOI 10.1016/j.compbiomed.2016.10.018; Acikkar M, 2012, INT S EL EL ENG COM, P17; Ahn JW, 2017, J KOREAN MED SCI, V32, P1847, DOI 10.3346/jkms.2017.32.12.1947; Akay MF, 2011, EXPERT SYST APPL, V38, P2007, DOI 10.1016/j.eswa.2010.07.135; Akay MF, 2009, EXPERT SYST APPL, V36, P10112, DOI 10.1016/j.eswa.2009.01.009; Altini M, 2016, J APPL PHYSIOL, V120, P1082, DOI 10.1152/japplphysiol.00519.2015; [Anonymous], 2014, ACSMS RESOURCE MANUA; Bassett DR, 2000, RES Q EXERCISE SPORT, V71, pS30, DOI 10.1080/02701367.2000.11082783; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bradshaw DI, 2005, RES Q EXERCISE SPORT, V76, P426; BUSKIRK ER, 1987, FASEB J, V46, P1824; Cao ZB, 2013, J PHYS ACT HEALTH, V10, P280, DOI 10.1123/jpah.10.2.280; Cao ZB, 2010, MED SCI SPORT EXER, V42, P179, DOI 10.1249/MSS.0b013e3181af238d; Coyle E F, 1995, Exerc Sport Sci Rev, V23, P25; EBBELING CB, 1991, MED SCI SPORT EXER, V23, P966; Freedson PS, 2000, RES Q EXERCISE SPORT, V71, pS21, DOI 10.1080/02701367.2000.11082782; Gaudino P, 2013, J SCI MED SPORT, V16, P271, DOI 10.1016/j.jsams.2012.07.003; George JD, 2009, MEAS PHYS EDUC EXERC, V13, P1, DOI 10.1080/10913670802609086; George JD, 1997, MED SCI SPORT EXER, V29, P415, DOI 10.1097/00005768-199703000-00019; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; JOYNER MJ, 1991, J APPL PHYSIOL, V70, P683, DOI 10.1152/jappl.1991.70.2.683; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; McGregor SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007355; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P320, DOI 10.1016/S0268-0033(98)00089-8; Moy ML, 2009, J REHABIL RES DEV, V46, P277, DOI 10.1682/JRRD.2008.07.0083; Plasqui G, 2005, MED SCI SPORT EXER, V37, P872, DOI 10.1249/01.MSS.0000161805.61893.C0; Plasqui G, 2006, MED SCI SPORT EXER, V38, P1510, DOI 10.1249/01.mss.0000228942.55152.84; Rowell L., 1986, HUMAN CIRCULATION RE; Shenoy S, 2012, J SPORT MED PHYS FIT, V52, P465; Tonis TM, 2012, J SPORT MED PHYS FIT, V52, P337; Weyand PG, 2001, J APPL PHYSIOL, V91, P451, DOI 10.1152/jappl.2001.91.1.451; Zoch A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129151	34	14	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0199509	10.1371/journal.pone.0199509	http://dx.doi.org/10.1371/journal.pone.0199509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0PZ	29958282	Green Published, gold, Green Submitted			2022-12-26	WOS:000436793500010
J	Dong, EZ; Zhu, GX; Chen, C; Tong, JG; Jiao, YJ; Du, SZ				Dong, Enzeng; Zhu, Guangxu; Chen, Chao; Tong, Jigang; Jiao, Yingjie; Du, Shengzhi			Introducing chaos behavior to kernel relevance vector machine (RVM) for four-class EEG classification	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; MOTOR IMAGERY TASKS; SIGNAL CLASSIFICATION; SEIZURE DETECTION; STATE; COMMUNICATION; EXTRACTION; NETWORKS; EPILEPSY; NOISE	This paper addresses a chaos kernel function for the relevance vector machine (RVM) in EEG signal classification, which is an important component of Brain-Computer Interface (BCI). The novel kernel function has evolved from a chaotic system, which is inspired by the fact that human brain signals depict some chaotic characteristics and behaviors. By introducing the chaotic dynamics to the kernel function, the RVM will be enabled for higher classification capacity. The proposed method is validated within the framework of one versus one common spatial pattern (OVO-CSP) classifier to classify motor imagination (MI) of four movements in a public accessible dataset. To illustrate the performance of the proposed kernel function, Gaussian and Polynomial kernel functions are considered for comparison. Experimental results show that the proposed kernel function achieved higher accuracy than Gaussian and Polynomial kernel functions, which shows that the chaotic behavior consideration is helpful in the EEG signal classification.	[Dong, Enzeng; Zhu, Guangxu; Chen, Chao; Tong, Jigang] Tianjin Univ Technol, Tianjin Key Lab Control Theory & Applicat Complic, Tianjin, Peoples R China; [Jiao, Yingjie] Xian Modern Control Technol Res Inst, Xian, Shaanxi, Peoples R China; [Du, Shengzhi] Tshwane Univ Technol, Dept Elect Engn, Pretoria, South Africa	Tianjin University of Technology; Tshwane University of Technology	Tong, JG (corresponding author), Tianjin Univ Technol, Tianjin Key Lab Control Theory & Applicat Complic, Tianjin, Peoples R China.	tjgtjut@163.com		Chen, Chao/0000-0001-7358-4332	Natural Science Foundation of China [61603274, 61374169]; Foundation of the Application Base and Frontier Technology Research Project of Tianjin [15JCYBJC51800]; Tianjin Key Laboratory Foundation of Complex System Control Theory and Application [TJKL-CTACS-201702]; South African National Research Foundation Incentive Grants [81705]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of the Application Base and Frontier Technology Research Project of Tianjin; Tianjin Key Laboratory Foundation of Complex System Control Theory and Application; South African National Research Foundation Incentive Grants	This work was partially supported by the Natural Science Foundation of China under Grants (No. 61603274 and No. 61374169), the Foundation of the Application Base and Frontier Technology Research Project of Tianjin (15JCYBJC51800), Tianjin Key Laboratory Foundation of Complex System Control Theory and Application (TJKL-CTACS-201702) and South African National Research Foundation Incentive Grants (No. 81705).	Acharya UR, 2011, INT J NEURAL SYST, V21, P199, DOI 10.1142/S0129065711002808; Bascil MS, 2016, AUSTRALAS PHYS ENG S, V39, P665, DOI 10.1007/s13246-016-0462-x; Belardinelli P, 2013, COGN PROCESS, V14, P357, DOI 10.1007/s10339-013-0568-y; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Brunner C., BCI COMPETITION 2008, P136; Cecotti H, 2011, J PHYSIOL-PARIS, V105, P106, DOI 10.1016/j.jphysparis.2011.08.003; Chagas S L, 2008, C AN 26 S BRAS TEL J, P1; Chaudhary U, 2017, NAT REV NEUROL, V13, P191, DOI 10.1038/nrneurol.2017.23; De Martino F, 2011, NEUROIMAGE, V56, P826, DOI 10.1016/j.neuroimage.2010.07.068; Direito B, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S012906571750006X; Dong EZ, 2017, MED BIOL ENG COMPUT, V55, P1809, DOI 10.1007/s11517-017-1611-4; Dong EZ, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION (ICMA), P1024, DOI 10.1109/ICMA.2017.8015957; Edelman BJ, 2016, IEEE T BIO-MED ENG, V63, P4, DOI 10.1109/TBME.2015.2467312; Ge S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098019; Gupta R, 2016, NEUROCOMPUTING, V174, P875, DOI 10.1016/j.neucom.2015.09.085; Han Min, 2011, Chinese Journal of Biomedical Engineering, V30, P864, DOI 10.3969/j.issn.0258-8021.2011.06.011; Hsu WY, 2015, INT J NEURAL SYST, V25, DOI 10.1142/S0129065715500379; Huang MW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0161501; Lotte F, 2011, IEEE T BIO-MED ENG, V58, P355, DOI 10.1109/TBME.2010.2082539; Mateo-Sotos J, 2016, CIRC SYST SIGNAL PR, V35, P4463, DOI 10.1007/s00034-016-0281-z; Matsumoto M, 2014, APPL SOFT COMPUT, V20, P95, DOI 10.1016/j.asoc.2013.10.023; Naseer Noman, 2015, Front Hum Neurosci, V9, P3, DOI 10.3389/fnhum.2015.00003; Nicolaou N, 2012, EXPERT SYST APPL, V39, P202, DOI 10.1016/j.eswa.2011.07.008; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; PIJN JP, 1991, ELECTROEN CLIN NEURO, V79, P371, DOI 10.1016/0013-4694(91)90202-F; Ramadan RA, 2017, NEUROCOMPUTING, V223, P26, DOI 10.1016/j.neucom.2016.10.024; Sarbadhikari SN, 2001, MED ENG PHYS, V23, P445, DOI 10.1016/S1350-4533(01)00075-3; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Subasi A, 2010, EXPERT SYST APPL, V37, P8659, DOI 10.1016/j.eswa.2010.06.065; Sun HY, 2016, AUTOMATIKA, V57, P66, DOI 10.7305/automatika.2016.07.1078; Tang ZC, 2017, OPTIK, V130, P11, DOI 10.1016/j.ijleo.2016.10.117; Temko A, 2011, CLIN NEUROPHYSIOL, V122, P464, DOI 10.1016/j.clinph.2010.06.034; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Triggiani AI, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00604; Tsai ZR, 2017, COMPUT HUM BEHAV, V67, P151, DOI 10.1016/j.chb.2016.10.006; Vikram TSH, 2010, MATH COMPUT SCI ENG, P147; Wang Xingyuan, 2010, Nonlinear Biomed Phys, V4, P2, DOI 10.1186/1753-4631-4-2; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xiao D, 1997, IEEE ENG MED BIOL, V16, P27, DOI 10.1109/51.603645; Zhang L, 2016, NEUROCOMPUTING, V218, P103, DOI 10.1016/j.neucom.2016.08.066; Zhang YL, 2015, INT J NEURAL SYST, V25, DOI 10.1142/S0129065715500203; Zhang Y, 2016, IEEE T NEUR NET LEAR, V27, P2256, DOI 10.1109/TNNLS.2015.2476656; Zhang Y, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065716500325	46	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2018	13	6							e0198786	10.1371/journal.pone.0198786	http://dx.doi.org/10.1371/journal.pone.0198786			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0PZ	29958301	Green Submitted, Green Published, gold			2022-12-26	WOS:000436793500004
J	Ledesma, DT; Scarpetta, SG				Ledesma, David T.; Scarpetta, Simon G.			The skull of the gerrhonotine lizard Elgaria panamintina (Squamata: Anguidae)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; CRANIAL OSTEOLOGY; REPTILIA SQUAMATA; SCLERAL OSSICLES; FOSSIL RECORD; EVOLUTION; BIOGEOGRAPHY; ANGUIMORPHA; CALIFORNIA; INTERVAL	We provide the first description of the skull, osteoderms, and hyoid apparatus of the poorly known alligator lizard Elgaria panamintina, and compare the cranial osteology of that species to the widespread and well-studied taxon Elgaria multicarinata. Patterns of morphological variation resulting from ontogenetic transformations and pathology are discussed. We employed x-ray computed tomography (CT) scans to examine two adult specimens of Elgaria panamintina and two adult specimens of Elgaria multicarinata, in addition to examining multiple traditionally prepared skeletal specimens of the latter species. CT scans provide simultaneous study of both articulated and disarticulated elements, allowing us to describe and document the morphology of the skull with exceptional precision and detail. The description of the skull of Elgaria panamintina serves as a generalization for all Elgaria; here we provide the first complete description of the skull of this genus for future uses in morphological and phylogenetic studies of both extant species and fossils.	[Ledesma, David T.; Scarpetta, Simon G.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Ledesma, DT (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.	ledesma-david@utexas.edu		Scarpetta, Simon/0000-0003-0976-9337; Ledesma, David/0000-0002-9668-3218	National Science Foundation [EAR-1561622]; University of Texas at Austin Undergraduate Research Fellowship; Jackson School of Geosciences; University of Texas at Austin High-Resolution CT Facility; University of Texas at Austin; National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Texas at Austin Undergraduate Research Fellowship; Jackson School of Geosciences; University of Texas at Austin High-Resolution CT Facility; University of Texas at Austin; National Science Foundation(National Science Foundation (NSF))	Computed tomography (CT) scans conducted at the University of Texas at Austin High-Resolution CT Facility were subsidized by National Science Foundation grant EAR-1561622. Two CT scans were funded by a University of Texas at Austin Undergraduate Research Fellowship awarded to DTL. The other two CT scans were funded by the Jackson School of Geosciences. The University of Texas at Austin High-Resolution CT Facility, The University of Texas at Austin, The Jackson School of Geosciences, and the National Science Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banta B. H., 1963, Occasional Papers California Academy of Sciences, VNo. 36, P1; Bell CJ, 2014, ANAT REC, V297, P344, DOI 10.1002/ar.22852; Bell CJ, 2010, QUATERN INT, V217, P30, DOI 10.1016/j.quaint.2009.08.009; Bell CJ, 2003, ZOOL J LINN SOC-LOND, V139, P283, DOI 10.1046/j.1096-3642.2003.00077.x; Bellairs A.d'A., 1981, Biology of Reptilia, V11, P1; Bever G.S., 2005, PALAEONT ELECT, V8, P1, DOI DOI 10.1080/08912960600679570; Bhullar B. -A. S., 2011, Bulletin of the Museum of Comparative Zoology, V160, P65; Bhullar BAS, 2012, J EXP ZOOL PART B, V318B, P521, DOI 10.1002/jez.b.22456; Conrad JL, 2011, CLADISTICS, V27, P230, DOI 10.1111/j.1096-0031.2010.00330.x; Conrad JL, 2008, AM MUS NOVIT, P1, DOI 10.1206/586.1; Conroy CJ, 2005, J HERPETOL, V39, P142, DOI 10.1670/0022-1511(2005)039[0142:PPOTPA]2.0.CO;2; Cope E., 1877, Proceedings of the American Philosophical Society, Vxvii, P85; Cope E. D., 1892, Proceedings of the American Philosophical Society, Vxxx, P185; Cope ED, 1900, ANN REPORT US NATL 2, P153; CRILEY BB, 1968, AM MIDL NAT, V80, P199, DOI 10.2307/2423610; de Blainville HD, 1835, NOUVELLES ANN MUSEUM, V4, P233; de Queiroz K., 1987, University of California Publications in Zoology, V118, P1; DEQUEIROZ K, 1988, AUK, V105, P29; DEQUEIROZ K, 1982, HERPETOLOGICA, V38, P302; Estes R., 1963, Copeia, V1963, P676, DOI 10.2307/1440971; Estes R., 1988, P119; ESTES RICHARD, 1964, AMER MIDLAND NATUR, V72, P453, DOI 10.2307/2423518; Evans Susan E., 2008, Contributions to Herpetology, V23, P1; Feldman CR, 2006, MOL ECOL, V15, P2201, DOI 10.1111/j.1365-294X.2006.02930.x; Frazzetta T., 1983, P222; Gauthier JA, 1982, ROCKY MT GEOL, V21, P7; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Gilmore CW, 1928, MEM NATL ACAD SCI, V12; Good D.A., 1988, Journal of Vertebrate Paleontology, V8, P188; Good D. A., 1988, U CALIFORNIA PUBL ZO, V121, P1; GOOD DA, 1987, J HERPETOL, V21, P285, DOI 10.2307/1563970; Good David A., 1995, Amphibia-Reptilia, V16, P157, DOI 10.1163/156853895X00334; Gray J. E., 1838, ANN MAGAZINE NATURAL, V1, P388, DOI DOI 10.1080/00222933809512320; GRISMER LL, 1988, HERPETOLOGICA, V44, P431; GUGG W., 1939, ZOOL JAHRB ABT ANAT U ONTOG TIERE, V65, P339; HOLMAN J A, 1973, Contributions from the Museum of Paleontology University of Michigan, V24, P125; HOLMAN J A, 1976, Herpetologica, V32, P262; Lamar William W., 2015, Mesoamerican Herpetology, V2, P88; Leavitt DH, 2017, MOL PHYLOGENET EVOL, V110, P104, DOI 10.1016/j.ympev.2017.02.010; Macey JR, 1999, MOL PHYLOGENET EVOL, V12, P250, DOI 10.1006/mpev.1999.0615; Maisano JA, 2002, J VERTEBR PALEONTOL, V22, P268, DOI 10.1671/0272-4634(2002)022[0268:TFOSEA]2.0.CO;2; McDOWELL SAMUEL BOOKER, 1954, BULL AMER MUS NAT HIST, V105, P1; Mead JI, 1999, COPEIA, P163; MESZOELY C A M, 1970, Bulletin of the Museum of Comparative Zoology, V139, P87; Montero R, 2017, J MORPHOL, V278, P1400, DOI 10.1002/jmor.20719; Norell M.A., 1989, CONTRIBUTIONS SCI NA, V414, P1; Oelrich T. M., 1956, Miscellaneous Publications Museum of Zoology University of Michigan, V94, P1; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Reeder TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118199; Rieppel O., 1980, Denkschriften der Schweizerischen Naturforschenden Gesellschaft, V94, P1; ROBINSON MD, 1973, COPEIA, P698, DOI 10.2307/1443070; SAVAGE JM, 1960, SYST ZOOL, V9, P184, DOI 10.2307/2411967; Save-Soderbergh G., 1947, ZOOL BIDRAG UPPSALA, V25, P489; SMITH H M, 1986, Bulletin of the Maryland Herpetological Society, V22, P21; Smith KT, 2013, B PEABODY MUS NAT HI, V54, P135; Smith KT, 2009, J SYST PALAEONTOL, V7, P299, DOI 10.1017/S1477201909002752; Stebbins R. C., 1958, American Museum Novitates, VNo. 1883, P1; Sullivan R.M., 1991, Journal of Vertebrate Paleontology, V11, P293; Tihen J. A., 1949, Kansas University Science Bulletin, V33, P217; TIHEN JA, 1949, AM MIDL NAT, V41, P580, DOI 10.2307/2421775; Underwood G., 1984, Symposia of the Zoological Society of London, P483; WADDICK J W, 1974, Great Basin Naturalist, V34, P257; Wiegmann AFA, 1828, ISIS OKEN, V21, P364; Wiens JJ, 2001, EVOLUTION, V55, P2303; WILSON R L, 1968, Contributions from the Museum of Paleontology University of Michigan, V22, P75; YATKOLA DA, 1976, COPEIA, P645, DOI 10.2307/1443444	66	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2018	13	6							e0199584	10.1371/journal.pone.0199584	http://dx.doi.org/10.1371/journal.pone.0199584			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL0GK	29953469	Green Published, gold, Green Submitted			2022-12-26	WOS:000436645400043
J	Brovarets, OO; Tsiupa, KS; Hovorun, DM				Brovarets, Ol'ha O.; Tsiupa, Kostiantyn S.; Hovorun, Dmytro M.			Novel pathway for mutagenic tautomerization of classical A.T DNA base pairs via sequential proton transfer through quasi-orthogonal transition states: A QM/QTAIM investigation	PLOS ONE			English	Article							PARALLEL-STRANDED DNA; SET SUPERPOSITION ERROR; BIOLOGICALLY IMPORTANT PAIRS; EXTERNAL ELECTRIC-FIELDS; FOCK AB-INITIO; WATSON-CRICK; ADENINE-THYMINE; DPT TAUTOMERIZATION; MOLECULAR-STRUCTURE; NUCLEIC-ACID	In this paper we have theoretically predicted a novel pathway for the mutagenic tautomerization of the classical A.T DNA base pairs in the free state, the Watson-Crick A.T(WC), reverse Watson-Crick A.T(rWC), Hoogsteen A.T(H) and reverse Hoogsteen A.T(rH) pairs, via sequential proton transfer accompanied by a significant change in the mutual orientation of the bases. Quantum-mechanical (QM) calculations were performed at the MP2/aug-cc-pVDZ//B3LYP/6-311++G(d,p) level in vacuum phase, along with Bader's quantum theory of Atoms in Molecules (QTAIM). These processes involve transition states (TSs) with quasi-orthogonal structures (symmetry C-1), which are highly polar, tight ion pairs (A(-), N6H(2)-deprotonated).(T+, O4/O2-protonated). Gibbs free energies of activation for the A.T(WC) / A.T(rWC)<--> A*.T(rw(WC)) / A*-T(rw(WC)) tautomeric transitions (similar to 43.5 kcal.mol(-1)) are lower than for the A.T(H) / A.T(rH) <--> A*(N7).T(rw(H))/A*N7.T(w(H)) tautomerisations (similar to 53.0 kcal.mol(-1)) (rare tautomers are marked by an asterisk; w-wobble configured tautomerisation products). The (T)N3(+)H center dot center dot center dot N1(-)(A), (T)O4(+)H center dot center dot center dot N1(-)(A) / (T)N3(+)H center dot center dot center dot N1(-)(A) and (T)O2(+)H center dot center dot center dot N1(-)(A) H-bonds are found in the transition states TSA.T(WC)<--> A*T(rwWC)A.T(rWC)<--> A*.T(wWC)A-.T+/TSA-.T+. However, in the transition state TSA.T(H)<--> A*N7.T(rwH)A-.T+ / TSA.T(rH)<--> A*N7.T(wH)A-.T+, the (T)N3(+)H center dot center dot center dot N7(-)(A), (T)O4(+)H center dot center dot center dot N7(-)(A) / (T)N3(+) H center dot center dot center dot N7(-)(A) and (T)O2(+)H center dot center dot center dot N7(-)(A) H-bonds are supplemented by the attractive (T)O4(+)/O2(+)center dot center dot center dot N6(-)(A) van der Waals contacts. It was demonstrated that the products of the tautomerization of the classical A.T DNA base pairs-A*.T (rw(wc)), A*(N7).T(rw(H)) and A*(N7).T(W-H) (symmetry C s )-further transform via double proton transfer into the energetically favorable wobble A center dot T*(rw(wc)), A.T*(rw(H)) and A.T*(O2)(W-H) base mispairs (symmetry C-s).	[Brovarets, Ol'ha O.; Tsiupa, Kostiantyn S.; Hovorun, Dmytro M.] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Dept Mol & Quantum Biophys, Kiev, Ukraine; [Brovarets, Ol'ha O.; Hovorun, Dmytro M.] Taras Shevchenko Natl Univ Kyiv, Dept Mol Biotechnol & Bioinformat, Inst High Technol, Kiev, Ukraine	National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev	Hovorun, DM (corresponding author), Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Dept Mol & Quantum Biophys, Kiev, Ukraine.; Hovorun, DM (corresponding author), Taras Shevchenko Natl Univ Kyiv, Dept Mol Biotechnol & Bioinformat, Inst High Technol, Kiev, Ukraine.	dhovorun@imbg.org.ua						Abrescia NGA, 2004, BIOCHEMISTRY-US, V43, P4092, DOI 10.1021/bi0355140; Abrescia NGA, 2002, P NATL ACAD SCI USA, V99, P2806, DOI 10.1073/pnas.052675499; Acosta-Reyes FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120241; Palafox MA, 2014, J BIOMOL STRUCT DYN, V32, P831, DOI 10.1080/07391102.2013.789402; Alvey HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5786; Arabi AA, 2018, PHYS CHEM CHEM PHYS, V20, P12406, DOI 10.1039/c8cp01122b; Arabi AA, 2011, PHYS CHEM CHEM PHYS, V13, P13738, DOI 10.1039/c1cp20175a; Bader R. F. W., 1990, ATOMS MOL QUANTUM TH; Bertran J., 2006, COMPUTATIONAL STUDIE, P411, DOI DOI 10.1007/978-1-4020-4851-3_16; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Brovarets' O O, 2013, Ukr Biokhim Zh (1999), V85, P98; Brovarets' O O, 2013, Ukr Biokhim Zh (1999), V85, P104; Brovarets' O O, 2010, Ukr Biokhim Zh (1999), V82, P57; Brovarets' O O, 2010, Ukr Biokhim Zh (1999), V82, P55; Brovarets O. O., 2010, Biopolymers and Cell, V26, P398; Brovarets O. O., 2015, THESIS; Brovarets O.O., 2009, UKRAIN BIOORG ACTA 2, V8, P12; Brovarets OO, 2018, RSC ADV, V8, P13433, DOI 10.1039/c8ra01446a; Brovarets OO, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00008; Brovarets' OO, 2018, J BIOMOL STRUCT DYN, V36, P1649, DOI 10.1080/07391102.2017.1331864; Brovarets OO, 2018, PHYS CHEM CHEM PHYS, V20, P623, DOI 10.1039/c7cp05139e; Brovarets' OO, 2017, NEW J CHEM, V41, P7232, DOI 10.1039/c7nj00717e; Brovarets' OO, 2017, J BIOMOL STRUCT DYN, V35, P3398, DOI 10.1080/07391102.2016.1253504; Brovarets' OO, 2016, RSC ADV, V6, P99546, DOI 10.1039/c6ra17787e; Brovarets OO, 2016, STRUCT CHEM, V27, P119, DOI 10.1007/s11224-015-0687-4; Brovarets' OO, 2015, J BIOMOL STRUCT DYN, V33, P2716, DOI 10.1080/07391102.2015.1092886; Brovarets OO, 2015, RSC ADV, V5, P99594, DOI 10.1039/c5ra19971a; Brovarets OO, 2015, RSC ADV, V5, P66318, DOI 10.1039/c5ra11773a; Brovarets OO, 2015, PHYS CHEM CHEM PHYS, V17, P21381, DOI 10.1039/c5cp03211c; Brovarets OO, 2015, J BIOMOL STRUCT DYN, V33, P2297, DOI 10.1080/07391102.2015.1046936; Brovarets OO, 2015, J BIOMOL STRUCT DYN, V33, P1624, DOI 10.1080/07391102.2014.968623; Brovarets OO, 2015, PHYS CHEM CHEM PHYS, V17, P15103, DOI 10.1039/c5cp01568e; Brovarets' OO, 2015, J BIOMOL STRUCT DYN, V33, P925, DOI 10.1080/07391102.2014.924879; Brovarets' OO, 2014, MOL PHYS, V112, P3033, DOI 10.1080/00268976.2014.927079; Brovarets' OO, 2015, J BIOMOL STRUCT DYN, V33, P674, DOI 10.1080/07391102.2014.897259; Brovarets' OO, 2014, PHYS CHEM CHEM PHYS, V16, P15886, DOI 10.1039/c4cp01241k; Brovarets OO, 2014, PHYS CHEM CHEM PHYS, V16, P9074, DOI 10.1039/c4cp00488d; Brovarets' OO, 2015, J BIOMOL STRUCT DYN, V33, P28, DOI 10.1080/07391102.2013.852133; Brovarets' OO, 2014, J COMPUT CHEM, V35, P451, DOI 10.1002/jcc.23515; Brovarets' OO, 2014, CHEM PHYS LETT, V592, P247, DOI 10.1016/j.cplett.2013.12.034; Brovarets' OO, 2014, J BIOMOL STRUCT DYN, V32, P1474, DOI 10.1080/07391102.2013.822829; Brovarets' OO, 2014, J BIOMOL STRUCT DYN, V32, P127, DOI 10.1080/07391102.2012.755795; Brovarets' OO, 2013, J MOL MODEL, V19, P4119, DOI 10.1007/s00894-012-1720-9; Brovarets' OO, 2014, J BIOMOL STRUCT DYN, V32, P993, DOI 10.1080/07391102.2013.799439; Brovarets OO, 2013, CHEM PHYS LETT, V578, P126, DOI 10.1016/j.cplett.2013.05.067; Brovarets' OO, 2012, QUANTUM CHEM MOL INN, P59; BROVARETS OO, 2016, RSC ADV, V0110, DOI DOI 10.1039/C6RA17787E; Campos L, 2006, BIOPHYS J, V91, P892, DOI 10.1529/biophysj.106.084210; Ceron-Carrasco JP, 2009, J PHYS CHEM A, V113, P7892, DOI 10.1021/jp900782h; Ceron-Carrasco JP, 2013, CHEM COMMUN, V49, P7578, DOI 10.1039/c3cc42593b; Cubero E, 2001, J AM CHEM SOC, V123, P12018, DOI 10.1021/ja011200t; Cukrowski I, 2010, CHEM PHYS LETT, V499, P66, DOI 10.1016/j.cplett.2010.09.013; Drake JW, 1998, GENETICS, V148, P1667; El-Sayed AA, 2015, J BIOMOL STRUCT DYN, V33, P723, DOI 10.1080/07391102.2014.909743; Espinosa E, 1998, CHEM PHYS LETT, V285, P170, DOI 10.1016/S0009-2614(98)00036-0; Felske LR, 2018, J PHYS CHEM A, V122, P410, DOI 10.1021/acs.jpca.7b10485; Fijalkowska IJ, 2012, FEMS MICROBIOL REV, V36, P1105, DOI 10.1111/j.1574-6976.2012.00338.x; FLORIAN J, 1994, J AM CHEM SOC, V116, P1457, DOI 10.1021/ja00083a034; Frisch M.J., 2009, GAUSSIAN 09 REVIS D0; FRISCH MJ, 1990, CHEM PHYS LETT, V166, P281, DOI 10.1016/0009-2614(90)80030-H; Gatti C, 2018, J COMPUT CHEM, V39, P1112, DOI 10.1002/jcc.25222; Gorb L, 2004, J AM CHEM SOC, V126, P10119, DOI 10.1021/ja049155n; GOVORUN DN, 1992, J MOL STRUCT, V267, P99, DOI 10.1016/0022-2860(92)87016-O; GUTOWSKI M, 1986, CHEM PHYS LETT, V124, P370, DOI 10.1016/0009-2614(86)85036-9; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; HOOGSTEEN K, 1963, ACTA CRYSTALLOGR, V16, P907, DOI 10.1107/S0365110X63002437; Hovorun DM, 1999, INT J QUANTUM CHEM, V75, P245, DOI 10.1002/(SICI)1097-461X(1999)75:3<245::AID-QUA14>3.0.CO;2-0; Hovorun DM, 2018, J BIOMOL STRUCT DYN; Hratchian HP, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P195, DOI 10.1016/B978-044451719-7/50053-6; Inostroza-Rivera R, 2015, PHYS CHEM CHEM PHYS, V17, P17797, DOI 10.1039/c5cp01515d; Iogansen AV, 1999, SPECTROCHIM ACTA A, V55, P1585, DOI 10.1016/S1386-1425(98)00348-5; Jurecka P, 2006, PHYS CHEM CHEM PHYS, V8, P1985, DOI 10.1039/b600027d; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; Kimsey IJ, 2015, NATURE, V519, P315, DOI 10.1038/nature14227; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; Lecomte C, 2015, IUCRJ, V2, P161, DOI 10.1107/S2052252515002067; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LOWDIN PO, 1963, REV MOD PHYS, V35, P724, DOI 10.1103/RevModPhys.35.724; LOWDIN PO, 1965, ADV QUANTUM CHEM, V2, P213, DOI DOI 10.1016/S0065-3276(08)60076-3; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; LYNGDOH RHD, 1994, J BIOSCIENCE, V19, P131, DOI 10.1007/BF02703049; Mata I, 2011, CHEM PHYS LETT, V507, P185, DOI 10.1016/j.cplett.2011.03.055; Matta C. F., 2007, QUANTUM THEORY ATOMS; Matta CF, 2006, J PHYS CHEM B, V110, P563, DOI 10.1021/jp054986g; Matta CF, 2003, J PHYS CHEM A, V107, P7496, DOI 10.1021/jp034952d; Matta CF, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2378720; Matta CF, 2014, J COMPUT CHEM, V35, P1165, DOI 10.1002/jcc.23608; Matta CF, 2010, J COMPUT CHEM, V31, P1297, DOI 10.1002/jcc.21417; Maximoff SN, 2017, J PHYS CHEM B, V121, P7813, DOI 10.1021/acs.jpcb.7b04874; Muller J, 2017, BEILSTEIN J ORG CHEM, V13, P2671, DOI 10.3762/bjoc.13.265; NEDDERMAN ANR, 1993, J MOL BIOL, V230, P1068, DOI 10.1006/jmbi.1993.1219; NEDDERMAN ANR, 1991, J CHEM SOC CHEM COMM, P1357, DOI 10.1039/c39910001357; Negi I, 2017, PHYS CHEM CHEM PHYS, V19, P16365, DOI 10.1039/c7cp02576a; Nikolaienko TY, 2011, J BIOMOL STRUCT DYN, V29, P563, DOI 10.1080/07391102.2011.10507406; Nikolaienko TY, 2012, PHYS CHEM CHEM PHYS, V14, P7441, DOI 10.1039/c2cp40176b; Nikolova EN, 2013, BIOPOLYMERS, V99, P955, DOI 10.1002/bip.22334; Parr R. G., 1989, DENSITY FUNCTIONAL T; Parvathy VR, 2002, NUCLEIC ACIDS RES, V30, P1500, DOI 10.1093/nar/30.7.1500; Peng CY, 1996, J COMPUT CHEM, V17, P49, DOI 10.1002/(SICI)1096-987X(19960115)17:1<49::AID-JCC5>3.0.CO;2-0; Peter Atkins P., 2014, ATKINSPHYSICAL CHEM; Poltev V. I., 2016, Biophysics, V61, P217, DOI 10.1134/S0006350916020160; Pous J, 2008, J AM CHEM SOC, V130, P6755, DOI 10.1021/ja078022+; Saenger W., 1984, PRINCIPLES NUCL ACID; Salam T, 2018, MUTAT RES-FUND MOL M, V807, P10, DOI 10.1016/j.mrfmmm.2017.10.004; Samijlenko SP, 2004, J MOL STRUCT, V708, P97, DOI 10.1016/j.molstruc.2004.05.034; SORDO JA, 1988, THEOR CHIM ACTA, V74, P101, DOI 10.1007/BF00528320; Sordo JA, 2001, J MOL STRUC-THEOCHEM, V537, P245, DOI 10.1016/S0166-1280(00)00681-3; Sponer J, 2004, J AM CHEM SOC, V126, P10142, DOI 10.1021/ja048436s; Szabat M, 2017, FEBS J, V284, P3986, DOI 10.1111/febs.14187; Szymanski ES, 2017, J AM CHEM SOC, V139, P4326, DOI 10.1021/jacs.7b01156; TCHURIKOV NA, 1989, FEBS LETT, V257, P415, DOI 10.1016/0014-5793(89)81585-6; Tirado-Rives J, 2008, J CHEM THEORY COMPUT, V4, P297, DOI 10.1021/ct700248k; TOPAL MD, 1976, NATURE, V263, P285, DOI 10.1038/263285a0; VENKATESWARLU D, 1995, J CHEM SOC PERK T 2, P839, DOI 10.1039/p29950000839; Venkateswarlu D, 1997, J MOL STRUC-THEOCHEM, V393, P151, DOI 10.1016/S0166-1280(96)04847-6; WATSON JD, 1953, COLD SPRING HARB SYM, V18, P123, DOI 10.1101/SQB.1953.018.01.020; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Ye MY, 2017, ANAL CHEM, V89, P8604, DOI 10.1021/acs.analchem.7b02467; Yepes D, 2012, PHYS CHEM CHEM PHYS, V14, P11125, DOI 10.1039/c2cp41064h; Zhou HX, 2016, THESIS; Zoete V, 2004, J CHEM PHYS, V121, P4377, DOI 10.1063/1.1774152	121	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0199044	10.1371/journal.pone.0199044	http://dx.doi.org/10.1371/journal.pone.0199044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949602	Green Submitted, gold, Green Published			2022-12-26	WOS:000436549200037
J	Reis, GSM; de Almeida, AAF; Mangabeira, PAO; dos Santos, IC; Pirovani, CP; Ahnert, D				Monteiro Reis, Graciele Santos; de Almeida, Alex-Alan Furtado; Oliveira Mangabeira, Pedro Antonio; dos Santos, Ivanildes Conceicao; Pirovani, Carlos Priminho; Ahnert, Dario			Mechanical stress caused by wind on leaves of Theobroma cacao: Photosynthetic, molecular, antioxidative and ultrastructural responses	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; OXIDATIVE STRESS; PHOTOSYSTEM-II; ASCORBATE PEROXIDASE; LIPID-PEROXIDATION; PLANT-RESPONSES; ARABIDOPSIS; CHLOROPLAST; PROTECTION; ALLOCATION	Theobroma cacao is cultivated in the shade, in a so-called 'Cabruca' system, in intercropped with Erithryna or other tree species of economic value, and in full sun as a monoculture in irrigated or chemically-irrigated systems. Since it is a species quite intolerant to wind, it is practically impossible to implant cacao crops under full exposure to the sun, or in areas of frequent winds, without the protection of windbreaks, using arboreal species around the area of culture in the form of box. Wind can cause mechanical stimuli in plants, affecting their growth and development. The objective of this work was to evaluate the photosynthetic changes in mature leaves and the molecular, biochemical and ultrastructural changes in young and mature leaves of the CCN 51 cloned genotype of T. cacao subjected to intermittent (IW) and constant (CW) wind, with velocities of 2.5, 3.5 and 4.5 m s(-1), during 3, 6 and 12 h of exposure. It was verified that CW and IW, considering different exposure times, interfered directly in stomata) conductance (gs), transpiration (E) and water use efficiency (WUE), causing a reduction of the photosynthetic rate (A) in mature leaves. In addition, the pulvinus and blade of young and mature leaves, exposed to IW and CW with different exposure times (3 and 12 h), showed marked macroscopic and microscopic mechanical injuries resulting from the constant leaf movement. At both speeds, there was rupture of the cell nuclear membrane in pulvinus and the mesophyll tissues, mainly in the young leaves. On the other hand, in young and mature leaves exposed to CW and IW at different speeds and exposure times, there was lipid peroxidation, increased activity of guaiacol (GPX) and ascorbate (APX) peroxidases in most treatments; and altered expression of transcripts of psba and psbo genes related to the phothosynthetic apparatus and Cu-Zn-sod and per genes related to antioxidative enzymes at the rate of 4.5 m s(-1). Younger leaves were more intolerant to mechanical stress caused by the wind, since presented greater macro and microscopic damages and, consequently, greater molecular, biochemical and ultrastructural changes. High wind speeds can seriously compromise the development of young leaves of T. cacao plants and affect their productivity.	[Monteiro Reis, Graciele Santos; de Almeida, Alex-Alan Furtado; Oliveira Mangabeira, Pedro Antonio; dos Santos, Ivanildes Conceicao; Pirovani, Carlos Priminho; Ahnert, Dario] Univ Estadual Santa Cruz, Dept Biol Sci, Campus Soane Nazare de Andrade, Ilheus, BA, Brazil	Universidade Estadual de Santa Cruz	de Almeida, AAF (corresponding author), Univ Estadual Santa Cruz, Dept Biol Sci, Campus Soane Nazare de Andrade, Ilheus, BA, Brazil.	alexalan@uesc.br	Mangabeira, Pedro A O/I-7742-2014; Pirovani, Carlos Priminho/N-1153-2019; Almeida, Alex-Alan/AAL-9505-2021	Mangabeira, Pedro A O/0000-0001-6563-4539; Pirovani, Carlos Priminho/0000-0002-6176-4069; Almeida, Alex-Alan/0000-0001-5313-0608				Alvim PT, 1978, REV THEOBROMA BRASIL, V8, P117; Amudha J., 2011, Biotechnology and Molecular Biology Reviews, V6, P31; Bellincampi D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00228; Bertolde FZ, 2012, PHOTOSYNTHETICA, V50, P447, DOI 10.1007/s11099-012-0052-4; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Brown TA, 2003, CLONAGEM GENICA ANAL; Calderone V, 2003, EMBO REP, V4, P900, DOI 10.1038/sj.embor.embor923; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Choudhury FK, 2017, PLANT J, V90, P856, DOI 10.1111/tpj.13299; Choudhury SR, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.23000, 10.4161/psb.23681]; Considine MJ, 2015, ANN BOT-LONDON, V116, P469, DOI 10.1093/aob/mcv153; Coutand C, 2010, PLANT SCI, V179, P168, DOI 10.1016/j.plantsci.2010.05.001; Dauphinee AN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0389-x; de Langre E, 2008, ANNU REV FLUID MECH, V40, P141, DOI 10.1146/annurev.fluid.40.111406.102135; Dietz KJ, 2015, J EXP BOT, V66, P2401, DOI 10.1093/jxb/eru505; Ennos AR, 1997, TRENDS ECOL EVOL, V12, P108, DOI 10.1016/S0169-5347(96)10066-5; Evans DE, 2004, NEW PHYTOL, V161, P35, DOI 10.1046/j.1469-8137.2003.00907.x; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Foyer CH, 2013, ANTIOXID REDOX SIGN, V18, P2087, DOI 10.1089/ars.2013.5278; Fukuda H, 2000, PLANT MOL BIOL, V44, P245, DOI 10.1023/A:1026532223173; Goldberg R, 1986, MOL PHYSL ASPECTS PL, P208; GOMES ARS, 1987, NEW PHYTOL, V107, P591, DOI 10.1111/j.1469-8137.1987.tb02929.x; Gururani MA, 2015, MOL PLANT, V8, P1304, DOI 10.1016/j.molp.2015.05.005; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Houston K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00984; Huang CW, 2015, ADV WATER RESOUR, V86, P240, DOI 10.1016/j.advwatres.2015.10.009; KAR M, 1976, PLANT PHYSIOL, V57, P315, DOI 10.1104/pp.57.2.315; Kieffer P, 2009, J PROTEOMICS, V72, P379, DOI 10.1016/j.jprot.2009.01.014; Kleine T, 2016, BBA-BIOENERGETICS, V1857, P1313, DOI 10.1016/j.bbabio.2016.03.017; Koca H, 2007, ENVIRON EXP BOT, V60, P344, DOI 10.1016/j.envexpbot.2006.12.005; KOSHIBA T, 1993, PLANT CELL PHYSIOL, V34, P713, DOI 10.1093/oxfordjournals.pcp.a078474; Kozlowski T. T., 1984, Flooding and plant growth, P165; Lambers H., 1998, PLANT PHYSL ECOLOGY, P10, DOI [10.1007/978-1-4757-2855-2_2, DOI 10.1007/978-1-4757-2855-2_2]; Leite RMO, 1978, THESIS; Li JM, 2007, TRENDS PLANT SCI, V12, P37, DOI 10.1016/j.tplants.2006.11.002; Lipka V, 2005, CURR OPIN PLANT BIOL, V8, P625, DOI 10.1016/j.pbi.2005.09.006; Liu Y, 2007, ANN BOT-LONDON, V99, P121, DOI 10.1093/aob/mcl230; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDERITZ T, 1981, EUR J BIOCHEM, V119, P115, DOI 10.1111/j.1432-1033.1981.tb05584.x; Martinelli F, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0858-5; Mignolet-Spruyt L, 2016, J EXP BOT, V67, P3831, DOI 10.1093/jxb/erw080; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Murakami R, 2005, FEBS J, V272, P2165, DOI 10.1111/j.1742-4658.2005.04636.x; Nagano S, 2009, PLANT BIOLOGY, V11, P94, DOI 10.1111/j.1438-8677.2009.00253.x; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Onoda Y, 2011, PLANT SIGNAL BEHAV, V6, P1057, DOI 10.4161/psb.6.7.15635; Papini A, 2011, J PHYCOL, V47, P118, DOI 10.1111/j.1529-8817.2010.00935.x; Puijalon S, 2011, NEW PHYTOL, V191, P1141, DOI 10.1111/j.1469-8137.2011.03763.x; Rehem BC, 2011, PHOTOSYNTHETICA, V49, P127, DOI 10.1007/s11099-011-0021-3; RETUERTO R, 1993, OECOLOGIA, V94, P415, DOI 10.1007/BF00317118; SALIN ML, 1991, FREE RADICAL RES COM, V12-3, P851, DOI 10.3109/10715769109145867; Santos I C, 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.0115746; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schymanski SJ, 2016, PLANT CELL ENVIRON, V39, P1448, DOI 10.1111/pce.12700; Shao HB, 2008, INT J BIOL SCI, V4, P8; Sharma P., 2012, J BOT, V2012, P26, DOI [10.1155/2012/217037, DOI 10.1155/2012/217037]; Souza VL, 2014, ENVIRON SCI POLLUT R, V21, P1217, DOI 10.1007/s11356-013-1983-4; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Taiz L., 2013, PLANT PHYSL; Tartachnyk I, 2002, ENVIRON EXP BOT, V48, P169, DOI 10.1016/S0098-8472(02)00022-9; Teixeira FK, 2006, PLANTA, V224, P300, DOI 10.1007/s00425-005-0214-8; THOMPSON JR, 1974, J EXP BOT, V25, P965, DOI 10.1093/jxb/25.5.965; Toth SZ, 2011, PLANT PHYSIOL, V156, P382, DOI 10.1104/pp.110.171918; van Doorn WG, 2011, J EXP BOT, V62, P4749, DOI 10.1093/jxb/err196; Wada H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110374; Wagner D, 2004, SCIENCE, V306, P1183, DOI 10.1126/science.1103178; WILSON J, 1984, ANN BOT-LONDON, V53, P73, DOI 10.1093/oxfordjournals.aob.a086673; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; Yu SW, 2004, ACTA BOT SIN, V46, P127	71	4	4	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198274	10.1371/journal.pone.0198274	http://dx.doi.org/10.1371/journal.pone.0198274			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949591	Green Published, gold, Green Submitted			2022-12-26	WOS:000436549200011
J	Pande, G; Kwesiga, B; Bwire, G; Kalyebi, P; Riolexus, A; Matovu, JKB; Makumbi, F; Mugerwa, S; Musinguzi, J; Wanyenze, RK; Zhu, BP				Pande, Gerald; Kwesiga, Benon; Bwire, Godfrey; Kalyebi, Peter; Riolexus, AlexArio; Matovu, Joseph K. B.; Makumbi, Fredrick; Mugerwa, Shaban; Musinguzi, Joshua; Wanyenze, Rhoda K.; Zhu, Bao-Ping			Cholera outbreak caused by drinking contaminated water from a lakeshore water-collection site, Kasese District, south-western Uganda, June-July 2015	PLOS ONE			English	Article								On 20 June 2015, a cholera outbreak affecting more than 30 people was reported in a fishing village, Katwe, in Kasese District, south-western Uganda. We investigated this outbreak to identify the mode of transmission and to recommend control measures. We defined a suspected case as onset of acute watery diarrhoea between 1 June and 15 July 2015 in a resident of Katwe village; a confirmed case was a suspected case with Vibrio cholerae cultured from stool. For case finding, we reviewed medical records and actively searched for cases in the community. In a case-control investigation we compared exposure histories of 32 suspected case-persons and 128 age-matched controls. We also conducted an environmental assessment on how the exposures had occurred. We found 61 suspected cases (attack rate = 4.9/1000) during this outbreak, of which eight were confirmed. The primary case-person had onset on 16 June; afterwards cases sharply increased, peaked on 19 June, and rapidly declined afterwards. After 22 June, eight scattered cases occurred. The case-control investigation showed that 97% (31/32) of cases and 62% (79/128) of controls usually collected water from inside a water-collection site "X" (ORM-H = 16; 95% CI = 2.4-107). The primary case-person who developed symptoms while fishing, reportedly came ashore in the early morning hours on 17 June, and defecated "near" water-collection site X. We concluded that this cholera outbreak was caused by drinking lake water collected from inside the lakeshore water-collection site X. At our recommendations, the village administration provided water chlorination tablets to the villagers, issued water boiling advisory to the villagers, rigorously disinfected all patients' faeces and, three weeks later, fixed the tap-water system.	[Pande, Gerald; Kwesiga, Benon; Bwire, Godfrey; Riolexus, AlexArio; Matovu, Joseph K. B.; Wanyenze, Rhoda K.] Uganda Publ Hlth Fellowship Program Field Epidemi, Kampala, Uganda; [Pande, Gerald; Kalyebi, Peter; Mugerwa, Shaban; Musinguzi, Joshua] Minist Hlth Uganda, Kampala, Uganda; [Kwesiga, Benon; Riolexus, AlexArio; Matovu, Joseph K. B.; Makumbi, Fredrick; Wanyenze, Rhoda K.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Zhu, Bao-Ping] US Ctr Dis Control & Prevent, Kampala, Uganda; [Zhu, Bao-Ping] US Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA	Makerere University; Centers for Disease Control & Prevention - USA	Pande, G (corresponding author), Uganda Publ Hlth Fellowship Program Field Epidemi, Kampala, Uganda.; Pande, G (corresponding author), Minist Hlth Uganda, Kampala, Uganda.	gpande@musph.ac.ug	Matovu, Joseph/AAO-5790-2020; Bwire, Godfrey/J-7715-2019; Ario, Alex Riolexus/AAE-9387-2019; Kwesiga, Benon/L-5341-2018	Bwire, Godfrey/0000-0002-8376-2857; Zhu, Baoping/0000-0003-0065-0153; Kwesiga, Benon/0000-0003-0400-8635; Matovu, Joseph KB/0000-0001-6480-2940	Cooperative Agreement - Provision of Comprehensive HIV/AIDS services and Developing National Capacity through the United States Centers for Disease Control and Prevention (US CDC) [5U2GGH000817-03]; President's Emergency Plan for AIDS Relief (PEPFAR) grant [GH001353-01]; US Centers for Disease Control and Prevention through Makerere University School of Public Health	Cooperative Agreement - Provision of Comprehensive HIV/AIDS services and Developing National Capacity through the United States Centers for Disease Control and Prevention (US CDC); President's Emergency Plan for AIDS Relief (PEPFAR) grant; US Centers for Disease Control and Prevention through Makerere University School of Public Health	This journal article was supported by Cooperative Agreement - Provision of Comprehensive HIV/AIDS services and Developing National Capacity to manage HIV/AIDS Programs, through the United States Centers for Disease Control and Prevention (US CDC) Cooperative Agreement number 5U2GGH000817-03. This project was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) grant number GH001353-01, funded by the US Centers for Disease Control and Prevention through Makerere University School of Public Health to the Uganda Public Health Fellowship Program, Ministry of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the US Centers for Disease Control and Prevention, the Department of Health and Human Services, Makerere University School of Public Health, or the Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajo Scholastica O, 2006, Afr Health Sci, V6, P93; Boncy J, 2013, DIAGN MICR INFEC DIS, V76, P521, DOI 10.1016/j.diagmicrobio.2013.03.010; Bwire G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005407; Bwire G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002545; Bwire G, 2013, J INFECT DIS, V208, pS78, DOI 10.1093/infdis/jit203; Cummings MJ, 2012, EPIDEMIOL INFECT, V140, P1376, DOI 10.1017/S0950268811001956; de Graaf MA, 2011, NEPHRON CLIN PRACT, V118, pC315, DOI 10.1159/000323136; Fontaine R.E., 2008, FIELD EPIDEMIOLOGY; Global Task Force on Cholera Control, 2013, CHOL OUTBR ASS OUTBR; Griffith DC, 2006, AM J TROP MED HYG, V75, P973, DOI 10.4269/ajtmh.2006.75.973; Heymann D., 2015, CONTROL COMMUNICABLE, V20th; Koo D, 2006, PRINCIPLES EPIDEMIOL; Kothary MH, 2001, J FOOD SAFETY, V21, P49, DOI 10.1111/j.1745-4565.2001.tb00307.x; Kwesiga B, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4589-9; Mara DD, 2003, PUBLIC HEALTH, V117, P452, DOI 10.1016/S0033-3506(03)00143-4; Mengel MA, 2014, CURR TOP MICROBIOL, V379, P117, DOI 10.1007/82_2014_369; Nalini C, 2015, J HLTH POPULATION NU, V33, P1; Nato F, 2003, CLIN DIAGN LAB IMMUN, V10, P476, DOI 10.1128/CDLI.10.3.476-478.2003; Nkoko DB, 2011, EMERG INFECT DIS, V17, P2026, DOI 10.3201/eid1711.110170; Oguttu DW, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0359-2; Poullis Dinos A., 2005, Reviews on Environmental Health, V20, P141; Pun SB, 2011, EMERG INFECT DIS, V17, P2178, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Rafei L., 2016, AFRICAS URBAN POPULA; Taylor DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135676; World Health Organization, 2016, WKLY EPIDEMIOL REC, V92, P521; World Health Organization, 2000, WHO REP GLOB SURV EP; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x	27	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2018	13	6							e0198431	10.1371/journal.pone.0198431	http://dx.doi.org/10.1371/journal.pone.0198431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK9FZ	29949592	Green Submitted, gold, Green Published			2022-12-26	WOS:000436549200016
J	Dong, H; Liu, ZY; Duan, LL; Hu, YH				Dong, Hao; Liu, Zhi-Yu; Duan, Ling-ling; Hu, Ya-hui			Research on the sliding friction associated spur-face gear meshing efficiency based on the loaded tooth contact analysis	PLOS ONE			English	Article							POWER LOSSES; PAIRS; PREDICTION; WINDAGE; SPEED; MODEL; OILS	In order to solve the problem of Meshing Efficiency of spur-face gear sliding friction, a method for calculating the Meshing Efficiency of Spur-Face gear is proposed based on Elas-tohydrodynamic lubrication (EHL) theory. Through the Tooth Contact Analysis (TCA) and Loaded Tooth Contact Analysis technique (LTCA) method, the meshing process of the Spur-Face gear was simulated. The calculation model of Sliding friction coefficient was established by using non Newtonian quasi steady thermal Elastohydrodynamic lubrication (TEHL) theory, and the calculation model of Meshing Efficiency of Spur-Face gear was established. The influence of input torque and rotational speed on Meshing Efficiency is analyzed. The results show that Sliding friction coefficient is an important factor affecting the Meshing Efficiency of gears. Sliding friction coefficient is not the same at different positions of the tooth surface. Sliding friction coefficient is affected by input speed and input torque. This method provides a theoretical basis for further optimization calculation of Spur-Face gear.	[Dong, Hao; Liu, Zhi-Yu; Hu, Ya-hui] Xian Technol Univ, Sch Mechatron Engn, Xian, Shaanxi, Peoples R China; [Duan, Ling-ling] Shaanxi Hualu Chem Green Environm Protect Co Ltd, Xian, Shaanxi, Peoples R China	Xi'an Technological University	Dong, H (corresponding author), Xian Technol Univ, Sch Mechatron Engn, Xian, Shaanxi, Peoples R China.	donghaofane@sina.com	he, liu/V-6567-2019		National Natural Science Foundation of China [51705390]; Xi'an Technological University Research and Innovation Team Program [45465889]; Xi'an Science and Technology Plan Project [2017075CG/RC038(XAGY008)]; Shaanxi Provincial Key Laboratory Project of Science and Technology Innovation Project [2014SZS20-K04]; Natural Science Foundation of Shaanxi Province of China [2018JQ5029]; commercial company; Shaanxi Hualu Chemical Green Environmental Protection Co.Ltd., Xi'an, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xi'an Technological University Research and Innovation Team Program; Xi'an Science and Technology Plan Project; Shaanxi Provincial Key Laboratory Project of Science and Technology Innovation Project; Natural Science Foundation of Shaanxi Province of China(Natural Science Foundation of Shaanxi Province); commercial company; Shaanxi Hualu Chemical Green Environmental Protection Co.Ltd., Xi'an, China	This study was funded by the National Natural Science Foundation of China (grant no. 51705390 to Hao Dong), Xi'an Technological University Research and Innovation Team Program (grant no. 45465889 to Hao Dong), the Xi'an Science and Technology Plan Project (grant no. 2017075CG/RC038(XAGY008) to Hao Dong), the Shaanxi Provincial Key Laboratory Project of Science and Technology Innovation Project (grant no. 2014SZS20-K04 to Hao Dong), and the Natural Science Foundation of Shaanxi Province of China (grant no. 2018JQ5029 to Hao Dong). Duan Ling Ling received support in the form of salary from the commercial company, Shaanxi Hualu Chemical Green Environmental Protection Co.Ltd., Xi'an, China. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Boness R J., 1989, P INT POW TRANSM GEA, P355; Concli F, 2016, TRIBOL INT, V103, P58, DOI 10.1016/j.triboint.2016.06.046; Diab Y, 2004, J MECH DESIGN, V126, P903, DOI 10.1115/1.1767815; Diez-Ibarbia A, 2018, MECH MACH THEORY, V121, P15, DOI 10.1016/j.mechmachtheory.2017.10.003; Kahraman A, 2015, MECH MACH THEORY, V86, P48, DOI 10.1016/j.mechmachtheory.2014.12.003; Kolivand M, 2010, MECH MACH THEORY, V45, P1568, DOI 10.1016/j.mechmachtheory.2010.06.015; Li JY, 2016, ENRGY PROCED, V100, P423, DOI 10.1016/j.egypro.2016.10.197; Li S, 2015, TRIBOL INT, V88, P170, DOI 10.1016/j.triboint.2015.03.022; Marques P, 2017, MECH MACH THEORY, V113, P126, DOI 10.1016/j.mechmachtheory.2017.03.007; Marques PMT, 2016, MECH MACH THEORY, V96, P1, DOI 10.1016/j.mechmachtheory.2015.09.005; Marques PMT, 2014, TRIBOL INT, V71, P7, DOI 10.1016/j.triboint.2013.10.017; Marques PMT, 2013, TRIBOL INT, V62, P186, DOI 10.1016/j.triboint.2013.02.026; Nutakor C, 2017, TRIBOL INT, V105, P42, DOI 10.1016/j.triboint.2016.09.029; Saxena A, 2016, ENG FAIL ANAL, V70, P200, DOI 10.1016/j.engfailanal.2016.09.003; [沈云波 Shen Yunbo], 2009, [机械传动, Journal of Mechanical Transmission], V33, P9; [沈云波 Shen Yunbo], 2009, [机械科学与技术, Mechanical Science and Technology], V28, P1096; Talbot D, 2014, INTERNATIONAL GEAR CONFERENCE 2014, P625; Wang C, 2012, J CENTRAL S U SCI TE, V43, P99; [王文中 Wang Wenzhong], 2011, [摩擦学学报, Tribology], V31, P604; Xu H, 2007, P I MECH ENG K-J MUL, V221, P387, DOI 10.1243/14644193JMBD48; Xu H, 2007, J MECH DESIGN, V129, P58, DOI 10.1115/1.2359478; Xu H, 2005, THESIS; Yang FC, 2015, MECH MACH THEORY, V92, P86, DOI 10.1016/j.mechmachtheory.2015.05.003; Yang P R., 1998, NUMERICAL ANAL FLUID, V48-93, P291; [张靖 Zhang Jing], 2012, [振动与冲击, Journal of Vibration and Shock], V31, P126; Zhang XG, 2017, TRIBOL INT, V114, P201, DOI 10.1016/j.triboint.2017.04.032; Ziegltrum A, 2017, TRIBOL INT, V113, P252, DOI 10.1016/j.triboint.2016.12.018	27	5	5	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0198677	10.1371/journal.pone.0198677	http://dx.doi.org/10.1371/journal.pone.0198677			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK7JR	29944661	Green Published, Green Submitted, gold			2022-12-26	WOS:000436377800013
J	Kimura, M; Yotsumoto, Y				Kimura, Marino; Yotsumoto, Yuko			Auditory traits of "own voice"	PLOS ONE			English	Article							BONE-CONDUCTION; COGNITIVE SCIENCE; SPEECH; PERCEPTION; SELF	People perceive their recorded voice differently from their actively spoken voice. The uncanny valley theory proposes that as an object approaches humanlike characteristics, there is an increase in the sense of familiarity; however, eventually a point is reached where the object becomes strangely similar and makes us feel uneasy. The feeling of discomfort experienced when people hear their recorded voice may correspond to the floor of the proposed uncanny valley. To overcome the feeling of eeriness of own-voice recordings, previous studies have suggested equalization of the recorded voice with various types of filters, such as step, bandpass, and low-pass, yet the effectiveness of these filters has not been evaluated. To address this, the aim of experiment 1 was to identify what type of voice recording was the most representative of one's own voice. The voice recordings were presented in five different conditions: unadjusted recorded voice, step filtered voice, bandpass filtered voice, low-pass filtered voice, and a voice for which the participants freely adjusted the parameters. We found large individual differences in the most representative own-voice filter. In order to consider roles of sense of agency, experiment 2 investigated if lip-synching would influence the rating of own voice. The result suggested lip-synching did not affect own voice ratings. In experiment 3, based on the assumption that the voices used in previous experiments corresponded to continuous representations of non-own voice to own voice, the existence of an uncanny valley was examined. Familiarity, eeriness, and the sense of own voice were rated. The result did not support the existence of an uncanny valley. Taken together, the experiments led us to the following conclusions: there is no general filter that can represent own voice for everyone, sense of agency has no effect on own voice rating, and the uncanny valley does not exist for own voice, specifically.	[Kimura, Marino; Yotsumoto, Yuko] Univ Tokyo, Dept Life Sci, Tokyo, Japan	University of Tokyo	Yotsumoto, Y (corresponding author), Univ Tokyo, Dept Life Sci, Tokyo, Japan.	cyuko@mail.ecc.u-tokyo.ac.jp		Yotsumoto, Yuko/0000-0001-7408-0339	Japan Society for the Promotion of Science [17K18693, 16H03749, 25119003]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/), #17K18693, #16H03749, #25119003 for YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aucouturier JJ, 2016, P NATL ACAD SCI USA, V113, P948, DOI 10.1073/pnas.1506552113; Bachorowski AJ, 2010, VOCAL EXPRESSION PER, V8, P53; Burleigh TJ, 2013, COMPUT HUM BEHAV, V29, P759, DOI 10.1016/j.chb.2012.11.021; Camacho A, 2008, J ACOUST SOC AM, V124, P1638, DOI 10.1121/1.2951592; Decartese R., 2008, DISCOURSE METHOD; Eyssel F, 2012, ACMIEEE INT CONF HUM, P125; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gotoh F, 2001, TSUKUBA PSYCHOL RES, P37, DOI [10.1037/0022-3514.80.2.294, DOI 10.1037/0022-3514.80.2.294]; HAKANSSON B, 1994, J ACOUST SOC AM, V95, P1474, DOI 10.1121/1.408535; Hanson David, 2005, IEEE RAS INT C HUM R; Hooper PG, 1993, J REPROD INFANT PSYC, P11; Kraus MW, 2017, AM PSYCHOL, V72, P644, DOI 10.1037/amp0000147; Latinus M, 2011, CURR BIOL, V21, pR143, DOI 10.1016/j.cub.2010.12.033; MacDorman K, 2006, ICCSCOGSCI 2006 LONG, P26, DOI DOI 10.1093/SCAN/NSR025; MacDorman KF, 2006, INTERACT STUD, V7, P361, DOI 10.1075/is.7.3.10mac; MAURER D, 1990, FOLIA PHONIATR, V42, P226, DOI 10.1159/000266070; OCKLEFORD EM, 1988, EARLY HUM DEV, V18, P27, DOI 10.1016/0378-3782(88)90040-0; Pfordresher PQ, 2007, MUSIC PERCEPT, V25, P95, DOI 10.1525/MP.2007.25.2.95; Purcell DW, 2003, J ACOUST SOC AM, V114, P907, DOI 10.1121/1.1582436; Qin XY, 2017, APPL ACOUST, V126, P19, DOI 10.1016/j.apacoust.2017.05.007; Rachman L, 2018, BEHAV RES METHODS, V50, P323, DOI 10.3758/s13428-017-0873-y; Scherer KR, 2001, J CROSS CULT PSYCHOL, V32, P76, DOI 10.1177/0022022101032001009; Shimokura R, 2004, AURAL CARTILAGE VIBR, P137; Shimokura R, 2014, J ACOUST SOC AM, V135, P1959, DOI 10.1121/1.4868372; Shuster LI, 2003, J COMMUN DISORD, V36, P1, DOI 10.1016/S0021-9924(02)00132-6; Sugimori E, 2013, CONSCIOUS COGN, V22, P360, DOI 10.1016/j.concog.2012.07.010; SUNDBERG J., 1994, STL QPSR, V35, P45; Tamagawa R, 2011, INT J SOC ROBOT, V3, P253, DOI 10.1007/s12369-011-0100-4; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; TONNDORF J, 1968, ARCH OTOLARYNGOL, V87, P595; Valley T.U., 1970, ENERGY, V7, P1; van Rijn RH, 1659, SELF PORTRAIT BERET; van Rijn RH, 1629, SELF PORTRAIT; VONBEKESY G, 1954, J ACOUST SOC AM, V26, P106; Vurma A, 2014, LOGOP PHONIATR VOCO, V39, P1, DOI 10.3109/14015439.2013.775334; Won S. Y., 2014, P INT C MUS PERC COG; Young JZ, 1987, PHILOS BRAIN	37	7	7	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2018	13	6							e0199443	10.1371/journal.pone.0199443	http://dx.doi.org/10.1371/journal.pone.0199443			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK7JR	29944698	gold, Green Submitted, Green Published			2022-12-26	WOS:000436377800034
